data_1cey_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cey _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 62.76 134.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 108.962 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -90.04 17.44 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.982 -1.074 . . . . 0.0 109.78 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 42.88 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.938 -1.101 . . . . 0.0 110.593 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.41 141.91 57.77 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -78.13 131.36 37.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 0.0 111.104 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.67 146.88 47.91 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.827 -0.545 . . . . 0.0 110.259 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 51' ' ' TYR . 60.9 tp -121.78 116.18 24.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.688 -0.632 . . . . 0.0 109.368 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 109.22 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 61.1 t -106.25 26.02 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.713 -0.617 . . . . 0.0 109.672 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 117.66 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.61 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -64.83 -14.41 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.313 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.0 140.86 4.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 p -97.96 47.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.446 -0.784 . . . . 0.0 109.512 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 tpt -61.13 -46.68 89.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.614 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -49.84 -31.69 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.912 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -74.01 -42.08 60.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.732 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.44 -52.73 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.755 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -40.48 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 110.234 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.94 -53.11 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -68.64 -57.74 5.26 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.769 0.795 . . . . 0.0 109.686 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -39.64 -56.53 1.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.663 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.36 -51.17 67.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.095 -1.003 . . . . 0.0 108.757 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -47.76 -40.41 20.63 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.249 -0.907 . . . . 0.0 108.983 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.12 -34.37 73.41 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.416 -0.803 . . . . 0.0 109.308 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.09 4.32 20.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.55 62.53 1.78 Allowed Glycine 0 N--CA 1.482 1.748 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -143.58 126.85 16.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -1.184 . . . . 0.0 109.092 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -133.63 65.32 1.59 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.632 -0.668 . . . . 0.0 109.815 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -172.48 89.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.75 150.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.0 109.938 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -119.17 -177.12 3.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -150.09 155.22 39.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.863 -1.148 . . . . 0.0 110.81 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.6 -165.41 2.22 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 17.1 mt-10 -137.34 -5.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 0.0 110.359 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -177.23 -177.92 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.79 -1.193 . . . . 0.0 109.733 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.63 -52.24 47.57 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.55 -31.85 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.263 . . . . 0.0 108.513 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.63 -47.64 30.94 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.122 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.08 -48.06 82.98 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 109.363 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.09 73.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 5.9 m-20 -81.56 -25.67 35.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -90.25 -23.88 21.1 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' CD2' ' H ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -80.11 -17.27 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.53 -1.356 . . . . 0.0 110.21 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -61.58 -5.94 2.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -52.77 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.019 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.88 11.57 1.67 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.473 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.44 86.21 0.26 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' H ' ' CD2' ' A' ' 46' ' ' LEU . 25.2 m-85 -58.92 157.58 9.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.406 -1.056 . . . . 0.0 110.43 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.73 -9.42 62.72 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 140.47 19.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.676 -0.896 . . . . 0.0 109.133 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.17 120.43 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.0 110.164 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.8 mt -104.08 128.51 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -146.38 147.02 30.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.066 -1.021 . . . . 0.0 109.672 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 58' ' ' TRP . 16.6 t70 -63.84 -120.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.402 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.417 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 61.9 t-105 -161.89 -28.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.782 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -166.64 34.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.633 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.2 -37.22 0.43 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -68.83 -70.65 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.846 1.031 . . . . 0.0 110.152 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.664 HD21 ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -154.81 -81.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.664 ' H ' HD21 ' A' ' 62' ' ' ASN . 3.4 mpp? -76.0 -113.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -142.14 -178.42 5.71 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . -93.79 -17.97 39.43 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.396 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.534 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 1.4 mm? -46.79 -68.98 0.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.687 -1.478 . . . . 0.0 110.042 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -43.57 -41.79 4.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.429 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.96 -42.9 99.96 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.614 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 5.4 tt -82.59 -64.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.877 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -33.75 -41.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.23 0.538 . . . . 0.0 110.144 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.6 m -58.96 -48.03 82.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 108.728 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 57.8 mt -50.76 -45.14 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 108.88 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -65.41 -39.29 91.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.34 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 109.574 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.35 -128.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.361 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 78' ' ' MET . . . 170.16 161.38 20.56 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 76' ' ' GLY . . . 71.79 -14.14 0.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -1.12 . . . . 0.0 109.413 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.513 ' H ' ' C ' ' A' ' 76' ' ' GLY . 2.3 mmt -146.82 17.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 m -68.78 7.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.351 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -93.92 2.7 56.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 109.645 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -43.86 107.59 0.61 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.543 -0.723 . . . . 0.0 109.397 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.58 136.5 58.92 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 120.76 0.973 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.27 129.27 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.64 72.03 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.45 145.53 22.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 t -113.56 129.97 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.533 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 15.3 t -150.13 166.29 30.27 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.114 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.533 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -91.05 147.72 22.88 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 49.33 -152.0 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 176.76 115.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.803 -1.186 . . . . 0.0 110.43 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.63 121.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -43.88 -45.24 7.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.299 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -51.89 -32.81 34.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.58 -41.52 13.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.54 -13.07 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.037 -1.04 . . . . 0.0 109.573 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.2 mt -80.56 -70.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.082 . . . . 0.0 109.885 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.804 . . . . 0.0 109.0 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -61.67 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.604 -0.685 . . . . 0.0 109.762 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -58.45 -34.63 71.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.222 -0.924 . . . . 0.0 109.699 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -50.91 -19.59 1.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 108.871 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -108.45 -115.03 0.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.83 -0.544 . . . . 0.0 109.603 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.742 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -120.67 -0.99 12.11 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -59.18 11.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.903 . . . . 0.0 109.23 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.742 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.2 m -29.2 -31.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.32 133.55 11.72 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.572 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.55 110.64 6.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 9.7 p -112.58 130.79 65.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -157.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.1 152.54 1.88 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.059 -1.026 . . . . 0.0 109.268 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.3 146.4 86.14 Favored 'Cis proline' 0 N--CA 1.487 1.111 0 O-C-N 122.576 0.777 . . . . 0.0 110.512 -2.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -112.97 155.04 25.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.936 0.874 . . . . 0.0 109.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.17 146.88 23.46 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -46.03 -29.66 1.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 0.0 109.387 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.14 -35.1 59.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 112' ' ' THR . 16.2 m -69.07 -60.88 2.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -45.83 -50.71 13.92 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.17 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.06 -32.48 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 115' ' ' THR . 4.5 tp10 -67.76 -43.9 78.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.84 . . . . 0.0 109.973 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -71.28 -51.33 25.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.975 . . . . 0.0 109.922 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tp -50.2 -59.59 3.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.127 -0.983 . . . . 0.0 109.856 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -52.74 -35.92 56.9 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -66.48 -24.58 66.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.83 -47.96 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.954 -1.091 . . . . 0.0 110.175 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -58.71 -12.4 4.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 110.339 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.09 -24.15 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.99 -29.09 16.8 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.35 -24.52 42.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.489 -0.757 . . . . 0.0 109.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.06 81.82 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.257 -1.143 . . . . 0.0 109.558 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.287 0.565 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.512 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.34 141.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -90.59 10.17 26.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.283 -0.886 . . . . 0.0 109.952 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.96 51.42 1.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 46.9 tp -84.17 107.81 16.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -48.5 112.83 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.02 . . . . 0.0 111.705 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 63.0 m-85 -102.6 153.98 19.57 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 tp -131.17 105.61 7.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.344 -0.847 . . . . 0.0 108.884 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.71 108.7 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.073 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 62.4 t -96.0 40.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.824 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -70.6 144.58 51.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -97.53 0.51 47.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.69 143.49 27.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.557 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -85.35 34.27 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -165.33 -8.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -37.55 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.07 -16.08 49.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 108.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -75.07 -42.08 57.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -53.44 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.871 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.57 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 110.2 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.12 -54.71 8.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.761 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.71 -57.77 6.45 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.981 0.896 . . . . 0.0 109.315 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.27 -64.59 0.53 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.436 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.1 -44.51 52.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 108.76 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -52.02 -48.01 64.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.356 -0.84 . . . . 0.0 109.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -23.47 63.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.478 -0.764 . . . . 0.0 109.291 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.1 mt -89.51 3.58 51.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.1 59.41 2.43 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 52.8 m-85 -148.33 142.82 26.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.291 . . . . 0.0 109.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -150.1 27.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.178 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -135.0 99.43 4.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.196 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.3 179.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.149 -0.969 . . . . 0.0 109.599 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.429 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 11.1 mt-10 -138.7 -174.28 3.79 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.91 157.27 46.33 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.794 0.807 . . . . 0.0 110.826 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.97 -174.26 4.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.9 pt-20 -148.77 13.56 0.91 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.912 -1.118 . . . . 0.0 110.226 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 178.16 -179.9 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.954 -1.091 . . . . 0.0 109.131 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.28 -39.55 61.96 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.1 -30.9 46.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.125 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -81.18 -46.09 15.38 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.507 -0.745 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.33 92.57 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.75 -58.04 7.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.061 -1.024 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -54.75 -29.06 52.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 110.072 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -90.13 -31.02 17.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.126 -0.984 . . . . 0.0 110.622 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.93 -41.01 67.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.037 -1.039 . . . . 0.0 109.712 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.7 -11.77 59.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.903 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.81 -65.21 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.4 7.65 1.81 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.43 87.04 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.48 ' C ' ' H ' ' A' ' 53' ' ' PHE . 61.3 m-85 -67.81 110.45 3.81 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.327 -1.102 . . . . 0.0 110.076 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.65 -10.1 2.02 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.75 126.78 11.22 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.195 -1.179 . . . . 0.0 110.289 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.92 120.24 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.9 mt -103.61 123.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -139.27 168.38 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.737 . . . . 0.0 109.095 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 9.8 t70 -84.47 -97.01 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 74.9 t-105 -172.4 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.506 ' N ' ' CD1' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -91.48 126.79 36.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.457 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.2 mtp 176.62 -50.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.0 Cg_exo -64.19 -168.87 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.815 1.01 . . . . 0.0 110.113 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.589 HD21 ' H ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -47.61 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 0.0 109.452 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.589 ' H ' HD21 ' A' ' 62' ' ' ASN . 21.6 mmt -69.76 -117.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -144.64 147.73 33.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.119 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.04 -8.6 3.27 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -74.71 -63.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.943 -1.328 . . . . 0.0 108.817 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.0 mm-40 -52.71 -25.78 12.05 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.66 -33.64 71.17 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' LEU . 18.0 tp -86.55 -58.26 2.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -43.26 -47.2 6.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.852 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 27.0 m -51.41 -47.36 63.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 108.99 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.52 -38.47 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 108.924 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -83.94 -20.7 32.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.1 -28.96 43.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -52.27 -70.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.62 -63.39 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.8 -26.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -1.115 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -90.11 -40.88 11.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' MET . 0.3 OUTLIER 75.78 -59.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.16 -54.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.653 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 80' ' ' ALA . 13.3 tp 59.3 120.3 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.85 131.76 43.83 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 120.606 0.87 . . . . 0.0 112.293 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -126.73 127.6 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.7 69.48 0.72 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.462 ' O ' ' CG ' ' A' ' 85' ' ' MET . 5.9 ptt? -61.33 123.62 18.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.83 127.13 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.02 . . . . 0.0 109.511 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.8 t -150.05 136.94 19.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.566 -1.334 . . . . 0.0 110.456 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.04 -14.34 34.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.288 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -102.94 34.52 2.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.458 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -62.58 114.19 3.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.513 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.65 -125.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -0.801 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 94' ' ' ASN . 18.6 tttm -117.17 -89.46 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.651 . . . . 0.0 109.816 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -18.74 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.054 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.477 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -70.68 -35.31 72.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.2 mt -85.25 -28.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.811 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -73.27 -60.75 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.019 -1.051 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.61 -43.26 12.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.249 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.54 73.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.34 50.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.94 -1.1 . . . . 0.0 109.721 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -56.76 -24.03 47.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.9 -103.9 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.717 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -135.89 -0.64 3.13 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -58.18 11.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.828 -0.807 . . . . 0.0 110.913 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 102' ' ' GLY . 49.1 m -29.4 -31.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.65 132.72 11.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -146.26 117.04 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -1.163 . . . . 0.0 109.446 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.57 139.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.4 103.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.76 -1.213 . . . . 0.0 108.337 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -71.72 155.33 92.43 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.873 -1.142 . . . . 0.0 109.38 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.33 168.64 75.49 Favored 'Cis proline' 0 N--CA 1.486 1.04 0 C-N-CA 124.811 -0.912 . . . . 0.0 110.234 -2.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -144.14 157.84 44.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -101.1 149.57 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.12 -32.15 4.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.254 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.62 82.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 5.7 m -69.23 -69.44 0.34 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.4 tp -43.9 -37.5 2.89 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.577 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.07 -59.4 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.24 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.38 -40.11 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.626 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -59.94 -55.35 35.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 123' ' ' ILE . 10.6 mt -50.07 -72.66 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -38.96 -44.42 1.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.486 -0.759 . . . . 0.0 111.851 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -66.5 -31.35 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.942 -1.099 . . . . 0.0 110.372 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 125' ' ' GLU . 18.6 mt -89.97 -40.26 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.092 -1.005 . . . . 0.0 111.075 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -62.16 0.97 0.35 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.059 -1.026 . . . . 0.0 110.558 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.9 mt-10 -77.06 -25.39 52.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -91.44 -29.52 17.0 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -29.62 63.08 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.55 80.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.127 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 2' ' ' ALA . 34.6 t70 -43.68 146.44 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.776 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.03 14.05 13.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.071 -1.018 . . . . 0.0 108.674 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 29.1 mp0 -147.24 50.38 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 29.3 tp -78.72 118.44 20.8 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.615 -1.303 . . . . 0.0 108.858 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 118.79 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.141 -0.974 . . . . 0.0 111.418 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 60.5 m-85 -113.44 151.57 31.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.82 102.94 6.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.53 116.86 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.251 -0.905 . . . . 0.0 109.258 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.37 129.49 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.522 -0.737 . . . . 0.0 110.368 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -165.42 -167.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 13' ' ' ASP . 7.8 t70 -148.5 13.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 0.0 109.729 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -74.88 -18.7 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.783 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.07 2.9 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.321 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -150.69 -22.01 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.865 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -26.96 66.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -40.81 97.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -64.19 -23.93 67.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.55 -52.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.514 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.05 -35.27 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 109.955 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.03 -56.69 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.24 -56.61 19.49 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.953 0.882 . . . . 0.0 109.042 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ASN . 2.9 tt -37.73 -51.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.07 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.9 mt -58.65 -52.27 66.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 108.593 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -52.6 -46.06 66.8 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.383 -0.823 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.22 -25.6 14.72 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.3 -64.57 1.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.557 -0.715 . . . . 0.0 109.134 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.96 67.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -149.96 155.38 39.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.98 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.09 61.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.918 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.89 99.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -0.943 . . . . 0.0 108.545 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.17 149.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 110.701 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -122.02 -169.38 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -147.33 152.87 38.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.07 167.82 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 5.8 mt-10 -99.94 -2.48 34.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -0.902 . . . . 0.0 110.489 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER 169.12 -179.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.917 -1.114 . . . . 0.0 109.628 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.25 76.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.19 -40.29 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.302 . . . . 0.0 108.789 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.56 -42.13 83.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.59 -0.694 . . . . 0.0 109.199 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.36 -57.13 8.12 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.363 -0.835 . . . . 0.0 109.409 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' ALA . 53.5 tp -41.95 -43.03 2.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 110.02 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.34 -34.92 70.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 0.0 109.892 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -89.99 -14.04 34.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.173 -0.954 . . . . 0.0 110.625 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -64.55 -18.05 64.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.027 . . . . 0.0 108.569 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -85.89 -3.02 58.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.536 -0.727 . . . . 0.0 109.264 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.62 -73.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.5 8.46 1.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 71.77 1.25 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.0 m-85 -47.87 113.52 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -1.036 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.3 -3.67 3.06 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.6 t80 -166.39 141.25 4.41 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.024 -1.28 . . . . 0.0 109.974 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 t -137.52 108.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 110.509 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.01 78.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 p -88.0 154.4 20.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.039 -1.038 . . . . 0.0 110.65 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.87 167.67 9.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -61.85 88.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -60.77 125.32 23.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.132 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.653 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 22.8 ttp -131.73 30.89 0.2 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.642 -0.661 . . . . 0.0 112.467 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -57.75 -59.06 0.62 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 N-CA-C 108.788 -1.274 . . . . 0.0 108.788 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -159.04 -28.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.458 ' O ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -175.52 108.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -177.05 -172.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.954 -1.091 . . . . 0.0 110.077 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.63 -71.97 1.8 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' C ' ' N ' ' A' ' 68' ' ' LEU . 1.1 mm? -65.97 -65.06 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.007 -1.29 . . . . 0.0 108.57 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 73.7 tt0 -49.81 -19.91 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' N ' ' C ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 72' ' ' ILE . 2.0 tt -45.94 -63.18 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 109.067 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -42.72 -50.23 5.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LEU . 54.1 mt -73.59 -23.31 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.08 -29.55 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.611 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.76 -28.13 1.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.506 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -47.29 126.7 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.28 -34.25 5.93 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -89.97 -46.69 8.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.4 t 45.8 19.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.22 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -140.93 2.34 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.695 . . . . 0.0 109.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.463 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 2.5 tp -47.32 110.48 1.33 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.046 -1.034 . . . . 0.0 108.53 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.19 113.81 1.83 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 121.196 1.264 . . . . 0.0 112.976 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.523 ' N ' ' OG ' ' A' ' 104' ' ' SER . 1.2 t -113.83 117.89 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.11 105.31 17.43 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.292 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 tpt -76.14 99.47 4.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.168 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.4 150.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.855 -1.153 . . . . 0.0 110.389 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.3 t -150.25 -179.81 7.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 109.878 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.35 -73.28 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.41 54.66 1.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.34 107.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 177.78 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 108.9 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -75.07 -34.84 61.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.06 -34.41 17.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.214 -0.929 . . . . 0.0 110.224 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.86 -24.47 63.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.047 -1.033 . . . . 0.0 109.958 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.0 mt -72.6 -36.21 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.033 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -80.95 -14.55 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.268 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.6 77.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.39 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.16 -58.98 6.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 108.849 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.7 -25.22 53.74 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.056 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.34 -32.26 37.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.07 -28.2 24.24 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 76.44 67.39 1.69 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.947 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.18 -111.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 117.103 -1.839 . . . . 0.0 110.368 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 50.0 m -91.46 -51.43 5.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.201 1.477 . . . . 0.0 107.554 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.77 -157.58 30.05 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.96 151.93 49.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -1.153 . . . . 0.0 109.244 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.472 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 8.5 p -147.15 124.74 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.189 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.88 162.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 108.828 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 pttt -135.65 159.5 71.2 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.329 -0.857 . . . . 0.0 108.747 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.34 132.88 29.01 Favored 'Cis proline' 0 C--N 1.32 -0.969 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.44 -2.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -93.42 158.37 15.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.157 -0.965 . . . . 0.0 109.417 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -89.88 147.39 23.78 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.61 -36.97 11.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.96 -1.088 . . . . 0.0 109.064 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 -33.11 74.4 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.252 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' THR . 10.8 m -71.74 -65.79 0.72 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -48.91 -38.74 23.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.343 -1.343 . . . . 0.0 108.637 179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.44 -48.38 79.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -45.79 -43.17 12.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -78.62 -34.51 46.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 109.762 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -35.61 81.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.94 -35.36 59.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 109.944 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -31.03 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.3 mt -77.7 -35.03 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -86.55 0.51 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -77.71 -26.72 50.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -96.43 -22.31 17.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.21 -24.97 22.0 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 85.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.215 -1.167 . . . . 0.0 109.501 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.84 128.54 11.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 108.742 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.71 30.95 0.87 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.999 -1.063 . . . . 0.0 109.459 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -148.39 38.14 0.86 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -75.31 141.35 43.4 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.662 ' HZ2' ' ND2' ' A' ' 32' ' ' ASN . 11.0 mttm -81.6 131.63 35.28 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.105 -0.997 . . . . 0.0 110.971 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 38.4 m-85 -119.56 148.11 43.69 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.789 -0.57 . . . . 0.0 110.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.2 tp -121.71 112.42 18.39 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.97 98.87 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.55 -0.719 . . . . 0.0 110.022 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 3.8 t -95.16 116.95 37.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 173.29 152.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.608 -1.308 . . . . 0.0 111.331 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 15' ' ' SER . 3.0 t0 -81.94 52.15 1.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -13.25 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.652 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 1.6 p 57.38 2.22 0.13 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.357 -1.465 . . . . 0.0 108.09 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.646 ' H ' ' C ' ' A' ' 14' ' ' PHE . 17.0 p 130.59 26.0 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.594 1.157 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' ARG . 30.1 tpp -92.19 -66.6 0.91 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -33.47 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.91 -39.05 61.65 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.123 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 mt -66.37 -53.34 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.074 -1.016 . . . . 0.0 109.358 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -30.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 110.232 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -53.61 26.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.437 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.731 0.777 . . . . 0.0 109.99 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -40.85 -49.18 3.18 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.933 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -63.54 -53.63 48.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.941 -1.099 . . . . 0.0 108.841 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -54.22 -28.89 44.08 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.205 -0.934 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -35.72 72.44 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.21 -57.78 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.51 74.4 0.02 OUTLIER Glycine 0 N--CA 1.48 1.604 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -150.12 139.17 21.09 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.434 . . . . 0.0 109.045 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -146.57 64.25 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -0.99 . . . . 0.0 109.921 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.662 ' ND2' ' HZ2' ' A' ' 7' ' ' LYS . 10.8 t-20 -173.63 96.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 108.866 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.02 148.44 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.039 -1.038 . . . . 0.0 110.367 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 11.9 mt-10 -122.48 -166.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -150.2 158.65 44.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.529 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.13 -166.63 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.94 13.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 0.0 111.636 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 1.7 t0 -178.85 151.24 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.6 -1.313 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.41 -52.98 12.92 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.52 -31.55 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.262 -1.14 . . . . 0.0 108.579 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 t0 -71.89 -45.0 62.81 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.164 -0.96 . . . . 0.0 108.894 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -58.46 -58.12 9.95 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.396 -0.815 . . . . 0.0 109.39 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.37 -42.65 15.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 110.034 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -78.43 -32.23 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -90.08 -7.01 54.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.774 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -77.72 -16.06 58.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.569 -1.332 . . . . 0.0 108.892 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -78.55 -0.4 29.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.246 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.34 -61.09 1.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.72 15.75 0.46 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.82 102.81 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' OH ' ' CG ' ' A' ' 34' ' ' GLU . 46.5 m-85 -85.81 142.68 28.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -1.162 . . . . 0.0 110.235 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.17 -7.46 54.77 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -152.78 136.96 16.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.29 116.78 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.625 -1.297 . . . . 0.0 110.484 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -97.87 116.08 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.66 134.73 30.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 108.99 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.76 -177.62 1.31 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.161 -0.962 . . . . 0.0 109.479 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 33.4 t-105 -67.47 -143.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.002 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 60' ' ' MET . 3.0 t30 -91.82 165.03 13.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.552 ' N ' ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER 179.03 -50.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.737 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -64.73 -77.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 120.779 0.986 . . . . 0.0 110.024 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.11 109.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 108.876 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 48.88 86.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.883 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.4 m-20 -163.71 -167.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . 58.73 -76.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -59.03 -71.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.889 -1.359 . . . . 0.0 109.302 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -53.1 -38.77 62.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.955 -1.091 . . . . 0.0 108.853 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HB3' ' N ' ' A' ' 65' ' ' GLY . 1.1 tp -54.23 -47.18 72.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD22 ' H ' ' A' ' 103' ' ' ALA . 39.0 tp -65.7 -62.13 1.69 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 21.0 tttm -41.83 -45.97 3.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -53.41 -44.27 68.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.024 . . . . 0.0 109.168 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 -37.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.054 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -2.16 44.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 109.574 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.65 -28.54 16.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -63.57 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.44 -25.19 20.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.66 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -1.134 . . . . 0.0 109.351 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.3 ttm -90.11 -31.64 17.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.91 . . . . 0.0 109.218 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.03 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.839 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.95 9.27 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.946 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.92 110.54 1.42 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.296 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.86 125.63 18.79 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 120.961 1.107 . . . . 0.0 112.394 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.5 124.44 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.7 77.2 1.86 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.482 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 155.51 13.45 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.28 132.54 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 t -150.1 -176.9 5.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.761 -1.212 . . . . 0.0 109.975 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.7 -49.47 2.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.605 -0.684 . . . . 0.0 109.771 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -78.43 -69.75 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 89' ' ' GLU . . . 70.64 68.08 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.251 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -61.68 -151.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.021 . . . . 0.0 109.899 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 13.3 mttt -97.39 -86.61 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.807 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' OE2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -47.65 -10.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.391 -0.818 . . . . 0.0 110.42 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.628 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -79.98 -33.4 39.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 0.0 109.512 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.0 mt -86.78 -9.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.45 -63.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.992 . . . . 0.0 109.859 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.31 -38.85 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.446 -0.784 . . . . 0.0 109.388 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.09 51.25 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.31 -51.37 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.971 . . . . 0.0 110.558 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -10.57 48.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.768 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.58 -33.69 12.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.196 -0.94 . . . . 0.0 110.891 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.69 -15.01 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.89 11.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.981 -0.717 . . . . 0.0 110.816 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.67 ' H ' ' C ' ' A' ' 102' ' ' GLY . 71.6 m -29.38 -32.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 122.181 -0.324 . . . . 0.0 111.452 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.97 122.99 7.49 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -141.52 128.74 20.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -1.012 . . . . 0.0 108.574 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.436 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.0 p -134.95 129.57 51.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -60.14 -165.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 150.91 5.62 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.452 -1.405 . . . . 0.0 109.779 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.62 155.36 99.79 Favored 'Cis proline' 0 N--CA 1.488 1.148 0 C-N-CA 125.275 -0.719 . . . . 0.0 110.621 -1.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.409 ' CE1' ' CD1' ' A' ' 116' ' ' LEU . 3.1 p90 -121.43 155.74 34.22 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.856 0.836 . . . . 0.0 109.803 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.414 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.9 150.8 22.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.87 -38.43 22.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.762 -1.211 . . . . 0.0 109.445 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.85 76.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 108.236 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.414 ' HB ' ' H ' ' A' ' 112' ' ' THR . 17.2 m -67.94 -65.26 0.71 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' CD1' ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.03 -45.39 31.97 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.795 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.83 -56.09 16.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.965 -1.084 . . . . 0.0 109.809 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -46.41 -40.17 11.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.459 -0.776 . . . . 0.0 110.029 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.53 -60.52 2.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tp -45.22 -58.99 2.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.45 -37.18 56.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.977 . . . . 0.0 109.95 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -30.1 68.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.741 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.89 -53.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -57.46 -10.01 1.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.175 -0.953 . . . . 0.0 110.077 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -73.32 -31.16 63.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -91.64 -28.25 17.61 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.86 -28.3 44.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.26 86.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.285 -1.127 . . . . 0.0 109.359 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.27 146.05 1.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -89.97 22.15 3.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -155.26 42.59 0.45 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 29.6 tp -71.2 119.67 15.67 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -61.84 128.37 35.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.496 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.0 m-85 -115.47 156.18 26.13 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.509 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.19 101.13 4.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 10' ' ' VAL . 5.0 m -92.17 116.65 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.394 -0.816 . . . . 0.0 109.867 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 t -95.49 93.78 3.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.354 -0.841 . . . . 0.0 109.414 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.58 121.7 26.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.739 . . . . 0.0 109.493 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -23.46 67.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 109.548 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.28 145.68 31.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.562 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.2 t -94.81 21.54 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -154.2 -7.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.2 ttt -65.5 -35.25 80.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.178 -0.951 . . . . 0.0 109.228 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.557 ' CD ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -48.74 -44.67 38.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.0 109.454 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -33.4 53.55 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.41 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.18 -54.91 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.028 -1.045 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -32.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.327 -0.858 . . . . 0.0 111.174 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -55.04 27.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 0.0 109.174 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -64.33 -57.44 9.36 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.707 0.765 . . . . 0.0 109.329 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -39.74 -58.6 1.31 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.775 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 mt -56.08 -50.53 70.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -29.36 63.7 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.186 -0.946 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.6 -36.93 72.39 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mt -81.15 -59.79 2.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.4 58.24 0.01 OUTLIER Glycine 0 N--CA 1.481 1.685 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -138.13 149.55 46.01 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.273 -1.134 . . . . 0.0 109.181 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.546 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.91 69.17 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.293 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.4 96.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.204 -0.935 . . . . 0.0 108.677 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -150.12 149.73 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.088 . . . . 0.0 110.565 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -121.36 -170.78 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 10.3 mp0 -143.67 153.63 42.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.8 -169.18 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -124.99 -2.18 7.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.501 -0.75 . . . . 0.0 110.742 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.73 -179.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.849 -1.157 . . . . 0.0 109.542 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.0 95.65 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.23 -42.92 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.301 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.53 -42.96 81.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 108.705 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -61.97 -58.17 8.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 0.0 109.07 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -46.37 -33.38 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -85.16 -31.32 23.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -89.95 -6.15 55.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.115 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -88.32 -26.51 22.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.975 -1.078 . . . . 0.0 108.483 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -57.66 -10.38 1.56 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.0 108.644 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.0 -68.75 0.17 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.547 -0.721 . . . . 0.0 109.222 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.53 -96.28 0.36 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.31 67.31 0.3 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' PHE . 22.0 m-85 -44.49 96.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.69 -0.888 . . . . 0.0 109.867 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -50.61 -10.32 0.36 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -157.57 141.11 15.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -1.182 . . . . 0.0 110.467 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.86 107.37 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.88 80.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.99 165.66 16.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.335 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.1 m-20 -97.73 -137.94 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.609 -0.682 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.669 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 49.7 t-105 -172.33 95.86 0.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 109.299 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -157.37 -157.66 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 109.043 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.4 mmt -142.7 50.91 1.64 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 111.66 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.4 Cg_endo -59.96 -25.6 80.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.962 -1.592 . . . . 0.0 107.962 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -173.39 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.4 mtt -158.48 143.63 16.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -87.88 166.27 14.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.752 -1.218 . . . . 0.0 110.047 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.38 -5.48 77.54 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 68' ' ' LEU . 53.1 tp -57.82 -64.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.256 . . . . 0.0 109.17 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -47.61 -15.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.096 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LEU . 6.1 tp -76.17 -57.18 4.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.812 . . . . 0.0 109.305 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -33.1 68.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.203 -0.936 . . . . 0.0 109.329 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -62.83 -67.41 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 m -48.46 -30.04 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 72' ' ' ILE . 11.7 mt -72.43 -40.28 63.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.266 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' CA ' ' HE ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -84.21 -17.19 40.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.453 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.78 -28.55 9.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.94 -138.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.383 -0.823 . . . . 0.0 109.322 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -136.54 -123.63 2.28 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.77 22.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.536 ' H ' ' C ' ' A' ' 76' ' ' GLY . 37.0 mtt -150.15 57.7 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 108.717 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 78' ' ' MET . 92.1 p -55.23 -113.13 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.35 58.42 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.0 109.387 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ALA . 12.3 mt 58.58 154.42 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.831 -0.543 . . . . 0.0 109.967 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.29 144.56 17.17 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.565 2.176 . . . . 0.0 114.897 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.446 ' O ' ' OG ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -129.83 122.18 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.58 107.74 19.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.77 98.3 6.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.401 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.92 158.4 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.76 -1.212 . . . . 0.0 109.791 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -150.07 159.26 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.67 -4.48 33.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' LYS . 1.4 tt0 -145.75 54.47 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.46 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 89' ' ' GLU . 24.1 tttm -76.16 -72.24 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.659 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -177.64 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.885 . . . . 0.0 109.336 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.38 -38.91 63.8 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.669 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 4.3 m-20 -69.04 -29.75 67.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.928 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.7 mt -67.89 -57.25 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 108.868 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -63.73 -18.94 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.394 -0.816 . . . . 0.0 109.205 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.38 -60.58 3.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.04 -54.23 42.15 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.11 -25.13 65.21 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.682 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.2 tp-100 -53.13 -31.15 40.72 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.26 -22.1 22.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.6 76.91 0.32 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.759 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.86 -111.89 0.08 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.088 -1.845 . . . . 0.0 109.795 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.453 ' HG ' ' H ' ' A' ' 105' ' ' GLY . 10.1 p -91.59 -50.78 5.59 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.786 1.279 . . . . 0.0 108.536 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.453 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . 165.83 -166.55 38.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.41 148.58 43.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.277 -1.131 . . . . 0.0 109.984 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.438 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 11.6 p -141.21 126.8 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 9.8 p -74.96 108.75 6.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.955 . . . . 0.0 110.06 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 163.78 48.08 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.2 125.81 10.48 Favored 'Cis proline' 0 N--CA 1.485 0.999 0 C-N-CA 125.121 -0.783 . . . . 0.0 110.842 -1.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.44 154.85 17.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.525 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.89 151.89 21.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.64 -31.51 4.67 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.938 -1.101 . . . . 0.0 109.432 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.05 82.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.043 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.31 -66.67 0.57 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.995 -1.066 . . . . 0.0 108.336 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.84 -35.75 33.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.567 -1.333 . . . . 0.0 109.557 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -70.65 -67.92 0.47 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.827 -1.171 . . . . 0.0 109.768 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -42.84 -29.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.711 -0.618 . . . . 0.0 109.385 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -78.7 -43.69 25.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.02 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -57.19 -66.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 0.0 109.947 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -40.2 -52.38 2.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.558 -0.714 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -60.39 -28.6 68.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 110.557 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.98 -38.5 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.0 110.402 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -76.53 -42.7 42.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 110.669 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -50.32 -23.09 2.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.899 -1.126 . . . . 0.0 108.207 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -92.77 -25.12 18.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' PHE . 2.1 tp -73.46 -26.14 60.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.01 -42.83 1.03 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 129' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.265 -1.138 . . . . 0.0 109.441 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.535 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER 63.88 130.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.027 . . . . 0.0 108.9 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -90.42 7.71 37.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.899 -1.126 . . . . 0.0 109.996 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.38 45.73 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.987 -1.07 . . . . 0.0 111.22 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.31 138.5 38.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.38 122.87 26.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.956 -1.09 . . . . 0.0 111.972 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.71 149.32 33.09 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.16 107.13 10.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.36 131.53 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.961 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.487 ' C ' ' H ' ' A' ' 13' ' ' ASP . 9.8 t -138.43 38.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.392 -0.817 . . . . 0.0 109.216 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -76.35 22.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.14 -0.975 . . . . 0.0 109.36 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER 47.82 -124.3 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.132 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 46.52 -168.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.33 -9.41 1.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.731 . . . . 0.0 109.052 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.66 -13.98 5.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 8.4 ttt -64.27 -49.48 71.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.483 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -45.48 16.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -52.23 -49.74 63.38 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.482 -0.761 . . . . 0.0 110.266 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -50.2 -55.56 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.952 . . . . 0.0 110.207 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -38.15 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 110.892 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.34 -58.28 4.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 109.521 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -62.53 -55.46 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.804 0.811 . . . . 0.0 109.495 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.09 -48.47 2.48 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.6 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.46 -49.37 71.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -48.87 -38.64 23.04 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.324 -0.86 . . . . 0.0 108.828 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -35.06 73.12 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 108.807 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.33 -3.47 33.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.472 -0.768 . . . . 0.0 109.053 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.65 33.25 16.65 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 26.2 m-85 -105.4 142.86 34.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.462 -1.022 . . . . 0.0 109.264 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -141.78 62.94 1.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.01 93.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.915 -1.116 . . . . 0.0 109.249 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.1 150.75 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 0.0 110.271 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.45 -170.5 2.19 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -147.32 157.84 43.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.049 -1.032 . . . . 0.0 110.918 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.57 -167.62 2.3 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.92 3.48 3.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.197 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.1 -179.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 109.63 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -39.79 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -1.085 . . . . 0.0 109.321 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -46.67 56.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.847 . . . . 0.0 109.065 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -59.04 -57.12 14.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.486 -0.758 . . . . 0.0 109.65 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 mt -46.46 -47.83 19.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 109.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.954 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.87 9.73 26.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.161 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -85.25 -36.9 20.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 109.053 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.07 -1.28 31.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.23 -58.64 3.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.85 9.8 1.37 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.03 94.9 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 31.6 m-85 -80.48 142.64 34.05 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.227 -1.161 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.54 6.22 65.19 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.07 142.71 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.616 -0.932 . . . . 0.0 108.618 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.4 t -141.75 121.19 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.75 -1.219 . . . . 0.0 110.075 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -107.91 132.04 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 p -151.4 145.63 25.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 0.0 109.421 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.8 p-10 -47.79 -80.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.529 ' CH2' ' OD1' ' A' ' 94' ' ' ASN . 28.0 t-105 -177.34 -68.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 59' ' ' ASN . 43.4 p-10 -170.54 53.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.948 -1.095 . . . . 0.0 109.742 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.524 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -60.65 -47.59 95.58 Favored Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.09 -1.006 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -65.62 -73.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.038 1.158 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.613 HD21 ' N ' ' A' ' 63' ' ' MET . 0.2 OUTLIER 179.32 -106.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.039 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.613 ' N ' HD21 ' A' ' 62' ' ' ASN . 1.1 mtp -70.99 73.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.956 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -150.62 162.49 40.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . 74.16 -66.93 1.83 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' LEU . 52.2 tp -68.68 -73.0 0.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.572 -1.546 . . . . 0.0 109.024 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.3 tp10 -46.9 -32.9 4.11 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.74 -41.13 88.36 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' LEU . 40.7 tp -76.66 -62.38 1.65 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.497 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' LEU . 12.8 ttmt -42.96 -35.48 1.24 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.323 -0.861 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.3 m -71.57 -34.94 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 43.3 mt -64.51 -26.15 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.214 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.06 -40.58 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.773 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.03 -28.57 1.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.24 162.14 6.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.621 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -109.79 22.4 23.81 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.72 0.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -125.06 16.2 8.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.2 t -72.87 16.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -129.31 35.9 4.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.546 -0.721 . . . . 0.0 109.288 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -110.83 99.82 43.71 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.68 147.85 93.47 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 112.624 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.23 129.5 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.6 tp -111.66 70.89 0.72 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.91 167.13 3.01 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.16 137.56 13.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.801 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -150.36 171.06 17.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.02 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.02 131.0 48.72 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 50.83 75.31 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.007 -1.058 . . . . 0.0 108.581 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -44.04 138.08 3.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.757 . . . . 0.0 110.299 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 10.4 ttpt -71.67 -6.02 38.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 0.0 109.486 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 2.6 tttm 74.79 -73.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.81 . . . . 0.0 109.683 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.33 -11.53 0.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.041 -1.037 . . . . 0.0 109.838 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.529 ' OD1' ' CH2' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -89.87 -51.49 5.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.89 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mm -46.04 -46.77 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.77 -65.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.962 -1.086 . . . . 0.0 109.509 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.49 -60.08 2.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 108.743 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -44.6 -44.04 8.58 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.597 . . . . 0.0 109.82 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 101' ' ' ALA . . . -60.81 -48.15 83.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.992 -1.067 . . . . 0.0 110.246 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -54.24 -11.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 109.437 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . -103.04 -110.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.593 -0.692 . . . . 0.0 110.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -132.96 -2.16 3.89 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -60.69 11.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.001 -0.705 . . . . 0.0 110.682 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -29.42 -30.56 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -176.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.24 128.23 9.14 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.124 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.64 117.82 7.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -1.137 . . . . 0.0 109.563 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.13 143.41 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.6 107.29 17.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.345 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 159.48 68.19 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.675 -1.265 . . . . 0.0 108.963 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.69 164.39 88.14 Favored 'Cis proline' 0 N--CA 1.487 1.139 0 C-N-CA 124.775 -0.927 . . . . 0.0 110.738 -1.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -144.57 152.99 41.34 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.097 0.951 . . . . 0.0 109.932 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.1 149.79 22.68 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.5 -37.95 12.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.982 -1.074 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.57 -33.52 75.85 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' THR . 88.9 m -72.57 -68.37 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 115' ' ' THR . 8.3 tp -43.87 -37.69 2.96 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.255 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp10 -56.33 -65.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -42.27 -53.67 4.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.323 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -57.2 -52.25 66.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -61.27 2.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -49.52 -36.47 23.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.799 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -28.88 70.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.459 ' C ' ' H ' ' A' ' 125' ' ' GLU . 13.0 mt -80.01 -48.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.019 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -55.17 -6.74 0.16 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 123' ' ' ILE . 1.5 mt-10 -70.31 -27.97 64.81 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -89.35 -26.06 21.28 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.25 -26.08 42.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.816 . . . . 0.0 108.842 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.9 81.7 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -1.149 . . . . 0.0 109.491 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 5' ' ' GLU . 5.0 t70 51.58 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -71.98 34.39 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.576 -1.328 . . . . 0.0 110.04 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 3' ' ' ASP . 46.2 mt-10 -150.37 32.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.91 142.5 57.87 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 108.715 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.42 122.93 28.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.084 -1.01 . . . . 0.0 112.181 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -113.71 154.6 27.04 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 tp -130.43 99.84 5.15 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 10' ' ' VAL . 10.7 m -89.89 107.19 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.078 -1.014 . . . . 0.0 109.833 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.433 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 58.4 t -96.89 65.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 3.6 p30 -89.1 -139.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 108.927 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 31.3 t0 -172.13 -33.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.82 156.51 8.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.746 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.2 t -91.02 39.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -175.17 3.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.3 ttm -84.01 -33.41 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.232 -0.917 . . . . 0.0 109.301 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.631 ' CD ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.12 -48.62 70.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -55.88 -28.84 58.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.038 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -67.61 -55.3 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.693 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -34.88 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.502 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -55.13 18.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.857 -1.152 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.6 t30 -58.09 -58.6 7.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.98 0.895 . . . . 0.0 108.73 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 2.2 tt -40.22 -62.55 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.907 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -52.85 -45.02 67.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.207 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -55.18 -43.13 74.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.393 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -19.34 21.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.88 -7.04 25.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.365 -0.835 . . . . 0.0 110.065 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.38 71.26 1.2 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -150.15 100.28 2.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.301 . . . . 0.0 108.819 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -108.41 67.51 0.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.084 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.08 93.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -150.16 147.79 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.96 -1.087 . . . . 0.0 110.398 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.12 -175.27 3.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -147.82 161.05 42.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.869 -1.145 . . . . 0.0 110.909 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.34 -168.08 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.31 2.55 4.23 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.445 -0.785 . . . . 0.0 110.009 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.68 -176.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 108.819 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.83 -30.94 62.89 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.46 -36.28 76.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.123 -1.221 . . . . 0.0 108.33 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -75.51 -46.79 30.15 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.14 -54.94 39.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.268 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -48.08 -49.57 31.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -67.36 -34.39 77.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.037 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -90.02 -5.06 57.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 110.457 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -72.8 -27.76 62.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.072 -1.018 . . . . 0.0 108.938 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 20.3 tt0 -68.31 0.65 3.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.394 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.92 -77.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.37 -67.78 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.97 68.6 0.08 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.0 m-85 -47.12 101.99 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.487 -1.008 . . . . 0.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.53 8.96 2.74 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -169.52 146.55 3.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -1.199 . . . . 0.0 109.588 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 t -145.31 120.44 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.744 -1.223 . . . . 0.0 110.404 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.43 92.69 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.6 p -98.58 151.24 20.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.272 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 8.6 p-10 -86.19 -107.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.324 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.55 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 55.3 t-105 -146.3 176.6 9.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.005 . . . . 0.0 109.529 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' OD1' ' CE2' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -73.98 69.29 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -79.27 -47.55 1.58 Allowed Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.968 . . . . 0.0 110.336 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -67.17 -68.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.082 1.188 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.667 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -152.31 -126.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.479 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 20.8 mtm -86.33 95.98 9.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 63' ' ' MET . 52.8 m-20 -160.98 171.73 18.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.43 -63.12 2.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 tp -74.04 -50.56 19.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.639 -1.507 . . . . 0.0 107.88 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -71.07 -14.73 62.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.6 -58.17 4.66 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -61.37 -34.73 75.8 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -68.43 -37.91 80.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.9 m -68.53 -48.45 64.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.06 -25.91 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.433 -0.792 . . . . 0.0 109.027 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -90.05 -29.31 18.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.41 -0.806 . . . . 0.0 110.005 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -67.75 -38.2 83.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -53.16 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.35 -79.28 1.44 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.87 54.94 2.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -1.116 . . . . 0.0 109.827 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.7 mmt -137.37 1.95 2.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 109.296 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -94.06 59.99 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.04 -31.47 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.64 118.92 67.38 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 120.911 -1.118 . . . . 0.0 109.463 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.31 107.88 0.4 Allowed 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 121.474 1.449 . . . . 0.0 113.096 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.45 113.61 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -95.78 103.05 14.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.078 -1.449 . . . . 0.0 108.331 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 38.4 tpp -68.74 137.78 54.34 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.1 t -122.64 148.27 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.642 -0.661 . . . . 0.0 110.518 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.95 148.62 29.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.02 -45.92 8.44 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.213 -0.93 . . . . 0.0 108.789 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.8 mt-10 -93.66 43.75 1.12 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -43.91 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 110.086 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -95.47 143.57 26.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -47.56 -16.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.3 mm-40 -90.09 -45.55 9.07 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.287 -0.883 . . . . 0.0 110.167 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.81 -13.77 55.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 110.065 -179.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -73.64 -46.78 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 mt -74.74 -14.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 108.897 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.75 95.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.36 -58.21 4.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.5 -25.96 60.6 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.228 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -32.44 50.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.01 -29.61 28.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.05 70.01 1.32 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.453 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.02 -111.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 116.721 -1.991 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 p -91.74 -49.72 6.12 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.844 1.306 . . . . 0.0 108.12 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.88 -168.62 39.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.19 151.19 51.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.505 -0.997 . . . . 0.0 109.961 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.629 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 9.6 p -144.08 135.74 22.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -80.47 157.19 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.014 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 160.19 67.5 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 108.901 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.49 129.94 19.69 Favored 'Cis proline' 0 N--CA 1.485 1.009 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.683 -2.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -179.18 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.153 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.492 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -110.64 145.08 38.54 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.77 -14.86 0.14 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.991 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -83.15 -36.72 24.52 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -71.7 -60.3 2.3 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 115' ' ' THR . 1.3 mt -50.03 -40.85 46.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.413 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.51 -54.69 43.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.514 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -47.5 -51.56 20.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.64 -39.8 85.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -54.03 -68.45 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.503 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -46.66 -48.15 20.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.958 . . . . 0.0 109.477 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -47.25 -40.83 17.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 125' ' ' GLU . 69.5 mt -81.93 -59.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.0 109.19 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.2 0.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.852 -0.53 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 123' ' ' ILE . 86.9 tt0 -73.78 -27.32 61.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 126' ' ' LYS . 4.5 mptt -92.78 -34.76 13.75 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.33 -22.44 61.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.03 89.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.334 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.6 m-20 -45.85 140.06 3.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.32 8.53 32.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 110.303 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -140.16 46.25 1.84 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.074 -1.016 . . . . 0.0 110.524 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -80.6 131.45 35.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 127.63 33.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.905 -1.122 . . . . 0.0 111.621 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -114.61 153.72 29.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.9 tp -123.85 111.5 16.17 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.74 108.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.902 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.9 55.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.445 -0.784 . . . . 0.0 109.332 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -97.69 142.45 29.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.57 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.81 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.74 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 t -139.45 13.38 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 109.057 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 -3.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -45.31 70.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -45.92 19.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.194 -0.941 . . . . 0.0 109.633 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -53.71 -53.03 57.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.394 -0.816 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -47.34 -59.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 109.972 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -40.68 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.729 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.475 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.4 OUTLIER -49.61 -54.31 19.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.842 -1.161 . . . . 0.0 109.512 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -62.66 -57.77 9.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.048 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.7 tt -40.04 -58.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.665 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.42 -45.59 84.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.048 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -54.78 -40.9 69.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.6 -15.5 63.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.312 -0.867 . . . . 0.0 109.285 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.28 4.36 48.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.428 -0.795 . . . . 0.0 109.757 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 59.82 1.63 Allowed Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.138 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 51.2 m-85 -150.04 138.52 20.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.363 . . . . 0.0 109.549 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -146.37 64.8 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.908 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.85 96.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 108.799 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.17 153.86 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -169.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -150.16 156.09 40.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 111.418 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' N ' ' OE1' ' A' ' 35' ' ' GLU . . . -144.8 -164.4 1.91 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 4.4 mt-10 -130.24 -14.37 3.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.542 -0.724 . . . . 0.0 110.547 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -173.38 -178.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.005 -1.059 . . . . 0.0 109.886 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.28 93.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG2' ' SD ' ' A' ' 63' ' ' MET . 91.0 t -63.92 -51.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.874 -1.368 . . . . 0.0 108.709 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 45.6 t0 -51.31 -47.73 62.55 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -60.91 -48.83 80.03 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 42' ' ' ALA . 2.4 tp -40.61 -35.94 0.53 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.26 -39.76 65.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 108.931 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' GLN . 35.4 mmtt -79.91 -53.39 6.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.469 -0.769 . . . . 0.0 109.65 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -42.49 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.595 -0.69 . . . . 0.0 109.379 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 45' ' ' LYS . 8.9 tt0 -53.36 -44.75 68.81 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 50' ' ' GLY . . . -48.87 -49.75 38.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 80.39 -20.51 5.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 48' ' ' ALA . . . -58.14 -8.27 4.58 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 53' ' ' PHE . 66.9 m-85 -71.33 89.85 0.92 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -1.131 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.01 6.99 1.8 Allowed Glycine 0 C--O 1.205 -1.709 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -165.86 141.08 4.83 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.463 -1.022 . . . . 0.0 109.241 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -131.56 117.51 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.266 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.0 mt -98.78 79.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 p -93.67 144.1 25.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -0.813 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' OD2' ' NZ ' ' A' ' 109' ' ' LYS . 31.6 m-20 -92.68 126.06 37.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.364 -0.835 . . . . 0.0 109.016 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.558 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 6.9 t90 -90.76 107.56 19.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 59' ' ' ASN . 0.3 OUTLIER -161.69 -124.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.409 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 7.3 ttt -159.63 57.97 1.1 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.132 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.3 Cg_endo -64.3 -38.89 32.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 107.32 -1.838 . . . . 0.0 107.32 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 19.3 m-80 -161.5 -26.09 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.408 ' SD ' ' CG2' ' A' ' 40' ' ' VAL . 7.5 mtt -159.7 143.02 14.25 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.88 155.84 32.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.717 -1.24 . . . . 0.0 109.579 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -82.22 -7.84 87.2 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.368 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -58.37 -49.3 77.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.419 -1.636 . . . . 0.0 107.716 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' O ' ' OG1' ' A' ' 71' ' ' THR . 78.9 tt0 -52.74 -15.8 0.82 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 7.1 tp -79.34 -54.51 5.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -60.51 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -44.93 -51.38 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.468 -0.77 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 10.9 p -61.69 -41.35 97.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.33 -21.58 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.22 -0.925 . . . . 0.0 108.583 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -90.03 -23.3 21.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.245 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -55.91 4.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.211 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.78 -58.38 3.85 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.16 -58.36 3.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.426 ' O ' ' OG ' ' A' ' 79' ' ' SER . 49.4 mtt -128.93 -9.73 4.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 78' ' ' MET . 73.8 p 46.21 -123.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.099 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.07 55.31 0.93 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 108.902 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 45.52 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 O-C-N 121.664 -0.647 . . . . 0.0 109.602 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 5.3 Cg_exo -63.56 149.51 90.81 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.096 1.864 . . . . 0.0 115.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.53 110.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 2.7 tp -89.76 105.13 17.6 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.139 -1.825 . . . . 0.0 107.262 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 tpp -72.19 109.77 6.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.172 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.57 140.39 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 109.496 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.21 157.82 43.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.65 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.9 mp0 -80.74 70.8 7.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.22 83.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 0.0 108.853 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 89' ' ' GLU . 13.7 tttp -44.69 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.76 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mttt 175.92 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.7 -30.61 33.16 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.558 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 1.4 m-20 -61.5 -54.71 39.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 95' ' ' ILE . 10.0 mm -45.43 -53.83 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.61 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.7 mp -57.19 -28.25 29.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -64.13 -44.95 90.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.415 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -69.01 -53.99 17.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.058 . . . . 0.0 108.168 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.575 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -56.78 -28.47 61.38 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.29 -34.0 73.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -78.45 -19.23 53.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 55.56 76.05 0.21 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.857 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.17 -112.04 0.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.763 -1.975 . . . . 0.0 110.51 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -50.28 5.83 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.732 1.253 . . . . 0.0 108.149 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 168.41 -155.31 25.86 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.56 122.82 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.547 -0.972 . . . . 0.0 108.782 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.82 131.68 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.33 132.43 33.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.932 -1.105 . . . . 0.0 109.121 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' NZ ' ' OD2' ' A' ' 57' ' ' ASP . 3.5 pttt -109.54 160.11 29.02 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.95 134.45 35.58 Favored 'Cis proline' 0 C--N 1.32 -0.924 0 C-N-CA 124.866 -0.889 . . . . 0.0 110.39 -1.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -100.69 160.39 14.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.971 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.503 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.88 149.76 21.51 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.03 -21.78 0.76 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.174 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.07 -31.8 25.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.503 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -76.78 -57.66 3.73 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -40.72 64.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.106 -1.621 . . . . 0.0 107.842 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.51 -52.3 66.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.939 -1.1 . . . . 0.0 109.74 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -45.54 -46.44 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.482 -0.761 . . . . 0.0 109.507 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -70.31 -48.86 54.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 tp -47.08 -65.15 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 0.0 109.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 -45.13 45.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 0.0 109.907 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -68.66 -19.35 64.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 109.652 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.08 -43.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 0.0 110.244 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -63.25 -16.47 60.33 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.083 -1.011 . . . . 0.0 109.964 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -70.84 -19.94 62.6 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -94.85 -34.18 12.55 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -22.08 52.14 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.86 90.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.209 -1.171 . . . . 0.0 109.557 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -47.5 113.06 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 pttt -73.04 36.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.978 -1.076 . . . . 0.0 109.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 3' ' ' ASP . 23.9 tt0 -152.96 30.66 0.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -72.83 138.8 46.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -81.29 127.36 32.64 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.969 -1.082 . . . . 0.0 111.697 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 40.7 m-85 -114.71 155.66 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.837 -0.539 . . . . 0.0 109.954 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 tp -127.61 109.34 11.6 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -97.3 107.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.355 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.5 99.55 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.4 -0.813 . . . . 0.0 109.372 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.54 170.13 18.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.734 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.25 26.04 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -70.76 -80.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 t 154.03 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 -26.2 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 ttt -45.2 -63.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.724 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -48.58 -26.86 2.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -76.61 -31.68 57.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.624 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -51.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -38.34 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -52.72 23.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.23 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -58.29 4.13 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.992 0.901 . . . . 0.0 109.712 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.71 -41.18 3.06 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.836 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.77 -46.18 63.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.98 -1.075 . . . . 0.0 108.624 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -56.39 -38.17 71.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.341 -0.849 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.93 -24.88 17.87 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.274 -0.891 . . . . 0.0 109.201 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.28 -39.49 16.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.675 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 137.54 6.9 1.51 Allowed Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.6 141.4 28.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.852 -1.381 . . . . 0.0 109.389 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.5 61.5 1.22 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 97.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.03 152.79 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.044 -1.035 . . . . 0.0 109.83 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -120.52 -167.48 1.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 36' ' ' ALA . 1.1 tt0 -150.11 147.93 28.36 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.109 -0.994 . . . . 0.0 110.861 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' O ' ' OE2' ' A' ' 35' ' ' GLU . . . -132.31 -167.72 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -140.12 -2.2 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.894 . . . . 0.0 110.416 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 1.9 p-10 -176.4 -157.7 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 108.502 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -86.08 -43.12 6.42 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.46 -36.11 17.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.856 -1.379 . . . . 0.0 108.056 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.69 -54.64 6.13 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.712 -0.618 . . . . 0.0 109.756 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -55.78 -53.48 56.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.087 -1.008 . . . . 0.0 110.018 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.77 -59.47 4.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -55.37 -33.67 63.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -90.03 -19.86 23.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.116 -0.99 . . . . 0.0 110.699 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -60.52 -22.13 63.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.841 -1.162 . . . . 0.0 109.287 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -90.69 -2.64 57.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 108.919 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.46 -71.9 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.57 -0.706 . . . . 0.0 109.848 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.36 -18.9 1.12 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.26 64.67 0.55 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.7 m-85 -47.01 114.81 0.92 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.463 -1.022 . . . . 0.0 109.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.27 2.39 9.92 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -161.36 140.93 10.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.08 . . . . 0.0 108.854 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.8 t -134.97 121.17 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.796 -1.19 . . . . 0.0 110.069 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 56' ' ' SER . 43.2 mt -110.43 139.14 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 36.7 m -165.98 157.5 13.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.098 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 6.5 m-20 -61.39 -131.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 0.0 110.085 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 35.6 t-105 -173.11 -2.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.647 HD21 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -143.25 -16.44 0.66 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.65 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 24.0 tpp -81.08 -33.01 0.67 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 111.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -66.98 -148.0 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.715 0.944 . . . . 0.0 109.871 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -57.44 -159.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.561 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -44.67 -25.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 175.54 135.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.24 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.82 2.8 0.81 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 64' ' ' ASP . 12.3 tp -65.91 -60.13 3.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.809 -1.406 . . . . 0.0 108.068 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -49.34 -39.64 32.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.87 -35.5 73.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -83.1 -63.66 1.32 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' LEU . 36.3 tttm -35.81 -49.95 0.63 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.083 0.468 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.4 m -49.2 -46.36 45.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 108.492 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.3 mt -57.09 -33.18 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' CZ ' ' O ' ' A' ' 100' ' ' GLN . 9.8 ttt180 -67.58 -24.4 65.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.04 -28.54 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.54 82.16 8.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.1 89.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.35 -37.26 10.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.457 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -95.13 -71.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.52 11.05 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.382 -0.824 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -107.28 -31.7 8.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.653 -0.654 . . . . 0.0 109.759 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -32.14 97.53 0.11 Allowed Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 122.288 -0.257 . . . . 0.0 110.418 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.58 139.09 52.08 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 121.055 1.17 . . . . 0.0 111.028 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.36 137.68 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 tp -119.81 69.85 0.85 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -51.58 170.52 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.247 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.0 t -140.84 131.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.263 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -149.3 166.14 29.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.077 -1.014 . . . . 0.0 110.351 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.55 32.3 6.21 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 109.714 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 91' ' ' LYS . 3.5 tt0 -153.84 -62.82 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.178 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 57.16 83.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -68.8 8.93 0.44 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.174 -0.954 . . . . 0.0 109.443 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER 73.18 -68.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.328 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -51.6 -43.45 62.52 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -18.64 65.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mm -83.99 -13.97 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.21 -63.17 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.46 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.22 -46.27 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.83 78.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 109.123 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.76 61.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' CZ ' ' A' ' 73' ' ' ARG . 74.3 mt-30 -53.0 -23.77 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.77 -109.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.708 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.8 -1.85 4.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.43 11.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.086 -0.655 . . . . 0.0 110.87 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.708 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.4 m -29.46 -33.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.74 130.63 10.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.576 ' H ' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -143.88 112.18 6.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 108.626 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.48 133.25 62.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 106' ' ' TYR . 18.4 m -67.67 -167.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 151.46 17.03 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.706 -1.247 . . . . 0.0 108.991 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.83 165.68 83.17 Favored 'Cis proline' 0 N--CA 1.489 1.236 0 O-C-N 122.459 0.715 . . . . 0.0 111.217 -1.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -132.82 156.94 46.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.694 0.759 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.07 143.93 26.78 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -42.97 -33.76 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.253 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.04 95.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.0 m -65.2 -69.76 0.27 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.15 -31.69 3.72 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.972 -1.08 . . . . 0.0 109.986 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 6.1 tp10 -67.7 -62.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.647 -1.283 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 5.9 tt0 -41.82 -59.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.747 -0.596 . . . . 0.0 110.137 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HZ2' ' H ' ' A' ' 106' ' ' TYR . 6.8 mmmt -50.06 -40.57 45.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.771 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -50.61 63.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -18.4 62.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.0 . . . . 0.0 109.811 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -81.91 -34.42 29.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 mt -78.89 -37.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.102 -0.999 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.6 m-85 -75.33 -30.22 60.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.23 -24.15 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 108.228 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -94.1 -23.26 18.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 124' ' ' PHE . 5.6 tp -83.3 -18.09 40.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 74.95 0.19 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.409 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -160.19 143.66 13.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.045 -1.035 . . . . 0.0 109.875 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -90.16 9.18 29.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.003 -1.061 . . . . 0.0 109.178 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -158.65 57.0 0.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 56.2 tp -84.87 120.57 26.61 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -57.29 112.12 1.29 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.988 -1.07 . . . . 0.0 111.764 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 67.1 m-85 -107.16 151.05 25.93 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -122.25 106.02 10.74 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.93 113.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.273 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -119.23 106.78 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.591 -0.693 . . . . 0.0 109.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -155.49 126.83 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.396 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' ASP . 64.7 t0 -57.77 -107.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.07 -156.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.282 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -150.35 24.98 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.115 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.65 4.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 tpp -68.84 -44.43 73.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.117 -0.989 . . . . 0.0 109.122 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -44.69 -47.03 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 109.85 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -56.38 -51.2 69.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.919 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.8 mt -49.77 -58.51 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.004 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -39.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.477 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -57.25 11.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 108.933 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.3 t-20 -57.63 -54.06 51.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -39.19 -55.08 1.72 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.814 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.82 -53.18 59.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 108.865 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 26' ' ' LYS . 8.1 mtpm? -52.55 -28.12 19.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.247 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -32.66 62.59 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.086 -1.009 . . . . 0.0 108.838 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.91 -69.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.254 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 18.41 0.02 OUTLIER Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 30.9 m-85 -96.07 153.99 17.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.351 . . . . 0.0 109.06 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -149.12 21.5 0.97 Allowed 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.87 -1.144 . . . . 0.0 110.894 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.749 HD21 ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -138.29 107.65 6.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.917 -1.114 . . . . 0.0 111.106 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.33 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.226 -0.921 . . . . 0.0 109.606 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -137.35 -166.69 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -150.1 154.68 38.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.935 -1.103 . . . . 0.0 110.824 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.87 -163.67 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.91 -4.15 2.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.0 110.484 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 2.8 p-10 179.7 -173.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.025 -1.047 . . . . 0.0 109.52 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.71 67.05 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.93 -41.78 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.68 -1.482 . . . . 0.0 108.739 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.42 -44.45 74.99 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -68.73 -37.55 79.54 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.38 -57.8 7.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -66.43 -39.64 89.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 110.034 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -22.62 62.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.306 -0.871 . . . . 0.0 110.464 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -65.09 -4.8 5.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.831 -1.168 . . . . 0.0 109.325 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.05 -7.71 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.712 . . . . 0.0 109.213 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.59 -65.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.614 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.61 5.34 2.04 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.72 76.93 1.1 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 53' ' ' PHE . 52.6 m-85 -54.07 113.62 1.3 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.502 -0.999 . . . . 0.0 110.214 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.52 -4.81 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.548 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -165.48 141.35 5.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -1.14 . . . . 0.0 110.166 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.94 116.11 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.379 -0.826 . . . . 0.0 110.95 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.34 85.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.8 p -92.64 172.07 8.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 0.0 110.457 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 1.5 p-10 -95.31 -109.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.531 -0.73 . . . . 0.0 109.855 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 60.4 t-105 -159.82 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.466 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.614 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 41.5 m-20 -139.16 8.57 2.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -53.45 -49.57 87.71 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.956 -1.09 . . . . 0.0 109.72 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.2 -157.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 120.98 1.12 . . . . 0.0 109.496 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.64 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -85.38 143.75 28.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.072 -1.017 . . . . 0.0 109.395 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 19.9 ttm 74.47 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -137.9 164.73 28.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.535 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -91.49 -14.55 56.87 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -52.95 41.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.645 -1.503 . . . . 0.0 108.819 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' CG2' ' A' ' 71' ' ' THR . 0.6 OUTLIER -53.18 -22.98 7.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 108.549 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 10.2 tp -67.54 -55.16 14.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.69 -64.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -44.86 -46.2 10.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 109.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 67' ' ' GLU . 25.1 p -64.58 -43.77 92.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 109.163 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.38 -27.25 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.344 -0.847 . . . . 0.0 108.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.01 -29.83 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.91 -29.92 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -0.894 . . . . 0.0 109.355 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.19 113.33 19.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.832 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.67 -23.71 77.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.35 77.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.178 . . . . 0.0 109.491 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.0 OUTLIER -100.34 -75.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.82 19.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.99 20.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.15 119.8 73.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.083 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.07 98.19 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 120.934 1.089 . . . . 0.0 112.13 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.533 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.4 t -99.17 121.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.95 107.13 19.02 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.51 110.52 18.74 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.061 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -98.77 161.68 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.586 -1.321 . . . . 0.0 110.049 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.468 ' C ' ' NZ ' ' A' ' 109' ' ' LYS . 11.6 t -149.96 -155.59 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.497 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.42 32.57 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.536 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.99 -60.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.568 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . . . 54.1 98.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 109.904 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 93' ' ' GLU . 32.0 tttp -112.59 54.62 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 mttt 54.12 -82.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.665 -0.647 . . . . 0.0 110.002 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LYS . 1.9 mt-10 -43.76 -56.05 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 110.509 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.642 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -55.32 -45.74 76.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.988 -1.07 . . . . 0.0 109.974 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 mt -48.86 -36.77 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 108.977 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 100' ' ' GLN . 15.2 mt -74.62 -25.62 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -56.18 -53.34 58.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 0.0 109.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.32 -59.36 5.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.917 -1.115 . . . . 0.0 108.451 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.06 -21.84 34.61 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.44 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.7 tt0 -52.21 -32.27 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.66 21.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.66 72.26 0.88 Allowed Glycine 0 N--CA 1.482 1.74 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.196 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.08 -112.32 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 116.55 -2.06 . . . . 0.0 110.192 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 20.5 m -91.93 -52.56 4.67 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.529 1.633 . . . . 0.0 107.58 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.48 -160.19 33.23 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.568 ' HH ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -135.22 147.01 49.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -1.076 . . . . 0.0 109.849 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.99 128.74 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 149.96 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.62 160.87 62.43 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.79 124.07 8.9 Favored 'Cis proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.803 -0.915 . . . . 0.0 110.554 -1.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.4 156.43 16.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.309 -0.869 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.527 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.28 150.06 22.09 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.19 -32.14 4.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.82 -35.46 80.74 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.095 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -71.38 -65.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.081 -1.012 . . . . 0.0 108.51 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 tp -52.34 -34.94 49.61 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.419 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 120' ' ' LEU . 4.3 tm-20 -69.12 -63.3 1.09 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.798 -1.189 . . . . 0.0 109.702 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.4 -41.84 9.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.632 -0.668 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -71.29 -27.78 63.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.1 tp -61.99 -62.1 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.36 -35.6 8.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.573 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -75.01 -29.89 60.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.166 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 120' ' ' LEU . 2.6 mm -77.05 -40.0 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.382 -0.824 . . . . 0.0 109.44 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -76.86 -0.24 23.32 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -31.41 58.61 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -90.18 -25.53 20.6 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -25.58 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.52 89.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -46.28 132.36 10.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -90.46 18.63 5.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.036 . . . . 0.0 109.646 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -129.32 42.6 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.7 tp -90.14 130.22 36.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.658 ' HZ2' HD22 ' A' ' 32' ' ' ASN . 19.6 mttm -76.93 124.79 28.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 111.422 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -109.29 152.08 25.71 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.9 tp -131.15 105.59 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.51 104.62 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.085 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.45 88.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.414 -0.804 . . . . 0.0 109.436 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -149.33 157.15 43.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.56 -13.66 14.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.639 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -47.4 136.06 10.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.536 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.4 t -86.14 30.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.35 -24.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.06 -61.17 2.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -47.82 -35.17 9.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 109.389 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -72.14 -39.86 68.47 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.963 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -62.6 -53.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.755 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -32.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -55.26 20.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.749 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.86 -53.49 17.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.812 0.815 . . . . 0.0 109.543 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.53 -52.37 2.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.508 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -59.46 -55.16 38.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.393 -0.817 . . . . 0.0 108.999 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -52.1 -31.4 30.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 109.073 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -32.13 55.94 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.286 -0.884 . . . . 0.0 109.336 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.47 -61.14 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 162.16 73.34 0.02 OUTLIER Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -150.15 134.52 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.79 -1.418 . . . . 0.0 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.97 26.16 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.745 . . . . 0.0 110.449 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.658 HD22 ' HZ2' ' A' ' 7' ' ' LYS . 27.0 t-20 -137.82 93.71 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 109.393 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -139.69 153.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.687 . . . . 0.0 110.336 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 12.4 mt-10 -127.63 -171.88 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.08 147.08 27.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.07 -1.019 . . . . 0.0 110.475 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.26 -165.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.11 0.77 2.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 3.8 t70 -176.43 164.77 2.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.766 -1.209 . . . . 0.0 109.849 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -56.67 -40.34 88.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.48 -40.38 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.119 -1.224 . . . . 0.0 108.336 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -66.88 -49.73 64.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -54.44 -56.98 13.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 42' ' ' ALA . 1.3 tp -41.1 -45.98 2.87 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.226 0.536 . . . . 0.0 109.735 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -70.93 -37.36 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' ALA . 31.2 mttt -90.09 4.4 50.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 110.045 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -90.08 -62.96 1.35 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.91 -1.119 . . . . 0.0 109.047 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -56.15 -8.51 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 108.861 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.33 -79.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.708 . . . . 0.0 109.742 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.75 1.4 11.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 77.55 0.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.6 m-85 -64.71 109.54 2.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -1.065 . . . . 0.0 109.772 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.97 -1.95 1.71 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.514 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -157.51 139.92 14.63 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.277 . . . . 0.0 109.698 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -141.8 124.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.165 -0.96 . . . . 0.0 109.568 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -132.52 168.95 17.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.785 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 54.5 t0 -94.4 -109.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.158 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.608 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 46.8 t-105 -164.75 -55.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.51 71.41 10.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.086 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mmm -92.4 149.63 38.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 109.191 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.37 -179.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 120.941 1.094 . . . . 0.0 109.945 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.83 -104.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 mtp -106.62 161.54 14.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 109.447 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -73.4 179.28 4.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.6 6.78 67.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.08 -40.29 60.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.02 -1.282 . . . . 0.0 108.247 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 6.2 tp10 -71.36 -15.95 62.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mt -74.01 -58.6 3.19 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -63.9 -38.43 91.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.209 -0.932 . . . . 0.0 109.34 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' ALA . 13.8 tptm -63.5 -51.18 66.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 108.892 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 24.0 p -60.35 -45.59 92.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 109.341 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.96 -34.63 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.252 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.4 OUTLIER -90.15 -8.05 52.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -108.62 -16.91 14.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 109.733 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 7.7 p30 -23.98 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.234 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.512 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -169.09 -82.34 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.33 26.85 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.958 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 tpt -147.94 36.37 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 73' ' ' ARG . 12.3 m -79.14 58.03 2.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.34 -18.74 0.44 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.84 . . . . 0.0 110.667 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.472 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -47.79 111.13 1.58 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 109.476 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.26 125.89 19.31 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 121.422 1.414 . . . . 0.0 113.442 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.26 116.93 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -97.53 107.42 19.92 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.708 -1.597 . . . . 0.0 106.926 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' C ' ' A' ' 85' ' ' MET . 5.0 ppp? -75.24 131.87 40.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.45 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.92 142.23 25.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.362 0.601 . . . . 0.0 110.834 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.0 t -150.12 176.53 10.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 109.345 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.49 -5.92 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.8 pm0 -139.47 57.6 1.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.337 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -47.14 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' GLU . 12.1 tptt -77.93 48.15 0.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.871 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.6 mttp 52.44 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.0 tt0 -45.11 -40.51 7.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.424 -0.797 . . . . 0.0 110.028 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.608 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 3.0 m-20 -57.44 -41.23 80.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 109.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.78 -51.44 72.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.063 -1.023 . . . . 0.0 108.446 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 3.4 mm -66.23 -26.36 37.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.523 -0.736 . . . . 0.0 109.313 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.71 39.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.089 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -79.42 -50.88 10.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.845 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.89 -30.08 61.01 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.088 -1.045 . . . . 0.0 108.998 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.452 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.6 tt0 -58.64 -34.16 70.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -77.88 -22.62 49.49 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 60.17 79.31 0.12 Allowed Glycine 0 N--CA 1.478 1.495 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.532 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -111.95 0.06 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 116.932 -1.907 . . . . 0.0 109.288 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.8 t -91.94 -49.73 6.08 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.753 1.263 . . . . 0.0 108.278 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.47 -165.7 37.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.27 125.63 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.947 . . . . 0.0 109.484 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 11.8 p -126.59 122.66 61.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -58.18 -167.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.8 pttm -164.71 155.25 12.68 Favored Pre-proline 0 C--N 1.297 -1.711 0 O-C-N 120.649 -1.282 . . . . 0.0 109.312 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.6 161.05 94.95 Favored 'Cis proline' 0 N--CA 1.485 0.991 0 C-N-CA 124.888 -0.88 . . . . 0.0 110.432 -2.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -127.92 166.23 18.7 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.704 0.764 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.562 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -95.24 146.34 24.41 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.39 0.73 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.998 -1.063 . . . . 0.0 109.596 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.75 72.92 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.008 -1.057 . . . . 0.0 108.521 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.562 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.86 -64.67 0.82 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.1 tp -49.67 -39.27 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.758 -1.214 . . . . 0.0 109.381 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 120' ' ' LEU . 30.4 tt0 -64.78 -64.47 0.86 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.063 -1.023 . . . . 0.0 109.749 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -44.97 -36.6 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -75.73 -29.53 58.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.941 . . . . 0.0 109.155 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 117' ' ' GLU . 6.3 tp -66.61 -56.98 8.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -52.9 -41.66 64.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -67.9 -27.45 66.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.666 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.32 -45.29 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 13.7 m-85 -65.62 -27.64 68.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -51.35 -29.57 15.73 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 108.274 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -88.14 -21.11 24.81 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 1.3 tt -80.2 -24.62 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.803 . . . . 0.0 108.861 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.34 -41.73 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.271 -1.135 . . . . 0.0 109.521 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.35 0.595 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.495 ' O ' ' CE2' ' A' ' 30' ' ' PHE . 1.2 t0 -55.63 146.67 20.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -90.07 27.46 1.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.667 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -158.2 37.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.45 137.7 46.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 2.3 mtmp? -76.89 136.62 38.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.039 -1.038 . . . . 0.0 111.531 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.8 m-85 -127.87 145.44 50.94 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.817 -0.552 . . . . 0.0 110.371 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.409 ' HB2' ' CD2' ' A' ' 51' ' ' TYR . 64.4 tp -118.4 118.35 31.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.31 104.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.79 116.57 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.501 -0.75 . . . . 0.0 109.383 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.77 178.42 8.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.723 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -118.99 13.63 13.07 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -161.82 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.262 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -138.82 -0.7 1.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 109.101 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.65 3.12 0.84 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.805 . . . . 0.0 109.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.6 ttt -74.72 -45.39 44.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.509 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.763 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.98 -27.11 61.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.6 ' N ' HH21 ' A' ' 18' ' ' ARG . 10.0 mmt180 -73.25 -31.23 63.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mt -64.88 -54.16 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.68 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 109.945 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 35' ' ' GLU . 8.5 mtt85 -46.71 -54.98 8.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.9 t30 -66.24 -58.47 5.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.438 -0.789 . . . . 0.0 109.432 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.26 -65.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.016 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.69 -45.92 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.163 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -38.28 78.92 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.211 -0.93 . . . . 0.0 109.397 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.61 -41.72 63.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -61.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 109.136 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.33 42.89 0.02 OUTLIER Glycine 0 N--CA 1.479 1.548 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 94.9 m-85 -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.448 -1.031 . . . . 0.0 109.052 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -149.99 67.41 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.884 -1.135 . . . . 0.0 110.4 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.68 97.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.132 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.14 152.29 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.99 -1.069 . . . . 0.0 110.13 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -124.44 -167.3 1.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' OE2' ' NH1' ' A' ' 22' ' ' ARG . 17.9 mt-10 -147.62 146.49 29.37 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 110.153 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.11 -165.13 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -144.98 -0.74 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.909 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 25.8 t0 -171.57 178.8 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.744 -1.222 . . . . 0.0 109.891 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . -67.22 -52.04 34.44 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -55.33 -27.66 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -1.097 . . . . 0.0 108.615 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -79.86 -42.73 23.65 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.315 -0.866 . . . . 0.0 108.911 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.26 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.338 -0.851 . . . . 0.0 109.644 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.76 -37.42 73.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.545 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -82.95 -26.72 31.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.029 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -85.24 -14.36 46.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.393 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.88 -19.4 57.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.662 -1.274 . . . . 0.0 109.405 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -68.08 -5.68 18.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 108.879 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.51 -70.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.809 . . . . 0.0 109.779 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.23 13.11 1.08 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.01 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 20.4 m-85 -70.82 140.71 51.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.377 -1.073 . . . . 0.0 110.09 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.84 -6.27 62.2 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -156.54 142.95 18.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.762 -0.846 . . . . 0.0 108.756 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.93 118.32 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.671 -1.268 . . . . 0.0 110.006 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 55' ' ' ILE . 61.1 mt -100.89 153.52 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.9 p -170.86 166.0 7.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.032 -1.042 . . . . 0.0 109.189 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CD1' ' OD1' ' A' ' 59' ' ' ASN . 61.8 t-105 -167.12 -57.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.05 -1.031 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.575 ' C ' HD21 ' A' ' 59' ' ' ASN . 0.2 OUTLIER -172.54 72.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 110.434 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -91.49 -47.69 0.34 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 110.511 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.94 -160.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 C-N-CA 121.129 1.219 . . . . 0.0 110.216 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -76.67 -40.6 48.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.658 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -79.95 143.98 33.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.33 146.16 27.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.85 -15.35 60.0 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -73.91 -72.74 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.163 -1.198 . . . . 0.0 109.951 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 69.5 tt0 -45.86 -26.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -69.11 -46.89 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 7.8 tt -74.67 -62.65 1.46 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.389 0.614 . . . . 0.0 109.397 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -43.39 -31.64 0.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 2.9 m -63.56 -41.84 98.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 47.9 mt -57.91 -40.04 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -68.37 -3.16 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.26 69.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -73.14 139.92 46.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.31 80.34 0.95 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -170.9 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -1.182 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.96 10.73 30.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.403 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m 52.49 -117.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.987 . . . . 0.0 109.18 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -125.91 0.92 7.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER 52.77 171.14 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.44 136.13 57.43 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 121.489 1.46 . . . . 0.0 112.874 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.94 139.85 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.82 68.28 0.76 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -61.57 131.57 50.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.89 135.74 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.192 -0.942 . . . . 0.0 110.813 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -150.07 156.11 41.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.567 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -85.53 156.8 20.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 6.3 tm-20 59.69 -75.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . 79.4 97.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -0.761 . . . . 0.0 109.205 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.6 mmmt -58.33 -107.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -163.47 -69.16 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -52.56 -16.46 0.93 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.902 . . . . 0.0 109.372 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -78.64 -29.41 45.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.7 -15.7 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.664 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 mt -82.22 -64.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.785 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.26 -47.85 18.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 0.0 109.376 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.71 68.59 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.47 -0.769 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -52.21 -48.65 64.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -47.99 -22.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 108.791 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -94.35 -116.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.659 -0.65 . . . . 0.0 109.531 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.755 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -127.58 -3.67 5.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -59.34 10.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.671 -0.899 . . . . 0.0 109.375 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.755 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.45 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.26 130.98 10.41 Favored Glycine 0 N--CA 1.497 2.722 0 C-N-CA 119.492 -1.337 . . . . 0.0 109.899 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.89 109.24 5.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -1.053 . . . . 0.0 109.351 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.54 139.82 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.2 t -81.82 119.18 30.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.34 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -88.4 151.62 48.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.892 -1.13 . . . . 0.0 109.624 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.82 162.24 92.57 Favored 'Cis proline' 0 N--CA 1.487 1.121 0 C-N-CA 125.226 -0.739 . . . . 0.0 110.512 -1.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -139.23 159.13 42.88 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 109.993 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.59 151.5 21.53 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.45 -17.33 0.15 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 108.835 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.85 -43.6 58.15 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -67.25 -63.84 0.98 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.3 tp -46.88 -36.11 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.432 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.62 -64.3 0.93 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.99 -1.069 . . . . 0.0 109.772 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -52.99 7.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -46.53 -46.51 19.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.92 -54.97 40.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -21.07 48.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -38.73 49.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.15 . . . . 0.0 109.624 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -90.1 -36.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.353 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -73.29 -41.03 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -51.15 -18.83 0.96 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.843 -1.16 . . . . 0.0 108.046 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -98.44 -23.72 15.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' PHE . 0.5 OUTLIER -82.33 -21.93 35.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 55.05 81.01 0.07 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 109.368 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.264 0.554 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 62.2 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.362 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -90.05 19.2 5.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -137.42 41.21 2.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 tp -75.0 127.73 33.92 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 122.74 24.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 111.712 -177.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 44.6 m-85 -109.98 152.87 25.34 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.1 tp -117.36 109.45 16.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.64 121.05 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 109.86 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.45 27.08 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -51.73 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.915 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -53.4 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.622 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.94 140.41 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.626 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -88.24 13.78 10.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.356 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -136.11 -18.56 1.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.711 . . . . 0.0 109.299 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 ttt -68.97 -17.68 63.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.244 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -34.91 78.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.872 . . . . 0.0 109.36 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -24.39 62.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 108.914 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -69.91 -52.35 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -30.7 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.747 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.2 -54.29 17.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.95 . . . . 0.0 109.408 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.3 t-20 -67.41 -57.29 6.84 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.804 0.811 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.21 -43.51 1.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.695 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.07 -38.97 75.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.778 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -63.96 -38.26 90.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.29 -0.881 . . . . 0.0 109.157 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -51.0 -35.09 32.01 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.351 -0.843 . . . . 0.0 109.036 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.56 -50.9 11.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.336 -0.852 . . . . 0.0 109.133 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.83 35.71 0.06 OUTLIER Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.39 147.39 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.391 -1.064 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -150.17 57.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.05 -1.031 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.88 110.2 0.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.766 -1.209 . . . . 0.0 110.181 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.2 -177.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.3 mm-40 -128.11 -171.89 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.77 145.77 30.95 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.125 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.09 -174.2 4.65 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.25 23.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.741 -1.224 . . . . 0.0 110.363 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 179.53 147.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.865 -1.147 . . . . 0.0 109.336 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.59 -39.89 23.77 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.32 -32.05 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -1.069 . . . . 0.0 108.793 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 38' ' ' ASP . 21.2 t0 -76.98 -45.69 26.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.55 74.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.555 -0.716 . . . . 0.0 109.394 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.22 -65.72 0.66 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -46.51 -27.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 3.9 mttm -90.0 -39.08 13.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.2 -37.6 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.04 . . . . 0.0 108.885 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 7.3 mt-30 -54.94 -24.36 23.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -44.23 -61.3 1.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.164 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.0 75.39 1.22 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -173.18 -31.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 53' ' ' PHE . 15.2 m-85 -61.35 86.27 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.269 -1.136 . . . . 0.0 110.015 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -66.92 6.08 2.22 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.6 t80 -158.08 146.2 18.69 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 121.565 -0.962 . . . . 0.0 109.099 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.6 t -144.01 127.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.617 -1.302 . . . . 0.0 110.687 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.77 103.19 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 23.4 p -109.32 -178.91 3.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 0.0 110.46 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 32.3 t70 -89.44 -131.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.842 . . . . 0.0 110.292 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.502 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 46.7 t-105 -162.7 -55.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.96 . . . . 0.0 110.092 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.531 ' O ' ' SD ' ' A' ' 60' ' ' MET . 24.0 t-20 -142.54 103.36 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.75 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.555 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.81 -46.22 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -69.36 -162.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.05 1.166 . . . . 0.0 109.979 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -54.07 130.38 37.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.106 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.425 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 36.7 mmm 51.17 -116.16 0.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -142.59 151.01 41.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 108.932 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.35 12.61 1.77 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 64' ' ' ASP . 1.2 tp -67.8 -57.2 6.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -1.185 . . . . 0.0 108.97 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -19.81 64.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.459 -0.776 . . . . 0.0 109.115 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -59.3 4.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' ILE . 1.5 tt -70.95 -59.46 2.78 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.8 tttt -38.38 -37.71 0.31 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -63.3 -44.17 95.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 108.794 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 56.0 mt -55.33 -38.0 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.97 -5.95 58.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.49 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -84.82 -26.74 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 109.625 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -46.07 -15.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 67.31 -0.65 8.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 75' ' ' ASP . . . -146.91 26.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -1.121 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 mmt -139.79 20.61 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 109.339 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.2 p -85.61 49.23 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.52 6.02 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 109.843 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.2 tp -92.98 119.59 67.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 108.636 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.91 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 120.774 0.982 . . . . 0.0 111.926 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.576 ' N ' ' OG ' ' A' ' 104' ' ' SER . 8.7 t -98.8 110.4 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.363 -0.836 . . . . 0.0 108.759 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.29 101.6 13.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 1.1 tpt -75.5 152.14 37.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.72 147.3 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.632 -0.668 . . . . 0.0 110.151 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 88' ' ' ALA . 30.9 m -143.77 163.18 34.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.969 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 87' ' ' THR . . . -105.09 -62.43 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -96.57 87.19 4.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.094 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -81.79 161.09 23.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.917 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.692 ' H ' HD21 ' A' ' 94' ' ' ASN . 14.4 tttt -147.39 154.23 40.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.169 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -48.39 61.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.12 -52.81 8.65 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.131 -0.981 . . . . 0.0 110.632 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -58.44 -10.21 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.113 -0.992 . . . . 0.0 110.561 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 95' ' ' ILE . 9.9 mt -86.35 -7.29 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.827 -1.171 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.5 mp -90.07 -46.59 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -46.01 -22.7 0.23 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.42 -52.57 45.02 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -49.22 -41.82 38.5 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.722 -1.861 . . . . 0.0 107.96 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.92 -31.27 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.71 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -134.82 -71.2 0.49 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -49.98 82.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 176.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -68.46 -110.13 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 112.586 -1.807 . . . . 0.0 115.08 -174.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -37.44 -57.22 0.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.723 -176.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.67 171.16 33.65 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.852 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.46 113.48 11.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 13.1 p -109.25 115.25 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.04 102.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 159.39 77.29 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.049 -1.032 . . . . 0.0 109.123 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.9 154.21 99.51 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.357 -2.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -129.57 160.83 32.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.859 0.838 . . . . 0.0 110.138 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -97.97 148.49 23.42 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.13 -35.48 7.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 109.327 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 -35.38 80.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.0 m -70.43 -67.8 0.47 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 115' ' ' THR . 10.6 tp -47.28 -39.62 14.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.656 -1.278 . . . . 0.0 109.344 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -62.7 -53.48 53.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.078 -1.014 . . . . 0.0 109.5 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.0 mm-40 -47.4 -28.32 2.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.286 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -79.55 -49.83 11.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.445 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -48.26 73.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.307 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.13 -47.36 86.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 109.956 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.8 mt -82.82 -35.86 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.888 . . . . 0.0 109.116 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -85.92 -2.15 57.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.46 -27.04 55.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -93.65 -31.09 14.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.59 -27.97 62.5 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.11 87.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.384 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -53.28 144.2 16.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.197 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.486 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 14.3 mttm -90.15 18.84 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 0.0 109.366 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -159.63 48.96 0.3 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 40.2 tp -77.51 113.02 14.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.999 -1.063 . . . . 0.0 108.433 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -53.78 106.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.938 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.498 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 69.0 m-85 -101.09 153.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -137.58 117.63 13.41 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -106.01 119.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.658 -0.651 . . . . 0.0 110.906 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.56 112.49 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 121.384 -0.823 . . . . 0.0 109.462 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.464 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -157.96 139.64 13.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -80.2 -12.17 59.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.439 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.52 141.66 58.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 t -92.65 41.18 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -172.06 -40.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 14.1 ttm -46.94 -15.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' THR . 2.9 mtt180 -86.15 -44.34 12.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 109.684 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -65.64 -13.44 59.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.458 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.15 -49.48 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -36.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' ' OE2' ' A' ' 35' ' ' GLU . 8.0 mtt180 -50.81 -52.87 36.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 109.267 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.23 -57.06 7.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.977 0.894 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.28 -48.88 3.67 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.836 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.56 -51.05 62.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.835 -1.166 . . . . 0.0 108.518 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.28 -32.99 5.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -48.59 -38.95 22.1 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.008 . . . . 0.0 109.1 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.416 ' CD1' ' OE2' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -76.57 -68.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.384 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.09 20.95 0.02 OUTLIER Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.461 ' C ' HD21 ' A' ' 31' ' ' ASN . 29.1 m-85 -97.15 139.22 33.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.862 -1.375 . . . . 0.0 109.75 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.634 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.84 67.21 1.28 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.124 -0.985 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -174.82 91.56 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.199 -0.938 . . . . 0.0 108.82 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.94 154.84 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.214 -0.929 . . . . 0.0 110.818 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' OE2' ' CE1' ' A' ' 51' ' ' TYR . 13.5 pt-20 -125.89 -171.02 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 13.3 mp0 -144.56 161.46 39.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.83 . . . . 0.0 110.045 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -170.45 3.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 68.1 mt-10 -134.32 0.71 3.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.532 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 175.7 -175.22 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.785 -1.197 . . . . 0.0 109.314 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.97 -54.07 33.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -57.3 -36.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -1.131 . . . . 0.0 108.799 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 12.2 t0 -63.48 -45.09 92.35 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.97 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.778 . . . . 0.0 109.035 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.17 -28.52 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -79.42 -50.35 10.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.908 -1.12 . . . . 0.0 110.818 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' OE2' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -89.79 -3.79 57.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.086 -1.009 . . . . 0.0 110.605 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 48' ' ' ALA . 4.4 tt -90.11 -41.21 11.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.074 -1.016 . . . . 0.0 109.624 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.43 0.79 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.31 -60.57 1.86 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.572 -0.705 . . . . 0.0 109.843 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.35 11.1 1.0 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.115 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.46 97.91 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 15.9 m-85 -79.22 124.23 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.204 -1.174 . . . . 0.0 110.405 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.83 -3.86 56.66 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -167.77 142.71 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.428 . . . . 0.0 109.369 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.78 158.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.278 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 mt -143.31 127.59 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 p -147.61 157.45 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.892 -1.13 . . . . 0.0 110.175 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 8.8 t0 -65.78 -137.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.528 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 60.6 t-105 -173.37 111.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.468 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 66.97 27.43 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.602 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.1 tpt -101.8 -41.99 0.21 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 111.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.2 Cg_exo -65.57 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.158 1.239 . . . . 0.0 110.518 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -74.17 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.064 -1.023 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.3 mtm -74.09 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 66' ' ' LEU . 61.9 t0 -172.38 140.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.063 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -70.98 15.69 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 64' ' ' ASP . 13.7 tp -81.09 -56.76 3.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.08 -1.247 . . . . 0.0 107.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.416 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -60.28 -22.25 62.9 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 71' ' ' THR . 22.5 tp -64.32 -59.06 4.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.06 -63.18 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.752 0.787 . . . . 0.0 108.953 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.2 tttm -40.29 -44.08 1.84 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 110.272 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -58.68 -39.13 79.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.915 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 69' ' ' LEU . 37.7 mt -58.98 -41.68 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.156 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -50.06 -30.07 10.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 109.559 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -45.98 -24.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 74' ' ' ALA . 12.2 t70 -44.1 -91.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -164.77 -142.88 3.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.25 -0.1 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.686 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.93 7.38 37.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.437 ' HG ' ' H ' ' A' ' 80' ' ' ALA . 11.3 t 47.29 -132.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.241 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -113.57 12.13 18.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.724 -0.61 . . . . 0.0 109.589 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 52.5 173.85 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.224 -0.922 . . . . 0.0 108.722 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.33 144.02 99.54 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.326 1.351 . . . . 0.0 113.452 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.54 135.86 43.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.3 tp -114.76 69.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ptm -56.66 156.07 6.8 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.557 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.08 138.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.852 -0.53 . . . . 0.0 109.588 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -146.63 179.88 7.25 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.466 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.69 -26.32 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.835 -0.54 . . . . 0.0 109.608 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -117.4 61.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 109.756 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.02 108.98 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -78.59 -79.65 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.794 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -174.48 -89.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.014 . . . . 0.0 109.548 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.64 45.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -54.64 -26.15 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.332 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.4 mt -85.12 -17.47 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 0.0 109.264 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' ALA . 72.5 mt -82.94 -62.92 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -45.82 -54.21 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.56 -52.38 17.84 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.42 -0.8 . . . . 0.0 109.418 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.54 69.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.584 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -59.01 -17.18 22.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.044 -1.035 . . . . 0.0 109.968 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.85 -34.99 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.336 -0.852 . . . . 0.0 109.88 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.738 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.06 -13.07 0.73 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -58.5 10.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.769 -0.842 . . . . 0.0 109.885 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.738 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.46 -35.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.113 -177.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.39 127.05 9.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.554 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -139.62 113.4 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -1.032 . . . . 0.0 108.567 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 108' ' ' VAL . 14.1 p -116.01 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.656 ' CG1' ' H ' ' A' ' 109' ' ' LYS . 33.1 t -61.27 -164.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.656 ' H ' ' CG1' ' A' ' 108' ' ' VAL . 9.9 pttm -164.88 156.09 13.03 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.464 -1.398 . . . . 0.0 108.737 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.96 166.69 81.64 Favored 'Cis proline' 0 N--CA 1.486 1.034 0 C-N-CA 125.158 -0.768 . . . . 0.0 110.857 -1.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.03 161.98 37.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.604 ' HG1' ' N ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -102.28 171.28 7.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 176.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.604 ' N ' ' HG1' ' A' ' 112' ' ' THR . . . -61.41 -25.52 67.25 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.555 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.56 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.416 -0.802 . . . . 0.0 109.138 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -64.55 0.83 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -47.76 -36.44 11.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.811 -1.18 . . . . 0.0 109.779 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 2.9 mm-40 -59.2 -66.69 0.47 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.816 -1.178 . . . . 0.0 109.939 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -45.62 -25.71 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.637 -0.665 . . . . 0.0 110.532 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -86.34 -44.54 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 110.246 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -43.13 91.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.437 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -64.81 -40.83 95.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -56.57 -31.73 64.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.257 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.508 ' C ' ' H ' ' A' ' 125' ' ' GLU . 67.8 mt -85.69 -45.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -70.46 10.12 0.52 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.235 -0.915 . . . . 0.0 109.368 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.5 tt0 -83.29 -24.68 32.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -96.21 -30.85 13.25 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.3 -26.07 61.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.88 88.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.445 ' SD ' ' OXT' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER 52.88 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.395 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -73.15 32.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.952 . . . . 0.0 109.137 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 3' ' ' ASP . 82.0 mt-10 -155.25 33.32 0.38 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 108.993 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.2 tp -70.12 132.9 46.53 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -76.09 117.55 17.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -106.12 152.44 23.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -126.78 111.06 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.77 116.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.782 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.86 110.74 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.912 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -177.2 124.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.985 -1.072 . . . . 0.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.14 7.47 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.717 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -172.16 -154.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.439 -1.413 . . . . 0.0 112.258 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.717 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 177.91 16.43 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.439 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -171.92 -48.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.927 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 22.0 ttt -38.85 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.665 -0.647 . . . . 0.0 110.853 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 51.1 mtm180 -43.37 -30.24 0.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.45 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -30.27 39.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.642 -1.287 . . . . 0.0 109.445 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.8 mt -69.66 -49.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -35.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -46.95 -54.1 10.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 109.039 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t30 -61.23 -56.76 17.0 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.845 0.831 . . . . 0.0 108.787 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -36.89 -67.61 0.17 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.897 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.29 -42.79 74.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.925 -1.109 . . . . 0.0 108.997 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -59.16 -28.4 66.56 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -46.61 68.92 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.138 -0.976 . . . . 0.0 109.213 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.0 -62.95 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -0.883 . . . . 0.0 109.077 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.09 18.7 0.02 OUTLIER Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.198 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.97 123.72 34.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.488 -1.595 . . . . 0.0 109.156 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.18 69.27 1.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.73 96.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.094 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.07 149.79 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.004 -1.06 . . . . 0.0 109.916 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 3.6 mt-10 -118.95 -172.18 2.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.8 mp0 -147.11 165.69 29.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 110.396 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.98 -170.46 3.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -130.25 0.27 4.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.475 -0.766 . . . . 0.0 110.326 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.18 176.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.034 . . . . 0.0 109.601 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.32 -47.31 91.72 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -52.85 -35.07 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.088 -1.242 . . . . 0.0 108.42 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.06 -52.87 11.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.501 -0.749 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.03 -57.44 12.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.304 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.49 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.0 109.777 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -72.52 -31.6 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 0.0 110.134 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -90.08 -7.06 54.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.973 . . . . 0.0 110.238 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -70.53 -6.44 36.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 0.0 108.77 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.51 -2.16 57.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.987 -1.07 . . . . 0.0 109.234 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.76 -67.82 0.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.822 . . . . 0.0 109.456 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.48 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.58 72.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.527 ' C ' ' H ' ' A' ' 53' ' ' PHE . 76.7 m-85 -54.9 95.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.94 -6.13 1.68 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.527 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -153.42 139.24 18.03 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.49 -1.006 . . . . 0.0 109.587 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -134.0 118.81 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.004 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 mt -99.51 114.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.6 p -132.24 166.21 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.806 . . . . 0.0 109.326 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 12.4 p-10 -90.01 -118.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.117 -0.99 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.526 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 43.2 t-105 -162.36 -18.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.331 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.38 96.21 5.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.312 0.577 . . . . 0.0 109.774 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 159.69 70.75 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.73 -41.82 73.65 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.144 1.23 . . . . 0.0 110.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -96.51 -107.74 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 0.0 109.192 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 63' ' ' MET . 2.8 mpp? -69.56 -161.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.5 176.38 6.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.064 -1.022 . . . . 0.0 109.29 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.93 59.25 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.571 -1.3 . . . . 0.0 109.874 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.8 tp -86.24 -40.68 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.808 -1.407 . . . . 0.0 107.58 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 15.8 mt-10 -66.74 -18.03 65.17 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.48 -66.48 0.85 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -40.03 74.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -47.53 86.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.288 -0.882 . . . . 0.0 109.023 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 52.9 m -51.23 -47.38 62.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.61 -46.09 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 108.795 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -62.09 -29.0 70.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.6 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.27 -29.13 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.73 99.69 0.83 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.452 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.71 76.58 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.26 -60.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.1 mmt -92.91 -71.03 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t 45.46 26.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.374 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.81 -12.59 4.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.654 -0.654 . . . . 0.0 109.487 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.2 tp -48.25 113.37 2.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.112 -0.993 . . . . 0.0 108.729 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.5 121.59 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.2 1.267 . . . . 0.0 112.751 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.52 115.52 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' MET . 5.5 tp -101.61 73.88 1.48 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.896 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' LEU . 6.0 mtt -48.15 172.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -147.15 120.18 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.413 -0.805 . . . . 0.0 109.344 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -150.04 -178.47 6.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.743 -1.223 . . . . 0.0 110.042 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.31 -41.64 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.51 56.42 2.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 109.375 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.26 111.51 6.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.708 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.203 -0.936 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -136.36 -70.21 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -45.97 -16.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.809 . . . . 0.0 109.553 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -90.13 -57.31 2.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 109.608 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -47.44 -28.42 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.377 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.95 -60.04 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.313 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.69 -52.8 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 108.971 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.64 -48.45 58.21 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.495 -0.753 . . . . 0.0 108.992 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.75 -45.92 49.92 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.651 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -50.23 -29.18 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 108.864 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -112.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.47 -0.769 . . . . 0.0 109.191 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.712 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -131.64 0.14 4.98 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.6 11.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.143 -0.622 . . . . 0.0 110.621 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.712 ' H ' ' C ' ' A' ' 102' ' ' GLY . 21.8 m -29.44 -32.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 122.265 -0.272 . . . . 0.0 111.723 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.81 135.48 12.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -152.06 110.23 3.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 108.822 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.5 p -104.44 139.75 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.07 105.19 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.531 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.21 160.12 83.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.903 -1.123 . . . . 0.0 109.059 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.08 166.33 83.54 Favored 'Cis proline' 0 N--CA 1.484 0.944 0 C-N-CA 124.747 -0.939 . . . . 0.0 110.577 -2.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -142.4 -170.98 3.3 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.978 0.894 . . . . 0.0 109.554 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -135.22 150.18 50.04 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.45 -33.65 6.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.418 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.83 -30.96 61.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -79.32 -61.3 2.05 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -49.99 -32.45 15.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.45 -1.406 . . . . 0.0 108.388 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.19 -56.99 10.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.066 -1.021 . . . . 0.0 109.942 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -44.16 -36.41 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.668 -0.645 . . . . 0.0 109.459 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -43.52 81.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.293 -0.879 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.56 -63.07 1.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 109.481 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -44.73 -49.48 10.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.339 -0.851 . . . . 0.0 110.598 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.13 -29.61 63.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.288 -0.883 . . . . 0.0 110.726 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.98 -44.63 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.156 . . . . 0.0 110.785 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -59.14 -9.95 2.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.014 -1.054 . . . . 0.0 110.571 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -20.9 63.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -95.49 -31.88 13.14 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -22.37 43.52 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.87 88.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.256 -1.143 . . . . 0.0 109.459 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.641 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -46.27 109.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.0 109.637 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 2.0 mmtp -56.36 7.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.157 -0.964 . . . . 0.0 110.635 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.641 ' H ' ' C ' ' A' ' 3' ' ' ASP . 73.3 mt-10 -141.92 45.34 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.058 -1.026 . . . . 0.0 108.738 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 45.0 tp -76.64 107.97 9.31 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 118.215 -1.394 . . . . 0.0 108.715 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -48.95 113.83 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 68.8 m-85 -104.94 155.46 18.92 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -130.97 103.4 6.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 107.78 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 0.0 109.802 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.3 t -107.87 106.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 -163.51 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.393 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.02 4.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.05 165.28 14.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -97.69 9.7 41.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -149.74 10.22 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 0.0 109.642 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.1 ttt -92.13 -47.14 7.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -28.81 69.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.415 ' CG ' HH21 ' A' ' 22' ' ' ARG . 31.6 ttp85 -68.49 -52.77 28.66 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.778 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt -46.24 -55.05 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.365 -0.835 . . . . 0.0 109.689 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -43.27 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.616 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.415 HH21 ' CG ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -46.88 -55.01 8.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.038 -1.039 . . . . 0.0 109.755 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.33 -55.13 19.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.111 0.958 . . . . 0.0 109.039 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -39.73 -55.25 1.96 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.893 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -59.94 -49.89 75.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.79 -34.11 38.37 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.909 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 2.8 tt0 -58.24 -30.17 66.31 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -87.08 -14.48 41.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.775 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.22 46.05 1.77 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.228 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -117.28 129.36 55.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.308 -1.113 . . . . 0.0 108.9 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -128.68 67.99 1.39 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.95 94.91 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -0.957 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.05 149.19 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 110.843 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.78 -169.06 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -150.0 154.52 38.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.021 -1.05 . . . . 0.0 110.69 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.11 -172.4 3.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -139.09 15.47 2.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.169 -0.957 . . . . 0.0 110.619 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 175.24 146.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.713 -1.242 . . . . 0.0 109.868 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.17 -32.98 10.05 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.04 -35.72 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.337 -1.096 . . . . 0.0 108.657 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ASP . 26.5 t0 -70.87 -44.94 65.34 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -63.25 -54.13 42.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.73 -43.15 17.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.922 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -73.94 -33.27 63.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -90.02 -7.68 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 110.006 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -68.07 -13.6 62.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -85.82 -2.83 58.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.45 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.464 -0.772 . . . . 0.0 109.722 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.61 9.97 1.43 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.84 83.75 1.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.485 ' C ' ' N ' ' A' ' 53' ' ' PHE . 57.2 m-85 -62.69 99.89 0.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.29 -1.123 . . . . 0.0 109.693 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.96 -14.28 0.41 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -148.99 119.23 7.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.48 -1.012 . . . . 0.0 109.884 -179.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.65 124.05 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.238 -0.913 . . . . 0.0 109.524 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.45 126.16 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -143.44 145.15 32.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -0.782 . . . . 0.0 108.987 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -98.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.081 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -172.57 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.145 -0.972 . . . . 0.0 109.726 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -134.84 -1.39 2.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.333 -0.854 . . . . 0.0 109.761 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.649 ' N ' HD21 ' A' ' 59' ' ' ASN . 2.2 mtp -60.16 -47.33 97.08 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 110.67 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.22 -66.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.118 1.212 . . . . 0.0 110.598 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -130.22 -152.43 0.51 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.596 -0.69 . . . . 0.0 109.634 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mtt -51.53 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.699 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 2.3 p30 -142.68 138.45 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.373 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.29 -2.8 21.55 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.42 -45.83 62.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.829 -1.395 . . . . 0.0 108.163 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -39.16 71.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 tp -53.78 -29.1 38.72 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -88.07 -64.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 109.333 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 69' ' ' LEU . 6.7 ttpp -34.88 -52.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.105 0.478 . . . . 0.0 110.381 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -45.53 41.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 108.766 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 69' ' ' LEU . 53.4 mt -59.37 -30.43 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 108.846 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' LYS . 4.3 ttp85 -83.47 -23.01 32.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.756 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -46.53 -28.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.563 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 18.0 t0 -61.37 -150.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.504 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -161.54 33.92 0.37 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.06 6.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -1.195 . . . . 0.0 109.404 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.9 ptm -150.03 52.94 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.349 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.7 t -92.76 -5.58 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.647 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.92 53.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.44 111.35 1.96 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.897 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.13 144.1 95.45 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 121.009 1.139 . . . . 0.0 112.584 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.26 137.88 37.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.13 75.13 0.92 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.4 mtt -65.42 122.69 17.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.19 140.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 110.774 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 109' ' ' LYS . 2.4 t -150.09 161.11 43.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.36 25.36 10.77 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' ALA . 48.8 tt0 -142.8 -64.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.475 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 48.77 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 109.165 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.522 ' NZ ' ' OD1' ' A' ' 94' ' ' ASN . 22.0 mtmm -59.63 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.208 -0.932 . . . . 0.0 109.811 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -145.25 -101.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -49.99 -27.28 5.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.022 -1.049 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.522 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -52.16 -27.12 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -71.62 -27.83 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -74.29 -51.43 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.1 26.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.083 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.19 -52.88 63.52 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.496 -0.753 . . . . 0.0 109.552 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.0 65.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -48.67 -27.97 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.997 . . . . 0.0 108.821 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.45 -114.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.608 -0.682 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -123.82 -8.32 6.27 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.53 10.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.026 -0.691 . . . . 0.0 110.581 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.69 ' H ' ' C ' ' A' ' 102' ' ' GLY . 4.7 m -29.59 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.46 132.94 11.13 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.185 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.504 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -145.33 129.03 17.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -1.097 . . . . 0.0 109.222 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.467 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -134.77 124.99 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.16 103.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.733 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' THR . 2.9 pttp -71.47 157.84 89.14 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.34 166.97 81.26 Favored 'Cis proline' 0 N--CA 1.485 1.011 0 C-N-CA 125.01 -0.829 . . . . 0.0 110.683 -1.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.02 158.0 43.95 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.04 0.924 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.36 148.94 23.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -45.88 -23.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 109.377 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -70.23 -41.96 72.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.14 -65.28 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.4 tp -47.59 -36.32 10.52 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.553 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -65.21 -66.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.975 -1.078 . . . . 0.0 109.733 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -45.21 -30.09 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.995 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 11.0 mmmt -81.35 -50.28 9.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.032 -1.043 . . . . 0.0 110.01 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -31.06 70.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.725 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.23 -28.73 47.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -77.82 -22.91 49.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.77 -43.54 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.502 ' CD2' ' SD ' ' A' ' 129' ' ' MET . 17.8 m-30 -73.82 -0.62 16.43 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.912 -1.118 . . . . 0.0 109.45 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -69.34 -20.28 63.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.35 -29.11 12.23 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -80.71 -16.54 53.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.99 90.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 124' ' ' PHE . 4.4 mtt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.319 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.13 145.13 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.392 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.25 17.64 6.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.312 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -152.05 44.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.26 143.11 52.23 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -78.3 131.85 37.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.988 -1.07 . . . . 0.0 111.247 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.94 147.52 46.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.736 -0.603 . . . . 0.0 109.821 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.97 110.72 13.29 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.76 105.25 16.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.62 95.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.413 -0.805 . . . . 0.0 109.86 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -142.1 -159.22 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.231 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 1.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' THR . 8.9 m-85 -91.21 98.06 11.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.419 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.51 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -93.25 -34.49 13.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.48 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 3.9 ttt -56.06 -56.63 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.77 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -35.28 5.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.318 -0.863 . . . . 0.0 109.669 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 ttm-85 -72.97 -35.66 66.95 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.065 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.3 -54.0 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.382 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -32.85 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.767 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -50.74 -53.62 30.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -58.24 5.39 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.939 0.876 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.739 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.39 -41.89 62.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -27.78 69.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 27' ' ' GLU . 7.5 tp10 -59.85 -35.9 75.73 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.054 -1.029 . . . . 0.0 109.375 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -59.55 2.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.16 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.62 73.91 0.02 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -149.97 144.54 25.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.24 . . . . 0.0 110.021 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.04 63.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -173.44 100.89 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.74 -1.225 . . . . 0.0 108.881 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.14 152.36 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.007 -1.058 . . . . 0.0 110.509 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.6 -173.35 2.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 13.5 mp0 -145.28 155.05 42.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.95 -172.75 4.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.01 8.65 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.045 . . . . 0.0 110.555 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 11.9 t70 -179.32 167.7 1.5 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.333 -0.855 . . . . 0.0 109.194 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -63.48 -25.59 68.81 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 t -72.46 -40.69 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 108.52 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.7 -45.67 67.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.66 -39.21 88.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.47 -37.34 72.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.351 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -86.92 -34.88 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.96 -53.98 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 48' ' ' ALA . 4.9 tt -50.07 -27.35 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 47' ' ' GLN . 1.4 tm0? -69.63 8.21 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 108.959 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.66 -68.72 0.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.98 0.31 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.126 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.62 99.16 1.79 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -79.53 110.39 14.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.373 -1.075 . . . . 0.0 110.437 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.76 -14.75 4.06 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.52 145.96 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -1.209 . . . . 0.0 110.179 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -141.93 120.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.138 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.6 mt -103.14 78.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -85.48 149.99 25.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.936 -1.102 . . . . 0.0 110.448 -177.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 27.7 t70 -94.64 178.21 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.567 -0.708 . . . . 0.0 109.291 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.539 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 53.5 t-105 -114.71 46.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -65.25 -154.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -162.81 60.05 0.95 Allowed Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 120.749 -1.219 . . . . 0.0 111.981 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.68 -39.53 42.82 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 107.576 -1.74 . . . . 0.0 107.576 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.46 -22.75 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -150.77 -83.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 65' ' ' GLY . 4.9 p-10 169.94 -107.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.528 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . -137.96 18.2 3.37 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' LEU . 25.3 tp -79.75 -54.17 6.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.083 -1.245 . . . . 0.0 108.152 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.4 tp10 -50.36 -21.89 1.61 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.9 mt -72.7 -59.67 2.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -46.95 -61.02 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.7 tttm -40.84 -48.55 3.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -61.17 -48.59 80.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.6 mt -57.76 -24.0 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -89.68 -28.04 19.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.709 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.72 -33.32 55.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.525 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.1 102.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.206 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.9 50.12 2.95 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.07 -71.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.142 . . . . 0.0 109.555 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.36 25.57 6.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER -65.93 6.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -95.22 20.99 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.82 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -67.23 118.78 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 108.661 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.79 98.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 120.909 1.072 . . . . 0.0 112.592 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.9 t -106.1 106.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -90.12 107.27 19.03 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.133 -1.827 . . . . 0.0 107.407 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.427 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -63.88 150.52 44.71 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.05 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -132.39 140.76 46.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.051 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -149.96 157.68 43.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.36 -44.33 7.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.842 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -64.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.836 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.442 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . . . 57.24 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.5 -88.61 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.504 -0.748 . . . . 0.0 109.14 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -156.81 -68.25 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.95 -32.56 61.48 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.193 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.539 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 2.4 t-20 -76.64 -47.45 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.03 -45.27 52.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.026 -1.046 . . . . 0.0 108.892 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 100' ' ' GLN . 17.7 mt -66.25 -17.04 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 100' ' ' GLN . . . -62.68 -69.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 109.326 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -47.43 -45.71 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 108.5 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -67.88 -27.35 66.59 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.326 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' ILE . 5.5 tp-100 -55.79 -31.76 62.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.86 -20.17 27.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.44 76.11 0.3 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.373 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.21 -112.09 0.08 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.844 -1.942 . . . . 0.0 110.454 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -50.69 5.59 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.832 1.301 . . . . 0.0 108.047 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 169.85 -155.66 25.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' HH ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -142.66 127.49 18.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -1.023 . . . . 0.0 109.586 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.6 p -117.96 134.87 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.94 121.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.567 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -94.18 162.06 27.62 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.253 -0.904 . . . . 0.0 108.611 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.6 128.32 15.98 Favored 'Cis proline' 0 N--CA 1.485 1.014 0 C-N-CA 124.755 -0.936 . . . . 0.0 110.427 -2.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -99.48 158.27 15.85 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.93 0.871 . . . . 0.0 110.084 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.503 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.25 146.79 23.44 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 117' ' ' GLU . . . -45.56 -23.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.973 -1.08 . . . . 0.0 109.829 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.47 -38.29 65.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.035 -1.041 . . . . 0.0 108.49 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.84 -62.46 1.37 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' THR . 7.1 tp -47.67 -41.76 23.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.721 -1.191 . . . . 0.0 108.939 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 19.3 mt-10 -61.82 -52.26 64.9 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.053 -1.029 . . . . 0.0 109.499 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -46.4 -49.19 18.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.479 -0.763 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -38.61 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.87 -63.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.79 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -47.59 -53.06 15.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -62.62 -18.21 61.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.8 mt -89.64 -45.66 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.0 109.987 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 16.7 m-85 -66.63 -31.48 72.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.002 -1.061 . . . . 0.0 110.014 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -52.71 -26.63 14.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -87.35 -26.48 23.34 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 44.0 tp -70.44 -24.01 62.82 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.19 23.41 19.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.7 mmt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.337 -1.096 . . . . 0.0 109.465 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.578 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -177.13 150.84 0.77 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.21 -0.931 . . . . 0.0 109.009 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -90.47 17.78 6.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.861 -1.149 . . . . 0.0 110.499 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.94 43.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.512 -1.368 . . . . 0.0 111.232 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.2 tp -67.02 110.98 3.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.424 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.59 111.29 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.828 -1.17 . . . . 0.0 111.611 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 62.2 m-85 -105.77 155.14 19.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 tp -132.65 104.06 6.45 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.95 130.16 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.261 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.4 t -137.99 105.37 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.44 -0.788 . . . . 0.0 109.078 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -149.6 116.39 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.148 -0.97 . . . . 0.0 109.431 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.17 -16.85 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.225 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.5 m-85 -59.49 130.03 44.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 m -92.26 48.7 1.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 t -175.72 -14.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 ttt -72.37 -35.56 68.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -63.05 -32.38 73.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.85 -20.16 58.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 20' ' ' ILE . 2.0 mt -75.33 -47.2 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -32.99 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.215 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -46.03 -52.61 11.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -73.64 -59.58 2.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.601 0.715 . . . . 0.0 110.161 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -40.22 -55.41 2.16 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.916 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -58.23 -50.45 73.52 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -54.0 -34.5 60.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.87 -38.53 49.93 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.391 -0.818 . . . . 0.0 109.38 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -65.03 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.48 26.2 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 54.0 m-85 -100.52 141.47 33.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -1.147 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -150.04 59.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 110.183 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.23 96.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.72 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.6 -178.26 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 109.895 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.55 -175.62 4.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 11.1 mp0 -144.35 150.21 37.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.65 176.29 9.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.67 3.56 14.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.267 -0.896 . . . . 0.0 110.477 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.29 -176.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.262 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.04 -26.42 73.9 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.76 -43.13 93.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.076 -1.249 . . . . 0.0 108.132 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -75.68 -40.85 55.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.26 92.15 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.238 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mt -62.49 -49.3 75.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.294 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 10.2 m-80 -63.55 -29.13 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -24.16 21.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.622 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -23.06 61.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 0.0 109.625 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -76.72 -1.62 28.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.472 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.42 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.424 -0.797 . . . . 0.0 109.604 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.85 12.18 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.79 88.21 1.37 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' PHE . 58.4 m-85 -69.23 103.95 2.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.297 -1.119 . . . . 0.0 109.588 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.69 -9.19 0.45 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.63 131.28 10.66 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.188 -1.183 . . . . 0.0 109.986 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.5 t -125.18 114.61 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 109.551 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.46 77.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 p -100.33 128.74 46.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.473 -0.767 . . . . 0.0 110.541 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 59' ' ' ASN . 4.5 t70 -65.12 164.0 13.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.793 -1.192 . . . . 0.0 108.645 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -2.2 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 108.877 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.1 m120 46.88 -153.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.647 -1.283 . . . . 0.0 110.302 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 171.25 -44.95 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.284 -0.885 . . . . 0.0 110.739 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.08 125.21 14.23 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.678 0.918 . . . . 0.0 110.259 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.11 -148.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.17 115.73 1.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -85.72 -162.32 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.84 2.79 0.51 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 6.5 tp -82.26 -65.21 1.04 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.768 -1.431 . . . . 0.0 110.341 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -48.3 -19.96 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -67.98 -62.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 72' ' ' ILE . 83.2 mt -56.04 -67.66 0.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.562 0.696 . . . . 0.0 109.236 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 69' ' ' LEU . 25.2 tttp -30.46 -53.28 0.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.626 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -59.29 -47.94 83.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.997 -1.064 . . . . 0.0 108.755 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 69' ' ' LEU . 35.5 mt -58.48 -38.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.469 -0.77 . . . . 0.0 109.281 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -84.2 -8.11 59.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.604 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -75.77 -26.59 57.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.2 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.813 . . . . 0.0 109.747 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 46.3 -143.35 4.56 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.02 76.85 4.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -1.112 . . . . 0.0 109.363 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.525 ' C ' ' H ' ' A' ' 80' ' ' ALA . 1.3 ttt -132.02 43.71 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 33.47 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.99 -47.41 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.228 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -32.8 97.85 0.12 Allowed Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.61 139.04 61.96 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.422 1.415 . . . . 0.0 112.326 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.93 125.5 58.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.39 72.23 0.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.425 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.7 mtp -51.63 151.71 3.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 t -126.51 128.55 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.635 0.731 . . . . 0.0 110.745 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.05 177.05 10.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.39 -123.42 0.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.93 -1.106 . . . . 0.0 108.862 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -47.92 133.26 14.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 109.306 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.497 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -93.34 109.94 21.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.696 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -73.12 -171.06 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 108.872 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 94' ' ' ASN . 45.3 mttp -94.32 -84.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.54 -8.0 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -76.84 -52.43 9.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.77 -28.08 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.75 -64.06 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 109.979 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.86 -57.16 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.69 95.31 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.023 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.62 -44.33 73.05 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -19.92 59.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.831 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.22 -103.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.279 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.649 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -133.22 0.7 4.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.99 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.179 -0.601 . . . . 0.0 111.198 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.649 ' H ' ' C ' ' A' ' 102' ' ' GLY . 22.0 m -29.24 -34.74 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.995 -0.441 . . . . 0.0 111.8 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.2 130.43 10.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.497 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 49.7 t80 -136.5 112.58 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.437 -1.037 . . . . 0.0 109.492 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -115.39 129.01 72.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.37 103.07 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 154.89 89.71 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.035 -1.041 . . . . 0.0 109.165 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.26 158.84 98.46 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 O-C-N 122.506 0.74 . . . . 0.0 111.368 -1.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -136.16 154.65 50.9 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.853 0.835 . . . . 0.0 109.204 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.5 146.29 23.79 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.69 -40.44 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 108.699 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.67 -34.07 76.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' THR . 25.4 m -68.38 -67.11 0.49 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.92 -46.94 2.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.584 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.32 -54.82 42.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 110.302 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -47.84 -30.13 3.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.885 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -72.19 -49.32 36.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.389 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 123' ' ' ILE . 11.0 mt -48.45 -54.9 12.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.81 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -25.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.676 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -86.85 -27.07 23.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.022 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 120' ' ' LEU . 37.7 mm -81.52 -34.35 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.5 -8.61 57.42 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.099 -1.001 . . . . 0.0 110.755 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.57 -17.5 60.03 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -101.31 -30.31 11.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.17 -29.96 54.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.04 74.49 0.51 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.438 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.1 t0 -44.78 151.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 mttm -90.14 20.36 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.059 -1.026 . . . . 0.0 109.835 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -163.77 45.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.042 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 25.4 tp -71.82 121.09 18.36 Favored 'General case' 0 C--O 1.203 -1.344 0 O-C-N 121.025 -1.047 . . . . 0.0 108.231 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -53.61 117.31 3.02 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.932 -1.105 . . . . 0.0 112.176 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 70.7 m-85 -112.4 147.77 35.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.69 108.29 13.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.154 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -92.95 104.46 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 108.735 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.94 38.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.83 147.01 23.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -98.76 -13.94 19.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.541 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.08 137.65 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 t -88.08 17.4 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.44 -40.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.2 ttt -50.33 -35.0 25.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' CG ' ' N ' ' A' ' 19' ' ' ARG . 4.7 ptm85 -63.27 -47.91 80.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.031 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -53.73 -32.54 52.46 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.129 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -53.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -31.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.09 15.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.903 -1.123 . . . . 0.0 109.408 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -69.96 -59.44 2.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.757 0.789 . . . . 0.0 109.858 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.23 -52.7 2.61 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.046 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -62.59 -50.22 72.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.014 . . . . 0.0 108.988 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -55.52 -30.71 61.18 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.89 -27.86 63.68 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.49 -37.57 16.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 139.28 7.69 1.07 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.9 m-85 -89.89 139.74 30.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.66 -1.494 . . . . 0.0 109.754 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 1.1 p30 -148.16 62.89 1.11 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.03 -1.044 . . . . 0.0 110.302 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.52 105.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.591 -1.318 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.15 179.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.105 -0.997 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -137.26 -170.37 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 18' ' ' ARG . 47.1 mt-10 -141.97 149.7 40.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.324 -0.86 . . . . 0.0 110.741 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.02 -172.82 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -148.67 7.15 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.015 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 175.73 177.86 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -69.39 -39.57 80.59 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 118.955 -1.593 . . . . 0.0 110.066 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.0 t -54.59 -40.79 51.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.406 -1.644 . . . . 0.0 107.654 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -81.01 -43.21 19.94 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.499 -0.751 . . . . 0.0 109.87 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -73.98 -58.22 3.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.391 -0.818 . . . . 0.0 109.504 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -53.53 -37.87 63.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.946 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -72.66 -42.91 63.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.371 -1.456 . . . . 0.0 109.216 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -77.35 -14.29 59.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.728 . . . . 0.0 110.389 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -71.77 -25.05 61.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.711 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -66.11 -2.29 4.03 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 0.0 109.237 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.09 -66.49 0.39 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.19 13.42 0.54 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.937 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.67 88.17 1.28 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -64.3 122.45 16.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.398 -1.06 . . . . 0.0 110.516 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.21 -6.1 82.55 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -159.17 136.78 10.07 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.011 -1.288 . . . . 0.0 109.34 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.42 123.97 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.099 -1.001 . . . . 0.0 109.81 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mt -109.16 96.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.771 -0.581 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.07 145.38 42.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -162.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.971 -1.081 . . . . 0.0 109.178 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -103.76 -26.01 12.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 0.0 109.258 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -96.79 135.33 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.538 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -133.95 159.29 72.96 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.96 -68.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.368 1.378 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 63' ' ' MET . 2.8 p30 -85.62 -102.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 1.6 mmt -63.3 -178.06 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.656 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -179.53 5.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.41 -31.63 18.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 tp -47.57 -37.92 13.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -1.198 . . . . 0.0 108.984 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.21 -35.13 75.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 109.333 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.8 mp -63.88 -27.19 68.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' LYS . 53.8 tp -77.76 -60.21 2.46 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 1.4 tmtp? -43.7 -32.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -55.57 -52.99 61.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 109.348 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -57.95 -36.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 108.902 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -69.15 -27.97 66.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.56 -28.81 2.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.6 -38.25 20.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 77' ' ' ALA . . . 59.8 46.14 94.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' GLY . . . 167.3 -52.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' ALA . 12.8 mtt -94.46 21.47 7.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -74.7 37.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -97.5 -20.12 17.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -52.51 113.38 4.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.011 -1.055 . . . . 0.0 109.174 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.16 145.99 90.25 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 121.164 1.243 . . . . 0.0 112.983 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.08 132.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -113.48 70.79 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.662 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 86' ' ' VAL . 14.0 tmm? -49.48 159.81 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' N ' ' SD ' ' A' ' 85' ' ' MET . 39.5 t -137.94 121.26 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.488 -0.758 . . . . 0.0 110.16 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.8 t -150.13 178.88 8.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 0.0 110.02 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 -45.64 2.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.533 -0.73 . . . . 0.0 109.362 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.59 -77.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 63.27 117.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -131.8 148.67 52.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -42.5 -48.59 5.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.259 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -64.44 -29.72 70.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.283 -0.886 . . . . 0.0 110.665 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -89.99 -23.56 21.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.561 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.95 -16.35 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.659 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -74.95 -68.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.18 -43.78 21.6 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.97 -51.19 70.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.42 -0.8 . . . . 0.0 109.223 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.66 64.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.803 . . . . 0.0 110.593 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -77.19 6.26 6.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 110.4 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.53 -17.79 13.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 0.0 110.396 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 136.36 -12.39 4.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.41 11.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.861 -0.788 . . . . 0.0 111.467 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.671 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.8 m -29.41 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.917 -0.489 . . . . 0.0 111.312 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.74 124.11 7.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -145.02 105.7 4.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -1.234 . . . . 0.0 109.405 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.03 136.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.41 100.07 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.097 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.9 pttt -63.52 154.44 79.52 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.71 -1.244 . . . . 0.0 109.09 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.33 161.93 93.5 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 O-C-N 122.479 0.726 . . . . 0.0 111.225 -1.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -142.9 162.75 34.64 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.009 0.909 . . . . 0.0 110.082 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.09 148.95 26.27 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.76 -19.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.982 -1.074 . . . . 0.0 109.249 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.44 -37.31 51.84 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.401 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.0 OUTLIER -73.27 -61.39 1.84 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 tp -47.92 -38.64 16.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.005 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.49 -44.82 77.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 15.4 tt0 -56.38 -26.69 53.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.333 -0.854 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -81.95 -58.83 2.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 tt -46.28 -48.72 18.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.55 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -62.68 -33.49 75.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -67.83 -31.48 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.72 -38.01 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.865 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.03 -3.69 27.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.149 -0.969 . . . . 0.0 109.736 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -74.03 -29.33 61.87 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -88.68 -30.62 19.0 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 -28.99 61.35 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.36 83.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 60.56 129.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.151 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -90.06 24.04 2.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.889 -1.132 . . . . 0.0 110.058 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.22 40.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.789 -1.194 . . . . 0.0 110.773 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.03 133.24 49.51 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -75.08 120.39 20.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.893 -1.13 . . . . 0.0 111.32 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.66 148.16 31.83 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.6 tp -122.29 118.97 29.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.92 103.96 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.577 -0.702 . . . . 0.0 109.77 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 58.5 t -93.41 31.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.27 157.46 22.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.745 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.85 -30.96 13.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 150.36 49.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -24.2 18.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.46 -20.58 20.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -52.25 49.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.491 HH11 ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -49.43 -32.13 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.29 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.71 77.17 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.802 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.8 mt -57.86 -57.87 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -38.16 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.29 -52.85 19.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.968 -1.082 . . . . 0.0 109.193 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.5 t30 -64.34 -56.9 11.27 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.775 0.798 . . . . 0.0 109.171 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.86 -52.39 2.38 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.744 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.4 mt -63.1 -46.26 88.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 0.0 108.811 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.25 -32.58 66.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.342 -0.848 . . . . 0.0 109.419 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 4.7 tt0 -55.48 -41.96 73.71 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.43 -55.39 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.792 . . . . 0.0 109.298 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 78.01 0.02 OUTLIER Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -150.01 147.46 27.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -150.03 58.53 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.55 93.32 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.077 -1.014 . . . . 0.0 109.177 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.5 151.28 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.77 -171.83 2.47 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.16 157.11 42.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.924 -1.11 . . . . 0.0 110.884 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.54 -168.97 2.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.81 0.32 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.375 -0.828 . . . . 0.0 110.478 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 9.7 t70 -174.21 174.9 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -59.57 -57.21 20.72 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 13.2 p -50.97 -28.24 6.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -1.083 . . . . 0.0 108.535 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -76.27 -47.01 25.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.41 -0.806 . . . . 0.0 109.133 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.65 -66.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.346 -0.847 . . . . 0.0 109.786 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.06 -45.21 52.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.446 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 72.4 m-20 -63.63 -39.25 93.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.0 -1.063 . . . . 0.0 110.554 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -90.1 -1.08 57.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -87.52 -30.87 20.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 108.882 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -54.81 -9.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.105 -0.997 . . . . 0.0 108.574 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.02 -67.01 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.63 -92.3 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -156.96 78.29 0.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 53' ' ' PHE . 41.9 m-85 -57.35 91.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.431 -1.04 . . . . 0.0 110.158 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -57.96 -9.31 5.38 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.5 137.64 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.246 -1.15 . . . . 0.0 110.057 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -134.92 120.02 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.155 -0.966 . . . . 0.0 109.684 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.53 131.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 83.7 p -149.79 150.14 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' SER . 36.9 m-20 -60.67 -115.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.184 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -150.45 -42.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.603 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.528 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 0.2 OUTLIER 178.15 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.587 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.35 -54.72 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.761 -0.587 . . . . 0.0 110.283 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.13 -61.2 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.563 0 N-CA-C 108.846 -1.251 . . . . 0.0 108.846 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 2.8 m-80 -154.47 -148.96 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.6 mtt -48.16 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 108.423 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 42.55 -156.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.518 -0.739 . . . . 0.0 110.785 178.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . 48.17 -83.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -51.11 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.869 -1.371 . . . . 0.0 110.037 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.98 -33.78 11.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 108.813 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.461 ' HB3' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -62.65 -35.67 80.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.631 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 8.9 tt -90.05 -60.51 1.91 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -36.06 -34.49 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.131 0.491 . . . . 0.0 110.012 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.5 m -59.14 -50.1 75.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.0 mt -54.41 -37.86 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -70.36 -32.74 70.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.452 -0.78 . . . . 0.0 109.515 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.68 33.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.927 . . . . 0.0 109.582 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.71 98.59 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.595 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -23.71 66.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.47 90.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -1.186 . . . . 0.0 109.415 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 mtm -136.39 45.88 2.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 79' ' ' SER . 9.3 t -77.95 45.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.03 10.22 0.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.0 -1.062 . . . . 0.0 110.063 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 9.6 tp -55.36 120.74 32.97 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 108.382 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.25 131.36 38.38 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 120.962 1.108 . . . . 0.0 112.233 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.69 125.18 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.0 tp -107.05 70.12 0.78 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.571 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -51.53 168.91 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -143.11 126.67 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.532 -0.73 . . . . 0.0 109.801 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -150.1 178.44 8.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.911 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.43 3.94 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.72 50.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.5 101.92 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.33 -82.62 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 109.332 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -173.01 -73.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.29 -33.6 29.45 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.151 -0.968 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.5 -24.3 61.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -83.16 -36.98 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.556 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.5 -57.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.2 -37.77 10.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 109.229 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.65 -60.28 3.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -55.1 -40.19 70.18 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.221 -0.924 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -19.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.26 -123.96 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.727 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -111.87 2.24 27.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.71 11.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.623 -0.928 . . . . 0.0 109.98 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.727 ' H ' ' C ' ' A' ' 102' ' ' GLY . 1.4 m -29.54 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -109.64 127.67 8.56 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.53 120.31 9.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 108.825 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.59 130.17 74.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.01 105.04 12.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.154 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.79 161.08 64.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.02 -1.05 . . . . 0.0 109.257 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.46 166.35 83.34 Favored 'Cis proline' 0 N--CA 1.488 1.153 0 C-N-CA 124.832 -0.904 . . . . 0.0 110.801 -2.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.77 164.1 33.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 110.344 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.46 148.21 27.43 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.462 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -45.87 -36.66 5.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.048 . . . . 0.0 109.479 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.4 87.39 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.9 m -69.85 -67.01 0.52 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -45.62 -36.89 5.09 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.033 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 6.5 tm-20 -66.99 -46.85 73.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 26.9 tt0 -47.77 -60.01 2.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -34.89 64.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.474 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.88 -72.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.6 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.45 -17.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.926 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.47 -33.13 60.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.14 -0.975 . . . . 0.0 109.733 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.0 mt -89.97 -43.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 109.934 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -57.16 -21.13 30.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.634 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -57.36 -20.37 28.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.763 -1.211 . . . . 0.0 108.221 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -96.82 -22.03 17.17 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.32 -18.98 25.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 79.07 0.06 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.541 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -142.57 135.0 27.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 108.883 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -90.05 21.55 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.977 . . . . 0.0 109.572 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -160.13 44.0 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.068 -1.02 . . . . 0.0 109.956 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.6 tp -84.46 125.7 32.6 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -74.67 123.28 24.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.169 -0.957 . . . . 0.0 112.155 -176.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -114.88 140.89 48.6 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 tp -106.02 116.76 32.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.57 102.8 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 t -95.02 62.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.243 -0.91 . . . . 0.0 109.644 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -103.27 132.48 49.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.12 -21.26 36.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.133 -0.979 . . . . 0.0 109.299 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -57.86 146.82 30.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.513 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 m -90.6 29.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 -38.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' OD2' ' A' ' 57' ' ' ASP . 27.5 ttt -48.41 -45.57 36.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -56.65 9.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -56.34 -41.59 76.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 110.133 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mt -54.61 -53.78 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -44.99 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.408 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.01 -52.83 22.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.872 -1.143 . . . . 0.0 109.034 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -62.02 -56.79 15.47 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.89 0.853 . . . . 0.0 109.049 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.32 -59.75 1.01 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.066 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -59.44 -47.28 86.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -53.43 -33.35 53.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.19 -33.16 39.54 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.165 -0.96 . . . . 0.0 109.177 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 9.9 mp -80.43 -67.62 0.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.08 17.54 0.02 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.294 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.0 m-85 -90.66 129.46 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.749 -1.442 . . . . 0.0 109.197 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.86 68.95 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.502 -0.749 . . . . 0.0 109.93 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.5 103.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.082 -1.011 . . . . 0.0 108.569 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -149.98 148.24 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.82 -171.4 2.18 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -149.86 150.31 31.75 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 110.832 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.5 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 1.8 mp0 -135.96 32.69 2.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.125 -0.984 . . . . 0.0 110.729 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 7.4 t0 175.04 145.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.277 -0.89 . . . . 0.0 108.832 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -50.6 -29.85 18.96 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -28.37 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.254 . . . . 0.0 108.534 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 5.1 t0 -81.4 -41.81 21.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.83 86.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.446 -0.784 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mt -70.73 -41.94 71.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -63.36 -27.04 69.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -53.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -19.67 17.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 108.645 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -50.36 -28.05 7.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.0 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 68.02 0.47 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.81 24.24 0.06 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' PHE . 52.6 m-85 -94.74 83.06 3.98 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.28 -1.13 . . . . 0.0 109.904 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.51 0.48 2.07 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -162.95 152.82 15.79 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.1 -1.235 . . . . 0.0 109.805 -179.115 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.4 128.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.724 -1.235 . . . . 0.0 109.78 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.44 128.79 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -132.67 163.04 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.171 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 18.3 m-20 -91.33 -106.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.645 -178.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -164.09 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -95.66 137.19 35.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.535 ' C ' ' H ' ' A' ' 62' ' ' ASN . 3.6 mmt -139.78 155.24 71.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.14 -1.13 0.16 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.431 1.421 . . . . 0.0 111.076 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 60' ' ' MET . 3.8 p30 -133.63 107.87 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.433 -0.792 . . . . 0.0 109.083 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.421 ' O ' ' OD2' ' A' ' 64' ' ' ASP . 42.1 mtm 53.67 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.0 109.405 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ASN . 1.2 m-20 -169.93 150.64 3.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 108.86 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.21 8.86 2.49 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' ASP . 9.2 mt -67.09 -52.85 36.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -1.107 . . . . 0.0 109.082 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -74.06 -14.13 60.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 109.563 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.7 tp -67.62 -57.35 6.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 108.836 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -73.24 -36.02 66.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 74' ' ' ALA . 16.8 tttt -47.03 -47.91 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 108.82 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.1 m -47.16 -59.24 3.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.477 -0.765 . . . . 0.0 109.638 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mt -49.82 -40.09 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.66 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -10.68 55.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -92.43 -26.62 17.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -45.13 158.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.28 -52.85 21.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.06 109.44 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.528 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.531 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -144.25 12.71 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.858 . . . . 0.0 109.281 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -65.31 4.84 0.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.175 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.87 -15.49 32.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 1.1 tp -112.03 99.13 44.88 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.66 139.0 78.63 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.037 1.825 . . . . 0.0 113.695 -178.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.5 t -124.75 119.55 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tp -99.0 109.78 22.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 ttm -86.2 146.85 26.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.9 144.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -150.09 173.92 13.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.943 -1.098 . . . . 0.0 110.74 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.61 148.7 35.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 49.08 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.426 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -83.42 119.08 24.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.022 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.9 -169.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 0.0 109.051 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -99.6 -39.05 8.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.704 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.89 -19.08 25.01 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.113 -0.992 . . . . 0.0 110.284 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -80.23 -22.59 41.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 110.106 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 24.7 mt -69.16 -8.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.132 . . . . 0.0 109.932 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.481 ' C ' ' N ' ' A' ' 98' ' ' ALA . 10.1 mt -90.17 -49.11 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.05 -24.63 0.16 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -50.28 -56.8 9.65 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -45.58 -44.73 13.17 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 119.629 -1.919 . . . . 0.0 108.924 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -59.69 -36.8 77.21 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -126.33 -72.51 0.65 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -48.8 82.17 0.01 OUTLIER Glycine 0 N--CA 1.496 2.643 0 N-CA-C 106.576 -2.609 . . . . 0.0 106.576 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -70.03 -109.81 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.824 0 CA-C-N 111.508 -2.346 . . . . 0.0 114.994 -174.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 83' ' ' VAL . 2.0 p -38.87 -54.18 1.65 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.564 -176.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . -156.8 171.17 34.29 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.12 116.2 15.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.407 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.1 p -115.59 126.34 73.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.43 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 9.5 p -78.67 108.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 157.38 88.33 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.991 -1.068 . . . . 0.0 109.583 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.79 159.39 97.22 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 O-C-N 122.768 0.878 . . . . 0.0 110.626 -2.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -136.63 160.06 39.93 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.658 0.742 . . . . 0.0 109.783 178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.47 148.81 22.42 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.0 -32.09 8.61 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.97 -1.082 . . . . 0.0 108.833 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.06 71.99 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' THR . 6.0 m -70.89 -66.94 0.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 115' ' ' THR . 11.6 tp -45.58 -41.62 10.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.859 -1.151 . . . . 0.0 109.195 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.72 -50.06 70.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.301 -0.874 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.22 -41.71 13.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -77.98 -43.69 28.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 109.124 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.44 -47.48 26.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 108.957 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 m-20 -49.9 -59.88 3.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.323 -0.861 . . . . 0.0 109.947 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -50.32 -35.46 27.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 110.016 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.7 mt -73.15 -41.54 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 110.005 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -77.92 0.85 22.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.095 -1.003 . . . . 0.0 110.215 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -75.65 -32.66 60.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -88.71 -25.97 22.05 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -33.61 27.67 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.28 82.43 0.03 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.464 -179.975 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.553 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER 61.08 116.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -90.39 27.24 1.73 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.745 -1.222 . . . . 0.0 110.31 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -145.82 36.83 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.38 141.09 35.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.434 ' NZ ' ' OD1' ' A' ' 32' ' ' ASN . 12.7 mttp -80.02 129.87 34.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.915 -1.116 . . . . 0.0 111.349 -177.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.79 151.56 37.82 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.781 -0.574 . . . . 0.0 109.655 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -127.04 109.88 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.77 114.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.347 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.56 108.76 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 124.31 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -29.29 70.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.678 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.77 139.18 10.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 p -93.56 22.24 5.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 p -145.79 -15.87 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.6 ttt -70.95 -39.3 72.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -35.35 80.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ttp85 -68.93 -21.02 64.23 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.077 -178.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.1 -45.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.868 . . . . 0.0 109.744 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -36.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -47.42 -53.02 15.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.364 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.31 -57.56 7.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.818 0.818 . . . . 0.0 109.371 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.18 -60.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -56.45 -46.05 80.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 109.125 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -55.45 -35.24 65.25 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.175 -0.953 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.32 -28.14 40.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.406 -0.809 . . . . 0.0 109.783 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.09 -33.6 22.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.43 10.69 2.09 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 79.4 m-85 -89.69 141.2 28.83 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.743 -1.445 . . . . 0.0 109.418 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -143.64 28.4 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.481 -0.762 . . . . 0.0 109.728 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 7' ' ' LYS . 15.9 t-20 -131.61 88.23 2.55 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.31 153.24 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.627 -0.671 . . . . 0.0 110.11 -178.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -125.57 -173.6 2.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.19 148.2 28.64 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.05 166.7 17.9 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 12.5 mm-40 -94.53 -3.02 50.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.867 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER 169.63 173.85 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.917 -1.114 . . . . 0.0 109.691 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.42 54.87 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -53.96 -42.87 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.988 -1.301 . . . . 0.0 108.727 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -63.99 -50.44 68.52 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -53.36 -49.38 67.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.276 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tp -53.22 -35.39 59.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.908 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.75 -33.44 35.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.371 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -90.07 -12.54 38.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.068 -1.02 . . . . 0.0 110.464 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -63.42 -20.58 65.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.029 -1.044 . . . . 0.0 109.212 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.93 1.21 24.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.138 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.94 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.409 -0.807 . . . . 0.0 109.657 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.25 11.93 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.32 80.63 1.47 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' C ' ' H ' ' A' ' 53' ' ' PHE . 38.3 m-85 -60.06 102.14 0.15 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -1.089 . . . . 0.0 109.769 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.47 -12.54 1.0 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -153.24 134.59 14.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.378 -1.072 . . . . 0.0 109.499 -179.427 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.26 117.69 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.827 -1.171 . . . . 0.0 109.939 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.94 119.6 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.8 p -141.47 144.1 34.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.808 . . . . 0.0 109.248 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.7 p-10 -60.47 -112.45 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.979 -1.075 . . . . 0.0 109.229 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -173.87 -32.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 108.834 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.5 58.57 2.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 0.0 109.54 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ptm -47.88 159.24 0.48 Allowed Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.47 -48.47 20.33 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.248 1.299 . . . . 0.0 110.514 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.09 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.853 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.1 mmt -90.9 -110.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.938 . . . . 0.0 109.869 -179.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.3 -175.56 4.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.78 12.29 70.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -62.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.8 -1.411 . . . . 0.0 108.569 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' O ' ' OG1' ' A' ' 71' ' ' THR . 23.0 tt0 -48.8 -37.52 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.3 -42.67 82.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' ILE . 1.2 mt -75.41 -63.5 1.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.524 0.678 . . . . 0.0 109.18 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' LEU . 39.9 tttp -40.29 -34.95 0.36 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.759 -0.588 . . . . 0.0 109.986 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 13.1 m -73.2 -37.19 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 108.664 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' LEU . 39.6 mt -61.08 -21.41 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -88.68 5.33 43.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.358 -0.839 . . . . 0.0 109.319 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -122.01 -20.88 6.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.5 m-20 -59.67 -140.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.54 0.686 . . . . 0.0 110.214 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -55.37 -167.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.81 50.32 1.79 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.04 -70.19 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 t 44.29 17.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -145.87 -3.52 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 tp -54.43 113.56 5.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 109.05 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 140.31 89.49 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.119 1.213 . . . . 0.0 112.351 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.83 127.88 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.42 78.42 1.16 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtt -72.24 132.2 43.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.23 140.2 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 t -150.02 171.49 16.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 109.604 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.01 -87.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.817 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -66.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.72 99.87 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 109.174 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -95.59 119.62 34.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.207 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -50.07 7.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.785 . . . . 0.0 109.983 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.23 -35.11 7.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.174 -0.954 . . . . 0.0 109.686 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 96' ' ' ILE . 2.3 t-20 -85.53 -39.04 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.191 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.1 mm -58.24 -0.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 94' ' ' ASN . 71.9 mt -89.82 -65.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.33 -34.72 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.54 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.95 36.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.876 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.7 67.58 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.044 -1.035 . . . . 0.0 110.011 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.47 -19.51 1.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 109.135 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.18 -112.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.724 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.81 -5.38 4.9 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.56 10.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.927 -0.749 . . . . 0.0 110.348 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.724 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.3 m -29.75 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.009 -178.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.05 125.68 8.66 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -142.38 109.38 5.51 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.286 -1.126 . . . . 0.0 109.697 179.189 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.53 150.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.48 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 39.9 t -90.52 111.72 23.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.729 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 152.44 78.07 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.786 -1.196 . . . . 0.0 109.514 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.85 165.6 84.49 Favored 'Cis proline' 0 N--CA 1.49 1.314 0 O-C-N 122.52 0.748 . . . . 0.0 110.909 -1.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -144.4 156.89 44.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.855 0.836 . . . . 0.0 110.106 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.548 ' H ' ' HG1' ' A' ' 115' ' ' THR . 1.0 OUTLIER -95.67 150.79 19.98 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.755 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.37 -15.36 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.783 -1.198 . . . . 0.0 109.194 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.27 -38.34 35.68 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.33 -62.41 1.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.537 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 115' ' ' THR . 4.6 tp -48.6 -38.73 21.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.195 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.56 -56.81 11.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 0.0 110.068 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.18 -66.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.554 -0.716 . . . . 0.0 109.931 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -35.25 5.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.25 -68.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.03 -32.91 10.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.78 -38.17 81.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.07 -47.83 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.055 -1.028 . . . . 0.0 109.963 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -53.19 -19.0 2.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.122 -0.986 . . . . 0.0 110.232 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -55.95 -35.43 66.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 107.949 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -79.6 -32.23 41.83 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 tt -65.11 -23.58 67.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.76 61.34 1.29 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.418 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER 51.81 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.818 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.2 ptmm? -76.83 47.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.006 -1.059 . . . . 0.0 109.544 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -160.42 27.11 0.16 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.6 tp -69.65 143.21 53.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 1.9 mtmp? -82.35 127.76 33.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.125 -0.984 . . . . 0.0 111.508 -177.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.41 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 35.4 m-85 -116.32 150.7 37.24 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.865 -0.522 . . . . 0.0 109.974 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -125.15 106.9 10.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.37 105.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 109.05 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.99 24.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.155 -0.965 . . . . 0.0 109.455 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -56.64 126.58 27.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -93.63 -2.59 53.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.34 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -58.81 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.965 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.05 8.52 5.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.578 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -22.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.748 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.3 tpp -47.71 -50.39 25.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.243 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' NE ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -45.38 -55.41 6.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 110.469 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -56.24 -37.39 69.67 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.577 -177.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.78 -49.02 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.119 -0.988 . . . . 0.0 110.046 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -33.25 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.995 -1.066 . . . . 0.0 110.515 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -53.51 21.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.989 -1.07 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.1 t30 -67.57 -58.15 5.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.881 0.848 . . . . 0.0 109.63 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 4.5 tt -40.09 -34.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.125 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.95 -42.08 27.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.905 -1.122 . . . . 0.0 108.233 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.578 ' CB ' ' HZ1' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -58.88 -34.9 72.18 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.346 -0.846 . . . . 0.0 108.925 179.318 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.85 -29.14 39.88 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.347 -0.845 . . . . 0.0 109.236 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.27 -12.86 42.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 106.09 15.39 18.16 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -89.83 126.84 35.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.479 . . . . 0.0 109.0 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -130.42 67.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.808 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.4 89.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 108.594 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -140.23 151.69 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.489 -178.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.2 mt-10 -126.18 -173.23 2.8 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.45 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 7.6 tt0 -149.13 159.48 44.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.769 -1.207 . . . . 0.0 111.157 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.99 -171.79 3.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.41 8.57 2.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.805 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.16 -170.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.34 -38.96 44.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.98 -1.581 . . . . 0.0 109.293 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 62.9 t -52.52 -40.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.915 -1.344 . . . . 0.0 107.763 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.15 -50.6 10.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.677 -0.639 . . . . 0.0 109.847 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -62.56 -59.46 4.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.9 tp -44.75 -50.75 9.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.313 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 60.6 m-20 -66.7 -36.28 82.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.012 . . . . 0.0 109.577 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -90.13 8.0 35.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -87.98 -44.18 11.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.898 -1.126 . . . . 0.0 109.076 179.681 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -65.75 1.55 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.186 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.44 -69.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.391 -0.818 . . . . 0.0 109.859 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.35 1.26 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 85.27 88.11 0.92 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.43 ' OH ' ' CG ' ' A' ' 34' ' ' GLU . 38.4 m-85 -71.1 136.66 48.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.304 -1.115 . . . . 0.0 109.66 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.49 -5.67 71.77 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -152.14 135.88 16.26 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.578 -0.954 . . . . 0.0 108.95 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.05 116.98 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.817 -1.177 . . . . 0.0 109.781 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.62 95.42 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.5 p -105.61 131.99 52.3 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 59' ' ' ASN . 37.7 p-10 -100.15 123.31 44.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.467 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ASP . 1.4 t-105 -45.76 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.244 -0.91 . . . . 0.0 108.679 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASP . 80.1 m-20 -92.57 -150.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 110.635 -178.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.619 ' H ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -124.65 -29.82 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.619 ' CD ' ' H ' ' A' ' 60' ' ' MET . 4.1 Cg_exo -62.01 164.48 16.7 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 CA-C-N 119.812 0.968 . . . . 0.0 110.842 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -41.73 -62.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.785 -0.572 . . . . 0.0 109.633 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.483 ' H ' HD21 ' A' ' 62' ' ' ASN . 0.8 OUTLIER -79.24 56.08 1.99 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.275 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' MET . 0.2 OUTLIER -46.9 -94.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.472 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.72 -24.29 0.07 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -70.67 -58.06 4.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.876 -1.367 . . . . 0.0 108.612 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.41 -33.46 6.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.59 -42.63 86.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -69.06 -45.05 71.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.529 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -58.66 -32.34 68.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 0.0 108.884 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -66.85 -42.98 84.79 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.282 -0.886 . . . . 0.0 108.999 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.27 -31.6 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -30.57 71.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.073 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -59.0 -24.14 62.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 6.3 t70 -42.85 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 75' ' ' ASP . . . 152.32 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.05 -21.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.187 . . . . 0.0 109.206 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.533 ' C ' ' H ' ' A' ' 80' ' ' ALA . 3.0 mtm -116.84 36.77 4.04 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -65.64 7.35 0.25 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.518 -0.739 . . . . 0.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.74 24.12 3.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tt -48.89 125.56 13.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.68 114.85 2.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.667 0.912 . . . . 0.0 112.257 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.34 118.74 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.49 79.1 2.72 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.229 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtp -64.75 108.85 1.85 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.42 134.57 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.632 -1.292 . . . . 0.0 109.362 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.2 t -150.2 177.57 9.8 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.812 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -122.76 141.51 51.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 5.8 tt0 67.99 35.59 3.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 0.0 109.148 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.473 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -45.52 127.33 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.814 . . . . 0.0 109.914 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -83.31 -133.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 -28.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.241 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -29.69 21.24 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -79.33 -36.43 39.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.1 mt -64.68 -5.92 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 108.966 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.94 -58.44 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 109.354 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.92 -60.57 2.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.46 34.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 108.755 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.91 28.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.982 -1.074 . . . . 0.0 109.419 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -27.84 56.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.228 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.84 -106.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.923 . . . . 0.0 109.558 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -145.36 12.11 1.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.6 11.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.045 0.538 . . . . 0.0 110.775 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.0 m -29.33 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.99 126.96 8.02 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.08 111.11 6.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.535 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.95 121.9 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.3 172.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.179 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' THR . 15.4 pttt -147.4 156.96 45.85 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 120.579 -1.326 . . . . 0.0 108.911 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.98 167.89 77.35 Favored 'Cis proline' 0 N--CA 1.485 0.983 0 C-N-CA 124.862 -0.891 . . . . 0.0 110.348 -1.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -134.6 155.64 50.1 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.017 0.913 . . . . 0.0 110.473 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -93.12 151.42 19.86 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.114 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.73 -38.39 9.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.918 -1.114 . . . . 0.0 109.733 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.02 84.32 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 116' ' ' LEU . 19.0 m -66.31 -65.1 0.72 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -42.68 -48.71 5.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.619 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.75 80.34 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.312 -0.868 . . . . 0.0 110.048 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp10 -57.63 -33.84 68.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.027 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -36.71 14.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 0.0 110.042 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -58.12 -67.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.236 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.1 -28.69 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.118 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -71.76 -33.06 68.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.146 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 125' ' ' GLU . 21.0 mt -79.88 -42.28 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.078 -1.014 . . . . 0.0 110.075 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -62.63 4.99 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 110.577 -178.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.1 mm-40 -81.91 -28.61 32.75 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -86.89 -34.86 19.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -30.06 71.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.1 77.09 0.32 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.273 -1.133 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.54 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 3.0 m-20 -43.94 145.53 0.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 29' ' ' GLY . 7.8 mtmm -90.5 7.48 38.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.221 -0.925 . . . . 0.0 110.302 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 45.7 mp0 -144.46 50.88 1.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.813 -1.18 . . . . 0.0 109.952 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.4 tp -80.26 114.76 19.4 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 121.5 7.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.059 -1.025 . . . . 0.0 112.046 -177.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.3 m-85 -113.41 149.5 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -121.55 109.45 14.82 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.61 99.77 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 110.122 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 58.6 t -91.94 12.48 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.09 -1.006 . . . . 0.0 109.758 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.2 OUTLIER -62.18 156.32 22.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.393 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' PHE . 14.2 p-10 -94.86 -142.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.493 ' O ' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 61.27 146.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.84 . . . . 0.0 109.619 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 t -92.46 17.0 10.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -143.49 -12.89 0.69 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 109.446 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 5.8 ttm -71.51 -57.79 4.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -47.22 -28.87 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -51.17 20.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.186 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.93 -53.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.798 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -44.64 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.863 . . . . 0.0 110.333 -178.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -46.87 -55.43 8.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -59.69 -58.03 10.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.108 0.956 . . . . 0.0 108.518 179.428 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.7 tt -39.29 -42.76 1.06 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.641 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.18 -41.96 69.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 108.899 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' ASN . 47.8 tttt -63.1 -30.71 71.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.22 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.57 -40.03 71.43 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tt -76.96 -58.6 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 159.55 43.22 0.02 OUTLIER Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.54 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 48.5 m-85 -126.98 125.42 41.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.821 -0.811 . . . . 0.0 109.662 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.67 66.22 1.46 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.566 -0.708 . . . . 0.0 109.518 -179.705 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.64 93.37 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.111 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.54 179.29 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.059 -1.026 . . . . 0.0 109.856 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.73 -164.98 1.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -147.68 149.86 33.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.141 -178.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.3 -168.87 2.83 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -146.61 3.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 110.643 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 175.66 -172.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.123 -0.986 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.88 -42.24 70.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.11 -34.02 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.236 . . . . 0.0 109.049 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.97 -57.16 3.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.96 -38.22 10.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.39 -58.92 3.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -58.16 -21.51 47.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.931 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -90.15 -43.09 10.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 110.587 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.669 -1.269 . . . . 0.0 109.291 -179.333 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -63.05 -4.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -53.95 -74.91 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.564 -0.71 . . . . 0.0 109.855 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.16 10.8 1.18 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.545 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.5 81.64 1.27 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 22.8 m-85 -54.94 144.74 22.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.548 -0.972 . . . . 0.0 110.297 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.56 -4.64 73.03 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -161.93 145.56 12.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.418 -1.048 . . . . 0.0 110.004 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -139.92 125.93 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.353 -0.842 . . . . 0.0 109.877 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.51 104.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.499 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 90.2 p -104.94 178.27 4.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.349 -0.844 . . . . 0.0 109.964 -179.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 29.2 p-10 -99.98 -115.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.485 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 61.4 t-105 -140.12 -81.14 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 0.0 110.135 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -170.43 68.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 109.93 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.508 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.08 -48.33 0.41 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.523 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.05 -160.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.012 1.141 . . . . 0.0 109.822 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.624 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -84.75 107.48 16.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 0.0 109.094 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.4 mmm 50.31 93.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.107 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.9 t70 -152.24 -177.43 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . 54.47 -80.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ASP . 95.7 mt -44.84 -68.65 0.18 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 109.66 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' O ' ' OG1' ' A' ' 71' ' ' THR . 43.2 tt0 -60.17 -35.69 75.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.846 -1.159 . . . . 0.0 109.375 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.23 -33.93 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 109.007 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 72' ' ' ILE . 1.6 tt -87.08 -59.99 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.173 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.0 ttpt -40.31 -32.81 0.2 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 38.1 m -66.2 -44.18 84.65 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.6 mt -54.65 -36.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 108.769 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtp-105 -75.59 -16.23 60.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.417 -0.802 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -54.42 -28.61 45.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 109.845 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 38.0 t70 -61.55 -121.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.606 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . 154.0 -32.65 0.73 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 -12.41 57.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.413 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.48 42.44 2.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 p -77.89 51.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -130.71 -26.14 2.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.644 -0.66 . . . . 0.0 109.715 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -38.65 103.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.896 -0.503 . . . . 0.0 109.78 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.2 108.87 1.04 Allowed 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 120.93 1.087 . . . . 0.0 111.574 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.81 111.51 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.463 178.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.99 110.75 21.71 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.499 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -91.51 116.28 28.73 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.34 -176.859 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -102.23 150.43 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.887 -1.133 . . . . 0.0 110.867 -178.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -150.09 -143.49 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.38 -17.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -79.85 -75.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.957 . . . . 0.0 109.506 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . 58.83 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.8 tptp -148.58 59.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.266 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 94' ' ' ASN . 74.1 tttt 53.12 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.9 pt-20 -47.17 -19.0 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.189 -0.945 . . . . 0.0 109.789 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' LYS . 3.0 m-20 -89.78 -35.78 15.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.82 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.87 -18.27 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.416 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.7 mp -83.54 -43.39 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.751 -1.218 . . . . 0.0 107.93 178.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.45 -24.82 1.39 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.1 -54.34 25.95 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.583 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.72 64.49 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.069 -1.644 . . . . 0.0 107.963 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -27.73 68.51 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -146.46 -68.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -58.61 79.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.82 -108.76 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.302 0 CA-C-N 111.549 -2.325 . . . . 0.0 115.676 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -29.83 -58.0 0.17 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.164 -175.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.31 176.26 37.0 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.95 -179.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -130.65 115.0 16.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.87 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 108' ' ' VAL . 14.3 p -122.6 123.01 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 107' ' ' VAL . 28.0 m -54.18 -169.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.15 153.19 11.77 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.504 -1.372 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.11 154.06 99.45 Favored 'Cis proline' 0 N--CA 1.487 1.101 0 C-N-CA 125.187 -0.755 . . . . 0.0 110.636 -1.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -118.32 155.25 30.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.84 0.829 . . . . 0.0 109.661 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.729 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.4 OUTLIER -90.07 150.49 22.05 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -50.61 -15.55 0.28 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.684 -1.26 . . . . 0.0 109.327 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -81.69 -34.44 30.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.729 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -74.13 -61.21 1.93 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -36.16 38.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.58 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 15.9 mt-10 -54.66 -66.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.009 -1.057 . . . . 0.0 109.521 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -44.25 -26.93 0.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.768 -0.583 . . . . 0.0 109.781 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.53 -44.03 15.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 110.325 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.57 -57.23 6.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.805 -1.184 . . . . 0.0 109.64 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.53 -27.02 5.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.986 -1.072 . . . . 0.0 109.82 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -84.4 -22.71 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.181 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.6 mt -88.36 -39.0 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.645 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -65.76 -5.68 9.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.998 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -26.17 62.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -90.38 -34.46 15.66 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.26 -15.52 59.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 58.41 85.76 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.228 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' CD1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER 173.52 134.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.397 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 28.69 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -171.68 41.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.01 -1.056 . . . . 0.0 110.579 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.2 tp -80.41 112.95 18.23 Favored 'General case' 0 C--O 1.205 -1.249 0 O-C-N 120.576 -1.328 . . . . 0.0 107.921 179.169 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.54 114.36 1.64 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.946 . . . . 0.0 112.481 -177.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 82.8 m-85 -109.2 151.12 26.91 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.5 tp -119.15 108.62 14.91 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.02 122.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.265 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.9 105.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.491 -0.756 . . . . 0.0 109.574 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.5 133.47 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 109.425 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 53.52 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.596 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.64 135.53 22.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.12 15.99 3.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.02 -1.64 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 109.558 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.0 ttt -89.96 -21.71 22.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.123 -0.986 . . . . 0.0 109.074 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -76.08 -45.39 34.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.835 . . . . 0.0 109.419 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -58.63 -20.87 51.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.878 . . . . 0.0 109.575 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -73.81 -55.56 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.849 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -23.14 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 110.263 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -53.05 62.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 109.122 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.05 -56.08 13.37 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.014 0.911 . . . . 0.0 108.991 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.6 -46.43 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.32 -45.0 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 0.0 108.541 179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -57.28 -30.4 64.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.478 -0.763 . . . . 0.0 109.147 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 -41.54 74.83 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.177 -0.952 . . . . 0.0 109.354 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.9 tp -76.86 -57.01 4.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -0.844 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . 152.3 77.37 0.02 OUTLIER Glycine 0 N--CA 1.478 1.483 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -150.22 147.99 28.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -1.073 . . . . 0.0 109.29 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.15 55.88 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.946 -1.096 . . . . 0.0 110.634 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.74 105.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.703 -1.248 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.76 -179.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.971 . . . . 0.0 109.384 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -134.71 -167.52 1.99 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -149.97 150.69 32.2 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.342 -178.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.531 ' O ' ' NH2' ' A' ' 18' ' ' ARG . . . -141.39 -169.22 2.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.5 mt-10 -139.73 9.31 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.257 -0.902 . . . . 0.0 110.222 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.2 m-20 170.85 173.32 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.0 108.896 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.1 -25.5 73.39 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -37.09 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.937 -1.331 . . . . 0.0 108.243 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -74.66 -39.96 61.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -75.32 -35.5 61.21 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.57 -52.72 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -62.08 -30.93 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -90.0 -18.83 25.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.323 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -61.02 -32.96 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.569 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -84.06 -0.15 50.65 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.38 -72.78 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.659 -0.651 . . . . 0.0 109.553 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.03 -86.78 0.3 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.17 72.79 0.18 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.593 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.6 m-85 -54.27 98.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.312 -1.111 . . . . 0.0 109.041 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.29 1.19 0.44 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -169.2 142.82 2.83 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.187 -1.184 . . . . 0.0 109.919 -179.652 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 t -133.59 145.43 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.088 -1.008 . . . . 0.0 109.57 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 55' ' ' ILE . 89.5 mt -132.19 85.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 3.6 p -103.98 143.54 32.74 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.696 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.3 p30 -60.37 -122.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.532 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 75.2 t-105 -158.25 -77.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.02 122.88 32.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.089 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.445 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.25 -50.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 110.44 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.09 -173.67 0.22 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.747 0.965 . . . . 0.0 110.055 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.675 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -52.68 -13.67 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.168 -0.958 . . . . 0.0 109.546 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.437 ' H ' HD21 ' A' ' 62' ' ' ASN . 3.7 mmt -147.23 -86.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -152.94 177.85 10.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.9 -9.52 77.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.7 tp -50.81 -25.65 4.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.679 -1.483 . . . . 0.0 108.239 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 64' ' ' ASP . 7.6 pt-20 -72.59 -34.48 67.46 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 25.7 mt -63.18 -56.13 19.28 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.11 -58.73 6.92 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.606 0.717 . . . . 0.0 109.193 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -53.86 -38.02 64.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 70.4 m -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.938 . . . . 0.0 109.097 179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.09 -24.79 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -18.68 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 108.918 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.4 -52.22 22.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.176 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 79' ' ' SER . 4.1 t70 -66.71 83.85 0.11 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.94 43.44 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.76 -89.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -1.195 . . . . 0.0 109.564 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.0 mtt -118.16 20.98 13.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.0 109.25 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.522 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 t 46.93 -118.31 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.09 52.71 0.91 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER 46.07 -175.03 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.6 Cg_exo -63.03 144.79 93.53 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 121.68 1.586 . . . . 0.0 114.522 -176.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 t -139.5 111.38 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -95.13 106.07 18.05 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 117.551 -1.659 . . . . 0.0 106.964 177.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 1.1 ttm -74.56 107.68 6.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.539 -0.865 . . . . 0.0 109.392 -178.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -92.17 144.83 8.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.453 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 5.8 t -146.24 170.2 17.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.015 -1.053 . . . . 0.0 110.426 -178.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.57 ' CB ' ' HZ1' ' A' ' 109' ' ' LYS . . . -109.86 -57.29 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.709 -0.619 . . . . 0.0 109.551 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.74 29.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -46.45 110.9 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 3.8 ttpp -148.47 94.89 2.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.743 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttt 44.61 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.85 . . . . 0.0 110.156 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -45.93 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.333 -0.855 . . . . 0.0 110.419 -179.183 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -41.19 -34.43 0.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.477 -0.764 . . . . 0.0 110.764 -178.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.528 ' C ' ' H ' ' A' ' 97' ' ' ALA . 24.6 mt -75.58 -66.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.969 -1.082 . . . . 0.0 109.304 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.16 -0.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.023 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -76.02 -37.85 57.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.401 -0.812 . . . . 0.0 109.119 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.98 -59.87 2.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.09 -1.006 . . . . 0.0 108.306 178.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -59.55 -22.37 61.6 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.514 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -49.32 -33.38 13.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.54 -36.82 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 90.29 64.94 1.22 Allowed Glycine 0 N--CA 1.482 1.71 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.001 175.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.12 -111.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.935 1.867 . . . . 0.0 108.678 177.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.62 -46.05 8.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 122.423 1.106 . . . . 0.0 108.611 177.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 163.23 -157.87 30.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -178.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -137.77 146.48 43.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.679 -0.895 . . . . 0.0 109.248 178.95 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.4 p -140.61 136.1 35.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' ' 109' ' ' LYS . 3.0 p -80.08 159.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.034 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HZ1' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.27 154.79 80.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.0 109.523 -179.301 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.26 126.85 13.46 Favored 'Cis proline' 0 N--CA 1.488 1.194 0 O-C-N 122.564 0.771 . . . . 0.0 110.14 -2.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.93 156.6 18.33 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.376 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -92.99 148.44 22.0 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 176.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -49.28 -12.44 0.05 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.706 -1.246 . . . . 0.0 109.343 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -83.07 -37.74 23.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.72 -59.69 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.144 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.62 -40.71 53.71 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.983 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 24.0 mm-40 -61.09 -55.12 36.31 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.185 -0.947 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -41.62 -38.27 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.42 0.628 . . . . 0.0 109.752 -179.33 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -88.19 -29.63 20.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.214 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp -65.53 -65.71 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.613 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.81 -36.36 11.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.651 ' HZ1' ' CB ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -73.73 -25.53 60.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.847 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.44 -41.38 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.922 . . . . 0.0 109.849 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.83 -19.83 62.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 110.252 -179.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' CA ' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -61.27 -20.88 63.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.758 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -94.51 -31.76 13.79 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.82 -26.05 61.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.62 77.73 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.266 -1.138 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -46.71 136.61 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.04 48.48 1.58 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -178.55 33.66 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 50.5 tp -71.12 111.12 6.23 Favored 'General case' 0 C--O 1.206 -1.212 0 O-C-N 120.599 -1.313 . . . . 0.0 108.147 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.476 ' CG ' HD21 ' A' ' 32' ' ' ASN . 13.6 mtpt -58.04 119.8 7.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.072 . . . . 0.0 111.409 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 80.9 m-85 -110.79 148.76 31.68 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.34 110.88 17.48 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.52 106.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.286 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.407 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 27.4 t -96.96 92.03 2.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.504 -0.748 . . . . 0.0 109.59 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -147.42 132.47 18.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -24.68 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.64 130.82 48.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -82.83 -20.08 36.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -33.3 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.499 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttt -57.6 -30.51 65.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -71.71 -34.75 69.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.923 -1.11 . . . . 0.0 108.679 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -75.87 -16.13 60.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.519 -0.738 . . . . 0.0 109.068 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.78 -50.83 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.48 -32.23 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 110.26 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -47.76 -53.35 15.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 109.391 179.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.02 -57.4 5.04 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.514 -0.742 . . . . 0.0 109.771 -179.576 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -40.42 -61.02 0.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.423 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 mt -51.46 -50.78 59.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 108.72 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -49.07 -33.18 10.98 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.241 -0.912 . . . . 0.0 108.918 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -49.43 -51.07 37.94 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.404 -0.81 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.56 -48.1 57.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.005 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.45 81.59 0.06 OUTLIER Glycine 0 C--O 1.208 -1.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.08 149.26 30.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -1.094 . . . . 0.0 108.896 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -150.1 64.06 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 110.224 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.476 HD21 ' CG ' ' A' ' 7' ' ' LYS . 2.2 t30 -176.7 103.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.864 -1.147 . . . . 0.0 109.258 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.15 151.83 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 110.288 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -120.55 -170.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.8 mp0 -146.63 155.99 42.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.721 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.16 -163.02 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -137.47 -7.89 1.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 110.783 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 62' ' ' ASN . 6.8 t0 -177.42 -165.57 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -26.59 57.28 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 6.3 p -75.64 -42.08 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.025 -1.28 . . . . 0.0 107.847 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 12.4 t0 -68.98 -43.73 74.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -64.75 -52.79 55.12 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' ALA . 3.4 tt -43.34 -36.71 1.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.419 -0.801 . . . . 0.0 109.242 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -71.62 -34.62 69.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.08 179.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 47' ' ' GLN . 11.7 mmmt -86.38 -53.59 4.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -41.13 -22.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.666 -0.646 . . . . 0.0 109.371 179.682 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -52.35 -43.63 64.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.36 -56.95 5.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 88.35 -19.26 36.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.75 -5.37 3.92 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 53' ' ' PHE . 61.6 m-85 -75.43 83.88 2.52 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.469 -1.019 . . . . 0.0 110.212 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.02 -3.93 1.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 177.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -155.87 144.57 20.33 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.53 -0.982 . . . . 0.0 110.221 -179.473 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.09 116.77 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 108.76 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 117.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.866 . . . . 0.0 108.861 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.1 p -120.05 166.95 12.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.629 -0.669 . . . . 0.0 109.681 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 12' ' ' ASP . 61.6 m-20 -95.58 -106.39 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.533 -0.73 . . . . 0.0 109.458 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CD1' ' OD2' ' A' ' 64' ' ' ASP . 56.6 t-105 -168.95 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.721 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.5 104.99 5.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.411 ' CE ' ' CA ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -130.9 174.09 5.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.339 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.42 -1.93 1.66 Allowed 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.534 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 8.5 m120 -127.05 83.67 2.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.283 -0.886 . . . . 0.0 109.488 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.9 mmt 48.46 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 109.599 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -165.04 179.09 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.961 -1.087 . . . . 0.0 109.405 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 60' ' ' MET . . . -70.96 14.66 1.46 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -68.3 -51.93 39.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -1.178 . . . . 0.0 108.854 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' O ' ' CG2' ' A' ' 71' ' ' THR . 1.8 mt-10 -63.53 -15.66 58.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.448 ' O ' ' OG1' ' A' ' 71' ' ' THR . 6.2 mt -79.98 -67.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.91 -62.17 1.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -58.23 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 16.6 p -52.91 -41.15 64.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.897 -1.127 . . . . 0.0 109.476 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.22 -42.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.399 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -84.75 -4.86 59.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 -29.12 22.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.528 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.5 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . 162.92 -90.35 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.39 70.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.162 . . . . 0.0 109.158 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.9 mtm -92.45 10.22 31.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.238 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 92.4 p -76.49 44.61 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 8.57 0.65 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.19 121.14 83.9 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.525 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 113.82 1.9 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.415 1.41 . . . . 0.0 113.433 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.597 ' N ' ' OG ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -103.25 105.65 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 175.224 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.42 105.92 18.14 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 116.749 -1.98 . . . . 0.0 106.55 178.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 85' ' ' MET . 2.7 ppp? -79.88 124.02 28.28 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.926 -177.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 140.78 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.209 -0.932 . . . . 0.0 109.103 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 t -150.07 174.98 12.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.044 . . . . 0.0 110.948 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.88 -64.68 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -75.82 63.96 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 108.873 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.622 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . . . -67.34 91.99 0.27 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 144.12 25.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -24.03 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -78.2 -54.18 6.52 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' ALA . 1.2 t30 -68.74 -45.27 71.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.2 mt -48.65 -30.48 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.073 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.8 mt -89.86 -20.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.358 -0.839 . . . . 0.0 109.075 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.92 -45.75 92.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.409 -0.807 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.88 -54.34 8.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 108.199 179.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.86 -27.24 50.75 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -53.78 -34.03 57.79 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 178.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.09 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.24 75.87 0.43 Allowed Glycine 0 N--CA 1.481 1.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.04 177.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 -112.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.824 -1.95 . . . . 0.0 111.158 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.8 OUTLIER -91.67 -53.77 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.801 1.286 . . . . 0.0 109.019 176.633 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.41 -161.0 31.66 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -177.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.622 ' HH ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -139.73 136.55 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 0.0 109.962 179.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.1 122.05 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.98 176.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.792 -1.193 . . . . 0.0 108.223 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.3 149.41 24.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.772 -1.205 . . . . 0.0 109.065 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.93 139.87 63.75 Favored 'Cis proline' 0 N--CA 1.484 0.923 0 C-N-CA 125.302 -0.707 . . . . 0.0 110.399 -1.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -99.04 163.79 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.77 146.05 23.94 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 177.63 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.35 -34.45 6.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.106 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.26 76.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.2 m -70.54 -66.97 0.53 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.509 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.8 tp -48.33 -40.12 24.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.593 -1.317 . . . . 0.0 109.497 178.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 119' ' ' LYS . 3.4 tm-20 -68.04 -68.45 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.027 . . . . 0.0 109.782 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 117' ' ' GLU . 86.0 tt0 -42.25 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.362 0.601 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' GLU . 5.5 mmmt -90.01 -47.57 7.76 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.071 179.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 123' ' ' ILE . 17.5 mt -56.07 -54.76 41.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -46.34 -49.93 17.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -57.15 -28.37 62.68 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 120' ' ' LEU . 27.3 mt -86.13 -40.95 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.47 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -68.65 -6.61 26.93 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.974 -1.079 . . . . 0.0 110.427 -178.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.84 -19.88 61.91 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -29.53 13.02 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -21.54 29.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.475 -0.766 . . . . 0.0 108.94 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.87 75.18 0.17 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 109.404 179.979 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 2.0 t0 76.85 131.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.466 -0.771 . . . . 0.0 109.289 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.41 18.44 6.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 110.172 -179.876 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 2.1 tm-20 -152.78 41.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.688 -1.257 . . . . 0.0 111.072 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 31.4 tp -81.87 118.67 23.1 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.497 -1.377 . . . . 0.0 107.912 178.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -63.87 123.28 18.54 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.19 -0.944 . . . . 0.0 111.754 -177.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 91.8 m-85 -115.56 144.51 43.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.13 111.56 18.41 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.4 100.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 108.609 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 58.2 t -94.95 98.96 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.388 -0.82 . . . . 0.0 109.633 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.1 t0 -156.86 142.88 17.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.0 109.389 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.23 93.71 7.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.21 149.56 13.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.11 16.95 13.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -145.19 -22.11 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.417 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 2.2 ttt -60.8 -65.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.65 -33.66 7.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -38.63 67.77 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.0 -177.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -64.51 -56.05 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.674 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -31.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -51.79 -54.29 30.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 109.319 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -65.77 -57.23 8.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.52 -0.737 . . . . 0.0 109.215 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.7 -59.48 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.977 -179.507 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.02 -50.19 67.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.015 179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -56.07 -39.11 71.57 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.323 -0.861 . . . . 0.0 109.505 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -54.77 -44.47 73.69 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.287 -0.883 . . . . 0.0 109.184 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -69.5 -58.49 3.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.94 74.8 0.01 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 46.0 m-85 -150.21 152.38 34.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -1.174 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.74 62.33 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.93 -1.106 . . . . 0.0 110.065 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -176.42 97.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.825 -1.172 . . . . 0.0 109.667 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -150.2 149.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.91 -1.119 . . . . 0.0 110.161 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' OH ' ' A' ' 51' ' ' TYR . 16.2 mt-10 -126.4 -166.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -148.59 149.28 31.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 110.655 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.32 -169.32 2.83 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -143.98 3.54 1.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.237 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -176.72 157.84 1.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.519 -1.363 . . . . 0.0 109.765 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.1 -52.83 21.14 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -50.78 -31.06 9.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.895 -1.356 . . . . 0.0 108.139 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.5 t0 -79.24 -46.13 18.44 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -64.54 -56.62 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mt -48.65 -52.95 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.862 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -69.19 -33.55 73.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -10.71 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.242 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -81.55 -22.65 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.148 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -63.65 -6.67 5.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 108.639 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.11 -69.3 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.584 -0.698 . . . . 0.0 109.843 -179.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 10.2 1.0 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.05 85.53 1.27 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.412 ' OH ' ' OE2' ' A' ' 34' ' ' GLU . 22.4 m-85 -64.71 139.23 58.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -1.038 . . . . 0.0 110.494 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.01 3.1 62.02 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -165.89 146.86 6.81 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.7 t -148.63 123.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.786 -1.196 . . . . 0.0 109.759 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.98 93.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.411 ' H ' ' HG ' ' A' ' 56' ' ' SER . 13.7 p -96.36 158.1 15.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -0.861 . . . . 0.0 108.999 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' ASN . 4.4 p-10 -119.57 161.81 20.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.765 -0.584 . . . . 0.0 109.815 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 93.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 108.795 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -108.76 121.54 45.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.443 -0.786 . . . . 0.0 109.721 -179.297 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.627 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.6 ppp? -137.99 38.19 0.34 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.599 -0.688 . . . . 0.0 111.78 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -55.89 -24.97 50.35 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 178.034 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 63' ' ' MET . 7.8 p30 179.63 58.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 2.2 ttm 77.99 99.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.209 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -168.25 -172.53 1.76 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.528 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 71.12 -69.68 0.82 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -67.75 -61.62 1.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.109 -1.23 . . . . 0.0 108.992 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.61 -12.12 9.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 108.653 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.514 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -73.02 -46.44 52.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.87 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -84.2 -30.57 25.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.242 179.992 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -61.68 -40.43 94.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.114 179.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.5 m -68.66 -41.49 79.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.018 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.64 -29.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.82 . . . . 0.0 108.795 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -90.03 -24.13 21.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.686 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.18 -28.94 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.69 131.79 34.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.05 -23.72 77.82 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.23 -28.56 17.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -1.193 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' ALA . 23.1 tpp -91.97 5.49 49.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 t -71.7 13.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -99.97 -37.24 9.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.708 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -38.55 102.67 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.766 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 96.25 0.23 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.164 1.243 . . . . 0.0 111.528 -178.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.84 105.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.3 tp -96.02 103.72 15.62 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.827 -1.549 . . . . 0.0 106.86 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.56 161.67 11.67 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.731 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.73 137.72 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 t -150.04 156.24 41.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.31 -31.14 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.45 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.14 -61.2 2.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.15 33.36 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -44.84 -67.27 0.3 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.0 109.795 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -167.35 -80.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -13.32 1.96 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 109.741 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -83.12 -21.88 33.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.637 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.89 -49.58 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.945 -1.097 . . . . 0.0 108.657 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 100' ' ' GLN . 1.8 mp -63.49 -19.5 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.336 -0.852 . . . . 0.0 108.949 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.36 -59.56 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.83 -53.42 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.79 -19.87 65.83 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.993 -178.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -50.61 -30.79 14.2 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.04 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.54 -26.62 17.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.46 72.54 1.05 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.815 177.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.24 -112.04 0.07 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 116.619 -2.032 . . . . 0.0 109.05 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.91 -49.41 6.25 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.754 1.264 . . . . 0.0 108.102 175.396 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.58 -160.0 32.48 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.482 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -138.57 124.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.849 . . . . 0.0 109.289 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.5 p -113.39 130.55 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.23 124.18 39.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 161.55 25.63 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.159 -0.963 . . . . 0.0 108.94 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.48 129.04 17.35 Favored 'Cis proline' 0 N--CA 1.484 0.933 0 O-C-N 122.842 0.917 . . . . 0.0 110.747 -2.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -96.93 163.76 12.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.935 . . . . 0.0 109.632 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.56 147.18 25.6 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.862 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.66 -20.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.808 -1.182 . . . . 0.0 109.047 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -75.74 -58.4 3.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.538 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -38.81 59.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.207 -1.558 . . . . 0.0 107.972 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 120' ' ' LEU . 11.3 tt0 -57.14 -57.3 13.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.046 -1.034 . . . . 0.0 109.895 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.56 -39.19 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.532 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.43 -29.22 63.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -73.46 -45.37 54.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.521 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 125' ' ' GLU . 2.6 m120 -57.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.914 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -61.04 -46.31 91.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 109.729 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.26 -34.34 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.371 -0.83 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.27 -7.18 57.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.919 -178.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 121' ' ' ASN . 5.9 mt-10 -71.44 -28.55 64.05 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.342 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -94.14 -25.11 17.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.54 -22.4 30.13 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.41 79.62 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.285 -1.126 . . . . 0.0 109.465 179.925 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 7.4 m-20 -45.37 146.7 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.313 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.6 tttp -90.25 13.13 16.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.876 -1.14 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 1.3 tt0 -152.46 45.59 0.72 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.708 -1.245 . . . . 0.0 110.415 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.56 136.56 44.03 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -73.98 115.9 13.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.958 -1.088 . . . . 0.0 111.978 -176.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.3 m-85 -106.4 153.24 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.063 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.512 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.72 104.53 5.55 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.411 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.67 122.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.969 -178.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.97 93.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.863 . . . . 0.0 109.069 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD1' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.34 -178.03 4.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.02 28.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.532 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -90.9 -7.85 51.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.427 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.51 -10.09 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.747 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -145.42 -8.88 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.9 ttt -64.9 -22.53 67.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.05 -63.64 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -46.75 -14.08 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.174 -178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' ARG . 4.2 mt -81.83 -50.13 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.014 -1.053 . . . . 0.0 109.628 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -27.72 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.786 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -55.71 -53.08 61.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 108.89 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -62.67 -59.22 5.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.525 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -40.61 -56.81 2.02 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.773 -179.985 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.84 -39.82 71.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.198 -0.939 . . . . 0.0 108.846 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -62.36 -50.71 70.5 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.282 -0.886 . . . . 0.0 109.207 179.642 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.04 -36.93 30.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -61.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.19 65.12 0.01 OUTLIER Glycine 0 C--N 1.3 -1.465 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 44.2 m-85 -150.14 148.53 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 109.129 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.4 OUTLIER -150.15 59.28 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.806 -1.183 . . . . 0.0 111.159 179.908 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.21 98.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.703 -1.248 . . . . 0.0 110.684 179.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.71 178.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.035 -1.04 . . . . 0.0 110.352 179.058 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -142.31 -177.34 5.21 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 178.456 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 13.5 mt-10 -140.85 156.23 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.052 -1.03 . . . . 0.0 111.483 -178.133 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.99 -173.0 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.03 19.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.689 -1.257 . . . . 0.0 110.87 -179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.488 ' OD1' ' ND2' ' A' ' 62' ' ' ASN . 42.0 t0 -174.48 145.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -0.992 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.19 -42.37 17.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -63.01 -33.37 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.245 -1.15 . . . . 0.0 108.492 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' ASP . 18.8 t0 -73.29 -47.55 41.93 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.2 80.93 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.42 -0.8 . . . . 0.0 108.845 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' CD1' ' C ' ' A' ' 43' ' ' LEU . 2.5 tm? -49.91 -50.43 46.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.708 -179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -55.44 -40.17 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.895 . . . . 0.0 111.05 -178.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -26.31 20.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.015 -1.053 . . . . 0.0 111.06 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.59 -19.51 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.818 -1.176 . . . . 0.0 109.256 -179.209 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -95.89 -5.9 40.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.125 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.29 -62.81 1.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.317 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.55 8.77 1.38 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.45 77.14 1.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' PHE . 36.6 m-85 -56.39 114.22 1.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.393 -1.063 . . . . 0.0 109.766 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.33 2.14 3.37 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -163.47 139.22 6.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.972 -1.311 . . . . 0.0 109.597 179.676 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.57 116.77 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.087 -1.008 . . . . 0.0 109.532 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -103.8 99.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.533 -0.729 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.475 ' O ' ' SD ' ' A' ' 85' ' ' MET . 15.2 p -110.25 156.74 20.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.56 162.96 14.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.468 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 42.0 t-105 -96.49 111.95 23.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 2.3 t-20 73.48 96.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.725 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.441 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.5 mtt 177.16 -50.63 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -66.27 -67.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 120.783 0.989 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.6 p30 -154.55 125.96 7.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 mtt 54.33 -86.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -149.0 144.0 26.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.06 1.78 4.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -67.28 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.266 . . . . 0.0 109.627 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.9 tt0 -46.31 -32.62 3.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -66.87 -52.06 48.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.916 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -58.58 -60.42 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.237 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' ALA . 10.5 tttt -42.82 -34.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 m -52.06 -44.45 64.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 108.692 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.69 -30.8 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -6.9 55.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -64.17 -51.38 64.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.835 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -46.9 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.27 -61.32 0.36 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.44 -8.15 59.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -1.151 . . . . 0.0 109.257 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.6 mtp -90.26 -7.1 54.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -74.98 65.79 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.58 -28.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 0.0 110.452 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 mt -60.14 125.05 80.25 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 120.9 -1.125 . . . . 0.0 109.28 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.9 150.79 75.82 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.231 1.287 . . . . 0.0 112.565 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.21 137.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.35 65.73 0.73 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.555 178.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' O ' ' A' ' 56' ' ' SER . 2.3 mmt -48.21 159.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.01 132.76 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 109.048 -179.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.1 t -150.12 166.47 29.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.49 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.35 -68.24 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 109.301 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.4 101.93 14.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.422 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -88.5 98.92 11.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.93 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -63.72 -151.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 108.977 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 94' ' ' ASN . 4.6 pttt -118.42 -71.43 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 109.413 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -48.97 -9.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.364 -0.835 . . . . 0.0 110.056 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -89.53 -49.02 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.856 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -61.58 -31.95 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.89 -63.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.087 -1.008 . . . . 0.0 109.651 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.88 19.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 108.834 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.97 -54.14 13.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.472 -0.768 . . . . 0.0 109.279 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -53.04 -45.23 67.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.878 . . . . 0.0 110.1 -179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.72 -19.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 109.116 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -98.97 -113.54 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.611 -0.681 . . . . 0.0 109.59 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.701 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.35 -2.89 5.82 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.79 10.94 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 122.206 -0.585 . . . . 0.0 111.326 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.701 ' H ' ' C ' ' A' ' 102' ' ' GLY . 14.0 m -29.45 -33.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.15 130.79 10.26 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.92 121.76 10.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 0.0 109.429 179.385 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.23 141.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 8.5 p -92.13 100.68 11.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 108.907 179.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.53 159.87 38.77 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.921 -1.112 . . . . 0.0 109.345 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.48 147.74 87.61 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 O-C-N 123.008 1.004 . . . . 0.0 109.835 -3.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.36 159.03 34.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.143 0.973 . . . . 0.0 110.414 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -103.19 153.15 20.65 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.9 -12.92 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.691 -1.256 . . . . 0.0 109.487 -179.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.67 -42.92 23.74 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -60.26 2.56 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -49.26 -37.91 25.14 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.094 179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -65.19 -48.83 72.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.35 -68.47 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 110.403 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.38 -47.49 9.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.83 . . . . 0.0 110.19 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.56 -44.56 96.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -34.84 79.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.247 -179.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -71.32 -34.57 70.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 109.8 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 mt -80.12 -41.31 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.74 -24.67 67.86 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.14 -29.84 65.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -29.4 29.65 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.4 tp -69.06 -22.11 64.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.89 5.38 57.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.373 -1.075 . . . . 0.0 109.372 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.449 0.643 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 63.01 131.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 109.369 -179.827 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -90.17 9.68 27.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.765 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -147.84 48.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.76 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 56.1 tp -76.35 115.86 16.48 Favored 'General case' 0 C--O 1.204 -1.302 0 O-C-N 120.612 -1.305 . . . . 0.0 107.827 178.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -57.43 120.19 7.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.851 -1.156 . . . . 0.0 111.694 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.2 m-85 -110.62 143.36 41.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -116.94 113.03 21.84 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.99 98.14 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.3 t -90.05 89.24 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.11 135.1 17.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.066 -1.021 . . . . 0.0 109.709 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.6 m-20 -87.41 1.48 53.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.17 140.23 58.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 19.8 5.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.8 -27.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.847 . . . . 0.0 109.499 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -58.79 5.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.487 -179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.66 -36.12 6.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.396 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.5 -39.62 74.05 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.736 -178.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mt -60.13 -55.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.394 -0.816 . . . . 0.0 109.847 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -34.0 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 110.638 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -53.12 -53.28 52.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.936 -1.103 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -69.29 -56.12 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.12 -57.27 2.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.741 -179.467 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.1 -48.63 80.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.064 -1.023 . . . . 0.0 109.02 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -57.39 -28.99 63.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.55 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.17 -30.88 68.51 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.1 -1.0 . . . . 0.0 108.874 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.74 -66.73 0.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.187 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.55 29.58 0.02 OUTLIER Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -98.08 152.34 19.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 109.6 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -150.04 60.29 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.096 -1.003 . . . . 0.0 109.727 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.73 100.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.09 153.72 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.101 -0.999 . . . . 0.0 110.176 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.74 -167.46 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 108.987 179.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.92 145.67 26.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.053 -1.03 . . . . 0.0 110.042 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.48 -169.03 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.15 6.31 1.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.212 -0.93 . . . . 0.0 111.176 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.58 -175.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.533 -1.354 . . . . 0.0 110.005 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.87 -41.12 73.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.01 -36.99 76.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -1.056 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -78.99 -45.47 20.19 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.87 98.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.989 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.76 -39.12 90.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.074 -1.016 . . . . 0.0 109.741 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -74.25 -23.96 59.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -0.961 . . . . 0.0 110.336 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -90.03 -28.92 18.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.04 . . . . 0.0 110.829 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -60.46 -13.04 11.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.581 -1.325 . . . . 0.0 109.417 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.17 -6.84 48.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.161 -0.962 . . . . 0.0 108.613 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.81 -71.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.578 -0.701 . . . . 0.0 109.826 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.14 12.64 1.08 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.89 94.78 0.97 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -73.97 148.8 41.79 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.257 -1.143 . . . . 0.0 110.128 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.82 -9.01 33.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 178.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.2 129.49 14.71 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.28 122.78 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.079 -1.013 . . . . 0.0 110.09 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -107.43 132.31 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -149.47 142.39 24.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -74.62 123.01 24.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.349 -0.845 . . . . 0.0 109.285 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 51.0 t-105 -61.61 98.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.871 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 63.13 122.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 109.826 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.496 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 169.99 -46.79 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 110.334 179.526 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.14 -55.37 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.719 0.946 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.51 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.27 -177.77 4.38 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -93.1 131.5 38.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.192 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.05 1.83 3.28 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ASP . 58.6 tp -73.36 -68.73 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -1.227 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -43.99 -31.4 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.533 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -66.08 -56.34 12.02 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.593 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 1.6 tt -63.42 -65.65 0.65 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.609 -0.682 . . . . 0.0 109.783 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' NZ ' HH21 ' A' ' 73' ' ' ARG . 6.7 tttm -39.89 -32.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.835 -0.541 . . . . 0.0 109.879 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 37.7 m -71.29 -39.99 71.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.083 -1.011 . . . . 0.0 108.776 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 96.4 mt -55.41 -42.05 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.429 HH21 ' NZ ' ' A' ' 70' ' ' LYS . 19.4 ptt85 -89.97 1.62 56.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.854 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.05 -28.25 48.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -36.21 53.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.73 -23.88 14.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.37 -52.41 65.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.16 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.421 ' O ' ' OG ' ' A' ' 79' ' ' SER . 4.9 mmt -90.04 16.58 8.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.684 ' HG ' ' H ' ' A' ' 80' ' ' ALA . 46.1 p 46.55 -107.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.819 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.684 ' H ' ' HG ' ' A' ' 79' ' ' SER . . . -150.03 56.55 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' ALA . 1.2 pp -42.77 149.44 0.49 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.32 142.89 67.51 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 121.818 1.678 . . . . 0.0 113.505 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.55 128.77 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.27 72.7 0.82 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.012 177.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt -53.06 169.46 0.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -141.16 129.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.449 -0.782 . . . . 0.0 109.664 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 109' ' ' LYS . 24.3 m -141.64 166.7 24.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 109.255 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.497 ' N ' ' CG2' ' A' ' 87' ' ' THR . . . -111.58 -27.86 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.65 -0.656 . . . . 0.0 109.269 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.3 mt-10 -99.91 -72.4 0.67 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -0.805 . . . . 0.0 109.684 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.407 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 62.14 118.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.24 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -122.16 -88.06 0.63 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.634 . . . . 0.0 109.67 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' ASN . 1.4 mtpp -152.98 -77.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -45.94 -16.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.744 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.551 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 12.4 t30 -89.99 -33.15 16.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 92' ' ' LYS . 54.1 mt -90.04 -20.69 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 97' ' ' ALA . 60.9 mt -73.66 -72.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.29 -50.66 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.7 -51.96 65.52 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.561 -0.712 . . . . 0.0 109.54 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.72 -41.93 70.92 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.317 -0.864 . . . . 0.0 109.902 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 2.9 mp0 -61.43 -11.85 12.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.859 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.36 -104.79 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 110.43 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.725 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -134.6 0.78 3.87 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.54 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.792 -0.828 . . . . 0.0 110.006 177.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.725 ' H ' ' C ' ' A' ' 102' ' ' GLY . 6.1 m -29.1 -32.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.59 126.28 7.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.0 112.01 5.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -1.217 . . . . 0.0 108.944 179.547 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -108.82 129.89 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 7.8 p -80.93 93.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 108.925 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 161.19 3.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.012 . . . . 0.0 109.314 -179.583 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.74 162.28 92.67 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 124.705 -0.956 . . . . 0.0 110.372 -2.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -143.64 155.04 44.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.166 0.984 . . . . 0.0 110.431 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.55 154.02 18.9 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.09 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.13 -12.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.684 -1.26 . . . . 0.0 109.499 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.49 -40.17 23.66 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 108.44 178.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.0 OUTLIER -71.42 -59.2 2.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.877 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -50.59 -38.31 44.74 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.289 -1.364 . . . . 0.0 108.614 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.25 -51.22 70.5 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.157 -0.964 . . . . 0.0 109.562 179.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -46.01 -59.94 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.65 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.115 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.71 -68.23 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.496 -0.752 . . . . 0.0 109.037 179.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.08 -22.4 39.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.464 ' O ' ' CG ' ' A' ' 125' ' ' GLU . 1.4 ttpt -81.14 -24.4 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 110.303 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mt -90.08 -38.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.0 110.779 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.79 -17.03 64.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.993 -1.067 . . . . 0.0 111.342 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -62.03 -27.85 69.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.723 -1.236 . . . . 0.0 107.714 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -87.71 -27.72 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -26.04 64.22 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.65 68.3 1.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.427 179.996 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER 61.94 131.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -90.07 10.57 23.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -146.44 50.19 1.15 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -78.74 131.9 36.75 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.05 118.5 19.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 0.0 113.18 -175.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 45.3 m-85 -110.29 143.91 39.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.204 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -114.04 107.74 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.16 101.51 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.9 120.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.367 -0.833 . . . . 0.0 110.619 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CE2' ' A' ' 14' ' ' PHE . 4.6 t0 -176.44 -178.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.467 -0.771 . . . . 0.0 109.389 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -114.94 9.96 16.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.064 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' ' CB ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -69.46 164.14 23.74 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.397 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.4 p -134.09 29.84 3.69 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -154.08 -60.62 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.481 -177.184 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.675 ' N ' ' HG1' ' A' ' 16' ' ' THR . 4.7 ttt -45.69 -58.13 3.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' HE ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -34.08 -33.99 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.469 0.652 . . . . 0.0 109.93 178.726 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -70.19 -46.54 64.38 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.621 -178.426 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.6 mp -54.46 -58.07 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.249 -0.907 . . . . 0.0 109.269 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -43.25 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.504 -0.747 . . . . 0.0 110.157 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.569 ' NH1' ' HE ' ' A' ' 18' ' ' ARG . 4.6 mtt85 -46.78 -53.36 12.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -64.69 -57.12 9.86 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.807 0.813 . . . . 0.0 109.192 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -38.43 -56.03 1.31 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.42 -52.18 65.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.01 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -52.53 -39.39 61.31 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.83 -31.22 26.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.95 -62.35 1.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.275 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 159.55 74.06 0.02 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 56.0 m-85 -150.1 155.12 39.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.215 . . . . 0.0 109.57 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.18 40.28 0.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.093 -1.004 . . . . 0.0 110.294 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -157.57 108.6 2.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.655 -1.278 . . . . 0.0 109.536 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -146.35 146.96 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.315 -0.865 . . . . 0.0 110.067 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.85 -172.55 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 74.5 mt-10 -149.95 154.11 37.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.01 -1.056 . . . . 0.0 110.38 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.15 -173.97 3.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 15.6 mm-40 -117.95 -2.13 11.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.487 -0.758 . . . . 0.0 110.443 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 165.01 166.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.31 -0.869 . . . . 0.0 109.041 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -42.74 -52.82 5.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 2.9 p -58.96 -42.27 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.881 -1.364 . . . . 0.0 109.176 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 8.7 t0 -58.83 -45.98 88.73 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.17 -40.99 91.86 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -39.62 36.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.926 -1.109 . . . . 0.0 108.624 179.405 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -88.18 -33.01 18.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.232 -0.918 . . . . 0.0 110.35 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -89.9 -55.8 3.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.104 -0.998 . . . . 0.0 109.879 -179.603 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ALA . 7.2 tt -45.68 -27.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.59 12.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 108.808 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -49.7 -55.47 13.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.52 -0.738 . . . . 0.0 109.652 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.65 33.78 0.07 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.89 124.52 2.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 53' ' ' PHE . 18.2 m-85 -113.64 107.18 15.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.76 -0.847 . . . . 0.0 110.193 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.89 0.46 1.7 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -168.39 144.32 3.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.257 . . . . 0.0 109.484 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.9 t -142.23 126.94 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.854 -1.154 . . . . 0.0 109.685 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.3 mt -110.51 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.7 p -91.04 141.62 28.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.88 -1.138 . . . . 0.0 109.461 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -106.61 24.71 12.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 110.521 -179.307 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.487 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 4.5 t-105 62.19 143.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.941 -1.099 . . . . 0.0 109.163 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -151.49 167.7 27.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 109.987 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.658 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -144.48 23.5 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 113.615 -179.932 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -59.33 -54.9 2.16 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 N-CA-C 108.598 -1.347 . . . . 0.0 108.598 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -155.31 -21.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.674 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 76.6 mtp -150.78 103.49 3.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.483 -0.76 . . . . 0.0 109.031 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -58.69 -175.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.081 -1.012 . . . . 0.0 110.183 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.02 -5.29 80.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.44 -50.53 67.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.795 -1.415 . . . . 0.0 107.832 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.45 -24.66 2.11 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 72' ' ' ILE . 3.8 tp -69.78 -57.43 5.11 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.08 -55.14 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.031 0.92 . . . . 0.0 109.052 178.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -59.79 -50.02 75.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.399 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.6 m -69.23 -14.86 63.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' LEU . 1.1 mt -78.26 -29.72 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -77.24 -35.12 55.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.933 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -45.25 -27.98 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.168 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.54 78.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.942 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 43.69 -157.91 0.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.65 57.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.652 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.2 tpt -90.0 -8.81 50.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 108.907 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m 45.45 -119.19 0.79 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.548 -0.72 . . . . 0.0 109.938 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.03 60.58 0.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 47.65 -178.92 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.815 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.5 Cg_exo -62.83 142.93 90.64 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.533 2.156 . . . . 0.0 115.451 -174.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.01 104.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -91.48 104.78 17.24 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.722 178.388 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.0 ttm -77.44 119.4 20.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.704 -1.198 . . . . 0.0 108.726 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -108.13 146.08 14.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.503 -0.748 . . . . 0.0 109.611 -178.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.72 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 3.0 t -150.12 -173.41 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.614 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.72 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -129.8 -46.41 1.15 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.5 pt-20 -74.67 26.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -52.64 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.378 -0.826 . . . . 0.0 109.448 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ttmt -99.99 -69.12 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 109.481 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -169.94 -44.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.97 -24.57 40.85 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.281 -0.887 . . . . 0.0 109.796 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 4.6 t30 -87.95 -28.05 21.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.865 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 mt -72.67 -58.0 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 108.938 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.34 -29.39 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.362 -0.836 . . . . 0.0 109.162 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.77 -40.05 39.98 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.964 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -80.92 -62.11 1.77 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -53.39 -28.4 29.23 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.816 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.51 -35.39 68.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -76.9 -26.05 53.71 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 176.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.49 71.84 0.88 Allowed Glycine 0 N--CA 1.484 1.846 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.745 175.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.412 ' HB2' ' H ' ' A' ' 104' ' ' SER . . . -90.2 -111.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 117.495 -1.682 . . . . 0.0 109.391 177.629 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.631 ' HG ' ' N ' ' A' ' 105' ' ' GLY . 0.9 OUTLIER -91.58 -47.48 7.38 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.53 1.157 . . . . 0.0 108.833 177.224 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.631 ' N ' ' HG ' ' A' ' 104' ' ' SER . . . 166.7 -159.02 32.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -178.155 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -142.62 136.39 29.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.705 -0.879 . . . . 0.0 109.833 179.308 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.427 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 6.2 p -134.71 134.24 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -161.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.86 151.76 8.32 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 108.784 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.86 138.08 53.96 Favored 'Cis proline' 0 N--CA 1.486 1.035 0 C-N-CA 125.281 -0.716 . . . . 0.0 110.341 -2.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.4 ' CD2' HD22 ' A' ' 116' ' ' LEU . 3.3 p90 -97.89 160.21 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.376 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.78 146.95 23.25 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -49.01 -34.73 13.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 108.442 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.47 -35.38 80.75 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.8 m -70.44 -70.57 0.29 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -51.67 -28.34 14.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.429 -1.419 . . . . 0.0 109.841 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 10.2 tt0 -62.22 -62.66 1.61 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.463 -1.398 . . . . 0.0 108.997 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.32 -44.45 16.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -62.04 -31.43 71.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 tt -81.63 -53.5 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -33.96 74.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.701 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -70.78 -44.0 67.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.46 -36.65 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 109.264 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -73.79 -29.85 62.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -51.67 -29.88 19.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -86.37 -30.7 21.96 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 tp -79.91 -10.05 59.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 0.0 108.846 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.69 41.19 12.71 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.317 -1.108 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.602 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -45.75 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -69.03 26.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 109.942 -179.934 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' H ' ' C ' ' A' ' 3' ' ' ASP . 30.6 mt-10 -134.62 35.71 3.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.85 136.16 34.23 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.2 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -83.94 129.91 34.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.91 -1.118 . . . . 0.0 111.237 -177.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.56 157.69 21.73 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.445 0.64 . . . . 0.0 109.767 179.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -132.64 108.35 9.0 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.461 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.63 110.12 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -177.608 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.03 92.68 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.071 -1.018 . . . . 0.0 109.506 179.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -144.99 151.69 38.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.15 -33.38 10.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.629 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.87 132.32 11.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 109.595 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -86.29 26.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -146.32 -23.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.27 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.4 ttt -65.67 -46.74 77.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -55.86 -30.97 62.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.635 ' NH2' HH12 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -70.02 -24.66 63.31 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.309 -177.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.15 -47.28 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 109.889 -179.639 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -34.43 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.22 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.635 HH12 ' NH2' ' A' ' 19' ' ' ARG . 8.6 mtp180 -47.43 -51.56 19.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.51 -58.53 3.86 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.677 0.751 . . . . 0.0 109.84 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -40.57 -46.41 2.51 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.474 -179.085 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -71.24 -41.91 69.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.124 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -61.91 -30.36 70.84 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.261 -0.9 . . . . 0.0 109.342 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.14 -23.27 62.02 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -90.78 -40.49 11.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 144.29 5.36 0.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.93 135.33 33.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.323 . . . . 0.0 109.794 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.53 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -145.76 64.24 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.102 -0.999 . . . . 0.0 109.894 -179.829 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.45 97.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 110.01 179.84 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.93 177.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -0.999 . . . . 0.0 110.228 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' A' ' 51' ' ' TYR . 13.5 pt-20 -134.91 -166.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -147.39 155.03 41.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 110.905 -179.259 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.37 -166.87 2.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -136.35 -7.94 1.99 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.387 -0.82 . . . . 0.0 110.211 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -178.12 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.052 . . . . 0.0 109.243 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.12 -52.16 46.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.05 -35.28 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.916 -1.343 . . . . 0.0 107.812 179.198 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -68.23 -50.57 53.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.02 -18.95 65.68 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.279 -0.888 . . . . 0.0 108.708 179.44 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.625 ' CD2' HE22 ' A' ' 47' ' ' GLN . 0.7 OUTLIER -77.41 -27.59 52.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.149 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -90.64 -33.35 15.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.316 -179.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -58.7 2.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.009 -1.057 . . . . 0.0 110.076 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tt -51.88 -22.41 3.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 109.089 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.625 HE22 ' CD2' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -51.84 -29.39 19.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 108.799 179.158 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.92 -59.31 2.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.42 112.18 3.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.39 -30.11 0.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.553 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.4 m-85 -64.21 85.29 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.296 -1.12 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.0 9.62 2.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -159.54 153.02 22.51 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.391 -1.064 . . . . 0.0 109.883 -179.355 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.07 142.93 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.918 -1.114 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.4 104.14 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.51 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 p -114.7 150.54 35.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.383 -0.823 . . . . 0.0 110.272 -178.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.24 -85.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 109.236 179.522 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.627 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 59.6 t-105 -165.76 169.11 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.278 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.627 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -76.33 44.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.735 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtp -71.17 -46.74 14.27 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.401 -0.812 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.47 -50.6 1.81 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.12 1.213 . . . . 0.0 110.299 -179.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -164.03 154.21 14.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -46.09 125.17 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.827 . . . . 0.0 109.342 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER 177.01 -61.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.027 -1.045 . . . . 0.0 109.902 -179.952 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -38.26 -40.13 0.84 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -55.62 6.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.332 . . . . 0.0 109.003 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -63.52 -10.01 15.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 108.76 179.339 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -73.95 -59.94 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.567 0.698 . . . . 0.0 109.126 179.621 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -76.68 -31.82 57.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.569 -0.707 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -67.35 -47.48 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.122 179.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 86.7 m -64.52 -41.45 96.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 108.973 179.681 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 46.4 mt -60.42 -26.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.845 . . . . 0.0 109.071 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -89.31 -25.49 21.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.749 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.27 69.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 109.362 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -78.36 93.03 4.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 109.477 179.98 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.13 -24.09 54.03 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.52 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -1.18 . . . . 0.0 109.59 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.3 mtt -149.14 21.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 75' ' ' ASP . 88.5 p -75.17 65.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.976 . . . . 0.0 109.397 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -149.98 -28.71 0.24 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 80' ' ' ALA . 1.5 tp -43.84 107.55 0.6 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 109.676 -179.362 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.6 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.469 1.446 . . . . 0.0 113.293 -178.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.72 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 176.587 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.89 105.11 17.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.279 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.67 118.48 22.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.084 -177.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -104.1 150.89 6.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.521 -0.737 . . . . 0.0 109.764 -178.532 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -150.01 165.99 31.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.98 -1.075 . . . . 0.0 110.046 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -90.55 -97.38 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 9.2 mp0 -59.78 81.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.086 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -70.21 70.48 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.501 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.257 -0.902 . . . . 0.0 108.72 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.466 ' CG ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER 179.53 -59.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.465 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 92' ' ' LYS . 15.5 mt-10 -55.07 -34.78 63.9 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.27 -0.894 . . . . 0.0 109.655 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -79.11 -11.55 59.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.723 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 35.0 mm -85.1 -67.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.131 -0.98 . . . . 0.0 109.067 179.814 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.5 mp -48.09 -21.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' ILE . . . -57.37 -63.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.138 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -49.94 -58.81 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.567 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.44 -24.65 46.9 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.48 -178.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.9 tt0 -51.59 -31.79 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.65 -23.31 20.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.557 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.02 75.86 0.5 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.461 177.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.06 -112.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 117.009 -1.876 . . . . 0.0 109.588 179.013 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -49.38 6.3 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 122.921 1.343 . . . . 0.0 108.042 175.554 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.94 -163.0 36.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.69 139.28 41.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.623 -0.927 . . . . 0.0 109.158 178.579 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.498 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.7 p -133.87 150.64 31.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.433 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 57.5 t -90.95 160.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.069 -1.02 . . . . 0.0 109.558 -179.528 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -129.01 156.06 78.73 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.193 -0.942 . . . . 0.0 108.755 178.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.72 123.78 9.34 Favored 'Cis proline' 0 N--CA 1.486 1.084 0 O-C-N 122.618 0.799 . . . . 0.0 110.625 -2.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.9 165.84 13.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.031 . . . . 0.0 109.215 179.132 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.508 ' HG1' ' H ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -99.8 167.05 10.78 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.041 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.508 ' H ' ' HG1' ' A' ' 112' ' ' THR . . . -62.88 -37.92 88.8 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.954 -179.47 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.57 66.29 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.45 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 116' ' ' LEU . 5.4 m -78.41 -69.88 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.623 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' THR . 9.1 tp -46.61 -36.0 6.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.726 -1.234 . . . . 0.0 109.213 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -63.14 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.109 -0.994 . . . . 0.0 110.822 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -45.8 -29.85 1.47 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.158 -0.964 . . . . 0.0 110.153 -178.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -85.25 -32.88 22.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 0.0 108.891 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.81 -52.0 49.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.441 -0.787 . . . . 0.0 109.469 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.26 -61.09 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 109.707 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -52.77 -27.96 20.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 110.133 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 mt -76.92 -43.73 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 0.0 109.974 -179.55 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 128' ' ' GLY . 12.0 m-85 -66.77 -5.9 13.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.833 -179.269 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.42 -24.64 62.95 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.057 -1.027 . . . . 0.0 108.249 178.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.08 -24.72 16.75 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.153 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.76 -14.14 25.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.53 -0.732 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' PHE . . . 46.2 86.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.221 0.534 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -46.62 146.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.499 179.889 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -90.37 14.82 11.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 109.943 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.12 45.39 0.44 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.761 -1.212 . . . . 0.0 110.941 -178.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 46.5 tp -71.96 111.93 7.62 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.792 -1.193 . . . . 0.0 107.817 179.053 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' CG ' HD21 ' A' ' 32' ' ' ASN . 17.6 mttt -48.13 118.77 2.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.719 -177.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 38.2 m-85 -109.83 155.44 21.65 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.75 0.786 . . . . 0.0 110.487 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.86 102.63 5.12 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.99 103.84 14.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.428 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 44.5 t -97.96 110.35 25.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.424 -0.798 . . . . 0.0 109.354 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -169.72 159.08 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.85 -179.741 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 14' ' ' PHE . 13.1 t0 -97.45 -100.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.536 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 45.2 -163.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -0.859 . . . . 0.0 109.752 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.1 12.34 2.41 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.748 . . . . 0.0 109.238 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.1 ttt -67.43 -66.26 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.798 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' CD ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.62 -35.67 4.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 109.84 -179.842 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -70.66 -41.2 72.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.52 -52.96 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -45.34 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.091 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -46.27 -53.76 10.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.974 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.87 -57.23 8.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.857 0.836 . . . . 0.0 109.304 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.08 -59.77 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 -179.792 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.39 -48.05 68.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.784 . . . . 0.0 109.431 179.693 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.32 -42.91 78.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 -179.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.48 -29.95 59.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.273 -0.892 . . . . 0.0 109.239 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.72 -62.97 1.41 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.69 35.07 0.02 OUTLIER Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.535 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 47.3 m-85 -115.66 139.09 50.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.751 -0.852 . . . . 0.0 109.733 -179.589 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.3 63.88 1.54 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.469 -0.769 . . . . 0.0 109.69 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.44 HD21 ' CG ' ' A' ' 7' ' ' LYS . 2.4 t30 -176.8 95.57 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.967 -1.083 . . . . 0.0 108.551 179.796 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.11 147.09 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.693 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -118.83 -164.87 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.351 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -150.15 159.19 44.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.87 -170.87 3.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -121.73 -10.1 8.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 111.004 -178.985 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.51 171.81 2.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.565 -1.334 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.45 91.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.622 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.32 -39.3 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.953 -1.322 . . . . 0.0 108.926 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -51.11 66.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.89 -48.96 63.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.29 -44.48 16.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 109.706 179.602 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -79.64 -29.62 41.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.296 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -89.77 -10.33 45.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.085 -1.009 . . . . 0.0 110.371 -179.29 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -71.08 -6.37 38.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.058 . . . . 0.0 108.726 -179.992 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' O ' ' NE2' ' A' ' 47' ' ' GLN . 29.6 tp60 -95.14 -13.14 25.32 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.96 -66.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.472 -0.768 . . . . 0.0 109.459 179.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.97 7.14 1.87 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.96 84.33 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -63.54 138.94 58.7 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -1.051 . . . . 0.0 110.4 -179.031 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.45 -4.03 86.19 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 4.0 t80 -169.35 94.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.89 -1.359 . . . . 0.0 110.35 -178.618 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.2 m -94.86 141.9 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.129 -1.607 . . . . 0.0 110.623 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.89 96.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.778 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -111.13 177.6 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.555 -0.716 . . . . 0.0 110.297 -179.476 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 11' ' ' VAL . 4.8 m-20 -89.8 -121.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.466 -0.771 . . . . 0.0 110.179 -179.2 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 61.3 t-105 -127.56 -173.64 2.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 1.2 p-10 -93.87 55.74 2.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 -179.762 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -75.87 -45.6 3.97 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.991 -1.068 . . . . 0.0 110.406 179.702 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -67.73 -44.77 3.89 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.208 1.272 . . . . 0.0 110.211 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.74 159.79 19.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 119.16 7.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -175.96 -63.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.978 179.901 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -34.22 -50.11 0.67 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.397 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -68.49 -60.55 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.768 -1.431 . . . . 0.0 108.81 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.6 tt0 -54.75 -13.06 0.9 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 108.561 179.404 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -72.45 -55.08 7.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.375 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.419 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -63.96 -37.46 87.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -64.24 -55.03 24.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 108.851 179.44 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 6.8 p -54.18 -44.24 71.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.331 -0.856 . . . . 0.0 108.731 179.427 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.94 -19.19 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.309 -0.869 . . . . 0.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -36.33 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 109.227 179.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.88 72.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.774 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' SER . 15.4 t70 -47.68 145.43 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.42 -34.05 4.61 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.42 -27.0 45.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.71 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.7 mmt -137.18 -55.83 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 46.78 24.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.06 3.59 0.53 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.885 -179.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -54.52 115.26 8.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 108.292 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 2.7 Cg_endo -60.46 134.6 55.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 121.182 1.255 . . . . 0.0 113.715 -177.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.689 ' H ' ' HG ' ' A' ' 104' ' ' SER . 1.0 OUTLIER -128.62 112.97 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.778 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.1 tp -97.85 96.52 8.26 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.447 179.245 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.3 144.14 54.44 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.713 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.81 145.15 33.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.559 0.695 . . . . 0.0 110.707 -177.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -150.08 165.04 33.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.087 179.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.46 38.11 3.35 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.598 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' ALA . 1.7 mt-10 -165.75 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.407 -0.808 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 45.18 84.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.869 0.842 . . . . 0.0 108.754 -179.435 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -75.41 16.66 0.33 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.963 . . . . 0.0 109.805 -178.924 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 13.4 ttmt 75.44 -45.4 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.884 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.26 -45.16 49.55 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.454 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 2.9 m-80 -74.06 -4.76 37.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.0 109.337 179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.464 ' C ' ' H ' ' A' ' 97' ' ' ALA . 8.9 mt -80.26 -57.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 108.521 179.381 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 79.5 mt -68.8 2.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.271 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -80.67 -47.52 13.92 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.508 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.68 -50.7 33.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.65 -25.79 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.289 -179.642 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -52.99 -33.04 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.593 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.27 25.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 75.61 0.51 Allowed Glycine 0 N--CA 1.48 1.572 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.544 177.771 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.99 -112.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.877 -1.929 . . . . 0.0 109.596 179.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.689 ' HG ' ' H ' ' A' ' 83' ' ' VAL . 67.3 m -91.88 -49.02 6.46 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.7 1.238 . . . . 0.0 108.06 175.531 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 167.31 -159.68 33.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.525 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 137.61 26.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.568 -0.96 . . . . 0.0 109.055 178.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.76 134.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 7.2 p -89.14 96.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.585 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.419 ' CD ' ' C ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -61.04 155.7 53.2 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 0.0 108.557 179.812 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.38 154.44 99.65 Favored 'Cis proline' 0 N--CA 1.487 1.094 0 C-N-CA 125.335 -0.694 . . . . 0.0 111.313 -1.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.33 156.54 48.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.693 0.758 . . . . 0.0 108.998 178.422 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.29 150.0 21.5 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.95 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.82 -35.0 21.33 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.735 -1.228 . . . . 0.0 108.985 -179.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.98 65.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 112' ' ' THR . 17.5 m -75.99 -65.23 0.94 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.921 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.73 -36.93 27.32 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.23 -1.388 . . . . 0.0 108.313 179.086 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 -53.21 39.16 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.002 -1.062 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -46.55 -25.02 0.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.516 -0.74 . . . . 0.0 109.05 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -88.51 -49.97 6.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 mt -48.49 -59.02 3.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.02 -61.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.34 -0.85 . . . . 0.0 110.237 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -45.4 -29.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 110.1 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 125' ' ' GLU . 4.6 mt -87.88 -44.01 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.217 -179.614 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -62.0 5.27 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.969 . . . . 0.0 110.579 -178.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.8 tt0 -77.91 -36.47 49.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -81.15 -35.56 31.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -32.85 70.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.021 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.61 75.28 0.9 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.234 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.313 -1.11 . . . . 0.0 109.428 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -45.87 143.36 2.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 23.8 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.96 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.28 42.92 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.3 tp -67.63 143.22 56.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.233 -0.917 . . . . 0.0 108.577 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -79.76 120.35 23.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.117 -0.989 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -109.05 152.79 24.55 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.672 -0.642 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 tp -130.43 110.76 11.72 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.12 104.38 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.81 100.73 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 120.937 -1.102 . . . . 0.0 109.66 -179.723 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -163.58 1.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.775 . . . . 0.0 109.227 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.29 1.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.988 -179.886 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.63 153.3 28.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.051 -1.031 . . . . 0.0 109.376 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.1 p -93.63 41.11 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.712 -179.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -173.9 -21.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.8 ttt -62.41 -46.42 88.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -45.58 78.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -55.37 -34.24 64.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 110.701 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -63.86 -48.51 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.158 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.21 -36.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.993 . . . . 0.0 110.575 -178.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -50.7 -53.11 33.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.73 -56.65 10.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.672 0.749 . . . . 0.0 109.471 179.915 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.94 -57.67 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.954 -179.669 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.81 -51.87 65.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.213 179.382 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -53.82 -35.08 61.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -55.49 -28.92 57.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.228 -0.92 . . . . 0.0 109.552 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 mt -87.82 -62.56 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.71 65.5 0.03 OUTLIER Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -150.01 145.31 26.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.251 . . . . 0.0 109.574 -179.82 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -150.02 66.63 0.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -173.91 99.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.15 150.94 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.05 -167.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.233 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.14 152.55 34.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 110.536 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.41 168.12 20.87 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.08 9.26 9.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.56 -0.712 . . . . 0.0 109.911 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.6 p-10 178.05 -176.23 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.69 -39.24 49.11 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.7 -35.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.05 -1.265 . . . . 0.0 108.025 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.69 -47.49 11.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.59 -0.694 . . . . 0.0 109.316 179.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -55.05 30.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -59.09 6.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.08 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -53.02 -33.43 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.028 -179.465 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -88.76 -13.24 39.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -82.17 -29.57 31.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.716 -1.24 . . . . 0.0 109.178 -179.976 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -8.41 0.31 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.174 -0.954 . . . . 0.0 108.653 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.8 -69.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.602 -0.686 . . . . 0.0 109.795 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.98 15.26 0.51 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.352 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 93.6 0.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.439 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 29.4 m-85 -72.11 104.91 3.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -1.083 . . . . 0.0 110.491 -178.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.23 -11.07 6.06 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.159 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -151.98 137.02 17.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.245 -1.15 . . . . 0.0 110.069 -178.93 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 p -144.5 133.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.715 -1.241 . . . . 0.0 109.52 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.94 157.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.196 0.522 . . . . 0.0 109.775 -178.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.2 p -144.93 168.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 108.942 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -93.31 -21.63 19.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.923 . . . . 0.0 110.584 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 59.65 35.36 22.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.206 -0.933 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -177.85 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.908 -1.12 . . . . 0.0 109.882 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 175.63 -50.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.148 -0.97 . . . . 0.0 110.732 179.573 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.8 Cg_endo -64.71 123.46 11.72 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 120.95 1.1 . . . . 0.0 110.455 -179.425 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 8.2 p30 41.82 -146.56 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.664 -0.647 . . . . 0.0 109.889 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 7.3 mtp -47.32 -65.2 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 108.811 179.753 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.47 -39.41 0.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 108.914 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.7 -3.57 2.34 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 69' ' ' LEU . 10.7 tp -71.64 -61.68 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.032 -1.275 . . . . 0.0 107.611 178.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 71' ' ' THR . 29.5 tt0 -47.17 -27.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.41 -36.5 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.0 109.246 179.818 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.4 tp -90.03 -36.04 15.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.808 -178.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -59.32 -50.58 73.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.967 -1.083 . . . . 0.0 109.405 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 3.0 m -48.89 -44.91 40.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.262 -0.898 . . . . 0.0 109.407 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.51 -38.16 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.29 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -65.82 -53.98 32.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.57 -45.45 18.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.5 130.97 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.677 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.47 40.87 2.97 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.99 -15.75 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 0.0 109.335 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.552 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.8 31.64 2.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.086 179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 m -71.08 23.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -150.04 12.11 0.75 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.009 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 8.2 tp -67.57 118.11 53.93 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 108.736 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.46 129.42 31.12 Favored 'Trans proline' 0 N--CA 1.479 0.648 0 C-N-CA 121.049 1.166 . . . . 0.0 112.366 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 t -118.52 114.97 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.254 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.4 tp -95.64 75.27 3.23 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.192 -1.403 . . . . 0.0 108.789 178.221 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -57.74 153.57 13.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.509 -0.744 . . . . 0.0 109.192 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.46 125.12 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -150.22 125.81 10.28 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.477 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.39 -27.52 41.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 0.0 109.015 179.344 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.75 39.86 1.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.434 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -46.44 106.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' CG ' ' H ' ' A' ' 92' ' ' LYS . 23.0 tptt -97.04 -144.73 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.572 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' ASN . 7.0 mtmp? -104.11 -80.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -45.18 -16.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.0 110.003 -179.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -82.0 -36.66 27.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.6 mt -89.97 -9.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -89.76 -68.24 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.92 -1.113 . . . . 0.0 110.002 -179.645 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.33 -49.87 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.431 -179.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.42 86.79 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.212 179.432 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.04 -50.43 27.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.085 -1.009 . . . . 0.0 109.941 -179.345 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -55.12 -24.42 25.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.592 -179.81 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.45 -104.91 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.694 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -141.58 7.59 2.51 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.488 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.22 11.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.014 -0.698 . . . . 0.0 110.6 178.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.27 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.799 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.03 125.72 8.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.213 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.98 110.7 5.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 179.817 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.68 134.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.072 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 7.7 p -89.6 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.049 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.84 160.92 1.9 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.108 -0.995 . . . . 0.0 109.775 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.92 163.01 91.12 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.702 -2.491 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.02 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.088 0.947 . . . . 0.0 110.443 178.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.82 154.36 18.99 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.875 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.65 -11.98 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.629 -1.294 . . . . 0.0 109.361 -179.213 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.33 -39.44 25.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.139 -0.975 . . . . 0.0 108.665 178.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -58.64 3.19 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.806 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 tp -50.56 -37.43 39.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 108.76 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.45 -52.84 62.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.101 -0.999 . . . . 0.0 109.654 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.29 -60.12 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 109.673 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -47.4 -41.36 19.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.814 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.84 -63.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -29.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.675 -179.727 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -34.26 67.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 120' ' ' LEU . 41.4 mt -73.49 -40.65 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.589 -179.361 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -71.18 0.67 7.27 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.924 -1.11 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.7 -35.6 62.72 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -89.61 -22.03 22.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -84.25 -31.0 25.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.54 86.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.144 -1.21 . . . . 0.0 109.448 -179.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.451 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 40.8 m-20 -45.82 134.51 7.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -90.12 15.63 9.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.968 -1.083 . . . . 0.0 109.926 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.9 42.76 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 -179.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.01 147.32 30.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' TYR . 7.5 mtmm -94.5 134.52 36.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.515 -1.366 . . . . 0.0 110.656 -177.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -115.25 150.9 35.45 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.884 -0.51 . . . . 0.0 110.076 -179.678 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 tp -123.23 106.15 10.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.808 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.89 119.37 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.143 -178.664 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.27 57.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 O-C-N 121.698 -0.626 . . . . 0.0 109.571 -179.739 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.88 145.45 25.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 109.329 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 14' ' ' PHE . 7.9 p30 -71.93 -29.91 64.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.209 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.514 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -50.61 120.27 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.336 179.907 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.5 45.33 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.973 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -172.9 -27.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.9 ttt -60.06 -35.05 74.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -53.6 -34.37 58.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.51 -33.81 62.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.98 -51.12 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.498 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -33.52 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mtp85 -46.73 -53.94 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.3 t30 -64.53 -55.93 17.36 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.938 0.875 . . . . 0.0 109.089 179.745 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -38.37 -56.5 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.972 -179.737 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.94 -52.34 64.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.092 -1.005 . . . . 0.0 109.068 179.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -51.4 -36.58 44.13 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.132 179.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.16 -44.28 32.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.412 -0.805 . . . . 0.0 109.472 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 10.9 mp -72.6 -62.32 1.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.45 54.46 0.01 OUTLIER Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 95.0 m-85 -129.11 149.91 50.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.608 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.2 OUTLIER -150.08 65.78 0.97 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.059 -1.026 . . . . 0.0 110.411 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -175.31 100.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.035 . . . . 0.0 109.31 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.25 151.38 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.976 -1.077 . . . . 0.0 110.591 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.19 -165.85 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.648 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -147.71 158.35 43.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.047 -1.033 . . . . 0.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.05 -168.85 3.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.304 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.45 5.79 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.108 -0.995 . . . . 0.0 110.778 -179.483 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 177.22 177.2 0.33 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.758 -1.214 . . . . 0.0 109.644 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.46 -27.72 73.57 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.27 -40.25 80.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -1.176 . . . . 0.0 108.754 179.314 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.48 -37.91 35.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.411 -0.805 . . . . 0.0 109.099 179.727 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.31 62.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.493 -0.754 . . . . 0.0 109.021 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.79 -43.18 72.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.179 -0.951 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -69.62 -27.44 65.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 47' ' ' GLN . 13.4 mttm -87.54 -39.14 15.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.368 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.87 -16.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' LYS . 33.5 mt-30 -91.81 22.4 4.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.312 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . -66.68 -65.23 0.71 Allowed 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.429 -0.794 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.6 23.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.4 179.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 83.96 1.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 7' ' ' LYS . 10.2 m-85 -63.98 -41.07 97.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.54 -0.977 . . . . 0.0 110.586 -178.347 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.5 -25.34 7.33 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 143.68 21.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.539 -0.977 . . . . 0.0 110.106 -179.745 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -140.03 124.98 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.093 -1.005 . . . . 0.0 109.806 179.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.67 105.91 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 15.3 p -126.31 144.75 50.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.056 -1.028 . . . . 0.0 110.708 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -64.94 -117.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' NE1' ' CG ' ' A' ' 94' ' ' ASN . 61.6 t-105 -173.81 134.73 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.728 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 62.39 129.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.5 mmm 177.8 -50.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 110.088 179.405 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.16 -69.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.758 0.972 . . . . 0.0 109.701 179.643 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.34 -34.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.09 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.6 mtt -102.03 -89.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.673 . . . . 0.0 109.398 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -172.31 175.55 3.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.44 179.95 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.71 26.21 1.13 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 64' ' ' ASP . 84.0 mt -82.06 -56.65 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -1.202 . . . . 0.0 108.87 179.611 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.9 tt0 -48.67 -19.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.017 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 66' ' ' LEU . 3.2 mt -76.93 -70.65 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.875 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -45.91 -65.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.206 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -43.78 -47.77 8.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.626 -0.671 . . . . 0.0 109.827 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 53.1 m -67.74 -26.65 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.534 -179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 69' ' ' LEU . 44.3 mt -77.09 -14.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -84.43 -27.39 27.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.73 12.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.52 -179.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' O ' ' CA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -50.64 116.73 2.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.994 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.64 -31.36 40.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.65 -63.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.99 -47.15 7.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.407 ' CA ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 48.22 13.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -0.843 . . . . 0.0 109.349 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.64 18.82 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 0.0 109.626 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 tp -44.97 113.42 1.79 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.055 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 5.1 Cg_exo -59.01 133.49 53.76 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.124 1.216 . . . . 0.0 113.07 -178.918 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.532 ' N ' ' OG ' ' A' ' 104' ' ' SER . 14.7 t -132.48 108.93 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.076 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.88 100.86 13.59 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 117.064 -1.854 . . . . 0.0 107.538 178.839 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 6.7 tpp -68.69 128.53 36.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.597 0.713 . . . . 0.0 109.385 -178.305 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -99.16 140.28 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.634 -0.666 . . . . 0.0 109.366 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.04 129.2 12.75 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.046 -179.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -66.05 96.77 0.33 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.388 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.0 tt0 74.47 114.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.486 -0.758 . . . . 0.0 109.202 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . -45.09 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.354 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -69.78 11.78 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 109.425 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.8 mtpp 58.96 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.82 . . . . 0.0 109.8 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 66.9 mt-10 -45.34 -46.92 13.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.978 . . . . 0.0 110.164 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.447 ' CG ' ' NE1' ' A' ' 58' ' ' TRP . 21.1 m-20 -69.34 -73.04 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.464 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -44.49 -52.51 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 109.088 -179.47 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.3 mt -56.68 -32.0 36.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.652 -1.28 . . . . 0.0 109.464 -179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -71.66 -45.61 61.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.044 -1.035 . . . . 0.0 108.959 179.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.19 72.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 109.008 179.182 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.51 -31.27 71.26 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.619 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -33.38 53.21 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.363 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.26 -22.51 28.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.39 80.52 0.12 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.958 177.237 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 104' ' ' SER . . . -90.3 -112.44 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.243 -1.783 . . . . 0.0 109.825 179.225 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 43.6 m -92.04 -52.46 4.7 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 123.21 1.481 . . . . 0.0 108.178 175.407 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.18 -162.13 32.48 Favored Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.253 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.506 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.49 115.79 9.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.527 -0.984 . . . . 0.0 109.576 179.549 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.64 136.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.334 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.41 145.59 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 108.929 179.808 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -115.14 154.25 47.27 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.17 132.48 27.63 Favored 'Cis proline' 0 N--CA 1.488 1.152 0 O-C-N 122.623 0.802 . . . . 0.0 110.68 -2.353 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.16 157.47 16.86 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 178.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.13 148.36 22.42 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 176.845 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.12 -25.32 1.41 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.728 -1.233 . . . . 0.0 109.701 -178.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.7 65.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -72.56 -62.48 1.43 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.977 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -37.82 55.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.428 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -65.44 -51.71 58.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.988 -1.07 . . . . 0.0 109.624 -179.755 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 20.4 tp10 -48.04 -48.33 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.855 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.67 -42.0 98.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.1 -60.13 4.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.552 -0.717 . . . . 0.0 109.92 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -32.07 57.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.057 -1.027 . . . . 0.0 110.263 -179.457 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -78.97 -23.5 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.4 mt -89.97 -39.07 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 110.271 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 127' ' ' LEU . 20.5 m-85 -74.16 -39.42 63.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.095 -1.003 . . . . 0.0 109.835 -179.248 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -50.76 -19.89 1.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' PHE . 24.6 mmtt -95.83 -27.25 15.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.508 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 124' ' ' PHE . 17.6 tp -75.58 -21.3 57.97 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.21 71.62 1.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.6 t70 -47.89 125.09 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.033 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -71.94 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 109.663 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 3' ' ' ASP . 1.9 tp10 -159.54 32.69 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.122 -0.986 . . . . 0.0 109.955 -179.939 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.85 135.27 49.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.018 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -81.43 128.1 33.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 -177.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 24.1 m-85 -112.38 153.13 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 179.465 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -126.52 106.67 9.61 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.792 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.81 113.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.73 83.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 121.74 -0.6 . . . . 0.0 109.545 -179.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.85 -154.18 0.55 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.345 0.593 . . . . 0.0 109.458 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -146.49 4.47 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.222 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' THR . 6.2 m-85 -95.26 122.74 38.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.78 33.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -151.74 -41.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.1 ttt -54.53 -43.35 71.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -40.17 68.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -68.59 -26.85 65.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 110.171 -178.507 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.97 -50.3 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.066 -1.021 . . . . 0.0 109.378 -179.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -39.39 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 -179.448 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -54.27 10.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.925 . . . . 0.0 109.591 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -56.78 12.78 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -54.44 1.96 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.353 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -59.63 -24.0 63.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.252 -0.905 . . . . 0.0 109.626 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -13.4 61.1 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.088 -1.007 . . . . 0.0 109.463 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mt -95.35 -38.71 10.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.764 -179.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.09 4.84 0.78 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 97.0 m-85 -89.89 148.79 22.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.803 -1.41 . . . . 0.0 109.489 -179.554 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -150.07 63.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 -179.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.33 96.02 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.118 -0.989 . . . . 0.0 109.237 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -140.27 153.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.98 -172.37 2.52 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.1 154.04 37.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 111.164 -178.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 -173.57 3.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -120.83 -2.41 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.196 -0.94 . . . . 0.0 110.548 -179.481 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 172.0 179.48 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.968 -1.082 . . . . 0.0 109.923 179.643 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.73 -42.08 96.19 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.46 -38.95 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.277 . . . . 0.0 109.23 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.21 -51.82 22.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.898 . . . . 0.0 108.941 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -50.05 -60.18 3.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.8 tp -45.23 -37.81 4.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.296 179.308 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 1.8 m-20 -70.77 -43.62 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 110.344 -179.578 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -90.11 -3.71 57.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.154 -0.966 . . . . 0.0 110.713 -179.194 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -73.93 -31.67 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 108.724 179.976 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -53.84 -20.41 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.108 179.859 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.9 -63.48 0.96 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.98 109.79 2.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . 147.41 -24.4 1.54 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.542 ' C ' ' H ' ' A' ' 53' ' ' PHE . 55.6 m-85 -64.81 78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.141 -1.211 . . . . 0.0 109.997 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -61.48 -3.31 3.97 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.493 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -148.03 130.41 15.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.569 -0.959 . . . . 0.0 108.777 -179.469 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.4 t -127.06 126.91 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.738 -1.226 . . . . 0.0 109.057 179.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.16 125.06 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 57' ' ' ASP . 60.0 p -142.51 142.55 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.0 m-20 -61.65 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.0 109.669 -179.715 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -169.51 134.2 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.94 . . . . 0.0 108.887 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 60' ' ' MET . 61.9 t30 52.92 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 108.864 -179.345 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 171.9 -46.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.65 -64.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.677 0.918 . . . . 0.0 110.098 -179.634 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' MET . 10.7 p30 -126.3 -39.47 2.05 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 25.6 ttt -172.62 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 171.63 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -49.79 -11.09 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.738 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' ASP . 5.7 mt -50.45 -35.06 27.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.641 -1.506 . . . . 0.0 107.719 179.197 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.439 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.7 mt-10 -75.23 -29.7 60.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.075 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 64.5 tp -74.1 -69.03 0.47 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.704 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -42.17 -67.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.364 0.602 . . . . 0.0 109.826 178.684 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -42.26 -51.76 4.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.585 -0.697 . . . . 0.0 110.262 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 77.4 m -49.3 -36.58 21.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.135 -179.88 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' LEU . 52.0 mt -64.22 -45.8 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.1 -1.0 . . . . 0.0 108.83 179.593 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -39.45 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.507 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.3 -28.57 59.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.5 111.28 2.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.07 -124.52 7.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.81 40.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -1.093 . . . . 0.0 109.617 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.15 -2.63 2.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.578 -0.701 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 80' ' ' ALA . 4.6 t 47.04 -134.94 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.672 179.827 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.449 ' H ' ' HG ' ' A' ' 79' ' ' SER . . . -126.38 40.29 3.76 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.717 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 82' ' ' PRO . 3.0 mt 47.37 -163.58 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.492 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.564 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 6.2 Cg_exo -57.3 155.79 28.33 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 121.2 1.464 . . . . 0.0 114.876 -176.364 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.21 135.62 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.375 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.1 72.46 0.79 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.185 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -58.96 160.08 6.36 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.264 -179.346 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -127.89 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.789 -0.569 . . . . 0.0 110.227 -177.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -150.03 -176.35 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 109.79 -179.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.89 52.35 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.74 53.42 12.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -48.79 140.76 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -92.84 -87.65 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.046 179.508 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER 179.8 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.391 179.634 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.93 -6.89 0.26 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 92' ' ' LYS . 26.9 m-80 -90.06 -22.61 21.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.99 -5.43 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.923 -179.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.76 -66.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.42 -41.11 13.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 109.031 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.42 -56.72 18.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.732 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.77 -44.84 63.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.95 -26.51 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.756 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.52 -115.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.21 -11.71 4.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 179.099 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -58.02 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.887 -0.772 . . . . 0.0 110.626 178.718 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.69 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.6 m -29.75 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.914 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -101.42 125.91 8.72 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.295 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.41 124.14 16.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.057 . . . . 0.0 108.885 178.661 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 14.4 p -123.67 123.83 68.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.433 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 13.6 p -76.43 102.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -64.42 161.22 44.44 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.273 -179.307 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -76.07 163.56 89.78 Favored 'Cis proline' 0 N--CA 1.485 0.985 0 O-C-N 122.879 0.937 . . . . 0.0 110.578 -2.327 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -143.28 161.0 39.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.902 178.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -101.85 152.22 21.16 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.234 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.02 -14.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.851 -1.156 . . . . 0.0 108.86 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.69 -41.17 38.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.663 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.5 -61.97 1.57 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.606 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp -48.57 -37.83 18.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.029 178.741 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.66 -56.34 22.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.925 -1.11 . . . . 0.0 109.659 179.837 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -46.03 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.83 -26.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 108.925 179.68 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.08 -19.05 2.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.928 -1.107 . . . . 0.0 110.583 -179.722 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -23.36 35.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.0 109.892 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.1 mt -89.93 -40.93 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.032 -1.043 . . . . 0.0 110.018 -179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.55 -5.57 8.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.992 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.61 -26.53 66.3 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -90.82 -35.42 14.83 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -24.42 61.86 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.97 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.95 89.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.444 179.718 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 43.8 t0 -45.04 141.28 2.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 109.311 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.17 13.61 14.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.944 -1.098 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -148.14 43.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.042 . . . . 0.0 110.332 -178.912 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.39 136.36 42.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.142 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.16 121.64 26.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.048 -1.032 . . . . 0.0 111.367 -177.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -106.71 157.59 17.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.702 -0.624 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -129.43 102.24 6.32 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.246 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.91 103.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.398 -179.082 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.12 113.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.276 -0.89 . . . . 0.0 109.25 179.528 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -171.7 163.92 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.504 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 2.9 m-20 -97.85 -58.36 2.01 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.968 -1.082 . . . . 0.0 108.781 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.6 ' CD2' ' N ' ' A' ' 15' ' ' SER . 22.2 p90 22.95 -145.77 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 CA-C-O 122.598 1.19 . . . . 0.0 112.831 177.398 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 179.47 -7.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.984 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.443 ' N ' ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -131.11 -34.15 1.47 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.967 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -37.34 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 111.117 -178.185 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' MET . 10.2 ptt180 -35.55 -31.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.805 -0.559 . . . . 0.0 110.473 -179.15 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.9 ttp180 -60.09 -49.66 76.77 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.877 -178.295 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.37 -54.51 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.716 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -18.52 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.341 -0.849 . . . . 0.0 110.84 -178.488 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -55.1 30.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.709 -1.245 . . . . 0.0 109.138 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -67.87 -53.39 27.06 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.673 0.749 . . . . 0.0 109.577 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -42.16 -56.23 2.96 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.544 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -58.95 -52.85 63.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 108.641 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -32.69 16.29 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.244 -0.91 . . . . 0.0 108.646 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -37.32 75.71 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.383 -0.823 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.63 -11.09 59.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.508 -0.745 . . . . 0.0 109.115 179.753 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.47 71.99 1.12 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 41.3 m-85 -150.0 146.19 26.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.325 . . . . 0.0 109.435 179.399 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.07 62.36 0.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.123 -0.985 . . . . 0.0 110.061 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.54 100.71 0.07 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.15 -0.968 . . . . 0.0 109.092 179.703 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.27 152.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.156 . . . . 0.0 110.179 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.48 -172.84 2.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.687 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -146.66 160.11 42.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.609 -179.276 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 -164.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -142.05 -5.08 1.01 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.11 -171.05 0.48 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.91 -1.118 . . . . 0.0 109.753 179.902 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.32 -45.01 57.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.86 -31.53 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.08 -1.247 . . . . 0.0 108.849 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -84.19 -51.84 6.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.448 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.54 -35.39 63.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.088 -1.008 . . . . 0.0 108.899 179.821 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -68.14 -56.96 6.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.3 -28.06 64.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.777 -179.743 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -90.06 -24.43 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 110.117 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.87 -20.05 61.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -87.23 -8.99 56.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 108.999 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.68 -72.23 0.06 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 109.757 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.67 10.1 1.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.01 87.48 0.77 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.6 m-85 -65.98 109.14 2.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.342 -1.093 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.62 -1.03 2.28 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' TYR . 6.5 t80 -165.57 148.02 7.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -1.1 . . . . 0.0 109.525 -178.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.59 145.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.635 -1.291 . . . . 0.0 110.837 -178.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.24 122.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.032 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.7 p -144.72 141.45 29.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.006 -179.291 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.36 167.08 17.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.856 -1.152 . . . . 0.0 108.429 179.127 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.526 ' NE1' ' OD1' ' A' ' 64' ' ' ASP . 73.2 t-105 -69.99 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.042 -1.036 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.06 131.6 46.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.347 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.406 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -171.16 -54.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 110.583 179.825 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -62.72 -161.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 N-CA-C 109.911 -0.842 . . . . 0.0 109.911 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.698 HD21 ' H ' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -67.32 -10.32 49.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.06 179.532 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.4 mmt -140.88 -100.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -125.17 146.75 49.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 109.479 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.24 -6.42 0.26 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.558 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.39 -71.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.257 . . . . 0.0 109.641 -179.592 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -45.17 -44.36 10.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.14 -179.501 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -56.27 -33.49 65.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 -179.773 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.08 -36.76 15.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.862 . . . . 0.0 109.333 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -61.48 -47.51 85.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.299 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -47.76 -39.22 17.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.55 -44.35 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 108.98 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -28.29 68.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 109.71 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.13 -29.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -168.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.473 ' CA ' ' HG ' ' A' ' 79' ' ' SER . . . -143.41 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.49 -56.03 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.101 . . . . 0.0 109.519 180.0 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.98 16.46 12.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.473 ' HG ' ' CA ' ' A' ' 76' ' ' GLY . 8.0 p -77.6 50.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 15.76 0.84 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.16 127.74 93.13 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.102 -0.999 . . . . 0.0 108.658 179.875 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.37 141.19 95.07 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.888 1.059 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.34 119.75 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.82 72.2 1.34 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.917 178.707 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -47.41 165.69 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.75 122.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.726 -178.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.691 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -150.1 174.22 13.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 109.411 179.323 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.691 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -106.74 -37.99 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.556 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -86.0 -72.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.684 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 91' ' ' LYS . . . 64.73 95.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 90' ' ' ALA . 13.9 mtpt -63.15 -128.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.148 -0.97 . . . . 0.0 109.327 179.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 93' ' ' GLU . 5.5 pttm -144.81 -48.75 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.361 179.751 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -75.06 -5.9 46.59 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.194 -0.941 . . . . 0.0 109.394 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -90.04 -28.06 19.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.666 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.9 -21.8 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 96' ' ' ILE . 92.5 mt -75.57 -65.94 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.29 -46.53 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.567 -0.708 . . . . 0.0 109.38 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.55 -53.23 60.48 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.738 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.79 61.54 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.205 -0.934 . . . . 0.0 109.914 -179.312 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -22.35 33.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.79 -61.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.369 -0.832 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.694 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -175.58 -10.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.08 -179.731 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.84 11.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.49 -1.006 . . . . 0.0 110.848 179.255 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.37 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.449 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.45 128.52 9.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.142 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.547 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -148.19 109.9 4.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.273 . . . . 0.0 109.116 179.376 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.98 135.51 43.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.65 95.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 pttt -56.37 155.12 14.1 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.789 -1.194 . . . . 0.0 109.283 -179.225 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.9 167.63 79.79 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 125.067 -0.806 . . . . 0.0 110.517 -2.086 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -146.73 163.55 35.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.102 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -102.36 146.83 27.49 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.721 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.19 -31.5 3.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.011 -1.056 . . . . 0.0 109.191 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.07 -37.34 78.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.585 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.4 m -68.78 -67.29 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.396 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -44.15 -39.73 4.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.259 178.753 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -62.47 -50.55 70.98 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.196 -0.94 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -46.29 -58.62 3.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 109.55 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 -38.82 26.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.303 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -39.66 85.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.83 -33.14 70.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.59 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -71.46 -25.42 62.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.705 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.05 -34.72 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -82.86 8.93 11.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -178.581 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -75.66 -25.4 56.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.14 -27.97 13.94 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.226 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -83.17 -22.49 33.24 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.97 85.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.32 -1.106 . . . . 0.0 109.431 179.792 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -44.53 149.6 0.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 109.409 179.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -90.55 9.14 30.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.1 -1.0 . . . . 0.0 110.112 179.812 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.2 50.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.777 -1.202 . . . . 0.0 110.574 -178.545 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 53.8 tp -78.74 111.11 14.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -48.32 118.12 2.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.94 -1.1 . . . . 0.0 111.713 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 64.5 m-85 -112.66 151.31 30.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.573 -0.705 . . . . 0.0 109.562 178.895 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 tp -123.7 108.22 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.673 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.97 110.19 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.548 -179.328 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.73 118.0 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.944 -179.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.67 41.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.47 -0.769 . . . . 0.0 109.279 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -106.44 6.52 30.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.674 -0.641 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -80.99 -21.57 40.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.864 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 p 75.17 -41.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' PHE . 5.2 t -98.13 1.24 47.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.7 ttt -80.05 -25.15 40.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -66.86 -45.75 77.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 109.668 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -22.29 56.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.283 -0.886 . . . . 0.0 109.777 -179.404 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -76.02 -55.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 -179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -13.97 17.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.855 . . . . 0.0 110.271 -178.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -65.68 -53.43 41.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 108.911 179.423 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -66.58 -55.52 14.99 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.859 0.838 . . . . 0.0 109.066 179.593 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.3 tt -41.86 -49.28 4.48 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.496 -179.628 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.08 -41.51 86.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 108.56 179.058 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -56.53 -36.93 69.8 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.478 -0.764 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.95 -16.1 48.58 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -102.1 5.44 40.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.564 -0.71 . . . . 0.0 109.849 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 79.48 47.62 7.26 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.379 179.609 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 39.2 m-85 -126.93 122.19 33.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.57 -0.959 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.83 64.53 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.734 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -172.23 90.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.964 -1.085 . . . . 0.0 109.482 179.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.22 -179.86 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.805 -179.849 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.52 -169.28 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -146.37 144.17 29.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.407 -179.065 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.26 -170.68 2.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.094 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 7.6 pt-20 -141.7 10.32 2.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 170.91 158.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.92 -1.113 . . . . 0.0 109.714 179.555 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -46.4 -44.29 15.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.46 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.24 -37.11 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.003 -1.292 . . . . 0.0 109.66 -179.555 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -45.9 60.9 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.151 -0.968 . . . . 0.0 108.732 179.619 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.86 -62.49 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.7 -0.625 . . . . 0.0 109.541 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -44.47 -48.29 10.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -65.32 -37.93 88.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.15 -3.07 58.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -83.36 -30.85 27.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.874 -1.141 . . . . 0.0 109.017 -179.836 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -62.37 -0.33 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.48 -61.16 1.8 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.536 -0.728 . . . . 0.0 109.738 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.18 21.74 0.12 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.96 108.07 1.11 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -179.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 24.2 m-85 -92.66 101.98 14.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.327 -1.102 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.17 -10.41 5.21 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -156.97 141.21 16.47 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.074 -1.25 . . . . 0.0 111.079 -179.311 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.24 105.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.393 -0.817 . . . . 0.0 110.209 179.273 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.9 69.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.97 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -101.33 148.68 24.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.258 -0.901 . . . . 0.0 109.161 -179.271 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 3.5 p30 -113.0 170.78 7.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.554 0.692 . . . . 0.0 109.989 -179.411 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 57' ' ' ASP . 1.5 t-105 -46.46 172.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 109.406 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.02 124.42 13.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.578 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -77.9 -39.25 1.82 Allowed Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.446 -0.784 . . . . 0.0 111.845 -179.842 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.4 Cg_exo -64.68 125.05 14.15 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 120.985 1.123 . . . . 0.0 110.763 -178.86 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 63' ' ' MET . 9.7 p30 42.72 -155.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.362 0.601 . . . . 0.0 110.19 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.516 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.87 155.42 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.753 -179.724 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 10.9 p-10 -97.33 -164.04 1.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 0.0 109.657 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.66 2.53 53.67 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.474 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.25 -55.74 8.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.309 . . . . 0.0 109.087 179.93 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.32 -15.55 0.65 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.065 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' N ' ' C ' ' A' ' 66' ' ' LEU . 7.1 tp -74.92 -62.77 1.43 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -43.92 -63.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.291 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -47.33 -43.54 22.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.7 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 m -70.86 -24.86 62.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 109.298 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' LEU . 48.0 mt -80.15 -9.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 108.777 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -86.93 -41.56 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 109.581 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.9 49.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -47.76 109.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.23 31.48 4.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.793 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 46.55 58.63 4.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 mmt -90.14 -62.84 1.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.19 30.59 1.44 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 109.193 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.62 -28.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 110.066 -179.577 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.9 tp -48.27 112.1 2.11 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 108.535 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.22 107.76 0.44 Allowed 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 120.988 1.126 . . . . 0.0 112.962 -178.505 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.549 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.1 t -108.85 119.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.654 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.35 102.49 14.27 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.131 -1.427 . . . . 0.0 108.015 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 110.4 15.16 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.791 -179.154 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.37 140.58 20.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.299 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -150.13 133.86 16.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.593 -1.317 . . . . 0.0 110.242 179.598 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.43 -59.24 2.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 108.985 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.33 67.21 3.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.04 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.78 109.35 7.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -91.37 133.13 35.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 108.93 179.604 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.22 -23.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 109.694 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.96 -50.93 5.74 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -64.91 -33.33 75.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 110.328 -179.115 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.67 -20.95 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.005 -1.059 . . . . 0.0 109.342 -179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.64 -16.09 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.968 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.73 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.6 -55.21 21.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.859 -1.151 . . . . 0.0 108.5 179.223 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.21 -30.87 70.69 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.272 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -53.99 -33.91 58.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.32 -25.25 36.58 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 176.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.63 74.02 0.65 Allowed Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.949 177.312 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.06 -111.95 0.08 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 117.184 -1.807 . . . . 0.0 109.36 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 51.7 m -91.79 -53.24 4.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 123.616 1.674 . . . . 0.0 107.483 175.344 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.6 37.99 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -177.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.92 153.46 51.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.509 -0.995 . . . . 0.0 110.353 179.865 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.636 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.2 p -145.46 150.19 15.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.325 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -170.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.26 179.193 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.73 156.67 25.03 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.81 133.1 29.79 Favored 'Cis proline' 0 C--N 1.32 -0.972 0 C-N-CA 124.423 -1.074 . . . . 0.0 109.682 -2.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.92 162.8 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 -179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.32 145.58 25.47 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 177.079 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -48.57 -22.58 0.78 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.765 -1.209 . . . . 0.0 109.227 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.33 53.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.372 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.9 m -70.9 -64.61 0.87 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.43 -36.17 21.52 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.21 -1.396 . . . . 0.0 108.921 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -57.18 -62.48 1.73 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.931 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 3.6 tm-20 -42.09 -42.6 2.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.794 -0.566 . . . . 0.0 109.877 -179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -74.1 -33.12 63.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.983 179.555 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -65.85 -65.52 0.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.803 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -45.5 -53.61 8.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 109.949 -179.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.95 -24.85 62.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 0.0 109.971 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.482 ' C ' ' H ' ' A' ' 125' ' ' GLU . 10.7 mt -84.32 -47.35 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.021 -1.049 . . . . 0.0 110.119 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.04 2.7 0.7 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.937 -1.102 . . . . 0.0 109.914 -179.202 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.2 tt0 -74.74 -34.89 62.61 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.136 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -82.72 -35.11 26.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.495 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tt -65.25 -27.36 68.6 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.11 80.85 0.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.017 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.373 -1.075 . . . . 0.0 109.444 179.724 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 59.61 122.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.394 -0.816 . . . . 0.0 109.415 -179.722 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 8.1 mttt -89.85 12.49 17.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.892 -1.13 . . . . 0.0 109.679 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.48 45.29 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 -179.732 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 21.2 tp -80.13 124.83 29.12 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.448 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 32' ' ' ASN . 34.6 mttp -73.91 122.97 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.0 111.858 -177.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 49.2 m-85 -113.7 147.88 37.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 51' ' ' TYR . 50.7 tp -114.89 126.41 54.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.543 177.951 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.65 102.78 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.622 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 58.2 t -97.18 24.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' OD2' ' OD1' ' A' ' 57' ' ' ASP . 2.1 m-20 -72.34 145.86 47.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.534 -179.995 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -103.97 9.96 36.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.56 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 109.577 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.87 4.06 9.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.679 -0.638 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -161.79 9.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpp -82.87 -43.44 16.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.31 -0.869 . . . . 0.0 109.267 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -35.38 70.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -27.86 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.55 -46.41 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.521 -179.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -31.84 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.276 -179.101 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.414 HH21 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.55 -57.41 9.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.431 179.853 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -64.72 -54.88 24.56 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.034 0.921 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -42.02 -58.99 1.89 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.552 -179.835 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.34 -47.66 83.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.014 -1.053 . . . . 0.0 108.849 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -52.1 -34.18 42.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 50.9 tt0 -48.61 -39.86 25.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.94 -66.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.98 30.19 0.02 OUTLIER Glycine 0 N--CA 1.482 1.751 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.53 148.35 22.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.305 . . . . 0.0 109.977 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.17 62.02 1.24 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.148 -0.97 . . . . 0.0 109.79 -179.879 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.505 ' CG ' ' HZ1' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -175.81 104.43 0.08 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.764 -1.21 . . . . 0.0 109.662 179.956 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.414 ' HB ' HH21 ' A' ' 22' ' ' ARG . 93.9 t -144.47 149.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -0.884 . . . . 0.0 109.629 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 21.2 mp0 -124.85 -172.23 2.53 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.671 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -150.06 151.07 32.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.793 -1.192 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.54 -178.15 5.75 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.06 19.36 1.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.028 -1.045 . . . . 0.0 110.554 -179.62 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 176.5 154.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.827 -1.17 . . . . 0.0 108.788 179.66 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.4 -55.85 15.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.453 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.9 t -50.44 -24.62 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 38' ' ' ASP . 3.1 t0 -85.18 -42.4 14.76 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.77 85.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.008 -1.058 . . . . 0.0 109.355 -179.856 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -55.3 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.617 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -57.12 -33.59 67.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.993 -1.067 . . . . 0.0 110.237 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.79 -8.05 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.709 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -78.4 -37.26 44.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.593 -1.317 . . . . 0.0 109.25 -179.701 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -7.43 0.69 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 108.967 179.647 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.24 -67.45 0.28 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.422 -0.798 . . . . 0.0 109.801 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.24 -94.98 0.24 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.7 78.03 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 53' ' ' PHE . 13.6 m-30 -59.62 86.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.329 -1.101 . . . . 0.0 109.915 179.663 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -62.18 -1.61 3.27 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.331 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.539 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -154.22 144.73 22.28 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.474 -1.016 . . . . 0.0 109.818 -178.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -142.51 119.99 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 0.0 110.389 -179.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.59 127.66 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' SD ' ' A' ' 85' ' ' MET . 13.3 p -149.22 146.59 27.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.998 -1.064 . . . . 0.0 109.873 -179.34 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' OD2' ' A' ' 12' ' ' ASP . 2.3 m-20 -71.59 163.36 27.89 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.242 -0.911 . . . . 0.0 108.81 179.406 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.82 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.519 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -172.75 171.85 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.016 -1.052 . . . . 0.0 110.027 -179.926 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.1 tpp 178.21 -46.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.495 179.014 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.2 Cg_endo -71.65 93.03 0.68 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.035 1.157 . . . . 0.0 109.524 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.497 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 41.91 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 0.0 109.845 179.999 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.2 tpp 47.6 -116.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.066 . . . . 0.0 109.062 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.76 -175.23 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 179.596 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.505 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 94.51 -72.08 1.11 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -47.52 63.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.998 -1.295 . . . . 0.0 107.854 178.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 15.7 mp0 -65.51 -22.63 66.74 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -64.65 -55.02 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.25 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' ILE . 2.0 mt -58.16 -67.09 0.38 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.21 0.528 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -37.55 -46.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.86 -0.525 . . . . 0.0 110.35 -179.56 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 25.2 m -57.64 -41.87 82.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.124 179.71 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 69' ' ' LEU . 60.3 mt -60.9 -30.07 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -76.98 -55.92 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.592 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.12 4.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 135.62 55.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' ALA . . . -87.3 161.19 32.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' GLY . . . 76.35 -7.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.451 -1.029 . . . . 0.0 109.683 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.4 mmm -109.89 -19.13 13.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.6 m 51.83 -108.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.06 56.16 0.95 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 80' ' ' ALA . 73.6 mt -43.06 148.68 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.684 -0.635 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.42 143.31 94.46 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.475 1.45 . . . . 0.0 111.804 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.26 119.85 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.676 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.8 tp -103.8 75.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.55 178.309 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -48.89 169.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.894 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.12 122.57 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.494 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.5 t -140.54 -169.03 2.69 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.613 -179.549 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -140.99 16.43 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -138.59 -61.74 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.068 -179.688 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . 54.48 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.48 31.85 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.966 -179.449 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ILE . 35.1 mtpt 54.49 -82.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 179.397 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.09 -25.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.337 -179.252 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 92' ' ' LYS . 22.0 t-20 -85.01 -31.49 23.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.0 109.857 -179.675 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' LYS . 72.4 mt -67.19 -15.27 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 110.142 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.25 -64.51 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.86 -179.798 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.79 -31.34 2.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.913 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.31 -55.05 11.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.75 -179.81 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.03 -42.66 60.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 -179.342 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -51.39 -26.8 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.97 -179.896 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.09 -113.43 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.423 179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.682 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.03 -1.17 6.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.414 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.32 11.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.154 -0.615 . . . . 0.0 110.831 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.682 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.48 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.275 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.43 130.62 10.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.391 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.85 115.16 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 108.866 179.112 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 14.0 p -114.26 121.89 67.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.617 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.51 96.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -59.44 160.87 11.86 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 0.0 109.141 -179.21 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.2 165.55 85.56 Favored 'Cis proline' 0 N--CA 1.485 0.988 0 O-C-N 122.86 0.926 . . . . 0.0 110.483 -2.257 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -146.03 159.36 43.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.121 -0.987 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.19 147.15 25.42 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.958 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.453 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -44.72 -28.26 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.625 -179.168 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.37 83.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.495 178.936 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -64.14 -64.6 0.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.962 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.6 tp -45.49 -43.51 11.71 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.058 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -61.98 -52.48 63.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.664 -1.272 . . . . 0.0 110.064 -179.882 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 117' ' ' GLU . 1.1 tp10 -43.59 -64.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.736 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -46.05 -46.41 16.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -45.56 -44.07 12.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -62.44 -42.91 99.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.375 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -58.86 -32.5 69.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.492 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.03 -34.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.248 -0.907 . . . . 0.0 109.907 -179.423 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -86.23 1.31 51.28 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 110.646 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -77.1 -28.47 54.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -94.81 -22.26 18.17 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -29.05 21.07 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.403 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.22 86.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.475 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.296 -1.12 . . . . 0.0 109.53 -179.954 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.352 0.596 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 66.39 142.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.227 -0.921 . . . . 0.0 109.887 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 mmmm -90.3 19.57 5.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 0.0 109.413 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.53 49.45 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.952 -1.092 . . . . 0.0 109.635 -179.321 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 60.5 tp -60.24 111.0 1.37 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 0.0 108.934 179.885 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -43.91 105.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.894 -1.129 . . . . 0.0 111.144 -178.835 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 56.8 m-85 -102.33 154.77 18.74 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.793 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 tp -132.09 103.41 6.25 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.59 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.55 113.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.093 -178.983 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.04 69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.583 -0.698 . . . . 0.0 110.025 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -114.58 131.0 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -77.5 -5.63 50.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.664 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.83 143.76 32.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.944 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.08 12.36 24.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -31.25 1.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 ttt -55.81 -32.19 63.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.267 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.507 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -69.25 -43.51 73.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 -179.979 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -59.18 -25.25 63.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.16 -49.24 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.766 -179.67 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -30.74 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.589 -178.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -51.38 60.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.939 -1.101 . . . . 0.0 108.694 179.456 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.44 -60.51 2.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.842 0.83 . . . . 0.0 109.546 179.85 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -45.03 -35.99 3.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.715 -179.226 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -74.22 -51.84 14.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 108.25 178.577 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -52.68 -33.82 49.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.45 -0.781 . . . . 0.0 108.968 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -49.24 -39.15 29.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.348 -0.845 . . . . 0.0 108.783 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 -64.98 0.98 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 160.06 41.43 0.02 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.765 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -113.8 134.6 54.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.61 -0.935 . . . . 0.0 109.184 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 65.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.946 -1.096 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -174.21 93.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.816 -1.178 . . . . 0.0 109.079 179.717 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.93 -179.73 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.036 -1.04 . . . . 0.0 110.653 -179.271 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 2.9 mt-10 -137.9 -171.39 3.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.516 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.507 ' CD ' HH11 ' A' ' 18' ' ' ARG . 58.3 mt-10 -140.13 154.2 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.038 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.03 -167.26 2.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.148 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -139.87 -10.68 1.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 0.0 111.004 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -174.57 -166.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.013 -1.054 . . . . 0.0 109.761 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.42 -42.81 32.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.1 t -55.46 -41.23 61.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.919 -1.342 . . . . 0.0 108.121 179.16 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.42 -54.48 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 109.291 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.42 -62.65 1.71 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.229 -0.92 . . . . 0.0 109.411 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.9 tp -41.73 -43.08 2.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.684 -0.635 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -74.36 -37.32 63.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -90.09 0.71 57.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -78.09 -40.56 37.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.051 -1.031 . . . . 0.0 109.029 179.955 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.98 -4.37 3.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.51 -72.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.482 -0.761 . . . . 0.0 109.549 -179.969 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.31 5.26 2.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.853 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.42 78.44 1.03 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.9 m-85 -57.51 114.75 2.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -1.034 . . . . 0.0 110.094 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.3 -7.61 2.04 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.437 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -160.75 137.23 8.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.732 -178.552 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.8 122.33 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.731 . . . . 0.0 109.847 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.44 151.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -167.64 162.58 14.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.007 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.38 -168.18 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 108.978 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 59' ' ' ASN . 13.7 t-105 -128.6 111.82 13.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.434 -0.791 . . . . 0.0 109.564 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER 52.76 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.751 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 177.38 -50.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 179.578 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.12 -54.93 0.54 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 120.832 1.021 . . . . 0.0 109.891 -179.873 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.97 -41.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.298 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -132.38 -179.83 5.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.43 151.66 32.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.606 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -79.3 -20.14 70.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -48.23 -29.04 3.4 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -1.196 . . . . 0.0 108.334 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.5 tp10 -83.15 -29.79 28.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 109.348 179.443 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -57.59 -35.02 69.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 108.707 179.719 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -86.74 -61.93 1.62 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 108.667 179.09 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -43.09 -26.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.914 -179.289 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 p -72.82 -39.45 66.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.054 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . 81.2 mt -63.6 -45.27 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -61.07 -29.2 69.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 109.64 -179.85 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.91 -28.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.568 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.9 -153.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.07 -12.77 0.1 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.25 -27.97 19.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -1.183 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.1 mtm -92.56 -11.24 34.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t 52.32 -111.32 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.1 58.61 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 80' ' ' ALA . 10.5 mt -38.01 153.77 0.13 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 122.042 -0.412 . . . . 0.0 110.086 -179.303 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.26 140.36 94.04 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.566 1.51 . . . . 0.0 111.481 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.32 130.44 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.56 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.1 tp -113.36 75.95 0.95 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.102 0.953 . . . . 0.0 108.543 178.473 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtt -51.24 172.24 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -145.75 125.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 109.273 -179.464 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 109' ' ' LYS . 15.2 t -150.06 178.11 9.26 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.026 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.61 -42.93 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.34 69.92 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.5 -0.75 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -65.37 107.83 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.927 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' CG ' ' N ' ' A' ' 92' ' ' LYS . 6.6 ttpt -73.52 -110.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 -179.778 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 31.5 ttpt -160.2 -75.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.351 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.5 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.758 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -89.32 -64.0 1.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 -179.766 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -47.99 -39.32 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 0.0 109.65 -179.82 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 97' ' ' ALA . 31.5 mt -68.57 -65.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.03 -53.0 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.434 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.97 -44.34 91.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.55 -0.718 . . . . 0.0 109.917 179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.78 -47.51 51.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.707 -1.246 . . . . 0.0 109.333 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -58.97 -23.64 61.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.816 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.21 -103.66 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.718 -179.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.715 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -129.91 -6.88 3.9 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.52 11.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.889 -0.771 . . . . 0.0 110.102 178.176 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.715 ' H ' ' C ' ' A' ' 102' ' ' GLY . 61.4 m -29.27 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.725 -176.339 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -115.94 129.9 8.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.97 110.18 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 108.39 179.385 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 10.9 p -110.68 123.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.401 HG13 ' H ' ' A' ' 109' ' ' LYS . 2.5 t -58.27 -178.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.9 pttt -155.61 157.95 31.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.32 -1.488 . . . . 0.0 109.194 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.85 164.51 87.3 Favored 'Cis proline' 0 N--CA 1.484 0.929 0 C-N-CA 124.706 -0.956 . . . . 0.0 110.298 -2.254 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.87 159.32 35.25 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.774 0.797 . . . . 0.0 109.938 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.21 145.45 24.49 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.149 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.08 -20.49 0.16 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.949 -1.095 . . . . 0.0 109.54 -178.746 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.57 -36.03 26.6 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.327 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.4 m -69.91 -59.86 2.66 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.1 OUTLIER -49.09 -46.57 44.85 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.155 178.802 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -55.7 -50.78 69.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 110.308 -179.563 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 5.1 tt0 -51.41 -68.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -45.56 -35.27 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.091 -1.006 . . . . 0.0 110.208 -179.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.28 -65.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.041 . . . . 0.0 110.014 -179.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -45.43 -28.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.433 -179.356 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -69.16 -47.76 64.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.962 -1.086 . . . . 0.0 109.765 -179.549 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.6 mt -69.56 -38.19 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -70.08 -4.77 22.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 110.723 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.04 -22.18 56.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.644 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -96.28 -24.37 16.24 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -86.08 -32.74 21.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.397 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 43.79 84.18 0.02 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.207 -1.172 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -45.88 135.36 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.522 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -90.54 16.17 9.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.668 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.28 47.27 2.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 108.785 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 22.3 tp -90.02 119.02 30.02 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.37 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -61.82 120.45 10.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.92 . . . . 0.0 110.986 -178.457 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 76.9 m-85 -110.81 152.03 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.889 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 tp -124.62 104.01 8.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -93.57 107.68 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.973 -1.079 . . . . 0.0 110.013 -179.328 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.27 -96.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.915 -1.115 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 52.91 -161.85 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.032 -1.042 . . . . 0.0 109.598 179.72 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.81 9.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -54.37 -21.07 8.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.651 -179.897 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER 72.26 -8.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.124 -179.743 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' PHE . 1.3 t -136.0 -10.33 2.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.629 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.412 ' SD ' ' C ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -69.58 -50.56 43.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 108.715 179.431 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -41.94 -41.54 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.338 0.59 . . . . 0.0 109.98 179.706 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -63.72 -45.11 91.43 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.049 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.95 -51.63 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.63 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -0.974 . . . . 0.0 110.53 -178.879 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -55.16 6.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t-20 -67.79 -58.26 4.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.1 -62.25 0.86 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.857 -179.698 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 mt -54.0 -42.16 68.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.228 -0.92 . . . . 0.0 109.519 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -62.16 -38.44 89.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -60.0 -33.74 72.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mt -76.12 -50.19 15.31 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 4' ' ' LYS . . . 148.38 54.2 0.02 OUTLIER Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.341 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -144.34 133.81 23.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.214 . . . . 0.0 110.04 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -145.37 55.47 1.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.354 179.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -162.18 98.02 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.03 152.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.112 -0.993 . . . . 0.0 110.428 -178.776 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.12 -170.87 1.76 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.754 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.91 151.01 32.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.991 -178.712 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.33 -171.39 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.93 10.9 1.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.133 -0.98 . . . . 0.0 110.032 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 169.03 163.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.804 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -55.27 -37.53 65.3 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.938 -179.38 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.83 -37.46 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.822 -1.399 . . . . 0.0 107.922 179.112 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -80.75 -55.45 4.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.598 -0.689 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.92 -54.1 33.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 109.281 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 5.0 tt -52.68 -58.4 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -0.857 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -56.58 -34.63 67.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.934 -178.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -90.03 -17.58 27.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.891 -1.131 . . . . 0.0 110.815 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -59.93 -28.29 67.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 0.0 109.046 -179.779 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 7.4 tt0 -72.64 2.6 6.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.18 179.695 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.61 -75.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.421 -0.799 . . . . 0.0 109.634 -179.878 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.49 -35.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.47 67.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' PHE . 70.4 m-85 -49.54 100.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.35 -6.44 0.99 Allowed Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.5 t80 -161.03 144.82 13.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -1.073 . . . . 0.0 109.805 -178.414 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.65 120.94 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.962 -1.086 . . . . 0.0 110.032 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.32 97.67 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.568 -0.707 . . . . 0.0 109.107 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 p -99.4 -177.07 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 12.7 t70 -140.39 50.67 1.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 109.686 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 47.32 77.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.217 -179.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -48.35 141.23 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -100.64 -36.67 0.23 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 111.802 -179.972 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.45 122.73 10.49 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.849 1.033 . . . . 0.0 110.715 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 m-80 48.16 53.98 10.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.845 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mtp 53.48 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 54.34 178.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.5 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.11 -46.62 2.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.175 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.6 -69.28 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.288 . . . . 0.0 108.027 178.79 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.75 -22.11 13.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.23 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.11 -53.17 57.67 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.97 -65.72 0.59 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.077 0.942 . . . . 0.0 109.131 179.352 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -41.63 -36.5 0.96 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.78 -179.85 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -41.95 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 108.551 179.768 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.12 -39.75 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.063 -1.023 . . . . 0.0 108.254 178.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -23.8 67.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.294 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.36 51.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.626 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -45.74 -36.07 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 109.633 -179.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.04 32.91 85.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.1 -54.79 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.533 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.01 -67.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m 57.24 4.33 0.2 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.333 -0.854 . . . . 0.0 109.274 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -106.37 -12.24 15.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.635 -0.665 . . . . 0.0 109.651 -179.762 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 80' ' ' ALA . 13.2 mt -45.18 107.78 0.69 Allowed Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.26 150.12 89.45 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.079 1.186 . . . . 0.0 112.899 -178.039 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.39 126.87 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.044 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -113.83 72.95 0.8 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.512 179.059 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' LEU . 9.7 mtt -46.39 170.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.328 0.585 . . . . 0.0 109.504 -179.245 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.15 125.07 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.22 -179.312 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 148.82 29.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.645 -1.284 . . . . 0.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 -42.33 8.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -96.32 50.72 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -61.14 101.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 109.437 -179.973 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -68.33 -110.62 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 94' ' ' ASN . 3.1 ttmt -162.39 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -19.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 109.565 -179.95 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -90.06 -37.65 14.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.54 -16.21 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.44 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.577 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.82 -38.81 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.54 -57.72 10.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.11 64.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -57.62 -17.39 14.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.69 -107.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.603 -0.685 . . . . 0.0 109.905 -179.664 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.86 -1.55 8.12 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.38 11.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.032 -0.687 . . . . 0.0 111.512 179.239 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.662 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.25 -31.44 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.119 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -116.84 135.08 11.71 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.661 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -151.23 114.15 4.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -1.152 . . . . 0.0 109.312 179.062 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.91 140.1 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.202 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 9.3 p -88.31 100.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.554 179.391 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.0 155.25 64.69 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.989 . . . . 0.0 109.531 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.58 167.75 79.39 Favored 'Cis proline' 0 N--CA 1.488 1.205 0 O-C-N 122.649 0.815 . . . . 0.0 111.068 -2.295 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.52 156.91 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.865 0.84 . . . . 0.0 109.829 178.73 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.09 146.17 23.85 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.053 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.5 -22.76 0.79 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.775 -1.203 . . . . 0.0 109.301 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.24 39.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.434 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 112' ' ' THR . 7.0 m -72.63 -61.72 1.7 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.779 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -38.65 47.76 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.213 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.25 -48.16 76.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.61 -43.88 8.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.665 -179.577 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -66.57 -50.78 61.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -25.76 9.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.05 -22.96 36.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -80.61 -25.11 38.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 109.393 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.94 -34.81 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.667 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -80.2 -1.61 41.25 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 -178.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -76.94 -21.14 55.27 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.609 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.45 -26.88 14.31 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.474 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -26.4 40.47 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.24 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.97 88.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.638 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.328 -1.101 . . . . 0.0 109.514 -179.783 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.4 0.619 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' ALA . 1.9 m-20 61.65 127.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.737 179.83 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -90.18 19.57 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 0.0 108.756 179.425 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 1.3 tt0 -144.89 45.62 1.36 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.564 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 20.7 tp -78.49 117.77 20.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 108.442 -179.92 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -63.72 121.2 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 111.842 -177.737 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 96.0 m-85 -115.19 142.85 46.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -116.82 117.99 31.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.123 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 1.2 m -105.57 112.61 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 109.665 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.522 ' C ' HH22 ' A' ' 18' ' ' ARG . 26.6 t -105.85 115.86 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.625 ' N ' ' NH2' ' A' ' 18' ' ' ARG . 13.4 t70 -149.89 -137.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -158.89 -20.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.952 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.08 126.8 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.95 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.8 p -81.62 41.43 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.517 -179.933 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -166.05 -29.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 179.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.8 ttp -57.96 -47.79 81.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.625 ' NH2' ' N ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -46.58 -29.1 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.716 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -67.72 -34.9 77.78 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.25 -55.89 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.854 -179.789 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -39.18 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 -179.079 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -46.89 -55.38 8.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -65.11 -56.12 14.77 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.859 0.838 . . . . 0.0 109.311 -179.968 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -38.84 -60.36 0.85 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.991 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.3 -46.5 86.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 109.114 179.428 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -32.7 65.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.326 -0.859 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.25 61.4 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.851 -1.156 . . . . 0.0 109.069 -179.53 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' CD1' ' OE1' ' A' ' 117' ' ' GLU . 3.3 tp -80.1 -66.56 0.86 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 109.188 179.533 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.73 0.02 OUTLIER Glycine 0 N--CA 1.482 1.719 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -101.85 153.14 20.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -1.18 . . . . 0.0 108.997 179.731 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.07 58.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.967 -1.083 . . . . 0.0 110.737 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.5 100.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.849 -1.157 . . . . 0.0 109.872 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.2 t -139.42 150.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.34 -0.85 . . . . 0.0 109.919 -179.611 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -122.01 -173.25 2.62 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.687 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.75 155.35 44.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.273 -0.892 . . . . 0.0 110.94 -178.345 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.6 -172.59 4.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' OE1' ' OD2' ' A' ' 41' ' ' ASP . 1.4 pm0 -143.46 2.57 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.103 -0.998 . . . . 0.0 110.652 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -168.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.781 -1.199 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.04 -47.05 19.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.203 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 4.1 p -52.22 -35.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.644 -1.504 . . . . 0.0 107.941 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 3.5 t0 -80.32 -45.86 17.11 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.482 -0.762 . . . . 0.0 109.728 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -70.32 -57.66 4.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.899 -1.125 . . . . 0.0 108.872 179.649 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 39' ' ' GLY . 2.9 tm? -44.78 -52.04 8.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 0.0 108.979 179.713 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 77.7 m-20 -65.07 -38.77 91.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.695 179.925 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -86.26 5.83 32.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 110.245 -179.436 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -90.15 -56.0 3.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 108.927 179.621 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.47 2.91 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 108.734 179.306 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.82 -65.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.817 -179.815 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 4.84 2.64 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 79.34 1.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.457 ' C ' ' H ' ' A' ' 53' ' ' PHE . 19.7 m-85 -66.59 108.72 2.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.5 -1.0 . . . . 0.0 109.954 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.86 -6.85 2.99 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.556 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.8 t80 -163.02 146.77 11.01 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.169 -1.195 . . . . 0.0 109.876 -178.601 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.74 126.85 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 110.273 179.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.2 mt -110.01 134.98 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.348 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.9 p -146.94 137.41 23.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.642 -179.889 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 m-20 -71.83 -151.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 -179.979 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 52.9 t-105 -101.9 -177.98 3.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.546 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.07 90.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.874 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -95.98 -46.8 0.25 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.956 -179.895 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.5 -54.9 0.51 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.14 1.227 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' ASP . 5.7 p30 -173.03 -148.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.651 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -61.86 78.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 108.724 179.39 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ASN . 49.1 m-20 -154.82 -157.97 0.8 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.885 . . . . 0.0 109.441 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.88 -72.78 0.38 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.632 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -66.42 -43.3 86.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.89 -1.359 . . . . 0.0 107.364 178.557 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.6 -27.58 67.82 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.406 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -60.69 2.55 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.447 HD21 ' H ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -55.97 -63.91 1.03 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.338 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' LEU . 13.7 ttmm -44.32 -39.43 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.523 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 m -68.82 -41.08 79.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.816 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.22 -23.83 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.162 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -27.47 19.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.479 -0.763 . . . . 0.0 109.183 179.803 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.22 -29.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.701 -179.825 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -172.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -58.77 -165.77 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.653 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.96 19.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.483 ' H ' ' C ' ' A' ' 76' ' ' GLY . 3.9 tpt -89.94 -28.76 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.009 179.627 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 45.89 -125.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.538 -0.727 . . . . 0.0 109.172 179.937 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.12 54.1 0.92 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER 44.0 -166.42 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.575 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.7 Cg_exo -61.63 151.21 81.74 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.966 1.381 . . . . 0.0 114.508 -176.336 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.58 138.42 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.769 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -117.1 78.46 1.22 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.403 ' N ' ' O ' ' A' ' 105' ' ' GLY . 18.0 ttp -61.9 159.54 13.83 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.337 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.19 142.33 17.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.806 -1.184 . . . . 0.0 109.953 -178.742 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.1 t -149.98 174.94 12.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.874 -179.973 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.7 -39.95 5.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.679 -0.638 . . . . 0.0 109.361 179.655 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.9 tt0 -81.77 -60.81 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . 51.32 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 179.97 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.0 ttmt -94.44 125.42 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.985 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -45.53 -24.77 0.36 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.633 -179.574 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -85.31 -31.19 23.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.7 m-80 -89.95 -15.09 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.784 -179.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 84.5 mt -75.84 -0.69 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.0 -58.24 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.762 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.04 -52.18 12.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -49.28 -54.06 18.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.722 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.59 -38.11 63.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.073 -1.017 . . . . 0.0 110.037 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -17.55 35.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.831 -179.688 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 -106.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.609 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.57 1.46 5.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -54.79 11.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.148 0.579 . . . . 0.0 111.385 179.001 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.67 ' H ' ' C ' ' A' ' 102' ' ' GLY . 54.2 m -29.29 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.92 -0.487 . . . . 0.0 111.991 -176.55 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -114.86 123.68 6.08 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.237 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.456 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -138.29 114.6 10.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.363 -1.08 . . . . 0.0 109.883 179.441 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.89 138.65 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.351 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.2 p -85.96 103.36 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.889 -1.132 . . . . 0.0 109.315 -179.582 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.5 pttt -63.28 159.16 51.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.943 -1.098 . . . . 0.0 109.199 -179.691 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.36 156.87 99.47 Favored 'Cis proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.693 -0.961 . . . . 0.0 110.103 -2.446 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -136.42 156.25 48.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 110.166 179.455 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.14 151.82 21.37 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.067 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.36 -18.15 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.691 -1.204 . . . . 0.0 108.909 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -72.42 -44.8 61.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.644 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.0 OUTLIER -67.26 -63.35 1.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.57 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.7 tp -47.77 -35.68 10.37 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.29 179.327 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' CD1' ' A' ' 28' ' ' LEU . 23.0 tt0 -72.28 -60.12 2.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.642 -1.286 . . . . 0.0 110.725 -179.248 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -40.8 -35.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.67 -0.644 . . . . 0.0 110.774 -178.738 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -79.26 -54.28 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.996 -1.065 . . . . 0.0 109.982 -179.556 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -47.33 -44.33 23.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.824 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -53.67 -45.68 70.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.188 -179.427 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -62.51 -50.66 70.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.36 -34.74 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.815 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 -1.38 57.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.797 -179.051 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.26 -26.89 35.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.19 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -95.97 -21.28 18.12 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.4 OUTLIER -88.31 -34.97 17.48 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.429 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 42.63 77.89 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.469 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.118 -1.225 . . . . 0.0 109.492 -179.918 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.05 144.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.989 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -90.12 11.36 21.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.086 -1.009 . . . . 0.0 109.803 -179.815 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -146.25 48.12 1.21 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.532 -179.736 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.15 126.06 29.15 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.475 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.76 118.19 12.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.08 -1.013 . . . . 0.0 111.534 -177.367 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.81 149.96 26.01 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.4 tp -125.57 104.95 8.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.984 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.86 104.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.578 -179.096 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.93 115.0 28.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -174.35 -166.85 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.025 -1.047 . . . . 0.0 109.882 -179.206 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.7 9.68 0.47 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.337 -0.852 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -51.04 -35.66 35.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.732 -1.23 . . . . 0.0 108.536 179.781 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 72.5 31.67 1.71 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.871 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 t -177.23 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.47 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.43 ' CB ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -73.88 -35.71 64.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.493 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.498 HH22 HH22 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.72 -50.23 13.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.044 178.587 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -26.84 67.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.353 -177.392 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -54.31 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.019 179.649 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.0 -40.29 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 -179.414 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.498 HH22 HH22 ' A' ' 18' ' ' ARG . 1.2 mtm180 -49.72 -52.18 33.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.441 179.347 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -59.05 -59.07 6.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.266 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.5 tt -42.71 -30.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -84.6 -33.12 23.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.941 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' ASN . 5.8 tttp -69.94 -35.36 74.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.427 -0.796 . . . . 0.0 108.905 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.26 -35.63 60.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.273 -0.892 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.44 -55.45 4.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.73 62.94 0.01 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.628 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 96.9 m-85 -150.12 141.84 23.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.909 -1.348 . . . . 0.0 109.757 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -150.15 66.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.042 -1.036 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.54 102.37 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.592 -1.317 . . . . 0.0 110.213 179.519 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.46 178.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 179.611 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.7 mt-10 -140.55 -167.11 2.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.367 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.52 149.52 32.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 111.1 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.57 -168.28 2.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.039 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.79 7.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.692 -179.449 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 15.7 t0 -176.46 151.4 0.96 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.052 -1.03 . . . . 0.0 109.674 179.881 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -52.54 -29.02 30.78 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.489 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.4 t -72.43 -38.61 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -1.183 . . . . 0.0 108.898 179.637 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -70.96 -43.82 67.31 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -65.52 -60.19 3.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.302 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.6 tp -45.38 -33.62 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.537 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.37 -38.98 23.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -86.26 -1.29 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.901 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -70.2 -10.74 59.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.235 -179.947 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -7.5 21.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.505 -0.747 . . . . 0.0 109.257 179.671 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.87 -55.01 7.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 109.573 -179.801 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.99 6.31 2.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 89.61 0.12 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.852 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.415 ' OH ' ' CG ' ' A' ' 34' ' ' GLU . 44.0 m-85 -76.09 153.34 36.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.225 -1.162 . . . . 0.0 110.024 -179.606 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.98 5.94 39.9 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.301 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -165.7 141.64 5.15 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.627 -0.925 . . . . 0.0 108.89 -179.569 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.93 109.43 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -0.837 . . . . 0.0 109.478 179.345 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.6 90.78 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 164.74 12.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.95 . . . . 0.0 109.142 -179.931 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.0 t0 -91.45 -95.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 110.189 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.555 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 55.7 t-105 -166.39 -123.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.975 . . . . 0.0 109.372 -179.266 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.433 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 21.2 t-20 -103.22 51.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.605 -0.684 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -92.74 -48.62 0.3 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 179.959 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.79 -71.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.006 1.138 . . . . 0.0 109.96 -179.581 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 63' ' ' MET . 4.2 p30 -153.71 -62.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.0 109.001 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.514 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 ttp -88.34 176.62 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.58 142.16 35.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 0.0 109.458 179.927 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.42 13.54 1.54 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -76.07 -58.15 3.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.038 -1.272 . . . . 0.0 108.264 179.25 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -62.37 -13.16 26.25 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.772 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.7 tp -77.03 -43.62 33.88 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.778 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -81.32 -28.69 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.988 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -66.42 -41.05 89.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.332 -0.855 . . . . 0.0 108.9 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 2.9 m -71.34 -39.66 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.96 -30.3 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.12 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -90.15 -31.05 17.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.39 -0.819 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -29.89 3.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.16 151.04 38.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.22 16.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.98 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.64 -29.85 16.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -1.134 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.54 ' C ' ' H ' ' A' ' 80' ' ' ALA . 15.8 mtt -89.97 6.23 43.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.371 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -73.77 34.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.804 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.61 21.73 3.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 109.27 -179.998 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.65 98.32 40.54 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.697 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.39 118.61 5.52 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.614 1.542 . . . . 0.0 114.03 -178.87 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.38 118.61 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 176.063 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.32 109.3 22.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.21 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.17 103.0 12.25 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.52 146.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.904 -1.122 . . . . 0.0 109.368 179.658 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.567 ' HG1' ' N ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -150.07 155.91 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.014 -179.82 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.567 ' N ' ' HG1' ' A' ' 87' ' ' THR . . . -88.07 -50.29 6.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.141 179.579 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 91' ' ' LYS . 50.7 mt-10 -93.36 58.84 2.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 109.079 179.634 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -53.86 86.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.713 -179.724 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 89' ' ' GLU . 20.1 tttm -71.35 139.36 49.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.055 -1.028 . . . . 0.0 108.961 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 91' ' ' LYS . 1.4 tppp? -42.08 -28.2 0.17 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.99 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' LYS . 13.3 tp10 -88.32 -29.39 20.37 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.225 -0.922 . . . . 0.0 109.9 -179.937 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 2.6 t30 -68.86 -28.8 67.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.095 -1.003 . . . . 0.0 110.29 -179.423 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.1 -58.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.728 -1.233 . . . . 0.0 108.711 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' GLN . 82.2 mt -63.63 -19.79 24.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.363 -0.836 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.14 -71.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.114 179.658 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.76 -44.75 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.968 -1.082 . . . . 0.0 108.169 179.059 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.22 -24.38 66.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.572 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 96' ' ' ILE . 6.8 tt0 -52.84 -30.99 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.879 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.41 -21.79 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.439 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.58 77.06 0.31 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.391 178.048 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.99 -111.8 0.08 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 117.223 -1.791 . . . . 0.0 109.634 178.924 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 105' ' ' GLY . 2.2 p -91.68 -50.3 5.83 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.997 1.379 . . . . 0.0 108.1 176.045 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.437 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 166.36 -163.6 37.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.373 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.506 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -143.52 124.7 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.547 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.57 115.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.542 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -87.64 161.42 45.03 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 108.665 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.68 131.03 21.98 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 124.798 -0.917 . . . . 0.0 110.432 -2.041 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.417 ' CE1' ' CD1' ' A' ' 116' ' ' LEU . 5.0 p90 -101.31 153.8 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.051 0.929 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.634 ' N ' ' HG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -89.94 149.44 22.59 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.0 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.83 -24.25 1.37 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.834 -1.166 . . . . 0.0 109.513 -178.776 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.45 -34.48 60.95 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.561 178.962 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.634 ' HG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.91 -61.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.545 179.069 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 ' CD1' ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.73 -36.9 38.68 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.178 -1.409 . . . . 0.0 108.295 179.127 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 120' ' ' LEU . 7.2 tp10 -65.74 -56.95 9.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.025 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 117' ' ' GLU . 2.8 mt-10 -42.39 -34.37 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 109.997 -179.456 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -90.04 -25.86 20.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.284 179.833 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 117' ' ' GLU . 3.3 tp -66.74 -66.96 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.924 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -44.39 -50.44 9.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.56 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -61.14 -27.13 68.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 109.994 -179.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 120' ' ' LEU . 12.3 mt -81.39 -45.72 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.98 . . . . 0.0 109.926 -179.725 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.93 -6.34 8.18 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 -179.264 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.49 -29.31 68.71 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.227 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.52 -34.59 19.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.2 -27.13 62.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.372 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.56 81.58 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.515 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.446 179.751 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -46.16 145.17 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.982 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 40.5 tttt -90.44 9.64 28.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.0 109.41 179.398 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.65 46.75 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.047 . . . . 0.0 110.356 -178.993 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.3 tp -78.29 112.34 15.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.528 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.01 123.34 17.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.927 -1.108 . . . . 0.0 111.98 -176.838 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 73.4 m-85 -109.45 152.04 25.9 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.942 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.0 tp -121.89 106.14 10.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.283 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.82 105.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.423 -178.012 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 63.9 t -104.72 103.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.577 -0.702 . . . . 0.0 109.86 -179.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -149.06 148.64 29.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 13' ' ' ASP . 9.1 t70 -85.08 -15.68 43.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -46.84 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.906 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.05 10.04 13.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 109.633 -179.71 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -155.52 -21.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.542 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' NZ ' ' A' ' 109' ' ' LYS . 13.8 tpt -48.89 -47.71 42.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NH2' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.69 -37.14 17.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 -179.841 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -30.72 62.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.784 -1.166 . . . . 0.0 109.769 -178.352 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mt -67.62 -55.32 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.885 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -32.34 47.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.86 -179.235 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.634 HH11 ' NH2' ' A' ' 18' ' ' ARG . 3.8 mtt180 -48.47 -52.31 22.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 108.949 179.475 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LYS . 1.4 t30 -66.15 -58.78 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.794 0.807 . . . . 0.0 109.28 179.901 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -42.18 -37.31 1.42 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.648 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.41 -42.94 58.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.75 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ASN . 23.1 tttm -61.12 -33.11 72.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.393 -0.817 . . . . 0.0 108.824 179.212 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.39 -50.34 65.32 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 179.654 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -49.69 59.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.98 74.66 0.04 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.551 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 56.4 m-85 -150.2 152.25 34.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.931 -1.335 . . . . 0.0 109.095 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.22 30.51 0.69 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 111.518 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.69 108.69 4.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.639 -1.288 . . . . 0.0 111.04 -179.255 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.06 179.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.04 . . . . 0.0 109.909 178.722 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 11.6 mt-10 -137.57 -168.02 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.87 150.38 31.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.984 -1.073 . . . . 0.0 111.167 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.82 -164.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.37 -6.63 5.3 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.67 . . . . 0.0 110.765 -179.528 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.96 179.8 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.728 -1.232 . . . . 0.0 109.948 179.873 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASN . . . -55.28 -57.56 17.91 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.7 p -51.99 -35.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.0 108.958 179.94 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 7.7 t0 -69.86 -41.89 74.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.39 88.36 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.44 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.6 -35.46 77.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.911 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.84 -34.5 69.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -89.97 -26.49 20.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.72 -31.76 58.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.085 -1.009 . . . . 0.0 108.836 -179.776 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 1.6 mt-30 -52.88 -22.18 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.503 -0.748 . . . . 0.0 109.309 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -45.59 -59.43 2.74 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.829 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.7 52.8 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.307 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -148.62 -44.98 0.03 OUTLIER Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.586 ' C ' ' H ' ' A' ' 53' ' ' PHE . 6.9 m-85 -49.7 92.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.367 -1.078 . . . . 0.0 110.636 -179.555 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -76.32 15.74 5.35 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 177.321 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -168.24 152.47 6.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.288 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.51 107.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.59 89.22 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.5 p -105.13 160.47 15.04 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -178.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.6 p-10 -73.13 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.221 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.501 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 5.3 t-105 -149.52 -6.46 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 108.79 179.035 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 4.7 m-80 43.4 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 110.959 178.468 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.48 20.87 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.884 178.76 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -59.09 -65.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 178.79 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.5 m-80 -151.94 -136.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.408 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.65 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.964 -1.085 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 9.4 m-20 -160.72 -167.77 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 -179.566 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.66 -79.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.32 -69.03 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -1.221 . . . . 0.0 109.327 -179.937 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.4 tt0 -61.32 -9.59 5.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.787 . . . . 0.0 109.744 -179.707 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tp -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 109.972 -179.491 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -79.16 -26.77 42.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.34 -179.687 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -59.93 -59.91 4.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.688 179.501 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -56.14 -31.44 63.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.151 -0.968 . . . . 0.0 109.877 -179.649 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -72.4 -21.74 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -31.49 17.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 75' ' ' ASP . . . -71.29 -60.43 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.208 179.812 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 79' ' ' SER . 6.1 p-10 39.94 -141.54 0.05 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.426 0.631 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.438 ' N ' ' OD2' ' A' ' 75' ' ' ASP . . . -159.84 -16.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.927 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.82 -7.26 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -1.107 . . . . 0.0 109.492 179.946 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -96.87 -72.43 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.527 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 11.2 t 44.72 45.26 8.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.579 -0.701 . . . . 0.0 109.831 179.824 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.09 -50.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.02 -1.05 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 80' ' ' ALA . 7.2 mt -27.41 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.455 -0.153 . . . . 0.0 111.112 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.477 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 6.3 Cg_exo -62.7 127.89 21.86 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.188 1.925 . . . . 0.0 114.02 -178.845 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.703 ' N ' ' HG ' ' A' ' 104' ' ' SER . 1.5 t -109.05 113.19 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 175.9 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.23 106.75 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.352 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.7 tpp -82.1 103.23 11.57 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.245 -178.004 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -98.85 148.31 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.854 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 160.06 43.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.37 129.0 35.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.864 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 49.56 74.76 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 179.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -46.27 120.19 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.278 179.684 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -68.89 -77.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.943 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -173.06 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.468 -179.763 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.1 mm-40 -69.5 -35.0 75.11 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -53.48 -35.11 60.23 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.12 -0.988 . . . . 0.0 109.69 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.25 -55.15 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.994 -1.066 . . . . 0.0 108.591 179.351 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 83.6 mt -69.28 -14.74 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.482 -0.761 . . . . 0.0 109.017 179.652 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' GLU . . . -67.72 -54.18 21.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 -179.997 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.61 -46.23 69.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.014 -1.054 . . . . 0.0 108.197 178.885 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -64.44 -27.34 68.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.726 -179.323 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -52.08 -32.64 35.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.803 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 77.09 0.41 Allowed Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.627 177.874 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.79 -111.66 0.07 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 117.411 -1.716 . . . . 0.0 108.941 178.64 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.703 ' HG ' ' N ' ' A' ' 83' ' ' VAL . 49.6 m -91.49 -49.75 6.15 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.905 1.336 . . . . 0.0 108.283 175.998 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.57 -162.89 33.74 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.071 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 150.07 42.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.127 -1.22 . . . . 0.0 109.75 179.461 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.69 126.06 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.274 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.92 113.25 10.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.138 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.589 ' NZ ' ' SD ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -87.35 162.53 42.6 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.579 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.4 123.36 8.49 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.836 -0.902 . . . . 0.0 110.478 -2.178 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -92.92 156.26 17.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.876 179.847 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.696 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.69 147.36 23.32 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.519 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.11 -25.5 0.88 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.053 . . . . 0.0 108.909 -179.414 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.92 78.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.728 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.87 -66.41 0.57 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.924 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tp -49.58 -36.08 22.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.506 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 4.5 tt0 -57.58 -62.41 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.031 -1.043 . . . . 0.0 110.227 -179.59 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' GLU . 34.9 mt-10 -46.09 -61.08 1.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 -179.51 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -50.97 -28.0 8.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.832 . . . . 0.0 109.691 179.832 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.85 -67.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.17 -0.956 . . . . 0.0 109.302 179.83 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.39 -28.46 66.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.003 -1.061 . . . . 0.0 110.506 -179.416 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -77.16 -23.79 51.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.966 -1.084 . . . . 0.0 109.84 -179.693 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.05 -42.38 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.506 -179.4 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -65.48 -14.89 61.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.087 -1.008 . . . . 0.0 110.104 -178.508 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -30.89 70.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.316 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -85.04 -26.49 27.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.541 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.5 -19.31 60.96 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.394 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.468 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 71.17 60.71 4.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.738 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.405 -179.705 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.26 150.45 0.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.997 -179.552 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.2 12.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.344 179.739 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -150.6 52.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.164 -179.665 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 50.5 tp -74.05 107.96 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.012 -1.055 . . . . 0.0 108.617 -179.879 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -49.73 106.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 111.458 -178.193 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 70.0 m-85 -99.53 153.84 18.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.268 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.9 tp -128.62 107.51 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.106 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.95 115.55 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 -179.813 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.679 ' N ' HH21 ' A' ' 18' ' ' ARG . 2.5 t -98.69 110.44 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 -179.144 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' CB ' ' HE ' ' A' ' 18' ' ' ARG . 37.7 t0 -166.28 168.47 15.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.028 -1.045 . . . . 0.0 109.758 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -103.06 -28.9 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.654 -0.654 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.3 138.5 55.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.974 . . . . 0.0 109.289 179.851 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.63 -33.48 11.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -21.57 56.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.945 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 ttm -73.72 -57.37 4.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.034 -1.041 . . . . 0.0 108.842 179.354 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.679 HH21 ' N ' ' A' ' 11' ' ' VAL . 19.2 mmt180 -58.67 -8.2 1.22 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.52 -178.708 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -76.73 -38.38 54.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 108.534 178.725 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.86 -55.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.955 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -57.76 -40.2 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.53 -179.185 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mtm180 -45.3 -53.45 8.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 -179.377 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -62.79 -56.77 14.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.328 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' ASN . 2.6 tt -37.98 -58.16 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.94 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -53.52 -51.11 63.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.117 179.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.05 -40.11 73.03 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.135 -0.978 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.02 -41.33 62.15 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.272 -0.893 . . . . 0.0 109.217 -179.983 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.39 -61.76 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.511 -0.743 . . . . 0.0 109.073 179.77 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.22 68.66 0.01 OUTLIER Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.865 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.23 145.82 26.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.128 -1.219 . . . . 0.0 109.307 179.744 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -150.01 68.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -176.78 99.55 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 0.0 108.653 179.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.16 150.82 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 110.562 -178.988 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.31 -169.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.323 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -141.46 161.98 36.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.405 -0.809 . . . . 0.0 110.808 -178.771 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.4 -167.93 2.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.242 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.91 -2.24 4.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.465 -0.772 . . . . 0.0 110.666 -179.413 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.43 -171.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.204 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.24 -37.27 80.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.974 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 18.8 m -65.8 -42.3 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 0.0 109.16 179.952 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.15 -50.53 60.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 108.464 179.266 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.89 -55.93 28.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.735 -0.603 . . . . 0.0 109.916 179.979 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -46.22 -53.82 9.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.94 . . . . 0.0 108.936 179.934 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 70.6 m-80 -61.27 -41.77 97.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.16 -12.25 59.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.106 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -66.71 -4.48 9.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 108.526 -179.908 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 47' ' ' GLN . 27.3 tt0 -97.26 -4.56 38.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.768 . . . . 0.0 109.266 179.729 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.4 -72.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.524 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.12 9.5 1.3 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.962 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.0 87.27 1.08 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.7 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.559 ' C ' ' H ' ' A' ' 53' ' ' PHE . 62.6 m-85 -66.8 109.62 2.96 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 -5.61 0.59 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.668 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.559 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.04 145.02 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 110.292 -178.842 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.78 115.11 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.137 -0.977 . . . . 0.0 110.225 179.632 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.246 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 145.61 29.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -0.807 . . . . 0.0 109.638 -179.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.7 p30 -67.54 -112.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.589 -179.998 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 62.3 t-105 -169.9 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.779 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.462 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 15.5 m-80 -83.36 121.26 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.462 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.27 -50.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 110.129 179.617 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.58 -64.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 120.89 1.06 . . . . 0.0 109.888 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.94 -76.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.26 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -88.34 0.22 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.367 179.713 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 178.99 150.7 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.731 179.836 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.16 17.39 1.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 68' ' ' LEU . 4.4 tt -78.4 -56.6 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.847 -1.384 . . . . 0.0 108.203 179.287 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.51 -9.76 0.54 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.565 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 66' ' ' LEU . 15.7 tp -81.91 -57.38 3.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.91 -34.91 78.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.603 -179.642 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -66.97 -59.07 3.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.146 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.9 m -54.84 -37.0 65.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.072 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mt -57.44 -38.58 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.506 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -66.21 -7.55 18.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.909 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -71.81 -27.55 63.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.785 -179.907 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -51.36 -178.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 109.653 -179.746 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.09 -146.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.13 -12.49 60.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttp -90.04 -2.53 58.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ASP . 14.6 m 47.28 -120.03 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -0.894 . . . . 0.0 108.895 -179.741 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.08 56.9 0.96 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.251 178.955 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 80' ' ' ALA . 11.0 mt 57.53 155.39 0.08 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.648 -0.657 . . . . 0.0 110.035 178.112 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.47 140.39 54.15 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.314 2.009 . . . . 0.0 114.959 -177.166 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.3 t -129.32 116.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.134 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -103.06 108.51 19.72 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.523 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.62 138.52 57.51 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.671 -178.484 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.35 139.92 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.675 -0.64 . . . . 0.0 110.168 -178.915 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.659 ' HG1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -149.96 165.96 31.08 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.747 179.532 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.659 ' N ' ' HG1' ' A' ' 87' ' ' THR . . . -100.19 128.63 46.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.667 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 91' ' ' LYS . 33.6 tt0 50.58 94.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.033 -179.598 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . -44.78 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.736 -179.683 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.524 ' CB ' HD22 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -76.57 16.81 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.474 -179.832 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 90' ' ' ALA . 22.2 tttt 69.74 -70.28 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 94' ' ' ASN . 12.4 tm-20 -49.82 -49.32 49.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.179 -0.95 . . . . 0.0 110.176 -179.475 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.524 HD22 ' CB ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -65.14 -66.79 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.21 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -45.54 -42.76 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.247 -0.908 . . . . 0.0 109.901 -179.16 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.19 -31.08 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.953 -1.092 . . . . 0.0 109.624 -179.782 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.41 85.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.655 -179.718 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.2 -53.69 18.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 108.366 179.39 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.61 -26.35 61.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.327 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -53.32 -32.44 48.97 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.45 -23.38 26.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.34 75.38 0.51 Allowed Glycine 0 N--CA 1.481 1.693 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.802 177.663 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -111.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 117.107 -1.837 . . . . 0.0 108.911 178.541 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 34.9 m -91.49 -46.68 7.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.473 1.13 . . . . 0.0 107.995 175.697 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.426 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 171.3 -159.73 31.64 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.732 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -138.23 131.67 30.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.829 -0.806 . . . . 0.0 108.997 179.175 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 11.9 p -127.65 120.95 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.658 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 109' ' ' LYS . 2.0 p -70.32 157.92 6.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 108.964 -179.485 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -131.63 160.41 67.55 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.885 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.57 126.32 11.94 Favored 'Cis proline' 0 C--N 1.32 -0.93 0 C-N-CA 124.716 -0.951 . . . . 0.0 110.429 -2.06 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -91.4 159.91 15.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.828 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.38 149.86 20.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.991 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.04 22.74 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.773 -1.204 . . . . 0.0 108.815 -179.53 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.93 -31.73 71.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.781 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.5 m -72.61 -68.13 0.5 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.729 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.6 tp -47.57 -36.72 11.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.62 -1.3 . . . . 0.0 109.253 178.861 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -62.31 -64.56 0.89 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.846 -1.159 . . . . 0.0 109.126 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -45.27 -51.0 11.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.629 -0.669 . . . . 0.0 109.738 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -54.34 45.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.464 -179.836 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.9 mt -55.97 -44.9 78.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.563 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -47.76 -69.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 109.977 -179.273 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -49.06 -27.44 3.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.317 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.34 -40.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.947 -1.096 . . . . 0.0 110.577 -179.208 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -74.28 -22.71 59.18 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.139 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -62.29 -20.43 64.29 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -97.51 -27.7 14.31 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.888 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.79 -13.07 49.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.264 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.21 71.94 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -159.72 147.32 16.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.1 8.48 32.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.989 -1.07 . . . . 0.0 109.972 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -155.62 52.74 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 0.0 109.844 -179.678 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 tp -77.21 131.04 38.03 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.881 -1.137 . . . . 0.0 107.943 179.471 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -67.48 110.7 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.107 . . . . 0.0 111.708 -177.388 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.4 148.01 27.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.185 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.72 105.08 9.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.185 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.4 111.24 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 109.998 -179.142 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.91 106.91 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 40.0 t0 -172.35 117.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.161 -0.962 . . . . 0.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.01 135.39 20.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.722 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -171.23 -153.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.478 -1.389 . . . . 0.0 112.121 -177.263 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.722 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -177.11 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.36 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.603 ' HG1' ' N ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -164.95 -59.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.516 0.674 . . . . 0.0 110.27 -177.868 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.603 ' N ' ' HG1' ' A' ' 16' ' ' THR . 3.4 ttt -35.62 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.034 -0.416 . . . . 0.0 111.296 179.596 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 34.5 mtm180 -46.2 -27.08 0.9 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.699 -1.251 . . . . 0.0 109.782 -178.615 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' THR . 4.0 ttp180 -78.54 -32.64 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.815 -1.178 . . . . 0.0 108.985 178.967 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 mt -66.94 -54.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 108.992 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -40.37 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -180.0 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -43.58 -53.7 5.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.479 -0.763 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -63.0 -57.12 11.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.901 0.858 . . . . 0.0 108.783 179.168 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -37.76 -57.74 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.714 179.964 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.83 -52.43 65.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.076 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -48.39 -30.6 5.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.77 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -48.22 -41.36 27.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.233 -0.917 . . . . 0.0 108.9 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -75.03 -65.31 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.116 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.69 22.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 68.9 m-85 -89.99 145.72 24.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.75 -1.441 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -150.14 59.54 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.074 -1.016 . . . . 0.0 110.42 179.718 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -174.38 104.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.228 . . . . 0.0 110.295 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.47 179.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.149 -0.97 . . . . 0.0 109.762 179.423 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -139.21 -169.76 2.73 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.627 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.0 145.88 26.68 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.858 -179.068 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.98 -171.01 3.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.814 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 2.0 mp0 -132.38 -2.05 3.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.251 -0.905 . . . . 0.0 110.495 -179.197 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.82 -177.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.229 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -67.23 -36.29 89.59 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 7.6 p -62.89 -45.68 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -1.202 . . . . 0.0 109.436 -179.935 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 8.0 t0 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.401 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.87 -22.93 61.44 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.659 -1.276 . . . . 0.0 108.294 179.205 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -72.92 -27.52 61.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.676 -0.64 . . . . 0.0 110.04 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.75 -37.87 14.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.959 . . . . 0.0 110.777 -178.868 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -49.96 -23.5 2.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.714 -1.241 . . . . 0.0 109.552 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 5.6 tp60 -96.89 -13.57 22.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -40.85 -62.08 0.86 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 -179.594 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.62 3.75 2.39 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.88 76.8 1.15 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.74 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -57.68 131.49 50.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 110.131 -179.392 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.33 3.75 83.65 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.037 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -168.15 146.32 4.37 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.101 -1.235 . . . . 0.0 110.264 -179.149 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.93 121.38 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.067 -1.021 . . . . 0.0 109.895 179.389 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.61 103.92 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.611 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.9 p -114.51 161.07 18.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.388 -0.82 . . . . 0.0 110.318 -178.599 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 17.1 p-10 -89.38 -110.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.541 -0.724 . . . . 0.0 109.2 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 77.3 t-105 -141.37 177.78 7.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 179.702 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.623 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -76.7 75.24 3.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.758 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtm -86.13 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.927 -1.108 . . . . 0.0 110.378 179.677 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.1 -55.2 0.41 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 C-N-CA 120.898 1.065 . . . . 0.0 109.747 179.932 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -172.49 -162.3 0.19 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.437 -0.789 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -47.55 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -164.91 137.08 4.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.565 -179.563 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.27 -50.53 0.89 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.699 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.505 ' H ' HD22 ' A' ' 59' ' ' ASN . 3.6 tp -85.78 -46.6 10.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.564 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.403 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.0 mm-40 -63.31 -20.03 65.13 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.581 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.7 mt -68.52 -61.77 1.68 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.684 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -45.81 -64.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.984 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.91 -49.74 4.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.2 -179.438 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -64.19 -32.91 74.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 46.4 mt -74.82 -31.18 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.174 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -20.0 23.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.43 -30.07 4.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.357 -179.836 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.76 100.12 0.38 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.372 -0.83 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.74 46.41 2.32 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.791 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.32 -28.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -1.168 . . . . 0.0 109.292 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -96.98 -70.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.453 179.946 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 16.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.159 -179.799 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -104.89 -39.27 6.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.583 -0.698 . . . . 0.0 109.736 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -32.41 97.14 0.1 Allowed Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.629 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.88 102.49 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.652 0 C-N-CA 121.169 1.246 . . . . 0.0 112.064 -178.767 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.557 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.5 t -107.67 116.24 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 177.364 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.42 106.66 17.24 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.58 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 ttm -67.23 160.42 27.03 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.039 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.49 144.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.29 -0.881 . . . . 0.0 110.183 -178.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -150.18 158.68 44.41 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.88 -82.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.115 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -77.51 68.88 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.933 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -42.83 123.67 2.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 110.646 -178.896 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.93 112.72 25.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.117 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -43.82 -25.97 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.468 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.87 -38.01 33.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.193 -0.942 . . . . 0.0 110.326 -179.447 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -90.06 -9.71 47.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.099 -1.001 . . . . 0.0 110.43 -179.299 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.23 -27.05 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.972 -1.08 . . . . 0.0 108.55 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.441 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.0 mt -87.05 -8.59 11.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 108.909 179.591 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.37 -52.89 10.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.471 -0.768 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.59 73.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.905 -1.122 . . . . 0.0 108.026 178.867 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.571 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -63.71 -31.7 72.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.89 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -59.25 -32.6 70.14 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.932 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.2 -24.08 47.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 176.091 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.88 74.01 0.49 Allowed Glycine 0 N--CA 1.481 1.657 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.387 176.243 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.22 -112.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 116.984 -1.887 . . . . 0.0 109.606 177.818 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.4 m -91.96 -50.91 5.46 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 123.009 1.385 . . . . 0.0 107.645 174.983 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 169.04 -164.17 37.83 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.391 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -133.47 121.79 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.123 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 8.3 p -113.46 123.53 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.446 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.573 ' CG2' ' H ' ' A' ' 109' ' ' LYS . 12.5 p -64.44 -177.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.126 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.573 ' H ' ' CG2' ' A' ' 108' ' ' VAL . 1.2 pttt -154.62 158.76 32.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.595 -1.315 . . . . 0.0 108.602 179.848 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.41 136.81 45.98 Favored 'Cis proline' 0 C--N 1.317 -1.121 0 C-N-CA 124.54 -1.025 . . . . 0.0 110.446 -2.191 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -96.59 162.32 13.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.008 . . . . 0.0 109.179 178.997 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.79 144.94 24.8 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 177.132 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.1 -33.22 4.82 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.962 -1.086 . . . . 0.0 109.56 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -32.33 66.52 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.634 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' THR . 13.4 m -71.69 -64.42 0.93 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.966 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -48.96 -40.3 29.82 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.6 -1.313 . . . . 0.0 108.419 179.406 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.09 -57.67 11.81 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.858 -1.151 . . . . 0.0 109.833 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.7 tt0 -44.59 -28.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.391 -179.685 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.18 -37.52 14.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 108.742 179.214 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.06 -55.48 14.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.628 -0.67 . . . . 0.0 109.868 -179.467 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 122' ' ' LYS . 1.2 p30 -48.12 -54.23 13.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.166 -0.959 . . . . 0.0 109.96 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.562 ' H ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 mttt -53.38 -38.11 63.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.43 -0.794 . . . . 0.0 110.236 -179.517 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.76 -41.5 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.461 -179.138 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -72.97 -6.97 48.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.957 -1.089 . . . . 0.0 110.589 -178.908 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.01 -19.42 60.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.746 -1.221 . . . . 0.0 107.774 178.654 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -97.63 -27.45 14.37 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.935 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -25.96 24.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.9 84.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.797 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.2 m-20 49.36 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 108.533 -179.486 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.585 ' NZ ' ' CB ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -63.13 11.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 0.0 110.498 -178.871 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' A' ' 3' ' ' ASP . 10.7 mm-40 -139.03 40.49 2.12 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.835 . . . . 0.0 109.339 -179.908 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.0 tp -75.23 129.51 37.58 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 120.603 -1.31 . . . . 0.0 108.178 179.782 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -80.24 124.62 28.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.153 -0.967 . . . . 0.0 111.991 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -113.55 143.52 44.41 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.36 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.42 110.2 20.27 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.136 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.74 106.74 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.2 t -89.92 16.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.535 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 13.7 p30 -51.0 162.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.984 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -144.9 33.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.195 179.952 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' ' CB ' ' A' ' 15' ' ' SER . 51.2 t80 -83.02 -75.97 0.29 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER 165.61 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.811 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.62 -5.7 1.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.511 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.9 ttm -56.02 -38.15 70.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.516 -0.74 . . . . 0.0 109.324 179.756 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.516 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -62.3 -56.35 19.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.887 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.14 -28.89 42.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -178.781 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.81 -57.8 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.127 -0.983 . . . . 0.0 109.637 -179.802 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -32.43 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.981 -179.25 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.629 ' CA ' ' HE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.11 -55.17 10.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.972 . . . . 0.0 109.449 179.703 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -63.33 -58.14 8.08 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.802 0.81 . . . . 0.0 109.223 179.896 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.4 tt -39.41 -55.95 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.003 -179.55 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.2 -42.21 94.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.069 -1.019 . . . . 0.0 108.926 179.263 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.638 ' HZ2' HD22 ' A' ' 31' ' ' ASN . 12.1 ttmm -58.79 -40.69 84.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.87 -46.6 67.98 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 -179.714 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.11 -56.37 11.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.334 -0.854 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.04 69.35 0.01 OUTLIER Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.951 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -150.11 130.82 14.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.328 . . . . 0.0 109.184 179.822 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.638 HD22 ' HZ2' ' A' ' 26' ' ' LYS . 2.1 m120 -133.74 71.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.814 . . . . 0.0 109.971 -179.402 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.59 98.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 0.0 108.524 179.642 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.5 149.47 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.144 -0.973 . . . . 0.0 110.458 -178.544 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -121.75 -172.88 2.52 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.385 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' CD ' HH11 ' A' ' 18' ' ' ARG . 39.8 mt-10 -141.71 155.44 45.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.919 0.866 . . . . 0.0 110.816 -178.608 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.05 -168.7 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.676 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.27 12.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 110.719 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD2' ' ND2' ' A' ' 62' ' ' ASN . 14.0 t0 -175.32 154.17 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.63 60.23 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 179.033 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -75.02 -37.33 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.627 -0.925 . . . . 0.0 108.825 179.165 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.68 -39.77 80.4 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.055 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -69.38 -46.49 66.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.53 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.03 -37.37 61.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.965 -179.693 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -76.07 -34.76 59.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.107 -179.412 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -90.02 -13.31 36.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.173 -179.419 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -61.32 -14.69 28.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 -179.971 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -93.89 -4.17 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.12 -65.93 0.47 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.546 -0.721 . . . . 0.0 109.637 -179.929 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.45 -92.2 0.26 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.906 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -162.6 67.16 0.24 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.824 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 53' ' ' PHE . 56.4 m-85 -47.02 98.56 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.546 -0.973 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -65.53 1.56 4.07 Favored Glycine 0 C--N 1.297 -1.599 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.402 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.12 150.57 11.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.397 -1.06 . . . . 0.0 109.21 -179.548 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -143.72 118.83 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.767 -1.208 . . . . 0.0 109.993 179.285 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -99.46 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.172 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.477 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 36.0 p -102.39 148.72 25.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.406 -0.809 . . . . 0.0 109.818 -179.134 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.91 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 109.06 179.678 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.432 ' C ' ' SD ' ' A' ' 60' ' ' MET . 65.9 t-105 -172.09 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.981 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.445 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.0 t-20 -97.25 98.23 9.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 109.742 -179.731 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.05 162.3 54.68 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.708 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' O ' ' OD2' ' A' ' 38' ' ' ASP . 3.2 Cg_exo -56.3 148.93 58.33 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.373 1.382 . . . . 0.0 110.134 179.362 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 65.99 -159.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.184 -179.73 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.94 156.71 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.8 173.05 12.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.99 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.81 -3.02 2.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.835 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 64' ' ' ASP . 17.3 tp -58.92 -52.5 65.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.18 . . . . 0.0 108.807 179.921 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' O ' ' OG1' ' A' ' 71' ' ' THR . 12.3 tp10 -61.81 -4.14 1.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 108.948 179.638 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 66' ' ' LEU . 11.0 tp -85.59 -64.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -32.34 73.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.865 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -67.35 -60.51 2.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.913 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 89.9 m -51.41 -40.29 58.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.408 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -60.68 -29.27 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 108.66 179.271 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.51 -22.9 32.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.441 -0.787 . . . . 0.0 109.426 179.787 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.53 -26.79 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.947 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 77' ' ' ALA . 48.3 t0 -73.75 -53.12 11.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.346 179.945 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.09 -21.29 4.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.894 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 75' ' ' ASP . . . -87.52 -86.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.596 -179.85 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.3 mpp? -96.53 -25.63 15.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.687 -179.691 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.8 m 53.46 -128.48 2.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -139.44 44.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.451 -0.781 . . . . 0.0 109.3 179.927 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 50.87 177.04 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.914 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.23 135.96 46.06 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 N-CA-C 116.499 1.692 . . . . 0.0 116.499 -175.551 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.585 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.3 t -124.33 115.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.856 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -102.47 105.88 16.51 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 117.919 -1.512 . . . . 0.0 107.309 177.996 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.477 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 2.0 tpt -66.09 156.22 34.54 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.089 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -135.48 141.06 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -0.816 . . . . 0.0 110.104 -178.529 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -150.09 176.31 10.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -95.33 -130.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -52.71 88.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -48.7 118.35 2.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.58 -179.695 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 13.6 tttt -94.86 6.9 47.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 4.3 ttpp 75.06 -62.39 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.406 -179.891 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.15 -34.45 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.707 -179.8 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -84.4 -45.06 13.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.964 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.4 mm -48.57 -42.23 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 108.935 179.545 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.7 mt -71.35 -26.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.307 -0.871 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.17 -51.77 67.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.212 -0.93 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.55 -51.69 12.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.436 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -58.3 -27.99 64.6 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.324 -0.95 . . . . 0.0 108.935 -179.254 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.0 tt0 -56.16 -33.22 65.02 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 178.151 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.7 -22.13 34.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.014 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 61.66 76.93 0.22 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.825 177.579 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.29 -112.08 0.05 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 116.75 -1.98 . . . . 0.0 109.104 178.661 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.0 m -91.86 -51.29 5.29 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 123.096 1.427 . . . . 0.0 107.913 175.058 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.413 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.65 -157.36 28.41 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -178.116 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.79 127.17 16.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.566 -0.961 . . . . 0.0 109.297 179.294 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.01 140.31 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.22 153.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.788 -179.926 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.21 153.38 80.42 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.785 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.64 132.23 26.1 Favored 'Cis proline' 0 N--CA 1.49 1.27 0 O-C-N 122.328 0.646 . . . . 0.0 111.259 -1.615 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -98.96 162.38 13.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.386 -0.821 . . . . 0.0 109.164 178.79 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -94.97 146.45 24.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.997 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.71 -31.21 4.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 109.127 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.29 -33.48 67.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.664 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.2 m -71.94 -65.61 0.75 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.446 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' THR . 8.7 tp -47.13 -41.01 16.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 0.0 109.2 178.741 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.31 -58.09 7.51 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 -179.634 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -44.22 -48.55 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.646 -0.659 . . . . 0.0 109.682 -179.703 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -65.75 -47.22 75.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.5 -39.77 70.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 109.634 -179.984 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -46.24 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.93 -179.645 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -71.35 -19.58 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.638 -179.635 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.03 -40.44 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.902 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.0 m-85 -73.82 -33.81 64.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 -179.711 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -50.92 -27.89 8.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.05 -1.031 . . . . 0.0 108.413 179.543 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -90.64 -21.82 21.49 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.043 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 124' ' ' PHE . 13.1 tp -83.3 -20.71 33.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.371 -0.831 . . . . 0.0 108.866 179.431 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.25 76.14 0.14 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.623 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 62.76 134.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 108.962 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -90.04 17.44 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.982 -1.074 . . . . 0.0 109.78 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 42.88 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.938 -1.101 . . . . 0.0 110.593 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.41 141.91 57.77 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -78.13 131.36 37.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 0.0 111.104 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.67 146.88 47.91 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.827 -0.545 . . . . 0.0 110.259 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.505 ' HB2' ' CD2' ' A' ' 51' ' ' TYR . 60.9 tp -121.78 116.18 24.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.688 -0.632 . . . . 0.0 109.368 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 109.22 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 61.1 t -106.25 26.02 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.713 -0.617 . . . . 0.0 109.672 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 117.66 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.61 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -64.83 -14.41 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.313 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.0 140.86 4.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 p -97.96 47.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.446 -0.784 . . . . 0.0 109.512 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 tpt -61.13 -46.68 89.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.614 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -49.84 -31.69 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.912 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -74.01 -42.08 60.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.732 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.44 -52.73 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.755 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -40.48 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 110.234 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.94 -53.11 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -68.64 -57.74 5.26 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.769 0.795 . . . . 0.0 109.686 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -39.64 -56.53 1.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.663 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.36 -51.17 67.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.095 -1.003 . . . . 0.0 108.757 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -47.76 -40.41 20.63 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.249 -0.907 . . . . 0.0 108.983 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.12 -34.37 73.41 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.416 -0.803 . . . . 0.0 109.308 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -81.09 4.32 20.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.55 62.53 1.78 Allowed Glycine 0 N--CA 1.482 1.748 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -143.58 126.85 16.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -1.184 . . . . 0.0 109.092 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -133.63 65.32 1.59 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.632 -0.668 . . . . 0.0 109.815 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -172.48 89.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.75 150.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.0 109.938 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -119.17 -177.12 3.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -150.09 155.22 39.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.863 -1.148 . . . . 0.0 110.81 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -146.6 -165.41 2.22 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 17.1 mt-10 -137.34 -5.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 0.0 110.359 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -177.23 -177.92 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.79 -1.193 . . . . 0.0 109.733 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.63 -52.24 47.57 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.55 -31.85 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.263 . . . . 0.0 108.513 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.63 -47.64 30.94 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.122 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.08 -48.06 82.98 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 109.363 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.2 -40.09 73.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.954 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 5.9 m-20 -81.56 -25.67 35.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -90.25 -23.88 21.1 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' CD2' ' H ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -80.11 -17.27 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.53 -1.356 . . . . 0.0 110.21 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -61.58 -5.94 2.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -52.77 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.019 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.88 11.57 1.67 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.473 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.44 86.21 0.26 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' H ' ' CD2' ' A' ' 46' ' ' LEU . 25.2 m-85 -58.92 157.58 9.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.406 -1.056 . . . . 0.0 110.43 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.73 -9.42 62.72 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 140.47 19.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.676 -0.896 . . . . 0.0 109.133 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.17 120.43 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.0 110.164 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.8 mt -104.08 128.51 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -146.38 147.02 30.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.066 -1.021 . . . . 0.0 109.672 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 58' ' ' TRP . 16.6 t70 -63.84 -120.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.402 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.417 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 61.9 t-105 -161.89 -28.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.782 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -166.64 34.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.633 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.2 -37.22 0.43 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -68.83 -70.65 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.846 1.031 . . . . 0.0 110.152 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.664 HD21 ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -154.81 -81.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.664 ' H ' HD21 ' A' ' 62' ' ' ASN . 3.4 mpp? -76.0 -113.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -142.14 -178.42 5.71 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . -93.79 -17.97 39.43 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.396 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.534 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 1.4 mm? -46.79 -68.98 0.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.687 -1.478 . . . . 0.0 110.042 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -43.57 -41.79 4.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.429 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.96 -42.9 99.96 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.614 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 5.4 tt -82.59 -64.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.877 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -33.75 -41.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.23 0.538 . . . . 0.0 110.144 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.6 m -58.96 -48.03 82.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 108.728 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 57.8 mt -50.76 -45.14 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 108.88 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -65.41 -39.29 91.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.34 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 109.574 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.35 -128.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.361 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 78' ' ' MET . . . 170.16 161.38 20.56 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 76' ' ' GLY . . . 71.79 -14.14 0.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -1.12 . . . . 0.0 109.413 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.513 ' H ' ' C ' ' A' ' 76' ' ' GLY . 2.3 mmt -146.82 17.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 m -68.78 7.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.351 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -93.92 2.7 56.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 109.645 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -43.86 107.59 0.61 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.543 -0.723 . . . . 0.0 109.397 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -62.58 136.5 58.92 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 120.76 0.973 . . . . 0.0 110.857 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 t -130.27 129.27 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 tp -110.64 72.03 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.45 145.53 22.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 t -113.56 129.97 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.533 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 15.3 t -150.13 166.29 30.27 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.114 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.533 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -91.05 147.72 22.88 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 49.33 -152.0 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 176.76 115.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.803 -1.186 . . . . 0.0 110.43 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.63 121.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -43.88 -45.24 7.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.299 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -51.89 -32.81 34.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.58 -41.52 13.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 mt -67.54 -13.07 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.037 -1.04 . . . . 0.0 109.573 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.2 mt -80.56 -70.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.082 . . . . 0.0 109.885 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.804 . . . . 0.0 109.0 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.35 -61.67 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.604 -0.685 . . . . 0.0 109.762 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -58.45 -34.63 71.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.222 -0.924 . . . . 0.0 109.699 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -50.91 -19.59 1.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 108.871 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -108.45 -115.03 0.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.83 -0.544 . . . . 0.0 109.603 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.742 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -120.67 -0.99 12.11 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.567 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -59.18 11.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.903 . . . . 0.0 109.23 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.742 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.2 m -29.2 -31.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.32 133.55 11.72 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.572 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.55 110.64 6.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.441 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 9.7 p -112.58 130.79 65.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -157.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.1 152.54 1.88 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.059 -1.026 . . . . 0.0 109.268 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.3 146.4 86.14 Favored 'Cis proline' 0 N--CA 1.487 1.111 0 O-C-N 122.576 0.777 . . . . 0.0 110.512 -2.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -112.97 155.04 25.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.936 0.874 . . . . 0.0 109.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.17 146.88 23.46 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -46.03 -29.66 1.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 0.0 109.387 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.14 -35.1 59.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 112' ' ' THR . 16.2 m -69.07 -60.88 2.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -45.83 -50.71 13.92 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.17 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.06 -32.48 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 115' ' ' THR . 4.5 tp10 -67.76 -43.9 78.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.84 . . . . 0.0 109.973 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -71.28 -51.33 25.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.975 . . . . 0.0 109.922 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tp -50.2 -59.59 3.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.127 -0.983 . . . . 0.0 109.856 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -52.74 -35.92 56.9 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -66.48 -24.58 66.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.83 -47.96 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.954 -1.091 . . . . 0.0 110.175 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -58.71 -12.4 4.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 110.339 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.09 -24.15 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.99 -29.09 16.8 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.35 -24.52 42.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.489 -0.757 . . . . 0.0 109.055 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.06 81.82 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.257 -1.143 . . . . 0.0 109.558 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.287 0.565 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.512 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.34 141.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -90.59 10.17 26.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.283 -0.886 . . . . 0.0 109.952 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.96 51.42 1.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 46.9 tp -84.17 107.81 16.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -48.5 112.83 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.02 . . . . 0.0 111.705 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 63.0 m-85 -102.6 153.98 19.57 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 tp -131.17 105.61 7.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.344 -0.847 . . . . 0.0 108.884 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.71 108.7 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.073 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 62.4 t -96.0 40.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.824 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -70.6 144.58 51.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -97.53 0.51 47.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.69 143.49 27.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.557 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -85.35 34.27 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -165.33 -8.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -37.55 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.07 -16.08 49.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 108.967 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -75.07 -42.08 57.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -53.44 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.871 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.57 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 110.2 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.12 -54.71 8.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.761 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.71 -57.77 6.45 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.981 0.896 . . . . 0.0 109.315 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.27 -64.59 0.53 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.436 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.1 -44.51 52.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 108.76 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -52.02 -48.01 64.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.356 -0.84 . . . . 0.0 109.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -23.47 63.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.478 -0.764 . . . . 0.0 109.291 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 28.1 mt -89.51 3.58 51.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.1 59.41 2.43 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 52.8 m-85 -148.33 142.82 26.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.291 . . . . 0.0 109.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -150.1 27.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.178 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -135.0 99.43 4.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.196 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.3 179.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.149 -0.969 . . . . 0.0 109.599 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.429 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 11.1 mt-10 -138.7 -174.28 3.79 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.91 157.27 46.33 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.794 0.807 . . . . 0.0 110.826 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.97 -174.26 4.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.9 pt-20 -148.77 13.56 0.91 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.912 -1.118 . . . . 0.0 110.226 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 178.16 -179.9 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.954 -1.091 . . . . 0.0 109.131 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.28 -39.55 61.96 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.1 -30.9 46.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.125 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -81.18 -46.09 15.38 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.507 -0.745 . . . . 0.0 109.674 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.43 -42.33 92.57 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.75 -58.04 7.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.061 -1.024 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -54.75 -29.06 52.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 110.072 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -90.13 -31.02 17.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.126 -0.984 . . . . 0.0 110.622 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.93 -41.01 67.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.037 -1.039 . . . . 0.0 109.712 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.7 -11.77 59.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.903 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.81 -65.21 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.4 7.65 1.81 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.43 87.04 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.48 ' C ' ' H ' ' A' ' 53' ' ' PHE . 61.3 m-85 -67.81 110.45 3.81 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.327 -1.102 . . . . 0.0 110.076 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.65 -10.1 2.02 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.75 126.78 11.22 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.195 -1.179 . . . . 0.0 110.289 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.92 120.24 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.9 mt -103.61 123.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -139.27 168.38 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.737 . . . . 0.0 109.095 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 9.8 t70 -84.47 -97.01 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 74.9 t-105 -172.4 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.506 ' N ' ' CD1' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -91.48 126.79 36.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.457 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.2 mtp 176.62 -50.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.0 Cg_exo -64.19 -168.87 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.815 1.01 . . . . 0.0 110.113 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.589 HD21 ' H ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -47.61 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 0.0 109.452 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.589 ' H ' HD21 ' A' ' 62' ' ' ASN . 21.6 mmt -69.76 -117.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -144.64 147.73 33.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.119 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.04 -8.6 3.27 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -74.71 -63.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.943 -1.328 . . . . 0.0 108.817 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.0 mm-40 -52.71 -25.78 12.05 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -70.66 -33.64 71.17 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 66' ' ' LEU . 18.0 tp -86.55 -58.26 2.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -43.26 -47.2 6.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.852 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 27.0 m -51.41 -47.36 63.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 108.99 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.52 -38.47 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 108.924 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -83.94 -20.7 32.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.1 -28.96 43.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -52.27 -70.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.62 -63.39 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.8 -26.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -1.115 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -90.11 -40.88 11.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' MET . 0.3 OUTLIER 75.78 -59.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.16 -54.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.653 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 80' ' ' ALA . 13.3 tp 59.3 120.3 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.85 131.76 43.83 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 120.606 0.87 . . . . 0.0 112.293 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -126.73 127.6 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.7 69.48 0.72 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.462 ' O ' ' CG ' ' A' ' 85' ' ' MET . 5.9 ptt? -61.33 123.62 18.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.83 127.13 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.02 . . . . 0.0 109.511 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.8 t -150.05 136.94 19.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.566 -1.334 . . . . 0.0 110.456 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.04 -14.34 34.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.288 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -102.94 34.52 2.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -62.58 114.19 3.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.513 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.65 -125.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -0.801 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 94' ' ' ASN . 18.6 tttm -117.17 -89.46 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.651 . . . . 0.0 109.816 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -18.74 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.054 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.477 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -70.68 -35.31 72.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.2 mt -85.25 -28.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.811 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -73.27 -60.75 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.019 -1.051 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.61 -43.26 12.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.249 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.54 73.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.34 50.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.94 -1.1 . . . . 0.0 109.721 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -56.76 -24.03 47.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.9 -103.9 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.717 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -135.89 -0.64 3.13 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -58.18 11.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.828 -0.807 . . . . 0.0 110.913 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 102' ' ' GLY . 49.1 m -29.4 -31.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.65 132.72 11.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -146.26 117.04 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -1.163 . . . . 0.0 109.446 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.57 139.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.4 103.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.76 -1.213 . . . . 0.0 108.337 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -71.72 155.33 92.43 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.873 -1.142 . . . . 0.0 109.38 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.33 168.64 75.49 Favored 'Cis proline' 0 N--CA 1.486 1.04 0 C-N-CA 124.811 -0.912 . . . . 0.0 110.234 -2.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -144.14 157.84 44.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -101.1 149.57 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.12 -32.15 4.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.254 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.62 82.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 5.7 m -69.23 -69.44 0.34 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.4 tp -43.9 -37.5 2.89 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.577 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -59.07 -59.4 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.24 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.38 -40.11 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.626 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -59.94 -55.35 35.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 123' ' ' ILE . 10.6 mt -50.07 -72.66 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -38.96 -44.42 1.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.486 -0.759 . . . . 0.0 111.851 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -66.5 -31.35 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.942 -1.099 . . . . 0.0 110.372 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.472 ' C ' ' H ' ' A' ' 125' ' ' GLU . 18.6 mt -89.97 -40.26 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.092 -1.005 . . . . 0.0 111.075 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -62.16 0.97 0.35 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.059 -1.026 . . . . 0.0 110.558 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.9 mt-10 -77.06 -25.39 52.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -91.44 -29.52 17.0 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.07 -29.62 63.08 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.55 80.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.127 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 2' ' ' ALA . 34.6 t70 -43.68 146.44 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.776 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.03 14.05 13.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.071 -1.018 . . . . 0.0 108.674 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 29.1 mp0 -147.24 50.38 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 29.3 tp -78.72 118.44 20.8 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.615 -1.303 . . . . 0.0 108.858 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 118.79 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.141 -0.974 . . . . 0.0 111.418 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 60.5 m-85 -113.44 151.57 31.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -129.82 102.94 6.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -90.53 116.86 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.251 -0.905 . . . . 0.0 109.258 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.37 129.49 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.522 -0.737 . . . . 0.0 110.368 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -165.42 -167.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 13' ' ' ASP . 7.8 t70 -148.5 13.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 0.0 109.729 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -74.88 -18.7 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.783 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.07 2.9 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.321 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -150.69 -22.01 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.865 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -26.96 66.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -40.81 97.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -64.19 -23.93 67.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.55 -52.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.514 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.05 -35.27 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 109.955 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.03 -56.69 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.24 -56.61 19.49 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.953 0.882 . . . . 0.0 109.042 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 23' ' ' ASN . 2.9 tt -37.73 -51.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.07 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.9 mt -58.65 -52.27 66.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 108.593 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -52.6 -46.06 66.8 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.383 -0.823 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.22 -25.6 14.72 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.3 -64.57 1.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.557 -0.715 . . . . 0.0 109.134 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.96 67.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -149.96 155.38 39.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.98 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.09 61.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.918 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.89 99.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -0.943 . . . . 0.0 108.545 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.17 149.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 110.701 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -122.02 -169.38 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -147.33 152.87 38.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.07 167.82 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 5.8 mt-10 -99.94 -2.48 34.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -0.902 . . . . 0.0 110.489 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER 169.12 -179.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.917 -1.114 . . . . 0.0 109.628 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.25 76.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -54.19 -40.29 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.302 . . . . 0.0 108.789 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -67.56 -42.13 83.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.59 -0.694 . . . . 0.0 109.199 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.36 -57.13 8.12 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.363 -0.835 . . . . 0.0 109.409 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' ALA . 53.5 tp -41.95 -43.03 2.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 110.02 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.34 -34.92 70.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 0.0 109.892 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -89.99 -14.04 34.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.173 -0.954 . . . . 0.0 110.625 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -64.55 -18.05 64.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.027 . . . . 0.0 108.569 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -85.89 -3.02 58.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.536 -0.727 . . . . 0.0 109.264 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.62 -73.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.5 8.46 1.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 71.77 1.25 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.0 m-85 -47.87 113.52 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -1.036 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.3 -3.67 3.06 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.6 t80 -166.39 141.25 4.41 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.024 -1.28 . . . . 0.0 109.974 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 t -137.52 108.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 110.509 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 51.9 mt -90.01 78.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 p -88.0 154.4 20.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.039 -1.038 . . . . 0.0 110.65 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.87 167.67 9.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -61.85 88.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -60.77 125.32 23.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.132 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.653 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 22.8 ttp -131.73 30.89 0.2 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.642 -0.661 . . . . 0.0 112.467 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -57.75 -59.06 0.62 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 N-CA-C 108.788 -1.274 . . . . 0.0 108.788 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -159.04 -28.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.458 ' O ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -175.52 108.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' O ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -177.05 -172.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.954 -1.091 . . . . 0.0 110.077 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.63 -71.97 1.8 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' C ' ' N ' ' A' ' 68' ' ' LEU . 1.1 mm? -65.97 -65.06 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.007 -1.29 . . . . 0.0 108.57 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 73.7 tt0 -49.81 -19.91 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' N ' ' C ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 72' ' ' ILE . 2.0 tt -45.94 -63.18 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 109.067 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -42.72 -50.23 5.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LEU . 54.1 mt -73.59 -23.31 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.08 -29.55 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.611 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.76 -28.13 1.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.506 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -47.29 126.7 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.28 -34.25 5.93 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -89.97 -46.69 8.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.4 t 45.8 19.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.22 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -140.93 2.34 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.695 . . . . 0.0 109.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.463 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 2.5 tp -47.32 110.48 1.33 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.046 -1.034 . . . . 0.0 108.53 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.19 113.81 1.83 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 121.196 1.264 . . . . 0.0 112.976 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.523 ' N ' ' OG ' ' A' ' 104' ' ' SER . 1.2 t -113.83 117.89 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.11 105.31 17.43 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.292 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 tpt -76.14 99.47 4.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.168 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.4 150.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.855 -1.153 . . . . 0.0 110.389 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.3 t -150.25 -179.81 7.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 109.878 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.35 -73.28 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.41 54.66 1.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -50.34 107.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 177.78 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 108.9 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -75.07 -34.84 61.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.06 -34.41 17.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.214 -0.929 . . . . 0.0 110.224 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.86 -24.47 63.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.047 -1.033 . . . . 0.0 109.958 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.0 mt -72.6 -36.21 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.033 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -80.95 -14.55 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.268 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.6 77.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.39 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.16 -58.98 6.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 108.849 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.7 -25.22 53.74 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.056 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.34 -32.26 37.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.07 -28.2 24.24 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 76.44 67.39 1.69 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.947 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.18 -111.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 117.103 -1.839 . . . . 0.0 110.368 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 50.0 m -91.46 -51.43 5.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.201 1.477 . . . . 0.0 107.554 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.77 -157.58 30.05 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.96 151.93 49.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -1.153 . . . . 0.0 109.244 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.472 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 8.5 p -147.15 124.74 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.189 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.88 162.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 108.828 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 pttt -135.65 159.5 71.2 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.329 -0.857 . . . . 0.0 108.747 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.34 132.88 29.01 Favored 'Cis proline' 0 C--N 1.32 -0.969 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.44 -2.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -93.42 158.37 15.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.157 -0.965 . . . . 0.0 109.417 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -89.88 147.39 23.78 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.61 -36.97 11.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.96 -1.088 . . . . 0.0 109.064 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 -33.11 74.4 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.252 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' THR . 10.8 m -71.74 -65.79 0.72 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -48.91 -38.74 23.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.343 -1.343 . . . . 0.0 108.637 179.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.44 -48.38 79.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -45.79 -43.17 12.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -78.62 -34.51 46.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 109.762 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -35.61 81.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.94 -35.36 59.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 109.944 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -31.03 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.3 mt -77.7 -35.03 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -86.55 0.51 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -77.71 -26.72 50.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -96.43 -22.31 17.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.21 -24.97 22.0 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 85.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.215 -1.167 . . . . 0.0 109.501 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.84 128.54 11.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 108.742 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.71 30.95 0.87 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.999 -1.063 . . . . 0.0 109.459 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -148.39 38.14 0.86 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -75.31 141.35 43.4 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.662 ' HZ2' ' ND2' ' A' ' 32' ' ' ASN . 11.0 mttm -81.6 131.63 35.28 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.105 -0.997 . . . . 0.0 110.971 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 38.4 m-85 -119.56 148.11 43.69 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.789 -0.57 . . . . 0.0 110.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.2 tp -121.71 112.42 18.39 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.97 98.87 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.55 -0.719 . . . . 0.0 110.022 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 3.8 t -95.16 116.95 37.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 173.29 152.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.608 -1.308 . . . . 0.0 111.331 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 15' ' ' SER . 3.0 t0 -81.94 52.15 1.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -13.25 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.652 ' N ' ' CD1' ' A' ' 14' ' ' PHE . 1.6 p 57.38 2.22 0.13 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.357 -1.465 . . . . 0.0 108.09 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.646 ' H ' ' C ' ' A' ' 14' ' ' PHE . 17.0 p 130.59 26.0 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.594 1.157 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' ARG . 30.1 tpp -92.19 -66.6 0.91 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.573 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -33.47 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.91 -39.05 61.65 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.123 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 mt -66.37 -53.34 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.074 -1.016 . . . . 0.0 109.358 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -30.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 110.232 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -53.61 26.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.437 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.731 0.777 . . . . 0.0 109.99 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -40.85 -49.18 3.18 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.933 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -63.54 -53.63 48.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.941 -1.099 . . . . 0.0 108.841 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -54.22 -28.89 44.08 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.205 -0.934 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -35.72 72.44 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.21 -57.78 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.51 74.4 0.02 OUTLIER Glycine 0 N--CA 1.48 1.604 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -150.12 139.17 21.09 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.434 . . . . 0.0 109.045 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -146.57 64.25 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -0.99 . . . . 0.0 109.921 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.662 ' ND2' ' HZ2' ' A' ' 7' ' ' LYS . 10.8 t-20 -173.63 96.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 108.866 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.02 148.44 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.039 -1.038 . . . . 0.0 110.367 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 11.9 mt-10 -122.48 -166.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -150.2 158.65 44.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.529 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.13 -166.63 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.94 13.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 0.0 111.636 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 1.7 t0 -178.85 151.24 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.6 -1.313 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.41 -52.98 12.92 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.8 t -55.52 -31.55 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.262 -1.14 . . . . 0.0 108.579 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 t0 -71.89 -45.0 62.81 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.164 -0.96 . . . . 0.0 108.894 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -58.46 -58.12 9.95 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.396 -0.815 . . . . 0.0 109.39 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.37 -42.65 15.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 110.034 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -78.43 -32.23 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -90.08 -7.01 54.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.774 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -77.72 -16.06 58.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.569 -1.332 . . . . 0.0 108.892 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -78.55 -0.4 29.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.246 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.34 -61.09 1.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.72 15.75 0.46 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.82 102.81 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' OH ' ' CG ' ' A' ' 34' ' ' GLU . 46.5 m-85 -85.81 142.68 28.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -1.162 . . . . 0.0 110.235 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.17 -7.46 54.77 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -152.78 136.96 16.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.29 116.78 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.625 -1.297 . . . . 0.0 110.484 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -97.87 116.08 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.66 134.73 30.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 108.99 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.76 -177.62 1.31 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.161 -0.962 . . . . 0.0 109.479 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 33.4 t-105 -67.47 -143.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.002 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 60' ' ' MET . 3.0 t30 -91.82 165.03 13.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.552 ' N ' ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER 179.03 -50.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.737 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -64.73 -77.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 120.779 0.986 . . . . 0.0 110.024 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.11 109.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 108.876 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 48.88 86.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.883 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.4 m-20 -163.71 -167.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . 58.73 -76.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -59.03 -71.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.889 -1.359 . . . . 0.0 109.302 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -53.1 -38.77 62.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.955 -1.091 . . . . 0.0 108.853 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HB3' ' N ' ' A' ' 65' ' ' GLY . 1.1 tp -54.23 -47.18 72.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD22 ' H ' ' A' ' 103' ' ' ALA . 39.0 tp -65.7 -62.13 1.69 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 21.0 tttm -41.83 -45.97 3.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -53.41 -44.27 68.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.024 . . . . 0.0 109.168 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 -37.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.054 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -2.16 44.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 109.574 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.65 -28.54 16.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -63.57 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.44 -25.19 20.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.66 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -1.134 . . . . 0.0 109.351 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.3 ttm -90.11 -31.64 17.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.91 . . . . 0.0 109.218 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.03 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.839 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.95 9.27 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.946 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.92 110.54 1.42 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.296 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.86 125.63 18.79 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 120.961 1.107 . . . . 0.0 112.394 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.5 124.44 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.7 tp -100.7 77.2 1.86 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.482 178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 155.51 13.45 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.28 132.54 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 t -150.1 -176.9 5.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.761 -1.212 . . . . 0.0 109.975 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.7 -49.47 2.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.605 -0.684 . . . . 0.0 109.771 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -78.43 -69.75 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 89' ' ' GLU . . . 70.64 68.08 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.251 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -61.68 -151.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.021 . . . . 0.0 109.899 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 13.3 mttt -97.39 -86.61 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.807 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' N ' ' OE2' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -47.65 -10.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.391 -0.818 . . . . 0.0 110.42 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.628 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -79.98 -33.4 39.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 0.0 109.512 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 61.0 mt -86.78 -9.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.45 -63.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.992 . . . . 0.0 109.859 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.31 -38.85 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.446 -0.784 . . . . 0.0 109.388 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.62 -49.09 51.25 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 109.822 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.31 -51.37 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.971 . . . . 0.0 110.558 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -10.57 48.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.768 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.58 -33.69 12.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.196 -0.94 . . . . 0.0 110.891 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.69 -15.01 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.89 11.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.981 -0.717 . . . . 0.0 110.816 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.67 ' H ' ' C ' ' A' ' 102' ' ' GLY . 71.6 m -29.38 -32.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 122.181 -0.324 . . . . 0.0 111.452 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.97 122.99 7.49 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -141.52 128.74 20.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -1.012 . . . . 0.0 108.574 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.436 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.0 p -134.95 129.57 51.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -60.14 -165.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 150.91 5.62 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.452 -1.405 . . . . 0.0 109.779 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.62 155.36 99.79 Favored 'Cis proline' 0 N--CA 1.488 1.148 0 C-N-CA 125.275 -0.719 . . . . 0.0 110.621 -1.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.409 ' CE1' ' CD1' ' A' ' 116' ' ' LEU . 3.1 p90 -121.43 155.74 34.22 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.856 0.836 . . . . 0.0 109.803 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.414 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.9 150.8 22.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.87 -38.43 22.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.762 -1.211 . . . . 0.0 109.445 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.85 76.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 108.236 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.414 ' HB ' ' H ' ' A' ' 112' ' ' THR . 17.2 m -67.94 -65.26 0.71 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' CD1' ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.03 -45.39 31.97 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.795 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.83 -56.09 16.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.965 -1.084 . . . . 0.0 109.809 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -46.41 -40.17 11.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.459 -0.776 . . . . 0.0 110.029 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.53 -60.52 2.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tp -45.22 -58.99 2.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.45 -37.18 56.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.977 . . . . 0.0 109.95 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -30.1 68.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.741 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.89 -53.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -57.46 -10.01 1.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.175 -0.953 . . . . 0.0 110.077 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -73.32 -31.16 63.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -91.64 -28.25 17.61 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.86 -28.3 44.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.26 86.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.285 -1.127 . . . . 0.0 109.359 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.27 146.05 1.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -89.97 22.15 3.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -155.26 42.59 0.45 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 29.6 tp -71.2 119.67 15.67 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -61.84 128.37 35.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.496 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.0 m-85 -115.47 156.18 26.13 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.509 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.19 101.13 4.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 10' ' ' VAL . 5.0 m -92.17 116.65 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.394 -0.816 . . . . 0.0 109.867 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.42 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 5.5 t -95.49 93.78 3.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.354 -0.841 . . . . 0.0 109.414 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.58 121.7 26.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.739 . . . . 0.0 109.493 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -23.46 67.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 109.548 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.28 145.68 31.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.562 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.2 t -94.81 21.54 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -154.2 -7.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.2 ttt -65.5 -35.25 80.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.178 -0.951 . . . . 0.0 109.228 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.557 ' CD ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -48.74 -44.67 38.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.0 109.454 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -33.4 53.55 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.41 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.18 -54.91 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.028 -1.045 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -32.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.327 -0.858 . . . . 0.0 111.174 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -55.04 27.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 0.0 109.174 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -64.33 -57.44 9.36 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.707 0.765 . . . . 0.0 109.329 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -39.74 -58.6 1.31 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.775 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 mt -56.08 -50.53 70.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -29.36 63.7 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.186 -0.946 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.6 -36.93 72.39 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mt -81.15 -59.79 2.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.4 58.24 0.01 OUTLIER Glycine 0 N--CA 1.481 1.685 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -138.13 149.55 46.01 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.273 -1.134 . . . . 0.0 109.181 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.546 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.91 69.17 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.293 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.4 96.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.204 -0.935 . . . . 0.0 108.677 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -150.12 149.73 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.088 . . . . 0.0 110.565 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' CD ' ' N ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -121.36 -170.78 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 10.3 mp0 -143.67 153.63 42.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.8 -169.18 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -124.99 -2.18 7.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.501 -0.75 . . . . 0.0 110.742 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.73 -179.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.849 -1.157 . . . . 0.0 109.542 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.0 95.65 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 t -66.23 -42.92 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.301 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.53 -42.96 81.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 108.705 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -61.97 -58.17 8.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 0.0 109.07 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -46.37 -33.38 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -85.16 -31.32 23.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -89.95 -6.15 55.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.115 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.428 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -88.32 -26.51 22.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.975 -1.078 . . . . 0.0 108.483 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -57.66 -10.38 1.56 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.0 108.644 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.0 -68.75 0.17 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.547 -0.721 . . . . 0.0 109.222 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.53 -96.28 0.36 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.31 67.31 0.3 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' PHE . 22.0 m-85 -44.49 96.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.69 -0.888 . . . . 0.0 109.867 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -50.61 -10.32 0.36 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -157.57 141.11 15.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -1.182 . . . . 0.0 110.467 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.2 t -131.86 107.37 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.88 80.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.99 165.66 16.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.335 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.1 m-20 -97.73 -137.94 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.609 -0.682 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.669 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 49.7 t-105 -172.33 95.86 0.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 109.299 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -157.37 -157.66 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 109.043 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.4 mmt -142.7 50.91 1.64 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 111.66 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.4 Cg_endo -59.96 -25.6 80.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.962 -1.592 . . . . 0.0 107.962 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -173.39 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.4 mtt -158.48 143.63 16.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -87.88 166.27 14.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.752 -1.218 . . . . 0.0 110.047 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.38 -5.48 77.54 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 68' ' ' LEU . 53.1 tp -57.82 -64.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.256 . . . . 0.0 109.17 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -47.61 -15.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.096 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LEU . 6.1 tp -76.17 -57.18 4.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.812 . . . . 0.0 109.305 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.71 -33.1 68.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.203 -0.936 . . . . 0.0 109.329 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -62.83 -67.41 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 m -48.46 -30.04 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 72' ' ' ILE . 11.7 mt -72.43 -40.28 63.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.266 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' CA ' ' HE ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -84.21 -17.19 40.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.453 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.78 -28.55 9.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.94 -138.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.383 -0.823 . . . . 0.0 109.322 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -136.54 -123.63 2.28 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.77 22.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.536 ' H ' ' C ' ' A' ' 76' ' ' GLY . 37.0 mtt -150.15 57.7 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 108.717 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 78' ' ' MET . 92.1 p -55.23 -113.13 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.35 58.42 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.0 109.387 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ALA . 12.3 mt 58.58 154.42 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.831 -0.543 . . . . 0.0 109.967 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.29 144.56 17.17 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.565 2.176 . . . . 0.0 114.897 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.446 ' O ' ' OG ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -129.83 122.18 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.58 107.74 19.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.77 98.3 6.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.401 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.92 158.4 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.76 -1.212 . . . . 0.0 109.791 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -150.07 159.26 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.67 -4.48 33.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' LYS . 1.4 tt0 -145.75 54.47 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.46 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 89' ' ' GLU . 24.1 tttm -76.16 -72.24 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.659 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -177.64 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.885 . . . . 0.0 109.336 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.38 -38.91 63.8 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.669 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 4.3 m-20 -69.04 -29.75 67.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.928 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.7 mt -67.89 -57.25 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 108.868 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -63.73 -18.94 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.394 -0.816 . . . . 0.0 109.205 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.38 -60.58 3.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.04 -54.23 42.15 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.11 -25.13 65.21 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.682 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.2 tp-100 -53.13 -31.15 40.72 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.26 -22.1 22.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.6 76.91 0.32 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.759 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.86 -111.89 0.08 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.088 -1.845 . . . . 0.0 109.795 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.453 ' HG ' ' H ' ' A' ' 105' ' ' GLY . 10.1 p -91.59 -50.78 5.59 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.786 1.279 . . . . 0.0 108.536 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.453 ' H ' ' HG ' ' A' ' 104' ' ' SER . . . 165.83 -166.55 38.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.41 148.58 43.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.277 -1.131 . . . . 0.0 109.984 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.438 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 11.6 p -141.21 126.8 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 9.8 p -74.96 108.75 6.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.955 . . . . 0.0 110.06 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.52 163.78 48.08 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.2 125.81 10.48 Favored 'Cis proline' 0 N--CA 1.485 0.999 0 C-N-CA 125.121 -0.783 . . . . 0.0 110.842 -1.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.44 154.85 17.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.525 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.89 151.89 21.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.64 -31.51 4.67 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.938 -1.101 . . . . 0.0 109.432 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.05 82.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.043 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.31 -66.67 0.57 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.995 -1.066 . . . . 0.0 108.336 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.84 -35.75 33.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.567 -1.333 . . . . 0.0 109.557 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -70.65 -67.92 0.47 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.827 -1.171 . . . . 0.0 109.768 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -42.84 -29.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.711 -0.618 . . . . 0.0 109.385 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -78.7 -43.69 25.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.02 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -57.19 -66.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 0.0 109.947 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -40.2 -52.38 2.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.558 -0.714 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -60.39 -28.6 68.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 110.557 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.98 -38.5 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.0 110.402 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -76.53 -42.7 42.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 110.669 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -50.32 -23.09 2.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.899 -1.126 . . . . 0.0 108.207 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -92.77 -25.12 18.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' PHE . 2.1 tp -73.46 -26.14 60.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.01 -42.83 1.03 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 129' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.265 -1.138 . . . . 0.0 109.441 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.535 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER 63.88 130.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.027 . . . . 0.0 108.9 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -90.42 7.71 37.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.899 -1.126 . . . . 0.0 109.996 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.38 45.73 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.987 -1.07 . . . . 0.0 111.22 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.31 138.5 38.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.38 122.87 26.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.956 -1.09 . . . . 0.0 111.972 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.71 149.32 33.09 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.16 107.13 10.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.36 131.53 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.961 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.487 ' C ' ' H ' ' A' ' 13' ' ' ASP . 9.8 t -138.43 38.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.392 -0.817 . . . . 0.0 109.216 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -76.35 22.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.14 -0.975 . . . . 0.0 109.36 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER 47.82 -124.3 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.132 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 46.52 -168.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.33 -9.41 1.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.731 . . . . 0.0 109.052 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.66 -13.98 5.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 8.4 ttt -64.27 -49.48 71.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.483 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -45.48 16.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -52.23 -49.74 63.38 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.482 -0.761 . . . . 0.0 110.266 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -50.2 -55.56 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.952 . . . . 0.0 110.207 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -38.15 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 110.892 -178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.34 -58.28 4.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 109.521 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -62.53 -55.46 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.804 0.811 . . . . 0.0 109.495 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.09 -48.47 2.48 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.6 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.46 -49.37 71.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -48.87 -38.64 23.04 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.324 -0.86 . . . . 0.0 108.828 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -35.06 73.12 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 108.807 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.33 -3.47 33.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.472 -0.768 . . . . 0.0 109.053 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.65 33.25 16.65 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 26.2 m-85 -105.4 142.86 34.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.462 -1.022 . . . . 0.0 109.264 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -141.78 62.94 1.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.01 93.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.915 -1.116 . . . . 0.0 109.249 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.1 150.75 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 0.0 110.271 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.45 -170.5 2.19 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -147.32 157.84 43.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.049 -1.032 . . . . 0.0 110.918 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.57 -167.62 2.3 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.92 3.48 3.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.197 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.1 -179.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 109.63 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.63 -39.79 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -1.085 . . . . 0.0 109.321 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -46.67 56.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.847 . . . . 0.0 109.065 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -59.04 -57.12 14.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.486 -0.758 . . . . 0.0 109.65 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 mt -46.46 -47.83 19.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 109.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.954 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.87 9.73 26.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.161 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -85.25 -36.9 20.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 109.053 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.07 -1.28 31.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.23 -58.64 3.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.85 9.8 1.37 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.03 94.9 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.482 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 31.6 m-85 -80.48 142.64 34.05 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.227 -1.161 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.54 6.22 65.19 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.07 142.71 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.616 -0.932 . . . . 0.0 108.618 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.4 t -141.75 121.19 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.75 -1.219 . . . . 0.0 110.075 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.1 mt -107.91 132.04 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 p -151.4 145.63 25.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 0.0 109.421 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.8 p-10 -47.79 -80.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.529 ' CH2' ' OD1' ' A' ' 94' ' ' ASN . 28.0 t-105 -177.34 -68.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 59' ' ' ASN . 43.4 p-10 -170.54 53.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.948 -1.095 . . . . 0.0 109.742 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.524 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -60.65 -47.59 95.58 Favored Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.09 -1.006 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -65.62 -73.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.038 1.158 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.613 HD21 ' N ' ' A' ' 63' ' ' MET . 0.2 OUTLIER 179.32 -106.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.039 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.613 ' N ' HD21 ' A' ' 62' ' ' ASN . 1.1 mtp -70.99 73.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.956 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -150.62 162.49 40.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . 74.16 -66.93 1.83 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' LEU . 52.2 tp -68.68 -73.0 0.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.572 -1.546 . . . . 0.0 109.024 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.3 tp10 -46.9 -32.9 4.11 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tp -66.74 -41.13 88.36 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' LEU . 40.7 tp -76.66 -62.38 1.65 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.497 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' LEU . 12.8 ttmt -42.96 -35.48 1.24 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.323 -0.861 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.3 m -71.57 -34.94 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 69' ' ' LEU . 43.3 mt -64.51 -26.15 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.214 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.06 -40.58 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.773 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.03 -28.57 1.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.24 162.14 6.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.621 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -109.79 22.4 23.81 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.72 0.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -125.06 16.2 8.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.2 t -72.87 16.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -129.31 35.9 4.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.546 -0.721 . . . . 0.0 109.288 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -110.83 99.82 43.71 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.68 147.85 93.47 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 112.624 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.23 129.5 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.6 tp -111.66 70.89 0.72 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.91 167.13 3.01 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.2 p -150.16 137.56 13.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.801 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -150.36 171.06 17.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.02 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.02 131.0 48.72 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 50.83 75.31 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.007 -1.058 . . . . 0.0 108.581 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -44.04 138.08 3.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.757 . . . . 0.0 110.299 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 10.4 ttpt -71.67 -6.02 38.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 0.0 109.486 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 2.6 tttm 74.79 -73.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.81 . . . . 0.0 109.683 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.33 -11.53 0.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.041 -1.037 . . . . 0.0 109.838 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.529 ' OD1' ' CH2' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -89.87 -51.49 5.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.89 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mm -46.04 -46.77 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.77 -65.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.962 -1.086 . . . . 0.0 109.509 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.49 -60.08 2.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 108.743 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -44.6 -44.04 8.58 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.597 . . . . 0.0 109.82 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 101' ' ' ALA . . . -60.81 -48.15 83.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.992 -1.067 . . . . 0.0 110.246 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -54.24 -11.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 109.437 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.436 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . -103.04 -110.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.593 -0.692 . . . . 0.0 110.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -132.96 -2.16 3.89 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -60.69 11.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.001 -0.705 . . . . 0.0 110.682 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -29.42 -30.56 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -176.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.24 128.23 9.14 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.124 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.64 117.82 7.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -1.137 . . . . 0.0 109.563 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 p -113.13 143.41 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.6 107.29 17.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.345 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 159.48 68.19 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.675 -1.265 . . . . 0.0 108.963 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.69 164.39 88.14 Favored 'Cis proline' 0 N--CA 1.487 1.139 0 C-N-CA 124.775 -0.927 . . . . 0.0 110.738 -1.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -144.57 152.99 41.34 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.097 0.951 . . . . 0.0 109.932 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.1 149.79 22.68 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.5 -37.95 12.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.982 -1.074 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.57 -33.52 75.85 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' THR . 88.9 m -72.57 -68.37 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.447 ' C ' ' O ' ' A' ' 115' ' ' THR . 8.3 tp -43.87 -37.69 2.96 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.255 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp10 -56.33 -65.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -42.27 -53.67 4.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.323 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -57.2 -52.25 66.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -61.27 2.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -49.52 -36.47 23.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.799 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -28.88 70.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.459 ' C ' ' H ' ' A' ' 125' ' ' GLU . 13.0 mt -80.01 -48.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.019 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -55.17 -6.74 0.16 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 123' ' ' ILE . 1.5 mt-10 -70.31 -27.97 64.81 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -89.35 -26.06 21.28 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.25 -26.08 42.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.816 . . . . 0.0 108.842 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.9 81.7 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -1.149 . . . . 0.0 109.491 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 5' ' ' GLU . 5.0 t70 51.58 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -71.98 34.39 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.576 -1.328 . . . . 0.0 110.04 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 3' ' ' ASP . 46.2 mt-10 -150.37 32.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.91 142.5 57.87 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 108.715 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.42 122.93 28.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.084 -1.01 . . . . 0.0 112.181 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -113.71 154.6 27.04 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.0 tp -130.43 99.84 5.15 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 10' ' ' VAL . 10.7 m -89.89 107.19 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.078 -1.014 . . . . 0.0 109.833 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.433 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 58.4 t -96.89 65.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 3.6 p30 -89.1 -139.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 108.927 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 31.3 t0 -172.13 -33.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.82 156.51 8.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.746 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.2 t -91.02 39.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -175.17 3.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.3 ttm -84.01 -33.41 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.232 -0.917 . . . . 0.0 109.301 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.631 ' CD ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.12 -48.62 70.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -55.88 -28.84 58.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.038 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -67.61 -55.3 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.693 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -34.88 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.502 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -55.13 18.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.857 -1.152 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.6 t30 -58.09 -58.6 7.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.98 0.895 . . . . 0.0 108.73 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 2.2 tt -40.22 -62.55 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.907 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -52.85 -45.02 67.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.207 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -55.18 -43.13 74.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.393 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -19.34 21.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.88 -7.04 25.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.365 -0.835 . . . . 0.0 110.065 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.38 71.26 1.2 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -150.15 100.28 2.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.301 . . . . 0.0 108.819 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -108.41 67.51 0.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.084 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.08 93.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -150.16 147.79 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.96 -1.087 . . . . 0.0 110.398 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.12 -175.27 3.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -147.82 161.05 42.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.869 -1.145 . . . . 0.0 110.909 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.34 -168.08 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.31 2.55 4.23 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.445 -0.785 . . . . 0.0 110.009 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.68 -176.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 108.819 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.83 -30.94 62.89 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.46 -36.28 76.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.123 -1.221 . . . . 0.0 108.33 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -75.51 -46.79 30.15 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.14 -54.94 39.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.268 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -48.08 -49.57 31.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -67.36 -34.39 77.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.037 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -90.02 -5.06 57.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 110.457 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -72.8 -27.76 62.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.072 -1.018 . . . . 0.0 108.938 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 20.3 tt0 -68.31 0.65 3.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.394 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.92 -77.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.37 -67.78 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.97 68.6 0.08 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.0 m-85 -47.12 101.99 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.487 -1.008 . . . . 0.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.53 8.96 2.74 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -169.52 146.55 3.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -1.199 . . . . 0.0 109.588 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.0 t -145.31 120.44 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.744 -1.223 . . . . 0.0 110.404 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.43 92.69 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.6 p -98.58 151.24 20.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.272 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 8.6 p-10 -86.19 -107.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.324 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.55 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 55.3 t-105 -146.3 176.6 9.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.005 . . . . 0.0 109.529 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' OD1' ' CE2' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -73.98 69.29 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -79.27 -47.55 1.58 Allowed Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.968 . . . . 0.0 110.336 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -67.17 -68.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.082 1.188 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.667 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -152.31 -126.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.479 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 20.8 mtm -86.33 95.98 9.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 63' ' ' MET . 52.8 m-20 -160.98 171.73 18.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.43 -63.12 2.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 tp -74.04 -50.56 19.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.639 -1.507 . . . . 0.0 107.88 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -71.07 -14.73 62.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 mt -68.6 -58.17 4.66 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -61.37 -34.73 75.8 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -68.43 -37.91 80.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.9 m -68.53 -48.45 64.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.06 -25.91 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.433 -0.792 . . . . 0.0 109.027 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -90.05 -29.31 18.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.41 -0.806 . . . . 0.0 110.005 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -67.75 -38.2 83.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -53.16 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.35 -79.28 1.44 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.87 54.94 2.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -1.116 . . . . 0.0 109.827 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.7 mmt -137.37 1.95 2.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 109.296 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -94.06 59.99 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.04 -31.47 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.64 118.92 67.38 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 120.911 -1.118 . . . . 0.0 109.463 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.31 107.88 0.4 Allowed 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 121.474 1.449 . . . . 0.0 113.096 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.45 113.61 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.402 ' CD1' ' C ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -95.78 103.05 14.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.078 -1.449 . . . . 0.0 108.331 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 38.4 tpp -68.74 137.78 54.34 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.1 t -122.64 148.27 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.642 -0.661 . . . . 0.0 110.518 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.95 148.62 29.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.02 -45.92 8.44 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.213 -0.93 . . . . 0.0 108.789 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.8 mt-10 -93.66 43.75 1.12 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -43.91 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 110.086 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -95.47 143.57 26.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -47.56 -16.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.3 mm-40 -90.09 -45.55 9.07 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.287 -0.883 . . . . 0.0 110.167 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' C ' ' ND2' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.81 -13.77 55.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 110.065 -179.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 mt -73.64 -46.78 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 mt -74.74 -14.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 108.897 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.75 95.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.36 -58.21 4.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.5 -25.96 60.6 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.228 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -32.44 50.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.01 -29.61 28.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.05 70.01 1.32 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.453 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.02 -111.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 116.721 -1.991 . . . . 0.0 109.486 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 p -91.74 -49.72 6.12 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.844 1.306 . . . . 0.0 108.12 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.88 -168.62 39.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.19 151.19 51.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.505 -0.997 . . . . 0.0 109.961 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.629 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 9.6 p -144.08 135.74 22.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -80.47 157.19 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.014 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 160.19 67.5 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 108.901 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.49 129.94 19.69 Favored 'Cis proline' 0 N--CA 1.485 1.009 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.683 -2.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.88 -179.18 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.153 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.492 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -110.64 145.08 38.54 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.77 -14.86 0.14 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.991 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -83.15 -36.72 24.52 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -71.7 -60.3 2.3 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 115' ' ' THR . 1.3 mt -50.03 -40.85 46.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.413 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -59.51 -54.69 43.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.514 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -47.5 -51.56 20.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.491 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.64 -39.8 85.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -54.03 -68.45 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.503 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -46.66 -48.15 20.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.958 . . . . 0.0 109.477 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -47.25 -40.83 17.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 125' ' ' GLU . 69.5 mt -81.93 -59.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.0 109.19 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.2 0.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.852 -0.53 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 123' ' ' ILE . 86.9 tt0 -73.78 -27.32 61.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 126' ' ' LYS . 4.5 mptt -92.78 -34.76 13.75 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.33 -22.44 61.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.03 89.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.334 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.6 m-20 -45.85 140.06 3.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.32 8.53 32.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 110.303 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -140.16 46.25 1.84 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.074 -1.016 . . . . 0.0 110.524 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -80.6 131.45 35.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 127.63 33.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.905 -1.122 . . . . 0.0 111.621 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -114.61 153.72 29.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.9 tp -123.85 111.5 16.17 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.74 108.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.902 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.9 55.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.445 -0.784 . . . . 0.0 109.332 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -97.69 142.45 29.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.57 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.81 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.74 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 t -139.45 13.38 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 109.057 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -164.55 -3.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.74 -45.31 70.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.594 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -45.92 19.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.194 -0.941 . . . . 0.0 109.633 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -53.71 -53.03 57.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.394 -0.816 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -47.34 -59.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 109.972 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -40.68 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.729 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.4 OUTLIER -49.61 -54.31 19.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.842 -1.161 . . . . 0.0 109.512 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -62.66 -57.77 9.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.048 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.7 tt -40.04 -58.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.665 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.9 mt -57.42 -45.59 84.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.048 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -54.78 -40.9 69.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.6 -15.5 63.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.312 -0.867 . . . . 0.0 109.285 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.28 4.36 48.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.428 -0.795 . . . . 0.0 109.757 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 59.82 1.63 Allowed Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.138 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 51.2 m-85 -150.04 138.52 20.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.363 . . . . 0.0 109.549 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -146.37 64.8 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.908 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.85 96.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 108.799 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.17 153.86 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -169.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -150.16 156.09 40.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 111.418 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' N ' ' OE1' ' A' ' 35' ' ' GLU . . . -144.8 -164.4 1.91 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 4.4 mt-10 -130.24 -14.37 3.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.542 -0.724 . . . . 0.0 110.547 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -173.38 -178.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.005 -1.059 . . . . 0.0 109.886 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.42 -43.28 93.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG2' ' SD ' ' A' ' 63' ' ' MET . 91.0 t -63.92 -51.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.874 -1.368 . . . . 0.0 108.709 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 45.6 t0 -51.31 -47.73 62.55 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -60.91 -48.83 80.03 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 42' ' ' ALA . 2.4 tp -40.61 -35.94 0.53 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.26 -39.76 65.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 108.931 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' GLN . 35.4 mmtt -79.91 -53.39 6.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.469 -0.769 . . . . 0.0 109.65 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -42.49 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.595 -0.69 . . . . 0.0 109.379 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 45' ' ' LYS . 8.9 tt0 -53.36 -44.75 68.81 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 50' ' ' GLY . . . -48.87 -49.75 38.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 80.39 -20.51 5.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 48' ' ' ALA . . . -58.14 -8.27 4.58 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' C ' ' H ' ' A' ' 53' ' ' PHE . 66.9 m-85 -71.33 89.85 0.92 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -1.131 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.01 6.99 1.8 Allowed Glycine 0 C--O 1.205 -1.709 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -165.86 141.08 4.83 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.463 -1.022 . . . . 0.0 109.241 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.0 t -131.56 117.51 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.266 . . . . 0.0 109.724 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.0 mt -98.78 79.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 p -93.67 144.1 25.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -0.813 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' OD2' ' NZ ' ' A' ' 109' ' ' LYS . 31.6 m-20 -92.68 126.06 37.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.364 -0.835 . . . . 0.0 109.016 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.558 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 6.9 t90 -90.76 107.56 19.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.413 ' C ' HD21 ' A' ' 59' ' ' ASN . 0.3 OUTLIER -161.69 -124.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.409 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 7.3 ttt -159.63 57.97 1.1 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.132 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.3 Cg_endo -64.3 -38.89 32.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 107.32 -1.838 . . . . 0.0 107.32 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 19.3 m-80 -161.5 -26.09 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.408 ' SD ' ' CG2' ' A' ' 40' ' ' VAL . 7.5 mtt -159.7 143.02 14.25 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.88 155.84 32.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.717 -1.24 . . . . 0.0 109.579 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -82.22 -7.84 87.2 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.368 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -58.37 -49.3 77.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.419 -1.636 . . . . 0.0 107.716 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' O ' ' OG1' ' A' ' 71' ' ' THR . 78.9 tt0 -52.74 -15.8 0.82 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 7.1 tp -79.34 -54.51 5.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -60.51 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -44.93 -51.38 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.468 -0.77 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 10.9 p -61.69 -41.35 97.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 mt -59.33 -21.58 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.22 -0.925 . . . . 0.0 108.583 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -90.03 -23.3 21.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.245 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -55.91 4.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.211 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.78 -58.38 3.85 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.16 -58.36 3.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.426 ' O ' ' OG ' ' A' ' 79' ' ' SER . 49.4 mtt -128.93 -9.73 4.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 78' ' ' MET . 73.8 p 46.21 -123.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.099 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.07 55.31 0.93 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 108.902 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 45.52 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 O-C-N 121.664 -0.647 . . . . 0.0 109.602 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 5.3 Cg_exo -63.56 149.51 90.81 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.096 1.864 . . . . 0.0 115.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.53 110.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 2.7 tp -89.76 105.13 17.6 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.139 -1.825 . . . . 0.0 107.262 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 tpp -72.19 109.77 6.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.172 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.57 140.39 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 109.496 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.21 157.82 43.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.65 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.9 mp0 -80.74 70.8 7.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.22 83.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 0.0 108.853 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 89' ' ' GLU . 13.7 tttp -44.69 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.76 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mttt 175.92 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.7 -30.61 33.16 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.558 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 1.4 m-20 -61.5 -54.71 39.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 95' ' ' ILE . 10.0 mm -45.43 -53.83 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.61 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 96' ' ' ILE . 1.7 mp -57.19 -28.25 29.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -64.13 -44.95 90.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.415 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -69.01 -53.99 17.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.058 . . . . 0.0 108.168 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.575 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -56.78 -28.47 61.38 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.29 -34.0 73.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -78.45 -19.23 53.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 55.56 76.05 0.21 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.857 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.17 -112.04 0.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.763 -1.975 . . . . 0.0 110.51 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -50.28 5.83 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.732 1.253 . . . . 0.0 108.149 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 168.41 -155.31 25.86 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.56 122.82 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.547 -0.972 . . . . 0.0 108.782 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.82 131.68 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.33 132.43 33.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.932 -1.105 . . . . 0.0 109.121 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' NZ ' ' OD2' ' A' ' 57' ' ' ASP . 3.5 pttt -109.54 160.11 29.02 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.95 134.45 35.58 Favored 'Cis proline' 0 C--N 1.32 -0.924 0 C-N-CA 124.866 -0.889 . . . . 0.0 110.39 -1.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -100.69 160.39 14.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.971 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.503 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.88 149.76 21.51 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.03 -21.78 0.76 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.174 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.07 -31.8 25.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.503 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -76.78 -57.66 3.73 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -40.72 64.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.106 -1.621 . . . . 0.0 107.842 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.51 -52.3 66.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.939 -1.1 . . . . 0.0 109.74 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -45.54 -46.44 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.482 -0.761 . . . . 0.0 109.507 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -70.31 -48.86 54.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 tp -47.08 -65.15 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 0.0 109.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 -45.13 45.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 0.0 109.907 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -68.66 -19.35 64.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 109.652 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.08 -43.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 0.0 110.244 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -63.25 -16.47 60.33 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.083 -1.011 . . . . 0.0 109.964 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -70.84 -19.94 62.6 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -94.85 -34.18 12.55 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -22.08 52.14 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.86 90.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.209 -1.171 . . . . 0.0 109.557 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -47.5 113.06 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 pttt -73.04 36.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.978 -1.076 . . . . 0.0 109.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 3' ' ' ASP . 23.9 tt0 -152.96 30.66 0.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -72.83 138.8 46.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -81.29 127.36 32.64 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.969 -1.082 . . . . 0.0 111.697 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 40.7 m-85 -114.71 155.66 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.837 -0.539 . . . . 0.0 109.954 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.3 tp -127.61 109.34 11.6 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -97.3 107.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.355 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -98.5 99.55 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.4 -0.813 . . . . 0.0 109.372 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.54 170.13 18.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.734 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.25 26.04 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -70.76 -80.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 t 154.03 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 -26.2 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 ttt -45.2 -63.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.724 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -48.58 -26.86 2.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -76.61 -31.68 57.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.624 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -51.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -38.34 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -52.72 23.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.23 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -58.29 4.13 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.992 0.901 . . . . 0.0 109.712 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.71 -41.18 3.06 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.836 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.77 -46.18 63.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.98 -1.075 . . . . 0.0 108.624 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -56.39 -38.17 71.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.341 -0.849 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.93 -24.88 17.87 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.274 -0.891 . . . . 0.0 109.201 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.28 -39.49 16.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.675 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 137.54 6.9 1.51 Allowed Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.6 141.4 28.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.852 -1.381 . . . . 0.0 109.389 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.508 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.5 61.5 1.22 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 97.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.03 152.79 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.044 -1.035 . . . . 0.0 109.83 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -120.52 -167.48 1.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 36' ' ' ALA . 1.1 tt0 -150.11 147.93 28.36 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.109 -0.994 . . . . 0.0 110.861 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' O ' ' OE2' ' A' ' 35' ' ' GLU . . . -132.31 -167.72 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -140.12 -2.2 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.894 . . . . 0.0 110.416 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 1.9 p-10 -176.4 -157.7 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 108.502 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -86.08 -43.12 6.42 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.46 -36.11 17.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.856 -1.379 . . . . 0.0 108.056 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -77.69 -54.64 6.13 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.712 -0.618 . . . . 0.0 109.756 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -55.78 -53.48 56.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.087 -1.008 . . . . 0.0 110.018 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.77 -59.47 4.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -55.37 -33.67 63.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -90.03 -19.86 23.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.116 -0.99 . . . . 0.0 110.699 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -60.52 -22.13 63.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.841 -1.162 . . . . 0.0 109.287 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -90.69 -2.64 57.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 108.919 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.46 -71.9 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.57 -0.706 . . . . 0.0 109.848 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.36 -18.9 1.12 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.26 64.67 0.55 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.46 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.7 m-85 -47.01 114.81 0.92 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.463 -1.022 . . . . 0.0 109.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.27 2.39 9.92 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -161.36 140.93 10.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.08 . . . . 0.0 108.854 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.8 t -134.97 121.17 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.796 -1.19 . . . . 0.0 110.069 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 56' ' ' SER . 43.2 mt -110.43 139.14 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 36.7 m -165.98 157.5 13.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.098 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 6.5 m-20 -61.39 -131.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 0.0 110.085 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 35.6 t-105 -173.11 -2.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.647 HD21 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -143.25 -16.44 0.66 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.65 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 24.0 tpp -81.08 -33.01 0.67 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 111.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -66.98 -148.0 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.715 0.944 . . . . 0.0 109.871 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.447 ' O ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -57.44 -159.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.561 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -44.67 -25.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 175.54 135.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.24 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.82 2.8 0.81 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 64' ' ' ASP . 12.3 tp -65.91 -60.13 3.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.809 -1.406 . . . . 0.0 108.068 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -49.34 -39.64 32.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.6 tt -58.87 -35.5 73.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -83.1 -63.66 1.32 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' LEU . 36.3 tttm -35.81 -49.95 0.63 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.083 0.468 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.4 m -49.2 -46.36 45.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 108.492 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.3 mt -57.09 -33.18 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' CZ ' ' O ' ' A' ' 100' ' ' GLN . 9.8 ttt180 -67.58 -24.4 65.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.04 -28.54 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.54 82.16 8.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.1 89.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.35 -37.26 10.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.457 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -95.13 -71.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.52 11.05 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.382 -0.824 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -107.28 -31.7 8.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.653 -0.654 . . . . 0.0 109.759 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -32.14 97.53 0.11 Allowed Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 122.288 -0.257 . . . . 0.0 110.418 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.58 139.09 52.08 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 121.055 1.17 . . . . 0.0 111.028 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 t -131.36 137.68 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.7 tp -119.81 69.85 0.85 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -51.58 170.52 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.247 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.0 t -140.84 131.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.263 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -149.3 166.14 29.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.077 -1.014 . . . . 0.0 110.351 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.55 32.3 6.21 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 109.714 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 91' ' ' LYS . 3.5 tt0 -153.84 -62.82 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.178 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 57.16 83.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -68.8 8.93 0.44 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.174 -0.954 . . . . 0.0 109.443 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER 73.18 -68.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.328 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -51.6 -43.45 62.52 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -18.64 65.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mm -83.99 -13.97 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.21 -63.17 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.46 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.22 -46.27 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.83 78.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 109.123 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.76 61.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' CZ ' ' A' ' 73' ' ' ARG . 74.3 mt-30 -53.0 -23.77 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.77 -109.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.708 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.8 -1.85 4.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.43 11.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.086 -0.655 . . . . 0.0 110.87 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.708 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.4 m -29.46 -33.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.74 130.63 10.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.576 ' H ' ' HZ2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -143.88 112.18 6.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 108.626 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.6 p -115.48 133.25 62.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 106' ' ' TYR . 18.4 m -67.67 -167.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 151.46 17.03 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.706 -1.247 . . . . 0.0 108.991 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.83 165.68 83.17 Favored 'Cis proline' 0 N--CA 1.489 1.236 0 O-C-N 122.459 0.715 . . . . 0.0 111.217 -1.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -132.82 156.94 46.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.694 0.759 . . . . 0.0 109.6 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.07 143.93 26.78 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -42.97 -33.76 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.253 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.04 95.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.0 m -65.2 -69.76 0.27 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.15 -31.69 3.72 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.972 -1.08 . . . . 0.0 109.986 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 6.1 tp10 -67.7 -62.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.647 -1.283 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 5.9 tt0 -41.82 -59.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.747 -0.596 . . . . 0.0 110.137 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HZ2' ' H ' ' A' ' 106' ' ' TYR . 6.8 mmmt -50.06 -40.57 45.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.771 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.02 -50.61 63.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -18.4 62.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.0 . . . . 0.0 109.811 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -81.91 -34.42 29.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 mt -78.89 -37.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.102 -0.999 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.6 m-85 -75.33 -30.22 60.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.23 -24.15 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 108.228 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -94.1 -23.26 18.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 124' ' ' PHE . 5.6 tp -83.3 -18.09 40.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 74.95 0.19 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.409 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -160.19 143.66 13.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.045 -1.035 . . . . 0.0 109.875 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -90.16 9.18 29.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.003 -1.061 . . . . 0.0 109.178 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -158.65 57.0 0.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 56.2 tp -84.87 120.57 26.61 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -57.29 112.12 1.29 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.988 -1.07 . . . . 0.0 111.764 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 67.1 m-85 -107.16 151.05 25.93 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -122.25 106.02 10.74 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.93 113.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.273 -178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -119.23 106.78 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.591 -0.693 . . . . 0.0 109.331 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -155.49 126.83 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.396 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' ASP . 64.7 t0 -57.77 -107.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.07 -156.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.282 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.1 t -150.35 24.98 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.115 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.65 4.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.8 tpp -68.84 -44.43 73.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.117 -0.989 . . . . 0.0 109.122 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -44.69 -47.03 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 109.85 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -56.38 -51.2 69.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.919 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.8 mt -49.77 -58.51 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.004 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -39.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.477 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -57.25 11.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 108.933 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.3 t-20 -57.63 -54.06 51.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -39.19 -55.08 1.72 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.814 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.82 -53.18 59.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 108.865 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 26' ' ' LYS . 8.1 mtpm? -52.55 -28.12 19.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.247 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -32.66 62.59 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.086 -1.009 . . . . 0.0 108.838 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.91 -69.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.254 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 18.41 0.02 OUTLIER Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 30.9 m-85 -96.07 153.99 17.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.351 . . . . 0.0 109.06 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -149.12 21.5 0.97 Allowed 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.87 -1.144 . . . . 0.0 110.894 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.749 HD21 ' H ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -138.29 107.65 6.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.917 -1.114 . . . . 0.0 111.106 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.33 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.226 -0.921 . . . . 0.0 109.606 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -137.35 -166.69 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -150.1 154.68 38.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.935 -1.103 . . . . 0.0 110.824 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.87 -163.67 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.91 -4.15 2.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.0 110.484 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 2.8 p-10 179.7 -173.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.025 -1.047 . . . . 0.0 109.52 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.71 67.05 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.93 -41.78 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.68 -1.482 . . . . 0.0 108.739 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -68.42 -44.45 74.99 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -68.73 -37.55 79.54 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.38 -57.8 7.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -66.43 -39.64 89.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 110.034 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -22.62 62.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.306 -0.871 . . . . 0.0 110.464 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -65.09 -4.8 5.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.831 -1.168 . . . . 0.0 109.325 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.05 -7.71 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.712 . . . . 0.0 109.213 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.59 -65.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.614 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.61 5.34 2.04 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.72 76.93 1.1 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.548 ' C ' ' H ' ' A' ' 53' ' ' PHE . 52.6 m-85 -54.07 113.62 1.3 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.502 -0.999 . . . . 0.0 110.214 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.52 -4.81 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.548 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -165.48 141.35 5.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -1.14 . . . . 0.0 110.166 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.6 t -133.94 116.11 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.379 -0.826 . . . . 0.0 110.95 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.34 85.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.8 p -92.64 172.07 8.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 0.0 110.457 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 1.5 p-10 -95.31 -109.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.531 -0.73 . . . . 0.0 109.855 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 60.4 t-105 -159.82 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.466 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.614 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 41.5 m-20 -139.16 8.57 2.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -53.45 -49.57 87.71 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.956 -1.09 . . . . 0.0 109.72 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.2 -157.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 120.98 1.12 . . . . 0.0 109.496 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.64 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -85.38 143.75 28.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.072 -1.017 . . . . 0.0 109.395 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 19.9 ttm 74.47 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -137.9 164.73 28.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.535 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -91.49 -14.55 56.87 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -52.95 41.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.645 -1.503 . . . . 0.0 108.819 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' O ' ' CG2' ' A' ' 71' ' ' THR . 0.6 OUTLIER -53.18 -22.98 7.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 108.549 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 10.2 tp -67.54 -55.16 14.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.69 -64.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -44.86 -46.2 10.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 109.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.463 ' CG2' ' O ' ' A' ' 67' ' ' GLU . 25.1 p -64.58 -43.77 92.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 109.163 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.38 -27.25 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.344 -0.847 . . . . 0.0 108.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.01 -29.83 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.91 -29.92 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -0.894 . . . . 0.0 109.355 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.19 113.33 19.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.832 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.67 -23.71 77.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.35 77.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.178 . . . . 0.0 109.491 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.0 OUTLIER -100.34 -75.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.82 19.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.99 20.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.15 119.8 73.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.083 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.07 98.19 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 120.934 1.089 . . . . 0.0 112.13 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.533 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.4 t -99.17 121.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.95 107.13 19.02 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.51 110.52 18.74 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.061 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -98.77 161.68 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.586 -1.321 . . . . 0.0 110.049 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.468 ' C ' ' NZ ' ' A' ' 109' ' ' LYS . 11.6 t -149.96 -155.59 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.497 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.42 32.57 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.536 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.99 -60.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.568 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . . . 54.1 98.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 109.904 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 93' ' ' GLU . 32.0 tttp -112.59 54.62 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 mttt 54.12 -82.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.665 -0.647 . . . . 0.0 110.002 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LYS . 1.9 mt-10 -43.76 -56.05 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 110.509 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.642 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -55.32 -45.74 76.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.988 -1.07 . . . . 0.0 109.974 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 mt -48.86 -36.77 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 108.977 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 100' ' ' GLN . 15.2 mt -74.62 -25.62 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -56.18 -53.34 58.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 0.0 109.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.32 -59.36 5.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.917 -1.115 . . . . 0.0 108.451 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.06 -21.84 34.61 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.44 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.7 tt0 -52.21 -32.27 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.07 -22.66 21.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.66 72.26 0.88 Allowed Glycine 0 N--CA 1.482 1.74 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.196 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.08 -112.32 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 116.55 -2.06 . . . . 0.0 110.192 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 20.5 m -91.93 -52.56 4.67 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.529 1.633 . . . . 0.0 107.58 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.48 -160.19 33.23 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.568 ' HH ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -135.22 147.01 49.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -1.076 . . . . 0.0 109.849 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.99 128.74 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 149.96 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.62 160.87 62.43 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.79 124.07 8.9 Favored 'Cis proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.803 -0.915 . . . . 0.0 110.554 -1.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -93.4 156.43 16.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.309 -0.869 . . . . 0.0 109.967 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.527 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.28 150.06 22.09 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.19 -32.14 4.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.82 -35.46 80.74 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.095 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -71.38 -65.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.081 -1.012 . . . . 0.0 108.51 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 tp -52.34 -34.94 49.61 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.419 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 120' ' ' LEU . 4.3 tm-20 -69.12 -63.3 1.09 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.798 -1.189 . . . . 0.0 109.702 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.4 -41.84 9.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.632 -0.668 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -71.29 -27.78 63.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.221 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.1 tp -61.99 -62.1 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.36 -35.6 8.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.573 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -75.01 -29.89 60.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.166 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 120' ' ' LEU . 2.6 mm -77.05 -40.0 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.382 -0.824 . . . . 0.0 109.44 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -76.86 -0.24 23.32 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -31.41 58.61 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -90.18 -25.53 20.6 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.93 -25.58 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.52 89.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -46.28 132.36 10.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -90.46 18.63 5.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.036 . . . . 0.0 109.646 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -129.32 42.6 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.7 tp -90.14 130.22 36.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.658 ' HZ2' HD22 ' A' ' 32' ' ' ASN . 19.6 mttm -76.93 124.79 28.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 111.422 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -109.29 152.08 25.71 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.9 tp -131.15 105.59 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.51 104.62 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.085 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.45 88.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.414 -0.804 . . . . 0.0 109.436 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -149.33 157.15 43.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.56 -13.66 14.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.639 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -47.4 136.06 10.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.536 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.4 t -86.14 30.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.35 -24.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.6 ttt -66.06 -61.17 2.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -47.82 -35.17 9.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 109.389 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -72.14 -39.86 68.47 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.963 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -62.6 -53.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.755 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -32.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -55.26 20.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.749 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.86 -53.49 17.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.812 0.815 . . . . 0.0 109.543 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.53 -52.37 2.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.508 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -59.46 -55.16 38.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.393 -0.817 . . . . 0.0 108.999 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -52.1 -31.4 30.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 109.073 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -32.13 55.94 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.286 -0.884 . . . . 0.0 109.336 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -89.47 -61.14 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 162.16 73.34 0.02 OUTLIER Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -150.15 134.52 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.79 -1.418 . . . . 0.0 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.97 26.16 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.745 . . . . 0.0 110.449 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.658 HD22 ' HZ2' ' A' ' 7' ' ' LYS . 27.0 t-20 -137.82 93.71 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 109.393 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -139.69 153.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.687 . . . . 0.0 110.336 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 12.4 mt-10 -127.63 -171.88 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.08 147.08 27.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.07 -1.019 . . . . 0.0 110.475 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.26 -165.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.11 0.77 2.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 3.8 t70 -176.43 164.77 2.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.766 -1.209 . . . . 0.0 109.849 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -56.67 -40.34 88.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.48 -40.38 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.119 -1.224 . . . . 0.0 108.336 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -66.88 -49.73 64.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -54.44 -56.98 13.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 42' ' ' ALA . 1.3 tp -41.1 -45.98 2.87 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.226 0.536 . . . . 0.0 109.735 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -70.93 -37.36 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' ALA . 31.2 mttt -90.09 4.4 50.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 110.045 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -90.08 -62.96 1.35 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.91 -1.119 . . . . 0.0 109.047 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -56.15 -8.51 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 108.861 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.33 -79.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.708 . . . . 0.0 109.742 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.75 1.4 11.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 77.55 0.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.6 m-85 -64.71 109.54 2.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -1.065 . . . . 0.0 109.772 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.97 -1.95 1.71 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.514 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -157.51 139.92 14.63 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.277 . . . . 0.0 109.698 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.2 t -141.8 124.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.165 -0.96 . . . . 0.0 109.568 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -132.52 168.95 17.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.785 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 54.5 t0 -94.4 -109.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.158 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.608 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 46.8 t-105 -164.75 -55.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.51 71.41 10.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.086 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mmm -92.4 149.63 38.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 109.191 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.37 -179.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 120.941 1.094 . . . . 0.0 109.945 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.83 -104.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 mtp -106.62 161.54 14.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 109.447 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -73.4 179.28 4.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.6 6.78 67.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.08 -40.29 60.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.02 -1.282 . . . . 0.0 108.247 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 6.2 tp10 -71.36 -15.95 62.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.7 mt -74.01 -58.6 3.19 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -63.9 -38.43 91.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.209 -0.932 . . . . 0.0 109.34 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' ALA . 13.8 tptm -63.5 -51.18 66.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 108.892 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 24.0 p -60.35 -45.59 92.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 109.341 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.96 -34.63 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.252 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.427 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.4 OUTLIER -90.15 -8.05 52.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -108.62 -16.91 14.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 109.733 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 7.7 p30 -23.98 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.234 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.512 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -169.09 -82.34 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.33 26.85 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.958 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 tpt -147.94 36.37 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 73' ' ' ARG . 12.3 m -79.14 58.03 2.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.34 -18.74 0.44 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.84 . . . . 0.0 110.667 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -47.79 111.13 1.58 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 109.476 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.26 125.89 19.31 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 121.422 1.414 . . . . 0.0 113.442 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 t -121.26 116.93 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -97.53 107.42 19.92 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.708 -1.597 . . . . 0.0 106.926 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' C ' ' A' ' 85' ' ' MET . 5.0 ppp? -75.24 131.87 40.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.45 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.92 142.23 25.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.362 0.601 . . . . 0.0 110.834 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.0 t -150.12 176.53 10.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 109.345 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.49 -5.92 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 109.232 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.8 pm0 -139.47 57.6 1.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.337 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -47.14 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' GLU . 12.1 tptt -77.93 48.15 0.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.871 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.6 mttp 52.44 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.0 tt0 -45.11 -40.51 7.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.424 -0.797 . . . . 0.0 110.028 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.608 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 3.0 m-20 -57.44 -41.23 80.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 109.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 95.2 mt -59.78 -51.44 72.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.063 -1.023 . . . . 0.0 108.446 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 3.4 mm -66.23 -26.36 37.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.523 -0.736 . . . . 0.0 109.313 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.71 39.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.089 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -79.42 -50.88 10.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.845 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.89 -30.08 61.01 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.088 -1.045 . . . . 0.0 108.998 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.452 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.6 tt0 -58.64 -34.16 70.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -77.88 -22.62 49.49 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 60.17 79.31 0.12 Allowed Glycine 0 N--CA 1.478 1.495 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.532 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.37 -111.95 0.06 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 116.932 -1.907 . . . . 0.0 109.288 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.8 t -91.94 -49.73 6.08 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.753 1.263 . . . . 0.0 108.278 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.47 -165.7 37.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.27 125.63 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.947 . . . . 0.0 109.484 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 11.8 p -126.59 122.66 61.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -58.18 -167.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.8 pttm -164.71 155.25 12.68 Favored Pre-proline 0 C--N 1.297 -1.711 0 O-C-N 120.649 -1.282 . . . . 0.0 109.312 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.6 161.05 94.95 Favored 'Cis proline' 0 N--CA 1.485 0.991 0 C-N-CA 124.888 -0.88 . . . . 0.0 110.432 -2.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -127.92 166.23 18.7 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.704 0.764 . . . . 0.0 109.791 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.562 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -95.24 146.34 24.41 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.39 0.73 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.998 -1.063 . . . . 0.0 109.596 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.75 72.92 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.008 -1.057 . . . . 0.0 108.521 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.562 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.86 -64.67 0.82 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.1 tp -49.67 -39.27 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.758 -1.214 . . . . 0.0 109.381 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 120' ' ' LEU . 30.4 tt0 -64.78 -64.47 0.86 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.063 -1.023 . . . . 0.0 109.749 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -44.97 -36.6 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -75.73 -29.53 58.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.941 . . . . 0.0 109.155 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 117' ' ' GLU . 6.3 tp -66.61 -56.98 8.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -52.9 -41.66 64.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -67.9 -27.45 66.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.666 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.32 -45.29 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 13.7 m-85 -65.62 -27.64 68.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -51.35 -29.57 15.73 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 108.274 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -88.14 -21.11 24.81 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 1.3 tt -80.2 -24.62 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.803 . . . . 0.0 108.861 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.34 -41.73 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.271 -1.135 . . . . 0.0 109.521 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.35 0.595 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.495 ' O ' ' CE2' ' A' ' 30' ' ' PHE . 1.2 t0 -55.63 146.67 20.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -90.07 27.46 1.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.667 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -158.2 37.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 tp -72.45 137.7 46.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 2.3 mtmp? -76.89 136.62 38.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.039 -1.038 . . . . 0.0 111.531 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.8 m-85 -127.87 145.44 50.94 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.817 -0.552 . . . . 0.0 110.371 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.409 ' HB2' ' CD2' ' A' ' 51' ' ' TYR . 64.4 tp -118.4 118.35 31.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.31 104.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.2 t -98.79 116.57 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.501 -0.75 . . . . 0.0 109.383 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.77 178.42 8.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.723 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -118.99 13.63 13.07 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -161.82 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.262 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -138.82 -0.7 1.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 109.101 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.65 3.12 0.84 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.805 . . . . 0.0 109.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.6 ttt -74.72 -45.39 44.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.509 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.763 ' H ' ' HE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.98 -27.11 61.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.6 ' N ' HH21 ' A' ' 18' ' ' ARG . 10.0 mmt180 -73.25 -31.23 63.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mt -64.88 -54.16 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.68 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 109.945 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 35' ' ' GLU . 8.5 mtt85 -46.71 -54.98 8.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.9 t30 -66.24 -58.47 5.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.438 -0.789 . . . . 0.0 109.432 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.26 -65.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.016 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.69 -45.92 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.163 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -38.28 78.92 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.211 -0.93 . . . . 0.0 109.397 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.61 -41.72 63.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -61.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 109.136 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.33 42.89 0.02 OUTLIER Glycine 0 N--CA 1.479 1.548 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 94.9 m-85 -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.448 -1.031 . . . . 0.0 109.052 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -149.99 67.41 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.884 -1.135 . . . . 0.0 110.4 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.68 97.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.132 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.14 152.29 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.99 -1.069 . . . . 0.0 110.13 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -124.44 -167.3 1.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' OE2' ' NH1' ' A' ' 22' ' ' ARG . 17.9 mt-10 -147.62 146.49 29.37 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 110.153 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.11 -165.13 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -144.98 -0.74 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.909 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 25.8 t0 -171.57 178.8 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.744 -1.222 . . . . 0.0 109.891 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . -67.22 -52.04 34.44 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -55.33 -27.66 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -1.097 . . . . 0.0 108.615 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -79.86 -42.73 23.65 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.315 -0.866 . . . . 0.0 108.911 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.26 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.338 -0.851 . . . . 0.0 109.644 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.76 -37.42 73.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.545 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -82.95 -26.72 31.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.029 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -85.24 -14.36 46.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.393 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.88 -19.4 57.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.662 -1.274 . . . . 0.0 109.405 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -68.08 -5.68 18.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 108.879 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.51 -70.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.809 . . . . 0.0 109.779 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.23 13.11 1.08 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.01 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 20.4 m-85 -70.82 140.71 51.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.377 -1.073 . . . . 0.0 110.09 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.84 -6.27 62.2 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.504 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -156.54 142.95 18.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.762 -0.846 . . . . 0.0 108.756 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.93 118.32 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.671 -1.268 . . . . 0.0 110.006 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 55' ' ' ILE . 61.1 mt -100.89 153.52 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.9 p -170.86 166.0 7.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.032 -1.042 . . . . 0.0 109.189 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CD1' ' OD1' ' A' ' 59' ' ' ASN . 61.8 t-105 -167.12 -57.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.05 -1.031 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.575 ' C ' HD21 ' A' ' 59' ' ' ASN . 0.2 OUTLIER -172.54 72.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 110.434 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -91.49 -47.69 0.34 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 110.511 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.94 -160.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 C-N-CA 121.129 1.219 . . . . 0.0 110.216 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.725 HD21 ' H ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -76.67 -40.6 48.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.658 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -79.95 143.98 33.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.33 146.16 27.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.85 -15.35 60.0 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -73.91 -72.74 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.163 -1.198 . . . . 0.0 109.951 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 69.5 tt0 -45.86 -26.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -69.11 -46.89 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 7.8 tt -74.67 -62.65 1.46 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.389 0.614 . . . . 0.0 109.397 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -43.39 -31.64 0.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 2.9 m -63.56 -41.84 98.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 47.9 mt -57.91 -40.04 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -68.37 -3.16 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.26 69.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -73.14 139.92 46.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.31 80.34 0.95 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -170.9 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -1.182 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.96 10.73 30.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.403 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m 52.49 -117.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.987 . . . . 0.0 109.18 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -125.91 0.92 7.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER 52.77 171.14 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.44 136.13 57.43 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 121.489 1.46 . . . . 0.0 112.874 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.94 139.85 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.82 68.28 0.76 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -61.57 131.57 50.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.89 135.74 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.192 -0.942 . . . . 0.0 110.813 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -150.07 156.11 41.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.567 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -85.53 156.8 20.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 6.3 tm-20 59.69 -75.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . 79.4 97.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -0.761 . . . . 0.0 109.205 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.6 mmmt -58.33 -107.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -163.47 -69.16 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -52.56 -16.46 0.93 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.902 . . . . 0.0 109.372 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -78.64 -29.41 45.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.7 -15.7 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.664 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 mt -82.22 -64.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.785 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.26 -47.85 18.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 0.0 109.376 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.71 68.59 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.47 -0.769 . . . . 0.0 109.758 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -52.21 -48.65 64.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -47.99 -22.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 108.791 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -94.35 -116.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.659 -0.65 . . . . 0.0 109.531 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.755 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -127.58 -3.67 5.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -59.34 10.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.671 -0.899 . . . . 0.0 109.375 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.755 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.45 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.26 130.98 10.41 Favored Glycine 0 N--CA 1.497 2.722 0 C-N-CA 119.492 -1.337 . . . . 0.0 109.899 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.89 109.24 5.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -1.053 . . . . 0.0 109.351 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.54 139.82 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.2 t -81.82 119.18 30.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.34 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -88.4 151.62 48.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.892 -1.13 . . . . 0.0 109.624 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.82 162.24 92.57 Favored 'Cis proline' 0 N--CA 1.487 1.121 0 C-N-CA 125.226 -0.739 . . . . 0.0 110.512 -1.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -139.23 159.13 42.88 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 109.993 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.59 151.5 21.53 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.45 -17.33 0.15 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 108.835 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.85 -43.6 58.15 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -67.25 -63.84 0.98 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.3 tp -46.88 -36.11 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.432 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -63.62 -64.3 0.93 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.99 -1.069 . . . . 0.0 109.772 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -52.99 7.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -46.53 -46.51 19.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.92 -54.97 40.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -21.07 48.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -38.73 49.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.15 . . . . 0.0 109.624 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -90.1 -36.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.353 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -73.29 -41.03 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -51.15 -18.83 0.96 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.843 -1.16 . . . . 0.0 108.046 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -98.44 -23.72 15.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' PHE . 0.5 OUTLIER -82.33 -21.93 35.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 55.05 81.01 0.07 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 109.368 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.264 0.554 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 62.2 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.362 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -90.05 19.2 5.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -137.42 41.21 2.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 tp -75.0 127.73 33.92 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 122.74 24.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 111.712 -177.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 44.6 m-85 -109.98 152.87 25.34 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.1 tp -117.36 109.45 16.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.64 121.05 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 109.86 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.45 27.08 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -51.73 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.915 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -53.4 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.622 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.94 140.41 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.626 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -88.24 13.78 10.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.356 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -136.11 -18.56 1.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.711 . . . . 0.0 109.299 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 ttt -68.97 -17.68 63.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.244 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -34.91 78.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.872 . . . . 0.0 109.36 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -24.39 62.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 108.914 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -69.91 -52.35 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -30.7 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.747 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.2 -54.29 17.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.95 . . . . 0.0 109.408 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.3 t-20 -67.41 -57.29 6.84 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.804 0.811 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.21 -43.51 1.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.695 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.07 -38.97 75.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.778 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -63.96 -38.26 90.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.29 -0.881 . . . . 0.0 109.157 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -51.0 -35.09 32.01 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.351 -0.843 . . . . 0.0 109.036 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.56 -50.9 11.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.336 -0.852 . . . . 0.0 109.133 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.83 35.71 0.06 OUTLIER Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.39 147.39 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.391 -1.064 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -150.17 57.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.05 -1.031 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.88 110.2 0.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.766 -1.209 . . . . 0.0 110.181 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.2 -177.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 0.0 109.673 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.3 mm-40 -128.11 -171.89 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.77 145.77 30.95 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.125 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.09 -174.2 4.65 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.25 23.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.741 -1.224 . . . . 0.0 110.363 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 179.53 147.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.865 -1.147 . . . . 0.0 109.336 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.59 -39.89 23.77 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.32 -32.05 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -1.069 . . . . 0.0 108.793 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 38' ' ' ASP . 21.2 t0 -76.98 -45.69 26.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.42 -32.55 74.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.555 -0.716 . . . . 0.0 109.394 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -68.22 -65.72 0.66 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -46.51 -27.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 3.9 mttm -90.0 -39.08 13.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.2 -37.6 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.04 . . . . 0.0 108.885 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 7.3 mt-30 -54.94 -24.36 23.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -44.23 -61.3 1.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.164 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.0 75.39 1.22 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -173.18 -31.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 53' ' ' PHE . 15.2 m-85 -61.35 86.27 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.269 -1.136 . . . . 0.0 110.015 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -66.92 6.08 2.22 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.6 t80 -158.08 146.2 18.69 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 121.565 -0.962 . . . . 0.0 109.099 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.6 t -144.01 127.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.617 -1.302 . . . . 0.0 110.687 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.77 103.19 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 23.4 p -109.32 -178.91 3.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 0.0 110.46 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 32.3 t70 -89.44 -131.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.842 . . . . 0.0 110.292 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.502 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 46.7 t-105 -162.7 -55.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.96 . . . . 0.0 110.092 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.531 ' O ' ' SD ' ' A' ' 60' ' ' MET . 24.0 t-20 -142.54 103.36 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.75 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.555 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.81 -46.22 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -69.36 -162.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.05 1.166 . . . . 0.0 109.979 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -54.07 130.38 37.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.106 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.425 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 36.7 mmm 51.17 -116.16 0.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -142.59 151.01 41.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 108.932 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.35 12.61 1.77 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 64' ' ' ASP . 1.2 tp -67.8 -57.2 6.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -1.185 . . . . 0.0 108.97 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -19.81 64.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.459 -0.776 . . . . 0.0 109.115 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -59.3 4.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' ILE . 1.5 tt -70.95 -59.46 2.78 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.8 tttt -38.38 -37.71 0.31 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -63.3 -44.17 95.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 108.794 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 56.0 mt -55.33 -38.0 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.97 -5.95 58.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.49 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -84.82 -26.74 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 109.625 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -46.07 -15.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 67.31 -0.65 8.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 75' ' ' ASP . . . -146.91 26.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -1.121 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 mmt -139.79 20.61 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 109.339 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.2 p -85.61 49.23 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.52 6.02 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 109.843 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.2 tp -92.98 119.59 67.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 108.636 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.91 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 120.774 0.982 . . . . 0.0 111.926 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.576 ' N ' ' OG ' ' A' ' 104' ' ' SER . 8.7 t -98.8 110.4 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.363 -0.836 . . . . 0.0 108.759 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.29 101.6 13.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 1.1 tpt -75.5 152.14 37.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.72 147.3 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.632 -0.668 . . . . 0.0 110.151 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.474 ' CG2' ' N ' ' A' ' 88' ' ' ALA . 30.9 m -143.77 163.18 34.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.969 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' N ' ' CG2' ' A' ' 87' ' ' THR . . . -105.09 -62.43 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -96.57 87.19 4.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.094 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -81.79 161.09 23.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.917 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.692 ' H ' HD21 ' A' ' 94' ' ' ASN . 14.4 tttt -147.39 154.23 40.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.169 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -48.39 61.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.12 -52.81 8.65 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.131 -0.981 . . . . 0.0 110.632 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -58.44 -10.21 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.113 -0.992 . . . . 0.0 110.561 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 95' ' ' ILE . 9.9 mt -86.35 -7.29 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.827 -1.171 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.5 mp -90.07 -46.59 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -46.01 -22.7 0.23 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.42 -52.57 45.02 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -49.22 -41.82 38.5 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.722 -1.861 . . . . 0.0 107.96 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.92 -31.27 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.71 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -134.82 -71.2 0.49 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -49.98 82.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 176.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -68.46 -110.13 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 112.586 -1.807 . . . . 0.0 115.08 -174.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -37.44 -57.22 0.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.723 -176.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.67 171.16 33.65 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.852 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.46 113.48 11.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 13.1 p -109.25 115.25 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.04 102.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 159.39 77.29 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.049 -1.032 . . . . 0.0 109.123 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.9 154.21 99.51 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.357 -2.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -129.57 160.83 32.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.859 0.838 . . . . 0.0 110.138 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -97.97 148.49 23.42 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.13 -35.48 7.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 109.327 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 -35.38 80.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.0 m -70.43 -67.8 0.47 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 115' ' ' THR . 10.6 tp -47.28 -39.62 14.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.656 -1.278 . . . . 0.0 109.344 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -62.7 -53.48 53.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.078 -1.014 . . . . 0.0 109.5 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.0 mm-40 -47.4 -28.32 2.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.286 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -79.55 -49.83 11.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.445 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -48.26 73.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.307 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.13 -47.36 86.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 109.956 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.8 mt -82.82 -35.86 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.888 . . . . 0.0 109.116 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -85.92 -2.15 57.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.46 -27.04 55.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -93.65 -31.09 14.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.59 -27.97 62.5 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.11 87.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.384 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -53.28 144.2 16.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.197 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 14.3 mttm -90.15 18.84 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 0.0 109.366 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -159.63 48.96 0.3 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 40.2 tp -77.51 113.02 14.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.999 -1.063 . . . . 0.0 108.433 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -53.78 106.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.938 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.498 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 69.0 m-85 -101.09 153.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -137.58 117.63 13.41 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 m -106.01 119.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.658 -0.651 . . . . 0.0 110.906 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.56 112.49 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 121.384 -0.823 . . . . 0.0 109.462 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.464 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -157.96 139.64 13.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -80.2 -12.17 59.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.439 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.52 141.66 58.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 t -92.65 41.18 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -172.06 -40.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 14.1 ttm -46.94 -15.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' THR . 2.9 mtt180 -86.15 -44.34 12.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 109.684 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -65.64 -13.44 59.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.458 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.15 -49.48 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -36.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' ' OE2' ' A' ' 35' ' ' GLU . 8.0 mtt180 -50.81 -52.87 36.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 109.267 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.23 -57.06 7.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.977 0.894 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.28 -48.88 3.67 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.836 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.56 -51.05 62.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.835 -1.166 . . . . 0.0 108.518 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.28 -32.99 5.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -48.59 -38.95 22.1 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.008 . . . . 0.0 109.1 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.416 ' CD1' ' OE2' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -76.57 -68.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.384 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.09 20.95 0.02 OUTLIER Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.461 ' C ' HD21 ' A' ' 31' ' ' ASN . 29.1 m-85 -97.15 139.22 33.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.862 -1.375 . . . . 0.0 109.75 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.634 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.84 67.21 1.28 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.124 -0.985 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -174.82 91.56 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.199 -0.938 . . . . 0.0 108.82 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.94 154.84 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.214 -0.929 . . . . 0.0 110.818 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' OE2' ' CE1' ' A' ' 51' ' ' TYR . 13.5 pt-20 -125.89 -171.02 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 13.3 mp0 -144.56 161.46 39.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.83 . . . . 0.0 110.045 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.45 -170.45 3.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.488 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 68.1 mt-10 -134.32 0.71 3.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.532 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 175.7 -175.22 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.785 -1.197 . . . . 0.0 109.314 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.97 -54.07 33.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.6 m -57.3 -36.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -1.131 . . . . 0.0 108.799 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 12.2 t0 -63.48 -45.09 92.35 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.97 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.778 . . . . 0.0 109.035 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.17 -28.52 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.305 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -79.42 -50.35 10.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.908 -1.12 . . . . 0.0 110.818 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' OE2' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -89.79 -3.79 57.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.086 -1.009 . . . . 0.0 110.605 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 48' ' ' ALA . 4.4 tt -90.11 -41.21 11.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.074 -1.016 . . . . 0.0 109.624 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.43 0.79 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.31 -60.57 1.86 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.572 -0.705 . . . . 0.0 109.843 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.35 11.1 1.0 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.115 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.46 97.91 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 15.9 m-85 -79.22 124.23 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.204 -1.174 . . . . 0.0 110.405 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.83 -3.86 56.66 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -167.77 142.71 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.428 . . . . 0.0 109.369 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.78 158.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.278 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 mt -143.31 127.59 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.7 p -147.61 157.45 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.892 -1.13 . . . . 0.0 110.175 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 8.8 t0 -65.78 -137.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.528 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 60.6 t-105 -173.37 111.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.468 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 66.97 27.43 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.602 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.1 tpt -101.8 -41.99 0.21 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 111.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.2 Cg_exo -65.57 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.158 1.239 . . . . 0.0 110.518 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -74.17 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.064 -1.023 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.3 mtm -74.09 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 66' ' ' LEU . 61.9 t0 -172.38 140.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.063 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -70.98 15.69 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 64' ' ' ASP . 13.7 tp -81.09 -56.76 3.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.08 -1.247 . . . . 0.0 107.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -60.28 -22.25 62.9 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' O ' ' OG1' ' A' ' 71' ' ' THR . 22.5 tp -64.32 -59.06 4.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -48.06 -63.18 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.752 0.787 . . . . 0.0 108.953 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.2 tttm -40.29 -44.08 1.84 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 110.272 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -58.68 -39.13 79.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.915 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 69' ' ' LEU . 37.7 mt -58.98 -41.68 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.156 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -50.06 -30.07 10.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 109.559 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -45.98 -24.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 74' ' ' ALA . 12.2 t70 -44.1 -91.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -164.77 -142.88 3.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.25 -0.1 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.686 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.93 7.38 37.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.437 ' HG ' ' H ' ' A' ' 80' ' ' ALA . 11.3 t 47.29 -132.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.241 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -113.57 12.13 18.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.724 -0.61 . . . . 0.0 109.589 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 52.5 173.85 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.224 -0.922 . . . . 0.0 108.722 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.33 144.02 99.54 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.326 1.351 . . . . 0.0 113.452 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.54 135.86 43.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.3 tp -114.76 69.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.1 ptm -56.66 156.07 6.8 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.557 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.08 138.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.852 -0.53 . . . . 0.0 109.588 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -146.63 179.88 7.25 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.466 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -130.69 -26.32 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.835 -0.54 . . . . 0.0 109.608 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -117.4 61.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 109.756 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.02 108.98 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -78.59 -79.65 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.794 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -174.48 -89.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.014 . . . . 0.0 109.548 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.64 45.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -54.64 -26.15 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.332 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.4 mt -85.12 -17.47 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 0.0 109.264 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' ALA . 72.5 mt -82.94 -62.92 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -45.82 -54.21 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.56 -52.38 17.84 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.42 -0.8 . . . . 0.0 109.418 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.54 69.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.584 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -59.01 -17.18 22.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.044 -1.035 . . . . 0.0 109.968 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.85 -34.99 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.336 -0.852 . . . . 0.0 109.88 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.738 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.06 -13.07 0.73 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -58.5 10.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.769 -0.842 . . . . 0.0 109.885 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.738 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.46 -35.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.113 -177.368 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.39 127.05 9.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.554 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -139.62 113.4 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -1.032 . . . . 0.0 108.567 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 108' ' ' VAL . 14.1 p -116.01 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.656 ' CG1' ' H ' ' A' ' 109' ' ' LYS . 33.1 t -61.27 -164.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.656 ' H ' ' CG1' ' A' ' 108' ' ' VAL . 9.9 pttm -164.88 156.09 13.03 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.464 -1.398 . . . . 0.0 108.737 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.96 166.69 81.64 Favored 'Cis proline' 0 N--CA 1.486 1.034 0 C-N-CA 125.158 -0.768 . . . . 0.0 110.857 -1.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.03 161.98 37.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.604 ' HG1' ' N ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -102.28 171.28 7.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 176.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.604 ' N ' ' HG1' ' A' ' 112' ' ' THR . . . -61.41 -25.52 67.25 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.555 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.56 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.416 -0.802 . . . . 0.0 109.138 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -64.55 0.83 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -47.76 -36.44 11.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.811 -1.18 . . . . 0.0 109.779 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 2.9 mm-40 -59.2 -66.69 0.47 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.816 -1.178 . . . . 0.0 109.939 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -45.62 -25.71 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.637 -0.665 . . . . 0.0 110.532 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -86.34 -44.54 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 110.246 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -43.13 91.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.437 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -64.81 -40.83 95.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -56.57 -31.73 64.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.257 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.508 ' C ' ' H ' ' A' ' 125' ' ' GLU . 67.8 mt -85.69 -45.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -70.46 10.12 0.52 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.235 -0.915 . . . . 0.0 109.368 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.5 tt0 -83.29 -24.68 32.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -96.21 -30.85 13.25 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.3 -26.07 61.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.88 88.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.445 ' SD ' ' OXT' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER 52.88 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.395 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -73.15 32.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.952 . . . . 0.0 109.137 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 3' ' ' ASP . 82.0 mt-10 -155.25 33.32 0.38 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 108.993 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.2 tp -70.12 132.9 46.53 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -76.09 117.55 17.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -106.12 152.44 23.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.2 tp -126.78 111.06 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.77 116.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.782 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.86 110.74 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.912 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -177.2 124.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.985 -1.072 . . . . 0.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.14 7.47 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.717 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -172.16 -154.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.439 -1.413 . . . . 0.0 112.258 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.717 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 177.91 16.43 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.439 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -171.92 -48.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.927 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 22.0 ttt -38.85 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.665 -0.647 . . . . 0.0 110.853 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 51.1 mtm180 -43.37 -30.24 0.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.45 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -30.27 39.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.642 -1.287 . . . . 0.0 109.445 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.8 mt -69.66 -49.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.93 -35.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -46.95 -54.1 10.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 109.039 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t30 -61.23 -56.76 17.0 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.845 0.831 . . . . 0.0 108.787 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -36.89 -67.61 0.17 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.897 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.29 -42.79 74.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.925 -1.109 . . . . 0.0 108.997 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -59.16 -28.4 66.56 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -46.61 68.92 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.138 -0.976 . . . . 0.0 109.213 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.0 -62.95 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -0.883 . . . . 0.0 109.077 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.09 18.7 0.02 OUTLIER Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.198 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.97 123.72 34.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.488 -1.595 . . . . 0.0 109.156 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.18 69.27 1.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.73 96.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.094 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.07 149.79 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.004 -1.06 . . . . 0.0 109.916 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 3.6 mt-10 -118.95 -172.18 2.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.8 mp0 -147.11 165.69 29.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 110.396 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.98 -170.46 3.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -130.25 0.27 4.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.475 -0.766 . . . . 0.0 110.326 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.18 176.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.034 . . . . 0.0 109.601 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.32 -47.31 91.72 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -52.85 -35.07 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.088 -1.242 . . . . 0.0 108.42 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.06 -52.87 11.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.501 -0.749 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.03 -57.44 12.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.304 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.28 -46.49 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.0 109.777 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -72.52 -31.6 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 0.0 110.134 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -90.08 -7.06 54.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.973 . . . . 0.0 110.238 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -70.53 -6.44 36.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 0.0 108.77 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.51 -2.16 57.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.987 -1.07 . . . . 0.0 109.234 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.76 -67.82 0.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.822 . . . . 0.0 109.456 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.48 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.58 72.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.527 ' C ' ' H ' ' A' ' 53' ' ' PHE . 76.7 m-85 -54.9 95.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.94 -6.13 1.68 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.527 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -153.42 139.24 18.03 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.49 -1.006 . . . . 0.0 109.587 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -134.0 118.81 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.004 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 mt -99.51 114.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.6 p -132.24 166.21 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.806 . . . . 0.0 109.326 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 12.4 p-10 -90.01 -118.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.117 -0.99 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.526 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 43.2 t-105 -162.36 -18.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.331 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.38 96.21 5.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.312 0.577 . . . . 0.0 109.774 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 159.69 70.75 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.73 -41.82 73.65 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.144 1.23 . . . . 0.0 110.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -96.51 -107.74 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 0.0 109.192 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.59 ' SD ' ' N ' ' A' ' 63' ' ' MET . 2.8 mpp? -69.56 -161.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.5 176.38 6.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.064 -1.022 . . . . 0.0 109.29 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.93 59.25 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.571 -1.3 . . . . 0.0 109.874 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.8 tp -86.24 -40.68 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.808 -1.407 . . . . 0.0 107.58 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 15.8 mt-10 -66.74 -18.03 65.17 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.48 -66.48 0.85 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.73 -40.03 74.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -47.53 86.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.288 -0.882 . . . . 0.0 109.023 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 52.9 m -51.23 -47.38 62.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.61 -46.09 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 108.795 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -62.09 -29.0 70.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.6 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.27 -29.13 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.73 99.69 0.83 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.452 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.71 76.58 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.26 -60.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 0.0 109.405 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.1 mmt -92.91 -71.03 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t 45.46 26.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.374 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.81 -12.59 4.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.654 -0.654 . . . . 0.0 109.487 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.2 tp -48.25 113.37 2.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.112 -0.993 . . . . 0.0 108.729 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.5 121.59 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.2 1.267 . . . . 0.0 112.751 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.52 115.52 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' MET . 5.5 tp -101.61 73.88 1.48 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.896 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' LEU . 6.0 mtt -48.15 172.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -147.15 120.18 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.413 -0.805 . . . . 0.0 109.344 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -150.04 -178.47 6.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.743 -1.223 . . . . 0.0 110.042 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.31 -41.64 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.51 56.42 2.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 109.375 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.26 111.51 6.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.708 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.203 -0.936 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -136.36 -70.21 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -45.97 -16.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.809 . . . . 0.0 109.553 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -90.13 -57.31 2.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 109.608 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.2 mt -47.44 -28.42 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.377 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.95 -60.04 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.313 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.69 -52.8 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 108.971 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.64 -48.45 58.21 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.495 -0.753 . . . . 0.0 108.992 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.75 -45.92 49.92 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.651 HE21 ' N ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -50.23 -29.18 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 108.864 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -112.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.47 -0.769 . . . . 0.0 109.191 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.712 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -131.64 0.14 4.98 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.6 11.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.143 -0.622 . . . . 0.0 110.621 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.712 ' H ' ' C ' ' A' ' 102' ' ' GLY . 21.8 m -29.44 -32.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 122.265 -0.272 . . . . 0.0 111.723 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.81 135.48 12.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -152.06 110.23 3.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 108.822 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.5 p -104.44 139.75 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.07 105.19 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.531 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.21 160.12 83.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.903 -1.123 . . . . 0.0 109.059 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.08 166.33 83.54 Favored 'Cis proline' 0 N--CA 1.484 0.944 0 C-N-CA 124.747 -0.939 . . . . 0.0 110.577 -2.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -142.4 -170.98 3.3 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.978 0.894 . . . . 0.0 109.554 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -135.22 150.18 50.04 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.45 -33.65 6.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.418 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.83 -30.96 61.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -79.32 -61.3 2.05 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -49.99 -32.45 15.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.45 -1.406 . . . . 0.0 108.388 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.19 -56.99 10.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.066 -1.021 . . . . 0.0 109.942 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -44.16 -36.41 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.668 -0.645 . . . . 0.0 109.459 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -43.52 81.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.293 -0.879 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.56 -63.07 1.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 109.481 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -44.73 -49.48 10.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.339 -0.851 . . . . 0.0 110.598 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.13 -29.61 63.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.288 -0.883 . . . . 0.0 110.726 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.98 -44.63 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.156 . . . . 0.0 110.785 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -59.14 -9.95 2.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.014 -1.054 . . . . 0.0 110.571 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -20.9 63.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -95.49 -31.88 13.14 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -22.37 43.52 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.87 88.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.256 -1.143 . . . . 0.0 109.459 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.641 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -46.27 109.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.0 109.637 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 2.0 mmtp -56.36 7.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.157 -0.964 . . . . 0.0 110.635 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.641 ' H ' ' C ' ' A' ' 3' ' ' ASP . 73.3 mt-10 -141.92 45.34 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.058 -1.026 . . . . 0.0 108.738 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 45.0 tp -76.64 107.97 9.31 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 118.215 -1.394 . . . . 0.0 108.715 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -48.95 113.83 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 68.8 m-85 -104.94 155.46 18.92 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -130.97 103.4 6.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 107.78 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 0.0 109.802 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 50.3 t -107.87 106.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 -163.51 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.393 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.02 4.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.05 165.28 14.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -97.69 9.7 41.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -149.74 10.22 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 0.0 109.642 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.1 ttt -92.13 -47.14 7.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -28.81 69.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.415 ' CG ' HH21 ' A' ' 22' ' ' ARG . 31.6 ttp85 -68.49 -52.77 28.66 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.778 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt -46.24 -55.05 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.365 -0.835 . . . . 0.0 109.689 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -43.27 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.616 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.415 HH21 ' CG ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -46.88 -55.01 8.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.038 -1.039 . . . . 0.0 109.755 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.33 -55.13 19.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.111 0.958 . . . . 0.0 109.039 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -39.73 -55.25 1.96 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.893 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.6 mt -59.94 -49.89 75.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.79 -34.11 38.37 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.909 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 2.8 tt0 -58.24 -30.17 66.31 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -87.08 -14.48 41.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.775 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.22 46.05 1.77 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.228 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -117.28 129.36 55.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.308 -1.113 . . . . 0.0 108.9 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -128.68 67.99 1.39 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.95 94.91 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -0.957 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.05 149.19 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 110.843 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.78 -169.06 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -150.0 154.52 38.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.021 -1.05 . . . . 0.0 110.69 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.11 -172.4 3.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -139.09 15.47 2.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.169 -0.957 . . . . 0.0 110.619 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 175.24 146.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.713 -1.242 . . . . 0.0 109.868 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.17 -32.98 10.05 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.04 -35.72 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.337 -1.096 . . . . 0.0 108.657 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 38' ' ' ASP . 26.5 t0 -70.87 -44.94 65.34 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -63.25 -54.13 42.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.73 -43.15 17.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.922 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -73.94 -33.27 63.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -90.02 -7.68 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 110.006 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -68.07 -13.6 62.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -85.82 -2.83 58.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.45 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.464 -0.772 . . . . 0.0 109.722 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.61 9.97 1.43 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.84 83.75 1.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.485 ' C ' ' N ' ' A' ' 53' ' ' PHE . 57.2 m-85 -62.69 99.89 0.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.29 -1.123 . . . . 0.0 109.693 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.96 -14.28 0.41 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -148.99 119.23 7.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.48 -1.012 . . . . 0.0 109.884 -179.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.65 124.05 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.238 -0.913 . . . . 0.0 109.524 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.1 mt -107.45 126.16 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -143.44 145.15 32.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -0.782 . . . . 0.0 108.987 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -98.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.081 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -172.57 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.145 -0.972 . . . . 0.0 109.726 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.649 HD21 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -134.84 -1.39 2.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.333 -0.854 . . . . 0.0 109.761 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.649 ' N ' HD21 ' A' ' 59' ' ' ASN . 2.2 mtp -60.16 -47.33 97.08 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 110.67 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.22 -66.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.118 1.212 . . . . 0.0 110.598 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -130.22 -152.43 0.51 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.596 -0.69 . . . . 0.0 109.634 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mtt -51.53 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.699 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 2.3 p30 -142.68 138.45 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.373 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.29 -2.8 21.55 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.42 -45.83 62.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.829 -1.395 . . . . 0.0 108.163 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -39.16 71.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 66.5 tp -53.78 -29.1 38.72 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -88.07 -64.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 109.333 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 69' ' ' LEU . 6.7 ttpp -34.88 -52.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.105 0.478 . . . . 0.0 110.381 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -45.53 41.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 108.766 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 69' ' ' LEU . 53.4 mt -59.37 -30.43 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 108.846 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' LYS . 4.3 ttp85 -83.47 -23.01 32.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.756 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -46.53 -28.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.563 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 18.0 t0 -61.37 -150.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.504 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -161.54 33.92 0.37 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.06 6.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -1.195 . . . . 0.0 109.404 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.9 ptm -150.03 52.94 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.349 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.7 t -92.76 -5.58 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.647 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.92 53.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.44 111.35 1.96 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.897 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.13 144.1 95.45 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 121.009 1.139 . . . . 0.0 112.584 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.26 137.88 37.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -115.13 75.13 0.92 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.4 mtt -65.42 122.69 17.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.19 140.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 110.774 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 109' ' ' LYS . 2.4 t -150.09 161.11 43.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.36 25.36 10.77 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' ALA . 48.8 tt0 -142.8 -64.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.475 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 48.77 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 109.165 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.522 ' NZ ' ' OD1' ' A' ' 94' ' ' ASN . 22.0 mtmm -59.63 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.208 -0.932 . . . . 0.0 109.811 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -145.25 -101.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -49.99 -27.28 5.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.022 -1.049 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.522 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -52.16 -27.12 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -71.62 -27.83 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -74.29 -51.43 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.1 26.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.083 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.19 -52.88 63.52 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.496 -0.753 . . . . 0.0 109.552 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.0 65.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -48.67 -27.97 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.997 . . . . 0.0 108.821 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.45 -114.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.608 -0.682 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -123.82 -8.32 6.27 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.53 10.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.026 -0.691 . . . . 0.0 110.581 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.69 ' H ' ' C ' ' A' ' 102' ' ' GLY . 4.7 m -29.59 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.46 132.94 11.13 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.185 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.504 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -145.33 129.03 17.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -1.097 . . . . 0.0 109.222 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.467 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -134.77 124.99 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.16 103.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.733 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' THR . 2.9 pttp -71.47 157.84 89.14 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.34 166.97 81.26 Favored 'Cis proline' 0 N--CA 1.485 1.011 0 C-N-CA 125.01 -0.829 . . . . 0.0 110.683 -1.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.02 158.0 43.95 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.04 0.924 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.36 148.94 23.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -45.88 -23.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 109.377 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -70.23 -41.96 72.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.14 -65.28 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.4 tp -47.59 -36.32 10.52 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.553 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -65.21 -66.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.975 -1.078 . . . . 0.0 109.733 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -45.21 -30.09 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.995 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 11.0 mmmt -81.35 -50.28 9.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.032 -1.043 . . . . 0.0 110.01 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -31.06 70.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.725 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.23 -28.73 47.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -77.82 -22.91 49.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.77 -43.54 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.502 ' CD2' ' SD ' ' A' ' 129' ' ' MET . 17.8 m-30 -73.82 -0.62 16.43 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.912 -1.118 . . . . 0.0 109.45 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -69.34 -20.28 63.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.35 -29.11 12.23 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -80.71 -16.54 53.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.99 90.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 124' ' ' PHE . 4.4 mtt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.319 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.13 145.13 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.392 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.25 17.64 6.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.312 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -152.05 44.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.26 143.11 52.23 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -78.3 131.85 37.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.988 -1.07 . . . . 0.0 111.247 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -122.94 147.52 46.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.736 -0.603 . . . . 0.0 109.821 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.97 110.72 13.29 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -95.76 105.25 16.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 63.0 t -98.62 95.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.413 -0.805 . . . . 0.0 109.86 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -142.1 -159.22 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.231 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 1.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' THR . 8.9 m-85 -91.21 98.06 11.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.419 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.51 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -93.25 -34.49 13.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.48 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 3.9 ttt -56.06 -56.63 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.77 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -35.28 5.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.318 -0.863 . . . . 0.0 109.669 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 ttm-85 -72.97 -35.66 66.95 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.065 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.3 -54.0 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.382 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -32.85 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.767 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -50.74 -53.62 30.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -58.24 5.39 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.939 0.876 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.739 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.39 -41.89 62.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -27.78 69.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 27' ' ' GLU . 7.5 tp10 -59.85 -35.9 75.73 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.054 -1.029 . . . . 0.0 109.375 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -59.55 2.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.16 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.62 73.91 0.02 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -149.97 144.54 25.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.24 . . . . 0.0 110.021 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.04 63.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -173.44 100.89 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.74 -1.225 . . . . 0.0 108.881 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.14 152.36 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.007 -1.058 . . . . 0.0 110.509 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.6 -173.35 2.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 13.5 mp0 -145.28 155.05 42.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.95 -172.75 4.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.01 8.65 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.045 . . . . 0.0 110.555 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 11.9 t70 -179.32 167.7 1.5 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.333 -0.855 . . . . 0.0 109.194 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.454 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -63.48 -25.59 68.81 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 t -72.46 -40.69 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 108.52 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -69.7 -45.67 67.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.66 -39.21 88.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.47 -37.34 72.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.351 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -86.92 -34.88 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.96 -53.98 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 48' ' ' ALA . 4.9 tt -50.07 -27.35 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 47' ' ' GLN . 1.4 tm0? -69.63 8.21 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 108.959 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.66 -68.72 0.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.98 0.31 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.126 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.62 99.16 1.79 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -79.53 110.39 14.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.373 -1.075 . . . . 0.0 110.437 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.76 -14.75 4.06 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.52 145.96 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -1.209 . . . . 0.0 110.179 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.5 t -141.93 120.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.138 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.6 mt -103.14 78.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -85.48 149.99 25.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.936 -1.102 . . . . 0.0 110.448 -177.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 27.7 t70 -94.64 178.21 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.567 -0.708 . . . . 0.0 109.291 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.539 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 53.5 t-105 -114.71 46.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -65.25 -154.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -162.81 60.05 0.95 Allowed Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 120.749 -1.219 . . . . 0.0 111.981 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.68 -39.53 42.82 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 107.576 -1.74 . . . . 0.0 107.576 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.46 -22.75 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -150.77 -83.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 65' ' ' GLY . 4.9 p-10 169.94 -107.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.528 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . -137.96 18.2 3.37 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' LEU . 25.3 tp -79.75 -54.17 6.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.083 -1.245 . . . . 0.0 108.152 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.4 tp10 -50.36 -21.89 1.61 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.423 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.9 mt -72.7 -59.67 2.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -46.95 -61.02 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.7 tttm -40.84 -48.55 3.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -61.17 -48.59 80.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.6 mt -57.76 -24.0 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -89.68 -28.04 19.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.709 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.72 -33.32 55.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.525 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.1 102.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.206 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.9 50.12 2.95 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.07 -71.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.142 . . . . 0.0 109.555 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.36 25.57 6.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER -65.93 6.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -95.22 20.99 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.82 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -67.23 118.78 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 108.661 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.79 98.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 120.909 1.072 . . . . 0.0 112.592 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.9 t -106.1 106.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -90.12 107.27 19.03 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.133 -1.827 . . . . 0.0 107.407 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.427 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -63.88 150.52 44.71 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.05 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 53.7 t -132.39 140.76 46.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.051 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.4 t -149.96 157.68 43.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.36 -44.33 7.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.842 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -64.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.836 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.442 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . . . 57.24 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.5 -88.61 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.504 -0.748 . . . . 0.0 109.14 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -156.81 -68.25 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.95 -32.56 61.48 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.193 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.539 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 2.4 t-20 -76.64 -47.45 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.03 -45.27 52.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.026 -1.046 . . . . 0.0 108.892 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 100' ' ' GLN . 17.7 mt -66.25 -17.04 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 100' ' ' GLN . . . -62.68 -69.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 109.326 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 97' ' ' ALA . . . -47.43 -45.71 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 108.5 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -67.88 -27.35 66.59 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.326 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' ILE . 5.5 tp-100 -55.79 -31.76 62.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.86 -20.17 27.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.44 76.11 0.3 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.373 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.21 -112.09 0.08 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.844 -1.942 . . . . 0.0 110.454 178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -50.69 5.59 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.832 1.301 . . . . 0.0 108.047 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 169.85 -155.66 25.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' HH ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -142.66 127.49 18.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -1.023 . . . . 0.0 109.586 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.6 p -117.96 134.87 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -88.94 121.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.567 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -94.18 162.06 27.62 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.253 -0.904 . . . . 0.0 108.611 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.6 128.32 15.98 Favored 'Cis proline' 0 N--CA 1.485 1.014 0 C-N-CA 124.755 -0.936 . . . . 0.0 110.427 -2.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -99.48 158.27 15.85 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.93 0.871 . . . . 0.0 110.084 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.503 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.25 146.79 23.44 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 117' ' ' GLU . . . -45.56 -23.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.973 -1.08 . . . . 0.0 109.829 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.47 -38.29 65.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.035 -1.041 . . . . 0.0 108.49 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.84 -62.46 1.37 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 115' ' ' THR . 7.1 tp -47.67 -41.76 23.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.721 -1.191 . . . . 0.0 108.939 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 19.3 mt-10 -61.82 -52.26 64.9 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.053 -1.029 . . . . 0.0 109.499 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -46.4 -49.19 18.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.479 -0.763 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -38.61 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.87 -63.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.79 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -47.59 -53.06 15.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -62.62 -18.21 61.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.8 mt -89.64 -45.66 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.0 109.987 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 16.7 m-85 -66.63 -31.48 72.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.002 -1.061 . . . . 0.0 110.014 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -52.71 -26.63 14.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -87.35 -26.48 23.34 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 44.0 tp -70.44 -24.01 62.82 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.19 23.41 19.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.7 mmt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.337 -1.096 . . . . 0.0 109.465 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.578 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -177.13 150.84 0.77 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.21 -0.931 . . . . 0.0 109.009 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -90.47 17.78 6.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.861 -1.149 . . . . 0.0 110.499 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.94 43.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.512 -1.368 . . . . 0.0 111.232 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.2 tp -67.02 110.98 3.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.424 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.59 111.29 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.828 -1.17 . . . . 0.0 111.611 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 62.2 m-85 -105.77 155.14 19.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 tp -132.65 104.06 6.45 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.95 130.16 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.261 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.4 t -137.99 105.37 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.44 -0.788 . . . . 0.0 109.078 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -149.6 116.39 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.148 -0.97 . . . . 0.0 109.431 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.17 -16.85 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.225 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.5 m-85 -59.49 130.03 44.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 m -92.26 48.7 1.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 t -175.72 -14.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 ttt -72.37 -35.56 68.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -63.05 -32.38 73.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.85 -20.16 58.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 20' ' ' ILE . 2.0 mt -75.33 -47.2 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.334 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -32.99 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.215 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -46.03 -52.61 11.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -73.64 -59.58 2.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.601 0.715 . . . . 0.0 110.161 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -40.22 -55.41 2.16 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.916 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -58.23 -50.45 73.52 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -54.0 -34.5 60.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.87 -38.53 49.93 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.391 -0.818 . . . . 0.0 109.38 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -65.03 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.48 26.2 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 54.0 m-85 -100.52 141.47 33.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -1.147 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -150.04 59.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 110.183 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.23 96.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.72 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.6 -178.26 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 109.895 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.55 -175.62 4.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 11.1 mp0 -144.35 150.21 37.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.65 176.29 9.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.67 3.56 14.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.267 -0.896 . . . . 0.0 110.477 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.29 -176.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.262 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.04 -26.42 73.9 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.76 -43.13 93.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.076 -1.249 . . . . 0.0 108.132 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -75.68 -40.85 55.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.26 92.15 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.238 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mt -62.49 -49.3 75.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.294 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 10.2 m-80 -63.55 -29.13 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -24.16 21.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.622 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -23.06 61.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 0.0 109.625 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -76.72 -1.62 28.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.472 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.42 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.424 -0.797 . . . . 0.0 109.604 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.85 12.18 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.79 88.21 1.37 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' PHE . 58.4 m-85 -69.23 103.95 2.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.297 -1.119 . . . . 0.0 109.588 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.69 -9.19 0.45 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.63 131.28 10.66 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.188 -1.183 . . . . 0.0 109.986 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 94.5 t -125.18 114.61 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 109.551 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.46 77.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 p -100.33 128.74 46.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.473 -0.767 . . . . 0.0 110.541 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 59' ' ' ASN . 4.5 t70 -65.12 164.0 13.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.793 -1.192 . . . . 0.0 108.645 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -2.2 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 108.877 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.56 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.1 m120 46.88 -153.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.647 -1.283 . . . . 0.0 110.302 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 171.25 -44.95 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.284 -0.885 . . . . 0.0 110.739 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.08 125.21 14.23 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.678 0.918 . . . . 0.0 110.259 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.11 -148.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.17 115.73 1.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -85.72 -162.32 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.84 2.79 0.51 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.801 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 6.5 tp -82.26 -65.21 1.04 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.768 -1.431 . . . . 0.0 110.341 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -48.3 -19.96 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -67.98 -62.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.469 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 72' ' ' ILE . 83.2 mt -56.04 -67.66 0.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.562 0.696 . . . . 0.0 109.236 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 69' ' ' LEU . 25.2 tttp -30.46 -53.28 0.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.626 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 m -59.29 -47.94 83.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.997 -1.064 . . . . 0.0 108.755 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 69' ' ' LEU . 35.5 mt -58.48 -38.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.469 -0.77 . . . . 0.0 109.281 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -84.2 -8.11 59.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.604 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -75.77 -26.59 57.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.2 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.813 . . . . 0.0 109.747 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 46.3 -143.35 4.56 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.02 76.85 4.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -1.112 . . . . 0.0 109.363 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.525 ' C ' ' H ' ' A' ' 80' ' ' ALA . 1.3 ttt -132.02 43.71 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 33.47 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.525 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.99 -47.41 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.228 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -32.8 97.85 0.12 Allowed Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -64.61 139.04 61.96 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.422 1.415 . . . . 0.0 112.326 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 6.1 t -130.93 125.5 58.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.3 tp -107.39 72.23 0.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.425 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 5.7 mtp -51.63 151.71 3.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 t -126.51 128.55 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.635 0.731 . . . . 0.0 110.745 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.05 177.05 10.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.39 -123.42 0.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.93 -1.106 . . . . 0.0 108.862 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -47.92 133.26 14.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 109.306 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.497 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -93.34 109.94 21.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.696 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -73.12 -171.06 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 108.872 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 94' ' ' ASN . 45.3 mttp -94.32 -84.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.54 -8.0 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -76.84 -52.43 9.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.77 -28.08 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.0 mt -64.75 -64.06 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 109.979 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.86 -57.16 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.69 95.31 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.023 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.62 -44.33 73.05 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -19.92 59.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.831 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.22 -103.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.279 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.649 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -133.22 0.7 4.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.99 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.179 -0.601 . . . . 0.0 111.198 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.649 ' H ' ' C ' ' A' ' 102' ' ' GLY . 22.0 m -29.24 -34.74 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.995 -0.441 . . . . 0.0 111.8 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.2 130.43 10.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.497 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 49.7 t80 -136.5 112.58 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.437 -1.037 . . . . 0.0 109.492 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -115.39 129.01 72.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -91.37 103.07 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 154.89 89.71 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.035 -1.041 . . . . 0.0 109.165 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.26 158.84 98.46 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 O-C-N 122.506 0.74 . . . . 0.0 111.368 -1.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -136.16 154.65 50.9 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.853 0.835 . . . . 0.0 109.204 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.5 146.29 23.79 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.69 -40.44 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 108.699 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.67 -34.07 76.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' THR . 25.4 m -68.38 -67.11 0.49 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.92 -46.94 2.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.584 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.32 -54.82 42.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 110.302 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -47.84 -30.13 3.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.885 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -72.19 -49.32 36.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.389 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 123' ' ' ILE . 11.0 mt -48.45 -54.9 12.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.81 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -25.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.676 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -86.85 -27.07 23.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.022 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 120' ' ' LEU . 37.7 mm -81.52 -34.35 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.5 -8.61 57.42 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.099 -1.001 . . . . 0.0 110.755 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.57 -17.5 60.03 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -101.31 -30.31 11.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.17 -29.96 54.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.04 74.49 0.51 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.438 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.1 t0 -44.78 151.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 mttm -90.14 20.36 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.059 -1.026 . . . . 0.0 109.835 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -163.77 45.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.042 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 25.4 tp -71.82 121.09 18.36 Favored 'General case' 0 C--O 1.203 -1.344 0 O-C-N 121.025 -1.047 . . . . 0.0 108.231 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -53.61 117.31 3.02 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.932 -1.105 . . . . 0.0 112.176 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 70.7 m-85 -112.4 147.77 35.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.4 tp -121.69 108.29 13.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.154 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -92.95 104.46 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 108.735 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.94 38.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.83 147.01 23.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -98.76 -13.94 19.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.541 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.08 137.65 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 t -88.08 17.4 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.44 -40.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.2 ttt -50.33 -35.0 25.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' CG ' ' N ' ' A' ' 19' ' ' ARG . 4.7 ptm85 -63.27 -47.91 80.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.031 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -53.73 -32.54 52.46 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.129 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -53.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -31.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.09 15.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.903 -1.123 . . . . 0.0 109.408 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -69.96 -59.44 2.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.757 0.789 . . . . 0.0 109.858 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.23 -52.7 2.61 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.046 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -62.59 -50.22 72.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.014 . . . . 0.0 108.988 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -55.52 -30.71 61.18 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.89 -27.86 63.68 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.49 -37.57 16.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 139.28 7.69 1.07 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.9 m-85 -89.89 139.74 30.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.66 -1.494 . . . . 0.0 109.754 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 1.1 p30 -148.16 62.89 1.11 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.03 -1.044 . . . . 0.0 110.302 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.52 105.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.591 -1.318 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.15 179.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.105 -0.997 . . . . 0.0 109.99 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -137.26 -170.37 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 18' ' ' ARG . 47.1 mt-10 -141.97 149.7 40.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.324 -0.86 . . . . 0.0 110.741 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.02 -172.82 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -148.67 7.15 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.015 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 175.73 177.86 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.524 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -69.39 -39.57 80.59 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 118.955 -1.593 . . . . 0.0 110.066 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.0 t -54.59 -40.79 51.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.406 -1.644 . . . . 0.0 107.654 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -81.01 -43.21 19.94 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.499 -0.751 . . . . 0.0 109.87 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -73.98 -58.22 3.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.391 -0.818 . . . . 0.0 109.504 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.505 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -53.53 -37.87 63.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.946 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -72.66 -42.91 63.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.371 -1.456 . . . . 0.0 109.216 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -77.35 -14.29 59.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.728 . . . . 0.0 110.389 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -71.77 -25.05 61.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.711 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -66.11 -2.29 4.03 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 0.0 109.237 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.09 -66.49 0.39 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 109.482 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.19 13.42 0.54 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.937 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.67 88.17 1.28 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -64.3 122.45 16.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.398 -1.06 . . . . 0.0 110.516 -178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.21 -6.1 82.55 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -159.17 136.78 10.07 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.011 -1.288 . . . . 0.0 109.34 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.42 123.97 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.099 -1.001 . . . . 0.0 109.81 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mt -109.16 96.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.771 -0.581 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.07 145.38 42.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -162.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.971 -1.081 . . . . 0.0 109.178 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -103.76 -26.01 12.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 0.0 109.258 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -96.79 135.33 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.538 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -133.95 159.29 72.96 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.96 -68.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.368 1.378 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 63' ' ' MET . 2.8 p30 -85.62 -102.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 1.6 mmt -63.3 -178.06 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.656 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -179.53 5.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.41 -31.63 18.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 tp -47.57 -37.92 13.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -1.198 . . . . 0.0 108.984 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.21 -35.13 75.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 109.333 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' OG1' ' A' ' 71' ' ' THR . 4.8 mp -63.88 -27.19 68.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 70' ' ' LYS . 53.8 tp -77.76 -60.21 2.46 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 1.4 tmtp? -43.7 -32.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -55.57 -52.99 61.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 109.348 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 mp -57.95 -36.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 108.902 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -69.15 -27.97 66.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.56 -28.81 2.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.6 -38.25 20.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' O ' ' CB ' ' A' ' 77' ' ' ALA . . . 59.8 46.14 94.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' GLY . . . 167.3 -52.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' ALA . 12.8 mtt -94.46 21.47 7.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -74.7 37.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -97.5 -20.12 17.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -52.51 113.38 4.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.011 -1.055 . . . . 0.0 109.174 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.16 145.99 90.25 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 121.164 1.243 . . . . 0.0 112.983 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.08 132.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.8 tp -113.48 70.79 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.662 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 86' ' ' VAL . 14.0 tmm? -49.48 159.81 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' N ' ' SD ' ' A' ' 85' ' ' MET . 39.5 t -137.94 121.26 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.488 -0.758 . . . . 0.0 110.16 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.8 t -150.13 178.88 8.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 0.0 110.02 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 -45.64 2.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.533 -0.73 . . . . 0.0 109.362 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -70.59 -77.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.558 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 63.27 117.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -131.8 148.67 52.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -42.5 -48.59 5.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.259 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -64.44 -29.72 70.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.283 -0.886 . . . . 0.0 110.665 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -89.99 -23.56 21.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.561 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.95 -16.35 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.659 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.1 mt -74.95 -68.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.18 -43.78 21.6 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.97 -51.19 70.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.42 -0.8 . . . . 0.0 109.223 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.66 64.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.803 . . . . 0.0 110.593 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -77.19 6.26 6.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 110.4 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.53 -17.79 13.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 0.0 110.396 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 136.36 -12.39 4.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.41 11.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.861 -0.788 . . . . 0.0 111.467 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.671 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.8 m -29.41 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.917 -0.489 . . . . 0.0 111.312 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.74 124.11 7.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -145.02 105.7 4.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -1.234 . . . . 0.0 109.405 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.5 p -103.03 136.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.41 100.07 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.097 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.9 pttt -63.52 154.44 79.52 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.71 -1.244 . . . . 0.0 109.09 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.33 161.93 93.5 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 O-C-N 122.479 0.726 . . . . 0.0 111.225 -1.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -142.9 162.75 34.64 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.009 0.909 . . . . 0.0 110.082 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.09 148.95 26.27 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.76 -19.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.982 -1.074 . . . . 0.0 109.249 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.44 -37.31 51.84 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.401 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.0 OUTLIER -73.27 -61.39 1.84 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.3 tp -47.92 -38.64 16.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.005 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.49 -44.82 77.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 15.4 tt0 -56.38 -26.69 53.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.333 -0.854 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -81.95 -58.83 2.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 tt -46.28 -48.72 18.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.55 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -62.68 -33.49 75.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -67.83 -31.48 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.1 mt -88.72 -38.01 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.865 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.03 -3.69 27.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.149 -0.969 . . . . 0.0 109.736 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -74.03 -29.33 61.87 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -88.68 -30.62 19.0 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.39 -28.99 61.35 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.36 83.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 60.56 129.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.151 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -90.06 24.04 2.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.889 -1.132 . . . . 0.0 110.058 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.22 40.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.789 -1.194 . . . . 0.0 110.773 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.03 133.24 49.51 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -75.08 120.39 20.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.893 -1.13 . . . . 0.0 111.32 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -109.66 148.16 31.83 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.6 tp -122.29 118.97 29.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.92 103.96 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.577 -0.702 . . . . 0.0 109.77 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 58.5 t -93.41 31.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.27 157.46 22.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.745 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.85 -30.96 13.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 150.36 49.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -24.2 18.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.46 -20.58 20.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -52.25 49.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.491 HH11 ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -49.43 -32.13 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.29 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.71 77.17 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.802 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.8 mt -57.86 -57.87 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -38.16 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.29 -52.85 19.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.968 -1.082 . . . . 0.0 109.193 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.5 t30 -64.34 -56.9 11.27 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.775 0.798 . . . . 0.0 109.171 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.86 -52.39 2.38 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.744 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.4 mt -63.1 -46.26 88.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 0.0 108.811 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.25 -32.58 66.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.342 -0.848 . . . . 0.0 109.419 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 4.7 tt0 -55.48 -41.96 73.71 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 mp -75.43 -55.39 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.792 . . . . 0.0 109.298 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 78.01 0.02 OUTLIER Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -150.01 147.46 27.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -150.03 58.53 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.55 93.32 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.077 -1.014 . . . . 0.0 109.177 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.4 t -138.5 151.28 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.77 -171.83 2.47 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.16 157.11 42.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.924 -1.11 . . . . 0.0 110.884 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.54 -168.97 2.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.81 0.32 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.375 -0.828 . . . . 0.0 110.478 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 9.7 t70 -174.21 174.9 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -59.57 -57.21 20.72 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 13.2 p -50.97 -28.24 6.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -1.083 . . . . 0.0 108.535 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -76.27 -47.01 25.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.41 -0.806 . . . . 0.0 109.133 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.65 -66.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.346 -0.847 . . . . 0.0 109.786 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.06 -45.21 52.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.446 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 72.4 m-20 -63.63 -39.25 93.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.0 -1.063 . . . . 0.0 110.554 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -90.1 -1.08 57.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -87.52 -30.87 20.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 108.882 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -54.81 -9.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.105 -0.997 . . . . 0.0 108.574 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.02 -67.01 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.63 -92.3 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -156.96 78.29 0.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.43 ' C ' ' H ' ' A' ' 53' ' ' PHE . 41.9 m-85 -57.35 91.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.431 -1.04 . . . . 0.0 110.158 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -57.96 -9.31 5.38 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.5 137.64 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.246 -1.15 . . . . 0.0 110.057 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 97.0 t -134.92 120.02 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.155 -0.966 . . . . 0.0 109.684 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.53 131.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 83.7 p -149.79 150.14 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' SER . 36.9 m-20 -60.67 -115.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.184 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -150.45 -42.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.603 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.528 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 0.2 OUTLIER 178.15 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.587 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.35 -54.72 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.761 -0.587 . . . . 0.0 110.283 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.13 -61.2 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.563 0 N-CA-C 108.846 -1.251 . . . . 0.0 108.846 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 2.8 m-80 -154.47 -148.96 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.6 mtt -48.16 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 108.423 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 42.55 -156.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.518 -0.739 . . . . 0.0 110.785 178.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.461 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . 48.17 -83.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -51.11 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.869 -1.371 . . . . 0.0 110.037 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.98 -33.78 11.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 108.813 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.461 ' HB3' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -62.65 -35.67 80.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.631 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 8.9 tt -90.05 -60.51 1.91 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -36.06 -34.49 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.131 0.491 . . . . 0.0 110.012 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.5 m -59.14 -50.1 75.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.0 mt -54.41 -37.86 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -70.36 -32.74 70.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.452 -0.78 . . . . 0.0 109.515 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.68 33.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.927 . . . . 0.0 109.582 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -75.71 98.59 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.595 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -23.71 66.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.19 -38.47 90.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -1.186 . . . . 0.0 109.415 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 mtm -136.39 45.88 2.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 79' ' ' SER . 9.3 t -77.95 45.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.03 10.22 0.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.0 -1.062 . . . . 0.0 110.063 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 9.6 tp -55.36 120.74 32.97 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 108.382 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.25 131.36 38.38 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 120.962 1.108 . . . . 0.0 112.233 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.69 125.18 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.0 tp -107.05 70.12 0.78 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.571 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -51.53 168.91 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -143.11 126.67 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.532 -0.73 . . . . 0.0 109.801 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -150.1 178.44 8.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.911 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.43 3.94 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.72 50.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -75.5 101.92 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 0.0 109.548 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.33 -82.62 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 109.332 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -173.01 -73.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.29 -33.6 29.45 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.151 -0.968 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.5 -24.3 61.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 96.3 mt -83.16 -36.98 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.556 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.4 mp -57.5 -57.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.237 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.2 -37.77 10.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 109.229 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.65 -60.28 3.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.733 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -55.1 -40.19 70.18 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.221 -0.924 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -19.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.26 -123.96 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.727 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -111.87 2.24 27.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.71 11.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.623 -0.928 . . . . 0.0 109.98 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.727 ' H ' ' C ' ' A' ' 102' ' ' GLY . 1.4 m -29.54 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -109.64 127.67 8.56 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.53 120.31 9.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 108.825 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.59 130.17 74.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.01 105.04 12.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.154 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.79 161.08 64.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.02 -1.05 . . . . 0.0 109.257 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.46 166.35 83.34 Favored 'Cis proline' 0 N--CA 1.488 1.153 0 C-N-CA 124.832 -0.904 . . . . 0.0 110.801 -2.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.77 164.1 33.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 110.344 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.46 148.21 27.43 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.462 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -45.87 -36.66 5.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.048 . . . . 0.0 109.479 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.4 87.39 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.9 m -69.85 -67.01 0.52 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -45.62 -36.89 5.09 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.033 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 6.5 tm-20 -66.99 -46.85 73.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 26.9 tt0 -47.77 -60.01 2.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -34.89 64.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.474 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.88 -72.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.6 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.45 -17.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.926 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.47 -33.13 60.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.14 -0.975 . . . . 0.0 109.733 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.0 mt -89.97 -43.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 109.934 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -57.16 -21.13 30.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.634 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -57.36 -20.37 28.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.763 -1.211 . . . . 0.0 108.221 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -96.82 -22.03 17.17 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.32 -18.98 25.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 79.07 0.06 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.541 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -142.57 135.0 27.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 108.883 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -90.05 21.55 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.977 . . . . 0.0 109.572 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -160.13 44.0 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.068 -1.02 . . . . 0.0 109.956 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.6 tp -84.46 125.7 32.6 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -74.67 123.28 24.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.169 -0.957 . . . . 0.0 112.155 -176.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -114.88 140.89 48.6 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 tp -106.02 116.76 32.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.169 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.57 102.8 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 t -95.02 62.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.243 -0.91 . . . . 0.0 109.644 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -103.27 132.48 49.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.12 -21.26 36.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.133 -0.979 . . . . 0.0 109.299 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -57.86 146.82 30.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.513 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 m -90.6 29.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 -38.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' OD2' ' A' ' 57' ' ' ASP . 27.5 ttt -48.41 -45.57 36.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -56.65 9.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -56.34 -41.59 76.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 110.133 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mt -54.61 -53.78 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -44.99 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.408 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.01 -52.83 22.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.872 -1.143 . . . . 0.0 109.034 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -62.02 -56.79 15.47 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.89 0.853 . . . . 0.0 109.049 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.32 -59.75 1.01 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.066 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -59.44 -47.28 86.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -53.43 -33.35 53.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.19 -33.16 39.54 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.165 -0.96 . . . . 0.0 109.177 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 9.9 mp -80.43 -67.62 0.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.08 17.54 0.02 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.294 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.0 m-85 -90.66 129.46 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.749 -1.442 . . . . 0.0 109.197 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.86 68.95 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.502 -0.749 . . . . 0.0 109.93 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.5 103.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.082 -1.011 . . . . 0.0 108.569 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -149.98 148.24 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.82 -171.4 2.18 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -149.86 150.31 31.75 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 110.832 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.96 165.5 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 1.8 mp0 -135.96 32.69 2.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.125 -0.984 . . . . 0.0 110.729 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 7.4 t0 175.04 145.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.277 -0.89 . . . . 0.0 108.832 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -50.6 -29.85 18.96 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.79 -28.37 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.254 . . . . 0.0 108.534 179.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 5.1 t0 -81.4 -41.81 21.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.83 86.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.446 -0.784 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mt -70.73 -41.94 71.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -63.36 -27.04 69.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -53.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.63 -19.67 17.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 108.645 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -50.36 -28.05 7.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.0 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 68.02 0.47 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.81 24.24 0.06 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' PHE . 52.6 m-85 -94.74 83.06 3.98 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.28 -1.13 . . . . 0.0 109.904 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.51 0.48 2.07 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -162.95 152.82 15.79 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.1 -1.235 . . . . 0.0 109.805 -179.115 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.4 128.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.724 -1.235 . . . . 0.0 109.78 179.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.44 128.79 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -132.67 163.04 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.171 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 18.3 m-20 -91.33 -106.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.645 -178.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -164.09 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -95.66 137.19 35.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.535 ' C ' ' H ' ' A' ' 62' ' ' ASN . 3.6 mmt -139.78 155.24 71.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.14 -1.13 0.16 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.431 1.421 . . . . 0.0 111.076 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 60' ' ' MET . 3.8 p30 -133.63 107.87 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.433 -0.792 . . . . 0.0 109.083 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.421 ' O ' ' OD2' ' A' ' 64' ' ' ASP . 42.1 mtm 53.67 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.0 109.405 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ASN . 1.2 m-20 -169.93 150.64 3.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 108.86 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.21 8.86 2.49 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' ASP . 9.2 mt -67.09 -52.85 36.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -1.107 . . . . 0.0 109.082 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -74.06 -14.13 60.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 109.563 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.7 tp -67.62 -57.35 6.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 108.836 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -73.24 -36.02 66.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 74' ' ' ALA . 16.8 tttt -47.03 -47.91 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 108.82 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.1 m -47.16 -59.24 3.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.477 -0.765 . . . . 0.0 109.638 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mt -49.82 -40.09 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.66 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -10.68 55.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -92.43 -26.62 17.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -45.13 158.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.28 -52.85 21.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.06 109.44 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.528 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.531 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -144.25 12.71 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.858 . . . . 0.0 109.281 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -65.31 4.84 0.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.175 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.87 -15.49 32.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 1.1 tp -112.03 99.13 44.88 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.66 139.0 78.63 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.037 1.825 . . . . 0.0 113.695 -178.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.424 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.5 t -124.75 119.55 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tp -99.0 109.78 22.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.8 ttm -86.2 146.85 26.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.9 144.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -150.09 173.92 13.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.943 -1.098 . . . . 0.0 110.74 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -113.61 148.7 35.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 49.08 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.426 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -83.42 119.08 24.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.022 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.9 -169.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 0.0 109.051 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -99.6 -39.05 8.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.704 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.89 -19.08 25.01 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.113 -0.992 . . . . 0.0 110.284 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -80.23 -22.59 41.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 110.106 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.413 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 24.7 mt -69.16 -8.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.132 . . . . 0.0 109.932 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' C ' ' N ' ' A' ' 98' ' ' ALA . 10.1 mt -90.17 -49.11 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.05 -24.63 0.16 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -50.28 -56.8 9.65 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -45.58 -44.73 13.17 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 119.629 -1.919 . . . . 0.0 108.924 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -59.69 -36.8 77.21 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -126.33 -72.51 0.65 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -48.8 82.17 0.01 OUTLIER Glycine 0 N--CA 1.496 2.643 0 N-CA-C 106.576 -2.609 . . . . 0.0 106.576 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -70.03 -109.81 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.824 0 CA-C-N 111.508 -2.346 . . . . 0.0 114.994 -174.236 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 83' ' ' VAL . 2.0 p -38.87 -54.18 1.65 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.564 -176.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . -156.8 171.17 34.29 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.12 116.2 15.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.407 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.1 p -115.59 126.34 73.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 9.5 p -78.67 108.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.54 157.38 88.33 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.991 -1.068 . . . . 0.0 109.583 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.79 159.39 97.22 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 O-C-N 122.768 0.878 . . . . 0.0 110.626 -2.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -136.63 160.06 39.93 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.658 0.742 . . . . 0.0 109.783 178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.47 148.81 22.42 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.0 -32.09 8.61 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.97 -1.082 . . . . 0.0 108.833 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.06 71.99 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' THR . 6.0 m -70.89 -66.94 0.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 115' ' ' THR . 11.6 tp -45.58 -41.62 10.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.859 -1.151 . . . . 0.0 109.195 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.72 -50.06 70.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.301 -0.874 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.22 -41.71 13.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -77.98 -43.69 28.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 109.124 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.44 -47.48 26.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 108.957 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 m-20 -49.9 -59.88 3.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.323 -0.861 . . . . 0.0 109.947 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -50.32 -35.46 27.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 110.016 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.7 mt -73.15 -41.54 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 110.005 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -77.92 0.85 22.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.095 -1.003 . . . . 0.0 110.215 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -75.65 -32.66 60.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -88.71 -25.97 22.05 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -33.61 27.67 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.28 82.43 0.03 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.464 -179.975 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.553 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER 61.08 116.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.873 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -90.39 27.24 1.73 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.745 -1.222 . . . . 0.0 110.31 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -145.82 36.83 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.38 141.09 35.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.434 ' NZ ' ' OD1' ' A' ' 32' ' ' ASN . 12.7 mttp -80.02 129.87 34.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.915 -1.116 . . . . 0.0 111.349 -177.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -118.79 151.56 37.82 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.781 -0.574 . . . . 0.0 109.655 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -127.04 109.88 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.77 114.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.347 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.56 108.76 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 -179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 124.31 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -29.29 70.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.678 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.77 139.18 10.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 p -93.56 22.24 5.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 p -145.79 -15.87 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.6 ttt -70.95 -39.3 72.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -35.35 80.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ttp85 -68.93 -21.02 64.23 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.077 -178.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.1 -45.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.868 . . . . 0.0 109.744 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -36.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -47.42 -53.02 15.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.364 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.31 -57.56 7.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.818 0.818 . . . . 0.0 109.371 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.18 -60.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -56.45 -46.05 80.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 109.125 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -55.45 -35.24 65.25 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.175 -0.953 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.32 -28.14 40.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.406 -0.809 . . . . 0.0 109.783 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.09 -33.6 22.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.43 10.69 2.09 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 79.4 m-85 -89.69 141.2 28.83 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.743 -1.445 . . . . 0.0 109.418 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -143.64 28.4 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.481 -0.762 . . . . 0.0 109.728 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 7' ' ' LYS . 15.9 t-20 -131.61 88.23 2.55 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -137.31 153.24 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.627 -0.671 . . . . 0.0 110.11 -178.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -125.57 -173.6 2.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.19 148.2 28.64 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.05 166.7 17.9 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 12.5 mm-40 -94.53 -3.02 50.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.867 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER 169.63 173.85 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.917 -1.114 . . . . 0.0 109.691 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.42 54.87 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -53.96 -42.87 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.988 -1.301 . . . . 0.0 108.727 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -63.99 -50.44 68.52 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -53.36 -49.38 67.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.276 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tp -53.22 -35.39 59.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.908 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.75 -33.44 35.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.371 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -90.07 -12.54 38.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.068 -1.02 . . . . 0.0 110.464 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -63.42 -20.58 65.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.029 -1.044 . . . . 0.0 109.212 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.93 1.21 24.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.138 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.94 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.409 -0.807 . . . . 0.0 109.657 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.25 11.93 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.32 80.63 1.47 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' C ' ' H ' ' A' ' 53' ' ' PHE . 38.3 m-85 -60.06 102.14 0.15 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -1.089 . . . . 0.0 109.769 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.47 -12.54 1.0 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.488 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -153.24 134.59 14.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.378 -1.072 . . . . 0.0 109.499 -179.427 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.26 117.69 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.827 -1.171 . . . . 0.0 109.939 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.94 119.6 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.8 p -141.47 144.1 34.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.808 . . . . 0.0 109.248 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.7 p-10 -60.47 -112.45 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.979 -1.075 . . . . 0.0 109.229 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -173.87 -32.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 108.834 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.5 58.57 2.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 0.0 109.54 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.1 ptm -47.88 159.24 0.48 Allowed Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.47 -48.47 20.33 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.248 1.299 . . . . 0.0 110.514 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.09 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.853 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.1 mmt -90.9 -110.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.938 . . . . 0.0 109.869 -179.565 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.3 -175.56 4.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.78 12.29 70.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -62.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.8 -1.411 . . . . 0.0 108.569 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' O ' ' OG1' ' A' ' 71' ' ' THR . 23.0 tt0 -48.8 -37.52 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.3 -42.67 82.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' ILE . 1.2 mt -75.41 -63.5 1.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.524 0.678 . . . . 0.0 109.18 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' LEU . 39.9 tttp -40.29 -34.95 0.36 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.759 -0.588 . . . . 0.0 109.986 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 13.1 m -73.2 -37.19 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 108.664 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' LEU . 39.6 mt -61.08 -21.41 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -88.68 5.33 43.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.358 -0.839 . . . . 0.0 109.319 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -122.01 -20.88 6.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.5 m-20 -59.67 -140.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.54 0.686 . . . . 0.0 110.214 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -55.37 -167.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.81 50.32 1.79 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.04 -70.19 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 t 44.29 17.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -145.87 -3.52 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 tp -54.43 113.56 5.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 109.05 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 140.31 89.49 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.119 1.213 . . . . 0.0 112.351 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.8 t -129.83 127.88 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.8 tp -108.42 78.42 1.16 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtt -72.24 132.2 43.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.3 m -113.23 140.2 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 t -150.02 171.49 16.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 109.604 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.01 -87.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.817 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.95 -66.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 67.72 99.87 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 109.174 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -95.59 119.62 34.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.207 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.51 -50.07 7.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.785 . . . . 0.0 109.983 -179.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.23 -35.11 7.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.174 -0.954 . . . . 0.0 109.686 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 96' ' ' ILE . 2.3 t-20 -85.53 -39.04 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.191 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.1 mm -58.24 -0.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 94' ' ' ASN . 71.9 mt -89.82 -65.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.33 -34.72 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.54 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.95 36.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.876 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.7 67.58 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.044 -1.035 . . . . 0.0 110.011 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.47 -19.51 1.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 109.135 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.18 -112.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.724 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.81 -5.38 4.9 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.56 10.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.927 -0.749 . . . . 0.0 110.348 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.724 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.3 m -29.75 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.009 -178.05 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.05 125.68 8.66 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -142.38 109.38 5.51 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.286 -1.126 . . . . 0.0 109.697 179.189 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -110.53 150.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.48 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 39.9 t -90.52 111.72 23.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.729 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 152.44 78.07 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.786 -1.196 . . . . 0.0 109.514 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.85 165.6 84.49 Favored 'Cis proline' 0 N--CA 1.49 1.314 0 O-C-N 122.52 0.748 . . . . 0.0 110.909 -1.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -144.4 156.89 44.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.855 0.836 . . . . 0.0 110.106 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.548 ' H ' ' HG1' ' A' ' 115' ' ' THR . 1.0 OUTLIER -95.67 150.79 19.98 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.755 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.37 -15.36 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.783 -1.198 . . . . 0.0 109.194 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.27 -38.34 35.68 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.548 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.33 -62.41 1.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.537 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 115' ' ' THR . 4.6 tp -48.6 -38.73 21.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.195 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.56 -56.81 11.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 0.0 110.068 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.18 -66.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.554 -0.716 . . . . 0.0 109.931 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -35.25 5.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.25 -68.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.03 -32.91 10.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.78 -38.17 81.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.07 -47.83 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.055 -1.028 . . . . 0.0 109.963 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -53.19 -19.0 2.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.122 -0.986 . . . . 0.0 110.232 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -55.95 -35.43 66.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 107.949 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -79.6 -32.23 41.83 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.6 tt -65.11 -23.58 67.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.76 61.34 1.29 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.418 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER 51.81 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.818 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.2 ptmm? -76.83 47.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.006 -1.059 . . . . 0.0 109.544 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -160.42 27.11 0.16 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.6 tp -69.65 143.21 53.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 1.9 mtmp? -82.35 127.76 33.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.125 -0.984 . . . . 0.0 111.508 -177.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.41 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 35.4 m-85 -116.32 150.7 37.24 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.865 -0.522 . . . . 0.0 109.974 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -125.15 106.9 10.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.37 105.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 109.05 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.99 24.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.155 -0.965 . . . . 0.0 109.455 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -56.64 126.58 27.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -93.63 -2.59 53.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.34 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -58.81 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.965 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.05 8.52 5.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.578 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -22.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.748 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.3 tpp -47.71 -50.39 25.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.243 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.45 ' NE ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -45.38 -55.41 6.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 110.469 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -56.24 -37.39 69.67 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.577 -177.319 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.78 -49.02 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.119 -0.988 . . . . 0.0 110.046 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -33.25 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.995 -1.066 . . . . 0.0 110.515 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -53.51 21.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.989 -1.07 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.1 t30 -67.57 -58.15 5.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.881 0.848 . . . . 0.0 109.63 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 4.5 tt -40.09 -34.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.125 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.95 -42.08 27.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.905 -1.122 . . . . 0.0 108.233 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.578 ' CB ' ' HZ1' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -58.88 -34.9 72.18 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.346 -0.846 . . . . 0.0 108.925 179.318 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.85 -29.14 39.88 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.347 -0.845 . . . . 0.0 109.236 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.27 -12.86 42.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 106.09 15.39 18.16 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -89.83 126.84 35.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.479 . . . . 0.0 109.0 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -130.42 67.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.808 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.4 89.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 108.594 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.2 t -140.23 151.69 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.489 -178.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.2 mt-10 -126.18 -173.23 2.8 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 7.6 tt0 -149.13 159.48 44.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.769 -1.207 . . . . 0.0 111.157 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.99 -171.79 3.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -139.41 8.57 2.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.805 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.16 -170.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.34 -38.96 44.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.98 -1.581 . . . . 0.0 109.293 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 62.9 t -52.52 -40.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.915 -1.344 . . . . 0.0 107.763 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -79.15 -50.6 10.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.677 -0.639 . . . . 0.0 109.847 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -62.56 -59.46 4.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.9 tp -44.75 -50.75 9.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.313 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 60.6 m-20 -66.7 -36.28 82.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.012 . . . . 0.0 109.577 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -90.13 8.0 35.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -87.98 -44.18 11.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.898 -1.126 . . . . 0.0 109.076 179.681 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -65.75 1.55 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.186 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.44 -69.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.391 -0.818 . . . . 0.0 109.859 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.35 1.26 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 85.27 88.11 0.92 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.43 ' OH ' ' CG ' ' A' ' 34' ' ' GLU . 38.4 m-85 -71.1 136.66 48.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.304 -1.115 . . . . 0.0 109.66 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.49 -5.67 71.77 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -152.14 135.88 16.26 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.578 -0.954 . . . . 0.0 108.95 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.05 116.98 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.817 -1.177 . . . . 0.0 109.781 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.62 95.42 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.5 p -105.61 131.99 52.3 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 59' ' ' ASN . 37.7 p-10 -100.15 123.31 44.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.467 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 57' ' ' ASP . 1.4 t-105 -45.76 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.244 -0.91 . . . . 0.0 108.679 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASP . 80.1 m-20 -92.57 -150.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 110.635 -178.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.619 ' H ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -124.65 -29.82 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.619 ' CD ' ' H ' ' A' ' 60' ' ' MET . 4.1 Cg_exo -62.01 164.48 16.7 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 CA-C-N 119.812 0.968 . . . . 0.0 110.842 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.629 ' ND2' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -41.73 -62.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.785 -0.572 . . . . 0.0 109.633 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.483 ' H ' HD21 ' A' ' 62' ' ' ASN . 0.8 OUTLIER -79.24 56.08 1.99 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.275 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' MET . 0.2 OUTLIER -46.9 -94.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.472 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.72 -24.29 0.07 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -70.67 -58.06 4.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.876 -1.367 . . . . 0.0 108.612 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.41 -33.46 6.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.59 -42.63 86.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -69.06 -45.05 71.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.529 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -58.66 -32.34 68.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 0.0 108.884 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -66.85 -42.98 84.79 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.282 -0.886 . . . . 0.0 108.999 179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.27 -31.6 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -30.57 71.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.073 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -59.0 -24.14 62.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 6.3 t70 -42.85 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 75' ' ' ASP . . . 152.32 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.05 -21.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.187 . . . . 0.0 109.206 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.533 ' C ' ' H ' ' A' ' 80' ' ' ALA . 3.0 mtm -116.84 36.77 4.04 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -65.64 7.35 0.25 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.518 -0.739 . . . . 0.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.74 24.12 3.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 tt -48.89 125.56 13.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.68 114.85 2.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.667 0.912 . . . . 0.0 112.257 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.34 118.74 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.2 tp -97.49 79.1 2.72 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.229 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtp -64.75 108.85 1.85 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.42 134.57 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.632 -1.292 . . . . 0.0 109.362 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.2 t -150.2 177.57 9.8 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.812 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -122.76 141.51 51.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 5.8 tt0 67.99 35.59 3.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 0.0 109.148 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.473 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -45.52 127.33 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.814 . . . . 0.0 109.914 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -83.31 -133.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 -28.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.241 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -29.69 21.24 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -79.33 -36.43 39.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 56.1 mt -64.68 -5.92 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 108.966 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.94 -58.44 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 109.354 179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.92 -60.57 2.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -49.02 -41.46 34.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 108.755 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -47.64 -48.91 28.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.982 -1.074 . . . . 0.0 109.419 -179.67 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -27.84 56.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.228 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.84 -106.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.923 . . . . 0.0 109.558 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.696 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -145.36 12.11 1.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.626 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.6 11.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.045 0.538 . . . . 0.0 110.775 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.696 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.0 m -29.33 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.99 126.96 8.02 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.08 111.11 6.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.535 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.7 p -117.95 121.9 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.3 172.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.179 179.37 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' THR . 15.4 pttt -147.4 156.96 45.85 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 120.579 -1.326 . . . . 0.0 108.911 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.98 167.89 77.35 Favored 'Cis proline' 0 N--CA 1.485 0.983 0 C-N-CA 124.862 -0.891 . . . . 0.0 110.348 -1.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -134.6 155.64 50.1 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.017 0.913 . . . . 0.0 110.473 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -93.12 151.42 19.86 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.114 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.73 -38.39 9.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.918 -1.114 . . . . 0.0 109.733 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.02 84.32 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 116' ' ' LEU . 19.0 m -66.31 -65.1 0.72 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -42.68 -48.71 5.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.619 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.75 80.34 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.312 -0.868 . . . . 0.0 110.048 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp10 -57.63 -33.84 68.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.027 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -36.71 14.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 0.0 110.042 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -58.12 -67.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.236 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.1 -28.69 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.118 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -71.76 -33.06 68.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.146 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.517 ' C ' ' H ' ' A' ' 125' ' ' GLU . 21.0 mt -79.88 -42.28 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.078 -1.014 . . . . 0.0 110.075 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -62.63 4.99 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 110.577 -178.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.1 mm-40 -81.91 -28.61 32.75 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -86.89 -34.86 19.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -30.06 71.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.115 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.1 77.09 0.32 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.273 -1.133 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.54 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 3.0 m-20 -43.94 145.53 0.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 29' ' ' GLY . 7.8 mtmm -90.5 7.48 38.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.221 -0.925 . . . . 0.0 110.302 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 5' ' ' GLU . 45.7 mp0 -144.46 50.88 1.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.813 -1.18 . . . . 0.0 109.952 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.4 tp -80.26 114.76 19.4 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 121.5 7.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.059 -1.025 . . . . 0.0 112.046 -177.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.3 m-85 -113.41 149.5 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.113 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -121.55 109.45 14.82 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.61 99.77 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 110.122 -178.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 58.6 t -91.94 12.48 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.09 -1.006 . . . . 0.0 109.758 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.2 OUTLIER -62.18 156.32 22.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.393 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' PHE . 14.2 p-10 -94.86 -142.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.493 ' O ' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 61.27 146.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.84 . . . . 0.0 109.619 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 t -92.46 17.0 10.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -143.49 -12.89 0.69 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 109.446 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 5.8 ttm -71.51 -57.79 4.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -47.22 -28.87 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -51.17 20.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.186 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.93 -53.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.798 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -44.64 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.863 . . . . 0.0 110.333 -178.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -46.87 -55.43 8.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -59.69 -58.03 10.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.108 0.956 . . . . 0.0 108.518 179.428 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.7 tt -39.29 -42.76 1.06 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.641 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.18 -41.96 69.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 108.899 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' ASN . 47.8 tttt -63.1 -30.71 71.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.22 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.57 -40.03 71.43 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tt -76.96 -58.6 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 159.55 43.22 0.02 OUTLIER Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.54 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 48.5 m-85 -126.98 125.42 41.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.821 -0.811 . . . . 0.0 109.662 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.67 66.22 1.46 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.566 -0.708 . . . . 0.0 109.518 -179.705 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.64 93.37 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.111 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.54 179.29 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.059 -1.026 . . . . 0.0 109.856 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -138.73 -164.98 1.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -147.68 149.86 33.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.141 -178.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -142.3 -168.87 2.83 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -146.61 3.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 110.643 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 175.66 -172.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.123 -0.986 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.88 -42.24 70.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.11 -34.02 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.236 . . . . 0.0 109.049 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.97 -57.16 3.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.96 -38.22 10.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.39 -58.92 3.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -58.16 -21.51 47.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.931 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -90.15 -43.09 10.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 110.587 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.669 -1.269 . . . . 0.0 109.291 -179.333 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -63.05 -4.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -53.95 -74.91 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.564 -0.71 . . . . 0.0 109.855 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.16 10.8 1.18 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.545 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.5 81.64 1.27 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 22.8 m-85 -54.94 144.74 22.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.548 -0.972 . . . . 0.0 110.297 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.56 -4.64 73.03 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -161.93 145.56 12.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.418 -1.048 . . . . 0.0 110.004 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -139.92 125.93 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.353 -0.842 . . . . 0.0 109.877 179.562 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.51 104.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.499 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 90.2 p -104.94 178.27 4.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.349 -0.844 . . . . 0.0 109.964 -179.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 29.2 p-10 -99.98 -115.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.485 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 61.4 t-105 -140.12 -81.14 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 0.0 110.135 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -170.43 68.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 109.93 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.508 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.08 -48.33 0.41 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.523 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.05 -160.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.012 1.141 . . . . 0.0 109.822 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.624 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -84.75 107.48 16.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 0.0 109.094 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.4 mmm 50.31 93.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.107 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.9 t70 -152.24 -177.43 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . 54.47 -80.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ASP . 95.7 mt -44.84 -68.65 0.18 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 109.66 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' O ' ' OG1' ' A' ' 71' ' ' THR . 43.2 tt0 -60.17 -35.69 75.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.846 -1.159 . . . . 0.0 109.375 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.23 -33.93 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 109.007 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 72' ' ' ILE . 1.6 tt -87.08 -59.99 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.173 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.0 ttpt -40.31 -32.81 0.2 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 38.1 m -66.2 -44.18 84.65 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.6 mt -54.65 -36.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 108.769 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtp-105 -75.59 -16.23 60.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.417 -0.802 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -54.42 -28.61 45.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 109.845 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 38.0 t70 -61.55 -121.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.606 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.521 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . 154.0 -32.65 0.73 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 -12.41 57.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.413 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.48 42.44 2.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 p -77.89 51.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -130.71 -26.14 2.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.644 -0.66 . . . . 0.0 109.715 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -38.65 103.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.896 -0.503 . . . . 0.0 109.78 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.2 108.87 1.04 Allowed 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 120.93 1.087 . . . . 0.0 111.574 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -108.81 111.51 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.463 178.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.99 110.75 21.71 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.499 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -91.51 116.28 28.73 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.34 -176.859 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -102.23 150.43 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.887 -1.133 . . . . 0.0 110.867 -178.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.3 t -150.09 -143.49 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.38 -17.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -79.85 -75.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.957 . . . . 0.0 109.506 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . 58.83 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.8 tptp -148.58 59.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.266 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 94' ' ' ASN . 74.1 tttt 53.12 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.9 pt-20 -47.17 -19.0 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.189 -0.945 . . . . 0.0 109.789 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 92' ' ' LYS . 3.0 m-20 -89.78 -35.78 15.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.82 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.87 -18.27 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.416 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.7 mp -83.54 -43.39 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.751 -1.218 . . . . 0.0 107.93 178.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.45 -24.82 1.39 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.1 -54.34 25.95 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.583 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.72 64.49 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.069 -1.644 . . . . 0.0 107.963 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -27.73 68.51 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.236 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -146.46 -68.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -58.61 79.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.82 -108.76 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.302 0 CA-C-N 111.549 -2.325 . . . . 0.0 115.676 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -29.83 -58.0 0.17 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.164 -175.768 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.31 176.26 37.0 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.95 -179.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -130.65 115.0 16.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.87 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 108' ' ' VAL . 14.3 p -122.6 123.01 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 107' ' ' VAL . 28.0 m -54.18 -169.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.15 153.19 11.77 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.504 -1.372 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.11 154.06 99.45 Favored 'Cis proline' 0 N--CA 1.487 1.101 0 C-N-CA 125.187 -0.755 . . . . 0.0 110.636 -1.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -118.32 155.25 30.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.84 0.829 . . . . 0.0 109.661 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.729 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.4 OUTLIER -90.07 150.49 22.05 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -50.61 -15.55 0.28 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.684 -1.26 . . . . 0.0 109.327 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -81.69 -34.44 30.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.729 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -74.13 -61.21 1.93 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.1 -36.16 38.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.58 179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 15.9 mt-10 -54.66 -66.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.009 -1.057 . . . . 0.0 109.521 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -44.25 -26.93 0.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.768 -0.583 . . . . 0.0 109.781 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.53 -44.03 15.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 110.325 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 18.6 mt -67.57 -57.23 6.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.805 -1.184 . . . . 0.0 109.64 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.53 -27.02 5.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.986 -1.072 . . . . 0.0 109.82 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -84.4 -22.71 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.181 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.6 mt -88.36 -39.0 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.645 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -65.76 -5.68 9.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.998 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -26.17 62.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -90.38 -34.46 15.66 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.26 -15.52 59.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 58.41 85.76 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.228 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' CD1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER 173.52 134.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.397 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 28.69 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -171.68 41.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.01 -1.056 . . . . 0.0 110.579 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.2 tp -80.41 112.95 18.23 Favored 'General case' 0 C--O 1.205 -1.249 0 O-C-N 120.576 -1.328 . . . . 0.0 107.921 179.169 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.54 114.36 1.64 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.946 . . . . 0.0 112.481 -177.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 82.8 m-85 -109.2 151.12 26.91 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.5 tp -119.15 108.62 14.91 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.02 122.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.265 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.3 t -126.9 105.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.491 -0.756 . . . . 0.0 109.574 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.5 133.47 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 109.425 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 53.52 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.596 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.64 135.53 22.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.12 15.99 3.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.02 -1.64 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 109.558 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.0 ttt -89.96 -21.71 22.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.123 -0.986 . . . . 0.0 109.074 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -76.08 -45.39 34.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.835 . . . . 0.0 109.419 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -58.63 -20.87 51.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.878 . . . . 0.0 109.575 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -73.81 -55.56 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.849 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -23.14 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 110.263 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -53.05 62.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 109.122 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.05 -56.08 13.37 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.014 0.911 . . . . 0.0 108.991 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -40.6 -46.43 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.32 -45.0 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 0.0 108.541 179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -57.28 -30.4 64.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.478 -0.763 . . . . 0.0 109.147 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 -41.54 74.83 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.177 -0.952 . . . . 0.0 109.354 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.9 tp -76.86 -57.01 4.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -0.844 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . 152.3 77.37 0.02 OUTLIER Glycine 0 N--CA 1.478 1.483 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -150.22 147.99 28.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -1.073 . . . . 0.0 109.29 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.15 55.88 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.946 -1.096 . . . . 0.0 110.634 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.74 105.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.703 -1.248 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.76 -179.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.971 . . . . 0.0 109.384 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -134.71 -167.52 1.99 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -149.97 150.69 32.2 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.342 -178.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.531 ' O ' ' NH2' ' A' ' 18' ' ' ARG . . . -141.39 -169.22 2.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.5 mt-10 -139.73 9.31 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.257 -0.902 . . . . 0.0 110.222 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.2 m-20 170.85 173.32 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.0 108.896 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.1 -25.5 73.39 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -37.09 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.937 -1.331 . . . . 0.0 108.243 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -74.66 -39.96 61.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.348 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -75.32 -35.5 61.21 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.57 -52.72 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -62.08 -30.93 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -90.0 -18.83 25.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.323 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -61.02 -32.96 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.569 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -84.06 -0.15 50.65 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.38 -72.78 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.659 -0.651 . . . . 0.0 109.553 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.03 -86.78 0.3 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.17 72.79 0.18 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.593 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.6 m-85 -54.27 98.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.312 -1.111 . . . . 0.0 109.041 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.29 1.19 0.44 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -169.2 142.82 2.83 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.187 -1.184 . . . . 0.0 109.919 -179.652 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.8 t -133.59 145.43 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.088 -1.008 . . . . 0.0 109.57 179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 55' ' ' ILE . 89.5 mt -132.19 85.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 3.6 p -103.98 143.54 32.74 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.696 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.3 p30 -60.37 -122.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.532 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 75.2 t-105 -158.25 -77.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.02 122.88 32.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.089 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.445 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.25 -50.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 110.44 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.09 -173.67 0.22 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.747 0.965 . . . . 0.0 110.055 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.675 ' N ' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -52.68 -13.67 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.168 -0.958 . . . . 0.0 109.546 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.437 ' H ' HD21 ' A' ' 62' ' ' ASN . 3.7 mmt -147.23 -86.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -152.94 177.85 10.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.9 -9.52 77.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 46.7 tp -50.81 -25.65 4.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.679 -1.483 . . . . 0.0 108.239 179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 64' ' ' ASP . 7.6 pt-20 -72.59 -34.48 67.46 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' N ' ' CG ' ' A' ' 67' ' ' GLU . 25.7 mt -63.18 -56.13 19.28 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.11 -58.73 6.92 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.606 0.717 . . . . 0.0 109.193 179.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -53.86 -38.02 64.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 70.4 m -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.938 . . . . 0.0 109.097 179.7 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mt -67.09 -24.79 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.457 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -18.68 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 108.918 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.4 -52.22 22.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.176 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 79' ' ' SER . 4.1 t70 -66.71 83.85 0.11 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.94 43.44 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.76 -89.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -1.195 . . . . 0.0 109.564 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.0 mtt -118.16 20.98 13.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.0 109.25 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.522 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 t 46.93 -118.31 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.09 52.71 0.91 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER 46.07 -175.03 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.6 Cg_exo -63.03 144.79 93.53 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 121.68 1.586 . . . . 0.0 114.522 -176.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 t -139.5 111.38 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -95.13 106.07 18.05 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 117.551 -1.659 . . . . 0.0 106.964 177.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 1.1 ttm -74.56 107.68 6.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.539 -0.865 . . . . 0.0 109.392 -178.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -92.17 144.83 8.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.453 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 5.8 t -146.24 170.2 17.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.015 -1.053 . . . . 0.0 110.426 -178.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.57 ' CB ' ' HZ1' ' A' ' 109' ' ' LYS . . . -109.86 -57.29 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.709 -0.619 . . . . 0.0 109.551 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.74 29.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.564 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -46.45 110.9 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 3.8 ttpp -148.47 94.89 2.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.743 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttt 44.61 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.85 . . . . 0.0 110.156 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -45.93 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.333 -0.855 . . . . 0.0 110.419 -179.183 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -41.19 -34.43 0.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.477 -0.764 . . . . 0.0 110.764 -178.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.528 ' C ' ' H ' ' A' ' 97' ' ' ALA . 24.6 mt -75.58 -66.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.969 -1.082 . . . . 0.0 109.304 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -62.16 -0.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.023 179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -76.02 -37.85 57.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.401 -0.812 . . . . 0.0 109.119 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.98 -59.87 2.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.09 -1.006 . . . . 0.0 108.306 178.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -59.55 -22.37 61.6 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.514 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -49.32 -33.38 13.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.54 -36.82 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 176.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 90.29 64.94 1.22 Allowed Glycine 0 N--CA 1.482 1.71 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.001 175.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.12 -111.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.935 1.867 . . . . 0.0 108.678 177.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.62 -46.05 8.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 122.423 1.106 . . . . 0.0 108.611 177.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 163.23 -157.87 30.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -178.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -137.77 146.48 43.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.679 -0.895 . . . . 0.0 109.248 178.95 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.4 p -140.61 136.1 35.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' A' ' 109' ' ' LYS . 3.0 p -80.08 159.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.034 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.57 ' HZ1' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.27 154.79 80.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.0 109.523 -179.301 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.26 126.85 13.46 Favored 'Cis proline' 0 N--CA 1.488 1.194 0 O-C-N 122.564 0.771 . . . . 0.0 110.14 -2.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.93 156.6 18.33 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.376 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -92.99 148.44 22.0 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 176.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -49.28 -12.44 0.05 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.706 -1.246 . . . . 0.0 109.343 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -83.07 -37.74 23.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.72 -59.69 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.144 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.62 -40.71 53.71 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.983 179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 24.0 mm-40 -61.09 -55.12 36.31 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.185 -0.947 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -41.62 -38.27 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.42 0.628 . . . . 0.0 109.752 -179.33 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -88.19 -29.63 20.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.214 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp -65.53 -65.71 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.613 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.81 -36.36 11.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.651 ' HZ1' ' CB ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -73.73 -25.53 60.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.847 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.44 -41.38 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.922 . . . . 0.0 109.849 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.83 -19.83 62.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 110.252 -179.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' CA ' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -61.27 -20.88 63.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.758 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -94.51 -31.76 13.79 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.7 tt -72.82 -26.05 61.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.62 77.73 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.266 -1.138 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -46.71 136.61 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.04 48.48 1.58 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -178.55 33.66 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 50.5 tp -71.12 111.12 6.23 Favored 'General case' 0 C--O 1.206 -1.212 0 O-C-N 120.599 -1.313 . . . . 0.0 108.147 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.476 ' CG ' HD21 ' A' ' 32' ' ' ASN . 13.6 mtpt -58.04 119.8 7.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.072 . . . . 0.0 111.409 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 80.9 m-85 -110.79 148.76 31.68 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.34 110.88 17.48 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.52 106.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.286 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.407 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 27.4 t -96.96 92.03 2.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.504 -0.748 . . . . 0.0 109.59 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -147.42 132.47 18.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -24.68 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.64 130.82 48.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -82.83 -20.08 36.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -33.3 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.499 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttt -57.6 -30.51 65.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -71.71 -34.75 69.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.923 -1.11 . . . . 0.0 108.679 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -75.87 -16.13 60.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.519 -0.738 . . . . 0.0 109.068 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.78 -50.83 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.48 -32.23 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 110.26 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -47.76 -53.35 15.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 109.391 179.651 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.02 -57.4 5.04 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.514 -0.742 . . . . 0.0 109.771 -179.576 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -40.42 -61.02 0.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.423 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 mt -51.46 -50.78 59.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 108.72 179.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -49.07 -33.18 10.98 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.241 -0.912 . . . . 0.0 108.918 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -49.43 -51.07 37.94 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.404 -0.81 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.56 -48.1 57.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.005 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.45 81.59 0.06 OUTLIER Glycine 0 C--O 1.208 -1.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.08 149.26 30.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -1.094 . . . . 0.0 108.896 179.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -150.1 64.06 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 110.224 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.476 HD21 ' CG ' ' A' ' 7' ' ' LYS . 2.2 t30 -176.7 103.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.864 -1.147 . . . . 0.0 109.258 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.15 151.83 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 110.288 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -120.55 -170.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.8 mp0 -146.63 155.99 42.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.721 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.16 -163.02 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -137.47 -7.89 1.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 110.783 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 62' ' ' ASN . 6.8 t0 -177.42 -165.57 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.24 -26.59 57.28 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 6.3 p -75.64 -42.08 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.025 -1.28 . . . . 0.0 107.847 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 12.4 t0 -68.98 -43.73 74.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -64.75 -52.79 55.12 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' ALA . 3.4 tt -43.34 -36.71 1.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.419 -0.801 . . . . 0.0 109.242 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -71.62 -34.62 69.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.08 179.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 47' ' ' GLN . 11.7 mmmt -86.38 -53.59 4.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -41.13 -22.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.666 -0.646 . . . . 0.0 109.371 179.682 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -52.35 -43.63 64.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.36 -56.95 5.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 88.35 -19.26 36.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.75 -5.37 3.92 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 53' ' ' PHE . 61.6 m-85 -75.43 83.88 2.52 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.469 -1.019 . . . . 0.0 110.212 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.02 -3.93 1.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 177.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.572 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -155.87 144.57 20.33 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.53 -0.982 . . . . 0.0 110.221 -179.473 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.8 t -141.09 116.77 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 108.76 179.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 117.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.866 . . . . 0.0 108.861 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.1 p -120.05 166.95 12.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.629 -0.669 . . . . 0.0 109.681 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 12' ' ' ASP . 61.6 m-20 -95.58 -106.39 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.533 -0.73 . . . . 0.0 109.458 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CD1' ' OD2' ' A' ' 64' ' ' ASP . 56.6 t-105 -168.95 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.721 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.5 104.99 5.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.411 ' CE ' ' CA ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -130.9 174.09 5.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.339 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.42 -1.93 1.66 Allowed 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.396 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 8.5 m120 -127.05 83.67 2.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.283 -0.886 . . . . 0.0 109.488 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.9 mmt 48.46 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 109.599 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -165.04 179.09 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.961 -1.087 . . . . 0.0 109.405 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 60' ' ' MET . . . -70.96 14.66 1.46 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -68.3 -51.93 39.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -1.178 . . . . 0.0 108.854 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' O ' ' CG2' ' A' ' 71' ' ' THR . 1.8 mt-10 -63.53 -15.66 58.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.448 ' O ' ' OG1' ' A' ' 71' ' ' THR . 6.2 mt -79.98 -67.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.91 -62.17 1.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -58.23 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 16.6 p -52.91 -41.15 64.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.897 -1.127 . . . . 0.0 109.476 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.9 mt -64.22 -42.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.399 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -84.75 -4.86 59.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 -29.12 22.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.528 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.5 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . . . 162.92 -90.35 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.39 70.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.162 . . . . 0.0 109.158 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.9 mtm -92.45 10.22 31.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.238 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 76' ' ' GLY . 92.4 p -76.49 44.61 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 8.57 0.65 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.6 mt -72.19 121.14 83.9 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.525 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 113.82 1.9 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.415 1.41 . . . . 0.0 113.433 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.597 ' N ' ' OG ' ' A' ' 104' ' ' SER . 0.9 OUTLIER -103.25 105.65 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 175.224 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.42 105.92 18.14 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 116.749 -1.98 . . . . 0.0 106.55 178.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.521 ' SD ' ' O ' ' A' ' 85' ' ' MET . 2.7 ppp? -79.88 124.02 28.28 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.926 -177.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 140.78 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.209 -0.932 . . . . 0.0 109.103 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 t -150.07 174.98 12.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.044 . . . . 0.0 110.948 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.88 -64.68 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -75.82 63.96 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 108.873 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.622 ' CB ' ' HH ' ' A' ' 106' ' ' TYR . . . -67.34 91.99 0.27 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 144.12 25.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -24.03 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -78.2 -54.18 6.52 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' ALA . 1.2 t30 -68.74 -45.27 71.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 54.2 mt -48.65 -30.48 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.073 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.8 mt -89.86 -20.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.358 -0.839 . . . . 0.0 109.075 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.92 -45.75 92.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.409 -0.807 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.88 -54.34 8.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 108.199 179.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.86 -27.24 50.75 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.307 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -53.78 -34.03 57.79 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 178.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.09 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.24 75.87 0.43 Allowed Glycine 0 N--CA 1.481 1.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.04 177.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 -112.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.824 -1.95 . . . . 0.0 111.158 179.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.8 OUTLIER -91.67 -53.77 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.801 1.286 . . . . 0.0 109.019 176.633 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.41 -161.0 31.66 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -177.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.622 ' HH ' ' CB ' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -139.73 136.55 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 0.0 109.962 179.859 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.1 122.05 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.98 176.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.792 -1.193 . . . . 0.0 108.223 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.3 149.41 24.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.772 -1.205 . . . . 0.0 109.065 179.636 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.93 139.87 63.75 Favored 'Cis proline' 0 N--CA 1.484 0.923 0 C-N-CA 125.302 -0.707 . . . . 0.0 110.399 -1.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -99.04 163.79 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.77 146.05 23.94 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 177.63 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.35 -34.45 6.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.106 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.26 76.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.2 m -70.54 -66.97 0.53 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.509 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.8 tp -48.33 -40.12 24.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.593 -1.317 . . . . 0.0 109.497 178.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 119' ' ' LYS . 3.4 tm-20 -68.04 -68.45 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.027 . . . . 0.0 109.782 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 117' ' ' GLU . 86.0 tt0 -42.25 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.362 0.601 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' GLU . 5.5 mmmt -90.01 -47.57 7.76 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.071 179.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 123' ' ' ILE . 17.5 mt -56.07 -54.76 41.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -46.34 -49.93 17.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -57.15 -28.37 62.68 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.411 ' N ' ' O ' ' A' ' 120' ' ' LEU . 27.3 mt -86.13 -40.95 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.47 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -68.65 -6.61 26.93 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.974 -1.079 . . . . 0.0 110.427 -178.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.84 -19.88 61.91 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -29.53 13.02 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -21.54 29.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.475 -0.766 . . . . 0.0 108.94 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.87 75.18 0.17 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 109.404 179.979 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 2.0 t0 76.85 131.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.466 -0.771 . . . . 0.0 109.289 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.41 18.44 6.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 110.172 -179.876 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 2.1 tm-20 -152.78 41.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.688 -1.257 . . . . 0.0 111.072 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 31.4 tp -81.87 118.67 23.1 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.497 -1.377 . . . . 0.0 107.912 178.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -63.87 123.28 18.54 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.19 -0.944 . . . . 0.0 111.754 -177.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 91.8 m-85 -115.56 144.51 43.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.0 tp -119.13 111.56 18.41 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.4 100.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 108.609 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 58.2 t -94.95 98.96 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.388 -0.82 . . . . 0.0 109.633 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.1 t0 -156.86 142.88 17.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.0 109.389 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.23 93.71 7.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -162.21 149.56 13.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.11 16.95 13.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -145.19 -22.11 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.417 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 2.2 ttt -60.8 -65.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.65 -33.66 7.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -38.63 67.77 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.0 -177.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -64.51 -56.05 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.674 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -31.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -51.79 -54.29 30.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 109.319 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -65.77 -57.23 8.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.52 -0.737 . . . . 0.0 109.215 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.7 -59.48 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.977 -179.507 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.02 -50.19 67.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.015 179.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -56.07 -39.11 71.57 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.323 -0.861 . . . . 0.0 109.505 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -54.77 -44.47 73.69 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.287 -0.883 . . . . 0.0 109.184 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mt -69.5 -58.49 3.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.94 74.8 0.01 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 46.0 m-85 -150.21 152.38 34.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -1.174 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.74 62.33 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.93 -1.106 . . . . 0.0 110.065 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -176.42 97.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.825 -1.172 . . . . 0.0 109.667 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -150.2 149.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.91 -1.119 . . . . 0.0 110.161 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' OE2' ' OH ' ' A' ' 51' ' ' TYR . 16.2 mt-10 -126.4 -166.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -148.59 149.28 31.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 110.655 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.32 -169.32 2.83 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.408 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -143.98 3.54 1.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.237 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -176.72 157.84 1.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.519 -1.363 . . . . 0.0 109.765 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.1 -52.83 21.14 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -50.78 -31.06 9.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.895 -1.356 . . . . 0.0 108.139 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.5 t0 -79.24 -46.13 18.44 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -64.54 -56.62 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mt -48.65 -52.95 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.862 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -69.19 -33.55 73.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -10.71 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.242 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -81.55 -22.65 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.148 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -63.65 -6.67 5.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 108.639 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.11 -69.3 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.584 -0.698 . . . . 0.0 109.843 -179.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 10.2 1.0 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.05 85.53 1.27 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.412 ' OH ' ' OE2' ' A' ' 34' ' ' GLU . 22.4 m-85 -64.71 139.23 58.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -1.038 . . . . 0.0 110.494 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.01 3.1 62.02 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -165.89 146.86 6.81 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 89.7 t -148.63 123.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.786 -1.196 . . . . 0.0 109.759 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.98 93.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.411 ' H ' ' HG ' ' A' ' 56' ' ' SER . 13.7 p -96.36 158.1 15.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -0.861 . . . . 0.0 108.999 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' ASN . 4.4 p-10 -119.57 161.81 20.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.765 -0.584 . . . . 0.0 109.815 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 93.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 108.795 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -108.76 121.54 45.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.443 -0.786 . . . . 0.0 109.721 -179.297 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.627 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.6 ppp? -137.99 38.19 0.34 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.599 -0.688 . . . . 0.0 111.78 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -55.89 -24.97 50.35 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 178.034 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 63' ' ' MET . 7.8 p30 179.63 58.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 2.2 ttm 77.99 99.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.209 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -168.25 -172.53 1.76 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.528 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 71.12 -69.68 0.82 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -67.75 -61.62 1.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.109 -1.23 . . . . 0.0 108.992 179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.61 -12.12 9.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 108.653 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.514 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -73.02 -46.44 52.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.87 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -84.2 -30.57 25.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.242 179.992 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -61.68 -40.43 94.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.114 179.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.5 m -68.66 -41.49 79.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.018 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.64 -29.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.82 . . . . 0.0 108.795 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -90.03 -24.13 21.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.686 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.18 -28.94 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.69 131.79 34.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.05 -23.72 77.82 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.23 -28.56 17.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -1.193 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' ALA . 23.1 tpp -91.97 5.49 49.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 t -71.7 13.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -99.97 -37.24 9.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.708 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -38.55 102.67 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.766 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 96.25 0.23 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.164 1.243 . . . . 0.0 111.528 -178.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.84 105.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.3 tp -96.02 103.72 15.62 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.827 -1.549 . . . . 0.0 106.86 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.56 161.67 11.67 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.731 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.73 137.72 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 t -150.04 156.24 41.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.31 -31.14 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.45 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.14 -61.2 2.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.15 33.36 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -44.84 -67.27 0.3 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.0 109.795 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -167.35 -80.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -13.32 1.96 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 109.741 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -83.12 -21.88 33.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.637 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.89 -49.58 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.945 -1.097 . . . . 0.0 108.657 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 100' ' ' GLN . 1.8 mp -63.49 -19.5 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.336 -0.852 . . . . 0.0 108.949 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.36 -59.56 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.83 -53.42 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.79 -19.87 65.83 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.993 -178.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -50.61 -30.79 14.2 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.04 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -92.54 -26.62 17.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.46 72.54 1.05 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.815 177.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.24 -112.04 0.07 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 116.619 -2.032 . . . . 0.0 109.05 178.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.91 -49.41 6.25 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.754 1.264 . . . . 0.0 108.102 175.396 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.58 -160.0 32.48 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.482 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -138.57 124.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.849 . . . . 0.0 109.289 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.5 p -113.39 130.55 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.175 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.23 124.18 39.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.972 -179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 161.55 25.63 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.159 -0.963 . . . . 0.0 108.94 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.48 129.04 17.35 Favored 'Cis proline' 0 N--CA 1.484 0.933 0 O-C-N 122.842 0.917 . . . . 0.0 110.747 -2.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -96.93 163.76 12.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.935 . . . . 0.0 109.632 179.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.56 147.18 25.6 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.862 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.66 -20.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.808 -1.182 . . . . 0.0 109.047 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -75.74 -58.4 3.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.538 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.41 -38.81 59.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.207 -1.558 . . . . 0.0 107.972 178.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 120' ' ' LEU . 11.3 tt0 -57.14 -57.3 13.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.046 -1.034 . . . . 0.0 109.895 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.56 -39.19 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.532 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.43 -29.22 63.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -73.46 -45.37 54.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.521 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 125' ' ' GLU . 2.6 m120 -57.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.914 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -61.04 -46.31 91.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 109.729 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.26 -34.34 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.371 -0.83 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.27 -7.18 57.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.919 -178.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 121' ' ' ASN . 5.9 mt-10 -71.44 -28.55 64.05 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.342 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -94.14 -25.11 17.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.54 -22.4 30.13 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.41 79.62 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.285 -1.126 . . . . 0.0 109.465 179.925 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 7.4 m-20 -45.37 146.7 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.313 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.6 tttp -90.25 13.13 16.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.876 -1.14 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 1.3 tt0 -152.46 45.59 0.72 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.708 -1.245 . . . . 0.0 110.415 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.56 136.56 44.03 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -73.98 115.9 13.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.958 -1.088 . . . . 0.0 111.978 -176.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.3 m-85 -106.4 153.24 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.063 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.72 104.53 5.55 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.411 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.67 122.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.969 -178.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -111.97 93.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.863 . . . . 0.0 109.069 178.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD1' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.34 -178.03 4.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.02 28.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.532 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -90.9 -7.85 51.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.427 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.51 -10.09 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.747 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER -145.42 -8.88 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.986 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.9 ttt -64.9 -22.53 67.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.05 -63.64 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -46.75 -14.08 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.174 -178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' ARG . 4.2 mt -81.83 -50.13 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.014 -1.053 . . . . 0.0 109.628 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -27.72 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.786 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -55.71 -53.08 61.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 108.89 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -62.67 -59.22 5.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.525 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -40.61 -56.81 2.02 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.773 -179.985 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.84 -39.82 71.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.198 -0.939 . . . . 0.0 108.846 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -62.36 -50.71 70.5 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.282 -0.886 . . . . 0.0 109.207 179.642 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.04 -36.93 30.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.55 -61.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.19 65.12 0.01 OUTLIER Glycine 0 C--N 1.3 -1.465 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 44.2 m-85 -150.14 148.53 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 109.129 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.4 OUTLIER -150.15 59.28 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.806 -1.183 . . . . 0.0 111.159 179.908 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.21 98.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.703 -1.248 . . . . 0.0 110.684 179.511 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.71 178.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.035 -1.04 . . . . 0.0 110.352 179.058 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -142.31 -177.34 5.21 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 178.456 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 13.5 mt-10 -140.85 156.23 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.052 -1.03 . . . . 0.0 111.483 -178.133 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.99 -173.0 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.03 19.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.689 -1.257 . . . . 0.0 110.87 -179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.488 ' OD1' ' ND2' ' A' ' 62' ' ' ASN . 42.0 t0 -174.48 145.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -0.992 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.19 -42.37 17.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -63.01 -33.37 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.245 -1.15 . . . . 0.0 108.492 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' ASP . 18.8 t0 -73.29 -47.55 41.93 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.12 -48.2 80.93 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.42 -0.8 . . . . 0.0 108.845 179.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' CD1' ' C ' ' A' ' 43' ' ' LEU . 2.5 tm? -49.91 -50.43 46.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.708 -179.588 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -55.44 -40.17 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.895 . . . . 0.0 111.05 -178.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -26.31 20.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.015 -1.053 . . . . 0.0 111.06 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.59 -19.51 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.818 -1.176 . . . . 0.0 109.256 -179.209 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -95.89 -5.9 40.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.125 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.29 -62.81 1.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.317 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.55 8.77 1.38 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.45 77.14 1.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.473 ' C ' ' H ' ' A' ' 53' ' ' PHE . 36.6 m-85 -56.39 114.22 1.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.393 -1.063 . . . . 0.0 109.766 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.33 2.14 3.37 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -163.47 139.22 6.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.972 -1.311 . . . . 0.0 109.597 179.676 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.3 t -136.57 116.77 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.087 -1.008 . . . . 0.0 109.532 179.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.1 mt -103.8 99.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.533 -0.729 . . . . 0.0 109.532 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.475 ' O ' ' SD ' ' A' ' 85' ' ' MET . 15.2 p -110.25 156.74 20.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.56 162.96 14.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.468 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 42.0 t-105 -96.49 111.95 23.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 2.3 t-20 73.48 96.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.725 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.441 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.5 mtt 177.16 -50.63 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -66.27 -67.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 120.783 0.989 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.6 p30 -154.55 125.96 7.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 mtt 54.33 -86.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -149.0 144.0 26.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.06 1.78 4.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -67.28 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.266 . . . . 0.0 109.627 -179.867 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.9 tt0 -46.31 -32.62 3.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -66.87 -52.06 48.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.916 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -58.58 -60.42 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.237 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' ALA . 10.5 tttt -42.82 -34.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 m -52.06 -44.45 64.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 108.692 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.69 -30.8 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -6.9 55.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -64.17 -51.38 64.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.835 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -46.9 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.27 -61.32 0.36 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.44 -8.15 59.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -1.151 . . . . 0.0 109.257 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.6 mtp -90.26 -7.1 54.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -74.98 65.79 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.58 -28.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 0.0 110.452 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.0 mt -60.14 125.05 80.25 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 120.9 -1.125 . . . . 0.0 109.28 -179.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.9 150.79 75.82 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.231 1.287 . . . . 0.0 112.565 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.21 137.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.35 65.73 0.73 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.555 178.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' O ' ' A' ' 56' ' ' SER . 2.3 mmt -48.21 159.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.01 132.76 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 109.048 -179.166 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.1 t -150.12 166.47 29.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.49 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.35 -68.24 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 109.301 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.4 101.93 14.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.422 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -88.5 98.92 11.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.93 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -63.72 -151.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 108.977 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 94' ' ' ASN . 4.6 pttt -118.42 -71.43 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 109.413 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -48.97 -9.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.364 -0.835 . . . . 0.0 110.056 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -89.53 -49.02 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.856 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -61.58 -31.95 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 -179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.89 -63.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.087 -1.008 . . . . 0.0 109.651 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.88 19.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 108.834 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -47.97 -54.14 13.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.472 -0.768 . . . . 0.0 109.279 179.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -53.04 -45.23 67.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.878 . . . . 0.0 110.1 -179.379 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.72 -19.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 109.116 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -98.97 -113.54 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.611 -0.681 . . . . 0.0 109.59 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.701 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.35 -2.89 5.82 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.79 10.94 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 122.206 -0.585 . . . . 0.0 111.326 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.701 ' H ' ' C ' ' A' ' 102' ' ' GLY . 14.0 m -29.45 -33.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.15 130.79 10.26 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.92 121.76 10.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 0.0 109.429 179.385 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.23 141.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 8.5 p -92.13 100.68 11.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 108.907 179.739 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.53 159.87 38.77 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.921 -1.112 . . . . 0.0 109.345 -179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.48 147.74 87.61 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 O-C-N 123.008 1.004 . . . . 0.0 109.835 -3.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -126.36 159.03 34.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.143 0.973 . . . . 0.0 110.414 179.154 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -103.19 153.15 20.65 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.933 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.9 -12.92 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.691 -1.256 . . . . 0.0 109.487 -179.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.67 -42.92 23.74 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -60.26 2.56 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tp -49.26 -37.91 25.14 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.094 179.04 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -65.19 -48.83 72.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 109.866 -179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.35 -68.47 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 110.403 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.38 -47.49 9.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.83 . . . . 0.0 110.19 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.56 -44.56 96.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -34.84 79.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.247 -179.425 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -71.32 -34.57 70.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 109.8 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 mt -80.12 -41.31 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.74 -24.67 67.86 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.14 -29.84 65.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -29.4 29.65 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.4 tp -69.06 -22.11 64.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.89 5.38 57.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.373 -1.075 . . . . 0.0 109.372 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.449 0.643 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 63.01 131.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 109.369 -179.827 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -90.17 9.68 27.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.765 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -147.84 48.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.76 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 56.1 tp -76.35 115.86 16.48 Favored 'General case' 0 C--O 1.204 -1.302 0 O-C-N 120.612 -1.305 . . . . 0.0 107.827 178.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -57.43 120.19 7.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.851 -1.156 . . . . 0.0 111.694 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.2 m-85 -110.62 143.36 41.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.9 tp -116.94 113.03 21.84 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.99 98.14 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.3 t -90.05 89.24 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.11 135.1 17.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.066 -1.021 . . . . 0.0 109.709 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.6 m-20 -87.41 1.48 53.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.17 140.23 58.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 19.8 5.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.8 -27.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.847 . . . . 0.0 109.499 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -58.79 5.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.487 -179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.66 -36.12 6.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.396 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.5 -39.62 74.05 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.736 -178.294 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mt -60.13 -55.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.394 -0.816 . . . . 0.0 109.847 -179.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -34.0 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 110.638 -178.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -53.12 -53.28 52.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.936 -1.103 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -69.29 -56.12 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.12 -57.27 2.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.741 -179.467 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.1 -48.63 80.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.064 -1.023 . . . . 0.0 109.02 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -57.39 -28.99 63.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.55 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.17 -30.88 68.51 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.1 -1.0 . . . . 0.0 108.874 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.74 -66.73 0.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.187 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.55 29.58 0.02 OUTLIER Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -98.08 152.34 19.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 109.6 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -150.04 60.29 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.096 -1.003 . . . . 0.0 109.727 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.73 100.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.09 153.72 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.101 -0.999 . . . . 0.0 110.176 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.74 -167.46 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 108.987 179.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.92 145.67 26.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.053 -1.03 . . . . 0.0 110.042 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.48 -169.03 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.15 6.31 1.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.212 -0.93 . . . . 0.0 111.176 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.58 -175.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.533 -1.354 . . . . 0.0 110.005 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.87 -41.12 73.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.01 -36.99 76.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -1.056 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -78.99 -45.47 20.19 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.87 98.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.989 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.76 -39.12 90.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.074 -1.016 . . . . 0.0 109.741 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -74.25 -23.96 59.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -0.961 . . . . 0.0 110.336 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -90.03 -28.92 18.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.04 . . . . 0.0 110.829 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -60.46 -13.04 11.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.581 -1.325 . . . . 0.0 109.417 -179.281 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.17 -6.84 48.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.161 -0.962 . . . . 0.0 108.613 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.81 -71.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.578 -0.701 . . . . 0.0 109.826 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.14 12.64 1.08 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.89 94.78 0.97 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -73.97 148.8 41.79 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.257 -1.143 . . . . 0.0 110.128 -179.199 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.82 -9.01 33.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 178.269 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.2 129.49 14.71 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.28 122.78 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.079 -1.013 . . . . 0.0 110.09 179.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -107.43 132.31 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -149.47 142.39 24.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -74.62 123.01 24.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.349 -0.845 . . . . 0.0 109.285 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 51.0 t-105 -61.61 98.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.871 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 63.13 122.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 109.826 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.496 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 169.99 -46.79 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 110.334 179.526 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.14 -55.37 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.719 0.946 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.51 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.27 -177.77 4.38 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -93.1 131.5 38.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.192 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.05 1.83 3.28 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 64' ' ' ASP . 58.6 tp -73.36 -68.73 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -1.227 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -43.99 -31.4 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.533 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -66.08 -56.34 12.02 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.562 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.593 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 1.6 tt -63.42 -65.65 0.65 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.609 -0.682 . . . . 0.0 109.783 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' NZ ' HH21 ' A' ' 73' ' ' ARG . 6.7 tttm -39.89 -32.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.835 -0.541 . . . . 0.0 109.879 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 37.7 m -71.29 -39.99 71.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.083 -1.011 . . . . 0.0 108.776 179.296 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.515 ' N ' ' O ' ' A' ' 69' ' ' LEU . 96.4 mt -55.41 -42.05 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.429 HH21 ' NZ ' ' A' ' 70' ' ' LYS . 19.4 ptt85 -89.97 1.62 56.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.854 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.05 -28.25 48.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -36.21 53.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.73 -23.88 14.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.37 -52.41 65.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.16 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.421 ' O ' ' OG ' ' A' ' 79' ' ' SER . 4.9 mmt -90.04 16.58 8.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 -179.987 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.684 ' HG ' ' H ' ' A' ' 80' ' ' ALA . 46.1 p 46.55 -107.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.819 179.893 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.684 ' H ' ' HG ' ' A' ' 79' ' ' SER . . . -150.03 56.55 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 80' ' ' ALA . 1.2 pp -42.77 149.44 0.49 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.32 142.89 67.51 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 121.818 1.678 . . . . 0.0 113.505 -178.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.55 128.77 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.0 tp -109.27 72.7 0.82 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.012 177.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt -53.06 169.46 0.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -141.16 129.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.449 -0.782 . . . . 0.0 109.664 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 109' ' ' LYS . 24.3 m -141.64 166.7 24.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 109.255 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.497 ' N ' ' CG2' ' A' ' 87' ' ' THR . . . -111.58 -27.86 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.65 -0.656 . . . . 0.0 109.269 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.3 mt-10 -99.91 -72.4 0.67 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -0.805 . . . . 0.0 109.684 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.407 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 62.14 118.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.24 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -122.16 -88.06 0.63 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.634 . . . . 0.0 109.67 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' ASN . 1.4 mtpp -152.98 -77.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -45.94 -16.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.744 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.551 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 12.4 t30 -89.99 -33.15 16.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.422 ' N ' ' O ' ' A' ' 92' ' ' LYS . 54.1 mt -90.04 -20.69 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 97' ' ' ALA . 60.9 mt -73.66 -72.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.29 -50.66 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.7 -51.96 65.52 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.561 -0.712 . . . . 0.0 109.54 179.266 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.72 -41.93 70.92 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.317 -0.864 . . . . 0.0 109.902 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 100' ' ' GLN . 2.9 mp0 -61.43 -11.85 12.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.859 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.36 -104.79 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 110.43 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.725 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -134.6 0.78 3.87 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.54 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.792 -0.828 . . . . 0.0 110.006 177.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.725 ' H ' ' C ' ' A' ' 102' ' ' GLY . 6.1 m -29.1 -32.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.59 126.28 7.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.0 112.01 5.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -1.217 . . . . 0.0 108.944 179.547 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.8 p -108.82 129.89 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 7.8 p -80.93 93.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 108.925 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 161.19 3.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.012 . . . . 0.0 109.314 -179.583 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.74 162.28 92.67 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 124.705 -0.956 . . . . 0.0 110.372 -2.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -143.64 155.04 44.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.166 0.984 . . . . 0.0 110.431 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.55 154.02 18.9 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.09 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.13 -12.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.684 -1.26 . . . . 0.0 109.499 -179.228 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.49 -40.17 23.66 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 108.44 178.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.0 OUTLIER -71.42 -59.2 2.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.877 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 tp -50.59 -38.31 44.74 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.289 -1.364 . . . . 0.0 108.614 178.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.25 -51.22 70.5 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.157 -0.964 . . . . 0.0 109.562 179.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -46.01 -59.94 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.65 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.115 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.71 -68.23 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.496 -0.752 . . . . 0.0 109.037 179.687 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.08 -22.4 39.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.464 ' O ' ' CG ' ' A' ' 125' ' ' GLU . 1.4 ttpt -81.14 -24.4 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 110.303 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mt -90.08 -38.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.0 110.779 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.79 -17.03 64.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.993 -1.067 . . . . 0.0 111.342 -177.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -62.03 -27.85 69.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.723 -1.236 . . . . 0.0 107.714 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -87.71 -27.72 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -26.04 64.22 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.65 68.3 1.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.427 179.996 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER 61.94 131.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -90.07 10.57 23.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -146.44 50.19 1.15 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 22.4 tp -78.74 131.9 36.75 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.554 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.05 118.5 19.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 0.0 113.18 -175.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 45.3 m-85 -110.29 143.91 39.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.204 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -114.04 107.74 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.16 101.51 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.9 120.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.367 -0.833 . . . . 0.0 110.619 -178.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CE2' ' A' ' 14' ' ' PHE . 4.6 t0 -176.44 -178.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.467 -0.771 . . . . 0.0 109.389 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -114.94 9.96 16.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.064 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' ' CB ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -69.46 164.14 23.74 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.397 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.4 p -134.09 29.84 3.69 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.675 ' HG1' ' N ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -154.08 -60.62 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.481 -177.184 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.675 ' N ' ' HG1' ' A' ' 16' ' ' THR . 4.7 ttt -45.69 -58.13 3.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' HE ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -34.08 -33.99 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.469 0.652 . . . . 0.0 109.93 178.726 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -70.19 -46.54 64.38 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.621 -178.426 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.6 mp -54.46 -58.07 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.249 -0.907 . . . . 0.0 109.269 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -43.25 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.504 -0.747 . . . . 0.0 110.157 -179.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.569 ' NH1' ' HE ' ' A' ' 18' ' ' ARG . 4.6 mtt85 -46.78 -53.36 12.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -64.69 -57.12 9.86 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.807 0.813 . . . . 0.0 109.192 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -38.43 -56.03 1.31 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.42 -52.18 65.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.01 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -52.53 -39.39 61.31 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.83 -31.22 26.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.95 -62.35 1.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.275 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 159.55 74.06 0.02 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 56.0 m-85 -150.1 155.12 39.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.215 . . . . 0.0 109.57 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.18 40.28 0.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.093 -1.004 . . . . 0.0 110.294 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -157.57 108.6 2.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.655 -1.278 . . . . 0.0 109.536 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -146.35 146.96 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.315 -0.865 . . . . 0.0 110.067 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.85 -172.55 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 74.5 mt-10 -149.95 154.11 37.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.01 -1.056 . . . . 0.0 110.38 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.15 -173.97 3.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 15.6 mm-40 -117.95 -2.13 11.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.487 -0.758 . . . . 0.0 110.443 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 165.01 166.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.31 -0.869 . . . . 0.0 109.041 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -42.74 -52.82 5.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 2.9 p -58.96 -42.27 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.881 -1.364 . . . . 0.0 109.176 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 8.7 t0 -58.83 -45.98 88.73 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.17 -40.99 91.86 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.65 -39.62 36.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.926 -1.109 . . . . 0.0 108.624 179.405 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -88.18 -33.01 18.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.232 -0.918 . . . . 0.0 110.35 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -89.9 -55.8 3.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.104 -0.998 . . . . 0.0 109.879 -179.603 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 42' ' ' ALA . 7.2 tt -45.68 -27.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.59 12.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 108.808 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -49.7 -55.47 13.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.52 -0.738 . . . . 0.0 109.652 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.65 33.78 0.07 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.89 124.52 2.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 53' ' ' PHE . 18.2 m-85 -113.64 107.18 15.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.76 -0.847 . . . . 0.0 110.193 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.89 0.46 1.7 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -168.39 144.32 3.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.257 . . . . 0.0 109.484 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 92.9 t -142.23 126.94 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.854 -1.154 . . . . 0.0 109.685 179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.3 mt -110.51 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.7 p -91.04 141.62 28.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.88 -1.138 . . . . 0.0 109.461 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -106.61 24.71 12.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 110.521 -179.307 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.487 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 4.5 t-105 62.19 143.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.941 -1.099 . . . . 0.0 109.163 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -151.49 167.7 27.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 109.987 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.658 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -144.48 23.5 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 113.615 -179.932 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -59.33 -54.9 2.16 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 N-CA-C 108.598 -1.347 . . . . 0.0 108.598 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -155.31 -21.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.674 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 76.6 mtp -150.78 103.49 3.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.483 -0.76 . . . . 0.0 109.031 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -58.69 -175.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.081 -1.012 . . . . 0.0 110.183 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.02 -5.29 80.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.44 -50.53 67.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.795 -1.415 . . . . 0.0 107.832 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.45 -24.66 2.11 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 72' ' ' ILE . 3.8 tp -69.78 -57.43 5.11 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.08 -55.14 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.031 0.92 . . . . 0.0 109.052 178.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -59.79 -50.02 75.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.399 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.6 m -69.23 -14.86 63.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 68' ' ' LEU . 1.1 mt -78.26 -29.72 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -77.24 -35.12 55.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.933 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -45.25 -27.98 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.168 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.54 78.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.942 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 43.69 -157.91 0.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.65 57.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.652 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.2 tpt -90.0 -8.81 50.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 108.907 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m 45.45 -119.19 0.79 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.548 -0.72 . . . . 0.0 109.938 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.03 60.58 0.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 47.65 -178.92 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.815 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.5 Cg_exo -62.83 142.93 90.64 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.533 2.156 . . . . 0.0 115.451 -174.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.01 104.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -91.48 104.78 17.24 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.722 178.388 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.0 ttm -77.44 119.4 20.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.704 -1.198 . . . . 0.0 108.726 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.2 p -108.13 146.08 14.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.503 -0.748 . . . . 0.0 109.611 -178.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.72 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 3.0 t -150.12 -173.41 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.614 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.72 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -129.8 -46.41 1.15 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.5 pt-20 -74.67 26.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -52.64 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.378 -0.826 . . . . 0.0 109.448 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ttmt -99.99 -69.12 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 109.481 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -169.94 -44.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -79.97 -24.57 40.85 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.281 -0.887 . . . . 0.0 109.796 -179.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 4.6 t30 -87.95 -28.05 21.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.865 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.7 mt -72.67 -58.0 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 108.938 179.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.34 -29.39 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.362 -0.836 . . . . 0.0 109.162 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.77 -40.05 39.98 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.964 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -80.92 -62.11 1.77 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -53.39 -28.4 29.23 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.816 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.51 -35.39 68.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -76.9 -26.05 53.71 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 176.57 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.49 71.84 0.88 Allowed Glycine 0 N--CA 1.484 1.846 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.745 175.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.412 ' HB2' ' H ' ' A' ' 104' ' ' SER . . . -90.2 -111.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 117.495 -1.682 . . . . 0.0 109.391 177.629 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.631 ' HG ' ' N ' ' A' ' 105' ' ' GLY . 0.9 OUTLIER -91.58 -47.48 7.38 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.53 1.157 . . . . 0.0 108.833 177.224 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.631 ' N ' ' HG ' ' A' ' 104' ' ' SER . . . 166.7 -159.02 32.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -178.155 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -142.62 136.39 29.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.705 -0.879 . . . . 0.0 109.833 179.308 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.427 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 6.2 p -134.71 134.24 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -161.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.86 151.76 8.32 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 108.784 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.86 138.08 53.96 Favored 'Cis proline' 0 N--CA 1.486 1.035 0 C-N-CA 125.281 -0.716 . . . . 0.0 110.341 -2.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.4 ' CD2' HD22 ' A' ' 116' ' ' LEU . 3.3 p90 -97.89 160.21 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.376 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.78 146.95 23.25 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.831 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -49.01 -34.73 13.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 108.442 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.47 -35.38 80.75 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.8 m -70.44 -70.57 0.29 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -51.67 -28.34 14.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.429 -1.419 . . . . 0.0 109.841 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 10.2 tt0 -62.22 -62.66 1.61 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.463 -1.398 . . . . 0.0 108.997 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.32 -44.45 16.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -62.04 -31.43 71.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 tt -81.63 -53.5 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -33.96 74.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.701 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -70.78 -44.0 67.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.46 -36.65 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 109.264 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -73.79 -29.85 62.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -51.67 -29.88 19.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -86.37 -30.7 21.96 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 tp -79.91 -10.05 59.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 0.0 108.846 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.69 41.19 12.71 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.317 -1.108 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.602 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -45.75 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -69.03 26.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 109.942 -179.934 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' H ' ' C ' ' A' ' 3' ' ' ASP . 30.6 mt-10 -134.62 35.71 3.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.85 136.16 34.23 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.2 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -83.94 129.91 34.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.91 -1.118 . . . . 0.0 111.237 -177.382 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.56 157.69 21.73 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.445 0.64 . . . . 0.0 109.767 179.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 0.5 OUTLIER -132.64 108.35 9.0 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.461 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -92.63 110.12 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -177.608 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.03 92.68 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.071 -1.018 . . . . 0.0 109.506 179.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -144.99 151.69 38.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.15 -33.38 10.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.629 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.87 132.32 11.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 109.595 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -86.29 26.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -146.32 -23.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.27 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.4 ttt -65.67 -46.74 77.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -55.86 -30.97 62.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.635 ' NH2' HH12 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -70.02 -24.66 63.31 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.309 -177.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.15 -47.28 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 109.889 -179.639 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -34.43 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.22 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.635 HH12 ' NH2' ' A' ' 19' ' ' ARG . 8.6 mtp180 -47.43 -51.56 19.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.51 -58.53 3.86 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.677 0.751 . . . . 0.0 109.84 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -40.57 -46.41 2.51 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.474 -179.085 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -71.24 -41.91 69.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.124 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -61.91 -30.36 70.84 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.261 -0.9 . . . . 0.0 109.342 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.14 -23.27 62.02 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -90.78 -40.49 11.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 144.29 5.36 0.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.93 135.33 33.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.323 . . . . 0.0 109.794 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.53 ' N ' ' ND2' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -145.76 64.24 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.102 -0.999 . . . . 0.0 109.894 -179.829 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.45 97.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 110.01 179.84 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.93 177.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -0.999 . . . . 0.0 110.228 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' CD ' ' CZ ' ' A' ' 51' ' ' TYR . 13.5 pt-20 -134.91 -166.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.937 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -147.39 155.03 41.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 110.905 -179.259 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.37 -166.87 2.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -136.35 -7.94 1.99 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.387 -0.82 . . . . 0.0 110.211 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -178.12 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.052 . . . . 0.0 109.243 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.12 -52.16 46.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.05 -35.28 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.916 -1.343 . . . . 0.0 107.812 179.198 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -68.23 -50.57 53.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.059 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.02 -18.95 65.68 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.279 -0.888 . . . . 0.0 108.708 179.44 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.625 ' CD2' HE22 ' A' ' 47' ' ' GLN . 0.7 OUTLIER -77.41 -27.59 52.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.149 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -90.64 -33.35 15.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.316 -179.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -58.7 2.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.009 -1.057 . . . . 0.0 110.076 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tt -51.88 -22.41 3.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 109.089 -179.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.625 HE22 ' CD2' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -51.84 -29.39 19.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 108.799 179.158 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.92 -59.31 2.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.42 112.18 3.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.39 -30.11 0.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.553 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.4 m-85 -64.21 85.29 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.296 -1.12 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.0 9.62 2.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -159.54 153.02 22.51 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.391 -1.064 . . . . 0.0 109.883 -179.355 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.07 142.93 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.918 -1.114 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.8 mt -126.4 104.14 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.51 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 p -114.7 150.54 35.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.383 -0.823 . . . . 0.0 110.272 -178.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.24 -85.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 109.236 179.522 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.627 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 59.6 t-105 -165.76 169.11 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.278 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.627 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -76.33 44.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.735 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtp -71.17 -46.74 14.27 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.401 -0.812 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.47 -50.6 1.81 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.12 1.213 . . . . 0.0 110.299 -179.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -164.03 154.21 14.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -46.09 125.17 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.827 . . . . 0.0 109.342 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER 177.01 -61.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.027 -1.045 . . . . 0.0 109.902 -179.952 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -38.26 -40.13 0.84 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -55.62 6.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.332 . . . . 0.0 109.003 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -63.52 -10.01 15.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 108.76 179.339 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -73.95 -59.94 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.567 0.698 . . . . 0.0 109.126 179.621 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -76.68 -31.82 57.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.569 -0.707 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -67.35 -47.48 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.122 179.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 86.7 m -64.52 -41.45 96.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 108.973 179.681 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 46.4 mt -60.42 -26.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.845 . . . . 0.0 109.071 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -89.31 -25.49 21.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.749 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.27 69.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 109.362 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -78.36 93.03 4.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 109.477 179.98 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.13 -24.09 54.03 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.52 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -1.18 . . . . 0.0 109.59 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.3 mtt -149.14 21.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 75' ' ' ASP . 88.5 p -75.17 65.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.976 . . . . 0.0 109.397 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -149.98 -28.71 0.24 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 80' ' ' ALA . 1.5 tp -43.84 107.55 0.6 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 109.676 -179.362 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.6 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.469 1.446 . . . . 0.0 113.293 -178.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.72 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 176.587 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.89 105.11 17.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.279 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.67 118.48 22.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.084 -177.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -104.1 150.89 6.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.521 -0.737 . . . . 0.0 109.764 -178.532 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -150.01 165.99 31.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.98 -1.075 . . . . 0.0 110.046 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -90.55 -97.38 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 9.2 mp0 -59.78 81.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.086 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -70.21 70.48 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.501 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.257 -0.902 . . . . 0.0 108.72 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' CG ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER 179.53 -59.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.465 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.466 ' H ' ' CG ' ' A' ' 92' ' ' LYS . 15.5 mt-10 -55.07 -34.78 63.9 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.27 -0.894 . . . . 0.0 109.655 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -79.11 -11.55 59.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.723 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 35.0 mm -85.1 -67.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.131 -0.98 . . . . 0.0 109.067 179.814 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.5 mp -48.09 -21.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' ILE . . . -57.37 -63.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.138 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -49.94 -58.81 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.567 179.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.44 -24.65 46.9 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.48 -178.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.9 tt0 -51.59 -31.79 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.75 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.65 -23.31 20.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.557 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.02 75.86 0.5 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.461 177.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.06 -112.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 117.009 -1.876 . . . . 0.0 109.588 179.013 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -49.38 6.3 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 122.921 1.343 . . . . 0.0 108.042 175.554 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.94 -163.0 36.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.384 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.69 139.28 41.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.623 -0.927 . . . . 0.0 109.158 178.579 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.498 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.7 p -133.87 150.64 31.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.433 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 57.5 t -90.95 160.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.069 -1.02 . . . . 0.0 109.558 -179.528 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.9 pttt -129.01 156.06 78.73 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.193 -0.942 . . . . 0.0 108.755 178.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.72 123.78 9.34 Favored 'Cis proline' 0 N--CA 1.486 1.084 0 O-C-N 122.618 0.799 . . . . 0.0 110.625 -2.515 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.9 165.84 13.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.031 . . . . 0.0 109.215 179.132 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.508 ' HG1' ' H ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -99.8 167.05 10.78 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.041 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.508 ' H ' ' HG1' ' A' ' 112' ' ' THR . . . -62.88 -37.92 88.8 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.954 -179.47 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.57 66.29 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.45 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.425 ' O ' ' C ' ' A' ' 116' ' ' LEU . 5.4 m -78.41 -69.88 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.623 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 115' ' ' THR . 9.1 tp -46.61 -36.0 6.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.726 -1.234 . . . . 0.0 109.213 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -63.14 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.109 -0.994 . . . . 0.0 110.822 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -45.8 -29.85 1.47 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.158 -0.964 . . . . 0.0 110.153 -178.89 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -85.25 -32.88 22.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 0.0 108.891 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.81 -52.0 49.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.441 -0.787 . . . . 0.0 109.469 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.26 -61.09 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 109.707 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -52.77 -27.96 20.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 110.133 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 mt -76.92 -43.73 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 0.0 109.974 -179.55 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 128' ' ' GLY . 12.0 m-85 -66.77 -5.9 13.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.833 -179.269 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.42 -24.64 62.95 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.057 -1.027 . . . . 0.0 108.249 178.924 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.08 -24.72 16.75 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.153 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.76 -14.14 25.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.53 -0.732 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' PHE . . . 46.2 86.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.221 0.534 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -46.62 146.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.499 179.889 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -90.37 14.82 11.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 109.943 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.12 45.39 0.44 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.761 -1.212 . . . . 0.0 110.941 -178.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 46.5 tp -71.96 111.93 7.62 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.792 -1.193 . . . . 0.0 107.817 179.053 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' CG ' HD21 ' A' ' 32' ' ' ASN . 17.6 mttt -48.13 118.77 2.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.719 -177.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 38.2 m-85 -109.83 155.44 21.65 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.75 0.786 . . . . 0.0 110.487 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.86 102.63 5.12 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.7 m -89.99 103.84 14.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.428 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 44.5 t -97.96 110.35 25.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.424 -0.798 . . . . 0.0 109.354 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -169.72 159.08 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.85 -179.741 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 14' ' ' PHE . 13.1 t0 -97.45 -100.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.536 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 45.2 -163.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -0.859 . . . . 0.0 109.752 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.1 12.34 2.41 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.748 . . . . 0.0 109.238 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.1 ttt -67.43 -66.26 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.798 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.573 ' CD ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.62 -35.67 4.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 109.84 -179.842 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -70.66 -41.2 72.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.52 -52.96 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.0 -45.34 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.091 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -46.27 -53.76 10.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.974 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.87 -57.23 8.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.857 0.836 . . . . 0.0 109.304 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.08 -59.77 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 -179.792 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.39 -48.05 68.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.784 . . . . 0.0 109.431 179.693 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.32 -42.91 78.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 -179.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.48 -29.95 59.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.273 -0.892 . . . . 0.0 109.239 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.72 -62.97 1.41 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.69 35.07 0.02 OUTLIER Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.535 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 47.3 m-85 -115.66 139.09 50.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.751 -0.852 . . . . 0.0 109.733 -179.589 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.3 63.88 1.54 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.469 -0.769 . . . . 0.0 109.69 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.44 HD21 ' CG ' ' A' ' 7' ' ' LYS . 2.4 t30 -176.8 95.57 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.967 -1.083 . . . . 0.0 108.551 179.796 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.11 147.09 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.693 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -118.83 -164.87 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.351 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -150.15 159.19 44.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.87 -170.87 3.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -121.73 -10.1 8.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 111.004 -178.985 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.51 171.81 2.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.565 -1.334 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.45 91.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.622 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.32 -39.3 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.953 -1.322 . . . . 0.0 108.926 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -63.74 -51.11 66.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.89 -48.96 63.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.29 -44.48 16.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 109.706 179.602 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -79.64 -29.62 41.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.296 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -89.77 -10.33 45.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.085 -1.009 . . . . 0.0 110.371 -179.29 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.4 OUTLIER -71.08 -6.37 38.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.058 . . . . 0.0 108.726 -179.992 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' O ' ' NE2' ' A' ' 47' ' ' GLN . 29.6 tp60 -95.14 -13.14 25.32 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.96 -66.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.472 -0.768 . . . . 0.0 109.459 179.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.97 7.14 1.87 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.96 84.33 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -63.54 138.94 58.7 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -1.051 . . . . 0.0 110.4 -179.031 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.45 -4.03 86.19 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 4.0 t80 -169.35 94.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.89 -1.359 . . . . 0.0 110.35 -178.618 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.2 m -94.86 141.9 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.129 -1.607 . . . . 0.0 110.623 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.89 96.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.778 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -111.13 177.6 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.555 -0.716 . . . . 0.0 110.297 -179.476 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 11' ' ' VAL . 4.8 m-20 -89.8 -121.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.466 -0.771 . . . . 0.0 110.179 -179.2 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 61.3 t-105 -127.56 -173.64 2.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 1.2 p-10 -93.87 55.74 2.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 -179.762 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -75.87 -45.6 3.97 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.991 -1.068 . . . . 0.0 110.406 179.702 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -67.73 -44.77 3.89 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.208 1.272 . . . . 0.0 110.211 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.74 159.79 19.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 119.16 7.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -175.96 -63.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.978 179.901 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -34.22 -50.11 0.67 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.397 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -68.49 -60.55 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.768 -1.431 . . . . 0.0 108.81 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.6 tt0 -54.75 -13.06 0.9 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 108.561 179.404 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -72.45 -55.08 7.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.375 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -63.96 -37.46 87.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -64.24 -55.03 24.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 108.851 179.44 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 6.8 p -54.18 -44.24 71.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.331 -0.856 . . . . 0.0 108.731 179.427 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.94 -19.19 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.309 -0.869 . . . . 0.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -36.33 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 109.227 179.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.88 72.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.774 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' SER . 15.4 t70 -47.68 145.43 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.42 -34.05 4.61 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.42 -27.0 45.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.71 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.7 mmt -137.18 -55.83 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 46.78 24.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.06 3.59 0.53 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.885 -179.514 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -54.52 115.26 8.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 108.292 -179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 2.7 Cg_endo -60.46 134.6 55.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 121.182 1.255 . . . . 0.0 113.715 -177.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.689 ' H ' ' HG ' ' A' ' 104' ' ' SER . 1.0 OUTLIER -128.62 112.97 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.778 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.1 tp -97.85 96.52 8.26 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.447 179.245 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.3 144.14 54.44 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.713 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 44.4 t -133.81 145.15 33.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.559 0.695 . . . . 0.0 110.707 -177.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -150.08 165.04 33.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.087 179.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.46 38.11 3.35 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.598 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' ALA . 1.7 mt-10 -165.75 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.407 -0.808 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 45.18 84.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.869 0.842 . . . . 0.0 108.754 -179.435 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -75.41 16.66 0.33 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.963 . . . . 0.0 109.805 -178.924 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.497 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 13.4 ttmt 75.44 -45.4 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.884 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.26 -45.16 49.55 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.454 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 2.9 m-80 -74.06 -4.76 37.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.0 109.337 179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.464 ' C ' ' H ' ' A' ' 97' ' ' ALA . 8.9 mt -80.26 -57.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 108.521 179.381 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 79.5 mt -68.8 2.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.271 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -80.67 -47.52 13.92 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.508 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.68 -50.7 33.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.534 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.65 -25.79 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.289 -179.642 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -52.99 -33.04 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.593 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.53 -23.27 25.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.24 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 75.61 0.51 Allowed Glycine 0 N--CA 1.48 1.572 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.544 177.771 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.99 -112.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.877 -1.929 . . . . 0.0 109.596 179.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.689 ' HG ' ' H ' ' A' ' 83' ' ' VAL . 67.3 m -91.88 -49.02 6.46 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.7 1.238 . . . . 0.0 108.06 175.531 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 167.31 -159.68 33.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.525 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 137.61 26.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.568 -0.96 . . . . 0.0 109.055 178.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -131.76 134.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 7.2 p -89.14 96.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.585 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.419 ' CD ' ' C ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -61.04 155.7 53.2 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 0.0 108.557 179.812 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.38 154.44 99.65 Favored 'Cis proline' 0 N--CA 1.487 1.094 0 C-N-CA 125.335 -0.694 . . . . 0.0 111.313 -1.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -135.33 156.54 48.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.693 0.758 . . . . 0.0 108.998 178.422 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.29 150.0 21.5 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.95 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.82 -35.0 21.33 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.735 -1.228 . . . . 0.0 108.985 -179.43 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.98 65.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 112' ' ' THR . 17.5 m -75.99 -65.23 0.94 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.921 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.73 -36.93 27.32 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.23 -1.388 . . . . 0.0 108.313 179.086 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 -53.21 39.16 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.002 -1.062 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -46.55 -25.02 0.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.516 -0.74 . . . . 0.0 109.05 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -88.51 -49.97 6.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 mt -48.49 -59.02 3.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.02 -61.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.34 -0.85 . . . . 0.0 110.237 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -45.4 -29.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 110.1 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.541 ' C ' ' H ' ' A' ' 125' ' ' GLU . 4.6 mt -87.88 -44.01 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.217 -179.614 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -62.0 5.27 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.969 . . . . 0.0 110.579 -178.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.541 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.8 tt0 -77.91 -36.47 49.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -81.15 -35.56 31.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -32.85 70.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.021 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.61 75.28 0.9 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.234 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.313 -1.11 . . . . 0.0 109.428 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -45.87 143.36 2.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 23.8 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.96 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.28 42.92 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.3 tp -67.63 143.22 56.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.233 -0.917 . . . . 0.0 108.577 179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -79.76 120.35 23.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.117 -0.989 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -109.05 152.79 24.55 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.672 -0.642 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.3 tp -130.43 110.76 11.72 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.12 104.38 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.81 100.73 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 120.937 -1.102 . . . . 0.0 109.66 -179.723 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -163.58 1.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.775 . . . . 0.0 109.227 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.29 1.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.988 -179.886 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.63 153.3 28.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.051 -1.031 . . . . 0.0 109.376 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.1 p -93.63 41.11 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.712 -179.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -173.9 -21.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.8 ttt -62.41 -46.42 88.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -45.58 78.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -55.37 -34.24 64.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 110.701 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -63.86 -48.51 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.158 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.21 -36.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.993 . . . . 0.0 110.575 -178.964 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -50.7 -53.11 33.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.73 -56.65 10.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.672 0.749 . . . . 0.0 109.471 179.915 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.94 -57.67 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.954 -179.669 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.81 -51.87 65.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.213 179.382 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -53.82 -35.08 61.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -55.49 -28.92 57.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.228 -0.92 . . . . 0.0 109.552 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 mt -87.82 -62.56 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.71 65.5 0.03 OUTLIER Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -150.01 145.31 26.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.251 . . . . 0.0 109.574 -179.82 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -150.02 66.63 0.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -173.91 99.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.15 150.94 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.05 -167.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.233 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.14 152.55 34.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 110.536 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.41 168.12 20.87 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.069 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.08 9.26 9.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.56 -0.712 . . . . 0.0 109.911 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.6 p-10 178.05 -176.23 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.69 -39.24 49.11 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.7 -35.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.05 -1.265 . . . . 0.0 108.025 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.69 -47.49 11.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.59 -0.694 . . . . 0.0 109.316 179.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -55.05 30.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -59.09 6.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.08 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -53.02 -33.43 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.028 -179.465 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -88.76 -13.24 39.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -82.17 -29.57 31.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.716 -1.24 . . . . 0.0 109.178 -179.976 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -8.41 0.31 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.174 -0.954 . . . . 0.0 108.653 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.8 -69.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.602 -0.686 . . . . 0.0 109.795 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.98 15.26 0.51 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.352 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 93.6 0.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.439 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 29.4 m-85 -72.11 104.91 3.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -1.083 . . . . 0.0 110.491 -178.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.23 -11.07 6.06 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.159 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -151.98 137.02 17.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.245 -1.15 . . . . 0.0 110.069 -178.93 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.3 p -144.5 133.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.715 -1.241 . . . . 0.0 109.52 178.643 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.94 157.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.196 0.522 . . . . 0.0 109.775 -178.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.2 p -144.93 168.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 108.942 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -93.31 -21.63 19.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.923 . . . . 0.0 110.584 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.5 t-105 59.65 35.36 22.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.206 -0.933 . . . . 0.0 109.911 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -177.85 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.908 -1.12 . . . . 0.0 109.882 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 175.63 -50.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.148 -0.97 . . . . 0.0 110.732 179.573 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.8 Cg_endo -64.71 123.46 11.72 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 120.95 1.1 . . . . 0.0 110.455 -179.425 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 8.2 p30 41.82 -146.56 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.664 -0.647 . . . . 0.0 109.889 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 7.3 mtp -47.32 -65.2 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 108.811 179.753 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.47 -39.41 0.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 108.914 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.7 -3.57 2.34 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 69' ' ' LEU . 10.7 tp -71.64 -61.68 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.032 -1.275 . . . . 0.0 107.611 178.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' O ' ' OG1' ' A' ' 71' ' ' THR . 29.5 tt0 -47.17 -27.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.726 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.41 -36.5 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.0 109.246 179.818 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 66' ' ' LEU . 1.4 tp -90.03 -36.04 15.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.808 -178.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -59.32 -50.58 73.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.967 -1.083 . . . . 0.0 109.405 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 3.0 m -48.89 -44.91 40.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.262 -0.898 . . . . 0.0 109.407 179.897 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.7 mt -57.51 -38.16 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.29 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -65.82 -53.98 32.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.57 -45.45 18.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.5 130.97 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.677 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.47 40.87 2.97 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.99 -15.75 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 0.0 109.335 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.552 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.8 31.64 2.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.086 179.986 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 m -71.08 23.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -150.04 12.11 0.75 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.009 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 8.2 tp -67.57 118.11 53.93 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 108.736 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.46 129.42 31.12 Favored 'Trans proline' 0 N--CA 1.479 0.648 0 C-N-CA 121.049 1.166 . . . . 0.0 112.366 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 t -118.52 114.97 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.254 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.4 tp -95.64 75.27 3.23 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.192 -1.403 . . . . 0.0 108.789 178.221 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -57.74 153.57 13.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.509 -0.744 . . . . 0.0 109.192 -179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.46 125.12 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.9 t -150.22 125.81 10.28 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.477 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.39 -27.52 41.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 0.0 109.015 179.344 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.75 39.86 1.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.434 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -46.44 106.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.634 -179.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' CG ' ' H ' ' A' ' 92' ' ' LYS . 23.0 tptt -97.04 -144.73 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.572 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' ASN . 7.0 mtmp? -104.11 -80.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -45.18 -16.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.0 110.003 -179.546 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -82.0 -36.66 27.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 39.6 mt -89.97 -9.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.75 -179.782 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -89.76 -68.24 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.92 -1.113 . . . . 0.0 110.002 -179.645 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.33 -49.87 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.431 -179.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.42 86.79 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.212 179.432 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.04 -50.43 27.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.085 -1.009 . . . . 0.0 109.941 -179.345 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -55.12 -24.42 25.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.592 -179.81 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.45 -104.91 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.694 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -141.58 7.59 2.51 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.488 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.22 11.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.014 -0.698 . . . . 0.0 110.6 178.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.27 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.799 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.03 125.72 8.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.213 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.98 110.7 5.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 179.817 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.68 134.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.072 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 7.7 p -89.6 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.049 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.84 160.92 1.9 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.108 -0.995 . . . . 0.0 109.775 -179.31 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.92 163.01 91.12 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.702 -2.491 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -146.02 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.088 0.947 . . . . 0.0 110.443 178.679 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.82 154.36 18.99 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.875 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.65 -11.98 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.629 -1.294 . . . . 0.0 109.361 -179.213 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.33 -39.44 25.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.139 -0.975 . . . . 0.0 108.665 178.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -58.64 3.19 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.806 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.0 tp -50.56 -37.43 39.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 108.76 178.638 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.45 -52.84 62.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.101 -0.999 . . . . 0.0 109.654 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.29 -60.12 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 109.673 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -47.4 -41.36 19.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.814 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.84 -63.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -29.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.675 -179.727 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -34.26 67.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.407 ' N ' ' O ' ' A' ' 120' ' ' LEU . 41.4 mt -73.49 -40.65 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.589 -179.361 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -71.18 0.67 7.27 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.924 -1.11 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.7 -35.6 62.72 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.705 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -89.61 -22.03 22.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -84.25 -31.0 25.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.54 86.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.144 -1.21 . . . . 0.0 109.448 -179.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.451 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 40.8 m-20 -45.82 134.51 7.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -90.12 15.63 9.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.968 -1.083 . . . . 0.0 109.926 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.9 42.76 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 -179.142 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.01 147.32 30.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' TYR . 7.5 mtmm -94.5 134.52 36.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.515 -1.366 . . . . 0.0 110.656 -177.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -115.25 150.9 35.45 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.884 -0.51 . . . . 0.0 110.076 -179.678 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.1 tp -123.23 106.15 10.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.808 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.89 119.37 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.143 -178.664 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.27 57.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 O-C-N 121.698 -0.626 . . . . 0.0 109.571 -179.739 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.88 145.45 25.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 109.329 179.973 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 14' ' ' PHE . 7.9 p30 -71.93 -29.91 64.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.209 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.514 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -50.61 120.27 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.336 179.907 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.5 45.33 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.973 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -172.9 -27.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.9 ttt -60.06 -35.05 74.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -53.6 -34.37 58.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.51 -33.81 62.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.98 -51.12 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.498 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -33.52 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mtp85 -46.73 -53.94 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.3 t30 -64.53 -55.93 17.36 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.938 0.875 . . . . 0.0 109.089 179.745 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -38.37 -56.5 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.972 -179.737 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.94 -52.34 64.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.092 -1.005 . . . . 0.0 109.068 179.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -51.4 -36.58 44.13 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.132 179.79 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.16 -44.28 32.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.412 -0.805 . . . . 0.0 109.472 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 10.9 mp -72.6 -62.32 1.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.45 54.46 0.01 OUTLIER Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 95.0 m-85 -129.11 149.91 50.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.608 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.446 ' C ' HD21 ' A' ' 31' ' ' ASN . 0.2 OUTLIER -150.08 65.78 0.97 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.059 -1.026 . . . . 0.0 110.411 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -175.31 100.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.035 . . . . 0.0 109.31 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.25 151.38 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.976 -1.077 . . . . 0.0 110.591 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.19 -165.85 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.648 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -147.71 158.35 43.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.047 -1.033 . . . . 0.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.05 -168.85 3.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.304 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.45 5.79 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.108 -0.995 . . . . 0.0 110.778 -179.483 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 177.22 177.2 0.33 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.758 -1.214 . . . . 0.0 109.644 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.46 -27.72 73.57 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.785 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.27 -40.25 80.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -1.176 . . . . 0.0 108.754 179.314 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -79.48 -37.91 35.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.411 -0.805 . . . . 0.0 109.099 179.727 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.31 62.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.493 -0.754 . . . . 0.0 109.021 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.79 -43.18 72.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.179 -0.951 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -69.62 -27.44 65.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 47' ' ' GLN . 13.4 mttm -87.54 -39.14 15.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.368 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -45.87 -16.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 179.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' LYS . 33.5 mt-30 -91.81 22.4 4.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.312 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . -66.68 -65.23 0.71 Allowed 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.429 -0.794 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.6 23.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.4 179.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 83.96 1.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 7' ' ' LYS . 10.2 m-85 -63.98 -41.07 97.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.54 -0.977 . . . . 0.0 110.586 -178.347 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.5 -25.34 7.33 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 143.68 21.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.539 -0.977 . . . . 0.0 110.106 -179.745 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.2 t -140.03 124.98 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.093 -1.005 . . . . 0.0 109.806 179.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.67 105.91 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 15.3 p -126.31 144.75 50.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.056 -1.028 . . . . 0.0 110.708 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -64.94 -117.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' NE1' ' CG ' ' A' ' 94' ' ' ASN . 61.6 t-105 -173.81 134.73 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.728 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 62.39 129.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.5 mmm 177.8 -50.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 110.088 179.405 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.16 -69.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.758 0.972 . . . . 0.0 109.701 179.643 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.34 -34.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.09 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.6 mtt -102.03 -89.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.673 . . . . 0.0 109.398 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -172.31 175.55 3.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.44 179.95 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.71 26.21 1.13 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 64' ' ' ASP . 84.0 mt -82.06 -56.65 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -1.202 . . . . 0.0 108.87 179.611 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.9 tt0 -48.67 -19.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.017 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.475 ' N ' ' C ' ' A' ' 66' ' ' LEU . 3.2 mt -76.93 -70.65 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.875 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -45.91 -65.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.206 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -43.78 -47.77 8.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.626 -0.671 . . . . 0.0 109.827 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 53.1 m -67.74 -26.65 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.534 -179.931 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 69' ' ' LEU . 44.3 mt -77.09 -14.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -84.43 -27.39 27.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.73 12.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.52 -179.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' O ' ' CA ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -50.64 116.73 2.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.994 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.64 -31.36 40.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.65 -63.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.99 -47.15 7.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.407 ' CA ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 48.22 13.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -0.843 . . . . 0.0 109.349 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.64 18.82 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 0.0 109.626 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 tp -44.97 113.42 1.79 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.055 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 5.1 Cg_exo -59.01 133.49 53.76 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.124 1.216 . . . . 0.0 113.07 -178.918 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.532 ' N ' ' OG ' ' A' ' 104' ' ' SER . 14.7 t -132.48 108.93 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.076 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.88 100.86 13.59 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 117.064 -1.854 . . . . 0.0 107.538 178.839 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 6.7 tpp -68.69 128.53 36.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.597 0.713 . . . . 0.0 109.385 -178.305 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -99.16 140.28 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.634 -0.666 . . . . 0.0 109.366 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.04 129.2 12.75 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.046 -179.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -66.05 96.77 0.33 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.388 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.0 tt0 74.47 114.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.486 -0.758 . . . . 0.0 109.202 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . -45.09 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.354 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -69.78 11.78 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 109.425 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.527 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.8 mtpp 58.96 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.82 . . . . 0.0 109.8 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 66.9 mt-10 -45.34 -46.92 13.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.978 . . . . 0.0 110.164 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.447 ' CG ' ' NE1' ' A' ' 58' ' ' TRP . 21.1 m-20 -69.34 -73.04 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.464 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -44.49 -52.51 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 109.088 -179.47 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.3 mt -56.68 -32.0 36.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.652 -1.28 . . . . 0.0 109.464 -179.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -71.66 -45.61 61.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.044 -1.035 . . . . 0.0 108.959 179.626 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.19 72.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 109.008 179.182 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.51 -31.27 71.26 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.619 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -33.38 53.21 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.363 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.26 -22.51 28.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.39 80.52 0.12 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.958 177.237 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 104' ' ' SER . . . -90.3 -112.44 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.243 -1.783 . . . . 0.0 109.825 179.225 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 43.6 m -92.04 -52.46 4.7 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 123.21 1.481 . . . . 0.0 108.178 175.407 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.18 -162.13 32.48 Favored Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.253 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.506 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.49 115.79 9.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.527 -0.984 . . . . 0.0 109.576 179.549 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.64 136.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.334 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -83.41 145.59 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 108.929 179.808 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -115.14 154.25 47.27 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.17 132.48 27.63 Favored 'Cis proline' 0 N--CA 1.488 1.152 0 O-C-N 122.623 0.802 . . . . 0.0 110.68 -2.353 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -102.16 157.47 16.86 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 178.76 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.13 148.36 22.42 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 176.845 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.12 -25.32 1.41 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.728 -1.233 . . . . 0.0 109.701 -178.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.7 65.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -72.56 -62.48 1.43 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.977 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -37.82 55.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.428 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -65.44 -51.71 58.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.988 -1.07 . . . . 0.0 109.624 -179.755 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 20.4 tp10 -48.04 -48.33 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.855 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.67 -42.0 98.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.1 -60.13 4.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.552 -0.717 . . . . 0.0 109.92 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -32.07 57.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.057 -1.027 . . . . 0.0 110.263 -179.457 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -78.97 -23.5 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.4 mt -89.97 -39.07 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 110.271 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 127' ' ' LEU . 20.5 m-85 -74.16 -39.42 63.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.095 -1.003 . . . . 0.0 109.835 -179.248 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -50.76 -19.89 1.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' PHE . 24.6 mmtt -95.83 -27.25 15.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.508 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 124' ' ' PHE . 17.6 tp -75.58 -21.3 57.97 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.21 71.62 1.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.6 t70 -47.89 125.09 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.033 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -71.94 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 109.663 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 3' ' ' ASP . 1.9 tp10 -159.54 32.69 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.122 -0.986 . . . . 0.0 109.955 -179.939 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.6 tp -69.85 135.27 49.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.018 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -81.43 128.1 33.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 -177.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 24.1 m-85 -112.38 153.13 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 179.465 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -126.52 106.67 9.61 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.792 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.81 113.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.73 83.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 121.74 -0.6 . . . . 0.0 109.545 -179.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.85 -154.18 0.55 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.345 0.593 . . . . 0.0 109.458 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -146.49 4.47 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.222 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.519 ' C ' ' H ' ' A' ' 16' ' ' THR . 6.2 m-85 -95.26 122.74 38.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.78 33.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -151.74 -41.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.1 ttt -54.53 -43.35 71.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -40.17 68.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -68.59 -26.85 65.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 110.171 -178.507 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.97 -50.3 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.066 -1.021 . . . . 0.0 109.378 -179.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -39.39 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 -179.448 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -54.27 10.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.925 . . . . 0.0 109.591 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -56.78 12.78 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -54.44 1.96 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.353 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -59.63 -24.0 63.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.252 -0.905 . . . . 0.0 109.626 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -13.4 61.1 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.088 -1.007 . . . . 0.0 109.463 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mt -95.35 -38.71 10.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.764 -179.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.09 4.84 0.78 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 97.0 m-85 -89.89 148.79 22.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.803 -1.41 . . . . 0.0 109.489 -179.554 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -150.07 63.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 -179.678 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.33 96.02 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.118 -0.989 . . . . 0.0 109.237 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.3 t -140.27 153.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.051 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.98 -172.37 2.52 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.1 154.04 37.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 111.164 -178.752 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -140.19 -173.57 3.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.789 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -120.83 -2.41 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.196 -0.94 . . . . 0.0 110.548 -179.481 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 172.0 179.48 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.968 -1.082 . . . . 0.0 109.923 179.643 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.73 -42.08 96.19 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.3 p -59.46 -38.95 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.277 . . . . 0.0 109.23 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -71.21 -51.82 22.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.898 . . . . 0.0 108.941 179.391 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -50.05 -60.18 3.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.8 tp -45.23 -37.81 4.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.296 179.308 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 1.8 m-20 -70.77 -43.62 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 110.344 -179.578 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -90.11 -3.71 57.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.154 -0.966 . . . . 0.0 110.713 -179.194 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -73.93 -31.67 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 108.724 179.976 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -53.84 -20.41 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.108 179.859 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.9 -63.48 0.96 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.98 109.79 2.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.235 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . 147.41 -24.4 1.54 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' C ' ' H ' ' A' ' 53' ' ' PHE . 55.6 m-85 -64.81 78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.141 -1.211 . . . . 0.0 109.997 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -61.48 -3.31 3.97 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.493 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.542 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -148.03 130.41 15.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.569 -0.959 . . . . 0.0 108.777 -179.469 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 75.4 t -127.06 126.91 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.738 -1.226 . . . . 0.0 109.057 179.425 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.16 125.06 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 57' ' ' ASP . 60.0 p -142.51 142.55 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.0 m-20 -61.65 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.0 109.669 -179.715 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -169.51 134.2 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.94 . . . . 0.0 108.887 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 60' ' ' MET . 61.9 t30 52.92 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 108.864 -179.345 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 171.9 -46.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.65 -64.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.677 0.918 . . . . 0.0 110.098 -179.634 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' MET . 10.7 p30 -126.3 -39.47 2.05 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 25.6 ttt -172.62 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 171.63 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -49.79 -11.09 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.738 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' ASP . 5.7 mt -50.45 -35.06 27.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.641 -1.506 . . . . 0.0 107.719 179.197 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.439 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.7 mt-10 -75.23 -29.7 60.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.075 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 64.5 tp -74.1 -69.03 0.47 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.704 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -42.17 -67.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.364 0.602 . . . . 0.0 109.826 178.684 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -42.26 -51.76 4.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.585 -0.697 . . . . 0.0 110.262 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 77.4 m -49.3 -36.58 21.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.135 -179.88 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' LEU . 52.0 mt -64.22 -45.8 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.1 -1.0 . . . . 0.0 108.83 179.593 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -39.45 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.507 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.3 -28.57 59.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.5 111.28 2.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.07 -124.52 7.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.81 40.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -1.093 . . . . 0.0 109.617 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.15 -2.63 2.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.578 -0.701 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.449 ' HG ' ' H ' ' A' ' 80' ' ' ALA . 4.6 t 47.04 -134.94 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.672 179.827 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.449 ' H ' ' HG ' ' A' ' 79' ' ' SER . . . -126.38 40.29 3.76 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.717 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 82' ' ' PRO . 3.0 mt 47.37 -163.58 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.492 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.564 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 6.2 Cg_exo -57.3 155.79 28.33 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 121.2 1.464 . . . . 0.0 114.876 -176.364 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.21 135.62 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.375 178.544 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 53.7 tp -115.1 72.46 0.79 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.185 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -58.96 160.08 6.36 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.264 -179.346 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -127.89 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.789 -0.569 . . . . 0.0 110.227 -177.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -150.03 -176.35 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 109.79 -179.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.89 52.35 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.74 53.42 12.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -48.79 140.76 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -92.84 -87.65 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.046 179.508 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER 179.8 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.391 179.634 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.93 -6.89 0.26 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.491 ' H ' ' C ' ' A' ' 92' ' ' LYS . 26.9 m-80 -90.06 -22.61 21.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.99 -5.43 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.923 -179.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.76 -66.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.42 -41.11 13.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 109.031 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.42 -56.72 18.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.732 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.77 -44.84 63.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.95 -26.51 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.756 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.52 -115.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.21 -11.71 4.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 179.099 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -58.02 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.887 -0.772 . . . . 0.0 110.626 178.718 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.69 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.6 m -29.75 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.914 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -101.42 125.91 8.72 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.295 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.41 124.14 16.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.057 . . . . 0.0 108.885 178.661 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 14.4 p -123.67 123.83 68.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.433 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 13.6 p -76.43 102.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -64.42 161.22 44.44 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.273 -179.307 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -76.07 163.56 89.78 Favored 'Cis proline' 0 N--CA 1.485 0.985 0 O-C-N 122.879 0.937 . . . . 0.0 110.578 -2.327 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -143.28 161.0 39.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.902 178.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -101.85 152.22 21.16 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.234 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.02 -14.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.851 -1.156 . . . . 0.0 108.86 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.69 -41.17 38.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.663 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.5 -61.97 1.57 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.606 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp -48.57 -37.83 18.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.029 178.741 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.66 -56.34 22.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.925 -1.11 . . . . 0.0 109.659 179.837 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -46.03 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.83 -26.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 108.925 179.68 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.08 -19.05 2.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.928 -1.107 . . . . 0.0 110.583 -179.722 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -23.36 35.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.0 109.892 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.1 mt -89.93 -40.93 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.032 -1.043 . . . . 0.0 110.018 -179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -65.55 -5.57 8.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.992 -179.203 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.61 -26.53 66.3 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -90.82 -35.42 14.83 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.63 -24.42 61.86 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.97 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.95 89.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.444 179.718 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 43.8 t0 -45.04 141.28 2.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 109.311 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.17 13.61 14.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.944 -1.098 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -148.14 43.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.042 . . . . 0.0 110.332 -178.912 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.39 136.36 42.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.142 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.16 121.64 26.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.048 -1.032 . . . . 0.0 111.367 -177.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -106.71 157.59 17.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.702 -0.624 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -129.43 102.24 6.32 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.246 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.91 103.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.398 -179.082 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.6 t -96.12 113.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.276 -0.89 . . . . 0.0 109.25 179.528 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -171.7 163.92 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.504 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 2.9 m-20 -97.85 -58.36 2.01 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.968 -1.082 . . . . 0.0 108.781 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.6 ' CD2' ' N ' ' A' ' 15' ' ' SER . 22.2 p90 22.95 -145.77 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 CA-C-O 122.598 1.19 . . . . 0.0 112.831 177.398 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 179.47 -7.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.984 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.443 ' N ' ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -131.11 -34.15 1.47 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.967 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -37.34 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 111.117 -178.185 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' MET . 10.2 ptt180 -35.55 -31.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.805 -0.559 . . . . 0.0 110.473 -179.15 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.9 ttp180 -60.09 -49.66 76.77 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.877 -178.295 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -62.37 -54.51 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.716 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -18.52 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.341 -0.849 . . . . 0.0 110.84 -178.488 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -55.1 30.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.709 -1.245 . . . . 0.0 109.138 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -67.87 -53.39 27.06 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.673 0.749 . . . . 0.0 109.577 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -42.16 -56.23 2.96 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.544 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -58.95 -52.85 63.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 108.641 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -32.69 16.29 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.244 -0.91 . . . . 0.0 108.646 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -37.32 75.71 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.383 -0.823 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.63 -11.09 59.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.508 -0.745 . . . . 0.0 109.115 179.753 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.47 71.99 1.12 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 41.3 m-85 -150.0 146.19 26.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.325 . . . . 0.0 109.435 179.399 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.07 62.36 0.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.123 -0.985 . . . . 0.0 110.061 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.54 100.71 0.07 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.15 -0.968 . . . . 0.0 109.092 179.703 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.27 152.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.156 . . . . 0.0 110.179 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.48 -172.84 2.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.687 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -146.66 160.11 42.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.609 -179.276 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.08 -164.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.962 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -142.05 -5.08 1.01 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.11 -171.05 0.48 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.91 -1.118 . . . . 0.0 109.753 179.902 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.32 -45.01 57.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.573 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.86 -31.53 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.08 -1.247 . . . . 0.0 108.849 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -84.19 -51.84 6.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.448 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.54 -35.39 63.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.088 -1.008 . . . . 0.0 108.899 179.821 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -68.14 -56.96 6.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.3 -28.06 64.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.777 -179.743 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -90.06 -24.43 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 110.117 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.87 -20.05 61.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -87.23 -8.99 56.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 108.999 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.68 -72.23 0.06 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 109.757 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.67 10.1 1.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.01 87.48 0.77 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.507 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.6 m-85 -65.98 109.14 2.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.342 -1.093 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.62 -1.03 2.28 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' TYR . 6.5 t80 -165.57 148.02 7.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -1.1 . . . . 0.0 109.525 -178.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.6 t -141.59 145.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.635 -1.291 . . . . 0.0 110.837 -178.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.24 122.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.032 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.7 p -144.72 141.45 29.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.006 -179.291 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.36 167.08 17.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.856 -1.152 . . . . 0.0 108.429 179.127 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.526 ' NE1' ' OD1' ' A' ' 64' ' ' ASP . 73.2 t-105 -69.99 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.042 -1.036 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.06 131.6 46.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.347 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.406 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -171.16 -54.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 110.583 179.825 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -62.72 -161.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 N-CA-C 109.911 -0.842 . . . . 0.0 109.911 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.698 HD21 ' H ' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -67.32 -10.32 49.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.06 179.532 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.4 mmt -140.88 -100.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -125.17 146.75 49.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 109.479 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.24 -6.42 0.26 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.558 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.39 -71.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.257 . . . . 0.0 109.641 -179.592 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -45.17 -44.36 10.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.14 -179.501 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' CD1' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -56.27 -33.49 65.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 -179.773 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.08 -36.76 15.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.862 . . . . 0.0 109.333 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -61.48 -47.51 85.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.299 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -47.76 -39.22 17.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.55 -44.35 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 108.98 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -28.29 68.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 109.71 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.13 -29.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -168.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.473 ' CA ' ' HG ' ' A' ' 79' ' ' SER . . . -143.41 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.49 -56.03 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.101 . . . . 0.0 109.519 180.0 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.98 16.46 12.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.473 ' HG ' ' CA ' ' A' ' 76' ' ' GLY . 8.0 p -77.6 50.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.596 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 15.76 0.84 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.6 mt -65.16 127.74 93.13 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.102 -0.999 . . . . 0.0 108.658 179.875 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.37 141.19 95.07 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.888 1.059 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.34 119.75 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.1 tp -101.82 72.2 1.34 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.917 178.707 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -47.41 165.69 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.75 122.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.726 -178.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.691 ' HG1' ' H ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -150.1 174.22 13.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 109.411 179.323 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.691 ' H ' ' HG1' ' A' ' 87' ' ' THR . . . -106.74 -37.99 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.556 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -86.0 -72.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.684 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 91' ' ' LYS . . . 64.73 95.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 90' ' ' ALA . 13.9 mtpt -63.15 -128.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.148 -0.97 . . . . 0.0 109.327 179.797 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 93' ' ' GLU . 5.5 pttm -144.81 -48.75 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.361 179.751 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -75.06 -5.9 46.59 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.194 -0.941 . . . . 0.0 109.394 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -90.04 -28.06 19.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.666 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.9 -21.8 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 96' ' ' ILE . 92.5 mt -75.57 -65.94 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.29 -46.53 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.567 -0.708 . . . . 0.0 109.38 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.55 -53.23 60.48 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.738 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.79 61.54 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.205 -0.934 . . . . 0.0 109.914 -179.312 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -22.35 33.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.79 -61.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.369 -0.832 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.694 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -175.58 -10.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.08 -179.731 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.84 11.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.49 -1.006 . . . . 0.0 110.848 179.255 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.37 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.449 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.45 128.52 9.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.142 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.547 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -148.19 109.9 4.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.273 . . . . 0.0 109.116 179.376 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.6 p -105.98 135.51 43.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.65 95.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.358 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 pttt -56.37 155.12 14.1 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.789 -1.194 . . . . 0.0 109.283 -179.225 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.9 167.63 79.79 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 125.067 -0.806 . . . . 0.0 110.517 -2.086 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -146.73 163.55 35.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.102 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -102.36 146.83 27.49 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.721 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.19 -31.5 3.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.011 -1.056 . . . . 0.0 109.191 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.07 -37.34 78.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.585 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.4 m -68.78 -67.29 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.396 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -44.15 -39.73 4.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.259 178.753 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -62.47 -50.55 70.98 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.196 -0.94 . . . . 0.0 109.645 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -46.29 -58.62 3.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 109.55 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.15 -38.82 26.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.303 179.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -39.66 85.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.83 -33.14 70.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.59 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -71.46 -25.42 62.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.705 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.05 -34.72 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -82.86 8.93 11.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -178.581 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -75.66 -25.4 56.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.14 -27.97 13.94 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.226 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -83.17 -22.49 33.24 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.97 85.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.416 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.32 -1.106 . . . . 0.0 109.431 179.792 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -44.53 149.6 0.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 109.409 179.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -90.55 9.14 30.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.1 -1.0 . . . . 0.0 110.112 179.812 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.2 50.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.777 -1.202 . . . . 0.0 110.574 -178.545 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 53.8 tp -78.74 111.11 14.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -48.32 118.12 2.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.94 -1.1 . . . . 0.0 111.713 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 64.5 m-85 -112.66 151.31 30.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.573 -0.705 . . . . 0.0 109.562 178.895 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.1 tp -123.7 108.22 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.673 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.97 110.19 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.548 -179.328 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -114.73 118.0 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.944 -179.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.67 41.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.47 -0.769 . . . . 0.0 109.279 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -106.44 6.52 30.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.674 -0.641 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -80.99 -21.57 40.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.864 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 p 75.17 -41.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 14' ' ' PHE . 5.2 t -98.13 1.24 47.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.7 ttt -80.05 -25.15 40.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -66.86 -45.75 77.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 109.668 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -22.29 56.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.283 -0.886 . . . . 0.0 109.777 -179.404 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -76.02 -55.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 -179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -13.97 17.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.855 . . . . 0.0 110.271 -178.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -65.68 -53.43 41.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 108.911 179.423 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -66.58 -55.52 14.99 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.859 0.838 . . . . 0.0 109.066 179.593 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.3 tt -41.86 -49.28 4.48 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.496 -179.628 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.08 -41.51 86.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 108.56 179.058 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -56.53 -36.93 69.8 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.478 -0.764 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.95 -16.1 48.58 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -102.1 5.44 40.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.564 -0.71 . . . . 0.0 109.849 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 79.48 47.62 7.26 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.379 179.609 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 39.2 m-85 -126.93 122.19 33.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.57 -0.959 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.83 64.53 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.734 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -172.23 90.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.964 -1.085 . . . . 0.0 109.482 179.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.22 -179.86 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.805 -179.849 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -137.52 -169.28 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -146.37 144.17 29.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.407 -179.065 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.26 -170.68 2.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.094 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 7.6 pt-20 -141.7 10.32 2.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 170.91 158.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.92 -1.113 . . . . 0.0 109.714 179.555 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -46.4 -44.29 15.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.46 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.24 -37.11 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.003 -1.292 . . . . 0.0 109.66 -179.555 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -71.58 -45.9 60.9 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.151 -0.968 . . . . 0.0 108.732 179.619 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.86 -62.49 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.7 -0.625 . . . . 0.0 109.541 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -44.47 -48.29 10.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -65.32 -37.93 88.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.15 -3.07 58.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -83.36 -30.85 27.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.874 -1.141 . . . . 0.0 109.017 -179.836 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -62.37 -0.33 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.48 -61.16 1.8 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.536 -0.728 . . . . 0.0 109.738 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.18 21.74 0.12 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.96 108.07 1.11 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -179.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 24.2 m-85 -92.66 101.98 14.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.327 -1.102 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.17 -10.41 5.21 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -156.97 141.21 16.47 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.074 -1.25 . . . . 0.0 111.079 -179.311 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.3 t -134.24 105.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.393 -0.817 . . . . 0.0 110.209 179.273 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.9 69.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.97 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -101.33 148.68 24.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.258 -0.901 . . . . 0.0 109.161 -179.271 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 3.5 p30 -113.0 170.78 7.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.554 0.692 . . . . 0.0 109.989 -179.411 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 57' ' ' ASP . 1.5 t-105 -46.46 172.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 109.406 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.02 124.42 13.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.578 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -77.9 -39.25 1.82 Allowed Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.446 -0.784 . . . . 0.0 111.845 -179.842 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.4 Cg_exo -64.68 125.05 14.15 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 120.985 1.123 . . . . 0.0 110.763 -178.86 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 63' ' ' MET . 9.7 p30 42.72 -155.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.362 0.601 . . . . 0.0 110.19 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.516 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.87 155.42 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.753 -179.724 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 10.9 p-10 -97.33 -164.04 1.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 0.0 109.657 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.66 2.53 53.67 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.25 -55.74 8.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.309 . . . . 0.0 109.087 179.93 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.32 -15.55 0.65 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.065 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' N ' ' C ' ' A' ' 66' ' ' LEU . 7.1 tp -74.92 -62.77 1.43 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -43.92 -63.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.291 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -47.33 -43.54 22.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.7 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 m -70.86 -24.86 62.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 109.298 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' LEU . 48.0 mt -80.15 -9.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 108.777 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -86.93 -41.56 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 109.581 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.9 49.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -47.76 109.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.23 31.48 4.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.793 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 46.55 58.63 4.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 mmt -90.14 -62.84 1.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.19 30.59 1.44 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 109.193 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.62 -28.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 110.066 -179.577 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.9 tp -48.27 112.1 2.11 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 108.535 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.22 107.76 0.44 Allowed 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 120.988 1.126 . . . . 0.0 112.962 -178.505 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.549 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.1 t -108.85 119.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.654 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.35 102.49 14.27 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.131 -1.427 . . . . 0.0 108.015 178.195 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 110.4 15.16 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.791 -179.154 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.37 140.58 20.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.299 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -150.13 133.86 16.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.593 -1.317 . . . . 0.0 110.242 179.598 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.43 -59.24 2.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 108.985 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.33 67.21 3.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.04 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.78 109.35 7.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.813 -179.56 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -91.37 133.13 35.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 108.93 179.604 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.22 -23.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 109.694 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.96 -50.93 5.74 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -64.91 -33.33 75.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 110.328 -179.115 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 68.2 mt -56.67 -20.95 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.005 -1.059 . . . . 0.0 109.342 -179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.9 mm -87.64 -16.09 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.968 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.4 -46.73 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.6 -55.21 21.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.859 -1.151 . . . . 0.0 108.5 179.223 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.21 -30.87 70.69 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.272 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -53.99 -33.91 58.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.32 -25.25 36.58 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 176.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.63 74.02 0.65 Allowed Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.949 177.312 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.06 -111.95 0.08 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 117.184 -1.807 . . . . 0.0 109.36 178.592 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 51.7 m -91.79 -53.24 4.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 123.616 1.674 . . . . 0.0 107.483 175.344 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.6 37.99 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -177.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.92 153.46 51.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.509 -0.995 . . . . 0.0 110.353 179.865 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.636 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.2 p -145.46 150.19 15.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.325 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -170.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.26 179.193 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.73 156.67 25.03 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.81 133.1 29.79 Favored 'Cis proline' 0 C--N 1.32 -0.972 0 C-N-CA 124.423 -1.074 . . . . 0.0 109.682 -2.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.92 162.8 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 -179.98 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.32 145.58 25.47 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 177.079 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -48.57 -22.58 0.78 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.765 -1.209 . . . . 0.0 109.227 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.33 53.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.372 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.9 m -70.9 -64.61 0.87 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.43 -36.17 21.52 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.21 -1.396 . . . . 0.0 108.921 179.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -57.18 -62.48 1.73 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.931 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 3.6 tm-20 -42.09 -42.6 2.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.794 -0.566 . . . . 0.0 109.877 -179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -74.1 -33.12 63.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.983 179.555 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -65.85 -65.52 0.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.803 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -45.5 -53.61 8.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 109.949 -179.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.95 -24.85 62.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 0.0 109.971 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.482 ' C ' ' H ' ' A' ' 125' ' ' GLU . 10.7 mt -84.32 -47.35 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.021 -1.049 . . . . 0.0 110.119 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.04 2.7 0.7 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.937 -1.102 . . . . 0.0 109.914 -179.202 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.2 tt0 -74.74 -34.89 62.61 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.136 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -82.72 -35.11 26.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.495 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tt -65.25 -27.36 68.6 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.11 80.85 0.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.017 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.373 -1.075 . . . . 0.0 109.444 179.724 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 59.61 122.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.394 -0.816 . . . . 0.0 109.415 -179.722 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 8.1 mttt -89.85 12.49 17.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.892 -1.13 . . . . 0.0 109.679 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.48 45.29 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 -179.732 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 21.2 tp -80.13 124.83 29.12 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.448 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 32' ' ' ASN . 34.6 mttp -73.91 122.97 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.0 111.858 -177.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 49.2 m-85 -113.7 147.88 37.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.434 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' HB2' ' CD2' ' A' ' 51' ' ' TYR . 50.7 tp -114.89 126.41 54.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.543 177.951 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.65 102.78 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.622 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 58.2 t -97.18 24.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' OD2' ' OD1' ' A' ' 57' ' ' ASP . 2.1 m-20 -72.34 145.86 47.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.534 -179.995 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -103.97 9.96 36.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.56 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 109.577 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.87 4.06 9.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.679 -0.638 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -161.79 9.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpp -82.87 -43.44 16.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.31 -0.869 . . . . 0.0 109.267 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.54 -35.38 70.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -27.86 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.55 -46.41 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.521 -179.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -31.84 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.276 -179.101 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.414 HH21 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.55 -57.41 9.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.431 179.853 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -64.72 -54.88 24.56 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.034 0.921 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -42.02 -58.99 1.89 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.552 -179.835 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.34 -47.66 83.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.014 -1.053 . . . . 0.0 108.849 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -52.1 -34.18 42.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 50.9 tt0 -48.61 -39.86 25.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.94 -66.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.98 30.19 0.02 OUTLIER Glycine 0 N--CA 1.482 1.751 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.53 148.35 22.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.305 . . . . 0.0 109.977 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.17 62.02 1.24 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.148 -0.97 . . . . 0.0 109.79 -179.879 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.505 ' CG ' ' HZ1' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -175.81 104.43 0.08 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.764 -1.21 . . . . 0.0 109.662 179.956 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.414 ' HB ' HH21 ' A' ' 22' ' ' ARG . 93.9 t -144.47 149.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -0.884 . . . . 0.0 109.629 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 21.2 mp0 -124.85 -172.23 2.53 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.671 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -150.06 151.07 32.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.793 -1.192 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -143.54 -178.15 5.75 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.06 19.36 1.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.028 -1.045 . . . . 0.0 110.554 -179.62 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 176.5 154.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.827 -1.17 . . . . 0.0 108.788 179.66 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.4 -55.85 15.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.453 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.9 t -50.44 -24.62 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 38' ' ' ASP . 3.1 t0 -85.18 -42.4 14.76 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.77 85.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.008 -1.058 . . . . 0.0 109.355 -179.856 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -55.3 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.617 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -57.12 -33.59 67.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.993 -1.067 . . . . 0.0 110.237 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.79 -8.05 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.709 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -78.4 -37.26 44.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.593 -1.317 . . . . 0.0 109.25 -179.701 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -7.43 0.69 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 108.967 179.647 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.24 -67.45 0.28 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.422 -0.798 . . . . 0.0 109.801 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.24 -94.98 0.24 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.696 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.7 78.03 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.539 ' C ' ' H ' ' A' ' 53' ' ' PHE . 13.6 m-30 -59.62 86.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.329 -1.101 . . . . 0.0 109.915 179.663 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -62.18 -1.61 3.27 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.331 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.539 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -154.22 144.73 22.28 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.474 -1.016 . . . . 0.0 109.818 -178.692 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -142.51 119.99 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 0.0 110.389 -179.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.59 127.66 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' SD ' ' A' ' 85' ' ' MET . 13.3 p -149.22 146.59 27.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.998 -1.064 . . . . 0.0 109.873 -179.34 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' OD2' ' A' ' 12' ' ' ASP . 2.3 m-20 -71.59 163.36 27.89 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.242 -0.911 . . . . 0.0 108.81 179.406 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.82 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.519 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -172.75 171.85 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.016 -1.052 . . . . 0.0 110.027 -179.926 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.1 tpp 178.21 -46.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.495 179.014 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.2 Cg_endo -71.65 93.03 0.68 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.035 1.157 . . . . 0.0 109.524 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 41.91 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 0.0 109.845 179.999 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.2 tpp 47.6 -116.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.066 . . . . 0.0 109.062 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.76 -175.23 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 179.596 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.505 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 94.51 -72.08 1.11 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -47.52 63.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.998 -1.295 . . . . 0.0 107.854 178.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.491 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 15.7 mp0 -65.51 -22.63 66.74 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -64.65 -55.02 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.25 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 72' ' ' ILE . 2.0 mt -58.16 -67.09 0.38 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.21 0.528 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -37.55 -46.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.86 -0.525 . . . . 0.0 110.35 -179.56 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 25.2 m -57.64 -41.87 82.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.124 179.71 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 69' ' ' LEU . 60.3 mt -60.9 -30.07 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -76.98 -55.92 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.592 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.12 4.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 135.62 55.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 77' ' ' ALA . . . -87.3 161.19 32.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 76' ' ' GLY . . . 76.35 -7.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.451 -1.029 . . . . 0.0 109.683 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.4 mmm -109.89 -19.13 13.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.6 m 51.83 -108.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.06 56.16 0.95 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 80' ' ' ALA . 73.6 mt -43.06 148.68 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.684 -0.635 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.42 143.31 94.46 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.475 1.45 . . . . 0.0 111.804 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -134.26 119.85 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.676 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.8 tp -103.8 75.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.55 178.309 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -48.89 169.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.894 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.12 122.57 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.494 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.5 t -140.54 -169.03 2.69 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.613 -179.549 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -140.99 16.43 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.925 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -138.59 -61.74 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.068 -179.688 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . 54.48 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.48 31.85 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.966 -179.449 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ILE . 35.1 mtpt 54.49 -82.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 179.397 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.09 -25.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.337 -179.252 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 92' ' ' LYS . 22.0 t-20 -85.01 -31.49 23.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.0 109.857 -179.675 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' LYS . 72.4 mt -67.19 -15.27 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 110.142 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.25 -64.51 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.86 -179.798 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.79 -31.34 2.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.913 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.31 -55.05 11.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.75 -179.81 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.03 -42.66 60.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 -179.342 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -51.39 -26.8 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.97 -179.896 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.09 -113.43 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.423 179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.682 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.03 -1.17 6.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.414 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.32 11.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.154 -0.615 . . . . 0.0 110.831 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.682 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.48 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.275 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.43 130.62 10.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.391 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.85 115.16 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 108.866 179.112 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 14.0 p -114.26 121.89 67.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.617 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -76.51 96.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -59.44 160.87 11.86 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 0.0 109.141 -179.21 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.2 165.55 85.56 Favored 'Cis proline' 0 N--CA 1.485 0.988 0 O-C-N 122.86 0.926 . . . . 0.0 110.483 -2.257 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -146.03 159.36 43.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.121 -0.987 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.19 147.15 25.42 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.958 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.453 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -44.72 -28.26 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.625 -179.168 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.37 83.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.495 178.936 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -64.14 -64.6 0.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.962 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.6 tp -45.49 -43.51 11.71 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.058 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -61.98 -52.48 63.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.664 -1.272 . . . . 0.0 110.064 -179.882 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 117' ' ' GLU . 1.1 tp10 -43.59 -64.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.736 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -46.05 -46.41 16.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -45.56 -44.07 12.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -62.44 -42.91 99.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.375 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -58.86 -32.5 69.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.492 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.03 -34.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.248 -0.907 . . . . 0.0 109.907 -179.423 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -86.23 1.31 51.28 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 110.646 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -77.1 -28.47 54.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -94.81 -22.26 18.17 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -29.05 21.07 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.403 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.22 86.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.475 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.296 -1.12 . . . . 0.0 109.53 -179.954 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.352 0.596 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 66.39 142.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.227 -0.921 . . . . 0.0 109.887 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 mmmm -90.3 19.57 5.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 0.0 109.413 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.53 49.45 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.952 -1.092 . . . . 0.0 109.635 -179.321 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 60.5 tp -60.24 111.0 1.37 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 0.0 108.934 179.885 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -43.91 105.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.894 -1.129 . . . . 0.0 111.144 -178.835 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 56.8 m-85 -102.33 154.77 18.74 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.793 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 tp -132.09 103.41 6.25 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.59 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.55 113.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.093 -178.983 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.5 t -103.04 69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.583 -0.698 . . . . 0.0 110.025 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -114.58 131.0 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -77.5 -5.63 50.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.664 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.83 143.76 32.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.944 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.08 12.36 24.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -31.25 1.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 ttt -55.81 -32.19 63.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.267 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.507 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -69.25 -43.51 73.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 -179.979 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -59.18 -25.25 63.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.16 -49.24 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.766 -179.67 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -30.74 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.589 -178.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -51.38 60.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.939 -1.101 . . . . 0.0 108.694 179.456 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.44 -60.51 2.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.842 0.83 . . . . 0.0 109.546 179.85 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 tt -45.03 -35.99 3.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.715 -179.226 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -74.22 -51.84 14.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 108.25 178.577 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -52.68 -33.82 49.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.45 -0.781 . . . . 0.0 108.968 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -49.24 -39.15 29.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.348 -0.845 . . . . 0.0 108.783 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 -64.98 0.98 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 160.06 41.43 0.02 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.765 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -113.8 134.6 54.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.61 -0.935 . . . . 0.0 109.184 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 65.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.946 -1.096 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -174.21 93.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.816 -1.178 . . . . 0.0 109.079 179.717 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -144.93 -179.73 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.036 -1.04 . . . . 0.0 110.653 -179.271 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 2.9 mt-10 -137.9 -171.39 3.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.516 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.507 ' CD ' HH11 ' A' ' 18' ' ' ARG . 58.3 mt-10 -140.13 154.2 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.038 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.03 -167.26 2.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.148 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -139.87 -10.68 1.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 0.0 111.004 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -174.57 -166.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.013 -1.054 . . . . 0.0 109.761 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.42 -42.81 32.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.1 t -55.46 -41.23 61.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.919 -1.342 . . . . 0.0 108.121 179.16 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.42 -54.48 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 109.291 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.42 -62.65 1.71 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.229 -0.92 . . . . 0.0 109.411 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.9 tp -41.73 -43.08 2.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.684 -0.635 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -74.36 -37.32 63.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -90.09 0.71 57.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -78.09 -40.56 37.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.051 -1.031 . . . . 0.0 109.029 179.955 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.98 -4.37 3.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.51 -72.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.482 -0.761 . . . . 0.0 109.549 -179.969 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.31 5.26 2.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.853 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.42 78.44 1.03 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.9 m-85 -57.51 114.75 2.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -1.034 . . . . 0.0 110.094 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.3 -7.61 2.04 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.437 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -160.75 137.23 8.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.732 -178.552 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.8 122.33 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.731 . . . . 0.0 109.847 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.44 151.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -167.64 162.58 14.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.007 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.38 -168.18 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 108.978 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 59' ' ' ASN . 13.7 t-105 -128.6 111.82 13.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.434 -0.791 . . . . 0.0 109.564 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER 52.76 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.751 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.456 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 177.38 -50.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 179.578 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.12 -54.93 0.54 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 120.832 1.021 . . . . 0.0 109.891 -179.873 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.97 -41.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.298 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -132.38 -179.83 5.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.43 151.66 32.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.606 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -79.3 -20.14 70.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -48.23 -29.04 3.4 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -1.196 . . . . 0.0 108.334 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.5 tp10 -83.15 -29.79 28.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 109.348 179.443 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -57.59 -35.02 69.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 108.707 179.719 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -86.74 -61.93 1.62 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 108.667 179.09 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -43.09 -26.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.914 -179.289 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 p -72.82 -39.45 66.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.054 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . 81.2 mt -63.6 -45.27 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -61.07 -29.2 69.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 109.64 -179.85 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.91 -28.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.568 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.9 -153.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.07 -12.77 0.1 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.25 -27.97 19.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -1.183 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.1 mtm -92.56 -11.24 34.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t 52.32 -111.32 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.1 58.61 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 80' ' ' ALA . 10.5 mt -38.01 153.77 0.13 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 122.042 -0.412 . . . . 0.0 110.086 -179.303 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.26 140.36 94.04 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.566 1.51 . . . . 0.0 111.481 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.32 130.44 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.56 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.1 tp -113.36 75.95 0.95 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.102 0.953 . . . . 0.0 108.543 178.473 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtt -51.24 172.24 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -145.75 125.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 109.273 -179.464 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 109' ' ' LYS . 15.2 t -150.06 178.11 9.26 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.026 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.61 -42.93 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.34 69.92 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.5 -0.75 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -65.37 107.83 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.927 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' CG ' ' N ' ' A' ' 92' ' ' LYS . 6.6 ttpt -73.52 -110.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 -179.778 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 31.5 ttpt -160.2 -75.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.351 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.5 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.758 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -89.32 -64.0 1.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 -179.766 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.6 mp -47.99 -39.32 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 0.0 109.65 -179.82 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 97' ' ' ALA . 31.5 mt -68.57 -65.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.03 -53.0 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.434 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.97 -44.34 91.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.55 -0.718 . . . . 0.0 109.917 179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.78 -47.51 51.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.707 -1.246 . . . . 0.0 109.333 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -58.97 -23.64 61.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.816 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.21 -103.66 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.718 -179.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.715 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -129.91 -6.88 3.9 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.52 11.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.889 -0.771 . . . . 0.0 110.102 178.176 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.715 ' H ' ' C ' ' A' ' 102' ' ' GLY . 61.4 m -29.27 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.725 -176.339 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -115.94 129.9 8.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.97 110.18 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 108.39 179.385 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.464 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 10.9 p -110.68 123.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.401 HG13 ' H ' ' A' ' 109' ' ' LYS . 2.5 t -58.27 -178.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.9 pttt -155.61 157.95 31.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.32 -1.488 . . . . 0.0 109.194 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.85 164.51 87.3 Favored 'Cis proline' 0 N--CA 1.484 0.929 0 C-N-CA 124.706 -0.956 . . . . 0.0 110.298 -2.254 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.87 159.32 35.25 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.774 0.797 . . . . 0.0 109.938 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.21 145.45 24.49 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.149 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.08 -20.49 0.16 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.949 -1.095 . . . . 0.0 109.54 -178.746 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.57 -36.03 26.6 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.327 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.4 m -69.91 -59.86 2.66 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.1 OUTLIER -49.09 -46.57 44.85 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.155 178.802 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -55.7 -50.78 69.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 110.308 -179.563 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 5.1 tt0 -51.41 -68.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -45.56 -35.27 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.091 -1.006 . . . . 0.0 110.208 -179.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.28 -65.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.041 . . . . 0.0 110.014 -179.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -45.43 -28.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.433 -179.356 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -69.16 -47.76 64.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.962 -1.086 . . . . 0.0 109.765 -179.549 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 32.6 mt -69.56 -38.19 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.958 -179.61 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -70.08 -4.77 22.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 110.723 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.04 -22.18 56.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.644 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -96.28 -24.37 16.24 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -86.08 -32.74 21.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.397 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 43.79 84.18 0.02 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.207 -1.172 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -45.88 135.36 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.522 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -90.54 16.17 9.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.668 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.28 47.27 2.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 108.785 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 22.3 tp -90.02 119.02 30.02 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.37 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -61.82 120.45 10.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.92 . . . . 0.0 110.986 -178.457 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 76.9 m-85 -110.81 152.03 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.889 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 tp -124.62 104.01 8.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.9 m -93.57 107.68 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.973 -1.079 . . . . 0.0 110.013 -179.328 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.27 -96.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.915 -1.115 . . . . 0.0 109.564 -179.766 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 52.91 -161.85 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.032 -1.042 . . . . 0.0 109.598 179.72 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.81 9.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -54.37 -21.07 8.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.651 -179.897 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER 72.26 -8.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.124 -179.743 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 14' ' ' PHE . 1.3 t -136.0 -10.33 2.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.629 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.412 ' SD ' ' C ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -69.58 -50.56 43.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 108.715 179.431 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -41.94 -41.54 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.338 0.59 . . . . 0.0 109.98 179.706 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -63.72 -45.11 91.43 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.049 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.95 -51.63 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.341 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.63 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -0.974 . . . . 0.0 110.53 -178.879 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -55.16 6.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t-20 -67.79 -58.26 4.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.1 -62.25 0.86 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.857 -179.698 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 mt -54.0 -42.16 68.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.228 -0.92 . . . . 0.0 109.519 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -62.16 -38.44 89.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -60.0 -33.74 72.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mt -76.12 -50.19 15.31 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 4' ' ' LYS . . . 148.38 54.2 0.02 OUTLIER Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.341 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -144.34 133.81 23.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.214 . . . . 0.0 110.04 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -145.37 55.47 1.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.354 179.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -162.18 98.02 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.03 152.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.112 -0.993 . . . . 0.0 110.428 -178.776 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.12 -170.87 1.76 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.754 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.91 151.01 32.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.991 -178.712 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.33 -171.39 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.185 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.93 10.9 1.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.133 -0.98 . . . . 0.0 110.032 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 169.03 163.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.804 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -55.27 -37.53 65.3 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.938 -179.38 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -54.83 -37.46 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.822 -1.399 . . . . 0.0 107.922 179.112 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -80.75 -55.45 4.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.598 -0.689 . . . . 0.0 109.616 179.761 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.92 -54.1 33.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 109.281 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 5.0 tt -52.68 -58.4 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -0.857 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -56.58 -34.63 67.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.934 -178.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -90.03 -17.58 27.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.891 -1.131 . . . . 0.0 110.815 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -59.93 -28.29 67.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 0.0 109.046 -179.779 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 7.4 tt0 -72.64 2.6 6.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.18 179.695 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.61 -75.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.421 -0.799 . . . . 0.0 109.634 -179.878 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.49 -35.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.47 67.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' PHE . 70.4 m-85 -49.54 100.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.35 -6.44 0.99 Allowed Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.5 t80 -161.03 144.82 13.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -1.073 . . . . 0.0 109.805 -178.414 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 65.7 t -136.65 120.94 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.962 -1.086 . . . . 0.0 110.032 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.32 97.67 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.568 -0.707 . . . . 0.0 109.107 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 p -99.4 -177.07 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 12.7 t70 -140.39 50.67 1.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 109.686 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 47.32 77.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.217 -179.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -48.35 141.23 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -100.64 -36.67 0.23 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 111.802 -179.972 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.45 122.73 10.49 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.849 1.033 . . . . 0.0 110.715 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 m-80 48.16 53.98 10.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.845 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mtp 53.48 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 54.34 178.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.5 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.11 -46.62 2.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.175 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.6 -69.28 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.288 . . . . 0.0 108.027 178.79 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.75 -22.11 13.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.23 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.11 -53.17 57.67 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 mt -57.97 -65.72 0.59 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.077 0.942 . . . . 0.0 109.131 179.352 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -41.63 -36.5 0.96 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.78 -179.85 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -41.95 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 108.551 179.768 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.12 -39.75 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.063 -1.023 . . . . 0.0 108.254 178.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -23.8 67.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.294 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.36 51.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.626 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -45.74 -36.07 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 109.633 -179.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.04 32.91 85.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.1 -54.79 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.533 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.01 -67.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m 57.24 4.33 0.2 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.333 -0.854 . . . . 0.0 109.274 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -106.37 -12.24 15.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.635 -0.665 . . . . 0.0 109.651 -179.762 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 80' ' ' ALA . 13.2 mt -45.18 107.78 0.69 Allowed Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.26 150.12 89.45 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.079 1.186 . . . . 0.0 112.899 -178.039 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.39 126.87 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.044 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -113.83 72.95 0.8 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.512 179.059 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' LEU . 9.7 mtt -46.39 170.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.328 0.585 . . . . 0.0 109.504 -179.245 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.15 125.07 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.22 -179.312 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 148.82 29.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.645 -1.284 . . . . 0.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 -42.33 8.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -96.32 50.72 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -61.14 101.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 109.437 -179.973 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -68.33 -110.62 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 94' ' ' ASN . 3.1 ttmt -162.39 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -19.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 109.565 -179.95 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -90.06 -37.65 14.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.2 mt -63.54 -16.21 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.531 -179.947 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.44 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.577 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.82 -38.81 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.54 -57.72 10.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.474 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.11 64.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -57.62 -17.39 14.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.69 -107.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.603 -0.685 . . . . 0.0 109.905 -179.664 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.86 -1.55 8.12 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -55.38 11.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.032 -0.687 . . . . 0.0 111.512 179.239 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.662 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.25 -31.44 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.119 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -116.84 135.08 11.71 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.661 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -151.23 114.15 4.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -1.152 . . . . 0.0 109.312 179.062 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.91 140.1 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.202 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 9.3 p -88.31 100.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.554 179.391 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.0 155.25 64.69 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.989 . . . . 0.0 109.531 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.58 167.75 79.39 Favored 'Cis proline' 0 N--CA 1.488 1.205 0 O-C-N 122.649 0.815 . . . . 0.0 111.068 -2.295 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.52 156.91 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.865 0.84 . . . . 0.0 109.829 178.73 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.09 146.17 23.85 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.053 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.5 -22.76 0.79 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.775 -1.203 . . . . 0.0 109.301 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.24 39.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.434 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 112' ' ' THR . 7.0 m -72.63 -61.72 1.7 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.779 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.67 -38.65 47.76 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.213 179.11 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.25 -48.16 76.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.61 -43.88 8.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.665 -179.577 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -66.57 -50.78 61.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -25.76 9.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.05 -22.96 36.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -80.61 -25.11 38.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 109.393 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.94 -34.81 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.667 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -80.2 -1.61 41.25 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 -178.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -76.94 -21.14 55.27 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.609 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.45 -26.88 14.31 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.474 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.83 -26.4 40.47 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.24 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.97 88.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.638 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.328 -1.101 . . . . 0.0 109.514 -179.783 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.4 0.619 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' ALA . 1.9 m-20 61.65 127.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.737 179.83 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -90.18 19.57 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 0.0 108.756 179.425 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 5' ' ' GLU . 1.3 tt0 -144.89 45.62 1.36 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.564 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 20.7 tp -78.49 117.77 20.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 108.442 -179.92 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -63.72 121.2 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 111.842 -177.737 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 96.0 m-85 -115.19 142.85 46.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -116.82 117.99 31.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.123 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 1.2 m -105.57 112.61 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 109.665 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.522 ' C ' HH22 ' A' ' 18' ' ' ARG . 26.6 t -105.85 115.86 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.625 ' N ' ' NH2' ' A' ' 18' ' ' ARG . 13.4 t70 -149.89 -137.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -158.89 -20.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.952 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.08 126.8 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.95 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.8 p -81.62 41.43 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.517 -179.933 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.4 t -166.05 -29.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 179.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.8 ttp -57.96 -47.79 81.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.625 ' NH2' ' N ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -46.58 -29.1 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.716 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -67.72 -34.9 77.78 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.25 -55.89 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.854 -179.789 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -39.18 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 -179.079 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -46.89 -55.38 8.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -65.11 -56.12 14.77 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.859 0.838 . . . . 0.0 109.311 -179.968 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -38.84 -60.36 0.85 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.991 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.3 -46.5 86.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 109.114 179.428 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -32.7 65.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.326 -0.859 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.25 61.4 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.851 -1.156 . . . . 0.0 109.069 -179.53 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' CD1' ' OE1' ' A' ' 117' ' ' GLU . 3.3 tp -80.1 -66.56 0.86 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 109.188 179.533 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.73 0.02 OUTLIER Glycine 0 N--CA 1.482 1.719 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -101.85 153.14 20.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -1.18 . . . . 0.0 108.997 179.731 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.07 58.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.967 -1.083 . . . . 0.0 110.737 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.5 100.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.849 -1.157 . . . . 0.0 109.872 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.2 t -139.42 150.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.34 -0.85 . . . . 0.0 109.919 -179.611 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -122.01 -173.25 2.62 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.687 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -142.75 155.35 44.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.273 -0.892 . . . . 0.0 110.94 -178.345 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -149.6 -172.59 4.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' OE1' ' OD2' ' A' ' 41' ' ' ASP . 1.4 pm0 -143.46 2.57 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.103 -0.998 . . . . 0.0 110.652 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -168.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.781 -1.199 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.04 -47.05 19.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.203 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 4.1 p -52.22 -35.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.644 -1.504 . . . . 0.0 107.941 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' OD2' ' OE1' ' A' ' 37' ' ' GLU . 3.5 t0 -80.32 -45.86 17.11 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.482 -0.762 . . . . 0.0 109.728 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -70.32 -57.66 4.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.899 -1.125 . . . . 0.0 108.872 179.649 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 39' ' ' GLY . 2.9 tm? -44.78 -52.04 8.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 0.0 108.979 179.713 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 77.7 m-20 -65.07 -38.77 91.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.695 179.925 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -86.26 5.83 32.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 110.245 -179.436 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -90.15 -56.0 3.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 108.927 179.621 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.47 2.91 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 108.734 179.306 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.82 -65.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.817 -179.815 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 4.84 2.64 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 79.34 1.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.457 ' C ' ' H ' ' A' ' 53' ' ' PHE . 19.7 m-85 -66.59 108.72 2.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.5 -1.0 . . . . 0.0 109.954 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.86 -6.85 2.99 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.556 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.8 t80 -163.02 146.77 11.01 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.169 -1.195 . . . . 0.0 109.876 -178.601 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.2 t -143.74 126.85 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 110.273 179.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.2 mt -110.01 134.98 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.348 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.9 p -146.94 137.41 23.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.642 -179.889 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.3 m-20 -71.83 -151.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 -179.979 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 52.9 t-105 -101.9 -177.98 3.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.546 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.07 90.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.874 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -95.98 -46.8 0.25 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.956 -179.895 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.5 -54.9 0.51 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.14 1.227 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' ASP . 5.7 p30 -173.03 -148.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.651 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -61.86 78.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 108.724 179.39 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ASN . 49.1 m-20 -154.82 -157.97 0.8 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.885 . . . . 0.0 109.441 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 68.88 -72.78 0.38 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.632 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -66.42 -43.3 86.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.89 -1.359 . . . . 0.0 107.364 178.557 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.6 -27.58 67.82 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.406 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -60.69 2.55 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.618 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.447 HD21 ' H ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -55.97 -63.91 1.03 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.338 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' LEU . 13.7 ttmm -44.32 -39.43 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.523 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 m -68.82 -41.08 79.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.816 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.22 -23.83 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.162 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -27.47 19.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.479 -0.763 . . . . 0.0 109.183 179.803 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.22 -29.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.701 -179.825 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -172.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -58.77 -165.77 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.653 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.96 19.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.483 ' H ' ' C ' ' A' ' 76' ' ' GLY . 3.9 tpt -89.94 -28.76 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.009 179.627 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 45.89 -125.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.538 -0.727 . . . . 0.0 109.172 179.937 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.12 54.1 0.92 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER 44.0 -166.42 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.575 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.7 Cg_exo -61.63 151.21 81.74 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.966 1.381 . . . . 0.0 114.508 -176.336 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.58 138.42 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.769 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -117.1 78.46 1.22 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.403 ' N ' ' O ' ' A' ' 105' ' ' GLY . 18.0 ttp -61.9 159.54 13.83 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.337 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.19 142.33 17.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.806 -1.184 . . . . 0.0 109.953 -178.742 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.1 t -149.98 174.94 12.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.874 -179.973 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.7 -39.95 5.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.679 -0.638 . . . . 0.0 109.361 179.655 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.9 tt0 -81.77 -60.81 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . 51.32 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 179.97 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.0 ttmt -94.44 125.42 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.985 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -45.53 -24.77 0.36 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.633 -179.574 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -85.31 -31.19 23.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.7 m-80 -89.95 -15.09 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.784 -179.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.462 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 84.5 mt -75.84 -0.69 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.0 -58.24 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.762 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.04 -52.18 12.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -49.28 -54.06 18.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.722 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.59 -38.11 63.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.073 -1.017 . . . . 0.0 110.037 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -17.55 35.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.831 -179.688 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 -106.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.609 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.57 1.46 5.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -54.79 11.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.148 0.579 . . . . 0.0 111.385 179.001 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.67 ' H ' ' C ' ' A' ' 102' ' ' GLY . 54.2 m -29.29 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.92 -0.487 . . . . 0.0 111.991 -176.55 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -114.86 123.68 6.08 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.237 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.456 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -138.29 114.6 10.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.363 -1.08 . . . . 0.0 109.883 179.441 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.89 138.65 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.351 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.2 p -85.96 103.36 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.889 -1.132 . . . . 0.0 109.315 -179.582 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.5 pttt -63.28 159.16 51.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.943 -1.098 . . . . 0.0 109.199 -179.691 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.36 156.87 99.47 Favored 'Cis proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.693 -0.961 . . . . 0.0 110.103 -2.446 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -136.42 156.25 48.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 110.166 179.455 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.14 151.82 21.37 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.067 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.36 -18.15 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.691 -1.204 . . . . 0.0 108.909 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -72.42 -44.8 61.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.644 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.511 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.0 OUTLIER -67.26 -63.35 1.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.57 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.7 tp -47.77 -35.68 10.37 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.29 179.327 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' CD1' ' A' ' 28' ' ' LEU . 23.0 tt0 -72.28 -60.12 2.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.642 -1.286 . . . . 0.0 110.725 -179.248 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -40.8 -35.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.67 -0.644 . . . . 0.0 110.774 -178.738 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -79.26 -54.28 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.996 -1.065 . . . . 0.0 109.982 -179.556 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -47.33 -44.33 23.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.824 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -53.67 -45.68 70.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.188 -179.427 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -62.51 -50.66 70.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.36 -34.74 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.815 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 -1.38 57.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.797 -179.051 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.26 -26.89 35.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.19 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -95.97 -21.28 18.12 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.4 OUTLIER -88.31 -34.97 17.48 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.429 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 42.63 77.89 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.469 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.118 -1.225 . . . . 0.0 109.492 -179.918 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.05 144.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.989 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -90.12 11.36 21.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.086 -1.009 . . . . 0.0 109.803 -179.815 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -146.25 48.12 1.21 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.532 -179.736 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.15 126.06 29.15 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.475 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.76 118.19 12.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.08 -1.013 . . . . 0.0 111.534 -177.367 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.81 149.96 26.01 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.4 tp -125.57 104.95 8.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.984 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.86 104.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.578 -179.096 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.93 115.0 28.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 -179.929 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -174.35 -166.85 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.025 -1.047 . . . . 0.0 109.882 -179.206 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.7 9.68 0.47 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.337 -0.852 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -51.04 -35.66 35.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.732 -1.23 . . . . 0.0 108.536 179.781 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 72.5 31.67 1.71 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.871 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 t -177.23 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.47 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.43 ' CB ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -73.88 -35.71 64.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.493 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.498 HH22 HH22 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.72 -50.23 13.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.044 178.587 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -26.84 67.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.353 -177.392 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.32 -54.31 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.019 179.649 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.0 -40.29 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 -179.414 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.498 HH22 HH22 ' A' ' 18' ' ' ARG . 1.2 mtm180 -49.72 -52.18 33.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.441 179.347 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -59.05 -59.07 6.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.266 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.5 tt -42.71 -30.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.84 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -84.6 -33.12 23.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.941 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' ASN . 5.8 tttp -69.94 -35.36 74.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.427 -0.796 . . . . 0.0 108.905 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.26 -35.63 60.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.273 -0.892 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.44 -55.45 4.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 179.878 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.73 62.94 0.01 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.628 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 96.9 m-85 -150.12 141.84 23.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.909 -1.348 . . . . 0.0 109.757 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -150.15 66.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.042 -1.036 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.54 102.37 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.592 -1.317 . . . . 0.0 110.213 179.519 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.46 178.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 179.611 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.7 mt-10 -140.55 -167.11 2.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.367 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.52 149.52 32.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 111.1 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -138.57 -168.28 2.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.039 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.79 7.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.692 -179.449 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 15.7 t0 -176.46 151.4 0.96 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.052 -1.03 . . . . 0.0 109.674 179.881 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -52.54 -29.02 30.78 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.489 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.4 t -72.43 -38.61 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -1.183 . . . . 0.0 108.898 179.637 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -70.96 -43.82 67.31 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -65.52 -60.19 3.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.302 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.6 tp -45.38 -33.62 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.537 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.37 -38.98 23.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -86.26 -1.29 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.901 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -70.2 -10.74 59.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.235 -179.947 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -7.5 21.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.505 -0.747 . . . . 0.0 109.257 179.671 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.87 -55.01 7.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 109.573 -179.801 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.99 6.31 2.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 89.61 0.12 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.852 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.415 ' OH ' ' CG ' ' A' ' 34' ' ' GLU . 44.0 m-85 -76.09 153.34 36.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.225 -1.162 . . . . 0.0 110.024 -179.606 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.98 5.94 39.9 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.301 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -165.7 141.64 5.15 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.627 -0.925 . . . . 0.0 108.89 -179.569 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.0 t -137.93 109.43 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -0.837 . . . . 0.0 109.478 179.345 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.6 90.78 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 164.74 12.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.95 . . . . 0.0 109.142 -179.931 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.0 t0 -91.45 -95.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 110.189 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.555 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 55.7 t-105 -166.39 -123.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.975 . . . . 0.0 109.372 -179.266 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.433 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 21.2 t-20 -103.22 51.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.605 -0.684 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -92.74 -48.62 0.3 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 179.959 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.79 -71.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.006 1.138 . . . . 0.0 109.96 -179.581 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 63' ' ' MET . 4.2 p30 -153.71 -62.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.0 109.001 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.514 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 ttp -88.34 176.62 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.58 142.16 35.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 0.0 109.458 179.927 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.42 13.54 1.54 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -76.07 -58.15 3.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.038 -1.272 . . . . 0.0 108.264 179.25 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.7 OUTLIER -62.37 -13.16 26.25 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.772 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.7 tp -77.03 -43.62 33.88 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.778 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -81.32 -28.69 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.988 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -66.42 -41.05 89.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.332 -0.855 . . . . 0.0 108.9 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 2.9 m -71.34 -39.66 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.541 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.96 -30.3 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.12 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -90.15 -31.05 17.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.39 -0.819 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -29.89 3.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.16 151.04 38.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.22 16.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.98 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.64 -29.85 16.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -1.134 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.54 ' C ' ' H ' ' A' ' 80' ' ' ALA . 15.8 mtt -89.97 6.23 43.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.371 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -73.77 34.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.804 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.61 21.73 3.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 109.27 -179.998 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.65 98.32 40.54 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.697 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.39 118.61 5.52 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.614 1.542 . . . . 0.0 114.03 -178.87 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.38 118.61 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 176.063 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.32 109.3 22.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.21 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.17 103.0 12.25 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.52 146.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.904 -1.122 . . . . 0.0 109.368 179.658 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.567 ' HG1' ' N ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -150.07 155.91 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.014 -179.82 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.567 ' N ' ' HG1' ' A' ' 87' ' ' THR . . . -88.07 -50.29 6.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.141 179.579 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 91' ' ' LYS . 50.7 mt-10 -93.36 58.84 2.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 109.079 179.634 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -53.86 86.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.713 -179.724 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 89' ' ' GLU . 20.1 tttm -71.35 139.36 49.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.055 -1.028 . . . . 0.0 108.961 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 91' ' ' LYS . 1.4 tppp? -42.08 -28.2 0.17 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.99 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' LYS . 13.3 tp10 -88.32 -29.39 20.37 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.225 -0.922 . . . . 0.0 109.9 -179.937 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 2.6 t30 -68.86 -28.8 67.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.095 -1.003 . . . . 0.0 110.29 -179.423 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.1 -58.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.728 -1.233 . . . . 0.0 108.711 179.503 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' GLN . 82.2 mt -63.63 -19.79 24.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.363 -0.836 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.14 -71.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.114 179.658 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.76 -44.75 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.968 -1.082 . . . . 0.0 108.169 179.059 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.562 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.22 -24.38 66.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.572 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 96' ' ' ILE . 6.8 tt0 -52.84 -30.99 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.879 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.41 -21.79 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.439 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.58 77.06 0.31 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.391 178.048 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.99 -111.8 0.08 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 117.223 -1.791 . . . . 0.0 109.634 178.924 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.437 ' OG ' ' N ' ' A' ' 105' ' ' GLY . 2.2 p -91.68 -50.3 5.83 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.997 1.379 . . . . 0.0 108.1 176.045 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.437 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 166.36 -163.6 37.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.373 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.506 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -143.52 124.7 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.547 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.57 115.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.542 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -87.64 161.42 45.03 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 108.665 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.68 131.03 21.98 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 124.798 -0.917 . . . . 0.0 110.432 -2.041 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.417 ' CE1' ' CD1' ' A' ' 116' ' ' LEU . 5.0 p90 -101.31 153.8 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.051 0.929 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.634 ' N ' ' HG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -89.94 149.44 22.59 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.0 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.83 -24.25 1.37 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.834 -1.166 . . . . 0.0 109.513 -178.776 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.45 -34.48 60.95 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.561 178.962 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.634 ' HG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.91 -61.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.545 179.069 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 ' CD1' ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.73 -36.9 38.68 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.178 -1.409 . . . . 0.0 108.295 179.127 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 120' ' ' LEU . 7.2 tp10 -65.74 -56.95 9.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.025 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 117' ' ' GLU . 2.8 mt-10 -42.39 -34.37 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 109.997 -179.456 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -90.04 -25.86 20.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.284 179.833 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 117' ' ' GLU . 3.3 tp -66.74 -66.96 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.924 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -44.39 -50.44 9.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.56 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -61.14 -27.13 68.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 109.994 -179.627 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 120' ' ' LEU . 12.3 mt -81.39 -45.72 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.98 . . . . 0.0 109.926 -179.725 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.93 -6.34 8.18 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 -179.264 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.49 -29.31 68.71 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.227 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.52 -34.59 19.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.2 -27.13 62.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.372 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.56 81.58 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.515 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.446 179.751 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -46.16 145.17 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.982 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 40.5 tttt -90.44 9.64 28.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.0 109.41 179.398 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.65 46.75 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.047 . . . . 0.0 110.356 -178.993 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.3 tp -78.29 112.34 15.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.528 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.01 123.34 17.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.927 -1.108 . . . . 0.0 111.98 -176.838 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 73.4 m-85 -109.45 152.04 25.9 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.942 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.0 tp -121.89 106.14 10.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.283 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.82 105.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.423 -178.012 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 63.9 t -104.72 103.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.577 -0.702 . . . . 0.0 109.86 -179.936 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -149.06 148.64 29.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 13' ' ' ASP . 9.1 t70 -85.08 -15.68 43.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -46.84 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.906 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.05 10.04 13.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 109.633 -179.71 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -155.52 -21.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.542 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' NZ ' ' A' ' 109' ' ' LYS . 13.8 tpt -48.89 -47.71 42.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NH2' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.69 -37.14 17.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 -179.841 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -30.72 62.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.784 -1.166 . . . . 0.0 109.769 -178.352 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mt -67.62 -55.32 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.885 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.9 -32.34 47.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.86 -179.235 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.634 HH11 ' NH2' ' A' ' 18' ' ' ARG . 3.8 mtt180 -48.47 -52.31 22.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 108.949 179.475 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LYS . 1.4 t30 -66.15 -58.78 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.794 0.807 . . . . 0.0 109.28 179.901 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -42.18 -37.31 1.42 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.648 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.41 -42.94 58.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.75 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ASN . 23.1 tttm -61.12 -33.11 72.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.393 -0.817 . . . . 0.0 108.824 179.212 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.39 -50.34 65.32 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 179.654 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -49.69 59.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.98 74.66 0.04 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.551 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 56.4 m-85 -150.2 152.25 34.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.931 -1.335 . . . . 0.0 109.095 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.22 30.51 0.69 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 111.518 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.69 108.69 4.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.639 -1.288 . . . . 0.0 111.04 -179.255 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.06 179.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.04 . . . . 0.0 109.909 178.722 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 11.6 mt-10 -137.57 -168.02 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.87 150.38 31.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.984 -1.073 . . . . 0.0 111.167 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -136.82 -164.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.37 -6.63 5.3 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.67 . . . . 0.0 110.765 -179.528 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.96 179.8 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.728 -1.232 . . . . 0.0 109.948 179.873 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASN . . . -55.28 -57.56 17.91 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.7 p -51.99 -35.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.0 108.958 179.94 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 7.7 t0 -69.86 -41.89 74.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.73 -40.39 88.36 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.44 179.993 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.6 -35.46 77.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.911 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.84 -34.5 69.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -89.97 -26.49 20.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.72 -31.76 58.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.085 -1.009 . . . . 0.0 108.836 -179.776 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 1.6 mt-30 -52.88 -22.18 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.503 -0.748 . . . . 0.0 109.309 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -45.59 -59.43 2.74 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.829 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.7 52.8 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.307 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -148.62 -44.98 0.03 OUTLIER Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.586 ' C ' ' H ' ' A' ' 53' ' ' PHE . 6.9 m-85 -49.7 92.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.367 -1.078 . . . . 0.0 110.636 -179.555 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -76.32 15.74 5.35 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 177.321 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.586 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -168.24 152.47 6.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.288 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.2 t -145.51 107.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 110.742 -179.649 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.59 89.22 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.5 p -105.13 160.47 15.04 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -178.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.6 p-10 -73.13 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.221 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.501 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 5.3 t-105 -149.52 -6.46 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 108.79 179.035 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 4.7 m-80 43.4 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 110.959 178.468 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.48 20.87 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.884 178.76 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -59.09 -65.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 178.79 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.5 m-80 -151.94 -136.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.408 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.65 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.964 -1.085 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 9.4 m-20 -160.72 -167.77 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 -179.566 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.66 -79.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.32 -69.03 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -1.221 . . . . 0.0 109.327 -179.937 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.4 tt0 -61.32 -9.59 5.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.787 . . . . 0.0 109.744 -179.707 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tp -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 109.972 -179.491 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -79.16 -26.77 42.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.34 -179.687 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -59.93 -59.91 4.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.688 179.501 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -56.14 -31.44 63.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.151 -0.968 . . . . 0.0 109.877 -179.649 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -72.4 -21.74 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -31.49 17.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 75' ' ' ASP . . . -71.29 -60.43 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.208 179.812 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 79' ' ' SER . 6.1 p-10 39.94 -141.54 0.05 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.426 0.631 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' N ' ' OD2' ' A' ' 75' ' ' ASP . . . -159.84 -16.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.927 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.82 -7.26 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -1.107 . . . . 0.0 109.492 179.946 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -96.87 -72.43 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.527 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 11.2 t 44.72 45.26 8.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.579 -0.701 . . . . 0.0 109.831 179.824 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.09 -50.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.02 -1.05 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 80' ' ' ALA . 7.2 mt -27.41 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.455 -0.153 . . . . 0.0 111.112 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.477 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 6.3 Cg_exo -62.7 127.89 21.86 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.188 1.925 . . . . 0.0 114.02 -178.845 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.703 ' N ' ' HG ' ' A' ' 104' ' ' SER . 1.5 t -109.05 113.19 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 175.9 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.23 106.75 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.352 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.7 tpp -82.1 103.23 11.57 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.245 -178.004 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -98.85 148.31 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.854 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 160.06 43.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.37 129.0 35.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.864 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 49.56 74.76 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 179.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -46.27 120.19 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.278 179.684 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -68.89 -77.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.943 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -173.06 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.468 -179.763 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.1 mm-40 -69.5 -35.0 75.11 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -53.48 -35.11 60.23 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.12 -0.988 . . . . 0.0 109.69 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.25 -55.15 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.994 -1.066 . . . . 0.0 108.591 179.351 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 83.6 mt -69.28 -14.74 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.482 -0.761 . . . . 0.0 109.017 179.652 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' GLU . . . -67.72 -54.18 21.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 -179.997 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.61 -46.23 69.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.014 -1.054 . . . . 0.0 108.197 178.885 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -64.44 -27.34 68.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.726 -179.323 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -52.08 -32.64 35.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.803 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 77.09 0.41 Allowed Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.627 177.874 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.79 -111.66 0.07 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 117.411 -1.716 . . . . 0.0 108.941 178.64 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.703 ' HG ' ' N ' ' A' ' 83' ' ' VAL . 49.6 m -91.49 -49.75 6.15 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.905 1.336 . . . . 0.0 108.283 175.998 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.57 -162.89 33.74 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.071 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 150.07 42.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.127 -1.22 . . . . 0.0 109.75 179.461 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.69 126.06 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.274 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.92 113.25 10.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.138 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.589 ' NZ ' ' SD ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -87.35 162.53 42.6 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.579 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.4 123.36 8.49 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.836 -0.902 . . . . 0.0 110.478 -2.178 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -92.92 156.26 17.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.876 179.847 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.696 ' H ' ' HG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.69 147.36 23.32 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.519 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.11 -25.5 0.88 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.053 . . . . 0.0 108.909 -179.414 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.92 78.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.728 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.696 ' HG1' ' H ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.87 -66.41 0.57 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.924 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tp -49.58 -36.08 22.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.506 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 4.5 tt0 -57.58 -62.41 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.031 -1.043 . . . . 0.0 110.227 -179.59 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' GLU . 34.9 mt-10 -46.09 -61.08 1.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 -179.51 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -50.97 -28.0 8.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.832 . . . . 0.0 109.691 179.832 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.85 -67.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.17 -0.956 . . . . 0.0 109.302 179.83 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.39 -28.46 66.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.003 -1.061 . . . . 0.0 110.506 -179.416 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -77.16 -23.79 51.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.966 -1.084 . . . . 0.0 109.84 -179.693 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.05 -42.38 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.506 -179.4 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -65.48 -14.89 61.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.087 -1.008 . . . . 0.0 110.104 -178.508 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -30.89 70.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.316 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -85.04 -26.49 27.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.541 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.5 -19.31 60.96 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.394 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.468 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 71.17 60.71 4.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.738 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.405 -179.705 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.26 150.45 0.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.997 -179.552 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.2 12.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.344 179.739 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -150.6 52.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.164 -179.665 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 50.5 tp -74.05 107.96 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.012 -1.055 . . . . 0.0 108.617 -179.879 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -49.73 106.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 111.458 -178.193 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 70.0 m-85 -99.53 153.84 18.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.268 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.9 tp -128.62 107.51 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.106 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.95 115.55 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 -179.813 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.679 ' N ' HH21 ' A' ' 18' ' ' ARG . 2.5 t -98.69 110.44 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 -179.144 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' CB ' ' HE ' ' A' ' 18' ' ' ARG . 37.7 t0 -166.28 168.47 15.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.028 -1.045 . . . . 0.0 109.758 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -103.06 -28.9 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.654 -0.654 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.3 138.5 55.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.974 . . . . 0.0 109.289 179.851 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.63 -33.48 11.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.94 -21.57 56.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.945 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 ttm -73.72 -57.37 4.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.034 -1.041 . . . . 0.0 108.842 179.354 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.679 HH21 ' N ' ' A' ' 11' ' ' VAL . 19.2 mmt180 -58.67 -8.2 1.22 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.52 -178.708 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -76.73 -38.38 54.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 108.534 178.725 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -61.86 -55.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.955 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -57.76 -40.2 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.53 -179.185 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mtm180 -45.3 -53.45 8.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 -179.377 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -62.79 -56.77 14.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.328 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 23' ' ' ASN . 2.6 tt -37.98 -58.16 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.94 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -53.52 -51.11 63.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.117 179.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.05 -40.11 73.03 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.135 -0.978 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.02 -41.33 62.15 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.272 -0.893 . . . . 0.0 109.217 -179.983 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.39 -61.76 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.511 -0.743 . . . . 0.0 109.073 179.77 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.22 68.66 0.01 OUTLIER Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.865 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.23 145.82 26.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.128 -1.219 . . . . 0.0 109.307 179.744 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -150.01 68.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -176.78 99.55 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 0.0 108.653 179.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.16 150.82 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 110.562 -178.988 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.31 -169.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.323 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -141.46 161.98 36.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.405 -0.809 . . . . 0.0 110.808 -178.771 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -144.4 -167.93 2.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.242 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.91 -2.24 4.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.465 -0.772 . . . . 0.0 110.666 -179.413 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.43 -171.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.204 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.24 -37.27 80.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.974 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 18.8 m -65.8 -42.3 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 0.0 109.16 179.952 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -67.15 -50.53 60.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 108.464 179.266 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.89 -55.93 28.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.735 -0.603 . . . . 0.0 109.916 179.979 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -46.22 -53.82 9.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.94 . . . . 0.0 108.936 179.934 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 70.6 m-80 -61.27 -41.77 97.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.16 -12.25 59.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.106 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -66.71 -4.48 9.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 108.526 -179.908 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 47' ' ' GLN . 27.3 tt0 -97.26 -4.56 38.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.768 . . . . 0.0 109.266 179.729 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.4 -72.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.524 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.12 9.5 1.3 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.962 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.0 87.27 1.08 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.7 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.559 ' C ' ' H ' ' A' ' 53' ' ' PHE . 62.6 m-85 -66.8 109.62 2.96 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 -5.61 0.59 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.668 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.559 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.04 145.02 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 110.292 -178.842 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.78 115.11 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.137 -0.977 . . . . 0.0 110.225 179.632 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.246 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 145.61 29.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -0.807 . . . . 0.0 109.638 -179.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.459 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.7 p30 -67.54 -112.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.589 -179.998 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 62.3 t-105 -169.9 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.779 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.462 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 15.5 m-80 -83.36 121.26 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.462 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.27 -50.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 110.129 179.617 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.58 -64.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 120.89 1.06 . . . . 0.0 109.888 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.94 -76.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.26 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -88.34 0.22 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.367 179.713 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 178.99 150.7 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.731 179.836 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.16 17.39 1.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 68' ' ' LEU . 4.4 tt -78.4 -56.6 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.847 -1.384 . . . . 0.0 108.203 179.287 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.51 -9.76 0.54 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.565 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 66' ' ' LEU . 15.7 tp -81.91 -57.38 3.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' CD1' ' C ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.91 -34.91 78.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.603 -179.642 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -66.97 -59.07 3.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.146 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.9 m -54.84 -37.0 65.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.072 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mt -57.44 -38.58 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.506 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -66.21 -7.55 18.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.909 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -71.81 -27.55 63.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.785 -179.907 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -51.36 -178.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 109.653 -179.746 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.09 -146.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.13 -12.49 60.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttp -90.04 -2.53 58.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ASP . 14.6 m 47.28 -120.03 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -0.894 . . . . 0.0 108.895 -179.741 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.08 56.9 0.96 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.251 178.955 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 80' ' ' ALA . 11.0 mt 57.53 155.39 0.08 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.648 -0.657 . . . . 0.0 110.035 178.112 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.47 140.39 54.15 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.314 2.009 . . . . 0.0 114.959 -177.166 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.3 t -129.32 116.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.134 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -103.06 108.51 19.72 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.523 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.62 138.52 57.51 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.671 -178.484 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.35 139.92 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.675 -0.64 . . . . 0.0 110.168 -178.915 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.659 ' HG1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -149.96 165.96 31.08 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.747 179.532 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.659 ' N ' ' HG1' ' A' ' 87' ' ' THR . . . -100.19 128.63 46.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.667 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 91' ' ' LYS . 33.6 tt0 50.58 94.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.033 -179.598 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . -44.78 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.736 -179.683 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.524 ' CB ' HD22 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -76.57 16.81 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.474 -179.832 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' H ' ' C ' ' A' ' 90' ' ' ALA . 22.2 tttt 69.74 -70.28 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 94' ' ' ASN . 12.4 tm-20 -49.82 -49.32 49.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.179 -0.95 . . . . 0.0 110.176 -179.475 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.524 HD22 ' CB ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -65.14 -66.79 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.21 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -45.54 -42.76 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.247 -0.908 . . . . 0.0 109.901 -179.16 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.19 -31.08 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.953 -1.092 . . . . 0.0 109.624 -179.782 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.41 85.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.655 -179.718 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.2 -53.69 18.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 108.366 179.39 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.61 -26.35 61.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.327 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -53.32 -32.44 48.97 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.45 -23.38 26.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.202 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.34 75.38 0.51 Allowed Glycine 0 N--CA 1.481 1.693 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.802 177.663 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.52 -111.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 117.107 -1.837 . . . . 0.0 108.911 178.541 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 34.9 m -91.49 -46.68 7.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.473 1.13 . . . . 0.0 107.995 175.697 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.426 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 171.3 -159.73 31.64 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.732 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -138.23 131.67 30.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.829 -0.806 . . . . 0.0 108.997 179.175 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.426 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 11.9 p -127.65 120.95 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.658 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 109' ' ' LYS . 2.0 p -70.32 157.92 6.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 108.964 -179.485 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -131.63 160.41 67.55 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.885 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.57 126.32 11.94 Favored 'Cis proline' 0 C--N 1.32 -0.93 0 C-N-CA 124.716 -0.951 . . . . 0.0 110.429 -2.06 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -91.4 159.91 15.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.828 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.38 149.86 20.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.991 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.04 22.74 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.773 -1.204 . . . . 0.0 108.815 -179.53 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.93 -31.73 71.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.781 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.5 m -72.61 -68.13 0.5 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.729 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.6 tp -47.57 -36.72 11.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.62 -1.3 . . . . 0.0 109.253 178.861 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -62.31 -64.56 0.89 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.846 -1.159 . . . . 0.0 109.126 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -45.27 -51.0 11.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.629 -0.669 . . . . 0.0 109.738 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -54.34 45.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.464 -179.836 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.9 mt -55.97 -44.9 78.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.563 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -47.76 -69.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 109.977 -179.273 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -49.06 -27.44 3.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.317 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.34 -40.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.947 -1.096 . . . . 0.0 110.577 -179.208 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -74.28 -22.71 59.18 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.139 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -62.29 -20.43 64.29 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -97.51 -27.7 14.31 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.888 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.79 -13.07 49.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.264 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.21 71.94 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -159.72 147.32 16.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.1 8.48 32.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.989 -1.07 . . . . 0.0 109.972 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -155.62 52.74 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 0.0 109.844 -179.678 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 tp -77.21 131.04 38.03 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.881 -1.137 . . . . 0.0 107.943 179.471 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -67.48 110.7 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.107 . . . . 0.0 111.708 -177.388 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.4 148.01 27.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.185 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.3 tp -124.72 105.08 9.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.185 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.4 111.24 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 109.998 -179.142 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.91 106.91 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 40.0 t0 -172.35 117.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.161 -0.962 . . . . 0.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.01 135.39 20.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.722 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -171.23 -153.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.478 -1.389 . . . . 0.0 112.121 -177.263 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.722 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -177.11 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.36 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.603 ' HG1' ' N ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -164.95 -59.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.516 0.674 . . . . 0.0 110.27 -177.868 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.603 ' N ' ' HG1' ' A' ' 16' ' ' THR . 3.4 ttt -35.62 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.034 -0.416 . . . . 0.0 111.296 179.596 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 34.5 mtm180 -46.2 -27.08 0.9 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.699 -1.251 . . . . 0.0 109.782 -178.615 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' THR . 4.0 ttp180 -78.54 -32.64 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.815 -1.178 . . . . 0.0 108.985 178.967 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 mt -66.94 -54.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 108.992 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -40.37 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -180.0 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -43.58 -53.7 5.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.479 -0.763 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -63.0 -57.12 11.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.901 0.858 . . . . 0.0 108.783 179.168 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -37.76 -57.74 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.714 179.964 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.83 -52.43 65.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.076 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -48.39 -30.6 5.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.77 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -48.22 -41.36 27.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.233 -0.917 . . . . 0.0 108.9 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -75.03 -65.31 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.116 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.69 22.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 68.9 m-85 -89.99 145.72 24.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.75 -1.441 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -150.14 59.54 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.074 -1.016 . . . . 0.0 110.42 179.718 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -174.38 104.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.228 . . . . 0.0 110.295 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -146.47 179.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.149 -0.97 . . . . 0.0 109.762 179.423 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -139.21 -169.76 2.73 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.627 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.0 145.88 26.68 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.858 -179.068 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -139.98 -171.01 3.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.814 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 2.0 mp0 -132.38 -2.05 3.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.251 -0.905 . . . . 0.0 110.495 -179.197 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.82 -177.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.229 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -67.23 -36.29 89.59 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 7.6 p -62.89 -45.68 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -1.202 . . . . 0.0 109.436 -179.935 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 8.0 t0 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.401 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.87 -22.93 61.44 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.414 179.956 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.659 -1.276 . . . . 0.0 108.294 179.205 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -72.92 -27.52 61.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.676 -0.64 . . . . 0.0 110.04 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.75 -37.87 14.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.959 . . . . 0.0 110.777 -178.868 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -49.96 -23.5 2.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.714 -1.241 . . . . 0.0 109.552 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 5.6 tp60 -96.89 -13.57 22.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -40.85 -62.08 0.86 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 -179.594 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.62 3.75 2.39 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.88 76.8 1.15 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.74 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -57.68 131.49 50.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 110.131 -179.392 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.33 3.75 83.65 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.037 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -168.15 146.32 4.37 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.101 -1.235 . . . . 0.0 110.264 -179.149 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 t -143.93 121.38 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.067 -1.021 . . . . 0.0 109.895 179.389 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.5 mt -106.61 103.92 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.611 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.9 p -114.51 161.07 18.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.388 -0.82 . . . . 0.0 110.318 -178.599 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 17.1 p-10 -89.38 -110.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.541 -0.724 . . . . 0.0 109.2 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 77.3 t-105 -141.37 177.78 7.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 179.702 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.623 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -76.7 75.24 3.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.758 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtm -86.13 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.927 -1.108 . . . . 0.0 110.378 179.677 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.1 -55.2 0.41 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 C-N-CA 120.898 1.065 . . . . 0.0 109.747 179.932 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -172.49 -162.3 0.19 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.437 -0.789 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -47.55 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -164.91 137.08 4.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.565 -179.563 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.27 -50.53 0.89 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.699 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.505 ' H ' HD22 ' A' ' 59' ' ' ASN . 3.6 tp -85.78 -46.6 10.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.564 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.403 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.0 mm-40 -63.31 -20.03 65.13 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.581 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.7 mt -68.52 -61.77 1.68 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.684 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -45.81 -64.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.984 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.91 -49.74 4.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.2 -179.438 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -64.19 -32.91 74.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 46.4 mt -74.82 -31.18 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.174 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -20.0 23.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.43 -30.07 4.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.357 -179.836 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.76 100.12 0.38 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.372 -0.83 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.74 46.41 2.32 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.791 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.32 -28.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -1.168 . . . . 0.0 109.292 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -96.98 -70.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.453 179.946 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 16.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.159 -179.799 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -104.89 -39.27 6.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.583 -0.698 . . . . 0.0 109.736 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' ALA . 0.1 OUTLIER -32.41 97.14 0.1 Allowed Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.629 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.88 102.49 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.652 0 C-N-CA 121.169 1.246 . . . . 0.0 112.064 -178.767 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.557 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.5 t -107.67 116.24 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 177.364 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.42 106.66 17.24 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.58 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 ttm -67.23 160.42 27.03 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.039 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.6 t -137.49 144.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.29 -0.881 . . . . 0.0 110.183 -178.967 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -150.18 158.68 44.41 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.88 -82.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.115 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -77.51 68.88 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.933 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -42.83 123.67 2.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 110.646 -178.896 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.93 112.72 25.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.117 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -43.82 -25.97 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.468 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.87 -38.01 33.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.193 -0.942 . . . . 0.0 110.326 -179.447 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -90.06 -9.71 47.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.099 -1.001 . . . . 0.0 110.43 -179.299 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.23 -27.05 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.972 -1.08 . . . . 0.0 108.55 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.441 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.0 mt -87.05 -8.59 11.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 108.909 179.591 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.37 -52.89 10.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.471 -0.768 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.59 73.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.905 -1.122 . . . . 0.0 108.026 178.867 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.571 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -63.71 -31.7 72.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.89 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -59.25 -32.6 70.14 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.932 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -78.2 -24.08 47.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 176.091 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.88 74.01 0.49 Allowed Glycine 0 N--CA 1.481 1.657 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.387 176.243 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.22 -112.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 116.984 -1.887 . . . . 0.0 109.606 177.818 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.4 m -91.96 -50.91 5.46 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 123.009 1.385 . . . . 0.0 107.645 174.983 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 169.04 -164.17 37.83 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.391 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -133.47 121.79 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.123 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 107' ' ' VAL . 8.3 p -113.46 123.53 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.446 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.573 ' CG2' ' H ' ' A' ' 109' ' ' LYS . 12.5 p -64.44 -177.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.126 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.573 ' H ' ' CG2' ' A' ' 108' ' ' VAL . 1.2 pttt -154.62 158.76 32.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.595 -1.315 . . . . 0.0 108.602 179.848 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.41 136.81 45.98 Favored 'Cis proline' 0 C--N 1.317 -1.121 0 C-N-CA 124.54 -1.025 . . . . 0.0 110.446 -2.191 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -96.59 162.32 13.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.008 . . . . 0.0 109.179 178.997 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.79 144.94 24.8 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 177.132 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.1 -33.22 4.82 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.962 -1.086 . . . . 0.0 109.56 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -32.33 66.52 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.634 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' THR . 13.4 m -71.69 -64.42 0.93 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.966 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -48.96 -40.3 29.82 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.6 -1.313 . . . . 0.0 108.419 179.406 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.09 -57.67 11.81 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.858 -1.151 . . . . 0.0 109.833 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.7 tt0 -44.59 -28.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.391 -179.685 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.18 -37.52 14.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 108.742 179.214 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.06 -55.48 14.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.628 -0.67 . . . . 0.0 109.868 -179.467 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 122' ' ' LYS . 1.2 p30 -48.12 -54.23 13.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.166 -0.959 . . . . 0.0 109.96 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.562 ' H ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 mttt -53.38 -38.11 63.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.43 -0.794 . . . . 0.0 110.236 -179.517 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.76 -41.5 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.461 -179.138 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -72.97 -6.97 48.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.957 -1.089 . . . . 0.0 110.589 -178.908 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.01 -19.42 60.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.746 -1.221 . . . . 0.0 107.774 178.654 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -97.63 -27.45 14.37 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.935 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -25.96 24.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.9 84.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.797 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.2 m-20 49.36 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 108.533 -179.486 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.585 ' NZ ' ' CB ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -63.13 11.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 0.0 110.498 -178.871 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' A' ' 3' ' ' ASP . 10.7 mm-40 -139.03 40.49 2.12 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.835 . . . . 0.0 109.339 -179.908 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.0 tp -75.23 129.51 37.58 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 120.603 -1.31 . . . . 0.0 108.178 179.782 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -80.24 124.62 28.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.153 -0.967 . . . . 0.0 111.991 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -113.55 143.52 44.41 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.36 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.7 tp -112.42 110.2 20.27 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.136 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.74 106.74 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.742 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.2 t -89.92 16.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.535 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 13.7 p30 -51.0 162.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.984 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -144.9 33.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.195 179.952 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' ' CB ' ' A' ' 15' ' ' SER . 51.2 t80 -83.02 -75.97 0.29 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER 165.61 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.811 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.62 -5.7 1.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.511 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.9 ttm -56.02 -38.15 70.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.516 -0.74 . . . . 0.0 109.324 179.756 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.516 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -62.3 -56.35 19.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.887 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.14 -28.89 42.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -178.781 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.81 -57.8 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.127 -0.983 . . . . 0.0 109.637 -179.802 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -32.43 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.981 -179.25 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.629 ' CA ' ' HE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.11 -55.17 10.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.972 . . . . 0.0 109.449 179.703 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -63.33 -58.14 8.08 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.802 0.81 . . . . 0.0 109.223 179.896 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.4 tt -39.41 -55.95 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.003 -179.55 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.2 -42.21 94.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.069 -1.019 . . . . 0.0 108.926 179.263 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.638 ' HZ2' HD22 ' A' ' 31' ' ' ASN . 12.1 ttmm -58.79 -40.69 84.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.87 -46.6 67.98 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 -179.714 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.11 -56.37 11.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.334 -0.854 . . . . 0.0 109.093 179.811 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.04 69.35 0.01 OUTLIER Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.951 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -150.11 130.82 14.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.328 . . . . 0.0 109.184 179.822 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.638 HD22 ' HZ2' ' A' ' 26' ' ' LYS . 2.1 m120 -133.74 71.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.814 . . . . 0.0 109.971 -179.402 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.59 98.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 0.0 108.524 179.642 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.5 149.47 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.144 -0.973 . . . . 0.0 110.458 -178.544 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -121.75 -172.88 2.52 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.385 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' CD ' HH11 ' A' ' 18' ' ' ARG . 39.8 mt-10 -141.71 155.44 45.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.919 0.866 . . . . 0.0 110.816 -178.608 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -150.05 -168.7 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.676 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.27 12.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 110.719 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD2' ' ND2' ' A' ' 62' ' ' ASN . 14.0 t0 -175.32 154.17 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.66 -28.63 60.23 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 179.033 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -75.02 -37.33 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.627 -0.925 . . . . 0.0 108.825 179.165 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.68 -39.77 80.4 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.055 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -69.38 -46.49 66.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.53 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.03 -37.37 61.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.965 -179.693 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -76.07 -34.76 59.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.107 -179.412 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -90.02 -13.31 36.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.173 -179.419 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -61.32 -14.69 28.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 -179.971 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -93.89 -4.17 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.12 -65.93 0.47 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.546 -0.721 . . . . 0.0 109.637 -179.929 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.45 -92.2 0.26 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.906 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -162.6 67.16 0.24 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.824 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.518 ' C ' ' H ' ' A' ' 53' ' ' PHE . 56.4 m-85 -47.02 98.56 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.546 -0.973 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -65.53 1.56 4.07 Favored Glycine 0 C--N 1.297 -1.599 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.402 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.12 150.57 11.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.397 -1.06 . . . . 0.0 109.21 -179.548 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.2 t -143.72 118.83 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.767 -1.208 . . . . 0.0 109.993 179.285 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.5 mt -99.46 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.172 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.477 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 36.0 p -102.39 148.72 25.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.406 -0.809 . . . . 0.0 109.818 -179.134 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.91 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 109.06 179.678 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.432 ' C ' ' SD ' ' A' ' 60' ' ' MET . 65.9 t-105 -172.09 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.981 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.445 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.0 t-20 -97.25 98.23 9.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 109.742 -179.731 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.05 162.3 54.68 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.708 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' O ' ' OD2' ' A' ' 38' ' ' ASP . 3.2 Cg_exo -56.3 148.93 58.33 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.373 1.382 . . . . 0.0 110.134 179.362 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 65.99 -159.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.184 -179.73 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.94 156.71 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.8 173.05 12.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.99 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.81 -3.02 2.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.835 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 64' ' ' ASP . 17.3 tp -58.92 -52.5 65.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.18 . . . . 0.0 108.807 179.921 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' O ' ' OG1' ' A' ' 71' ' ' THR . 12.3 tp10 -61.81 -4.14 1.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 108.948 179.638 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 66' ' ' LEU . 11.0 tp -85.59 -64.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -32.34 73.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.865 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -67.35 -60.51 2.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.913 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 89.9 m -51.41 -40.29 58.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.408 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -60.68 -29.27 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 108.66 179.271 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.51 -22.9 32.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.441 -0.787 . . . . 0.0 109.426 179.787 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.53 -26.79 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.947 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 77' ' ' ALA . 48.3 t0 -73.75 -53.12 11.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.346 179.945 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.09 -21.29 4.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.894 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 75' ' ' ASP . . . -87.52 -86.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.596 -179.85 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.3 mpp? -96.53 -25.63 15.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.687 -179.691 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.8 m 53.46 -128.48 2.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -139.44 44.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.451 -0.781 . . . . 0.0 109.3 179.927 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 50.87 177.04 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.914 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.23 135.96 46.06 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 N-CA-C 116.499 1.692 . . . . 0.0 116.499 -175.551 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.585 ' N ' ' OG ' ' A' ' 104' ' ' SER . 2.3 t -124.33 115.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.856 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -102.47 105.88 16.51 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 117.919 -1.512 . . . . 0.0 107.309 177.996 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.477 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 2.0 tpt -66.09 156.22 34.54 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.089 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.0 t -135.48 141.06 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -0.816 . . . . 0.0 110.104 -178.529 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -150.09 176.31 10.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -95.33 -130.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -52.71 88.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -48.7 118.35 2.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.58 -179.695 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 13.6 tttt -94.86 6.9 47.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 4.3 ttpp 75.06 -62.39 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.406 -179.891 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.15 -34.45 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.707 -179.8 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -84.4 -45.06 13.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.964 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.4 mm -48.57 -42.23 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 108.935 179.545 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.7 mt -71.35 -26.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.307 -0.871 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.17 -51.77 67.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.212 -0.93 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.55 -51.69 12.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.436 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -58.3 -27.99 64.6 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.324 -0.95 . . . . 0.0 108.935 -179.254 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.0 tt0 -56.16 -33.22 65.02 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 178.151 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.7 -22.13 34.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.014 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 61.66 76.93 0.22 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.825 177.579 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.29 -112.08 0.05 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 116.75 -1.98 . . . . 0.0 109.104 178.661 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.0 m -91.86 -51.29 5.29 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 123.096 1.427 . . . . 0.0 107.913 175.058 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.413 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.65 -157.36 28.41 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -178.116 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.79 127.17 16.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.566 -0.961 . . . . 0.0 109.297 179.294 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.01 140.31 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.838 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.22 153.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.788 -179.926 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.21 153.38 80.42 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.785 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.64 132.23 26.1 Favored 'Cis proline' 0 N--CA 1.49 1.27 0 O-C-N 122.328 0.646 . . . . 0.0 111.259 -1.615 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -98.96 162.38 13.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.386 -0.821 . . . . 0.0 109.164 178.79 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -94.97 146.45 24.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.997 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.71 -31.21 4.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 109.127 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.29 -33.48 67.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.664 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.2 m -71.94 -65.61 0.75 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.446 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 115' ' ' THR . 8.7 tp -47.13 -41.01 16.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 0.0 109.2 178.741 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -64.31 -58.09 7.51 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 -179.634 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -44.22 -48.55 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.646 -0.659 . . . . 0.0 109.682 -179.703 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -65.75 -47.22 75.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.5 -39.77 70.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 109.634 -179.984 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -46.24 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.93 -179.645 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -71.35 -19.58 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.638 -179.635 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.03 -40.44 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.902 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.0 m-85 -73.82 -33.81 64.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 -179.711 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -50.92 -27.89 8.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.05 -1.031 . . . . 0.0 108.413 179.543 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -90.64 -21.82 21.49 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.043 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 124' ' ' PHE . 13.1 tp -83.3 -20.71 33.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.371 -0.831 . . . . 0.0 108.866 179.431 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.25 76.14 0.14 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.623 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 62.76 134.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 108.962 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -90.04 17.44 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.982 -1.074 . . . . 0.0 109.78 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 42.88 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.938 -1.101 . . . . 0.0 110.593 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.41 141.91 57.77 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -78.13 131.36 37.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 0.0 111.104 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.646 ' HB2' HG22 ' A' ' 33' ' ' VAL . 83.2 m-85 -123.67 146.88 47.91 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.827 -0.545 . . . . 0.0 110.259 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.664 ' HB3' HG13 ' A' ' 54' ' ' VAL . 60.9 tp -121.78 116.18 24.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.688 -0.632 . . . . 0.0 109.368 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 109.22 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -106.25 26.02 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.713 -0.617 . . . . 0.0 109.672 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 117.66 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.61 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -64.83 -14.41 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.313 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.0 140.86 4.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.474 ' C ' HG22 ' A' ' 16' ' ' THR . 53.5 p -97.96 47.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.446 -0.784 . . . . 0.0 109.512 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.474 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER 178.23 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 tpt -61.13 -46.68 89.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.614 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -49.84 -31.69 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.912 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -74.01 -42.08 60.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.732 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.44 -52.73 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.755 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -40.48 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 110.234 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.94 -53.11 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -68.64 -57.74 5.26 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.769 0.795 . . . . 0.0 109.686 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -39.64 -56.53 1.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.663 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.36 -51.17 67.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.095 -1.003 . . . . 0.0 108.757 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -47.76 -40.41 20.63 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.249 -0.907 . . . . 0.0 108.983 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.12 -34.37 73.41 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.416 -0.803 . . . . 0.0 109.308 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 117' ' ' GLU . 1.6 mm? -81.09 4.32 20.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.55 62.53 1.78 Allowed Glycine 0 N--CA 1.482 1.748 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -143.58 126.85 16.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -1.184 . . . . 0.0 109.092 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -133.63 65.32 1.59 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.632 -0.668 . . . . 0.0 109.815 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -172.48 89.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -135.75 150.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.0 109.938 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -119.17 -177.12 3.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -150.09 155.22 39.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.863 -1.148 . . . . 0.0 110.81 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -146.6 -165.41 2.22 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 17.1 mt-10 -137.34 -5.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 0.0 110.359 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -177.23 -177.92 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.79 -1.193 . . . . 0.0 109.733 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.63 -52.24 47.57 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.55 -31.85 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.263 . . . . 0.0 108.513 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.8 t0 -74.63 -47.64 30.94 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.122 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -59.08 -48.06 82.98 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.2 -40.09 73.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.954 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 5.9 m-20 -81.56 -25.67 35.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -90.25 -23.88 21.1 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CD2' ' H ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -80.11 -17.27 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.53 -1.356 . . . . 0.0 110.21 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -61.58 -5.94 2.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -52.77 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.019 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.88 11.57 1.67 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.473 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.44 86.21 0.26 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.826 ' O ' HD11 ' A' ' 81' ' ' LEU . 25.2 m-85 -58.92 157.58 9.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.406 -1.056 . . . . 0.0 110.43 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.73 -9.42 62.72 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 140.47 19.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.676 -0.896 . . . . 0.0 109.133 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 9' ' ' LEU . 20.6 t -135.17 120.43 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.0 110.164 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.8 mt -104.08 128.51 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -146.38 147.02 30.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.066 -1.021 . . . . 0.0 109.672 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 58' ' ' TRP . 16.6 t70 -63.84 -120.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.402 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.417 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 61.9 t-105 -161.89 -28.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.782 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -166.64 34.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.633 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.2 -37.22 0.43 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -68.83 -70.65 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.846 1.031 . . . . 0.0 110.152 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.81 -81.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -76.0 -113.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -142.14 -178.42 5.71 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . -93.79 -17.97 39.43 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.396 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.572 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 1.4 mm? -46.79 -68.98 0.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.687 -1.478 . . . . 0.0 110.042 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -43.57 -41.79 4.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.96 -42.9 99.96 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.706 HD21 ' H ' ' A' ' 102' ' ' GLY . 5.4 tt -82.59 -64.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.877 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -33.75 -41.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.23 0.538 . . . . 0.0 110.144 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.465 HG21 HD21 ' A' ' 43' ' ' LEU . 19.6 m -58.96 -48.03 82.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 108.728 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 57.8 mt -50.76 -45.14 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 108.88 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -65.41 -39.29 91.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.34 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 109.574 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.35 -128.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.361 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.621 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . 170.16 161.38 20.56 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 71.79 -14.14 0.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -1.12 . . . . 0.0 109.413 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 76' ' ' GLY . 2.3 mmt -146.82 17.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 m -68.78 7.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.351 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -93.92 2.7 56.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 109.645 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.826 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -43.86 107.59 0.61 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.543 -0.723 . . . . 0.0 109.397 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HD2' HD13 ' A' ' 81' ' ' LEU . 4.1 Cg_exo -62.58 136.5 58.92 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 120.76 0.973 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.2 t -130.27 129.27 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.617 ' CD2' HD21 ' A' ' 116' ' ' LEU . 38.4 tp -110.64 72.03 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.45 145.53 22.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 t -113.56 129.97 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.13 166.29 30.27 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.114 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -91.05 147.72 22.88 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 6.4 mt-10 49.33 -152.0 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.909 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 176.76 115.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.803 -1.186 . . . . 0.0 110.43 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.63 121.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -43.88 -45.24 7.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.299 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -51.89 -32.81 34.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.58 -41.52 13.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.909 HD11 ' HB1' ' A' ' 90' ' ' ALA . 9.2 mt -67.54 -13.07 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.037 -1.04 . . . . 0.0 109.573 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.2 mt -80.56 -70.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.082 . . . . 0.0 109.885 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.804 . . . . 0.0 109.0 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' A' ' 103' ' ' ALA . . . -70.35 -61.67 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.604 -0.685 . . . . 0.0 109.762 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -58.45 -34.63 71.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.222 -0.924 . . . . 0.0 109.699 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -50.91 -19.59 1.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 108.871 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -108.45 -115.03 0.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.83 -0.544 . . . . 0.0 109.603 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.731 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -120.67 -0.99 12.11 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' C ' ' A' ' 98' ' ' ALA . . . -59.18 11.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.903 . . . . 0.0 109.23 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.731 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.2 m -29.2 -31.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.32 133.55 11.72 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.572 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.55 110.64 6.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.7 p -112.58 130.79 65.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.459 HG22 ' OH ' ' A' ' 106' ' ' TYR . 0.5 OUTLIER -64.86 -157.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -174.1 152.54 1.88 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.059 -1.026 . . . . 0.0 109.268 179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.3 146.4 86.14 Favored 'Cis proline' 0 N--CA 1.487 1.111 0 O-C-N 122.576 0.777 . . . . 0.0 110.512 -2.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -112.97 155.04 25.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.936 0.874 . . . . 0.0 109.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.17 146.88 23.46 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -46.03 -29.66 1.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 0.0 109.387 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.14 -35.1 59.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 112' ' ' THR . 16.2 m -69.07 -60.88 2.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -45.83 -50.71 13.92 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.17 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' HG3' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -51.06 -32.48 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 115' ' ' THR . 4.5 tp10 -67.76 -43.9 78.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.84 . . . . 0.0 109.973 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -71.28 -51.33 25.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.975 . . . . 0.0 109.922 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tp -50.2 -59.59 3.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.127 -0.983 . . . . 0.0 109.856 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -52.74 -35.92 56.9 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -66.48 -24.58 66.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 105' ' ' GLY . 22.2 mt -88.83 -47.96 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.954 -1.091 . . . . 0.0 110.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -58.71 -12.4 4.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 110.339 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.09 -24.15 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.99 -29.09 16.8 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.35 -24.52 42.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.489 -0.757 . . . . 0.0 109.055 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.06 81.82 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.257 -1.143 . . . . 0.0 109.558 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.287 0.565 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.512 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.34 141.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -90.59 10.17 26.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.283 -0.886 . . . . 0.0 109.952 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.96 51.42 1.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 46.9 tp -84.17 107.81 16.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -48.5 112.83 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.02 . . . . 0.0 111.705 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 63.0 m-85 -102.6 153.98 19.57 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 46' ' ' LEU . 12.9 tp -131.17 105.61 7.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.344 -0.847 . . . . 0.0 108.884 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -93.71 108.7 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.073 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.914 HG22 ' HB3' ' A' ' 36' ' ' ALA . 62.4 t -96.0 40.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.824 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -70.6 144.58 51.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -97.53 0.51 47.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.69 143.49 27.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.557 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -85.35 34.27 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -165.33 -8.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -37.55 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 1.5 mpt_? -62.07 -16.08 49.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 108.967 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -75.07 -42.08 57.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -53.44 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.871 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.57 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 110.2 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.12 -54.71 8.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.761 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.71 -57.77 6.45 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.981 0.896 . . . . 0.0 109.315 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.27 -64.59 0.53 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.436 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.0 mt -50.1 -44.51 52.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 108.76 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -52.02 -48.01 64.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.356 -0.84 . . . . 0.0 109.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -23.47 63.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.478 -0.764 . . . . 0.0 109.291 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 117' ' ' GLU . 28.1 mt -89.51 3.58 51.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.1 59.41 2.43 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 52.8 m-85 -148.33 142.82 26.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.291 . . . . 0.0 109.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -150.1 27.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.178 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -135.0 99.43 4.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.196 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -146.3 179.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.149 -0.969 . . . . 0.0 109.599 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.1 mt-10 -138.7 -174.28 3.79 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.91 157.27 46.33 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.794 0.807 . . . . 0.0 110.826 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.914 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.97 -174.26 4.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.9 pt-20 -148.77 13.56 0.91 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.912 -1.118 . . . . 0.0 110.226 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 178.16 -179.9 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.954 -1.091 . . . . 0.0 109.131 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -71.28 -39.55 61.96 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.1 -30.9 46.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.125 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.601 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.2 t0 -81.18 -46.09 15.38 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.507 -0.745 . . . . 0.0 109.674 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.43 -42.33 92.57 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.75 -58.04 7.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.061 -1.024 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -54.75 -29.06 52.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 110.072 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -90.13 -31.02 17.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.126 -0.984 . . . . 0.0 110.622 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -53.93 -41.01 67.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.037 -1.039 . . . . 0.0 109.712 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.7 -11.77 59.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.903 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.81 -65.21 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.4 7.65 1.81 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.43 87.04 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.693 ' O ' HD21 ' A' ' 81' ' ' LEU . 61.3 m-85 -67.81 110.45 3.81 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.327 -1.102 . . . . 0.0 110.076 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 81' ' ' LEU . . . -54.65 -10.1 2.02 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.75 126.78 11.22 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.195 -1.179 . . . . 0.0 110.289 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 83' ' ' VAL . 95.9 t -122.92 120.24 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.9 mt -103.61 123.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -139.27 168.38 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.737 . . . . 0.0 109.095 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 9.8 t70 -84.47 -97.01 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 74.9 t-105 -172.4 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.506 ' N ' ' CD1' ' A' ' 58' ' ' TRP . 19.8 t-20 -91.48 126.79 36.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.528 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.47 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.2 mtp 176.62 -50.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.0 Cg_exo -64.19 -168.87 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.815 1.01 . . . . 0.0 110.113 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.61 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.6 mmt -69.76 -117.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.64 147.73 33.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.119 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.04 -8.6 3.27 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -74.71 -63.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.943 -1.328 . . . . 0.0 108.817 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.71 -25.78 12.05 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.3 tt -70.66 -33.64 71.17 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.785 HD21 ' H ' ' A' ' 103' ' ' ALA . 18.0 tp -86.55 -58.26 2.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -43.26 -47.2 6.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.852 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.0 m -51.41 -47.36 63.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 108.99 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.52 -38.47 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 108.924 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -83.94 -20.7 32.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.1 -28.96 43.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -52.27 -70.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.62 -63.39 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.8 -26.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -1.115 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -90.11 -40.88 11.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' MET . 0.3 OUTLIER 75.78 -59.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.16 -54.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.653 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 51' ' ' TYR . 13.3 tp 59.3 120.3 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.85 131.76 43.83 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 120.606 0.87 . . . . 0.0 112.293 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -126.73 127.6 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.7 69.48 0.72 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.462 ' O ' ' CG ' ' A' ' 85' ' ' MET . 5.9 ptt? -61.33 123.62 18.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.83 127.13 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.02 . . . . 0.0 109.511 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.8 t -150.05 136.94 19.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.566 -1.334 . . . . 0.0 110.456 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.04 -14.34 34.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.288 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -102.94 34.52 2.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.58 114.19 3.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.513 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.65 -125.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -0.801 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 94' ' ' ASN . 18.6 tttm -117.17 -89.46 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.651 . . . . 0.0 109.816 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -18.74 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.054 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.477 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -70.68 -35.31 72.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.603 HD11 ' HB1' ' A' ' 90' ' ' ALA . 49.2 mt -85.25 -28.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -73.27 -60.75 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.019 -1.051 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.61 -43.26 12.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.249 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -66.35 -47.54 73.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.34 50.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.94 -1.1 . . . . 0.0 109.721 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -56.76 -24.03 47.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.9 -103.9 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.717 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -135.89 -0.64 3.13 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.785 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -58.18 11.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.828 -0.807 . . . . 0.0 110.913 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 102' ' ' GLY . 49.1 m -29.4 -31.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.65 132.72 11.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -146.26 117.04 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -1.163 . . . . 0.0 109.446 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.57 139.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.4 103.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.76 -1.213 . . . . 0.0 108.337 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -71.72 155.33 92.43 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.873 -1.142 . . . . 0.0 109.38 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.33 168.64 75.49 Favored 'Cis proline' 0 N--CA 1.486 1.04 0 C-N-CA 124.811 -0.912 . . . . 0.0 110.234 -2.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -144.14 157.84 44.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -101.1 149.57 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.416 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -47.12 -32.15 4.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.254 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.62 82.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 5.7 m -69.23 -69.44 0.34 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.4 tp -43.9 -37.5 2.89 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.577 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.2 tt0 -59.07 -59.4 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.24 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.38 -40.11 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.626 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -59.94 -55.35 35.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 121' ' ' ASN . 10.6 mt -50.07 -72.66 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -38.96 -44.42 1.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.486 -0.759 . . . . 0.0 111.851 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -66.5 -31.35 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.942 -1.099 . . . . 0.0 110.372 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 125' ' ' GLU . 18.6 mt -89.97 -40.26 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.092 -1.005 . . . . 0.0 111.075 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -62.16 0.97 0.35 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.059 -1.026 . . . . 0.0 110.558 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.9 mt-10 -77.06 -25.39 52.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -91.44 -29.52 17.0 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -73.07 -29.62 63.08 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.55 80.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.127 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 2' ' ' ALA . 34.6 t70 -43.68 146.44 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.776 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.03 14.05 13.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.071 -1.018 . . . . 0.0 108.674 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 29.1 mp0 -147.24 50.38 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 29.3 tp -78.72 118.44 20.8 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.615 -1.303 . . . . 0.0 108.858 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 118.79 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.141 -0.974 . . . . 0.0 111.418 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 60.5 m-85 -113.44 151.57 31.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG22 ' A' ' 54' ' ' VAL . 53.7 tp -129.82 102.94 6.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 21' ' ' VAL . 1.3 m -90.53 116.86 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.251 -0.905 . . . . 0.0 109.258 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.89 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.8 t -112.37 129.49 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.522 -0.737 . . . . 0.0 110.368 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -165.42 -167.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 7.8 t70 -148.5 13.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 0.0 109.729 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -74.88 -18.7 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.783 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.07 2.9 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.321 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -150.69 -22.01 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.865 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -26.96 66.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -40.81 97.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -64.19 -23.93 67.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.55 -52.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.514 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -66.05 -35.27 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.03 -56.69 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.24 -56.61 19.49 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.953 0.882 . . . . 0.0 109.042 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 tt -37.73 -51.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.07 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 25' ' ' LEU . 28.9 mt -58.65 -52.27 66.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 108.593 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -52.6 -46.06 66.8 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.383 -0.823 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.22 -25.6 14.72 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.435 HD13 ' HE2' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -83.3 -64.57 1.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.557 -0.715 . . . . 0.0 109.134 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.96 67.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HE2' HD13 ' A' ' 28' ' ' LEU . 71.4 m-85 -149.96 155.38 39.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.98 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -150.09 61.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.918 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.89 99.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -0.943 . . . . 0.0 108.545 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.17 149.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 110.701 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -122.02 -169.38 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -147.33 152.87 38.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.89 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.07 167.82 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 5.8 mt-10 -99.94 -2.48 34.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -0.902 . . . . 0.0 110.489 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER 169.12 -179.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.917 -1.114 . . . . 0.0 109.628 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.25 76.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' OD2' ' A' ' 64' ' ' ASP . 58.3 t -54.19 -40.29 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.302 . . . . 0.0 108.789 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 4.3 t70 -67.56 -42.13 83.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.59 -0.694 . . . . 0.0 109.199 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.36 -57.13 8.12 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.363 -0.835 . . . . 0.0 109.409 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' ALA . 53.5 tp -41.95 -43.03 2.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 110.02 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.34 -34.92 70.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 0.0 109.892 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -89.99 -14.04 34.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.173 -0.954 . . . . 0.0 110.625 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -64.55 -18.05 64.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.027 . . . . 0.0 108.569 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -85.89 -3.02 58.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.536 -0.727 . . . . 0.0 109.264 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.62 -73.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.5 8.46 1.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 71.77 1.25 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HD21 ' A' ' 81' ' ' LEU . 34.0 m-85 -47.87 113.52 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -1.036 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.3 -3.67 3.06 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.6 t80 -166.39 141.25 4.41 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.024 -1.28 . . . . 0.0 109.974 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 9' ' ' LEU . 13.3 t -137.52 108.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 110.509 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 55' ' ' ILE . 51.9 mt -90.01 78.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 p -88.0 154.4 20.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.039 -1.038 . . . . 0.0 110.65 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.87 167.67 9.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -61.85 88.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -60.77 125.32 23.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.132 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.653 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 22.8 ttp -131.73 30.89 0.2 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.642 -0.661 . . . . 0.0 112.467 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -57.75 -59.06 0.62 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 N-CA-C 108.788 -1.274 . . . . 0.0 108.788 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -159.04 -28.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.458 ' O ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -175.52 108.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' HG23 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -177.05 -172.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.954 -1.091 . . . . 0.0 110.077 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.63 -71.97 1.8 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' C ' ' N ' ' A' ' 68' ' ' LEU . 1.1 mm? -65.97 -65.06 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.007 -1.29 . . . . 0.0 108.57 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -49.81 -19.91 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' N ' ' C ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 101' ' ' ALA . 2.0 tt -45.94 -63.18 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 109.067 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -42.72 -50.23 5.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LEU . 54.1 mt -73.59 -23.31 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.08 -29.55 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.611 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.76 -28.13 1.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.506 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -47.29 126.7 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.28 -34.25 5.93 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -89.97 -46.69 8.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.4 t 45.8 19.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.22 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -140.93 2.34 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.695 . . . . 0.0 109.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 51' ' ' TYR . 2.5 tp -47.32 110.48 1.33 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.046 -1.034 . . . . 0.0 108.53 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.19 113.81 1.83 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 121.196 1.264 . . . . 0.0 112.976 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.2 t -113.83 117.89 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.715 HD12 HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -98.11 105.31 17.43 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.292 178.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 tpt -76.14 99.47 4.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.168 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -99.4 150.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.855 -1.153 . . . . 0.0 110.389 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.3 t -150.25 -179.81 7.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 109.878 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.35 -73.28 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.41 54.66 1.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 95' ' ' ILE . . . -50.34 107.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 177.78 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 108.9 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -75.07 -34.84 61.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.06 -34.41 17.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.214 -0.929 . . . . 0.0 110.224 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.86 -24.47 63.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.047 -1.033 . . . . 0.0 109.958 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 16.0 mt -72.6 -36.21 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.033 . . . . 0.0 109.401 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.9 mt -80.95 -14.55 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.268 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -63.43 -48.6 77.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.16 -58.98 6.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 108.849 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.7 -25.22 53.74 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.056 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.34 -32.26 37.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.07 -28.2 24.24 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 76.44 67.39 1.69 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.947 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.18 -111.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 117.103 -1.839 . . . . 0.0 110.368 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.575 ' HB2' HD22 ' A' ' 84' ' ' LEU . 50.0 m -91.46 -51.43 5.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.201 1.477 . . . . 0.0 107.554 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.77 -157.58 30.05 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.96 151.93 49.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -1.153 . . . . 0.0 109.244 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 84' ' ' LEU . 8.5 p -147.15 124.74 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.189 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.88 162.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 108.828 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 pttt -135.65 159.5 71.2 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.329 -0.857 . . . . 0.0 108.747 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.34 132.88 29.01 Favored 'Cis proline' 0 C--N 1.32 -0.969 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.44 -2.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.6 p90 -93.42 158.37 15.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.157 -0.965 . . . . 0.0 109.417 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -89.88 147.39 23.78 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.61 -36.97 11.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.96 -1.088 . . . . 0.0 109.064 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 -33.11 74.4 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.252 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' THR . 10.8 m -71.74 -65.79 0.72 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.678 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.91 -38.74 23.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.343 -1.343 . . . . 0.0 108.637 179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.44 -48.38 79.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -45.79 -43.17 12.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -78.62 -34.51 46.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 109.762 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.441 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -63.64 -35.61 81.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.94 -35.36 59.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 109.944 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -31.03 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.3 mt -77.7 -35.03 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -86.55 0.51 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -77.71 -26.72 50.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -96.43 -22.31 17.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.21 -24.97 22.0 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 85.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.215 -1.167 . . . . 0.0 109.501 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.84 128.54 11.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 108.742 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.71 30.95 0.87 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.999 -1.063 . . . . 0.0 109.459 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -148.39 38.14 0.86 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -75.31 141.35 43.4 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HZ3' ' CG ' ' A' ' 32' ' ' ASN . 11.0 mttm -81.6 131.63 35.28 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.105 -0.997 . . . . 0.0 110.971 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 38.4 m-85 -119.56 148.11 43.69 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.789 -0.57 . . . . 0.0 110.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.625 ' CD2' HD12 ' A' ' 46' ' ' LEU . 45.2 tp -121.71 112.42 18.39 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.97 98.87 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.55 -0.719 . . . . 0.0 110.022 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 36' ' ' ALA . 3.8 t -95.16 116.95 37.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER 173.29 152.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.608 -1.308 . . . . 0.0 111.331 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 15' ' ' SER . 3.0 t0 -81.94 52.15 1.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -13.25 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' THR . 1.6 p 57.38 2.22 0.13 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.357 -1.465 . . . . 0.0 108.09 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 15' ' ' SER . 17.0 p 130.59 26.0 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.594 1.157 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' ARG . 30.1 tpp -92.19 -66.6 0.91 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.618 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -33.47 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.91 -39.05 61.65 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.123 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 mt -66.37 -53.34 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.074 -1.016 . . . . 0.0 109.358 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -30.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 110.232 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -53.61 26.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.437 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.731 0.777 . . . . 0.0 109.99 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 113' ' ' ALA . 1.2 tt -40.85 -49.18 3.18 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.933 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -63.54 -53.63 48.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.941 -1.099 . . . . 0.0 108.841 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -54.22 -28.89 44.08 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.205 -0.934 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -35.72 72.44 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.21 -57.78 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.51 74.4 0.02 OUTLIER Glycine 0 N--CA 1.48 1.604 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -150.12 139.17 21.09 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.434 . . . . 0.0 109.045 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -146.57 64.25 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -0.99 . . . . 0.0 109.921 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.516 ' CG ' ' HZ3' ' A' ' 7' ' ' LYS . 10.8 t-20 -173.63 96.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 108.866 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.02 148.44 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.039 -1.038 . . . . 0.0 110.367 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 11.9 mt-10 -122.48 -166.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -150.2 158.65 44.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.529 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.13 -166.63 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.94 13.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 0.0 111.636 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 1.7 t0 -178.85 151.24 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.6 -1.313 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.41 -52.98 12.92 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 40' ' ' VAL . 4.8 t -55.52 -31.55 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.262 -1.14 . . . . 0.0 108.579 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 t0 -71.89 -45.0 62.81 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.164 -0.96 . . . . 0.0 108.894 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -58.46 -58.12 9.95 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.396 -0.815 . . . . 0.0 109.39 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -46.37 -42.65 15.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 110.034 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -78.43 -32.23 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -90.08 -7.01 54.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.774 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -77.72 -16.06 58.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.569 -1.332 . . . . 0.0 108.892 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -78.55 -0.4 29.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.246 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.34 -61.09 1.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.72 15.75 0.46 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.82 102.81 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.565 ' O ' HD21 ' A' ' 81' ' ' LEU . 46.5 m-85 -85.81 142.68 28.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -1.162 . . . . 0.0 110.235 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.17 -7.46 54.77 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -152.78 136.96 16.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.29 116.78 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.625 -1.297 . . . . 0.0 110.484 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -97.87 116.08 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.66 134.73 30.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 108.99 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.76 -177.62 1.31 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.161 -0.962 . . . . 0.0 109.479 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 33.4 t-105 -67.47 -143.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.002 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 60' ' ' MET . 23.3 t-20 -91.82 165.03 13.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.477 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.03 -50.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.737 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -64.73 -77.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 120.779 0.986 . . . . 0.0 110.024 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.11 109.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 108.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 48.88 86.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.883 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.4 m-20 -163.71 -167.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 58.73 -76.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -59.03 -71.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.889 -1.359 . . . . 0.0 109.302 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -53.1 -38.77 62.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.955 -1.091 . . . . 0.0 108.853 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.699 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.1 tp -54.23 -47.18 72.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.857 HD21 ' H ' ' A' ' 103' ' ' ALA . 39.0 tp -65.7 -62.13 1.69 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 21.0 tttm -41.83 -45.97 3.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -44.27 68.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.024 . . . . 0.0 109.168 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 69' ' ' LEU . 67.7 mt -57.35 -37.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.054 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -2.16 44.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 109.574 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.65 -28.54 16.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -63.57 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.44 -25.19 20.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.66 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -1.134 . . . . 0.0 109.351 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.3 ttm -90.11 -31.64 17.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.91 . . . . 0.0 109.218 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.03 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.839 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.95 9.27 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.946 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD21 ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -47.92 110.54 1.42 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 81' ' ' LEU . 6.3 Cg_exo -58.86 125.63 18.79 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 120.961 1.107 . . . . 0.0 112.394 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.5 124.44 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.678 HD21 HD21 ' A' ' 116' ' ' LEU . 50.7 tp -100.7 77.2 1.86 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.482 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 155.51 13.45 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.28 132.54 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 t -150.1 -176.9 5.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.761 -1.212 . . . . 0.0 109.975 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.7 -49.47 2.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.605 -0.684 . . . . 0.0 109.771 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -78.43 -69.75 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 70.64 68.08 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.251 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -61.68 -151.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.021 . . . . 0.0 109.899 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 13.3 mttt -97.39 -86.61 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.807 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -47.65 -10.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.391 -0.818 . . . . 0.0 110.42 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.628 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -79.98 -33.4 39.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 0.0 109.512 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 90' ' ' ALA . 61.0 mt -86.78 -9.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.45 -63.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.992 . . . . 0.0 109.859 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.31 -38.85 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.446 -0.784 . . . . 0.0 109.388 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -70.62 -49.09 51.25 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 109.822 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.31 -51.37 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.971 . . . . 0.0 110.558 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.74 -10.57 48.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.768 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -95.58 -33.69 12.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.196 -0.94 . . . . 0.0 110.891 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.69 -15.01 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.857 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -56.89 11.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.981 -0.717 . . . . 0.0 110.816 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.665 ' H ' ' C ' ' A' ' 102' ' ' GLY . 71.6 m -29.38 -32.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 122.181 -0.324 . . . . 0.0 111.452 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.97 122.99 7.49 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -141.52 128.74 20.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -1.012 . . . . 0.0 108.574 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -134.95 129.57 51.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -60.14 -165.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 150.91 5.62 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.452 -1.405 . . . . 0.0 109.779 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.62 155.36 99.79 Favored 'Cis proline' 0 N--CA 1.488 1.148 0 C-N-CA 125.275 -0.719 . . . . 0.0 110.621 -1.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.723 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -121.43 155.74 34.22 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.856 0.836 . . . . 0.0 109.803 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.418 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.9 150.8 22.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -48.87 -38.43 22.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.762 -1.211 . . . . 0.0 109.445 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.85 76.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 108.236 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 112' ' ' THR . 17.2 m -67.94 -65.26 0.71 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.723 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.03 -45.39 31.97 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.795 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.83 -56.09 16.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.965 -1.084 . . . . 0.0 109.809 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -46.41 -40.17 11.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.459 -0.776 . . . . 0.0 110.029 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.53 -60.52 2.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tp -45.22 -58.99 2.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.45 -37.18 56.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.977 . . . . 0.0 109.95 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -30.1 68.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.741 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.463 HD11 ' HA2' ' A' ' 105' ' ' GLY . 64.1 mt -89.89 -53.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -57.46 -10.01 1.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.175 -0.953 . . . . 0.0 110.077 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -73.32 -31.16 63.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -91.64 -28.25 17.61 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.86 -28.3 44.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.26 86.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.285 -1.127 . . . . 0.0 109.359 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.27 146.05 1.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -89.97 22.15 3.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -155.26 42.59 0.45 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 29.6 tp -71.2 119.67 15.67 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -61.84 128.37 35.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.496 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.0 m-85 -115.47 156.18 26.13 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.19 101.13 4.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 10' ' ' VAL . 5.0 m -92.17 116.65 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.394 -0.816 . . . . 0.0 109.867 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.572 HG13 ' HB3' ' A' ' 36' ' ' ALA . 5.5 t -95.49 93.78 3.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.354 -0.841 . . . . 0.0 109.414 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.58 121.7 26.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.739 . . . . 0.0 109.493 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -23.46 67.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 109.548 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.28 145.68 31.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.562 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.2 t -94.81 21.54 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -154.2 -7.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.2 ttt -65.5 -35.25 80.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.178 -0.951 . . . . 0.0 109.228 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.645 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -48.74 -44.67 38.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.0 109.454 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -33.4 53.55 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.41 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.18 -54.91 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.028 -1.045 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -32.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.327 -0.858 . . . . 0.0 111.174 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -55.04 27.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 0.0 109.174 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -64.33 -57.44 9.36 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.707 0.765 . . . . 0.0 109.329 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -39.74 -58.6 1.31 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.775 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 mt -56.08 -50.53 70.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -29.36 63.7 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.186 -0.946 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.6 -36.93 72.39 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mt -81.15 -59.79 2.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.4 58.24 0.01 OUTLIER Glycine 0 N--CA 1.481 1.685 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' HD2' ' H ' ' A' ' 6' ' ' LEU . 96.1 m-85 -138.13 149.55 46.01 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.273 -1.134 . . . . 0.0 109.181 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -149.91 69.17 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.293 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.4 96.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.204 -0.935 . . . . 0.0 108.677 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -150.12 149.73 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.088 . . . . 0.0 110.565 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' OE2' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -121.36 -170.78 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 10.3 mp0 -143.67 153.63 42.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -137.8 -169.18 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 4.5 mt-10 -124.99 -2.18 7.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.501 -0.75 . . . . 0.0 110.742 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.73 -179.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.849 -1.157 . . . . 0.0 109.542 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.52 -38.0 95.65 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG22 ' SD ' ' A' ' 63' ' ' MET . 1.4 t -66.23 -42.92 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.301 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 7.6 t70 -67.53 -42.96 81.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 108.705 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -61.97 -58.17 8.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 0.0 109.07 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -46.37 -33.38 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -85.16 -31.32 23.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -89.95 -6.15 55.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.115 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.32 -26.51 22.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.975 -1.078 . . . . 0.0 108.483 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -57.66 -10.38 1.56 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.0 108.644 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 46' ' ' LEU . . . -46.0 -68.75 0.17 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.547 -0.721 . . . . 0.0 109.222 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.53 -96.28 0.36 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.31 67.31 0.3 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.469 ' C ' ' N ' ' A' ' 53' ' ' PHE . 22.0 m-85 -44.49 96.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.69 -0.888 . . . . 0.0 109.867 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -50.61 -10.32 0.36 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -157.57 141.11 15.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -1.182 . . . . 0.0 110.467 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 83' ' ' VAL . 39.2 t -131.86 107.37 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG12 ' A' ' 10' ' ' VAL . 39.8 mt -89.88 80.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.99 165.66 16.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.335 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.1 m-20 -97.73 -137.94 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.609 -0.682 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -172.33 95.86 0.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 109.299 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -157.37 -157.66 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 109.043 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.4 mmt -142.7 50.91 1.64 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 111.66 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.4 Cg_endo -59.96 -25.6 80.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.962 -1.592 . . . . 0.0 107.962 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -173.39 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 40' ' ' VAL . 31.4 mtt -158.48 143.63 16.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -87.88 166.27 14.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.752 -1.218 . . . . 0.0 110.047 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.38 -5.48 77.54 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 68' ' ' LEU . 53.1 tp -57.82 -64.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.256 . . . . 0.0 109.17 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -47.61 -15.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.096 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LEU . 6.1 tp -76.17 -57.18 4.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.812 . . . . 0.0 109.305 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.71 -33.1 68.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.203 -0.936 . . . . 0.0 109.329 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -62.83 -67.41 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 m -48.46 -30.04 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 80' ' ' ALA . 11.7 mt -72.43 -40.28 63.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.266 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HE ' ' CA ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -84.21 -17.19 40.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.453 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.78 -28.55 9.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.94 -138.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.383 -0.823 . . . . 0.0 109.322 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -136.54 -123.63 2.28 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.77 22.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.51 ' H ' ' C ' ' A' ' 76' ' ' GLY . 37.0 mtt -150.15 57.7 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 108.717 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 78' ' ' MET . 92.1 p -55.23 -113.13 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.35 58.42 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.0 109.387 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ALA . 12.3 mt 58.58 154.42 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.831 -0.543 . . . . 0.0 109.967 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.29 144.56 17.17 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.565 2.176 . . . . 0.0 114.897 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -129.83 122.18 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.855 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -101.58 107.74 19.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.77 98.3 6.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.401 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.92 158.4 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.76 -1.212 . . . . 0.0 109.791 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -150.07 159.26 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.804 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -98.67 -4.48 33.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' LYS . 1.4 tt0 -145.75 54.47 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.46 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.733 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 89' ' ' GLU . 24.1 tttm -76.16 -72.24 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.659 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -177.64 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.885 . . . . 0.0 109.336 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.38 -38.91 63.8 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -69.04 -29.75 67.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.928 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 90' ' ' ALA . 6.7 mt -67.89 -57.25 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 108.868 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -63.73 -18.94 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.394 -0.816 . . . . 0.0 109.205 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.38 -60.58 3.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.636 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -54.04 -54.23 42.15 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.11 -25.13 65.21 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.682 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 15.9 tp60 -53.13 -31.15 40.72 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -89.26 -22.1 22.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.6 76.91 0.32 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.759 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.86 -111.89 0.08 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.088 -1.845 . . . . 0.0 109.795 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.855 ' OG ' HD22 ' A' ' 84' ' ' LEU . 10.1 p -91.59 -50.78 5.59 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.786 1.279 . . . . 0.0 108.536 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.422 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 165.83 -166.55 38.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.41 148.58 43.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.277 -1.131 . . . . 0.0 109.984 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.6 p -141.21 126.8 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.8 p -74.96 108.75 6.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.955 . . . . 0.0 110.06 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.804 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.52 163.78 48.08 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.2 125.81 10.48 Favored 'Cis proline' 0 N--CA 1.485 0.999 0 C-N-CA 125.121 -0.783 . . . . 0.0 110.842 -1.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.44 154.85 17.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.525 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.89 151.89 21.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.64 -31.51 4.67 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.938 -1.101 . . . . 0.0 109.432 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.05 82.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.043 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.31 -66.67 0.57 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.995 -1.066 . . . . 0.0 108.336 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.84 -35.75 33.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.567 -1.333 . . . . 0.0 109.557 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -70.65 -67.92 0.47 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.827 -1.171 . . . . 0.0 109.768 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -42.84 -29.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.711 -0.618 . . . . 0.0 109.385 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -78.7 -43.69 25.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.02 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 53' ' ' PHE . 2.6 tp -57.19 -66.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 0.0 109.947 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -40.2 -52.38 2.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.558 -0.714 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -60.39 -28.6 68.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 110.557 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.98 -38.5 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.0 110.402 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -76.53 -42.7 42.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 110.669 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -50.32 -23.09 2.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.899 -1.126 . . . . 0.0 108.207 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -92.77 -25.12 18.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' PHE . 2.1 tp -73.46 -26.14 60.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.01 -42.83 1.03 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 129' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.265 -1.138 . . . . 0.0 109.441 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.535 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER 63.88 130.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.027 . . . . 0.0 108.9 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -90.42 7.71 37.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.899 -1.126 . . . . 0.0 109.996 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.38 45.73 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.987 -1.07 . . . . 0.0 111.22 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.31 138.5 38.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.38 122.87 26.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.956 -1.09 . . . . 0.0 111.972 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.71 149.32 33.09 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.16 107.13 10.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -90.36 131.53 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.961 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 36' ' ' ALA . 9.8 t -138.43 38.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.392 -0.817 . . . . 0.0 109.216 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -76.35 22.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.14 -0.975 . . . . 0.0 109.36 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER 47.82 -124.3 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.132 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 46.52 -168.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.33 -9.41 1.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.731 . . . . 0.0 109.052 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.66 -13.98 5.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 8.4 ttt -64.27 -49.48 71.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.483 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -45.48 16.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -52.23 -49.74 63.38 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.482 -0.761 . . . . 0.0 110.266 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -50.2 -55.56 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.952 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.09 -38.15 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 110.892 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.34 -58.28 4.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 109.521 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -62.53 -55.46 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.804 0.811 . . . . 0.0 109.495 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.09 -48.47 2.48 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.6 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.46 -49.37 71.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -48.87 -38.64 23.04 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.324 -0.86 . . . . 0.0 108.828 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -35.06 73.12 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 108.807 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.33 -3.47 33.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.472 -0.768 . . . . 0.0 109.053 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.65 33.25 16.65 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 26.2 m-85 -105.4 142.86 34.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.462 -1.022 . . . . 0.0 109.264 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -141.78 62.94 1.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.01 93.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.915 -1.116 . . . . 0.0 109.249 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.1 150.75 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 0.0 110.271 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.45 -170.5 2.19 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -147.32 157.84 43.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.049 -1.032 . . . . 0.0 110.918 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.57 -167.62 2.3 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.92 3.48 3.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.197 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.1 -179.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 109.63 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.681 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -60.63 -39.79 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -1.085 . . . . 0.0 109.321 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.4 t70 -72.02 -46.67 56.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.847 . . . . 0.0 109.065 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -59.04 -57.12 14.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.486 -0.758 . . . . 0.0 109.65 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 mt -46.46 -47.83 19.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 109.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.954 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.87 9.73 26.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.161 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -85.25 -36.9 20.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 109.053 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.07 -1.28 31.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.23 -58.64 3.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.85 9.8 1.37 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.03 94.9 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.785 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.6 m-85 -80.48 142.64 34.05 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.227 -1.161 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.54 6.22 65.19 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.07 142.71 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.616 -0.932 . . . . 0.0 108.618 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 83' ' ' VAL . 56.4 t -141.75 121.19 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.75 -1.219 . . . . 0.0 110.075 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 84' ' ' LEU . 10.1 mt -107.91 132.04 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 p -151.4 145.63 25.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 0.0 109.421 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.8 p-10 -47.79 -80.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.529 ' CH2' ' OD1' ' A' ' 94' ' ' ASN . 28.0 t-105 -177.34 -68.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 43.4 p-10 -170.54 53.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.948 -1.095 . . . . 0.0 109.742 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.524 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -60.65 -47.59 95.58 Favored Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.09 -1.006 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -65.62 -73.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.038 1.158 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 p30 179.32 -106.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.039 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -70.99 73.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.956 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -150.62 162.49 40.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.743 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 74.16 -66.93 1.83 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' LEU . 52.2 tp -68.68 -73.0 0.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.572 -1.546 . . . . 0.0 109.024 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.3 tp10 -46.9 -32.9 4.11 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.743 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.7 tp -66.74 -41.13 88.36 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.822 HD21 ' H ' ' A' ' 103' ' ' ALA . 40.7 tp -76.66 -62.38 1.65 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.497 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' LEU . 12.8 ttmt -42.96 -35.48 1.24 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.323 -0.861 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.3 m -71.57 -34.94 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.3 mt -64.51 -26.15 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.214 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.06 -40.58 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.773 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.03 -28.57 1.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.24 162.14 6.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.621 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -109.79 22.4 23.81 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.72 0.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -125.06 16.2 8.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.2 t -72.87 16.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -129.31 35.9 4.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.546 -0.721 . . . . 0.0 109.288 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -110.83 99.82 43.71 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.68 147.85 93.47 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 112.624 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 69' ' ' LEU . 3.0 t -130.23 129.5 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 55' ' ' ILE . 24.6 tp -111.66 70.89 0.72 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.91 167.13 3.01 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.518 HG23 HG13 ' A' ' 107' ' ' VAL . 7.2 p -150.16 137.56 13.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.801 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -150.36 171.06 17.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.02 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.02 131.0 48.72 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 50.83 75.31 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.007 -1.058 . . . . 0.0 108.581 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -44.04 138.08 3.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.757 . . . . 0.0 110.299 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 10.4 ttpt -71.67 -6.02 38.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 0.0 109.486 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 2.6 tttm 74.79 -73.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.81 . . . . 0.0 109.683 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.33 -11.53 0.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.041 -1.037 . . . . 0.0 109.838 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.529 ' OD1' ' CH2' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -89.87 -51.49 5.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.89 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mm -46.04 -46.77 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.77 -65.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.962 -1.086 . . . . 0.0 109.509 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.49 -60.08 2.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 108.743 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -44.6 -44.04 8.58 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.597 . . . . 0.0 109.82 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -60.81 -48.15 83.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.992 -1.067 . . . . 0.0 110.246 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -54.24 -11.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 109.437 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.04 -110.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.593 -0.692 . . . . 0.0 110.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -132.96 -2.16 3.89 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.822 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -60.69 11.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.001 -0.705 . . . . 0.0 110.682 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -29.42 -30.56 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -176.08 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 123' ' ' ILE . . . -107.24 128.23 9.14 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.124 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.64 117.82 7.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -1.137 . . . . 0.0 109.563 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 116' ' ' LEU . 1.5 p -113.13 143.41 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -89.6 107.29 17.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.345 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 159.48 68.19 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.675 -1.265 . . . . 0.0 108.963 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.69 164.39 88.14 Favored 'Cis proline' 0 N--CA 1.487 1.139 0 C-N-CA 124.775 -0.927 . . . . 0.0 110.738 -1.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.494 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.6 p90 -144.57 152.99 41.34 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.097 0.951 . . . . 0.0 109.932 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.1 149.79 22.68 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.5 -37.95 12.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.982 -1.074 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.57 -33.52 75.85 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' THR . 88.9 m -72.57 -68.37 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.61 HD11 HG11 ' A' ' 107' ' ' VAL . 8.3 tp -43.87 -37.69 2.96 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.255 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp10 -56.33 -65.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -42.27 -53.67 4.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.323 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -57.2 -52.25 66.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -61.27 2.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -49.52 -36.47 23.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.799 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -28.88 70.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.607 HD11 ' HA2' ' A' ' 105' ' ' GLY . 13.0 mt -80.01 -48.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.019 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -55.17 -6.74 0.16 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 123' ' ' ILE . 1.5 mt-10 -70.31 -27.97 64.81 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -89.35 -26.06 21.28 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.25 -26.08 42.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.816 . . . . 0.0 108.842 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.9 81.7 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -1.149 . . . . 0.0 109.491 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 5' ' ' GLU . 5.0 t70 51.58 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -71.98 34.39 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.576 -1.328 . . . . 0.0 110.04 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 3' ' ' ASP . 46.2 mt-10 -150.37 32.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.91 142.5 57.87 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 108.715 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.42 122.93 28.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.084 -1.01 . . . . 0.0 112.181 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -113.71 154.6 27.04 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 54' ' ' VAL . 18.0 tp -130.43 99.84 5.15 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 10' ' ' VAL . 10.7 m -89.89 107.19 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.078 -1.014 . . . . 0.0 109.833 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.4 t -96.89 65.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 3.6 p30 -89.1 -139.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 108.927 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 31.3 t0 -172.13 -33.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.82 156.51 8.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.746 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.2 t -91.02 39.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -175.17 3.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.3 ttm -84.01 -33.41 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.232 -0.917 . . . . 0.0 109.301 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.699 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.12 -48.62 70.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -55.88 -28.84 58.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.038 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -67.61 -55.3 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.693 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -34.88 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.502 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -55.13 18.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.857 -1.152 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.6 t30 -58.09 -58.6 7.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.98 0.895 . . . . 0.0 108.73 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 tt -40.22 -62.55 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.907 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -52.85 -45.02 67.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.207 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -55.18 -43.13 74.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.393 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -19.34 21.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 117' ' ' GLU . 1.1 mt -99.88 -7.04 25.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.365 -0.835 . . . . 0.0 110.065 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.38 71.26 1.2 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -150.15 100.28 2.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.301 . . . . 0.0 108.819 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -108.41 67.51 0.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.084 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.08 93.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -150.16 147.79 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.96 -1.087 . . . . 0.0 110.398 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.12 -175.27 3.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -147.82 161.05 42.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.869 -1.145 . . . . 0.0 110.909 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.763 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.34 -168.08 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.31 2.55 4.23 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.445 -0.785 . . . . 0.0 110.009 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.68 -176.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 108.819 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.734 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -72.83 -30.94 62.89 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.46 -36.28 76.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.123 -1.221 . . . . 0.0 108.33 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.623 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.7 t0 -75.51 -46.79 30.15 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.14 -54.94 39.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.268 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.6 tt -48.08 -49.57 31.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -67.36 -34.39 77.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.037 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -90.02 -5.06 57.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 110.457 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -72.8 -27.76 62.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.072 -1.018 . . . . 0.0 108.938 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 20.3 tt0 -68.31 0.65 3.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.394 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.92 -77.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.37 -67.78 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.97 68.6 0.08 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.0 m-85 -47.12 101.99 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.487 -1.008 . . . . 0.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.53 8.96 2.74 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -169.52 146.55 3.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -1.199 . . . . 0.0 109.588 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.0 t -145.31 120.44 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.744 -1.223 . . . . 0.0 110.404 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.622 HG23 HG21 ' A' ' 86' ' ' VAL . 9.4 mt -101.43 92.69 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.6 p -98.58 151.24 20.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.272 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 8.6 p-10 -86.19 -107.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.324 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.636 ' CE2' ' ND2' ' A' ' 59' ' ' ASN . 55.3 t-105 -146.3 176.6 9.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.005 . . . . 0.0 109.529 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.636 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -73.98 69.29 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -79.27 -47.55 1.58 Allowed Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.968 . . . . 0.0 110.336 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -67.17 -68.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.082 1.188 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.475 ' CG ' ' N ' ' A' ' 63' ' ' MET . 25.6 p-10 -152.31 -126.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.475 ' N ' ' CG ' ' A' ' 62' ' ' ASN . 20.8 mtm -86.33 95.98 9.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 63' ' ' MET . 52.8 m-20 -160.98 171.73 18.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 74.43 -63.12 2.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 tp -74.04 -50.56 19.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.639 -1.507 . . . . 0.0 107.88 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -71.07 -14.73 62.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.734 HD11 ' HA2' ' A' ' 39' ' ' GLY . 9.8 mt -68.6 -58.17 4.66 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -61.37 -34.73 75.8 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -68.43 -37.91 80.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.9 m -68.53 -48.45 64.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.06 -25.91 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.433 -0.792 . . . . 0.0 109.027 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -90.05 -29.31 18.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.41 -0.806 . . . . 0.0 110.005 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -67.75 -38.2 83.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -53.16 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.35 -79.28 1.44 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.87 54.94 2.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -1.116 . . . . 0.0 109.827 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.7 mmt -137.37 1.95 2.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 109.296 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -94.06 59.99 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.04 -31.47 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 51' ' ' TYR . 10.1 mt -69.64 118.92 67.38 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 120.911 -1.118 . . . . 0.0 109.463 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.31 107.88 0.4 Allowed 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 121.474 1.449 . . . . 0.0 113.096 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.4 t -98.45 113.61 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -95.78 103.05 14.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.078 -1.449 . . . . 0.0 108.331 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 38.4 tpp -68.74 137.78 54.34 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 55' ' ' ILE . 11.1 t -122.64 148.27 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.642 -0.661 . . . . 0.0 110.518 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.95 148.62 29.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.02 -45.92 8.44 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.213 -0.93 . . . . 0.0 108.789 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.8 mt-10 -93.66 43.75 1.12 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -43.91 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 110.086 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -95.47 143.57 26.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -47.56 -16.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.3 mm-40 -90.09 -45.55 9.07 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.287 -0.883 . . . . 0.0 110.167 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.81 -13.77 55.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 110.065 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.423 HG23 ' CD2' ' A' ' 106' ' ' TYR . 8.0 mt -73.64 -46.78 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 mt -74.74 -14.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 108.897 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.75 95.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.36 -58.21 4.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.5 -25.96 60.6 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.228 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.54 -32.44 50.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.891 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -83.01 -29.61 28.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.05 70.01 1.32 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.453 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.775 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.02 -111.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 116.721 -1.991 . . . . 0.0 109.486 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.696 ' OG ' HD22 ' A' ' 84' ' ' LEU . 3.1 p -91.74 -49.72 6.12 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.844 1.306 . . . . 0.0 108.12 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.88 -168.62 39.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.19 151.19 51.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.505 -0.997 . . . . 0.0 109.961 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.629 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 9.6 p -144.08 135.74 22.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 109' ' ' LYS . 11.8 p -80.47 157.19 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.014 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.512 ' HZ2' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -130.69 160.19 67.5 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 108.901 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.49 129.94 19.69 Favored 'Cis proline' 0 N--CA 1.485 1.009 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.683 -2.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.407 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -89.88 -179.18 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.153 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.492 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -110.64 145.08 38.54 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.516 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.77 -14.86 0.14 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.991 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -83.15 -36.72 24.52 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -71.7 -60.3 2.3 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 116' ' ' LEU . 1.3 mt -50.03 -40.85 46.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.413 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' A' ' 28' ' ' LEU . 2.2 tm-20 -59.51 -54.69 43.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.514 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -47.5 -51.56 20.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.42 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.64 -39.8 85.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -54.03 -68.45 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.503 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -46.66 -48.15 20.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.958 . . . . 0.0 109.477 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -47.25 -40.83 17.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 125' ' ' GLU . 69.5 mt -81.93 -59.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.0 109.19 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.2 0.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.852 -0.53 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 123' ' ' ILE . 86.9 tt0 -73.78 -27.32 61.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 126' ' ' LYS . 4.5 mptt -92.78 -34.76 13.75 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.33 -22.44 61.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.03 89.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.334 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.6 m-20 -45.85 140.06 3.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.32 8.53 32.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 110.303 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -140.16 46.25 1.84 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.074 -1.016 . . . . 0.0 110.524 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.404 HD11 ' HA3' ' A' ' 52' ' ' GLY . 54.9 tp -80.6 131.45 35.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 127.63 33.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.905 -1.122 . . . . 0.0 111.621 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -114.61 153.72 29.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.656 ' HB3' HG13 ' A' ' 54' ' ' VAL . 35.9 tp -123.85 111.5 16.17 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.74 108.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.902 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -105.9 55.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.445 -0.784 . . . . 0.0 109.332 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -97.69 142.45 29.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.57 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.81 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.74 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 t -139.45 13.38 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 109.057 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -164.55 -3.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.412 ' H ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -53.74 -45.31 70.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.594 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -45.92 19.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.194 -0.941 . . . . 0.0 109.633 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -53.71 -53.03 57.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.394 -0.816 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mp -47.34 -59.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 109.972 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.468 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -61.85 -40.68 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.729 -178.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.4 OUTLIER -49.61 -54.31 19.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.842 -1.161 . . . . 0.0 109.512 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -62.66 -57.77 9.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.048 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -40.04 -58.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.665 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 55' ' ' ILE . 13.9 mt -57.42 -45.59 84.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.048 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -54.78 -40.9 69.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.6 -15.5 63.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.312 -0.867 . . . . 0.0 109.285 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.28 4.36 48.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.428 -0.795 . . . . 0.0 109.757 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 59.82 1.63 Allowed Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.138 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 51.2 m-85 -150.04 138.52 20.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.363 . . . . 0.0 109.549 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -146.37 64.8 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.908 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.85 96.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 108.799 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.17 153.86 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -169.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -150.16 156.09 40.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 111.418 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.8 -164.4 1.91 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 4.4 mt-10 -130.24 -14.37 3.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.542 -0.724 . . . . 0.0 110.547 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 1.2 p-10 -173.38 -178.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.005 -1.059 . . . . 0.0 109.886 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.553 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.42 -43.28 93.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG2' ' SD ' ' A' ' 63' ' ' MET . 91.0 t -63.92 -51.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.874 -1.368 . . . . 0.0 108.709 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 45.6 t0 -51.31 -47.73 62.55 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.91 -48.83 80.03 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 42' ' ' ALA . 2.4 tp -40.61 -35.94 0.53 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.26 -39.76 65.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 108.931 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' GLN . 35.4 mmtt -79.91 -53.39 6.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.469 -0.769 . . . . 0.0 109.65 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -42.49 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.595 -0.69 . . . . 0.0 109.379 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 45' ' ' LYS . 8.9 tt0 -53.36 -44.75 68.81 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.87 -49.75 38.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 51' ' ' TYR . . . 80.39 -20.51 5.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.14 -8.27 4.58 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 53' ' ' PHE . 66.9 m-85 -71.33 89.85 0.92 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -1.131 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -67.01 6.99 1.8 Allowed Glycine 0 C--O 1.205 -1.709 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -165.86 141.08 4.83 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.463 -1.022 . . . . 0.0 109.241 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 83' ' ' VAL . 10.0 t -131.56 117.51 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.266 . . . . 0.0 109.724 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.445 HD11 HD11 ' A' ' 25' ' ' LEU . 59.0 mt -98.78 79.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 p -93.67 144.1 25.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -0.813 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -92.68 126.06 37.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.364 -0.835 . . . . 0.0 109.016 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.594 ' CH2' HD23 ' A' ' 66' ' ' LEU . 6.9 t90 -90.76 107.56 19.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -161.69 -124.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.438 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 7.3 ttt -159.63 57.97 1.1 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.132 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -64.3 -38.89 32.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 107.32 -1.838 . . . . 0.0 107.32 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -161.5 -26.09 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.408 ' SD ' ' CG2' ' A' ' 40' ' ' VAL . 7.5 mtt -159.7 143.02 14.25 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.88 155.84 32.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.717 -1.24 . . . . 0.0 109.579 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -82.22 -7.84 87.2 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.368 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.594 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -58.37 -49.3 77.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.419 -1.636 . . . . 0.0 107.716 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 71' ' ' THR . 78.9 tt0 -52.74 -15.8 0.82 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.553 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -79.34 -54.51 5.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -56.29 -60.51 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -44.93 -51.38 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.468 -0.77 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 67' ' ' GLU . 10.9 p -61.69 -41.35 97.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 83' ' ' VAL . 17.1 mt -59.33 -21.58 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.22 -0.925 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -90.03 -23.3 21.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.245 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -55.91 4.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.211 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.78 -58.38 3.85 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.16 -58.36 3.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 mtt -128.93 -9.73 4.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.8 p 46.21 -123.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.099 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.07 55.31 0.93 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 108.902 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 45.52 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 O-C-N 121.664 -0.647 . . . . 0.0 109.602 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 5.3 Cg_exo -63.56 149.51 90.81 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.096 1.864 . . . . 0.0 115.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 72' ' ' ILE . 32.3 t -138.53 110.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 2.7 tp -89.76 105.13 17.6 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.139 -1.825 . . . . 0.0 107.262 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 tpp -72.19 109.77 6.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.172 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.57 140.39 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 109.496 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.21 157.82 43.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.65 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.9 mp0 -80.74 70.8 7.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.22 83.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 0.0 108.853 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 89' ' ' GLU . 13.7 tttp -44.69 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.76 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mttt 175.92 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.7 -30.61 33.16 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -61.5 -54.71 39.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 0.0 109.223 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 mm -45.43 -53.83 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.61 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -57.19 -28.25 29.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -64.13 -44.95 90.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.415 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -69.01 -53.99 17.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.058 . . . . 0.0 108.168 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -56.78 -28.47 61.38 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.29 -34.0 73.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.45 -19.23 53.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 55.56 76.05 0.21 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.857 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.17 -112.04 0.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.763 -1.975 . . . . 0.0 110.51 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -50.28 5.83 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.732 1.253 . . . . 0.0 108.149 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 168.41 -155.31 25.86 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.56 122.82 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.547 -0.972 . . . . 0.0 108.782 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 107' ' ' VAL . 8.7 p -119.82 131.68 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.33 132.43 33.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.932 -1.105 . . . . 0.0 109.121 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -109.54 160.11 29.02 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.95 134.45 35.58 Favored 'Cis proline' 0 C--N 1.32 -0.924 0 C-N-CA 124.866 -0.889 . . . . 0.0 110.39 -1.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 2.1 p90 -100.69 160.39 14.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.971 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.88 149.76 21.51 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.03 -21.78 0.76 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.174 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.07 -31.8 25.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -76.78 -57.66 3.73 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -53.23 -40.72 64.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.106 -1.621 . . . . 0.0 107.842 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.51 -52.3 66.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.939 -1.1 . . . . 0.0 109.74 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -45.54 -46.44 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.482 -0.761 . . . . 0.0 109.507 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -70.31 -48.86 54.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 tp -47.08 -65.15 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 0.0 109.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 -45.13 45.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 0.0 109.907 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -68.66 -19.35 64.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 109.652 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.08 -43.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 0.0 110.244 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -63.25 -16.47 60.33 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.083 -1.011 . . . . 0.0 109.964 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -70.84 -19.94 62.6 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -94.85 -34.18 12.55 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -22.08 52.14 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.86 90.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.209 -1.171 . . . . 0.0 109.557 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -47.5 113.06 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 pttt -73.04 36.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.978 -1.076 . . . . 0.0 109.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 3' ' ' ASP . 23.9 tt0 -152.96 30.66 0.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.8 tp -72.83 138.8 46.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -81.29 127.36 32.64 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.969 -1.082 . . . . 0.0 111.697 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 40.7 m-85 -114.71 155.66 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.837 -0.539 . . . . 0.0 109.954 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.3 tp -127.61 109.34 11.6 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -97.3 107.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.355 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 36' ' ' ALA . 37.8 t -98.5 99.55 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.4 -0.813 . . . . 0.0 109.372 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.54 170.13 18.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.734 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.25 26.04 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -70.76 -80.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 t 154.03 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 -26.2 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 ttt -45.2 -63.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.724 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -48.58 -26.86 2.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -76.61 -31.68 57.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.624 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -51.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -38.34 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -52.72 23.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.23 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -58.29 4.13 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.992 0.901 . . . . 0.0 109.712 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.71 -41.18 3.06 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.836 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.77 -46.18 63.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.98 -1.075 . . . . 0.0 108.624 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -56.39 -38.17 71.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.341 -0.849 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.93 -24.88 17.87 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.274 -0.891 . . . . 0.0 109.201 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.745 HD21 ' OE2' ' A' ' 117' ' ' GLU . 1.3 mt -86.28 -39.49 16.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 137.54 6.9 1.51 Allowed Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.6 141.4 28.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.852 -1.381 . . . . 0.0 109.389 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -146.5 61.5 1.22 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -168.89 97.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.03 152.79 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.044 -1.035 . . . . 0.0 109.83 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -120.52 -167.48 1.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 36' ' ' ALA . 1.1 tt0 -150.11 147.93 28.36 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.109 -0.994 . . . . 0.0 110.861 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -132.31 -167.72 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -140.12 -2.2 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.894 . . . . 0.0 110.416 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 1.9 p-10 -176.4 -157.7 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 108.502 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -86.08 -43.12 6.42 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.46 -36.11 17.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.856 -1.379 . . . . 0.0 108.056 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.607 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 15.1 t0 -77.69 -54.64 6.13 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.712 -0.618 . . . . 0.0 109.756 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -55.78 -53.48 56.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.087 -1.008 . . . . 0.0 110.018 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.77 -59.47 4.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -55.37 -33.67 63.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -90.03 -19.86 23.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.116 -0.99 . . . . 0.0 110.699 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -60.52 -22.13 63.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.841 -1.162 . . . . 0.0 109.287 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -90.69 -2.64 57.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 108.919 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.46 -71.9 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.57 -0.706 . . . . 0.0 109.848 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.36 -18.9 1.12 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.26 64.67 0.55 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.783 ' O ' HD11 ' A' ' 81' ' ' LEU . 84.7 m-85 -47.01 114.81 0.92 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.463 -1.022 . . . . 0.0 109.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.27 2.39 9.92 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -161.36 140.93 10.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.08 . . . . 0.0 108.854 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.8 t -134.97 121.17 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.796 -1.19 . . . . 0.0 110.069 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 56' ' ' SER . 43.2 mt -110.43 139.14 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 36.7 m -165.98 157.5 13.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.098 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 6.5 m-20 -61.39 -131.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 0.0 110.085 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 35.6 t-105 -173.11 -2.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.9 p30 -143.25 -16.44 0.66 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.65 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 24.0 tpp -81.08 -33.01 0.67 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 111.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -66.98 -148.0 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.715 0.944 . . . . 0.0 109.871 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -57.44 -159.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.561 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -44.67 -25.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 175.54 135.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.24 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.82 2.8 0.81 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 64' ' ' ASP . 12.3 tp -65.91 -60.13 3.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.809 -1.406 . . . . 0.0 108.068 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -49.34 -39.64 32.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.6 tt -58.87 -35.5 73.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -83.1 -63.66 1.32 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' LEU . 36.3 tttm -35.81 -49.95 0.63 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.083 0.468 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.4 m -49.2 -46.36 45.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 108.492 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 69' ' ' LEU . 55.3 mt -57.09 -33.18 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' CZ ' ' O ' ' A' ' 100' ' ' GLN . 9.8 ttt180 -67.58 -24.4 65.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.04 -28.54 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.54 82.16 8.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.1 89.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.35 -37.26 10.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.424 ' C ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -95.13 -71.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.52 11.05 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.382 -0.824 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -107.28 -31.7 8.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.653 -0.654 . . . . 0.0 109.759 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.783 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.14 97.53 0.11 Allowed Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 122.288 -0.257 . . . . 0.0 110.418 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.58 139.09 52.08 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 121.055 1.17 . . . . 0.0 111.028 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.9 t -131.36 137.68 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' LEU . 39.7 tp -119.81 69.85 0.85 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -51.58 170.52 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.247 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.0 t -140.84 131.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.263 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -149.3 166.14 29.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.077 -1.014 . . . . 0.0 110.351 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.55 32.3 6.21 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 109.714 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 91' ' ' LYS . 3.5 tt0 -153.84 -62.82 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.178 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 57.16 83.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -68.8 8.93 0.44 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.174 -0.954 . . . . 0.0 109.443 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER 73.18 -68.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.328 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -51.6 -43.45 62.52 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -18.64 65.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mm -83.99 -13.97 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.21 -63.17 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.46 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.22 -46.27 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.64 -48.83 78.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 109.123 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.76 61.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' CZ ' ' A' ' 73' ' ' ARG . 74.3 mt-30 -53.0 -23.77 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.77 -109.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.8 -1.85 4.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.43 11.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.086 -0.655 . . . . 0.0 110.87 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.675 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.4 m -29.46 -33.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.74 130.63 10.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.523 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.88 112.18 6.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 108.626 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.823 HG21 ' CD2' ' A' ' 116' ' ' LEU . 13.6 p -115.48 133.25 62.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 106' ' ' TYR . 18.4 m -67.67 -167.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 151.46 17.03 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.706 -1.247 . . . . 0.0 108.991 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.83 165.68 83.17 Favored 'Cis proline' 0 N--CA 1.489 1.236 0 O-C-N 122.459 0.715 . . . . 0.0 111.217 -1.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.825 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.2 p90 -132.82 156.94 46.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.694 0.759 . . . . 0.0 109.6 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.07 143.93 26.78 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -42.97 -33.76 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.253 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.04 95.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.0 m -65.2 -69.76 0.27 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.825 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -47.15 -31.69 3.72 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.972 -1.08 . . . . 0.0 109.986 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.745 ' OE2' HD21 ' A' ' 28' ' ' LEU . 6.1 tp10 -67.7 -62.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.647 -1.283 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 5.9 tt0 -41.82 -59.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.747 -0.596 . . . . 0.0 110.137 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -50.06 -40.57 45.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -66.02 -50.61 63.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -18.4 62.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.0 . . . . 0.0 109.811 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -81.91 -34.42 29.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 mt -78.89 -37.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.102 -0.999 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.6 m-85 -75.33 -30.22 60.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.23 -24.15 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 108.228 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -94.1 -23.26 18.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 124' ' ' PHE . 5.6 tp -83.3 -18.09 40.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 74.95 0.19 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.409 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -160.19 143.66 13.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.045 -1.035 . . . . 0.0 109.875 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -90.16 9.18 29.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.003 -1.061 . . . . 0.0 109.178 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.792 ' C ' HD22 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -158.65 57.0 0.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 56.2 tp -84.87 120.57 26.61 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -57.29 112.12 1.29 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.988 -1.07 . . . . 0.0 111.764 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 25' ' ' LEU . 67.1 m-85 -107.16 151.05 25.93 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -122.25 106.02 10.74 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -89.93 113.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.273 -178.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' ' 36' ' ' ALA . 31.2 t -119.23 106.78 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.591 -0.693 . . . . 0.0 109.331 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -155.49 126.83 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.396 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' ASP . 64.7 t0 -57.77 -107.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.07 -156.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.282 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.434 ' C ' HG22 ' A' ' 16' ' ' THR . 38.1 t -150.35 24.98 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.115 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.434 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -178.65 4.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' THR . 1.8 tpp -68.84 -44.43 73.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.117 -0.989 . . . . 0.0 109.122 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -44.69 -47.03 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 109.85 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -56.38 -51.2 69.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.919 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -49.77 -58.51 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.004 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.49 -39.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.477 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -57.25 11.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 108.933 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.3 t-20 -57.63 -54.06 51.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -39.19 -55.08 1.72 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.814 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 8' ' ' PHE . 60.9 mt -61.82 -53.18 59.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 108.865 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 26' ' ' LYS . 8.1 mtpm? -52.55 -28.12 19.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.247 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -32.66 62.59 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.086 -1.009 . . . . 0.0 108.838 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.91 -69.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.254 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 18.41 0.02 OUTLIER Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 30.9 m-85 -96.07 153.99 17.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.351 . . . . 0.0 109.06 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -149.12 21.5 0.97 Allowed 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.87 -1.144 . . . . 0.0 110.894 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.792 HD22 ' C ' ' A' ' 5' ' ' GLU . 27.0 p-10 -138.29 107.65 6.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.917 -1.114 . . . . 0.0 111.106 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -148.33 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.226 -0.921 . . . . 0.0 109.606 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.3 mm-40 -137.35 -166.69 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -150.1 154.68 38.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.935 -1.103 . . . . 0.0 110.824 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.846 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.87 -163.67 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.91 -4.15 2.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.0 110.484 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 2.8 p-10 179.7 -173.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.025 -1.047 . . . . 0.0 109.52 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.71 67.05 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.93 -41.78 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.68 -1.482 . . . . 0.0 108.739 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 10.9 t70 -68.42 -44.45 74.99 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.73 -37.55 79.54 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.38 -57.8 7.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -66.43 -39.64 89.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 110.034 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -22.62 62.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.306 -0.871 . . . . 0.0 110.464 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.09 -4.8 5.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.831 -1.168 . . . . 0.0 109.325 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.05 -7.71 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.712 . . . . 0.0 109.213 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.59 -65.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.614 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.61 5.34 2.04 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.72 76.93 1.1 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.816 ' O ' HD22 ' A' ' 81' ' ' LEU . 52.6 m-85 -54.07 113.62 1.3 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.502 -0.999 . . . . 0.0 110.214 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.52 -4.81 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -165.48 141.35 5.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -1.14 . . . . 0.0 110.166 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 33.6 t -133.94 116.11 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.379 -0.826 . . . . 0.0 110.95 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.34 85.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.8 p -92.64 172.07 8.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 0.0 110.457 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 1.5 p-10 -95.31 -109.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.531 -0.73 . . . . 0.0 109.855 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.614 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 60.4 t-105 -159.82 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.466 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.614 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 41.5 m-20 -139.16 8.57 2.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -53.45 -49.57 87.71 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.956 -1.09 . . . . 0.0 109.72 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.2 -157.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 120.98 1.12 . . . . 0.0 109.496 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 63' ' ' MET . 38.3 p-10 -85.38 143.75 28.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.072 -1.017 . . . . 0.0 109.395 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 19.9 ttm 74.47 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -137.9 164.73 28.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.535 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -91.49 -14.55 56.87 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -52.95 41.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.645 -1.503 . . . . 0.0 108.819 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -53.18 -22.98 7.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 108.549 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 10.2 tp -67.54 -55.16 14.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -57.69 -64.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -44.86 -46.2 10.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 109.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 67' ' ' GLU . 25.1 p -64.58 -43.77 92.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 109.163 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.973 HD13 HG21 ' A' ' 83' ' ' VAL . 25.4 mt -55.38 -27.25 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.344 -0.847 . . . . 0.0 108.735 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.01 -29.83 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.91 -29.92 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -0.894 . . . . 0.0 109.355 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.19 113.33 19.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.832 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.67 -23.71 77.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.35 77.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.178 . . . . 0.0 109.491 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.0 OUTLIER -100.34 -75.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.82 19.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.99 20.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 51' ' ' TYR . 10.5 mt -84.15 119.8 73.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.083 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.07 98.19 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 120.934 1.089 . . . . 0.0 112.13 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.973 HG21 HD13 ' A' ' 72' ' ' ILE . 2.4 t -99.17 121.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD12 HG12 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -99.95 107.13 19.02 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.51 110.52 18.74 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.061 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG12 ' CG1' ' A' ' 107' ' ' VAL . 0.7 OUTLIER -98.77 161.68 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.586 -1.321 . . . . 0.0 110.049 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.468 ' C ' ' NZ ' ' A' ' 109' ' ' LYS . 11.6 t -149.96 -155.59 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.497 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.42 32.57 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.536 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.99 -60.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.1 98.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 109.904 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 93' ' ' GLU . 32.0 tttp -112.59 54.62 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 mttt 54.12 -82.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.665 -0.647 . . . . 0.0 110.002 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LYS . 1.9 mt-10 -43.76 -56.05 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 110.509 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.492 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -55.32 -45.74 76.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.988 -1.07 . . . . 0.0 109.974 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.8 mt -48.86 -36.77 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 108.977 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 100' ' ' GLN . 15.2 mt -74.62 -25.62 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -56.18 -53.34 58.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 0.0 109.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.42 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -58.32 -59.36 5.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.917 -1.115 . . . . 0.0 108.451 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.06 -21.84 34.61 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.44 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.7 tt0 -52.21 -32.27 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.66 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -90.07 -22.66 21.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.66 72.26 0.88 Allowed Glycine 0 N--CA 1.482 1.74 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.196 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.08 -112.32 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 116.55 -2.06 . . . . 0.0 110.192 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 20.5 m -91.93 -52.56 4.67 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.529 1.633 . . . . 0.0 107.58 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.48 -160.19 33.23 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.22 147.01 49.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -1.076 . . . . 0.0 109.849 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 116' ' ' LEU . 7.5 p -136.99 128.74 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 149.96 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.62 160.87 62.43 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.79 124.07 8.9 Favored 'Cis proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.803 -0.915 . . . . 0.0 110.554 -1.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 116' ' ' LEU . 5.0 p90 -93.4 156.43 16.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.309 -0.869 . . . . 0.0 109.967 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.527 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.28 150.06 22.09 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.19 -32.14 4.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.82 -35.46 80.74 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.095 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -71.38 -65.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.081 -1.012 . . . . 0.0 108.51 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 107' ' ' VAL . 3.0 tp -52.34 -34.94 49.61 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.419 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 120' ' ' LEU . 4.3 tm-20 -69.12 -63.3 1.09 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.798 -1.189 . . . . 0.0 109.702 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.4 -41.84 9.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.632 -0.668 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HE3' HG23 ' A' ' 107' ' ' VAL . 2.6 mtmm -71.29 -27.78 63.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.1 tp -61.99 -62.1 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.36 -35.6 8.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.573 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -75.01 -29.89 60.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.166 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mm -77.05 -40.0 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.382 -0.824 . . . . 0.0 109.44 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -76.86 -0.24 23.32 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -31.41 58.61 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -90.18 -25.53 20.6 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.93 -25.58 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.52 89.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -46.28 132.36 10.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -90.46 18.63 5.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.036 . . . . 0.0 109.646 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -129.32 42.6 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 6' ' ' LEU . 30.7 tp -90.14 130.22 36.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -76.93 124.79 28.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 111.422 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.495 ' HB2' HG22 ' A' ' 33' ' ' VAL . 62.4 m-85 -109.29 152.08 25.71 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 46' ' ' LEU . 22.9 tp -131.15 105.59 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.51 104.62 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.085 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.7 t -94.45 88.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.414 -0.804 . . . . 0.0 109.436 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -149.33 157.15 43.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.56 -13.66 14.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.639 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HB3' ' H ' ' A' ' 17' ' ' MET . 1.5 m-85 -47.4 136.06 10.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.536 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.4 t -86.14 30.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.35 -24.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.409 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 23.6 ttt -66.06 -61.17 2.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -47.82 -35.17 9.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 109.389 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -72.14 -39.86 68.47 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.963 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -62.6 -53.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.755 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -32.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -55.26 20.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.749 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.86 -53.49 17.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.812 0.815 . . . . 0.0 109.543 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.53 -52.37 2.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.508 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 8' ' ' PHE . 5.2 mt -59.46 -55.16 38.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.393 -0.817 . . . . 0.0 108.999 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -52.1 -31.4 30.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 109.073 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -32.13 55.94 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.286 -0.884 . . . . 0.0 109.336 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -89.47 -61.14 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 162.16 73.34 0.02 OUTLIER Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -150.15 134.52 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.79 -1.418 . . . . 0.0 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.97 26.16 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.745 . . . . 0.0 110.449 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.82 93.71 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 109.393 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 8' ' ' PHE . 44.7 t -139.69 153.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.687 . . . . 0.0 110.336 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 12.4 mt-10 -127.63 -171.88 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.08 147.08 27.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.07 -1.019 . . . . 0.0 110.475 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.26 -165.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.11 0.77 2.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 3.8 t70 -176.43 164.77 2.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.766 -1.209 . . . . 0.0 109.849 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.632 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -56.67 -40.34 88.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.48 -40.38 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.119 -1.224 . . . . 0.0 108.336 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.569 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.3 t0 -66.88 -49.73 64.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.68 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.44 -56.98 13.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 42' ' ' ALA . 1.3 tp -41.1 -45.98 2.87 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.226 0.536 . . . . 0.0 109.735 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -70.93 -37.36 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' ALA . 31.2 mttt -90.09 4.4 50.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 110.045 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.578 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.08 -62.96 1.35 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.91 -1.119 . . . . 0.0 109.047 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -56.15 -8.51 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 108.861 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.33 -79.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.708 . . . . 0.0 109.742 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.75 1.4 11.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 77.55 0.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' O ' HD21 ' A' ' 81' ' ' LEU . 43.6 m-85 -64.71 109.54 2.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -1.065 . . . . 0.0 109.772 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.97 -1.95 1.71 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -157.51 139.92 14.63 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.277 . . . . 0.0 109.698 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 83' ' ' VAL . 25.2 t -141.8 124.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.165 -0.96 . . . . 0.0 109.568 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -132.52 168.95 17.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.785 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 54.5 t0 -94.4 -109.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.158 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.455 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 46.8 t-105 -164.75 -55.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.51 71.41 10.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.086 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mmm -92.4 149.63 38.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 109.191 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.37 -179.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 120.941 1.094 . . . . 0.0 109.945 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.83 -104.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 mtp -106.62 161.54 14.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 109.447 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -73.4 179.28 4.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -82.6 6.78 67.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.08 -40.29 60.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.02 -1.282 . . . . 0.0 108.247 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 6.2 tp10 -71.36 -15.95 62.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.7 mt -74.01 -58.6 3.19 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.854 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.9 -38.43 91.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.209 -0.932 . . . . 0.0 109.34 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' ALA . 13.8 tptm -63.5 -51.18 66.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 108.892 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 67' ' ' GLU . 24.0 p -60.35 -45.59 92.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 109.341 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.96 -34.63 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.252 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.15 -8.05 52.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -108.62 -16.91 14.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 109.733 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 74' ' ' ALA . 7.7 p30 -23.98 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.234 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -169.09 -82.34 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.33 26.85 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.958 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 tpt -147.94 36.37 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.3 m -79.14 58.03 2.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.34 -18.74 0.44 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.84 . . . . 0.0 110.667 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -47.79 111.13 1.58 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 109.476 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.26 125.89 19.31 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 121.422 1.414 . . . . 0.0 113.442 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -121.26 116.93 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -97.53 107.42 19.92 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.708 -1.597 . . . . 0.0 106.926 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.475 ' C ' ' SD ' ' A' ' 85' ' ' MET . 5.0 ppp? -75.24 131.87 40.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.45 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.92 142.23 25.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.362 0.601 . . . . 0.0 110.834 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.0 t -150.12 176.53 10.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 109.345 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -128.49 -5.92 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 109.232 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.8 pm0 -139.47 57.6 1.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.337 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -47.14 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' GLU . 12.1 tptt -77.93 48.15 0.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.871 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.6 mttp 52.44 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.0 tt0 -45.11 -40.51 7.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.424 -0.797 . . . . 0.0 110.028 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.453 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.8 OUTLIER -57.44 -41.23 80.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 109.036 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.694 HD11 ' HB1' ' A' ' 90' ' ' ALA . 95.2 mt -59.78 -51.44 72.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.063 -1.023 . . . . 0.0 108.446 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -66.23 -26.36 37.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.523 -0.736 . . . . 0.0 109.313 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.71 39.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.089 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -79.42 -50.88 10.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.845 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -55.89 -30.08 61.01 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.088 -1.045 . . . . 0.0 108.998 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.452 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.6 tt0 -58.64 -34.16 70.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.854 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -77.88 -22.62 49.49 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 60.17 79.31 0.12 Allowed Glycine 0 N--CA 1.478 1.495 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.532 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.812 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.37 -111.95 0.06 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 116.932 -1.907 . . . . 0.0 109.288 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.8 t -91.94 -49.73 6.08 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.753 1.263 . . . . 0.0 108.278 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.47 -165.7 37.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.27 125.63 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.947 . . . . 0.0 109.484 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.8 p -126.59 122.66 61.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -58.18 -167.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.8 pttm -164.71 155.25 12.68 Favored Pre-proline 0 C--N 1.297 -1.711 0 O-C-N 120.649 -1.282 . . . . 0.0 109.312 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.6 161.05 94.95 Favored 'Cis proline' 0 N--CA 1.485 0.991 0 C-N-CA 124.888 -0.88 . . . . 0.0 110.432 -2.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.6 p90 -127.92 166.23 18.7 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.704 0.764 . . . . 0.0 109.791 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -95.24 146.34 24.41 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.39 0.73 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.998 -1.063 . . . . 0.0 109.596 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.75 72.92 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.008 -1.057 . . . . 0.0 108.521 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.86 -64.67 0.82 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -49.67 -39.27 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.758 -1.214 . . . . 0.0 109.381 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 120' ' ' LEU . 30.4 tt0 -64.78 -64.47 0.86 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.063 -1.023 . . . . 0.0 109.749 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -44.97 -36.6 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -75.73 -29.53 58.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.941 . . . . 0.0 109.155 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 117' ' ' GLU . 6.3 tp -66.61 -56.98 8.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -52.9 -41.66 64.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -67.9 -27.45 66.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.666 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.32 -45.29 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 13.7 m-85 -65.62 -27.64 68.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -51.35 -29.57 15.73 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 108.274 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -88.14 -21.11 24.81 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 1.3 tt -80.2 -24.62 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.803 . . . . 0.0 108.861 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.34 -41.73 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.271 -1.135 . . . . 0.0 109.521 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.35 0.595 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.495 ' O ' ' CE2' ' A' ' 30' ' ' PHE . 1.2 t0 -55.63 146.67 20.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -90.07 27.46 1.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.667 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -158.2 37.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.6 tp -72.45 137.7 46.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 2.3 mtmp? -76.89 136.62 38.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.039 -1.038 . . . . 0.0 111.531 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.8 m-85 -127.87 145.44 50.94 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.817 -0.552 . . . . 0.0 110.371 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.553 HD22 HD12 ' A' ' 46' ' ' LEU . 64.4 tp -118.4 118.35 31.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.31 104.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.997 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.2 t -98.79 116.57 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.501 -0.75 . . . . 0.0 109.383 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.77 178.42 8.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.723 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -118.99 13.63 13.07 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -161.82 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.262 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -138.82 -0.7 1.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 109.101 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.65 3.12 0.84 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.805 . . . . 0.0 109.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.6 ttt -74.72 -45.39 44.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.509 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.98 -27.11 61.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.618 ' N ' HH21 ' A' ' 18' ' ' ARG . 10.0 mmt180 -73.25 -31.23 63.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mt -64.88 -54.16 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.68 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 109.945 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 35' ' ' GLU . 8.5 mtt85 -46.71 -54.98 8.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.9 t30 -66.24 -58.47 5.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.438 -0.789 . . . . 0.0 109.432 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.26 -65.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.016 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.69 -45.92 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.163 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -38.28 78.92 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.211 -0.93 . . . . 0.0 109.397 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.61 -41.72 63.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 ' CD ' ' A' ' 117' ' ' GLU . 2.1 mm? -70.94 -61.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 109.136 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.33 42.89 0.02 OUTLIER Glycine 0 N--CA 1.479 1.548 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 94.9 m-85 -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.448 -1.031 . . . . 0.0 109.052 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -149.99 67.41 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.884 -1.135 . . . . 0.0 110.4 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.68 97.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.132 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.14 152.29 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.99 -1.069 . . . . 0.0 110.13 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -124.44 -167.3 1.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' OE2' ' NH1' ' A' ' 22' ' ' ARG . 17.9 mt-10 -147.62 146.49 29.37 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 110.153 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.997 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.11 -165.13 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -144.98 -0.74 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.909 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 25.8 t0 -171.57 178.8 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.744 -1.222 . . . . 0.0 109.891 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . -67.22 -52.04 34.44 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -55.33 -27.66 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -1.097 . . . . 0.0 108.615 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -79.86 -42.73 23.65 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.315 -0.866 . . . . 0.0 108.911 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.86 -36.26 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.338 -0.851 . . . . 0.0 109.644 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.76 -37.42 73.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.545 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -82.95 -26.72 31.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.029 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -85.24 -14.36 46.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.393 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.553 HD12 HD22 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -76.88 -19.4 57.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.662 -1.274 . . . . 0.0 109.405 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -68.08 -5.68 18.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 108.879 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.51 -70.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.809 . . . . 0.0 109.779 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.23 13.11 1.08 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.01 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 20.4 m-85 -70.82 140.71 51.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.377 -1.073 . . . . 0.0 110.09 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.84 -6.27 62.2 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -156.54 142.95 18.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.762 -0.846 . . . . 0.0 108.756 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.93 118.32 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.671 -1.268 . . . . 0.0 110.006 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.1 mt -100.89 153.52 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.9 p -170.86 166.0 7.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.032 -1.042 . . . . 0.0 109.189 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 61.8 t-105 -167.12 -57.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.05 -1.031 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.592 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 29.5 p30 -172.54 72.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 110.434 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -91.49 -47.69 0.34 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 110.511 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.94 -160.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 C-N-CA 121.129 1.219 . . . . 0.0 110.216 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -76.67 -40.6 48.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.658 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -79.95 143.98 33.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.33 146.16 27.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -64.85 -15.35 60.0 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -73.91 -72.74 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.163 -1.198 . . . . 0.0 109.951 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' LEU . 69.5 tt0 -45.86 -26.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -69.11 -46.89 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.643 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 7.8 tt -74.67 -62.65 1.46 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.389 0.614 . . . . 0.0 109.397 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -43.39 -31.64 0.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -63.56 -41.84 98.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 47.9 mt -57.91 -40.04 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -68.37 -3.16 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.26 69.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -73.14 139.92 46.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.31 80.34 0.95 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -170.9 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -1.182 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.96 10.73 30.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.403 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m 52.49 -117.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.987 . . . . 0.0 109.18 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -125.91 0.92 7.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER 52.77 171.14 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.44 136.13 57.43 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 121.489 1.46 . . . . 0.0 112.874 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.94 139.85 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.82 68.28 0.76 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -61.57 131.57 50.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.45 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.89 135.74 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.192 -0.942 . . . . 0.0 110.813 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -150.07 156.11 41.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.567 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -85.53 156.8 20.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 tm-20 59.69 -75.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 79.4 97.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -0.761 . . . . 0.0 109.205 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.6 mmmt -58.33 -107.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -163.47 -69.16 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -52.56 -16.46 0.93 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.902 . . . . 0.0 109.372 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -78.64 -29.41 45.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.7 -15.7 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.664 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 97' ' ' ALA . 14.9 mt -82.22 -64.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.785 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -46.26 -47.85 18.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 0.0 109.376 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.654 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -58.2 -51.71 68.59 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.47 -0.769 . . . . 0.0 109.758 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -52.21 -48.65 64.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -47.99 -22.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 108.791 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -94.35 -116.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.659 -0.65 . . . . 0.0 109.531 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.707 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -127.58 -3.67 5.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -59.34 10.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.671 -0.899 . . . . 0.0 109.375 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.707 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.45 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.26 130.98 10.41 Favored Glycine 0 N--CA 1.497 2.722 0 C-N-CA 119.492 -1.337 . . . . 0.0 109.899 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.89 109.24 5.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -1.053 . . . . 0.0 109.351 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG1' HG12 ' A' ' 86' ' ' VAL . 7.3 p -107.54 139.82 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.503 HG22 ' OH ' ' A' ' 106' ' ' TYR . 1.2 t -81.82 119.18 30.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.34 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -88.4 151.62 48.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.892 -1.13 . . . . 0.0 109.624 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.82 162.24 92.57 Favored 'Cis proline' 0 N--CA 1.487 1.121 0 C-N-CA 125.226 -0.739 . . . . 0.0 110.512 -1.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -139.23 159.13 42.88 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 109.993 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.59 151.5 21.53 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.269 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.45 -17.33 0.15 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 108.835 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.85 -43.6 58.15 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -67.25 -63.84 0.98 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.3 tp -46.88 -36.11 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.432 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.62 ' CD ' HD11 ' A' ' 28' ' ' LEU . 16.6 tt0 -63.62 -64.3 0.93 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.99 -1.069 . . . . 0.0 109.772 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -52.99 7.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -46.53 -46.51 19.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.529 HD11 ' CE2' ' A' ' 53' ' ' PHE . 1.3 tp -57.92 -54.97 40.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -21.07 48.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -38.73 49.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.15 . . . . 0.0 109.624 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -90.1 -36.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.353 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -73.29 -41.03 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -51.15 -18.83 0.96 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.843 -1.16 . . . . 0.0 108.046 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -98.44 -23.72 15.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' PHE . 0.5 OUTLIER -82.33 -21.93 35.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 55.05 81.01 0.07 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 109.368 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.264 0.554 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 62.2 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.362 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -90.05 19.2 5.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -137.42 41.21 2.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 tp -75.0 127.73 33.92 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 122.74 24.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 111.712 -177.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 44.6 m-85 -109.98 152.87 25.34 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.5 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.1 tp -117.36 109.45 16.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.64 121.05 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 109.86 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 36' ' ' ALA . 46.1 t -123.45 27.08 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -51.73 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.915 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -53.4 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.622 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -46.94 140.41 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.626 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -88.24 13.78 10.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.356 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -136.11 -18.56 1.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.711 . . . . 0.0 109.299 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.417 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -68.97 -17.68 63.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.244 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -34.91 78.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.872 . . . . 0.0 109.36 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -24.39 62.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 108.914 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -69.91 -52.35 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -30.7 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.747 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.2 -54.29 17.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.95 . . . . 0.0 109.408 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.3 t-20 -67.41 -57.29 6.84 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.804 0.811 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.21 -43.51 1.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.695 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 12.2 mt -70.07 -38.97 75.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.778 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -63.96 -38.26 90.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.29 -0.881 . . . . 0.0 109.157 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -51.0 -35.09 32.01 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.351 -0.843 . . . . 0.0 109.036 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 28' ' ' LEU . 11.0 mp -77.56 -50.9 11.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.336 -0.852 . . . . 0.0 109.133 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.83 35.71 0.06 OUTLIER Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.39 147.39 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.391 -1.064 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -150.17 57.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.05 -1.031 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.88 110.2 0.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.766 -1.209 . . . . 0.0 110.181 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 34' ' ' GLU . 1.3 m -148.2 -177.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 0.0 109.673 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.3 mm-40 -128.11 -171.89 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.77 145.77 30.95 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.125 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.09 -174.2 4.65 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.25 23.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.741 -1.224 . . . . 0.0 110.363 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 179.53 147.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.865 -1.147 . . . . 0.0 109.336 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.59 -39.89 23.77 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.32 -32.05 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -1.069 . . . . 0.0 108.793 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.546 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.2 t0 -76.98 -45.69 26.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.42 -32.55 74.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.555 -0.716 . . . . 0.0 109.394 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 43' ' ' LEU . 3.2 tt -68.22 -65.72 0.66 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -46.51 -27.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 3.9 mttm -90.0 -39.08 13.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.5 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -53.2 -37.6 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.04 . . . . 0.0 108.885 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 7.3 mt-30 -54.94 -24.36 23.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -44.23 -61.3 1.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.164 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.0 75.39 1.22 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -173.18 -31.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.591 ' O ' HD21 ' A' ' 81' ' ' LEU . 15.2 m-85 -61.35 86.27 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.269 -1.136 . . . . 0.0 110.015 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -66.92 6.08 2.22 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.6 t80 -158.08 146.2 18.69 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 121.565 -0.962 . . . . 0.0 109.099 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 83' ' ' VAL . 76.6 t -144.01 127.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.617 -1.302 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.77 103.19 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.481 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 23.4 p -109.32 -178.91 3.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 0.0 110.46 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 85' ' ' MET . 32.3 t70 -89.44 -131.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.842 . . . . 0.0 110.292 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.452 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 46.7 t-105 -162.7 -55.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.96 . . . . 0.0 110.092 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.531 ' O ' ' SD ' ' A' ' 60' ' ' MET . 24.0 t-20 -142.54 103.36 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.75 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.558 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.81 -46.22 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -69.36 -162.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.05 1.166 . . . . 0.0 109.979 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -54.07 130.38 37.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.106 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.425 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 36.7 mmm 51.17 -116.16 0.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -142.59 151.01 41.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 108.932 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.35 12.61 1.77 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 64' ' ' ASP . 1.2 tp -67.8 -57.2 6.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -1.185 . . . . 0.0 108.97 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -19.81 64.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.459 -0.776 . . . . 0.0 109.115 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -59.3 4.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.5 tt -70.95 -59.46 2.78 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.8 tttt -38.38 -37.71 0.31 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -63.3 -44.17 95.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 108.794 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 56.0 mt -55.33 -38.0 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.97 -5.95 58.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.49 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -84.82 -26.74 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 109.625 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.07 -15.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 67.31 -0.65 8.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.91 26.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -1.121 . . . . 0.0 109.413 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 mmt -139.79 20.61 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 109.339 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.2 p -85.61 49.23 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.52 6.02 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 109.843 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 51' ' ' TYR . 7.2 tp -92.98 119.59 67.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 108.636 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.91 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 120.774 0.982 . . . . 0.0 111.926 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.737 HG11 HD11 ' A' ' 69' ' ' LEU . 8.7 t -98.8 110.4 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.363 -0.836 . . . . 0.0 108.759 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.29 101.6 13.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 1.1 tpt -75.5 152.14 37.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.72 147.3 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.632 -0.668 . . . . 0.0 110.151 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.55 HG22 ' N ' ' A' ' 88' ' ' ALA . 30.9 m -143.77 163.18 34.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.969 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.55 ' N ' HG22 ' A' ' 87' ' ' THR . . . -105.09 -62.43 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -96.57 87.19 4.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.094 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -81.79 161.09 23.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.917 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -147.39 154.23 40.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.169 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -48.39 61.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.12 -52.81 8.65 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.131 -0.981 . . . . 0.0 110.632 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -10.21 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.113 -0.992 . . . . 0.0 110.561 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 9.9 mt -86.35 -7.29 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.827 -1.171 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.5 mp -90.07 -46.59 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -46.01 -22.7 0.23 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.42 -52.57 45.02 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -49.22 -41.82 38.5 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.722 -1.861 . . . . 0.0 107.96 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.92 -31.27 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.798 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -134.82 -71.2 0.49 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -49.98 82.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 176.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -68.46 -110.13 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 112.586 -1.807 . . . . 0.0 115.08 -174.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -37.44 -57.22 0.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.723 -176.424 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.67 171.16 33.65 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.852 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.46 113.48 11.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.116 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 107' ' ' VAL . 13.1 p -109.25 115.25 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 108' ' ' VAL . 1.1 p -71.04 102.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 159.39 77.29 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.049 -1.032 . . . . 0.0 109.123 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.9 154.21 99.51 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.357 -2.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -129.57 160.83 32.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.859 0.838 . . . . 0.0 110.138 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -97.97 148.49 23.42 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.13 -35.48 7.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 109.327 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 -35.38 80.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.0 m -70.43 -67.8 0.47 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 115' ' ' THR . 10.6 tp -47.28 -39.62 14.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.656 -1.278 . . . . 0.0 109.344 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -62.7 -53.48 53.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.078 -1.014 . . . . 0.0 109.5 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.0 mm-40 -47.4 -28.32 2.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.286 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -79.55 -49.83 11.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.445 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -48.26 73.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.307 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.13 -47.36 86.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 109.956 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.8 mt -82.82 -35.86 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.888 . . . . 0.0 109.116 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -85.92 -2.15 57.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.46 -27.04 55.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -93.65 -31.09 14.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.59 -27.97 62.5 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.11 87.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.384 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -53.28 144.2 16.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.197 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -90.15 18.84 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 0.0 109.366 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.593 ' OE1' ' ND2' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -159.63 48.96 0.3 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 40.2 tp -77.51 113.02 14.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.999 -1.063 . . . . 0.0 108.433 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -53.78 106.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.938 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.594 ' HB2' HG22 ' A' ' 33' ' ' VAL . 69.0 m-85 -101.09 153.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.899 HD23 HD12 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -137.58 117.63 13.41 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.475 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.813 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.3 m -106.01 119.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.658 -0.651 . . . . 0.0 110.906 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' ' 36' ' ' ALA . 54.4 t -103.56 112.49 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 121.384 -0.823 . . . . 0.0 109.462 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.464 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -157.96 139.64 13.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -80.2 -12.17 59.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.439 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.52 141.66 58.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 t -92.65 41.18 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -172.06 -40.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 14.1 ttm -46.94 -15.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' THR . 2.9 mtt180 -86.15 -44.34 12.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 109.684 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -65.64 -13.44 59.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.458 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.15 -49.48 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -36.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' ' OE2' ' A' ' 35' ' ' GLU . 8.0 mtt180 -50.81 -52.87 36.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 109.267 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -57.06 7.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.977 0.894 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.28 -48.88 3.67 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.836 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.56 -51.05 62.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.835 -1.166 . . . . 0.0 108.518 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.28 -32.99 5.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -48.59 -38.95 22.1 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.008 . . . . 0.0 109.1 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' OE2' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -76.57 -68.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.384 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.09 20.95 0.02 OUTLIER Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 29.1 m-85 -97.15 139.22 33.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.862 -1.375 . . . . 0.0 109.75 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.593 ' ND2' ' OE1' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -143.84 67.21 1.28 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.124 -0.985 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -174.82 91.56 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.199 -0.938 . . . . 0.0 108.82 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 8' ' ' PHE . 22.0 t -138.94 154.84 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.214 -0.929 . . . . 0.0 110.818 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.671 ' OE2' HD22 ' A' ' 9' ' ' LEU . 13.5 pt-20 -125.89 -171.02 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 13.3 mp0 -144.56 161.46 39.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.83 . . . . 0.0 110.045 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.45 -170.45 3.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.535 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 68.1 mt-10 -134.32 0.71 3.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.532 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 0.2 OUTLIER 175.7 -175.22 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.785 -1.197 . . . . 0.0 109.314 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.97 -54.07 33.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 41' ' ' ASP . 29.6 m -57.3 -36.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -1.131 . . . . 0.0 108.799 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 12.2 t0 -63.48 -45.09 92.35 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -55.73 -67.97 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.778 . . . . 0.0 109.035 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -43.17 -28.52 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.305 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -79.42 -50.35 10.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.908 -1.12 . . . . 0.0 110.818 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' OE2' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -89.79 -3.79 57.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.086 -1.009 . . . . 0.0 110.605 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.899 HD12 HD23 ' A' ' 9' ' ' LEU . 4.4 tt -90.11 -41.21 11.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.074 -1.016 . . . . 0.0 109.624 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.43 0.79 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.31 -60.57 1.86 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.572 -0.705 . . . . 0.0 109.843 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.35 11.1 1.0 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.115 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.46 97.91 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 15.9 m-85 -79.22 124.23 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.204 -1.174 . . . . 0.0 110.405 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.83 -3.86 56.66 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -167.77 142.71 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.428 . . . . 0.0 109.369 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.5 t -134.78 158.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.278 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 84' ' ' LEU . 13.9 mt -143.31 127.59 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 85' ' ' MET . 15.7 p -147.61 157.45 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.892 -1.13 . . . . 0.0 110.175 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 8.8 t0 -65.78 -137.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.758 ' HE1' HD22 ' A' ' 94' ' ' ASN . 60.6 t-105 -173.37 111.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.468 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 66.97 27.43 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.602 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.1 tpt -101.8 -41.99 0.21 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 111.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.2 Cg_exo -65.57 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.158 1.239 . . . . 0.0 110.518 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -74.17 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.064 -1.023 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.3 mtm -74.09 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 65' ' ' GLY . 61.9 t0 -172.38 140.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.063 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -70.98 15.69 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 64' ' ' ASP . 13.7 tp -81.09 -56.76 3.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.08 -1.247 . . . . 0.0 107.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -60.28 -22.25 62.9 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.522 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD13 ' CA ' ' A' ' 39' ' ' GLY . 22.5 tp -64.32 -59.06 4.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -48.06 -63.18 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.752 0.787 . . . . 0.0 108.953 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.2 tttm -40.29 -44.08 1.84 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 110.272 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -58.68 -39.13 79.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.915 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 69' ' ' LEU . 37.7 mt -58.98 -41.68 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.156 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -50.06 -30.07 10.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 109.559 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -45.98 -24.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 74' ' ' ALA . 12.2 t70 -44.1 -91.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -164.77 -142.88 3.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.25 -0.1 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.686 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.93 7.38 37.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 47.29 -132.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.241 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -113.57 12.13 18.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.724 -0.61 . . . . 0.0 109.589 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 52.5 173.85 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.224 -0.922 . . . . 0.0 108.722 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.33 144.02 99.54 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.326 1.351 . . . . 0.0 113.452 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -138.54 135.86 43.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.3 tp -114.76 69.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 56' ' ' SER . 5.1 ptm -56.66 156.07 6.8 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.557 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.08 138.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.852 -0.53 . . . . 0.0 109.588 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -146.63 179.88 7.25 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.466 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -130.69 -26.32 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.835 -0.54 . . . . 0.0 109.608 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -117.4 61.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 109.756 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.02 108.98 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.173 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -78.59 -79.65 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.794 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -174.48 -89.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.014 . . . . 0.0 109.548 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.64 45.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.758 HD22 ' HE1' ' A' ' 58' ' ' TRP . 6.8 t-20 -54.64 -26.15 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.332 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.692 HD11 ' HB1' ' A' ' 90' ' ' ALA . 36.4 mt -85.12 -17.47 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 0.0 109.264 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' ALA . 72.5 mt -82.94 -62.92 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -45.82 -54.21 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.56 -52.38 17.84 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.42 -0.8 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.54 69.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.584 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -59.01 -17.18 22.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.044 -1.035 . . . . 0.0 109.968 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.85 -34.99 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.336 -0.852 . . . . 0.0 109.88 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.709 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.06 -13.07 0.73 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.5 10.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.769 -0.842 . . . . 0.0 109.885 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.709 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.46 -35.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.113 -177.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.39 127.05 9.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.554 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -139.62 113.4 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -1.032 . . . . 0.0 108.567 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.811 HG21 HD12 ' A' ' 116' ' ' LEU . 14.1 p -116.01 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.029 HG12 ' H ' ' A' ' 109' ' ' LYS . 33.1 t -61.27 -164.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 1.029 ' H ' HG12 ' A' ' 108' ' ' VAL . 9.9 pttm -164.88 156.09 13.03 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.464 -1.398 . . . . 0.0 108.737 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.96 166.69 81.64 Favored 'Cis proline' 0 N--CA 1.486 1.034 0 C-N-CA 125.158 -0.768 . . . . 0.0 110.857 -1.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.03 161.98 37.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -102.28 171.28 7.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 176.501 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -61.41 -25.52 67.25 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.555 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.56 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.416 -0.802 . . . . 0.0 109.138 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -66.34 -64.55 0.83 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 107' ' ' VAL . 4.1 tp -47.76 -36.44 11.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.811 -1.18 . . . . 0.0 109.779 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 2.9 mm-40 -59.2 -66.69 0.47 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.816 -1.178 . . . . 0.0 109.939 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -45.62 -25.71 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.637 -0.665 . . . . 0.0 110.532 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -86.34 -44.54 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 110.246 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -43.13 91.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.437 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -64.81 -40.83 95.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -56.57 -31.73 64.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.257 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 125' ' ' GLU . 67.8 mt -85.69 -45.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -70.46 10.12 0.52 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.235 -0.915 . . . . 0.0 109.368 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.5 tt0 -83.29 -24.68 32.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -96.21 -30.85 13.25 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -72.3 -26.07 61.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.88 88.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.445 ' SD ' ' OXT' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER 52.88 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.395 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -73.15 32.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.952 . . . . 0.0 109.137 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' ASP . 82.0 mt-10 -155.25 33.32 0.38 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 108.993 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 53' ' ' PHE . 39.2 tp -70.12 132.9 46.53 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -76.09 117.55 17.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -106.12 152.44 23.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.2 tp -126.78 111.06 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -97.77 116.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.782 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' A' ' 36' ' ' ALA . 56.5 t -118.86 110.74 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.912 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -177.2 124.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.985 -1.072 . . . . 0.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.14 7.47 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.717 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -172.16 -154.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.439 -1.413 . . . . 0.0 112.258 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.717 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 177.91 16.43 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.491 HG22 ' C ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -171.92 -48.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.927 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 22.0 ttt -38.85 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.665 -0.647 . . . . 0.0 110.853 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 51.1 mtm180 -43.37 -30.24 0.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.45 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -30.27 39.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.642 -1.287 . . . . 0.0 109.445 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.8 mt -69.66 -49.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.93 -35.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -46.95 -54.1 10.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 109.039 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t30 -61.23 -56.76 17.0 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.845 0.831 . . . . 0.0 108.787 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -36.89 -67.61 0.17 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.897 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.29 -42.79 74.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.925 -1.109 . . . . 0.0 108.997 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -59.16 -28.4 66.56 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -46.61 68.92 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.138 -0.976 . . . . 0.0 109.213 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.0 -62.95 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -0.883 . . . . 0.0 109.077 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.09 18.7 0.02 OUTLIER Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.198 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.97 123.72 34.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.488 -1.595 . . . . 0.0 109.156 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.18 69.27 1.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.73 96.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.094 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.07 149.79 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.004 -1.06 . . . . 0.0 109.916 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 3.6 mt-10 -118.95 -172.18 2.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.8 mp0 -147.11 165.69 29.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 110.396 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.902 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.98 -170.46 3.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -130.25 0.27 4.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.475 -0.766 . . . . 0.0 110.326 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.18 176.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.034 . . . . 0.0 109.601 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -60.32 -47.31 91.72 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -52.85 -35.07 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.088 -1.242 . . . . 0.0 108.42 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 34.9 t0 -74.06 -52.87 11.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.501 -0.749 . . . . 0.0 109.247 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -56.03 -57.44 12.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.304 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.857 HD11 HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -46.28 -46.49 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.0 109.777 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -72.52 -31.6 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 0.0 110.134 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -90.08 -7.06 54.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.973 . . . . 0.0 110.238 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -70.53 -6.44 36.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 0.0 108.77 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.51 -2.16 57.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.987 -1.07 . . . . 0.0 109.234 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.76 -67.82 0.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.822 . . . . 0.0 109.456 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.48 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.58 72.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.724 ' O ' HD21 ' A' ' 81' ' ' LEU . 76.7 m-85 -54.9 95.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.94 -6.13 1.68 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -153.42 139.24 18.03 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.49 -1.006 . . . . 0.0 109.587 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 9' ' ' LEU . 47.8 t -134.0 118.81 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.004 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 55' ' ' ILE . 34.8 mt -99.51 114.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.6 p -132.24 166.21 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.806 . . . . 0.0 109.326 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 12.4 p-10 -90.01 -118.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.117 -0.99 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 43.2 t-105 -162.36 -18.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.331 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.38 96.21 5.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.312 0.577 . . . . 0.0 109.774 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 159.69 70.75 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.73 -41.82 73.65 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.144 1.23 . . . . 0.0 110.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -96.51 -107.74 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 0.0 109.192 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 63' ' ' MET . 2.8 mpp? -69.56 -161.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.5 176.38 6.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.064 -1.022 . . . . 0.0 109.29 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.93 59.25 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.571 -1.3 . . . . 0.0 109.874 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.8 tp -86.24 -40.68 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.808 -1.407 . . . . 0.0 107.58 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.74 -18.03 65.17 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' CA ' ' A' ' 39' ' ' GLY . 25.6 tp -78.48 -66.48 0.85 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -56.73 -40.03 74.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -47.53 86.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.288 -0.882 . . . . 0.0 109.023 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.857 HG21 HD11 ' A' ' 43' ' ' LEU . 52.9 m -51.23 -47.38 62.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.61 -46.09 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 108.795 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -62.09 -29.0 70.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.6 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 71' ' ' THR . . . -45.27 -29.13 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 11.1 t70 -67.73 99.69 0.83 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.71 76.58 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -168.26 -60.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 0.0 109.405 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.1 mmt -92.91 -71.03 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t 45.46 26.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.374 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.81 -12.59 4.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.654 -0.654 . . . . 0.0 109.487 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.2 tp -48.25 113.37 2.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.112 -0.993 . . . . 0.0 108.729 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.5 121.59 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.2 1.267 . . . . 0.0 112.751 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.52 115.52 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' MET . 5.5 tp -101.61 73.88 1.48 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.896 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' LEU . 6.0 mtt -48.15 172.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -147.15 120.18 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.413 -0.805 . . . . 0.0 109.344 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -150.04 -178.47 6.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.743 -1.223 . . . . 0.0 110.042 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.31 -41.64 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.51 56.42 2.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 109.375 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -71.26 111.51 6.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.708 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.203 -0.936 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -136.36 -70.21 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -45.97 -16.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.809 . . . . 0.0 109.553 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -90.13 -57.31 2.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 109.608 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 90' ' ' ALA . 69.2 mt -47.44 -28.42 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.377 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.95 -60.04 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.313 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.69 -52.8 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 108.971 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.462 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -50.64 -48.45 58.21 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.495 -0.753 . . . . 0.0 108.992 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.75 -45.92 49.92 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.23 -29.18 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -112.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.47 -0.769 . . . . 0.0 109.191 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -131.64 0.14 4.98 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.6 11.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.143 -0.622 . . . . 0.0 110.621 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 21.8 m -29.44 -32.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 122.265 -0.272 . . . . 0.0 111.723 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.81 135.48 12.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -152.06 110.23 3.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 108.822 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.5 p -104.44 139.75 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -88.07 105.19 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.531 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.21 160.12 83.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.903 -1.123 . . . . 0.0 109.059 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.08 166.33 83.54 Favored 'Cis proline' 0 N--CA 1.484 0.944 0 C-N-CA 124.747 -0.939 . . . . 0.0 110.577 -2.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CE1' HD12 ' A' ' 116' ' ' LEU . 6.6 p90 -142.4 -170.98 3.3 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.978 0.894 . . . . 0.0 109.554 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.529 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -135.22 150.18 50.04 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.506 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.45 -33.65 6.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.418 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.83 -30.96 61.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -79.32 -61.3 2.05 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.613 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -49.99 -32.45 15.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.45 -1.406 . . . . 0.0 108.388 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.19 -56.99 10.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.066 -1.021 . . . . 0.0 109.942 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -44.16 -36.41 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.668 -0.645 . . . . 0.0 109.459 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -43.52 81.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.293 -0.879 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.56 -63.07 1.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 109.481 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -44.73 -49.48 10.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.339 -0.851 . . . . 0.0 110.598 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.13 -29.61 63.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.288 -0.883 . . . . 0.0 110.726 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.55 HD11 ' HA2' ' A' ' 105' ' ' GLY . 15.1 mt -89.98 -44.63 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.156 . . . . 0.0 110.785 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -59.14 -9.95 2.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.014 -1.054 . . . . 0.0 110.571 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -20.9 63.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -95.49 -31.88 13.14 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -22.37 43.52 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.87 88.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.256 -1.143 . . . . 0.0 109.459 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -46.27 109.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.0 109.637 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 2.0 mmtp -56.36 7.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.157 -0.964 . . . . 0.0 110.635 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' ' C ' ' A' ' 3' ' ' ASP . 73.3 mt-10 -141.92 45.34 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.058 -1.026 . . . . 0.0 108.738 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 45.0 tp -76.64 107.97 9.31 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 118.215 -1.394 . . . . 0.0 108.715 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -48.95 113.83 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 68.8 m-85 -104.94 155.46 18.92 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -130.97 103.4 6.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 107.78 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 0.0 109.802 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 36' ' ' ALA . 50.3 t -107.87 106.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 -163.51 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.393 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.02 4.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.05 165.28 14.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -97.69 9.7 41.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -149.74 10.22 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 0.0 109.642 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.1 ttt -92.13 -47.14 7.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -28.81 69.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' CG ' HH21 ' A' ' 22' ' ' ARG . 31.6 ttp85 -68.49 -52.77 28.66 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.778 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.5 mt -46.24 -55.05 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.365 -0.835 . . . . 0.0 109.689 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.4 -43.27 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.616 -178.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.432 HH21 ' CG ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -46.88 -55.01 8.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.038 -1.039 . . . . 0.0 109.755 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.33 -55.13 19.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.111 0.958 . . . . 0.0 109.039 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -39.73 -55.25 1.96 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.893 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 30.6 mt -59.94 -49.89 75.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.07 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.79 -34.11 38.37 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.909 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 2.8 tt0 -58.24 -30.17 66.31 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -87.08 -14.48 41.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.775 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.22 46.05 1.77 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.228 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -117.28 129.36 55.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.308 -1.113 . . . . 0.0 108.9 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -128.68 67.99 1.39 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -174.95 94.91 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -0.957 . . . . 0.0 108.861 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.05 149.19 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 110.843 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.78 -169.06 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -150.0 154.52 38.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.021 -1.05 . . . . 0.0 110.69 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.11 -172.4 3.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -139.09 15.47 2.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.169 -0.957 . . . . 0.0 110.619 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 175.24 146.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.713 -1.242 . . . . 0.0 109.868 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -32.98 10.05 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.04 -35.72 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.337 -1.096 . . . . 0.0 108.657 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 26.5 t0 -70.87 -44.94 65.34 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.25 -54.13 42.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.73 -43.15 17.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.922 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -73.94 -33.27 63.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -90.02 -7.68 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 110.006 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -68.07 -13.6 62.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -85.82 -2.83 58.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.45 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.464 -0.772 . . . . 0.0 109.722 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.61 9.97 1.43 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.84 83.75 1.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.485 ' C ' ' N ' ' A' ' 53' ' ' PHE . 57.2 m-85 -62.69 99.89 0.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.29 -1.123 . . . . 0.0 109.693 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.96 -14.28 0.41 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -148.99 119.23 7.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.48 -1.012 . . . . 0.0 109.884 -179.186 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HB ' HG22 ' A' ' 83' ' ' VAL . 53.8 t -116.65 124.05 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.238 -0.913 . . . . 0.0 109.524 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 55' ' ' ILE . 1.1 mt -107.45 126.16 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -143.44 145.15 32.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -0.782 . . . . 0.0 108.987 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -98.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.081 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -172.57 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.145 -0.972 . . . . 0.0 109.726 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -134.84 -1.39 2.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.333 -0.854 . . . . 0.0 109.761 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.532 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.2 mtp -60.16 -47.33 97.08 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 110.67 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.22 -66.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.118 1.212 . . . . 0.0 110.598 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -130.22 -152.43 0.51 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.596 -0.69 . . . . 0.0 109.634 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mtt -51.53 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.699 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 2.3 p30 -142.68 138.45 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.373 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.29 -2.8 21.55 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.42 -45.83 62.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.829 -1.395 . . . . 0.0 108.163 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -39.16 71.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.465 HD13 ' CA ' ' A' ' 39' ' ' GLY . 66.5 tp -53.78 -29.1 38.72 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -88.07 -64.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 109.333 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 69' ' ' LEU . 6.7 ttpp -34.88 -52.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.105 0.478 . . . . 0.0 110.381 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -45.53 41.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 108.766 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 69' ' ' LEU . 53.4 mt -59.37 -30.43 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 108.846 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' LYS . 4.3 ttp85 -83.47 -23.01 32.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.756 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -46.53 -28.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.563 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 18.0 t0 -61.37 -150.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -161.54 33.92 0.37 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.06 6.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -1.195 . . . . 0.0 109.404 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.449 ' HB2' HD23 ' A' ' 81' ' ' LEU . 5.9 ptm -150.03 52.94 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.349 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.7 t -92.76 -5.58 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.647 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.92 53.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 78' ' ' MET . 0.7 OUTLIER -49.44 111.35 1.96 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.897 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.13 144.1 95.45 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 121.009 1.139 . . . . 0.0 112.584 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.4 t -140.26 137.88 37.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 HD11 ' A' ' 116' ' ' LEU . 55.5 tp -115.13 75.13 0.92 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.4 mtt -65.42 122.69 17.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.19 140.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 110.774 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 109' ' ' LYS . 2.4 t -150.09 161.11 43.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.36 25.36 10.77 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' ALA . 48.8 tt0 -142.8 -64.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.475 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 48.77 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 109.165 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 94' ' ' ASN . 22.0 mtmm -59.63 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.208 -0.932 . . . . 0.0 109.811 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -145.25 -101.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -49.99 -27.28 5.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.022 -1.049 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -52.16 -27.12 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -71.62 -27.83 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -74.29 -51.43 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.1 26.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.083 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.19 -52.88 63.52 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.496 -0.753 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.0 65.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -48.67 -27.97 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.997 . . . . 0.0 108.821 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.45 -114.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.608 -0.682 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -123.82 -8.32 6.27 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.53 10.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.026 -0.691 . . . . 0.0 110.581 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 4.7 m -29.59 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.46 132.94 11.13 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.185 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.504 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -145.33 129.03 17.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -1.097 . . . . 0.0 109.222 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -134.77 124.99 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -71.16 103.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.733 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' THR . 2.9 pttp -71.47 157.84 89.14 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.34 166.97 81.26 Favored 'Cis proline' 0 N--CA 1.485 1.011 0 C-N-CA 125.01 -0.829 . . . . 0.0 110.683 -1.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.02 158.0 43.95 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.04 0.924 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.36 148.94 23.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -45.88 -23.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 109.377 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -70.23 -41.96 72.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.14 -65.28 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.663 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 107' ' ' VAL . 2.4 tp -47.59 -36.32 10.52 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.553 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -65.21 -66.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.975 -1.078 . . . . 0.0 109.733 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -45.21 -30.09 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.995 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 11.0 mmmt -81.35 -50.28 9.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.032 -1.043 . . . . 0.0 110.01 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -31.06 70.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.725 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.23 -28.73 47.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -77.82 -22.91 49.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.77 -43.54 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.502 ' CD2' ' SD ' ' A' ' 129' ' ' MET . 17.8 m-30 -73.82 -0.62 16.43 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.912 -1.118 . . . . 0.0 109.45 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -69.34 -20.28 63.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.35 -29.11 12.23 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -80.71 -16.54 53.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.99 90.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 124' ' ' PHE . 4.4 mtt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.319 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.13 145.13 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.392 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.25 17.64 6.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.312 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -152.05 44.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.26 143.11 52.23 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -78.3 131.85 37.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.988 -1.07 . . . . 0.0 111.247 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 25' ' ' LEU . 76.6 m-85 -122.94 147.52 46.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.736 -0.603 . . . . 0.0 109.821 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.607 ' CD2' HD12 ' A' ' 46' ' ' LEU . 12.9 tp -126.97 110.72 13.29 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -95.76 105.25 16.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.0 t -98.62 95.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.413 -0.805 . . . . 0.0 109.86 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -142.1 -159.22 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.231 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 1.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' THR . 8.9 m-85 -91.21 98.06 11.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.419 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.51 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -93.25 -34.49 13.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.48 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 3.9 ttt -56.06 -56.63 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.77 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -35.28 5.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.318 -0.863 . . . . 0.0 109.669 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 ttm-85 -72.97 -35.66 66.95 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.065 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.2 mp -65.3 -54.0 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.382 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -60.95 -32.85 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.767 -179.378 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -50.74 -53.62 30.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -58.24 5.39 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.939 0.876 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.739 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -73.39 -41.89 62.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -27.78 69.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 7.5 tp10 -59.85 -35.9 75.73 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.054 -1.029 . . . . 0.0 109.375 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -81.11 -59.55 2.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.16 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.62 73.91 0.02 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -149.97 144.54 25.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.24 . . . . 0.0 110.021 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.04 63.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.44 100.89 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.74 -1.225 . . . . 0.0 108.881 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.14 152.36 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.007 -1.058 . . . . 0.0 110.509 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.6 -173.35 2.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 13.5 mp0 -145.28 155.05 42.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.95 -172.75 4.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.01 8.65 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.045 . . . . 0.0 110.555 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 11.9 t70 -179.32 167.7 1.5 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.333 -0.855 . . . . 0.0 109.194 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -63.48 -25.59 68.81 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 t -72.46 -40.69 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 108.52 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 12.3 t0 -69.7 -45.67 67.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.66 -39.21 88.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.47 -37.34 72.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.351 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -86.92 -34.88 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.96 -53.98 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 54' ' ' VAL . 4.9 tt -50.07 -27.35 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 47' ' ' GLN . 1.4 tm0? -69.63 8.21 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 108.959 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.66 -68.72 0.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.98 0.31 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.126 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.62 99.16 1.79 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.84 ' O ' HD22 ' A' ' 81' ' ' LEU . 16.9 m-85 -79.53 110.39 14.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.373 -1.075 . . . . 0.0 110.437 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.76 -14.75 4.06 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.52 145.96 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -1.209 . . . . 0.0 110.179 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.5 t -141.93 120.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.138 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.491 ' CG2' HG21 ' A' ' 86' ' ' VAL . 53.6 mt -103.14 78.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -85.48 149.99 25.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.936 -1.102 . . . . 0.0 110.448 -177.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 27.7 t70 -94.64 178.21 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.567 -0.708 . . . . 0.0 109.291 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.672 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 53.5 t-105 -114.71 46.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.414 ' C ' ' SD ' ' A' ' 60' ' ' MET . 18.9 p30 -65.25 -154.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -162.81 60.05 0.95 Allowed Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 120.749 -1.219 . . . . 0.0 111.981 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -62.68 -39.53 42.82 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 107.576 -1.74 . . . . 0.0 107.576 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -147.46 -22.75 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.42 ' H ' ' H ' ' A' ' 62' ' ' ASN . 1.2 mtt -150.77 -83.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 65' ' ' GLY . 4.9 p-10 169.94 -107.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . -137.96 18.2 3.37 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' LEU . 25.3 tp -79.75 -54.17 6.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.083 -1.245 . . . . 0.0 108.152 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -50.36 -21.89 1.61 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD11 ' HA2' ' A' ' 39' ' ' GLY . 1.9 mt -72.7 -59.67 2.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.962 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.95 -61.02 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.7 tttm -40.84 -48.55 3.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.17 -48.59 80.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.911 HD13 HG21 ' A' ' 83' ' ' VAL . 6.6 mt -57.76 -24.0 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -89.68 -28.04 19.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.709 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.72 -33.32 55.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.525 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.1 102.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.206 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.9 50.12 2.95 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.07 -71.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.142 . . . . 0.0 109.555 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.36 25.57 6.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER -65.93 6.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -95.22 20.99 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.82 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 51' ' ' TYR . 9.9 mt -67.23 118.78 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 108.661 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.79 98.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 120.909 1.072 . . . . 0.0 112.592 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.911 HG21 HD13 ' A' ' 72' ' ' ILE . 8.9 t -106.1 106.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -90.12 107.27 19.03 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.133 -1.827 . . . . 0.0 107.407 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.427 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -63.88 150.52 44.71 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.05 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 55' ' ' ILE . 53.7 t -132.39 140.76 46.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.051 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 90' ' ' ALA . 7.4 t -149.96 157.68 43.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.36 -44.33 7.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.842 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -64.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.836 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.591 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 57.24 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.5 -88.61 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.504 -0.748 . . . . 0.0 109.14 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -156.81 -68.25 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.95 -32.56 61.48 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.193 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.672 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 8.9 t30 -76.64 -47.45 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.03 -45.27 52.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.026 -1.046 . . . . 0.0 108.892 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 100' ' ' GLN . 17.7 mt -66.25 -17.04 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -62.68 -69.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 109.326 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -47.43 -45.71 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 108.5 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -67.88 -27.35 66.59 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.326 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' ILE . 5.5 tp-100 -55.79 -31.76 62.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.962 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.86 -20.17 27.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.44 76.11 0.3 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.373 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.21 -112.09 0.08 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.844 -1.942 . . . . 0.0 110.454 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -50.69 5.59 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.832 1.301 . . . . 0.0 108.047 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 169.85 -155.66 25.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.66 127.49 18.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -1.023 . . . . 0.0 109.586 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.458 ' CG1' HG22 ' A' ' 86' ' ' VAL . 13.6 p -117.96 134.87 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.406 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -88.94 121.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.567 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -94.18 162.06 27.62 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.253 -0.904 . . . . 0.0 108.611 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.6 128.32 15.98 Favored 'Cis proline' 0 N--CA 1.485 1.014 0 C-N-CA 124.755 -0.936 . . . . 0.0 110.427 -2.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 116' ' ' LEU . 3.9 p90 -99.48 158.27 15.85 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.93 0.871 . . . . 0.0 110.084 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.25 146.79 23.44 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 117' ' ' GLU . . . -45.56 -23.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.973 -1.08 . . . . 0.0 109.829 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.47 -38.29 65.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.035 -1.041 . . . . 0.0 108.49 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.84 -62.46 1.37 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -47.67 -41.76 23.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.721 -1.191 . . . . 0.0 108.939 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 19.3 mt-10 -61.82 -52.26 64.9 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.053 -1.029 . . . . 0.0 109.499 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -46.4 -49.19 18.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.479 -0.763 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -38.61 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.87 -63.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.79 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -47.59 -53.06 15.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -62.62 -18.21 61.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.8 mt -89.64 -45.66 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.0 109.987 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 127' ' ' LEU . 16.7 m-85 -66.63 -31.48 72.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.002 -1.061 . . . . 0.0 110.014 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -52.71 -26.63 14.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -87.35 -26.48 23.34 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 124' ' ' PHE . 44.0 tp -70.44 -24.01 62.82 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.19 23.41 19.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.7 mmt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.337 -1.096 . . . . 0.0 109.465 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.578 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -177.13 150.84 0.77 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.21 -0.931 . . . . 0.0 109.009 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -90.47 17.78 6.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.861 -1.149 . . . . 0.0 110.499 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.94 43.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.512 -1.368 . . . . 0.0 111.232 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.2 tp -67.02 110.98 3.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.424 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.59 111.29 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.828 -1.17 . . . . 0.0 111.611 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 62.2 m-85 -105.77 155.14 19.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 tp -132.65 104.06 6.45 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.95 130.16 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.261 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 36' ' ' ALA . 13.4 t -137.99 105.37 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.44 -0.788 . . . . 0.0 109.078 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -149.6 116.39 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.148 -0.97 . . . . 0.0 109.431 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.17 -16.85 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.225 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.5 m-85 -59.49 130.03 44.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 m -92.26 48.7 1.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 t -175.72 -14.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 ttt -72.37 -35.56 68.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -63.05 -32.38 73.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.85 -20.16 58.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -75.33 -47.2 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.334 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -32.99 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.215 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -46.03 -52.61 11.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -73.64 -59.58 2.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.601 0.715 . . . . 0.0 110.161 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -40.22 -55.41 2.16 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.916 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -58.23 -50.45 73.52 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -54.0 -34.5 60.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.87 -38.53 49.93 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.391 -0.818 . . . . 0.0 109.38 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -65.03 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.48 26.2 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 54.0 m-85 -100.52 141.47 33.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -1.147 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -150.04 59.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 110.183 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.23 96.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.72 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.6 -178.26 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 109.895 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.8 mm-40 -139.55 -175.62 4.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 11.1 mp0 -144.35 150.21 37.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -141.65 176.29 9.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.67 3.56 14.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.267 -0.896 . . . . 0.0 110.477 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.29 -176.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.262 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.04 -26.42 73.9 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.76 -43.13 93.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.076 -1.249 . . . . 0.0 108.132 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.4 t70 -75.68 -40.85 55.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -62.2 -39.26 92.15 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.238 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 71' ' ' THR . 3.5 mt -62.49 -49.3 75.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.294 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 10.2 m-80 -63.55 -29.13 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -24.16 21.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.622 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -23.06 61.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 0.0 109.625 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 3.2 pt20 -76.72 -1.62 28.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.472 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.42 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.424 -0.797 . . . . 0.0 109.604 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.85 12.18 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.79 88.21 1.37 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' PHE . 58.4 m-85 -69.23 103.95 2.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.297 -1.119 . . . . 0.0 109.588 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.69 -9.19 0.45 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.63 131.28 10.66 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.188 -1.183 . . . . 0.0 109.986 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 83' ' ' VAL . 94.5 t -125.18 114.61 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 109.551 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.46 77.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 p -100.33 128.74 46.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.473 -0.767 . . . . 0.0 110.541 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 59' ' ' ASN . 4.5 t70 -65.12 164.0 13.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.793 -1.192 . . . . 0.0 108.645 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.489 ' CH2' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -55.38 -2.2 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 108.877 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.546 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.1 m120 46.88 -153.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.647 -1.283 . . . . 0.0 110.302 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.515 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 171.25 -44.95 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.284 -0.885 . . . . 0.0 110.739 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.08 125.21 14.23 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.678 0.918 . . . . 0.0 110.259 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.11 -148.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.17 115.73 1.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -85.72 -162.32 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -60.84 2.79 0.51 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 58' ' ' TRP . 6.5 tp -82.26 -65.21 1.04 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.768 -1.431 . . . . 0.0 110.341 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -48.3 -19.96 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -67.98 -62.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.75 HD21 HG11 ' A' ' 83' ' ' VAL . 83.2 mt -56.04 -67.66 0.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.562 0.696 . . . . 0.0 109.236 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 69' ' ' LEU . 25.2 tttp -30.46 -53.28 0.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.626 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.515 HG21 ' CD2' ' A' ' 43' ' ' LEU . 6.7 m -59.29 -47.94 83.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.997 -1.064 . . . . 0.0 108.755 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 69' ' ' LEU . 35.5 mt -58.48 -38.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.469 -0.77 . . . . 0.0 109.281 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -84.2 -8.11 59.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.604 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -75.77 -26.59 57.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.2 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.813 . . . . 0.0 109.747 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 46.3 -143.35 4.56 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.02 76.85 4.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -1.112 . . . . 0.0 109.363 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' ALA . 1.3 ttt -132.02 43.71 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 33.47 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.99 -47.41 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.228 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.462 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -32.8 97.85 0.12 Allowed Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 127' ' ' LEU . 4.2 Cg_exo -64.61 139.04 61.96 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.422 1.415 . . . . 0.0 112.326 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.75 HG11 HD21 ' A' ' 69' ' ' LEU . 6.1 t -130.93 125.5 58.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.583 ' CD2' HD21 ' A' ' 116' ' ' LEU . 42.3 tp -107.39 72.23 0.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.425 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 69' ' ' LEU . 5.7 mtp -51.63 151.71 3.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 t -126.51 128.55 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.635 0.731 . . . . 0.0 110.745 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -150.05 177.05 10.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . . . -89.39 -123.42 0.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.93 -1.106 . . . . 0.0 108.862 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -47.92 133.26 14.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 109.306 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -93.34 109.94 21.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.696 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -73.12 -171.06 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 108.872 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 45.3 mttp -94.32 -84.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HA ' HD12 ' A' ' 96' ' ' ILE . 0.8 OUTLIER -49.54 -8.0 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 4.7 m-20 -76.84 -52.43 9.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.871 HD11 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -68.77 -28.08 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 93' ' ' GLU . 52.0 mt -64.75 -64.06 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 109.979 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.86 -57.16 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -60.08 -43.69 95.31 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.023 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.62 -44.33 73.05 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -19.92 59.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.831 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.22 -103.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.279 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -133.22 0.7 4.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.99 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.179 -0.601 . . . . 0.0 111.198 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.629 ' H ' ' C ' ' A' ' 102' ' ' GLY . 22.0 m -29.24 -34.74 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.995 -0.441 . . . . 0.0 111.8 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.2 130.43 10.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.668 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 49.7 t80 -136.5 112.58 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.437 -1.037 . . . . 0.0 109.492 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -115.39 129.01 72.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.6 p -91.37 103.07 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 154.89 89.71 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.035 -1.041 . . . . 0.0 109.165 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.26 158.84 98.46 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 O-C-N 122.506 0.74 . . . . 0.0 111.368 -1.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -136.16 154.65 50.9 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.853 0.835 . . . . 0.0 109.204 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.5 146.29 23.79 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.313 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.69 -40.44 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 108.699 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.67 -34.07 76.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' THR . 25.4 m -68.38 -67.11 0.49 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -40.92 -46.94 2.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.584 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.32 -54.82 42.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 110.302 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.412 ' OE2' HG23 ' A' ' 115' ' ' THR . 1.6 pt-20 -47.84 -30.13 3.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.885 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -72.19 -49.32 36.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.389 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 123' ' ' ILE . 11.0 mt -48.45 -54.9 12.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.81 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -25.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.676 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -86.85 -27.07 23.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.022 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 120' ' ' LEU . 37.7 mm -81.52 -34.35 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.5 -8.61 57.42 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.099 -1.001 . . . . 0.0 110.755 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.57 -17.5 60.03 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -101.31 -30.31 11.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -77.17 -29.96 54.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.04 74.49 0.51 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.438 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.1 t0 -44.78 151.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 mttm -90.14 20.36 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.059 -1.026 . . . . 0.0 109.835 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -163.77 45.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.042 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 25.4 tp -71.82 121.09 18.36 Favored 'General case' 0 C--O 1.203 -1.344 0 O-C-N 121.025 -1.047 . . . . 0.0 108.231 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -53.61 117.31 3.02 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.932 -1.105 . . . . 0.0 112.176 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 70.7 m-85 -112.4 147.77 35.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' CD2' HD12 ' A' ' 46' ' ' LEU . 62.4 tp -121.69 108.29 13.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.154 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -92.95 104.46 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 108.735 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.5 t -89.94 38.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.83 147.01 23.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -98.76 -13.94 19.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.541 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -61.08 137.65 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 t -88.08 17.4 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.44 -40.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.421 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 6.2 ttt -50.33 -35.0 25.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' CG ' ' N ' ' A' ' 19' ' ' ARG . 4.7 ptm85 -63.27 -47.91 80.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.031 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -53.73 -32.54 52.46 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.129 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -53.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -31.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.09 15.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.903 -1.123 . . . . 0.0 109.408 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -69.96 -59.44 2.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.757 0.789 . . . . 0.0 109.858 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.23 -52.7 2.61 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.046 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -62.59 -50.22 72.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.014 . . . . 0.0 108.988 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -55.52 -30.71 61.18 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.89 -27.86 63.68 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.49 -37.57 16.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 139.28 7.69 1.07 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.9 m-85 -89.89 139.74 30.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.66 -1.494 . . . . 0.0 109.754 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 1.1 p30 -148.16 62.89 1.11 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.03 -1.044 . . . . 0.0 110.302 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.52 105.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.591 -1.318 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.15 179.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.105 -0.997 . . . . 0.0 109.99 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.8 mm-40 -137.26 -170.37 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 18' ' ' ARG . 47.1 mt-10 -141.97 149.7 40.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.324 -0.86 . . . . 0.0 110.741 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.02 -172.82 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -148.67 7.15 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.015 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER 175.73 177.86 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.695 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -69.39 -39.57 80.59 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 118.955 -1.593 . . . . 0.0 110.066 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.0 t -54.59 -40.79 51.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.406 -1.644 . . . . 0.0 107.654 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -81.01 -43.21 19.94 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.499 -0.751 . . . . 0.0 109.87 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -73.98 -58.22 3.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.391 -0.818 . . . . 0.0 109.504 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.668 ' C ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -53.53 -37.87 63.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.946 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -72.66 -42.91 63.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.371 -1.456 . . . . 0.0 109.216 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -77.35 -14.29 59.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.728 . . . . 0.0 110.389 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -71.77 -25.05 61.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.711 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -66.11 -2.29 4.03 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 0.0 109.237 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.09 -66.49 0.39 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 109.482 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.19 13.42 0.54 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.937 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.67 88.17 1.28 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' O ' HD13 ' A' ' 81' ' ' LEU . 29.1 m-85 -64.3 122.45 16.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.398 -1.06 . . . . 0.0 110.516 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.21 -6.1 82.55 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -159.17 136.78 10.07 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.011 -1.288 . . . . 0.0 109.34 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.42 123.97 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.099 -1.001 . . . . 0.0 109.81 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mt -109.16 96.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.771 -0.581 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.07 145.38 42.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -162.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.971 -1.081 . . . . 0.0 109.178 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -103.76 -26.01 12.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 0.0 109.258 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -96.79 135.33 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.538 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -133.95 159.29 72.96 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.96 -68.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.368 1.378 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 63' ' ' MET . 2.8 p30 -85.62 -102.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 1.6 mmt -63.3 -178.06 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.656 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -179.53 5.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.41 -31.63 18.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 tp -47.57 -37.92 13.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -1.198 . . . . 0.0 108.984 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.21 -35.13 75.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 109.333 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.695 HD11 ' N ' ' A' ' 39' ' ' GLY . 4.8 mp -63.88 -27.19 68.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.815 HD21 ' N ' ' A' ' 103' ' ' ALA . 53.8 tp -77.76 -60.21 2.46 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 1.4 tmtp? -43.7 -32.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -55.57 -52.99 61.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 109.348 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.5 mp -57.95 -36.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -69.15 -27.97 66.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.56 -28.81 2.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.6 -38.25 20.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . 59.8 46.14 94.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 167.3 -52.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.445 ' C ' ' H ' ' A' ' 80' ' ' ALA . 12.8 mtt -94.46 21.47 7.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -74.7 37.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -97.5 -20.12 17.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 51' ' ' TYR . 15.0 mt -52.51 113.38 4.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.011 -1.055 . . . . 0.0 109.174 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.16 145.99 90.25 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 121.164 1.243 . . . . 0.0 112.983 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 69' ' ' LEU . 2.4 t -126.08 132.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 116' ' ' LEU . 43.8 tp -113.48 70.79 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.662 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 86' ' ' VAL . 14.0 tmm? -49.48 159.81 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' N ' ' SD ' ' A' ' 85' ' ' MET . 39.5 t -137.94 121.26 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.488 -0.758 . . . . 0.0 110.16 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.8 t -150.13 178.88 8.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 0.0 110.02 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 -45.64 2.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.533 -0.73 . . . . 0.0 109.362 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 13.3 mt-10 -70.59 -77.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 63.27 117.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -131.8 148.67 52.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -42.5 -48.59 5.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.259 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -64.44 -29.72 70.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.283 -0.886 . . . . 0.0 110.665 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -89.99 -23.56 21.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.561 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.3 mt -89.95 -16.35 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.659 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 97' ' ' ALA . 19.1 mt -74.95 -68.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.18 -43.78 21.6 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -59.97 -51.19 70.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.42 -0.8 . . . . 0.0 109.223 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.66 64.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.803 . . . . 0.0 110.593 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -77.19 6.26 6.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 110.4 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -110.53 -17.79 13.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 0.0 110.396 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 136.36 -12.39 4.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.815 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -55.41 11.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.861 -0.788 . . . . 0.0 111.467 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.8 m -29.41 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.917 -0.489 . . . . 0.0 111.312 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.74 124.11 7.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -145.02 105.7 4.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -1.234 . . . . 0.0 109.405 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 107' ' ' VAL . 9.5 p -103.03 136.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -87.41 100.07 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.097 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.9 pttt -63.52 154.44 79.52 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.71 -1.244 . . . . 0.0 109.09 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.33 161.93 93.5 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 O-C-N 122.479 0.726 . . . . 0.0 111.225 -1.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -142.9 162.75 34.64 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.009 0.909 . . . . 0.0 110.082 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.09 148.95 26.27 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.76 -19.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.982 -1.074 . . . . 0.0 109.249 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.44 -37.31 51.84 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.401 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.27 -61.39 1.84 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 84' ' ' LEU . 5.3 tp -47.92 -38.64 16.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.005 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.49 -44.82 77.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 15.4 tt0 -56.38 -26.69 53.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.333 -0.854 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -81.95 -58.83 2.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 tt -46.28 -48.72 18.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.55 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -62.68 -33.49 75.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -67.83 -31.48 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.474 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.1 mt -88.72 -38.01 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.865 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.03 -3.69 27.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.149 -0.969 . . . . 0.0 109.736 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -74.03 -29.33 61.87 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -88.68 -30.62 19.0 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -74.39 -28.99 61.35 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.36 83.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 60.56 129.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.151 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -90.06 24.04 2.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.889 -1.132 . . . . 0.0 110.058 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.22 40.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.789 -1.194 . . . . 0.0 110.773 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 52' ' ' GLY . 58.5 tp -67.03 133.24 49.51 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -75.08 120.39 20.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.893 -1.13 . . . . 0.0 111.32 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' HG22 ' A' ' 33' ' ' VAL . 74.1 m-85 -109.66 148.16 31.83 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.439 ' CD2' HD12 ' A' ' 46' ' ' LEU . 35.6 tp -122.29 118.97 29.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.92 103.96 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.577 -0.702 . . . . 0.0 109.77 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.5 t -93.41 31.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.27 157.46 22.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.745 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.85 -30.96 13.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 150.36 49.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -24.2 18.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.46 -20.58 20.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -52.25 49.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -49.43 -32.13 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.29 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.4 -40.71 77.17 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.802 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -57.86 -57.87 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.88 -38.16 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.29 -52.85 19.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.968 -1.082 . . . . 0.0 109.193 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.5 t30 -64.34 -56.9 11.27 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.775 0.798 . . . . 0.0 109.171 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.86 -52.39 2.38 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.744 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.4 mt -63.1 -46.26 88.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 0.0 108.811 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.25 -32.58 66.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.342 -0.848 . . . . 0.0 109.419 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 4.7 tt0 -55.48 -41.96 73.71 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 117' ' ' GLU . 6.2 mp -75.43 -55.39 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.792 . . . . 0.0 109.298 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 78.01 0.02 OUTLIER Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -150.01 147.46 27.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -150.03 58.53 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.55 93.32 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.077 -1.014 . . . . 0.0 109.177 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 8' ' ' PHE . 73.4 t -138.5 151.28 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.77 -171.83 2.47 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.16 157.11 42.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.924 -1.11 . . . . 0.0 110.884 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.896 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.54 -168.97 2.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.81 0.32 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.375 -0.828 . . . . 0.0 110.478 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 9.7 t70 -174.21 174.9 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -59.57 -57.21 20.72 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.434 HG22 ' OD1' ' A' ' 44' ' ' ASN . 13.2 p -50.97 -28.24 6.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -1.083 . . . . 0.0 108.535 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.4 t0 -76.27 -47.01 25.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.41 -0.806 . . . . 0.0 109.133 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.65 -66.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.346 -0.847 . . . . 0.0 109.786 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.06 -45.21 52.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.446 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' ' 40' ' ' VAL . 7.8 m120 -63.63 -39.25 93.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.0 -1.063 . . . . 0.0 110.554 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -90.1 -1.08 57.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -87.52 -30.87 20.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 108.882 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -54.81 -9.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.105 -0.997 . . . . 0.0 108.574 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.02 -67.01 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.63 -92.3 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -156.96 78.29 0.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' O ' HD21 ' A' ' 81' ' ' LEU . 41.9 m-85 -57.35 91.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.431 -1.04 . . . . 0.0 110.158 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.96 -9.31 5.38 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.5 137.64 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.246 -1.15 . . . . 0.0 110.057 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.0 t -134.92 120.02 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.155 -0.966 . . . . 0.0 109.684 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.53 131.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 83.7 p -149.79 150.14 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' SER . 36.9 m-20 -60.67 -115.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.184 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -150.45 -42.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.603 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER 178.15 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.712 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.35 -54.72 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.761 -0.587 . . . . 0.0 110.283 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.13 -61.2 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.563 0 N-CA-C 108.846 -1.251 . . . . 0.0 108.846 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.588 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 2.8 m120 -154.47 -148.96 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.6 mtt -48.16 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 108.423 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 42.55 -156.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.518 -0.739 . . . . 0.0 110.785 178.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 48.17 -83.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -51.11 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.869 -1.371 . . . . 0.0 110.037 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.98 -33.78 11.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 108.813 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.65 -35.67 80.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.729 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 8.9 tt -90.05 -60.51 1.91 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -36.06 -34.49 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.131 0.491 . . . . 0.0 110.012 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.5 m -59.14 -50.1 75.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.0 mt -54.41 -37.86 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -70.36 -32.74 70.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.452 -0.78 . . . . 0.0 109.515 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.68 33.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.927 . . . . 0.0 109.582 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t0 -75.71 98.59 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.595 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -23.71 66.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -65.19 -38.47 90.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -1.186 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 mtm -136.39 45.88 2.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 79' ' ' SER . 9.3 t -77.95 45.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.03 10.22 0.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.0 -1.062 . . . . 0.0 110.063 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.822 HD21 ' O ' ' A' ' 51' ' ' TYR . 9.6 tp -55.36 120.74 32.97 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 108.382 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.25 131.36 38.38 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 120.962 1.108 . . . . 0.0 112.233 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.8 t -125.69 125.18 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.0 tp -107.05 70.12 0.78 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.571 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -51.53 168.91 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -143.11 126.67 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.532 -0.73 . . . . 0.0 109.801 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -150.1 178.44 8.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.911 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.43 3.94 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.72 50.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -75.5 101.92 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.33 -82.62 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 109.332 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -173.01 -73.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.29 -33.6 29.45 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.151 -0.968 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.5 -24.3 61.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.77 HD11 ' HB1' ' A' ' 90' ' ' ALA . 96.3 mt -83.16 -36.98 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 97' ' ' ALA . 1.4 mp -57.5 -57.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.237 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.2 -37.77 10.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 109.229 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -64.65 -60.28 3.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.733 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -55.1 -40.19 70.18 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.221 -0.924 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -48.23 -19.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.26 -123.96 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.729 ' H ' ' CD2' ' A' ' 69' ' ' LEU . . . -111.87 2.24 27.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.71 11.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.623 -0.928 . . . . 0.0 109.98 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 102' ' ' GLY . 1.4 m -29.54 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -109.64 127.67 8.56 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.53 120.31 9.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 108.825 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 116' ' ' LEU . 7.5 p -119.59 130.17 74.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.01 105.04 12.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.154 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.79 161.08 64.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.02 -1.05 . . . . 0.0 109.257 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.46 166.35 83.34 Favored 'Cis proline' 0 N--CA 1.488 1.153 0 C-N-CA 124.832 -0.904 . . . . 0.0 110.801 -2.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.77 164.1 33.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 110.344 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.46 148.21 27.43 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.455 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.462 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -45.87 -36.66 5.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.048 . . . . 0.0 109.479 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.4 87.39 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.9 m -69.85 -67.01 0.52 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.572 HD11 HG11 ' A' ' 107' ' ' VAL . 5.7 tp -45.62 -36.89 5.09 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.033 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 6.5 tm-20 -66.99 -46.85 73.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 26.9 tt0 -47.77 -60.01 2.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -34.89 64.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.474 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.88 -72.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.6 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.45 -17.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.926 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.47 -33.13 60.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.14 -0.975 . . . . 0.0 109.733 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.447 HD11 ' HA2' ' A' ' 105' ' ' GLY . 8.0 mt -89.97 -43.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 109.934 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -57.16 -21.13 30.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.634 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -57.36 -20.37 28.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.763 -1.211 . . . . 0.0 108.221 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -96.82 -22.03 17.17 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -89.32 -18.98 25.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 79.07 0.06 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.541 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -142.57 135.0 27.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 108.883 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -90.05 21.55 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.977 . . . . 0.0 109.572 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -160.13 44.0 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.068 -1.02 . . . . 0.0 109.956 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.6 tp -84.46 125.7 32.6 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -74.67 123.28 24.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.169 -0.957 . . . . 0.0 112.155 -176.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 65.9 m-85 -114.88 140.89 48.6 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.8 tp -106.02 116.76 32.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.57 102.8 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 36' ' ' ALA . 30.0 t -95.02 62.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.243 -0.91 . . . . 0.0 109.644 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -103.27 132.48 49.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.12 -21.26 36.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.133 -0.979 . . . . 0.0 109.299 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -57.86 146.82 30.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.513 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 m -90.6 29.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 -38.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' OD2' ' A' ' 57' ' ' ASP . 27.5 ttt -48.41 -45.57 36.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -56.65 9.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -56.34 -41.59 76.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 110.133 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mt -54.61 -53.78 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -44.99 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.408 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.01 -52.83 22.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.872 -1.143 . . . . 0.0 109.034 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -62.02 -56.79 15.47 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.89 0.853 . . . . 0.0 109.049 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.32 -59.75 1.01 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.066 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -59.44 -47.28 86.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -53.43 -33.35 53.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.19 -33.16 39.54 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.165 -0.96 . . . . 0.0 109.177 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.9 mp -80.43 -67.62 0.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.08 17.54 0.02 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.294 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.0 m-85 -90.66 129.46 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.749 -1.442 . . . . 0.0 109.197 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.86 68.95 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.502 -0.749 . . . . 0.0 109.93 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.5 103.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.082 -1.011 . . . . 0.0 108.569 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -149.98 148.24 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.82 -171.4 2.18 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -149.86 150.31 31.75 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 110.832 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.96 165.5 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 1.8 mp0 -135.96 32.69 2.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.125 -0.984 . . . . 0.0 110.729 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 7.4 t0 175.04 145.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.277 -0.89 . . . . 0.0 108.832 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -50.6 -29.85 18.96 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -73.79 -28.37 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.254 . . . . 0.0 108.534 179.171 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.1 t0 -81.4 -41.81 21.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.83 86.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.446 -0.784 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mt -70.73 -41.94 71.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -63.36 -27.04 69.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -53.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -56.63 -19.67 17.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 108.645 179.855 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -50.36 -28.05 7.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.0 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 68.02 0.47 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.81 24.24 0.06 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' O ' HD21 ' A' ' 81' ' ' LEU . 52.6 m-85 -94.74 83.06 3.98 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.28 -1.13 . . . . 0.0 109.904 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.51 0.48 2.07 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -162.95 152.82 15.79 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.1 -1.235 . . . . 0.0 109.805 -179.115 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 9' ' ' LEU . 93.6 t -149.4 128.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.724 -1.235 . . . . 0.0 109.78 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.44 128.79 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -132.67 163.04 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.171 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 18.3 m-20 -91.33 -106.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.645 -178.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.864 ' CZ2' HD21 ' A' ' 66' ' ' LEU . 36.5 t-105 -164.09 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.665 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -95.66 137.19 35.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 62' ' ' ASN . 3.6 mmt -139.78 155.24 71.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.14 -1.13 0.16 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.431 1.421 . . . . 0.0 111.076 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.8 p-10 -133.63 107.87 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.433 -0.792 . . . . 0.0 109.083 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.421 ' O ' ' OD2' ' A' ' 64' ' ' ASP . 42.1 mtm 53.67 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.0 109.405 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ASN . 1.2 m-20 -169.93 150.64 3.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 108.86 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.21 8.86 2.49 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.864 HD21 ' CZ2' ' A' ' 58' ' ' TRP . 9.2 mt -67.09 -52.85 36.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -1.107 . . . . 0.0 109.082 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -74.06 -14.13 60.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 109.563 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.516 HD13 ' HA2' ' A' ' 39' ' ' GLY . 7.7 tp -67.62 -57.35 6.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 108.836 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.896 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.24 -36.02 66.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 74' ' ' ALA . 16.8 tttt -47.03 -47.91 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 108.82 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.1 m -47.16 -59.24 3.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.477 -0.765 . . . . 0.0 109.638 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mt -49.82 -40.09 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.66 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -10.68 55.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -92.43 -26.62 17.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -45.13 158.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.28 -52.85 21.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.06 109.44 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.528 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -144.25 12.71 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.858 . . . . 0.0 109.281 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -65.31 4.84 0.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.175 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.87 -15.49 32.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.498 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.1 tp -112.03 99.13 44.88 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.66 139.0 78.63 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.037 1.825 . . . . 0.0 113.695 -178.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 69' ' ' LEU . 2.5 t -124.75 119.55 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.425 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' ' HG ' ' A' ' 104' ' ' SER . 2.1 tp -99.0 109.78 22.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.458 ' CE ' HD23 ' A' ' 69' ' ' LEU . 6.8 ttm -86.2 146.85 26.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.9 144.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -150.09 173.92 13.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.943 -1.098 . . . . 0.0 110.74 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -113.61 148.7 35.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 49.08 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -83.42 119.08 24.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.022 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.9 -169.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 0.0 109.051 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -99.6 -39.05 8.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.704 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.89 -19.08 25.01 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.113 -0.992 . . . . 0.0 110.284 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -80.23 -22.59 41.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 110.106 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 90' ' ' ALA . 24.7 mt -69.16 -8.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.132 . . . . 0.0 109.932 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.481 ' C ' ' N ' ' A' ' 98' ' ' ALA . 10.1 mt -90.17 -49.11 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.05 -24.63 0.16 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -50.28 -56.8 9.65 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -45.58 -44.73 13.17 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 119.629 -1.919 . . . . 0.0 108.924 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -59.69 -36.8 77.21 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -126.33 -72.51 0.65 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -48.8 82.17 0.01 OUTLIER Glycine 0 N--CA 1.496 2.643 0 N-CA-C 106.576 -2.609 . . . . 0.0 106.576 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -70.03 -109.81 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.824 0 CA-C-N 111.508 -2.346 . . . . 0.0 114.994 -174.236 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.527 ' HG ' ' HA ' ' A' ' 84' ' ' LEU . 2.0 p -38.87 -54.18 1.65 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.564 -176.194 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . -156.8 171.17 34.29 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.12 116.2 15.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.407 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.1 p -115.59 126.34 73.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.5 p -78.67 108.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.54 157.38 88.33 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.991 -1.068 . . . . 0.0 109.583 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.79 159.39 97.22 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 O-C-N 122.768 0.878 . . . . 0.0 110.626 -2.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.463 ' CE2' HD13 ' A' ' 116' ' ' LEU . 2.7 p90 -136.63 160.06 39.93 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.658 0.742 . . . . 0.0 109.783 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.47 148.81 22.42 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.0 -32.09 8.61 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.97 -1.082 . . . . 0.0 108.833 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.06 71.99 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' THR . 6.0 m -70.89 -66.94 0.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 111' ' ' PHE . 11.6 tp -45.58 -41.62 10.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.859 -1.151 . . . . 0.0 109.195 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.72 -50.06 70.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.301 -0.874 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.22 -41.71 13.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -77.98 -43.69 28.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 109.124 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.44 -47.48 26.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 108.957 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 m-20 -49.9 -59.88 3.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.323 -0.861 . . . . 0.0 109.947 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -50.32 -35.46 27.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 110.016 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.7 mt -73.15 -41.54 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 110.005 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -77.92 0.85 22.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.095 -1.003 . . . . 0.0 110.215 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -75.65 -32.66 60.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -88.71 -25.97 22.05 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -33.61 27.67 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.28 82.43 0.03 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.464 -179.975 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.553 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER 61.08 116.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.873 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -90.39 27.24 1.73 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.745 -1.222 . . . . 0.0 110.31 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -145.82 36.83 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.38 141.09 35.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -80.02 129.87 34.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.915 -1.116 . . . . 0.0 111.349 -177.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.598 ' HB2' HG22 ' A' ' 33' ' ' VAL . 63.2 m-85 -118.79 151.56 37.82 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.781 -0.574 . . . . 0.0 109.655 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -127.04 109.88 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.77 114.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.347 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.851 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.8 t -110.56 108.76 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 124.31 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -29.29 70.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.678 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.77 139.18 10.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 p -93.56 22.24 5.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 p -145.79 -15.87 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.6 ttt -70.95 -39.3 72.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -35.35 80.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ttp85 -68.93 -21.02 64.23 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.077 -178.039 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.1 -45.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.868 . . . . 0.0 109.744 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -36.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -47.42 -53.02 15.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.364 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.31 -57.56 7.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.818 0.818 . . . . 0.0 109.371 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.18 -60.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -56.45 -46.05 80.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 109.125 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -55.45 -35.24 65.25 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.175 -0.953 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.32 -28.14 40.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.406 -0.809 . . . . 0.0 109.783 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.09 -33.6 22.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.43 10.69 2.09 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 79.4 m-85 -89.69 141.2 28.83 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.743 -1.445 . . . . 0.0 109.418 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.64 28.4 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.481 -0.762 . . . . 0.0 109.728 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.61 88.23 2.55 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -137.31 153.24 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.627 -0.671 . . . . 0.0 110.11 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -125.57 -173.6 2.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.19 148.2 28.64 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.851 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -128.05 166.7 17.9 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 12.5 mm-40 -94.53 -3.02 50.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.867 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER 169.63 173.85 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.917 -1.114 . . . . 0.0 109.691 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.42 54.87 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -53.96 -42.87 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.988 -1.301 . . . . 0.0 108.727 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.626 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 27.5 t0 -63.99 -50.44 68.52 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -53.36 -49.38 67.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.276 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tp -53.22 -35.39 59.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.908 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.75 -33.44 35.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.371 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -90.07 -12.54 38.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.068 -1.02 . . . . 0.0 110.464 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -63.42 -20.58 65.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.029 -1.044 . . . . 0.0 109.212 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.93 1.21 24.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.138 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.94 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.409 -0.807 . . . . 0.0 109.657 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.25 11.93 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.32 80.63 1.47 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.765 ' O ' HD21 ' A' ' 81' ' ' LEU . 38.3 m-85 -60.06 102.14 0.15 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -1.089 . . . . 0.0 109.769 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.47 -12.54 1.0 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -153.24 134.59 14.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.378 -1.072 . . . . 0.0 109.499 -179.427 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 83' ' ' VAL . 88.9 t -131.26 117.69 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.827 -1.171 . . . . 0.0 109.939 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.94 119.6 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.8 p -141.47 144.1 34.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.808 . . . . 0.0 109.248 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.7 p-10 -60.47 -112.45 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.979 -1.075 . . . . 0.0 109.229 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -173.87 -32.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 108.834 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.5 58.57 2.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 0.0 109.54 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.423 ' HG3' ' H ' ' A' ' 62' ' ' ASN . 2.1 ptm -47.88 159.24 0.48 Allowed Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.47 -48.47 20.33 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.248 1.299 . . . . 0.0 110.514 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' A' ' 60' ' ' MET . 6.4 m-20 -79.09 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.853 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.1 mmt -90.9 -110.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.938 . . . . 0.0 109.869 -179.565 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.3 -175.56 4.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.78 12.29 70.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -62.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.8 -1.411 . . . . 0.0 108.569 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -48.8 -37.52 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.3 -42.67 82.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 72' ' ' ILE . 1.2 mt -75.41 -63.5 1.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.524 0.678 . . . . 0.0 109.18 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' LEU . 39.9 tttp -40.29 -34.95 0.36 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.759 -0.588 . . . . 0.0 109.986 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -73.2 -37.19 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 108.664 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 69' ' ' LEU . 39.6 mt -61.08 -21.41 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -88.68 5.33 43.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.358 -0.839 . . . . 0.0 109.319 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -122.01 -20.88 6.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.5 m-20 -59.67 -140.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.54 0.686 . . . . 0.0 110.214 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -55.37 -167.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.81 50.32 1.79 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.04 -70.19 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 t 44.29 17.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -145.87 -3.52 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 51' ' ' TYR . 5.4 tp -54.43 113.56 5.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 109.05 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 140.31 89.49 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.119 1.213 . . . . 0.0 112.351 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.8 t -129.83 127.88 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 116' ' ' LEU . 54.8 tp -108.42 78.42 1.16 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtt -72.24 132.2 43.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.3 m -113.23 140.2 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.9 t -150.02 171.49 16.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.01 -87.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.817 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -46.95 -66.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.864 -179.659 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 67.72 99.87 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 109.174 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -95.59 119.62 34.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.207 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -43.51 -50.07 7.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.785 . . . . 0.0 109.983 -179.504 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.23 -35.11 7.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.174 -0.954 . . . . 0.0 109.686 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 96' ' ' ILE . 2.3 t-20 -85.53 -39.04 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.191 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 95' ' ' ILE . 35.1 mm -58.24 -0.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 94' ' ' ASN . 71.9 mt -89.82 -65.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.33 -34.72 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.54 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.708 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -65.33 -53.95 36.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.876 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.7 67.58 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.044 -1.035 . . . . 0.0 110.011 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.47 -19.51 1.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 109.135 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.18 -112.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.81 -5.38 4.9 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.708 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.56 10.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.927 -0.749 . . . . 0.0 110.348 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.3 m -29.75 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.009 -178.05 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.05 125.68 8.66 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -142.38 109.38 5.51 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.286 -1.126 . . . . 0.0 109.697 179.189 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.681 HG11 ' CD1' ' A' ' 116' ' ' LEU . 2.7 p -110.53 150.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.708 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.48 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 39.9 t -90.52 111.72 23.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.729 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 152.44 78.07 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.786 -1.196 . . . . 0.0 109.514 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.85 165.6 84.49 Favored 'Cis proline' 0 N--CA 1.49 1.314 0 O-C-N 122.52 0.748 . . . . 0.0 110.909 -1.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -144.4 156.89 44.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.855 0.836 . . . . 0.0 110.106 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 114' ' ' ALA . 1.0 OUTLIER -95.67 150.79 19.98 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.755 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.37 -15.36 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.783 -1.198 . . . . 0.0 109.194 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.27 -38.34 35.68 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.33 -62.41 1.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.537 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 107' ' ' VAL . 4.6 tp -48.6 -38.73 21.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.195 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.56 -56.81 11.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 0.0 110.068 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.18 -66.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.554 -0.716 . . . . 0.0 109.931 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -35.25 5.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.25 -68.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.03 -32.91 10.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.78 -38.17 81.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.07 -47.83 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.055 -1.028 . . . . 0.0 109.963 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.457 ' CE2' HD13 ' A' ' 127' ' ' LEU . 23.2 m-85 -53.19 -19.0 2.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.122 -0.986 . . . . 0.0 110.232 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -55.95 -35.43 66.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 107.949 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -79.6 -32.23 41.83 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 127' ' ' LEU . 7.6 tt -65.11 -23.58 67.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.76 61.34 1.29 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.418 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER 51.81 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.818 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.2 ptmm? -76.83 47.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.006 -1.059 . . . . 0.0 109.544 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -160.42 27.11 0.16 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.6 tp -69.65 143.21 53.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 1.9 mtmp? -82.35 127.76 33.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.125 -0.984 . . . . 0.0 111.508 -177.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 33' ' ' VAL . 35.4 m-85 -116.32 150.7 37.24 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.865 -0.522 . . . . 0.0 109.974 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -125.15 106.9 10.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.37 105.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 109.05 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 11' ' ' VAL . 25.3 t -89.99 24.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.155 -0.965 . . . . 0.0 109.455 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -56.64 126.58 27.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -93.63 -2.59 53.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.34 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -58.81 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.965 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.05 8.52 5.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.578 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -22.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.748 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.3 tpp -47.71 -50.39 25.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.243 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' NE ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -45.38 -55.41 6.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 110.469 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -56.24 -37.39 69.67 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.577 -177.319 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.78 -49.02 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.119 -0.988 . . . . 0.0 110.046 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -33.25 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.995 -1.066 . . . . 0.0 110.515 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -53.51 21.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.989 -1.07 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.1 t30 -67.57 -58.15 5.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.881 0.848 . . . . 0.0 109.63 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.814 HD22 HD12 ' A' ' 116' ' ' LEU . 4.5 tt -40.09 -34.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.125 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.95 -42.08 27.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.905 -1.122 . . . . 0.0 108.233 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -58.88 -34.9 72.18 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.346 -0.846 . . . . 0.0 108.925 179.318 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.85 -29.14 39.88 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.347 -0.845 . . . . 0.0 109.236 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.27 -12.86 42.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 106.09 15.39 18.16 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -89.83 126.84 35.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.479 . . . . 0.0 109.0 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -130.42 67.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.808 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.4 89.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 108.594 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 8' ' ' PHE . 45.2 t -140.23 151.69 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.489 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.2 mt-10 -126.18 -173.23 2.8 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.018 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.45 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 7.6 tt0 -149.13 159.48 44.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.769 -1.207 . . . . 0.0 111.157 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.99 -171.79 3.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 3.6 pt-20 -139.41 8.57 2.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.805 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.16 -170.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.567 ' CA ' HD11 ' A' ' 68' ' ' LEU . . . -74.34 -38.96 44.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.98 -1.581 . . . . 0.0 109.293 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 62.9 t -52.52 -40.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.915 -1.344 . . . . 0.0 107.763 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.7 t0 -79.15 -50.6 10.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.677 -0.639 . . . . 0.0 109.847 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -62.56 -59.46 4.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 71' ' ' THR . 49.9 tp -44.75 -50.75 9.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.313 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 60.6 m-20 -66.7 -36.28 82.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.012 . . . . 0.0 109.577 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -90.13 8.0 35.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -87.98 -44.18 11.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.898 -1.126 . . . . 0.0 109.076 179.681 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -65.75 1.55 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.186 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.44 -69.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.391 -0.818 . . . . 0.0 109.859 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.35 1.26 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 85.27 88.11 0.92 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.906 ' O ' HD11 ' A' ' 81' ' ' LEU . 38.4 m-85 -71.1 136.66 48.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.304 -1.115 . . . . 0.0 109.66 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.49 -5.67 71.77 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -152.14 135.88 16.26 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.578 -0.954 . . . . 0.0 108.95 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.05 116.98 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.817 -1.177 . . . . 0.0 109.781 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.62 95.42 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.5 p -105.61 131.99 52.3 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 59' ' ' ASN . 37.7 p-10 -100.15 123.31 44.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.467 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.517 ' CH2' HD12 ' A' ' 66' ' ' LEU . 1.4 t-105 -45.76 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.244 -0.91 . . . . 0.0 108.679 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASP . 80.1 m-20 -92.57 -150.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 110.635 -178.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.719 ' H ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -124.65 -29.82 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 60' ' ' MET . 4.1 Cg_exo -62.01 164.48 16.7 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 CA-C-N 119.812 0.968 . . . . 0.0 110.842 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -41.73 -62.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.785 -0.572 . . . . 0.0 109.633 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -79.24 56.08 1.99 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.275 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' MET . 0.2 OUTLIER -46.9 -94.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.472 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.72 -24.29 0.07 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.517 HD12 ' CH2' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -70.67 -58.06 4.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.876 -1.367 . . . . 0.0 108.612 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.41 -33.46 6.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.567 HD11 ' CA ' ' A' ' 39' ' ' GLY . 5.8 mp -66.59 -42.63 86.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.727 HD11 ' H ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -69.06 -45.05 71.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.529 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -58.66 -32.34 68.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 0.0 108.884 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.67 HG21 HD13 ' A' ' 43' ' ' LEU . 3.9 m -66.85 -42.98 84.79 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.282 -0.886 . . . . 0.0 108.999 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.27 -31.6 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -30.57 71.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.073 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -59.0 -24.14 62.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 6.3 t70 -42.85 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 75' ' ' ASP . . . 152.32 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.05 -21.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.187 . . . . 0.0 109.206 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' ALA . 3.0 mtm -116.84 36.77 4.04 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -65.64 7.35 0.25 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.518 -0.739 . . . . 0.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.74 24.12 3.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 51' ' ' TYR . 4.7 tt -48.89 125.56 13.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.68 114.85 2.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.667 0.912 . . . . 0.0 112.257 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.34 118.74 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 116' ' ' LEU . 37.2 tp -97.49 79.1 2.72 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.229 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtp -64.75 108.85 1.85 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.8 m -96.42 134.57 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.632 -1.292 . . . . 0.0 109.362 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.2 t -150.2 177.57 9.8 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.812 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -122.76 141.51 51.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 5.8 tt0 67.99 35.59 3.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 0.0 109.148 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -45.52 127.33 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.814 . . . . 0.0 109.914 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -83.31 -133.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 -28.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.241 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -29.69 21.24 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -79.33 -36.43 39.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 90' ' ' ALA . 56.1 mt -64.68 -5.92 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 108.966 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 16.6 mt -89.94 -58.44 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 109.354 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.92 -60.57 2.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -49.02 -41.46 34.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 108.755 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 96' ' ' ILE . . . -47.64 -48.91 28.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.982 -1.074 . . . . 0.0 109.419 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -27.84 56.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.228 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.84 -106.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.923 . . . . 0.0 109.558 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.727 ' H ' HD11 ' A' ' 69' ' ' LEU . . . -145.36 12.11 1.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . . . -56.6 11.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.045 0.538 . . . . 0.0 110.775 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.0 m -29.33 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.016 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.99 126.96 8.02 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.08 111.11 6.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.535 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.634 ' CG1' HG12 ' A' ' 86' ' ' VAL . 8.7 p -117.95 121.9 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -53.3 172.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.179 179.37 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' THR . 15.4 pttt -147.4 156.96 45.85 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 120.579 -1.326 . . . . 0.0 108.911 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.98 167.89 77.35 Favored 'Cis proline' 0 N--CA 1.485 0.983 0 C-N-CA 124.862 -0.891 . . . . 0.0 110.348 -1.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -134.6 155.64 50.1 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.017 0.913 . . . . 0.0 110.473 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -93.12 151.42 19.86 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.114 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.73 -38.39 9.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.918 -1.114 . . . . 0.0 109.733 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.02 84.32 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 116' ' ' LEU . 19.0 m -66.31 -65.1 0.72 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.814 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -42.68 -48.71 5.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.619 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.75 80.34 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.312 -0.868 . . . . 0.0 110.048 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp10 -57.63 -33.84 68.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.027 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -36.71 14.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 0.0 110.042 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -58.12 -67.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.236 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.1 -28.69 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.118 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -71.76 -33.06 68.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.146 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 105' ' ' GLY . 21.0 mt -79.88 -42.28 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.078 -1.014 . . . . 0.0 110.075 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -62.63 4.99 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 110.577 -178.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.1 mm-40 -81.91 -28.61 32.75 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -86.89 -34.86 19.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -63.75 -30.06 71.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.115 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.1 77.09 0.32 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.273 -1.133 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.54 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 3.0 m-20 -43.94 145.53 0.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 29' ' ' GLY . 7.8 mtmm -90.5 7.48 38.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.221 -0.925 . . . . 0.0 110.302 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 45.7 mp0 -144.46 50.88 1.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.813 -1.18 . . . . 0.0 109.952 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.4 tp -80.26 114.76 19.4 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 121.5 7.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.059 -1.025 . . . . 0.0 112.046 -177.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.3 m-85 -113.41 149.5 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.113 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 54' ' ' VAL . 27.0 tp -121.55 109.45 14.82 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.61 99.77 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 110.122 -178.928 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.6 t -91.94 12.48 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.09 -1.006 . . . . 0.0 109.758 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.2 OUTLIER -62.18 156.32 22.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.393 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' PHE . 14.2 p-10 -94.86 -142.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.493 ' O ' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 61.27 146.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.84 . . . . 0.0 109.619 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 t -92.46 17.0 10.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -143.49 -12.89 0.69 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 109.446 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 5.8 ttm -71.51 -57.79 4.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -47.22 -28.87 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -51.17 20.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.186 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.93 -53.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.798 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -44.64 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.863 . . . . 0.0 110.333 -178.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -46.87 -55.43 8.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -59.69 -58.03 10.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.108 0.956 . . . . 0.0 108.518 179.428 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -39.29 -42.76 1.06 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.641 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.18 -41.96 69.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 108.899 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' ASN . 47.8 tttt -63.1 -30.71 71.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.22 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.57 -40.03 71.43 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.3 tt -76.96 -58.6 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 159.55 43.22 0.02 OUTLIER Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.54 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 48.5 m-85 -126.98 125.42 41.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.821 -0.811 . . . . 0.0 109.662 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.67 66.22 1.46 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.566 -0.708 . . . . 0.0 109.518 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.64 93.37 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.111 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.54 179.29 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.059 -1.026 . . . . 0.0 109.856 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.4 mt-10 -138.73 -164.98 1.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -147.68 149.86 33.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.141 -178.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -142.3 -168.87 2.83 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -146.61 3.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 110.643 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 175.66 -172.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.123 -0.986 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -69.88 -42.24 70.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.11 -34.02 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.236 . . . . 0.0 109.049 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.97 -57.16 3.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.96 -38.22 10.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.39 -58.92 3.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -58.16 -21.51 47.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.931 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -90.15 -43.09 10.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 110.587 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.669 -1.269 . . . . 0.0 109.291 -179.333 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -63.05 -4.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -53.95 -74.91 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.564 -0.71 . . . . 0.0 109.855 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.16 10.8 1.18 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.545 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.5 81.64 1.27 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.761 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.8 m-85 -54.94 144.74 22.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.548 -0.972 . . . . 0.0 110.297 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.56 -4.64 73.03 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -161.93 145.56 12.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.418 -1.048 . . . . 0.0 110.004 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.702 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.2 t -139.92 125.93 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.353 -0.842 . . . . 0.0 109.877 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.51 104.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.499 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 90.2 p -104.94 178.27 4.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.349 -0.844 . . . . 0.0 109.964 -179.519 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 29.2 p-10 -99.98 -115.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.444 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 61.4 t-105 -140.12 -81.14 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 0.0 110.135 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.453 HD21 ' C ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -170.43 68.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 109.93 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.508 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.08 -48.33 0.41 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.523 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.05 -160.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.012 1.141 . . . . 0.0 109.822 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 1.8 p30 -84.75 107.48 16.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 0.0 109.094 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.4 mmm 50.31 93.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.107 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.9 t70 -152.24 -177.43 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.648 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 54.47 -80.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ASP . 95.7 mt -44.84 -68.65 0.18 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 109.66 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.17 -35.69 75.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.846 -1.159 . . . . 0.0 109.375 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.919 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.23 -33.93 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 109.007 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.6 tt -87.08 -59.99 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.173 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.0 ttpt -40.31 -32.81 0.2 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 m -66.2 -44.18 84.65 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.6 mt -54.65 -36.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 108.769 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtp-105 -75.59 -16.23 60.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.417 -0.802 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -54.42 -28.61 45.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 109.845 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 38.0 t70 -61.55 -121.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.606 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . 154.0 -32.65 0.73 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 -12.41 57.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.413 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.48 42.44 2.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 p -77.89 51.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -130.71 -26.14 2.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.644 -0.66 . . . . 0.0 109.715 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -38.65 103.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.896 -0.503 . . . . 0.0 109.78 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.2 108.87 1.04 Allowed 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 120.93 1.087 . . . . 0.0 111.574 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' HB ' ' A' ' 54' ' ' VAL . 25.5 t -108.81 111.51 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.463 178.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.99 110.75 21.71 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.8 ' SD ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -91.51 116.28 28.73 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.34 -176.859 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -102.23 150.43 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.887 -1.133 . . . . 0.0 110.867 -178.789 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 88' ' ' ALA . 9.3 t -150.09 -143.49 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 87' ' ' THR . . . -161.38 -17.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -79.85 -75.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.957 . . . . 0.0 109.506 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 106' ' ' TYR . . . 58.83 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.8 tptp -148.58 59.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.266 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 94' ' ' ASN . 74.1 tttt 53.12 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.9 pt-20 -47.17 -19.0 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.189 -0.945 . . . . 0.0 109.789 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' HB2' ' H ' ' A' ' 91' ' ' LYS . 3.0 m-20 -89.78 -35.78 15.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.82 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.87 -18.27 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -83.54 -43.39 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.751 -1.218 . . . . 0.0 107.93 178.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.45 -24.82 1.39 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 102' ' ' GLY . . . -51.1 -54.34 25.95 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.583 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.72 64.49 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.069 -1.644 . . . . 0.0 107.963 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -27.73 68.51 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.236 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.879 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -146.46 -68.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.825 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -58.61 79.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.82 -108.76 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.302 0 CA-C-N 111.549 -2.325 . . . . 0.0 115.676 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -29.83 -58.0 0.17 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.164 -175.768 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.31 176.26 37.0 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.95 -179.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -130.65 115.0 16.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.87 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.3 p -122.6 123.01 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 107' ' ' VAL . 28.0 m -54.18 -169.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.15 153.19 11.77 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.504 -1.372 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.11 154.06 99.45 Favored 'Cis proline' 0 N--CA 1.487 1.101 0 C-N-CA 125.187 -0.755 . . . . 0.0 110.636 -1.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.9 p90 -118.32 155.25 30.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.84 0.829 . . . . 0.0 109.661 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.483 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.4 OUTLIER -90.07 150.49 22.05 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -50.61 -15.55 0.28 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.684 -1.26 . . . . 0.0 109.327 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -81.69 -34.44 30.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.483 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -74.13 -61.21 1.93 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -51.1 -36.16 38.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.58 179.662 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 15.9 mt-10 -54.66 -66.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.009 -1.057 . . . . 0.0 109.521 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -44.25 -26.93 0.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.768 -0.583 . . . . 0.0 109.781 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.53 -44.03 15.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 110.325 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 120' ' ' LEU . 18.6 mt -67.57 -57.23 6.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.805 -1.184 . . . . 0.0 109.64 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.53 -27.02 5.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.986 -1.072 . . . . 0.0 109.82 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -84.4 -22.71 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.181 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.6 mt -88.36 -39.0 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.645 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -65.76 -5.68 9.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.998 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -26.17 62.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -90.38 -34.46 15.66 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.26 -15.52 59.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 58.41 85.76 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.228 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' CD1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER 173.52 134.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.397 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 28.69 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -171.68 41.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.01 -1.056 . . . . 0.0 110.579 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.2 tp -80.41 112.95 18.23 Favored 'General case' 0 C--O 1.205 -1.249 0 O-C-N 120.576 -1.328 . . . . 0.0 107.921 179.169 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.54 114.36 1.64 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.946 . . . . 0.0 112.481 -177.453 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 82.8 m-85 -109.2 151.12 26.91 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 54' ' ' VAL . 20.5 tp -119.15 108.62 14.91 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.02 122.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.265 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 33.3 t -126.9 105.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.491 -0.756 . . . . 0.0 109.574 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.5 133.47 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 109.425 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 53.52 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.596 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.64 135.53 22.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.12 15.99 3.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.02 -1.64 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 109.558 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.0 ttt -89.96 -21.71 22.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.123 -0.986 . . . . 0.0 109.074 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -76.08 -45.39 34.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.835 . . . . 0.0 109.419 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -58.63 -20.87 51.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.878 . . . . 0.0 109.575 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -73.81 -55.56 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.849 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -23.14 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 110.263 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.536 ' NH1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.81 -53.05 62.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 109.122 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.05 -56.08 13.37 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.014 0.911 . . . . 0.0 108.991 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.3 tt -40.6 -46.43 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.92 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.32 -45.0 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 0.0 108.541 179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -57.28 -30.4 64.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.478 -0.763 . . . . 0.0 109.147 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 -41.54 74.83 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.177 -0.952 . . . . 0.0 109.354 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.688 HD22 ' OE2' ' A' ' 117' ' ' GLU . 14.9 tp -76.86 -57.01 4.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -0.844 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . 152.3 77.37 0.02 OUTLIER Glycine 0 N--CA 1.478 1.483 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -150.22 147.99 28.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -1.073 . . . . 0.0 109.29 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -150.15 55.88 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.946 -1.096 . . . . 0.0 110.634 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.74 105.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.703 -1.248 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.536 HG22 ' NH1' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -146.76 -179.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.971 . . . . 0.0 109.384 179.21 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.1 mm-40 -134.71 -167.52 1.99 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -149.97 150.69 32.2 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.342 -178.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.39 -169.22 2.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.5 mt-10 -139.73 9.31 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.257 -0.902 . . . . 0.0 110.222 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.2 m-20 170.85 173.32 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.0 108.896 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.1 -25.5 73.39 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -37.09 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.937 -1.331 . . . . 0.0 108.243 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.9 t0 -74.66 -39.96 61.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -75.32 -35.5 61.21 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.57 -52.72 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -62.08 -30.93 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -90.0 -18.83 25.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.323 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -61.02 -32.96 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.569 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -84.06 -0.15 50.65 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.38 -72.78 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.659 -0.651 . . . . 0.0 109.553 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.03 -86.78 0.3 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.17 72.79 0.18 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.6 m-85 -54.27 98.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.312 -1.111 . . . . 0.0 109.041 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.29 1.19 0.44 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -169.2 142.82 2.83 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.187 -1.184 . . . . 0.0 109.919 -179.652 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 83' ' ' VAL . 12.8 t -133.59 145.43 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.088 -1.008 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.19 85.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 3.6 p -103.98 143.54 32.74 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.696 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.3 p30 -60.37 -122.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.532 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 75.2 t-105 -158.25 -77.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.154 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -89.02 122.88 32.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.089 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.495 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.25 -50.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 110.44 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.09 -173.67 0.22 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.747 0.965 . . . . 0.0 110.055 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -52.68 -13.67 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.168 -0.958 . . . . 0.0 109.546 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.402 ' N ' ' C ' ' A' ' 61' ' ' PRO . 3.7 mmt -147.23 -86.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -152.94 177.85 10.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.9 -9.52 77.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 97' ' ' ALA . 46.7 tp -50.81 -25.65 4.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.679 -1.483 . . . . 0.0 108.239 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 64' ' ' ASP . 7.6 pt-20 -72.59 -34.48 67.46 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 39' ' ' GLY . 25.7 mt -63.18 -56.13 19.28 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt -57.11 -58.73 6.92 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.606 0.717 . . . . 0.0 109.193 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -53.86 -38.02 64.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 70.4 m -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.938 . . . . 0.0 109.097 179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.934 HD13 HG21 ' A' ' 83' ' ' VAL . 4.2 mt -67.09 -24.79 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -18.68 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 108.918 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.4 -52.22 22.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.176 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 79' ' ' SER . 4.1 t70 -66.71 83.85 0.11 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.94 43.44 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.76 -89.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -1.195 . . . . 0.0 109.564 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.0 mtt -118.16 20.98 13.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.0 109.25 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.522 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 t 46.93 -118.31 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.09 52.71 0.91 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER 46.07 -175.03 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.6 Cg_exo -63.03 144.79 93.53 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 121.68 1.586 . . . . 0.0 114.522 -176.071 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.934 HG21 HD13 ' A' ' 72' ' ' ILE . 5.4 t -139.5 111.38 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -95.13 106.07 18.05 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 117.551 -1.659 . . . . 0.0 106.964 177.963 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 1.1 ttm -74.56 107.68 6.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.539 -0.865 . . . . 0.0 109.392 -178.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -92.17 144.83 8.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 90' ' ' ALA . 5.8 t -146.24 170.2 17.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.015 -1.053 . . . . 0.0 110.426 -178.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.528 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -109.86 -57.29 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.709 -0.619 . . . . 0.0 109.551 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.74 29.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -46.45 110.9 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 3.8 ttpp -148.47 94.89 2.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.743 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttt 44.61 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.85 . . . . 0.0 110.156 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -45.93 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.333 -0.855 . . . . 0.0 110.419 -179.183 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -41.19 -34.43 0.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.477 -0.764 . . . . 0.0 110.764 -178.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.607 HG23 ' CD2' ' A' ' 106' ' ' TYR . 24.6 mt -75.58 -66.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.969 -1.082 . . . . 0.0 109.304 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 96' ' ' ILE . 69.2 mt -62.16 -0.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.023 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -76.02 -37.85 57.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.401 -0.812 . . . . 0.0 109.119 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -71.98 -59.87 2.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.09 -1.006 . . . . 0.0 108.306 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -59.55 -22.37 61.6 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.514 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -49.32 -33.38 13.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.727 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 69' ' ' LEU . . . -85.54 -36.82 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 90.29 64.94 1.22 Allowed Glycine 0 N--CA 1.482 1.71 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.001 175.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.893 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.12 -111.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.935 1.867 . . . . 0.0 108.678 177.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.62 -46.05 8.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 122.423 1.106 . . . . 0.0 108.611 177.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 163.23 -157.87 30.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -178.316 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.607 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -137.77 146.48 43.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.679 -0.895 . . . . 0.0 109.248 178.95 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.4 p -140.61 136.1 35.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 109' ' ' LYS . 3.0 p -80.08 159.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.034 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.528 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.27 154.79 80.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.0 109.523 -179.301 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.26 126.85 13.46 Favored 'Cis proline' 0 N--CA 1.488 1.194 0 O-C-N 122.564 0.771 . . . . 0.0 110.14 -2.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.93 156.6 18.33 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.376 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -92.99 148.44 22.0 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 176.784 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -49.28 -12.44 0.05 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.706 -1.246 . . . . 0.0 109.343 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -83.07 -37.74 23.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.72 -59.69 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.144 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -50.62 -40.71 53.71 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.983 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.688 ' OE2' HD22 ' A' ' 28' ' ' LEU . 24.0 mm-40 -61.09 -55.12 36.31 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.185 -0.947 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -41.62 -38.27 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.42 0.628 . . . . 0.0 109.752 -179.33 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -88.19 -29.63 20.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.214 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp -65.53 -65.71 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.613 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.81 -36.36 11.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.478 ' HB3' ' HZ3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -73.73 -25.53 60.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.847 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.44 -41.38 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.922 . . . . 0.0 109.849 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.83 -19.83 62.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 110.252 -179.142 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' CA ' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -61.27 -20.88 63.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.758 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -94.51 -31.76 13.79 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 127' ' ' LEU . 2.7 tt -72.82 -26.05 61.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.62 77.73 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.266 -1.138 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -46.71 136.61 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.04 48.48 1.58 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -178.55 33.66 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 50.5 tp -71.12 111.12 6.23 Favored 'General case' 0 C--O 1.206 -1.212 0 O-C-N 120.599 -1.313 . . . . 0.0 108.147 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -58.04 119.8 7.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.072 . . . . 0.0 111.409 -177.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 80.9 m-85 -110.79 148.76 31.68 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 54' ' ' VAL . 66.6 tp -119.34 110.88 17.48 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.52 106.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.286 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 36' ' ' ALA . 27.4 t -96.96 92.03 2.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.504 -0.748 . . . . 0.0 109.59 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -147.42 132.47 18.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -24.68 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.64 130.82 48.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -82.83 -20.08 36.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -33.3 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.499 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttt -57.6 -30.51 65.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -71.71 -34.75 69.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.923 -1.11 . . . . 0.0 108.679 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -75.87 -16.13 60.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.519 -0.738 . . . . 0.0 109.068 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.78 -50.83 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.48 -32.23 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 110.26 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -47.76 -53.35 15.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 109.391 179.651 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.02 -57.4 5.04 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.514 -0.742 . . . . 0.0 109.771 -179.576 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -40.42 -61.02 0.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.423 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 25' ' ' LEU . 23.7 mt -51.46 -50.78 59.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 108.72 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -49.07 -33.18 10.98 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.241 -0.912 . . . . 0.0 108.918 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -49.43 -51.07 37.94 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.404 -0.81 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.519 HD23 ' CE2' ' A' ' 30' ' ' PHE . 35.9 tp -70.56 -48.1 57.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.005 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.45 81.59 0.06 OUTLIER Glycine 0 C--O 1.208 -1.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 28' ' ' LEU . 67.2 m-85 -150.08 149.26 30.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -1.094 . . . . 0.0 108.896 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -150.1 64.06 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 110.224 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.7 103.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.864 -1.147 . . . . 0.0 109.258 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.15 151.83 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 110.288 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -120.55 -170.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.8 mp0 -146.63 155.99 42.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.721 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.16 -163.02 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -137.47 -7.89 1.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 110.783 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 62' ' ' ASN . 6.8 t0 -177.42 -165.57 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -79.24 -26.59 57.28 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 6.3 p -75.64 -42.08 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.025 -1.28 . . . . 0.0 107.847 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 12.4 t0 -68.98 -43.73 74.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.636 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -64.75 -52.79 55.12 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' ALA . 3.4 tt -43.34 -36.71 1.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.419 -0.801 . . . . 0.0 109.242 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -71.62 -34.62 69.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.08 179.089 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 47' ' ' GLN . 11.7 mmmt -86.38 -53.59 4.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -41.13 -22.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.666 -0.646 . . . . 0.0 109.371 179.682 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -52.35 -43.63 64.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.36 -56.95 5.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.23 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 88.35 -19.26 36.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.75 -5.37 3.92 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.773 ' O ' HD22 ' A' ' 81' ' ' LEU . 61.6 m-85 -75.43 83.88 2.52 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.469 -1.019 . . . . 0.0 110.212 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.02 -3.93 1.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 177.992 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -155.87 144.57 20.33 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.53 -0.982 . . . . 0.0 110.221 -179.473 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 9' ' ' LEU . 98.8 t -141.09 116.77 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 108.76 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 117.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.866 . . . . 0.0 108.861 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.1 p -120.05 166.95 12.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.629 -0.669 . . . . 0.0 109.681 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 12' ' ' ASP . 61.6 m-20 -95.58 -106.39 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.533 -0.73 . . . . 0.0 109.458 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CD1' ' OD2' ' A' ' 64' ' ' ASP . 56.6 t-105 -168.95 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.721 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.5 104.99 5.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.411 ' CE ' ' CA ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -130.9 174.09 5.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.339 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.42 -1.93 1.66 Allowed 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.396 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.534 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 8.5 m120 -127.05 83.67 2.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.283 -0.886 . . . . 0.0 109.488 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.9 mmt 48.46 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 109.599 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -165.04 179.09 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.961 -1.087 . . . . 0.0 109.405 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 60' ' ' MET . . . -70.96 14.66 1.46 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -68.3 -51.93 39.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -1.178 . . . . 0.0 108.854 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' THR . 1.8 mt-10 -63.53 -15.66 58.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.2 mt -79.98 -67.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.98 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.91 -62.17 1.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.682 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -58.23 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' GLU . 16.6 p -52.91 -41.15 64.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.897 -1.127 . . . . 0.0 109.476 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.9 mt -64.22 -42.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.399 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -84.75 -4.86 59.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 -29.12 22.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.528 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.5 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.92 -90.35 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.39 70.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.162 . . . . 0.0 109.158 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.9 mtm -92.45 10.22 31.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.238 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.4 p -76.49 44.61 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 8.57 0.65 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.6 mt -72.19 121.14 83.9 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.525 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 113.82 1.9 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.415 1.41 . . . . 0.0 113.433 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -103.25 105.65 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 175.224 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.42 105.92 18.14 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 116.749 -1.98 . . . . 0.0 106.55 178.587 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.521 ' O ' ' SD ' ' A' ' 85' ' ' MET . 2.7 ppp? -79.88 124.02 28.28 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.926 -177.317 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 140.78 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.209 -0.932 . . . . 0.0 109.103 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 t -150.07 174.98 12.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.044 . . . . 0.0 110.948 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -106.88 -64.68 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -75.82 63.96 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 108.873 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -67.34 91.99 0.27 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 144.12 25.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.581 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -24.03 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -78.2 -54.18 6.52 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' ALA . 1.2 t30 -68.74 -45.27 71.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.2 mt -48.65 -30.48 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.8 mt -89.86 -20.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.358 -0.839 . . . . 0.0 109.075 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.92 -45.75 92.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.409 -0.807 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -73.88 -54.34 8.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 108.199 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.86 -27.24 50.75 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.307 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -53.78 -34.03 57.79 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 178.374 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.98 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -83.04 -25.09 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.24 75.87 0.43 Allowed Glycine 0 N--CA 1.481 1.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.04 177.155 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.26 -112.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.824 -1.95 . . . . 0.0 111.158 179.174 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.8 OUTLIER -91.67 -53.77 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.801 1.286 . . . . 0.0 109.019 176.633 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.41 -161.0 31.66 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -177.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.73 136.55 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 0.0 109.962 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.3 p -136.1 122.05 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.98 176.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.792 -1.193 . . . . 0.0 108.223 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -151.3 149.41 24.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.772 -1.205 . . . . 0.0 109.065 179.636 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.93 139.87 63.75 Favored 'Cis proline' 0 N--CA 1.484 0.923 0 C-N-CA 125.302 -0.707 . . . . 0.0 110.399 -1.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.426 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.8 p90 -99.04 163.79 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.77 146.05 23.94 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 177.63 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.35 -34.45 6.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.106 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.26 76.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.2 m -70.54 -66.97 0.53 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.509 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 111' ' ' PHE . 6.8 tp -48.33 -40.12 24.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.593 -1.317 . . . . 0.0 109.497 178.701 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 119' ' ' LYS . 3.4 tm-20 -68.04 -68.45 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.027 . . . . 0.0 109.782 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 117' ' ' GLU . 86.0 tt0 -42.25 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.362 0.601 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' GLU . 5.5 mmmt -90.01 -47.57 7.76 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.071 179.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 120' ' ' LEU . 17.5 mt -56.07 -54.76 41.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -46.34 -49.93 17.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -57.15 -28.37 62.68 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.13 -40.95 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.47 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -68.65 -6.61 26.93 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.974 -1.079 . . . . 0.0 110.427 -178.843 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.84 -19.88 61.91 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -29.53 13.02 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -21.54 29.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.475 -0.766 . . . . 0.0 108.94 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.87 75.18 0.17 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 109.404 179.979 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 2.0 t0 76.85 131.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.466 -0.771 . . . . 0.0 109.289 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.41 18.44 6.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 110.172 -179.876 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 2.1 tm-20 -152.78 41.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.688 -1.257 . . . . 0.0 111.072 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 31.4 tp -81.87 118.67 23.1 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.497 -1.377 . . . . 0.0 107.912 178.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -63.87 123.28 18.54 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.19 -0.944 . . . . 0.0 111.754 -177.513 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 91.8 m-85 -115.56 144.51 43.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.62 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.0 tp -119.13 111.56 18.41 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.4 100.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 108.609 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.007 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -94.95 98.96 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.388 -0.82 . . . . 0.0 109.633 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.1 t0 -156.86 142.88 17.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.0 109.389 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.23 93.71 7.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -162.21 149.56 13.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.11 16.95 13.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -145.19 -22.11 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.438 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -60.8 -65.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.65 -33.66 7.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -38.63 67.77 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.0 -177.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -64.51 -56.05 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.674 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -31.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -51.79 -54.29 30.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 109.319 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -65.77 -57.23 8.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.52 -0.737 . . . . 0.0 109.215 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.7 -59.48 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.977 -179.507 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.02 -50.19 67.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.015 179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -56.07 -39.11 71.57 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.323 -0.861 . . . . 0.0 109.505 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -54.77 -44.47 73.69 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.287 -0.883 . . . . 0.0 109.184 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' OE2' ' A' ' 117' ' ' GLU . 4.5 mt -69.5 -58.49 3.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.94 74.8 0.01 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 46.0 m-85 -150.21 152.38 34.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -1.174 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -146.74 62.33 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.93 -1.106 . . . . 0.0 110.065 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -176.42 97.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.825 -1.172 . . . . 0.0 109.667 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -150.2 149.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.91 -1.119 . . . . 0.0 110.161 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -126.4 -166.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -148.59 149.28 31.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 110.655 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.007 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.32 -169.32 2.83 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -143.98 3.54 1.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.237 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -176.72 157.84 1.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.519 -1.363 . . . . 0.0 109.765 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -49.1 -52.83 21.14 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -50.78 -31.06 9.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.895 -1.356 . . . . 0.0 108.139 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.5 t0 -79.24 -46.13 18.44 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -64.54 -56.62 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mt -48.65 -52.95 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.862 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -69.19 -33.55 73.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.527 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -10.71 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.242 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -81.55 -22.65 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.148 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -63.65 -6.67 5.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 108.639 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.11 -69.3 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.584 -0.698 . . . . 0.0 109.843 -179.728 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 10.2 1.0 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.05 85.53 1.27 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.4 m-85 -64.71 139.23 58.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -1.038 . . . . 0.0 110.494 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.01 3.1 62.02 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -165.89 146.86 6.81 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 9' ' ' LEU . 89.7 t -148.63 123.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.786 -1.196 . . . . 0.0 109.759 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.98 93.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 p -96.36 158.1 15.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -0.861 . . . . 0.0 108.999 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' ASN . 4.4 p-10 -119.57 161.81 20.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.765 -0.584 . . . . 0.0 109.815 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 93.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 108.795 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ASP . 6.7 m-20 -108.76 121.54 45.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.443 -0.786 . . . . 0.0 109.721 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.627 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.6 ppp? -137.99 38.19 0.34 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.599 -0.688 . . . . 0.0 111.78 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -55.89 -24.97 50.35 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 178.034 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 63' ' ' MET . 7.8 p30 179.63 58.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 2.2 ttm 77.99 99.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.209 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -168.25 -172.53 1.76 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.528 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.689 ' H ' HD12 ' A' ' 68' ' ' LEU . . . 71.12 -69.68 0.82 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 97' ' ' ALA . 1.7 mm? -67.75 -61.62 1.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.109 -1.23 . . . . 0.0 108.992 179.354 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.61 -12.12 9.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 108.653 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -73.02 -46.44 52.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.87 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.88 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -84.2 -30.57 25.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.242 179.992 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -61.68 -40.43 94.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.114 179.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.5 m -68.66 -41.49 79.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.018 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.64 -29.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.82 . . . . 0.0 108.795 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -90.03 -24.13 21.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.686 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.18 -28.94 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -87.69 131.79 34.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.05 -23.72 77.82 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.23 -28.56 17.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -1.193 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.484 ' C ' ' H ' ' A' ' 80' ' ' ALA . 23.1 tpp -91.97 5.49 49.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 t -71.7 13.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -99.97 -37.24 9.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.708 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -38.55 102.67 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.766 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 96.25 0.23 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.164 1.243 . . . . 0.0 111.528 -178.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 83' ' ' VAL . 2.1 t -98.84 105.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.3 tp -96.02 103.72 15.62 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.827 -1.549 . . . . 0.0 106.86 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.56 161.67 11.67 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.731 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.73 137.72 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 t -150.04 156.24 41.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.31 -31.14 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.45 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.14 -61.2 2.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.15 33.36 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -44.84 -67.27 0.3 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.0 109.795 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -167.35 -80.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -13.32 1.96 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 109.741 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -83.12 -21.88 33.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.637 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.56 HG23 ' CD2' ' A' ' 106' ' ' TYR . 66.1 mt -78.89 -49.58 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.945 -1.097 . . . . 0.0 108.657 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.8 mp -63.49 -19.5 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.336 -0.852 . . . . 0.0 108.949 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -60.36 -59.56 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.83 -53.42 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.79 -19.87 65.83 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.993 -178.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -50.61 -30.79 14.2 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.04 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -92.54 -26.62 17.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.329 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.46 72.54 1.05 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.815 177.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.24 -112.04 0.07 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 116.619 -2.032 . . . . 0.0 109.05 178.6 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.91 -49.41 6.25 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.754 1.264 . . . . 0.0 108.102 175.396 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.58 -160.0 32.48 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.57 124.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.849 . . . . 0.0 109.289 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.5 p -113.39 130.55 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.459 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -84.23 124.18 39.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.972 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 161.55 25.63 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.159 -0.963 . . . . 0.0 108.94 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.48 129.04 17.35 Favored 'Cis proline' 0 N--CA 1.484 0.933 0 O-C-N 122.842 0.917 . . . . 0.0 110.747 -2.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.7 p90 -96.93 163.76 12.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.935 . . . . 0.0 109.632 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.56 147.18 25.6 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.862 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.436 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.66 -20.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.808 -1.182 . . . . 0.0 109.047 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.577 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -75.74 -58.4 3.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.538 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.639 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -52.41 -38.81 59.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.207 -1.558 . . . . 0.0 107.972 178.612 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.581 ' OE2' HD21 ' A' ' 28' ' ' LEU . 11.3 tt0 -57.14 -57.3 13.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.046 -1.034 . . . . 0.0 109.895 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.56 -39.19 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.532 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.43 -29.22 63.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -73.46 -45.37 54.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.521 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 125' ' ' GLU . 2.6 m120 -57.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.914 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -61.04 -46.31 91.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 109.729 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.26 -34.34 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.371 -0.83 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.27 -7.18 57.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.919 -178.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 121' ' ' ASN . 5.9 mt-10 -71.44 -28.55 64.05 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.342 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -94.14 -25.11 17.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.577 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -84.54 -22.4 30.13 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.487 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.41 79.62 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.285 -1.126 . . . . 0.0 109.465 179.925 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 7.4 m-20 -45.37 146.7 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.313 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.6 tttp -90.25 13.13 16.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.876 -1.14 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -152.46 45.59 0.72 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.708 -1.245 . . . . 0.0 110.415 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.56 136.56 44.03 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -73.98 115.9 13.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.958 -1.088 . . . . 0.0 111.978 -176.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.3 m-85 -106.4 153.24 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.063 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.784 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.72 104.53 5.55 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.411 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.515 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -91.67 122.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.969 -178.986 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.2 t -111.97 93.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.863 . . . . 0.0 109.069 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD1' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.34 -178.03 4.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.02 28.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.532 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -90.9 -7.85 51.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.427 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.51 -10.09 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.747 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.42 -8.88 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.9 ttt -64.9 -22.53 67.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.05 -63.64 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -46.75 -14.08 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.174 -178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' ARG . 4.2 mt -81.83 -50.13 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.014 -1.053 . . . . 0.0 109.628 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -27.72 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.786 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -55.71 -53.08 61.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 108.89 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -62.67 -59.22 5.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.525 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -40.61 -56.81 2.02 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.773 -179.985 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.84 -39.82 71.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.198 -0.939 . . . . 0.0 108.846 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -62.36 -50.71 70.5 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.282 -0.886 . . . . 0.0 109.207 179.642 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.04 -36.93 30.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.477 HD11 ' OE1' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -71.55 -61.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.563 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.19 65.12 0.01 OUTLIER Glycine 0 C--N 1.3 -1.465 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 44.2 m-85 -150.14 148.53 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 109.129 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -150.15 59.28 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.806 -1.183 . . . . 0.0 111.159 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -172.21 98.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.703 -1.248 . . . . 0.0 110.684 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.71 178.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.035 -1.04 . . . . 0.0 110.352 179.058 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -142.31 -177.34 5.21 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 178.456 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 13.5 mt-10 -140.85 156.23 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.052 -1.03 . . . . 0.0 111.483 -178.133 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.99 -173.0 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.569 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.03 19.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.689 -1.257 . . . . 0.0 110.87 -179.551 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.488 ' OD1' ' ND2' ' A' ' 62' ' ' ASN . 42.0 t0 -174.48 145.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -0.992 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.19 -42.37 17.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -63.01 -33.37 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.245 -1.15 . . . . 0.0 108.492 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 18.8 t0 -73.29 -47.55 41.93 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -58.12 -48.2 80.93 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.42 -0.8 . . . . 0.0 108.845 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.5 tm? -49.91 -50.43 46.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.708 -179.588 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -55.44 -40.17 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.895 . . . . 0.0 111.05 -178.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -26.31 20.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.015 -1.053 . . . . 0.0 111.06 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.688 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -58.59 -19.51 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.818 -1.176 . . . . 0.0 109.256 -179.209 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -95.89 -5.9 40.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.125 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.29 -62.81 1.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.317 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.55 8.77 1.38 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.45 77.14 1.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.478 ' O ' HD13 ' A' ' 81' ' ' LEU . 36.6 m-85 -56.39 114.22 1.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.393 -1.063 . . . . 0.0 109.766 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.33 2.14 3.37 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -163.47 139.22 6.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.972 -1.311 . . . . 0.0 109.597 179.676 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.3 t -136.57 116.77 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.087 -1.008 . . . . 0.0 109.532 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.1 mt -103.8 99.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.533 -0.729 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.475 ' O ' ' SD ' ' A' ' 85' ' ' MET . 15.2 p -110.25 156.74 20.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.56 162.96 14.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.468 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 42.0 t-105 -96.49 111.95 23.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 2.3 t-20 73.48 96.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.725 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.455 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.5 mtt 177.16 -50.63 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -66.27 -67.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 120.783 0.989 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.6 p30 -154.55 125.96 7.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 mtt 54.33 -86.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -149.0 144.0 26.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.06 1.78 4.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.266 . . . . 0.0 109.627 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.9 tt0 -46.31 -32.62 3.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -66.87 -52.06 48.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.916 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -58.58 -60.42 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.237 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' ALA . 10.5 tttt -42.82 -34.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 m -52.06 -44.45 64.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 108.692 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.69 -30.8 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -6.9 55.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -64.17 -51.38 64.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.835 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -46.9 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.27 -61.32 0.36 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.44 -8.15 59.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -1.151 . . . . 0.0 109.257 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.6 mtp -90.26 -7.1 54.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -74.98 65.79 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.58 -28.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 0.0 110.452 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 51' ' ' TYR . 30.0 mt -60.14 125.05 80.25 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 120.9 -1.125 . . . . 0.0 109.28 -179.396 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.9 150.79 75.82 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.231 1.287 . . . . 0.0 112.565 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.9 t -133.21 137.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.396 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 84' ' ' LEU . 34.2 tp -117.35 65.73 0.73 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.555 178.404 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' O ' ' A' ' 56' ' ' SER . 2.3 mmt -48.21 159.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.01 132.76 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 109.048 -179.166 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.1 t -150.12 166.47 29.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.49 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -87.35 -68.24 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.4 101.93 14.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -88.5 98.92 11.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.93 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -63.72 -151.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 108.977 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.6 pttt -118.42 -71.43 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 109.413 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -48.97 -9.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.364 -0.835 . . . . 0.0 110.056 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -89.53 -49.02 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.856 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 35.9 mt -61.58 -31.95 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.89 -63.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.087 -1.008 . . . . 0.0 109.651 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.88 19.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 108.834 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.97 -54.14 13.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.472 -0.768 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -53.04 -45.23 67.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.878 . . . . 0.0 110.1 -179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.72 -19.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 109.116 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -98.97 -113.54 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.611 -0.681 . . . . 0.0 109.59 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.35 -2.89 5.82 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.695 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -55.79 10.94 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 122.206 -0.585 . . . . 0.0 111.326 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 102' ' ' GLY . 14.0 m -29.45 -33.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.15 130.79 10.26 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.92 121.76 10.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 0.0 109.429 179.385 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.23 141.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 108' ' ' VAL . 8.5 p -92.13 100.68 11.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 108.907 179.739 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -62.53 159.87 38.77 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.921 -1.112 . . . . 0.0 109.345 -179.323 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.48 147.74 87.61 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 O-C-N 123.008 1.004 . . . . 0.0 109.835 -3.184 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 116' ' ' LEU . 6.4 p90 -126.36 159.03 34.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.143 0.973 . . . . 0.0 110.414 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -103.19 153.15 20.65 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.933 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -48.9 -12.92 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.691 -1.256 . . . . 0.0 109.487 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.67 -42.92 23.74 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.637 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -60.26 2.56 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 111' ' ' PHE . 4.1 tp -49.26 -37.91 25.14 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.094 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' OE1' HD11 ' A' ' 28' ' ' LEU . 41.8 tt0 -65.19 -48.83 72.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 109.866 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.35 -68.47 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 110.403 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.38 -47.49 9.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.83 . . . . 0.0 110.19 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.56 -44.56 96.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -34.84 79.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.247 -179.425 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -71.32 -34.57 70.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 109.8 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 mt -80.12 -41.31 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.74 -24.67 67.86 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.14 -29.84 65.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -29.4 29.65 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.4 tp -69.06 -22.11 64.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.89 5.38 57.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.373 -1.075 . . . . 0.0 109.372 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.696 ' HB2' ' SD ' ' A' ' 129' ' ' MET . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.449 0.643 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 63.01 131.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 109.369 -179.827 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -90.17 9.68 27.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.765 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -147.84 48.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.76 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 56.1 tp -76.35 115.86 16.48 Favored 'General case' 0 C--O 1.204 -1.302 0 O-C-N 120.612 -1.305 . . . . 0.0 107.827 178.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -57.43 120.19 7.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.851 -1.156 . . . . 0.0 111.694 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.2 m-85 -110.62 143.36 41.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.588 HD22 ' CD1' ' A' ' 46' ' ' LEU . 53.9 tp -116.94 113.03 21.84 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.99 98.14 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 36' ' ' ALA . 18.3 t -90.05 89.24 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.11 135.1 17.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.066 -1.021 . . . . 0.0 109.709 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.6 m-20 -87.41 1.48 53.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -66.17 140.23 58.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 19.8 5.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.8 -27.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.847 . . . . 0.0 109.499 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -63.85 -58.79 5.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.487 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.66 -36.12 6.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.396 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.5 -39.62 74.05 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.736 -178.294 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 21' ' ' VAL . 2.5 mt -60.13 -55.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.394 -0.816 . . . . 0.0 109.847 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.38 -34.0 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 110.638 -178.484 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -53.12 -53.28 52.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.936 -1.103 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -69.29 -56.12 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.12 -57.27 2.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.741 -179.467 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.1 -48.63 80.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.064 -1.023 . . . . 0.0 109.02 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -57.39 -28.99 63.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.55 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.17 -30.88 68.51 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.1 -1.0 . . . . 0.0 108.874 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.74 -66.73 0.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.187 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.55 29.58 0.02 OUTLIER Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -98.08 152.34 19.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 109.6 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -150.04 60.29 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.096 -1.003 . . . . 0.0 109.727 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.73 100.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.09 153.72 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.101 -0.999 . . . . 0.0 110.176 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.74 -167.46 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 108.987 179.469 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.92 145.67 26.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.053 -1.03 . . . . 0.0 110.042 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.48 -169.03 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.15 6.31 1.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.212 -0.93 . . . . 0.0 111.176 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.58 -175.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.533 -1.354 . . . . 0.0 110.005 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.87 -41.12 73.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.757 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.01 -36.99 76.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -1.056 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.1 t0 -78.99 -45.47 20.19 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.87 98.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.989 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.76 -39.12 90.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.074 -1.016 . . . . 0.0 109.741 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -74.25 -23.96 59.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -0.961 . . . . 0.0 110.336 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -90.03 -28.92 18.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.04 . . . . 0.0 110.829 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.588 ' CD1' HD22 ' A' ' 9' ' ' LEU . 1.6 mp -60.46 -13.04 11.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.581 -1.325 . . . . 0.0 109.417 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.17 -6.84 48.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.161 -0.962 . . . . 0.0 108.613 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.81 -71.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.578 -0.701 . . . . 0.0 109.826 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.14 12.64 1.08 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.89 94.78 0.97 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.44 ' O ' HD22 ' A' ' 81' ' ' LEU . 17.2 m-85 -73.97 148.8 41.79 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.257 -1.143 . . . . 0.0 110.128 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' C ' HD13 ' A' ' 81' ' ' LEU . . . -105.82 -9.01 33.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.2 129.49 14.71 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.3 t -128.28 122.78 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.079 -1.013 . . . . 0.0 110.09 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -107.43 132.31 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -149.47 142.39 24.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -74.62 123.01 24.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.349 -0.845 . . . . 0.0 109.285 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 51.0 t-105 -61.61 98.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.871 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 60' ' ' MET . 10.0 t-20 63.13 122.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 109.826 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.496 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 169.99 -46.79 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 110.334 179.526 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.14 -55.37 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.719 0.946 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.51 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.27 -177.77 4.38 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -93.1 131.5 38.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.192 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.05 1.83 3.28 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 64' ' ' ASP . 58.6 tp -73.36 -68.73 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -1.227 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -43.99 -31.4 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.533 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -66.08 -56.34 12.02 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.562 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 102' ' ' GLY . 1.6 tt -63.42 -65.65 0.65 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.609 -0.682 . . . . 0.0 109.783 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' HH21 ' A' ' 73' ' ' ARG . 6.7 tttm -39.89 -32.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.835 -0.541 . . . . 0.0 109.879 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.7 m -71.29 -39.99 71.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.083 -1.011 . . . . 0.0 108.776 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 69' ' ' LEU . 96.4 mt -55.41 -42.05 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 HH21 ' NZ ' ' A' ' 70' ' ' LYS . 19.4 ptt85 -89.97 1.62 56.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.854 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.05 -28.25 48.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -36.21 53.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.73 -23.88 14.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.37 -52.41 65.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.16 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.9 mmt -90.04 16.58 8.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.1 p 46.55 -107.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.03 56.55 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 82' ' ' PRO . 1.2 pp -42.77 149.44 0.49 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.6 ' O ' HD12 ' A' ' 81' ' ' LEU . 4.2 Cg_exo -54.32 142.89 67.51 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 121.818 1.678 . . . . 0.0 113.505 -178.105 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 69' ' ' LEU . 2.3 t -134.55 128.77 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.514 HD21 HD11 ' A' ' 116' ' ' LEU . 48.0 tp -109.27 72.7 0.82 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.012 177.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt -53.06 169.46 0.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -141.16 129.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.449 -0.782 . . . . 0.0 109.664 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 88' ' ' ALA . 24.3 m -141.64 166.7 24.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 109.255 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 87' ' ' THR . . . -111.58 -27.86 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.65 -0.656 . . . . 0.0 109.269 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt-10 -99.91 -72.4 0.67 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -0.805 . . . . 0.0 109.684 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 62.14 118.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.24 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -122.16 -88.06 0.63 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.634 . . . . 0.0 109.67 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' ASN . 1.4 mtpp -152.98 -77.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -45.94 -16.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.744 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.551 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 12.4 t30 -89.99 -33.15 16.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.659 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.1 mt -90.04 -20.69 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 97' ' ' ALA . 60.9 mt -73.66 -72.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.29 -50.66 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -55.7 -51.96 65.52 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.561 -0.712 . . . . 0.0 109.54 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.72 -41.93 70.92 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.317 -0.864 . . . . 0.0 109.902 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.497 ' OE1' ' N ' ' A' ' 100' ' ' GLN . 2.9 mp0 -61.43 -11.85 12.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.859 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.36 -104.79 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 110.43 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.735 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -134.6 0.78 3.87 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.54 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.792 -0.828 . . . . 0.0 110.006 177.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 6.1 m -29.1 -32.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.59 126.28 7.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.0 112.01 5.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -1.217 . . . . 0.0 108.944 179.547 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.8 p -108.82 129.89 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.8 p -80.93 93.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 108.925 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 161.19 3.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.012 . . . . 0.0 109.314 -179.583 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.74 162.28 92.67 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 124.705 -0.956 . . . . 0.0 110.372 -2.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -143.64 155.04 44.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.166 0.984 . . . . 0.0 110.431 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.55 154.02 18.9 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.09 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -49.13 -12.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.684 -1.26 . . . . 0.0 109.499 -179.228 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.49 -40.17 23.66 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 108.44 178.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -59.2 2.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD11 HD21 ' A' ' 84' ' ' LEU . 4.7 tp -50.59 -38.31 44.74 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.289 -1.364 . . . . 0.0 108.614 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.25 -51.22 70.5 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.157 -0.964 . . . . 0.0 109.562 179.659 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -46.01 -59.94 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.65 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.115 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -45.71 -68.23 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.496 -0.752 . . . . 0.0 109.037 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.08 -22.4 39.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.464 ' O ' ' CG ' ' A' ' 125' ' ' GLU . 1.4 ttpt -81.14 -24.4 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 110.303 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mt -90.08 -38.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.0 110.779 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 120' ' ' LEU . 16.5 m-85 -67.79 -17.03 64.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.993 -1.067 . . . . 0.0 111.342 -177.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -62.03 -27.85 69.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.723 -1.236 . . . . 0.0 107.714 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -87.71 -27.72 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -26.04 64.22 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.65 68.3 1.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.696 ' SD ' ' HB2' ' A' ' 2' ' ' ALA . 2.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER 61.94 131.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -90.07 10.57 23.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -146.44 50.19 1.15 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 52' ' ' GLY . 22.4 tp -78.74 131.9 36.75 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.05 118.5 19.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 0.0 113.18 -175.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 45.3 m-85 -110.29 143.91 39.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.204 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 46' ' ' LEU . 41.3 tp -114.04 107.74 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.569 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.16 101.51 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.9 t -96.9 120.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.367 -0.833 . . . . 0.0 110.619 -178.75 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CE2' ' A' ' 14' ' ' PHE . 4.6 t0 -176.44 -178.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.467 -0.771 . . . . 0.0 109.389 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -114.94 9.96 16.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.064 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' ' CB ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -69.46 164.14 23.74 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.397 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.4 p -134.09 29.84 3.69 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.144 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -154.08 -60.62 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.481 -177.184 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CE2' ' A' ' 14' ' ' PHE . 4.7 ttt -45.69 -58.13 3.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HE ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -34.08 -33.99 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.469 0.652 . . . . 0.0 109.93 178.726 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -70.19 -46.54 64.38 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.621 -178.426 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.6 mp -54.46 -58.07 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.249 -0.907 . . . . 0.0 109.269 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -55.39 -43.25 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.504 -0.747 . . . . 0.0 110.157 -179.309 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' NH1' ' HE ' ' A' ' 18' ' ' ARG . 4.6 mtt85 -46.78 -53.36 12.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -64.69 -57.12 9.86 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.807 0.813 . . . . 0.0 109.192 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -38.43 -56.03 1.31 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.42 -52.18 65.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.01 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -52.53 -39.39 61.31 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.83 -31.22 26.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.95 -62.35 1.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.275 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 159.55 74.06 0.02 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 56.0 m-85 -150.1 155.12 39.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.215 . . . . 0.0 109.57 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.18 40.28 0.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.093 -1.004 . . . . 0.0 110.294 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -157.57 108.6 2.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.655 -1.278 . . . . 0.0 109.536 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -146.35 146.96 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.315 -0.865 . . . . 0.0 110.067 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.85 -172.55 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 74.5 mt-10 -149.95 154.11 37.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.01 -1.056 . . . . 0.0 110.38 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.15 -173.97 3.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.19 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.584 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 15.6 mm-40 -117.95 -2.13 11.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.487 -0.758 . . . . 0.0 110.443 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 165.01 166.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.31 -0.869 . . . . 0.0 109.041 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -42.74 -52.82 5.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 2.9 p -58.96 -42.27 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.881 -1.364 . . . . 0.0 109.176 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.584 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 8.7 t0 -58.83 -45.98 88.73 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.17 -40.99 91.86 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -49.65 -39.62 36.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.926 -1.109 . . . . 0.0 108.624 179.405 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -88.18 -33.01 18.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.232 -0.918 . . . . 0.0 110.35 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -89.9 -55.8 3.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.104 -0.998 . . . . 0.0 109.879 -179.603 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 9' ' ' LEU . 7.2 tt -45.68 -27.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.59 12.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 108.808 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -49.7 -55.47 13.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.52 -0.738 . . . . 0.0 109.652 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.65 33.78 0.07 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.89 124.52 2.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 53' ' ' PHE . 18.2 m-85 -113.64 107.18 15.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.76 -0.847 . . . . 0.0 110.193 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.89 0.46 1.7 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -168.39 144.32 3.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.257 . . . . 0.0 109.484 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.9 t -142.23 126.94 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.854 -1.154 . . . . 0.0 109.685 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.3 mt -110.51 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.7 p -91.04 141.62 28.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.88 -1.138 . . . . 0.0 109.461 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -106.61 24.71 12.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 110.521 -179.307 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 57' ' ' ASP . 4.5 t-105 62.19 143.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.941 -1.099 . . . . 0.0 109.163 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.49 167.7 27.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 109.987 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.658 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -144.48 23.5 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 113.615 -179.932 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -59.33 -54.9 2.16 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 N-CA-C 108.598 -1.347 . . . . 0.0 108.598 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.31 -21.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 76.6 mtp -150.78 103.49 3.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.483 -0.76 . . . . 0.0 109.031 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -58.69 -175.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.081 -1.012 . . . . 0.0 110.183 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.02 -5.29 80.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.44 -50.53 67.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.795 -1.415 . . . . 0.0 107.832 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.45 -24.66 2.11 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.578 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' ILE . 3.8 tp -69.78 -57.43 5.11 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.796 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -50.08 -55.14 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.031 0.92 . . . . 0.0 109.052 178.988 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -59.79 -50.02 75.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.399 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.6 m -69.23 -14.86 63.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.847 HD13 HG21 ' A' ' 83' ' ' VAL . 1.1 mt -78.26 -29.72 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -77.24 -35.12 55.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.933 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -45.25 -27.98 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.168 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.54 78.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.942 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 43.69 -157.91 0.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.65 57.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.652 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.2 tpt -90.0 -8.81 50.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 108.907 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m 45.45 -119.19 0.79 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.548 -0.72 . . . . 0.0 109.938 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.03 60.58 0.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 47.65 -178.92 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.815 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.5 Cg_exo -62.83 142.93 90.64 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.533 2.156 . . . . 0.0 115.451 -174.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.847 HG21 HD13 ' A' ' 72' ' ' ILE . 15.2 t -137.01 104.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.31 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -91.48 104.78 17.24 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.722 178.388 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.0 ttm -77.44 119.4 20.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.704 -1.198 . . . . 0.0 108.726 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 107' ' ' VAL . 2.2 p -108.13 146.08 14.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.503 -0.748 . . . . 0.0 109.611 -178.66 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.444 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 3.0 t -150.12 -173.41 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.614 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . -129.8 -46.41 1.15 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.5 pt-20 -74.67 26.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.827 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.64 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.378 -0.826 . . . . 0.0 109.448 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ttmt -99.99 -69.12 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 109.481 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -169.94 -44.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -79.97 -24.57 40.85 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.281 -0.887 . . . . 0.0 109.796 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 4.6 t30 -87.95 -28.05 21.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.865 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.827 HD11 ' HB1' ' A' ' 90' ' ' ALA . 15.7 mt -72.67 -58.0 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 108.938 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.34 -29.39 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.362 -0.836 . . . . 0.0 109.162 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.77 -40.05 39.98 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.964 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -80.92 -62.11 1.77 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -53.39 -28.4 29.23 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.816 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -56.51 -35.39 68.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.415 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -76.9 -26.05 53.71 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 176.57 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.49 71.84 0.88 Allowed Glycine 0 N--CA 1.484 1.846 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.745 175.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.2 -111.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 117.495 -1.682 . . . . 0.0 109.391 177.629 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.58 -47.48 7.38 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.53 1.157 . . . . 0.0 108.833 177.224 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 166.7 -159.02 32.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -178.155 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -142.62 136.39 29.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.705 -0.879 . . . . 0.0 109.833 179.308 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG11 HD21 ' A' ' 116' ' ' LEU . 6.2 p -134.71 134.24 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.893 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -161.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.86 151.76 8.32 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 108.784 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.86 138.08 53.96 Favored 'Cis proline' 0 N--CA 1.486 1.035 0 C-N-CA 125.281 -0.716 . . . . 0.0 110.341 -2.034 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.822 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.3 p90 -97.89 160.21 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.376 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.78 146.95 23.25 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.831 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.01 -34.73 13.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 108.442 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.47 -35.38 80.75 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.8 m -70.44 -70.57 0.29 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -51.67 -28.34 14.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.429 -1.419 . . . . 0.0 109.841 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 10.2 tt0 -62.22 -62.66 1.61 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.463 -1.398 . . . . 0.0 108.997 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.32 -44.45 16.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -62.04 -31.43 71.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 tt -81.63 -53.5 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -33.96 74.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.701 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -70.78 -44.0 67.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.46 -36.65 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 109.264 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -73.79 -29.85 62.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -51.67 -29.88 19.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -86.37 -30.7 21.96 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 tp -79.91 -10.05 59.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 0.0 108.846 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.69 41.19 12.71 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.317 -1.108 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -45.75 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -69.03 26.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 109.942 -179.934 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 3' ' ' ASP . 30.6 mt-10 -134.62 35.71 3.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.918 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.85 136.16 34.23 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.2 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -83.94 129.91 34.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.91 -1.118 . . . . 0.0 111.237 -177.382 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.56 157.69 21.73 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.445 0.64 . . . . 0.0 109.767 179.768 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.043 HD23 HD12 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -132.64 108.35 9.0 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.461 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.554 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.5 m -92.63 110.12 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -177.608 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.5 t -90.03 92.68 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.071 -1.018 . . . . 0.0 109.506 179.705 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -144.99 151.69 38.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.15 -33.38 10.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.629 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.87 132.32 11.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 109.595 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -86.29 26.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -146.32 -23.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.27 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.4 ttt -65.67 -46.74 77.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -55.86 -30.97 62.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.645 ' NH2' HH12 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -70.02 -24.66 63.31 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.309 -177.777 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.15 -47.28 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 109.889 -179.639 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -34.43 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.22 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.645 HH12 ' NH2' ' A' ' 19' ' ' ARG . 8.6 mtp180 -47.43 -51.56 19.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.51 -58.53 3.86 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.677 0.751 . . . . 0.0 109.84 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -40.57 -46.41 2.51 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.474 -179.085 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -71.24 -41.91 69.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.124 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -61.91 -30.36 70.84 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.261 -0.9 . . . . 0.0 109.342 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.14 -23.27 62.02 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.882 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -90.78 -40.49 11.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 144.29 5.36 0.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.93 135.33 33.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.323 . . . . 0.0 109.794 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -145.76 64.24 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.102 -0.999 . . . . 0.0 109.894 -179.829 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -172.45 97.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 110.01 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.93 177.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -0.999 . . . . 0.0 110.228 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.677 ' HG3' HD13 ' A' ' 9' ' ' LEU . 13.5 pt-20 -134.91 -166.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.937 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 3.8 tt0 -147.39 155.03 41.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 110.905 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -148.37 -166.87 2.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -136.35 -7.94 1.99 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.387 -0.82 . . . . 0.0 110.211 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -178.12 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.052 . . . . 0.0 109.243 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 64' ' ' ASP . . . -64.12 -52.16 46.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -51.05 -35.28 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.916 -1.343 . . . . 0.0 107.812 179.198 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 20.8 t0 -68.23 -50.57 53.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.059 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.02 -18.95 65.68 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.279 -0.888 . . . . 0.0 108.708 179.44 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.652 ' CD2' HE22 ' A' ' 47' ' ' GLN . 0.7 OUTLIER -77.41 -27.59 52.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.149 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -90.64 -33.35 15.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.316 -179.725 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -58.7 2.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.009 -1.057 . . . . 0.0 110.076 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 HD23 ' A' ' 9' ' ' LEU . 2.1 tt -51.88 -22.41 3.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.652 HE22 ' CD2' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -51.84 -29.39 19.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 108.799 179.158 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.92 -59.31 2.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.42 112.18 3.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.39 -30.11 0.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.4 m-85 -64.21 85.29 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.296 -1.12 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.0 9.62 2.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -159.54 153.02 22.51 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.391 -1.064 . . . . 0.0 109.883 -179.355 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.3 t -146.07 142.93 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.918 -1.114 . . . . 0.0 109.687 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 55' ' ' ILE . 12.8 mt -126.4 104.14 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 p -114.7 150.54 35.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.383 -0.823 . . . . 0.0 110.272 -178.872 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.24 -85.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 109.236 179.522 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.528 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 59.6 t-105 -165.76 169.11 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.278 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.476 ' OD1' ' CD1' ' A' ' 58' ' ' TRP . 31.0 p-10 -76.33 44.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtp -71.17 -46.74 14.27 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.401 -0.812 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.47 -50.6 1.81 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.12 1.213 . . . . 0.0 110.299 -179.343 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -164.03 154.21 14.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -46.09 125.17 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.827 . . . . 0.0 109.342 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER 177.01 -61.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.027 -1.045 . . . . 0.0 109.902 -179.952 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -38.26 -40.13 0.84 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -55.62 6.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.332 . . . . 0.0 109.003 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -10.01 15.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 108.76 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -73.95 -59.94 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.567 0.698 . . . . 0.0 109.126 179.621 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.837 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -76.68 -31.82 57.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.569 -0.707 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -67.35 -47.48 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.122 179.302 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.7 m -64.52 -41.45 96.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 108.973 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 46.4 mt -60.42 -26.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.845 . . . . 0.0 109.071 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -89.31 -25.49 21.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.749 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.27 69.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 109.362 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -78.36 93.03 4.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 109.477 179.98 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.13 -24.09 54.03 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.52 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -1.18 . . . . 0.0 109.59 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.3 mtt -149.14 21.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 75' ' ' ASP . 88.5 p -75.17 65.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.976 . . . . 0.0 109.397 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -149.98 -28.71 0.24 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -43.84 107.55 0.6 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 109.676 -179.362 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.6 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.469 1.446 . . . . 0.0 113.293 -178.909 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -110.72 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 176.587 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.89 105.11 17.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.279 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.67 118.48 22.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.084 -177.933 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -104.1 150.89 6.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.521 -0.737 . . . . 0.0 109.764 -178.532 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -150.01 165.99 31.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.98 -1.075 . . . . 0.0 110.046 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -90.55 -97.38 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 89' ' ' GLU . 9.2 mp0 -59.78 81.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.086 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -70.21 70.48 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.501 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.257 -0.902 . . . . 0.0 108.72 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER 179.53 -59.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.465 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' ' CG ' ' A' ' 92' ' ' LYS . 15.5 mt-10 -55.07 -34.78 63.9 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.27 -0.894 . . . . 0.0 109.655 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -79.11 -11.55 59.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.723 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 35.0 mm -85.1 -67.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.131 -0.98 . . . . 0.0 109.067 179.814 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.5 mp -48.09 -21.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' ILE . . . -57.37 -63.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.138 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -49.94 -58.81 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.567 179.166 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.44 -24.65 46.9 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.48 -178.939 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.9 tt0 -51.59 -31.79 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.75 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.65 -23.31 20.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.557 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.02 75.86 0.5 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.461 177.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.837 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.06 -112.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 117.009 -1.876 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -49.38 6.3 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 122.921 1.343 . . . . 0.0 108.042 175.554 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.94 -163.0 36.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.384 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.69 139.28 41.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.623 -0.927 . . . . 0.0 109.158 178.579 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.498 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.7 p -133.87 150.64 31.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.433 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 57.5 t -90.95 160.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.069 -1.02 . . . . 0.0 109.558 -179.528 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.463 ' N ' HG12 ' A' ' 108' ' ' VAL . 11.9 pttt -129.01 156.06 78.73 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.193 -0.942 . . . . 0.0 108.755 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.72 123.78 9.34 Favored 'Cis proline' 0 N--CA 1.486 1.084 0 O-C-N 122.618 0.799 . . . . 0.0 110.625 -2.515 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -89.9 165.84 13.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.031 . . . . 0.0 109.215 179.132 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -99.8 167.05 10.78 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.041 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.92 88.8 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.954 -179.47 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.57 66.29 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.45 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 112' ' ' THR . 5.4 m -78.41 -69.88 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.623 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.642 HD13 ' CE2' ' A' ' 111' ' ' PHE . 9.1 tp -46.61 -36.0 6.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.726 -1.234 . . . . 0.0 109.213 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -63.14 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.109 -0.994 . . . . 0.0 110.822 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -45.8 -29.85 1.47 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.158 -0.964 . . . . 0.0 110.153 -178.89 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -85.25 -32.88 22.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 0.0 108.891 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.81 -52.0 49.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.441 -0.787 . . . . 0.0 109.469 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -53.26 -61.09 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 109.707 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -52.77 -27.96 20.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 110.133 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 mt -76.92 -43.73 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 0.0 109.974 -179.55 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 128' ' ' GLY . 12.0 m-85 -66.77 -5.9 13.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.833 -179.269 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.42 -24.64 62.95 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.057 -1.027 . . . . 0.0 108.249 178.924 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.08 -24.72 16.75 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.153 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.76 -14.14 25.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.53 -0.732 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' PHE . . . 46.2 86.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.221 0.534 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -46.62 146.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.499 179.889 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -90.37 14.82 11.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 109.943 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.12 45.39 0.44 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.761 -1.212 . . . . 0.0 110.941 -178.815 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 46.5 tp -71.96 111.93 7.62 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.792 -1.193 . . . . 0.0 107.817 179.053 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -48.13 118.77 2.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.719 -177.883 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 38.2 m-85 -109.83 155.44 21.65 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.75 0.786 . . . . 0.0 110.487 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG12 ' A' ' 54' ' ' VAL . 7.6 tp -135.86 102.63 5.12 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.832 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 21' ' ' VAL . 16.7 m -89.99 103.84 14.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.5 t -97.96 110.35 25.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.424 -0.798 . . . . 0.0 109.354 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -169.72 159.08 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.85 -179.741 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 14' ' ' PHE . 13.1 t0 -97.45 -100.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.536 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 45.2 -163.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -0.859 . . . . 0.0 109.752 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.1 12.34 2.41 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.748 . . . . 0.0 109.238 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.1 ttt -67.43 -66.26 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.798 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.657 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.62 -35.67 4.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 109.84 -179.842 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -70.66 -41.2 72.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.52 -52.96 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -63.0 -45.34 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.091 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -46.27 -53.76 10.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.974 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.87 -57.23 8.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.857 0.836 . . . . 0.0 109.304 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -40.08 -59.77 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 -179.792 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.39 -48.05 68.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.784 . . . . 0.0 109.431 179.693 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.32 -42.91 78.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 -179.797 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.48 -29.95 59.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.273 -0.892 . . . . 0.0 109.239 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.72 -62.97 1.41 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.69 35.07 0.02 OUTLIER Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.535 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 47.3 m-85 -115.66 139.09 50.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.751 -0.852 . . . . 0.0 109.733 -179.589 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.3 63.88 1.54 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.469 -0.769 . . . . 0.0 109.69 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -176.8 95.57 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.967 -1.083 . . . . 0.0 108.551 179.796 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.11 147.09 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.693 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -118.83 -164.87 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.351 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -150.15 159.19 44.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.791 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.87 -170.87 3.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -121.73 -10.1 8.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 111.004 -178.985 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.51 171.81 2.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.565 -1.334 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.45 91.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.622 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 41' ' ' ASP . 9.4 p -57.32 -39.3 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.953 -1.322 . . . . 0.0 108.926 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.8 t70 -63.74 -51.11 66.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.253 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -51.89 -48.96 63.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.29 -44.48 16.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 109.706 179.602 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -79.64 -29.62 41.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.296 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -89.77 -10.33 45.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.085 -1.009 . . . . 0.0 110.371 -179.29 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.659 HD21 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.08 -6.37 38.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.058 . . . . 0.0 108.726 -179.992 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 47' ' ' GLN . 29.6 tp60 -95.14 -13.14 25.32 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.96 -66.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.472 -0.768 . . . . 0.0 109.459 179.879 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.97 7.14 1.87 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.96 84.33 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 82.1 m-85 -63.54 138.94 58.7 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -1.051 . . . . 0.0 110.4 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.45 -4.03 86.19 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 4.0 t80 -169.35 94.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.89 -1.359 . . . . 0.0 110.35 -178.618 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 HD21 ' A' ' 46' ' ' LEU . 30.2 m -94.86 141.9 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.129 -1.607 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.89 96.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -111.13 177.6 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.555 -0.716 . . . . 0.0 110.297 -179.476 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 11' ' ' VAL . 4.8 m-20 -89.8 -121.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.466 -0.771 . . . . 0.0 110.179 -179.2 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 61.3 t-105 -127.56 -173.64 2.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 1.2 p-10 -93.87 55.74 2.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 -179.762 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -75.87 -45.6 3.97 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.991 -1.068 . . . . 0.0 110.406 179.702 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -67.73 -44.77 3.89 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.208 1.272 . . . . 0.0 110.211 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.74 159.79 19.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 119.16 7.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -175.96 -63.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.978 179.901 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -34.22 -50.11 0.67 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.397 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.415 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -68.49 -60.55 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.768 -1.431 . . . . 0.0 108.81 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.75 -13.06 0.9 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 108.561 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -72.45 -55.08 7.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.375 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.862 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.96 -37.46 87.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -64.24 -55.03 24.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 108.851 179.44 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -54.18 -44.24 71.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.331 -0.856 . . . . 0.0 108.731 179.427 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.94 -19.19 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.309 -0.869 . . . . 0.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -36.33 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 109.227 179.723 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.88 72.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.774 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' SER . 15.4 t70 -47.68 145.43 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.42 -34.05 4.61 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.42 -27.0 45.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.71 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.7 mmt -137.18 -55.83 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 46.78 24.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.06 3.59 0.53 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.885 -179.514 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 51' ' ' TYR . 11.6 mt -54.52 115.26 8.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 108.292 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 2.7 Cg_endo -60.46 134.6 55.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 121.182 1.255 . . . . 0.0 113.715 -177.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -128.62 112.97 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.778 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.1 tp -97.85 96.52 8.26 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.447 179.245 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.3 144.14 54.44 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.713 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 107' ' ' VAL . 44.4 t -133.81 145.15 33.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.559 0.695 . . . . 0.0 110.707 -177.724 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -150.08 165.04 33.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.087 179.441 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.46 38.11 3.35 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.598 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' ALA . 1.7 mt-10 -165.75 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.407 -0.808 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 1.033 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 45.18 84.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.869 0.842 . . . . 0.0 108.754 -179.435 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -75.41 16.66 0.33 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.963 . . . . 0.0 109.805 -178.924 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.627 ' HA ' HD12 ' A' ' 95' ' ' ILE . 13.4 ttmt 75.44 -45.4 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.884 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.26 -45.16 49.55 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.454 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 2.9 m-80 -74.06 -4.76 37.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.0 109.337 179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.033 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.9 mt -80.26 -57.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 108.521 179.381 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 96' ' ' ILE . 79.5 mt -68.8 2.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.271 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -80.67 -47.52 13.92 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.508 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -70.68 -50.7 33.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.534 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.65 -25.79 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.289 -179.642 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -52.99 -33.04 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.593 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.862 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.53 -23.27 25.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.24 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 75.61 0.51 Allowed Glycine 0 N--CA 1.48 1.572 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.544 177.771 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -112.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.877 -1.929 . . . . 0.0 109.596 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 67.3 m -91.88 -49.02 6.46 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.7 1.238 . . . . 0.0 108.06 175.531 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 167.31 -159.68 33.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.525 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 137.61 26.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.568 -0.96 . . . . 0.0 109.055 178.914 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.478 HG12 HG22 ' A' ' 86' ' ' VAL . 12.4 p -131.76 134.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.94 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.2 p -89.14 96.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.585 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.419 ' CD ' ' C ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -61.04 155.7 53.2 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 0.0 108.557 179.812 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.38 154.44 99.65 Favored 'Cis proline' 0 N--CA 1.487 1.094 0 C-N-CA 125.335 -0.694 . . . . 0.0 111.313 -1.354 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -135.33 156.54 48.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.693 0.758 . . . . 0.0 108.998 178.422 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.29 150.0 21.5 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.95 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.82 -35.0 21.33 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.735 -1.228 . . . . 0.0 108.985 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.98 65.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.944 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 17.5 m -75.99 -65.23 0.94 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.921 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -49.73 -36.93 27.32 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.23 -1.388 . . . . 0.0 108.313 179.086 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 -53.21 39.16 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.002 -1.062 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -46.55 -25.02 0.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.516 -0.74 . . . . 0.0 109.05 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -88.51 -49.97 6.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 mt -48.49 -59.02 3.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.02 -61.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.34 -0.85 . . . . 0.0 110.237 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -45.4 -29.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 110.1 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 125' ' ' GLU . 4.6 mt -87.88 -44.01 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.217 -179.614 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -62.0 5.27 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.969 . . . . 0.0 110.579 -178.916 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.8 tt0 -77.91 -36.47 49.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -81.15 -35.56 31.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.33 -32.85 70.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.021 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.61 75.28 0.9 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.234 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.313 -1.11 . . . . 0.0 109.428 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -45.87 143.36 2.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 23.8 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.96 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.28 42.92 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 52' ' ' GLY . 51.3 tp -67.63 143.22 56.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.233 -0.917 . . . . 0.0 108.577 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -79.76 120.35 23.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.117 -0.989 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -109.05 152.79 24.55 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.672 -0.642 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.611 ' HB3' HG23 ' A' ' 54' ' ' VAL . 9.3 tp -130.43 110.76 11.72 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.342 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.12 104.38 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 36' ' ' ALA . 94.8 t -89.81 100.73 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 120.937 -1.102 . . . . 0.0 109.66 -179.723 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -163.58 1.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.775 . . . . 0.0 109.227 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.29 1.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.988 -179.886 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.63 153.3 28.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.051 -1.031 . . . . 0.0 109.376 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.1 p -93.63 41.11 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.712 -179.714 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -173.9 -21.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.8 ttt -62.41 -46.42 88.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -45.58 78.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -55.37 -34.24 64.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 110.701 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -63.86 -48.51 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.158 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.21 -36.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.993 . . . . 0.0 110.575 -178.964 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -50.7 -53.11 33.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.73 -56.65 10.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.672 0.749 . . . . 0.0 109.471 179.915 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.94 -57.67 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.954 -179.669 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.81 -51.87 65.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.213 179.382 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -53.82 -35.08 61.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -55.49 -28.92 57.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.228 -0.92 . . . . 0.0 109.552 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 mt -87.82 -62.56 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.71 65.5 0.03 OUTLIER Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -150.01 145.31 26.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.251 . . . . 0.0 109.574 -179.82 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -150.02 66.63 0.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -173.91 99.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.15 150.94 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.05 -167.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.233 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.14 152.55 34.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 110.536 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.959 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.41 168.12 20.87 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.069 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.08 9.26 9.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.56 -0.712 . . . . 0.0 109.911 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.6 p-10 178.05 -176.23 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.69 -39.24 49.11 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.7 -35.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.05 -1.265 . . . . 0.0 108.025 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.656 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.2 t0 -82.69 -47.49 11.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.59 -0.694 . . . . 0.0 109.316 179.503 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -55.05 30.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -59.09 6.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.08 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -53.02 -33.43 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.028 -179.465 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -88.76 -13.24 39.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -82.17 -29.57 31.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.716 -1.24 . . . . 0.0 109.178 -179.976 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -8.41 0.31 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.174 -0.954 . . . . 0.0 108.653 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.8 -69.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.602 -0.686 . . . . 0.0 109.795 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.98 15.26 0.51 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.352 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 93.6 0.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.866 ' O ' HD21 ' A' ' 81' ' ' LEU . 29.4 m-85 -72.11 104.91 3.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -1.083 . . . . 0.0 110.491 -178.899 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.23 -11.07 6.06 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.159 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.98 137.02 17.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.245 -1.15 . . . . 0.0 110.069 -178.93 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 83' ' ' VAL . 10.3 p -144.5 133.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.715 -1.241 . . . . 0.0 109.52 178.643 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 84' ' ' LEU . 8.8 mt -113.94 157.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.196 0.522 . . . . 0.0 109.775 -178.362 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.2 p -144.93 168.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 108.942 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -93.31 -21.63 19.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.923 . . . . 0.0 110.584 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.549 ' CH2' ' HB2' ' A' ' 98' ' ' ALA . 37.5 t-105 59.65 35.36 22.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.206 -0.933 . . . . 0.0 109.911 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -177.85 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.908 -1.12 . . . . 0.0 109.882 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 175.63 -50.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.148 -0.97 . . . . 0.0 110.732 179.573 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.8 Cg_endo -64.71 123.46 11.72 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 120.95 1.1 . . . . 0.0 110.455 -179.425 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 8.2 p30 41.82 -146.56 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.664 -0.647 . . . . 0.0 109.889 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 7.3 mtp -47.32 -65.2 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 108.811 179.753 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.47 -39.41 0.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 108.914 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.7 -3.57 2.34 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 69' ' ' LEU . 10.7 tp -71.64 -61.68 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.032 -1.275 . . . . 0.0 107.611 178.93 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LEU . 29.5 tt0 -47.17 -27.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.726 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.41 -36.5 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.0 109.246 179.818 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -90.03 -36.04 15.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.808 -178.997 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -59.32 -50.58 73.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.967 -1.083 . . . . 0.0 109.405 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -48.89 -44.91 40.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.262 -0.898 . . . . 0.0 109.407 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 69' ' ' LEU . 33.7 mt -57.51 -38.16 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.29 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -65.82 -53.98 32.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.57 -45.45 18.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.5 130.97 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.677 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.47 40.87 2.97 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.99 -15.75 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 0.0 109.335 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.8 31.64 2.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.086 179.986 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 m -71.08 23.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -150.04 12.11 0.75 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.009 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' O ' ' A' ' 51' ' ' TYR . 8.2 tp -67.57 118.11 53.93 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 108.736 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.46 129.42 31.12 Favored 'Trans proline' 0 N--CA 1.479 0.648 0 C-N-CA 121.049 1.166 . . . . 0.0 112.366 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.643 HG22 HG13 ' A' ' 54' ' ' VAL . 3.0 t -118.52 114.97 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.254 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.4 tp -95.64 75.27 3.23 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.192 -1.403 . . . . 0.0 108.789 178.221 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.448 ' SD ' HG22 ' A' ' 87' ' ' THR . 9.6 tmm? -57.74 153.57 13.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.509 -0.744 . . . . 0.0 109.192 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.46 125.12 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.871 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 90' ' ' ALA . 4.9 t -150.22 125.81 10.28 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.477 -179.751 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -79.39 -27.52 41.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 0.0 109.015 179.344 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.75 39.86 1.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.434 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.791 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.44 106.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' CG ' ' H ' ' A' ' 92' ' ' LYS . 23.0 tptt -97.04 -144.73 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.572 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' ASN . 7.0 mtmp? -104.11 -80.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -45.18 -16.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.0 110.003 -179.546 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -82.0 -36.66 27.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.791 HD11 ' HB1' ' A' ' 90' ' ' ALA . 39.6 mt -89.97 -9.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.75 -179.782 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -89.76 -68.24 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.92 -1.113 . . . . 0.0 110.002 -179.645 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.33 -49.87 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.431 -179.588 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.52 -46.42 86.79 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.212 179.432 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.04 -50.43 27.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.085 -1.009 . . . . 0.0 109.941 -179.345 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -55.12 -24.42 25.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.592 -179.81 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.45 -104.91 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -141.58 7.59 2.51 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.488 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.22 11.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.014 -0.698 . . . . 0.0 110.6 178.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.672 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.27 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.799 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.03 125.72 8.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.98 110.7 5.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 179.817 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.2 p -107.68 134.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.072 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -89.6 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.049 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -53.84 160.92 1.9 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.108 -0.995 . . . . 0.0 109.775 -179.31 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.92 163.01 91.12 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.702 -2.491 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 12.1 p90 -146.02 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.088 0.947 . . . . 0.0 110.443 178.679 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.82 154.36 18.99 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.875 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.65 -11.98 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.629 -1.294 . . . . 0.0 109.361 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.33 -39.44 25.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.139 -0.975 . . . . 0.0 108.665 178.971 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -58.64 3.19 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.806 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 5.0 tp -50.56 -37.43 39.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 108.76 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.45 -52.84 62.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.101 -0.999 . . . . 0.0 109.654 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.29 -60.12 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 109.673 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 5.4 mptt -47.4 -41.36 19.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.84 -63.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -29.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.675 -179.727 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -34.26 67.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.493 HD11 ' CA ' ' A' ' 105' ' ' GLY . 41.4 mt -73.49 -40.65 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.589 -179.361 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -71.18 0.67 7.27 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.924 -1.11 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.7 -35.6 62.72 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.705 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -89.61 -22.03 22.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -84.25 -31.0 25.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.488 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.54 86.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.144 -1.21 . . . . 0.0 109.448 -179.916 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.451 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 40.8 m-20 -45.82 134.51 7.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -90.12 15.63 9.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.968 -1.083 . . . . 0.0 109.926 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.9 42.76 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 -179.142 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.01 147.32 30.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' TYR . 7.5 mtmm -94.5 134.52 36.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.515 -1.366 . . . . 0.0 110.656 -177.811 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -115.25 150.9 35.45 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.884 -0.51 . . . . 0.0 110.076 -179.678 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.676 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.1 tp -123.23 106.15 10.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.808 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -89.89 119.37 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.143 -178.664 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' A' ' 36' ' ' ALA . 21.7 t -124.27 57.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 O-C-N 121.698 -0.626 . . . . 0.0 109.571 -179.739 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -96.88 145.45 25.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 109.329 179.973 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 14' ' ' PHE . 7.9 p30 -71.93 -29.91 64.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.209 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.514 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -50.61 120.27 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.336 179.907 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.5 45.33 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.973 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -172.9 -27.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.9 ttt -60.06 -35.05 74.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -53.6 -34.37 58.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.51 -33.81 62.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.98 -51.12 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.498 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -33.52 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mtp85 -46.73 -53.94 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.3 t30 -64.53 -55.93 17.36 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.938 0.875 . . . . 0.0 109.089 179.745 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -38.37 -56.5 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.972 -179.737 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.94 -52.34 64.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.092 -1.005 . . . . 0.0 109.068 179.383 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -51.4 -36.58 44.13 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.132 179.79 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.16 -44.28 32.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.412 -0.805 . . . . 0.0 109.472 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -72.6 -62.32 1.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.45 54.46 0.01 OUTLIER Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 95.0 m-85 -129.11 149.91 50.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.608 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -150.08 65.78 0.97 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.059 -1.026 . . . . 0.0 110.411 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -175.31 100.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.035 . . . . 0.0 109.31 179.679 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.25 151.38 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.976 -1.077 . . . . 0.0 110.591 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.19 -165.85 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.648 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -147.71 158.35 43.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.047 -1.033 . . . . 0.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.858 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.05 -168.85 3.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.45 5.79 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.108 -0.995 . . . . 0.0 110.778 -179.483 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 177.22 177.2 0.33 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.758 -1.214 . . . . 0.0 109.644 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.46 -27.72 73.57 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.785 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.27 -40.25 80.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -1.176 . . . . 0.0 108.754 179.314 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t70 -79.48 -37.91 35.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.411 -0.805 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.31 62.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.493 -0.754 . . . . 0.0 109.021 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.79 -43.18 72.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.179 -0.951 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -69.62 -27.44 65.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 47' ' ' GLN . 13.4 mttm -87.54 -39.14 15.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.368 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -45.87 -16.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 179.803 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' LYS . 33.5 mt-30 -91.81 22.4 4.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.312 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . -66.68 -65.23 0.71 Allowed 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.429 -0.794 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.6 23.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.4 179.76 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 83.96 1.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 7' ' ' LYS . 10.2 m-85 -63.98 -41.07 97.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.54 -0.977 . . . . 0.0 110.586 -178.347 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.5 -25.34 7.33 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 143.68 21.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.539 -0.977 . . . . 0.0 110.106 -179.745 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.746 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.2 t -140.03 124.98 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.093 -1.005 . . . . 0.0 109.806 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.67 105.91 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 15.3 p -126.31 144.75 50.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.056 -1.028 . . . . 0.0 110.708 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -64.94 -117.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' NE1' ' CG ' ' A' ' 94' ' ' ASN . 61.6 t-105 -173.81 134.73 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.728 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 62.39 129.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.5 mmm 177.8 -50.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 110.088 179.405 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.16 -69.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.758 0.972 . . . . 0.0 109.701 179.643 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.34 -34.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.09 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.6 mtt -102.03 -89.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.673 . . . . 0.0 109.398 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -172.31 175.55 3.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.44 179.95 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.71 26.21 1.13 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 84.0 mt -82.06 -56.65 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -1.202 . . . . 0.0 108.87 179.611 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.67 -19.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.017 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 ' HA2' ' A' ' 39' ' ' GLY . 3.2 mt -76.93 -70.65 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.875 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.045 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -45.91 -65.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.206 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -43.78 -47.77 8.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.626 -0.671 . . . . 0.0 109.827 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.1 m -67.74 -26.65 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 69' ' ' LEU . 44.3 mt -77.09 -14.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -84.43 -27.39 27.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.73 12.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.52 -179.917 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -50.64 116.73 2.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.994 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.64 -31.36 40.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.65 -63.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.99 -47.15 7.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 48.22 13.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -0.843 . . . . 0.0 109.349 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.64 18.82 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 0.0 109.626 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 tp -44.97 113.42 1.79 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.055 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 5.1 Cg_exo -59.01 133.49 53.76 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.124 1.216 . . . . 0.0 113.07 -178.918 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.746 HG22 ' HB ' ' A' ' 54' ' ' VAL . 14.7 t -132.48 108.93 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.076 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.88 100.86 13.59 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 117.064 -1.854 . . . . 0.0 107.538 178.839 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 6.7 tpp -68.69 128.53 36.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.597 0.713 . . . . 0.0 109.385 -178.305 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -99.16 140.28 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.634 -0.666 . . . . 0.0 109.366 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.04 129.2 12.75 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.046 -179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -66.05 96.77 0.33 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.388 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.819 ' H ' HG23 ' A' ' 108' ' ' VAL . 5.0 tt0 74.47 114.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.486 -0.758 . . . . 0.0 109.202 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 106' ' ' TYR . . . -45.09 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.354 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -69.78 11.78 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 109.425 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.8 mtpp 58.96 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.82 . . . . 0.0 109.8 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 66.9 mt-10 -45.34 -46.92 13.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.978 . . . . 0.0 110.164 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.447 ' CG ' ' NE1' ' A' ' 58' ' ' TRP . 21.1 m-20 -69.34 -73.04 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.464 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -44.49 -52.51 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 109.088 -179.47 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.634 HG22 ' OE1' ' A' ' 100' ' ' GLN . 92.3 mt -56.68 -32.0 36.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.652 -1.28 . . . . 0.0 109.464 -179.902 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -71.66 -45.61 61.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.044 -1.035 . . . . 0.0 108.959 179.626 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.19 72.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 109.008 179.182 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.51 -31.27 71.26 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.619 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.634 ' OE1' HG22 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -53.32 -33.38 53.21 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.363 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.744 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -85.26 -22.51 28.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.363 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.39 80.52 0.12 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.958 177.237 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.3 -112.44 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.243 -1.783 . . . . 0.0 109.825 179.225 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 43.6 m -92.04 -52.46 4.7 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 123.21 1.481 . . . . 0.0 108.178 175.407 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.18 -162.13 32.48 Favored Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.253 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.49 115.79 9.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.527 -0.984 . . . . 0.0 109.576 179.549 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -107.64 136.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.334 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.819 HG23 ' H ' ' A' ' 89' ' ' GLU . 1.8 p -83.41 145.59 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 108.929 179.808 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -115.14 154.25 47.27 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.17 132.48 27.63 Favored 'Cis proline' 0 N--CA 1.488 1.152 0 O-C-N 122.623 0.802 . . . . 0.0 110.68 -2.353 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.8 p90 -102.16 157.47 16.86 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 178.76 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.13 148.36 22.42 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 176.845 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.12 -25.32 1.41 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.728 -1.233 . . . . 0.0 109.701 -178.98 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.7 65.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -72.56 -62.48 1.43 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.977 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -52.11 -37.82 55.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.428 179.687 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -65.44 -51.71 58.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.988 -1.07 . . . . 0.0 109.624 -179.755 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 20.4 tp10 -48.04 -48.33 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.855 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.67 -42.0 98.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.1 -60.13 4.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.552 -0.717 . . . . 0.0 109.92 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -32.07 57.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.057 -1.027 . . . . 0.0 110.263 -179.457 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -78.97 -23.5 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.4 mt -89.97 -39.07 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 110.271 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 127' ' ' LEU . 20.5 m-85 -74.16 -39.42 63.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.095 -1.003 . . . . 0.0 109.835 -179.248 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -50.76 -19.89 1.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.92 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' PHE . 24.6 mmtt -95.83 -27.25 15.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.508 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 124' ' ' PHE . 17.6 tp -75.58 -21.3 57.97 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.21 71.62 1.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.396 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.6 t70 -47.89 125.09 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.033 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -71.94 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 109.663 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 3' ' ' ASP . 1.9 tp10 -159.54 32.69 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.122 -0.986 . . . . 0.0 109.955 -179.939 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD11 ' HA3' ' A' ' 52' ' ' GLY . 53.6 tp -69.85 135.27 49.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.018 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -81.43 128.1 33.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 -177.235 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 33' ' ' VAL . 24.1 m-85 -112.38 153.13 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 179.465 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -126.52 106.67 9.61 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.792 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.81 113.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.0 t -113.73 83.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 121.74 -0.6 . . . . 0.0 109.545 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.85 -154.18 0.55 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.345 0.593 . . . . 0.0 109.458 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -146.49 4.47 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.222 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 16' ' ' THR . 6.2 m-85 -95.26 122.74 38.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.78 33.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -151.74 -41.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.1 ttt -54.53 -43.35 71.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -40.17 68.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -68.59 -26.85 65.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 110.171 -178.507 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.97 -50.3 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.066 -1.021 . . . . 0.0 109.378 -179.847 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -39.39 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 -179.448 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -54.27 10.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.925 . . . . 0.0 109.591 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -56.78 12.78 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -54.44 1.96 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.353 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -59.63 -24.0 63.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.252 -0.905 . . . . 0.0 109.626 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -13.4 61.1 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.088 -1.007 . . . . 0.0 109.463 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mt -95.35 -38.71 10.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.764 -179.81 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.09 4.84 0.78 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.899 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 97.0 m-85 -89.89 148.79 22.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.803 -1.41 . . . . 0.0 109.489 -179.554 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -150.07 63.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 -179.678 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.33 96.02 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.118 -0.989 . . . . 0.0 109.237 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 8' ' ' PHE . 58.3 t -140.27 153.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.051 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.98 -172.37 2.52 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.1 154.04 37.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 111.164 -178.752 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.822 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.19 -173.57 3.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.789 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -120.83 -2.41 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.196 -0.94 . . . . 0.0 110.548 -179.481 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 172.0 179.48 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.968 -1.082 . . . . 0.0 109.923 179.643 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -42.08 96.19 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.359 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.3 p -59.46 -38.95 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.277 . . . . 0.0 109.23 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 46.0 t0 -71.21 -51.82 22.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.898 . . . . 0.0 108.941 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -50.05 -60.18 3.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.8 tp -45.23 -37.81 4.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.296 179.308 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 1.8 m-20 -70.77 -43.62 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 110.344 -179.578 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -90.11 -3.71 57.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.154 -0.966 . . . . 0.0 110.713 -179.194 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -73.93 -31.67 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 108.724 179.976 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -53.84 -20.41 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.108 179.859 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.9 -63.48 0.96 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.98 109.79 2.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.235 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . 147.41 -24.4 1.54 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 55.6 m-85 -64.81 78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.141 -1.211 . . . . 0.0 109.997 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.729 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -61.48 -3.31 3.97 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.493 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -148.03 130.41 15.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.569 -0.959 . . . . 0.0 108.777 -179.469 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 83' ' ' VAL . 75.4 t -127.06 126.91 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.738 -1.226 . . . . 0.0 109.057 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.16 125.06 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.726 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 57' ' ' ASP . 60.0 p -142.51 142.55 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.0 m-20 -61.65 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.0 109.669 -179.715 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -169.51 134.2 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.94 . . . . 0.0 108.887 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' H ' ' HA ' ' A' ' 64' ' ' ASP . 8.3 t-20 52.92 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 108.864 -179.345 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 171.9 -46.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.65 -64.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.677 0.918 . . . . 0.0 110.098 -179.634 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' MET . 10.7 p30 -126.3 -39.47 2.05 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 25.6 ttt -172.62 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 59' ' ' ASN . 0.4 OUTLIER 171.63 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -49.79 -11.09 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.738 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' ASP . 5.7 mt -50.45 -35.06 27.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.641 -1.506 . . . . 0.0 107.719 179.197 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.23 -29.7 60.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.075 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 64.5 tp -74.1 -69.03 0.47 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.704 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -42.17 -67.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.364 0.602 . . . . 0.0 109.826 178.684 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -42.26 -51.76 4.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.585 -0.697 . . . . 0.0 110.262 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.4 m -49.3 -36.58 21.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.135 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.838 HG21 ' HB2' ' A' ' 80' ' ' ALA . 52.0 mt -64.22 -45.8 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.1 -1.0 . . . . 0.0 108.83 179.593 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -39.45 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.507 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.3 -28.57 59.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.5 111.28 2.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.07 -124.52 7.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.81 40.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -1.093 . . . . 0.0 109.617 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.15 -2.63 2.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.578 -0.701 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t 47.04 -134.94 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.672 179.827 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.838 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -126.38 40.29 3.76 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.717 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.729 HD12 ' HA2' ' A' ' 52' ' ' GLY . 3.0 mt 47.37 -163.58 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.492 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.564 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 6.2 Cg_exo -57.3 155.79 28.33 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 121.2 1.464 . . . . 0.0 114.876 -176.364 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.0 t -138.21 135.62 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.375 178.544 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 116' ' ' LEU . 53.7 tp -115.1 72.46 0.79 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.185 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -58.96 160.08 6.36 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.264 -179.346 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -127.89 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.789 -0.569 . . . . 0.0 110.227 -177.956 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -150.03 -176.35 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 109.79 -179.877 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.89 52.35 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.74 53.42 12.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -48.79 140.76 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -92.84 -87.65 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.046 179.508 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER 179.8 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.391 179.634 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.93 -6.89 0.26 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 92' ' ' LYS . 26.9 m-80 -90.06 -22.61 21.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.0 mm -89.99 -5.43 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.923 -179.582 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.76 -66.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.42 -41.11 13.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 109.031 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 103' ' ' ALA . . . -58.42 -56.72 18.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.732 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.77 -44.84 63.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.95 -26.51 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.756 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.52 -115.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.498 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.658 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.21 -11.71 4.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 179.099 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.02 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.887 -0.772 . . . . 0.0 110.626 178.718 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.6 m -29.75 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.914 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -101.42 125.91 8.72 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.295 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.41 124.14 16.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.057 . . . . 0.0 108.885 178.661 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.4 p -123.67 123.83 68.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.433 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 108' ' ' VAL . 13.6 p -76.43 102.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -64.42 161.22 44.44 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.273 -179.307 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -76.07 163.56 89.78 Favored 'Cis proline' 0 N--CA 1.485 0.985 0 O-C-N 122.879 0.937 . . . . 0.0 110.578 -2.327 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -143.28 161.0 39.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.902 178.534 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -101.85 152.22 21.16 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.234 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.02 -14.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.851 -1.156 . . . . 0.0 108.86 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.69 -41.17 38.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.663 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.5 -61.97 1.57 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.606 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 84' ' ' LEU . 3.1 tp -48.57 -37.83 18.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.029 178.741 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.66 -56.34 22.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.925 -1.11 . . . . 0.0 109.659 179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -46.03 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.83 -26.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -67.91 -76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 108.925 179.68 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.08 -19.05 2.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.928 -1.107 . . . . 0.0 110.583 -179.722 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -23.36 35.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.0 109.892 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.1 mt -89.93 -40.93 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.032 -1.043 . . . . 0.0 110.018 -179.874 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 120' ' ' LEU . 23.8 m-85 -65.55 -5.57 8.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.992 -179.203 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.61 -26.53 66.3 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -90.82 -35.42 14.83 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.603 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -71.63 -24.42 61.86 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.95 89.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.444 179.718 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 43.8 t0 -45.04 141.28 2.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 109.311 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.17 13.61 14.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.944 -1.098 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -148.14 43.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.042 . . . . 0.0 110.332 -178.912 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.39 136.36 42.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.142 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.16 121.64 26.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.048 -1.032 . . . . 0.0 111.367 -177.525 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -106.71 157.59 17.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.702 -0.624 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 51' ' ' TYR . 21.5 tp -129.43 102.24 6.32 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.246 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -91.91 103.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.398 -179.082 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.938 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.6 t -96.12 113.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.276 -0.89 . . . . 0.0 109.25 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -171.7 163.92 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.504 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 2.9 m-20 -97.85 -58.36 2.01 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.968 -1.082 . . . . 0.0 108.781 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.6 ' CD2' ' N ' ' A' ' 15' ' ' SER . 22.2 p90 22.95 -145.77 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 CA-C-O 122.598 1.19 . . . . 0.0 112.831 177.398 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 179.47 -7.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.984 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' N ' ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -131.11 -34.15 1.47 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.967 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -37.34 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 111.117 -178.185 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' MET . 10.2 ptt180 -35.55 -31.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.805 -0.559 . . . . 0.0 110.473 -179.15 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.9 ttp180 -60.09 -49.66 76.77 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.877 -178.295 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -62.37 -54.51 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.716 -179.803 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.8 -18.52 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.341 -0.849 . . . . 0.0 110.84 -178.488 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -55.1 30.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.709 -1.245 . . . . 0.0 109.138 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -67.87 -53.39 27.06 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.673 0.749 . . . . 0.0 109.577 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -42.16 -56.23 2.96 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.544 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -58.95 -52.85 63.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 108.641 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -32.69 16.29 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.244 -0.91 . . . . 0.0 108.646 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -37.32 75.71 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.383 -0.823 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 117' ' ' GLU . 2.6 mp -75.63 -11.09 59.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.508 -0.745 . . . . 0.0 109.115 179.753 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.47 71.99 1.12 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 41.3 m-85 -150.0 146.19 26.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.325 . . . . 0.0 109.435 179.399 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.07 62.36 0.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.123 -0.985 . . . . 0.0 110.061 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.54 100.71 0.07 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.15 -0.968 . . . . 0.0 109.092 179.703 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.27 152.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.156 . . . . 0.0 110.179 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.48 -172.84 2.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.687 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -146.66 160.11 42.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.609 -179.276 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.938 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.08 -164.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.962 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -142.05 -5.08 1.01 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.11 -171.05 0.48 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.91 -1.118 . . . . 0.0 109.753 179.902 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.609 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -70.32 -45.01 57.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.86 -31.53 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.08 -1.247 . . . . 0.0 108.849 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.9 t0 -84.19 -51.84 6.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.448 179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.635 ' O ' HD23 ' A' ' 46' ' ' LEU . . . -54.54 -35.39 63.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.088 -1.008 . . . . 0.0 108.899 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -68.14 -56.96 6.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.3 -28.06 64.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.777 -179.743 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -90.06 -24.43 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 110.117 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -60.87 -20.05 61.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -87.23 -8.99 56.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 108.999 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.68 -72.23 0.06 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 109.757 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.67 10.1 1.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.01 87.48 0.77 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' HD22 ' A' ' 9' ' ' LEU . 54.6 m-85 -65.98 109.14 2.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.342 -1.093 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.62 -1.03 2.28 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' TYR . 6.5 t80 -165.57 148.02 7.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -1.1 . . . . 0.0 109.525 -178.809 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 9' ' ' LEU . 26.6 t -141.59 145.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.635 -1.291 . . . . 0.0 110.837 -178.769 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.24 122.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.032 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.7 p -144.72 141.45 29.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.006 -179.291 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.36 167.08 17.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.856 -1.152 . . . . 0.0 108.429 179.127 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.526 ' NE1' ' OD1' ' A' ' 64' ' ' ASP . 73.2 t-105 -69.99 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.042 -1.036 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.06 131.6 46.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.347 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.488 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -171.16 -54.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 110.583 179.825 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -62.72 -161.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 N-CA-C 109.911 -0.842 . . . . 0.0 109.911 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -67.32 -10.32 49.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.06 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.4 mmt -140.88 -100.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -125.17 146.75 49.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 109.479 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.24 -6.42 0.26 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.558 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.39 -71.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.257 . . . . 0.0 109.641 -179.592 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -45.17 -44.36 10.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.14 -179.501 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -56.27 -33.49 65.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 -179.773 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.691 HD11 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -89.08 -36.76 15.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.862 . . . . 0.0 109.333 -179.904 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -61.48 -47.51 85.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.299 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -47.76 -39.22 17.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.55 -44.35 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 108.98 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -28.29 68.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 109.71 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.13 -29.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -168.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.41 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.49 -56.03 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.101 . . . . 0.0 109.519 180.0 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.98 16.46 12.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 p -77.6 50.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.596 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 15.76 0.84 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 51' ' ' TYR . 26.6 mt -65.16 127.74 93.13 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.102 -0.999 . . . . 0.0 108.658 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.37 141.19 95.07 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.888 1.059 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 54' ' ' VAL . 4.3 t -127.34 119.75 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.849 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD21 ' CD1' ' A' ' 116' ' ' LEU . 42.1 tp -101.82 72.2 1.34 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.917 178.707 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -47.41 165.69 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.75 122.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.726 -178.36 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -150.1 174.22 13.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 109.411 179.323 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -106.74 -37.99 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.556 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 14.9 tt0 -86.0 -72.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.684 -179.891 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 64.73 95.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 90' ' ' ALA . 13.9 mtpt -63.15 -128.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.148 -0.97 . . . . 0.0 109.327 179.797 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 93' ' ' GLU . 5.5 pttm -144.81 -48.75 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.361 179.751 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -75.06 -5.9 46.59 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.194 -0.941 . . . . 0.0 109.394 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -90.04 -28.06 19.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.666 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.9 -21.8 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.57 -65.94 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.29 -46.53 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.567 -0.708 . . . . 0.0 109.38 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.467 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -59.55 -53.23 60.48 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.738 . . . . 0.0 109.52 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.79 61.54 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.205 -0.934 . . . . 0.0 109.914 -179.312 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -22.35 33.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.79 -61.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.369 -0.832 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -175.58 -10.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.08 -179.731 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -55.84 11.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.49 -1.006 . . . . 0.0 110.848 179.255 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.37 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.449 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.45 128.52 9.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.142 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.547 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -148.19 109.9 4.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.273 . . . . 0.0 109.116 179.376 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 107' ' ' VAL . 12.6 p -105.98 135.51 43.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -85.65 95.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.358 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 pttt -56.37 155.12 14.1 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.789 -1.194 . . . . 0.0 109.283 -179.225 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.9 167.63 79.79 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 125.067 -0.806 . . . . 0.0 110.517 -2.086 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -146.73 163.55 35.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.102 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -102.36 146.83 27.49 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.721 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.19 -31.5 3.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.011 -1.056 . . . . 0.0 109.191 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.07 -37.34 78.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.585 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.4 m -68.78 -67.29 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.396 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -44.15 -39.73 4.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.259 178.753 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . 57.1 tt0 -62.47 -50.55 70.98 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.196 -0.94 . . . . 0.0 109.645 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -46.29 -58.62 3.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 109.55 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HZ1' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -49.15 -38.82 26.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.303 179.928 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -39.66 85.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.83 -33.14 70.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.59 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -71.46 -25.42 62.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.705 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.05 -34.72 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -82.86 8.93 11.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -178.581 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -75.66 -25.4 56.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.14 -27.97 13.94 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.226 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -83.17 -22.49 33.24 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.97 85.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.416 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.32 -1.106 . . . . 0.0 109.431 179.792 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -44.53 149.6 0.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 109.409 179.992 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -90.55 9.14 30.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.1 -1.0 . . . . 0.0 110.112 179.812 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.2 50.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.777 -1.202 . . . . 0.0 110.574 -178.545 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 53.8 tp -78.74 111.11 14.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -48.32 118.12 2.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.94 -1.1 . . . . 0.0 111.713 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 64.5 m-85 -112.66 151.31 30.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.573 -0.705 . . . . 0.0 109.562 178.895 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB3' HG13 ' A' ' 54' ' ' VAL . 62.1 tp -123.7 108.22 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.673 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.97 110.19 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.548 -179.328 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.3 t -114.73 118.0 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.67 41.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.47 -0.769 . . . . 0.0 109.279 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -106.44 6.52 30.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.674 -0.641 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -80.99 -21.57 40.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.864 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 p 75.17 -41.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 20' ' ' ILE . 5.2 t -98.13 1.24 47.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.7 ttt -80.05 -25.15 40.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -66.86 -45.75 77.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 109.668 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -22.29 56.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.283 -0.886 . . . . 0.0 109.777 -179.404 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -76.02 -55.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.4 -13.97 17.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.855 . . . . 0.0 110.271 -178.959 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -65.68 -53.43 41.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 108.911 179.423 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -66.58 -55.52 14.99 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.859 0.838 . . . . 0.0 109.066 179.593 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.3 tt -41.86 -49.28 4.48 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.496 -179.628 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.08 -41.51 86.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 108.56 179.058 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -56.53 -36.93 69.8 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.478 -0.764 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.95 -16.1 48.58 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -102.1 5.44 40.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.564 -0.71 . . . . 0.0 109.849 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 79.48 47.62 7.26 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.379 179.609 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 39.2 m-85 -126.93 122.19 33.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.57 -0.959 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.83 64.53 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.734 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -172.23 90.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.964 -1.085 . . . . 0.0 109.482 179.777 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.22 -179.86 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.805 -179.849 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' VAL . 9.1 mt-10 -137.52 -169.28 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.899 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -146.37 144.17 29.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.407 -179.065 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.26 -170.68 2.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.094 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 7.6 pt-20 -141.7 10.32 2.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 170.91 158.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.92 -1.113 . . . . 0.0 109.714 179.555 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -46.4 -44.29 15.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.46 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.24 -37.11 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.003 -1.292 . . . . 0.0 109.66 -179.555 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.2 t70 -71.58 -45.9 60.9 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.151 -0.968 . . . . 0.0 108.732 179.619 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.86 -62.49 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.7 -0.625 . . . . 0.0 109.541 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -44.47 -48.29 10.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -65.32 -37.93 88.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.15 -3.07 58.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.565 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -83.36 -30.85 27.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.874 -1.141 . . . . 0.0 109.017 -179.836 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -62.37 -0.33 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.48 -61.16 1.8 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.536 -0.728 . . . . 0.0 109.738 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.18 21.74 0.12 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.96 108.07 1.11 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -179.713 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.643 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.2 m-85 -92.66 101.98 14.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.327 -1.102 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.17 -10.41 5.21 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -156.97 141.21 16.47 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.074 -1.25 . . . . 0.0 111.079 -179.311 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.763 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.3 t -134.24 105.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.393 -0.817 . . . . 0.0 110.209 179.273 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.9 69.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.97 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -101.33 148.68 24.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.258 -0.901 . . . . 0.0 109.161 -179.271 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 3.5 p30 -113.0 170.78 7.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.554 0.692 . . . . 0.0 109.989 -179.411 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 57' ' ' ASP . 1.5 t-105 -46.46 172.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 109.406 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.02 124.42 13.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.578 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -77.9 -39.25 1.82 Allowed Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.446 -0.784 . . . . 0.0 111.845 -179.842 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.4 Cg_exo -64.68 125.05 14.15 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 120.985 1.123 . . . . 0.0 110.763 -178.86 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 63' ' ' MET . 9.7 p30 42.72 -155.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.362 0.601 . . . . 0.0 110.19 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.516 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.87 155.42 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.753 -179.724 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 10.9 p-10 -97.33 -164.04 1.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 0.0 109.657 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.66 2.53 53.67 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.474 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.25 -55.74 8.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.309 . . . . 0.0 109.087 179.93 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.32 -15.55 0.65 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.065 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.579 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -74.92 -62.77 1.43 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -43.92 -63.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.291 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -47.33 -43.54 22.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.7 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 m -70.86 -24.86 62.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 109.298 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.591 HD13 HG21 ' A' ' 83' ' ' VAL . 48.0 mt -80.15 -9.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 108.777 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -86.93 -41.56 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 109.581 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.9 49.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -179.806 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -47.76 109.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.23 31.48 4.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.793 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 46.55 58.63 4.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 mmt -90.14 -62.84 1.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.19 30.59 1.44 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 109.193 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.62 -28.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 110.066 -179.577 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.9 tp -48.27 112.1 2.11 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 108.535 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.22 107.76 0.44 Allowed 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 120.988 1.126 . . . . 0.0 112.962 -178.505 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.763 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.1 t -108.85 119.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.654 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.35 102.49 14.27 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.131 -1.427 . . . . 0.0 108.015 178.195 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 110.4 15.16 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.791 -179.154 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.37 140.58 20.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.299 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -150.13 133.86 16.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.593 -1.317 . . . . 0.0 110.242 179.598 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.43 -59.24 2.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 108.985 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.33 67.21 3.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.04 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -73.78 109.35 7.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.813 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -91.37 133.13 35.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 108.93 179.604 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.22 -23.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 109.694 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.96 -50.93 5.74 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.497 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -64.91 -33.33 75.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 110.328 -179.115 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.833 HD11 ' HB1' ' A' ' 90' ' ' ALA . 68.2 mt -56.67 -20.95 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.005 -1.059 . . . . 0.0 109.342 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.426 HD13 ' N ' ' A' ' 96' ' ' ILE . 4.9 mm -87.64 -16.09 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -67.4 -46.73 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.403 -179.945 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.6 -55.21 21.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.859 -1.151 . . . . 0.0 108.5 179.223 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.21 -30.87 70.69 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.272 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -53.99 -33.91 58.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.706 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -81.32 -25.25 36.58 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 176.747 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.63 74.02 0.65 Allowed Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.949 177.312 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.85 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.06 -111.95 0.08 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 117.184 -1.807 . . . . 0.0 109.36 178.592 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 51.7 m -91.79 -53.24 4.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 123.616 1.674 . . . . 0.0 107.483 175.344 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.6 37.99 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -177.983 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.92 153.46 51.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.509 -0.995 . . . . 0.0 110.353 179.865 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.636 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.2 p -145.46 150.19 15.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.325 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.54 -170.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.26 179.193 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.73 156.67 25.03 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.81 133.1 29.79 Favored 'Cis proline' 0 C--N 1.32 -0.972 0 C-N-CA 124.423 -1.074 . . . . 0.0 109.682 -2.691 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -89.92 162.8 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 -179.98 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.32 145.58 25.47 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 177.079 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.57 -22.58 0.78 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.765 -1.209 . . . . 0.0 109.227 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.33 53.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.372 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.9 m -70.9 -64.61 0.87 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.864 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -49.43 -36.17 21.52 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.21 -1.396 . . . . 0.0 108.921 179.575 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -57.18 -62.48 1.73 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.931 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 3.6 tm-20 -42.09 -42.6 2.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.794 -0.566 . . . . 0.0 109.877 -179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -74.1 -33.12 63.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.983 179.555 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -65.85 -65.52 0.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.803 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -45.5 -53.61 8.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 109.949 -179.6 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.95 -24.85 62.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 0.0 109.971 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 10.7 mt -84.32 -47.35 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.021 -1.049 . . . . 0.0 110.119 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.04 2.7 0.7 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.937 -1.102 . . . . 0.0 109.914 -179.202 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.2 tt0 -74.74 -34.89 62.61 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.136 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -82.72 -35.11 26.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.495 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.5 tt -65.25 -27.36 68.6 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.931 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.11 80.85 0.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.017 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.373 -1.075 . . . . 0.0 109.444 179.724 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 59.61 122.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.394 -0.816 . . . . 0.0 109.415 -179.722 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 8.1 mttt -89.85 12.49 17.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.892 -1.13 . . . . 0.0 109.679 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.48 45.29 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 -179.732 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 21.2 tp -80.13 124.83 29.12 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.448 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' NZ ' ' OD1' ' A' ' 32' ' ' ASN . 34.6 mttp -73.91 122.97 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.0 111.858 -177.469 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 49.2 m-85 -113.7 147.88 37.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.434 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.584 HD13 ' CE2' ' A' ' 51' ' ' TYR . 50.7 tp -114.89 126.41 54.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.543 177.951 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.65 102.78 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.622 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.947 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -97.18 24.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' OD2' ' OD1' ' A' ' 57' ' ' ASP . 2.1 m-20 -72.34 145.86 47.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.534 -179.995 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -103.97 9.96 36.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.56 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 109.577 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.87 4.06 9.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.679 -0.638 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -161.79 9.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpp -82.87 -43.44 16.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.31 -0.869 . . . . 0.0 109.267 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.54 -35.38 70.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.429 179.977 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -27.86 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.55 -46.41 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.521 -179.839 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -31.84 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.276 -179.101 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.445 HH21 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.55 -57.41 9.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.431 179.853 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -64.72 -54.88 24.56 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.034 0.921 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -42.02 -58.99 1.89 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.552 -179.835 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.34 -47.66 83.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.014 -1.053 . . . . 0.0 108.849 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -52.1 -34.18 42.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 50.9 tt0 -48.61 -39.86 25.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.94 -66.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.98 30.19 0.02 OUTLIER Glycine 0 N--CA 1.482 1.751 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.53 148.35 22.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.305 . . . . 0.0 109.977 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.17 62.02 1.24 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.148 -0.97 . . . . 0.0 109.79 -179.879 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -175.81 104.43 0.08 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.764 -1.21 . . . . 0.0 109.662 179.956 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HB ' HH21 ' A' ' 22' ' ' ARG . 93.9 t -144.47 149.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -0.884 . . . . 0.0 109.629 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 21.2 mp0 -124.85 -172.23 2.53 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.671 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -150.06 151.07 32.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.793 -1.192 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.947 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.54 -178.15 5.75 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.06 19.36 1.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.028 -1.045 . . . . 0.0 110.554 -179.62 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 176.5 154.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.827 -1.17 . . . . 0.0 108.788 179.66 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.4 -55.85 15.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.453 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.9 t -50.44 -24.62 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.1 t0 -85.18 -42.4 14.76 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.77 85.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.008 -1.058 . . . . 0.0 109.355 -179.856 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -65.53 -55.3 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.617 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -57.12 -33.59 67.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.993 -1.067 . . . . 0.0 110.237 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.79 -8.05 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.709 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -78.4 -37.26 44.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.593 -1.317 . . . . 0.0 109.25 -179.701 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -7.43 0.69 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 108.967 179.647 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.24 -67.45 0.28 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.422 -0.798 . . . . 0.0 109.801 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.24 -94.98 0.24 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.696 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.7 78.03 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.584 ' CE2' HD13 ' A' ' 9' ' ' LEU . 13.6 m-30 -59.62 86.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.329 -1.101 . . . . 0.0 109.915 179.663 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -62.18 -1.61 3.27 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.331 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -154.22 144.73 22.28 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.474 -1.016 . . . . 0.0 109.818 -178.692 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.0 t -142.51 119.99 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 0.0 110.389 -179.914 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.59 127.66 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' SD ' ' A' ' 85' ' ' MET . 13.3 p -149.22 146.59 27.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.998 -1.064 . . . . 0.0 109.873 -179.34 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' OD2' ' A' ' 12' ' ' ASP . 2.3 m-20 -71.59 163.36 27.89 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.242 -0.911 . . . . 0.0 108.81 179.406 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.82 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.519 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.9 OUTLIER -172.75 171.85 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.016 -1.052 . . . . 0.0 110.027 -179.926 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.1 tpp 178.21 -46.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.495 179.014 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.2 Cg_endo -71.65 93.03 0.68 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.035 1.157 . . . . 0.0 109.524 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.497 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 41.91 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 0.0 109.845 179.999 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.2 tpp 47.6 -116.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.066 . . . . 0.0 109.062 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.76 -175.23 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 179.596 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.561 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 94.51 -72.08 1.11 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -47.52 63.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.998 -1.295 . . . . 0.0 107.854 178.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 15.7 mp0 -65.51 -22.63 66.74 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -64.65 -55.02 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.25 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 72' ' ' ILE . 2.0 mt -58.16 -67.09 0.38 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.21 0.528 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -37.55 -46.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.86 -0.525 . . . . 0.0 110.35 -179.56 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.2 m -57.64 -41.87 82.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.124 179.71 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -60.9 -30.07 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -76.98 -55.92 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.592 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.12 4.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 135.62 55.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . -87.3 161.19 32.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.835 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 76.35 -7.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.451 -1.029 . . . . 0.0 109.683 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.4 mmm -109.89 -19.13 13.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.857 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.6 m 51.83 -108.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.06 56.16 0.95 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 51' ' ' TYR . 73.6 mt -43.06 148.68 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.684 -0.635 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.42 143.31 94.46 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.475 1.45 . . . . 0.0 111.804 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -134.26 119.85 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.676 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.8 tp -103.8 75.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.55 178.309 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -48.89 169.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.894 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.12 122.57 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.494 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.5 t -140.54 -169.03 2.69 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.613 -179.549 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -140.99 16.43 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.925 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -138.59 -61.74 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.068 -179.688 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 1.049 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.48 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.48 31.85 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.966 -179.449 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ILE . 35.1 mtpt 54.49 -82.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 179.397 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.09 -25.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.337 -179.252 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 92' ' ' LYS . 22.0 t-20 -85.01 -31.49 23.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.0 109.857 -179.675 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.049 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.4 mt -67.19 -15.27 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 110.142 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.25 -64.51 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.86 -179.798 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.79 -31.34 2.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.913 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -69.31 -55.05 11.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.03 -42.66 60.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 -179.342 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -51.39 -26.8 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.97 -179.896 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.09 -113.43 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.423 179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.03 -1.17 6.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.414 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.583 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -56.32 11.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.154 -0.615 . . . . 0.0 110.831 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.48 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.275 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.43 130.62 10.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.391 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.85 115.16 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 108.866 179.112 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -114.26 121.89 67.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.617 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -76.51 96.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.835 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -59.44 160.87 11.86 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 0.0 109.141 -179.21 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.2 165.55 85.56 Favored 'Cis proline' 0 N--CA 1.485 0.988 0 O-C-N 122.86 0.926 . . . . 0.0 110.483 -2.257 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -146.03 159.36 43.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.121 -0.987 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.19 147.15 25.42 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.958 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.453 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -44.72 -28.26 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.625 -179.168 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.37 83.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.495 178.936 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -64.14 -64.6 0.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.962 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.6 tp -45.49 -43.51 11.71 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.058 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -61.98 -52.48 63.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.664 -1.272 . . . . 0.0 110.064 -179.882 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 117' ' ' GLU . 1.1 tp10 -43.59 -64.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.736 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -46.05 -46.41 16.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -45.56 -44.07 12.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -62.44 -42.91 99.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.375 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -58.86 -32.5 69.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.492 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.03 -34.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.248 -0.907 . . . . 0.0 109.907 -179.423 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -86.23 1.31 51.28 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 110.646 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -77.1 -28.47 54.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.952 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -94.81 -22.26 18.17 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -87.97 -29.05 21.07 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.22 86.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.475 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.296 -1.12 . . . . 0.0 109.53 -179.954 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.352 0.596 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 66.39 142.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.227 -0.921 . . . . 0.0 109.887 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 mmmm -90.3 19.57 5.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 0.0 109.413 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.53 49.45 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.952 -1.092 . . . . 0.0 109.635 -179.321 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 60.5 tp -60.24 111.0 1.37 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 0.0 108.934 179.885 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -43.91 105.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.894 -1.129 . . . . 0.0 111.144 -178.835 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 56.8 m-85 -102.33 154.77 18.74 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.793 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 tp -132.09 103.41 6.25 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.59 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -90.55 113.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.093 -178.983 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.5 t -103.04 69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.583 -0.698 . . . . 0.0 110.025 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -114.58 131.0 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -77.5 -5.63 50.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.664 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -80.83 143.76 32.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.944 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.08 12.36 24.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -31.25 1.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.437 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 8.1 ttt -55.81 -32.19 63.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.267 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.523 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -69.25 -43.51 73.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 -179.979 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -59.18 -25.25 63.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.16 -49.24 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.766 -179.67 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -30.74 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.589 -178.788 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -51.38 60.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.939 -1.101 . . . . 0.0 108.694 179.456 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.44 -60.51 2.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.842 0.83 . . . . 0.0 109.546 179.85 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 116' ' ' LEU . 1.7 tt -45.03 -35.99 3.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.715 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -74.22 -51.84 14.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 108.25 178.577 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -52.68 -33.82 49.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.45 -0.781 . . . . 0.0 108.968 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -49.24 -39.15 29.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.348 -0.845 . . . . 0.0 108.783 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 -64.98 0.98 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.422 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 160.06 41.43 0.02 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.765 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -113.8 134.6 54.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.61 -0.935 . . . . 0.0 109.184 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 65.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.946 -1.096 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -174.21 93.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.816 -1.178 . . . . 0.0 109.079 179.717 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.93 -179.73 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.036 -1.04 . . . . 0.0 110.653 -179.271 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.9 mt-10 -137.9 -171.39 3.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.516 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' CD ' HH11 ' A' ' 18' ' ' ARG . 58.3 mt-10 -140.13 154.2 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.038 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.962 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.03 -167.26 2.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -139.87 -10.68 1.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 0.0 111.004 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -174.57 -166.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.013 -1.054 . . . . 0.0 109.761 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.42 -42.81 32.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.1 t -55.46 -41.23 61.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.919 -1.342 . . . . 0.0 108.121 179.16 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.42 -54.48 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 109.291 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.42 -62.65 1.71 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.229 -0.92 . . . . 0.0 109.411 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.9 tp -41.73 -43.08 2.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.684 -0.635 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -74.36 -37.32 63.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -90.09 0.71 57.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -78.09 -40.56 37.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.051 -1.031 . . . . 0.0 109.029 179.955 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.98 -4.37 3.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -72.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.482 -0.761 . . . . 0.0 109.549 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.31 5.26 2.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.853 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.42 78.44 1.03 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.9 m-85 -57.51 114.75 2.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -1.034 . . . . 0.0 110.094 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.3 -7.61 2.04 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.437 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -160.75 137.23 8.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.732 -178.552 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.8 122.33 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.731 . . . . 0.0 109.847 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.44 151.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -167.64 162.58 14.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.007 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.38 -168.18 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 108.978 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 59' ' ' ASN . 13.7 t-105 -128.6 111.82 13.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.434 -0.791 . . . . 0.0 109.564 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 12.3 t-20 52.76 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.473 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 177.38 -50.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 179.578 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.12 -54.93 0.54 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 120.832 1.021 . . . . 0.0 109.891 -179.873 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.97 -41.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.298 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -132.38 -179.83 5.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.43 151.66 32.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.606 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -79.3 -20.14 70.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -48.23 -29.04 3.4 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -1.196 . . . . 0.0 108.334 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 71' ' ' THR . 1.5 tp10 -83.15 -29.79 28.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 109.348 179.443 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -57.59 -35.02 69.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 108.707 179.719 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -86.74 -61.93 1.62 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 108.667 179.09 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -43.09 -26.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.914 -179.289 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 67' ' ' GLU . 5.2 p -72.82 -39.45 66.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.054 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . 81.2 mt -63.6 -45.27 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -61.07 -29.2 69.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 109.64 -179.85 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.91 -28.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.568 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.9 -153.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.07 -12.77 0.1 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.25 -27.97 19.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -1.183 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.1 mtm -92.56 -11.24 34.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t 52.32 -111.32 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.1 58.61 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 80' ' ' ALA . 10.5 mt -38.01 153.77 0.13 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 122.042 -0.412 . . . . 0.0 110.086 -179.303 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.26 140.36 94.04 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.566 1.51 . . . . 0.0 111.481 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 69' ' ' LEU . 2.9 t -133.32 130.44 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.56 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD21 HD21 ' A' ' 116' ' ' LEU . 55.1 tp -113.36 75.95 0.95 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.102 0.953 . . . . 0.0 108.543 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtt -51.24 172.24 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -145.75 125.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 109.273 -179.464 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 109' ' ' LYS . 15.2 t -150.06 178.11 9.26 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.026 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.61 -42.93 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.34 69.92 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.5 -0.75 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -65.37 107.83 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.927 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' CG ' ' N ' ' A' ' 92' ' ' LYS . 6.6 ttpt -73.52 -110.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 -179.778 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 31.5 ttpt -160.2 -75.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.351 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.5 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.758 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -89.32 -64.0 1.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 -179.766 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.6 mp -47.99 -39.32 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 97' ' ' ALA . 31.5 mt -68.57 -65.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.03 -53.0 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.434 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.97 -44.34 91.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.55 -0.718 . . . . 0.0 109.917 179.986 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.78 -47.51 51.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.707 -1.246 . . . . 0.0 109.333 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -58.97 -23.64 61.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.816 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.21 -103.66 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.718 -179.733 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -129.91 -6.88 3.9 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' H ' HD13 ' A' ' 69' ' ' LEU . . . -57.52 11.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.889 -0.771 . . . . 0.0 110.102 178.176 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.695 ' H ' ' C ' ' A' ' 102' ' ' GLY . 61.4 m -29.27 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.725 -176.339 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -115.94 129.9 8.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.97 110.18 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 108.39 179.385 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.9 p -110.68 123.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 109' ' ' LYS . 2.5 t -58.27 -178.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.798 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.9 pttt -155.61 157.95 31.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.32 -1.488 . . . . 0.0 109.194 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.85 164.51 87.3 Favored 'Cis proline' 0 N--CA 1.484 0.929 0 C-N-CA 124.706 -0.956 . . . . 0.0 110.298 -2.254 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.87 159.32 35.25 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.774 0.797 . . . . 0.0 109.938 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.21 145.45 24.49 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.149 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -47.08 -20.49 0.16 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.949 -1.095 . . . . 0.0 109.54 -178.746 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.57 -36.03 26.6 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.327 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.4 m -69.91 -59.86 2.66 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.792 HD12 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -49.09 -46.57 44.85 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.155 178.802 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -55.7 -50.78 69.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 110.308 -179.563 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 5.1 tt0 -51.41 -68.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -45.56 -35.27 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.091 -1.006 . . . . 0.0 110.208 -179.407 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.28 -65.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.041 . . . . 0.0 110.014 -179.548 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -45.43 -28.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.433 -179.356 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -69.16 -47.76 64.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.962 -1.086 . . . . 0.0 109.765 -179.549 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.53 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.6 mt -69.56 -38.19 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.958 -179.61 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -70.08 -4.77 22.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 110.723 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.04 -22.18 56.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.644 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -96.28 -24.37 16.24 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -86.08 -32.74 21.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.397 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 43.79 84.18 0.02 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.207 -1.172 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -45.88 135.36 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.522 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -90.54 16.17 9.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.668 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.28 47.27 2.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 108.785 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 22.3 tp -90.02 119.02 30.02 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.37 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -61.82 120.45 10.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.92 . . . . 0.0 110.986 -178.457 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 76.9 m-85 -110.81 152.03 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.889 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 tp -124.62 104.01 8.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.815 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' VAL . 27.9 m -93.57 107.68 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.973 -1.079 . . . . 0.0 110.013 -179.328 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 49.1 t -90.27 -96.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.915 -1.115 . . . . 0.0 109.564 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 52.91 -161.85 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.032 -1.042 . . . . 0.0 109.598 179.72 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.81 9.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -54.37 -21.07 8.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.651 -179.897 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER 72.26 -8.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.124 -179.743 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 14' ' ' PHE . 1.3 t -136.0 -10.33 2.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.629 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.412 ' C ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -69.58 -50.56 43.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 108.715 179.431 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -41.94 -41.54 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.338 0.59 . . . . 0.0 109.98 179.706 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -63.72 -45.11 91.43 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.049 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.95 -51.63 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.341 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.63 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -0.974 . . . . 0.0 110.53 -178.879 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -55.16 6.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t-20 -67.79 -58.26 4.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.1 -62.25 0.86 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.857 -179.698 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 15.1 mt -54.0 -42.16 68.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.228 -0.92 . . . . 0.0 109.519 179.543 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -62.16 -38.44 89.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -60.0 -33.74 72.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.634 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mt -76.12 -50.19 15.31 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 4' ' ' LYS . . . 148.38 54.2 0.02 OUTLIER Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.341 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -144.34 133.81 23.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.214 . . . . 0.0 110.04 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -145.37 55.47 1.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.354 179.947 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -162.18 98.02 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.03 152.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.112 -0.993 . . . . 0.0 110.428 -178.776 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.12 -170.87 1.76 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.754 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.91 151.01 32.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.991 -178.712 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.33 -171.39 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.185 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.93 10.9 1.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.133 -0.98 . . . . 0.0 110.032 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 169.03 163.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.804 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -55.27 -37.53 65.3 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.938 -179.38 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.516 HG23 ' OD2' ' A' ' 38' ' ' ASP . 61.2 t -54.83 -37.46 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.822 -1.399 . . . . 0.0 107.922 179.112 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.647 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 22.0 t0 -80.75 -55.45 4.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.598 -0.689 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.92 -54.1 33.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 109.281 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 43' ' ' LEU . 5.0 tt -52.68 -58.4 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -0.857 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -56.58 -34.63 67.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.934 -178.993 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -90.03 -17.58 27.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.891 -1.131 . . . . 0.0 110.815 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -59.93 -28.29 67.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 0.0 109.046 -179.779 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 7.4 tt0 -72.64 2.6 6.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.18 179.695 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.61 -75.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.421 -0.799 . . . . 0.0 109.634 -179.878 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.49 -35.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.47 67.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' PHE . 70.4 m-85 -49.54 100.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.35 -6.44 0.99 Allowed Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.5 t80 -161.03 144.82 13.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -1.073 . . . . 0.0 109.805 -178.414 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HB ' HG22 ' A' ' 83' ' ' VAL . 65.7 t -136.65 120.94 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.962 -1.086 . . . . 0.0 110.032 -179.782 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.32 97.67 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.568 -0.707 . . . . 0.0 109.107 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 p -99.4 -177.07 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 12.7 t70 -140.39 50.67 1.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 109.686 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 47.32 77.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.217 -179.935 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -48.35 141.23 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.695 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -100.64 -36.67 0.23 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 111.802 -179.972 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.45 122.73 10.49 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.849 1.033 . . . . 0.0 110.715 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 m-80 48.16 53.98 10.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.845 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mtp 53.48 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 54.34 178.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.5 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.11 -46.62 2.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.175 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.6 -69.28 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.288 . . . . 0.0 108.027 178.79 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.75 -22.11 13.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.23 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.11 -53.17 57.67 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.93 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 83' ' ' VAL . 43.9 mt -57.97 -65.72 0.59 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.077 0.942 . . . . 0.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -41.63 -36.5 0.96 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.78 -179.85 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -41.95 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 108.551 179.768 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.12 -39.75 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.063 -1.023 . . . . 0.0 108.254 178.898 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -23.8 67.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.294 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.36 51.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.626 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -45.74 -36.07 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 109.633 -179.866 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.04 32.91 85.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.1 -54.79 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.01 -67.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m 57.24 4.33 0.2 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.333 -0.854 . . . . 0.0 109.274 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -106.37 -12.24 15.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.635 -0.665 . . . . 0.0 109.651 -179.762 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.2 mt -45.18 107.78 0.69 Allowed Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.97 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.26 150.12 89.45 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.079 1.186 . . . . 0.0 112.899 -178.039 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 69' ' ' LEU . 2.5 t -136.39 126.87 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.044 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -113.83 72.95 0.8 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.512 179.059 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' LEU . 9.7 mtt -46.39 170.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.328 0.585 . . . . 0.0 109.504 -179.245 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.15 125.07 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.22 -179.312 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 148.82 29.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.645 -1.284 . . . . 0.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 -42.33 8.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -96.32 50.72 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 1.003 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -61.14 101.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 109.437 -179.973 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -68.33 -110.62 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 94' ' ' ASN . 3.1 ttmt -162.39 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -19.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 109.565 -179.95 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -90.06 -37.65 14.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.003 HD11 ' HB1' ' A' ' 90' ' ' ALA . 77.2 mt -63.54 -16.21 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.44 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.577 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.82 -38.81 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -54.54 -57.72 10.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.474 179.555 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.11 64.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -57.62 -17.39 14.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.703 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.69 -107.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.603 -0.685 . . . . 0.0 109.905 -179.664 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.62 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.86 -1.55 8.12 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.38 11.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.032 -0.687 . . . . 0.0 111.512 179.239 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.62 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.25 -31.44 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.119 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -116.84 135.08 11.71 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.661 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -151.23 114.15 4.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -1.152 . . . . 0.0 109.312 179.062 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.91 140.1 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.202 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.3 p -88.31 100.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.554 179.391 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.0 155.25 64.69 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.989 . . . . 0.0 109.531 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.58 167.75 79.39 Favored 'Cis proline' 0 N--CA 1.488 1.205 0 O-C-N 122.649 0.815 . . . . 0.0 111.068 -2.295 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.1 p90 -146.52 156.91 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.865 0.84 . . . . 0.0 109.829 178.73 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.09 146.17 23.85 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.053 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.5 -22.76 0.79 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.775 -1.203 . . . . 0.0 109.301 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.24 39.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.434 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 112' ' ' THR . 7.0 m -72.63 -61.72 1.7 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.779 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.67 -38.65 47.76 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.213 179.11 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.25 -48.16 76.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.61 -43.88 8.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.665 -179.577 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -66.57 -50.78 61.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -25.76 9.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.05 -22.96 36.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -80.61 -25.11 38.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 109.393 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.94 -34.81 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.667 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -80.2 -1.61 41.25 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 -178.533 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -76.94 -21.14 55.27 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.609 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.45 -26.88 14.31 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.474 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -79.83 -26.4 40.47 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.24 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.97 88.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.638 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.328 -1.101 . . . . 0.0 109.514 -179.783 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.4 0.619 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' ALA . 1.9 m-20 61.65 127.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.737 179.83 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -90.18 19.57 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 0.0 108.756 179.425 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -144.89 45.62 1.36 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.564 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 20.7 tp -78.49 117.77 20.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 108.442 -179.92 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -63.72 121.2 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 111.842 -177.737 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.636 ' HB2' HG22 ' A' ' 33' ' ' VAL . 96.0 m-85 -115.19 142.85 46.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 46' ' ' LEU . 43.5 tp -116.82 117.99 31.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.123 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 1.2 m -105.57 112.61 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 109.665 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.948 HG22 ' HB3' ' A' ' 36' ' ' ALA . 26.6 t -105.85 115.86 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.625 ' N ' ' NH2' ' A' ' 18' ' ' ARG . 13.4 t70 -149.89 -137.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.89 -20.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CD1' HG22 ' A' ' 16' ' ' THR . 0.1 OUTLIER -68.08 126.8 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.95 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.8 p -81.62 41.43 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.517 -179.933 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.449 HG22 ' CD1' ' A' ' 14' ' ' PHE . 7.4 t -166.05 -29.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.8 ttp -57.96 -47.79 81.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.625 ' NH2' ' N ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -46.58 -29.1 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.716 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -67.72 -34.9 77.78 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -61.25 -55.89 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -39.18 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 -179.079 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -46.89 -55.38 8.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -65.11 -56.12 14.77 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.859 0.838 . . . . 0.0 109.311 -179.968 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -38.84 -60.36 0.85 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.991 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.3 -46.5 86.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 109.114 179.428 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -32.7 65.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.326 -0.859 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.25 61.4 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.851 -1.156 . . . . 0.0 109.069 -179.53 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' CD1' ' OE1' ' A' ' 117' ' ' GLU . 3.3 tp -80.1 -66.56 0.86 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 109.188 179.533 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.73 0.02 OUTLIER Glycine 0 N--CA 1.482 1.719 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -101.85 153.14 20.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -1.18 . . . . 0.0 108.997 179.731 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.07 58.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.967 -1.083 . . . . 0.0 110.737 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.5 100.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.849 -1.157 . . . . 0.0 109.872 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 8' ' ' PHE . 93.2 t -139.42 150.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.34 -0.85 . . . . 0.0 109.919 -179.611 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -122.01 -173.25 2.62 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.687 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 18' ' ' ARG . 26.6 mt-10 -142.75 155.35 44.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.273 -0.892 . . . . 0.0 110.94 -178.345 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.948 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.6 -172.59 4.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' OE1' ' OD2' ' A' ' 41' ' ' ASP . 1.4 pm0 -143.46 2.57 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.103 -0.998 . . . . 0.0 110.652 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -168.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.781 -1.199 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -74.04 -47.05 19.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.203 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 4.1 p -52.22 -35.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.644 -1.504 . . . . 0.0 107.941 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t0 -80.32 -45.86 17.11 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.482 -0.762 . . . . 0.0 109.728 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -70.32 -57.66 4.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.899 -1.125 . . . . 0.0 108.872 179.649 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.712 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.9 tm? -44.78 -52.04 8.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 0.0 108.979 179.713 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 77.7 m-20 -65.07 -38.77 91.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.695 179.925 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -86.26 5.83 32.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 110.245 -179.436 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -90.15 -56.0 3.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 108.927 179.621 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.47 2.91 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 108.734 179.306 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.82 -65.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.817 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 4.84 2.64 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 79.34 1.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' O ' HD13 ' A' ' 81' ' ' LEU . 19.7 m-85 -66.59 108.72 2.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.5 -1.0 . . . . 0.0 109.954 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.86 -6.85 2.99 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.556 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' N ' ' C ' ' A' ' 51' ' ' TYR . 1.8 t80 -163.02 146.77 11.01 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.169 -1.195 . . . . 0.0 109.876 -178.601 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 46' ' ' LEU . 93.2 t -143.74 126.85 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.2 mt -110.01 134.98 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.348 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.9 p -146.94 137.41 23.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.642 -179.889 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.3 m-20 -71.83 -151.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 -179.979 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.595 ' CH2' HD23 ' A' ' 66' ' ' LEU . 52.9 t-105 -101.9 -177.98 3.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.546 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.07 90.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.874 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -95.98 -46.8 0.25 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.956 -179.895 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.5 -54.9 0.51 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.14 1.227 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' ASP . 5.7 p30 -173.03 -148.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.651 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -61.86 78.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 108.724 179.39 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ASN . 49.1 m-20 -154.82 -157.97 0.8 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.885 . . . . 0.0 109.441 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.725 ' H ' HD13 ' A' ' 68' ' ' LEU . . . 68.88 -72.78 0.38 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -66.42 -43.3 86.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.89 -1.359 . . . . 0.0 107.364 178.557 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.6 -27.58 67.82 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.406 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.725 HD13 ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -66.23 -60.69 2.55 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.618 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -55.97 -63.91 1.03 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.338 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' LEU . 13.7 ttmm -44.32 -39.43 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.523 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 m -68.82 -41.08 79.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.816 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 69' ' ' LEU . 61.1 mt -56.22 -23.83 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -27.47 19.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.479 -0.763 . . . . 0.0 109.183 179.803 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.22 -29.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.701 -179.825 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -172.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -58.77 -165.77 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.653 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.96 19.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . 3.9 tpt -89.94 -28.76 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.009 179.627 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 45.89 -125.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.538 -0.727 . . . . 0.0 109.172 179.937 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.495 ' C ' HD12 ' A' ' 81' ' ' LEU . . . -150.12 54.1 0.92 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER 44.0 -166.42 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.575 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.7 Cg_exo -61.63 151.21 81.74 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.966 1.381 . . . . 0.0 114.508 -176.336 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.58 138.42 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.769 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 55' ' ' ILE . 48.5 tp -117.1 78.46 1.22 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.403 ' N ' ' O ' ' A' ' 105' ' ' GLY . 18.0 ttp -61.9 159.54 13.83 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.337 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.547 HG23 HG13 ' A' ' 107' ' ' VAL . 7.5 p -150.19 142.33 17.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.806 -1.184 . . . . 0.0 109.953 -178.742 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 t -149.98 174.94 12.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.874 -179.973 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.7 -39.95 5.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.679 -0.638 . . . . 0.0 109.361 179.655 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.9 tt0 -81.77 -60.81 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.622 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 51.32 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 179.97 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.0 ttmt -94.44 125.42 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.985 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -45.53 -24.77 0.36 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.633 -179.574 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -85.31 -31.19 23.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.7 m-80 -89.95 -15.09 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.784 -179.794 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 95' ' ' ILE . 84.5 mt -75.84 -0.69 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.0 -58.24 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.762 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.04 -52.18 12.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -49.28 -54.06 18.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.722 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.59 -38.11 63.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.073 -1.017 . . . . 0.0 110.037 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -59.68 -17.55 35.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 -106.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.609 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.57 1.46 5.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -54.79 11.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.148 0.579 . . . . 0.0 111.385 179.001 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 102' ' ' GLY . 54.2 m -29.29 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.92 -0.487 . . . . 0.0 111.991 -176.55 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -114.86 123.68 6.08 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.237 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.456 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -138.29 114.6 10.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.363 -1.08 . . . . 0.0 109.883 179.441 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.7 p -114.89 138.65 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.351 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.454 ' H ' HG12 ' A' ' 108' ' ' VAL . 1.2 p -85.96 103.36 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.889 -1.132 . . . . 0.0 109.315 -179.582 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.5 pttt -63.28 159.16 51.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.943 -1.098 . . . . 0.0 109.199 -179.691 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.36 156.87 99.47 Favored 'Cis proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.693 -0.961 . . . . 0.0 110.103 -2.446 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.8 p90 -136.42 156.25 48.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.14 151.82 21.37 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.067 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.36 -18.15 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.691 -1.204 . . . . 0.0 108.909 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -72.42 -44.8 61.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.644 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -63.35 1.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.57 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 107' ' ' VAL . 2.7 tp -47.77 -35.68 10.37 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.29 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' CD1' ' A' ' 28' ' ' LEU . 23.0 tt0 -72.28 -60.12 2.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.642 -1.286 . . . . 0.0 110.725 -179.248 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -40.8 -35.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.67 -0.644 . . . . 0.0 110.774 -178.738 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -79.26 -54.28 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.996 -1.065 . . . . 0.0 109.982 -179.556 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -47.33 -44.33 23.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.824 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -53.67 -45.68 70.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.188 -179.427 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -62.51 -50.66 70.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.36 -34.74 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.815 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 -1.38 57.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.797 -179.051 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.26 -26.89 35.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.19 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -95.97 -21.28 18.12 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.4 OUTLIER -88.31 -34.97 17.48 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.429 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 42.63 77.89 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.469 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.118 -1.225 . . . . 0.0 109.492 -179.918 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.05 144.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.989 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -90.12 11.36 21.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.086 -1.009 . . . . 0.0 109.803 -179.815 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -146.25 48.12 1.21 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.532 -179.736 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.15 126.06 29.15 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.475 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.76 118.19 12.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.08 -1.013 . . . . 0.0 111.534 -177.367 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.81 149.96 26.01 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.687 ' HB3' HG22 ' A' ' 54' ' ' VAL . 18.4 tp -125.57 104.95 8.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.984 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.86 104.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.578 -179.096 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 36' ' ' ALA . 24.0 t -89.93 115.0 28.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 -179.929 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -174.35 -166.85 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.025 -1.047 . . . . 0.0 109.882 -179.206 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.7 9.68 0.47 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.337 -0.852 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -51.04 -35.66 35.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.732 -1.23 . . . . 0.0 108.536 179.781 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 72.5 31.67 1.71 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.871 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 t -177.23 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.47 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.43 ' CB ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -73.88 -35.71 64.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.493 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.72 -50.23 13.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.044 178.587 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -66.13 -26.84 67.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.353 -177.392 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -69.32 -54.31 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.019 179.649 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.0 -40.29 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 -179.414 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 18' ' ' ARG . 1.2 mtm180 -49.72 -52.18 33.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.441 179.347 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -59.05 -59.07 6.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.266 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 5.5 tt -42.71 -30.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.84 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.1 mt -84.6 -33.12 23.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.941 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' ASN . 5.8 tttp -69.94 -35.36 74.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.427 -0.796 . . . . 0.0 108.905 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.26 -35.63 60.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.273 -0.892 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.597 HD21 ' OE1' ' A' ' 117' ' ' GLU . 3.5 mp -80.44 -55.45 4.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.73 62.94 0.01 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.628 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 96.9 m-85 -150.12 141.84 23.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.909 -1.348 . . . . 0.0 109.757 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -150.15 66.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.042 -1.036 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -175.54 102.37 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.592 -1.317 . . . . 0.0 110.213 179.519 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.46 178.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 179.611 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.7 mt-10 -140.55 -167.11 2.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.367 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.52 149.52 32.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 111.1 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.57 -168.28 2.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.039 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.79 7.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.692 -179.449 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 15.7 t0 -176.46 151.4 0.96 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.052 -1.03 . . . . 0.0 109.674 179.881 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.578 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -52.54 -29.02 30.78 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.489 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.4 t -72.43 -38.61 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -1.183 . . . . 0.0 108.898 179.637 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -70.96 -43.82 67.31 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -65.52 -60.19 3.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.302 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.6 tp -45.38 -33.62 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.537 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.37 -38.98 23.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -86.26 -1.29 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.901 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -70.2 -10.74 59.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.235 -179.947 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -7.5 21.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.505 -0.747 . . . . 0.0 109.257 179.671 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.87 -55.01 7.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 109.573 -179.801 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.99 6.31 2.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 89.61 0.12 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.852 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.606 ' O ' HD11 ' A' ' 81' ' ' LEU . 44.0 m-85 -76.09 153.34 36.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.225 -1.162 . . . . 0.0 110.024 -179.606 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.98 5.94 39.9 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.301 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -165.7 141.64 5.15 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.627 -0.925 . . . . 0.0 108.89 -179.569 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 9' ' ' LEU . 46.0 t -137.93 109.43 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -0.837 . . . . 0.0 109.478 179.345 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.6 90.78 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 164.74 12.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.95 . . . . 0.0 109.142 -179.931 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.0 t0 -91.45 -95.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 110.189 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.555 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 55.7 t-105 -166.39 -123.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.975 . . . . 0.0 109.372 -179.266 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.433 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 21.2 t-20 -103.22 51.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.605 -0.684 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -92.74 -48.62 0.3 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 179.959 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.79 -71.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.006 1.138 . . . . 0.0 109.96 -179.581 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 63' ' ' MET . 4.2 p30 -153.71 -62.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.0 109.001 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.476 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 ttp -88.34 176.62 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.58 142.16 35.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 0.0 109.458 179.927 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.42 13.54 1.54 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -76.07 -58.15 3.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.038 -1.272 . . . . 0.0 108.264 179.25 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -13.16 26.25 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.772 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.578 HD13 ' CA ' ' A' ' 39' ' ' GLY . 56.7 tp -77.03 -43.62 33.88 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.834 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -81.32 -28.69 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.988 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -66.42 -41.05 89.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.332 -0.855 . . . . 0.0 108.9 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -71.34 -39.66 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.541 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.96 -30.3 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.12 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -90.15 -31.05 17.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.39 -0.819 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -29.89 3.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.16 151.04 38.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.22 16.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.98 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.64 -29.85 16.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -1.134 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 80' ' ' ALA . 15.8 mtt -89.97 6.23 43.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.371 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -73.77 34.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.804 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.61 21.73 3.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 109.27 -179.998 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -111.65 98.32 40.54 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.697 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.39 118.61 5.52 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.614 1.542 . . . . 0.0 114.03 -178.87 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -105.38 118.61 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 176.063 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.814 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -98.32 109.3 22.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.21 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.17 103.0 12.25 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.52 146.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.904 -1.122 . . . . 0.0 109.368 179.658 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.07 155.91 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.07 -50.29 6.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.141 179.579 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 91' ' ' LYS . 50.7 mt-10 -93.36 58.84 2.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 109.079 179.634 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -53.86 86.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.713 -179.724 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 89' ' ' GLU . 20.1 tttm -71.35 139.36 49.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.055 -1.028 . . . . 0.0 108.961 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 91' ' ' LYS . 1.4 tppp? -42.08 -28.2 0.17 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.99 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' LYS . 13.3 tp10 -88.32 -29.39 20.37 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.225 -0.922 . . . . 0.0 109.9 -179.937 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 2.6 t30 -68.86 -28.8 67.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.095 -1.003 . . . . 0.0 110.29 -179.423 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.813 HD11 ' HB1' ' A' ' 90' ' ' ALA . 2.2 mp -68.1 -58.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.728 -1.233 . . . . 0.0 108.711 179.503 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' GLN . 82.2 mt -63.63 -19.79 24.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.363 -0.836 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.14 -71.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.114 179.658 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.668 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -50.76 -44.75 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.968 -1.082 . . . . 0.0 108.169 179.059 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -66.22 -24.38 66.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.572 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 96' ' ' ILE . 6.8 tt0 -52.84 -30.99 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.879 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.41 -21.79 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.439 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 66.58 77.06 0.31 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.391 178.048 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.834 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -111.8 0.08 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 117.223 -1.791 . . . . 0.0 109.634 178.924 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.814 ' OG ' HD22 ' A' ' 84' ' ' LEU . 2.2 p -91.68 -50.3 5.83 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.997 1.379 . . . . 0.0 108.1 176.045 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.437 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 166.36 -163.6 37.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.373 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.506 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -143.52 124.7 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.547 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -72.57 115.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -87.64 161.42 45.03 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 108.665 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.68 131.03 21.98 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 124.798 -0.917 . . . . 0.0 110.432 -2.041 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.0 p90 -101.31 153.8 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.051 0.929 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.46 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -89.94 149.44 22.59 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.0 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.546 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.83 -24.25 1.37 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.834 -1.166 . . . . 0.0 109.513 -178.776 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.45 -34.48 60.95 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.561 178.962 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.91 -61.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.545 179.069 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.73 -36.9 38.68 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.178 -1.409 . . . . 0.0 108.295 179.127 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.597 ' OE1' HD21 ' A' ' 28' ' ' LEU . 7.2 tp10 -65.74 -56.95 9.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.025 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 117' ' ' GLU . 2.8 mt-10 -42.39 -34.37 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 109.997 -179.456 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -90.04 -25.86 20.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.284 179.833 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 117' ' ' GLU . 3.3 tp -66.74 -66.96 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.924 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -44.39 -50.44 9.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.56 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -61.14 -27.13 68.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 109.994 -179.627 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 120' ' ' LEU . 12.3 mt -81.39 -45.72 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.98 . . . . 0.0 109.926 -179.725 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.93 -6.34 8.18 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 -179.264 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.49 -29.31 68.71 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.227 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.52 -34.59 19.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.3 tt -72.2 -27.13 62.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.372 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.56 81.58 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.515 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.446 179.751 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -46.16 145.17 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.982 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 40.5 tttt -90.44 9.64 28.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.0 109.41 179.398 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.65 46.75 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.047 . . . . 0.0 110.356 -178.993 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.3 tp -78.29 112.34 15.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.528 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.01 123.34 17.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.927 -1.108 . . . . 0.0 111.98 -176.838 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 73.4 m-85 -109.45 152.04 25.9 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.942 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 54' ' ' VAL . 31.0 tp -121.89 106.14 10.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.283 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.82 105.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.423 -178.012 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.9 t -104.72 103.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.577 -0.702 . . . . 0.0 109.86 -179.936 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -149.06 148.64 29.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 9.1 t70 -85.08 -15.68 43.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -46.84 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.906 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.05 10.04 13.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 109.633 -179.71 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -155.52 -21.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.542 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' NZ ' ' A' ' 109' ' ' LYS . 13.8 tpt -48.89 -47.71 42.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.648 ' NH2' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.69 -37.14 17.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 -179.841 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -73.9 -30.72 62.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.784 -1.166 . . . . 0.0 109.769 -178.352 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.8 mt -67.62 -55.32 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.885 . . . . 0.0 109.338 -179.895 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.9 -32.34 47.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.86 -179.235 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.648 HH11 ' NH2' ' A' ' 18' ' ' ARG . 3.8 mtt180 -48.47 -52.31 22.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 108.949 179.475 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LYS . 1.4 t30 -66.15 -58.78 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.794 0.807 . . . . 0.0 109.28 179.901 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -42.18 -37.31 1.42 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.648 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.41 -42.94 58.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.75 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ASN . 23.1 tttm -61.12 -33.11 72.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.393 -0.817 . . . . 0.0 108.824 179.212 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.39 -50.34 65.32 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 179.654 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -49.69 59.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.98 74.66 0.04 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.551 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 56.4 m-85 -150.2 152.25 34.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.931 -1.335 . . . . 0.0 109.095 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.22 30.51 0.69 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 111.518 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.69 108.69 4.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.639 -1.288 . . . . 0.0 111.04 -179.255 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -150.06 179.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.04 . . . . 0.0 109.909 178.722 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.6 mt-10 -137.57 -168.02 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.87 150.38 31.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.984 -1.073 . . . . 0.0 111.167 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -136.82 -164.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.37 -6.63 5.3 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.67 . . . . 0.0 110.765 -179.528 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.96 179.8 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.728 -1.232 . . . . 0.0 109.948 179.873 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASN . . . -55.28 -57.56 17.91 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.772 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.7 p -51.99 -35.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.0 108.958 179.94 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.7 t0 -69.86 -41.89 74.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.73 -40.39 88.36 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.6 -35.46 77.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.911 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 -34.5 69.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -89.97 -26.49 20.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.434 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -54.72 -31.76 58.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.085 -1.009 . . . . 0.0 108.836 -179.776 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 1.6 mt-30 -52.88 -22.18 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.503 -0.748 . . . . 0.0 109.309 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -45.59 -59.43 2.74 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.829 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.7 52.8 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.307 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -148.62 -44.98 0.03 OUTLIER Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 53' ' ' PHE . 6.9 m-85 -49.7 92.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.367 -1.078 . . . . 0.0 110.636 -179.555 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -76.32 15.74 5.35 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 177.321 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -168.24 152.47 6.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.288 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.2 t -145.51 107.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.59 89.22 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.5 p -105.13 160.47 15.04 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -178.682 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.6 p-10 -73.13 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.221 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.3 t-105 -149.52 -6.46 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 108.79 179.035 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 4.7 m-80 43.4 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 110.959 178.468 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.48 20.87 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.884 178.76 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -59.09 -65.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 178.79 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.5 m-80 -151.94 -136.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.408 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.65 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.964 -1.085 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 9.4 m-20 -160.72 -167.77 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 -179.566 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.66 -79.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.32 -69.03 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -1.221 . . . . 0.0 109.327 -179.937 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.4 tt0 -61.32 -9.59 5.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.787 . . . . 0.0 109.744 -179.707 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tp -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 109.972 -179.491 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -79.16 -26.77 42.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.34 -179.687 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -59.93 -59.91 4.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.688 179.501 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -56.14 -31.44 63.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.151 -0.968 . . . . 0.0 109.877 -179.649 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -72.4 -21.74 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -31.49 17.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 75' ' ' ASP . . . -71.29 -60.43 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.208 179.812 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 79' ' ' SER . 6.1 p-10 39.94 -141.54 0.05 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.426 0.631 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.438 ' N ' ' OD2' ' A' ' 75' ' ' ASP . . . -159.84 -16.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.927 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.82 -7.26 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -1.107 . . . . 0.0 109.492 179.946 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -96.87 -72.43 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.579 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 11.2 t 44.72 45.26 8.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.579 -0.701 . . . . 0.0 109.831 179.824 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.09 -50.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.02 -1.05 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 80' ' ' ALA . 7.2 mt -27.41 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.455 -0.153 . . . . 0.0 111.112 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.477 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 6.3 Cg_exo -62.7 127.89 21.86 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.188 1.925 . . . . 0.0 114.02 -178.845 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -109.05 113.19 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 175.9 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.23 106.75 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.352 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.7 tpp -82.1 103.23 11.57 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.245 -178.004 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -98.85 148.31 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.854 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 160.06 43.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.37 129.0 35.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.864 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 49.56 74.76 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 179.962 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.27 120.19 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.278 179.684 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -68.89 -77.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.943 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -173.06 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.468 -179.763 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.1 mm-40 -69.5 -35.0 75.11 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -53.48 -35.11 60.23 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.12 -0.988 . . . . 0.0 109.69 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.802 HD11 ' HB1' ' A' ' 90' ' ' ALA . 63.9 mt -66.25 -55.15 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.994 -1.066 . . . . 0.0 108.591 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 100' ' ' GLN . 83.6 mt -69.28 -14.74 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.482 -0.761 . . . . 0.0 109.017 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' GLU . . . -67.72 -54.18 21.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 -179.997 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.579 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -68.61 -46.23 69.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.014 -1.054 . . . . 0.0 108.197 178.885 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -64.44 -27.34 68.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.726 -179.323 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HG2' HG22 ' A' ' 96' ' ' ILE . 2.7 mm-40 -52.08 -32.64 35.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.803 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.75 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.548 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 77.09 0.41 Allowed Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.627 177.874 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -88.79 -111.66 0.07 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 117.411 -1.716 . . . . 0.0 108.941 178.64 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 49.6 m -91.49 -49.75 6.15 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.905 1.336 . . . . 0.0 108.283 175.998 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.57 -162.89 33.74 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.071 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 150.07 42.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.127 -1.22 . . . . 0.0 109.75 179.461 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.69 126.06 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.274 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.92 113.25 10.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.138 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.589 ' NZ ' ' SD ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -87.35 162.53 42.6 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.579 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.4 123.36 8.49 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.836 -0.902 . . . . 0.0 110.478 -2.178 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -92.92 156.26 17.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.876 179.847 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.515 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.69 147.36 23.32 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.519 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.11 -25.5 0.88 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.053 . . . . 0.0 108.909 -179.414 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.92 78.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.728 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.87 -66.41 0.57 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.924 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tp -49.58 -36.08 22.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.506 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 4.5 tt0 -57.58 -62.41 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.031 -1.043 . . . . 0.0 110.227 -179.59 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' GLU . 34.9 mt-10 -46.09 -61.08 1.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 -179.51 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -50.97 -28.0 8.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.832 . . . . 0.0 109.691 179.832 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.489 HD13 ' CD1' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -65.85 -67.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.17 -0.956 . . . . 0.0 109.302 179.83 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.39 -28.46 66.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.003 -1.061 . . . . 0.0 110.506 -179.416 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -77.16 -23.79 51.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.966 -1.084 . . . . 0.0 109.84 -179.693 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.05 -42.38 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.506 -179.4 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 120' ' ' LEU . 11.8 m-85 -65.48 -14.89 61.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.087 -1.008 . . . . 0.0 110.104 -178.508 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -30.89 70.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.316 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -85.04 -26.49 27.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.541 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.5 -19.31 60.96 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.394 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.468 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 71.17 60.71 4.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.738 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.405 -179.705 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.26 150.45 0.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.997 -179.552 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.2 12.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.344 179.739 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -150.6 52.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.164 -179.665 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 50.5 tp -74.05 107.96 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.012 -1.055 . . . . 0.0 108.617 -179.879 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -49.73 106.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 111.458 -178.193 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 70.0 m-85 -99.53 153.84 18.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.268 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.585 ' HB3' HG13 ' A' ' 54' ' ' VAL . 30.9 tp -128.62 107.51 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.106 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.95 115.55 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 -179.813 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 36' ' ' ALA . 2.5 t -98.69 110.44 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 -179.144 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.455 ' CB ' ' HE ' ' A' ' 18' ' ' ARG . 37.7 t0 -166.28 168.47 15.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.028 -1.045 . . . . 0.0 109.758 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -103.06 -28.9 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.654 -0.654 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.3 138.5 55.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.974 . . . . 0.0 109.289 179.851 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.63 -33.48 11.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -75.94 -21.57 56.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.945 -179.634 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 ttm -73.72 -57.37 4.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.034 -1.041 . . . . 0.0 108.842 179.354 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.693 HH21 ' N ' ' A' ' 11' ' ' VAL . 19.2 mmt180 -58.67 -8.2 1.22 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.52 -178.708 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -76.73 -38.38 54.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 108.534 178.725 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -61.86 -55.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.76 -40.2 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.53 -179.185 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mtm180 -45.3 -53.45 8.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 -179.377 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -62.79 -56.77 14.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.328 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 tt -37.98 -58.16 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.94 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -53.52 -51.11 63.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.117 179.692 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.05 -40.11 73.03 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.135 -0.978 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.02 -41.33 62.15 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.272 -0.893 . . . . 0.0 109.217 -179.983 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 113' ' ' ALA . 15.3 mt -73.39 -61.76 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.511 -0.743 . . . . 0.0 109.073 179.77 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.22 68.66 0.01 OUTLIER Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.865 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.23 145.82 26.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.128 -1.219 . . . . 0.0 109.307 179.744 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -150.01 68.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -176.78 99.55 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 0.0 108.653 179.788 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.16 150.82 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 110.562 -178.988 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.31 -169.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.323 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -141.46 161.98 36.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.405 -0.809 . . . . 0.0 110.808 -178.771 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -144.4 -167.93 2.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.242 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.91 -2.24 4.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.465 -0.772 . . . . 0.0 110.666 -179.413 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.43 -171.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.204 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.625 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -69.24 -37.27 80.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.974 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 18.8 m -65.8 -42.3 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 0.0 109.16 179.952 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 40' ' ' VAL . 44.8 t0 -67.15 -50.53 60.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 108.464 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.89 -55.93 28.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.735 -0.603 . . . . 0.0 109.916 179.979 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.3 tm? -46.22 -53.82 9.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.94 . . . . 0.0 108.936 179.934 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 70.6 m-80 -61.27 -41.77 97.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.16 -12.25 59.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.106 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -66.71 -4.48 9.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 108.526 -179.908 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 27.3 tt0 -97.26 -4.56 38.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.768 . . . . 0.0 109.266 179.729 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.4 -72.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.524 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.12 9.5 1.3 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.962 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.0 87.27 1.08 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.7 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 53' ' ' PHE . 62.6 m-85 -66.8 109.62 2.96 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 -5.61 0.59 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.668 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.04 145.02 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 110.292 -178.842 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 83' ' ' VAL . 11.6 t -138.78 115.11 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.137 -0.977 . . . . 0.0 110.225 179.632 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.246 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 145.61 29.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -0.807 . . . . 0.0 109.638 -179.351 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.7 p30 -67.54 -112.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.589 -179.998 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 62.3 t-105 -169.9 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.779 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.462 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 15.5 m-80 -83.36 121.26 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.462 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.27 -50.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 110.129 179.617 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.58 -64.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 120.89 1.06 . . . . 0.0 109.888 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -150.94 -76.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.26 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -88.34 0.22 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.367 179.713 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 178.99 150.7 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.731 179.836 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.16 17.39 1.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 66' ' ' LEU . 4.4 tt -78.4 -56.6 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.847 -1.384 . . . . 0.0 108.203 179.287 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.51 -9.76 0.54 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.565 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD13 ' CA ' ' A' ' 39' ' ' GLY . 15.7 tp -81.91 -57.38 3.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -66.91 -34.91 78.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.603 -179.642 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -66.97 -59.07 3.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.146 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.9 m -54.84 -37.0 65.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.072 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt -57.44 -38.58 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.506 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -66.21 -7.55 18.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.909 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -71.81 -27.55 63.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.785 -179.907 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -51.36 -178.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 109.653 -179.746 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.09 -146.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.13 -12.49 60.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttp -90.04 -2.53 58.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ASP . 14.6 m 47.28 -120.03 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -0.894 . . . . 0.0 108.895 -179.741 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.08 56.9 0.96 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.251 178.955 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 80' ' ' ALA . 11.0 mt 57.53 155.39 0.08 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.648 -0.657 . . . . 0.0 110.035 178.112 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.47 140.39 54.15 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.314 2.009 . . . . 0.0 114.959 -177.166 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -129.32 116.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.134 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -103.06 108.51 19.72 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.523 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.62 138.52 57.51 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.671 -178.484 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 107' ' ' VAL . 2.0 t -116.35 139.92 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.675 -0.64 . . . . 0.0 110.168 -178.915 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -149.96 165.96 31.08 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.747 179.532 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . -100.19 128.63 46.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.667 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 91' ' ' LYS . 33.6 tt0 50.58 94.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.033 -179.598 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 95' ' ' ILE . . . -44.78 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.736 -179.683 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' CB ' HD21 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -76.57 16.81 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.474 -179.832 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 22.2 tttt 69.74 -70.28 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 94' ' ' ASN . 12.4 tm-20 -49.82 -49.32 49.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.179 -0.95 . . . . 0.0 110.176 -179.475 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.549 HD21 ' CB ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -65.14 -66.79 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.21 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.777 HD12 ' CE2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -45.54 -42.76 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.247 -0.908 . . . . 0.0 109.901 -179.16 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.19 -31.08 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.953 -1.092 . . . . 0.0 109.624 -179.782 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.41 85.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.655 -179.718 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.58 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -69.2 -53.69 18.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 108.366 179.39 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.61 -26.35 61.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.327 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -53.32 -32.44 48.97 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.45 -23.38 26.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.202 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.34 75.38 0.51 Allowed Glycine 0 N--CA 1.481 1.693 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.802 177.663 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.786 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -85.52 -111.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 117.107 -1.837 . . . . 0.0 108.911 178.541 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 34.9 m -91.49 -46.68 7.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.473 1.13 . . . . 0.0 107.995 175.697 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.426 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 171.3 -159.73 31.64 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.732 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.777 ' CE2' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.23 131.67 30.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.829 -0.806 . . . . 0.0 108.997 179.175 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.901 HG21 HD12 ' A' ' 116' ' ' LEU . 11.9 p -127.65 120.95 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.658 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 89' ' ' GLU . 2.0 p -70.32 157.92 6.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 108.964 -179.485 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -131.63 160.41 67.55 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.885 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.57 126.32 11.94 Favored 'Cis proline' 0 C--N 1.32 -0.93 0 C-N-CA 124.716 -0.951 . . . . 0.0 110.429 -2.06 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' CE1' HD22 ' A' ' 116' ' ' LEU . 4.9 p90 -91.4 159.91 15.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.828 179.932 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.38 149.86 20.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.991 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -49.96 -35.04 22.74 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.773 -1.204 . . . . 0.0 108.815 -179.53 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.93 -31.73 71.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.781 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.5 m -72.61 -68.13 0.5 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.729 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.901 HD12 HG21 ' A' ' 107' ' ' VAL . 3.6 tp -47.57 -36.72 11.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.62 -1.3 . . . . 0.0 109.253 178.861 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -62.31 -64.56 0.89 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.846 -1.159 . . . . 0.0 109.126 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -45.27 -51.0 11.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.629 -0.669 . . . . 0.0 109.738 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.739 ' NZ ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -55.5 -54.34 45.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.464 -179.836 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 120' ' ' LEU . 26.9 mt -55.97 -44.9 78.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.563 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -47.76 -69.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 109.977 -179.273 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -49.06 -27.44 3.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.317 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.34 -40.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.947 -1.096 . . . . 0.0 110.577 -179.208 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -74.28 -22.71 59.18 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.139 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -62.29 -20.43 64.29 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.692 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -97.51 -27.7 14.31 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.888 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.79 -13.07 49.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.264 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.21 71.94 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -159.72 147.32 16.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.1 8.48 32.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.989 -1.07 . . . . 0.0 109.972 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -155.62 52.74 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 0.0 109.844 -179.678 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 tp -77.21 131.04 38.03 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.881 -1.137 . . . . 0.0 107.943 179.471 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -67.48 110.7 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.107 . . . . 0.0 111.708 -177.388 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 81.7 m-85 -105.4 148.01 27.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.3 tp -124.72 105.08 9.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -91.4 111.24 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 109.998 -179.142 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.2 t -113.91 106.91 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 40.0 t0 -172.35 117.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.161 -0.962 . . . . 0.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.01 135.39 20.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.722 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -171.23 -153.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.478 -1.389 . . . . 0.0 112.121 -177.263 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.722 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -177.11 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.36 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.524 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -164.95 -59.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.516 0.674 . . . . 0.0 110.27 -177.868 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.4 ttt -35.62 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.034 -0.416 . . . . 0.0 111.296 179.596 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 34.5 mtm180 -46.2 -27.08 0.9 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.699 -1.251 . . . . 0.0 109.782 -178.615 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' THR . 4.0 ttp180 -78.54 -32.64 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.815 -1.178 . . . . 0.0 108.985 178.967 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 mt -66.94 -54.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 108.992 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -56.08 -40.37 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -180.0 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -43.58 -53.7 5.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.479 -0.763 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -63.0 -57.12 11.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.901 0.858 . . . . 0.0 108.783 179.168 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -37.76 -57.74 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.714 179.964 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.83 -52.43 65.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.076 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -48.39 -30.6 5.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.77 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -48.22 -41.36 27.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.233 -0.917 . . . . 0.0 108.9 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -75.03 -65.31 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.116 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.69 22.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 68.9 m-85 -89.99 145.72 24.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.75 -1.441 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -150.14 59.54 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.074 -1.016 . . . . 0.0 110.42 179.718 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -174.38 104.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.228 . . . . 0.0 110.295 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -146.47 179.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.149 -0.97 . . . . 0.0 109.762 179.423 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.5 mm-40 -139.21 -169.76 2.73 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.627 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.0 145.88 26.68 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.858 -179.068 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.873 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.98 -171.01 3.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.814 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 2.0 mp0 -132.38 -2.05 3.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.251 -0.905 . . . . 0.0 110.495 -179.197 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.82 -177.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.229 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -67.23 -36.29 89.59 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 41' ' ' ASP . 7.6 p -62.89 -45.68 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -1.202 . . . . 0.0 109.436 -179.935 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.0 t0 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.401 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -71.87 -22.93 61.44 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.414 179.956 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.659 -1.276 . . . . 0.0 108.294 179.205 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -72.92 -27.52 61.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.676 -0.64 . . . . 0.0 110.04 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.75 -37.87 14.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.959 . . . . 0.0 110.777 -178.868 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -49.96 -23.5 2.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.714 -1.241 . . . . 0.0 109.552 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 5.6 tp60 -96.89 -13.57 22.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -40.85 -62.08 0.86 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 -179.594 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.62 3.75 2.39 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.88 76.8 1.15 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.74 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.722 ' O ' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -57.68 131.49 50.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 110.131 -179.392 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.33 3.75 83.65 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.037 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -168.15 146.32 4.37 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.101 -1.235 . . . . 0.0 110.264 -179.149 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.7 t -143.93 121.38 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.067 -1.021 . . . . 0.0 109.895 179.389 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.477 ' CG2' HG21 ' A' ' 86' ' ' VAL . 44.5 mt -106.61 103.92 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.611 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.9 p -114.51 161.07 18.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.388 -0.82 . . . . 0.0 110.318 -178.599 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 17.1 p-10 -89.38 -110.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.541 -0.724 . . . . 0.0 109.2 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 77.3 t-105 -141.37 177.78 7.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 179.702 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.869 ' H ' HD21 ' A' ' 59' ' ' ASN . 0.0 OUTLIER -76.7 75.24 3.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.758 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtm -86.13 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.927 -1.108 . . . . 0.0 110.378 179.677 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.1 -55.2 0.41 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 C-N-CA 120.898 1.065 . . . . 0.0 109.747 179.932 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -172.49 -162.3 0.19 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.437 -0.789 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -47.55 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -164.91 137.08 4.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.565 -179.563 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 103.27 -50.53 0.89 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.699 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 tp -85.78 -46.6 10.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.564 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.403 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.0 mm-40 -63.31 -20.03 65.13 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.581 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 65' ' ' GLY . 3.7 mt -68.52 -61.77 1.68 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.684 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.929 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -45.81 -64.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.984 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.91 -49.74 4.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.2 -179.438 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -64.19 -32.91 74.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.793 HD13 HG21 ' A' ' 83' ' ' VAL . 46.4 mt -74.82 -31.18 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.174 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -20.0 23.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.43 -30.07 4.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.357 -179.836 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.76 100.12 0.38 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.372 -0.83 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.74 46.41 2.32 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.791 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.32 -28.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -1.168 . . . . 0.0 109.292 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -96.98 -70.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.453 179.946 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 16.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.159 -179.799 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -104.89 -39.27 6.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.583 -0.698 . . . . 0.0 109.736 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.41 97.14 0.1 Allowed Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.629 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.88 102.49 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.652 0 C-N-CA 121.169 1.246 . . . . 0.0 112.064 -178.767 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 72' ' ' ILE . 2.5 t -107.67 116.24 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 177.364 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.42 106.66 17.24 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.58 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 98' ' ' ALA . 7.4 ttm -67.23 160.42 27.03 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.039 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 55' ' ' ILE . 18.6 t -137.49 144.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.29 -0.881 . . . . 0.0 110.183 -178.967 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -150.18 158.68 44.41 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.88 -82.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.115 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -77.51 68.88 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.933 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.759 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -42.83 123.67 2.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 110.646 -178.896 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.93 112.72 25.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.117 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -43.82 -25.97 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.468 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.87 -38.01 33.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.193 -0.942 . . . . 0.0 110.326 -179.447 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -90.06 -9.71 47.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.099 -1.001 . . . . 0.0 110.43 -179.299 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.3 mp -74.23 -27.05 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.972 -1.08 . . . . 0.0 108.55 -179.816 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 96' ' ' ILE . 13.0 mt -87.05 -8.59 11.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 108.909 179.591 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.37 -52.89 10.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.471 -0.768 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB2' ' SD ' ' A' ' 85' ' ' MET . . . -64.82 -48.59 73.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.905 -1.122 . . . . 0.0 108.026 178.867 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -63.71 -31.7 72.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.89 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 5.6 tt0 -59.25 -32.6 70.14 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.932 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.929 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.2 -24.08 47.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 176.091 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.88 74.01 0.49 Allowed Glycine 0 N--CA 1.481 1.657 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.387 176.243 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.22 -112.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 116.984 -1.887 . . . . 0.0 109.606 177.818 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.4 m -91.96 -50.91 5.46 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 123.009 1.385 . . . . 0.0 107.645 174.983 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 169.04 -164.17 37.83 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.391 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -133.47 121.79 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.123 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -113.46 123.53 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.446 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.801 HG22 ' H ' ' A' ' 109' ' ' LYS . 12.5 p -64.44 -177.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.126 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.801 ' H ' HG22 ' A' ' 108' ' ' VAL . 1.2 pttt -154.62 158.76 32.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.595 -1.315 . . . . 0.0 108.602 179.848 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.41 136.81 45.98 Favored 'Cis proline' 0 C--N 1.317 -1.121 0 C-N-CA 124.54 -1.025 . . . . 0.0 110.446 -2.191 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.1 p90 -96.59 162.32 13.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.008 . . . . 0.0 109.179 178.997 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.79 144.94 24.8 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 177.132 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.1 -33.22 4.82 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.962 -1.086 . . . . 0.0 109.56 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -32.33 66.52 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.634 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' THR . 13.4 m -71.69 -64.42 0.93 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.966 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -48.96 -40.3 29.82 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.6 -1.313 . . . . 0.0 108.419 179.406 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.09 -57.67 11.81 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.858 -1.151 . . . . 0.0 109.833 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 1.7 tt0 -44.59 -28.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.391 -179.685 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.18 -37.52 14.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 108.742 179.214 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.06 -55.48 14.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.628 -0.67 . . . . 0.0 109.868 -179.467 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CG ' ' N ' ' A' ' 122' ' ' LYS . 3.1 p-10 -48.12 -54.23 13.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.166 -0.959 . . . . 0.0 109.96 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 121' ' ' ASN . 22.5 mttt -53.38 -38.11 63.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.43 -0.794 . . . . 0.0 110.236 -179.517 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.76 -41.5 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.461 -179.138 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -72.97 -6.97 48.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.957 -1.089 . . . . 0.0 110.589 -178.908 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.01 -19.42 60.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.746 -1.221 . . . . 0.0 107.774 178.654 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -97.63 -27.45 14.37 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.935 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -25.96 24.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.9 84.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.797 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.2 m-20 49.36 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 108.533 -179.486 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.585 ' CB ' ' NZ ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -63.13 11.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 0.0 110.498 -178.871 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 3' ' ' ASP . 10.7 mm-40 -139.03 40.49 2.12 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.835 . . . . 0.0 109.339 -179.908 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.0 tp -75.23 129.51 37.58 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 120.603 -1.31 . . . . 0.0 108.178 179.782 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -80.24 124.62 28.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.153 -0.967 . . . . 0.0 111.991 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -113.55 143.52 44.41 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.36 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG13 ' A' ' 54' ' ' VAL . 17.7 tp -112.42 110.2 20.27 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.136 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -92.74 106.74 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.742 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 11' ' ' VAL . 15.2 t -89.92 16.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.535 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 13.7 p30 -51.0 162.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.984 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -144.9 33.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.195 179.952 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' ' CB ' ' A' ' 15' ' ' SER . 51.2 t80 -83.02 -75.97 0.29 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER 165.61 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.811 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.62 -5.7 1.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.511 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.9 ttm -56.02 -38.15 70.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.516 -0.74 . . . . 0.0 109.324 179.756 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.537 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -62.3 -56.35 19.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.887 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.14 -28.89 42.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -178.781 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.9 mt -67.81 -57.8 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.127 -0.983 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.97 -32.43 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.981 -179.25 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.658 ' CA ' ' HE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.11 -55.17 10.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.972 . . . . 0.0 109.449 179.703 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -63.33 -58.14 8.08 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.802 0.81 . . . . 0.0 109.223 179.896 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.4 tt -39.41 -55.95 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.003 -179.55 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.2 -42.21 94.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.069 -1.019 . . . . 0.0 108.926 179.263 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -58.79 -40.69 84.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.818 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.87 -46.6 67.98 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 -179.714 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 117' ' ' GLU . 10.6 mp -66.11 -56.37 11.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.334 -0.854 . . . . 0.0 109.093 179.811 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.04 69.35 0.01 OUTLIER Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.951 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -150.11 130.82 14.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.328 . . . . 0.0 109.184 179.822 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.74 71.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.814 . . . . 0.0 109.971 -179.402 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.59 98.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 0.0 108.524 179.642 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.5 149.47 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.144 -0.973 . . . . 0.0 110.458 -178.544 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -121.75 -172.88 2.52 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.385 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CD ' HH11 ' A' ' 18' ' ' ARG . 39.8 mt-10 -141.71 155.44 45.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.919 0.866 . . . . 0.0 110.816 -178.608 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.05 -168.7 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.27 12.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 110.719 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' OD2' ' O ' ' A' ' 61' ' ' PRO . 14.0 t0 -175.32 154.17 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.538 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.66 -28.63 60.23 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 179.033 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -75.02 -37.33 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.627 -0.925 . . . . 0.0 108.825 179.165 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.68 -39.77 80.4 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.055 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -69.38 -46.49 66.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.53 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.03 -37.37 61.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.965 -179.693 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -76.07 -34.76 59.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.107 -179.412 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -90.02 -13.31 36.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.173 -179.419 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -61.32 -14.69 28.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 -179.971 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -93.89 -4.17 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.12 -65.93 0.47 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.546 -0.721 . . . . 0.0 109.637 -179.929 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.45 -92.2 0.26 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.906 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -162.6 67.16 0.24 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.824 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' PHE . 56.4 m-85 -47.02 98.56 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.546 -0.973 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -65.53 1.56 4.07 Favored Glycine 0 C--N 1.297 -1.599 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.402 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.12 150.57 11.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.397 -1.06 . . . . 0.0 109.21 -179.548 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 83' ' ' VAL . 44.2 t -143.72 118.83 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.767 -1.208 . . . . 0.0 109.993 179.285 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' CG2' HG21 ' A' ' 86' ' ' VAL . 55.5 mt -99.46 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.477 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 36.0 p -102.39 148.72 25.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.406 -0.809 . . . . 0.0 109.818 -179.134 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.91 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 109.06 179.678 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.432 ' C ' ' SD ' ' A' ' 60' ' ' MET . 65.9 t-105 -172.09 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.981 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.445 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.0 t-20 -97.25 98.23 9.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 109.742 -179.731 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.05 162.3 54.68 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.708 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' O ' ' OD2' ' A' ' 38' ' ' ASP . 3.2 Cg_exo -56.3 148.93 58.33 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.373 1.382 . . . . 0.0 110.134 179.362 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.447 ' ND2' ' N ' ' A' ' 62' ' ' ASN . 0.5 OUTLIER 65.99 -159.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.184 -179.73 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.94 156.71 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.8 173.05 12.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.99 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.81 -3.02 2.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.835 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 64' ' ' ASP . 17.3 tp -58.92 -52.5 65.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.18 . . . . 0.0 108.807 179.921 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.81 -4.14 1.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 108.948 179.638 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' CA ' ' A' ' 39' ' ' GLY . 11.0 tp -85.59 -64.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -63.69 -32.34 73.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.865 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -67.35 -60.51 2.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.913 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.9 m -51.41 -40.29 58.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.408 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -60.68 -29.27 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 108.66 179.271 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.51 -22.9 32.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.441 -0.787 . . . . 0.0 109.426 179.787 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.53 -26.79 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.947 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -73.75 -53.12 11.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.346 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.09 -21.29 4.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.894 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.52 -86.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.596 -179.85 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.3 mpp? -96.53 -25.63 15.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.687 -179.691 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.8 m 53.46 -128.48 2.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -139.44 44.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.451 -0.781 . . . . 0.0 109.3 179.927 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.449 HD22 ' HA2' ' A' ' 52' ' ' GLY . 0.3 OUTLIER 50.87 177.04 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.914 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.23 135.96 46.06 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 N-CA-C 116.499 1.692 . . . . 0.0 116.499 -175.551 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -124.33 115.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.856 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -102.47 105.88 16.51 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 117.919 -1.512 . . . . 0.0 107.309 177.996 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.477 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 2.0 tpt -66.09 156.22 34.54 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.089 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG21 ' CG2' ' A' ' 55' ' ' ILE . 29.0 t -135.48 141.06 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -0.816 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -150.09 176.31 10.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -95.33 -130.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -52.71 88.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -48.7 118.35 2.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.58 -179.695 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 13.6 tttt -94.86 6.9 47.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 4.3 ttpp 75.06 -62.39 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.406 -179.891 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.15 -34.45 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.707 -179.8 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -84.4 -45.06 13.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.964 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 106' ' ' TYR . 29.4 mm -48.57 -42.23 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 108.935 179.545 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.7 mt -71.35 -26.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.307 -0.871 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.17 -51.77 67.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.212 -0.93 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -75.55 -51.69 12.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -58.3 -27.99 64.6 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.324 -0.95 . . . . 0.0 108.935 -179.254 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.0 tt0 -56.16 -33.22 65.02 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 178.151 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -82.7 -22.13 34.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.014 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 61.66 76.93 0.22 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.825 177.579 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.829 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.29 -112.08 0.05 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 116.75 -1.98 . . . . 0.0 109.104 178.661 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.0 m -91.86 -51.29 5.29 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 123.096 1.427 . . . . 0.0 107.913 175.058 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.413 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.65 -157.36 28.41 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -178.116 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.79 127.17 16.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.566 -0.961 . . . . 0.0 109.297 179.294 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.01 140.31 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.838 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.22 153.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.788 -179.926 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.21 153.38 80.42 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.785 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.64 132.23 26.1 Favored 'Cis proline' 0 N--CA 1.49 1.27 0 O-C-N 122.328 0.646 . . . . 0.0 111.259 -1.615 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.5 p90 -98.96 162.38 13.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.386 -0.821 . . . . 0.0 109.164 178.79 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -94.97 146.45 24.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.997 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.71 -31.21 4.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 109.127 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.29 -33.48 67.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.664 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.2 m -71.94 -65.61 0.75 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.446 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 111' ' ' PHE . 8.7 tp -47.13 -41.01 16.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 0.0 109.2 178.741 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HB2' HD21 ' A' ' 28' ' ' LEU . 40.2 tt0 -64.31 -58.09 7.51 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 -179.634 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -44.22 -48.55 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.646 -0.659 . . . . 0.0 109.682 -179.703 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -65.75 -47.22 75.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.5 -39.77 70.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 109.634 -179.984 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -46.24 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.93 -179.645 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -71.35 -19.58 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.638 -179.635 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.03 -40.44 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.902 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.0 m-85 -73.82 -33.81 64.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 -179.711 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -50.92 -27.89 8.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.05 -1.031 . . . . 0.0 108.413 179.543 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -90.64 -21.82 21.49 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.043 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 124' ' ' PHE . 13.1 tp -83.3 -20.71 33.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.371 -0.831 . . . . 0.0 108.866 179.431 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.25 76.14 0.14 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.623 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 62.76 134.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 108.962 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -90.04 17.44 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.982 -1.074 . . . . 0.0 109.78 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 42.88 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.938 -1.101 . . . . 0.0 110.593 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.41 141.91 57.77 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -78.13 131.36 37.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 0.0 111.104 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.646 ' HB2' HG22 ' A' ' 33' ' ' VAL . 83.2 m-85 -123.67 146.88 47.91 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.827 -0.545 . . . . 0.0 110.259 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.664 ' HB3' HG13 ' A' ' 54' ' ' VAL . 60.9 tp -121.78 116.18 24.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.688 -0.632 . . . . 0.0 109.368 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 109.22 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -106.25 26.02 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.713 -0.617 . . . . 0.0 109.672 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 117.66 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.61 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -64.83 -14.41 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.313 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.0 140.86 4.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.474 ' C ' HG22 ' A' ' 16' ' ' THR . 53.5 p -97.96 47.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.446 -0.784 . . . . 0.0 109.512 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.474 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER 178.23 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 tpt -61.13 -46.68 89.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.614 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -49.84 -31.69 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.912 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -74.01 -42.08 60.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.732 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.44 -52.73 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.755 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -40.48 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 110.234 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.94 -53.11 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -68.64 -57.74 5.26 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.769 0.795 . . . . 0.0 109.686 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -39.64 -56.53 1.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.663 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.36 -51.17 67.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.095 -1.003 . . . . 0.0 108.757 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -47.76 -40.41 20.63 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.249 -0.907 . . . . 0.0 108.983 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.12 -34.37 73.41 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.416 -0.803 . . . . 0.0 109.308 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 117' ' ' GLU . 1.6 mm? -81.09 4.32 20.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.55 62.53 1.78 Allowed Glycine 0 N--CA 1.482 1.748 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -143.58 126.85 16.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -1.184 . . . . 0.0 109.092 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -133.63 65.32 1.59 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.632 -0.668 . . . . 0.0 109.815 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -172.48 89.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -135.75 150.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.0 109.938 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -119.17 -177.12 3.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -150.09 155.22 39.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.863 -1.148 . . . . 0.0 110.81 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -146.6 -165.41 2.22 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 17.1 mt-10 -137.34 -5.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 0.0 110.359 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -177.23 -177.92 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.79 -1.193 . . . . 0.0 109.733 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.63 -52.24 47.57 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.55 -31.85 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.263 . . . . 0.0 108.513 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.8 t0 -74.63 -47.64 30.94 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.122 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -59.08 -48.06 82.98 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.2 -40.09 73.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.954 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 5.9 m-20 -81.56 -25.67 35.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -90.25 -23.88 21.1 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CD2' ' H ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -80.11 -17.27 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.53 -1.356 . . . . 0.0 110.21 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -61.58 -5.94 2.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -52.77 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.019 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.88 11.57 1.67 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.473 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.44 86.21 0.26 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.826 ' O ' HD11 ' A' ' 81' ' ' LEU . 25.2 m-85 -58.92 157.58 9.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.406 -1.056 . . . . 0.0 110.43 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.73 -9.42 62.72 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 140.47 19.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.676 -0.896 . . . . 0.0 109.133 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 9' ' ' LEU . 20.6 t -135.17 120.43 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.0 110.164 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.8 mt -104.08 128.51 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -146.38 147.02 30.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.066 -1.021 . . . . 0.0 109.672 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 58' ' ' TRP . 16.6 t70 -63.84 -120.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.402 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.417 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 61.9 t-105 -161.89 -28.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.782 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -166.64 34.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.633 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.2 -37.22 0.43 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -68.83 -70.65 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.846 1.031 . . . . 0.0 110.152 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.81 -81.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -76.0 -113.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -142.14 -178.42 5.71 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . -93.79 -17.97 39.43 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.396 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.572 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 1.4 mm? -46.79 -68.98 0.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.687 -1.478 . . . . 0.0 110.042 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -43.57 -41.79 4.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.96 -42.9 99.96 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.706 HD21 ' H ' ' A' ' 102' ' ' GLY . 5.4 tt -82.59 -64.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.877 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -33.75 -41.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.23 0.538 . . . . 0.0 110.144 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.465 HG21 HD21 ' A' ' 43' ' ' LEU . 19.6 m -58.96 -48.03 82.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 108.728 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 57.8 mt -50.76 -45.14 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 108.88 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -65.41 -39.29 91.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.34 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 109.574 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.35 -128.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.361 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.621 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . 170.16 161.38 20.56 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 71.79 -14.14 0.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -1.12 . . . . 0.0 109.413 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 76' ' ' GLY . 2.3 mmt -146.82 17.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 m -68.78 7.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.351 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -93.92 2.7 56.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 109.645 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.826 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -43.86 107.59 0.61 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.543 -0.723 . . . . 0.0 109.397 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HD2' HD13 ' A' ' 81' ' ' LEU . 4.1 Cg_exo -62.58 136.5 58.92 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 120.76 0.973 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.2 t -130.27 129.27 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.617 ' CD2' HD21 ' A' ' 116' ' ' LEU . 38.4 tp -110.64 72.03 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.45 145.53 22.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 t -113.56 129.97 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.13 166.29 30.27 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.114 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -91.05 147.72 22.88 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 6.4 mt-10 49.33 -152.0 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.909 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 176.76 115.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.803 -1.186 . . . . 0.0 110.43 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.63 121.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -43.88 -45.24 7.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.299 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -51.89 -32.81 34.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.58 -41.52 13.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.909 HD11 ' HB1' ' A' ' 90' ' ' ALA . 9.2 mt -67.54 -13.07 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.037 -1.04 . . . . 0.0 109.573 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.2 mt -80.56 -70.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.082 . . . . 0.0 109.885 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.804 . . . . 0.0 109.0 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' A' ' 103' ' ' ALA . . . -70.35 -61.67 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.604 -0.685 . . . . 0.0 109.762 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -58.45 -34.63 71.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.222 -0.924 . . . . 0.0 109.699 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -50.91 -19.59 1.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 108.871 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -108.45 -115.03 0.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.83 -0.544 . . . . 0.0 109.603 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.731 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -120.67 -0.99 12.11 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' C ' ' A' ' 98' ' ' ALA . . . -59.18 11.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.903 . . . . 0.0 109.23 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.731 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.2 m -29.2 -31.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.32 133.55 11.72 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.572 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.55 110.64 6.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.7 p -112.58 130.79 65.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.459 HG22 ' OH ' ' A' ' 106' ' ' TYR . 0.5 OUTLIER -64.86 -157.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -174.1 152.54 1.88 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.059 -1.026 . . . . 0.0 109.268 179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.3 146.4 86.14 Favored 'Cis proline' 0 N--CA 1.487 1.111 0 O-C-N 122.576 0.777 . . . . 0.0 110.512 -2.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -112.97 155.04 25.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.936 0.874 . . . . 0.0 109.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.17 146.88 23.46 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -46.03 -29.66 1.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 0.0 109.387 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.14 -35.1 59.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 112' ' ' THR . 16.2 m -69.07 -60.88 2.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -45.83 -50.71 13.92 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.17 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' HG3' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -51.06 -32.48 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 115' ' ' THR . 4.5 tp10 -67.76 -43.9 78.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.84 . . . . 0.0 109.973 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -71.28 -51.33 25.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.975 . . . . 0.0 109.922 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tp -50.2 -59.59 3.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.127 -0.983 . . . . 0.0 109.856 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -52.74 -35.92 56.9 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -66.48 -24.58 66.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 105' ' ' GLY . 22.2 mt -88.83 -47.96 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.954 -1.091 . . . . 0.0 110.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -58.71 -12.4 4.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 110.339 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.09 -24.15 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.99 -29.09 16.8 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.35 -24.52 42.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.489 -0.757 . . . . 0.0 109.055 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.06 81.82 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.257 -1.143 . . . . 0.0 109.558 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.287 0.565 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.512 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.34 141.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -90.59 10.17 26.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.283 -0.886 . . . . 0.0 109.952 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.96 51.42 1.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 46.9 tp -84.17 107.81 16.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -48.5 112.83 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.02 . . . . 0.0 111.705 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 63.0 m-85 -102.6 153.98 19.57 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 46' ' ' LEU . 12.9 tp -131.17 105.61 7.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.344 -0.847 . . . . 0.0 108.884 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -93.71 108.7 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.073 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.914 HG22 ' HB3' ' A' ' 36' ' ' ALA . 62.4 t -96.0 40.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.824 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -70.6 144.58 51.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -97.53 0.51 47.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.69 143.49 27.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.557 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -85.35 34.27 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -165.33 -8.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -37.55 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 1.5 mpt_? -62.07 -16.08 49.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 108.967 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -75.07 -42.08 57.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -53.44 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.871 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.57 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 110.2 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.12 -54.71 8.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.761 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.71 -57.77 6.45 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.981 0.896 . . . . 0.0 109.315 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.27 -64.59 0.53 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.436 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.0 mt -50.1 -44.51 52.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 108.76 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -52.02 -48.01 64.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.356 -0.84 . . . . 0.0 109.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -23.47 63.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.478 -0.764 . . . . 0.0 109.291 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 117' ' ' GLU . 28.1 mt -89.51 3.58 51.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.1 59.41 2.43 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 52.8 m-85 -148.33 142.82 26.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.291 . . . . 0.0 109.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -150.1 27.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.178 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -135.0 99.43 4.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.196 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -146.3 179.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.149 -0.969 . . . . 0.0 109.599 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.1 mt-10 -138.7 -174.28 3.79 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.91 157.27 46.33 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.794 0.807 . . . . 0.0 110.826 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.914 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.97 -174.26 4.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.9 pt-20 -148.77 13.56 0.91 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.912 -1.118 . . . . 0.0 110.226 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 178.16 -179.9 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.954 -1.091 . . . . 0.0 109.131 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -71.28 -39.55 61.96 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.1 -30.9 46.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.125 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.601 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.2 t0 -81.18 -46.09 15.38 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.507 -0.745 . . . . 0.0 109.674 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.43 -42.33 92.57 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.75 -58.04 7.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.061 -1.024 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -54.75 -29.06 52.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 110.072 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -90.13 -31.02 17.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.126 -0.984 . . . . 0.0 110.622 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -53.93 -41.01 67.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.037 -1.039 . . . . 0.0 109.712 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.7 -11.77 59.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.903 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.81 -65.21 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.4 7.65 1.81 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.43 87.04 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.693 ' O ' HD21 ' A' ' 81' ' ' LEU . 61.3 m-85 -67.81 110.45 3.81 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.327 -1.102 . . . . 0.0 110.076 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 81' ' ' LEU . . . -54.65 -10.1 2.02 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.75 126.78 11.22 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.195 -1.179 . . . . 0.0 110.289 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 83' ' ' VAL . 95.9 t -122.92 120.24 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.9 mt -103.61 123.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -139.27 168.38 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.737 . . . . 0.0 109.095 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 9.8 t70 -84.47 -97.01 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 74.9 t-105 -172.4 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.506 ' N ' ' CD1' ' A' ' 58' ' ' TRP . 19.8 t-20 -91.48 126.79 36.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.528 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.47 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.2 mtp 176.62 -50.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.0 Cg_exo -64.19 -168.87 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.815 1.01 . . . . 0.0 110.113 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.61 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.6 mmt -69.76 -117.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.64 147.73 33.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.119 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.04 -8.6 3.27 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -74.71 -63.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.943 -1.328 . . . . 0.0 108.817 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.71 -25.78 12.05 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.3 tt -70.66 -33.64 71.17 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.785 HD21 ' H ' ' A' ' 103' ' ' ALA . 18.0 tp -86.55 -58.26 2.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -43.26 -47.2 6.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.852 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.0 m -51.41 -47.36 63.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 108.99 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.52 -38.47 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 108.924 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -83.94 -20.7 32.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.1 -28.96 43.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -52.27 -70.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.62 -63.39 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.8 -26.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -1.115 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -90.11 -40.88 11.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' MET . 0.3 OUTLIER 75.78 -59.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.16 -54.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.653 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 51' ' ' TYR . 13.3 tp 59.3 120.3 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.85 131.76 43.83 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 120.606 0.87 . . . . 0.0 112.293 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -126.73 127.6 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.7 69.48 0.72 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.462 ' O ' ' CG ' ' A' ' 85' ' ' MET . 5.9 ptt? -61.33 123.62 18.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.83 127.13 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.02 . . . . 0.0 109.511 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.8 t -150.05 136.94 19.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.566 -1.334 . . . . 0.0 110.456 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.04 -14.34 34.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.288 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -102.94 34.52 2.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.58 114.19 3.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.513 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.65 -125.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -0.801 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 94' ' ' ASN . 18.6 tttm -117.17 -89.46 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.651 . . . . 0.0 109.816 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -18.74 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.054 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.477 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -70.68 -35.31 72.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.603 HD11 ' HB1' ' A' ' 90' ' ' ALA . 49.2 mt -85.25 -28.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -73.27 -60.75 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.019 -1.051 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.61 -43.26 12.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.249 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -66.35 -47.54 73.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.34 50.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.94 -1.1 . . . . 0.0 109.721 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -56.76 -24.03 47.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.9 -103.9 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.717 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -135.89 -0.64 3.13 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.785 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -58.18 11.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.828 -0.807 . . . . 0.0 110.913 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 102' ' ' GLY . 49.1 m -29.4 -31.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.65 132.72 11.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -146.26 117.04 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -1.163 . . . . 0.0 109.446 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.57 139.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.4 103.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.76 -1.213 . . . . 0.0 108.337 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -71.72 155.33 92.43 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.873 -1.142 . . . . 0.0 109.38 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.33 168.64 75.49 Favored 'Cis proline' 0 N--CA 1.486 1.04 0 C-N-CA 124.811 -0.912 . . . . 0.0 110.234 -2.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -144.14 157.84 44.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -101.1 149.57 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.416 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -47.12 -32.15 4.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.254 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.62 82.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 5.7 m -69.23 -69.44 0.34 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.4 tp -43.9 -37.5 2.89 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.577 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.2 tt0 -59.07 -59.4 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.24 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.38 -40.11 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.626 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -59.94 -55.35 35.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 121' ' ' ASN . 10.6 mt -50.07 -72.66 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -38.96 -44.42 1.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.486 -0.759 . . . . 0.0 111.851 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -66.5 -31.35 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.942 -1.099 . . . . 0.0 110.372 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 125' ' ' GLU . 18.6 mt -89.97 -40.26 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.092 -1.005 . . . . 0.0 111.075 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -62.16 0.97 0.35 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.059 -1.026 . . . . 0.0 110.558 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.9 mt-10 -77.06 -25.39 52.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -91.44 -29.52 17.0 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -73.07 -29.62 63.08 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.55 80.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.127 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 2' ' ' ALA . 34.6 t70 -43.68 146.44 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.776 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.03 14.05 13.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.071 -1.018 . . . . 0.0 108.674 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 29.1 mp0 -147.24 50.38 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 29.3 tp -78.72 118.44 20.8 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.615 -1.303 . . . . 0.0 108.858 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 118.79 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.141 -0.974 . . . . 0.0 111.418 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 60.5 m-85 -113.44 151.57 31.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG22 ' A' ' 54' ' ' VAL . 53.7 tp -129.82 102.94 6.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 21' ' ' VAL . 1.3 m -90.53 116.86 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.251 -0.905 . . . . 0.0 109.258 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.89 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.8 t -112.37 129.49 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.522 -0.737 . . . . 0.0 110.368 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -165.42 -167.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 7.8 t70 -148.5 13.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 0.0 109.729 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -74.88 -18.7 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.783 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.07 2.9 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.321 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -150.69 -22.01 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.865 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -26.96 66.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -40.81 97.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -64.19 -23.93 67.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.55 -52.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.514 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -66.05 -35.27 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.03 -56.69 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.24 -56.61 19.49 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.953 0.882 . . . . 0.0 109.042 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 tt -37.73 -51.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.07 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 25' ' ' LEU . 28.9 mt -58.65 -52.27 66.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 108.593 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -52.6 -46.06 66.8 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.383 -0.823 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.22 -25.6 14.72 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.435 HD13 ' HE2' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -83.3 -64.57 1.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.557 -0.715 . . . . 0.0 109.134 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.96 67.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HE2' HD13 ' A' ' 28' ' ' LEU . 71.4 m-85 -149.96 155.38 39.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.98 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -150.09 61.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.918 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.89 99.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -0.943 . . . . 0.0 108.545 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.17 149.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 110.701 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -122.02 -169.38 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -147.33 152.87 38.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.89 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.07 167.82 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 5.8 mt-10 -99.94 -2.48 34.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -0.902 . . . . 0.0 110.489 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER 169.12 -179.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.917 -1.114 . . . . 0.0 109.628 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.25 76.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' OD2' ' A' ' 64' ' ' ASP . 58.3 t -54.19 -40.29 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.302 . . . . 0.0 108.789 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 4.3 t70 -67.56 -42.13 83.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.59 -0.694 . . . . 0.0 109.199 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.36 -57.13 8.12 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.363 -0.835 . . . . 0.0 109.409 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' ALA . 53.5 tp -41.95 -43.03 2.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 110.02 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.34 -34.92 70.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 0.0 109.892 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -89.99 -14.04 34.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.173 -0.954 . . . . 0.0 110.625 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -64.55 -18.05 64.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.027 . . . . 0.0 108.569 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -85.89 -3.02 58.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.536 -0.727 . . . . 0.0 109.264 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.62 -73.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.5 8.46 1.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 71.77 1.25 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HD21 ' A' ' 81' ' ' LEU . 34.0 m-85 -47.87 113.52 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -1.036 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.3 -3.67 3.06 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.6 t80 -166.39 141.25 4.41 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.024 -1.28 . . . . 0.0 109.974 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 9' ' ' LEU . 13.3 t -137.52 108.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 110.509 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 55' ' ' ILE . 51.9 mt -90.01 78.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 p -88.0 154.4 20.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.039 -1.038 . . . . 0.0 110.65 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.87 167.67 9.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -61.85 88.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -60.77 125.32 23.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.132 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.653 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 22.8 ttp -131.73 30.89 0.2 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.642 -0.661 . . . . 0.0 112.467 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -57.75 -59.06 0.62 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 N-CA-C 108.788 -1.274 . . . . 0.0 108.788 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -159.04 -28.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.458 ' O ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -175.52 108.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' HG23 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -177.05 -172.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.954 -1.091 . . . . 0.0 110.077 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.63 -71.97 1.8 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' C ' ' N ' ' A' ' 68' ' ' LEU . 1.1 mm? -65.97 -65.06 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.007 -1.29 . . . . 0.0 108.57 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -49.81 -19.91 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' N ' ' C ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 101' ' ' ALA . 2.0 tt -45.94 -63.18 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 109.067 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -42.72 -50.23 5.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LEU . 54.1 mt -73.59 -23.31 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.08 -29.55 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.611 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.76 -28.13 1.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.506 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -47.29 126.7 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.28 -34.25 5.93 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -89.97 -46.69 8.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.4 t 45.8 19.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.22 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -140.93 2.34 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.695 . . . . 0.0 109.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 51' ' ' TYR . 2.5 tp -47.32 110.48 1.33 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.046 -1.034 . . . . 0.0 108.53 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.19 113.81 1.83 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 121.196 1.264 . . . . 0.0 112.976 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.2 t -113.83 117.89 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.715 HD12 HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -98.11 105.31 17.43 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.292 178.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 tpt -76.14 99.47 4.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.168 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -99.4 150.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.855 -1.153 . . . . 0.0 110.389 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.3 t -150.25 -179.81 7.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 109.878 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.35 -73.28 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.41 54.66 1.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 95' ' ' ILE . . . -50.34 107.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 177.78 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 108.9 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -75.07 -34.84 61.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.06 -34.41 17.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.214 -0.929 . . . . 0.0 110.224 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.86 -24.47 63.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.047 -1.033 . . . . 0.0 109.958 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 16.0 mt -72.6 -36.21 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.033 . . . . 0.0 109.401 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.9 mt -80.95 -14.55 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.268 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -63.43 -48.6 77.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.16 -58.98 6.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 108.849 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.7 -25.22 53.74 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.056 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.34 -32.26 37.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.07 -28.2 24.24 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 76.44 67.39 1.69 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.947 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.18 -111.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 117.103 -1.839 . . . . 0.0 110.368 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.575 ' HB2' HD22 ' A' ' 84' ' ' LEU . 50.0 m -91.46 -51.43 5.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.201 1.477 . . . . 0.0 107.554 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.77 -157.58 30.05 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.96 151.93 49.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -1.153 . . . . 0.0 109.244 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 84' ' ' LEU . 8.5 p -147.15 124.74 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.189 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.88 162.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 108.828 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 pttt -135.65 159.5 71.2 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.329 -0.857 . . . . 0.0 108.747 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.34 132.88 29.01 Favored 'Cis proline' 0 C--N 1.32 -0.969 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.44 -2.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.6 p90 -93.42 158.37 15.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.157 -0.965 . . . . 0.0 109.417 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -89.88 147.39 23.78 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.61 -36.97 11.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.96 -1.088 . . . . 0.0 109.064 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 -33.11 74.4 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.252 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' THR . 10.8 m -71.74 -65.79 0.72 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.678 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.91 -38.74 23.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.343 -1.343 . . . . 0.0 108.637 179.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.44 -48.38 79.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -45.79 -43.17 12.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -78.62 -34.51 46.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 109.762 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.441 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -63.64 -35.61 81.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.94 -35.36 59.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 109.944 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -31.03 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.3 mt -77.7 -35.03 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -86.55 0.51 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -77.71 -26.72 50.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -96.43 -22.31 17.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.21 -24.97 22.0 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 85.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.215 -1.167 . . . . 0.0 109.501 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.84 128.54 11.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 108.742 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.71 30.95 0.87 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.999 -1.063 . . . . 0.0 109.459 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -148.39 38.14 0.86 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -75.31 141.35 43.4 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HZ3' ' CG ' ' A' ' 32' ' ' ASN . 11.0 mttm -81.6 131.63 35.28 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.105 -0.997 . . . . 0.0 110.971 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 38.4 m-85 -119.56 148.11 43.69 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.789 -0.57 . . . . 0.0 110.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.625 ' CD2' HD12 ' A' ' 46' ' ' LEU . 45.2 tp -121.71 112.42 18.39 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.97 98.87 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.55 -0.719 . . . . 0.0 110.022 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 36' ' ' ALA . 3.8 t -95.16 116.95 37.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER 173.29 152.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.608 -1.308 . . . . 0.0 111.331 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 15' ' ' SER . 3.0 t0 -81.94 52.15 1.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -13.25 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' THR . 1.6 p 57.38 2.22 0.13 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.357 -1.465 . . . . 0.0 108.09 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 15' ' ' SER . 17.0 p 130.59 26.0 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.594 1.157 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' ARG . 30.1 tpp -92.19 -66.6 0.91 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.618 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -33.47 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.91 -39.05 61.65 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.123 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 mt -66.37 -53.34 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.074 -1.016 . . . . 0.0 109.358 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -30.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 110.232 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -53.61 26.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.437 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.731 0.777 . . . . 0.0 109.99 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 113' ' ' ALA . 1.2 tt -40.85 -49.18 3.18 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.933 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -63.54 -53.63 48.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.941 -1.099 . . . . 0.0 108.841 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -54.22 -28.89 44.08 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.205 -0.934 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -35.72 72.44 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.21 -57.78 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.51 74.4 0.02 OUTLIER Glycine 0 N--CA 1.48 1.604 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -150.12 139.17 21.09 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.434 . . . . 0.0 109.045 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -146.57 64.25 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -0.99 . . . . 0.0 109.921 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.516 ' CG ' ' HZ3' ' A' ' 7' ' ' LYS . 10.8 t-20 -173.63 96.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 108.866 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.02 148.44 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.039 -1.038 . . . . 0.0 110.367 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 11.9 mt-10 -122.48 -166.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -150.2 158.65 44.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.529 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.13 -166.63 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.94 13.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 0.0 111.636 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 1.7 t0 -178.85 151.24 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.6 -1.313 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.41 -52.98 12.92 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 40' ' ' VAL . 4.8 t -55.52 -31.55 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.262 -1.14 . . . . 0.0 108.579 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 t0 -71.89 -45.0 62.81 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.164 -0.96 . . . . 0.0 108.894 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -58.46 -58.12 9.95 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.396 -0.815 . . . . 0.0 109.39 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -46.37 -42.65 15.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 110.034 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -78.43 -32.23 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -90.08 -7.01 54.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.774 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -77.72 -16.06 58.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.569 -1.332 . . . . 0.0 108.892 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -78.55 -0.4 29.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.246 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.34 -61.09 1.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.72 15.75 0.46 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.82 102.81 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.565 ' O ' HD21 ' A' ' 81' ' ' LEU . 46.5 m-85 -85.81 142.68 28.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -1.162 . . . . 0.0 110.235 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.17 -7.46 54.77 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -152.78 136.96 16.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.29 116.78 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.625 -1.297 . . . . 0.0 110.484 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -97.87 116.08 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.66 134.73 30.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 108.99 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.76 -177.62 1.31 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.161 -0.962 . . . . 0.0 109.479 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 33.4 t-105 -67.47 -143.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.002 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 60' ' ' MET . 23.3 t-20 -91.82 165.03 13.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.477 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.03 -50.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.737 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -64.73 -77.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 120.779 0.986 . . . . 0.0 110.024 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.11 109.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 108.876 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 48.88 86.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.883 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.4 m-20 -163.71 -167.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 58.73 -76.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -59.03 -71.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.889 -1.359 . . . . 0.0 109.302 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -53.1 -38.77 62.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.955 -1.091 . . . . 0.0 108.853 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.699 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.1 tp -54.23 -47.18 72.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.857 HD21 ' H ' ' A' ' 103' ' ' ALA . 39.0 tp -65.7 -62.13 1.69 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 21.0 tttm -41.83 -45.97 3.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -44.27 68.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.024 . . . . 0.0 109.168 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 69' ' ' LEU . 67.7 mt -57.35 -37.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.054 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -2.16 44.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 109.574 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.65 -28.54 16.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -63.57 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.44 -25.19 20.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.66 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -1.134 . . . . 0.0 109.351 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.3 ttm -90.11 -31.64 17.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.91 . . . . 0.0 109.218 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.03 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.839 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.95 9.27 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.946 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD21 ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -47.92 110.54 1.42 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 81' ' ' LEU . 6.3 Cg_exo -58.86 125.63 18.79 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 120.961 1.107 . . . . 0.0 112.394 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.5 124.44 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.678 HD21 HD21 ' A' ' 116' ' ' LEU . 50.7 tp -100.7 77.2 1.86 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.482 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 155.51 13.45 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.28 132.54 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 t -150.1 -176.9 5.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.761 -1.212 . . . . 0.0 109.975 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.7 -49.47 2.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.605 -0.684 . . . . 0.0 109.771 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -78.43 -69.75 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 70.64 68.08 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.251 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -61.68 -151.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.021 . . . . 0.0 109.899 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 13.3 mttt -97.39 -86.61 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.807 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -47.65 -10.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.391 -0.818 . . . . 0.0 110.42 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.628 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -79.98 -33.4 39.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 0.0 109.512 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 90' ' ' ALA . 61.0 mt -86.78 -9.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.45 -63.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.992 . . . . 0.0 109.859 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.31 -38.85 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.446 -0.784 . . . . 0.0 109.388 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -70.62 -49.09 51.25 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 109.822 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.31 -51.37 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.971 . . . . 0.0 110.558 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -66.74 -10.57 48.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.768 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -95.58 -33.69 12.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.196 -0.94 . . . . 0.0 110.891 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.69 -15.01 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.857 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -56.89 11.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.981 -0.717 . . . . 0.0 110.816 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.665 ' H ' ' C ' ' A' ' 102' ' ' GLY . 71.6 m -29.38 -32.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 122.181 -0.324 . . . . 0.0 111.452 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.97 122.99 7.49 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -141.52 128.74 20.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -1.012 . . . . 0.0 108.574 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -134.95 129.57 51.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -60.14 -165.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 150.91 5.62 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.452 -1.405 . . . . 0.0 109.779 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.62 155.36 99.79 Favored 'Cis proline' 0 N--CA 1.488 1.148 0 C-N-CA 125.275 -0.719 . . . . 0.0 110.621 -1.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.723 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -121.43 155.74 34.22 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.856 0.836 . . . . 0.0 109.803 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.418 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.9 150.8 22.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -48.87 -38.43 22.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.762 -1.211 . . . . 0.0 109.445 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.85 76.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 108.236 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 112' ' ' THR . 17.2 m -67.94 -65.26 0.71 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.723 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.03 -45.39 31.97 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.795 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.83 -56.09 16.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.965 -1.084 . . . . 0.0 109.809 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -46.41 -40.17 11.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.459 -0.776 . . . . 0.0 110.029 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.53 -60.52 2.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tp -45.22 -58.99 2.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.45 -37.18 56.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.977 . . . . 0.0 109.95 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -30.1 68.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.741 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.463 HD11 ' HA2' ' A' ' 105' ' ' GLY . 64.1 mt -89.89 -53.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -57.46 -10.01 1.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.175 -0.953 . . . . 0.0 110.077 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -73.32 -31.16 63.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -91.64 -28.25 17.61 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.86 -28.3 44.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.26 86.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.285 -1.127 . . . . 0.0 109.359 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.27 146.05 1.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -89.97 22.15 3.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -155.26 42.59 0.45 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 29.6 tp -71.2 119.67 15.67 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -61.84 128.37 35.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.496 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.0 m-85 -115.47 156.18 26.13 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.19 101.13 4.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 10' ' ' VAL . 5.0 m -92.17 116.65 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.394 -0.816 . . . . 0.0 109.867 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.572 HG13 ' HB3' ' A' ' 36' ' ' ALA . 5.5 t -95.49 93.78 3.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.354 -0.841 . . . . 0.0 109.414 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.58 121.7 26.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.739 . . . . 0.0 109.493 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -23.46 67.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 109.548 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.28 145.68 31.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.562 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.2 t -94.81 21.54 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -154.2 -7.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.2 ttt -65.5 -35.25 80.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.178 -0.951 . . . . 0.0 109.228 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.645 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -48.74 -44.67 38.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.0 109.454 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -33.4 53.55 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.41 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.18 -54.91 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.028 -1.045 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -32.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.327 -0.858 . . . . 0.0 111.174 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -55.04 27.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 0.0 109.174 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -64.33 -57.44 9.36 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.707 0.765 . . . . 0.0 109.329 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -39.74 -58.6 1.31 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.775 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 mt -56.08 -50.53 70.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -29.36 63.7 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.186 -0.946 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.6 -36.93 72.39 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mt -81.15 -59.79 2.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.4 58.24 0.01 OUTLIER Glycine 0 N--CA 1.481 1.685 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' HD2' ' H ' ' A' ' 6' ' ' LEU . 96.1 m-85 -138.13 149.55 46.01 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.273 -1.134 . . . . 0.0 109.181 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -149.91 69.17 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.293 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.4 96.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.204 -0.935 . . . . 0.0 108.677 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -150.12 149.73 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.088 . . . . 0.0 110.565 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' OE2' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -121.36 -170.78 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 10.3 mp0 -143.67 153.63 42.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -137.8 -169.18 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 4.5 mt-10 -124.99 -2.18 7.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.501 -0.75 . . . . 0.0 110.742 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.73 -179.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.849 -1.157 . . . . 0.0 109.542 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.52 -38.0 95.65 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG22 ' SD ' ' A' ' 63' ' ' MET . 1.4 t -66.23 -42.92 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.301 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 7.6 t70 -67.53 -42.96 81.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 108.705 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -61.97 -58.17 8.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 0.0 109.07 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -46.37 -33.38 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -85.16 -31.32 23.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -89.95 -6.15 55.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.115 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.32 -26.51 22.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.975 -1.078 . . . . 0.0 108.483 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -57.66 -10.38 1.56 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.0 108.644 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 46' ' ' LEU . . . -46.0 -68.75 0.17 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.547 -0.721 . . . . 0.0 109.222 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.53 -96.28 0.36 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.31 67.31 0.3 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.469 ' C ' ' N ' ' A' ' 53' ' ' PHE . 22.0 m-85 -44.49 96.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.69 -0.888 . . . . 0.0 109.867 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -50.61 -10.32 0.36 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -157.57 141.11 15.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -1.182 . . . . 0.0 110.467 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 83' ' ' VAL . 39.2 t -131.86 107.37 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG12 ' A' ' 10' ' ' VAL . 39.8 mt -89.88 80.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.99 165.66 16.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.335 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.1 m-20 -97.73 -137.94 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.609 -0.682 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -172.33 95.86 0.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 109.299 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -157.37 -157.66 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 109.043 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.4 mmt -142.7 50.91 1.64 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 111.66 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.4 Cg_endo -59.96 -25.6 80.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.962 -1.592 . . . . 0.0 107.962 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -173.39 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 40' ' ' VAL . 31.4 mtt -158.48 143.63 16.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -87.88 166.27 14.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.752 -1.218 . . . . 0.0 110.047 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.38 -5.48 77.54 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 68' ' ' LEU . 53.1 tp -57.82 -64.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.256 . . . . 0.0 109.17 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -47.61 -15.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.096 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LEU . 6.1 tp -76.17 -57.18 4.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.812 . . . . 0.0 109.305 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.71 -33.1 68.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.203 -0.936 . . . . 0.0 109.329 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -62.83 -67.41 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 m -48.46 -30.04 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 80' ' ' ALA . 11.7 mt -72.43 -40.28 63.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.266 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HE ' ' CA ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -84.21 -17.19 40.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.453 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.78 -28.55 9.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.94 -138.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.383 -0.823 . . . . 0.0 109.322 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -136.54 -123.63 2.28 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.77 22.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.51 ' H ' ' C ' ' A' ' 76' ' ' GLY . 37.0 mtt -150.15 57.7 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 108.717 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 78' ' ' MET . 92.1 p -55.23 -113.13 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.35 58.42 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.0 109.387 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ALA . 12.3 mt 58.58 154.42 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.831 -0.543 . . . . 0.0 109.967 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.29 144.56 17.17 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.565 2.176 . . . . 0.0 114.897 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -129.83 122.18 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.855 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -101.58 107.74 19.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.77 98.3 6.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.401 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.92 158.4 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.76 -1.212 . . . . 0.0 109.791 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -150.07 159.26 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.804 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -98.67 -4.48 33.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' LYS . 1.4 tt0 -145.75 54.47 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.46 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.733 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 89' ' ' GLU . 24.1 tttm -76.16 -72.24 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.659 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -177.64 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.885 . . . . 0.0 109.336 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.38 -38.91 63.8 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -69.04 -29.75 67.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.928 -179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 90' ' ' ALA . 6.7 mt -67.89 -57.25 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 108.868 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -63.73 -18.94 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.394 -0.816 . . . . 0.0 109.205 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.38 -60.58 3.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.636 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -54.04 -54.23 42.15 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.11 -25.13 65.21 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.682 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 15.9 tp60 -53.13 -31.15 40.72 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -89.26 -22.1 22.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.6 76.91 0.32 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.759 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.86 -111.89 0.08 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.088 -1.845 . . . . 0.0 109.795 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.855 ' OG ' HD22 ' A' ' 84' ' ' LEU . 10.1 p -91.59 -50.78 5.59 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.786 1.279 . . . . 0.0 108.536 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.422 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 165.83 -166.55 38.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.41 148.58 43.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.277 -1.131 . . . . 0.0 109.984 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.6 p -141.21 126.8 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.8 p -74.96 108.75 6.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.955 . . . . 0.0 110.06 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.804 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.52 163.78 48.08 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.2 125.81 10.48 Favored 'Cis proline' 0 N--CA 1.485 0.999 0 C-N-CA 125.121 -0.783 . . . . 0.0 110.842 -1.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.44 154.85 17.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.525 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.89 151.89 21.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.64 -31.51 4.67 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.938 -1.101 . . . . 0.0 109.432 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.05 82.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.043 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.31 -66.67 0.57 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.995 -1.066 . . . . 0.0 108.336 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.84 -35.75 33.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.567 -1.333 . . . . 0.0 109.557 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -70.65 -67.92 0.47 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.827 -1.171 . . . . 0.0 109.768 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -42.84 -29.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.711 -0.618 . . . . 0.0 109.385 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -78.7 -43.69 25.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.02 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 53' ' ' PHE . 2.6 tp -57.19 -66.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 0.0 109.947 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -40.2 -52.38 2.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.558 -0.714 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -60.39 -28.6 68.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 110.557 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.98 -38.5 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.0 110.402 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -76.53 -42.7 42.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 110.669 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -50.32 -23.09 2.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.899 -1.126 . . . . 0.0 108.207 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -92.77 -25.12 18.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' PHE . 2.1 tp -73.46 -26.14 60.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.01 -42.83 1.03 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 129' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.265 -1.138 . . . . 0.0 109.441 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.535 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER 63.88 130.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.027 . . . . 0.0 108.9 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -90.42 7.71 37.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.899 -1.126 . . . . 0.0 109.996 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.38 45.73 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.987 -1.07 . . . . 0.0 111.22 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.31 138.5 38.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.38 122.87 26.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.956 -1.09 . . . . 0.0 111.972 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.71 149.32 33.09 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.16 107.13 10.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -90.36 131.53 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.961 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 36' ' ' ALA . 9.8 t -138.43 38.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.392 -0.817 . . . . 0.0 109.216 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -76.35 22.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.14 -0.975 . . . . 0.0 109.36 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER 47.82 -124.3 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.132 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 46.52 -168.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.33 -9.41 1.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.731 . . . . 0.0 109.052 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.66 -13.98 5.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 8.4 ttt -64.27 -49.48 71.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.483 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -45.48 16.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -52.23 -49.74 63.38 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.482 -0.761 . . . . 0.0 110.266 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -50.2 -55.56 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.952 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.09 -38.15 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 110.892 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.34 -58.28 4.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 109.521 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -62.53 -55.46 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.804 0.811 . . . . 0.0 109.495 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.09 -48.47 2.48 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.6 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.46 -49.37 71.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -48.87 -38.64 23.04 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.324 -0.86 . . . . 0.0 108.828 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -35.06 73.12 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 108.807 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.33 -3.47 33.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.472 -0.768 . . . . 0.0 109.053 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.65 33.25 16.65 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 26.2 m-85 -105.4 142.86 34.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.462 -1.022 . . . . 0.0 109.264 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -141.78 62.94 1.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.01 93.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.915 -1.116 . . . . 0.0 109.249 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.1 150.75 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 0.0 110.271 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.45 -170.5 2.19 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -147.32 157.84 43.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.049 -1.032 . . . . 0.0 110.918 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.57 -167.62 2.3 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.92 3.48 3.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.197 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.1 -179.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 109.63 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.681 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -60.63 -39.79 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -1.085 . . . . 0.0 109.321 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.4 t70 -72.02 -46.67 56.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.847 . . . . 0.0 109.065 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -59.04 -57.12 14.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.486 -0.758 . . . . 0.0 109.65 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 mt -46.46 -47.83 19.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 109.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.954 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.87 9.73 26.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.161 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -85.25 -36.9 20.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 109.053 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.07 -1.28 31.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.23 -58.64 3.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.85 9.8 1.37 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.03 94.9 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.785 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.6 m-85 -80.48 142.64 34.05 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.227 -1.161 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.54 6.22 65.19 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.07 142.71 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.616 -0.932 . . . . 0.0 108.618 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 83' ' ' VAL . 56.4 t -141.75 121.19 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.75 -1.219 . . . . 0.0 110.075 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 84' ' ' LEU . 10.1 mt -107.91 132.04 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 p -151.4 145.63 25.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 0.0 109.421 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.8 p-10 -47.79 -80.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.529 ' CH2' ' OD1' ' A' ' 94' ' ' ASN . 28.0 t-105 -177.34 -68.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 43.4 p-10 -170.54 53.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.948 -1.095 . . . . 0.0 109.742 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.524 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -60.65 -47.59 95.58 Favored Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.09 -1.006 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -65.62 -73.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.038 1.158 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.5 p30 179.32 -106.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.039 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtp -70.99 73.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.956 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -150.62 162.49 40.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.743 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 74.16 -66.93 1.83 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' LEU . 52.2 tp -68.68 -73.0 0.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.572 -1.546 . . . . 0.0 109.024 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.3 tp10 -46.9 -32.9 4.11 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.743 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.7 tp -66.74 -41.13 88.36 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.822 HD21 ' H ' ' A' ' 103' ' ' ALA . 40.7 tp -76.66 -62.38 1.65 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.497 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' LEU . 12.8 ttmt -42.96 -35.48 1.24 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.323 -0.861 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.3 m -71.57 -34.94 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.3 mt -64.51 -26.15 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.214 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.06 -40.58 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.773 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.03 -28.57 1.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.24 162.14 6.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.621 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -109.79 22.4 23.81 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.72 0.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -125.06 16.2 8.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.2 t -72.87 16.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -129.31 35.9 4.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.546 -0.721 . . . . 0.0 109.288 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -110.83 99.82 43.71 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.68 147.85 93.47 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 112.624 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 69' ' ' LEU . 3.0 t -130.23 129.5 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 55' ' ' ILE . 24.6 tp -111.66 70.89 0.72 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.91 167.13 3.01 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.518 HG23 HG13 ' A' ' 107' ' ' VAL . 7.2 p -150.16 137.56 13.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.801 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -150.36 171.06 17.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.02 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.02 131.0 48.72 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 50.83 75.31 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.007 -1.058 . . . . 0.0 108.581 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -44.04 138.08 3.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.757 . . . . 0.0 110.299 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 10.4 ttpt -71.67 -6.02 38.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 0.0 109.486 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 2.6 tttm 74.79 -73.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.81 . . . . 0.0 109.683 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.33 -11.53 0.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.041 -1.037 . . . . 0.0 109.838 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.529 ' OD1' ' CH2' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -89.87 -51.49 5.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.89 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mm -46.04 -46.77 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.77 -65.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.962 -1.086 . . . . 0.0 109.509 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.49 -60.08 2.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 108.743 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -44.6 -44.04 8.58 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.597 . . . . 0.0 109.82 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -60.81 -48.15 83.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.992 -1.067 . . . . 0.0 110.246 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -54.24 -11.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 109.437 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.04 -110.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.593 -0.692 . . . . 0.0 110.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -132.96 -2.16 3.89 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.822 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -60.69 11.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.001 -0.705 . . . . 0.0 110.682 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -29.42 -30.56 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -176.08 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 123' ' ' ILE . . . -107.24 128.23 9.14 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.124 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.64 117.82 7.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -1.137 . . . . 0.0 109.563 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 116' ' ' LEU . 1.5 p -113.13 143.41 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -89.6 107.29 17.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.345 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 159.48 68.19 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.675 -1.265 . . . . 0.0 108.963 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.69 164.39 88.14 Favored 'Cis proline' 0 N--CA 1.487 1.139 0 C-N-CA 124.775 -0.927 . . . . 0.0 110.738 -1.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.494 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.6 p90 -144.57 152.99 41.34 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.097 0.951 . . . . 0.0 109.932 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.1 149.79 22.68 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.5 -37.95 12.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.982 -1.074 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.57 -33.52 75.85 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' THR . 88.9 m -72.57 -68.37 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.61 HD11 HG11 ' A' ' 107' ' ' VAL . 8.3 tp -43.87 -37.69 2.96 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.255 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp10 -56.33 -65.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -42.27 -53.67 4.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.323 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -57.2 -52.25 66.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -61.27 2.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -49.52 -36.47 23.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.799 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -28.88 70.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.607 HD11 ' HA2' ' A' ' 105' ' ' GLY . 13.0 mt -80.01 -48.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.019 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -55.17 -6.74 0.16 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 123' ' ' ILE . 1.5 mt-10 -70.31 -27.97 64.81 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -89.35 -26.06 21.28 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.25 -26.08 42.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.816 . . . . 0.0 108.842 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.9 81.7 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -1.149 . . . . 0.0 109.491 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 5' ' ' GLU . 5.0 t70 51.58 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -71.98 34.39 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.576 -1.328 . . . . 0.0 110.04 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 3' ' ' ASP . 46.2 mt-10 -150.37 32.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.91 142.5 57.87 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 108.715 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.42 122.93 28.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.084 -1.01 . . . . 0.0 112.181 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -113.71 154.6 27.04 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 54' ' ' VAL . 18.0 tp -130.43 99.84 5.15 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 10' ' ' VAL . 10.7 m -89.89 107.19 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.078 -1.014 . . . . 0.0 109.833 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.4 t -96.89 65.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 3.6 p30 -89.1 -139.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 108.927 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 31.3 t0 -172.13 -33.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.82 156.51 8.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.746 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.2 t -91.02 39.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -175.17 3.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.3 ttm -84.01 -33.41 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.232 -0.917 . . . . 0.0 109.301 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.699 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.12 -48.62 70.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -55.88 -28.84 58.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.038 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -67.61 -55.3 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.693 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -34.88 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.502 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -55.13 18.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.857 -1.152 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.6 t30 -58.09 -58.6 7.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.98 0.895 . . . . 0.0 108.73 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 tt -40.22 -62.55 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.907 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -52.85 -45.02 67.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.207 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -55.18 -43.13 74.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.393 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -19.34 21.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 117' ' ' GLU . 1.1 mt -99.88 -7.04 25.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.365 -0.835 . . . . 0.0 110.065 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.38 71.26 1.2 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -150.15 100.28 2.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.301 . . . . 0.0 108.819 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -108.41 67.51 0.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.084 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.08 93.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -150.16 147.79 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.96 -1.087 . . . . 0.0 110.398 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.12 -175.27 3.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -147.82 161.05 42.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.869 -1.145 . . . . 0.0 110.909 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.763 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.34 -168.08 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.31 2.55 4.23 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.445 -0.785 . . . . 0.0 110.009 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.68 -176.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 108.819 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.734 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -72.83 -30.94 62.89 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.46 -36.28 76.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.123 -1.221 . . . . 0.0 108.33 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.623 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.7 t0 -75.51 -46.79 30.15 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.14 -54.94 39.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.268 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.6 tt -48.08 -49.57 31.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -67.36 -34.39 77.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.037 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -90.02 -5.06 57.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 110.457 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -72.8 -27.76 62.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.072 -1.018 . . . . 0.0 108.938 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 20.3 tt0 -68.31 0.65 3.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.394 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.92 -77.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.37 -67.78 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.97 68.6 0.08 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.0 m-85 -47.12 101.99 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.487 -1.008 . . . . 0.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.53 8.96 2.74 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -169.52 146.55 3.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -1.199 . . . . 0.0 109.588 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.0 t -145.31 120.44 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.744 -1.223 . . . . 0.0 110.404 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.622 HG23 HG21 ' A' ' 86' ' ' VAL . 9.4 mt -101.43 92.69 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.6 p -98.58 151.24 20.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.272 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 8.6 p-10 -86.19 -107.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.324 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.636 ' CE2' ' ND2' ' A' ' 59' ' ' ASN . 55.3 t-105 -146.3 176.6 9.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.005 . . . . 0.0 109.529 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.636 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 0.9 OUTLIER -73.98 69.29 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -79.27 -47.55 1.58 Allowed Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.968 . . . . 0.0 110.336 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -67.17 -68.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.082 1.188 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.475 ' CG ' ' N ' ' A' ' 63' ' ' MET . 25.6 p-10 -152.31 -126.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.475 ' N ' ' CG ' ' A' ' 62' ' ' ASN . 20.8 mtm -86.33 95.98 9.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 63' ' ' MET . 52.8 m-20 -160.98 171.73 18.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 74.43 -63.12 2.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 tp -74.04 -50.56 19.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.639 -1.507 . . . . 0.0 107.88 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -71.07 -14.73 62.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.734 HD11 ' HA2' ' A' ' 39' ' ' GLY . 9.8 mt -68.6 -58.17 4.66 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -61.37 -34.73 75.8 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -68.43 -37.91 80.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.9 m -68.53 -48.45 64.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.06 -25.91 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.433 -0.792 . . . . 0.0 109.027 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -90.05 -29.31 18.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.41 -0.806 . . . . 0.0 110.005 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -67.75 -38.2 83.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -53.16 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.35 -79.28 1.44 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.87 54.94 2.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -1.116 . . . . 0.0 109.827 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.7 mmt -137.37 1.95 2.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 109.296 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -94.06 59.99 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.04 -31.47 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 51' ' ' TYR . 10.1 mt -69.64 118.92 67.38 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 120.911 -1.118 . . . . 0.0 109.463 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.31 107.88 0.4 Allowed 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 121.474 1.449 . . . . 0.0 113.096 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.4 t -98.45 113.61 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -95.78 103.05 14.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.078 -1.449 . . . . 0.0 108.331 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 38.4 tpp -68.74 137.78 54.34 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 55' ' ' ILE . 11.1 t -122.64 148.27 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.642 -0.661 . . . . 0.0 110.518 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.95 148.62 29.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.02 -45.92 8.44 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.213 -0.93 . . . . 0.0 108.789 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.8 mt-10 -93.66 43.75 1.12 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -43.91 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 110.086 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -95.47 143.57 26.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -47.56 -16.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.3 mm-40 -90.09 -45.55 9.07 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.287 -0.883 . . . . 0.0 110.167 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.81 -13.77 55.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 110.065 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.423 HG23 ' CD2' ' A' ' 106' ' ' TYR . 8.0 mt -73.64 -46.78 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 mt -74.74 -14.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 108.897 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.75 95.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.36 -58.21 4.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.5 -25.96 60.6 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.228 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -53.54 -32.44 50.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.891 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -83.01 -29.61 28.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.05 70.01 1.32 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.453 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.775 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.02 -111.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 116.721 -1.991 . . . . 0.0 109.486 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.696 ' OG ' HD22 ' A' ' 84' ' ' LEU . 3.1 p -91.74 -49.72 6.12 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.844 1.306 . . . . 0.0 108.12 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.88 -168.62 39.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.19 151.19 51.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.505 -0.997 . . . . 0.0 109.961 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.629 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 9.6 p -144.08 135.74 22.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 109' ' ' LYS . 11.8 p -80.47 157.19 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.014 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.512 ' HZ2' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -130.69 160.19 67.5 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 108.901 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.49 129.94 19.69 Favored 'Cis proline' 0 N--CA 1.485 1.009 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.683 -2.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.407 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -89.88 -179.18 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.153 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.492 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -110.64 145.08 38.54 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.516 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.77 -14.86 0.14 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.991 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -83.15 -36.72 24.52 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -71.7 -60.3 2.3 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 116' ' ' LEU . 1.3 mt -50.03 -40.85 46.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.413 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' A' ' 28' ' ' LEU . 2.2 tm-20 -59.51 -54.69 43.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.514 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -47.5 -51.56 20.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.64 -39.8 85.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -54.03 -68.45 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.503 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -46.66 -48.15 20.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.958 . . . . 0.0 109.477 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -47.25 -40.83 17.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 125' ' ' GLU . 69.5 mt -81.93 -59.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.0 109.19 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.2 0.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.852 -0.53 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 123' ' ' ILE . 86.9 tt0 -73.78 -27.32 61.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 126' ' ' LYS . 4.5 mptt -92.78 -34.76 13.75 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.33 -22.44 61.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.03 89.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.334 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.6 m-20 -45.85 140.06 3.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.32 8.53 32.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 110.303 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -140.16 46.25 1.84 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.074 -1.016 . . . . 0.0 110.524 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.404 HD11 ' HA3' ' A' ' 52' ' ' GLY . 54.9 tp -80.6 131.45 35.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 127.63 33.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.905 -1.122 . . . . 0.0 111.621 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -114.61 153.72 29.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.656 ' HB3' HG13 ' A' ' 54' ' ' VAL . 35.9 tp -123.85 111.5 16.17 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.74 108.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.902 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -105.9 55.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.445 -0.784 . . . . 0.0 109.332 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -97.69 142.45 29.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.57 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.81 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.74 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 t -139.45 13.38 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 109.057 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -164.55 -3.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.412 ' H ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -53.74 -45.31 70.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.594 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -45.92 19.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.194 -0.941 . . . . 0.0 109.633 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -53.71 -53.03 57.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.394 -0.816 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mp -47.34 -59.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 109.972 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.468 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -61.85 -40.68 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.729 -178.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.4 OUTLIER -49.61 -54.31 19.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.842 -1.161 . . . . 0.0 109.512 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -62.66 -57.77 9.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.048 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -40.04 -58.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.665 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 55' ' ' ILE . 13.9 mt -57.42 -45.59 84.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.048 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -54.78 -40.9 69.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.6 -15.5 63.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.312 -0.867 . . . . 0.0 109.285 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.28 4.36 48.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.428 -0.795 . . . . 0.0 109.757 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 59.82 1.63 Allowed Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.138 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 51.2 m-85 -150.04 138.52 20.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.363 . . . . 0.0 109.549 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -146.37 64.8 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.908 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.85 96.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 108.799 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.17 153.86 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -169.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -150.16 156.09 40.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 111.418 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.8 -164.4 1.91 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 4.4 mt-10 -130.24 -14.37 3.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.542 -0.724 . . . . 0.0 110.547 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 1.2 p-10 -173.38 -178.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.005 -1.059 . . . . 0.0 109.886 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.42 -43.28 93.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG2' ' SD ' ' A' ' 63' ' ' MET . 91.0 t -63.92 -51.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.874 -1.368 . . . . 0.0 108.709 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 45.6 t0 -51.31 -47.73 62.55 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.91 -48.83 80.03 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 42' ' ' ALA . 2.4 tp -40.61 -35.94 0.53 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.26 -39.76 65.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 108.931 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' GLN . 35.4 mmtt -79.91 -53.39 6.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.469 -0.769 . . . . 0.0 109.65 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -42.49 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.595 -0.69 . . . . 0.0 109.379 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 45' ' ' LYS . 8.9 tt0 -53.36 -44.75 68.81 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.87 -49.75 38.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 51' ' ' TYR . . . 80.39 -20.51 5.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.14 -8.27 4.58 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 53' ' ' PHE . 66.9 m-85 -71.33 89.85 0.92 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -1.131 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -67.01 6.99 1.8 Allowed Glycine 0 C--O 1.205 -1.709 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -165.86 141.08 4.83 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.463 -1.022 . . . . 0.0 109.241 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 83' ' ' VAL . 10.0 t -131.56 117.51 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.266 . . . . 0.0 109.724 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD11 HD11 ' A' ' 25' ' ' LEU . 59.0 mt -98.78 79.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 p -93.67 144.1 25.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -0.813 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -92.68 126.06 37.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.364 -0.835 . . . . 0.0 109.016 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.594 ' CH2' HD23 ' A' ' 66' ' ' LEU . 6.9 t90 -90.76 107.56 19.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -161.69 -124.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.438 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 7.3 ttt -159.63 57.97 1.1 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.132 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -64.3 -38.89 32.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 107.32 -1.838 . . . . 0.0 107.32 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -161.5 -26.09 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.408 ' SD ' ' CG2' ' A' ' 40' ' ' VAL . 7.5 mtt -159.7 143.02 14.25 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.88 155.84 32.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.717 -1.24 . . . . 0.0 109.579 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -82.22 -7.84 87.2 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.368 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.594 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -58.37 -49.3 77.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.419 -1.636 . . . . 0.0 107.716 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 71' ' ' THR . 78.9 tt0 -52.74 -15.8 0.82 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.553 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -79.34 -54.51 5.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -56.29 -60.51 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -44.93 -51.38 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.468 -0.77 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 67' ' ' GLU . 10.9 p -61.69 -41.35 97.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 83' ' ' VAL . 17.1 mt -59.33 -21.58 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.22 -0.925 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -90.03 -23.3 21.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.245 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -55.91 4.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.211 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.78 -58.38 3.85 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.16 -58.36 3.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 mtt -128.93 -9.73 4.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.8 p 46.21 -123.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.099 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.07 55.31 0.93 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 108.902 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 45.52 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 O-C-N 121.664 -0.647 . . . . 0.0 109.602 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 5.3 Cg_exo -63.56 149.51 90.81 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.096 1.864 . . . . 0.0 115.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 72' ' ' ILE . 32.3 t -138.53 110.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 2.7 tp -89.76 105.13 17.6 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.139 -1.825 . . . . 0.0 107.262 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 tpp -72.19 109.77 6.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.172 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.57 140.39 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 109.496 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.21 157.82 43.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.65 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.9 mp0 -80.74 70.8 7.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.22 83.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 0.0 108.853 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 89' ' ' GLU . 13.7 tttp -44.69 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.76 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mttt 175.92 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.7 -30.61 33.16 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' O ' ' HB3' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -61.5 -54.71 39.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 0.0 109.223 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 mm -45.43 -53.83 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.61 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -57.19 -28.25 29.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -64.13 -44.95 90.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.415 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -69.01 -53.99 17.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.058 . . . . 0.0 108.168 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -56.78 -28.47 61.38 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.29 -34.0 73.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.45 -19.23 53.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 55.56 76.05 0.21 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.857 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.17 -112.04 0.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.763 -1.975 . . . . 0.0 110.51 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -50.28 5.83 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.732 1.253 . . . . 0.0 108.149 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 168.41 -155.31 25.86 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.56 122.82 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.547 -0.972 . . . . 0.0 108.782 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 107' ' ' VAL . 8.7 p -119.82 131.68 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.33 132.43 33.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.932 -1.105 . . . . 0.0 109.121 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -109.54 160.11 29.02 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.95 134.45 35.58 Favored 'Cis proline' 0 C--N 1.32 -0.924 0 C-N-CA 124.866 -0.889 . . . . 0.0 110.39 -1.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 2.1 p90 -100.69 160.39 14.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.971 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.88 149.76 21.51 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.03 -21.78 0.76 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.174 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.07 -31.8 25.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -76.78 -57.66 3.73 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -53.23 -40.72 64.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.106 -1.621 . . . . 0.0 107.842 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.51 -52.3 66.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.939 -1.1 . . . . 0.0 109.74 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -45.54 -46.44 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.482 -0.761 . . . . 0.0 109.507 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -70.31 -48.86 54.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 tp -47.08 -65.15 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 0.0 109.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 -45.13 45.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 0.0 109.907 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -68.66 -19.35 64.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 109.652 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.08 -43.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 0.0 110.244 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -63.25 -16.47 60.33 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.083 -1.011 . . . . 0.0 109.964 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -70.84 -19.94 62.6 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -94.85 -34.18 12.55 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -22.08 52.14 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.86 90.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.209 -1.171 . . . . 0.0 109.557 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -47.5 113.06 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 pttt -73.04 36.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.978 -1.076 . . . . 0.0 109.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 3' ' ' ASP . 23.9 tt0 -152.96 30.66 0.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.8 tp -72.83 138.8 46.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -81.29 127.36 32.64 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.969 -1.082 . . . . 0.0 111.697 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 40.7 m-85 -114.71 155.66 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.837 -0.539 . . . . 0.0 109.954 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.3 tp -127.61 109.34 11.6 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -97.3 107.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.355 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 36' ' ' ALA . 37.8 t -98.5 99.55 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.4 -0.813 . . . . 0.0 109.372 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.54 170.13 18.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.734 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.25 26.04 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -70.76 -80.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 t 154.03 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 -26.2 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 ttt -45.2 -63.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.724 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -48.58 -26.86 2.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -76.61 -31.68 57.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.624 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -51.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -38.34 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -52.72 23.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.23 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -58.29 4.13 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.992 0.901 . . . . 0.0 109.712 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.71 -41.18 3.06 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.836 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.77 -46.18 63.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.98 -1.075 . . . . 0.0 108.624 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -56.39 -38.17 71.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.341 -0.849 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.93 -24.88 17.87 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.274 -0.891 . . . . 0.0 109.201 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.745 HD21 ' OE2' ' A' ' 117' ' ' GLU . 1.3 mt -86.28 -39.49 16.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 137.54 6.9 1.51 Allowed Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.6 141.4 28.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.852 -1.381 . . . . 0.0 109.389 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -146.5 61.5 1.22 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -168.89 97.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.03 152.79 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.044 -1.035 . . . . 0.0 109.83 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -120.52 -167.48 1.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 36' ' ' ALA . 1.1 tt0 -150.11 147.93 28.36 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.109 -0.994 . . . . 0.0 110.861 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -132.31 -167.72 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -140.12 -2.2 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.894 . . . . 0.0 110.416 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 1.9 p-10 -176.4 -157.7 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 108.502 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -86.08 -43.12 6.42 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.46 -36.11 17.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.856 -1.379 . . . . 0.0 108.056 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.607 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 15.1 t0 -77.69 -54.64 6.13 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.712 -0.618 . . . . 0.0 109.756 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -55.78 -53.48 56.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.087 -1.008 . . . . 0.0 110.018 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.77 -59.47 4.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -55.37 -33.67 63.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -90.03 -19.86 23.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.116 -0.99 . . . . 0.0 110.699 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -60.52 -22.13 63.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.841 -1.162 . . . . 0.0 109.287 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -90.69 -2.64 57.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 108.919 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.46 -71.9 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.57 -0.706 . . . . 0.0 109.848 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.36 -18.9 1.12 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.26 64.67 0.55 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.783 ' O ' HD11 ' A' ' 81' ' ' LEU . 84.7 m-85 -47.01 114.81 0.92 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.463 -1.022 . . . . 0.0 109.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.27 2.39 9.92 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -161.36 140.93 10.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.08 . . . . 0.0 108.854 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.8 t -134.97 121.17 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.796 -1.19 . . . . 0.0 110.069 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 56' ' ' SER . 43.2 mt -110.43 139.14 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 36.7 m -165.98 157.5 13.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.098 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 6.5 m-20 -61.39 -131.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 0.0 110.085 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 35.6 t-105 -173.11 -2.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 1.9 p30 -143.25 -16.44 0.66 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.65 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 24.0 tpp -81.08 -33.01 0.67 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 111.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -66.98 -148.0 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.715 0.944 . . . . 0.0 109.871 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -57.44 -159.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.561 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -44.67 -25.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 175.54 135.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.24 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.82 2.8 0.81 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 64' ' ' ASP . 12.3 tp -65.91 -60.13 3.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.809 -1.406 . . . . 0.0 108.068 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -49.34 -39.64 32.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.6 tt -58.87 -35.5 73.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -83.1 -63.66 1.32 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' LEU . 36.3 tttm -35.81 -49.95 0.63 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.083 0.468 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.4 m -49.2 -46.36 45.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 108.492 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 69' ' ' LEU . 55.3 mt -57.09 -33.18 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' CZ ' ' O ' ' A' ' 100' ' ' GLN . 9.8 ttt180 -67.58 -24.4 65.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.04 -28.54 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.54 82.16 8.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.1 89.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.35 -37.26 10.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.424 ' C ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -95.13 -71.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.52 11.05 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.382 -0.824 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -107.28 -31.7 8.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.653 -0.654 . . . . 0.0 109.759 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.783 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.14 97.53 0.11 Allowed Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 122.288 -0.257 . . . . 0.0 110.418 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.58 139.09 52.08 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 121.055 1.17 . . . . 0.0 111.028 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.9 t -131.36 137.68 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' LEU . 39.7 tp -119.81 69.85 0.85 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -51.58 170.52 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.247 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.0 t -140.84 131.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.263 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -149.3 166.14 29.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.077 -1.014 . . . . 0.0 110.351 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.55 32.3 6.21 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 109.714 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 91' ' ' LYS . 3.5 tt0 -153.84 -62.82 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.178 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 57.16 83.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -68.8 8.93 0.44 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.174 -0.954 . . . . 0.0 109.443 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER 73.18 -68.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.328 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -51.6 -43.45 62.52 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -18.64 65.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mm -83.99 -13.97 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.21 -63.17 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.46 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.22 -46.27 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.64 -48.83 78.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 109.123 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.76 61.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' CZ ' ' A' ' 73' ' ' ARG . 74.3 mt-30 -53.0 -23.77 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.77 -109.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.8 -1.85 4.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.43 11.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.086 -0.655 . . . . 0.0 110.87 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.675 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.4 m -29.46 -33.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.74 130.63 10.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.523 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.88 112.18 6.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 108.626 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.823 HG21 ' CD2' ' A' ' 116' ' ' LEU . 13.6 p -115.48 133.25 62.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 106' ' ' TYR . 18.4 m -67.67 -167.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 151.46 17.03 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.706 -1.247 . . . . 0.0 108.991 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.83 165.68 83.17 Favored 'Cis proline' 0 N--CA 1.489 1.236 0 O-C-N 122.459 0.715 . . . . 0.0 111.217 -1.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.825 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.2 p90 -132.82 156.94 46.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.694 0.759 . . . . 0.0 109.6 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.07 143.93 26.78 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -42.97 -33.76 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.253 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.04 95.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.0 m -65.2 -69.76 0.27 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.825 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -47.15 -31.69 3.72 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.972 -1.08 . . . . 0.0 109.986 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.745 ' OE2' HD21 ' A' ' 28' ' ' LEU . 6.1 tp10 -67.7 -62.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.647 -1.283 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 5.9 tt0 -41.82 -59.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.747 -0.596 . . . . 0.0 110.137 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -50.06 -40.57 45.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -66.02 -50.61 63.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -18.4 62.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.0 . . . . 0.0 109.811 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -81.91 -34.42 29.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 mt -78.89 -37.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.102 -0.999 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.6 m-85 -75.33 -30.22 60.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.23 -24.15 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 108.228 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -94.1 -23.26 18.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 124' ' ' PHE . 5.6 tp -83.3 -18.09 40.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 74.95 0.19 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.409 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -160.19 143.66 13.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.045 -1.035 . . . . 0.0 109.875 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -90.16 9.18 29.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.003 -1.061 . . . . 0.0 109.178 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.792 ' C ' HD22 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -158.65 57.0 0.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 56.2 tp -84.87 120.57 26.61 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -57.29 112.12 1.29 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.988 -1.07 . . . . 0.0 111.764 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 25' ' ' LEU . 67.1 m-85 -107.16 151.05 25.93 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -122.25 106.02 10.74 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -89.93 113.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.273 -178.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' ' 36' ' ' ALA . 31.2 t -119.23 106.78 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.591 -0.693 . . . . 0.0 109.331 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -155.49 126.83 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.396 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' ASP . 64.7 t0 -57.77 -107.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.07 -156.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.282 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.434 ' C ' HG22 ' A' ' 16' ' ' THR . 38.1 t -150.35 24.98 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.115 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.434 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -178.65 4.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' THR . 1.8 tpp -68.84 -44.43 73.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.117 -0.989 . . . . 0.0 109.122 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -44.69 -47.03 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 109.85 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -56.38 -51.2 69.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.919 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -49.77 -58.51 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.004 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.49 -39.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.477 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -57.25 11.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 108.933 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.3 t-20 -57.63 -54.06 51.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -39.19 -55.08 1.72 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.814 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 8' ' ' PHE . 60.9 mt -61.82 -53.18 59.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 108.865 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 26' ' ' LYS . 8.1 mtpm? -52.55 -28.12 19.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.247 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -32.66 62.59 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.086 -1.009 . . . . 0.0 108.838 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.91 -69.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.254 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 18.41 0.02 OUTLIER Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 30.9 m-85 -96.07 153.99 17.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.351 . . . . 0.0 109.06 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -149.12 21.5 0.97 Allowed 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.87 -1.144 . . . . 0.0 110.894 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.792 HD22 ' C ' ' A' ' 5' ' ' GLU . 27.0 p-10 -138.29 107.65 6.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.917 -1.114 . . . . 0.0 111.106 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -148.33 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.226 -0.921 . . . . 0.0 109.606 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.3 mm-40 -137.35 -166.69 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -150.1 154.68 38.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.935 -1.103 . . . . 0.0 110.824 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.846 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.87 -163.67 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.91 -4.15 2.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.0 110.484 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 2.8 p-10 179.7 -173.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.025 -1.047 . . . . 0.0 109.52 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.71 67.05 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.93 -41.78 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.68 -1.482 . . . . 0.0 108.739 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 10.9 t70 -68.42 -44.45 74.99 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.73 -37.55 79.54 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.38 -57.8 7.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -66.43 -39.64 89.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 110.034 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -22.62 62.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.306 -0.871 . . . . 0.0 110.464 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.09 -4.8 5.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.831 -1.168 . . . . 0.0 109.325 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.05 -7.71 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.712 . . . . 0.0 109.213 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.59 -65.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.614 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.61 5.34 2.04 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.72 76.93 1.1 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.816 ' O ' HD22 ' A' ' 81' ' ' LEU . 52.6 m-85 -54.07 113.62 1.3 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.502 -0.999 . . . . 0.0 110.214 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.52 -4.81 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -165.48 141.35 5.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -1.14 . . . . 0.0 110.166 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 33.6 t -133.94 116.11 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.379 -0.826 . . . . 0.0 110.95 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.34 85.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.8 p -92.64 172.07 8.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 0.0 110.457 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 1.5 p-10 -95.31 -109.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.531 -0.73 . . . . 0.0 109.855 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.614 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 60.4 t-105 -159.82 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.466 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.614 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 41.5 m-20 -139.16 8.57 2.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -53.45 -49.57 87.71 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.956 -1.09 . . . . 0.0 109.72 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.2 -157.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 120.98 1.12 . . . . 0.0 109.496 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 63' ' ' MET . 38.3 p-10 -85.38 143.75 28.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.072 -1.017 . . . . 0.0 109.395 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 19.9 ttm 74.47 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -137.9 164.73 28.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.535 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -91.49 -14.55 56.87 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -52.95 41.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.645 -1.503 . . . . 0.0 108.819 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -53.18 -22.98 7.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 108.549 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 10.2 tp -67.54 -55.16 14.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -57.69 -64.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -44.86 -46.2 10.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 109.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 67' ' ' GLU . 25.1 p -64.58 -43.77 92.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 109.163 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.973 HD13 HG21 ' A' ' 83' ' ' VAL . 25.4 mt -55.38 -27.25 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.344 -0.847 . . . . 0.0 108.735 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.01 -29.83 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.91 -29.92 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -0.894 . . . . 0.0 109.355 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.19 113.33 19.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.832 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.67 -23.71 77.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.35 77.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.178 . . . . 0.0 109.491 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.0 OUTLIER -100.34 -75.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.82 19.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.99 20.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 51' ' ' TYR . 10.5 mt -84.15 119.8 73.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.083 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.07 98.19 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 120.934 1.089 . . . . 0.0 112.13 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.973 HG21 HD13 ' A' ' 72' ' ' ILE . 2.4 t -99.17 121.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD12 HG12 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -99.95 107.13 19.02 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.51 110.52 18.74 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.061 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG12 ' CG1' ' A' ' 107' ' ' VAL . 0.7 OUTLIER -98.77 161.68 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.586 -1.321 . . . . 0.0 110.049 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.468 ' C ' ' NZ ' ' A' ' 109' ' ' LYS . 11.6 t -149.96 -155.59 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.497 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.42 32.57 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.536 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.99 -60.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.1 98.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 109.904 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 93' ' ' GLU . 32.0 tttp -112.59 54.62 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 mttt 54.12 -82.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.665 -0.647 . . . . 0.0 110.002 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LYS . 1.9 mt-10 -43.76 -56.05 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 110.509 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.492 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -55.32 -45.74 76.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.988 -1.07 . . . . 0.0 109.974 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.8 mt -48.86 -36.77 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 108.977 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 100' ' ' GLN . 15.2 mt -74.62 -25.62 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -56.18 -53.34 58.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 0.0 109.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.42 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -58.32 -59.36 5.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.917 -1.115 . . . . 0.0 108.451 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.06 -21.84 34.61 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.44 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.7 tt0 -52.21 -32.27 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.66 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -90.07 -22.66 21.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.66 72.26 0.88 Allowed Glycine 0 N--CA 1.482 1.74 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.196 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.08 -112.32 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 116.55 -2.06 . . . . 0.0 110.192 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 20.5 m -91.93 -52.56 4.67 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.529 1.633 . . . . 0.0 107.58 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.48 -160.19 33.23 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.22 147.01 49.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -1.076 . . . . 0.0 109.849 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 116' ' ' LEU . 7.5 p -136.99 128.74 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 149.96 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.62 160.87 62.43 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.79 124.07 8.9 Favored 'Cis proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.803 -0.915 . . . . 0.0 110.554 -1.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 116' ' ' LEU . 5.0 p90 -93.4 156.43 16.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.309 -0.869 . . . . 0.0 109.967 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.527 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.28 150.06 22.09 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.19 -32.14 4.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.82 -35.46 80.74 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.095 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -71.38 -65.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.081 -1.012 . . . . 0.0 108.51 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 107' ' ' VAL . 3.0 tp -52.34 -34.94 49.61 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.419 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 120' ' ' LEU . 4.3 tm-20 -69.12 -63.3 1.09 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.798 -1.189 . . . . 0.0 109.702 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.4 -41.84 9.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.632 -0.668 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HE3' HG23 ' A' ' 107' ' ' VAL . 2.6 mtmm -71.29 -27.78 63.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.1 tp -61.99 -62.1 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.36 -35.6 8.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.573 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -75.01 -29.89 60.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.166 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mm -77.05 -40.0 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.382 -0.824 . . . . 0.0 109.44 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -76.86 -0.24 23.32 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -31.41 58.61 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -90.18 -25.53 20.6 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.93 -25.58 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.52 89.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -46.28 132.36 10.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -90.46 18.63 5.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.036 . . . . 0.0 109.646 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -129.32 42.6 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 6' ' ' LEU . 30.7 tp -90.14 130.22 36.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -76.93 124.79 28.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 111.422 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.495 ' HB2' HG22 ' A' ' 33' ' ' VAL . 62.4 m-85 -109.29 152.08 25.71 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 46' ' ' LEU . 22.9 tp -131.15 105.59 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.51 104.62 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.085 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.7 t -94.45 88.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.414 -0.804 . . . . 0.0 109.436 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -149.33 157.15 43.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.56 -13.66 14.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.639 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HB3' ' H ' ' A' ' 17' ' ' MET . 1.5 m-85 -47.4 136.06 10.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.536 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.4 t -86.14 30.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.35 -24.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.409 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 23.6 ttt -66.06 -61.17 2.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -47.82 -35.17 9.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 109.389 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -72.14 -39.86 68.47 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.963 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -62.6 -53.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.755 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -32.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -55.26 20.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.749 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.86 -53.49 17.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.812 0.815 . . . . 0.0 109.543 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.53 -52.37 2.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.508 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 8' ' ' PHE . 5.2 mt -59.46 -55.16 38.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.393 -0.817 . . . . 0.0 108.999 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -52.1 -31.4 30.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 109.073 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -32.13 55.94 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.286 -0.884 . . . . 0.0 109.336 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -89.47 -61.14 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 162.16 73.34 0.02 OUTLIER Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -150.15 134.52 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.79 -1.418 . . . . 0.0 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.97 26.16 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.745 . . . . 0.0 110.449 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.82 93.71 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 109.393 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 8' ' ' PHE . 44.7 t -139.69 153.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.687 . . . . 0.0 110.336 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 12.4 mt-10 -127.63 -171.88 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.08 147.08 27.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.07 -1.019 . . . . 0.0 110.475 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.26 -165.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.11 0.77 2.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 3.8 t70 -176.43 164.77 2.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.766 -1.209 . . . . 0.0 109.849 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.632 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -56.67 -40.34 88.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.48 -40.38 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.119 -1.224 . . . . 0.0 108.336 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.569 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.3 t0 -66.88 -49.73 64.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.68 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.44 -56.98 13.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 42' ' ' ALA . 1.3 tp -41.1 -45.98 2.87 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.226 0.536 . . . . 0.0 109.735 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -70.93 -37.36 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' ALA . 31.2 mttt -90.09 4.4 50.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 110.045 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.578 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.08 -62.96 1.35 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.91 -1.119 . . . . 0.0 109.047 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -56.15 -8.51 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 108.861 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.33 -79.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.708 . . . . 0.0 109.742 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.75 1.4 11.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 77.55 0.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' O ' HD21 ' A' ' 81' ' ' LEU . 43.6 m-85 -64.71 109.54 2.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -1.065 . . . . 0.0 109.772 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.97 -1.95 1.71 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -157.51 139.92 14.63 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.277 . . . . 0.0 109.698 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 83' ' ' VAL . 25.2 t -141.8 124.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.165 -0.96 . . . . 0.0 109.568 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -132.52 168.95 17.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.785 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 54.5 t0 -94.4 -109.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.158 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.455 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 46.8 t-105 -164.75 -55.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.51 71.41 10.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.086 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mmm -92.4 149.63 38.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 109.191 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.37 -179.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 120.941 1.094 . . . . 0.0 109.945 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.83 -104.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 mtp -106.62 161.54 14.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 109.447 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -73.4 179.28 4.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -82.6 6.78 67.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.08 -40.29 60.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.02 -1.282 . . . . 0.0 108.247 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 6.2 tp10 -71.36 -15.95 62.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.7 mt -74.01 -58.6 3.19 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.854 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.9 -38.43 91.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.209 -0.932 . . . . 0.0 109.34 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' ALA . 13.8 tptm -63.5 -51.18 66.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 108.892 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 67' ' ' GLU . 24.0 p -60.35 -45.59 92.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 109.341 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.96 -34.63 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.252 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.15 -8.05 52.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -108.62 -16.91 14.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 109.733 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 74' ' ' ALA . 7.7 p30 -23.98 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.234 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -169.09 -82.34 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.33 26.85 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.958 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 tpt -147.94 36.37 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.3 m -79.14 58.03 2.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.34 -18.74 0.44 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.84 . . . . 0.0 110.667 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -47.79 111.13 1.58 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 109.476 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.26 125.89 19.31 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 121.422 1.414 . . . . 0.0 113.442 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -121.26 116.93 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -97.53 107.42 19.92 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.708 -1.597 . . . . 0.0 106.926 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.475 ' C ' ' SD ' ' A' ' 85' ' ' MET . 5.0 ppp? -75.24 131.87 40.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.45 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.92 142.23 25.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.362 0.601 . . . . 0.0 110.834 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.0 t -150.12 176.53 10.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 109.345 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -128.49 -5.92 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 109.232 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.8 pm0 -139.47 57.6 1.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.337 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -47.14 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' GLU . 12.1 tptt -77.93 48.15 0.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.871 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.6 mttp 52.44 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.0 tt0 -45.11 -40.51 7.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.424 -0.797 . . . . 0.0 110.028 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.453 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.8 OUTLIER -57.44 -41.23 80.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 109.036 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.694 HD11 ' HB1' ' A' ' 90' ' ' ALA . 95.2 mt -59.78 -51.44 72.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.063 -1.023 . . . . 0.0 108.446 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -66.23 -26.36 37.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.523 -0.736 . . . . 0.0 109.313 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.71 39.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.089 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -79.42 -50.88 10.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.845 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -55.89 -30.08 61.01 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.088 -1.045 . . . . 0.0 108.998 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.452 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.6 tt0 -58.64 -34.16 70.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.854 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -77.88 -22.62 49.49 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 60.17 79.31 0.12 Allowed Glycine 0 N--CA 1.478 1.495 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.532 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.812 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.37 -111.95 0.06 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 116.932 -1.907 . . . . 0.0 109.288 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.8 t -91.94 -49.73 6.08 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.753 1.263 . . . . 0.0 108.278 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.47 -165.7 37.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.27 125.63 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.947 . . . . 0.0 109.484 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.8 p -126.59 122.66 61.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -58.18 -167.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.8 pttm -164.71 155.25 12.68 Favored Pre-proline 0 C--N 1.297 -1.711 0 O-C-N 120.649 -1.282 . . . . 0.0 109.312 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.6 161.05 94.95 Favored 'Cis proline' 0 N--CA 1.485 0.991 0 C-N-CA 124.888 -0.88 . . . . 0.0 110.432 -2.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.6 p90 -127.92 166.23 18.7 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.704 0.764 . . . . 0.0 109.791 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -95.24 146.34 24.41 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.39 0.73 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.998 -1.063 . . . . 0.0 109.596 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.75 72.92 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.008 -1.057 . . . . 0.0 108.521 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.86 -64.67 0.82 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -49.67 -39.27 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.758 -1.214 . . . . 0.0 109.381 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 120' ' ' LEU . 30.4 tt0 -64.78 -64.47 0.86 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.063 -1.023 . . . . 0.0 109.749 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -44.97 -36.6 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -75.73 -29.53 58.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.941 . . . . 0.0 109.155 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 117' ' ' GLU . 6.3 tp -66.61 -56.98 8.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -52.9 -41.66 64.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -67.9 -27.45 66.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.666 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.32 -45.29 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 13.7 m-85 -65.62 -27.64 68.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -51.35 -29.57 15.73 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 108.274 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -88.14 -21.11 24.81 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 1.3 tt -80.2 -24.62 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.803 . . . . 0.0 108.861 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.34 -41.73 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.271 -1.135 . . . . 0.0 109.521 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.35 0.595 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.495 ' O ' ' CE2' ' A' ' 30' ' ' PHE . 1.2 t0 -55.63 146.67 20.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -90.07 27.46 1.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.667 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -158.2 37.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.6 tp -72.45 137.7 46.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 2.3 mtmp? -76.89 136.62 38.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.039 -1.038 . . . . 0.0 111.531 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.8 m-85 -127.87 145.44 50.94 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.817 -0.552 . . . . 0.0 110.371 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.553 HD22 HD12 ' A' ' 46' ' ' LEU . 64.4 tp -118.4 118.35 31.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.31 104.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.997 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.2 t -98.79 116.57 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.501 -0.75 . . . . 0.0 109.383 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.77 178.42 8.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.723 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -118.99 13.63 13.07 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -161.82 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.262 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -138.82 -0.7 1.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 109.101 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.65 3.12 0.84 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.805 . . . . 0.0 109.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.6 ttt -74.72 -45.39 44.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.509 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.98 -27.11 61.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.618 ' N ' HH21 ' A' ' 18' ' ' ARG . 10.0 mmt180 -73.25 -31.23 63.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mt -64.88 -54.16 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.68 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 109.945 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 35' ' ' GLU . 8.5 mtt85 -46.71 -54.98 8.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.9 t30 -66.24 -58.47 5.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.438 -0.789 . . . . 0.0 109.432 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.26 -65.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.016 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.69 -45.92 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.163 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -38.28 78.92 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.211 -0.93 . . . . 0.0 109.397 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.61 -41.72 63.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 ' CD ' ' A' ' 117' ' ' GLU . 2.1 mm? -70.94 -61.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 109.136 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.33 42.89 0.02 OUTLIER Glycine 0 N--CA 1.479 1.548 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 94.9 m-85 -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.448 -1.031 . . . . 0.0 109.052 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -149.99 67.41 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.884 -1.135 . . . . 0.0 110.4 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.68 97.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.132 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.14 152.29 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.99 -1.069 . . . . 0.0 110.13 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -124.44 -167.3 1.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' OE2' ' NH1' ' A' ' 22' ' ' ARG . 17.9 mt-10 -147.62 146.49 29.37 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 110.153 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.997 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.11 -165.13 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -144.98 -0.74 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.909 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 25.8 t0 -171.57 178.8 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.744 -1.222 . . . . 0.0 109.891 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . -67.22 -52.04 34.44 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -55.33 -27.66 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -1.097 . . . . 0.0 108.615 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -79.86 -42.73 23.65 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.315 -0.866 . . . . 0.0 108.911 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.86 -36.26 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.338 -0.851 . . . . 0.0 109.644 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.76 -37.42 73.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.545 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -82.95 -26.72 31.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.029 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -85.24 -14.36 46.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.393 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.553 HD12 HD22 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -76.88 -19.4 57.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.662 -1.274 . . . . 0.0 109.405 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -68.08 -5.68 18.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 108.879 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.51 -70.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.809 . . . . 0.0 109.779 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.23 13.11 1.08 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.01 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 20.4 m-85 -70.82 140.71 51.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.377 -1.073 . . . . 0.0 110.09 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.84 -6.27 62.2 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -156.54 142.95 18.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.762 -0.846 . . . . 0.0 108.756 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.93 118.32 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.671 -1.268 . . . . 0.0 110.006 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.1 mt -100.89 153.52 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.9 p -170.86 166.0 7.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.032 -1.042 . . . . 0.0 109.189 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.592 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 61.8 t-105 -167.12 -57.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.05 -1.031 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.592 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 29.5 p30 -172.54 72.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 110.434 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -91.49 -47.69 0.34 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 110.511 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.94 -160.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 C-N-CA 121.129 1.219 . . . . 0.0 110.216 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -76.67 -40.6 48.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.658 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -79.95 143.98 33.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.33 146.16 27.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -64.85 -15.35 60.0 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -73.91 -72.74 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.163 -1.198 . . . . 0.0 109.951 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' LEU . 69.5 tt0 -45.86 -26.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -69.11 -46.89 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.643 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 7.8 tt -74.67 -62.65 1.46 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.389 0.614 . . . . 0.0 109.397 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -43.39 -31.64 0.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -63.56 -41.84 98.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 47.9 mt -57.91 -40.04 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -68.37 -3.16 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.26 69.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -73.14 139.92 46.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.31 80.34 0.95 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -170.9 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -1.182 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.96 10.73 30.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.403 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m 52.49 -117.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.987 . . . . 0.0 109.18 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -125.91 0.92 7.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER 52.77 171.14 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.44 136.13 57.43 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 121.489 1.46 . . . . 0.0 112.874 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.94 139.85 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.82 68.28 0.76 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -61.57 131.57 50.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.45 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.89 135.74 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.192 -0.942 . . . . 0.0 110.813 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -150.07 156.11 41.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.567 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -85.53 156.8 20.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 tm-20 59.69 -75.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 79.4 97.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -0.761 . . . . 0.0 109.205 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.6 mmmt -58.33 -107.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -163.47 -69.16 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -52.56 -16.46 0.93 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.902 . . . . 0.0 109.372 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -78.64 -29.41 45.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.7 -15.7 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.664 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 97' ' ' ALA . 14.9 mt -82.22 -64.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.785 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -46.26 -47.85 18.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 0.0 109.376 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.654 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -58.2 -51.71 68.59 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.47 -0.769 . . . . 0.0 109.758 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -52.21 -48.65 64.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -47.99 -22.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 108.791 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -94.35 -116.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.659 -0.65 . . . . 0.0 109.531 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.707 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -127.58 -3.67 5.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -59.34 10.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.671 -0.899 . . . . 0.0 109.375 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.707 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.45 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.26 130.98 10.41 Favored Glycine 0 N--CA 1.497 2.722 0 C-N-CA 119.492 -1.337 . . . . 0.0 109.899 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.89 109.24 5.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -1.053 . . . . 0.0 109.351 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG1' HG12 ' A' ' 86' ' ' VAL . 7.3 p -107.54 139.82 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.503 HG22 ' OH ' ' A' ' 106' ' ' TYR . 1.2 t -81.82 119.18 30.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.34 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -88.4 151.62 48.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.892 -1.13 . . . . 0.0 109.624 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.82 162.24 92.57 Favored 'Cis proline' 0 N--CA 1.487 1.121 0 C-N-CA 125.226 -0.739 . . . . 0.0 110.512 -1.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -139.23 159.13 42.88 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 109.993 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.59 151.5 21.53 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.269 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.45 -17.33 0.15 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 108.835 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.85 -43.6 58.15 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -67.25 -63.84 0.98 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.3 tp -46.88 -36.11 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.432 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.62 ' CD ' HD11 ' A' ' 28' ' ' LEU . 16.6 tt0 -63.62 -64.3 0.93 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.99 -1.069 . . . . 0.0 109.772 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -52.99 7.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -46.53 -46.51 19.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.529 HD11 ' CE2' ' A' ' 53' ' ' PHE . 1.3 tp -57.92 -54.97 40.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -21.07 48.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -38.73 49.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.15 . . . . 0.0 109.624 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -90.1 -36.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.353 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -73.29 -41.03 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -51.15 -18.83 0.96 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.843 -1.16 . . . . 0.0 108.046 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -98.44 -23.72 15.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' PHE . 0.5 OUTLIER -82.33 -21.93 35.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 55.05 81.01 0.07 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 109.368 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.264 0.554 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 62.2 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.362 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -90.05 19.2 5.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -137.42 41.21 2.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 tp -75.0 127.73 33.92 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 122.74 24.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 111.712 -177.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 44.6 m-85 -109.98 152.87 25.34 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.5 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.1 tp -117.36 109.45 16.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.64 121.05 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 109.86 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 36' ' ' ALA . 46.1 t -123.45 27.08 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -51.73 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.915 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -53.4 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.622 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -46.94 140.41 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.626 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -88.24 13.78 10.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.356 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -136.11 -18.56 1.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.711 . . . . 0.0 109.299 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.417 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -68.97 -17.68 63.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.244 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -34.91 78.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.872 . . . . 0.0 109.36 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -24.39 62.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 108.914 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -69.91 -52.35 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -30.7 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.747 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.2 -54.29 17.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.95 . . . . 0.0 109.408 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.3 t-20 -67.41 -57.29 6.84 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.804 0.811 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.21 -43.51 1.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.695 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 12.2 mt -70.07 -38.97 75.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.778 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -63.96 -38.26 90.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.29 -0.881 . . . . 0.0 109.157 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -51.0 -35.09 32.01 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.351 -0.843 . . . . 0.0 109.036 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 28' ' ' LEU . 11.0 mp -77.56 -50.9 11.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.336 -0.852 . . . . 0.0 109.133 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.83 35.71 0.06 OUTLIER Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.39 147.39 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.391 -1.064 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -150.17 57.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.05 -1.031 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.88 110.2 0.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.766 -1.209 . . . . 0.0 110.181 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 34' ' ' GLU . 1.3 m -148.2 -177.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 0.0 109.673 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.3 mm-40 -128.11 -171.89 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.77 145.77 30.95 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.125 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.09 -174.2 4.65 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.25 23.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.741 -1.224 . . . . 0.0 110.363 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 179.53 147.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.865 -1.147 . . . . 0.0 109.336 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.59 -39.89 23.77 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.32 -32.05 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -1.069 . . . . 0.0 108.793 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.546 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.2 t0 -76.98 -45.69 26.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.42 -32.55 74.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.555 -0.716 . . . . 0.0 109.394 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 43' ' ' LEU . 3.2 tt -68.22 -65.72 0.66 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -46.51 -27.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 3.9 mttm -90.0 -39.08 13.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.5 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -53.2 -37.6 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.04 . . . . 0.0 108.885 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 7.3 mt-30 -54.94 -24.36 23.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -44.23 -61.3 1.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.164 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.0 75.39 1.22 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -173.18 -31.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.591 ' O ' HD21 ' A' ' 81' ' ' LEU . 15.2 m-85 -61.35 86.27 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.269 -1.136 . . . . 0.0 110.015 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -66.92 6.08 2.22 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.6 t80 -158.08 146.2 18.69 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 121.565 -0.962 . . . . 0.0 109.099 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 83' ' ' VAL . 76.6 t -144.01 127.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.617 -1.302 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.77 103.19 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.481 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 23.4 p -109.32 -178.91 3.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 0.0 110.46 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 85' ' ' MET . 32.3 t70 -89.44 -131.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.842 . . . . 0.0 110.292 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.452 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 46.7 t-105 -162.7 -55.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.96 . . . . 0.0 110.092 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.531 ' O ' ' SD ' ' A' ' 60' ' ' MET . 24.0 t-20 -142.54 103.36 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.75 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.558 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.81 -46.22 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -69.36 -162.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.05 1.166 . . . . 0.0 109.979 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -54.07 130.38 37.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.106 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.425 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 36.7 mmm 51.17 -116.16 0.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -142.59 151.01 41.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 108.932 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.35 12.61 1.77 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 64' ' ' ASP . 1.2 tp -67.8 -57.2 6.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -1.185 . . . . 0.0 108.97 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -19.81 64.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.459 -0.776 . . . . 0.0 109.115 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -59.3 4.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.5 tt -70.95 -59.46 2.78 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.8 tttt -38.38 -37.71 0.31 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -63.3 -44.17 95.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 108.794 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 56.0 mt -55.33 -38.0 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.97 -5.95 58.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.49 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -84.82 -26.74 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 109.625 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.07 -15.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 67.31 -0.65 8.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.91 26.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -1.121 . . . . 0.0 109.413 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 mmt -139.79 20.61 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 109.339 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.2 p -85.61 49.23 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.52 6.02 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 109.843 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 51' ' ' TYR . 7.2 tp -92.98 119.59 67.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 108.636 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.91 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 120.774 0.982 . . . . 0.0 111.926 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.737 HG11 HD11 ' A' ' 69' ' ' LEU . 8.7 t -98.8 110.4 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.363 -0.836 . . . . 0.0 108.759 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.29 101.6 13.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 1.1 tpt -75.5 152.14 37.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.72 147.3 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.632 -0.668 . . . . 0.0 110.151 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.55 HG22 ' N ' ' A' ' 88' ' ' ALA . 30.9 m -143.77 163.18 34.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.969 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.55 ' N ' HG22 ' A' ' 87' ' ' THR . . . -105.09 -62.43 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -96.57 87.19 4.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.094 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -81.79 161.09 23.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.917 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -147.39 154.23 40.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.169 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -48.39 61.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.12 -52.81 8.65 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.131 -0.981 . . . . 0.0 110.632 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.44 -10.21 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.113 -0.992 . . . . 0.0 110.561 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 9.9 mt -86.35 -7.29 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.827 -1.171 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.5 mp -90.07 -46.59 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -46.01 -22.7 0.23 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.42 -52.57 45.02 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -49.22 -41.82 38.5 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.722 -1.861 . . . . 0.0 107.96 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.92 -31.27 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.798 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -134.82 -71.2 0.49 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -49.98 82.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 176.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -68.46 -110.13 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 112.586 -1.807 . . . . 0.0 115.08 -174.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -37.44 -57.22 0.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.723 -176.424 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.67 171.16 33.65 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.852 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.46 113.48 11.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 107' ' ' VAL . 13.1 p -109.25 115.25 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 108' ' ' VAL . 1.1 p -71.04 102.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 159.39 77.29 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.049 -1.032 . . . . 0.0 109.123 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.9 154.21 99.51 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.357 -2.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -129.57 160.83 32.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.859 0.838 . . . . 0.0 110.138 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -97.97 148.49 23.42 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.13 -35.48 7.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 109.327 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 -35.38 80.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.0 m -70.43 -67.8 0.47 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 115' ' ' THR . 10.6 tp -47.28 -39.62 14.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.656 -1.278 . . . . 0.0 109.344 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -62.7 -53.48 53.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.078 -1.014 . . . . 0.0 109.5 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.0 mm-40 -47.4 -28.32 2.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.286 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -79.55 -49.83 11.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.445 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -48.26 73.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.307 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.13 -47.36 86.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 109.956 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.8 mt -82.82 -35.86 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.888 . . . . 0.0 109.116 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -85.92 -2.15 57.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.46 -27.04 55.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -93.65 -31.09 14.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.59 -27.97 62.5 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.11 87.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.384 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -53.28 144.2 16.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.197 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.3 mttm -90.15 18.84 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 0.0 109.366 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.593 ' OE1' ' ND2' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -159.63 48.96 0.3 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 40.2 tp -77.51 113.02 14.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.999 -1.063 . . . . 0.0 108.433 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -53.78 106.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.938 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.594 ' HB2' HG22 ' A' ' 33' ' ' VAL . 69.0 m-85 -101.09 153.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.899 HD23 HD12 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -137.58 117.63 13.41 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.475 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.813 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.3 m -106.01 119.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.658 -0.651 . . . . 0.0 110.906 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' ' 36' ' ' ALA . 54.4 t -103.56 112.49 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 121.384 -0.823 . . . . 0.0 109.462 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.464 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -157.96 139.64 13.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -80.2 -12.17 59.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.439 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.52 141.66 58.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 t -92.65 41.18 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -172.06 -40.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 14.1 ttm -46.94 -15.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' THR . 2.9 mtt180 -86.15 -44.34 12.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 109.684 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -65.64 -13.44 59.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.458 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.15 -49.48 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -36.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' ' OE2' ' A' ' 35' ' ' GLU . 8.0 mtt180 -50.81 -52.87 36.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 109.267 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.23 -57.06 7.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.977 0.894 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.28 -48.88 3.67 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.836 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.56 -51.05 62.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.835 -1.166 . . . . 0.0 108.518 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.28 -32.99 5.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -48.59 -38.95 22.1 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.008 . . . . 0.0 109.1 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' OE2' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -76.57 -68.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.384 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.09 20.95 0.02 OUTLIER Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 29.1 m-85 -97.15 139.22 33.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.862 -1.375 . . . . 0.0 109.75 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.593 ' ND2' ' OE1' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -143.84 67.21 1.28 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.124 -0.985 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -174.82 91.56 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.199 -0.938 . . . . 0.0 108.82 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 8' ' ' PHE . 22.0 t -138.94 154.84 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.214 -0.929 . . . . 0.0 110.818 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.671 ' OE2' HD22 ' A' ' 9' ' ' LEU . 13.5 pt-20 -125.89 -171.02 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 13.3 mp0 -144.56 161.46 39.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.83 . . . . 0.0 110.045 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.45 -170.45 3.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.535 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 68.1 mt-10 -134.32 0.71 3.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.532 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 0.2 OUTLIER 175.7 -175.22 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.785 -1.197 . . . . 0.0 109.314 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.97 -54.07 33.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 41' ' ' ASP . 29.6 m -57.3 -36.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -1.131 . . . . 0.0 108.799 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 12.2 t0 -63.48 -45.09 92.35 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -55.73 -67.97 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.778 . . . . 0.0 109.035 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -43.17 -28.52 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.305 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -79.42 -50.35 10.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.908 -1.12 . . . . 0.0 110.818 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' OE2' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -89.79 -3.79 57.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.086 -1.009 . . . . 0.0 110.605 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.899 HD12 HD23 ' A' ' 9' ' ' LEU . 4.4 tt -90.11 -41.21 11.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.074 -1.016 . . . . 0.0 109.624 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.43 0.79 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.31 -60.57 1.86 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.572 -0.705 . . . . 0.0 109.843 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.35 11.1 1.0 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.115 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.46 97.91 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 15.9 m-85 -79.22 124.23 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.204 -1.174 . . . . 0.0 110.405 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.83 -3.86 56.66 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -167.77 142.71 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.428 . . . . 0.0 109.369 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.5 t -134.78 158.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.278 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 84' ' ' LEU . 13.9 mt -143.31 127.59 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 85' ' ' MET . 15.7 p -147.61 157.45 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.892 -1.13 . . . . 0.0 110.175 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 8.8 t0 -65.78 -137.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.758 ' HE1' HD22 ' A' ' 94' ' ' ASN . 60.6 t-105 -173.37 111.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.468 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 66.97 27.43 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.602 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.1 tpt -101.8 -41.99 0.21 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 111.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.2 Cg_exo -65.57 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.158 1.239 . . . . 0.0 110.518 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -74.17 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.064 -1.023 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.3 mtm -74.09 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 65' ' ' GLY . 61.9 t0 -172.38 140.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.063 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -70.98 15.69 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 64' ' ' ASP . 13.7 tp -81.09 -56.76 3.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.08 -1.247 . . . . 0.0 107.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -60.28 -22.25 62.9 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.522 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD13 ' CA ' ' A' ' 39' ' ' GLY . 22.5 tp -64.32 -59.06 4.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -48.06 -63.18 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.752 0.787 . . . . 0.0 108.953 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.2 tttm -40.29 -44.08 1.84 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 110.272 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -58.68 -39.13 79.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.915 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 69' ' ' LEU . 37.7 mt -58.98 -41.68 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.156 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -50.06 -30.07 10.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 109.559 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -45.98 -24.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 74' ' ' ALA . 12.2 t70 -44.1 -91.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -164.77 -142.88 3.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.25 -0.1 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.686 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.93 7.38 37.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 47.29 -132.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.241 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -113.57 12.13 18.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.724 -0.61 . . . . 0.0 109.589 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 52.5 173.85 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.224 -0.922 . . . . 0.0 108.722 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.33 144.02 99.54 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.326 1.351 . . . . 0.0 113.452 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -138.54 135.86 43.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.3 tp -114.76 69.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 56' ' ' SER . 5.1 ptm -56.66 156.07 6.8 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.557 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.08 138.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.852 -0.53 . . . . 0.0 109.588 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -146.63 179.88 7.25 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.466 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -130.69 -26.32 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.835 -0.54 . . . . 0.0 109.608 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -117.4 61.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 109.756 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.02 108.98 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.173 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -78.59 -79.65 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.794 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -174.48 -89.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.014 . . . . 0.0 109.548 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.64 45.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.758 HD22 ' HE1' ' A' ' 58' ' ' TRP . 6.8 t-20 -54.64 -26.15 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.332 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.692 HD11 ' HB1' ' A' ' 90' ' ' ALA . 36.4 mt -85.12 -17.47 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 0.0 109.264 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' ALA . 72.5 mt -82.94 -62.92 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -45.82 -54.21 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.56 -52.38 17.84 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.42 -0.8 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.54 69.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.584 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -59.01 -17.18 22.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.044 -1.035 . . . . 0.0 109.968 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.85 -34.99 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.336 -0.852 . . . . 0.0 109.88 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.709 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.06 -13.07 0.73 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.5 10.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.769 -0.842 . . . . 0.0 109.885 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.709 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.46 -35.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.113 -177.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.39 127.05 9.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.554 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -139.62 113.4 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -1.032 . . . . 0.0 108.567 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.811 HG21 HD12 ' A' ' 116' ' ' LEU . 14.1 p -116.01 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.029 HG12 ' H ' ' A' ' 109' ' ' LYS . 33.1 t -61.27 -164.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 1.029 ' H ' HG12 ' A' ' 108' ' ' VAL . 9.9 pttm -164.88 156.09 13.03 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.464 -1.398 . . . . 0.0 108.737 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.96 166.69 81.64 Favored 'Cis proline' 0 N--CA 1.486 1.034 0 C-N-CA 125.158 -0.768 . . . . 0.0 110.857 -1.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.03 161.98 37.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -102.28 171.28 7.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 176.501 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -61.41 -25.52 67.25 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.555 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.56 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.416 -0.802 . . . . 0.0 109.138 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -66.34 -64.55 0.83 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 107' ' ' VAL . 4.1 tp -47.76 -36.44 11.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.811 -1.18 . . . . 0.0 109.779 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 2.9 mm-40 -59.2 -66.69 0.47 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.816 -1.178 . . . . 0.0 109.939 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -45.62 -25.71 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.637 -0.665 . . . . 0.0 110.532 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -86.34 -44.54 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 110.246 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -43.13 91.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.437 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -64.81 -40.83 95.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -56.57 -31.73 64.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.257 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 125' ' ' GLU . 67.8 mt -85.69 -45.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -70.46 10.12 0.52 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.235 -0.915 . . . . 0.0 109.368 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.5 tt0 -83.29 -24.68 32.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -96.21 -30.85 13.25 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -72.3 -26.07 61.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.88 88.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.445 ' SD ' ' OXT' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER 52.88 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.395 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -73.15 32.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.952 . . . . 0.0 109.137 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' ASP . 82.0 mt-10 -155.25 33.32 0.38 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 108.993 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 53' ' ' PHE . 39.2 tp -70.12 132.9 46.53 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -76.09 117.55 17.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -106.12 152.44 23.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.2 tp -126.78 111.06 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -97.77 116.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.782 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' A' ' 36' ' ' ALA . 56.5 t -118.86 110.74 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.912 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -177.2 124.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.985 -1.072 . . . . 0.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.14 7.47 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.717 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -172.16 -154.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.439 -1.413 . . . . 0.0 112.258 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.717 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 177.91 16.43 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.491 HG22 ' C ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -171.92 -48.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.927 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 22.0 ttt -38.85 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.665 -0.647 . . . . 0.0 110.853 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 51.1 mtm180 -43.37 -30.24 0.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.45 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -30.27 39.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.642 -1.287 . . . . 0.0 109.445 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.8 mt -69.66 -49.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.93 -35.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -46.95 -54.1 10.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 109.039 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t30 -61.23 -56.76 17.0 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.845 0.831 . . . . 0.0 108.787 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -36.89 -67.61 0.17 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.897 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.29 -42.79 74.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.925 -1.109 . . . . 0.0 108.997 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -59.16 -28.4 66.56 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -46.61 68.92 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.138 -0.976 . . . . 0.0 109.213 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.0 -62.95 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -0.883 . . . . 0.0 109.077 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.09 18.7 0.02 OUTLIER Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.198 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.97 123.72 34.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.488 -1.595 . . . . 0.0 109.156 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.18 69.27 1.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.73 96.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.094 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.07 149.79 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.004 -1.06 . . . . 0.0 109.916 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 3.6 mt-10 -118.95 -172.18 2.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.8 mp0 -147.11 165.69 29.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 110.396 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.902 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.98 -170.46 3.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -130.25 0.27 4.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.475 -0.766 . . . . 0.0 110.326 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.18 176.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.034 . . . . 0.0 109.601 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -60.32 -47.31 91.72 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -52.85 -35.07 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.088 -1.242 . . . . 0.0 108.42 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 34.9 t0 -74.06 -52.87 11.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.501 -0.749 . . . . 0.0 109.247 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -56.03 -57.44 12.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.304 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.857 HD11 HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -46.28 -46.49 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.0 109.777 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -72.52 -31.6 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 0.0 110.134 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -90.08 -7.06 54.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.973 . . . . 0.0 110.238 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -70.53 -6.44 36.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 0.0 108.77 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.51 -2.16 57.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.987 -1.07 . . . . 0.0 109.234 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.76 -67.82 0.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.822 . . . . 0.0 109.456 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.48 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.58 72.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.724 ' O ' HD21 ' A' ' 81' ' ' LEU . 76.7 m-85 -54.9 95.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.94 -6.13 1.68 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -153.42 139.24 18.03 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.49 -1.006 . . . . 0.0 109.587 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 9' ' ' LEU . 47.8 t -134.0 118.81 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.004 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 55' ' ' ILE . 34.8 mt -99.51 114.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.6 p -132.24 166.21 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.806 . . . . 0.0 109.326 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 12.4 p-10 -90.01 -118.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.117 -0.99 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.482 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 43.2 t-105 -162.36 -18.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.331 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.38 96.21 5.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.312 0.577 . . . . 0.0 109.774 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 159.69 70.75 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.73 -41.82 73.65 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.144 1.23 . . . . 0.0 110.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -96.51 -107.74 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 0.0 109.192 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 63' ' ' MET . 2.8 mpp? -69.56 -161.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.5 176.38 6.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.064 -1.022 . . . . 0.0 109.29 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.93 59.25 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.571 -1.3 . . . . 0.0 109.874 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.8 tp -86.24 -40.68 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.808 -1.407 . . . . 0.0 107.58 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.74 -18.03 65.17 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' CA ' ' A' ' 39' ' ' GLY . 25.6 tp -78.48 -66.48 0.85 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -56.73 -40.03 74.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -47.53 86.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.288 -0.882 . . . . 0.0 109.023 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.857 HG21 HD11 ' A' ' 43' ' ' LEU . 52.9 m -51.23 -47.38 62.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.61 -46.09 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 108.795 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -62.09 -29.0 70.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.6 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 71' ' ' THR . . . -45.27 -29.13 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 11.1 t70 -67.73 99.69 0.83 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.71 76.58 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -168.26 -60.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 0.0 109.405 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.1 mmt -92.91 -71.03 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t 45.46 26.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.374 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.81 -12.59 4.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.654 -0.654 . . . . 0.0 109.487 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.2 tp -48.25 113.37 2.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.112 -0.993 . . . . 0.0 108.729 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.5 121.59 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.2 1.267 . . . . 0.0 112.751 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.52 115.52 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' MET . 5.5 tp -101.61 73.88 1.48 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.896 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' LEU . 6.0 mtt -48.15 172.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -147.15 120.18 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.413 -0.805 . . . . 0.0 109.344 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -150.04 -178.47 6.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.743 -1.223 . . . . 0.0 110.042 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.31 -41.64 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.51 56.42 2.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 109.375 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -71.26 111.51 6.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.708 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.203 -0.936 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -136.36 -70.21 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -45.97 -16.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.809 . . . . 0.0 109.553 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -90.13 -57.31 2.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 109.608 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 90' ' ' ALA . 69.2 mt -47.44 -28.42 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.377 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.95 -60.04 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.313 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.69 -52.8 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 108.971 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.462 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -50.64 -48.45 58.21 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.495 -0.753 . . . . 0.0 108.992 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.75 -45.92 49.92 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.23 -29.18 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -112.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.47 -0.769 . . . . 0.0 109.191 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -131.64 0.14 4.98 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.6 11.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.143 -0.622 . . . . 0.0 110.621 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 21.8 m -29.44 -32.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 122.265 -0.272 . . . . 0.0 111.723 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.81 135.48 12.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -152.06 110.23 3.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 108.822 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.5 p -104.44 139.75 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -88.07 105.19 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.531 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.21 160.12 83.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.903 -1.123 . . . . 0.0 109.059 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.08 166.33 83.54 Favored 'Cis proline' 0 N--CA 1.484 0.944 0 C-N-CA 124.747 -0.939 . . . . 0.0 110.577 -2.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CE1' HD12 ' A' ' 116' ' ' LEU . 6.6 p90 -142.4 -170.98 3.3 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.978 0.894 . . . . 0.0 109.554 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.529 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -135.22 150.18 50.04 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.506 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.45 -33.65 6.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.418 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.83 -30.96 61.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -79.32 -61.3 2.05 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.613 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -49.99 -32.45 15.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.45 -1.406 . . . . 0.0 108.388 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.19 -56.99 10.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.066 -1.021 . . . . 0.0 109.942 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -44.16 -36.41 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.668 -0.645 . . . . 0.0 109.459 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -43.52 81.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.293 -0.879 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.56 -63.07 1.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 109.481 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -44.73 -49.48 10.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.339 -0.851 . . . . 0.0 110.598 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.13 -29.61 63.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.288 -0.883 . . . . 0.0 110.726 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.55 HD11 ' HA2' ' A' ' 105' ' ' GLY . 15.1 mt -89.98 -44.63 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.156 . . . . 0.0 110.785 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -59.14 -9.95 2.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.014 -1.054 . . . . 0.0 110.571 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -20.9 63.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -95.49 -31.88 13.14 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -22.37 43.52 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.87 88.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.256 -1.143 . . . . 0.0 109.459 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -46.27 109.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.0 109.637 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 2.0 mmtp -56.36 7.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.157 -0.964 . . . . 0.0 110.635 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' ' C ' ' A' ' 3' ' ' ASP . 73.3 mt-10 -141.92 45.34 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.058 -1.026 . . . . 0.0 108.738 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 45.0 tp -76.64 107.97 9.31 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 118.215 -1.394 . . . . 0.0 108.715 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -48.95 113.83 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 68.8 m-85 -104.94 155.46 18.92 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -130.97 103.4 6.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 107.78 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 0.0 109.802 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 36' ' ' ALA . 50.3 t -107.87 106.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 -163.51 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.393 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.02 4.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.05 165.28 14.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -97.69 9.7 41.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -149.74 10.22 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 0.0 109.642 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.1 ttt -92.13 -47.14 7.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -28.81 69.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' CG ' HH21 ' A' ' 22' ' ' ARG . 31.6 ttp85 -68.49 -52.77 28.66 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.778 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.5 mt -46.24 -55.05 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.365 -0.835 . . . . 0.0 109.689 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.4 -43.27 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.616 -178.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.432 HH21 ' CG ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -46.88 -55.01 8.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.038 -1.039 . . . . 0.0 109.755 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.33 -55.13 19.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.111 0.958 . . . . 0.0 109.039 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -39.73 -55.25 1.96 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.893 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 30.6 mt -59.94 -49.89 75.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.07 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.79 -34.11 38.37 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.909 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 2.8 tt0 -58.24 -30.17 66.31 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -87.08 -14.48 41.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.775 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.22 46.05 1.77 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.228 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -117.28 129.36 55.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.308 -1.113 . . . . 0.0 108.9 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -128.68 67.99 1.39 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -174.95 94.91 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -0.957 . . . . 0.0 108.861 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.05 149.19 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 110.843 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.78 -169.06 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -150.0 154.52 38.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.021 -1.05 . . . . 0.0 110.69 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.11 -172.4 3.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -139.09 15.47 2.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.169 -0.957 . . . . 0.0 110.619 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 175.24 146.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.713 -1.242 . . . . 0.0 109.868 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -32.98 10.05 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.04 -35.72 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.337 -1.096 . . . . 0.0 108.657 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 26.5 t0 -70.87 -44.94 65.34 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.25 -54.13 42.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.73 -43.15 17.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.922 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -73.94 -33.27 63.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -90.02 -7.68 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 110.006 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -68.07 -13.6 62.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -85.82 -2.83 58.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.45 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.464 -0.772 . . . . 0.0 109.722 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.61 9.97 1.43 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.84 83.75 1.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.485 ' C ' ' N ' ' A' ' 53' ' ' PHE . 57.2 m-85 -62.69 99.89 0.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.29 -1.123 . . . . 0.0 109.693 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.96 -14.28 0.41 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -148.99 119.23 7.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.48 -1.012 . . . . 0.0 109.884 -179.186 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HB ' HG22 ' A' ' 83' ' ' VAL . 53.8 t -116.65 124.05 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.238 -0.913 . . . . 0.0 109.524 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 55' ' ' ILE . 1.1 mt -107.45 126.16 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -143.44 145.15 32.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -0.782 . . . . 0.0 108.987 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -98.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.081 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -172.57 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.145 -0.972 . . . . 0.0 109.726 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -134.84 -1.39 2.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.333 -0.854 . . . . 0.0 109.761 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.532 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.2 mtp -60.16 -47.33 97.08 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 110.67 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.22 -66.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.118 1.212 . . . . 0.0 110.598 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -130.22 -152.43 0.51 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.596 -0.69 . . . . 0.0 109.634 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mtt -51.53 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.699 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 2.3 p30 -142.68 138.45 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.373 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.29 -2.8 21.55 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.42 -45.83 62.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.829 -1.395 . . . . 0.0 108.163 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -39.16 71.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.465 HD13 ' CA ' ' A' ' 39' ' ' GLY . 66.5 tp -53.78 -29.1 38.72 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -88.07 -64.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 109.333 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 69' ' ' LEU . 6.7 ttpp -34.88 -52.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.105 0.478 . . . . 0.0 110.381 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -45.53 41.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 108.766 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 69' ' ' LEU . 53.4 mt -59.37 -30.43 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 108.846 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' LYS . 4.3 ttp85 -83.47 -23.01 32.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.756 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -46.53 -28.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.563 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 18.0 t0 -61.37 -150.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -161.54 33.92 0.37 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.06 6.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -1.195 . . . . 0.0 109.404 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.449 ' HB2' HD23 ' A' ' 81' ' ' LEU . 5.9 ptm -150.03 52.94 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.349 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.7 t -92.76 -5.58 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.647 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.92 53.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 78' ' ' MET . 0.7 OUTLIER -49.44 111.35 1.96 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.897 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.13 144.1 95.45 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 121.009 1.139 . . . . 0.0 112.584 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.4 t -140.26 137.88 37.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 HD11 ' A' ' 116' ' ' LEU . 55.5 tp -115.13 75.13 0.92 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.4 mtt -65.42 122.69 17.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.19 140.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 110.774 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 109' ' ' LYS . 2.4 t -150.09 161.11 43.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.36 25.36 10.77 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' ALA . 48.8 tt0 -142.8 -64.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.475 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 48.77 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 109.165 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 94' ' ' ASN . 22.0 mtmm -59.63 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.208 -0.932 . . . . 0.0 109.811 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -145.25 -101.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -49.99 -27.28 5.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.022 -1.049 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -52.16 -27.12 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -71.62 -27.83 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.7 mt -74.29 -51.43 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.1 26.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.083 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.19 -52.88 63.52 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.496 -0.753 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.0 65.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -48.67 -27.97 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.997 . . . . 0.0 108.821 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.45 -114.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.608 -0.682 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -123.82 -8.32 6.27 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.53 10.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.026 -0.691 . . . . 0.0 110.581 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 4.7 m -29.59 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.46 132.94 11.13 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.185 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.504 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -145.33 129.03 17.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -1.097 . . . . 0.0 109.222 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -134.77 124.99 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -71.16 103.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.733 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' THR . 2.9 pttp -71.47 157.84 89.14 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.34 166.97 81.26 Favored 'Cis proline' 0 N--CA 1.485 1.011 0 C-N-CA 125.01 -0.829 . . . . 0.0 110.683 -1.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.02 158.0 43.95 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.04 0.924 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.36 148.94 23.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -45.88 -23.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 109.377 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -70.23 -41.96 72.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.14 -65.28 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 107' ' ' VAL . 2.4 tp -47.59 -36.32 10.52 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.553 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -65.21 -66.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.975 -1.078 . . . . 0.0 109.733 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -45.21 -30.09 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.995 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 11.0 mmmt -81.35 -50.28 9.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.032 -1.043 . . . . 0.0 110.01 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -31.06 70.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.725 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.23 -28.73 47.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -77.82 -22.91 49.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.77 -43.54 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.502 ' CD2' ' SD ' ' A' ' 129' ' ' MET . 17.8 m-30 -73.82 -0.62 16.43 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.912 -1.118 . . . . 0.0 109.45 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -69.34 -20.28 63.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.35 -29.11 12.23 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -80.71 -16.54 53.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.99 90.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 124' ' ' PHE . 4.4 mtt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.319 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.13 145.13 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.392 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.25 17.64 6.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.312 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -152.05 44.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.26 143.11 52.23 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -78.3 131.85 37.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.988 -1.07 . . . . 0.0 111.247 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 25' ' ' LEU . 76.6 m-85 -122.94 147.52 46.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.736 -0.603 . . . . 0.0 109.821 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.607 ' CD2' HD12 ' A' ' 46' ' ' LEU . 12.9 tp -126.97 110.72 13.29 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -95.76 105.25 16.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.0 t -98.62 95.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.413 -0.805 . . . . 0.0 109.86 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -142.1 -159.22 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.231 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 1.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' THR . 8.9 m-85 -91.21 98.06 11.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.419 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.51 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -93.25 -34.49 13.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.48 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 3.9 ttt -56.06 -56.63 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.77 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -35.28 5.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.318 -0.863 . . . . 0.0 109.669 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 ttm-85 -72.97 -35.66 66.95 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.065 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.2 mp -65.3 -54.0 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.382 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -60.95 -32.85 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.767 -179.378 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -50.74 -53.62 30.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -58.24 5.39 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.939 0.876 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.739 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -73.39 -41.89 62.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -27.78 69.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 7.5 tp10 -59.85 -35.9 75.73 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.054 -1.029 . . . . 0.0 109.375 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -81.11 -59.55 2.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.16 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.62 73.91 0.02 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -149.97 144.54 25.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.24 . . . . 0.0 110.021 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.04 63.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.44 100.89 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.74 -1.225 . . . . 0.0 108.881 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.14 152.36 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.007 -1.058 . . . . 0.0 110.509 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.6 -173.35 2.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 13.5 mp0 -145.28 155.05 42.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.95 -172.75 4.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.01 8.65 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.045 . . . . 0.0 110.555 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 11.9 t70 -179.32 167.7 1.5 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.333 -0.855 . . . . 0.0 109.194 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -63.48 -25.59 68.81 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 t -72.46 -40.69 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 108.52 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 12.3 t0 -69.7 -45.67 67.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.66 -39.21 88.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.47 -37.34 72.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.351 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -86.92 -34.88 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.96 -53.98 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 54' ' ' VAL . 4.9 tt -50.07 -27.35 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 47' ' ' GLN . 1.4 tm0? -69.63 8.21 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 108.959 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.66 -68.72 0.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.98 0.31 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.126 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.62 99.16 1.79 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.84 ' O ' HD22 ' A' ' 81' ' ' LEU . 16.9 m-85 -79.53 110.39 14.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.373 -1.075 . . . . 0.0 110.437 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.76 -14.75 4.06 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.52 145.96 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -1.209 . . . . 0.0 110.179 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.5 t -141.93 120.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.138 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.491 ' CG2' HG21 ' A' ' 86' ' ' VAL . 53.6 mt -103.14 78.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -85.48 149.99 25.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.936 -1.102 . . . . 0.0 110.448 -177.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 27.7 t70 -94.64 178.21 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.567 -0.708 . . . . 0.0 109.291 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.672 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 53.5 t-105 -114.71 46.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.414 ' C ' ' SD ' ' A' ' 60' ' ' MET . 18.9 p30 -65.25 -154.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -162.81 60.05 0.95 Allowed Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 120.749 -1.219 . . . . 0.0 111.981 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -62.68 -39.53 42.82 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 107.576 -1.74 . . . . 0.0 107.576 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -147.46 -22.75 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.42 ' H ' ' H ' ' A' ' 62' ' ' ASN . 1.2 mtt -150.77 -83.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 65' ' ' GLY . 4.9 p-10 169.94 -107.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . -137.96 18.2 3.37 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' LEU . 25.3 tp -79.75 -54.17 6.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.083 -1.245 . . . . 0.0 108.152 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -50.36 -21.89 1.61 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD11 ' HA2' ' A' ' 39' ' ' GLY . 1.9 mt -72.7 -59.67 2.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.962 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.95 -61.02 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.7 tttm -40.84 -48.55 3.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.17 -48.59 80.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.911 HD13 HG21 ' A' ' 83' ' ' VAL . 6.6 mt -57.76 -24.0 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -89.68 -28.04 19.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.709 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.72 -33.32 55.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.525 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.1 102.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.206 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.9 50.12 2.95 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.07 -71.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.142 . . . . 0.0 109.555 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.36 25.57 6.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER -65.93 6.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -95.22 20.99 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.82 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 51' ' ' TYR . 9.9 mt -67.23 118.78 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 108.661 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.79 98.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 120.909 1.072 . . . . 0.0 112.592 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.911 HG21 HD13 ' A' ' 72' ' ' ILE . 8.9 t -106.1 106.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -90.12 107.27 19.03 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.133 -1.827 . . . . 0.0 107.407 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.427 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -63.88 150.52 44.71 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.05 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 55' ' ' ILE . 53.7 t -132.39 140.76 46.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.051 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 90' ' ' ALA . 7.4 t -149.96 157.68 43.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.36 -44.33 7.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.842 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -64.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.836 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.591 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 57.24 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.5 -88.61 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.504 -0.748 . . . . 0.0 109.14 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -156.81 -68.25 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.95 -32.56 61.48 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.193 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.672 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 8.9 t30 -76.64 -47.45 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.03 -45.27 52.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.026 -1.046 . . . . 0.0 108.892 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 100' ' ' GLN . 17.7 mt -66.25 -17.04 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -62.68 -69.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 109.326 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -47.43 -45.71 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 108.5 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -67.88 -27.35 66.59 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.326 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' ILE . 5.5 tp-100 -55.79 -31.76 62.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.962 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.86 -20.17 27.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.44 76.11 0.3 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.373 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.21 -112.09 0.08 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.844 -1.942 . . . . 0.0 110.454 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -50.69 5.59 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.832 1.301 . . . . 0.0 108.047 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 169.85 -155.66 25.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.66 127.49 18.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -1.023 . . . . 0.0 109.586 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.458 ' CG1' HG22 ' A' ' 86' ' ' VAL . 13.6 p -117.96 134.87 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -88.94 121.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.567 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -94.18 162.06 27.62 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.253 -0.904 . . . . 0.0 108.611 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.6 128.32 15.98 Favored 'Cis proline' 0 N--CA 1.485 1.014 0 C-N-CA 124.755 -0.936 . . . . 0.0 110.427 -2.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 116' ' ' LEU . 3.9 p90 -99.48 158.27 15.85 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.93 0.871 . . . . 0.0 110.084 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.25 146.79 23.44 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 117' ' ' GLU . . . -45.56 -23.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.973 -1.08 . . . . 0.0 109.829 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.47 -38.29 65.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.035 -1.041 . . . . 0.0 108.49 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.84 -62.46 1.37 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -47.67 -41.76 23.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.721 -1.191 . . . . 0.0 108.939 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 19.3 mt-10 -61.82 -52.26 64.9 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.053 -1.029 . . . . 0.0 109.499 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -46.4 -49.19 18.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.479 -0.763 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -38.61 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.87 -63.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.79 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -47.59 -53.06 15.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -62.62 -18.21 61.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.8 mt -89.64 -45.66 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.0 109.987 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 127' ' ' LEU . 16.7 m-85 -66.63 -31.48 72.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.002 -1.061 . . . . 0.0 110.014 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -52.71 -26.63 14.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -87.35 -26.48 23.34 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 124' ' ' PHE . 44.0 tp -70.44 -24.01 62.82 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.19 23.41 19.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.7 mmt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.337 -1.096 . . . . 0.0 109.465 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.578 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -177.13 150.84 0.77 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.21 -0.931 . . . . 0.0 109.009 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -90.47 17.78 6.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.861 -1.149 . . . . 0.0 110.499 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.94 43.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.512 -1.368 . . . . 0.0 111.232 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.2 tp -67.02 110.98 3.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.424 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.59 111.29 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.828 -1.17 . . . . 0.0 111.611 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 62.2 m-85 -105.77 155.14 19.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 tp -132.65 104.06 6.45 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.95 130.16 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.261 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 36' ' ' ALA . 13.4 t -137.99 105.37 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.44 -0.788 . . . . 0.0 109.078 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -149.6 116.39 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.148 -0.97 . . . . 0.0 109.431 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.17 -16.85 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.225 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.5 m-85 -59.49 130.03 44.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 m -92.26 48.7 1.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 t -175.72 -14.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 ttt -72.37 -35.56 68.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -63.05 -32.38 73.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.85 -20.16 58.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -75.33 -47.2 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.334 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -32.99 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.215 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -46.03 -52.61 11.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -73.64 -59.58 2.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.601 0.715 . . . . 0.0 110.161 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -40.22 -55.41 2.16 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.916 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -58.23 -50.45 73.52 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -54.0 -34.5 60.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.87 -38.53 49.93 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.391 -0.818 . . . . 0.0 109.38 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -65.03 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.48 26.2 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 54.0 m-85 -100.52 141.47 33.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -1.147 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -150.04 59.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 110.183 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.23 96.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.72 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.6 -178.26 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 109.895 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.8 mm-40 -139.55 -175.62 4.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 11.1 mp0 -144.35 150.21 37.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -141.65 176.29 9.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.67 3.56 14.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.267 -0.896 . . . . 0.0 110.477 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.29 -176.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.262 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.04 -26.42 73.9 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.76 -43.13 93.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.076 -1.249 . . . . 0.0 108.132 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.4 t70 -75.68 -40.85 55.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -62.2 -39.26 92.15 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.238 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 71' ' ' THR . 3.5 mt -62.49 -49.3 75.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.294 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 10.2 m-80 -63.55 -29.13 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -24.16 21.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.622 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -23.06 61.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 0.0 109.625 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 3.2 pt20 -76.72 -1.62 28.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.472 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.42 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.424 -0.797 . . . . 0.0 109.604 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.85 12.18 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.79 88.21 1.37 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' PHE . 58.4 m-85 -69.23 103.95 2.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.297 -1.119 . . . . 0.0 109.588 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.69 -9.19 0.45 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.63 131.28 10.66 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.188 -1.183 . . . . 0.0 109.986 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 83' ' ' VAL . 94.5 t -125.18 114.61 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 109.551 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.46 77.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 p -100.33 128.74 46.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.473 -0.767 . . . . 0.0 110.541 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 59' ' ' ASN . 4.5 t70 -65.12 164.0 13.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.793 -1.192 . . . . 0.0 108.645 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.489 ' CH2' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -55.38 -2.2 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 108.877 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.546 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.1 m120 46.88 -153.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.647 -1.283 . . . . 0.0 110.302 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.515 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 171.25 -44.95 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.284 -0.885 . . . . 0.0 110.739 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.08 125.21 14.23 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.678 0.918 . . . . 0.0 110.259 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.11 -148.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.17 115.73 1.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -85.72 -162.32 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -60.84 2.79 0.51 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 58' ' ' TRP . 6.5 tp -82.26 -65.21 1.04 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.768 -1.431 . . . . 0.0 110.341 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -48.3 -19.96 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -67.98 -62.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.75 HD21 HG11 ' A' ' 83' ' ' VAL . 83.2 mt -56.04 -67.66 0.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.562 0.696 . . . . 0.0 109.236 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 69' ' ' LEU . 25.2 tttp -30.46 -53.28 0.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.626 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.515 HG21 ' CD2' ' A' ' 43' ' ' LEU . 6.7 m -59.29 -47.94 83.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.997 -1.064 . . . . 0.0 108.755 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 69' ' ' LEU . 35.5 mt -58.48 -38.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.469 -0.77 . . . . 0.0 109.281 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -84.2 -8.11 59.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.604 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -75.77 -26.59 57.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.2 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.813 . . . . 0.0 109.747 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 46.3 -143.35 4.56 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.02 76.85 4.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -1.112 . . . . 0.0 109.363 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' ALA . 1.3 ttt -132.02 43.71 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 33.47 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.99 -47.41 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.228 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.462 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -32.8 97.85 0.12 Allowed Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 127' ' ' LEU . 4.2 Cg_exo -64.61 139.04 61.96 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.422 1.415 . . . . 0.0 112.326 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.75 HG11 HD21 ' A' ' 69' ' ' LEU . 6.1 t -130.93 125.5 58.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' CD2' HD21 ' A' ' 116' ' ' LEU . 42.3 tp -107.39 72.23 0.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.425 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 69' ' ' LEU . 5.7 mtp -51.63 151.71 3.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 t -126.51 128.55 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.635 0.731 . . . . 0.0 110.745 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -150.05 177.05 10.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . . . -89.39 -123.42 0.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.93 -1.106 . . . . 0.0 108.862 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -47.92 133.26 14.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 109.306 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -93.34 109.94 21.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.696 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -73.12 -171.06 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 108.872 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 45.3 mttp -94.32 -84.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HA ' HD12 ' A' ' 96' ' ' ILE . 0.8 OUTLIER -49.54 -8.0 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 4.7 m-20 -76.84 -52.43 9.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.871 HD11 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -68.77 -28.08 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 93' ' ' GLU . 52.0 mt -64.75 -64.06 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 109.979 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.86 -57.16 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -60.08 -43.69 95.31 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.023 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.62 -44.33 73.05 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -19.92 59.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.831 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.22 -103.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.279 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -133.22 0.7 4.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.99 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.179 -0.601 . . . . 0.0 111.198 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.629 ' H ' ' C ' ' A' ' 102' ' ' GLY . 22.0 m -29.24 -34.74 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.995 -0.441 . . . . 0.0 111.8 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.2 130.43 10.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.668 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 49.7 t80 -136.5 112.58 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.437 -1.037 . . . . 0.0 109.492 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -115.39 129.01 72.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.6 p -91.37 103.07 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 154.89 89.71 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.035 -1.041 . . . . 0.0 109.165 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.26 158.84 98.46 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 O-C-N 122.506 0.74 . . . . 0.0 111.368 -1.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -136.16 154.65 50.9 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.853 0.835 . . . . 0.0 109.204 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.5 146.29 23.79 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.313 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.69 -40.44 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 108.699 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.67 -34.07 76.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' THR . 25.4 m -68.38 -67.11 0.49 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -40.92 -46.94 2.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.584 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.32 -54.82 42.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 110.302 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.412 ' OE2' HG23 ' A' ' 115' ' ' THR . 1.6 pt-20 -47.84 -30.13 3.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.885 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -72.19 -49.32 36.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.389 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 123' ' ' ILE . 11.0 mt -48.45 -54.9 12.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.81 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -25.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.676 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -86.85 -27.07 23.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.022 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 120' ' ' LEU . 37.7 mm -81.52 -34.35 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.5 -8.61 57.42 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.099 -1.001 . . . . 0.0 110.755 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.57 -17.5 60.03 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -101.31 -30.31 11.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -77.17 -29.96 54.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.04 74.49 0.51 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.438 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.1 t0 -44.78 151.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 mttm -90.14 20.36 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.059 -1.026 . . . . 0.0 109.835 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -163.77 45.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.042 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 25.4 tp -71.82 121.09 18.36 Favored 'General case' 0 C--O 1.203 -1.344 0 O-C-N 121.025 -1.047 . . . . 0.0 108.231 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -53.61 117.31 3.02 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.932 -1.105 . . . . 0.0 112.176 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 70.7 m-85 -112.4 147.77 35.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' CD2' HD12 ' A' ' 46' ' ' LEU . 62.4 tp -121.69 108.29 13.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.154 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -92.95 104.46 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 108.735 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.5 t -89.94 38.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.83 147.01 23.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -98.76 -13.94 19.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.541 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -61.08 137.65 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 t -88.08 17.4 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.44 -40.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.421 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 6.2 ttt -50.33 -35.0 25.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' CG ' ' N ' ' A' ' 19' ' ' ARG . 4.7 ptm85 -63.27 -47.91 80.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.031 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -53.73 -32.54 52.46 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.129 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -53.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -31.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.09 15.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.903 -1.123 . . . . 0.0 109.408 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -69.96 -59.44 2.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.757 0.789 . . . . 0.0 109.858 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.23 -52.7 2.61 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.046 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -62.59 -50.22 72.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.014 . . . . 0.0 108.988 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -55.52 -30.71 61.18 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.89 -27.86 63.68 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.49 -37.57 16.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 139.28 7.69 1.07 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.9 m-85 -89.89 139.74 30.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.66 -1.494 . . . . 0.0 109.754 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 1.1 p30 -148.16 62.89 1.11 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.03 -1.044 . . . . 0.0 110.302 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.52 105.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.591 -1.318 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.15 179.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.105 -0.997 . . . . 0.0 109.99 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.8 mm-40 -137.26 -170.37 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 18' ' ' ARG . 47.1 mt-10 -141.97 149.7 40.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.324 -0.86 . . . . 0.0 110.741 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.02 -172.82 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -148.67 7.15 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.015 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER 175.73 177.86 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.695 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -69.39 -39.57 80.59 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 118.955 -1.593 . . . . 0.0 110.066 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.0 t -54.59 -40.79 51.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.406 -1.644 . . . . 0.0 107.654 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -81.01 -43.21 19.94 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.499 -0.751 . . . . 0.0 109.87 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -73.98 -58.22 3.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.391 -0.818 . . . . 0.0 109.504 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.668 ' C ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -53.53 -37.87 63.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.946 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -72.66 -42.91 63.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.371 -1.456 . . . . 0.0 109.216 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -77.35 -14.29 59.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.728 . . . . 0.0 110.389 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -71.77 -25.05 61.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.711 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -66.11 -2.29 4.03 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 0.0 109.237 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.09 -66.49 0.39 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 109.482 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.19 13.42 0.54 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.937 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.67 88.17 1.28 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' O ' HD13 ' A' ' 81' ' ' LEU . 29.1 m-85 -64.3 122.45 16.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.398 -1.06 . . . . 0.0 110.516 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.21 -6.1 82.55 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -159.17 136.78 10.07 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.011 -1.288 . . . . 0.0 109.34 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.42 123.97 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.099 -1.001 . . . . 0.0 109.81 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mt -109.16 96.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.771 -0.581 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.07 145.38 42.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -162.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.971 -1.081 . . . . 0.0 109.178 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -103.76 -26.01 12.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 0.0 109.258 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -96.79 135.33 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.538 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -133.95 159.29 72.96 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.96 -68.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.368 1.378 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 63' ' ' MET . 2.8 p30 -85.62 -102.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 1.6 mmt -63.3 -178.06 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.656 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -179.53 5.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.41 -31.63 18.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 tp -47.57 -37.92 13.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -1.198 . . . . 0.0 108.984 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.21 -35.13 75.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 109.333 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.695 HD11 ' N ' ' A' ' 39' ' ' GLY . 4.8 mp -63.88 -27.19 68.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.815 HD21 ' N ' ' A' ' 103' ' ' ALA . 53.8 tp -77.76 -60.21 2.46 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 1.4 tmtp? -43.7 -32.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -55.57 -52.99 61.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 109.348 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.5 mp -57.95 -36.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -69.15 -27.97 66.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.56 -28.81 2.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.6 -38.25 20.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . 59.8 46.14 94.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 167.3 -52.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.445 ' C ' ' H ' ' A' ' 80' ' ' ALA . 12.8 mtt -94.46 21.47 7.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -74.7 37.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -97.5 -20.12 17.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 51' ' ' TYR . 15.0 mt -52.51 113.38 4.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.011 -1.055 . . . . 0.0 109.174 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.16 145.99 90.25 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 121.164 1.243 . . . . 0.0 112.983 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 69' ' ' LEU . 2.4 t -126.08 132.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 116' ' ' LEU . 43.8 tp -113.48 70.79 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.662 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 86' ' ' VAL . 14.0 tmm? -49.48 159.81 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' N ' ' SD ' ' A' ' 85' ' ' MET . 39.5 t -137.94 121.26 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.488 -0.758 . . . . 0.0 110.16 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.8 t -150.13 178.88 8.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 0.0 110.02 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 -45.64 2.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.533 -0.73 . . . . 0.0 109.362 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 13.3 mt-10 -70.59 -77.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 63.27 117.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -131.8 148.67 52.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -42.5 -48.59 5.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.259 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -64.44 -29.72 70.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.283 -0.886 . . . . 0.0 110.665 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -89.99 -23.56 21.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.561 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.3 mt -89.95 -16.35 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.659 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 97' ' ' ALA . 19.1 mt -74.95 -68.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.18 -43.78 21.6 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -59.97 -51.19 70.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.42 -0.8 . . . . 0.0 109.223 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.66 64.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.803 . . . . 0.0 110.593 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -77.19 6.26 6.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 110.4 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -110.53 -17.79 13.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 0.0 110.396 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 136.36 -12.39 4.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.815 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -55.41 11.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.861 -0.788 . . . . 0.0 111.467 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.8 m -29.41 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.917 -0.489 . . . . 0.0 111.312 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.74 124.11 7.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -145.02 105.7 4.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -1.234 . . . . 0.0 109.405 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 107' ' ' VAL . 9.5 p -103.03 136.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -87.41 100.07 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.097 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.9 pttt -63.52 154.44 79.52 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.71 -1.244 . . . . 0.0 109.09 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.33 161.93 93.5 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 O-C-N 122.479 0.726 . . . . 0.0 111.225 -1.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -142.9 162.75 34.64 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.009 0.909 . . . . 0.0 110.082 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.09 148.95 26.27 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.76 -19.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.982 -1.074 . . . . 0.0 109.249 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.44 -37.31 51.84 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.401 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.27 -61.39 1.84 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 84' ' ' LEU . 5.3 tp -47.92 -38.64 16.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.005 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.49 -44.82 77.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 15.4 tt0 -56.38 -26.69 53.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.333 -0.854 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -81.95 -58.83 2.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 tt -46.28 -48.72 18.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.55 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -62.68 -33.49 75.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -67.83 -31.48 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.474 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.1 mt -88.72 -38.01 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.865 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.03 -3.69 27.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.149 -0.969 . . . . 0.0 109.736 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -74.03 -29.33 61.87 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -88.68 -30.62 19.0 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -74.39 -28.99 61.35 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.36 83.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 60.56 129.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.151 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -90.06 24.04 2.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.889 -1.132 . . . . 0.0 110.058 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.22 40.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.789 -1.194 . . . . 0.0 110.773 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 52' ' ' GLY . 58.5 tp -67.03 133.24 49.51 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -75.08 120.39 20.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.893 -1.13 . . . . 0.0 111.32 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' HG22 ' A' ' 33' ' ' VAL . 74.1 m-85 -109.66 148.16 31.83 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' CD2' HD12 ' A' ' 46' ' ' LEU . 35.6 tp -122.29 118.97 29.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.92 103.96 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.577 -0.702 . . . . 0.0 109.77 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.5 t -93.41 31.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.27 157.46 22.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.745 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.85 -30.96 13.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 150.36 49.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -24.2 18.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.46 -20.58 20.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -52.25 49.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -49.43 -32.13 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.29 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.4 -40.71 77.17 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.802 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -57.86 -57.87 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.88 -38.16 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.29 -52.85 19.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.968 -1.082 . . . . 0.0 109.193 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.5 t30 -64.34 -56.9 11.27 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.775 0.798 . . . . 0.0 109.171 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.86 -52.39 2.38 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.744 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.4 mt -63.1 -46.26 88.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 0.0 108.811 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.25 -32.58 66.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.342 -0.848 . . . . 0.0 109.419 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 4.7 tt0 -55.48 -41.96 73.71 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 117' ' ' GLU . 6.2 mp -75.43 -55.39 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.792 . . . . 0.0 109.298 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 78.01 0.02 OUTLIER Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -150.01 147.46 27.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -150.03 58.53 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.55 93.32 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.077 -1.014 . . . . 0.0 109.177 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 8' ' ' PHE . 73.4 t -138.5 151.28 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.77 -171.83 2.47 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.16 157.11 42.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.924 -1.11 . . . . 0.0 110.884 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.896 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.54 -168.97 2.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.81 0.32 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.375 -0.828 . . . . 0.0 110.478 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 9.7 t70 -174.21 174.9 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -59.57 -57.21 20.72 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.434 HG22 ' OD1' ' A' ' 44' ' ' ASN . 13.2 p -50.97 -28.24 6.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -1.083 . . . . 0.0 108.535 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.4 t0 -76.27 -47.01 25.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.41 -0.806 . . . . 0.0 109.133 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.65 -66.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.346 -0.847 . . . . 0.0 109.786 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.06 -45.21 52.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.446 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.434 ' OD1' HG22 ' A' ' 40' ' ' VAL . 7.8 m120 -63.63 -39.25 93.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.0 -1.063 . . . . 0.0 110.554 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -90.1 -1.08 57.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -87.52 -30.87 20.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 108.882 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -54.81 -9.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.105 -0.997 . . . . 0.0 108.574 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.02 -67.01 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.63 -92.3 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -156.96 78.29 0.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' O ' HD21 ' A' ' 81' ' ' LEU . 41.9 m-85 -57.35 91.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.431 -1.04 . . . . 0.0 110.158 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.96 -9.31 5.38 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.5 137.64 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.246 -1.15 . . . . 0.0 110.057 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.0 t -134.92 120.02 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.155 -0.966 . . . . 0.0 109.684 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.53 131.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 83.7 p -149.79 150.14 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' SER . 36.9 m-20 -60.67 -115.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.184 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -150.45 -42.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.603 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER 178.15 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.712 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.35 -54.72 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.761 -0.587 . . . . 0.0 110.283 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.13 -61.2 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.563 0 N-CA-C 108.846 -1.251 . . . . 0.0 108.846 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.588 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 2.8 m120 -154.47 -148.96 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.6 mtt -48.16 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 108.423 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 42.55 -156.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.518 -0.739 . . . . 0.0 110.785 178.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 48.17 -83.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -51.11 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.869 -1.371 . . . . 0.0 110.037 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.98 -33.78 11.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 108.813 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.65 -35.67 80.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.729 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 8.9 tt -90.05 -60.51 1.91 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -36.06 -34.49 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.131 0.491 . . . . 0.0 110.012 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.5 m -59.14 -50.1 75.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.0 mt -54.41 -37.86 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -70.36 -32.74 70.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.452 -0.78 . . . . 0.0 109.515 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.68 33.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.927 . . . . 0.0 109.582 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t0 -75.71 98.59 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.595 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -23.71 66.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -65.19 -38.47 90.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -1.186 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 mtm -136.39 45.88 2.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 79' ' ' SER . 9.3 t -77.95 45.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.03 10.22 0.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.0 -1.062 . . . . 0.0 110.063 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.822 HD21 ' O ' ' A' ' 51' ' ' TYR . 9.6 tp -55.36 120.74 32.97 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 108.382 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.25 131.36 38.38 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 120.962 1.108 . . . . 0.0 112.233 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.8 t -125.69 125.18 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.0 tp -107.05 70.12 0.78 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.571 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -51.53 168.91 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -143.11 126.67 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.532 -0.73 . . . . 0.0 109.801 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -150.1 178.44 8.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.911 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.43 3.94 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.72 50.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -75.5 101.92 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.33 -82.62 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 109.332 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -173.01 -73.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.29 -33.6 29.45 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.151 -0.968 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.5 -24.3 61.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.77 HD11 ' HB1' ' A' ' 90' ' ' ALA . 96.3 mt -83.16 -36.98 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 97' ' ' ALA . 1.4 mp -57.5 -57.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.237 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.2 -37.77 10.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 109.229 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -64.65 -60.28 3.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.733 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -55.1 -40.19 70.18 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.221 -0.924 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -48.23 -19.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.26 -123.96 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.729 ' H ' ' CD2' ' A' ' 69' ' ' LEU . . . -111.87 2.24 27.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.71 11.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.623 -0.928 . . . . 0.0 109.98 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 102' ' ' GLY . 1.4 m -29.54 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -109.64 127.67 8.56 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.53 120.31 9.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 108.825 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 116' ' ' LEU . 7.5 p -119.59 130.17 74.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.01 105.04 12.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.154 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.79 161.08 64.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.02 -1.05 . . . . 0.0 109.257 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.46 166.35 83.34 Favored 'Cis proline' 0 N--CA 1.488 1.153 0 C-N-CA 124.832 -0.904 . . . . 0.0 110.801 -2.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.77 164.1 33.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 110.344 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.46 148.21 27.43 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.455 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.462 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -45.87 -36.66 5.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.048 . . . . 0.0 109.479 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.4 87.39 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.9 m -69.85 -67.01 0.52 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.572 HD11 HG11 ' A' ' 107' ' ' VAL . 5.7 tp -45.62 -36.89 5.09 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.033 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 6.5 tm-20 -66.99 -46.85 73.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 26.9 tt0 -47.77 -60.01 2.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -34.89 64.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.474 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.88 -72.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.6 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.45 -17.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.926 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.47 -33.13 60.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.14 -0.975 . . . . 0.0 109.733 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.447 HD11 ' HA2' ' A' ' 105' ' ' GLY . 8.0 mt -89.97 -43.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 109.934 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -57.16 -21.13 30.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.634 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -57.36 -20.37 28.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.763 -1.211 . . . . 0.0 108.221 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -96.82 -22.03 17.17 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -89.32 -18.98 25.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 79.07 0.06 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.541 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -142.57 135.0 27.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 108.883 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -90.05 21.55 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.977 . . . . 0.0 109.572 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -160.13 44.0 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.068 -1.02 . . . . 0.0 109.956 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.6 tp -84.46 125.7 32.6 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -74.67 123.28 24.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.169 -0.957 . . . . 0.0 112.155 -176.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 65.9 m-85 -114.88 140.89 48.6 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.8 tp -106.02 116.76 32.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.57 102.8 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 36' ' ' ALA . 30.0 t -95.02 62.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.243 -0.91 . . . . 0.0 109.644 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -103.27 132.48 49.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.12 -21.26 36.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.133 -0.979 . . . . 0.0 109.299 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -57.86 146.82 30.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.513 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 m -90.6 29.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 -38.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' OD2' ' A' ' 57' ' ' ASP . 27.5 ttt -48.41 -45.57 36.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -56.65 9.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -56.34 -41.59 76.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 110.133 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mt -54.61 -53.78 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -44.99 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.408 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.01 -52.83 22.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.872 -1.143 . . . . 0.0 109.034 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -62.02 -56.79 15.47 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.89 0.853 . . . . 0.0 109.049 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.32 -59.75 1.01 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.066 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -59.44 -47.28 86.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -53.43 -33.35 53.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.19 -33.16 39.54 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.165 -0.96 . . . . 0.0 109.177 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.9 mp -80.43 -67.62 0.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.08 17.54 0.02 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.294 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.0 m-85 -90.66 129.46 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.749 -1.442 . . . . 0.0 109.197 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.86 68.95 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.502 -0.749 . . . . 0.0 109.93 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.5 103.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.082 -1.011 . . . . 0.0 108.569 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -149.98 148.24 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.82 -171.4 2.18 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -149.86 150.31 31.75 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 110.832 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.96 165.5 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 1.8 mp0 -135.96 32.69 2.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.125 -0.984 . . . . 0.0 110.729 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 7.4 t0 175.04 145.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.277 -0.89 . . . . 0.0 108.832 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -50.6 -29.85 18.96 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -73.79 -28.37 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.254 . . . . 0.0 108.534 179.171 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.1 t0 -81.4 -41.81 21.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.83 86.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.446 -0.784 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mt -70.73 -41.94 71.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -63.36 -27.04 69.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -53.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -56.63 -19.67 17.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 108.645 179.855 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -50.36 -28.05 7.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.0 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 68.02 0.47 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.81 24.24 0.06 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' O ' HD21 ' A' ' 81' ' ' LEU . 52.6 m-85 -94.74 83.06 3.98 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.28 -1.13 . . . . 0.0 109.904 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.51 0.48 2.07 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -162.95 152.82 15.79 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.1 -1.235 . . . . 0.0 109.805 -179.115 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 9' ' ' LEU . 93.6 t -149.4 128.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.724 -1.235 . . . . 0.0 109.78 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.44 128.79 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -132.67 163.04 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.171 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 18.3 m-20 -91.33 -106.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.645 -178.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.864 ' CZ2' HD21 ' A' ' 66' ' ' LEU . 36.5 t-105 -164.09 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -95.66 137.19 35.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 62' ' ' ASN . 3.6 mmt -139.78 155.24 71.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.14 -1.13 0.16 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.431 1.421 . . . . 0.0 111.076 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.8 p-10 -133.63 107.87 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.433 -0.792 . . . . 0.0 109.083 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.421 ' O ' ' OD2' ' A' ' 64' ' ' ASP . 42.1 mtm 53.67 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.0 109.405 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ASN . 1.2 m-20 -169.93 150.64 3.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 108.86 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.21 8.86 2.49 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.864 HD21 ' CZ2' ' A' ' 58' ' ' TRP . 9.2 mt -67.09 -52.85 36.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -1.107 . . . . 0.0 109.082 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -74.06 -14.13 60.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 109.563 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.516 HD13 ' HA2' ' A' ' 39' ' ' GLY . 7.7 tp -67.62 -57.35 6.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 108.836 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.896 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.24 -36.02 66.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 74' ' ' ALA . 16.8 tttt -47.03 -47.91 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 108.82 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.1 m -47.16 -59.24 3.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.477 -0.765 . . . . 0.0 109.638 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mt -49.82 -40.09 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.66 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -10.68 55.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -92.43 -26.62 17.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -45.13 158.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.28 -52.85 21.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.06 109.44 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.528 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -144.25 12.71 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.858 . . . . 0.0 109.281 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -65.31 4.84 0.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.175 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.87 -15.49 32.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.498 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.1 tp -112.03 99.13 44.88 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.66 139.0 78.63 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.037 1.825 . . . . 0.0 113.695 -178.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 69' ' ' LEU . 2.5 t -124.75 119.55 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' ' HG ' ' A' ' 104' ' ' SER . 2.1 tp -99.0 109.78 22.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.458 ' CE ' HD23 ' A' ' 69' ' ' LEU . 6.8 ttm -86.2 146.85 26.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.9 144.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -150.09 173.92 13.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.943 -1.098 . . . . 0.0 110.74 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -113.61 148.7 35.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 49.08 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -83.42 119.08 24.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.022 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.9 -169.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 0.0 109.051 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -99.6 -39.05 8.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.704 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.89 -19.08 25.01 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.113 -0.992 . . . . 0.0 110.284 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -80.23 -22.59 41.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 110.106 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 90' ' ' ALA . 24.7 mt -69.16 -8.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.132 . . . . 0.0 109.932 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' C ' ' N ' ' A' ' 98' ' ' ALA . 10.1 mt -90.17 -49.11 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.05 -24.63 0.16 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -50.28 -56.8 9.65 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -45.58 -44.73 13.17 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 119.629 -1.919 . . . . 0.0 108.924 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -59.69 -36.8 77.21 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -126.33 -72.51 0.65 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -48.8 82.17 0.01 OUTLIER Glycine 0 N--CA 1.496 2.643 0 N-CA-C 106.576 -2.609 . . . . 0.0 106.576 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -70.03 -109.81 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.824 0 CA-C-N 111.508 -2.346 . . . . 0.0 114.994 -174.236 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.527 ' HG ' ' HA ' ' A' ' 84' ' ' LEU . 2.0 p -38.87 -54.18 1.65 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.564 -176.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . -156.8 171.17 34.29 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.12 116.2 15.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.407 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.1 p -115.59 126.34 73.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.5 p -78.67 108.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.54 157.38 88.33 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.991 -1.068 . . . . 0.0 109.583 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.79 159.39 97.22 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 O-C-N 122.768 0.878 . . . . 0.0 110.626 -2.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.463 ' CE2' HD13 ' A' ' 116' ' ' LEU . 2.7 p90 -136.63 160.06 39.93 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.658 0.742 . . . . 0.0 109.783 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.47 148.81 22.42 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.0 -32.09 8.61 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.97 -1.082 . . . . 0.0 108.833 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.06 71.99 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' THR . 6.0 m -70.89 -66.94 0.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 111' ' ' PHE . 11.6 tp -45.58 -41.62 10.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.859 -1.151 . . . . 0.0 109.195 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.72 -50.06 70.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.301 -0.874 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.22 -41.71 13.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -77.98 -43.69 28.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 109.124 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.44 -47.48 26.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 108.957 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 m-20 -49.9 -59.88 3.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.323 -0.861 . . . . 0.0 109.947 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -50.32 -35.46 27.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 110.016 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.7 mt -73.15 -41.54 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 110.005 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -77.92 0.85 22.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.095 -1.003 . . . . 0.0 110.215 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -75.65 -32.66 60.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -88.71 -25.97 22.05 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -33.61 27.67 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.28 82.43 0.03 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.464 -179.975 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.553 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER 61.08 116.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.873 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -90.39 27.24 1.73 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.745 -1.222 . . . . 0.0 110.31 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -145.82 36.83 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.38 141.09 35.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -80.02 129.87 34.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.915 -1.116 . . . . 0.0 111.349 -177.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.598 ' HB2' HG22 ' A' ' 33' ' ' VAL . 63.2 m-85 -118.79 151.56 37.82 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.781 -0.574 . . . . 0.0 109.655 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -127.04 109.88 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.77 114.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.347 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.851 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.8 t -110.56 108.76 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 124.31 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -29.29 70.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.678 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.77 139.18 10.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 p -93.56 22.24 5.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 p -145.79 -15.87 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.6 ttt -70.95 -39.3 72.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -35.35 80.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ttp85 -68.93 -21.02 64.23 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.077 -178.039 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.1 -45.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.868 . . . . 0.0 109.744 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -36.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -47.42 -53.02 15.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.364 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.31 -57.56 7.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.818 0.818 . . . . 0.0 109.371 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.18 -60.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -56.45 -46.05 80.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 109.125 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -55.45 -35.24 65.25 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.175 -0.953 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.32 -28.14 40.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.406 -0.809 . . . . 0.0 109.783 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.09 -33.6 22.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.43 10.69 2.09 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 79.4 m-85 -89.69 141.2 28.83 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.743 -1.445 . . . . 0.0 109.418 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -143.64 28.4 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.481 -0.762 . . . . 0.0 109.728 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.61 88.23 2.55 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -137.31 153.24 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.627 -0.671 . . . . 0.0 110.11 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -125.57 -173.6 2.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.19 148.2 28.64 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.851 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -128.05 166.7 17.9 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 12.5 mm-40 -94.53 -3.02 50.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.867 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER 169.63 173.85 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.917 -1.114 . . . . 0.0 109.691 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.42 54.87 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -53.96 -42.87 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.988 -1.301 . . . . 0.0 108.727 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.626 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 27.5 t0 -63.99 -50.44 68.52 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -53.36 -49.38 67.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.276 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tp -53.22 -35.39 59.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.908 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.75 -33.44 35.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.371 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -90.07 -12.54 38.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.068 -1.02 . . . . 0.0 110.464 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -63.42 -20.58 65.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.029 -1.044 . . . . 0.0 109.212 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.93 1.21 24.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.138 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.94 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.409 -0.807 . . . . 0.0 109.657 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.25 11.93 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.32 80.63 1.47 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.765 ' O ' HD21 ' A' ' 81' ' ' LEU . 38.3 m-85 -60.06 102.14 0.15 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -1.089 . . . . 0.0 109.769 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.47 -12.54 1.0 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -153.24 134.59 14.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.378 -1.072 . . . . 0.0 109.499 -179.427 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 83' ' ' VAL . 88.9 t -131.26 117.69 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.827 -1.171 . . . . 0.0 109.939 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.94 119.6 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.8 p -141.47 144.1 34.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.808 . . . . 0.0 109.248 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.7 p-10 -60.47 -112.45 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.979 -1.075 . . . . 0.0 109.229 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -173.87 -32.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 108.834 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.5 58.57 2.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 0.0 109.54 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.423 ' HG3' ' H ' ' A' ' 62' ' ' ASN . 2.1 ptm -47.88 159.24 0.48 Allowed Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.47 -48.47 20.33 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.248 1.299 . . . . 0.0 110.514 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' A' ' 60' ' ' MET . 6.4 m-20 -79.09 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.853 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.1 mmt -90.9 -110.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.938 . . . . 0.0 109.869 -179.565 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.3 -175.56 4.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.78 12.29 70.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -62.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.8 -1.411 . . . . 0.0 108.569 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -48.8 -37.52 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.3 -42.67 82.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 72' ' ' ILE . 1.2 mt -75.41 -63.5 1.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.524 0.678 . . . . 0.0 109.18 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' LEU . 39.9 tttp -40.29 -34.95 0.36 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.759 -0.588 . . . . 0.0 109.986 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -73.2 -37.19 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 108.664 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 69' ' ' LEU . 39.6 mt -61.08 -21.41 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -88.68 5.33 43.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.358 -0.839 . . . . 0.0 109.319 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -122.01 -20.88 6.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.5 m-20 -59.67 -140.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.54 0.686 . . . . 0.0 110.214 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -55.37 -167.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.81 50.32 1.79 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.04 -70.19 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 t 44.29 17.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -145.87 -3.52 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 51' ' ' TYR . 5.4 tp -54.43 113.56 5.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 109.05 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 140.31 89.49 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.119 1.213 . . . . 0.0 112.351 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.8 t -129.83 127.88 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 116' ' ' LEU . 54.8 tp -108.42 78.42 1.16 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtt -72.24 132.2 43.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.3 m -113.23 140.2 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.9 t -150.02 171.49 16.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.01 -87.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.817 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -46.95 -66.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.864 -179.659 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 67.72 99.87 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 109.174 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -95.59 119.62 34.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.207 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -43.51 -50.07 7.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.785 . . . . 0.0 109.983 -179.504 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.23 -35.11 7.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.174 -0.954 . . . . 0.0 109.686 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 96' ' ' ILE . 2.3 t-20 -85.53 -39.04 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.191 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 95' ' ' ILE . 35.1 mm -58.24 -0.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 94' ' ' ASN . 71.9 mt -89.82 -65.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.33 -34.72 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.54 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.708 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -65.33 -53.95 36.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.876 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.7 67.58 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.044 -1.035 . . . . 0.0 110.011 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.47 -19.51 1.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 109.135 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.18 -112.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.81 -5.38 4.9 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.708 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.56 10.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.927 -0.749 . . . . 0.0 110.348 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.3 m -29.75 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.009 -178.05 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.05 125.68 8.66 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -142.38 109.38 5.51 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.286 -1.126 . . . . 0.0 109.697 179.189 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.681 HG11 ' CD1' ' A' ' 116' ' ' LEU . 2.7 p -110.53 150.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.48 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 39.9 t -90.52 111.72 23.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.729 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 152.44 78.07 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.786 -1.196 . . . . 0.0 109.514 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.85 165.6 84.49 Favored 'Cis proline' 0 N--CA 1.49 1.314 0 O-C-N 122.52 0.748 . . . . 0.0 110.909 -1.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -144.4 156.89 44.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.855 0.836 . . . . 0.0 110.106 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 114' ' ' ALA . 1.0 OUTLIER -95.67 150.79 19.98 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.755 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.37 -15.36 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.783 -1.198 . . . . 0.0 109.194 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.27 -38.34 35.68 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.33 -62.41 1.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.537 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 107' ' ' VAL . 4.6 tp -48.6 -38.73 21.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.195 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.56 -56.81 11.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 0.0 110.068 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.18 -66.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.554 -0.716 . . . . 0.0 109.931 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -35.25 5.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.25 -68.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.03 -32.91 10.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.78 -38.17 81.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.07 -47.83 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.055 -1.028 . . . . 0.0 109.963 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.457 ' CE2' HD13 ' A' ' 127' ' ' LEU . 23.2 m-85 -53.19 -19.0 2.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.122 -0.986 . . . . 0.0 110.232 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -55.95 -35.43 66.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 107.949 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -79.6 -32.23 41.83 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 127' ' ' LEU . 7.6 tt -65.11 -23.58 67.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.76 61.34 1.29 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.418 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER 51.81 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.818 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.2 ptmm? -76.83 47.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.006 -1.059 . . . . 0.0 109.544 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -160.42 27.11 0.16 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.6 tp -69.65 143.21 53.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 1.9 mtmp? -82.35 127.76 33.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.125 -0.984 . . . . 0.0 111.508 -177.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 33' ' ' VAL . 35.4 m-85 -116.32 150.7 37.24 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.865 -0.522 . . . . 0.0 109.974 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -125.15 106.9 10.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.37 105.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 109.05 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 11' ' ' VAL . 25.3 t -89.99 24.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.155 -0.965 . . . . 0.0 109.455 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -56.64 126.58 27.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -93.63 -2.59 53.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.34 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -58.81 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.965 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.05 8.52 5.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.578 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -22.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.748 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.3 tpp -47.71 -50.39 25.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.243 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.45 ' NE ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -45.38 -55.41 6.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 110.469 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -56.24 -37.39 69.67 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.577 -177.319 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.78 -49.02 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.119 -0.988 . . . . 0.0 110.046 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -33.25 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.995 -1.066 . . . . 0.0 110.515 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -53.51 21.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.989 -1.07 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.1 t30 -67.57 -58.15 5.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.881 0.848 . . . . 0.0 109.63 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.814 HD22 HD12 ' A' ' 116' ' ' LEU . 4.5 tt -40.09 -34.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.125 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.95 -42.08 27.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.905 -1.122 . . . . 0.0 108.233 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -58.88 -34.9 72.18 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.346 -0.846 . . . . 0.0 108.925 179.318 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.85 -29.14 39.88 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.347 -0.845 . . . . 0.0 109.236 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.27 -12.86 42.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 106.09 15.39 18.16 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -89.83 126.84 35.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.479 . . . . 0.0 109.0 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -130.42 67.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.808 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.4 89.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 108.594 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 8' ' ' PHE . 45.2 t -140.23 151.69 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.489 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.2 mt-10 -126.18 -173.23 2.8 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 7.6 tt0 -149.13 159.48 44.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.769 -1.207 . . . . 0.0 111.157 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.99 -171.79 3.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 3.6 pt-20 -139.41 8.57 2.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.805 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.16 -170.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.567 ' CA ' HD11 ' A' ' 68' ' ' LEU . . . -74.34 -38.96 44.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.98 -1.581 . . . . 0.0 109.293 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 62.9 t -52.52 -40.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.915 -1.344 . . . . 0.0 107.763 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.7 t0 -79.15 -50.6 10.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.677 -0.639 . . . . 0.0 109.847 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -62.56 -59.46 4.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 71' ' ' THR . 49.9 tp -44.75 -50.75 9.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.313 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 60.6 m-20 -66.7 -36.28 82.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.012 . . . . 0.0 109.577 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -90.13 8.0 35.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -87.98 -44.18 11.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.898 -1.126 . . . . 0.0 109.076 179.681 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -65.75 1.55 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.186 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.44 -69.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.391 -0.818 . . . . 0.0 109.859 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.35 1.26 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 85.27 88.11 0.92 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.906 ' O ' HD11 ' A' ' 81' ' ' LEU . 38.4 m-85 -71.1 136.66 48.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.304 -1.115 . . . . 0.0 109.66 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.49 -5.67 71.77 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -152.14 135.88 16.26 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.578 -0.954 . . . . 0.0 108.95 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.05 116.98 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.817 -1.177 . . . . 0.0 109.781 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.62 95.42 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.5 p -105.61 131.99 52.3 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 59' ' ' ASN . 37.7 p-10 -100.15 123.31 44.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.467 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.517 ' CH2' HD12 ' A' ' 66' ' ' LEU . 1.4 t-105 -45.76 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.244 -0.91 . . . . 0.0 108.679 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASP . 80.1 m-20 -92.57 -150.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 110.635 -178.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.719 ' H ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -124.65 -29.82 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 60' ' ' MET . 4.1 Cg_exo -62.01 164.48 16.7 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 CA-C-N 119.812 0.968 . . . . 0.0 110.842 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -41.73 -62.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.785 -0.572 . . . . 0.0 109.633 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -79.24 56.08 1.99 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.275 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' MET . 0.2 OUTLIER -46.9 -94.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.472 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.72 -24.29 0.07 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.517 HD12 ' CH2' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -70.67 -58.06 4.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.876 -1.367 . . . . 0.0 108.612 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.41 -33.46 6.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.567 HD11 ' CA ' ' A' ' 39' ' ' GLY . 5.8 mp -66.59 -42.63 86.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.727 HD11 ' H ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -69.06 -45.05 71.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.529 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -58.66 -32.34 68.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 0.0 108.884 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.67 HG21 HD13 ' A' ' 43' ' ' LEU . 3.9 m -66.85 -42.98 84.79 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.282 -0.886 . . . . 0.0 108.999 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.27 -31.6 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -30.57 71.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.073 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -59.0 -24.14 62.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 6.3 t70 -42.85 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 75' ' ' ASP . . . 152.32 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.05 -21.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.187 . . . . 0.0 109.206 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' ALA . 3.0 mtm -116.84 36.77 4.04 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -65.64 7.35 0.25 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.518 -0.739 . . . . 0.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.74 24.12 3.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 51' ' ' TYR . 4.7 tt -48.89 125.56 13.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.68 114.85 2.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.667 0.912 . . . . 0.0 112.257 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.34 118.74 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 116' ' ' LEU . 37.2 tp -97.49 79.1 2.72 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.229 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtp -64.75 108.85 1.85 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.8 m -96.42 134.57 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.632 -1.292 . . . . 0.0 109.362 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.2 t -150.2 177.57 9.8 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.812 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -122.76 141.51 51.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 5.8 tt0 67.99 35.59 3.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 0.0 109.148 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -45.52 127.33 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.814 . . . . 0.0 109.914 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -83.31 -133.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 -28.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.241 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -29.69 21.24 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -79.33 -36.43 39.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 90' ' ' ALA . 56.1 mt -64.68 -5.92 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 108.966 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 16.6 mt -89.94 -58.44 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 109.354 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.92 -60.57 2.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -49.02 -41.46 34.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 108.755 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 96' ' ' ILE . . . -47.64 -48.91 28.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.982 -1.074 . . . . 0.0 109.419 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -27.84 56.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.228 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.84 -106.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.923 . . . . 0.0 109.558 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.727 ' H ' HD11 ' A' ' 69' ' ' LEU . . . -145.36 12.11 1.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . . . -56.6 11.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.045 0.538 . . . . 0.0 110.775 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.0 m -29.33 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.016 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.99 126.96 8.02 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.08 111.11 6.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.535 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.634 ' CG1' HG12 ' A' ' 86' ' ' VAL . 8.7 p -117.95 121.9 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -53.3 172.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.179 179.37 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' THR . 15.4 pttt -147.4 156.96 45.85 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 120.579 -1.326 . . . . 0.0 108.911 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.98 167.89 77.35 Favored 'Cis proline' 0 N--CA 1.485 0.983 0 C-N-CA 124.862 -0.891 . . . . 0.0 110.348 -1.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -134.6 155.64 50.1 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.017 0.913 . . . . 0.0 110.473 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -93.12 151.42 19.86 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.114 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.73 -38.39 9.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.918 -1.114 . . . . 0.0 109.733 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.02 84.32 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 116' ' ' LEU . 19.0 m -66.31 -65.1 0.72 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.814 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -42.68 -48.71 5.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.619 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.75 80.34 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.312 -0.868 . . . . 0.0 110.048 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp10 -57.63 -33.84 68.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.027 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -36.71 14.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 0.0 110.042 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -58.12 -67.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.236 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.1 -28.69 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.118 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -71.76 -33.06 68.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.146 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 105' ' ' GLY . 21.0 mt -79.88 -42.28 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.078 -1.014 . . . . 0.0 110.075 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -62.63 4.99 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 110.577 -178.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.1 mm-40 -81.91 -28.61 32.75 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -86.89 -34.86 19.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -63.75 -30.06 71.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.115 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.1 77.09 0.32 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.273 -1.133 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.54 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 3.0 m-20 -43.94 145.53 0.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 29' ' ' GLY . 7.8 mtmm -90.5 7.48 38.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.221 -0.925 . . . . 0.0 110.302 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 45.7 mp0 -144.46 50.88 1.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.813 -1.18 . . . . 0.0 109.952 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.4 tp -80.26 114.76 19.4 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 121.5 7.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.059 -1.025 . . . . 0.0 112.046 -177.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.3 m-85 -113.41 149.5 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.113 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 54' ' ' VAL . 27.0 tp -121.55 109.45 14.82 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.61 99.77 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 110.122 -178.928 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.6 t -91.94 12.48 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.09 -1.006 . . . . 0.0 109.758 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.2 OUTLIER -62.18 156.32 22.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.393 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' PHE . 14.2 p-10 -94.86 -142.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.493 ' O ' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 61.27 146.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.84 . . . . 0.0 109.619 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 t -92.46 17.0 10.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -143.49 -12.89 0.69 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 109.446 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 5.8 ttm -71.51 -57.79 4.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -47.22 -28.87 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -51.17 20.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.186 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.93 -53.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.798 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -44.64 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.863 . . . . 0.0 110.333 -178.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -46.87 -55.43 8.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -59.69 -58.03 10.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.108 0.956 . . . . 0.0 108.518 179.428 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -39.29 -42.76 1.06 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.641 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.18 -41.96 69.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 108.899 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' ASN . 47.8 tttt -63.1 -30.71 71.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.22 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.57 -40.03 71.43 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.3 tt -76.96 -58.6 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 159.55 43.22 0.02 OUTLIER Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.54 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 48.5 m-85 -126.98 125.42 41.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.821 -0.811 . . . . 0.0 109.662 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.67 66.22 1.46 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.566 -0.708 . . . . 0.0 109.518 -179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.64 93.37 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.111 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.54 179.29 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.059 -1.026 . . . . 0.0 109.856 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.4 mt-10 -138.73 -164.98 1.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -147.68 149.86 33.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.141 -178.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -142.3 -168.87 2.83 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -146.61 3.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 110.643 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 175.66 -172.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.123 -0.986 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -69.88 -42.24 70.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.11 -34.02 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.236 . . . . 0.0 109.049 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.97 -57.16 3.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.96 -38.22 10.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.39 -58.92 3.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -58.16 -21.51 47.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.931 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -90.15 -43.09 10.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 110.587 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.669 -1.269 . . . . 0.0 109.291 -179.333 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -63.05 -4.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -53.95 -74.91 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.564 -0.71 . . . . 0.0 109.855 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.16 10.8 1.18 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.545 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.5 81.64 1.27 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.761 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.8 m-85 -54.94 144.74 22.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.548 -0.972 . . . . 0.0 110.297 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.56 -4.64 73.03 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -161.93 145.56 12.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.418 -1.048 . . . . 0.0 110.004 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.702 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.2 t -139.92 125.93 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.353 -0.842 . . . . 0.0 109.877 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.51 104.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.499 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 90.2 p -104.94 178.27 4.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.349 -0.844 . . . . 0.0 109.964 -179.519 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 29.2 p-10 -99.98 -115.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.444 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 61.4 t-105 -140.12 -81.14 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 0.0 110.135 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.453 HD21 ' C ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -170.43 68.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 109.93 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.508 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.08 -48.33 0.41 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.523 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.05 -160.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.012 1.141 . . . . 0.0 109.822 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 1.8 p30 -84.75 107.48 16.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 0.0 109.094 179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.4 mmm 50.31 93.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.107 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.9 t70 -152.24 -177.43 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.648 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 54.47 -80.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ASP . 95.7 mt -44.84 -68.65 0.18 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 109.66 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.17 -35.69 75.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.846 -1.159 . . . . 0.0 109.375 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.919 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.23 -33.93 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 109.007 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.6 tt -87.08 -59.99 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.173 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.0 ttpt -40.31 -32.81 0.2 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 m -66.2 -44.18 84.65 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.6 mt -54.65 -36.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 108.769 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtp-105 -75.59 -16.23 60.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.417 -0.802 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -54.42 -28.61 45.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 109.845 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 38.0 t70 -61.55 -121.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.606 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . 154.0 -32.65 0.73 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 -12.41 57.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.413 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.48 42.44 2.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 p -77.89 51.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -130.71 -26.14 2.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.644 -0.66 . . . . 0.0 109.715 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -38.65 103.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.896 -0.503 . . . . 0.0 109.78 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.2 108.87 1.04 Allowed 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 120.93 1.087 . . . . 0.0 111.574 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' HB ' ' A' ' 54' ' ' VAL . 25.5 t -108.81 111.51 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.463 178.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.99 110.75 21.71 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.8 ' SD ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -91.51 116.28 28.73 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.34 -176.859 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -102.23 150.43 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.887 -1.133 . . . . 0.0 110.867 -178.789 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 88' ' ' ALA . 9.3 t -150.09 -143.49 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 87' ' ' THR . . . -161.38 -17.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -79.85 -75.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.957 . . . . 0.0 109.506 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 106' ' ' TYR . . . 58.83 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.8 tptp -148.58 59.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.266 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 94' ' ' ASN . 74.1 tttt 53.12 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.9 pt-20 -47.17 -19.0 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.189 -0.945 . . . . 0.0 109.789 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' HB2' ' H ' ' A' ' 91' ' ' LYS . 3.0 m-20 -89.78 -35.78 15.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.82 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.87 -18.27 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -83.54 -43.39 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.751 -1.218 . . . . 0.0 107.93 178.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.45 -24.82 1.39 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 102' ' ' GLY . . . -51.1 -54.34 25.95 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.583 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.72 64.49 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.069 -1.644 . . . . 0.0 107.963 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -27.73 68.51 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.236 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.879 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -146.46 -68.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.825 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -58.61 79.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.82 -108.76 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.302 0 CA-C-N 111.549 -2.325 . . . . 0.0 115.676 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -29.83 -58.0 0.17 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.164 -175.768 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.31 176.26 37.0 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.95 -179.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -130.65 115.0 16.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.87 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.3 p -122.6 123.01 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 107' ' ' VAL . 28.0 m -54.18 -169.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.15 153.19 11.77 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.504 -1.372 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.11 154.06 99.45 Favored 'Cis proline' 0 N--CA 1.487 1.101 0 C-N-CA 125.187 -0.755 . . . . 0.0 110.636 -1.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.9 p90 -118.32 155.25 30.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.84 0.829 . . . . 0.0 109.661 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.483 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.4 OUTLIER -90.07 150.49 22.05 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -50.61 -15.55 0.28 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.684 -1.26 . . . . 0.0 109.327 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -81.69 -34.44 30.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.483 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -74.13 -61.21 1.93 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -51.1 -36.16 38.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.58 179.662 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 15.9 mt-10 -54.66 -66.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.009 -1.057 . . . . 0.0 109.521 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -44.25 -26.93 0.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.768 -0.583 . . . . 0.0 109.781 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.53 -44.03 15.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 110.325 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 120' ' ' LEU . 18.6 mt -67.57 -57.23 6.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.805 -1.184 . . . . 0.0 109.64 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.53 -27.02 5.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.986 -1.072 . . . . 0.0 109.82 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -84.4 -22.71 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.181 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.6 mt -88.36 -39.0 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.645 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -65.76 -5.68 9.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.998 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -26.17 62.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -90.38 -34.46 15.66 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.26 -15.52 59.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 58.41 85.76 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.228 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' CD1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER 173.52 134.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.397 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 28.69 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -171.68 41.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.01 -1.056 . . . . 0.0 110.579 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.2 tp -80.41 112.95 18.23 Favored 'General case' 0 C--O 1.205 -1.249 0 O-C-N 120.576 -1.328 . . . . 0.0 107.921 179.169 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.54 114.36 1.64 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.946 . . . . 0.0 112.481 -177.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 82.8 m-85 -109.2 151.12 26.91 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 54' ' ' VAL . 20.5 tp -119.15 108.62 14.91 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.02 122.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.265 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 33.3 t -126.9 105.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.491 -0.756 . . . . 0.0 109.574 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.5 133.47 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 109.425 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 53.52 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.596 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.64 135.53 22.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.12 15.99 3.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.02 -1.64 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 109.558 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.0 ttt -89.96 -21.71 22.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.123 -0.986 . . . . 0.0 109.074 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -76.08 -45.39 34.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.835 . . . . 0.0 109.419 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -58.63 -20.87 51.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.878 . . . . 0.0 109.575 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -73.81 -55.56 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.849 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -23.14 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 110.263 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.536 ' NH1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.81 -53.05 62.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 109.122 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.05 -56.08 13.37 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.014 0.911 . . . . 0.0 108.991 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.3 tt -40.6 -46.43 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.92 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.32 -45.0 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 0.0 108.541 179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -57.28 -30.4 64.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.478 -0.763 . . . . 0.0 109.147 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 -41.54 74.83 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.177 -0.952 . . . . 0.0 109.354 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.688 HD22 ' OE2' ' A' ' 117' ' ' GLU . 14.9 tp -76.86 -57.01 4.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -0.844 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . 152.3 77.37 0.02 OUTLIER Glycine 0 N--CA 1.478 1.483 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -150.22 147.99 28.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -1.073 . . . . 0.0 109.29 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -150.15 55.88 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.946 -1.096 . . . . 0.0 110.634 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.74 105.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.703 -1.248 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.536 HG22 ' NH1' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -146.76 -179.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.971 . . . . 0.0 109.384 179.21 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.1 mm-40 -134.71 -167.52 1.99 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -149.97 150.69 32.2 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.342 -178.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.39 -169.22 2.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.5 mt-10 -139.73 9.31 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.257 -0.902 . . . . 0.0 110.222 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.2 m-20 170.85 173.32 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.0 108.896 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.1 -25.5 73.39 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -37.09 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.937 -1.331 . . . . 0.0 108.243 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.9 t0 -74.66 -39.96 61.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -75.32 -35.5 61.21 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.57 -52.72 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -62.08 -30.93 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -90.0 -18.83 25.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.323 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -61.02 -32.96 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.569 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -84.06 -0.15 50.65 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.38 -72.78 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.659 -0.651 . . . . 0.0 109.553 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.03 -86.78 0.3 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.17 72.79 0.18 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.6 m-85 -54.27 98.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.312 -1.111 . . . . 0.0 109.041 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.29 1.19 0.44 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -169.2 142.82 2.83 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.187 -1.184 . . . . 0.0 109.919 -179.652 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 83' ' ' VAL . 12.8 t -133.59 145.43 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.088 -1.008 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.19 85.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 3.6 p -103.98 143.54 32.74 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.696 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.3 p30 -60.37 -122.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.532 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 75.2 t-105 -158.25 -77.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.154 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -89.02 122.88 32.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.089 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.495 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.25 -50.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 110.44 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.09 -173.67 0.22 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.747 0.965 . . . . 0.0 110.055 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -52.68 -13.67 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.168 -0.958 . . . . 0.0 109.546 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.402 ' N ' ' C ' ' A' ' 61' ' ' PRO . 3.7 mmt -147.23 -86.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -152.94 177.85 10.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.9 -9.52 77.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 97' ' ' ALA . 46.7 tp -50.81 -25.65 4.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.679 -1.483 . . . . 0.0 108.239 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 64' ' ' ASP . 7.6 pt-20 -72.59 -34.48 67.46 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 39' ' ' GLY . 25.7 mt -63.18 -56.13 19.28 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt -57.11 -58.73 6.92 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.606 0.717 . . . . 0.0 109.193 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -53.86 -38.02 64.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 70.4 m -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.938 . . . . 0.0 109.097 179.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.934 HD13 HG21 ' A' ' 83' ' ' VAL . 4.2 mt -67.09 -24.79 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -18.68 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 108.918 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.4 -52.22 22.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.176 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 79' ' ' SER . 4.1 t70 -66.71 83.85 0.11 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.94 43.44 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.76 -89.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -1.195 . . . . 0.0 109.564 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.0 mtt -118.16 20.98 13.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.0 109.25 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.522 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 t 46.93 -118.31 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.09 52.71 0.91 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER 46.07 -175.03 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.6 Cg_exo -63.03 144.79 93.53 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 121.68 1.586 . . . . 0.0 114.522 -176.071 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.934 HG21 HD13 ' A' ' 72' ' ' ILE . 5.4 t -139.5 111.38 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -95.13 106.07 18.05 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 117.551 -1.659 . . . . 0.0 106.964 177.963 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 1.1 ttm -74.56 107.68 6.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.539 -0.865 . . . . 0.0 109.392 -178.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -92.17 144.83 8.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 90' ' ' ALA . 5.8 t -146.24 170.2 17.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.015 -1.053 . . . . 0.0 110.426 -178.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.528 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -109.86 -57.29 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.709 -0.619 . . . . 0.0 109.551 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.74 29.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -46.45 110.9 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 3.8 ttpp -148.47 94.89 2.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.743 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttt 44.61 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.85 . . . . 0.0 110.156 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -45.93 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.333 -0.855 . . . . 0.0 110.419 -179.183 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -41.19 -34.43 0.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.477 -0.764 . . . . 0.0 110.764 -178.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.607 HG23 ' CD2' ' A' ' 106' ' ' TYR . 24.6 mt -75.58 -66.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.969 -1.082 . . . . 0.0 109.304 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 96' ' ' ILE . 69.2 mt -62.16 -0.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.023 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -76.02 -37.85 57.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.401 -0.812 . . . . 0.0 109.119 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -71.98 -59.87 2.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.09 -1.006 . . . . 0.0 108.306 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -59.55 -22.37 61.6 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.514 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -49.32 -33.38 13.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.727 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 69' ' ' LEU . . . -85.54 -36.82 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 90.29 64.94 1.22 Allowed Glycine 0 N--CA 1.482 1.71 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.001 175.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.893 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.12 -111.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.935 1.867 . . . . 0.0 108.678 177.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.62 -46.05 8.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 122.423 1.106 . . . . 0.0 108.611 177.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 163.23 -157.87 30.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -178.316 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.607 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -137.77 146.48 43.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.679 -0.895 . . . . 0.0 109.248 178.95 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.4 p -140.61 136.1 35.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 109' ' ' LYS . 3.0 p -80.08 159.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.034 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.528 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.27 154.79 80.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.0 109.523 -179.301 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.26 126.85 13.46 Favored 'Cis proline' 0 N--CA 1.488 1.194 0 O-C-N 122.564 0.771 . . . . 0.0 110.14 -2.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.93 156.6 18.33 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.376 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -92.99 148.44 22.0 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 176.784 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -49.28 -12.44 0.05 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.706 -1.246 . . . . 0.0 109.343 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -83.07 -37.74 23.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.72 -59.69 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.144 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -50.62 -40.71 53.71 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.983 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.688 ' OE2' HD22 ' A' ' 28' ' ' LEU . 24.0 mm-40 -61.09 -55.12 36.31 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.185 -0.947 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -41.62 -38.27 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.42 0.628 . . . . 0.0 109.752 -179.33 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -88.19 -29.63 20.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.214 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp -65.53 -65.71 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.613 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.81 -36.36 11.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.478 ' HB3' ' HZ3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -73.73 -25.53 60.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.847 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.44 -41.38 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.922 . . . . 0.0 109.849 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.83 -19.83 62.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 110.252 -179.142 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' CA ' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -61.27 -20.88 63.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.758 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -94.51 -31.76 13.79 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 127' ' ' LEU . 2.7 tt -72.82 -26.05 61.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.62 77.73 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.266 -1.138 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -46.71 136.61 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.04 48.48 1.58 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -178.55 33.66 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 50.5 tp -71.12 111.12 6.23 Favored 'General case' 0 C--O 1.206 -1.212 0 O-C-N 120.599 -1.313 . . . . 0.0 108.147 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -58.04 119.8 7.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.072 . . . . 0.0 111.409 -177.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 80.9 m-85 -110.79 148.76 31.68 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 54' ' ' VAL . 66.6 tp -119.34 110.88 17.48 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.52 106.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.286 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 36' ' ' ALA . 27.4 t -96.96 92.03 2.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.504 -0.748 . . . . 0.0 109.59 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -147.42 132.47 18.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -24.68 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.64 130.82 48.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -82.83 -20.08 36.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -33.3 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.499 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttt -57.6 -30.51 65.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -71.71 -34.75 69.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.923 -1.11 . . . . 0.0 108.679 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -75.87 -16.13 60.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.519 -0.738 . . . . 0.0 109.068 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.78 -50.83 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.48 -32.23 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 110.26 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -47.76 -53.35 15.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 109.391 179.651 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.02 -57.4 5.04 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.514 -0.742 . . . . 0.0 109.771 -179.576 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -40.42 -61.02 0.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.423 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 25' ' ' LEU . 23.7 mt -51.46 -50.78 59.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 108.72 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -49.07 -33.18 10.98 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.241 -0.912 . . . . 0.0 108.918 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -49.43 -51.07 37.94 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.404 -0.81 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.519 HD23 ' CE2' ' A' ' 30' ' ' PHE . 35.9 tp -70.56 -48.1 57.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.005 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.45 81.59 0.06 OUTLIER Glycine 0 C--O 1.208 -1.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 28' ' ' LEU . 67.2 m-85 -150.08 149.26 30.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -1.094 . . . . 0.0 108.896 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -150.1 64.06 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 110.224 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.7 103.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.864 -1.147 . . . . 0.0 109.258 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.15 151.83 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 110.288 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -120.55 -170.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.8 mp0 -146.63 155.99 42.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.721 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.16 -163.02 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -137.47 -7.89 1.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 110.783 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 62' ' ' ASN . 6.8 t0 -177.42 -165.57 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -79.24 -26.59 57.28 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 6.3 p -75.64 -42.08 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.025 -1.28 . . . . 0.0 107.847 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 12.4 t0 -68.98 -43.73 74.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.636 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -64.75 -52.79 55.12 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' ALA . 3.4 tt -43.34 -36.71 1.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.419 -0.801 . . . . 0.0 109.242 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -71.62 -34.62 69.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.08 179.089 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 47' ' ' GLN . 11.7 mmmt -86.38 -53.59 4.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -41.13 -22.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.666 -0.646 . . . . 0.0 109.371 179.682 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -52.35 -43.63 64.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.36 -56.95 5.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.23 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 88.35 -19.26 36.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.75 -5.37 3.92 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.773 ' O ' HD22 ' A' ' 81' ' ' LEU . 61.6 m-85 -75.43 83.88 2.52 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.469 -1.019 . . . . 0.0 110.212 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.02 -3.93 1.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 177.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -155.87 144.57 20.33 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.53 -0.982 . . . . 0.0 110.221 -179.473 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 9' ' ' LEU . 98.8 t -141.09 116.77 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 108.76 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 117.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.866 . . . . 0.0 108.861 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.1 p -120.05 166.95 12.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.629 -0.669 . . . . 0.0 109.681 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 12' ' ' ASP . 61.6 m-20 -95.58 -106.39 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.533 -0.73 . . . . 0.0 109.458 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CD1' ' OD2' ' A' ' 64' ' ' ASP . 56.6 t-105 -168.95 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.721 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.5 104.99 5.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.411 ' CE ' ' CA ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -130.9 174.09 5.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.339 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.42 -1.93 1.66 Allowed 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.396 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 8.5 m120 -127.05 83.67 2.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.283 -0.886 . . . . 0.0 109.488 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.9 mmt 48.46 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 109.599 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -165.04 179.09 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.961 -1.087 . . . . 0.0 109.405 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 60' ' ' MET . . . -70.96 14.66 1.46 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -68.3 -51.93 39.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -1.178 . . . . 0.0 108.854 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' THR . 1.8 mt-10 -63.53 -15.66 58.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.2 mt -79.98 -67.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.98 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.91 -62.17 1.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.682 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -58.23 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' GLU . 16.6 p -52.91 -41.15 64.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.897 -1.127 . . . . 0.0 109.476 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.9 mt -64.22 -42.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.399 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -84.75 -4.86 59.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 -29.12 22.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.528 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.5 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.92 -90.35 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.39 70.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.162 . . . . 0.0 109.158 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.9 mtm -92.45 10.22 31.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.238 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.4 p -76.49 44.61 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 8.57 0.65 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.6 mt -72.19 121.14 83.9 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.525 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 113.82 1.9 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.415 1.41 . . . . 0.0 113.433 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -103.25 105.65 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 175.224 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.42 105.92 18.14 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 116.749 -1.98 . . . . 0.0 106.55 178.587 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.521 ' O ' ' SD ' ' A' ' 85' ' ' MET . 2.7 ppp? -79.88 124.02 28.28 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.926 -177.317 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 140.78 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.209 -0.932 . . . . 0.0 109.103 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 t -150.07 174.98 12.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.044 . . . . 0.0 110.948 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -106.88 -64.68 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -75.82 63.96 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 108.873 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -67.34 91.99 0.27 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 144.12 25.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.581 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -24.03 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -78.2 -54.18 6.52 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' ALA . 1.2 t30 -68.74 -45.27 71.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.2 mt -48.65 -30.48 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.8 mt -89.86 -20.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.358 -0.839 . . . . 0.0 109.075 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.92 -45.75 92.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.409 -0.807 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -73.88 -54.34 8.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 108.199 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.86 -27.24 50.75 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.307 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -53.78 -34.03 57.79 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 178.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.98 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -83.04 -25.09 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.24 75.87 0.43 Allowed Glycine 0 N--CA 1.481 1.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.04 177.155 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.26 -112.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.824 -1.95 . . . . 0.0 111.158 179.174 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.8 OUTLIER -91.67 -53.77 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.801 1.286 . . . . 0.0 109.019 176.633 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.41 -161.0 31.66 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -177.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.73 136.55 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 0.0 109.962 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.3 p -136.1 122.05 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.98 176.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.792 -1.193 . . . . 0.0 108.223 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -151.3 149.41 24.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.772 -1.205 . . . . 0.0 109.065 179.636 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.93 139.87 63.75 Favored 'Cis proline' 0 N--CA 1.484 0.923 0 C-N-CA 125.302 -0.707 . . . . 0.0 110.399 -1.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.426 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.8 p90 -99.04 163.79 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.77 146.05 23.94 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 177.63 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.35 -34.45 6.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.106 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.26 76.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.2 m -70.54 -66.97 0.53 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.509 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 111' ' ' PHE . 6.8 tp -48.33 -40.12 24.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.593 -1.317 . . . . 0.0 109.497 178.701 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 119' ' ' LYS . 3.4 tm-20 -68.04 -68.45 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.027 . . . . 0.0 109.782 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 117' ' ' GLU . 86.0 tt0 -42.25 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.362 0.601 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' GLU . 5.5 mmmt -90.01 -47.57 7.76 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.071 179.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 120' ' ' LEU . 17.5 mt -56.07 -54.76 41.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -46.34 -49.93 17.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -57.15 -28.37 62.68 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.13 -40.95 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.47 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -68.65 -6.61 26.93 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.974 -1.079 . . . . 0.0 110.427 -178.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.84 -19.88 61.91 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -29.53 13.02 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -21.54 29.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.475 -0.766 . . . . 0.0 108.94 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.87 75.18 0.17 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 109.404 179.979 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 2.0 t0 76.85 131.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.466 -0.771 . . . . 0.0 109.289 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.41 18.44 6.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 110.172 -179.876 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 2.1 tm-20 -152.78 41.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.688 -1.257 . . . . 0.0 111.072 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 31.4 tp -81.87 118.67 23.1 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.497 -1.377 . . . . 0.0 107.912 178.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -63.87 123.28 18.54 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.19 -0.944 . . . . 0.0 111.754 -177.513 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 91.8 m-85 -115.56 144.51 43.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.62 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.0 tp -119.13 111.56 18.41 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.4 100.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 108.609 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.007 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -94.95 98.96 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.388 -0.82 . . . . 0.0 109.633 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.1 t0 -156.86 142.88 17.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.0 109.389 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.23 93.71 7.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -162.21 149.56 13.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.11 16.95 13.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -145.19 -22.11 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.438 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -60.8 -65.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.65 -33.66 7.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -38.63 67.77 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.0 -177.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -64.51 -56.05 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.674 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -31.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -51.79 -54.29 30.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 109.319 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -65.77 -57.23 8.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.52 -0.737 . . . . 0.0 109.215 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.7 -59.48 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.977 -179.507 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.02 -50.19 67.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.015 179.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -56.07 -39.11 71.57 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.323 -0.861 . . . . 0.0 109.505 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -54.77 -44.47 73.69 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.287 -0.883 . . . . 0.0 109.184 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' OE2' ' A' ' 117' ' ' GLU . 4.5 mt -69.5 -58.49 3.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.94 74.8 0.01 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 46.0 m-85 -150.21 152.38 34.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -1.174 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -146.74 62.33 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.93 -1.106 . . . . 0.0 110.065 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -176.42 97.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.825 -1.172 . . . . 0.0 109.667 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -150.2 149.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.91 -1.119 . . . . 0.0 110.161 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -126.4 -166.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -148.59 149.28 31.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 110.655 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.007 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.32 -169.32 2.83 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -143.98 3.54 1.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.237 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -176.72 157.84 1.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.519 -1.363 . . . . 0.0 109.765 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -49.1 -52.83 21.14 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -50.78 -31.06 9.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.895 -1.356 . . . . 0.0 108.139 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.5 t0 -79.24 -46.13 18.44 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -64.54 -56.62 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mt -48.65 -52.95 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.862 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -69.19 -33.55 73.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.527 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -10.71 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.242 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -81.55 -22.65 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.148 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -63.65 -6.67 5.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 108.639 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.11 -69.3 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.584 -0.698 . . . . 0.0 109.843 -179.728 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 10.2 1.0 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.05 85.53 1.27 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.4 m-85 -64.71 139.23 58.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -1.038 . . . . 0.0 110.494 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.01 3.1 62.02 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -165.89 146.86 6.81 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 9' ' ' LEU . 89.7 t -148.63 123.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.786 -1.196 . . . . 0.0 109.759 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.98 93.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 p -96.36 158.1 15.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -0.861 . . . . 0.0 108.999 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' ASN . 4.4 p-10 -119.57 161.81 20.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.765 -0.584 . . . . 0.0 109.815 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 93.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 108.795 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ASP . 6.7 m-20 -108.76 121.54 45.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.443 -0.786 . . . . 0.0 109.721 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.627 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.6 ppp? -137.99 38.19 0.34 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.599 -0.688 . . . . 0.0 111.78 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -55.89 -24.97 50.35 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 178.034 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 63' ' ' MET . 7.8 p30 179.63 58.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 2.2 ttm 77.99 99.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.209 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -168.25 -172.53 1.76 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.528 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.689 ' H ' HD12 ' A' ' 68' ' ' LEU . . . 71.12 -69.68 0.82 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 97' ' ' ALA . 1.7 mm? -67.75 -61.62 1.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.109 -1.23 . . . . 0.0 108.992 179.354 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.61 -12.12 9.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 108.653 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -73.02 -46.44 52.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.87 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.88 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -84.2 -30.57 25.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.242 179.992 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -61.68 -40.43 94.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.114 179.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.5 m -68.66 -41.49 79.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.018 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.64 -29.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.82 . . . . 0.0 108.795 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -90.03 -24.13 21.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.686 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.18 -28.94 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -87.69 131.79 34.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.05 -23.72 77.82 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.23 -28.56 17.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -1.193 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.484 ' C ' ' H ' ' A' ' 80' ' ' ALA . 23.1 tpp -91.97 5.49 49.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 t -71.7 13.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -99.97 -37.24 9.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.708 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -38.55 102.67 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.766 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 96.25 0.23 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.164 1.243 . . . . 0.0 111.528 -178.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 83' ' ' VAL . 2.1 t -98.84 105.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.3 tp -96.02 103.72 15.62 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.827 -1.549 . . . . 0.0 106.86 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.56 161.67 11.67 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.731 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.73 137.72 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 t -150.04 156.24 41.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.31 -31.14 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.45 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.14 -61.2 2.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.15 33.36 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -44.84 -67.27 0.3 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.0 109.795 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -167.35 -80.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -13.32 1.96 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 109.741 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -83.12 -21.88 33.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.637 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.56 HG23 ' CD2' ' A' ' 106' ' ' TYR . 66.1 mt -78.89 -49.58 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.945 -1.097 . . . . 0.0 108.657 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.8 mp -63.49 -19.5 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.336 -0.852 . . . . 0.0 108.949 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -60.36 -59.56 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.83 -53.42 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.79 -19.87 65.83 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.993 -178.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -50.61 -30.79 14.2 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.04 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -92.54 -26.62 17.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.329 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.46 72.54 1.05 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.815 177.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.24 -112.04 0.07 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 116.619 -2.032 . . . . 0.0 109.05 178.6 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.91 -49.41 6.25 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.754 1.264 . . . . 0.0 108.102 175.396 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.58 -160.0 32.48 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.57 124.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.849 . . . . 0.0 109.289 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.5 p -113.39 130.55 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.459 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -84.23 124.18 39.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.972 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 161.55 25.63 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.159 -0.963 . . . . 0.0 108.94 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.48 129.04 17.35 Favored 'Cis proline' 0 N--CA 1.484 0.933 0 O-C-N 122.842 0.917 . . . . 0.0 110.747 -2.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.7 p90 -96.93 163.76 12.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.935 . . . . 0.0 109.632 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.56 147.18 25.6 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.862 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.436 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.66 -20.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.808 -1.182 . . . . 0.0 109.047 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.577 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -75.74 -58.4 3.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.538 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.639 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -52.41 -38.81 59.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.207 -1.558 . . . . 0.0 107.972 178.612 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.581 ' OE2' HD21 ' A' ' 28' ' ' LEU . 11.3 tt0 -57.14 -57.3 13.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.046 -1.034 . . . . 0.0 109.895 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.56 -39.19 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.532 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.43 -29.22 63.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -73.46 -45.37 54.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.521 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 125' ' ' GLU . 2.6 m120 -57.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.914 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -61.04 -46.31 91.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 109.729 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.26 -34.34 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.371 -0.83 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.27 -7.18 57.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.919 -178.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 121' ' ' ASN . 5.9 mt-10 -71.44 -28.55 64.05 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.342 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -94.14 -25.11 17.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -84.54 -22.4 30.13 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.487 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.41 79.62 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.285 -1.126 . . . . 0.0 109.465 179.925 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 7.4 m-20 -45.37 146.7 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.313 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.6 tttp -90.25 13.13 16.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.876 -1.14 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -152.46 45.59 0.72 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.708 -1.245 . . . . 0.0 110.415 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.56 136.56 44.03 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -73.98 115.9 13.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.958 -1.088 . . . . 0.0 111.978 -176.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.3 m-85 -106.4 153.24 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.063 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.784 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.72 104.53 5.55 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.411 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.515 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -91.67 122.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.969 -178.986 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.2 t -111.97 93.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.863 . . . . 0.0 109.069 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD1' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.34 -178.03 4.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.02 28.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.532 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -90.9 -7.85 51.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.427 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.51 -10.09 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.747 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.42 -8.88 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.9 ttt -64.9 -22.53 67.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.05 -63.64 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -46.75 -14.08 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.174 -178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' ARG . 4.2 mt -81.83 -50.13 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.014 -1.053 . . . . 0.0 109.628 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -27.72 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.786 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -55.71 -53.08 61.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 108.89 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -62.67 -59.22 5.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.525 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -40.61 -56.81 2.02 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.773 -179.985 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.84 -39.82 71.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.198 -0.939 . . . . 0.0 108.846 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -62.36 -50.71 70.5 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.282 -0.886 . . . . 0.0 109.207 179.642 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.04 -36.93 30.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.477 HD11 ' OE1' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -71.55 -61.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.563 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.19 65.12 0.01 OUTLIER Glycine 0 C--N 1.3 -1.465 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 44.2 m-85 -150.14 148.53 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 109.129 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -150.15 59.28 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.806 -1.183 . . . . 0.0 111.159 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -172.21 98.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.703 -1.248 . . . . 0.0 110.684 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.71 178.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.035 -1.04 . . . . 0.0 110.352 179.058 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -142.31 -177.34 5.21 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 178.456 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 13.5 mt-10 -140.85 156.23 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.052 -1.03 . . . . 0.0 111.483 -178.133 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.99 -173.0 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.03 19.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.689 -1.257 . . . . 0.0 110.87 -179.551 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.488 ' OD1' ' ND2' ' A' ' 62' ' ' ASN . 42.0 t0 -174.48 145.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -0.992 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.19 -42.37 17.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -63.01 -33.37 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.245 -1.15 . . . . 0.0 108.492 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 18.8 t0 -73.29 -47.55 41.93 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -58.12 -48.2 80.93 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.42 -0.8 . . . . 0.0 108.845 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.5 tm? -49.91 -50.43 46.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.708 -179.588 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -55.44 -40.17 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.895 . . . . 0.0 111.05 -178.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -26.31 20.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.015 -1.053 . . . . 0.0 111.06 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.688 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -58.59 -19.51 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.818 -1.176 . . . . 0.0 109.256 -179.209 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -95.89 -5.9 40.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.125 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.29 -62.81 1.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.317 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.55 8.77 1.38 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.45 77.14 1.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.478 ' O ' HD13 ' A' ' 81' ' ' LEU . 36.6 m-85 -56.39 114.22 1.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.393 -1.063 . . . . 0.0 109.766 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.33 2.14 3.37 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -163.47 139.22 6.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.972 -1.311 . . . . 0.0 109.597 179.676 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.3 t -136.57 116.77 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.087 -1.008 . . . . 0.0 109.532 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.1 mt -103.8 99.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.533 -0.729 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.475 ' O ' ' SD ' ' A' ' 85' ' ' MET . 15.2 p -110.25 156.74 20.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.56 162.96 14.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.468 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 42.0 t-105 -96.49 111.95 23.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 2.3 t-20 73.48 96.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.725 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.455 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.5 mtt 177.16 -50.63 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -66.27 -67.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 120.783 0.989 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.6 p30 -154.55 125.96 7.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 mtt 54.33 -86.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -149.0 144.0 26.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.06 1.78 4.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.266 . . . . 0.0 109.627 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.9 tt0 -46.31 -32.62 3.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -66.87 -52.06 48.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.916 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -58.58 -60.42 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.237 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' ALA . 10.5 tttt -42.82 -34.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 m -52.06 -44.45 64.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 108.692 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.69 -30.8 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -6.9 55.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -64.17 -51.38 64.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.835 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -46.9 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.27 -61.32 0.36 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.44 -8.15 59.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -1.151 . . . . 0.0 109.257 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.6 mtp -90.26 -7.1 54.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -74.98 65.79 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.58 -28.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 0.0 110.452 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 51' ' ' TYR . 30.0 mt -60.14 125.05 80.25 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 120.9 -1.125 . . . . 0.0 109.28 -179.396 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.9 150.79 75.82 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.231 1.287 . . . . 0.0 112.565 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.9 t -133.21 137.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.396 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 84' ' ' LEU . 34.2 tp -117.35 65.73 0.73 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.555 178.404 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' O ' ' A' ' 56' ' ' SER . 2.3 mmt -48.21 159.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.01 132.76 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 109.048 -179.166 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.1 t -150.12 166.47 29.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.49 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -87.35 -68.24 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.4 101.93 14.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -88.5 98.92 11.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.93 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -63.72 -151.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 108.977 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.6 pttt -118.42 -71.43 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 109.413 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -48.97 -9.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.364 -0.835 . . . . 0.0 110.056 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -89.53 -49.02 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.856 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 35.9 mt -61.58 -31.95 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.89 -63.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.087 -1.008 . . . . 0.0 109.651 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.88 19.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 108.834 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.97 -54.14 13.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.472 -0.768 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -53.04 -45.23 67.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.878 . . . . 0.0 110.1 -179.379 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.72 -19.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 109.116 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -98.97 -113.54 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.611 -0.681 . . . . 0.0 109.59 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.35 -2.89 5.82 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.695 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -55.79 10.94 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 122.206 -0.585 . . . . 0.0 111.326 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 102' ' ' GLY . 14.0 m -29.45 -33.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.15 130.79 10.26 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.92 121.76 10.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 0.0 109.429 179.385 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.23 141.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 108' ' ' VAL . 8.5 p -92.13 100.68 11.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 108.907 179.739 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -62.53 159.87 38.77 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.921 -1.112 . . . . 0.0 109.345 -179.323 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.48 147.74 87.61 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 O-C-N 123.008 1.004 . . . . 0.0 109.835 -3.184 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 116' ' ' LEU . 6.4 p90 -126.36 159.03 34.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.143 0.973 . . . . 0.0 110.414 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -103.19 153.15 20.65 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.933 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -48.9 -12.92 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.691 -1.256 . . . . 0.0 109.487 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.67 -42.92 23.74 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -60.26 2.56 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 111' ' ' PHE . 4.1 tp -49.26 -37.91 25.14 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.094 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' OE1' HD11 ' A' ' 28' ' ' LEU . 41.8 tt0 -65.19 -48.83 72.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 109.866 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.35 -68.47 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 110.403 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.38 -47.49 9.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.83 . . . . 0.0 110.19 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.56 -44.56 96.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -34.84 79.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.247 -179.425 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -71.32 -34.57 70.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 109.8 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 mt -80.12 -41.31 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.74 -24.67 67.86 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.14 -29.84 65.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -29.4 29.65 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.4 tp -69.06 -22.11 64.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.89 5.38 57.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.373 -1.075 . . . . 0.0 109.372 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.696 ' HB2' ' SD ' ' A' ' 129' ' ' MET . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.449 0.643 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 63.01 131.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 109.369 -179.827 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -90.17 9.68 27.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.765 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -147.84 48.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.76 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 56.1 tp -76.35 115.86 16.48 Favored 'General case' 0 C--O 1.204 -1.302 0 O-C-N 120.612 -1.305 . . . . 0.0 107.827 178.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -57.43 120.19 7.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.851 -1.156 . . . . 0.0 111.694 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.2 m-85 -110.62 143.36 41.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.588 HD22 ' CD1' ' A' ' 46' ' ' LEU . 53.9 tp -116.94 113.03 21.84 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.99 98.14 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 36' ' ' ALA . 18.3 t -90.05 89.24 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.11 135.1 17.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.066 -1.021 . . . . 0.0 109.709 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.6 m-20 -87.41 1.48 53.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -66.17 140.23 58.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 19.8 5.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.8 -27.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.847 . . . . 0.0 109.499 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -63.85 -58.79 5.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.487 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.66 -36.12 6.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.396 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.5 -39.62 74.05 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.736 -178.294 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 21' ' ' VAL . 2.5 mt -60.13 -55.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.394 -0.816 . . . . 0.0 109.847 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.38 -34.0 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 110.638 -178.484 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -53.12 -53.28 52.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.936 -1.103 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -69.29 -56.12 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.12 -57.27 2.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.741 -179.467 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.1 -48.63 80.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.064 -1.023 . . . . 0.0 109.02 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -57.39 -28.99 63.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.55 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.17 -30.88 68.51 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.1 -1.0 . . . . 0.0 108.874 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.74 -66.73 0.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.187 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.55 29.58 0.02 OUTLIER Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -98.08 152.34 19.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 109.6 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -150.04 60.29 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.096 -1.003 . . . . 0.0 109.727 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.73 100.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.09 153.72 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.101 -0.999 . . . . 0.0 110.176 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.74 -167.46 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 108.987 179.469 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.92 145.67 26.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.053 -1.03 . . . . 0.0 110.042 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.48 -169.03 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.15 6.31 1.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.212 -0.93 . . . . 0.0 111.176 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.58 -175.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.533 -1.354 . . . . 0.0 110.005 179.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.87 -41.12 73.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.01 -36.99 76.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -1.056 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.1 t0 -78.99 -45.47 20.19 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.87 98.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.989 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.76 -39.12 90.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.074 -1.016 . . . . 0.0 109.741 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -74.25 -23.96 59.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -0.961 . . . . 0.0 110.336 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -90.03 -28.92 18.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.04 . . . . 0.0 110.829 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.588 ' CD1' HD22 ' A' ' 9' ' ' LEU . 1.6 mp -60.46 -13.04 11.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.581 -1.325 . . . . 0.0 109.417 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.17 -6.84 48.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.161 -0.962 . . . . 0.0 108.613 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.81 -71.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.578 -0.701 . . . . 0.0 109.826 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.14 12.64 1.08 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.89 94.78 0.97 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.44 ' O ' HD22 ' A' ' 81' ' ' LEU . 17.2 m-85 -73.97 148.8 41.79 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.257 -1.143 . . . . 0.0 110.128 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' C ' HD13 ' A' ' 81' ' ' LEU . . . -105.82 -9.01 33.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.2 129.49 14.71 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.3 t -128.28 122.78 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.079 -1.013 . . . . 0.0 110.09 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -107.43 132.31 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -149.47 142.39 24.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -74.62 123.01 24.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.349 -0.845 . . . . 0.0 109.285 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 51.0 t-105 -61.61 98.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.871 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 60' ' ' MET . 10.0 t-20 63.13 122.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 109.826 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.496 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 169.99 -46.79 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 110.334 179.526 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.14 -55.37 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.719 0.946 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.51 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.27 -177.77 4.38 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -93.1 131.5 38.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.192 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.05 1.83 3.28 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 64' ' ' ASP . 58.6 tp -73.36 -68.73 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -1.227 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -43.99 -31.4 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.533 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -66.08 -56.34 12.02 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.562 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 102' ' ' GLY . 1.6 tt -63.42 -65.65 0.65 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.609 -0.682 . . . . 0.0 109.783 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' HH21 ' A' ' 73' ' ' ARG . 6.7 tttm -39.89 -32.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.835 -0.541 . . . . 0.0 109.879 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.7 m -71.29 -39.99 71.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.083 -1.011 . . . . 0.0 108.776 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 69' ' ' LEU . 96.4 mt -55.41 -42.05 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 HH21 ' NZ ' ' A' ' 70' ' ' LYS . 19.4 ptt85 -89.97 1.62 56.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.854 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.05 -28.25 48.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -36.21 53.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.73 -23.88 14.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.37 -52.41 65.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.16 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.9 mmt -90.04 16.58 8.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.1 p 46.55 -107.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.03 56.55 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 82' ' ' PRO . 1.2 pp -42.77 149.44 0.49 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.6 ' O ' HD12 ' A' ' 81' ' ' LEU . 4.2 Cg_exo -54.32 142.89 67.51 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 121.818 1.678 . . . . 0.0 113.505 -178.105 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 69' ' ' LEU . 2.3 t -134.55 128.77 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.514 HD21 HD11 ' A' ' 116' ' ' LEU . 48.0 tp -109.27 72.7 0.82 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.012 177.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt -53.06 169.46 0.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -141.16 129.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.449 -0.782 . . . . 0.0 109.664 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 88' ' ' ALA . 24.3 m -141.64 166.7 24.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 109.255 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 87' ' ' THR . . . -111.58 -27.86 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.65 -0.656 . . . . 0.0 109.269 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt-10 -99.91 -72.4 0.67 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -0.805 . . . . 0.0 109.684 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 62.14 118.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.24 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -122.16 -88.06 0.63 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.634 . . . . 0.0 109.67 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' ASN . 1.4 mtpp -152.98 -77.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -45.94 -16.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.744 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.551 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 12.4 t30 -89.99 -33.15 16.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.659 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.1 mt -90.04 -20.69 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 97' ' ' ALA . 60.9 mt -73.66 -72.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.29 -50.66 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -55.7 -51.96 65.52 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.561 -0.712 . . . . 0.0 109.54 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.72 -41.93 70.92 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.317 -0.864 . . . . 0.0 109.902 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.497 ' OE1' ' N ' ' A' ' 100' ' ' GLN . 2.9 mp0 -61.43 -11.85 12.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.859 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.36 -104.79 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 110.43 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.735 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -134.6 0.78 3.87 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.54 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.792 -0.828 . . . . 0.0 110.006 177.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 6.1 m -29.1 -32.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.59 126.28 7.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.0 112.01 5.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -1.217 . . . . 0.0 108.944 179.547 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.8 p -108.82 129.89 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.8 p -80.93 93.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 108.925 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 161.19 3.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.012 . . . . 0.0 109.314 -179.583 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.74 162.28 92.67 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 124.705 -0.956 . . . . 0.0 110.372 -2.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -143.64 155.04 44.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.166 0.984 . . . . 0.0 110.431 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.55 154.02 18.9 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.09 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -49.13 -12.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.684 -1.26 . . . . 0.0 109.499 -179.228 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.49 -40.17 23.66 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 108.44 178.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -59.2 2.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD11 HD21 ' A' ' 84' ' ' LEU . 4.7 tp -50.59 -38.31 44.74 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.289 -1.364 . . . . 0.0 108.614 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.25 -51.22 70.5 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.157 -0.964 . . . . 0.0 109.562 179.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -46.01 -59.94 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.65 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.115 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -45.71 -68.23 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.496 -0.752 . . . . 0.0 109.037 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.08 -22.4 39.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.464 ' O ' ' CG ' ' A' ' 125' ' ' GLU . 1.4 ttpt -81.14 -24.4 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 110.303 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mt -90.08 -38.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.0 110.779 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 120' ' ' LEU . 16.5 m-85 -67.79 -17.03 64.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.993 -1.067 . . . . 0.0 111.342 -177.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -62.03 -27.85 69.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.723 -1.236 . . . . 0.0 107.714 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -87.71 -27.72 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -26.04 64.22 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.65 68.3 1.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.696 ' SD ' ' HB2' ' A' ' 2' ' ' ALA . 2.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER 61.94 131.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -90.07 10.57 23.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -146.44 50.19 1.15 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 52' ' ' GLY . 22.4 tp -78.74 131.9 36.75 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.05 118.5 19.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 0.0 113.18 -175.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 45.3 m-85 -110.29 143.91 39.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.204 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 46' ' ' LEU . 41.3 tp -114.04 107.74 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.569 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.16 101.51 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.9 t -96.9 120.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.367 -0.833 . . . . 0.0 110.619 -178.75 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CE2' ' A' ' 14' ' ' PHE . 4.6 t0 -176.44 -178.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.467 -0.771 . . . . 0.0 109.389 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -114.94 9.96 16.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.064 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' ' CB ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -69.46 164.14 23.74 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.397 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.4 p -134.09 29.84 3.69 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -154.08 -60.62 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.481 -177.184 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CE2' ' A' ' 14' ' ' PHE . 4.7 ttt -45.69 -58.13 3.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HE ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -34.08 -33.99 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.469 0.652 . . . . 0.0 109.93 178.726 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -70.19 -46.54 64.38 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.621 -178.426 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.6 mp -54.46 -58.07 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.249 -0.907 . . . . 0.0 109.269 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -55.39 -43.25 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.504 -0.747 . . . . 0.0 110.157 -179.309 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' NH1' ' HE ' ' A' ' 18' ' ' ARG . 4.6 mtt85 -46.78 -53.36 12.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -64.69 -57.12 9.86 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.807 0.813 . . . . 0.0 109.192 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -38.43 -56.03 1.31 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.42 -52.18 65.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.01 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -52.53 -39.39 61.31 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.83 -31.22 26.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.95 -62.35 1.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.275 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 159.55 74.06 0.02 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 56.0 m-85 -150.1 155.12 39.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.215 . . . . 0.0 109.57 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.18 40.28 0.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.093 -1.004 . . . . 0.0 110.294 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -157.57 108.6 2.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.655 -1.278 . . . . 0.0 109.536 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -146.35 146.96 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.315 -0.865 . . . . 0.0 110.067 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.85 -172.55 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 74.5 mt-10 -149.95 154.11 37.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.01 -1.056 . . . . 0.0 110.38 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.15 -173.97 3.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.19 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.584 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 15.6 mm-40 -117.95 -2.13 11.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.487 -0.758 . . . . 0.0 110.443 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 165.01 166.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.31 -0.869 . . . . 0.0 109.041 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -42.74 -52.82 5.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 2.9 p -58.96 -42.27 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.881 -1.364 . . . . 0.0 109.176 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.584 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 8.7 t0 -58.83 -45.98 88.73 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.17 -40.99 91.86 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -49.65 -39.62 36.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.926 -1.109 . . . . 0.0 108.624 179.405 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -88.18 -33.01 18.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.232 -0.918 . . . . 0.0 110.35 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -89.9 -55.8 3.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.104 -0.998 . . . . 0.0 109.879 -179.603 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 9' ' ' LEU . 7.2 tt -45.68 -27.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.59 12.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 108.808 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -49.7 -55.47 13.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.52 -0.738 . . . . 0.0 109.652 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.65 33.78 0.07 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.89 124.52 2.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 53' ' ' PHE . 18.2 m-85 -113.64 107.18 15.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.76 -0.847 . . . . 0.0 110.193 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.89 0.46 1.7 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -168.39 144.32 3.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.257 . . . . 0.0 109.484 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.9 t -142.23 126.94 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.854 -1.154 . . . . 0.0 109.685 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.3 mt -110.51 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.7 p -91.04 141.62 28.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.88 -1.138 . . . . 0.0 109.461 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -106.61 24.71 12.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 110.521 -179.307 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.446 ' O ' ' O ' ' A' ' 57' ' ' ASP . 4.5 t-105 62.19 143.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.941 -1.099 . . . . 0.0 109.163 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.49 167.7 27.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 109.987 -179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.658 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -144.48 23.5 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 113.615 -179.932 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -59.33 -54.9 2.16 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 N-CA-C 108.598 -1.347 . . . . 0.0 108.598 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.31 -21.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.674 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 76.6 mtp -150.78 103.49 3.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.483 -0.76 . . . . 0.0 109.031 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -58.69 -175.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.081 -1.012 . . . . 0.0 110.183 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.02 -5.29 80.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.44 -50.53 67.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.795 -1.415 . . . . 0.0 107.832 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.45 -24.66 2.11 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.578 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' ILE . 3.8 tp -69.78 -57.43 5.11 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -50.08 -55.14 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.031 0.92 . . . . 0.0 109.052 178.988 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -59.79 -50.02 75.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.399 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.6 m -69.23 -14.86 63.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.847 HD13 HG21 ' A' ' 83' ' ' VAL . 1.1 mt -78.26 -29.72 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -77.24 -35.12 55.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.933 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -45.25 -27.98 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.168 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.54 78.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.942 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 43.69 -157.91 0.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.65 57.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.652 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.2 tpt -90.0 -8.81 50.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 108.907 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m 45.45 -119.19 0.79 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.548 -0.72 . . . . 0.0 109.938 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.03 60.58 0.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 47.65 -178.92 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.815 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.5 Cg_exo -62.83 142.93 90.64 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.533 2.156 . . . . 0.0 115.451 -174.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.847 HG21 HD13 ' A' ' 72' ' ' ILE . 15.2 t -137.01 104.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.31 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -91.48 104.78 17.24 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.722 178.388 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.0 ttm -77.44 119.4 20.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.704 -1.198 . . . . 0.0 108.726 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 107' ' ' VAL . 2.2 p -108.13 146.08 14.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.503 -0.748 . . . . 0.0 109.611 -178.66 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.444 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 3.0 t -150.12 -173.41 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.614 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . -129.8 -46.41 1.15 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.5 pt-20 -74.67 26.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.827 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.64 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.378 -0.826 . . . . 0.0 109.448 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ttmt -99.99 -69.12 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 109.481 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -169.94 -44.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -79.97 -24.57 40.85 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.281 -0.887 . . . . 0.0 109.796 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 4.6 t30 -87.95 -28.05 21.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.865 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.827 HD11 ' HB1' ' A' ' 90' ' ' ALA . 15.7 mt -72.67 -58.0 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 108.938 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.34 -29.39 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.362 -0.836 . . . . 0.0 109.162 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.77 -40.05 39.98 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.964 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -80.92 -62.11 1.77 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -53.39 -28.4 29.23 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.816 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -56.51 -35.39 68.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.415 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -76.9 -26.05 53.71 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 176.57 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.49 71.84 0.88 Allowed Glycine 0 N--CA 1.484 1.846 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.745 175.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.2 -111.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 117.495 -1.682 . . . . 0.0 109.391 177.629 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.58 -47.48 7.38 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.53 1.157 . . . . 0.0 108.833 177.224 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 166.7 -159.02 32.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -178.155 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -142.62 136.39 29.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.705 -0.879 . . . . 0.0 109.833 179.308 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG11 HD21 ' A' ' 116' ' ' LEU . 6.2 p -134.71 134.24 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -161.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.86 151.76 8.32 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 108.784 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.86 138.08 53.96 Favored 'Cis proline' 0 N--CA 1.486 1.035 0 C-N-CA 125.281 -0.716 . . . . 0.0 110.341 -2.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.822 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.3 p90 -97.89 160.21 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.376 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.78 146.95 23.25 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.831 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.01 -34.73 13.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 108.442 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.47 -35.38 80.75 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.509 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.8 m -70.44 -70.57 0.29 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -51.67 -28.34 14.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.429 -1.419 . . . . 0.0 109.841 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 10.2 tt0 -62.22 -62.66 1.61 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.463 -1.398 . . . . 0.0 108.997 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.32 -44.45 16.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -62.04 -31.43 71.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 tt -81.63 -53.5 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -33.96 74.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.701 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -70.78 -44.0 67.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.46 -36.65 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 109.264 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -73.79 -29.85 62.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -51.67 -29.88 19.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -86.37 -30.7 21.96 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 tp -79.91 -10.05 59.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 0.0 108.846 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.69 41.19 12.71 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.317 -1.108 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -45.75 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -69.03 26.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 109.942 -179.934 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 3' ' ' ASP . 30.6 mt-10 -134.62 35.71 3.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.918 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.85 136.16 34.23 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.2 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -83.94 129.91 34.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.91 -1.118 . . . . 0.0 111.237 -177.382 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.56 157.69 21.73 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.445 0.64 . . . . 0.0 109.767 179.768 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.043 HD23 HD12 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -132.64 108.35 9.0 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.461 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.554 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.5 m -92.63 110.12 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -177.608 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.5 t -90.03 92.68 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.071 -1.018 . . . . 0.0 109.506 179.705 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -144.99 151.69 38.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.15 -33.38 10.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.629 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.87 132.32 11.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 109.595 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -86.29 26.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -146.32 -23.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.27 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.4 ttt -65.67 -46.74 77.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -55.86 -30.97 62.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.645 ' NH2' HH12 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -70.02 -24.66 63.31 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.309 -177.777 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.15 -47.28 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 109.889 -179.639 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -34.43 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.22 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.645 HH12 ' NH2' ' A' ' 19' ' ' ARG . 8.6 mtp180 -47.43 -51.56 19.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.51 -58.53 3.86 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.677 0.751 . . . . 0.0 109.84 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -40.57 -46.41 2.51 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.474 -179.085 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -71.24 -41.91 69.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.124 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -61.91 -30.36 70.84 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.261 -0.9 . . . . 0.0 109.342 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.14 -23.27 62.02 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.882 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -90.78 -40.49 11.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 144.29 5.36 0.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.93 135.33 33.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.323 . . . . 0.0 109.794 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.9 OUTLIER -145.76 64.24 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.102 -0.999 . . . . 0.0 109.894 -179.829 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -172.45 97.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 110.01 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.93 177.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -0.999 . . . . 0.0 110.228 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.677 ' HG3' HD13 ' A' ' 9' ' ' LEU . 13.5 pt-20 -134.91 -166.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.937 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 3.8 tt0 -147.39 155.03 41.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 110.905 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -148.37 -166.87 2.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -136.35 -7.94 1.99 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.387 -0.82 . . . . 0.0 110.211 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -178.12 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.052 . . . . 0.0 109.243 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 64' ' ' ASP . . . -64.12 -52.16 46.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -51.05 -35.28 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.916 -1.343 . . . . 0.0 107.812 179.198 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 20.8 t0 -68.23 -50.57 53.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.059 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.02 -18.95 65.68 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.279 -0.888 . . . . 0.0 108.708 179.44 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.652 ' CD2' HE22 ' A' ' 47' ' ' GLN . 0.7 OUTLIER -77.41 -27.59 52.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.149 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -90.64 -33.35 15.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.316 -179.725 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -58.7 2.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.009 -1.057 . . . . 0.0 110.076 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 HD23 ' A' ' 9' ' ' LEU . 2.1 tt -51.88 -22.41 3.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.652 HE22 ' CD2' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -51.84 -29.39 19.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 108.799 179.158 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.92 -59.31 2.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.42 112.18 3.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.39 -30.11 0.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.4 m-85 -64.21 85.29 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.296 -1.12 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.0 9.62 2.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -159.54 153.02 22.51 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.391 -1.064 . . . . 0.0 109.883 -179.355 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.3 t -146.07 142.93 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.918 -1.114 . . . . 0.0 109.687 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 55' ' ' ILE . 12.8 mt -126.4 104.14 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 p -114.7 150.54 35.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.383 -0.823 . . . . 0.0 110.272 -178.872 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.24 -85.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 109.236 179.522 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.528 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 59.6 t-105 -165.76 169.11 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.278 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.476 ' OD1' ' CD1' ' A' ' 58' ' ' TRP . 31.0 p-10 -76.33 44.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtp -71.17 -46.74 14.27 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.401 -0.812 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.47 -50.6 1.81 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.12 1.213 . . . . 0.0 110.299 -179.343 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -164.03 154.21 14.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -46.09 125.17 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.827 . . . . 0.0 109.342 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER 177.01 -61.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.027 -1.045 . . . . 0.0 109.902 -179.952 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -38.26 -40.13 0.84 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -55.62 6.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.332 . . . . 0.0 109.003 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -10.01 15.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 108.76 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -73.95 -59.94 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.567 0.698 . . . . 0.0 109.126 179.621 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.837 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -76.68 -31.82 57.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.569 -0.707 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -67.35 -47.48 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.122 179.302 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.7 m -64.52 -41.45 96.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 108.973 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 46.4 mt -60.42 -26.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.845 . . . . 0.0 109.071 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -89.31 -25.49 21.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.749 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.27 69.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 109.362 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -78.36 93.03 4.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 109.477 179.98 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.13 -24.09 54.03 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.52 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -1.18 . . . . 0.0 109.59 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.3 mtt -149.14 21.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 75' ' ' ASP . 88.5 p -75.17 65.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.976 . . . . 0.0 109.397 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -149.98 -28.71 0.24 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -43.84 107.55 0.6 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 109.676 -179.362 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.6 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.469 1.446 . . . . 0.0 113.293 -178.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -110.72 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 176.587 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.89 105.11 17.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.279 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.67 118.48 22.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.084 -177.933 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -104.1 150.89 6.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.521 -0.737 . . . . 0.0 109.764 -178.532 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -150.01 165.99 31.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.98 -1.075 . . . . 0.0 110.046 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -90.55 -97.38 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 89' ' ' GLU . 9.2 mp0 -59.78 81.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.086 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -70.21 70.48 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.501 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.257 -0.902 . . . . 0.0 108.72 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER 179.53 -59.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.465 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' ' CG ' ' A' ' 92' ' ' LYS . 15.5 mt-10 -55.07 -34.78 63.9 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.27 -0.894 . . . . 0.0 109.655 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -79.11 -11.55 59.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.723 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 35.0 mm -85.1 -67.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.131 -0.98 . . . . 0.0 109.067 179.814 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.5 mp -48.09 -21.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' ILE . . . -57.37 -63.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.138 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -49.94 -58.81 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.567 179.166 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.44 -24.65 46.9 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.48 -178.939 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.9 tt0 -51.59 -31.79 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.75 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.65 -23.31 20.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.557 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.02 75.86 0.5 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.461 177.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.837 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.06 -112.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 117.009 -1.876 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -49.38 6.3 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 122.921 1.343 . . . . 0.0 108.042 175.554 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.94 -163.0 36.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.384 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.69 139.28 41.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.623 -0.927 . . . . 0.0 109.158 178.579 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.498 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.7 p -133.87 150.64 31.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.433 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 57.5 t -90.95 160.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.069 -1.02 . . . . 0.0 109.558 -179.528 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.463 ' N ' HG12 ' A' ' 108' ' ' VAL . 11.9 pttt -129.01 156.06 78.73 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.193 -0.942 . . . . 0.0 108.755 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.72 123.78 9.34 Favored 'Cis proline' 0 N--CA 1.486 1.084 0 O-C-N 122.618 0.799 . . . . 0.0 110.625 -2.515 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -89.9 165.84 13.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.031 . . . . 0.0 109.215 179.132 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -99.8 167.05 10.78 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.041 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.92 88.8 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.954 -179.47 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.57 66.29 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.45 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 112' ' ' THR . 5.4 m -78.41 -69.88 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.623 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.642 HD13 ' CE2' ' A' ' 111' ' ' PHE . 9.1 tp -46.61 -36.0 6.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.726 -1.234 . . . . 0.0 109.213 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -63.14 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.109 -0.994 . . . . 0.0 110.822 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -45.8 -29.85 1.47 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.158 -0.964 . . . . 0.0 110.153 -178.89 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -85.25 -32.88 22.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 0.0 108.891 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.81 -52.0 49.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.441 -0.787 . . . . 0.0 109.469 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -53.26 -61.09 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 109.707 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -52.77 -27.96 20.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 110.133 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 mt -76.92 -43.73 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 0.0 109.974 -179.55 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 128' ' ' GLY . 12.0 m-85 -66.77 -5.9 13.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.833 -179.269 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.42 -24.64 62.95 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.057 -1.027 . . . . 0.0 108.249 178.924 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.08 -24.72 16.75 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.153 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.76 -14.14 25.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.53 -0.732 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' PHE . . . 46.2 86.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.221 0.534 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -46.62 146.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.499 179.889 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -90.37 14.82 11.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 109.943 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.12 45.39 0.44 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.761 -1.212 . . . . 0.0 110.941 -178.815 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 46.5 tp -71.96 111.93 7.62 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.792 -1.193 . . . . 0.0 107.817 179.053 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -48.13 118.77 2.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.719 -177.883 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 38.2 m-85 -109.83 155.44 21.65 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.75 0.786 . . . . 0.0 110.487 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG12 ' A' ' 54' ' ' VAL . 7.6 tp -135.86 102.63 5.12 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.832 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 21' ' ' VAL . 16.7 m -89.99 103.84 14.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.5 t -97.96 110.35 25.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.424 -0.798 . . . . 0.0 109.354 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -169.72 159.08 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.85 -179.741 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 14' ' ' PHE . 13.1 t0 -97.45 -100.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.536 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 45.2 -163.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -0.859 . . . . 0.0 109.752 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.1 12.34 2.41 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.748 . . . . 0.0 109.238 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.1 ttt -67.43 -66.26 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.798 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.657 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.62 -35.67 4.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 109.84 -179.842 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -70.66 -41.2 72.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.52 -52.96 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -63.0 -45.34 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.091 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -46.27 -53.76 10.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.974 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.87 -57.23 8.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.857 0.836 . . . . 0.0 109.304 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -40.08 -59.77 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 -179.792 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.39 -48.05 68.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.784 . . . . 0.0 109.431 179.693 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.32 -42.91 78.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 -179.797 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.48 -29.95 59.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.273 -0.892 . . . . 0.0 109.239 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.72 -62.97 1.41 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.69 35.07 0.02 OUTLIER Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.535 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 47.3 m-85 -115.66 139.09 50.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.751 -0.852 . . . . 0.0 109.733 -179.589 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.3 63.88 1.54 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.469 -0.769 . . . . 0.0 109.69 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -176.8 95.57 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.967 -1.083 . . . . 0.0 108.551 179.796 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.11 147.09 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.693 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -118.83 -164.87 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.351 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -150.15 159.19 44.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.791 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.87 -170.87 3.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -121.73 -10.1 8.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 111.004 -178.985 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.51 171.81 2.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.565 -1.334 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.45 91.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.622 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 41' ' ' ASP . 9.4 p -57.32 -39.3 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.953 -1.322 . . . . 0.0 108.926 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.8 t70 -63.74 -51.11 66.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.253 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -51.89 -48.96 63.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.29 -44.48 16.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 109.706 179.602 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -79.64 -29.62 41.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.296 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -89.77 -10.33 45.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.085 -1.009 . . . . 0.0 110.371 -179.29 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.659 HD21 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.08 -6.37 38.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.058 . . . . 0.0 108.726 -179.992 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 47' ' ' GLN . 29.6 tp60 -95.14 -13.14 25.32 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.96 -66.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.472 -0.768 . . . . 0.0 109.459 179.879 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.97 7.14 1.87 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.96 84.33 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 82.1 m-85 -63.54 138.94 58.7 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -1.051 . . . . 0.0 110.4 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.45 -4.03 86.19 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 4.0 t80 -169.35 94.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.89 -1.359 . . . . 0.0 110.35 -178.618 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 HD21 ' A' ' 46' ' ' LEU . 30.2 m -94.86 141.9 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.129 -1.607 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.89 96.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -111.13 177.6 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.555 -0.716 . . . . 0.0 110.297 -179.476 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 11' ' ' VAL . 4.8 m-20 -89.8 -121.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.466 -0.771 . . . . 0.0 110.179 -179.2 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 61.3 t-105 -127.56 -173.64 2.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 1.2 p-10 -93.87 55.74 2.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 -179.762 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -75.87 -45.6 3.97 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.991 -1.068 . . . . 0.0 110.406 179.702 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -67.73 -44.77 3.89 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.208 1.272 . . . . 0.0 110.211 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.74 159.79 19.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 119.16 7.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -175.96 -63.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.978 179.901 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -34.22 -50.11 0.67 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.397 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.415 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -68.49 -60.55 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.768 -1.431 . . . . 0.0 108.81 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.75 -13.06 0.9 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 108.561 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -72.45 -55.08 7.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.375 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.862 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.96 -37.46 87.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -64.24 -55.03 24.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 108.851 179.44 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -54.18 -44.24 71.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.331 -0.856 . . . . 0.0 108.731 179.427 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.94 -19.19 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.309 -0.869 . . . . 0.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -36.33 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 109.227 179.723 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.88 72.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.774 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' SER . 15.4 t70 -47.68 145.43 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.42 -34.05 4.61 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.42 -27.0 45.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.71 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.7 mmt -137.18 -55.83 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 46.78 24.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.06 3.59 0.53 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.885 -179.514 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 51' ' ' TYR . 11.6 mt -54.52 115.26 8.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 108.292 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 2.7 Cg_endo -60.46 134.6 55.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 121.182 1.255 . . . . 0.0 113.715 -177.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -128.62 112.97 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.778 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.1 tp -97.85 96.52 8.26 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.447 179.245 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.3 144.14 54.44 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.713 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 107' ' ' VAL . 44.4 t -133.81 145.15 33.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.559 0.695 . . . . 0.0 110.707 -177.724 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -150.08 165.04 33.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.087 179.441 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.46 38.11 3.35 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.598 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' ALA . 1.7 mt-10 -165.75 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.407 -0.808 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 1.033 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 45.18 84.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.869 0.842 . . . . 0.0 108.754 -179.435 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -75.41 16.66 0.33 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.963 . . . . 0.0 109.805 -178.924 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.627 ' HA ' HD12 ' A' ' 95' ' ' ILE . 13.4 ttmt 75.44 -45.4 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.884 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.26 -45.16 49.55 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.454 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 2.9 m-80 -74.06 -4.76 37.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.0 109.337 179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.033 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.9 mt -80.26 -57.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 108.521 179.381 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 96' ' ' ILE . 79.5 mt -68.8 2.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.271 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -80.67 -47.52 13.92 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.508 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -70.68 -50.7 33.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.534 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.65 -25.79 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.289 -179.642 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -52.99 -33.04 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.593 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.862 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.53 -23.27 25.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.24 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 75.61 0.51 Allowed Glycine 0 N--CA 1.48 1.572 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.544 177.771 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -112.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.877 -1.929 . . . . 0.0 109.596 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 67.3 m -91.88 -49.02 6.46 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.7 1.238 . . . . 0.0 108.06 175.531 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 167.31 -159.68 33.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.525 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 137.61 26.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.568 -0.96 . . . . 0.0 109.055 178.914 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.478 HG12 HG22 ' A' ' 86' ' ' VAL . 12.4 p -131.76 134.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.94 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.2 p -89.14 96.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.585 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.419 ' CD ' ' C ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -61.04 155.7 53.2 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 0.0 108.557 179.812 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.38 154.44 99.65 Favored 'Cis proline' 0 N--CA 1.487 1.094 0 C-N-CA 125.335 -0.694 . . . . 0.0 111.313 -1.354 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -135.33 156.54 48.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.693 0.758 . . . . 0.0 108.998 178.422 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.29 150.0 21.5 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.95 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.82 -35.0 21.33 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.735 -1.228 . . . . 0.0 108.985 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.98 65.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 17.5 m -75.99 -65.23 0.94 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.921 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -49.73 -36.93 27.32 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.23 -1.388 . . . . 0.0 108.313 179.086 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 -53.21 39.16 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.002 -1.062 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -46.55 -25.02 0.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.516 -0.74 . . . . 0.0 109.05 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -88.51 -49.97 6.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 mt -48.49 -59.02 3.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.02 -61.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.34 -0.85 . . . . 0.0 110.237 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -45.4 -29.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 110.1 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 125' ' ' GLU . 4.6 mt -87.88 -44.01 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.217 -179.614 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -62.0 5.27 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.969 . . . . 0.0 110.579 -178.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.8 tt0 -77.91 -36.47 49.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -81.15 -35.56 31.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.33 -32.85 70.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.021 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.61 75.28 0.9 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.234 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.313 -1.11 . . . . 0.0 109.428 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -45.87 143.36 2.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 23.8 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.96 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.28 42.92 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 52' ' ' GLY . 51.3 tp -67.63 143.22 56.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.233 -0.917 . . . . 0.0 108.577 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -79.76 120.35 23.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.117 -0.989 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -109.05 152.79 24.55 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.672 -0.642 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' HB3' HG23 ' A' ' 54' ' ' VAL . 9.3 tp -130.43 110.76 11.72 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.342 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.12 104.38 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 36' ' ' ALA . 94.8 t -89.81 100.73 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 120.937 -1.102 . . . . 0.0 109.66 -179.723 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -163.58 1.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.775 . . . . 0.0 109.227 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.29 1.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.988 -179.886 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.63 153.3 28.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.051 -1.031 . . . . 0.0 109.376 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.1 p -93.63 41.11 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.712 -179.714 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -173.9 -21.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.8 ttt -62.41 -46.42 88.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -45.58 78.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -55.37 -34.24 64.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 110.701 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -63.86 -48.51 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.158 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.21 -36.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.993 . . . . 0.0 110.575 -178.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -50.7 -53.11 33.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.73 -56.65 10.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.672 0.749 . . . . 0.0 109.471 179.915 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.94 -57.67 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.954 -179.669 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.81 -51.87 65.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.213 179.382 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -53.82 -35.08 61.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -55.49 -28.92 57.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.228 -0.92 . . . . 0.0 109.552 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 mt -87.82 -62.56 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.71 65.5 0.03 OUTLIER Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -150.01 145.31 26.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.251 . . . . 0.0 109.574 -179.82 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -150.02 66.63 0.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -173.91 99.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.15 150.94 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.05 -167.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.233 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.14 152.55 34.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 110.536 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.959 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.41 168.12 20.87 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.069 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.08 9.26 9.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.56 -0.712 . . . . 0.0 109.911 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.6 p-10 178.05 -176.23 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.69 -39.24 49.11 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.7 -35.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.05 -1.265 . . . . 0.0 108.025 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.656 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.2 t0 -82.69 -47.49 11.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.59 -0.694 . . . . 0.0 109.316 179.503 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -55.05 30.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -59.09 6.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.08 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -53.02 -33.43 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.028 -179.465 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -88.76 -13.24 39.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -82.17 -29.57 31.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.716 -1.24 . . . . 0.0 109.178 -179.976 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -8.41 0.31 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.174 -0.954 . . . . 0.0 108.653 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.8 -69.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.602 -0.686 . . . . 0.0 109.795 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.98 15.26 0.51 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.352 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 93.6 0.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.866 ' O ' HD21 ' A' ' 81' ' ' LEU . 29.4 m-85 -72.11 104.91 3.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -1.083 . . . . 0.0 110.491 -178.899 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.23 -11.07 6.06 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.159 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.98 137.02 17.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.245 -1.15 . . . . 0.0 110.069 -178.93 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 83' ' ' VAL . 10.3 p -144.5 133.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.715 -1.241 . . . . 0.0 109.52 178.643 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 84' ' ' LEU . 8.8 mt -113.94 157.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.196 0.522 . . . . 0.0 109.775 -178.362 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.2 p -144.93 168.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 108.942 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -93.31 -21.63 19.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.923 . . . . 0.0 110.584 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.549 ' CH2' ' HB2' ' A' ' 98' ' ' ALA . 37.5 t-105 59.65 35.36 22.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.206 -0.933 . . . . 0.0 109.911 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -177.85 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.908 -1.12 . . . . 0.0 109.882 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 175.63 -50.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.148 -0.97 . . . . 0.0 110.732 179.573 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.8 Cg_endo -64.71 123.46 11.72 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 120.95 1.1 . . . . 0.0 110.455 -179.425 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 8.2 p30 41.82 -146.56 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.664 -0.647 . . . . 0.0 109.889 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 7.3 mtp -47.32 -65.2 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 108.811 179.753 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.47 -39.41 0.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 108.914 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.7 -3.57 2.34 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 69' ' ' LEU . 10.7 tp -71.64 -61.68 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.032 -1.275 . . . . 0.0 107.611 178.93 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LEU . 29.5 tt0 -47.17 -27.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.726 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.41 -36.5 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.0 109.246 179.818 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -90.03 -36.04 15.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.808 -178.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -59.32 -50.58 73.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.967 -1.083 . . . . 0.0 109.405 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -48.89 -44.91 40.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.262 -0.898 . . . . 0.0 109.407 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 69' ' ' LEU . 33.7 mt -57.51 -38.16 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.29 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -65.82 -53.98 32.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.57 -45.45 18.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.5 130.97 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.677 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.47 40.87 2.97 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.99 -15.75 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 0.0 109.335 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.8 31.64 2.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.086 179.986 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 m -71.08 23.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -150.04 12.11 0.75 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.009 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' O ' ' A' ' 51' ' ' TYR . 8.2 tp -67.57 118.11 53.93 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 108.736 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.46 129.42 31.12 Favored 'Trans proline' 0 N--CA 1.479 0.648 0 C-N-CA 121.049 1.166 . . . . 0.0 112.366 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.643 HG22 HG13 ' A' ' 54' ' ' VAL . 3.0 t -118.52 114.97 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.254 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.4 tp -95.64 75.27 3.23 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.192 -1.403 . . . . 0.0 108.789 178.221 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.448 ' SD ' HG22 ' A' ' 87' ' ' THR . 9.6 tmm? -57.74 153.57 13.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.509 -0.744 . . . . 0.0 109.192 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.46 125.12 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.871 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 90' ' ' ALA . 4.9 t -150.22 125.81 10.28 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.477 -179.751 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -79.39 -27.52 41.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 0.0 109.015 179.344 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.75 39.86 1.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.434 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.791 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.44 106.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' CG ' ' H ' ' A' ' 92' ' ' LYS . 23.0 tptt -97.04 -144.73 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.572 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' ASN . 7.0 mtmp? -104.11 -80.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -45.18 -16.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.0 110.003 -179.546 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -82.0 -36.66 27.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.791 HD11 ' HB1' ' A' ' 90' ' ' ALA . 39.6 mt -89.97 -9.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.75 -179.782 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -89.76 -68.24 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.92 -1.113 . . . . 0.0 110.002 -179.645 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.33 -49.87 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.431 -179.588 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.52 -46.42 86.79 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.212 179.432 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.04 -50.43 27.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.085 -1.009 . . . . 0.0 109.941 -179.345 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -55.12 -24.42 25.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.592 -179.81 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.45 -104.91 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -141.58 7.59 2.51 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.488 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.22 11.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.014 -0.698 . . . . 0.0 110.6 178.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.672 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.27 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.799 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.03 125.72 8.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.98 110.7 5.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 179.817 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.2 p -107.68 134.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.072 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -89.6 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.049 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -53.84 160.92 1.9 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.108 -0.995 . . . . 0.0 109.775 -179.31 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.92 163.01 91.12 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.702 -2.491 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 12.1 p90 -146.02 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.088 0.947 . . . . 0.0 110.443 178.679 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.82 154.36 18.99 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.875 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.65 -11.98 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.629 -1.294 . . . . 0.0 109.361 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.33 -39.44 25.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.139 -0.975 . . . . 0.0 108.665 178.971 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -58.64 3.19 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.806 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 5.0 tp -50.56 -37.43 39.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 108.76 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.45 -52.84 62.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.101 -0.999 . . . . 0.0 109.654 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.29 -60.12 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 109.673 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 5.4 mptt -47.4 -41.36 19.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.84 -63.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -29.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.675 -179.727 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -34.26 67.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.493 HD11 ' CA ' ' A' ' 105' ' ' GLY . 41.4 mt -73.49 -40.65 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.589 -179.361 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -71.18 0.67 7.27 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.924 -1.11 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.7 -35.6 62.72 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.705 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -89.61 -22.03 22.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -84.25 -31.0 25.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.488 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.54 86.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.144 -1.21 . . . . 0.0 109.448 -179.916 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.451 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 40.8 m-20 -45.82 134.51 7.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -90.12 15.63 9.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.968 -1.083 . . . . 0.0 109.926 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.9 42.76 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 -179.142 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.01 147.32 30.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' TYR . 7.5 mtmm -94.5 134.52 36.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.515 -1.366 . . . . 0.0 110.656 -177.811 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -115.25 150.9 35.45 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.884 -0.51 . . . . 0.0 110.076 -179.678 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.676 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.1 tp -123.23 106.15 10.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.808 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -89.89 119.37 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.143 -178.664 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' A' ' 36' ' ' ALA . 21.7 t -124.27 57.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 O-C-N 121.698 -0.626 . . . . 0.0 109.571 -179.739 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -96.88 145.45 25.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 109.329 179.973 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 14' ' ' PHE . 7.9 p30 -71.93 -29.91 64.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.209 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.514 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -50.61 120.27 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.336 179.907 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.5 45.33 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.973 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -172.9 -27.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.9 ttt -60.06 -35.05 74.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -53.6 -34.37 58.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.51 -33.81 62.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.98 -51.12 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.498 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -33.52 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mtp85 -46.73 -53.94 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.3 t30 -64.53 -55.93 17.36 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.938 0.875 . . . . 0.0 109.089 179.745 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -38.37 -56.5 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.972 -179.737 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.94 -52.34 64.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.092 -1.005 . . . . 0.0 109.068 179.383 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -51.4 -36.58 44.13 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.132 179.79 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.16 -44.28 32.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.412 -0.805 . . . . 0.0 109.472 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -72.6 -62.32 1.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.45 54.46 0.01 OUTLIER Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 95.0 m-85 -129.11 149.91 50.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.608 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -150.08 65.78 0.97 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.059 -1.026 . . . . 0.0 110.411 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -175.31 100.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.035 . . . . 0.0 109.31 179.679 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.25 151.38 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.976 -1.077 . . . . 0.0 110.591 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.19 -165.85 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.648 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -147.71 158.35 43.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.047 -1.033 . . . . 0.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.858 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.05 -168.85 3.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.45 5.79 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.108 -0.995 . . . . 0.0 110.778 -179.483 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 177.22 177.2 0.33 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.758 -1.214 . . . . 0.0 109.644 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.46 -27.72 73.57 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.785 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.27 -40.25 80.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -1.176 . . . . 0.0 108.754 179.314 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t70 -79.48 -37.91 35.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.411 -0.805 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.31 62.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.493 -0.754 . . . . 0.0 109.021 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.79 -43.18 72.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.179 -0.951 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -69.62 -27.44 65.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 47' ' ' GLN . 13.4 mttm -87.54 -39.14 15.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.368 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -45.87 -16.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 179.803 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' LYS . 33.5 mt-30 -91.81 22.4 4.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.312 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . -66.68 -65.23 0.71 Allowed 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.429 -0.794 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.6 23.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.4 179.76 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 83.96 1.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 7' ' ' LYS . 10.2 m-85 -63.98 -41.07 97.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.54 -0.977 . . . . 0.0 110.586 -178.347 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.5 -25.34 7.33 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 143.68 21.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.539 -0.977 . . . . 0.0 110.106 -179.745 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.746 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.2 t -140.03 124.98 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.093 -1.005 . . . . 0.0 109.806 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.67 105.91 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 15.3 p -126.31 144.75 50.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.056 -1.028 . . . . 0.0 110.708 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -64.94 -117.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' NE1' ' CG ' ' A' ' 94' ' ' ASN . 61.6 t-105 -173.81 134.73 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.728 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 62.39 129.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.5 mmm 177.8 -50.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 110.088 179.405 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.16 -69.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.758 0.972 . . . . 0.0 109.701 179.643 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.34 -34.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.09 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.6 mtt -102.03 -89.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.673 . . . . 0.0 109.398 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -172.31 175.55 3.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.44 179.95 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.71 26.21 1.13 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 84.0 mt -82.06 -56.65 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -1.202 . . . . 0.0 108.87 179.611 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.67 -19.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.017 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 ' HA2' ' A' ' 39' ' ' GLY . 3.2 mt -76.93 -70.65 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.875 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.045 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -45.91 -65.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.206 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -43.78 -47.77 8.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.626 -0.671 . . . . 0.0 109.827 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.1 m -67.74 -26.65 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 69' ' ' LEU . 44.3 mt -77.09 -14.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -84.43 -27.39 27.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.73 12.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.52 -179.917 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -50.64 116.73 2.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.994 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.64 -31.36 40.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.65 -63.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.99 -47.15 7.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 48.22 13.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -0.843 . . . . 0.0 109.349 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.64 18.82 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 0.0 109.626 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 tp -44.97 113.42 1.79 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.055 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 5.1 Cg_exo -59.01 133.49 53.76 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.124 1.216 . . . . 0.0 113.07 -178.918 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.746 HG22 ' HB ' ' A' ' 54' ' ' VAL . 14.7 t -132.48 108.93 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.076 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.88 100.86 13.59 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 117.064 -1.854 . . . . 0.0 107.538 178.839 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 6.7 tpp -68.69 128.53 36.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.597 0.713 . . . . 0.0 109.385 -178.305 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -99.16 140.28 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.634 -0.666 . . . . 0.0 109.366 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.04 129.2 12.75 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.046 -179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -66.05 96.77 0.33 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.388 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.819 ' H ' HG23 ' A' ' 108' ' ' VAL . 5.0 tt0 74.47 114.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.486 -0.758 . . . . 0.0 109.202 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 106' ' ' TYR . . . -45.09 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.354 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -69.78 11.78 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 109.425 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.8 mtpp 58.96 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.82 . . . . 0.0 109.8 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 66.9 mt-10 -45.34 -46.92 13.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.978 . . . . 0.0 110.164 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.447 ' CG ' ' NE1' ' A' ' 58' ' ' TRP . 21.1 m-20 -69.34 -73.04 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.464 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -44.49 -52.51 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 109.088 -179.47 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.634 HG22 ' OE1' ' A' ' 100' ' ' GLN . 92.3 mt -56.68 -32.0 36.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.652 -1.28 . . . . 0.0 109.464 -179.902 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -71.66 -45.61 61.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.044 -1.035 . . . . 0.0 108.959 179.626 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.19 72.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 109.008 179.182 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.51 -31.27 71.26 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.619 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.634 ' OE1' HG22 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -53.32 -33.38 53.21 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.363 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.744 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -85.26 -22.51 28.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.363 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.39 80.52 0.12 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.958 177.237 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.3 -112.44 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.243 -1.783 . . . . 0.0 109.825 179.225 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 43.6 m -92.04 -52.46 4.7 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 123.21 1.481 . . . . 0.0 108.178 175.407 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.18 -162.13 32.48 Favored Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.253 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.49 115.79 9.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.527 -0.984 . . . . 0.0 109.576 179.549 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -107.64 136.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.334 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.819 HG23 ' H ' ' A' ' 89' ' ' GLU . 1.8 p -83.41 145.59 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 108.929 179.808 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -115.14 154.25 47.27 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.17 132.48 27.63 Favored 'Cis proline' 0 N--CA 1.488 1.152 0 O-C-N 122.623 0.802 . . . . 0.0 110.68 -2.353 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.8 p90 -102.16 157.47 16.86 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 178.76 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.13 148.36 22.42 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 176.845 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.12 -25.32 1.41 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.728 -1.233 . . . . 0.0 109.701 -178.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.7 65.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -72.56 -62.48 1.43 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.977 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -52.11 -37.82 55.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.428 179.687 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -65.44 -51.71 58.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.988 -1.07 . . . . 0.0 109.624 -179.755 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 20.4 tp10 -48.04 -48.33 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.855 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.67 -42.0 98.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.1 -60.13 4.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.552 -0.717 . . . . 0.0 109.92 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -32.07 57.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.057 -1.027 . . . . 0.0 110.263 -179.457 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -78.97 -23.5 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.4 mt -89.97 -39.07 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 110.271 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 127' ' ' LEU . 20.5 m-85 -74.16 -39.42 63.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.095 -1.003 . . . . 0.0 109.835 -179.248 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -50.76 -19.89 1.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.92 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' PHE . 24.6 mmtt -95.83 -27.25 15.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.508 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 124' ' ' PHE . 17.6 tp -75.58 -21.3 57.97 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.21 71.62 1.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.396 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.6 t70 -47.89 125.09 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.033 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -71.94 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 109.663 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 3' ' ' ASP . 1.9 tp10 -159.54 32.69 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.122 -0.986 . . . . 0.0 109.955 -179.939 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD11 ' HA3' ' A' ' 52' ' ' GLY . 53.6 tp -69.85 135.27 49.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.018 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -81.43 128.1 33.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 -177.235 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 33' ' ' VAL . 24.1 m-85 -112.38 153.13 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 179.465 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -126.52 106.67 9.61 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.792 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.81 113.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.0 t -113.73 83.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 121.74 -0.6 . . . . 0.0 109.545 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.85 -154.18 0.55 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.345 0.593 . . . . 0.0 109.458 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -146.49 4.47 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.222 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 16' ' ' THR . 6.2 m-85 -95.26 122.74 38.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.78 33.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -151.74 -41.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.1 ttt -54.53 -43.35 71.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -40.17 68.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -68.59 -26.85 65.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 110.171 -178.507 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.97 -50.3 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.066 -1.021 . . . . 0.0 109.378 -179.847 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -39.39 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 -179.448 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -54.27 10.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.925 . . . . 0.0 109.591 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -56.78 12.78 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -54.44 1.96 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.353 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -59.63 -24.0 63.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.252 -0.905 . . . . 0.0 109.626 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -13.4 61.1 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.088 -1.007 . . . . 0.0 109.463 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mt -95.35 -38.71 10.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.764 -179.81 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.09 4.84 0.78 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.899 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 97.0 m-85 -89.89 148.79 22.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.803 -1.41 . . . . 0.0 109.489 -179.554 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -150.07 63.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 -179.678 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.33 96.02 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.118 -0.989 . . . . 0.0 109.237 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 8' ' ' PHE . 58.3 t -140.27 153.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.051 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.98 -172.37 2.52 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.1 154.04 37.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 111.164 -178.752 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.822 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.19 -173.57 3.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.789 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -120.83 -2.41 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.196 -0.94 . . . . 0.0 110.548 -179.481 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 172.0 179.48 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.968 -1.082 . . . . 0.0 109.923 179.643 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -42.08 96.19 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.359 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.3 p -59.46 -38.95 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.277 . . . . 0.0 109.23 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 46.0 t0 -71.21 -51.82 22.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.898 . . . . 0.0 108.941 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -50.05 -60.18 3.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.8 tp -45.23 -37.81 4.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.296 179.308 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 1.8 m-20 -70.77 -43.62 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 110.344 -179.578 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -90.11 -3.71 57.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.154 -0.966 . . . . 0.0 110.713 -179.194 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -73.93 -31.67 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 108.724 179.976 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -53.84 -20.41 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.108 179.859 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.9 -63.48 0.96 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.98 109.79 2.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.235 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . 147.41 -24.4 1.54 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 55.6 m-85 -64.81 78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.141 -1.211 . . . . 0.0 109.997 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.729 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -61.48 -3.31 3.97 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.493 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -148.03 130.41 15.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.569 -0.959 . . . . 0.0 108.777 -179.469 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 83' ' ' VAL . 75.4 t -127.06 126.91 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.738 -1.226 . . . . 0.0 109.057 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.16 125.06 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.726 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 57' ' ' ASP . 60.0 p -142.51 142.55 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.0 m-20 -61.65 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.0 109.669 -179.715 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -169.51 134.2 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.94 . . . . 0.0 108.887 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' H ' ' HA ' ' A' ' 64' ' ' ASP . 8.3 t-20 52.92 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 108.864 -179.345 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 171.9 -46.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.65 -64.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.677 0.918 . . . . 0.0 110.098 -179.634 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' MET . 10.7 p30 -126.3 -39.47 2.05 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 25.6 ttt -172.62 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 59' ' ' ASN . 0.4 OUTLIER 171.63 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -49.79 -11.09 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.738 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' ASP . 5.7 mt -50.45 -35.06 27.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.641 -1.506 . . . . 0.0 107.719 179.197 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.23 -29.7 60.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.075 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 64.5 tp -74.1 -69.03 0.47 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.704 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -42.17 -67.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.364 0.602 . . . . 0.0 109.826 178.684 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -42.26 -51.76 4.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.585 -0.697 . . . . 0.0 110.262 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.4 m -49.3 -36.58 21.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.135 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.838 HG21 ' HB2' ' A' ' 80' ' ' ALA . 52.0 mt -64.22 -45.8 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.1 -1.0 . . . . 0.0 108.83 179.593 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -39.45 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.507 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.3 -28.57 59.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.5 111.28 2.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.07 -124.52 7.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.81 40.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -1.093 . . . . 0.0 109.617 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.15 -2.63 2.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.578 -0.701 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t 47.04 -134.94 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.672 179.827 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.838 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -126.38 40.29 3.76 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.717 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.729 HD12 ' HA2' ' A' ' 52' ' ' GLY . 3.0 mt 47.37 -163.58 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.492 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.564 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 6.2 Cg_exo -57.3 155.79 28.33 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 121.2 1.464 . . . . 0.0 114.876 -176.364 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.0 t -138.21 135.62 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.375 178.544 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 116' ' ' LEU . 53.7 tp -115.1 72.46 0.79 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.185 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -58.96 160.08 6.36 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.264 -179.346 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -127.89 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.789 -0.569 . . . . 0.0 110.227 -177.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -150.03 -176.35 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 109.79 -179.877 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.89 52.35 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.74 53.42 12.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -48.79 140.76 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -92.84 -87.65 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.046 179.508 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER 179.8 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.391 179.634 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.93 -6.89 0.26 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 92' ' ' LYS . 26.9 m-80 -90.06 -22.61 21.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.0 mm -89.99 -5.43 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.923 -179.582 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.76 -66.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.42 -41.11 13.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 109.031 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 103' ' ' ALA . . . -58.42 -56.72 18.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.732 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.77 -44.84 63.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.95 -26.51 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.756 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.52 -115.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.498 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.658 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.21 -11.71 4.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 179.099 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.02 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.887 -0.772 . . . . 0.0 110.626 178.718 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.6 m -29.75 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.914 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -101.42 125.91 8.72 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.295 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.41 124.14 16.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.057 . . . . 0.0 108.885 178.661 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.4 p -123.67 123.83 68.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.433 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 108' ' ' VAL . 13.6 p -76.43 102.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -64.42 161.22 44.44 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.273 -179.307 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -76.07 163.56 89.78 Favored 'Cis proline' 0 N--CA 1.485 0.985 0 O-C-N 122.879 0.937 . . . . 0.0 110.578 -2.327 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -143.28 161.0 39.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.902 178.534 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -101.85 152.22 21.16 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.234 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.02 -14.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.851 -1.156 . . . . 0.0 108.86 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.69 -41.17 38.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.663 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.5 -61.97 1.57 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.606 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 84' ' ' LEU . 3.1 tp -48.57 -37.83 18.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.029 178.741 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.66 -56.34 22.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.925 -1.11 . . . . 0.0 109.659 179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -46.03 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.83 -26.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -67.91 -76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 108.925 179.68 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.08 -19.05 2.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.928 -1.107 . . . . 0.0 110.583 -179.722 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -23.36 35.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.0 109.892 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.1 mt -89.93 -40.93 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.032 -1.043 . . . . 0.0 110.018 -179.874 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 120' ' ' LEU . 23.8 m-85 -65.55 -5.57 8.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.992 -179.203 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.61 -26.53 66.3 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -90.82 -35.42 14.83 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.603 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -71.63 -24.42 61.86 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.95 89.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.444 179.718 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 43.8 t0 -45.04 141.28 2.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 109.311 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.17 13.61 14.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.944 -1.098 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -148.14 43.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.042 . . . . 0.0 110.332 -178.912 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.39 136.36 42.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.142 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.16 121.64 26.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.048 -1.032 . . . . 0.0 111.367 -177.525 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -106.71 157.59 17.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.702 -0.624 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 51' ' ' TYR . 21.5 tp -129.43 102.24 6.32 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.246 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -91.91 103.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.398 -179.082 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.938 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.6 t -96.12 113.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.276 -0.89 . . . . 0.0 109.25 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -171.7 163.92 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.504 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 2.9 m-20 -97.85 -58.36 2.01 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.968 -1.082 . . . . 0.0 108.781 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.6 ' CD2' ' N ' ' A' ' 15' ' ' SER . 22.2 p90 22.95 -145.77 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 CA-C-O 122.598 1.19 . . . . 0.0 112.831 177.398 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 179.47 -7.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.984 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' N ' ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -131.11 -34.15 1.47 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.967 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -37.34 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 111.117 -178.185 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' MET . 10.2 ptt180 -35.55 -31.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.805 -0.559 . . . . 0.0 110.473 -179.15 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.9 ttp180 -60.09 -49.66 76.77 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.877 -178.295 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -62.37 -54.51 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.716 -179.803 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.8 -18.52 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.341 -0.849 . . . . 0.0 110.84 -178.488 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -55.1 30.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.709 -1.245 . . . . 0.0 109.138 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -67.87 -53.39 27.06 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.673 0.749 . . . . 0.0 109.577 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -42.16 -56.23 2.96 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.544 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -58.95 -52.85 63.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 108.641 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -32.69 16.29 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.244 -0.91 . . . . 0.0 108.646 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -37.32 75.71 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.383 -0.823 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 117' ' ' GLU . 2.6 mp -75.63 -11.09 59.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.508 -0.745 . . . . 0.0 109.115 179.753 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.47 71.99 1.12 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 41.3 m-85 -150.0 146.19 26.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.325 . . . . 0.0 109.435 179.399 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.07 62.36 0.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.123 -0.985 . . . . 0.0 110.061 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.54 100.71 0.07 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.15 -0.968 . . . . 0.0 109.092 179.703 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.27 152.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.156 . . . . 0.0 110.179 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.48 -172.84 2.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.687 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -146.66 160.11 42.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.609 -179.276 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.938 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.08 -164.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -142.05 -5.08 1.01 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.11 -171.05 0.48 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.91 -1.118 . . . . 0.0 109.753 179.902 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.609 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -70.32 -45.01 57.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.86 -31.53 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.08 -1.247 . . . . 0.0 108.849 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.9 t0 -84.19 -51.84 6.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.448 179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' O ' HD23 ' A' ' 46' ' ' LEU . . . -54.54 -35.39 63.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.088 -1.008 . . . . 0.0 108.899 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -68.14 -56.96 6.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.3 -28.06 64.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.777 -179.743 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -90.06 -24.43 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 110.117 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -60.87 -20.05 61.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -87.23 -8.99 56.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 108.999 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.68 -72.23 0.06 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 109.757 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.67 10.1 1.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.01 87.48 0.77 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' HD22 ' A' ' 9' ' ' LEU . 54.6 m-85 -65.98 109.14 2.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.342 -1.093 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.62 -1.03 2.28 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' TYR . 6.5 t80 -165.57 148.02 7.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -1.1 . . . . 0.0 109.525 -178.809 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 9' ' ' LEU . 26.6 t -141.59 145.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.635 -1.291 . . . . 0.0 110.837 -178.769 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.24 122.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.032 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.7 p -144.72 141.45 29.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.006 -179.291 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.36 167.08 17.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.856 -1.152 . . . . 0.0 108.429 179.127 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.526 ' NE1' ' OD1' ' A' ' 64' ' ' ASP . 73.2 t-105 -69.99 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.042 -1.036 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.06 131.6 46.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.347 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.488 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -171.16 -54.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 110.583 179.825 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -62.72 -161.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 N-CA-C 109.911 -0.842 . . . . 0.0 109.911 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -67.32 -10.32 49.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.06 179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.4 mmt -140.88 -100.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -125.17 146.75 49.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 109.479 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.24 -6.42 0.26 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.558 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.39 -71.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.257 . . . . 0.0 109.641 -179.592 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -45.17 -44.36 10.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.14 -179.501 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -56.27 -33.49 65.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 -179.773 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.691 HD11 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -89.08 -36.76 15.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.862 . . . . 0.0 109.333 -179.904 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -61.48 -47.51 85.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.299 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -47.76 -39.22 17.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.55 -44.35 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 108.98 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -28.29 68.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 109.71 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.13 -29.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -168.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.41 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.845 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.49 -56.03 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.101 . . . . 0.0 109.519 180.0 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.98 16.46 12.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 p -77.6 50.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.596 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 15.76 0.84 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 51' ' ' TYR . 26.6 mt -65.16 127.74 93.13 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.102 -0.999 . . . . 0.0 108.658 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.37 141.19 95.07 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.888 1.059 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 54' ' ' VAL . 4.3 t -127.34 119.75 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.849 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD21 ' CD1' ' A' ' 116' ' ' LEU . 42.1 tp -101.82 72.2 1.34 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.917 178.707 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -47.41 165.69 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.75 122.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.726 -178.36 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -150.1 174.22 13.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 109.411 179.323 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -106.74 -37.99 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.556 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 14.9 tt0 -86.0 -72.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.684 -179.891 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 64.73 95.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 90' ' ' ALA . 13.9 mtpt -63.15 -128.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.148 -0.97 . . . . 0.0 109.327 179.797 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 93' ' ' GLU . 5.5 pttm -144.81 -48.75 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.361 179.751 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -75.06 -5.9 46.59 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.194 -0.941 . . . . 0.0 109.394 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -90.04 -28.06 19.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.666 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.9 -21.8 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.57 -65.94 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.29 -46.53 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.567 -0.708 . . . . 0.0 109.38 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.467 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -59.55 -53.23 60.48 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.738 . . . . 0.0 109.52 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.79 61.54 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.205 -0.934 . . . . 0.0 109.914 -179.312 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -22.35 33.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.79 -61.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.369 -0.832 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -175.58 -10.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.08 -179.731 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -55.84 11.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.49 -1.006 . . . . 0.0 110.848 179.255 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.37 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.449 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.45 128.52 9.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.142 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.547 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -148.19 109.9 4.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.273 . . . . 0.0 109.116 179.376 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 107' ' ' VAL . 12.6 p -105.98 135.51 43.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -85.65 95.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.358 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 pttt -56.37 155.12 14.1 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.789 -1.194 . . . . 0.0 109.283 -179.225 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.9 167.63 79.79 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 125.067 -0.806 . . . . 0.0 110.517 -2.086 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -146.73 163.55 35.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.102 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -102.36 146.83 27.49 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.721 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.19 -31.5 3.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.011 -1.056 . . . . 0.0 109.191 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.07 -37.34 78.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.585 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.4 m -68.78 -67.29 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.396 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -44.15 -39.73 4.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.259 178.753 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . 57.1 tt0 -62.47 -50.55 70.98 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.196 -0.94 . . . . 0.0 109.645 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -46.29 -58.62 3.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 109.55 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HZ1' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -49.15 -38.82 26.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.303 179.928 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -39.66 85.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.83 -33.14 70.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.59 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -71.46 -25.42 62.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.705 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.05 -34.72 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -82.86 8.93 11.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -178.581 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -75.66 -25.4 56.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.14 -27.97 13.94 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.226 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -83.17 -22.49 33.24 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.97 85.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.416 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.32 -1.106 . . . . 0.0 109.431 179.792 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -44.53 149.6 0.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 109.409 179.992 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -90.55 9.14 30.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.1 -1.0 . . . . 0.0 110.112 179.812 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.2 50.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.777 -1.202 . . . . 0.0 110.574 -178.545 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 53.8 tp -78.74 111.11 14.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -48.32 118.12 2.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.94 -1.1 . . . . 0.0 111.713 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 64.5 m-85 -112.66 151.31 30.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.573 -0.705 . . . . 0.0 109.562 178.895 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB3' HG13 ' A' ' 54' ' ' VAL . 62.1 tp -123.7 108.22 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.673 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.97 110.19 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.548 -179.328 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.3 t -114.73 118.0 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.67 41.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.47 -0.769 . . . . 0.0 109.279 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -106.44 6.52 30.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.674 -0.641 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -80.99 -21.57 40.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.864 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 p 75.17 -41.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 20' ' ' ILE . 5.2 t -98.13 1.24 47.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.7 ttt -80.05 -25.15 40.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -66.86 -45.75 77.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 109.668 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -22.29 56.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.283 -0.886 . . . . 0.0 109.777 -179.404 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -76.02 -55.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.4 -13.97 17.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.855 . . . . 0.0 110.271 -178.959 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -65.68 -53.43 41.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 108.911 179.423 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -66.58 -55.52 14.99 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.859 0.838 . . . . 0.0 109.066 179.593 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.3 tt -41.86 -49.28 4.48 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.496 -179.628 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.08 -41.51 86.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 108.56 179.058 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -56.53 -36.93 69.8 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.478 -0.764 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.95 -16.1 48.58 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -102.1 5.44 40.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.564 -0.71 . . . . 0.0 109.849 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 79.48 47.62 7.26 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.379 179.609 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 39.2 m-85 -126.93 122.19 33.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.57 -0.959 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.83 64.53 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.734 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -172.23 90.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.964 -1.085 . . . . 0.0 109.482 179.777 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.22 -179.86 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.805 -179.849 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' VAL . 9.1 mt-10 -137.52 -169.28 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.899 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -146.37 144.17 29.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.407 -179.065 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.26 -170.68 2.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.094 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 7.6 pt-20 -141.7 10.32 2.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 170.91 158.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.92 -1.113 . . . . 0.0 109.714 179.555 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -46.4 -44.29 15.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.46 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.24 -37.11 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.003 -1.292 . . . . 0.0 109.66 -179.555 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.2 t70 -71.58 -45.9 60.9 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.151 -0.968 . . . . 0.0 108.732 179.619 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.86 -62.49 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.7 -0.625 . . . . 0.0 109.541 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -44.47 -48.29 10.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -65.32 -37.93 88.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.15 -3.07 58.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.565 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -83.36 -30.85 27.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.874 -1.141 . . . . 0.0 109.017 -179.836 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -62.37 -0.33 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.48 -61.16 1.8 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.536 -0.728 . . . . 0.0 109.738 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.18 21.74 0.12 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.96 108.07 1.11 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -179.713 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.643 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.2 m-85 -92.66 101.98 14.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.327 -1.102 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.17 -10.41 5.21 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -156.97 141.21 16.47 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.074 -1.25 . . . . 0.0 111.079 -179.311 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.763 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.3 t -134.24 105.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.393 -0.817 . . . . 0.0 110.209 179.273 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.9 69.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.97 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -101.33 148.68 24.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.258 -0.901 . . . . 0.0 109.161 -179.271 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 3.5 p30 -113.0 170.78 7.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.554 0.692 . . . . 0.0 109.989 -179.411 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 57' ' ' ASP . 1.5 t-105 -46.46 172.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 109.406 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.02 124.42 13.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.578 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -77.9 -39.25 1.82 Allowed Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.446 -0.784 . . . . 0.0 111.845 -179.842 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.4 Cg_exo -64.68 125.05 14.15 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 120.985 1.123 . . . . 0.0 110.763 -178.86 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 63' ' ' MET . 9.7 p30 42.72 -155.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.362 0.601 . . . . 0.0 110.19 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.516 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.87 155.42 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.753 -179.724 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 10.9 p-10 -97.33 -164.04 1.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 0.0 109.657 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.66 2.53 53.67 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.25 -55.74 8.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.309 . . . . 0.0 109.087 179.93 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.32 -15.55 0.65 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.065 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.579 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -74.92 -62.77 1.43 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -43.92 -63.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.291 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -47.33 -43.54 22.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.7 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 m -70.86 -24.86 62.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 109.298 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.591 HD13 HG21 ' A' ' 83' ' ' VAL . 48.0 mt -80.15 -9.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 108.777 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -86.93 -41.56 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 109.581 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.9 49.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -179.806 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -47.76 109.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.23 31.48 4.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.793 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 46.55 58.63 4.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 mmt -90.14 -62.84 1.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.19 30.59 1.44 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 109.193 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.62 -28.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 110.066 -179.577 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.9 tp -48.27 112.1 2.11 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 108.535 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.22 107.76 0.44 Allowed 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 120.988 1.126 . . . . 0.0 112.962 -178.505 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.763 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.1 t -108.85 119.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.654 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.35 102.49 14.27 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.131 -1.427 . . . . 0.0 108.015 178.195 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 110.4 15.16 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.791 -179.154 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.37 140.58 20.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.299 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -150.13 133.86 16.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.593 -1.317 . . . . 0.0 110.242 179.598 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.43 -59.24 2.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 108.985 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.33 67.21 3.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.04 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -73.78 109.35 7.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.813 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -91.37 133.13 35.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 108.93 179.604 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.22 -23.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 109.694 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.96 -50.93 5.74 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.497 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -64.91 -33.33 75.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 110.328 -179.115 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.833 HD11 ' HB1' ' A' ' 90' ' ' ALA . 68.2 mt -56.67 -20.95 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.005 -1.059 . . . . 0.0 109.342 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.426 HD13 ' N ' ' A' ' 96' ' ' ILE . 4.9 mm -87.64 -16.09 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -67.4 -46.73 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.403 -179.945 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.6 -55.21 21.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.859 -1.151 . . . . 0.0 108.5 179.223 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.21 -30.87 70.69 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.272 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -53.99 -33.91 58.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.706 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -81.32 -25.25 36.58 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 176.747 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.63 74.02 0.65 Allowed Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.949 177.312 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.85 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.06 -111.95 0.08 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 117.184 -1.807 . . . . 0.0 109.36 178.592 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 51.7 m -91.79 -53.24 4.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 123.616 1.674 . . . . 0.0 107.483 175.344 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.6 37.99 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -177.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.92 153.46 51.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.509 -0.995 . . . . 0.0 110.353 179.865 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.636 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.2 p -145.46 150.19 15.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.325 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.54 -170.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.26 179.193 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.73 156.67 25.03 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.81 133.1 29.79 Favored 'Cis proline' 0 C--N 1.32 -0.972 0 C-N-CA 124.423 -1.074 . . . . 0.0 109.682 -2.691 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -89.92 162.8 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 -179.98 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.32 145.58 25.47 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 177.079 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.57 -22.58 0.78 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.765 -1.209 . . . . 0.0 109.227 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.33 53.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.372 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.9 m -70.9 -64.61 0.87 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.864 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -49.43 -36.17 21.52 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.21 -1.396 . . . . 0.0 108.921 179.575 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -57.18 -62.48 1.73 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.931 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 3.6 tm-20 -42.09 -42.6 2.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.794 -0.566 . . . . 0.0 109.877 -179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -74.1 -33.12 63.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.983 179.555 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -65.85 -65.52 0.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.803 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -45.5 -53.61 8.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 109.949 -179.6 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.95 -24.85 62.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 0.0 109.971 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 10.7 mt -84.32 -47.35 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.021 -1.049 . . . . 0.0 110.119 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.04 2.7 0.7 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.937 -1.102 . . . . 0.0 109.914 -179.202 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.2 tt0 -74.74 -34.89 62.61 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.136 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -82.72 -35.11 26.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.495 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.5 tt -65.25 -27.36 68.6 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.931 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.11 80.85 0.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.017 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.373 -1.075 . . . . 0.0 109.444 179.724 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 59.61 122.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.394 -0.816 . . . . 0.0 109.415 -179.722 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 8.1 mttt -89.85 12.49 17.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.892 -1.13 . . . . 0.0 109.679 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.48 45.29 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 -179.732 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 21.2 tp -80.13 124.83 29.12 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.448 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' NZ ' ' OD1' ' A' ' 32' ' ' ASN . 34.6 mttp -73.91 122.97 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.0 111.858 -177.469 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 49.2 m-85 -113.7 147.88 37.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.434 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.584 HD13 ' CE2' ' A' ' 51' ' ' TYR . 50.7 tp -114.89 126.41 54.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.543 177.951 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.65 102.78 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.622 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.947 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -97.18 24.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' OD2' ' OD1' ' A' ' 57' ' ' ASP . 2.1 m-20 -72.34 145.86 47.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.534 -179.995 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -103.97 9.96 36.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.56 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 109.577 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.87 4.06 9.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.679 -0.638 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -161.79 9.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpp -82.87 -43.44 16.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.31 -0.869 . . . . 0.0 109.267 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.54 -35.38 70.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.429 179.977 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -27.86 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.55 -46.41 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.521 -179.839 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -31.84 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.276 -179.101 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.445 HH21 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.55 -57.41 9.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.431 179.853 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -64.72 -54.88 24.56 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.034 0.921 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -42.02 -58.99 1.89 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.552 -179.835 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.34 -47.66 83.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.014 -1.053 . . . . 0.0 108.849 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -52.1 -34.18 42.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 50.9 tt0 -48.61 -39.86 25.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.94 -66.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.98 30.19 0.02 OUTLIER Glycine 0 N--CA 1.482 1.751 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.53 148.35 22.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.305 . . . . 0.0 109.977 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.17 62.02 1.24 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.148 -0.97 . . . . 0.0 109.79 -179.879 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -175.81 104.43 0.08 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.764 -1.21 . . . . 0.0 109.662 179.956 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HB ' HH21 ' A' ' 22' ' ' ARG . 93.9 t -144.47 149.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -0.884 . . . . 0.0 109.629 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 21.2 mp0 -124.85 -172.23 2.53 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.671 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -150.06 151.07 32.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.793 -1.192 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.947 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.54 -178.15 5.75 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.06 19.36 1.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.028 -1.045 . . . . 0.0 110.554 -179.62 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 176.5 154.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.827 -1.17 . . . . 0.0 108.788 179.66 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.4 -55.85 15.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.453 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.9 t -50.44 -24.62 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.1 t0 -85.18 -42.4 14.76 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.77 85.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.008 -1.058 . . . . 0.0 109.355 -179.856 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -65.53 -55.3 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.617 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -57.12 -33.59 67.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.993 -1.067 . . . . 0.0 110.237 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.79 -8.05 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.709 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -78.4 -37.26 44.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.593 -1.317 . . . . 0.0 109.25 -179.701 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -7.43 0.69 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 108.967 179.647 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.24 -67.45 0.28 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.422 -0.798 . . . . 0.0 109.801 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.24 -94.98 0.24 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.696 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.7 78.03 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.584 ' CE2' HD13 ' A' ' 9' ' ' LEU . 13.6 m-30 -59.62 86.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.329 -1.101 . . . . 0.0 109.915 179.663 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -62.18 -1.61 3.27 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.331 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -154.22 144.73 22.28 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.474 -1.016 . . . . 0.0 109.818 -178.692 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.0 t -142.51 119.99 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 0.0 110.389 -179.914 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.59 127.66 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' SD ' ' A' ' 85' ' ' MET . 13.3 p -149.22 146.59 27.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.998 -1.064 . . . . 0.0 109.873 -179.34 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' OD2' ' A' ' 12' ' ' ASP . 2.3 m-20 -71.59 163.36 27.89 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.242 -0.911 . . . . 0.0 108.81 179.406 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.82 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.519 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.9 OUTLIER -172.75 171.85 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.016 -1.052 . . . . 0.0 110.027 -179.926 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.1 tpp 178.21 -46.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.495 179.014 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.2 Cg_endo -71.65 93.03 0.68 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.035 1.157 . . . . 0.0 109.524 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 41.91 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 0.0 109.845 179.999 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.2 tpp 47.6 -116.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.066 . . . . 0.0 109.062 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.76 -175.23 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 179.596 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.561 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 94.51 -72.08 1.11 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -47.52 63.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.998 -1.295 . . . . 0.0 107.854 178.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 15.7 mp0 -65.51 -22.63 66.74 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -64.65 -55.02 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.25 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 72' ' ' ILE . 2.0 mt -58.16 -67.09 0.38 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.21 0.528 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -37.55 -46.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.86 -0.525 . . . . 0.0 110.35 -179.56 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.2 m -57.64 -41.87 82.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.124 179.71 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -60.9 -30.07 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -76.98 -55.92 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.592 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.12 4.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 135.62 55.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . -87.3 161.19 32.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.835 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 76.35 -7.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.451 -1.029 . . . . 0.0 109.683 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.4 mmm -109.89 -19.13 13.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.857 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.6 m 51.83 -108.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.06 56.16 0.95 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 51' ' ' TYR . 73.6 mt -43.06 148.68 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.684 -0.635 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.42 143.31 94.46 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.475 1.45 . . . . 0.0 111.804 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -134.26 119.85 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.676 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.8 tp -103.8 75.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.55 178.309 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -48.89 169.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.894 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.12 122.57 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.494 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.5 t -140.54 -169.03 2.69 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.613 -179.549 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -140.99 16.43 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.925 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -138.59 -61.74 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.068 -179.688 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 1.049 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.48 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.48 31.85 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.966 -179.449 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ILE . 35.1 mtpt 54.49 -82.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 179.397 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.09 -25.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.337 -179.252 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 92' ' ' LYS . 22.0 t-20 -85.01 -31.49 23.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.0 109.857 -179.675 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.049 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.4 mt -67.19 -15.27 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 110.142 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.25 -64.51 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.86 -179.798 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.79 -31.34 2.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.913 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -69.31 -55.05 11.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.03 -42.66 60.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 -179.342 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -51.39 -26.8 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.97 -179.896 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.09 -113.43 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.423 179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.03 -1.17 6.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.414 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.583 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -56.32 11.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.154 -0.615 . . . . 0.0 110.831 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.48 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.275 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.43 130.62 10.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.391 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.85 115.16 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 108.866 179.112 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -114.26 121.89 67.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.617 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -76.51 96.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.835 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -59.44 160.87 11.86 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 0.0 109.141 -179.21 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.2 165.55 85.56 Favored 'Cis proline' 0 N--CA 1.485 0.988 0 O-C-N 122.86 0.926 . . . . 0.0 110.483 -2.257 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -146.03 159.36 43.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.121 -0.987 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.19 147.15 25.42 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.958 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.453 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -44.72 -28.26 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.625 -179.168 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.37 83.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.495 178.936 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -64.14 -64.6 0.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.962 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.6 tp -45.49 -43.51 11.71 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.058 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -61.98 -52.48 63.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.664 -1.272 . . . . 0.0 110.064 -179.882 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 117' ' ' GLU . 1.1 tp10 -43.59 -64.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.736 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -46.05 -46.41 16.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -45.56 -44.07 12.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -62.44 -42.91 99.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.375 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -58.86 -32.5 69.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.492 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.03 -34.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.248 -0.907 . . . . 0.0 109.907 -179.423 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -86.23 1.31 51.28 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 110.646 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -77.1 -28.47 54.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -94.81 -22.26 18.17 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -87.97 -29.05 21.07 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.22 86.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.475 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.296 -1.12 . . . . 0.0 109.53 -179.954 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.352 0.596 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 66.39 142.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.227 -0.921 . . . . 0.0 109.887 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 mmmm -90.3 19.57 5.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 0.0 109.413 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.53 49.45 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.952 -1.092 . . . . 0.0 109.635 -179.321 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 60.5 tp -60.24 111.0 1.37 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 0.0 108.934 179.885 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -43.91 105.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.894 -1.129 . . . . 0.0 111.144 -178.835 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 56.8 m-85 -102.33 154.77 18.74 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.793 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 tp -132.09 103.41 6.25 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.59 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -90.55 113.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.093 -178.983 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.5 t -103.04 69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.583 -0.698 . . . . 0.0 110.025 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -114.58 131.0 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -77.5 -5.63 50.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.664 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -80.83 143.76 32.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.944 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.08 12.36 24.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -31.25 1.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.437 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 8.1 ttt -55.81 -32.19 63.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.267 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.523 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -69.25 -43.51 73.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 -179.979 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -59.18 -25.25 63.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.16 -49.24 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.766 -179.67 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -30.74 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.589 -178.788 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -51.38 60.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.939 -1.101 . . . . 0.0 108.694 179.456 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.44 -60.51 2.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.842 0.83 . . . . 0.0 109.546 179.85 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 116' ' ' LEU . 1.7 tt -45.03 -35.99 3.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.715 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -74.22 -51.84 14.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 108.25 178.577 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -52.68 -33.82 49.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.45 -0.781 . . . . 0.0 108.968 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -49.24 -39.15 29.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.348 -0.845 . . . . 0.0 108.783 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 -64.98 0.98 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.422 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 160.06 41.43 0.02 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.765 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -113.8 134.6 54.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.61 -0.935 . . . . 0.0 109.184 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 65.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.946 -1.096 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -174.21 93.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.816 -1.178 . . . . 0.0 109.079 179.717 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.93 -179.73 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.036 -1.04 . . . . 0.0 110.653 -179.271 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.9 mt-10 -137.9 -171.39 3.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.516 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' CD ' HH11 ' A' ' 18' ' ' ARG . 58.3 mt-10 -140.13 154.2 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.038 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.962 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.03 -167.26 2.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -139.87 -10.68 1.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 0.0 111.004 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -174.57 -166.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.013 -1.054 . . . . 0.0 109.761 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.42 -42.81 32.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.1 t -55.46 -41.23 61.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.919 -1.342 . . . . 0.0 108.121 179.16 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.42 -54.48 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 109.291 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.42 -62.65 1.71 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.229 -0.92 . . . . 0.0 109.411 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.9 tp -41.73 -43.08 2.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.684 -0.635 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -74.36 -37.32 63.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -90.09 0.71 57.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -78.09 -40.56 37.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.051 -1.031 . . . . 0.0 109.029 179.955 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.98 -4.37 3.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -72.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.482 -0.761 . . . . 0.0 109.549 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.31 5.26 2.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.853 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.42 78.44 1.03 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.455 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.9 m-85 -57.51 114.75 2.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -1.034 . . . . 0.0 110.094 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.3 -7.61 2.04 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.437 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -160.75 137.23 8.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.732 -178.552 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.8 122.33 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.731 . . . . 0.0 109.847 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.44 151.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -167.64 162.58 14.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.007 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.38 -168.18 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 108.978 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 59' ' ' ASN . 13.7 t-105 -128.6 111.82 13.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.434 -0.791 . . . . 0.0 109.564 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 12.3 t-20 52.76 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.751 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.473 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 177.38 -50.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 179.578 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.12 -54.93 0.54 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 120.832 1.021 . . . . 0.0 109.891 -179.873 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.97 -41.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.298 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -132.38 -179.83 5.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.43 151.66 32.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.606 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -79.3 -20.14 70.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -48.23 -29.04 3.4 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -1.196 . . . . 0.0 108.334 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 71' ' ' THR . 1.5 tp10 -83.15 -29.79 28.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 109.348 179.443 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -57.59 -35.02 69.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 108.707 179.719 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -86.74 -61.93 1.62 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 108.667 179.09 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -43.09 -26.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.914 -179.289 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 67' ' ' GLU . 5.2 p -72.82 -39.45 66.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.054 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . 81.2 mt -63.6 -45.27 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -61.07 -29.2 69.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 109.64 -179.85 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.91 -28.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.568 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.9 -153.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.07 -12.77 0.1 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.25 -27.97 19.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -1.183 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.1 mtm -92.56 -11.24 34.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t 52.32 -111.32 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.1 58.61 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 80' ' ' ALA . 10.5 mt -38.01 153.77 0.13 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 122.042 -0.412 . . . . 0.0 110.086 -179.303 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.26 140.36 94.04 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.566 1.51 . . . . 0.0 111.481 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 69' ' ' LEU . 2.9 t -133.32 130.44 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.56 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD21 HD21 ' A' ' 116' ' ' LEU . 55.1 tp -113.36 75.95 0.95 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.102 0.953 . . . . 0.0 108.543 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtt -51.24 172.24 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -145.75 125.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 109.273 -179.464 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 109' ' ' LYS . 15.2 t -150.06 178.11 9.26 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.026 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.61 -42.93 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.34 69.92 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.5 -0.75 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -65.37 107.83 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.927 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' CG ' ' N ' ' A' ' 92' ' ' LYS . 6.6 ttpt -73.52 -110.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 -179.778 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 31.5 ttpt -160.2 -75.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.351 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.5 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.758 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -89.32 -64.0 1.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 -179.766 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.6 mp -47.99 -39.32 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 97' ' ' ALA . 31.5 mt -68.57 -65.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.03 -53.0 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.434 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.97 -44.34 91.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.55 -0.718 . . . . 0.0 109.917 179.986 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.78 -47.51 51.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.707 -1.246 . . . . 0.0 109.333 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -58.97 -23.64 61.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.816 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.21 -103.66 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.718 -179.733 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -129.91 -6.88 3.9 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' H ' HD13 ' A' ' 69' ' ' LEU . . . -57.52 11.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.889 -0.771 . . . . 0.0 110.102 178.176 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.695 ' H ' ' C ' ' A' ' 102' ' ' GLY . 61.4 m -29.27 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.725 -176.339 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -115.94 129.9 8.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.97 110.18 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 108.39 179.385 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.9 p -110.68 123.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 109' ' ' LYS . 2.5 t -58.27 -178.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.798 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.9 pttt -155.61 157.95 31.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.32 -1.488 . . . . 0.0 109.194 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.85 164.51 87.3 Favored 'Cis proline' 0 N--CA 1.484 0.929 0 C-N-CA 124.706 -0.956 . . . . 0.0 110.298 -2.254 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.87 159.32 35.25 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.774 0.797 . . . . 0.0 109.938 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.21 145.45 24.49 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.149 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -47.08 -20.49 0.16 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.949 -1.095 . . . . 0.0 109.54 -178.746 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.57 -36.03 26.6 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.327 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.4 m -69.91 -59.86 2.66 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.792 HD12 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -49.09 -46.57 44.85 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.155 178.802 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -55.7 -50.78 69.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 110.308 -179.563 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 5.1 tt0 -51.41 -68.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -45.56 -35.27 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.091 -1.006 . . . . 0.0 110.208 -179.407 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.28 -65.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.041 . . . . 0.0 110.014 -179.548 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -45.43 -28.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.433 -179.356 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -69.16 -47.76 64.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.962 -1.086 . . . . 0.0 109.765 -179.549 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.53 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.6 mt -69.56 -38.19 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.958 -179.61 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -70.08 -4.77 22.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 110.723 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.04 -22.18 56.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.644 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -96.28 -24.37 16.24 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -86.08 -32.74 21.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.397 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 43.79 84.18 0.02 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.207 -1.172 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -45.88 135.36 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.522 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -90.54 16.17 9.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.668 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.28 47.27 2.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 108.785 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 22.3 tp -90.02 119.02 30.02 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.37 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -61.82 120.45 10.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.92 . . . . 0.0 110.986 -178.457 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 76.9 m-85 -110.81 152.03 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.889 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 tp -124.62 104.01 8.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.815 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' VAL . 27.9 m -93.57 107.68 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.973 -1.079 . . . . 0.0 110.013 -179.328 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 49.1 t -90.27 -96.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.915 -1.115 . . . . 0.0 109.564 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 52.91 -161.85 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.032 -1.042 . . . . 0.0 109.598 179.72 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.81 9.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -54.37 -21.07 8.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.651 -179.897 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER 72.26 -8.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.124 -179.743 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 14' ' ' PHE . 1.3 t -136.0 -10.33 2.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.629 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.412 ' C ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -69.58 -50.56 43.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 108.715 179.431 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -41.94 -41.54 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.338 0.59 . . . . 0.0 109.98 179.706 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -63.72 -45.11 91.43 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.049 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.95 -51.63 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.341 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.63 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -0.974 . . . . 0.0 110.53 -178.879 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -55.16 6.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t-20 -67.79 -58.26 4.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.1 -62.25 0.86 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.857 -179.698 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 15.1 mt -54.0 -42.16 68.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.228 -0.92 . . . . 0.0 109.519 179.543 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -62.16 -38.44 89.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -60.0 -33.74 72.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.634 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mt -76.12 -50.19 15.31 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 4' ' ' LYS . . . 148.38 54.2 0.02 OUTLIER Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.341 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -144.34 133.81 23.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.214 . . . . 0.0 110.04 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -145.37 55.47 1.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.354 179.947 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -162.18 98.02 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.03 152.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.112 -0.993 . . . . 0.0 110.428 -178.776 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.12 -170.87 1.76 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.754 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.91 151.01 32.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.991 -178.712 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.33 -171.39 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.185 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.93 10.9 1.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.133 -0.98 . . . . 0.0 110.032 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 169.03 163.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.804 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -55.27 -37.53 65.3 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.938 -179.38 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG23 ' OD2' ' A' ' 38' ' ' ASP . 61.2 t -54.83 -37.46 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.822 -1.399 . . . . 0.0 107.922 179.112 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.647 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 22.0 t0 -80.75 -55.45 4.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.598 -0.689 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.92 -54.1 33.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 109.281 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 43' ' ' LEU . 5.0 tt -52.68 -58.4 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -0.857 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -56.58 -34.63 67.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.934 -178.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -90.03 -17.58 27.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.891 -1.131 . . . . 0.0 110.815 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -59.93 -28.29 67.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 0.0 109.046 -179.779 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 7.4 tt0 -72.64 2.6 6.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.18 179.695 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.61 -75.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.421 -0.799 . . . . 0.0 109.634 -179.878 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.49 -35.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.47 67.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' PHE . 70.4 m-85 -49.54 100.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.35 -6.44 0.99 Allowed Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.5 t80 -161.03 144.82 13.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -1.073 . . . . 0.0 109.805 -178.414 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HB ' HG22 ' A' ' 83' ' ' VAL . 65.7 t -136.65 120.94 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.962 -1.086 . . . . 0.0 110.032 -179.782 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.32 97.67 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.568 -0.707 . . . . 0.0 109.107 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 p -99.4 -177.07 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 12.7 t70 -140.39 50.67 1.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 109.686 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 47.32 77.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.217 -179.935 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -48.35 141.23 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.695 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -100.64 -36.67 0.23 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 111.802 -179.972 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.45 122.73 10.49 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.849 1.033 . . . . 0.0 110.715 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 m-80 48.16 53.98 10.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.845 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mtp 53.48 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 54.34 178.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.5 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.11 -46.62 2.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.175 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.6 -69.28 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.288 . . . . 0.0 108.027 178.79 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.75 -22.11 13.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.23 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.11 -53.17 57.67 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.93 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 83' ' ' VAL . 43.9 mt -57.97 -65.72 0.59 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.077 0.942 . . . . 0.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -41.63 -36.5 0.96 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.78 -179.85 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -41.95 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 108.551 179.768 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.12 -39.75 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.063 -1.023 . . . . 0.0 108.254 178.898 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -23.8 67.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.294 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.36 51.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.626 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -45.74 -36.07 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 109.633 -179.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.04 32.91 85.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.1 -54.79 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.01 -67.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m 57.24 4.33 0.2 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.333 -0.854 . . . . 0.0 109.274 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -106.37 -12.24 15.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.635 -0.665 . . . . 0.0 109.651 -179.762 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.2 mt -45.18 107.78 0.69 Allowed Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.97 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.26 150.12 89.45 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.079 1.186 . . . . 0.0 112.899 -178.039 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 69' ' ' LEU . 2.5 t -136.39 126.87 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.044 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -113.83 72.95 0.8 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.512 179.059 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' LEU . 9.7 mtt -46.39 170.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.328 0.585 . . . . 0.0 109.504 -179.245 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.15 125.07 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.22 -179.312 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 148.82 29.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.645 -1.284 . . . . 0.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 -42.33 8.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -96.32 50.72 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 1.003 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -61.14 101.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 109.437 -179.973 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -68.33 -110.62 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 94' ' ' ASN . 3.1 ttmt -162.39 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -19.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 109.565 -179.95 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -90.06 -37.65 14.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.003 HD11 ' HB1' ' A' ' 90' ' ' ALA . 77.2 mt -63.54 -16.21 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.44 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.577 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.82 -38.81 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -54.54 -57.72 10.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.474 179.555 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.11 64.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -57.62 -17.39 14.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.703 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.69 -107.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.603 -0.685 . . . . 0.0 109.905 -179.664 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.62 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.86 -1.55 8.12 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.38 11.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.032 -0.687 . . . . 0.0 111.512 179.239 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.62 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.25 -31.44 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.119 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -116.84 135.08 11.71 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.661 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -151.23 114.15 4.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -1.152 . . . . 0.0 109.312 179.062 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.91 140.1 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.202 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.3 p -88.31 100.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.554 179.391 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.0 155.25 64.69 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.989 . . . . 0.0 109.531 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.58 167.75 79.39 Favored 'Cis proline' 0 N--CA 1.488 1.205 0 O-C-N 122.649 0.815 . . . . 0.0 111.068 -2.295 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.1 p90 -146.52 156.91 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.865 0.84 . . . . 0.0 109.829 178.73 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.09 146.17 23.85 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.053 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.5 -22.76 0.79 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.775 -1.203 . . . . 0.0 109.301 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.24 39.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.434 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 112' ' ' THR . 7.0 m -72.63 -61.72 1.7 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.779 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.67 -38.65 47.76 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.213 179.11 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.25 -48.16 76.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.61 -43.88 8.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.665 -179.577 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -66.57 -50.78 61.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -25.76 9.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.05 -22.96 36.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -80.61 -25.11 38.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 109.393 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.94 -34.81 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.667 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -80.2 -1.61 41.25 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 -178.533 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -76.94 -21.14 55.27 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.609 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.45 -26.88 14.31 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.474 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -79.83 -26.4 40.47 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.24 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.97 88.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.638 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.328 -1.101 . . . . 0.0 109.514 -179.783 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.4 0.619 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' ALA . 1.9 m-20 61.65 127.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.737 179.83 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -90.18 19.57 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 0.0 108.756 179.425 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -144.89 45.62 1.36 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.564 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 20.7 tp -78.49 117.77 20.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 108.442 -179.92 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -63.72 121.2 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 111.842 -177.737 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.636 ' HB2' HG22 ' A' ' 33' ' ' VAL . 96.0 m-85 -115.19 142.85 46.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 46' ' ' LEU . 43.5 tp -116.82 117.99 31.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.123 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 1.2 m -105.57 112.61 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 109.665 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.948 HG22 ' HB3' ' A' ' 36' ' ' ALA . 26.6 t -105.85 115.86 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.625 ' N ' ' NH2' ' A' ' 18' ' ' ARG . 13.4 t70 -149.89 -137.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.89 -20.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CD1' HG22 ' A' ' 16' ' ' THR . 0.1 OUTLIER -68.08 126.8 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.95 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.8 p -81.62 41.43 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.517 -179.933 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.449 HG22 ' CD1' ' A' ' 14' ' ' PHE . 7.4 t -166.05 -29.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.8 ttp -57.96 -47.79 81.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.625 ' NH2' ' N ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -46.58 -29.1 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.716 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -67.72 -34.9 77.78 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -61.25 -55.89 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -39.18 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 -179.079 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -46.89 -55.38 8.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -65.11 -56.12 14.77 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.859 0.838 . . . . 0.0 109.311 -179.968 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -38.84 -60.36 0.85 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.991 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.3 -46.5 86.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 109.114 179.428 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -32.7 65.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.326 -0.859 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.25 61.4 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.851 -1.156 . . . . 0.0 109.069 -179.53 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' CD1' ' OE1' ' A' ' 117' ' ' GLU . 3.3 tp -80.1 -66.56 0.86 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 109.188 179.533 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.73 0.02 OUTLIER Glycine 0 N--CA 1.482 1.719 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -101.85 153.14 20.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -1.18 . . . . 0.0 108.997 179.731 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.07 58.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.967 -1.083 . . . . 0.0 110.737 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.5 100.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.849 -1.157 . . . . 0.0 109.872 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 8' ' ' PHE . 93.2 t -139.42 150.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.34 -0.85 . . . . 0.0 109.919 -179.611 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -122.01 -173.25 2.62 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.687 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 18' ' ' ARG . 26.6 mt-10 -142.75 155.35 44.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.273 -0.892 . . . . 0.0 110.94 -178.345 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.948 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.6 -172.59 4.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' OE1' ' OD2' ' A' ' 41' ' ' ASP . 1.4 pm0 -143.46 2.57 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.103 -0.998 . . . . 0.0 110.652 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -168.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.781 -1.199 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -74.04 -47.05 19.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.203 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 4.1 p -52.22 -35.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.644 -1.504 . . . . 0.0 107.941 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t0 -80.32 -45.86 17.11 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.482 -0.762 . . . . 0.0 109.728 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -70.32 -57.66 4.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.899 -1.125 . . . . 0.0 108.872 179.649 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.712 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.9 tm? -44.78 -52.04 8.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 0.0 108.979 179.713 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 77.7 m-20 -65.07 -38.77 91.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.695 179.925 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -86.26 5.83 32.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 110.245 -179.436 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -90.15 -56.0 3.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 108.927 179.621 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.47 2.91 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 108.734 179.306 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.82 -65.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.817 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 4.84 2.64 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 79.34 1.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' O ' HD13 ' A' ' 81' ' ' LEU . 19.7 m-85 -66.59 108.72 2.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.5 -1.0 . . . . 0.0 109.954 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.86 -6.85 2.99 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.556 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' N ' ' C ' ' A' ' 51' ' ' TYR . 1.8 t80 -163.02 146.77 11.01 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.169 -1.195 . . . . 0.0 109.876 -178.601 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 46' ' ' LEU . 93.2 t -143.74 126.85 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.2 mt -110.01 134.98 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.348 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.9 p -146.94 137.41 23.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.642 -179.889 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.3 m-20 -71.83 -151.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 -179.979 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.595 ' CH2' HD23 ' A' ' 66' ' ' LEU . 52.9 t-105 -101.9 -177.98 3.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.546 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.07 90.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.874 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -95.98 -46.8 0.25 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.956 -179.895 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.5 -54.9 0.51 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.14 1.227 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' ASP . 5.7 p30 -173.03 -148.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.651 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -61.86 78.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 108.724 179.39 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ASN . 49.1 m-20 -154.82 -157.97 0.8 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.885 . . . . 0.0 109.441 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.725 ' H ' HD13 ' A' ' 68' ' ' LEU . . . 68.88 -72.78 0.38 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -66.42 -43.3 86.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.89 -1.359 . . . . 0.0 107.364 178.557 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.6 -27.58 67.82 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.406 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.725 HD13 ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -66.23 -60.69 2.55 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.618 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -55.97 -63.91 1.03 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.338 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' LEU . 13.7 ttmm -44.32 -39.43 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.523 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 m -68.82 -41.08 79.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.816 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 69' ' ' LEU . 61.1 mt -56.22 -23.83 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -27.47 19.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.479 -0.763 . . . . 0.0 109.183 179.803 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.22 -29.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.701 -179.825 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -172.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -58.77 -165.77 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.653 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.96 19.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . 3.9 tpt -89.94 -28.76 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.009 179.627 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 45.89 -125.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.538 -0.727 . . . . 0.0 109.172 179.937 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' C ' HD12 ' A' ' 81' ' ' LEU . . . -150.12 54.1 0.92 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER 44.0 -166.42 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.575 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.7 Cg_exo -61.63 151.21 81.74 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.966 1.381 . . . . 0.0 114.508 -176.336 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.58 138.42 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.769 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 55' ' ' ILE . 48.5 tp -117.1 78.46 1.22 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.403 ' N ' ' O ' ' A' ' 105' ' ' GLY . 18.0 ttp -61.9 159.54 13.83 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.337 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.547 HG23 HG13 ' A' ' 107' ' ' VAL . 7.5 p -150.19 142.33 17.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.806 -1.184 . . . . 0.0 109.953 -178.742 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 t -149.98 174.94 12.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.874 -179.973 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.7 -39.95 5.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.679 -0.638 . . . . 0.0 109.361 179.655 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.9 tt0 -81.77 -60.81 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.622 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 51.32 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 179.97 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.0 ttmt -94.44 125.42 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.985 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -45.53 -24.77 0.36 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.633 -179.574 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -85.31 -31.19 23.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.7 m-80 -89.95 -15.09 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.784 -179.794 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 95' ' ' ILE . 84.5 mt -75.84 -0.69 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.0 -58.24 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.762 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.04 -52.18 12.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -49.28 -54.06 18.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.722 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.59 -38.11 63.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.073 -1.017 . . . . 0.0 110.037 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -59.68 -17.55 35.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.831 -179.688 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 -106.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.609 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.57 1.46 5.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -54.79 11.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.148 0.579 . . . . 0.0 111.385 179.001 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 102' ' ' GLY . 54.2 m -29.29 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.92 -0.487 . . . . 0.0 111.991 -176.55 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -114.86 123.68 6.08 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.237 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.456 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -138.29 114.6 10.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.363 -1.08 . . . . 0.0 109.883 179.441 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.7 p -114.89 138.65 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.351 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' H ' HG12 ' A' ' 108' ' ' VAL . 1.2 p -85.96 103.36 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.889 -1.132 . . . . 0.0 109.315 -179.582 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.5 pttt -63.28 159.16 51.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.943 -1.098 . . . . 0.0 109.199 -179.691 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.36 156.87 99.47 Favored 'Cis proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.693 -0.961 . . . . 0.0 110.103 -2.446 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.8 p90 -136.42 156.25 48.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.14 151.82 21.37 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.067 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.36 -18.15 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.691 -1.204 . . . . 0.0 108.909 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -72.42 -44.8 61.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.644 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -63.35 1.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.57 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 107' ' ' VAL . 2.7 tp -47.77 -35.68 10.37 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.29 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' CD1' ' A' ' 28' ' ' LEU . 23.0 tt0 -72.28 -60.12 2.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.642 -1.286 . . . . 0.0 110.725 -179.248 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -40.8 -35.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.67 -0.644 . . . . 0.0 110.774 -178.738 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -79.26 -54.28 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.996 -1.065 . . . . 0.0 109.982 -179.556 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -47.33 -44.33 23.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.824 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -53.67 -45.68 70.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.188 -179.427 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -62.51 -50.66 70.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.36 -34.74 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.815 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 -1.38 57.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.797 -179.051 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.26 -26.89 35.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.19 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -95.97 -21.28 18.12 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.4 OUTLIER -88.31 -34.97 17.48 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.429 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 42.63 77.89 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.469 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.118 -1.225 . . . . 0.0 109.492 -179.918 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.05 144.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.989 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -90.12 11.36 21.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.086 -1.009 . . . . 0.0 109.803 -179.815 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -146.25 48.12 1.21 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.532 -179.736 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.15 126.06 29.15 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.475 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.76 118.19 12.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.08 -1.013 . . . . 0.0 111.534 -177.367 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.81 149.96 26.01 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.687 ' HB3' HG22 ' A' ' 54' ' ' VAL . 18.4 tp -125.57 104.95 8.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.984 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.86 104.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.578 -179.096 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 36' ' ' ALA . 24.0 t -89.93 115.0 28.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 -179.929 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -174.35 -166.85 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.025 -1.047 . . . . 0.0 109.882 -179.206 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.7 9.68 0.47 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.337 -0.852 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -51.04 -35.66 35.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.732 -1.23 . . . . 0.0 108.536 179.781 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 72.5 31.67 1.71 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.871 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 t -177.23 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.47 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.43 ' CB ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -73.88 -35.71 64.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.493 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.72 -50.23 13.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.044 178.587 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -66.13 -26.84 67.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.353 -177.392 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -69.32 -54.31 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.019 179.649 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.0 -40.29 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 -179.414 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 18' ' ' ARG . 1.2 mtm180 -49.72 -52.18 33.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.441 179.347 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -59.05 -59.07 6.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.266 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 5.5 tt -42.71 -30.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.84 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.1 mt -84.6 -33.12 23.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.941 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' ASN . 5.8 tttp -69.94 -35.36 74.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.427 -0.796 . . . . 0.0 108.905 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.26 -35.63 60.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.273 -0.892 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.597 HD21 ' OE1' ' A' ' 117' ' ' GLU . 3.5 mp -80.44 -55.45 4.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.73 62.94 0.01 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.628 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 96.9 m-85 -150.12 141.84 23.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.909 -1.348 . . . . 0.0 109.757 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -150.15 66.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.042 -1.036 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -175.54 102.37 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.592 -1.317 . . . . 0.0 110.213 179.519 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.46 178.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 179.611 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.7 mt-10 -140.55 -167.11 2.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.367 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.52 149.52 32.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 111.1 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.57 -168.28 2.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.039 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.79 7.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.692 -179.449 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 15.7 t0 -176.46 151.4 0.96 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.052 -1.03 . . . . 0.0 109.674 179.881 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.578 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -52.54 -29.02 30.78 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.489 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.4 t -72.43 -38.61 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -1.183 . . . . 0.0 108.898 179.637 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -70.96 -43.82 67.31 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -65.52 -60.19 3.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.302 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.6 tp -45.38 -33.62 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.537 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.37 -38.98 23.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -86.26 -1.29 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.901 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -70.2 -10.74 59.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.235 -179.947 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -7.5 21.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.505 -0.747 . . . . 0.0 109.257 179.671 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.87 -55.01 7.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 109.573 -179.801 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.99 6.31 2.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 89.61 0.12 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.852 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.606 ' O ' HD11 ' A' ' 81' ' ' LEU . 44.0 m-85 -76.09 153.34 36.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.225 -1.162 . . . . 0.0 110.024 -179.606 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.98 5.94 39.9 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.301 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -165.7 141.64 5.15 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.627 -0.925 . . . . 0.0 108.89 -179.569 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 9' ' ' LEU . 46.0 t -137.93 109.43 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -0.837 . . . . 0.0 109.478 179.345 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.6 90.78 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 164.74 12.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.95 . . . . 0.0 109.142 -179.931 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.0 t0 -91.45 -95.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 110.189 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.555 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 55.7 t-105 -166.39 -123.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.975 . . . . 0.0 109.372 -179.266 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.433 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 21.2 t-20 -103.22 51.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.605 -0.684 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -92.74 -48.62 0.3 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 179.959 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.79 -71.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.006 1.138 . . . . 0.0 109.96 -179.581 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 63' ' ' MET . 4.2 p30 -153.71 -62.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.0 109.001 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.476 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 ttp -88.34 176.62 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.58 142.16 35.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 0.0 109.458 179.927 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.42 13.54 1.54 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -76.07 -58.15 3.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.038 -1.272 . . . . 0.0 108.264 179.25 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -13.16 26.25 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.772 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.578 HD13 ' CA ' ' A' ' 39' ' ' GLY . 56.7 tp -77.03 -43.62 33.88 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.834 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -81.32 -28.69 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.988 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -66.42 -41.05 89.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.332 -0.855 . . . . 0.0 108.9 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -71.34 -39.66 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.541 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.96 -30.3 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.12 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -90.15 -31.05 17.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.39 -0.819 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -29.89 3.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.16 151.04 38.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.22 16.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.98 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.64 -29.85 16.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -1.134 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 80' ' ' ALA . 15.8 mtt -89.97 6.23 43.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.371 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -73.77 34.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.804 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.61 21.73 3.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 109.27 -179.998 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -111.65 98.32 40.54 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.697 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.39 118.61 5.52 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.614 1.542 . . . . 0.0 114.03 -178.87 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -105.38 118.61 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 176.063 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.814 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -98.32 109.3 22.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.21 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.17 103.0 12.25 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.52 146.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.904 -1.122 . . . . 0.0 109.368 179.658 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.07 155.91 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.07 -50.29 6.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.141 179.579 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 91' ' ' LYS . 50.7 mt-10 -93.36 58.84 2.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 109.079 179.634 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -53.86 86.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.713 -179.724 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 89' ' ' GLU . 20.1 tttm -71.35 139.36 49.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.055 -1.028 . . . . 0.0 108.961 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 91' ' ' LYS . 1.4 tppp? -42.08 -28.2 0.17 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.99 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' LYS . 13.3 tp10 -88.32 -29.39 20.37 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.225 -0.922 . . . . 0.0 109.9 -179.937 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 2.6 t30 -68.86 -28.8 67.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.095 -1.003 . . . . 0.0 110.29 -179.423 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.813 HD11 ' HB1' ' A' ' 90' ' ' ALA . 2.2 mp -68.1 -58.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.728 -1.233 . . . . 0.0 108.711 179.503 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' GLN . 82.2 mt -63.63 -19.79 24.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.363 -0.836 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.14 -71.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.114 179.658 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.668 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -50.76 -44.75 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.968 -1.082 . . . . 0.0 108.169 179.059 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -66.22 -24.38 66.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.572 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 96' ' ' ILE . 6.8 tt0 -52.84 -30.99 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.879 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.41 -21.79 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.439 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 66.58 77.06 0.31 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.391 178.048 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.834 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -111.8 0.08 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 117.223 -1.791 . . . . 0.0 109.634 178.924 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.814 ' OG ' HD22 ' A' ' 84' ' ' LEU . 2.2 p -91.68 -50.3 5.83 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.997 1.379 . . . . 0.0 108.1 176.045 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.437 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 166.36 -163.6 37.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.373 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.506 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -143.52 124.7 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.547 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -72.57 115.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -87.64 161.42 45.03 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 108.665 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.68 131.03 21.98 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 124.798 -0.917 . . . . 0.0 110.432 -2.041 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.0 p90 -101.31 153.8 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.051 0.929 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.46 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -89.94 149.44 22.59 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.0 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.546 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.83 -24.25 1.37 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.834 -1.166 . . . . 0.0 109.513 -178.776 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.45 -34.48 60.95 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.561 178.962 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.91 -61.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.545 179.069 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.73 -36.9 38.68 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.178 -1.409 . . . . 0.0 108.295 179.127 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.597 ' OE1' HD21 ' A' ' 28' ' ' LEU . 7.2 tp10 -65.74 -56.95 9.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.025 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 117' ' ' GLU . 2.8 mt-10 -42.39 -34.37 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 109.997 -179.456 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -90.04 -25.86 20.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.284 179.833 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 117' ' ' GLU . 3.3 tp -66.74 -66.96 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.924 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -44.39 -50.44 9.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.56 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -61.14 -27.13 68.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 109.994 -179.627 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 120' ' ' LEU . 12.3 mt -81.39 -45.72 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.98 . . . . 0.0 109.926 -179.725 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.93 -6.34 8.18 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 -179.264 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.49 -29.31 68.71 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.227 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.52 -34.59 19.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.3 tt -72.2 -27.13 62.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.372 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.56 81.58 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.515 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.446 179.751 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -46.16 145.17 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.982 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 40.5 tttt -90.44 9.64 28.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.0 109.41 179.398 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.65 46.75 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.047 . . . . 0.0 110.356 -178.993 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.3 tp -78.29 112.34 15.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.528 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.01 123.34 17.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.927 -1.108 . . . . 0.0 111.98 -176.838 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 73.4 m-85 -109.45 152.04 25.9 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.942 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 54' ' ' VAL . 31.0 tp -121.89 106.14 10.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.283 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.82 105.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.423 -178.012 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.9 t -104.72 103.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.577 -0.702 . . . . 0.0 109.86 -179.936 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -149.06 148.64 29.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 9.1 t70 -85.08 -15.68 43.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -46.84 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.906 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.05 10.04 13.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 109.633 -179.71 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -155.52 -21.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.542 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' NZ ' ' A' ' 109' ' ' LYS . 13.8 tpt -48.89 -47.71 42.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.648 ' NH2' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.69 -37.14 17.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 -179.841 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -73.9 -30.72 62.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.784 -1.166 . . . . 0.0 109.769 -178.352 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.8 mt -67.62 -55.32 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.885 . . . . 0.0 109.338 -179.895 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.9 -32.34 47.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.86 -179.235 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.648 HH11 ' NH2' ' A' ' 18' ' ' ARG . 3.8 mtt180 -48.47 -52.31 22.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 108.949 179.475 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LYS . 1.4 t30 -66.15 -58.78 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.794 0.807 . . . . 0.0 109.28 179.901 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -42.18 -37.31 1.42 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.648 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.41 -42.94 58.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.75 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ASN . 23.1 tttm -61.12 -33.11 72.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.393 -0.817 . . . . 0.0 108.824 179.212 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.39 -50.34 65.32 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 179.654 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -49.69 59.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.98 74.66 0.04 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.551 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 56.4 m-85 -150.2 152.25 34.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.931 -1.335 . . . . 0.0 109.095 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.22 30.51 0.69 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 111.518 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.69 108.69 4.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.639 -1.288 . . . . 0.0 111.04 -179.255 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -150.06 179.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.04 . . . . 0.0 109.909 178.722 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.6 mt-10 -137.57 -168.02 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.87 150.38 31.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.984 -1.073 . . . . 0.0 111.167 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -136.82 -164.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.37 -6.63 5.3 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.67 . . . . 0.0 110.765 -179.528 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.96 179.8 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.728 -1.232 . . . . 0.0 109.948 179.873 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASN . . . -55.28 -57.56 17.91 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.772 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.7 p -51.99 -35.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.0 108.958 179.94 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.7 t0 -69.86 -41.89 74.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.73 -40.39 88.36 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.6 -35.46 77.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.911 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -71.84 -34.5 69.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -89.97 -26.49 20.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.434 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -54.72 -31.76 58.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.085 -1.009 . . . . 0.0 108.836 -179.776 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 1.6 mt-30 -52.88 -22.18 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.503 -0.748 . . . . 0.0 109.309 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -45.59 -59.43 2.74 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.829 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.7 52.8 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.307 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -148.62 -44.98 0.03 OUTLIER Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 53' ' ' PHE . 6.9 m-85 -49.7 92.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.367 -1.078 . . . . 0.0 110.636 -179.555 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -76.32 15.74 5.35 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 177.321 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -168.24 152.47 6.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.288 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.2 t -145.51 107.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.59 89.22 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.5 p -105.13 160.47 15.04 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -178.682 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.6 p-10 -73.13 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.221 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.3 t-105 -149.52 -6.46 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 108.79 179.035 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 4.7 m-80 43.4 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 110.959 178.468 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.48 20.87 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.884 178.76 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -59.09 -65.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 178.79 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.5 m-80 -151.94 -136.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.408 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.65 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.964 -1.085 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 9.4 m-20 -160.72 -167.77 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 -179.566 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.66 -79.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.32 -69.03 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -1.221 . . . . 0.0 109.327 -179.937 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.4 tt0 -61.32 -9.59 5.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.787 . . . . 0.0 109.744 -179.707 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tp -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 109.972 -179.491 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -79.16 -26.77 42.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.34 -179.687 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -59.93 -59.91 4.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.688 179.501 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -56.14 -31.44 63.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.151 -0.968 . . . . 0.0 109.877 -179.649 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -72.4 -21.74 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -31.49 17.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 75' ' ' ASP . . . -71.29 -60.43 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.208 179.812 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 79' ' ' SER . 6.1 p-10 39.94 -141.54 0.05 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.426 0.631 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' N ' ' OD2' ' A' ' 75' ' ' ASP . . . -159.84 -16.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.927 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.82 -7.26 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -1.107 . . . . 0.0 109.492 179.946 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -96.87 -72.43 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.579 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 11.2 t 44.72 45.26 8.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.579 -0.701 . . . . 0.0 109.831 179.824 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.09 -50.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.02 -1.05 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 80' ' ' ALA . 7.2 mt -27.41 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.455 -0.153 . . . . 0.0 111.112 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.477 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 6.3 Cg_exo -62.7 127.89 21.86 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.188 1.925 . . . . 0.0 114.02 -178.845 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -109.05 113.19 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 175.9 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.23 106.75 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.352 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.7 tpp -82.1 103.23 11.57 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.245 -178.004 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -98.85 148.31 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.854 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 160.06 43.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.37 129.0 35.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.864 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 49.56 74.76 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 179.962 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.27 120.19 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.278 179.684 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -68.89 -77.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.943 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -173.06 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.468 -179.763 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.1 mm-40 -69.5 -35.0 75.11 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -53.48 -35.11 60.23 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.12 -0.988 . . . . 0.0 109.69 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.802 HD11 ' HB1' ' A' ' 90' ' ' ALA . 63.9 mt -66.25 -55.15 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.994 -1.066 . . . . 0.0 108.591 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 100' ' ' GLN . 83.6 mt -69.28 -14.74 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.482 -0.761 . . . . 0.0 109.017 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' GLU . . . -67.72 -54.18 21.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 -179.997 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.579 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -68.61 -46.23 69.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.014 -1.054 . . . . 0.0 108.197 178.885 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -64.44 -27.34 68.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.726 -179.323 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HG2' HG22 ' A' ' 96' ' ' ILE . 2.7 mm-40 -52.08 -32.64 35.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.803 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.75 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.548 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 77.09 0.41 Allowed Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.627 177.874 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -88.79 -111.66 0.07 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 117.411 -1.716 . . . . 0.0 108.941 178.64 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 49.6 m -91.49 -49.75 6.15 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.905 1.336 . . . . 0.0 108.283 175.998 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.57 -162.89 33.74 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.071 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 150.07 42.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.127 -1.22 . . . . 0.0 109.75 179.461 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.69 126.06 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.274 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.92 113.25 10.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.138 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.589 ' NZ ' ' SD ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -87.35 162.53 42.6 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.579 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.4 123.36 8.49 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.836 -0.902 . . . . 0.0 110.478 -2.178 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -92.92 156.26 17.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.876 179.847 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.515 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.69 147.36 23.32 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.519 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.11 -25.5 0.88 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.053 . . . . 0.0 108.909 -179.414 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.92 78.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.728 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.87 -66.41 0.57 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.924 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tp -49.58 -36.08 22.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.506 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 4.5 tt0 -57.58 -62.41 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.031 -1.043 . . . . 0.0 110.227 -179.59 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' GLU . 34.9 mt-10 -46.09 -61.08 1.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 -179.51 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -50.97 -28.0 8.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.832 . . . . 0.0 109.691 179.832 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.489 HD13 ' CD1' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -65.85 -67.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.17 -0.956 . . . . 0.0 109.302 179.83 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.39 -28.46 66.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.003 -1.061 . . . . 0.0 110.506 -179.416 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -77.16 -23.79 51.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.966 -1.084 . . . . 0.0 109.84 -179.693 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.05 -42.38 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.506 -179.4 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 120' ' ' LEU . 11.8 m-85 -65.48 -14.89 61.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.087 -1.008 . . . . 0.0 110.104 -178.508 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -30.89 70.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.316 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -85.04 -26.49 27.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.541 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.5 -19.31 60.96 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.394 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.468 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 71.17 60.71 4.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.738 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.405 -179.705 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.26 150.45 0.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.997 -179.552 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.2 12.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.344 179.739 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -150.6 52.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.164 -179.665 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 50.5 tp -74.05 107.96 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.012 -1.055 . . . . 0.0 108.617 -179.879 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -49.73 106.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 111.458 -178.193 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 70.0 m-85 -99.53 153.84 18.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.268 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.585 ' HB3' HG13 ' A' ' 54' ' ' VAL . 30.9 tp -128.62 107.51 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.106 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.95 115.55 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 -179.813 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 36' ' ' ALA . 2.5 t -98.69 110.44 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 -179.144 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.455 ' CB ' ' HE ' ' A' ' 18' ' ' ARG . 37.7 t0 -166.28 168.47 15.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.028 -1.045 . . . . 0.0 109.758 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -103.06 -28.9 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.654 -0.654 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.3 138.5 55.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.974 . . . . 0.0 109.289 179.851 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.63 -33.48 11.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -75.94 -21.57 56.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.945 -179.634 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 ttm -73.72 -57.37 4.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.034 -1.041 . . . . 0.0 108.842 179.354 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.693 HH21 ' N ' ' A' ' 11' ' ' VAL . 19.2 mmt180 -58.67 -8.2 1.22 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.52 -178.708 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -76.73 -38.38 54.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 108.534 178.725 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -61.86 -55.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.76 -40.2 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.53 -179.185 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mtm180 -45.3 -53.45 8.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 -179.377 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -62.79 -56.77 14.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.328 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 tt -37.98 -58.16 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.94 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -53.52 -51.11 63.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.117 179.692 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.05 -40.11 73.03 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.135 -0.978 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.02 -41.33 62.15 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.272 -0.893 . . . . 0.0 109.217 -179.983 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 113' ' ' ALA . 15.3 mt -73.39 -61.76 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.511 -0.743 . . . . 0.0 109.073 179.77 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.22 68.66 0.01 OUTLIER Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.865 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.23 145.82 26.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.128 -1.219 . . . . 0.0 109.307 179.744 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -150.01 68.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -176.78 99.55 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 0.0 108.653 179.788 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.16 150.82 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 110.562 -178.988 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.31 -169.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.323 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -141.46 161.98 36.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.405 -0.809 . . . . 0.0 110.808 -178.771 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -144.4 -167.93 2.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.242 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.91 -2.24 4.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.465 -0.772 . . . . 0.0 110.666 -179.413 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.43 -171.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.204 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.625 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -69.24 -37.27 80.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.974 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 18.8 m -65.8 -42.3 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 0.0 109.16 179.952 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 40' ' ' VAL . 44.8 t0 -67.15 -50.53 60.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 108.464 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.89 -55.93 28.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.735 -0.603 . . . . 0.0 109.916 179.979 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.3 tm? -46.22 -53.82 9.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.94 . . . . 0.0 108.936 179.934 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 70.6 m-80 -61.27 -41.77 97.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.16 -12.25 59.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.106 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -66.71 -4.48 9.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 108.526 -179.908 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 27.3 tt0 -97.26 -4.56 38.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.768 . . . . 0.0 109.266 179.729 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.4 -72.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.524 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.12 9.5 1.3 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.962 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.0 87.27 1.08 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.7 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 53' ' ' PHE . 62.6 m-85 -66.8 109.62 2.96 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 -5.61 0.59 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.668 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.04 145.02 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 110.292 -178.842 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 83' ' ' VAL . 11.6 t -138.78 115.11 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.137 -0.977 . . . . 0.0 110.225 179.632 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.246 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 145.61 29.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -0.807 . . . . 0.0 109.638 -179.351 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.7 p30 -67.54 -112.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.589 -179.998 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 62.3 t-105 -169.9 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.779 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.462 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 15.5 m-80 -83.36 121.26 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.462 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.27 -50.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 110.129 179.617 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.58 -64.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 120.89 1.06 . . . . 0.0 109.888 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -150.94 -76.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.26 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -88.34 0.22 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.367 179.713 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 178.99 150.7 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.731 179.836 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.16 17.39 1.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 66' ' ' LEU . 4.4 tt -78.4 -56.6 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.847 -1.384 . . . . 0.0 108.203 179.287 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.51 -9.76 0.54 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.565 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD13 ' CA ' ' A' ' 39' ' ' GLY . 15.7 tp -81.91 -57.38 3.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -66.91 -34.91 78.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.603 -179.642 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -66.97 -59.07 3.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.146 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.9 m -54.84 -37.0 65.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.072 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt -57.44 -38.58 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.506 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -66.21 -7.55 18.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.909 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -71.81 -27.55 63.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.785 -179.907 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -51.36 -178.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 109.653 -179.746 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.09 -146.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.13 -12.49 60.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttp -90.04 -2.53 58.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ASP . 14.6 m 47.28 -120.03 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -0.894 . . . . 0.0 108.895 -179.741 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.08 56.9 0.96 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.251 178.955 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 80' ' ' ALA . 11.0 mt 57.53 155.39 0.08 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.648 -0.657 . . . . 0.0 110.035 178.112 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.47 140.39 54.15 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.314 2.009 . . . . 0.0 114.959 -177.166 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -129.32 116.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.134 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -103.06 108.51 19.72 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.523 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.62 138.52 57.51 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.671 -178.484 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 107' ' ' VAL . 2.0 t -116.35 139.92 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.675 -0.64 . . . . 0.0 110.168 -178.915 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -149.96 165.96 31.08 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.747 179.532 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . -100.19 128.63 46.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.667 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 91' ' ' LYS . 33.6 tt0 50.58 94.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.033 -179.598 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 95' ' ' ILE . . . -44.78 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.736 -179.683 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' CB ' HD21 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -76.57 16.81 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.474 -179.832 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 22.2 tttt 69.74 -70.28 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 94' ' ' ASN . 12.4 tm-20 -49.82 -49.32 49.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.179 -0.95 . . . . 0.0 110.176 -179.475 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.549 HD21 ' CB ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -65.14 -66.79 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.21 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.777 HD12 ' CE2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -45.54 -42.76 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.247 -0.908 . . . . 0.0 109.901 -179.16 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.19 -31.08 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.953 -1.092 . . . . 0.0 109.624 -179.782 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.41 85.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.655 -179.718 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.58 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -69.2 -53.69 18.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 108.366 179.39 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.61 -26.35 61.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.327 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -53.32 -32.44 48.97 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.45 -23.38 26.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.202 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.34 75.38 0.51 Allowed Glycine 0 N--CA 1.481 1.693 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.802 177.663 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.786 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -85.52 -111.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 117.107 -1.837 . . . . 0.0 108.911 178.541 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 34.9 m -91.49 -46.68 7.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.473 1.13 . . . . 0.0 107.995 175.697 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.426 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 171.3 -159.73 31.64 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.732 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.777 ' CE2' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.23 131.67 30.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.829 -0.806 . . . . 0.0 108.997 179.175 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.901 HG21 HD12 ' A' ' 116' ' ' LEU . 11.9 p -127.65 120.95 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.658 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 89' ' ' GLU . 2.0 p -70.32 157.92 6.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 108.964 -179.485 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -131.63 160.41 67.55 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.885 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.57 126.32 11.94 Favored 'Cis proline' 0 C--N 1.32 -0.93 0 C-N-CA 124.716 -0.951 . . . . 0.0 110.429 -2.06 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' CE1' HD22 ' A' ' 116' ' ' LEU . 4.9 p90 -91.4 159.91 15.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.828 179.932 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.38 149.86 20.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.991 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -49.96 -35.04 22.74 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.773 -1.204 . . . . 0.0 108.815 -179.53 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.93 -31.73 71.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.781 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.5 m -72.61 -68.13 0.5 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.729 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.901 HD12 HG21 ' A' ' 107' ' ' VAL . 3.6 tp -47.57 -36.72 11.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.62 -1.3 . . . . 0.0 109.253 178.861 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -62.31 -64.56 0.89 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.846 -1.159 . . . . 0.0 109.126 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -45.27 -51.0 11.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.629 -0.669 . . . . 0.0 109.738 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.739 ' NZ ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -55.5 -54.34 45.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.464 -179.836 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 120' ' ' LEU . 26.9 mt -55.97 -44.9 78.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.563 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -47.76 -69.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 109.977 -179.273 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -49.06 -27.44 3.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.317 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.34 -40.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.947 -1.096 . . . . 0.0 110.577 -179.208 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -74.28 -22.71 59.18 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.139 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -62.29 -20.43 64.29 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.692 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -97.51 -27.7 14.31 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.888 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.79 -13.07 49.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.264 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.21 71.94 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -159.72 147.32 16.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.1 8.48 32.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.989 -1.07 . . . . 0.0 109.972 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -155.62 52.74 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 0.0 109.844 -179.678 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 tp -77.21 131.04 38.03 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.881 -1.137 . . . . 0.0 107.943 179.471 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -67.48 110.7 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.107 . . . . 0.0 111.708 -177.388 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 81.7 m-85 -105.4 148.01 27.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.3 tp -124.72 105.08 9.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -91.4 111.24 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 109.998 -179.142 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.2 t -113.91 106.91 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 40.0 t0 -172.35 117.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.161 -0.962 . . . . 0.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.01 135.39 20.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.722 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -171.23 -153.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.478 -1.389 . . . . 0.0 112.121 -177.263 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.722 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -177.11 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.36 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.524 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -164.95 -59.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.516 0.674 . . . . 0.0 110.27 -177.868 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.4 ttt -35.62 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.034 -0.416 . . . . 0.0 111.296 179.596 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 34.5 mtm180 -46.2 -27.08 0.9 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.699 -1.251 . . . . 0.0 109.782 -178.615 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' THR . 4.0 ttp180 -78.54 -32.64 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.815 -1.178 . . . . 0.0 108.985 178.967 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 mt -66.94 -54.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 108.992 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -56.08 -40.37 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -180.0 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -43.58 -53.7 5.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.479 -0.763 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -63.0 -57.12 11.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.901 0.858 . . . . 0.0 108.783 179.168 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -37.76 -57.74 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.714 179.964 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.83 -52.43 65.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.076 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -48.39 -30.6 5.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.77 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -48.22 -41.36 27.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.233 -0.917 . . . . 0.0 108.9 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -75.03 -65.31 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.116 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.69 22.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 68.9 m-85 -89.99 145.72 24.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.75 -1.441 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -150.14 59.54 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.074 -1.016 . . . . 0.0 110.42 179.718 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -174.38 104.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.228 . . . . 0.0 110.295 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -146.47 179.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.149 -0.97 . . . . 0.0 109.762 179.423 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.5 mm-40 -139.21 -169.76 2.73 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.627 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.0 145.88 26.68 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.858 -179.068 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.873 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.98 -171.01 3.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.814 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 2.0 mp0 -132.38 -2.05 3.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.251 -0.905 . . . . 0.0 110.495 -179.197 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.82 -177.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.229 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -67.23 -36.29 89.59 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 41' ' ' ASP . 7.6 p -62.89 -45.68 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -1.202 . . . . 0.0 109.436 -179.935 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.0 t0 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.401 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -71.87 -22.93 61.44 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.414 179.956 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.659 -1.276 . . . . 0.0 108.294 179.205 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -72.92 -27.52 61.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.676 -0.64 . . . . 0.0 110.04 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.75 -37.87 14.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.959 . . . . 0.0 110.777 -178.868 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -49.96 -23.5 2.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.714 -1.241 . . . . 0.0 109.552 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 5.6 tp60 -96.89 -13.57 22.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -40.85 -62.08 0.86 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 -179.594 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.62 3.75 2.39 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.88 76.8 1.15 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.74 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.722 ' O ' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -57.68 131.49 50.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 110.131 -179.392 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.33 3.75 83.65 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.037 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -168.15 146.32 4.37 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.101 -1.235 . . . . 0.0 110.264 -179.149 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.7 t -143.93 121.38 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.067 -1.021 . . . . 0.0 109.895 179.389 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.477 ' CG2' HG21 ' A' ' 86' ' ' VAL . 44.5 mt -106.61 103.92 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.611 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.9 p -114.51 161.07 18.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.388 -0.82 . . . . 0.0 110.318 -178.599 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 17.1 p-10 -89.38 -110.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.541 -0.724 . . . . 0.0 109.2 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 77.3 t-105 -141.37 177.78 7.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 179.702 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.869 ' H ' HD21 ' A' ' 59' ' ' ASN . 0.0 OUTLIER -76.7 75.24 3.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.758 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtm -86.13 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.927 -1.108 . . . . 0.0 110.378 179.677 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.1 -55.2 0.41 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 C-N-CA 120.898 1.065 . . . . 0.0 109.747 179.932 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -172.49 -162.3 0.19 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.437 -0.789 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -47.55 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -164.91 137.08 4.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.565 -179.563 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 103.27 -50.53 0.89 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.699 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 tp -85.78 -46.6 10.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.564 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.403 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.0 mm-40 -63.31 -20.03 65.13 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.581 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 65' ' ' GLY . 3.7 mt -68.52 -61.77 1.68 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.684 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.929 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -45.81 -64.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.984 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.91 -49.74 4.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.2 -179.438 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -64.19 -32.91 74.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.793 HD13 HG21 ' A' ' 83' ' ' VAL . 46.4 mt -74.82 -31.18 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.174 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -20.0 23.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.43 -30.07 4.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.357 -179.836 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.76 100.12 0.38 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.372 -0.83 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.74 46.41 2.32 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.791 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.32 -28.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -1.168 . . . . 0.0 109.292 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -96.98 -70.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.453 179.946 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 16.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.159 -179.799 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -104.89 -39.27 6.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.583 -0.698 . . . . 0.0 109.736 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.41 97.14 0.1 Allowed Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.629 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.88 102.49 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.652 0 C-N-CA 121.169 1.246 . . . . 0.0 112.064 -178.767 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 72' ' ' ILE . 2.5 t -107.67 116.24 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 177.364 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.42 106.66 17.24 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.58 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 98' ' ' ALA . 7.4 ttm -67.23 160.42 27.03 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.039 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 55' ' ' ILE . 18.6 t -137.49 144.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.29 -0.881 . . . . 0.0 110.183 -178.967 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -150.18 158.68 44.41 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.88 -82.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.115 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -77.51 68.88 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.933 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.759 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -42.83 123.67 2.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 110.646 -178.896 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.93 112.72 25.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.117 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -43.82 -25.97 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.468 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.87 -38.01 33.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.193 -0.942 . . . . 0.0 110.326 -179.447 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -90.06 -9.71 47.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.099 -1.001 . . . . 0.0 110.43 -179.299 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.3 mp -74.23 -27.05 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.972 -1.08 . . . . 0.0 108.55 -179.816 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 96' ' ' ILE . 13.0 mt -87.05 -8.59 11.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 108.909 179.591 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.37 -52.89 10.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.471 -0.768 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB2' ' SD ' ' A' ' 85' ' ' MET . . . -64.82 -48.59 73.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.905 -1.122 . . . . 0.0 108.026 178.867 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -63.71 -31.7 72.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.89 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 5.6 tt0 -59.25 -32.6 70.14 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.932 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.929 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.2 -24.08 47.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 176.091 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.88 74.01 0.49 Allowed Glycine 0 N--CA 1.481 1.657 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.387 176.243 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.22 -112.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 116.984 -1.887 . . . . 0.0 109.606 177.818 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.4 m -91.96 -50.91 5.46 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 123.009 1.385 . . . . 0.0 107.645 174.983 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 169.04 -164.17 37.83 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.391 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -133.47 121.79 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.123 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -113.46 123.53 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.446 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.801 HG22 ' H ' ' A' ' 109' ' ' LYS . 12.5 p -64.44 -177.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.126 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.801 ' H ' HG22 ' A' ' 108' ' ' VAL . 1.2 pttt -154.62 158.76 32.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.595 -1.315 . . . . 0.0 108.602 179.848 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.41 136.81 45.98 Favored 'Cis proline' 0 C--N 1.317 -1.121 0 C-N-CA 124.54 -1.025 . . . . 0.0 110.446 -2.191 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.1 p90 -96.59 162.32 13.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.008 . . . . 0.0 109.179 178.997 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.79 144.94 24.8 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 177.132 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.1 -33.22 4.82 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.962 -1.086 . . . . 0.0 109.56 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -32.33 66.52 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.634 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' THR . 13.4 m -71.69 -64.42 0.93 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.966 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -48.96 -40.3 29.82 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.6 -1.313 . . . . 0.0 108.419 179.406 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.09 -57.67 11.81 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.858 -1.151 . . . . 0.0 109.833 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 121' ' ' ASN . 1.7 tt0 -44.59 -28.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.391 -179.685 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.18 -37.52 14.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 108.742 179.214 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.06 -55.48 14.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.628 -0.67 . . . . 0.0 109.868 -179.467 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.547 ' CG ' ' N ' ' A' ' 122' ' ' LYS . 3.1 p-10 -48.12 -54.23 13.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.166 -0.959 . . . . 0.0 109.96 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.547 ' N ' ' CG ' ' A' ' 121' ' ' ASN . 22.5 mttt -53.38 -38.11 63.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.43 -0.794 . . . . 0.0 110.236 -179.517 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.76 -41.5 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.461 -179.138 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -72.97 -6.97 48.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.957 -1.089 . . . . 0.0 110.589 -178.908 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.01 -19.42 60.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.746 -1.221 . . . . 0.0 107.774 178.654 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -97.63 -27.45 14.37 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.935 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -25.96 24.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.9 84.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.797 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.2 m-20 49.36 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 108.533 -179.486 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.585 ' CB ' ' NZ ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -63.13 11.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 0.0 110.498 -178.871 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 3' ' ' ASP . 10.7 mm-40 -139.03 40.49 2.12 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.835 . . . . 0.0 109.339 -179.908 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.0 tp -75.23 129.51 37.58 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 120.603 -1.31 . . . . 0.0 108.178 179.782 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -80.24 124.62 28.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.153 -0.967 . . . . 0.0 111.991 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -113.55 143.52 44.41 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.36 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG13 ' A' ' 54' ' ' VAL . 17.7 tp -112.42 110.2 20.27 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.136 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -92.74 106.74 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.742 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 11' ' ' VAL . 15.2 t -89.92 16.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.535 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 13.7 p30 -51.0 162.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.984 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -144.9 33.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.195 179.952 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' ' CB ' ' A' ' 15' ' ' SER . 51.2 t80 -83.02 -75.97 0.29 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER 165.61 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.811 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.62 -5.7 1.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.511 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.9 ttm -56.02 -38.15 70.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.516 -0.74 . . . . 0.0 109.324 179.756 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.537 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -62.3 -56.35 19.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.887 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.14 -28.89 42.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -178.781 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.9 mt -67.81 -57.8 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.127 -0.983 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.97 -32.43 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.981 -179.25 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.658 ' CA ' ' HE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.11 -55.17 10.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.972 . . . . 0.0 109.449 179.703 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -63.33 -58.14 8.08 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.802 0.81 . . . . 0.0 109.223 179.896 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.4 tt -39.41 -55.95 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.003 -179.55 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.2 -42.21 94.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.069 -1.019 . . . . 0.0 108.926 179.263 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -58.79 -40.69 84.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.818 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.87 -46.6 67.98 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 -179.714 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 117' ' ' GLU . 10.6 mp -66.11 -56.37 11.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.334 -0.854 . . . . 0.0 109.093 179.811 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.04 69.35 0.01 OUTLIER Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.951 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -150.11 130.82 14.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.328 . . . . 0.0 109.184 179.822 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.74 71.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.814 . . . . 0.0 109.971 -179.402 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.59 98.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 0.0 108.524 179.642 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.5 149.47 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.144 -0.973 . . . . 0.0 110.458 -178.544 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -121.75 -172.88 2.52 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.385 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CD ' HH11 ' A' ' 18' ' ' ARG . 39.8 mt-10 -141.71 155.44 45.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.919 0.866 . . . . 0.0 110.816 -178.608 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.05 -168.7 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.27 12.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 110.719 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' OD2' ' O ' ' A' ' 61' ' ' PRO . 14.0 t0 -175.32 154.17 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.66 -28.63 60.23 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 179.033 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -75.02 -37.33 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.627 -0.925 . . . . 0.0 108.825 179.165 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.68 -39.77 80.4 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.055 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -69.38 -46.49 66.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.53 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.03 -37.37 61.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.965 -179.693 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -76.07 -34.76 59.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.107 -179.412 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -90.02 -13.31 36.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.173 -179.419 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -61.32 -14.69 28.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 -179.971 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -93.89 -4.17 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.12 -65.93 0.47 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.546 -0.721 . . . . 0.0 109.637 -179.929 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.45 -92.2 0.26 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.906 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -162.6 67.16 0.24 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.824 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' PHE . 56.4 m-85 -47.02 98.56 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.546 -0.973 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -65.53 1.56 4.07 Favored Glycine 0 C--N 1.297 -1.599 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.402 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.12 150.57 11.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.397 -1.06 . . . . 0.0 109.21 -179.548 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 83' ' ' VAL . 44.2 t -143.72 118.83 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.767 -1.208 . . . . 0.0 109.993 179.285 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' CG2' HG21 ' A' ' 86' ' ' VAL . 55.5 mt -99.46 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.477 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 36.0 p -102.39 148.72 25.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.406 -0.809 . . . . 0.0 109.818 -179.134 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.91 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 109.06 179.678 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.432 ' C ' ' SD ' ' A' ' 60' ' ' MET . 65.9 t-105 -172.09 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.981 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.445 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.0 t-20 -97.25 98.23 9.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 109.742 -179.731 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.05 162.3 54.68 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.708 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' O ' ' OD2' ' A' ' 38' ' ' ASP . 3.2 Cg_exo -56.3 148.93 58.33 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.373 1.382 . . . . 0.0 110.134 179.362 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.447 ' ND2' ' N ' ' A' ' 62' ' ' ASN . 0.5 OUTLIER 65.99 -159.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.184 -179.73 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.94 156.71 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.8 173.05 12.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.99 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.81 -3.02 2.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.835 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 64' ' ' ASP . 17.3 tp -58.92 -52.5 65.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.18 . . . . 0.0 108.807 179.921 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.81 -4.14 1.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 108.948 179.638 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' CA ' ' A' ' 39' ' ' GLY . 11.0 tp -85.59 -64.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -63.69 -32.34 73.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.865 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -67.35 -60.51 2.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.913 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.9 m -51.41 -40.29 58.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.408 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -60.68 -29.27 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 108.66 179.271 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.51 -22.9 32.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.441 -0.787 . . . . 0.0 109.426 179.787 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.53 -26.79 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.947 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -73.75 -53.12 11.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.346 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.09 -21.29 4.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.894 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.52 -86.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.596 -179.85 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.3 mpp? -96.53 -25.63 15.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.687 -179.691 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.8 m 53.46 -128.48 2.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -139.44 44.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.451 -0.781 . . . . 0.0 109.3 179.927 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD22 ' HA2' ' A' ' 52' ' ' GLY . 0.3 OUTLIER 50.87 177.04 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.914 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.23 135.96 46.06 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 N-CA-C 116.499 1.692 . . . . 0.0 116.499 -175.551 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -124.33 115.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.856 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -102.47 105.88 16.51 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 117.919 -1.512 . . . . 0.0 107.309 177.996 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.477 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 2.0 tpt -66.09 156.22 34.54 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.089 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG21 ' CG2' ' A' ' 55' ' ' ILE . 29.0 t -135.48 141.06 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -0.816 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -150.09 176.31 10.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -95.33 -130.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -52.71 88.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -48.7 118.35 2.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.58 -179.695 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 13.6 tttt -94.86 6.9 47.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 4.3 ttpp 75.06 -62.39 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.406 -179.891 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.15 -34.45 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.707 -179.8 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -84.4 -45.06 13.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.964 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 106' ' ' TYR . 29.4 mm -48.57 -42.23 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 108.935 179.545 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.7 mt -71.35 -26.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.307 -0.871 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.17 -51.77 67.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.212 -0.93 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -75.55 -51.69 12.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -58.3 -27.99 64.6 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.324 -0.95 . . . . 0.0 108.935 -179.254 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.0 tt0 -56.16 -33.22 65.02 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 178.151 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -82.7 -22.13 34.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.014 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 61.66 76.93 0.22 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.825 177.579 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.829 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.29 -112.08 0.05 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 116.75 -1.98 . . . . 0.0 109.104 178.661 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.0 m -91.86 -51.29 5.29 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 123.096 1.427 . . . . 0.0 107.913 175.058 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.413 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.65 -157.36 28.41 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -178.116 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.79 127.17 16.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.566 -0.961 . . . . 0.0 109.297 179.294 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.01 140.31 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.838 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.22 153.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.788 -179.926 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.21 153.38 80.42 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.785 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.64 132.23 26.1 Favored 'Cis proline' 0 N--CA 1.49 1.27 0 O-C-N 122.328 0.646 . . . . 0.0 111.259 -1.615 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.5 p90 -98.96 162.38 13.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.386 -0.821 . . . . 0.0 109.164 178.79 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -94.97 146.45 24.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.997 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.71 -31.21 4.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 109.127 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.29 -33.48 67.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.664 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.2 m -71.94 -65.61 0.75 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.446 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 111' ' ' PHE . 8.7 tp -47.13 -41.01 16.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 0.0 109.2 178.741 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HB2' HD21 ' A' ' 28' ' ' LEU . 40.2 tt0 -64.31 -58.09 7.51 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 -179.634 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -44.22 -48.55 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.646 -0.659 . . . . 0.0 109.682 -179.703 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -65.75 -47.22 75.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.5 -39.77 70.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 109.634 -179.984 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -46.24 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.93 -179.645 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -71.35 -19.58 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.638 -179.635 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.03 -40.44 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.902 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.0 m-85 -73.82 -33.81 64.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 -179.711 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -50.92 -27.89 8.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.05 -1.031 . . . . 0.0 108.413 179.543 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -90.64 -21.82 21.49 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.043 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 124' ' ' PHE . 13.1 tp -83.3 -20.71 33.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.371 -0.831 . . . . 0.0 108.866 179.431 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.25 76.14 0.14 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.623 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 62.76 134.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 108.962 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -90.04 17.44 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.982 -1.074 . . . . 0.0 109.78 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 42.88 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.938 -1.101 . . . . 0.0 110.593 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.41 141.91 57.77 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -78.13 131.36 37.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 0.0 111.104 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.646 ' HB2' HG22 ' A' ' 33' ' ' VAL . 83.2 m-85 -123.67 146.88 47.91 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.827 -0.545 . . . . 0.0 110.259 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.664 ' HB3' HG13 ' A' ' 54' ' ' VAL . 60.9 tp -121.78 116.18 24.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.688 -0.632 . . . . 0.0 109.368 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 109.22 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -106.25 26.02 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.713 -0.617 . . . . 0.0 109.672 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 117.66 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.61 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -64.83 -14.41 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.313 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.0 140.86 4.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.474 ' C ' HG22 ' A' ' 16' ' ' THR . 53.5 p -97.96 47.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.446 -0.784 . . . . 0.0 109.512 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.474 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER 178.23 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 tpt -61.13 -46.68 89.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.614 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -49.84 -31.69 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.912 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -74.01 -42.08 60.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.732 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.44 -52.73 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.755 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -40.48 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 110.234 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.94 -53.11 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -68.64 -57.74 5.26 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.769 0.795 . . . . 0.0 109.686 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -39.64 -56.53 1.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.663 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.36 -51.17 67.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.095 -1.003 . . . . 0.0 108.757 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -47.76 -40.41 20.63 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.249 -0.907 . . . . 0.0 108.983 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.12 -34.37 73.41 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.416 -0.803 . . . . 0.0 109.308 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 117' ' ' GLU . 1.6 mm? -81.09 4.32 20.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.55 62.53 1.78 Allowed Glycine 0 N--CA 1.482 1.748 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -143.58 126.85 16.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -1.184 . . . . 0.0 109.092 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -133.63 65.32 1.59 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.632 -0.668 . . . . 0.0 109.815 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -172.48 89.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -135.75 150.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.0 109.938 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -119.17 -177.12 3.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -150.09 155.22 39.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.863 -1.148 . . . . 0.0 110.81 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -146.6 -165.41 2.22 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 17.1 mt-10 -137.34 -5.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 0.0 110.359 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -177.23 -177.92 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.79 -1.193 . . . . 0.0 109.733 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.63 -52.24 47.57 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.55 -31.85 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.263 . . . . 0.0 108.513 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.8 t0 -74.63 -47.64 30.94 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.122 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -59.08 -48.06 82.98 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.2 -40.09 73.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.954 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 5.9 m-20 -81.56 -25.67 35.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -90.25 -23.88 21.1 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CD2' ' H ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -80.11 -17.27 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.53 -1.356 . . . . 0.0 110.21 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -61.58 -5.94 2.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -52.77 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.019 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.88 11.57 1.67 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.473 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.44 86.21 0.26 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.826 ' O ' HD11 ' A' ' 81' ' ' LEU . 25.2 m-85 -58.92 157.58 9.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.406 -1.056 . . . . 0.0 110.43 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.73 -9.42 62.72 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 140.47 19.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.676 -0.896 . . . . 0.0 109.133 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 9' ' ' LEU . 20.6 t -135.17 120.43 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.0 110.164 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.8 mt -104.08 128.51 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -146.38 147.02 30.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.066 -1.021 . . . . 0.0 109.672 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 58' ' ' TRP . 16.6 t70 -63.84 -120.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.402 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.417 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 61.9 t-105 -161.89 -28.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.782 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -166.64 34.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.633 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.2 -37.22 0.43 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -68.83 -70.65 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.846 1.031 . . . . 0.0 110.152 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.71 HD22 ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -154.81 -81.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.71 ' H ' HD22 ' A' ' 62' ' ' ASN . 3.4 mpp? -76.0 -113.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -142.14 -178.42 5.71 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . -93.79 -17.97 39.43 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.396 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.572 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 1.4 mm? -46.79 -68.98 0.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.687 -1.478 . . . . 0.0 110.042 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -43.57 -41.79 4.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.96 -42.9 99.96 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.706 HD21 ' H ' ' A' ' 102' ' ' GLY . 5.4 tt -82.59 -64.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.877 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -33.75 -41.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.23 0.538 . . . . 0.0 110.144 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.465 HG21 HD21 ' A' ' 43' ' ' LEU . 19.6 m -58.96 -48.03 82.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 108.728 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 57.8 mt -50.76 -45.14 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 108.88 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -65.41 -39.29 91.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.34 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 109.574 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.35 -128.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.361 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.621 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . 170.16 161.38 20.56 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 71.79 -14.14 0.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -1.12 . . . . 0.0 109.413 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 76' ' ' GLY . 2.3 mmt -146.82 17.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 m -68.78 7.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.351 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -93.92 2.7 56.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 109.645 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.826 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -43.86 107.59 0.61 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.543 -0.723 . . . . 0.0 109.397 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HD2' HD13 ' A' ' 81' ' ' LEU . 4.1 Cg_exo -62.58 136.5 58.92 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 120.76 0.973 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.2 t -130.27 129.27 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.617 ' CD2' HD21 ' A' ' 116' ' ' LEU . 38.4 tp -110.64 72.03 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.45 145.53 22.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 t -113.56 129.97 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.13 166.29 30.27 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.114 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -91.05 147.72 22.88 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 6.4 mt-10 49.33 -152.0 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.909 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 176.76 115.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.803 -1.186 . . . . 0.0 110.43 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.63 121.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -43.88 -45.24 7.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.299 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -51.89 -32.81 34.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.58 -41.52 13.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.909 HD11 ' HB1' ' A' ' 90' ' ' ALA . 9.2 mt -67.54 -13.07 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.037 -1.04 . . . . 0.0 109.573 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.2 mt -80.56 -70.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.082 . . . . 0.0 109.885 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.804 . . . . 0.0 109.0 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' A' ' 103' ' ' ALA . . . -70.35 -61.67 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.604 -0.685 . . . . 0.0 109.762 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -58.45 -34.63 71.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.222 -0.924 . . . . 0.0 109.699 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -50.91 -19.59 1.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 108.871 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -108.45 -115.03 0.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.83 -0.544 . . . . 0.0 109.603 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.731 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -120.67 -0.99 12.11 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' C ' ' A' ' 98' ' ' ALA . . . -59.18 11.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.903 . . . . 0.0 109.23 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.731 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.2 m -29.2 -31.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.32 133.55 11.72 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.572 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.55 110.64 6.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.7 p -112.58 130.79 65.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.459 HG22 ' OH ' ' A' ' 106' ' ' TYR . 0.5 OUTLIER -64.86 -157.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -174.1 152.54 1.88 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.059 -1.026 . . . . 0.0 109.268 179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.3 146.4 86.14 Favored 'Cis proline' 0 N--CA 1.487 1.111 0 O-C-N 122.576 0.777 . . . . 0.0 110.512 -2.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -112.97 155.04 25.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.936 0.874 . . . . 0.0 109.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.17 146.88 23.46 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -46.03 -29.66 1.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 0.0 109.387 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.14 -35.1 59.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 112' ' ' THR . 16.2 m -69.07 -60.88 2.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -45.83 -50.71 13.92 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.17 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' HG3' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -51.06 -32.48 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 115' ' ' THR . 4.5 tp10 -67.76 -43.9 78.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.84 . . . . 0.0 109.973 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -71.28 -51.33 25.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.975 . . . . 0.0 109.922 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tp -50.2 -59.59 3.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.127 -0.983 . . . . 0.0 109.856 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -52.74 -35.92 56.9 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -66.48 -24.58 66.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 105' ' ' GLY . 22.2 mt -88.83 -47.96 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.954 -1.091 . . . . 0.0 110.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -58.71 -12.4 4.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 110.339 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.09 -24.15 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.99 -29.09 16.8 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.35 -24.52 42.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.489 -0.757 . . . . 0.0 109.055 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.06 81.82 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.257 -1.143 . . . . 0.0 109.558 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.287 0.565 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.512 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.34 141.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -90.59 10.17 26.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.283 -0.886 . . . . 0.0 109.952 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.96 51.42 1.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 46.9 tp -84.17 107.81 16.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -48.5 112.83 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.02 . . . . 0.0 111.705 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 63.0 m-85 -102.6 153.98 19.57 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 46' ' ' LEU . 12.9 tp -131.17 105.61 7.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.344 -0.847 . . . . 0.0 108.884 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -93.71 108.7 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.073 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.914 HG22 ' HB3' ' A' ' 36' ' ' ALA . 62.4 t -96.0 40.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.824 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -70.6 144.58 51.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -97.53 0.51 47.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.69 143.49 27.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.557 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -85.35 34.27 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -165.33 -8.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -37.55 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 1.5 mpt_? -62.07 -16.08 49.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 108.967 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -75.07 -42.08 57.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -53.44 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.871 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.57 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 110.2 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.12 -54.71 8.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.761 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.71 -57.77 6.45 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.981 0.896 . . . . 0.0 109.315 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.27 -64.59 0.53 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.436 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.0 mt -50.1 -44.51 52.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 108.76 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -52.02 -48.01 64.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.356 -0.84 . . . . 0.0 109.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -23.47 63.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.478 -0.764 . . . . 0.0 109.291 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 117' ' ' GLU . 28.1 mt -89.51 3.58 51.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.1 59.41 2.43 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 52.8 m-85 -148.33 142.82 26.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.291 . . . . 0.0 109.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -150.1 27.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.178 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -135.0 99.43 4.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.196 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -146.3 179.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.149 -0.969 . . . . 0.0 109.599 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.1 mt-10 -138.7 -174.28 3.79 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.91 157.27 46.33 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.794 0.807 . . . . 0.0 110.826 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.914 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.97 -174.26 4.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.9 pt-20 -148.77 13.56 0.91 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.912 -1.118 . . . . 0.0 110.226 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 178.16 -179.9 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.954 -1.091 . . . . 0.0 109.131 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -71.28 -39.55 61.96 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.1 -30.9 46.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.125 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.601 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.2 t0 -81.18 -46.09 15.38 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.507 -0.745 . . . . 0.0 109.674 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.43 -42.33 92.57 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.75 -58.04 7.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.061 -1.024 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -54.75 -29.06 52.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 110.072 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -90.13 -31.02 17.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.126 -0.984 . . . . 0.0 110.622 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -53.93 -41.01 67.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.037 -1.039 . . . . 0.0 109.712 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.7 -11.77 59.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.903 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.81 -65.21 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.4 7.65 1.81 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.43 87.04 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.693 ' O ' HD21 ' A' ' 81' ' ' LEU . 61.3 m-85 -67.81 110.45 3.81 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.327 -1.102 . . . . 0.0 110.076 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 81' ' ' LEU . . . -54.65 -10.1 2.02 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.75 126.78 11.22 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.195 -1.179 . . . . 0.0 110.289 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 83' ' ' VAL . 95.9 t -122.92 120.24 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.9 mt -103.61 123.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -139.27 168.38 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.737 . . . . 0.0 109.095 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 9.8 t70 -84.47 -97.01 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 74.9 t-105 -172.4 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.506 ' N ' ' CD1' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -91.48 126.79 36.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.47 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.2 mtp 176.62 -50.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.0 Cg_exo -64.19 -168.87 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.815 1.01 . . . . 0.0 110.113 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.579 HD22 ' H ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -47.61 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 0.0 109.452 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.579 ' H ' HD22 ' A' ' 62' ' ' ASN . 21.6 mmt -69.76 -117.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.64 147.73 33.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.119 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.04 -8.6 3.27 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -74.71 -63.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.943 -1.328 . . . . 0.0 108.817 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.71 -25.78 12.05 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.3 tt -70.66 -33.64 71.17 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.785 HD21 ' H ' ' A' ' 103' ' ' ALA . 18.0 tp -86.55 -58.26 2.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -43.26 -47.2 6.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.852 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.0 m -51.41 -47.36 63.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 108.99 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.52 -38.47 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 108.924 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -83.94 -20.7 32.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.1 -28.96 43.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -52.27 -70.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.62 -63.39 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.8 -26.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -1.115 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -90.11 -40.88 11.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' MET . 0.3 OUTLIER 75.78 -59.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.16 -54.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.653 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 51' ' ' TYR . 13.3 tp 59.3 120.3 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.85 131.76 43.83 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 120.606 0.87 . . . . 0.0 112.293 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -126.73 127.6 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.7 69.48 0.72 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.462 ' O ' ' CG ' ' A' ' 85' ' ' MET . 5.9 ptt? -61.33 123.62 18.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.83 127.13 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.02 . . . . 0.0 109.511 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.8 t -150.05 136.94 19.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.566 -1.334 . . . . 0.0 110.456 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.04 -14.34 34.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.288 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -102.94 34.52 2.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.58 114.19 3.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.513 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.65 -125.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -0.801 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 94' ' ' ASN . 18.6 tttm -117.17 -89.46 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.651 . . . . 0.0 109.816 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -18.74 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.054 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.477 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -70.68 -35.31 72.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.603 HD11 ' HB1' ' A' ' 90' ' ' ALA . 49.2 mt -85.25 -28.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -73.27 -60.75 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.019 -1.051 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.61 -43.26 12.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.249 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -66.35 -47.54 73.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.34 50.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.94 -1.1 . . . . 0.0 109.721 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -56.76 -24.03 47.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.9 -103.9 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.717 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -135.89 -0.64 3.13 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.785 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -58.18 11.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.828 -0.807 . . . . 0.0 110.913 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 102' ' ' GLY . 49.1 m -29.4 -31.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.65 132.72 11.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -146.26 117.04 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -1.163 . . . . 0.0 109.446 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.57 139.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.4 103.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.76 -1.213 . . . . 0.0 108.337 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -71.72 155.33 92.43 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.873 -1.142 . . . . 0.0 109.38 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.33 168.64 75.49 Favored 'Cis proline' 0 N--CA 1.486 1.04 0 C-N-CA 124.811 -0.912 . . . . 0.0 110.234 -2.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -144.14 157.84 44.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -101.1 149.57 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.416 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -47.12 -32.15 4.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.254 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.62 82.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 5.7 m -69.23 -69.44 0.34 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.4 tp -43.9 -37.5 2.89 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.577 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.2 tt0 -59.07 -59.4 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.24 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.38 -40.11 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.626 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -59.94 -55.35 35.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 121' ' ' ASN . 10.6 mt -50.07 -72.66 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -38.96 -44.42 1.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.486 -0.759 . . . . 0.0 111.851 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -66.5 -31.35 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.942 -1.099 . . . . 0.0 110.372 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 125' ' ' GLU . 18.6 mt -89.97 -40.26 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.092 -1.005 . . . . 0.0 111.075 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -62.16 0.97 0.35 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.059 -1.026 . . . . 0.0 110.558 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.9 mt-10 -77.06 -25.39 52.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -91.44 -29.52 17.0 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -73.07 -29.62 63.08 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.55 80.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.127 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 2' ' ' ALA . 34.6 t70 -43.68 146.44 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.776 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.03 14.05 13.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.071 -1.018 . . . . 0.0 108.674 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 29.1 mp0 -147.24 50.38 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 29.3 tp -78.72 118.44 20.8 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.615 -1.303 . . . . 0.0 108.858 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 118.79 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.141 -0.974 . . . . 0.0 111.418 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 60.5 m-85 -113.44 151.57 31.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG22 ' A' ' 54' ' ' VAL . 53.7 tp -129.82 102.94 6.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 21' ' ' VAL . 1.3 m -90.53 116.86 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.251 -0.905 . . . . 0.0 109.258 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.89 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.8 t -112.37 129.49 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.522 -0.737 . . . . 0.0 110.368 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -165.42 -167.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 7.8 t70 -148.5 13.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 0.0 109.729 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -74.88 -18.7 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.783 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.07 2.9 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.321 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -150.69 -22.01 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.865 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -26.96 66.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -40.81 97.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -64.19 -23.93 67.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.55 -52.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.514 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -66.05 -35.27 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.03 -56.69 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.24 -56.61 19.49 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.953 0.882 . . . . 0.0 109.042 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 tt -37.73 -51.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.07 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 25' ' ' LEU . 28.9 mt -58.65 -52.27 66.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 108.593 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -52.6 -46.06 66.8 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.383 -0.823 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.22 -25.6 14.72 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.435 HD13 ' HE2' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -83.3 -64.57 1.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.557 -0.715 . . . . 0.0 109.134 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.96 67.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HE2' HD13 ' A' ' 28' ' ' LEU . 71.4 m-85 -149.96 155.38 39.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.98 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.09 61.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.918 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.89 99.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -0.943 . . . . 0.0 108.545 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.17 149.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 110.701 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -122.02 -169.38 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -147.33 152.87 38.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.89 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.07 167.82 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 5.8 mt-10 -99.94 -2.48 34.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -0.902 . . . . 0.0 110.489 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER 169.12 -179.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.917 -1.114 . . . . 0.0 109.628 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.25 76.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' OD2' ' A' ' 64' ' ' ASP . 58.3 t -54.19 -40.29 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.302 . . . . 0.0 108.789 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 4.3 t70 -67.56 -42.13 83.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.59 -0.694 . . . . 0.0 109.199 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.36 -57.13 8.12 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.363 -0.835 . . . . 0.0 109.409 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' ALA . 53.5 tp -41.95 -43.03 2.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 110.02 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.34 -34.92 70.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 0.0 109.892 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -89.99 -14.04 34.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.173 -0.954 . . . . 0.0 110.625 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -64.55 -18.05 64.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.027 . . . . 0.0 108.569 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -85.89 -3.02 58.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.536 -0.727 . . . . 0.0 109.264 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.62 -73.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.5 8.46 1.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 71.77 1.25 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HD21 ' A' ' 81' ' ' LEU . 34.0 m-85 -47.87 113.52 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -1.036 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.3 -3.67 3.06 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.6 t80 -166.39 141.25 4.41 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.024 -1.28 . . . . 0.0 109.974 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 9' ' ' LEU . 13.3 t -137.52 108.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 110.509 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 55' ' ' ILE . 51.9 mt -90.01 78.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 p -88.0 154.4 20.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.039 -1.038 . . . . 0.0 110.65 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.87 167.67 9.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -61.85 88.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -60.77 125.32 23.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.132 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.653 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 22.8 ttp -131.73 30.89 0.2 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.642 -0.661 . . . . 0.0 112.467 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -57.75 -59.06 0.62 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 N-CA-C 108.788 -1.274 . . . . 0.0 108.788 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -159.04 -28.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.458 ' O ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -175.52 108.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' HG23 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -177.05 -172.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.954 -1.091 . . . . 0.0 110.077 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.63 -71.97 1.8 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.473 ' C ' ' N ' ' A' ' 68' ' ' LEU . 1.1 mm? -65.97 -65.06 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.007 -1.29 . . . . 0.0 108.57 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -49.81 -19.91 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' N ' ' C ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 101' ' ' ALA . 2.0 tt -45.94 -63.18 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 109.067 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -42.72 -50.23 5.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LEU . 54.1 mt -73.59 -23.31 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.08 -29.55 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.611 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.76 -28.13 1.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.506 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -47.29 126.7 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.28 -34.25 5.93 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -89.97 -46.69 8.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.4 t 45.8 19.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.22 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -140.93 2.34 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.695 . . . . 0.0 109.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 51' ' ' TYR . 2.5 tp -47.32 110.48 1.33 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.046 -1.034 . . . . 0.0 108.53 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.19 113.81 1.83 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 121.196 1.264 . . . . 0.0 112.976 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.2 t -113.83 117.89 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.715 HD12 HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -98.11 105.31 17.43 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.292 178.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 tpt -76.14 99.47 4.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.168 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -99.4 150.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.855 -1.153 . . . . 0.0 110.389 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.3 t -150.25 -179.81 7.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 109.878 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.35 -73.28 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.41 54.66 1.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 95' ' ' ILE . . . -50.34 107.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 177.78 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 108.9 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -75.07 -34.84 61.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.06 -34.41 17.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.214 -0.929 . . . . 0.0 110.224 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.86 -24.47 63.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.047 -1.033 . . . . 0.0 109.958 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 16.0 mt -72.6 -36.21 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.033 . . . . 0.0 109.401 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.9 mt -80.95 -14.55 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.268 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -63.43 -48.6 77.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.16 -58.98 6.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 108.849 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.7 -25.22 53.74 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.056 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.34 -32.26 37.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.07 -28.2 24.24 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 76.44 67.39 1.69 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.947 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.18 -111.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 117.103 -1.839 . . . . 0.0 110.368 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.575 ' HB2' HD22 ' A' ' 84' ' ' LEU . 50.0 m -91.46 -51.43 5.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.201 1.477 . . . . 0.0 107.554 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.77 -157.58 30.05 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.96 151.93 49.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -1.153 . . . . 0.0 109.244 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 84' ' ' LEU . 8.5 p -147.15 124.74 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.189 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.88 162.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 108.828 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 pttt -135.65 159.5 71.2 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.329 -0.857 . . . . 0.0 108.747 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.34 132.88 29.01 Favored 'Cis proline' 0 C--N 1.32 -0.969 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.44 -2.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.6 p90 -93.42 158.37 15.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.157 -0.965 . . . . 0.0 109.417 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -89.88 147.39 23.78 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.61 -36.97 11.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.96 -1.088 . . . . 0.0 109.064 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 -33.11 74.4 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.252 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' THR . 10.8 m -71.74 -65.79 0.72 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.678 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.91 -38.74 23.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.343 -1.343 . . . . 0.0 108.637 179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.44 -48.38 79.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -45.79 -43.17 12.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -78.62 -34.51 46.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 109.762 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.441 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -63.64 -35.61 81.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.94 -35.36 59.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 109.944 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -31.03 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.3 mt -77.7 -35.03 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -86.55 0.51 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -77.71 -26.72 50.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -96.43 -22.31 17.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.21 -24.97 22.0 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 85.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.215 -1.167 . . . . 0.0 109.501 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.84 128.54 11.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 108.742 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.71 30.95 0.87 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.999 -1.063 . . . . 0.0 109.459 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -148.39 38.14 0.86 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -75.31 141.35 43.4 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HZ3' ' CG ' ' A' ' 32' ' ' ASN . 11.0 mttm -81.6 131.63 35.28 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.105 -0.997 . . . . 0.0 110.971 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 38.4 m-85 -119.56 148.11 43.69 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.789 -0.57 . . . . 0.0 110.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.625 ' CD2' HD12 ' A' ' 46' ' ' LEU . 45.2 tp -121.71 112.42 18.39 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.97 98.87 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.55 -0.719 . . . . 0.0 110.022 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 36' ' ' ALA . 3.8 t -95.16 116.95 37.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER 173.29 152.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.608 -1.308 . . . . 0.0 111.331 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 15' ' ' SER . 3.0 t0 -81.94 52.15 1.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -13.25 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' THR . 1.6 p 57.38 2.22 0.13 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.357 -1.465 . . . . 0.0 108.09 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 15' ' ' SER . 17.0 p 130.59 26.0 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.594 1.157 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' ARG . 30.1 tpp -92.19 -66.6 0.91 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.618 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -33.47 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.91 -39.05 61.65 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.123 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 mt -66.37 -53.34 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.074 -1.016 . . . . 0.0 109.358 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -30.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 110.232 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -53.61 26.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.437 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.731 0.777 . . . . 0.0 109.99 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 113' ' ' ALA . 1.2 tt -40.85 -49.18 3.18 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.933 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -63.54 -53.63 48.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.941 -1.099 . . . . 0.0 108.841 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -54.22 -28.89 44.08 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.205 -0.934 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -35.72 72.44 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.21 -57.78 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.51 74.4 0.02 OUTLIER Glycine 0 N--CA 1.48 1.604 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -150.12 139.17 21.09 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.434 . . . . 0.0 109.045 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -146.57 64.25 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -0.99 . . . . 0.0 109.921 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.516 ' CG ' ' HZ3' ' A' ' 7' ' ' LYS . 10.8 t-20 -173.63 96.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 108.866 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.02 148.44 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.039 -1.038 . . . . 0.0 110.367 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 11.9 mt-10 -122.48 -166.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -150.2 158.65 44.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.529 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.13 -166.63 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.94 13.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 0.0 111.636 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 1.7 t0 -178.85 151.24 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.6 -1.313 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.41 -52.98 12.92 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 40' ' ' VAL . 4.8 t -55.52 -31.55 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.262 -1.14 . . . . 0.0 108.579 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 t0 -71.89 -45.0 62.81 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.164 -0.96 . . . . 0.0 108.894 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -58.46 -58.12 9.95 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.396 -0.815 . . . . 0.0 109.39 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -46.37 -42.65 15.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 110.034 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -78.43 -32.23 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -90.08 -7.01 54.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.774 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -77.72 -16.06 58.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.569 -1.332 . . . . 0.0 108.892 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -78.55 -0.4 29.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.246 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.34 -61.09 1.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.72 15.75 0.46 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.82 102.81 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.565 ' O ' HD21 ' A' ' 81' ' ' LEU . 46.5 m-85 -85.81 142.68 28.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -1.162 . . . . 0.0 110.235 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.17 -7.46 54.77 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -152.78 136.96 16.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.29 116.78 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.625 -1.297 . . . . 0.0 110.484 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -97.87 116.08 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.66 134.73 30.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 108.99 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.76 -177.62 1.31 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.161 -0.962 . . . . 0.0 109.479 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 33.4 t-105 -67.47 -143.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.002 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 60' ' ' MET . 3.0 t30 -91.82 165.03 13.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.552 ' N ' ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER 179.03 -50.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.737 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -64.73 -77.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 120.779 0.986 . . . . 0.0 110.024 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.11 109.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 108.876 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 48.88 86.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.883 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.4 m-20 -163.71 -167.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 58.73 -76.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -59.03 -71.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.889 -1.359 . . . . 0.0 109.302 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -53.1 -38.77 62.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.955 -1.091 . . . . 0.0 108.853 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.699 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.1 tp -54.23 -47.18 72.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.857 HD21 ' H ' ' A' ' 103' ' ' ALA . 39.0 tp -65.7 -62.13 1.69 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 21.0 tttm -41.83 -45.97 3.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -44.27 68.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.024 . . . . 0.0 109.168 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 69' ' ' LEU . 67.7 mt -57.35 -37.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.054 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -2.16 44.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 109.574 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.65 -28.54 16.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -63.57 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.44 -25.19 20.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.66 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -1.134 . . . . 0.0 109.351 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.3 ttm -90.11 -31.64 17.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.91 . . . . 0.0 109.218 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.03 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.839 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.95 9.27 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.946 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD21 ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -47.92 110.54 1.42 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 81' ' ' LEU . 6.3 Cg_exo -58.86 125.63 18.79 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 120.961 1.107 . . . . 0.0 112.394 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.5 124.44 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.678 HD21 HD21 ' A' ' 116' ' ' LEU . 50.7 tp -100.7 77.2 1.86 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.482 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 155.51 13.45 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.28 132.54 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 t -150.1 -176.9 5.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.761 -1.212 . . . . 0.0 109.975 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.7 -49.47 2.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.605 -0.684 . . . . 0.0 109.771 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -78.43 -69.75 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 70.64 68.08 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.251 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -61.68 -151.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.021 . . . . 0.0 109.899 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 13.3 mttt -97.39 -86.61 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.807 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -47.65 -10.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.391 -0.818 . . . . 0.0 110.42 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.628 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -79.98 -33.4 39.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 0.0 109.512 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 90' ' ' ALA . 61.0 mt -86.78 -9.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.45 -63.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.992 . . . . 0.0 109.859 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.31 -38.85 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.446 -0.784 . . . . 0.0 109.388 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -70.62 -49.09 51.25 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 109.822 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.31 -51.37 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.971 . . . . 0.0 110.558 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -10.57 48.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.768 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -95.58 -33.69 12.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.196 -0.94 . . . . 0.0 110.891 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.69 -15.01 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.857 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -56.89 11.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.981 -0.717 . . . . 0.0 110.816 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.665 ' H ' ' C ' ' A' ' 102' ' ' GLY . 71.6 m -29.38 -32.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 122.181 -0.324 . . . . 0.0 111.452 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.97 122.99 7.49 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -141.52 128.74 20.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -1.012 . . . . 0.0 108.574 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -134.95 129.57 51.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -60.14 -165.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 150.91 5.62 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.452 -1.405 . . . . 0.0 109.779 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.62 155.36 99.79 Favored 'Cis proline' 0 N--CA 1.488 1.148 0 C-N-CA 125.275 -0.719 . . . . 0.0 110.621 -1.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.723 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -121.43 155.74 34.22 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.856 0.836 . . . . 0.0 109.803 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.418 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.9 150.8 22.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -48.87 -38.43 22.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.762 -1.211 . . . . 0.0 109.445 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.85 76.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 108.236 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 112' ' ' THR . 17.2 m -67.94 -65.26 0.71 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.723 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.03 -45.39 31.97 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.795 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.83 -56.09 16.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.965 -1.084 . . . . 0.0 109.809 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -46.41 -40.17 11.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.459 -0.776 . . . . 0.0 110.029 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.53 -60.52 2.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tp -45.22 -58.99 2.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.45 -37.18 56.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.977 . . . . 0.0 109.95 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -30.1 68.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.741 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.463 HD11 ' HA2' ' A' ' 105' ' ' GLY . 64.1 mt -89.89 -53.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -57.46 -10.01 1.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.175 -0.953 . . . . 0.0 110.077 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -73.32 -31.16 63.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -91.64 -28.25 17.61 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.86 -28.3 44.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.26 86.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.285 -1.127 . . . . 0.0 109.359 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.27 146.05 1.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -89.97 22.15 3.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -155.26 42.59 0.45 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 29.6 tp -71.2 119.67 15.67 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -61.84 128.37 35.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.496 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.0 m-85 -115.47 156.18 26.13 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.19 101.13 4.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 10' ' ' VAL . 5.0 m -92.17 116.65 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.394 -0.816 . . . . 0.0 109.867 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.572 HG13 ' HB3' ' A' ' 36' ' ' ALA . 5.5 t -95.49 93.78 3.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.354 -0.841 . . . . 0.0 109.414 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.58 121.7 26.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.739 . . . . 0.0 109.493 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -23.46 67.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 109.548 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.28 145.68 31.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.562 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.2 t -94.81 21.54 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -154.2 -7.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.2 ttt -65.5 -35.25 80.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.178 -0.951 . . . . 0.0 109.228 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.645 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -48.74 -44.67 38.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.0 109.454 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -33.4 53.55 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.41 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.18 -54.91 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.028 -1.045 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -32.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.327 -0.858 . . . . 0.0 111.174 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -55.04 27.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 0.0 109.174 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -64.33 -57.44 9.36 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.707 0.765 . . . . 0.0 109.329 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -39.74 -58.6 1.31 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.775 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 mt -56.08 -50.53 70.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -29.36 63.7 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.186 -0.946 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.6 -36.93 72.39 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mt -81.15 -59.79 2.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.4 58.24 0.01 OUTLIER Glycine 0 N--CA 1.481 1.685 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' HD2' ' H ' ' A' ' 6' ' ' LEU . 96.1 m-85 -138.13 149.55 46.01 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.273 -1.134 . . . . 0.0 109.181 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.574 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.91 69.17 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.293 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.4 96.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.204 -0.935 . . . . 0.0 108.677 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -150.12 149.73 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.088 . . . . 0.0 110.565 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' OE2' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -121.36 -170.78 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 10.3 mp0 -143.67 153.63 42.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -137.8 -169.18 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 4.5 mt-10 -124.99 -2.18 7.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.501 -0.75 . . . . 0.0 110.742 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.73 -179.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.849 -1.157 . . . . 0.0 109.542 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.52 -38.0 95.65 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG22 ' SD ' ' A' ' 63' ' ' MET . 1.4 t -66.23 -42.92 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.301 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 7.6 t70 -67.53 -42.96 81.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 108.705 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -61.97 -58.17 8.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 0.0 109.07 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -46.37 -33.38 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -85.16 -31.32 23.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -89.95 -6.15 55.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.115 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.32 -26.51 22.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.975 -1.078 . . . . 0.0 108.483 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -57.66 -10.38 1.56 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.0 108.644 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 46' ' ' LEU . . . -46.0 -68.75 0.17 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.547 -0.721 . . . . 0.0 109.222 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.53 -96.28 0.36 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.31 67.31 0.3 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.469 ' C ' ' N ' ' A' ' 53' ' ' PHE . 22.0 m-85 -44.49 96.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.69 -0.888 . . . . 0.0 109.867 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -50.61 -10.32 0.36 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -157.57 141.11 15.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -1.182 . . . . 0.0 110.467 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 83' ' ' VAL . 39.2 t -131.86 107.37 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG12 ' A' ' 10' ' ' VAL . 39.8 mt -89.88 80.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.99 165.66 16.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.335 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.1 m-20 -97.73 -137.94 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.609 -0.682 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.711 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 49.7 t-105 -172.33 95.86 0.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 109.299 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -157.37 -157.66 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 109.043 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.4 mmt -142.7 50.91 1.64 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 111.66 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.4 Cg_endo -59.96 -25.6 80.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.962 -1.592 . . . . 0.0 107.962 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -173.39 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 40' ' ' VAL . 31.4 mtt -158.48 143.63 16.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -87.88 166.27 14.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.752 -1.218 . . . . 0.0 110.047 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.38 -5.48 77.54 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 68' ' ' LEU . 53.1 tp -57.82 -64.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.256 . . . . 0.0 109.17 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -47.61 -15.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.096 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LEU . 6.1 tp -76.17 -57.18 4.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.812 . . . . 0.0 109.305 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.71 -33.1 68.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.203 -0.936 . . . . 0.0 109.329 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -62.83 -67.41 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 m -48.46 -30.04 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 80' ' ' ALA . 11.7 mt -72.43 -40.28 63.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.266 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HE ' ' CA ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -84.21 -17.19 40.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.453 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.78 -28.55 9.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.94 -138.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.383 -0.823 . . . . 0.0 109.322 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -136.54 -123.63 2.28 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.77 22.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.51 ' H ' ' C ' ' A' ' 76' ' ' GLY . 37.0 mtt -150.15 57.7 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 108.717 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 78' ' ' MET . 92.1 p -55.23 -113.13 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.35 58.42 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.0 109.387 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ALA . 12.3 mt 58.58 154.42 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.831 -0.543 . . . . 0.0 109.967 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.29 144.56 17.17 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.565 2.176 . . . . 0.0 114.897 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -129.83 122.18 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.855 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -101.58 107.74 19.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.77 98.3 6.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.401 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.92 158.4 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.76 -1.212 . . . . 0.0 109.791 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -150.07 159.26 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.804 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -98.67 -4.48 33.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' LYS . 1.4 tt0 -145.75 54.47 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.46 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.733 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 89' ' ' GLU . 24.1 tttm -76.16 -72.24 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.659 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -177.64 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.885 . . . . 0.0 109.336 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.38 -38.91 63.8 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.711 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 4.3 m-20 -69.04 -29.75 67.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.928 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 90' ' ' ALA . 6.7 mt -67.89 -57.25 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 108.868 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -63.73 -18.94 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.394 -0.816 . . . . 0.0 109.205 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.38 -60.58 3.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.636 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -54.04 -54.23 42.15 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.11 -25.13 65.21 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.682 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.2 tp-100 -53.13 -31.15 40.72 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -89.26 -22.1 22.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.6 76.91 0.32 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.759 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.86 -111.89 0.08 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.088 -1.845 . . . . 0.0 109.795 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.855 ' OG ' HD22 ' A' ' 84' ' ' LEU . 10.1 p -91.59 -50.78 5.59 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.786 1.279 . . . . 0.0 108.536 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.422 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 165.83 -166.55 38.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.41 148.58 43.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.277 -1.131 . . . . 0.0 109.984 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.6 p -141.21 126.8 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.8 p -74.96 108.75 6.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.955 . . . . 0.0 110.06 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.804 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.52 163.78 48.08 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.2 125.81 10.48 Favored 'Cis proline' 0 N--CA 1.485 0.999 0 C-N-CA 125.121 -0.783 . . . . 0.0 110.842 -1.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.44 154.85 17.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.525 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.89 151.89 21.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.64 -31.51 4.67 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.938 -1.101 . . . . 0.0 109.432 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.05 82.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.043 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.31 -66.67 0.57 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.995 -1.066 . . . . 0.0 108.336 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.84 -35.75 33.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.567 -1.333 . . . . 0.0 109.557 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -70.65 -67.92 0.47 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.827 -1.171 . . . . 0.0 109.768 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -42.84 -29.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.711 -0.618 . . . . 0.0 109.385 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -78.7 -43.69 25.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.02 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 53' ' ' PHE . 2.6 tp -57.19 -66.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 0.0 109.947 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -40.2 -52.38 2.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.558 -0.714 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -60.39 -28.6 68.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 110.557 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.98 -38.5 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.0 110.402 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -76.53 -42.7 42.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 110.669 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -50.32 -23.09 2.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.899 -1.126 . . . . 0.0 108.207 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -92.77 -25.12 18.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' PHE . 2.1 tp -73.46 -26.14 60.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.01 -42.83 1.03 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 129' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.265 -1.138 . . . . 0.0 109.441 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.535 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER 63.88 130.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.027 . . . . 0.0 108.9 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -90.42 7.71 37.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.899 -1.126 . . . . 0.0 109.996 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.38 45.73 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.987 -1.07 . . . . 0.0 111.22 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.31 138.5 38.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.38 122.87 26.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.956 -1.09 . . . . 0.0 111.972 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.71 149.32 33.09 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.16 107.13 10.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -90.36 131.53 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.961 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 36' ' ' ALA . 9.8 t -138.43 38.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.392 -0.817 . . . . 0.0 109.216 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -76.35 22.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.14 -0.975 . . . . 0.0 109.36 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER 47.82 -124.3 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.132 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 46.52 -168.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.33 -9.41 1.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.731 . . . . 0.0 109.052 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.66 -13.98 5.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 8.4 ttt -64.27 -49.48 71.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.483 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -45.48 16.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -52.23 -49.74 63.38 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.482 -0.761 . . . . 0.0 110.266 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -50.2 -55.56 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.952 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.09 -38.15 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 110.892 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.34 -58.28 4.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 109.521 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -62.53 -55.46 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.804 0.811 . . . . 0.0 109.495 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.09 -48.47 2.48 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.6 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.46 -49.37 71.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -48.87 -38.64 23.04 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.324 -0.86 . . . . 0.0 108.828 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -35.06 73.12 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 108.807 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.33 -3.47 33.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.472 -0.768 . . . . 0.0 109.053 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.65 33.25 16.65 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 26.2 m-85 -105.4 142.86 34.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.462 -1.022 . . . . 0.0 109.264 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -141.78 62.94 1.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.01 93.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.915 -1.116 . . . . 0.0 109.249 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.1 150.75 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 0.0 110.271 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.45 -170.5 2.19 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -147.32 157.84 43.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.049 -1.032 . . . . 0.0 110.918 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.57 -167.62 2.3 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.92 3.48 3.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.197 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.1 -179.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 109.63 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.681 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -60.63 -39.79 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -1.085 . . . . 0.0 109.321 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.4 t70 -72.02 -46.67 56.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.847 . . . . 0.0 109.065 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -59.04 -57.12 14.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.486 -0.758 . . . . 0.0 109.65 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 mt -46.46 -47.83 19.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 109.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.954 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.87 9.73 26.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.161 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -85.25 -36.9 20.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 109.053 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.07 -1.28 31.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.23 -58.64 3.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.85 9.8 1.37 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.03 94.9 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.785 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.6 m-85 -80.48 142.64 34.05 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.227 -1.161 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.54 6.22 65.19 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.07 142.71 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.616 -0.932 . . . . 0.0 108.618 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 83' ' ' VAL . 56.4 t -141.75 121.19 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.75 -1.219 . . . . 0.0 110.075 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 84' ' ' LEU . 10.1 mt -107.91 132.04 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 p -151.4 145.63 25.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 0.0 109.421 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.8 p-10 -47.79 -80.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.529 ' CH2' ' OD1' ' A' ' 94' ' ' ASN . 28.0 t-105 -177.34 -68.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 43.4 p-10 -170.54 53.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.948 -1.095 . . . . 0.0 109.742 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.524 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -60.65 -47.59 95.58 Favored Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.09 -1.006 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -65.62 -73.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.038 1.158 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.635 HD22 ' N ' ' A' ' 63' ' ' MET . 0.2 OUTLIER 179.32 -106.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.039 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.635 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.1 mtp -70.99 73.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.956 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -150.62 162.49 40.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.743 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 74.16 -66.93 1.83 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' LEU . 52.2 tp -68.68 -73.0 0.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.572 -1.546 . . . . 0.0 109.024 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.3 tp10 -46.9 -32.9 4.11 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.743 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.7 tp -66.74 -41.13 88.36 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.822 HD21 ' H ' ' A' ' 103' ' ' ALA . 40.7 tp -76.66 -62.38 1.65 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.497 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' LEU . 12.8 ttmt -42.96 -35.48 1.24 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.323 -0.861 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.3 m -71.57 -34.94 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.3 mt -64.51 -26.15 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.214 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.06 -40.58 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.773 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.03 -28.57 1.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.24 162.14 6.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.621 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -109.79 22.4 23.81 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.72 0.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -125.06 16.2 8.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.2 t -72.87 16.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -129.31 35.9 4.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.546 -0.721 . . . . 0.0 109.288 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -110.83 99.82 43.71 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.68 147.85 93.47 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 112.624 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 69' ' ' LEU . 3.0 t -130.23 129.5 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 55' ' ' ILE . 24.6 tp -111.66 70.89 0.72 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.91 167.13 3.01 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.518 HG23 HG13 ' A' ' 107' ' ' VAL . 7.2 p -150.16 137.56 13.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.801 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -150.36 171.06 17.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.02 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.02 131.0 48.72 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 50.83 75.31 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.007 -1.058 . . . . 0.0 108.581 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -44.04 138.08 3.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.757 . . . . 0.0 110.299 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 10.4 ttpt -71.67 -6.02 38.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 0.0 109.486 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 2.6 tttm 74.79 -73.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.81 . . . . 0.0 109.683 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.33 -11.53 0.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.041 -1.037 . . . . 0.0 109.838 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.529 ' OD1' ' CH2' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -89.87 -51.49 5.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.89 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mm -46.04 -46.77 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.77 -65.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.962 -1.086 . . . . 0.0 109.509 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.49 -60.08 2.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 108.743 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -44.6 -44.04 8.58 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.597 . . . . 0.0 109.82 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -60.81 -48.15 83.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.992 -1.067 . . . . 0.0 110.246 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -54.24 -11.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 109.437 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.04 -110.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.593 -0.692 . . . . 0.0 110.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -132.96 -2.16 3.89 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.822 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -60.69 11.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.001 -0.705 . . . . 0.0 110.682 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -29.42 -30.56 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -176.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 123' ' ' ILE . . . -107.24 128.23 9.14 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.124 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.64 117.82 7.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -1.137 . . . . 0.0 109.563 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 116' ' ' LEU . 1.5 p -113.13 143.41 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -89.6 107.29 17.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.345 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 159.48 68.19 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.675 -1.265 . . . . 0.0 108.963 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.69 164.39 88.14 Favored 'Cis proline' 0 N--CA 1.487 1.139 0 C-N-CA 124.775 -0.927 . . . . 0.0 110.738 -1.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.494 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.6 p90 -144.57 152.99 41.34 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.097 0.951 . . . . 0.0 109.932 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.1 149.79 22.68 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.5 -37.95 12.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.982 -1.074 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.57 -33.52 75.85 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' THR . 88.9 m -72.57 -68.37 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.61 HD11 HG11 ' A' ' 107' ' ' VAL . 8.3 tp -43.87 -37.69 2.96 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.255 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp10 -56.33 -65.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -42.27 -53.67 4.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.323 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -57.2 -52.25 66.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -61.27 2.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -49.52 -36.47 23.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.799 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -28.88 70.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.607 HD11 ' HA2' ' A' ' 105' ' ' GLY . 13.0 mt -80.01 -48.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.019 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -55.17 -6.74 0.16 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 123' ' ' ILE . 1.5 mt-10 -70.31 -27.97 64.81 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -89.35 -26.06 21.28 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.25 -26.08 42.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.816 . . . . 0.0 108.842 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.9 81.7 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -1.149 . . . . 0.0 109.491 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 5' ' ' GLU . 5.0 t70 51.58 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -71.98 34.39 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.576 -1.328 . . . . 0.0 110.04 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 3' ' ' ASP . 46.2 mt-10 -150.37 32.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.91 142.5 57.87 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 108.715 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.42 122.93 28.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.084 -1.01 . . . . 0.0 112.181 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -113.71 154.6 27.04 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 54' ' ' VAL . 18.0 tp -130.43 99.84 5.15 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 10' ' ' VAL . 10.7 m -89.89 107.19 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.078 -1.014 . . . . 0.0 109.833 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.4 t -96.89 65.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 3.6 p30 -89.1 -139.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 108.927 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 31.3 t0 -172.13 -33.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.82 156.51 8.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.746 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.2 t -91.02 39.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -175.17 3.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.3 ttm -84.01 -33.41 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.232 -0.917 . . . . 0.0 109.301 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.699 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.12 -48.62 70.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -55.88 -28.84 58.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.038 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -67.61 -55.3 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.693 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -34.88 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.502 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -55.13 18.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.857 -1.152 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.6 t30 -58.09 -58.6 7.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.98 0.895 . . . . 0.0 108.73 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 tt -40.22 -62.55 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.907 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -52.85 -45.02 67.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.207 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -55.18 -43.13 74.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.393 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -19.34 21.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 117' ' ' GLU . 1.1 mt -99.88 -7.04 25.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.365 -0.835 . . . . 0.0 110.065 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.38 71.26 1.2 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -150.15 100.28 2.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.301 . . . . 0.0 108.819 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -108.41 67.51 0.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.084 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.08 93.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -150.16 147.79 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.96 -1.087 . . . . 0.0 110.398 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.12 -175.27 3.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -147.82 161.05 42.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.869 -1.145 . . . . 0.0 110.909 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.763 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.34 -168.08 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.31 2.55 4.23 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.445 -0.785 . . . . 0.0 110.009 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.68 -176.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 108.819 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.734 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -72.83 -30.94 62.89 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.46 -36.28 76.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.123 -1.221 . . . . 0.0 108.33 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.623 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.7 t0 -75.51 -46.79 30.15 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.14 -54.94 39.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.268 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.6 tt -48.08 -49.57 31.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -67.36 -34.39 77.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.037 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -90.02 -5.06 57.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 110.457 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -72.8 -27.76 62.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.072 -1.018 . . . . 0.0 108.938 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 20.3 tt0 -68.31 0.65 3.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.394 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.92 -77.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.37 -67.78 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.97 68.6 0.08 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.0 m-85 -47.12 101.99 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.487 -1.008 . . . . 0.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.53 8.96 2.74 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -169.52 146.55 3.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -1.199 . . . . 0.0 109.588 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.0 t -145.31 120.44 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.744 -1.223 . . . . 0.0 110.404 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.622 HG23 HG21 ' A' ' 86' ' ' VAL . 9.4 mt -101.43 92.69 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.6 p -98.58 151.24 20.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.272 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 8.6 p-10 -86.19 -107.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.324 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.516 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 55.3 t-105 -146.3 176.6 9.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.005 . . . . 0.0 109.529 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.489 ' OD1' ' CE2' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -73.98 69.29 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -79.27 -47.55 1.58 Allowed Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.968 . . . . 0.0 110.336 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -67.17 -68.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.082 1.188 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.697 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -152.31 -126.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.475 ' N ' ' CG ' ' A' ' 62' ' ' ASN . 20.8 mtm -86.33 95.98 9.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 63' ' ' MET . 52.8 m-20 -160.98 171.73 18.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 74.43 -63.12 2.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 tp -74.04 -50.56 19.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.639 -1.507 . . . . 0.0 107.88 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -71.07 -14.73 62.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.734 HD11 ' HA2' ' A' ' 39' ' ' GLY . 9.8 mt -68.6 -58.17 4.66 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -61.37 -34.73 75.8 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -68.43 -37.91 80.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.9 m -68.53 -48.45 64.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.06 -25.91 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.433 -0.792 . . . . 0.0 109.027 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -90.05 -29.31 18.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.41 -0.806 . . . . 0.0 110.005 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -67.75 -38.2 83.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -53.16 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.35 -79.28 1.44 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.87 54.94 2.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -1.116 . . . . 0.0 109.827 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.7 mmt -137.37 1.95 2.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 109.296 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -94.06 59.99 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.04 -31.47 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 51' ' ' TYR . 10.1 mt -69.64 118.92 67.38 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 120.911 -1.118 . . . . 0.0 109.463 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.31 107.88 0.4 Allowed 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 121.474 1.449 . . . . 0.0 113.096 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.4 t -98.45 113.61 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -95.78 103.05 14.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.078 -1.449 . . . . 0.0 108.331 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 38.4 tpp -68.74 137.78 54.34 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 55' ' ' ILE . 11.1 t -122.64 148.27 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.642 -0.661 . . . . 0.0 110.518 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.95 148.62 29.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.02 -45.92 8.44 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.213 -0.93 . . . . 0.0 108.789 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.8 mt-10 -93.66 43.75 1.12 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -43.91 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 110.086 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -95.47 143.57 26.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -47.56 -16.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.3 mm-40 -90.09 -45.55 9.07 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.287 -0.883 . . . . 0.0 110.167 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' ND2' ' C ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.81 -13.77 55.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 110.065 -179.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.423 HG23 ' CD2' ' A' ' 106' ' ' TYR . 8.0 mt -73.64 -46.78 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 mt -74.74 -14.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 108.897 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.75 95.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.36 -58.21 4.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.5 -25.96 60.6 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.228 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -32.44 50.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.891 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -83.01 -29.61 28.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.05 70.01 1.32 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.453 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.775 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.02 -111.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 116.721 -1.991 . . . . 0.0 109.486 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.696 ' OG ' HD22 ' A' ' 84' ' ' LEU . 3.1 p -91.74 -49.72 6.12 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.844 1.306 . . . . 0.0 108.12 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.88 -168.62 39.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.19 151.19 51.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.505 -0.997 . . . . 0.0 109.961 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.629 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 9.6 p -144.08 135.74 22.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 109' ' ' LYS . 11.8 p -80.47 157.19 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.014 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.512 ' HZ2' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -130.69 160.19 67.5 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 108.901 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.49 129.94 19.69 Favored 'Cis proline' 0 N--CA 1.485 1.009 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.683 -2.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.407 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -89.88 -179.18 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.153 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.492 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -110.64 145.08 38.54 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.516 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.77 -14.86 0.14 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.991 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -83.15 -36.72 24.52 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -71.7 -60.3 2.3 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 116' ' ' LEU . 1.3 mt -50.03 -40.85 46.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.413 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' A' ' 28' ' ' LEU . 2.2 tm-20 -59.51 -54.69 43.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.514 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -47.5 -51.56 20.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.42 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.64 -39.8 85.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -54.03 -68.45 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.503 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -46.66 -48.15 20.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.958 . . . . 0.0 109.477 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -47.25 -40.83 17.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 125' ' ' GLU . 69.5 mt -81.93 -59.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.0 109.19 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.2 0.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.852 -0.53 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 123' ' ' ILE . 86.9 tt0 -73.78 -27.32 61.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 126' ' ' LYS . 4.5 mptt -92.78 -34.76 13.75 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.33 -22.44 61.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.03 89.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.334 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.6 m-20 -45.85 140.06 3.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.32 8.53 32.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 110.303 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -140.16 46.25 1.84 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.074 -1.016 . . . . 0.0 110.524 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.404 HD11 ' HA3' ' A' ' 52' ' ' GLY . 54.9 tp -80.6 131.45 35.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 127.63 33.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.905 -1.122 . . . . 0.0 111.621 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -114.61 153.72 29.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.656 ' HB3' HG13 ' A' ' 54' ' ' VAL . 35.9 tp -123.85 111.5 16.17 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.74 108.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.902 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -105.9 55.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.445 -0.784 . . . . 0.0 109.332 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -97.69 142.45 29.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.57 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.81 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.74 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 t -139.45 13.38 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 109.057 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -164.55 -3.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.412 ' H ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -53.74 -45.31 70.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.594 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -45.92 19.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.194 -0.941 . . . . 0.0 109.633 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -53.71 -53.03 57.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.394 -0.816 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mp -47.34 -59.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 109.972 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.468 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -61.85 -40.68 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.729 -178.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.4 OUTLIER -49.61 -54.31 19.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.842 -1.161 . . . . 0.0 109.512 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -62.66 -57.77 9.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.048 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -40.04 -58.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.665 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 55' ' ' ILE . 13.9 mt -57.42 -45.59 84.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.048 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -54.78 -40.9 69.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.6 -15.5 63.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.312 -0.867 . . . . 0.0 109.285 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.28 4.36 48.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.428 -0.795 . . . . 0.0 109.757 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 59.82 1.63 Allowed Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.138 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 51.2 m-85 -150.04 138.52 20.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.363 . . . . 0.0 109.549 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -146.37 64.8 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.908 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.85 96.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 108.799 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.17 153.86 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -169.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -150.16 156.09 40.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 111.418 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.8 -164.4 1.91 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.483 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 4.4 mt-10 -130.24 -14.37 3.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.542 -0.724 . . . . 0.0 110.547 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 1.2 p-10 -173.38 -178.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.005 -1.059 . . . . 0.0 109.886 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.553 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.42 -43.28 93.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG2' ' SD ' ' A' ' 63' ' ' MET . 91.0 t -63.92 -51.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.874 -1.368 . . . . 0.0 108.709 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 45.6 t0 -51.31 -47.73 62.55 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.91 -48.83 80.03 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 42' ' ' ALA . 2.4 tp -40.61 -35.94 0.53 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.26 -39.76 65.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 108.931 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' GLN . 35.4 mmtt -79.91 -53.39 6.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.469 -0.769 . . . . 0.0 109.65 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -42.49 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.595 -0.69 . . . . 0.0 109.379 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 45' ' ' LYS . 8.9 tt0 -53.36 -44.75 68.81 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.87 -49.75 38.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 51' ' ' TYR . . . 80.39 -20.51 5.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.14 -8.27 4.58 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 53' ' ' PHE . 66.9 m-85 -71.33 89.85 0.92 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -1.131 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -67.01 6.99 1.8 Allowed Glycine 0 C--O 1.205 -1.709 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -165.86 141.08 4.83 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.463 -1.022 . . . . 0.0 109.241 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 83' ' ' VAL . 10.0 t -131.56 117.51 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.266 . . . . 0.0 109.724 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.445 HD11 HD11 ' A' ' 25' ' ' LEU . 59.0 mt -98.78 79.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 p -93.67 144.1 25.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -0.813 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -92.68 126.06 37.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.364 -0.835 . . . . 0.0 109.016 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.594 ' CH2' HD23 ' A' ' 66' ' ' LEU . 6.9 t90 -90.76 107.56 19.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.436 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.3 OUTLIER -161.69 -124.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.438 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 7.3 ttt -159.63 57.97 1.1 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.132 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.3 Cg_endo -64.3 -38.89 32.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 107.32 -1.838 . . . . 0.0 107.32 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 19.3 m-80 -161.5 -26.09 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.408 ' SD ' ' CG2' ' A' ' 40' ' ' VAL . 7.5 mtt -159.7 143.02 14.25 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.88 155.84 32.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.717 -1.24 . . . . 0.0 109.579 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -82.22 -7.84 87.2 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.368 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.594 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -58.37 -49.3 77.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.419 -1.636 . . . . 0.0 107.716 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 71' ' ' THR . 78.9 tt0 -52.74 -15.8 0.82 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.553 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -79.34 -54.51 5.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -56.29 -60.51 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -44.93 -51.38 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.468 -0.77 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 67' ' ' GLU . 10.9 p -61.69 -41.35 97.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 83' ' ' VAL . 17.1 mt -59.33 -21.58 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.22 -0.925 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -90.03 -23.3 21.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.245 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -55.91 4.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.211 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.78 -58.38 3.85 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.16 -58.36 3.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 mtt -128.93 -9.73 4.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.8 p 46.21 -123.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.099 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.07 55.31 0.93 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 108.902 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 45.52 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 O-C-N 121.664 -0.647 . . . . 0.0 109.602 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 5.3 Cg_exo -63.56 149.51 90.81 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.096 1.864 . . . . 0.0 115.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 72' ' ' ILE . 32.3 t -138.53 110.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 2.7 tp -89.76 105.13 17.6 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.139 -1.825 . . . . 0.0 107.262 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 tpp -72.19 109.77 6.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.172 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.57 140.39 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 109.496 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.21 157.82 43.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.65 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.9 mp0 -80.74 70.8 7.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.22 83.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 0.0 108.853 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 89' ' ' GLU . 13.7 tttp -44.69 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.76 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mttt 175.92 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.7 -30.61 33.16 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.558 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 1.4 m-20 -61.5 -54.71 39.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 mm -45.43 -53.83 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.61 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -57.19 -28.25 29.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -64.13 -44.95 90.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.415 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -69.01 -53.99 17.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.058 . . . . 0.0 108.168 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -56.78 -28.47 61.38 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.29 -34.0 73.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.45 -19.23 53.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 55.56 76.05 0.21 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.857 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.17 -112.04 0.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.763 -1.975 . . . . 0.0 110.51 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -50.28 5.83 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.732 1.253 . . . . 0.0 108.149 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 168.41 -155.31 25.86 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.56 122.82 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.547 -0.972 . . . . 0.0 108.782 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 107' ' ' VAL . 8.7 p -119.82 131.68 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.33 132.43 33.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.932 -1.105 . . . . 0.0 109.121 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -109.54 160.11 29.02 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.95 134.45 35.58 Favored 'Cis proline' 0 C--N 1.32 -0.924 0 C-N-CA 124.866 -0.889 . . . . 0.0 110.39 -1.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 2.1 p90 -100.69 160.39 14.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.971 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.88 149.76 21.51 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.03 -21.78 0.76 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.174 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.07 -31.8 25.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -76.78 -57.66 3.73 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -53.23 -40.72 64.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.106 -1.621 . . . . 0.0 107.842 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.51 -52.3 66.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.939 -1.1 . . . . 0.0 109.74 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -45.54 -46.44 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.482 -0.761 . . . . 0.0 109.507 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -70.31 -48.86 54.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 tp -47.08 -65.15 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 0.0 109.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 -45.13 45.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 0.0 109.907 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -68.66 -19.35 64.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 109.652 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.08 -43.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 0.0 110.244 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -63.25 -16.47 60.33 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.083 -1.011 . . . . 0.0 109.964 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -70.84 -19.94 62.6 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -94.85 -34.18 12.55 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -22.08 52.14 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.86 90.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.209 -1.171 . . . . 0.0 109.557 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -47.5 113.06 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 pttt -73.04 36.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.978 -1.076 . . . . 0.0 109.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 3' ' ' ASP . 23.9 tt0 -152.96 30.66 0.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.8 tp -72.83 138.8 46.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -81.29 127.36 32.64 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.969 -1.082 . . . . 0.0 111.697 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 40.7 m-85 -114.71 155.66 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.837 -0.539 . . . . 0.0 109.954 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.3 tp -127.61 109.34 11.6 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -97.3 107.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.355 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 36' ' ' ALA . 37.8 t -98.5 99.55 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.4 -0.813 . . . . 0.0 109.372 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.54 170.13 18.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.734 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.25 26.04 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -70.76 -80.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 t 154.03 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 -26.2 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 ttt -45.2 -63.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.724 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -48.58 -26.86 2.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -76.61 -31.68 57.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.624 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -51.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -38.34 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -52.72 23.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.23 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -58.29 4.13 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.992 0.901 . . . . 0.0 109.712 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.71 -41.18 3.06 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.836 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.77 -46.18 63.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.98 -1.075 . . . . 0.0 108.624 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -56.39 -38.17 71.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.341 -0.849 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.93 -24.88 17.87 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.274 -0.891 . . . . 0.0 109.201 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.745 HD21 ' OE2' ' A' ' 117' ' ' GLU . 1.3 mt -86.28 -39.49 16.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 137.54 6.9 1.51 Allowed Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.6 141.4 28.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.852 -1.381 . . . . 0.0 109.389 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.536 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.5 61.5 1.22 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 97.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.03 152.79 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.044 -1.035 . . . . 0.0 109.83 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -120.52 -167.48 1.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 36' ' ' ALA . 1.1 tt0 -150.11 147.93 28.36 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.109 -0.994 . . . . 0.0 110.861 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -132.31 -167.72 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -140.12 -2.2 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.894 . . . . 0.0 110.416 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 1.9 p-10 -176.4 -157.7 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 108.502 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -86.08 -43.12 6.42 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.46 -36.11 17.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.856 -1.379 . . . . 0.0 108.056 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.607 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 15.1 t0 -77.69 -54.64 6.13 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.712 -0.618 . . . . 0.0 109.756 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -55.78 -53.48 56.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.087 -1.008 . . . . 0.0 110.018 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.77 -59.47 4.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -55.37 -33.67 63.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -90.03 -19.86 23.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.116 -0.99 . . . . 0.0 110.699 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -60.52 -22.13 63.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.841 -1.162 . . . . 0.0 109.287 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -90.69 -2.64 57.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 108.919 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.46 -71.9 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.57 -0.706 . . . . 0.0 109.848 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.36 -18.9 1.12 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.26 64.67 0.55 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.783 ' O ' HD11 ' A' ' 81' ' ' LEU . 84.7 m-85 -47.01 114.81 0.92 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.463 -1.022 . . . . 0.0 109.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.27 2.39 9.92 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -161.36 140.93 10.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.08 . . . . 0.0 108.854 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.8 t -134.97 121.17 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.796 -1.19 . . . . 0.0 110.069 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 56' ' ' SER . 43.2 mt -110.43 139.14 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 36.7 m -165.98 157.5 13.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.098 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 6.5 m-20 -61.39 -131.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 0.0 110.085 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 35.6 t-105 -173.11 -2.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.682 HD22 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -143.25 -16.44 0.66 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' HD22 ' A' ' 59' ' ' ASN . 24.0 tpp -81.08 -33.01 0.67 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 111.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -66.98 -148.0 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.715 0.944 . . . . 0.0 109.871 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -57.44 -159.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.561 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -44.67 -25.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 175.54 135.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.24 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.82 2.8 0.81 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 64' ' ' ASP . 12.3 tp -65.91 -60.13 3.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.809 -1.406 . . . . 0.0 108.068 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -49.34 -39.64 32.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.6 tt -58.87 -35.5 73.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -83.1 -63.66 1.32 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' LEU . 36.3 tttm -35.81 -49.95 0.63 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.083 0.468 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.4 m -49.2 -46.36 45.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 108.492 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 69' ' ' LEU . 55.3 mt -57.09 -33.18 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' CZ ' ' O ' ' A' ' 100' ' ' GLN . 9.8 ttt180 -67.58 -24.4 65.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.04 -28.54 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.54 82.16 8.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.1 89.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.35 -37.26 10.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.424 ' C ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -95.13 -71.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.52 11.05 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.382 -0.824 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -107.28 -31.7 8.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.653 -0.654 . . . . 0.0 109.759 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.783 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.14 97.53 0.11 Allowed Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 122.288 -0.257 . . . . 0.0 110.418 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.58 139.09 52.08 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 121.055 1.17 . . . . 0.0 111.028 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.9 t -131.36 137.68 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' LEU . 39.7 tp -119.81 69.85 0.85 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -51.58 170.52 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.247 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.0 t -140.84 131.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.263 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -149.3 166.14 29.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.077 -1.014 . . . . 0.0 110.351 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.55 32.3 6.21 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 109.714 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 91' ' ' LYS . 3.5 tt0 -153.84 -62.82 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.178 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 57.16 83.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -68.8 8.93 0.44 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.174 -0.954 . . . . 0.0 109.443 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER 73.18 -68.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.328 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -51.6 -43.45 62.52 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -18.64 65.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mm -83.99 -13.97 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.21 -63.17 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.46 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.22 -46.27 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.64 -48.83 78.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 109.123 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.76 61.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' CZ ' ' A' ' 73' ' ' ARG . 74.3 mt-30 -53.0 -23.77 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.77 -109.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.8 -1.85 4.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.43 11.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.086 -0.655 . . . . 0.0 110.87 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.675 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.4 m -29.46 -33.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.74 130.63 10.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.523 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.88 112.18 6.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 108.626 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.823 HG21 ' CD2' ' A' ' 116' ' ' LEU . 13.6 p -115.48 133.25 62.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 106' ' ' TYR . 18.4 m -67.67 -167.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 151.46 17.03 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.706 -1.247 . . . . 0.0 108.991 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.83 165.68 83.17 Favored 'Cis proline' 0 N--CA 1.489 1.236 0 O-C-N 122.459 0.715 . . . . 0.0 111.217 -1.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.825 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.2 p90 -132.82 156.94 46.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.694 0.759 . . . . 0.0 109.6 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.07 143.93 26.78 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -42.97 -33.76 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.253 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.04 95.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.0 m -65.2 -69.76 0.27 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.825 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -47.15 -31.69 3.72 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.972 -1.08 . . . . 0.0 109.986 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.745 ' OE2' HD21 ' A' ' 28' ' ' LEU . 6.1 tp10 -67.7 -62.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.647 -1.283 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 5.9 tt0 -41.82 -59.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.747 -0.596 . . . . 0.0 110.137 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -50.06 -40.57 45.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -66.02 -50.61 63.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -18.4 62.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.0 . . . . 0.0 109.811 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -81.91 -34.42 29.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 mt -78.89 -37.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.102 -0.999 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.6 m-85 -75.33 -30.22 60.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.23 -24.15 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 108.228 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -94.1 -23.26 18.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 124' ' ' PHE . 5.6 tp -83.3 -18.09 40.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 74.95 0.19 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.409 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -160.19 143.66 13.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.045 -1.035 . . . . 0.0 109.875 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -90.16 9.18 29.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.003 -1.061 . . . . 0.0 109.178 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -158.65 57.0 0.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 56.2 tp -84.87 120.57 26.61 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -57.29 112.12 1.29 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.988 -1.07 . . . . 0.0 111.764 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 25' ' ' LEU . 67.1 m-85 -107.16 151.05 25.93 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -122.25 106.02 10.74 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -89.93 113.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.273 -178.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' ' 36' ' ' ALA . 31.2 t -119.23 106.78 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.591 -0.693 . . . . 0.0 109.331 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -155.49 126.83 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.396 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' ASP . 64.7 t0 -57.77 -107.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.07 -156.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.282 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.434 ' C ' HG22 ' A' ' 16' ' ' THR . 38.1 t -150.35 24.98 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.115 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.434 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -178.65 4.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' THR . 1.8 tpp -68.84 -44.43 73.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.117 -0.989 . . . . 0.0 109.122 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -44.69 -47.03 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 109.85 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -56.38 -51.2 69.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.919 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -49.77 -58.51 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.004 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.49 -39.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.477 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -57.25 11.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 108.933 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.3 t-20 -57.63 -54.06 51.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -39.19 -55.08 1.72 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.814 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 8' ' ' PHE . 60.9 mt -61.82 -53.18 59.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 108.865 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 26' ' ' LYS . 8.1 mtpm? -52.55 -28.12 19.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.247 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -32.66 62.59 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.086 -1.009 . . . . 0.0 108.838 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.91 -69.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.254 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 18.41 0.02 OUTLIER Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 30.9 m-85 -96.07 153.99 17.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.351 . . . . 0.0 109.06 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -149.12 21.5 0.97 Allowed 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.87 -1.144 . . . . 0.0 110.894 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.855 ' H ' HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -138.29 107.65 6.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.917 -1.114 . . . . 0.0 111.106 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -148.33 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.226 -0.921 . . . . 0.0 109.606 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.3 mm-40 -137.35 -166.69 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -150.1 154.68 38.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.935 -1.103 . . . . 0.0 110.824 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.846 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.87 -163.67 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.91 -4.15 2.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.0 110.484 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 2.8 p-10 179.7 -173.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.025 -1.047 . . . . 0.0 109.52 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.71 67.05 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.93 -41.78 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.68 -1.482 . . . . 0.0 108.739 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 10.9 t70 -68.42 -44.45 74.99 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.73 -37.55 79.54 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.38 -57.8 7.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -66.43 -39.64 89.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 110.034 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -22.62 62.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.306 -0.871 . . . . 0.0 110.464 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.09 -4.8 5.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.831 -1.168 . . . . 0.0 109.325 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.05 -7.71 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.712 . . . . 0.0 109.213 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.59 -65.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.614 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.61 5.34 2.04 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.72 76.93 1.1 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.816 ' O ' HD22 ' A' ' 81' ' ' LEU . 52.6 m-85 -54.07 113.62 1.3 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.502 -0.999 . . . . 0.0 110.214 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.52 -4.81 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -165.48 141.35 5.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -1.14 . . . . 0.0 110.166 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 33.6 t -133.94 116.11 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.379 -0.826 . . . . 0.0 110.95 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.34 85.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.8 p -92.64 172.07 8.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 0.0 110.457 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 1.5 p-10 -95.31 -109.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.531 -0.73 . . . . 0.0 109.855 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 60.4 t-105 -159.82 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.466 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.614 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 41.5 m-20 -139.16 8.57 2.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -53.45 -49.57 87.71 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.956 -1.09 . . . . 0.0 109.72 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.2 -157.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 120.98 1.12 . . . . 0.0 109.496 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.666 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -85.38 143.75 28.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.072 -1.017 . . . . 0.0 109.395 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 19.9 ttm 74.47 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -137.9 164.73 28.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.535 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -91.49 -14.55 56.87 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -52.95 41.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.645 -1.503 . . . . 0.0 108.819 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -53.18 -22.98 7.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 108.549 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 10.2 tp -67.54 -55.16 14.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -57.69 -64.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -44.86 -46.2 10.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 109.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 67' ' ' GLU . 25.1 p -64.58 -43.77 92.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 109.163 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.973 HD13 HG21 ' A' ' 83' ' ' VAL . 25.4 mt -55.38 -27.25 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.344 -0.847 . . . . 0.0 108.735 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.01 -29.83 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.91 -29.92 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -0.894 . . . . 0.0 109.355 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.19 113.33 19.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.832 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.67 -23.71 77.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.35 77.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.178 . . . . 0.0 109.491 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.0 OUTLIER -100.34 -75.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.82 19.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.99 20.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 51' ' ' TYR . 10.5 mt -84.15 119.8 73.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.083 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.07 98.19 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 120.934 1.089 . . . . 0.0 112.13 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.973 HG21 HD13 ' A' ' 72' ' ' ILE . 2.4 t -99.17 121.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.684 HD12 HG12 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -99.95 107.13 19.02 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.51 110.52 18.74 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.061 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.436 HG12 ' CG1' ' A' ' 107' ' ' VAL . 0.7 OUTLIER -98.77 161.68 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.586 -1.321 . . . . 0.0 110.049 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.468 ' C ' ' NZ ' ' A' ' 109' ' ' LYS . 11.6 t -149.96 -155.59 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.497 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.42 32.57 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.536 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.99 -60.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.1 98.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 109.904 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 93' ' ' GLU . 32.0 tttp -112.59 54.62 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 mttt 54.12 -82.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.665 -0.647 . . . . 0.0 110.002 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LYS . 1.9 mt-10 -43.76 -56.05 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 110.509 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.642 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -55.32 -45.74 76.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.988 -1.07 . . . . 0.0 109.974 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.8 mt -48.86 -36.77 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 108.977 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 100' ' ' GLN . 15.2 mt -74.62 -25.62 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -56.18 -53.34 58.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 0.0 109.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.42 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -58.32 -59.36 5.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.917 -1.115 . . . . 0.0 108.451 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.06 -21.84 34.61 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.44 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.7 tt0 -52.21 -32.27 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.66 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -90.07 -22.66 21.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.66 72.26 0.88 Allowed Glycine 0 N--CA 1.482 1.74 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.196 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.08 -112.32 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 116.55 -2.06 . . . . 0.0 110.192 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 20.5 m -91.93 -52.56 4.67 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.529 1.633 . . . . 0.0 107.58 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.48 -160.19 33.23 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.22 147.01 49.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -1.076 . . . . 0.0 109.849 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 116' ' ' LEU . 7.5 p -136.99 128.74 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 149.96 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.62 160.87 62.43 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.79 124.07 8.9 Favored 'Cis proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.803 -0.915 . . . . 0.0 110.554 -1.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 116' ' ' LEU . 5.0 p90 -93.4 156.43 16.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.309 -0.869 . . . . 0.0 109.967 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.527 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.28 150.06 22.09 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.19 -32.14 4.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.82 -35.46 80.74 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.095 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -71.38 -65.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.081 -1.012 . . . . 0.0 108.51 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 107' ' ' VAL . 3.0 tp -52.34 -34.94 49.61 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.419 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 120' ' ' LEU . 4.3 tm-20 -69.12 -63.3 1.09 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.798 -1.189 . . . . 0.0 109.702 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.4 -41.84 9.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.632 -0.668 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HE3' HG23 ' A' ' 107' ' ' VAL . 2.6 mtmm -71.29 -27.78 63.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.1 tp -61.99 -62.1 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.36 -35.6 8.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.573 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -75.01 -29.89 60.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.166 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mm -77.05 -40.0 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.382 -0.824 . . . . 0.0 109.44 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -76.86 -0.24 23.32 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -31.41 58.61 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -90.18 -25.53 20.6 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.93 -25.58 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.52 89.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -46.28 132.36 10.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -90.46 18.63 5.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.036 . . . . 0.0 109.646 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -129.32 42.6 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 6' ' ' LEU . 30.7 tp -90.14 130.22 36.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -76.93 124.79 28.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 111.422 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.495 ' HB2' HG22 ' A' ' 33' ' ' VAL . 62.4 m-85 -109.29 152.08 25.71 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 46' ' ' LEU . 22.9 tp -131.15 105.59 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.51 104.62 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.085 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.7 t -94.45 88.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.414 -0.804 . . . . 0.0 109.436 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -149.33 157.15 43.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.56 -13.66 14.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.639 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HB3' ' H ' ' A' ' 17' ' ' MET . 1.5 m-85 -47.4 136.06 10.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.536 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.4 t -86.14 30.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.35 -24.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.409 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 23.6 ttt -66.06 -61.17 2.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -47.82 -35.17 9.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 109.389 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -72.14 -39.86 68.47 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.963 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -62.6 -53.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.755 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -32.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -55.26 20.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.749 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.86 -53.49 17.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.812 0.815 . . . . 0.0 109.543 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.53 -52.37 2.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.508 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 8' ' ' PHE . 5.2 mt -59.46 -55.16 38.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.393 -0.817 . . . . 0.0 108.999 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -52.1 -31.4 30.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 109.073 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -32.13 55.94 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.286 -0.884 . . . . 0.0 109.336 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -89.47 -61.14 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 162.16 73.34 0.02 OUTLIER Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -150.15 134.52 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.79 -1.418 . . . . 0.0 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.97 26.16 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.745 . . . . 0.0 110.449 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -137.82 93.71 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 109.393 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 8' ' ' PHE . 44.7 t -139.69 153.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.687 . . . . 0.0 110.336 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 12.4 mt-10 -127.63 -171.88 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.08 147.08 27.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.07 -1.019 . . . . 0.0 110.475 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.26 -165.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.11 0.77 2.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 3.8 t70 -176.43 164.77 2.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.766 -1.209 . . . . 0.0 109.849 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.632 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -56.67 -40.34 88.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.48 -40.38 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.119 -1.224 . . . . 0.0 108.336 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.569 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.3 t0 -66.88 -49.73 64.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.68 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.44 -56.98 13.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 42' ' ' ALA . 1.3 tp -41.1 -45.98 2.87 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.226 0.536 . . . . 0.0 109.735 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -70.93 -37.36 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' ALA . 31.2 mttt -90.09 4.4 50.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 110.045 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.578 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.08 -62.96 1.35 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.91 -1.119 . . . . 0.0 109.047 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -56.15 -8.51 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 108.861 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.33 -79.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.708 . . . . 0.0 109.742 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.75 1.4 11.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 77.55 0.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' O ' HD21 ' A' ' 81' ' ' LEU . 43.6 m-85 -64.71 109.54 2.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -1.065 . . . . 0.0 109.772 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.97 -1.95 1.71 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -157.51 139.92 14.63 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.277 . . . . 0.0 109.698 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 83' ' ' VAL . 25.2 t -141.8 124.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.165 -0.96 . . . . 0.0 109.568 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -132.52 168.95 17.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.785 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 54.5 t0 -94.4 -109.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.158 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.638 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 46.8 t-105 -164.75 -55.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.51 71.41 10.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.086 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mmm -92.4 149.63 38.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 109.191 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.37 -179.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 120.941 1.094 . . . . 0.0 109.945 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.83 -104.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 mtp -106.62 161.54 14.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 109.447 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -73.4 179.28 4.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.429 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -82.6 6.78 67.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.08 -40.29 60.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.02 -1.282 . . . . 0.0 108.247 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 6.2 tp10 -71.36 -15.95 62.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.7 mt -74.01 -58.6 3.19 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.854 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.9 -38.43 91.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.209 -0.932 . . . . 0.0 109.34 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' ALA . 13.8 tptm -63.5 -51.18 66.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 108.892 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 67' ' ' GLU . 24.0 p -60.35 -45.59 92.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 109.341 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.96 -34.63 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.252 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.15 -8.05 52.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -108.62 -16.91 14.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 109.733 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 74' ' ' ALA . 7.7 p30 -23.98 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.234 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -169.09 -82.34 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.33 26.85 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.958 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 tpt -147.94 36.37 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.3 m -79.14 58.03 2.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.34 -18.74 0.44 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.84 . . . . 0.0 110.667 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -47.79 111.13 1.58 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 109.476 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.26 125.89 19.31 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 121.422 1.414 . . . . 0.0 113.442 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -121.26 116.93 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -97.53 107.42 19.92 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.708 -1.597 . . . . 0.0 106.926 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.475 ' C ' ' SD ' ' A' ' 85' ' ' MET . 5.0 ppp? -75.24 131.87 40.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.45 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.92 142.23 25.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.362 0.601 . . . . 0.0 110.834 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.0 t -150.12 176.53 10.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 109.345 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -128.49 -5.92 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 109.232 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.8 pm0 -139.47 57.6 1.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.337 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -47.14 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' GLU . 12.1 tptt -77.93 48.15 0.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.871 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.6 mttp 52.44 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.0 tt0 -45.11 -40.51 7.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.424 -0.797 . . . . 0.0 110.028 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.638 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 3.0 m-20 -57.44 -41.23 80.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 109.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.694 HD11 ' HB1' ' A' ' 90' ' ' ALA . 95.2 mt -59.78 -51.44 72.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.063 -1.023 . . . . 0.0 108.446 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -66.23 -26.36 37.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.523 -0.736 . . . . 0.0 109.313 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.71 39.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.089 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -79.42 -50.88 10.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.845 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -55.89 -30.08 61.01 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.088 -1.045 . . . . 0.0 108.998 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.452 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.6 tt0 -58.64 -34.16 70.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.854 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -77.88 -22.62 49.49 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 60.17 79.31 0.12 Allowed Glycine 0 N--CA 1.478 1.495 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.532 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.812 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.37 -111.95 0.06 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 116.932 -1.907 . . . . 0.0 109.288 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.8 t -91.94 -49.73 6.08 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.753 1.263 . . . . 0.0 108.278 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.47 -165.7 37.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.27 125.63 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.947 . . . . 0.0 109.484 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.8 p -126.59 122.66 61.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -58.18 -167.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.8 pttm -164.71 155.25 12.68 Favored Pre-proline 0 C--N 1.297 -1.711 0 O-C-N 120.649 -1.282 . . . . 0.0 109.312 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.6 161.05 94.95 Favored 'Cis proline' 0 N--CA 1.485 0.991 0 C-N-CA 124.888 -0.88 . . . . 0.0 110.432 -2.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.6 p90 -127.92 166.23 18.7 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.704 0.764 . . . . 0.0 109.791 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -95.24 146.34 24.41 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.39 0.73 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.998 -1.063 . . . . 0.0 109.596 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.75 72.92 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.008 -1.057 . . . . 0.0 108.521 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.86 -64.67 0.82 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -49.67 -39.27 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.758 -1.214 . . . . 0.0 109.381 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 120' ' ' LEU . 30.4 tt0 -64.78 -64.47 0.86 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.063 -1.023 . . . . 0.0 109.749 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -44.97 -36.6 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -75.73 -29.53 58.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.941 . . . . 0.0 109.155 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 117' ' ' GLU . 6.3 tp -66.61 -56.98 8.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -52.9 -41.66 64.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -67.9 -27.45 66.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.666 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.32 -45.29 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 13.7 m-85 -65.62 -27.64 68.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -51.35 -29.57 15.73 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 108.274 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -88.14 -21.11 24.81 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 1.3 tt -80.2 -24.62 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.803 . . . . 0.0 108.861 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.34 -41.73 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.271 -1.135 . . . . 0.0 109.521 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.35 0.595 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.495 ' O ' ' CE2' ' A' ' 30' ' ' PHE . 1.2 t0 -55.63 146.67 20.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -90.07 27.46 1.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.667 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -158.2 37.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.6 tp -72.45 137.7 46.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 2.3 mtmp? -76.89 136.62 38.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.039 -1.038 . . . . 0.0 111.531 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.8 m-85 -127.87 145.44 50.94 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.817 -0.552 . . . . 0.0 110.371 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.553 HD22 HD12 ' A' ' 46' ' ' LEU . 64.4 tp -118.4 118.35 31.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.31 104.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.997 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.2 t -98.79 116.57 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.501 -0.75 . . . . 0.0 109.383 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.77 178.42 8.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.723 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -118.99 13.63 13.07 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -161.82 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.262 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -138.82 -0.7 1.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 109.101 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.65 3.12 0.84 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.805 . . . . 0.0 109.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.6 ttt -74.72 -45.39 44.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.509 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.98 -27.11 61.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.618 ' N ' HH21 ' A' ' 18' ' ' ARG . 10.0 mmt180 -73.25 -31.23 63.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mt -64.88 -54.16 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.68 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 109.945 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 35' ' ' GLU . 8.5 mtt85 -46.71 -54.98 8.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.9 t30 -66.24 -58.47 5.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.438 -0.789 . . . . 0.0 109.432 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.26 -65.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.016 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.69 -45.92 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.163 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -38.28 78.92 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.211 -0.93 . . . . 0.0 109.397 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.61 -41.72 63.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 ' CD ' ' A' ' 117' ' ' GLU . 2.1 mm? -70.94 -61.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 109.136 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.33 42.89 0.02 OUTLIER Glycine 0 N--CA 1.479 1.548 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 94.9 m-85 -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.448 -1.031 . . . . 0.0 109.052 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -149.99 67.41 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.884 -1.135 . . . . 0.0 110.4 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.68 97.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.132 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.14 152.29 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.99 -1.069 . . . . 0.0 110.13 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -124.44 -167.3 1.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' OE2' ' NH1' ' A' ' 22' ' ' ARG . 17.9 mt-10 -147.62 146.49 29.37 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 110.153 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.997 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.11 -165.13 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -144.98 -0.74 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.909 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 25.8 t0 -171.57 178.8 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.744 -1.222 . . . . 0.0 109.891 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.448 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . -67.22 -52.04 34.44 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -55.33 -27.66 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -1.097 . . . . 0.0 108.615 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -79.86 -42.73 23.65 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.315 -0.866 . . . . 0.0 108.911 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.86 -36.26 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.338 -0.851 . . . . 0.0 109.644 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.76 -37.42 73.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.545 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -82.95 -26.72 31.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.029 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -85.24 -14.36 46.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.393 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.553 HD12 HD22 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -76.88 -19.4 57.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.662 -1.274 . . . . 0.0 109.405 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -68.08 -5.68 18.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 108.879 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.51 -70.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.809 . . . . 0.0 109.779 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.23 13.11 1.08 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.01 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 20.4 m-85 -70.82 140.71 51.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.377 -1.073 . . . . 0.0 110.09 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.84 -6.27 62.2 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -156.54 142.95 18.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.762 -0.846 . . . . 0.0 108.756 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.93 118.32 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.671 -1.268 . . . . 0.0 110.006 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.1 mt -100.89 153.52 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.9 p -170.86 166.0 7.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.032 -1.042 . . . . 0.0 109.189 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CD1' ' OD1' ' A' ' 59' ' ' ASN . 61.8 t-105 -167.12 -57.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.05 -1.031 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.605 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -172.54 72.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 110.434 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -91.49 -47.69 0.34 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 110.511 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.94 -160.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 C-N-CA 121.129 1.219 . . . . 0.0 110.216 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.835 HD22 ' H ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -76.67 -40.6 48.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.658 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -79.95 143.98 33.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.33 146.16 27.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -64.85 -15.35 60.0 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -73.91 -72.74 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.163 -1.198 . . . . 0.0 109.951 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' LEU . 69.5 tt0 -45.86 -26.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -69.11 -46.89 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.643 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 7.8 tt -74.67 -62.65 1.46 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.389 0.614 . . . . 0.0 109.397 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -43.39 -31.64 0.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -63.56 -41.84 98.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 47.9 mt -57.91 -40.04 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -68.37 -3.16 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.26 69.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -73.14 139.92 46.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.31 80.34 0.95 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -170.9 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -1.182 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.96 10.73 30.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.403 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m 52.49 -117.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.987 . . . . 0.0 109.18 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -125.91 0.92 7.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER 52.77 171.14 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.44 136.13 57.43 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 121.489 1.46 . . . . 0.0 112.874 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.94 139.85 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.82 68.28 0.76 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -61.57 131.57 50.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.45 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.89 135.74 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.192 -0.942 . . . . 0.0 110.813 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -150.07 156.11 41.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.567 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -85.53 156.8 20.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 tm-20 59.69 -75.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 79.4 97.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -0.761 . . . . 0.0 109.205 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.6 mmmt -58.33 -107.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -163.47 -69.16 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -52.56 -16.46 0.93 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.902 . . . . 0.0 109.372 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -78.64 -29.41 45.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.7 -15.7 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.664 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 97' ' ' ALA . 14.9 mt -82.22 -64.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.785 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -46.26 -47.85 18.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 0.0 109.376 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.654 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -58.2 -51.71 68.59 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.47 -0.769 . . . . 0.0 109.758 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -52.21 -48.65 64.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -47.99 -22.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 108.791 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -94.35 -116.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.659 -0.65 . . . . 0.0 109.531 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.707 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -127.58 -3.67 5.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -59.34 10.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.671 -0.899 . . . . 0.0 109.375 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.707 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.45 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.26 130.98 10.41 Favored Glycine 0 N--CA 1.497 2.722 0 C-N-CA 119.492 -1.337 . . . . 0.0 109.899 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.89 109.24 5.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -1.053 . . . . 0.0 109.351 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG1' HG12 ' A' ' 86' ' ' VAL . 7.3 p -107.54 139.82 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.503 HG22 ' OH ' ' A' ' 106' ' ' TYR . 1.2 t -81.82 119.18 30.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.34 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -88.4 151.62 48.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.892 -1.13 . . . . 0.0 109.624 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.82 162.24 92.57 Favored 'Cis proline' 0 N--CA 1.487 1.121 0 C-N-CA 125.226 -0.739 . . . . 0.0 110.512 -1.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -139.23 159.13 42.88 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 109.993 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.59 151.5 21.53 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.45 -17.33 0.15 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 108.835 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.85 -43.6 58.15 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -67.25 -63.84 0.98 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.3 tp -46.88 -36.11 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.432 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.62 ' CD ' HD11 ' A' ' 28' ' ' LEU . 16.6 tt0 -63.62 -64.3 0.93 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.99 -1.069 . . . . 0.0 109.772 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -52.99 7.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -46.53 -46.51 19.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.529 HD11 ' CE2' ' A' ' 53' ' ' PHE . 1.3 tp -57.92 -54.97 40.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -21.07 48.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -38.73 49.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.15 . . . . 0.0 109.624 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -90.1 -36.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.353 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -73.29 -41.03 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -51.15 -18.83 0.96 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.843 -1.16 . . . . 0.0 108.046 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -98.44 -23.72 15.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' PHE . 0.5 OUTLIER -82.33 -21.93 35.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 55.05 81.01 0.07 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 109.368 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.264 0.554 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 62.2 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.362 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -90.05 19.2 5.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -137.42 41.21 2.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 tp -75.0 127.73 33.92 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 122.74 24.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 111.712 -177.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 44.6 m-85 -109.98 152.87 25.34 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.5 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.1 tp -117.36 109.45 16.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.64 121.05 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 109.86 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 36' ' ' ALA . 46.1 t -123.45 27.08 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -51.73 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.915 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -53.4 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.622 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -46.94 140.41 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.626 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -88.24 13.78 10.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.356 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -136.11 -18.56 1.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.711 . . . . 0.0 109.299 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.417 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -68.97 -17.68 63.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.244 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -34.91 78.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.872 . . . . 0.0 109.36 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -24.39 62.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 108.914 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -69.91 -52.35 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -30.7 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.747 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.2 -54.29 17.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.95 . . . . 0.0 109.408 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.3 t-20 -67.41 -57.29 6.84 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.804 0.811 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.21 -43.51 1.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.695 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 12.2 mt -70.07 -38.97 75.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.778 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -63.96 -38.26 90.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.29 -0.881 . . . . 0.0 109.157 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -51.0 -35.09 32.01 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.351 -0.843 . . . . 0.0 109.036 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 28' ' ' LEU . 11.0 mp -77.56 -50.9 11.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.336 -0.852 . . . . 0.0 109.133 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.83 35.71 0.06 OUTLIER Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.39 147.39 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.391 -1.064 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -150.17 57.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.05 -1.031 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.88 110.2 0.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.766 -1.209 . . . . 0.0 110.181 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 34' ' ' GLU . 1.3 m -148.2 -177.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 0.0 109.673 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.3 mm-40 -128.11 -171.89 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.77 145.77 30.95 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.125 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.09 -174.2 4.65 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.25 23.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.741 -1.224 . . . . 0.0 110.363 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 179.53 147.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.865 -1.147 . . . . 0.0 109.336 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.59 -39.89 23.77 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.32 -32.05 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -1.069 . . . . 0.0 108.793 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.546 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.2 t0 -76.98 -45.69 26.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.42 -32.55 74.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.555 -0.716 . . . . 0.0 109.394 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 43' ' ' LEU . 3.2 tt -68.22 -65.72 0.66 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -46.51 -27.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 3.9 mttm -90.0 -39.08 13.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.5 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -53.2 -37.6 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.04 . . . . 0.0 108.885 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 7.3 mt-30 -54.94 -24.36 23.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -44.23 -61.3 1.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.164 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.0 75.39 1.22 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -173.18 -31.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.591 ' O ' HD21 ' A' ' 81' ' ' LEU . 15.2 m-85 -61.35 86.27 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.269 -1.136 . . . . 0.0 110.015 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -66.92 6.08 2.22 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.6 t80 -158.08 146.2 18.69 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 121.565 -0.962 . . . . 0.0 109.099 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 83' ' ' VAL . 76.6 t -144.01 127.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.617 -1.302 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.77 103.19 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.481 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 23.4 p -109.32 -178.91 3.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 0.0 110.46 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 85' ' ' MET . 32.3 t70 -89.44 -131.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.842 . . . . 0.0 110.292 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.452 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 46.7 t-105 -162.7 -55.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.96 . . . . 0.0 110.092 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.531 ' O ' ' SD ' ' A' ' 60' ' ' MET . 24.0 t-20 -142.54 103.36 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.75 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.558 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.81 -46.22 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -69.36 -162.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.05 1.166 . . . . 0.0 109.979 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -54.07 130.38 37.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.106 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.425 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 36.7 mmm 51.17 -116.16 0.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -142.59 151.01 41.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 108.932 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.35 12.61 1.77 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 64' ' ' ASP . 1.2 tp -67.8 -57.2 6.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -1.185 . . . . 0.0 108.97 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -19.81 64.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.459 -0.776 . . . . 0.0 109.115 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -59.3 4.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.5 tt -70.95 -59.46 2.78 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.8 tttt -38.38 -37.71 0.31 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -63.3 -44.17 95.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 108.794 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 56.0 mt -55.33 -38.0 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.97 -5.95 58.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.49 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -84.82 -26.74 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 109.625 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.07 -15.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 67.31 -0.65 8.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.91 26.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -1.121 . . . . 0.0 109.413 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 mmt -139.79 20.61 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 109.339 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.2 p -85.61 49.23 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.52 6.02 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 109.843 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 51' ' ' TYR . 7.2 tp -92.98 119.59 67.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 108.636 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.91 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 120.774 0.982 . . . . 0.0 111.926 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.737 HG11 HD11 ' A' ' 69' ' ' LEU . 8.7 t -98.8 110.4 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.363 -0.836 . . . . 0.0 108.759 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.29 101.6 13.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 1.1 tpt -75.5 152.14 37.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.72 147.3 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.632 -0.668 . . . . 0.0 110.151 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.55 HG22 ' N ' ' A' ' 88' ' ' ALA . 30.9 m -143.77 163.18 34.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.969 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.55 ' N ' HG22 ' A' ' 87' ' ' THR . . . -105.09 -62.43 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -96.57 87.19 4.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.094 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -81.79 161.09 23.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.917 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.772 ' H ' HD22 ' A' ' 94' ' ' ASN . 14.4 tttt -147.39 154.23 40.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.169 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -48.39 61.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.12 -52.81 8.65 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.131 -0.981 . . . . 0.0 110.632 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.772 HD22 ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -58.44 -10.21 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.113 -0.992 . . . . 0.0 110.561 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 9.9 mt -86.35 -7.29 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.827 -1.171 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.5 mp -90.07 -46.59 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -46.01 -22.7 0.23 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.42 -52.57 45.02 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -49.22 -41.82 38.5 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.722 -1.861 . . . . 0.0 107.96 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.92 -31.27 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.798 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -134.82 -71.2 0.49 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -49.98 82.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 176.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -68.46 -110.13 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 112.586 -1.807 . . . . 0.0 115.08 -174.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -37.44 -57.22 0.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.723 -176.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.67 171.16 33.65 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.852 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.46 113.48 11.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 107' ' ' VAL . 13.1 p -109.25 115.25 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 108' ' ' VAL . 1.1 p -71.04 102.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 159.39 77.29 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.049 -1.032 . . . . 0.0 109.123 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.9 154.21 99.51 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.357 -2.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -129.57 160.83 32.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.859 0.838 . . . . 0.0 110.138 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -97.97 148.49 23.42 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.13 -35.48 7.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 109.327 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 -35.38 80.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.0 m -70.43 -67.8 0.47 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 115' ' ' THR . 10.6 tp -47.28 -39.62 14.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.656 -1.278 . . . . 0.0 109.344 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -62.7 -53.48 53.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.078 -1.014 . . . . 0.0 109.5 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.0 mm-40 -47.4 -28.32 2.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.286 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -79.55 -49.83 11.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.445 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -48.26 73.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.307 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.13 -47.36 86.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 109.956 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.8 mt -82.82 -35.86 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.888 . . . . 0.0 109.116 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -85.92 -2.15 57.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.46 -27.04 55.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -93.65 -31.09 14.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.59 -27.97 62.5 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.11 87.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.384 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -53.28 144.2 16.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.197 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.486 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 14.3 mttm -90.15 18.84 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 0.0 109.366 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -159.63 48.96 0.3 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 40.2 tp -77.51 113.02 14.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.999 -1.063 . . . . 0.0 108.433 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -53.78 106.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.938 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.594 ' HB2' HG22 ' A' ' 33' ' ' VAL . 69.0 m-85 -101.09 153.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.899 HD23 HD12 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -137.58 117.63 13.41 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.813 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.3 m -106.01 119.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.658 -0.651 . . . . 0.0 110.906 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' ' 36' ' ' ALA . 54.4 t -103.56 112.49 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 121.384 -0.823 . . . . 0.0 109.462 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.464 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -157.96 139.64 13.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -80.2 -12.17 59.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.439 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.52 141.66 58.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 t -92.65 41.18 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -172.06 -40.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 14.1 ttm -46.94 -15.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' THR . 2.9 mtt180 -86.15 -44.34 12.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 109.684 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -65.64 -13.44 59.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.458 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.15 -49.48 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -36.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' ' OE2' ' A' ' 35' ' ' GLU . 8.0 mtt180 -50.81 -52.87 36.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 109.267 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.23 -57.06 7.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.977 0.894 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.28 -48.88 3.67 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.836 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.56 -51.05 62.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.835 -1.166 . . . . 0.0 108.518 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.28 -32.99 5.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -48.59 -38.95 22.1 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.008 . . . . 0.0 109.1 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' OE2' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -76.57 -68.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.384 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.09 20.95 0.02 OUTLIER Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.498 ' C ' HD22 ' A' ' 31' ' ' ASN . 29.1 m-85 -97.15 139.22 33.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.862 -1.375 . . . . 0.0 109.75 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.634 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.84 67.21 1.28 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.124 -0.985 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -174.82 91.56 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.199 -0.938 . . . . 0.0 108.82 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 8' ' ' PHE . 22.0 t -138.94 154.84 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.214 -0.929 . . . . 0.0 110.818 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.671 ' OE2' HD22 ' A' ' 9' ' ' LEU . 13.5 pt-20 -125.89 -171.02 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 13.3 mp0 -144.56 161.46 39.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.83 . . . . 0.0 110.045 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.45 -170.45 3.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.535 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 68.1 mt-10 -134.32 0.71 3.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.532 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 0.2 OUTLIER 175.7 -175.22 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.785 -1.197 . . . . 0.0 109.314 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.97 -54.07 33.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 41' ' ' ASP . 29.6 m -57.3 -36.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -1.131 . . . . 0.0 108.799 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 12.2 t0 -63.48 -45.09 92.35 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -55.73 -67.97 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.778 . . . . 0.0 109.035 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -43.17 -28.52 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.305 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -79.42 -50.35 10.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.908 -1.12 . . . . 0.0 110.818 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' OE2' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -89.79 -3.79 57.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.086 -1.009 . . . . 0.0 110.605 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.899 HD12 HD23 ' A' ' 9' ' ' LEU . 4.4 tt -90.11 -41.21 11.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.074 -1.016 . . . . 0.0 109.624 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.43 0.79 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.31 -60.57 1.86 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.572 -0.705 . . . . 0.0 109.843 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.35 11.1 1.0 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.115 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.46 97.91 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 15.9 m-85 -79.22 124.23 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.204 -1.174 . . . . 0.0 110.405 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.83 -3.86 56.66 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -167.77 142.71 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.428 . . . . 0.0 109.369 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.5 t -134.78 158.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.278 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 84' ' ' LEU . 13.9 mt -143.31 127.59 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 85' ' ' MET . 15.7 p -147.61 157.45 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.892 -1.13 . . . . 0.0 110.175 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 8.8 t0 -65.78 -137.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.528 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 60.6 t-105 -173.37 111.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.468 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 66.97 27.43 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.602 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.1 tpt -101.8 -41.99 0.21 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 111.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.2 Cg_exo -65.57 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.158 1.239 . . . . 0.0 110.518 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -74.17 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.064 -1.023 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.3 mtm -74.09 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 65' ' ' GLY . 61.9 t0 -172.38 140.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.063 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -70.98 15.69 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 64' ' ' ASP . 13.7 tp -81.09 -56.76 3.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.08 -1.247 . . . . 0.0 107.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -60.28 -22.25 62.9 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD13 ' CA ' ' A' ' 39' ' ' GLY . 22.5 tp -64.32 -59.06 4.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -48.06 -63.18 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.752 0.787 . . . . 0.0 108.953 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.2 tttm -40.29 -44.08 1.84 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 110.272 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -58.68 -39.13 79.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.915 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 69' ' ' LEU . 37.7 mt -58.98 -41.68 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.156 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -50.06 -30.07 10.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 109.559 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -45.98 -24.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 74' ' ' ALA . 12.2 t70 -44.1 -91.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -164.77 -142.88 3.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.25 -0.1 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.686 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.93 7.38 37.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 47.29 -132.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.241 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -113.57 12.13 18.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.724 -0.61 . . . . 0.0 109.589 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 52.5 173.85 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.224 -0.922 . . . . 0.0 108.722 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.33 144.02 99.54 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.326 1.351 . . . . 0.0 113.452 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -138.54 135.86 43.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.3 tp -114.76 69.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 56' ' ' SER . 5.1 ptm -56.66 156.07 6.8 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.557 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.08 138.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.852 -0.53 . . . . 0.0 109.588 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -146.63 179.88 7.25 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.466 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -130.69 -26.32 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.835 -0.54 . . . . 0.0 109.608 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -117.4 61.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 109.756 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.02 108.98 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.173 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -78.59 -79.65 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.794 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -174.48 -89.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.014 . . . . 0.0 109.548 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.64 45.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -54.64 -26.15 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.332 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.692 HD11 ' HB1' ' A' ' 90' ' ' ALA . 36.4 mt -85.12 -17.47 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 0.0 109.264 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' ALA . 72.5 mt -82.94 -62.92 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -45.82 -54.21 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.56 -52.38 17.84 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.42 -0.8 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.54 69.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.584 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -59.01 -17.18 22.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.044 -1.035 . . . . 0.0 109.968 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.85 -34.99 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.336 -0.852 . . . . 0.0 109.88 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.709 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.06 -13.07 0.73 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.5 10.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.769 -0.842 . . . . 0.0 109.885 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.709 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.46 -35.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.113 -177.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.39 127.05 9.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.554 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -139.62 113.4 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -1.032 . . . . 0.0 108.567 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.811 HG21 HD12 ' A' ' 116' ' ' LEU . 14.1 p -116.01 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.029 HG12 ' H ' ' A' ' 109' ' ' LYS . 33.1 t -61.27 -164.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 1.029 ' H ' HG12 ' A' ' 108' ' ' VAL . 9.9 pttm -164.88 156.09 13.03 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.464 -1.398 . . . . 0.0 108.737 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.96 166.69 81.64 Favored 'Cis proline' 0 N--CA 1.486 1.034 0 C-N-CA 125.158 -0.768 . . . . 0.0 110.857 -1.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.03 161.98 37.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -102.28 171.28 7.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 176.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -61.41 -25.52 67.25 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.555 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.56 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.416 -0.802 . . . . 0.0 109.138 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -66.34 -64.55 0.83 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 107' ' ' VAL . 4.1 tp -47.76 -36.44 11.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.811 -1.18 . . . . 0.0 109.779 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 2.9 mm-40 -59.2 -66.69 0.47 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.816 -1.178 . . . . 0.0 109.939 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -45.62 -25.71 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.637 -0.665 . . . . 0.0 110.532 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -86.34 -44.54 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 110.246 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -43.13 91.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.437 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -64.81 -40.83 95.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -56.57 -31.73 64.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.257 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 125' ' ' GLU . 67.8 mt -85.69 -45.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -70.46 10.12 0.52 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.235 -0.915 . . . . 0.0 109.368 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.5 tt0 -83.29 -24.68 32.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -96.21 -30.85 13.25 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -72.3 -26.07 61.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.88 88.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.445 ' SD ' ' OXT' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER 52.88 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.395 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -73.15 32.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.952 . . . . 0.0 109.137 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' ASP . 82.0 mt-10 -155.25 33.32 0.38 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 108.993 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 53' ' ' PHE . 39.2 tp -70.12 132.9 46.53 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -76.09 117.55 17.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -106.12 152.44 23.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.2 tp -126.78 111.06 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -97.77 116.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.782 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' A' ' 36' ' ' ALA . 56.5 t -118.86 110.74 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.912 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -177.2 124.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.985 -1.072 . . . . 0.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.14 7.47 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.717 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -172.16 -154.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.439 -1.413 . . . . 0.0 112.258 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.717 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 177.91 16.43 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.491 HG22 ' C ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -171.92 -48.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.927 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 22.0 ttt -38.85 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.665 -0.647 . . . . 0.0 110.853 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 51.1 mtm180 -43.37 -30.24 0.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.45 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -30.27 39.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.642 -1.287 . . . . 0.0 109.445 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.8 mt -69.66 -49.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.93 -35.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -46.95 -54.1 10.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 109.039 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t30 -61.23 -56.76 17.0 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.845 0.831 . . . . 0.0 108.787 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -36.89 -67.61 0.17 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.897 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.29 -42.79 74.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.925 -1.109 . . . . 0.0 108.997 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -59.16 -28.4 66.56 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -46.61 68.92 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.138 -0.976 . . . . 0.0 109.213 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.0 -62.95 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -0.883 . . . . 0.0 109.077 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.09 18.7 0.02 OUTLIER Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.198 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.97 123.72 34.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.488 -1.595 . . . . 0.0 109.156 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.18 69.27 1.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.73 96.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.094 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.07 149.79 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.004 -1.06 . . . . 0.0 109.916 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 3.6 mt-10 -118.95 -172.18 2.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.8 mp0 -147.11 165.69 29.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 110.396 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.902 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.98 -170.46 3.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -130.25 0.27 4.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.475 -0.766 . . . . 0.0 110.326 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.18 176.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.034 . . . . 0.0 109.601 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.433 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -60.32 -47.31 91.72 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -52.85 -35.07 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.088 -1.242 . . . . 0.0 108.42 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 34.9 t0 -74.06 -52.87 11.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.501 -0.749 . . . . 0.0 109.247 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -56.03 -57.44 12.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.304 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.857 HD11 HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -46.28 -46.49 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.0 109.777 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -72.52 -31.6 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 0.0 110.134 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -90.08 -7.06 54.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.973 . . . . 0.0 110.238 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -70.53 -6.44 36.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 0.0 108.77 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.51 -2.16 57.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.987 -1.07 . . . . 0.0 109.234 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.76 -67.82 0.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.822 . . . . 0.0 109.456 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.48 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.58 72.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.724 ' O ' HD21 ' A' ' 81' ' ' LEU . 76.7 m-85 -54.9 95.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.94 -6.13 1.68 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -153.42 139.24 18.03 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.49 -1.006 . . . . 0.0 109.587 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 9' ' ' LEU . 47.8 t -134.0 118.81 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.004 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 55' ' ' ILE . 34.8 mt -99.51 114.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.6 p -132.24 166.21 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.806 . . . . 0.0 109.326 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 12.4 p-10 -90.01 -118.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.117 -0.99 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 43.2 t-105 -162.36 -18.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.331 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.38 96.21 5.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.312 0.577 . . . . 0.0 109.774 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 159.69 70.75 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.73 -41.82 73.65 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.144 1.23 . . . . 0.0 110.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.7 m120 -96.51 -107.74 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 0.0 109.192 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 63' ' ' MET . 2.8 mpp? -69.56 -161.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.5 176.38 6.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.064 -1.022 . . . . 0.0 109.29 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.93 59.25 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.571 -1.3 . . . . 0.0 109.874 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.8 tp -86.24 -40.68 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.808 -1.407 . . . . 0.0 107.58 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.74 -18.03 65.17 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' CA ' ' A' ' 39' ' ' GLY . 25.6 tp -78.48 -66.48 0.85 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -56.73 -40.03 74.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -47.53 86.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.288 -0.882 . . . . 0.0 109.023 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.857 HG21 HD11 ' A' ' 43' ' ' LEU . 52.9 m -51.23 -47.38 62.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.61 -46.09 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 108.795 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -62.09 -29.0 70.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.6 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 71' ' ' THR . . . -45.27 -29.13 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 11.1 t70 -67.73 99.69 0.83 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.71 76.58 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -168.26 -60.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 0.0 109.405 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.1 mmt -92.91 -71.03 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t 45.46 26.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.374 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.81 -12.59 4.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.654 -0.654 . . . . 0.0 109.487 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.2 tp -48.25 113.37 2.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.112 -0.993 . . . . 0.0 108.729 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.5 121.59 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.2 1.267 . . . . 0.0 112.751 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.52 115.52 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' MET . 5.5 tp -101.61 73.88 1.48 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.896 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' LEU . 6.0 mtt -48.15 172.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -147.15 120.18 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.413 -0.805 . . . . 0.0 109.344 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -150.04 -178.47 6.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.743 -1.223 . . . . 0.0 110.042 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.31 -41.64 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.51 56.42 2.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 109.375 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -71.26 111.51 6.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.708 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.203 -0.936 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -136.36 -70.21 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -45.97 -16.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.809 . . . . 0.0 109.553 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -90.13 -57.31 2.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 109.608 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 90' ' ' ALA . 69.2 mt -47.44 -28.42 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.377 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.95 -60.04 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.313 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.69 -52.8 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 108.971 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.462 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -50.64 -48.45 58.21 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.495 -0.753 . . . . 0.0 108.992 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.75 -45.92 49.92 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.687 ' N ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -50.23 -29.18 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 108.864 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -112.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.47 -0.769 . . . . 0.0 109.191 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -131.64 0.14 4.98 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.6 11.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.143 -0.622 . . . . 0.0 110.621 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 21.8 m -29.44 -32.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 122.265 -0.272 . . . . 0.0 111.723 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.81 135.48 12.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -152.06 110.23 3.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 108.822 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.5 p -104.44 139.75 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -88.07 105.19 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.531 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.21 160.12 83.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.903 -1.123 . . . . 0.0 109.059 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.08 166.33 83.54 Favored 'Cis proline' 0 N--CA 1.484 0.944 0 C-N-CA 124.747 -0.939 . . . . 0.0 110.577 -2.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CE1' HD12 ' A' ' 116' ' ' LEU . 6.6 p90 -142.4 -170.98 3.3 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.978 0.894 . . . . 0.0 109.554 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.529 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -135.22 150.18 50.04 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.45 -33.65 6.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.418 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.83 -30.96 61.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -79.32 -61.3 2.05 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.613 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -49.99 -32.45 15.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.45 -1.406 . . . . 0.0 108.388 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.19 -56.99 10.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.066 -1.021 . . . . 0.0 109.942 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -44.16 -36.41 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.668 -0.645 . . . . 0.0 109.459 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -43.52 81.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.293 -0.879 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.56 -63.07 1.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 109.481 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -44.73 -49.48 10.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.339 -0.851 . . . . 0.0 110.598 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.13 -29.61 63.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.288 -0.883 . . . . 0.0 110.726 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.55 HD11 ' HA2' ' A' ' 105' ' ' GLY . 15.1 mt -89.98 -44.63 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.156 . . . . 0.0 110.785 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -59.14 -9.95 2.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.014 -1.054 . . . . 0.0 110.571 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -20.9 63.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -95.49 -31.88 13.14 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -22.37 43.52 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.87 88.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.256 -1.143 . . . . 0.0 109.459 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -46.27 109.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.0 109.637 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 2.0 mmtp -56.36 7.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.157 -0.964 . . . . 0.0 110.635 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' ' C ' ' A' ' 3' ' ' ASP . 73.3 mt-10 -141.92 45.34 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.058 -1.026 . . . . 0.0 108.738 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 45.0 tp -76.64 107.97 9.31 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 118.215 -1.394 . . . . 0.0 108.715 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -48.95 113.83 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 68.8 m-85 -104.94 155.46 18.92 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -130.97 103.4 6.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 107.78 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 0.0 109.802 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 36' ' ' ALA . 50.3 t -107.87 106.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 -163.51 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.393 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.02 4.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.05 165.28 14.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -97.69 9.7 41.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -149.74 10.22 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 0.0 109.642 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.1 ttt -92.13 -47.14 7.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -28.81 69.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' CG ' HH21 ' A' ' 22' ' ' ARG . 31.6 ttp85 -68.49 -52.77 28.66 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.778 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.5 mt -46.24 -55.05 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.365 -0.835 . . . . 0.0 109.689 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.4 -43.27 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.616 -178.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.432 HH21 ' CG ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -46.88 -55.01 8.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.038 -1.039 . . . . 0.0 109.755 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.33 -55.13 19.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.111 0.958 . . . . 0.0 109.039 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -39.73 -55.25 1.96 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.893 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 30.6 mt -59.94 -49.89 75.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.07 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.79 -34.11 38.37 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.909 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 2.8 tt0 -58.24 -30.17 66.31 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -87.08 -14.48 41.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.775 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.22 46.05 1.77 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.228 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -117.28 129.36 55.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.308 -1.113 . . . . 0.0 108.9 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -128.68 67.99 1.39 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.95 94.91 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -0.957 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.05 149.19 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 110.843 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.78 -169.06 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -150.0 154.52 38.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.021 -1.05 . . . . 0.0 110.69 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.11 -172.4 3.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -139.09 15.47 2.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.169 -0.957 . . . . 0.0 110.619 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 175.24 146.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.713 -1.242 . . . . 0.0 109.868 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -32.98 10.05 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.04 -35.72 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.337 -1.096 . . . . 0.0 108.657 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 26.5 t0 -70.87 -44.94 65.34 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.25 -54.13 42.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.73 -43.15 17.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.922 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -73.94 -33.27 63.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -90.02 -7.68 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 110.006 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -68.07 -13.6 62.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -85.82 -2.83 58.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.45 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.464 -0.772 . . . . 0.0 109.722 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.61 9.97 1.43 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.84 83.75 1.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.485 ' C ' ' N ' ' A' ' 53' ' ' PHE . 57.2 m-85 -62.69 99.89 0.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.29 -1.123 . . . . 0.0 109.693 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.96 -14.28 0.41 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -148.99 119.23 7.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.48 -1.012 . . . . 0.0 109.884 -179.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HB ' HG22 ' A' ' 83' ' ' VAL . 53.8 t -116.65 124.05 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.238 -0.913 . . . . 0.0 109.524 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 55' ' ' ILE . 1.1 mt -107.45 126.16 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -143.44 145.15 32.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -0.782 . . . . 0.0 108.987 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -98.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.081 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -172.57 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.145 -0.972 . . . . 0.0 109.726 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -134.84 -1.39 2.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.333 -0.854 . . . . 0.0 109.761 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.684 ' N ' HD22 ' A' ' 59' ' ' ASN . 2.2 mtp -60.16 -47.33 97.08 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 110.67 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.22 -66.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.118 1.212 . . . . 0.0 110.598 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -130.22 -152.43 0.51 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.596 -0.69 . . . . 0.0 109.634 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mtt -51.53 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.699 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 2.3 p30 -142.68 138.45 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.373 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.29 -2.8 21.55 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.42 -45.83 62.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.829 -1.395 . . . . 0.0 108.163 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -39.16 71.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.465 HD13 ' CA ' ' A' ' 39' ' ' GLY . 66.5 tp -53.78 -29.1 38.72 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -88.07 -64.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 109.333 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 69' ' ' LEU . 6.7 ttpp -34.88 -52.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.105 0.478 . . . . 0.0 110.381 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -45.53 41.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 108.766 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 69' ' ' LEU . 53.4 mt -59.37 -30.43 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 108.846 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' LYS . 4.3 ttp85 -83.47 -23.01 32.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.756 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -46.53 -28.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.563 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 18.0 t0 -61.37 -150.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -161.54 33.92 0.37 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.06 6.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -1.195 . . . . 0.0 109.404 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.449 ' HB2' HD23 ' A' ' 81' ' ' LEU . 5.9 ptm -150.03 52.94 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.349 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.7 t -92.76 -5.58 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.647 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.92 53.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 78' ' ' MET . 0.7 OUTLIER -49.44 111.35 1.96 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.897 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.13 144.1 95.45 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 121.009 1.139 . . . . 0.0 112.584 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.4 t -140.26 137.88 37.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 HD11 ' A' ' 116' ' ' LEU . 55.5 tp -115.13 75.13 0.92 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.4 mtt -65.42 122.69 17.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.19 140.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 110.774 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 109' ' ' LYS . 2.4 t -150.09 161.11 43.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.36 25.36 10.77 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' ALA . 48.8 tt0 -142.8 -64.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.475 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 48.77 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 109.165 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 94' ' ' ASN . 22.0 mtmm -59.63 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.208 -0.932 . . . . 0.0 109.811 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -145.25 -101.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -49.99 -27.28 5.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.022 -1.049 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -52.16 -27.12 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -71.62 -27.83 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.462 HG22 HE21 ' A' ' 100' ' ' GLN . 68.7 mt -74.29 -51.43 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.1 26.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.083 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.19 -52.88 63.52 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.496 -0.753 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.0 65.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.462 HE21 HG22 ' A' ' 96' ' ' ILE . 79.7 mt-30 -48.67 -27.97 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.997 . . . . 0.0 108.821 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.45 -114.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.608 -0.682 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -123.82 -8.32 6.27 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.53 10.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.026 -0.691 . . . . 0.0 110.581 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 4.7 m -29.59 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.46 132.94 11.13 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.185 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.504 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -145.33 129.03 17.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -1.097 . . . . 0.0 109.222 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -134.77 124.99 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -71.16 103.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.733 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' THR . 2.9 pttp -71.47 157.84 89.14 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.34 166.97 81.26 Favored 'Cis proline' 0 N--CA 1.485 1.011 0 C-N-CA 125.01 -0.829 . . . . 0.0 110.683 -1.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.02 158.0 43.95 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.04 0.924 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.36 148.94 23.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -45.88 -23.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 109.377 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -70.23 -41.96 72.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.14 -65.28 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 107' ' ' VAL . 2.4 tp -47.59 -36.32 10.52 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.553 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -65.21 -66.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.975 -1.078 . . . . 0.0 109.733 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -45.21 -30.09 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.995 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 11.0 mmmt -81.35 -50.28 9.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.032 -1.043 . . . . 0.0 110.01 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -31.06 70.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.725 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.23 -28.73 47.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -77.82 -22.91 49.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.77 -43.54 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.502 ' CD2' ' SD ' ' A' ' 129' ' ' MET . 17.8 m-30 -73.82 -0.62 16.43 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.912 -1.118 . . . . 0.0 109.45 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -69.34 -20.28 63.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.35 -29.11 12.23 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -80.71 -16.54 53.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.99 90.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 124' ' ' PHE . 4.4 mtt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.319 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.13 145.13 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.392 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.25 17.64 6.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.312 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -152.05 44.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.26 143.11 52.23 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -78.3 131.85 37.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.988 -1.07 . . . . 0.0 111.247 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 25' ' ' LEU . 76.6 m-85 -122.94 147.52 46.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.736 -0.603 . . . . 0.0 109.821 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.607 ' CD2' HD12 ' A' ' 46' ' ' LEU . 12.9 tp -126.97 110.72 13.29 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -95.76 105.25 16.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.0 t -98.62 95.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.413 -0.805 . . . . 0.0 109.86 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -142.1 -159.22 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.231 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 1.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' THR . 8.9 m-85 -91.21 98.06 11.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.419 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.51 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -93.25 -34.49 13.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.48 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 3.9 ttt -56.06 -56.63 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.77 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -35.28 5.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.318 -0.863 . . . . 0.0 109.669 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 ttm-85 -72.97 -35.66 66.95 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.065 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.2 mp -65.3 -54.0 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.382 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -60.95 -32.85 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.767 -179.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -50.74 -53.62 30.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -58.24 5.39 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.939 0.876 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.739 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -73.39 -41.89 62.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -27.78 69.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 7.5 tp10 -59.85 -35.9 75.73 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.054 -1.029 . . . . 0.0 109.375 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -81.11 -59.55 2.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.16 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.62 73.91 0.02 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -149.97 144.54 25.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.24 . . . . 0.0 110.021 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.04 63.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -173.44 100.89 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.74 -1.225 . . . . 0.0 108.881 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.14 152.36 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.007 -1.058 . . . . 0.0 110.509 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.6 -173.35 2.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 13.5 mp0 -145.28 155.05 42.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.95 -172.75 4.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.01 8.65 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.045 . . . . 0.0 110.555 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 11.9 t70 -179.32 167.7 1.5 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.333 -0.855 . . . . 0.0 109.194 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -63.48 -25.59 68.81 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 t -72.46 -40.69 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 108.52 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 12.3 t0 -69.7 -45.67 67.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.66 -39.21 88.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.47 -37.34 72.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.351 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -86.92 -34.88 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.96 -53.98 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 54' ' ' VAL . 4.9 tt -50.07 -27.35 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 47' ' ' GLN . 1.4 tm0? -69.63 8.21 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 108.959 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.66 -68.72 0.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.98 0.31 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.126 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.62 99.16 1.79 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.84 ' O ' HD22 ' A' ' 81' ' ' LEU . 16.9 m-85 -79.53 110.39 14.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.373 -1.075 . . . . 0.0 110.437 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.76 -14.75 4.06 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.52 145.96 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -1.209 . . . . 0.0 110.179 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.5 t -141.93 120.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.138 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.491 ' CG2' HG21 ' A' ' 86' ' ' VAL . 53.6 mt -103.14 78.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -85.48 149.99 25.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.936 -1.102 . . . . 0.0 110.448 -177.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 27.7 t70 -94.64 178.21 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.567 -0.708 . . . . 0.0 109.291 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.539 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 53.5 t-105 -114.71 46.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.496 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -65.25 -154.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -162.81 60.05 0.95 Allowed Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 120.749 -1.219 . . . . 0.0 111.981 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -62.68 -39.53 42.82 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 107.576 -1.74 . . . . 0.0 107.576 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -147.46 -22.75 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.42 ' H ' ' H ' ' A' ' 62' ' ' ASN . 1.2 mtt -150.77 -83.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 65' ' ' GLY . 4.9 p-10 169.94 -107.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . -137.96 18.2 3.37 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' LEU . 25.3 tp -79.75 -54.17 6.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.083 -1.245 . . . . 0.0 108.152 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -50.36 -21.89 1.61 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD11 ' HA2' ' A' ' 39' ' ' GLY . 1.9 mt -72.7 -59.67 2.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.962 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.95 -61.02 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.7 tttm -40.84 -48.55 3.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.17 -48.59 80.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.911 HD13 HG21 ' A' ' 83' ' ' VAL . 6.6 mt -57.76 -24.0 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -89.68 -28.04 19.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.709 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.72 -33.32 55.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.525 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.1 102.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.206 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.9 50.12 2.95 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.07 -71.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.142 . . . . 0.0 109.555 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.36 25.57 6.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER -65.93 6.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -95.22 20.99 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.82 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 51' ' ' TYR . 9.9 mt -67.23 118.78 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 108.661 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.79 98.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 120.909 1.072 . . . . 0.0 112.592 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.911 HG21 HD13 ' A' ' 72' ' ' ILE . 8.9 t -106.1 106.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -90.12 107.27 19.03 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.133 -1.827 . . . . 0.0 107.407 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.427 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -63.88 150.52 44.71 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.05 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 55' ' ' ILE . 53.7 t -132.39 140.76 46.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.051 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 90' ' ' ALA . 7.4 t -149.96 157.68 43.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.36 -44.33 7.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.842 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -64.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.836 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.591 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 57.24 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.5 -88.61 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.504 -0.748 . . . . 0.0 109.14 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -156.81 -68.25 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.95 -32.56 61.48 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.193 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.539 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 2.4 t-20 -76.64 -47.45 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.03 -45.27 52.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.026 -1.046 . . . . 0.0 108.892 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 100' ' ' GLN . 17.7 mt -66.25 -17.04 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -62.68 -69.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 109.326 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -47.43 -45.71 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 108.5 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -67.88 -27.35 66.59 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.326 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' ILE . 5.5 tp-100 -55.79 -31.76 62.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.962 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.86 -20.17 27.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.44 76.11 0.3 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.373 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.21 -112.09 0.08 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.844 -1.942 . . . . 0.0 110.454 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -50.69 5.59 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.832 1.301 . . . . 0.0 108.047 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 169.85 -155.66 25.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.66 127.49 18.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -1.023 . . . . 0.0 109.586 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.458 ' CG1' HG22 ' A' ' 86' ' ' VAL . 13.6 p -117.96 134.87 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.406 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -88.94 121.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.567 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -94.18 162.06 27.62 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.253 -0.904 . . . . 0.0 108.611 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.6 128.32 15.98 Favored 'Cis proline' 0 N--CA 1.485 1.014 0 C-N-CA 124.755 -0.936 . . . . 0.0 110.427 -2.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 116' ' ' LEU . 3.9 p90 -99.48 158.27 15.85 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.93 0.871 . . . . 0.0 110.084 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.25 146.79 23.44 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 117' ' ' GLU . . . -45.56 -23.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.973 -1.08 . . . . 0.0 109.829 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.47 -38.29 65.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.035 -1.041 . . . . 0.0 108.49 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.84 -62.46 1.37 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -47.67 -41.76 23.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.721 -1.191 . . . . 0.0 108.939 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 19.3 mt-10 -61.82 -52.26 64.9 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.053 -1.029 . . . . 0.0 109.499 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -46.4 -49.19 18.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.479 -0.763 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -38.61 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.87 -63.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.79 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -47.59 -53.06 15.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -62.62 -18.21 61.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.8 mt -89.64 -45.66 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.0 109.987 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 127' ' ' LEU . 16.7 m-85 -66.63 -31.48 72.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.002 -1.061 . . . . 0.0 110.014 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -52.71 -26.63 14.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -87.35 -26.48 23.34 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 124' ' ' PHE . 44.0 tp -70.44 -24.01 62.82 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.19 23.41 19.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.7 mmt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.337 -1.096 . . . . 0.0 109.465 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.578 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -177.13 150.84 0.77 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.21 -0.931 . . . . 0.0 109.009 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -90.47 17.78 6.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.861 -1.149 . . . . 0.0 110.499 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.94 43.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.512 -1.368 . . . . 0.0 111.232 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.2 tp -67.02 110.98 3.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.424 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.59 111.29 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.828 -1.17 . . . . 0.0 111.611 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 62.2 m-85 -105.77 155.14 19.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 tp -132.65 104.06 6.45 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.95 130.16 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.261 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 36' ' ' ALA . 13.4 t -137.99 105.37 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.44 -0.788 . . . . 0.0 109.078 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -149.6 116.39 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.148 -0.97 . . . . 0.0 109.431 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.17 -16.85 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.225 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.5 m-85 -59.49 130.03 44.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 m -92.26 48.7 1.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 t -175.72 -14.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 ttt -72.37 -35.56 68.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -63.05 -32.38 73.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.85 -20.16 58.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -75.33 -47.2 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.334 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -32.99 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.215 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -46.03 -52.61 11.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -73.64 -59.58 2.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.601 0.715 . . . . 0.0 110.161 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -40.22 -55.41 2.16 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.916 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -58.23 -50.45 73.52 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -54.0 -34.5 60.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.87 -38.53 49.93 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.391 -0.818 . . . . 0.0 109.38 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -65.03 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.48 26.2 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 54.0 m-85 -100.52 141.47 33.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -1.147 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -150.04 59.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 110.183 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.23 96.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.72 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.6 -178.26 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 109.895 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.8 mm-40 -139.55 -175.62 4.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 11.1 mp0 -144.35 150.21 37.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -141.65 176.29 9.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.67 3.56 14.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.267 -0.896 . . . . 0.0 110.477 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.29 -176.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.262 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.04 -26.42 73.9 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.76 -43.13 93.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.076 -1.249 . . . . 0.0 108.132 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.4 t70 -75.68 -40.85 55.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -62.2 -39.26 92.15 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.238 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 71' ' ' THR . 3.5 mt -62.49 -49.3 75.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.294 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 10.2 m-80 -63.55 -29.13 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -24.16 21.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.622 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -23.06 61.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 0.0 109.625 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -76.72 -1.62 28.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.472 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.42 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.424 -0.797 . . . . 0.0 109.604 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.85 12.18 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.79 88.21 1.37 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' PHE . 58.4 m-85 -69.23 103.95 2.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.297 -1.119 . . . . 0.0 109.588 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.69 -9.19 0.45 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.63 131.28 10.66 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.188 -1.183 . . . . 0.0 109.986 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 83' ' ' VAL . 94.5 t -125.18 114.61 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 109.551 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.46 77.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 p -100.33 128.74 46.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.473 -0.767 . . . . 0.0 110.541 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 59' ' ' ASN . 4.5 t70 -65.12 164.0 13.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.793 -1.192 . . . . 0.0 108.645 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.489 ' CH2' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -55.38 -2.2 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 108.877 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.546 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.1 m120 46.88 -153.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.647 -1.283 . . . . 0.0 110.302 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.515 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 171.25 -44.95 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.284 -0.885 . . . . 0.0 110.739 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.08 125.21 14.23 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.678 0.918 . . . . 0.0 110.259 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.11 -148.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.17 115.73 1.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -85.72 -162.32 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -60.84 2.79 0.51 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 58' ' ' TRP . 6.5 tp -82.26 -65.21 1.04 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.768 -1.431 . . . . 0.0 110.341 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -48.3 -19.96 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -67.98 -62.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.75 HD21 HG11 ' A' ' 83' ' ' VAL . 83.2 mt -56.04 -67.66 0.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.562 0.696 . . . . 0.0 109.236 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 69' ' ' LEU . 25.2 tttp -30.46 -53.28 0.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.626 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.515 HG21 ' CD2' ' A' ' 43' ' ' LEU . 6.7 m -59.29 -47.94 83.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.997 -1.064 . . . . 0.0 108.755 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 69' ' ' LEU . 35.5 mt -58.48 -38.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.469 -0.77 . . . . 0.0 109.281 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -84.2 -8.11 59.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.604 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -75.77 -26.59 57.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.2 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.813 . . . . 0.0 109.747 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 46.3 -143.35 4.56 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.02 76.85 4.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -1.112 . . . . 0.0 109.363 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' ALA . 1.3 ttt -132.02 43.71 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 33.47 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.99 -47.41 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.228 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.462 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -32.8 97.85 0.12 Allowed Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 127' ' ' LEU . 4.2 Cg_exo -64.61 139.04 61.96 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.422 1.415 . . . . 0.0 112.326 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.75 HG11 HD21 ' A' ' 69' ' ' LEU . 6.1 t -130.93 125.5 58.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.583 ' CD2' HD21 ' A' ' 116' ' ' LEU . 42.3 tp -107.39 72.23 0.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.425 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 69' ' ' LEU . 5.7 mtp -51.63 151.71 3.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 t -126.51 128.55 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.635 0.731 . . . . 0.0 110.745 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -150.05 177.05 10.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . . . -89.39 -123.42 0.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.93 -1.106 . . . . 0.0 108.862 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -47.92 133.26 14.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 109.306 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -93.34 109.94 21.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.696 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -73.12 -171.06 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 108.872 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 45.3 mttp -94.32 -84.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HA ' HD12 ' A' ' 96' ' ' ILE . 0.8 OUTLIER -49.54 -8.0 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -76.84 -52.43 9.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.871 HD11 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -68.77 -28.08 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 93' ' ' GLU . 52.0 mt -64.75 -64.06 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 109.979 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.86 -57.16 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -60.08 -43.69 95.31 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.023 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.62 -44.33 73.05 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -19.92 59.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.831 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.22 -103.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.279 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -133.22 0.7 4.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.99 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.179 -0.601 . . . . 0.0 111.198 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.629 ' H ' ' C ' ' A' ' 102' ' ' GLY . 22.0 m -29.24 -34.74 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.995 -0.441 . . . . 0.0 111.8 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.2 130.43 10.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.668 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 49.7 t80 -136.5 112.58 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.437 -1.037 . . . . 0.0 109.492 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -115.39 129.01 72.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.6 p -91.37 103.07 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 154.89 89.71 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.035 -1.041 . . . . 0.0 109.165 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.26 158.84 98.46 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 O-C-N 122.506 0.74 . . . . 0.0 111.368 -1.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -136.16 154.65 50.9 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.853 0.835 . . . . 0.0 109.204 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.5 146.29 23.79 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.69 -40.44 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 108.699 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.67 -34.07 76.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' THR . 25.4 m -68.38 -67.11 0.49 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -40.92 -46.94 2.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.584 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.32 -54.82 42.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 110.302 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.412 ' OE2' HG23 ' A' ' 115' ' ' THR . 1.6 pt-20 -47.84 -30.13 3.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.885 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -72.19 -49.32 36.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.389 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 123' ' ' ILE . 11.0 mt -48.45 -54.9 12.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.81 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -25.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.676 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -86.85 -27.07 23.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.022 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 120' ' ' LEU . 37.7 mm -81.52 -34.35 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.5 -8.61 57.42 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.099 -1.001 . . . . 0.0 110.755 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.57 -17.5 60.03 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -101.31 -30.31 11.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -77.17 -29.96 54.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.04 74.49 0.51 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.438 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.1 t0 -44.78 151.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 mttm -90.14 20.36 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.059 -1.026 . . . . 0.0 109.835 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -163.77 45.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.042 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 25.4 tp -71.82 121.09 18.36 Favored 'General case' 0 C--O 1.203 -1.344 0 O-C-N 121.025 -1.047 . . . . 0.0 108.231 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -53.61 117.31 3.02 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.932 -1.105 . . . . 0.0 112.176 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 70.7 m-85 -112.4 147.77 35.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' CD2' HD12 ' A' ' 46' ' ' LEU . 62.4 tp -121.69 108.29 13.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.154 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -92.95 104.46 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 108.735 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.5 t -89.94 38.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.83 147.01 23.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -98.76 -13.94 19.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.541 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -61.08 137.65 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 t -88.08 17.4 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.44 -40.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.421 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 6.2 ttt -50.33 -35.0 25.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' CG ' ' N ' ' A' ' 19' ' ' ARG . 4.7 ptm85 -63.27 -47.91 80.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.031 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -53.73 -32.54 52.46 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.129 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -53.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -31.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.09 15.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.903 -1.123 . . . . 0.0 109.408 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -69.96 -59.44 2.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.757 0.789 . . . . 0.0 109.858 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.23 -52.7 2.61 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.046 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -62.59 -50.22 72.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.014 . . . . 0.0 108.988 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -55.52 -30.71 61.18 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.89 -27.86 63.68 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.49 -37.57 16.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 139.28 7.69 1.07 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.9 m-85 -89.89 139.74 30.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.66 -1.494 . . . . 0.0 109.754 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 1.1 p30 -148.16 62.89 1.11 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.03 -1.044 . . . . 0.0 110.302 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.52 105.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.591 -1.318 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.15 179.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.105 -0.997 . . . . 0.0 109.99 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.8 mm-40 -137.26 -170.37 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 18' ' ' ARG . 47.1 mt-10 -141.97 149.7 40.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.324 -0.86 . . . . 0.0 110.741 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.02 -172.82 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -148.67 7.15 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.015 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER 175.73 177.86 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.695 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -69.39 -39.57 80.59 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 118.955 -1.593 . . . . 0.0 110.066 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.0 t -54.59 -40.79 51.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.406 -1.644 . . . . 0.0 107.654 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -81.01 -43.21 19.94 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.499 -0.751 . . . . 0.0 109.87 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -73.98 -58.22 3.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.391 -0.818 . . . . 0.0 109.504 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.668 ' C ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -53.53 -37.87 63.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.946 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -72.66 -42.91 63.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.371 -1.456 . . . . 0.0 109.216 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -77.35 -14.29 59.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.728 . . . . 0.0 110.389 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -71.77 -25.05 61.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.711 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -66.11 -2.29 4.03 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 0.0 109.237 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.09 -66.49 0.39 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 109.482 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.19 13.42 0.54 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.937 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.67 88.17 1.28 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.605 ' O ' HD13 ' A' ' 81' ' ' LEU . 29.1 m-85 -64.3 122.45 16.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.398 -1.06 . . . . 0.0 110.516 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.21 -6.1 82.55 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -159.17 136.78 10.07 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.011 -1.288 . . . . 0.0 109.34 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.42 123.97 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.099 -1.001 . . . . 0.0 109.81 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mt -109.16 96.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.771 -0.581 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.07 145.38 42.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -162.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.971 -1.081 . . . . 0.0 109.178 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -103.76 -26.01 12.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 0.0 109.258 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -96.79 135.33 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.538 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -133.95 159.29 72.96 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.96 -68.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.368 1.378 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 63' ' ' MET . 2.8 p30 -85.62 -102.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 1.6 mmt -63.3 -178.06 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.656 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -179.53 5.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.41 -31.63 18.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 tp -47.57 -37.92 13.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -1.198 . . . . 0.0 108.984 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.21 -35.13 75.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 109.333 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.695 HD11 ' N ' ' A' ' 39' ' ' GLY . 4.8 mp -63.88 -27.19 68.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.815 HD21 ' N ' ' A' ' 103' ' ' ALA . 53.8 tp -77.76 -60.21 2.46 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 1.4 tmtp? -43.7 -32.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -55.57 -52.99 61.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 109.348 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.5 mp -57.95 -36.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -69.15 -27.97 66.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.56 -28.81 2.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.6 -38.25 20.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . 59.8 46.14 94.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 167.3 -52.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.445 ' C ' ' H ' ' A' ' 80' ' ' ALA . 12.8 mtt -94.46 21.47 7.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -74.7 37.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -97.5 -20.12 17.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 51' ' ' TYR . 15.0 mt -52.51 113.38 4.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.011 -1.055 . . . . 0.0 109.174 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.16 145.99 90.25 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 121.164 1.243 . . . . 0.0 112.983 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 69' ' ' LEU . 2.4 t -126.08 132.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 116' ' ' LEU . 43.8 tp -113.48 70.79 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.662 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 86' ' ' VAL . 14.0 tmm? -49.48 159.81 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' N ' ' SD ' ' A' ' 85' ' ' MET . 39.5 t -137.94 121.26 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.488 -0.758 . . . . 0.0 110.16 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.8 t -150.13 178.88 8.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 0.0 110.02 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 -45.64 2.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.533 -0.73 . . . . 0.0 109.362 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 13.3 mt-10 -70.59 -77.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 63.27 117.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -131.8 148.67 52.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -42.5 -48.59 5.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.259 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -64.44 -29.72 70.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.283 -0.886 . . . . 0.0 110.665 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -89.99 -23.56 21.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.561 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.3 mt -89.95 -16.35 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.659 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 97' ' ' ALA . 19.1 mt -74.95 -68.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.18 -43.78 21.6 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -59.97 -51.19 70.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.42 -0.8 . . . . 0.0 109.223 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.66 64.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.803 . . . . 0.0 110.593 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -77.19 6.26 6.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 110.4 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -110.53 -17.79 13.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 0.0 110.396 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 136.36 -12.39 4.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.815 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -55.41 11.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.861 -0.788 . . . . 0.0 111.467 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.8 m -29.41 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.917 -0.489 . . . . 0.0 111.312 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.74 124.11 7.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -145.02 105.7 4.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -1.234 . . . . 0.0 109.405 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 107' ' ' VAL . 9.5 p -103.03 136.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -87.41 100.07 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.097 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.9 pttt -63.52 154.44 79.52 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.71 -1.244 . . . . 0.0 109.09 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.33 161.93 93.5 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 O-C-N 122.479 0.726 . . . . 0.0 111.225 -1.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -142.9 162.75 34.64 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.009 0.909 . . . . 0.0 110.082 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.09 148.95 26.27 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.76 -19.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.982 -1.074 . . . . 0.0 109.249 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.44 -37.31 51.84 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.401 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.27 -61.39 1.84 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 84' ' ' LEU . 5.3 tp -47.92 -38.64 16.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.005 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.49 -44.82 77.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 15.4 tt0 -56.38 -26.69 53.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.333 -0.854 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -81.95 -58.83 2.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 tt -46.28 -48.72 18.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.55 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -62.68 -33.49 75.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -67.83 -31.48 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.474 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.1 mt -88.72 -38.01 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.865 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.03 -3.69 27.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.149 -0.969 . . . . 0.0 109.736 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -74.03 -29.33 61.87 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -88.68 -30.62 19.0 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -74.39 -28.99 61.35 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.36 83.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 60.56 129.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.151 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -90.06 24.04 2.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.889 -1.132 . . . . 0.0 110.058 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.22 40.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.789 -1.194 . . . . 0.0 110.773 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 52' ' ' GLY . 58.5 tp -67.03 133.24 49.51 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -75.08 120.39 20.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.893 -1.13 . . . . 0.0 111.32 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' HG22 ' A' ' 33' ' ' VAL . 74.1 m-85 -109.66 148.16 31.83 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.439 ' CD2' HD12 ' A' ' 46' ' ' LEU . 35.6 tp -122.29 118.97 29.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.92 103.96 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.577 -0.702 . . . . 0.0 109.77 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.5 t -93.41 31.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.27 157.46 22.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.745 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.85 -30.96 13.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 150.36 49.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -24.2 18.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.46 -20.58 20.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -52.25 49.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -49.43 -32.13 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.29 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.4 -40.71 77.17 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.802 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -57.86 -57.87 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.88 -38.16 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.29 -52.85 19.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.968 -1.082 . . . . 0.0 109.193 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.5 t30 -64.34 -56.9 11.27 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.775 0.798 . . . . 0.0 109.171 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.86 -52.39 2.38 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.744 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.4 mt -63.1 -46.26 88.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 0.0 108.811 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.25 -32.58 66.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.342 -0.848 . . . . 0.0 109.419 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 4.7 tt0 -55.48 -41.96 73.71 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 117' ' ' GLU . 6.2 mp -75.43 -55.39 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.792 . . . . 0.0 109.298 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 78.01 0.02 OUTLIER Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -150.01 147.46 27.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -150.03 58.53 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.55 93.32 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.077 -1.014 . . . . 0.0 109.177 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 8' ' ' PHE . 73.4 t -138.5 151.28 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.77 -171.83 2.47 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.16 157.11 42.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.924 -1.11 . . . . 0.0 110.884 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.896 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.54 -168.97 2.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.81 0.32 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.375 -0.828 . . . . 0.0 110.478 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 9.7 t70 -174.21 174.9 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -59.57 -57.21 20.72 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.576 HG22 ' ND2' ' A' ' 44' ' ' ASN . 13.2 p -50.97 -28.24 6.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -1.083 . . . . 0.0 108.535 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.4 t0 -76.27 -47.01 25.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.41 -0.806 . . . . 0.0 109.133 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.65 -66.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.346 -0.847 . . . . 0.0 109.786 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.06 -45.21 52.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.446 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.576 ' ND2' HG22 ' A' ' 40' ' ' VAL . 72.4 m-20 -63.63 -39.25 93.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.0 -1.063 . . . . 0.0 110.554 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -90.1 -1.08 57.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -87.52 -30.87 20.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 108.882 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -54.81 -9.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.105 -0.997 . . . . 0.0 108.574 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.02 -67.01 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.63 -92.3 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -156.96 78.29 0.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' O ' HD21 ' A' ' 81' ' ' LEU . 41.9 m-85 -57.35 91.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.431 -1.04 . . . . 0.0 110.158 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.96 -9.31 5.38 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.5 137.64 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.246 -1.15 . . . . 0.0 110.057 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.0 t -134.92 120.02 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.155 -0.966 . . . . 0.0 109.684 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.53 131.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 83.7 p -149.79 150.14 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' SER . 36.9 m-20 -60.67 -115.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.184 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -150.45 -42.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.603 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER 178.15 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.712 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.35 -54.72 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.761 -0.587 . . . . 0.0 110.283 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.13 -61.2 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.563 0 N-CA-C 108.846 -1.251 . . . . 0.0 108.846 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 2.8 m-80 -154.47 -148.96 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.6 mtt -48.16 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 108.423 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 42.55 -156.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.518 -0.739 . . . . 0.0 110.785 178.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 48.17 -83.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -51.11 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.869 -1.371 . . . . 0.0 110.037 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.98 -33.78 11.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 108.813 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.65 -35.67 80.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.729 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 8.9 tt -90.05 -60.51 1.91 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -36.06 -34.49 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.131 0.491 . . . . 0.0 110.012 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.5 m -59.14 -50.1 75.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.0 mt -54.41 -37.86 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -70.36 -32.74 70.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.452 -0.78 . . . . 0.0 109.515 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.68 33.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.927 . . . . 0.0 109.582 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t0 -75.71 98.59 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.595 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -23.71 66.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -65.19 -38.47 90.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -1.186 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 mtm -136.39 45.88 2.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 79' ' ' SER . 9.3 t -77.95 45.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.03 10.22 0.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.0 -1.062 . . . . 0.0 110.063 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.822 HD21 ' O ' ' A' ' 51' ' ' TYR . 9.6 tp -55.36 120.74 32.97 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 108.382 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.25 131.36 38.38 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 120.962 1.108 . . . . 0.0 112.233 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.8 t -125.69 125.18 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.0 tp -107.05 70.12 0.78 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.571 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -51.53 168.91 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -143.11 126.67 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.532 -0.73 . . . . 0.0 109.801 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -150.1 178.44 8.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.911 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.43 3.94 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.72 50.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -75.5 101.92 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.33 -82.62 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 109.332 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -173.01 -73.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.29 -33.6 29.45 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.151 -0.968 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.5 -24.3 61.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.77 HD11 ' HB1' ' A' ' 90' ' ' ALA . 96.3 mt -83.16 -36.98 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 97' ' ' ALA . 1.4 mp -57.5 -57.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.237 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.2 -37.77 10.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 109.229 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -64.65 -60.28 3.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.733 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -55.1 -40.19 70.18 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.221 -0.924 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -19.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.26 -123.96 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.729 ' H ' ' CD2' ' A' ' 69' ' ' LEU . . . -111.87 2.24 27.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.71 11.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.623 -0.928 . . . . 0.0 109.98 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 102' ' ' GLY . 1.4 m -29.54 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -109.64 127.67 8.56 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.53 120.31 9.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 108.825 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 116' ' ' LEU . 7.5 p -119.59 130.17 74.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.01 105.04 12.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.154 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.79 161.08 64.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.02 -1.05 . . . . 0.0 109.257 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.46 166.35 83.34 Favored 'Cis proline' 0 N--CA 1.488 1.153 0 C-N-CA 124.832 -0.904 . . . . 0.0 110.801 -2.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.77 164.1 33.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 110.344 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.46 148.21 27.43 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.462 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -45.87 -36.66 5.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.048 . . . . 0.0 109.479 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.4 87.39 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.9 m -69.85 -67.01 0.52 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.572 HD11 HG11 ' A' ' 107' ' ' VAL . 5.7 tp -45.62 -36.89 5.09 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.033 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 6.5 tm-20 -66.99 -46.85 73.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 26.9 tt0 -47.77 -60.01 2.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -34.89 64.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.474 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.88 -72.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.6 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.45 -17.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.926 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.47 -33.13 60.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.14 -0.975 . . . . 0.0 109.733 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.447 HD11 ' HA2' ' A' ' 105' ' ' GLY . 8.0 mt -89.97 -43.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 109.934 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -57.16 -21.13 30.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.634 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -57.36 -20.37 28.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.763 -1.211 . . . . 0.0 108.221 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -96.82 -22.03 17.17 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -89.32 -18.98 25.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 79.07 0.06 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.541 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -142.57 135.0 27.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 108.883 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -90.05 21.55 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.977 . . . . 0.0 109.572 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -160.13 44.0 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.068 -1.02 . . . . 0.0 109.956 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.6 tp -84.46 125.7 32.6 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -74.67 123.28 24.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.169 -0.957 . . . . 0.0 112.155 -176.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 65.9 m-85 -114.88 140.89 48.6 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.8 tp -106.02 116.76 32.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.57 102.8 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 36' ' ' ALA . 30.0 t -95.02 62.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.243 -0.91 . . . . 0.0 109.644 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -103.27 132.48 49.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.12 -21.26 36.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.133 -0.979 . . . . 0.0 109.299 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -57.86 146.82 30.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.513 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 m -90.6 29.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 -38.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' OD2' ' A' ' 57' ' ' ASP . 27.5 ttt -48.41 -45.57 36.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -56.65 9.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -56.34 -41.59 76.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 110.133 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mt -54.61 -53.78 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -44.99 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.408 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.01 -52.83 22.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.872 -1.143 . . . . 0.0 109.034 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -62.02 -56.79 15.47 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.89 0.853 . . . . 0.0 109.049 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.32 -59.75 1.01 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.066 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -59.44 -47.28 86.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -53.43 -33.35 53.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.19 -33.16 39.54 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.165 -0.96 . . . . 0.0 109.177 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.9 mp -80.43 -67.62 0.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.08 17.54 0.02 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.294 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.0 m-85 -90.66 129.46 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.749 -1.442 . . . . 0.0 109.197 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.86 68.95 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.502 -0.749 . . . . 0.0 109.93 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.5 103.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.082 -1.011 . . . . 0.0 108.569 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -149.98 148.24 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.82 -171.4 2.18 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -149.86 150.31 31.75 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 110.832 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.96 165.5 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 1.8 mp0 -135.96 32.69 2.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.125 -0.984 . . . . 0.0 110.729 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 7.4 t0 175.04 145.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.277 -0.89 . . . . 0.0 108.832 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -50.6 -29.85 18.96 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -73.79 -28.37 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.254 . . . . 0.0 108.534 179.171 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.1 t0 -81.4 -41.81 21.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.83 86.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.446 -0.784 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mt -70.73 -41.94 71.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -63.36 -27.04 69.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -53.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -56.63 -19.67 17.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 108.645 179.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -50.36 -28.05 7.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.0 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 68.02 0.47 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.81 24.24 0.06 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' O ' HD21 ' A' ' 81' ' ' LEU . 52.6 m-85 -94.74 83.06 3.98 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.28 -1.13 . . . . 0.0 109.904 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.51 0.48 2.07 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -162.95 152.82 15.79 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.1 -1.235 . . . . 0.0 109.805 -179.115 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 9' ' ' LEU . 93.6 t -149.4 128.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.724 -1.235 . . . . 0.0 109.78 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.44 128.79 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -132.67 163.04 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.171 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 18.3 m-20 -91.33 -106.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.645 -178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.864 ' CZ2' HD21 ' A' ' 66' ' ' LEU . 36.5 t-105 -164.09 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -95.66 137.19 35.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 62' ' ' ASN . 3.6 mmt -139.78 155.24 71.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.14 -1.13 0.16 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.431 1.421 . . . . 0.0 111.076 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -133.63 107.87 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.433 -0.792 . . . . 0.0 109.083 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.421 ' O ' ' OD2' ' A' ' 64' ' ' ASP . 42.1 mtm 53.67 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.0 109.405 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ASN . 1.2 m-20 -169.93 150.64 3.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 108.86 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.21 8.86 2.49 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.864 HD21 ' CZ2' ' A' ' 58' ' ' TRP . 9.2 mt -67.09 -52.85 36.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -1.107 . . . . 0.0 109.082 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -74.06 -14.13 60.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 109.563 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.516 HD13 ' HA2' ' A' ' 39' ' ' GLY . 7.7 tp -67.62 -57.35 6.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 108.836 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.896 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.24 -36.02 66.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 74' ' ' ALA . 16.8 tttt -47.03 -47.91 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 108.82 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.1 m -47.16 -59.24 3.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.477 -0.765 . . . . 0.0 109.638 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mt -49.82 -40.09 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.66 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -10.68 55.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -92.43 -26.62 17.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -45.13 158.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.28 -52.85 21.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.06 109.44 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.528 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -144.25 12.71 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.858 . . . . 0.0 109.281 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -65.31 4.84 0.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.175 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.87 -15.49 32.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.498 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.1 tp -112.03 99.13 44.88 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.66 139.0 78.63 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.037 1.825 . . . . 0.0 113.695 -178.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 69' ' ' LEU . 2.5 t -124.75 119.55 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' ' HG ' ' A' ' 104' ' ' SER . 2.1 tp -99.0 109.78 22.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.458 ' CE ' HD23 ' A' ' 69' ' ' LEU . 6.8 ttm -86.2 146.85 26.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.9 144.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -150.09 173.92 13.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.943 -1.098 . . . . 0.0 110.74 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -113.61 148.7 35.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 49.08 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -83.42 119.08 24.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.022 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.9 -169.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 0.0 109.051 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -99.6 -39.05 8.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.704 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.89 -19.08 25.01 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.113 -0.992 . . . . 0.0 110.284 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -80.23 -22.59 41.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 110.106 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 90' ' ' ALA . 24.7 mt -69.16 -8.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.132 . . . . 0.0 109.932 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.481 ' C ' ' N ' ' A' ' 98' ' ' ALA . 10.1 mt -90.17 -49.11 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.05 -24.63 0.16 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -50.28 -56.8 9.65 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -45.58 -44.73 13.17 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 119.629 -1.919 . . . . 0.0 108.924 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -59.69 -36.8 77.21 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -126.33 -72.51 0.65 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -48.8 82.17 0.01 OUTLIER Glycine 0 N--CA 1.496 2.643 0 N-CA-C 106.576 -2.609 . . . . 0.0 106.576 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -70.03 -109.81 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.824 0 CA-C-N 111.508 -2.346 . . . . 0.0 114.994 -174.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.527 ' HG ' ' HA ' ' A' ' 84' ' ' LEU . 2.0 p -38.87 -54.18 1.65 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.564 -176.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.402 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . -156.8 171.17 34.29 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.12 116.2 15.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.407 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.1 p -115.59 126.34 73.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.5 p -78.67 108.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.54 157.38 88.33 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.991 -1.068 . . . . 0.0 109.583 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.79 159.39 97.22 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 O-C-N 122.768 0.878 . . . . 0.0 110.626 -2.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.463 ' CE2' HD13 ' A' ' 116' ' ' LEU . 2.7 p90 -136.63 160.06 39.93 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.658 0.742 . . . . 0.0 109.783 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.47 148.81 22.42 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.0 -32.09 8.61 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.97 -1.082 . . . . 0.0 108.833 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.06 71.99 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' THR . 6.0 m -70.89 -66.94 0.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 111' ' ' PHE . 11.6 tp -45.58 -41.62 10.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.859 -1.151 . . . . 0.0 109.195 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.72 -50.06 70.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.301 -0.874 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.22 -41.71 13.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -77.98 -43.69 28.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 109.124 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.44 -47.48 26.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 108.957 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 m-20 -49.9 -59.88 3.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.323 -0.861 . . . . 0.0 109.947 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -50.32 -35.46 27.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 110.016 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.7 mt -73.15 -41.54 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 110.005 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -77.92 0.85 22.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.095 -1.003 . . . . 0.0 110.215 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -75.65 -32.66 60.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -88.71 -25.97 22.05 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -33.61 27.67 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.28 82.43 0.03 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.464 -179.975 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.553 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER 61.08 116.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -90.39 27.24 1.73 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.745 -1.222 . . . . 0.0 110.31 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -145.82 36.83 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.38 141.09 35.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -80.02 129.87 34.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.915 -1.116 . . . . 0.0 111.349 -177.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.598 ' HB2' HG22 ' A' ' 33' ' ' VAL . 63.2 m-85 -118.79 151.56 37.82 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.781 -0.574 . . . . 0.0 109.655 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -127.04 109.88 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.77 114.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.347 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.851 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.8 t -110.56 108.76 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 124.31 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -29.29 70.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.678 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.77 139.18 10.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 p -93.56 22.24 5.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 p -145.79 -15.87 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.6 ttt -70.95 -39.3 72.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -35.35 80.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ttp85 -68.93 -21.02 64.23 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.077 -178.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.1 -45.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.868 . . . . 0.0 109.744 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -36.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -47.42 -53.02 15.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.364 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.31 -57.56 7.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.818 0.818 . . . . 0.0 109.371 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.18 -60.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -56.45 -46.05 80.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 109.125 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -55.45 -35.24 65.25 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.175 -0.953 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.32 -28.14 40.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.406 -0.809 . . . . 0.0 109.783 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.09 -33.6 22.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.43 10.69 2.09 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 79.4 m-85 -89.69 141.2 28.83 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.743 -1.445 . . . . 0.0 109.418 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -143.64 28.4 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.481 -0.762 . . . . 0.0 109.728 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.61 88.23 2.55 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -137.31 153.24 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.627 -0.671 . . . . 0.0 110.11 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -125.57 -173.6 2.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.19 148.2 28.64 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.851 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -128.05 166.7 17.9 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 12.5 mm-40 -94.53 -3.02 50.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.867 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER 169.63 173.85 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.917 -1.114 . . . . 0.0 109.691 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.42 54.87 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -53.96 -42.87 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.988 -1.301 . . . . 0.0 108.727 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.626 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 27.5 t0 -63.99 -50.44 68.52 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -53.36 -49.38 67.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.276 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tp -53.22 -35.39 59.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.908 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.75 -33.44 35.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.371 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -90.07 -12.54 38.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.068 -1.02 . . . . 0.0 110.464 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -63.42 -20.58 65.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.029 -1.044 . . . . 0.0 109.212 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.93 1.21 24.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.138 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.94 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.409 -0.807 . . . . 0.0 109.657 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.25 11.93 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.32 80.63 1.47 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.765 ' O ' HD21 ' A' ' 81' ' ' LEU . 38.3 m-85 -60.06 102.14 0.15 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -1.089 . . . . 0.0 109.769 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.47 -12.54 1.0 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -153.24 134.59 14.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.378 -1.072 . . . . 0.0 109.499 -179.427 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 83' ' ' VAL . 88.9 t -131.26 117.69 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.827 -1.171 . . . . 0.0 109.939 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.94 119.6 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.8 p -141.47 144.1 34.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.808 . . . . 0.0 109.248 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.7 p-10 -60.47 -112.45 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.979 -1.075 . . . . 0.0 109.229 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -173.87 -32.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 108.834 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.5 58.57 2.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 0.0 109.54 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.423 ' HG3' ' H ' ' A' ' 62' ' ' ASN . 2.1 ptm -47.88 159.24 0.48 Allowed Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.47 -48.47 20.33 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.248 1.299 . . . . 0.0 110.514 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' A' ' 60' ' ' MET . 0.9 OUTLIER -79.09 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.853 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.1 mmt -90.9 -110.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.938 . . . . 0.0 109.869 -179.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.3 -175.56 4.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.78 12.29 70.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -62.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.8 -1.411 . . . . 0.0 108.569 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -48.8 -37.52 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.3 -42.67 82.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 72' ' ' ILE . 1.2 mt -75.41 -63.5 1.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.524 0.678 . . . . 0.0 109.18 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' LEU . 39.9 tttp -40.29 -34.95 0.36 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.759 -0.588 . . . . 0.0 109.986 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -73.2 -37.19 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 108.664 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 69' ' ' LEU . 39.6 mt -61.08 -21.41 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -88.68 5.33 43.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.358 -0.839 . . . . 0.0 109.319 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -122.01 -20.88 6.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.5 m-20 -59.67 -140.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.54 0.686 . . . . 0.0 110.214 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -55.37 -167.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.81 50.32 1.79 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.04 -70.19 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 t 44.29 17.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -145.87 -3.52 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 51' ' ' TYR . 5.4 tp -54.43 113.56 5.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 109.05 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 140.31 89.49 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.119 1.213 . . . . 0.0 112.351 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.8 t -129.83 127.88 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 116' ' ' LEU . 54.8 tp -108.42 78.42 1.16 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtt -72.24 132.2 43.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.3 m -113.23 140.2 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.9 t -150.02 171.49 16.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.01 -87.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.817 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -46.95 -66.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.864 -179.659 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 67.72 99.87 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 109.174 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -95.59 119.62 34.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.207 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -43.51 -50.07 7.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.785 . . . . 0.0 109.983 -179.504 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.23 -35.11 7.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.174 -0.954 . . . . 0.0 109.686 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 96' ' ' ILE . 2.3 t-20 -85.53 -39.04 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.191 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 95' ' ' ILE . 35.1 mm -58.24 -0.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 94' ' ' ASN . 71.9 mt -89.82 -65.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.33 -34.72 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.54 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.708 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -65.33 -53.95 36.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.876 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.7 67.58 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.044 -1.035 . . . . 0.0 110.011 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.47 -19.51 1.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 109.135 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.18 -112.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.81 -5.38 4.9 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.708 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.56 10.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.927 -0.749 . . . . 0.0 110.348 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.3 m -29.75 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.009 -178.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.05 125.68 8.66 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -142.38 109.38 5.51 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.286 -1.126 . . . . 0.0 109.697 179.189 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.681 HG11 ' CD1' ' A' ' 116' ' ' LEU . 2.7 p -110.53 150.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.48 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 39.9 t -90.52 111.72 23.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.729 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 152.44 78.07 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.786 -1.196 . . . . 0.0 109.514 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.85 165.6 84.49 Favored 'Cis proline' 0 N--CA 1.49 1.314 0 O-C-N 122.52 0.748 . . . . 0.0 110.909 -1.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -144.4 156.89 44.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.855 0.836 . . . . 0.0 110.106 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 114' ' ' ALA . 1.0 OUTLIER -95.67 150.79 19.98 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.755 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.37 -15.36 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.783 -1.198 . . . . 0.0 109.194 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.27 -38.34 35.68 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.33 -62.41 1.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.537 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 107' ' ' VAL . 4.6 tp -48.6 -38.73 21.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.195 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.56 -56.81 11.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 0.0 110.068 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.18 -66.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.554 -0.716 . . . . 0.0 109.931 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -35.25 5.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.25 -68.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.03 -32.91 10.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.78 -38.17 81.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.07 -47.83 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.055 -1.028 . . . . 0.0 109.963 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.457 ' CE2' HD13 ' A' ' 127' ' ' LEU . 23.2 m-85 -53.19 -19.0 2.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.122 -0.986 . . . . 0.0 110.232 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -55.95 -35.43 66.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 107.949 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -79.6 -32.23 41.83 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 127' ' ' LEU . 7.6 tt -65.11 -23.58 67.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.76 61.34 1.29 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.418 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER 51.81 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.818 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.2 ptmm? -76.83 47.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.006 -1.059 . . . . 0.0 109.544 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -160.42 27.11 0.16 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.6 tp -69.65 143.21 53.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 1.9 mtmp? -82.35 127.76 33.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.125 -0.984 . . . . 0.0 111.508 -177.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 33' ' ' VAL . 35.4 m-85 -116.32 150.7 37.24 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.865 -0.522 . . . . 0.0 109.974 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -125.15 106.9 10.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.37 105.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 109.05 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 11' ' ' VAL . 25.3 t -89.99 24.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.155 -0.965 . . . . 0.0 109.455 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -56.64 126.58 27.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -93.63 -2.59 53.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.34 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -58.81 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.965 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.05 8.52 5.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.578 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -22.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.748 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.3 tpp -47.71 -50.39 25.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.243 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' NE ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -45.38 -55.41 6.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 110.469 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -56.24 -37.39 69.67 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.577 -177.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.78 -49.02 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.119 -0.988 . . . . 0.0 110.046 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -33.25 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.995 -1.066 . . . . 0.0 110.515 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -53.51 21.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.989 -1.07 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.1 t30 -67.57 -58.15 5.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.881 0.848 . . . . 0.0 109.63 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.814 HD22 HD12 ' A' ' 116' ' ' LEU . 4.5 tt -40.09 -34.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.125 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.95 -42.08 27.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.905 -1.122 . . . . 0.0 108.233 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -58.88 -34.9 72.18 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.346 -0.846 . . . . 0.0 108.925 179.318 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.85 -29.14 39.88 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.347 -0.845 . . . . 0.0 109.236 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.27 -12.86 42.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 106.09 15.39 18.16 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -89.83 126.84 35.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.479 . . . . 0.0 109.0 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -130.42 67.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.808 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.4 89.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 108.594 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 8' ' ' PHE . 45.2 t -140.23 151.69 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.489 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.2 mt-10 -126.18 -173.23 2.8 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.45 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 7.6 tt0 -149.13 159.48 44.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.769 -1.207 . . . . 0.0 111.157 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.99 -171.79 3.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 3.6 pt-20 -139.41 8.57 2.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.805 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.16 -170.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.567 ' CA ' HD11 ' A' ' 68' ' ' LEU . . . -74.34 -38.96 44.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.98 -1.581 . . . . 0.0 109.293 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 62.9 t -52.52 -40.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.915 -1.344 . . . . 0.0 107.763 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.7 t0 -79.15 -50.6 10.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.677 -0.639 . . . . 0.0 109.847 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -62.56 -59.46 4.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 71' ' ' THR . 49.9 tp -44.75 -50.75 9.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.313 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 60.6 m-20 -66.7 -36.28 82.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.012 . . . . 0.0 109.577 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -90.13 8.0 35.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -87.98 -44.18 11.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.898 -1.126 . . . . 0.0 109.076 179.681 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -65.75 1.55 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.186 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.44 -69.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.391 -0.818 . . . . 0.0 109.859 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.35 1.26 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 85.27 88.11 0.92 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.906 ' O ' HD11 ' A' ' 81' ' ' LEU . 38.4 m-85 -71.1 136.66 48.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.304 -1.115 . . . . 0.0 109.66 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.49 -5.67 71.77 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -152.14 135.88 16.26 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.578 -0.954 . . . . 0.0 108.95 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.05 116.98 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.817 -1.177 . . . . 0.0 109.781 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.62 95.42 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.5 p -105.61 131.99 52.3 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 59' ' ' ASN . 37.7 p-10 -100.15 123.31 44.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.467 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.517 ' CH2' HD12 ' A' ' 66' ' ' LEU . 1.4 t-105 -45.76 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.244 -0.91 . . . . 0.0 108.679 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASP . 80.1 m-20 -92.57 -150.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 110.635 -178.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.719 ' H ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -124.65 -29.82 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 60' ' ' MET . 4.1 Cg_exo -62.01 164.48 16.7 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 CA-C-N 119.812 0.968 . . . . 0.0 110.842 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.629 ' N ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -41.73 -62.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.785 -0.572 . . . . 0.0 109.633 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.511 ' H ' HD22 ' A' ' 62' ' ' ASN . 0.8 OUTLIER -79.24 56.08 1.99 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.275 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' MET . 0.2 OUTLIER -46.9 -94.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.472 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.72 -24.29 0.07 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.517 HD12 ' CH2' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -70.67 -58.06 4.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.876 -1.367 . . . . 0.0 108.612 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.41 -33.46 6.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.567 HD11 ' CA ' ' A' ' 39' ' ' GLY . 5.8 mp -66.59 -42.63 86.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.727 HD11 ' H ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -69.06 -45.05 71.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.529 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -58.66 -32.34 68.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 0.0 108.884 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.67 HG21 HD13 ' A' ' 43' ' ' LEU . 3.9 m -66.85 -42.98 84.79 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.282 -0.886 . . . . 0.0 108.999 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.27 -31.6 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -30.57 71.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.073 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -59.0 -24.14 62.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 6.3 t70 -42.85 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 75' ' ' ASP . . . 152.32 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.05 -21.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.187 . . . . 0.0 109.206 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' ALA . 3.0 mtm -116.84 36.77 4.04 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -65.64 7.35 0.25 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.518 -0.739 . . . . 0.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.74 24.12 3.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 51' ' ' TYR . 4.7 tt -48.89 125.56 13.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.68 114.85 2.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.667 0.912 . . . . 0.0 112.257 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.34 118.74 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 116' ' ' LEU . 37.2 tp -97.49 79.1 2.72 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.229 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtp -64.75 108.85 1.85 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.8 m -96.42 134.57 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.632 -1.292 . . . . 0.0 109.362 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.2 t -150.2 177.57 9.8 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.812 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -122.76 141.51 51.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 5.8 tt0 67.99 35.59 3.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 0.0 109.148 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -45.52 127.33 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.814 . . . . 0.0 109.914 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -83.31 -133.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 -28.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.241 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -29.69 21.24 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -79.33 -36.43 39.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 90' ' ' ALA . 56.1 mt -64.68 -5.92 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 108.966 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 16.6 mt -89.94 -58.44 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 109.354 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.92 -60.57 2.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -49.02 -41.46 34.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 108.755 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 96' ' ' ILE . . . -47.64 -48.91 28.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.982 -1.074 . . . . 0.0 109.419 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -27.84 56.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.228 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.84 -106.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.923 . . . . 0.0 109.558 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.727 ' H ' HD11 ' A' ' 69' ' ' LEU . . . -145.36 12.11 1.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . . . -56.6 11.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.045 0.538 . . . . 0.0 110.775 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.0 m -29.33 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.99 126.96 8.02 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.08 111.11 6.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.535 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.634 ' CG1' HG12 ' A' ' 86' ' ' VAL . 8.7 p -117.95 121.9 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -53.3 172.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.179 179.37 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' THR . 15.4 pttt -147.4 156.96 45.85 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 120.579 -1.326 . . . . 0.0 108.911 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.98 167.89 77.35 Favored 'Cis proline' 0 N--CA 1.485 0.983 0 C-N-CA 124.862 -0.891 . . . . 0.0 110.348 -1.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -134.6 155.64 50.1 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.017 0.913 . . . . 0.0 110.473 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -93.12 151.42 19.86 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.114 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.73 -38.39 9.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.918 -1.114 . . . . 0.0 109.733 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.02 84.32 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 116' ' ' LEU . 19.0 m -66.31 -65.1 0.72 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.814 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -42.68 -48.71 5.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.619 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.75 80.34 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.312 -0.868 . . . . 0.0 110.048 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp10 -57.63 -33.84 68.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.027 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -36.71 14.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 0.0 110.042 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -58.12 -67.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.236 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.1 -28.69 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.118 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -71.76 -33.06 68.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.146 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 105' ' ' GLY . 21.0 mt -79.88 -42.28 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.078 -1.014 . . . . 0.0 110.075 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -62.63 4.99 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 110.577 -178.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.1 mm-40 -81.91 -28.61 32.75 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -86.89 -34.86 19.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -63.75 -30.06 71.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.115 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.1 77.09 0.32 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.273 -1.133 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.54 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 3.0 m-20 -43.94 145.53 0.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 29' ' ' GLY . 7.8 mtmm -90.5 7.48 38.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.221 -0.925 . . . . 0.0 110.302 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 45.7 mp0 -144.46 50.88 1.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.813 -1.18 . . . . 0.0 109.952 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.4 tp -80.26 114.76 19.4 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 121.5 7.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.059 -1.025 . . . . 0.0 112.046 -177.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.3 m-85 -113.41 149.5 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 54' ' ' VAL . 27.0 tp -121.55 109.45 14.82 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.61 99.77 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 110.122 -178.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.6 t -91.94 12.48 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.09 -1.006 . . . . 0.0 109.758 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.2 OUTLIER -62.18 156.32 22.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.393 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' PHE . 14.2 p-10 -94.86 -142.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.493 ' O ' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 61.27 146.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.84 . . . . 0.0 109.619 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 t -92.46 17.0 10.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -143.49 -12.89 0.69 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 109.446 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 5.8 ttm -71.51 -57.79 4.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -47.22 -28.87 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -51.17 20.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.186 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.93 -53.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.798 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -44.64 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.863 . . . . 0.0 110.333 -178.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -46.87 -55.43 8.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -59.69 -58.03 10.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.108 0.956 . . . . 0.0 108.518 179.428 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -39.29 -42.76 1.06 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.641 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.18 -41.96 69.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 108.899 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' ASN . 47.8 tttt -63.1 -30.71 71.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.22 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.57 -40.03 71.43 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.3 tt -76.96 -58.6 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 159.55 43.22 0.02 OUTLIER Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.54 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 48.5 m-85 -126.98 125.42 41.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.821 -0.811 . . . . 0.0 109.662 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.67 66.22 1.46 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.566 -0.708 . . . . 0.0 109.518 -179.705 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.64 93.37 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.111 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.54 179.29 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.059 -1.026 . . . . 0.0 109.856 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.4 mt-10 -138.73 -164.98 1.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -147.68 149.86 33.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.141 -178.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -142.3 -168.87 2.83 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -146.61 3.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 110.643 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 175.66 -172.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.123 -0.986 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -69.88 -42.24 70.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.11 -34.02 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.236 . . . . 0.0 109.049 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.97 -57.16 3.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.96 -38.22 10.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.39 -58.92 3.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -58.16 -21.51 47.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.931 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -90.15 -43.09 10.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 110.587 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.669 -1.269 . . . . 0.0 109.291 -179.333 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -63.05 -4.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -53.95 -74.91 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.564 -0.71 . . . . 0.0 109.855 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.16 10.8 1.18 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.545 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.5 81.64 1.27 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.761 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.8 m-85 -54.94 144.74 22.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.548 -0.972 . . . . 0.0 110.297 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.56 -4.64 73.03 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -161.93 145.56 12.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.418 -1.048 . . . . 0.0 110.004 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.702 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.2 t -139.92 125.93 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.353 -0.842 . . . . 0.0 109.877 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.51 104.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.499 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 90.2 p -104.94 178.27 4.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.349 -0.844 . . . . 0.0 109.964 -179.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 29.2 p-10 -99.98 -115.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.444 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 61.4 t-105 -140.12 -81.14 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 0.0 110.135 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.406 HD21 ' HA ' ' A' ' 63' ' ' MET . 29.1 t-20 -170.43 68.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 109.93 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.508 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.08 -48.33 0.41 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.523 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.05 -160.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.012 1.141 . . . . 0.0 109.822 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.691 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -84.75 107.48 16.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 0.0 109.094 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.4 mmm 50.31 93.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.107 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.9 t70 -152.24 -177.43 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.648 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 54.47 -80.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ASP . 95.7 mt -44.84 -68.65 0.18 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 109.66 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.17 -35.69 75.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.846 -1.159 . . . . 0.0 109.375 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.919 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.23 -33.93 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 109.007 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.6 tt -87.08 -59.99 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.173 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.0 ttpt -40.31 -32.81 0.2 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 m -66.2 -44.18 84.65 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.6 mt -54.65 -36.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 108.769 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtp-105 -75.59 -16.23 60.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.417 -0.802 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -54.42 -28.61 45.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 109.845 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 38.0 t70 -61.55 -121.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.606 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . 154.0 -32.65 0.73 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 -12.41 57.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.413 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.48 42.44 2.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 p -77.89 51.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -130.71 -26.14 2.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.644 -0.66 . . . . 0.0 109.715 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -38.65 103.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.896 -0.503 . . . . 0.0 109.78 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.2 108.87 1.04 Allowed 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 120.93 1.087 . . . . 0.0 111.574 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' HB ' ' A' ' 54' ' ' VAL . 25.5 t -108.81 111.51 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.463 178.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.99 110.75 21.71 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.8 ' SD ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -91.51 116.28 28.73 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.34 -176.859 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -102.23 150.43 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.887 -1.133 . . . . 0.0 110.867 -178.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 88' ' ' ALA . 9.3 t -150.09 -143.49 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 87' ' ' THR . . . -161.38 -17.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -79.85 -75.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.957 . . . . 0.0 109.506 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 106' ' ' TYR . . . 58.83 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.8 tptp -148.58 59.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.266 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 94' ' ' ASN . 74.1 tttt 53.12 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.9 pt-20 -47.17 -19.0 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.189 -0.945 . . . . 0.0 109.789 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' HB2' ' H ' ' A' ' 91' ' ' LYS . 3.0 m-20 -89.78 -35.78 15.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.82 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.87 -18.27 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -83.54 -43.39 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.751 -1.218 . . . . 0.0 107.93 178.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.45 -24.82 1.39 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 102' ' ' GLY . . . -51.1 -54.34 25.95 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.583 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.72 64.49 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.069 -1.644 . . . . 0.0 107.963 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -27.73 68.51 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.879 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -146.46 -68.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.825 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -58.61 79.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.82 -108.76 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.302 0 CA-C-N 111.549 -2.325 . . . . 0.0 115.676 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -29.83 -58.0 0.17 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.164 -175.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.31 176.26 37.0 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.95 -179.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -130.65 115.0 16.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.87 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.3 p -122.6 123.01 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 107' ' ' VAL . 28.0 m -54.18 -169.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.15 153.19 11.77 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.504 -1.372 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.11 154.06 99.45 Favored 'Cis proline' 0 N--CA 1.487 1.101 0 C-N-CA 125.187 -0.755 . . . . 0.0 110.636 -1.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.9 p90 -118.32 155.25 30.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.84 0.829 . . . . 0.0 109.661 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.483 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.4 OUTLIER -90.07 150.49 22.05 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -50.61 -15.55 0.28 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.684 -1.26 . . . . 0.0 109.327 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -81.69 -34.44 30.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.483 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -74.13 -61.21 1.93 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -51.1 -36.16 38.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.58 179.662 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 15.9 mt-10 -54.66 -66.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.009 -1.057 . . . . 0.0 109.521 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -44.25 -26.93 0.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.768 -0.583 . . . . 0.0 109.781 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.53 -44.03 15.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 110.325 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 120' ' ' LEU . 18.6 mt -67.57 -57.23 6.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.805 -1.184 . . . . 0.0 109.64 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.53 -27.02 5.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.986 -1.072 . . . . 0.0 109.82 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -84.4 -22.71 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.181 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.6 mt -88.36 -39.0 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.645 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -65.76 -5.68 9.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.998 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -26.17 62.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -90.38 -34.46 15.66 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.26 -15.52 59.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 58.41 85.76 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.228 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' CD1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER 173.52 134.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.397 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 28.69 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -171.68 41.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.01 -1.056 . . . . 0.0 110.579 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.2 tp -80.41 112.95 18.23 Favored 'General case' 0 C--O 1.205 -1.249 0 O-C-N 120.576 -1.328 . . . . 0.0 107.921 179.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.54 114.36 1.64 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.946 . . . . 0.0 112.481 -177.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 82.8 m-85 -109.2 151.12 26.91 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 54' ' ' VAL . 20.5 tp -119.15 108.62 14.91 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.02 122.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.265 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 33.3 t -126.9 105.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.491 -0.756 . . . . 0.0 109.574 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.5 133.47 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 109.425 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 53.52 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.596 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.64 135.53 22.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.12 15.99 3.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.02 -1.64 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 109.558 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.0 ttt -89.96 -21.71 22.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.123 -0.986 . . . . 0.0 109.074 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -76.08 -45.39 34.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.835 . . . . 0.0 109.419 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -58.63 -20.87 51.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.878 . . . . 0.0 109.575 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -73.81 -55.56 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.849 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -23.14 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 110.263 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.536 ' NH1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.81 -53.05 62.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 109.122 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.05 -56.08 13.37 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.014 0.911 . . . . 0.0 108.991 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.3 tt -40.6 -46.43 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.92 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.32 -45.0 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 0.0 108.541 179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -57.28 -30.4 64.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.478 -0.763 . . . . 0.0 109.147 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 -41.54 74.83 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.177 -0.952 . . . . 0.0 109.354 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.688 HD22 ' OE2' ' A' ' 117' ' ' GLU . 14.9 tp -76.86 -57.01 4.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -0.844 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . 152.3 77.37 0.02 OUTLIER Glycine 0 N--CA 1.478 1.483 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -150.22 147.99 28.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -1.073 . . . . 0.0 109.29 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.15 55.88 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.946 -1.096 . . . . 0.0 110.634 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.74 105.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.703 -1.248 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.536 HG22 ' NH1' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -146.76 -179.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.971 . . . . 0.0 109.384 179.21 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.1 mm-40 -134.71 -167.52 1.99 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -149.97 150.69 32.2 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.342 -178.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.39 -169.22 2.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.5 mt-10 -139.73 9.31 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.257 -0.902 . . . . 0.0 110.222 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.2 m-20 170.85 173.32 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.0 108.896 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.1 -25.5 73.39 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -37.09 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.937 -1.331 . . . . 0.0 108.243 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.9 t0 -74.66 -39.96 61.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -75.32 -35.5 61.21 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.57 -52.72 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -62.08 -30.93 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -90.0 -18.83 25.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.323 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -61.02 -32.96 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.569 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -84.06 -0.15 50.65 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.38 -72.78 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.659 -0.651 . . . . 0.0 109.553 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.03 -86.78 0.3 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.17 72.79 0.18 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.6 m-85 -54.27 98.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.312 -1.111 . . . . 0.0 109.041 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.29 1.19 0.44 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -169.2 142.82 2.83 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.187 -1.184 . . . . 0.0 109.919 -179.652 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 83' ' ' VAL . 12.8 t -133.59 145.43 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.088 -1.008 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.19 85.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 3.6 p -103.98 143.54 32.74 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.696 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.3 p30 -60.37 -122.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.532 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 75.2 t-105 -158.25 -77.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.02 122.88 32.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.089 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.495 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.25 -50.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 110.44 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.09 -173.67 0.22 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.747 0.965 . . . . 0.0 110.055 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.7 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -52.68 -13.67 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.168 -0.958 . . . . 0.0 109.546 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.44 ' N ' HD22 ' A' ' 62' ' ' ASN . 3.7 mmt -147.23 -86.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.42 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -152.94 177.85 10.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.9 -9.52 77.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 97' ' ' ALA . 46.7 tp -50.81 -25.65 4.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.679 -1.483 . . . . 0.0 108.239 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 64' ' ' ASP . 7.6 pt-20 -72.59 -34.48 67.46 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 39' ' ' GLY . 25.7 mt -63.18 -56.13 19.28 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt -57.11 -58.73 6.92 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.606 0.717 . . . . 0.0 109.193 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -53.86 -38.02 64.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 70.4 m -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.938 . . . . 0.0 109.097 179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.934 HD13 HG21 ' A' ' 83' ' ' VAL . 4.2 mt -67.09 -24.79 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -18.68 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 108.918 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.4 -52.22 22.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.176 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 79' ' ' SER . 4.1 t70 -66.71 83.85 0.11 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.94 43.44 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.76 -89.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -1.195 . . . . 0.0 109.564 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.0 mtt -118.16 20.98 13.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.0 109.25 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.522 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 t 46.93 -118.31 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.09 52.71 0.91 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER 46.07 -175.03 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.6 Cg_exo -63.03 144.79 93.53 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 121.68 1.586 . . . . 0.0 114.522 -176.071 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.934 HG21 HD13 ' A' ' 72' ' ' ILE . 5.4 t -139.5 111.38 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -95.13 106.07 18.05 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 117.551 -1.659 . . . . 0.0 106.964 177.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 1.1 ttm -74.56 107.68 6.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.539 -0.865 . . . . 0.0 109.392 -178.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -92.17 144.83 8.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 90' ' ' ALA . 5.8 t -146.24 170.2 17.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.015 -1.053 . . . . 0.0 110.426 -178.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.528 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -109.86 -57.29 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.709 -0.619 . . . . 0.0 109.551 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.74 29.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -46.45 110.9 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 3.8 ttpp -148.47 94.89 2.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.743 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttt 44.61 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.85 . . . . 0.0 110.156 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -45.93 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.333 -0.855 . . . . 0.0 110.419 -179.183 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -41.19 -34.43 0.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.477 -0.764 . . . . 0.0 110.764 -178.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.607 HG23 ' CD2' ' A' ' 106' ' ' TYR . 24.6 mt -75.58 -66.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.969 -1.082 . . . . 0.0 109.304 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 96' ' ' ILE . 69.2 mt -62.16 -0.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.023 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -76.02 -37.85 57.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.401 -0.812 . . . . 0.0 109.119 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -71.98 -59.87 2.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.09 -1.006 . . . . 0.0 108.306 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -59.55 -22.37 61.6 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.514 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -49.32 -33.38 13.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 69' ' ' LEU . . . -85.54 -36.82 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 90.29 64.94 1.22 Allowed Glycine 0 N--CA 1.482 1.71 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.001 175.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.893 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.12 -111.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.935 1.867 . . . . 0.0 108.678 177.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.62 -46.05 8.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 122.423 1.106 . . . . 0.0 108.611 177.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 163.23 -157.87 30.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -178.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.607 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -137.77 146.48 43.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.679 -0.895 . . . . 0.0 109.248 178.95 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.4 p -140.61 136.1 35.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 109' ' ' LYS . 3.0 p -80.08 159.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.034 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.528 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.27 154.79 80.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.0 109.523 -179.301 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.26 126.85 13.46 Favored 'Cis proline' 0 N--CA 1.488 1.194 0 O-C-N 122.564 0.771 . . . . 0.0 110.14 -2.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.93 156.6 18.33 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.376 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -92.99 148.44 22.0 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 176.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.496 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -49.28 -12.44 0.05 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.706 -1.246 . . . . 0.0 109.343 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -83.07 -37.74 23.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.72 -59.69 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.144 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -50.62 -40.71 53.71 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.983 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.688 ' OE2' HD22 ' A' ' 28' ' ' LEU . 24.0 mm-40 -61.09 -55.12 36.31 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.185 -0.947 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -41.62 -38.27 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.42 0.628 . . . . 0.0 109.752 -179.33 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -88.19 -29.63 20.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.214 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp -65.53 -65.71 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.613 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.81 -36.36 11.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.478 ' HB3' ' HZ3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -73.73 -25.53 60.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.847 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.44 -41.38 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.922 . . . . 0.0 109.849 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.83 -19.83 62.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 110.252 -179.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' CA ' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -61.27 -20.88 63.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.758 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -94.51 -31.76 13.79 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 127' ' ' LEU . 2.7 tt -72.82 -26.05 61.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.62 77.73 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.266 -1.138 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -46.71 136.61 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.04 48.48 1.58 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -178.55 33.66 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 50.5 tp -71.12 111.12 6.23 Favored 'General case' 0 C--O 1.206 -1.212 0 O-C-N 120.599 -1.313 . . . . 0.0 108.147 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.513 ' CG ' HD22 ' A' ' 32' ' ' ASN . 13.6 mtpt -58.04 119.8 7.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.072 . . . . 0.0 111.409 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 80.9 m-85 -110.79 148.76 31.68 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 54' ' ' VAL . 66.6 tp -119.34 110.88 17.48 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.52 106.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.286 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 36' ' ' ALA . 27.4 t -96.96 92.03 2.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.504 -0.748 . . . . 0.0 109.59 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -147.42 132.47 18.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -24.68 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.64 130.82 48.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -82.83 -20.08 36.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -33.3 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.499 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttt -57.6 -30.51 65.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -71.71 -34.75 69.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.923 -1.11 . . . . 0.0 108.679 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -75.87 -16.13 60.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.519 -0.738 . . . . 0.0 109.068 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.78 -50.83 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.48 -32.23 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 110.26 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -47.76 -53.35 15.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 109.391 179.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.02 -57.4 5.04 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.514 -0.742 . . . . 0.0 109.771 -179.576 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -40.42 -61.02 0.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.423 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 25' ' ' LEU . 23.7 mt -51.46 -50.78 59.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 108.72 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -49.07 -33.18 10.98 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.241 -0.912 . . . . 0.0 108.918 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -49.43 -51.07 37.94 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.404 -0.81 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.519 HD23 ' CE2' ' A' ' 30' ' ' PHE . 35.9 tp -70.56 -48.1 57.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.005 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.45 81.59 0.06 OUTLIER Glycine 0 C--O 1.208 -1.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 28' ' ' LEU . 67.2 m-85 -150.08 149.26 30.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -1.094 . . . . 0.0 108.896 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -150.1 64.06 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 110.224 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.513 HD22 ' CG ' ' A' ' 7' ' ' LYS . 2.2 t30 -176.7 103.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.864 -1.147 . . . . 0.0 109.258 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.15 151.83 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 110.288 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -120.55 -170.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.8 mp0 -146.63 155.99 42.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.721 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.16 -163.02 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -137.47 -7.89 1.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 110.783 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 62' ' ' ASN . 6.8 t0 -177.42 -165.57 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -79.24 -26.59 57.28 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 6.3 p -75.64 -42.08 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.025 -1.28 . . . . 0.0 107.847 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 12.4 t0 -68.98 -43.73 74.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -64.75 -52.79 55.12 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' ALA . 3.4 tt -43.34 -36.71 1.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.419 -0.801 . . . . 0.0 109.242 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -71.62 -34.62 69.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.08 179.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 47' ' ' GLN . 11.7 mmmt -86.38 -53.59 4.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -41.13 -22.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.666 -0.646 . . . . 0.0 109.371 179.682 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -52.35 -43.63 64.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.36 -56.95 5.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 88.35 -19.26 36.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.75 -5.37 3.92 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.773 ' O ' HD22 ' A' ' 81' ' ' LEU . 61.6 m-85 -75.43 83.88 2.52 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.469 -1.019 . . . . 0.0 110.212 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.02 -3.93 1.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 177.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -155.87 144.57 20.33 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.53 -0.982 . . . . 0.0 110.221 -179.473 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 9' ' ' LEU . 98.8 t -141.09 116.77 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 108.76 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 117.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.866 . . . . 0.0 108.861 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.1 p -120.05 166.95 12.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.629 -0.669 . . . . 0.0 109.681 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 12' ' ' ASP . 61.6 m-20 -95.58 -106.39 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.533 -0.73 . . . . 0.0 109.458 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CD1' ' OD2' ' A' ' 64' ' ' ASP . 56.6 t-105 -168.95 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.721 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.5 104.99 5.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.411 ' CE ' ' CA ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -130.9 174.09 5.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.339 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.42 -1.93 1.66 Allowed 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.534 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 8.5 m120 -127.05 83.67 2.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.283 -0.886 . . . . 0.0 109.488 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.9 mmt 48.46 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 109.599 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -165.04 179.09 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.961 -1.087 . . . . 0.0 109.405 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 60' ' ' MET . . . -70.96 14.66 1.46 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -68.3 -51.93 39.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -1.178 . . . . 0.0 108.854 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' THR . 1.8 mt-10 -63.53 -15.66 58.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.2 mt -79.98 -67.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.98 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.91 -62.17 1.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.682 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -58.23 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' GLU . 16.6 p -52.91 -41.15 64.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.897 -1.127 . . . . 0.0 109.476 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.9 mt -64.22 -42.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.399 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -84.75 -4.86 59.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 -29.12 22.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.528 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.5 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.92 -90.35 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.39 70.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.162 . . . . 0.0 109.158 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.9 mtm -92.45 10.22 31.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.238 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.4 p -76.49 44.61 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 8.57 0.65 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.6 mt -72.19 121.14 83.9 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.525 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 113.82 1.9 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.415 1.41 . . . . 0.0 113.433 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -103.25 105.65 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 175.224 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.42 105.92 18.14 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 116.749 -1.98 . . . . 0.0 106.55 178.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.521 ' O ' ' SD ' ' A' ' 85' ' ' MET . 2.7 ppp? -79.88 124.02 28.28 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.926 -177.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 140.78 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.209 -0.932 . . . . 0.0 109.103 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 t -150.07 174.98 12.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.044 . . . . 0.0 110.948 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -106.88 -64.68 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -75.82 63.96 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 108.873 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -67.34 91.99 0.27 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 144.12 25.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -24.03 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -78.2 -54.18 6.52 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' ALA . 1.2 t30 -68.74 -45.27 71.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.2 mt -48.65 -30.48 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.8 mt -89.86 -20.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.358 -0.839 . . . . 0.0 109.075 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.92 -45.75 92.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.409 -0.807 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -73.88 -54.34 8.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 108.199 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.86 -27.24 50.75 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -53.78 -34.03 57.79 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 178.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.98 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -83.04 -25.09 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.24 75.87 0.43 Allowed Glycine 0 N--CA 1.481 1.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.04 177.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.26 -112.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.824 -1.95 . . . . 0.0 111.158 179.174 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.8 OUTLIER -91.67 -53.77 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.801 1.286 . . . . 0.0 109.019 176.633 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.41 -161.0 31.66 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -177.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.73 136.55 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 0.0 109.962 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.3 p -136.1 122.05 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.98 176.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.792 -1.193 . . . . 0.0 108.223 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -151.3 149.41 24.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.772 -1.205 . . . . 0.0 109.065 179.636 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.93 139.87 63.75 Favored 'Cis proline' 0 N--CA 1.484 0.923 0 C-N-CA 125.302 -0.707 . . . . 0.0 110.399 -1.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.426 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.8 p90 -99.04 163.79 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.77 146.05 23.94 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 177.63 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.35 -34.45 6.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.106 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.26 76.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.2 m -70.54 -66.97 0.53 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.509 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 111' ' ' PHE . 6.8 tp -48.33 -40.12 24.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.593 -1.317 . . . . 0.0 109.497 178.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 119' ' ' LYS . 3.4 tm-20 -68.04 -68.45 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.027 . . . . 0.0 109.782 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 117' ' ' GLU . 86.0 tt0 -42.25 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.362 0.601 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' GLU . 5.5 mmmt -90.01 -47.57 7.76 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.071 179.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 120' ' ' LEU . 17.5 mt -56.07 -54.76 41.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -46.34 -49.93 17.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -57.15 -28.37 62.68 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.13 -40.95 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.47 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -68.65 -6.61 26.93 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.974 -1.079 . . . . 0.0 110.427 -178.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.84 -19.88 61.91 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -29.53 13.02 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -21.54 29.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.475 -0.766 . . . . 0.0 108.94 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.87 75.18 0.17 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 109.404 179.979 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 2.0 t0 76.85 131.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.466 -0.771 . . . . 0.0 109.289 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.41 18.44 6.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 110.172 -179.876 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 2.1 tm-20 -152.78 41.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.688 -1.257 . . . . 0.0 111.072 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 31.4 tp -81.87 118.67 23.1 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.497 -1.377 . . . . 0.0 107.912 178.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -63.87 123.28 18.54 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.19 -0.944 . . . . 0.0 111.754 -177.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 91.8 m-85 -115.56 144.51 43.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.62 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.0 tp -119.13 111.56 18.41 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.4 100.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 108.609 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.007 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -94.95 98.96 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.388 -0.82 . . . . 0.0 109.633 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.1 t0 -156.86 142.88 17.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.0 109.389 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.23 93.71 7.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -162.21 149.56 13.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.11 16.95 13.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -145.19 -22.11 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.438 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -60.8 -65.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.65 -33.66 7.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -38.63 67.77 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.0 -177.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -64.51 -56.05 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.674 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -31.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -51.79 -54.29 30.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 109.319 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -65.77 -57.23 8.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.52 -0.737 . . . . 0.0 109.215 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.7 -59.48 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.977 -179.507 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.02 -50.19 67.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.015 179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -56.07 -39.11 71.57 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.323 -0.861 . . . . 0.0 109.505 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -54.77 -44.47 73.69 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.287 -0.883 . . . . 0.0 109.184 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' OE2' ' A' ' 117' ' ' GLU . 4.5 mt -69.5 -58.49 3.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.94 74.8 0.01 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 46.0 m-85 -150.21 152.38 34.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -1.174 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.74 62.33 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.93 -1.106 . . . . 0.0 110.065 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -176.42 97.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.825 -1.172 . . . . 0.0 109.667 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -150.2 149.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.91 -1.119 . . . . 0.0 110.161 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -126.4 -166.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -148.59 149.28 31.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 110.655 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.007 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.32 -169.32 2.83 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -143.98 3.54 1.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.237 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -176.72 157.84 1.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.519 -1.363 . . . . 0.0 109.765 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -49.1 -52.83 21.14 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -50.78 -31.06 9.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.895 -1.356 . . . . 0.0 108.139 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.5 t0 -79.24 -46.13 18.44 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -64.54 -56.62 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mt -48.65 -52.95 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.862 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -69.19 -33.55 73.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -10.71 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.242 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -81.55 -22.65 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.148 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -63.65 -6.67 5.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 108.639 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.11 -69.3 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.584 -0.698 . . . . 0.0 109.843 -179.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 10.2 1.0 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.05 85.53 1.27 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.4 m-85 -64.71 139.23 58.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -1.038 . . . . 0.0 110.494 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.01 3.1 62.02 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -165.89 146.86 6.81 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 9' ' ' LEU . 89.7 t -148.63 123.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.786 -1.196 . . . . 0.0 109.759 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.98 93.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 p -96.36 158.1 15.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -0.861 . . . . 0.0 108.999 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' ASN . 4.4 p-10 -119.57 161.81 20.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.765 -0.584 . . . . 0.0 109.815 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 93.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 108.795 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -108.76 121.54 45.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.443 -0.786 . . . . 0.0 109.721 -179.297 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.627 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.6 ppp? -137.99 38.19 0.34 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.599 -0.688 . . . . 0.0 111.78 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -55.89 -24.97 50.35 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 178.034 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 63' ' ' MET . 7.8 p30 179.63 58.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 2.2 ttm 77.99 99.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.209 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -168.25 -172.53 1.76 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.528 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.689 ' H ' HD12 ' A' ' 68' ' ' LEU . . . 71.12 -69.68 0.82 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 97' ' ' ALA . 1.7 mm? -67.75 -61.62 1.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.109 -1.23 . . . . 0.0 108.992 179.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.61 -12.12 9.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 108.653 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -73.02 -46.44 52.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.87 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.88 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -84.2 -30.57 25.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.242 179.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -61.68 -40.43 94.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.114 179.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.5 m -68.66 -41.49 79.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.018 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.64 -29.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.82 . . . . 0.0 108.795 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -90.03 -24.13 21.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.686 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.18 -28.94 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -87.69 131.79 34.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.05 -23.72 77.82 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.23 -28.56 17.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -1.193 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.484 ' C ' ' H ' ' A' ' 80' ' ' ALA . 23.1 tpp -91.97 5.49 49.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 t -71.7 13.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -99.97 -37.24 9.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.708 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -38.55 102.67 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.766 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 96.25 0.23 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.164 1.243 . . . . 0.0 111.528 -178.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 83' ' ' VAL . 2.1 t -98.84 105.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.3 tp -96.02 103.72 15.62 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.827 -1.549 . . . . 0.0 106.86 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.56 161.67 11.67 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.731 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.73 137.72 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 t -150.04 156.24 41.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.31 -31.14 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.45 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.14 -61.2 2.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.15 33.36 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -44.84 -67.27 0.3 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.0 109.795 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -167.35 -80.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -13.32 1.96 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 109.741 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -83.12 -21.88 33.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.637 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.56 HG23 ' CD2' ' A' ' 106' ' ' TYR . 66.1 mt -78.89 -49.58 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.945 -1.097 . . . . 0.0 108.657 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.8 mp -63.49 -19.5 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.336 -0.852 . . . . 0.0 108.949 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -60.36 -59.56 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.83 -53.42 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.79 -19.87 65.83 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.993 -178.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -50.61 -30.79 14.2 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.04 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -92.54 -26.62 17.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.329 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.46 72.54 1.05 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.815 177.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.24 -112.04 0.07 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 116.619 -2.032 . . . . 0.0 109.05 178.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.91 -49.41 6.25 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.754 1.264 . . . . 0.0 108.102 175.396 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.58 -160.0 32.48 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.57 124.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.849 . . . . 0.0 109.289 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.5 p -113.39 130.55 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.459 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -84.23 124.18 39.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.972 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 161.55 25.63 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.159 -0.963 . . . . 0.0 108.94 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.48 129.04 17.35 Favored 'Cis proline' 0 N--CA 1.484 0.933 0 O-C-N 122.842 0.917 . . . . 0.0 110.747 -2.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.7 p90 -96.93 163.76 12.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.935 . . . . 0.0 109.632 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.56 147.18 25.6 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.862 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.436 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.66 -20.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.808 -1.182 . . . . 0.0 109.047 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -75.74 -58.4 3.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.538 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.639 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -52.41 -38.81 59.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.207 -1.558 . . . . 0.0 107.972 178.612 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.581 ' OE2' HD21 ' A' ' 28' ' ' LEU . 11.3 tt0 -57.14 -57.3 13.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.046 -1.034 . . . . 0.0 109.895 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.56 -39.19 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.532 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.43 -29.22 63.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -73.46 -45.37 54.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.521 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 125' ' ' GLU . 2.6 m120 -57.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.914 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -61.04 -46.31 91.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 109.729 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.26 -34.34 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.371 -0.83 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.27 -7.18 57.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.919 -178.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 121' ' ' ASN . 5.9 mt-10 -71.44 -28.55 64.05 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.342 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -94.14 -25.11 17.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -84.54 -22.4 30.13 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.487 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.41 79.62 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.285 -1.126 . . . . 0.0 109.465 179.925 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 7.4 m-20 -45.37 146.7 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.313 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.6 tttp -90.25 13.13 16.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.876 -1.14 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -152.46 45.59 0.72 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.708 -1.245 . . . . 0.0 110.415 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.56 136.56 44.03 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -73.98 115.9 13.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.958 -1.088 . . . . 0.0 111.978 -176.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.3 m-85 -106.4 153.24 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.063 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.784 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.72 104.53 5.55 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.411 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.515 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -91.67 122.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.969 -178.986 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.2 t -111.97 93.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.863 . . . . 0.0 109.069 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD1' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.34 -178.03 4.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.02 28.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.532 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -90.9 -7.85 51.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.427 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.51 -10.09 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.747 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.42 -8.88 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.9 ttt -64.9 -22.53 67.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.05 -63.64 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -46.75 -14.08 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.174 -178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' ARG . 4.2 mt -81.83 -50.13 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.014 -1.053 . . . . 0.0 109.628 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -27.72 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.786 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -55.71 -53.08 61.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 108.89 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -62.67 -59.22 5.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.525 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -40.61 -56.81 2.02 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.773 -179.985 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.84 -39.82 71.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.198 -0.939 . . . . 0.0 108.846 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -62.36 -50.71 70.5 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.282 -0.886 . . . . 0.0 109.207 179.642 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.04 -36.93 30.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.477 HD11 ' OE1' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -71.55 -61.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.563 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.19 65.12 0.01 OUTLIER Glycine 0 C--N 1.3 -1.465 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 44.2 m-85 -150.14 148.53 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 109.129 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.427 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.4 OUTLIER -150.15 59.28 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.806 -1.183 . . . . 0.0 111.159 179.908 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.21 98.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.703 -1.248 . . . . 0.0 110.684 179.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.71 178.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.035 -1.04 . . . . 0.0 110.352 179.058 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -142.31 -177.34 5.21 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 178.456 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 13.5 mt-10 -140.85 156.23 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.052 -1.03 . . . . 0.0 111.483 -178.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.99 -173.0 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.03 19.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.689 -1.257 . . . . 0.0 110.87 -179.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.488 ' OD1' ' ND2' ' A' ' 62' ' ' ASN . 42.0 t0 -174.48 145.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -0.992 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.19 -42.37 17.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -63.01 -33.37 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.245 -1.15 . . . . 0.0 108.492 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 18.8 t0 -73.29 -47.55 41.93 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -58.12 -48.2 80.93 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.42 -0.8 . . . . 0.0 108.845 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.5 tm? -49.91 -50.43 46.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.708 -179.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -55.44 -40.17 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.895 . . . . 0.0 111.05 -178.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -26.31 20.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.015 -1.053 . . . . 0.0 111.06 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.688 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -58.59 -19.51 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.818 -1.176 . . . . 0.0 109.256 -179.209 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -95.89 -5.9 40.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.125 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.29 -62.81 1.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.317 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.55 8.77 1.38 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.45 77.14 1.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.478 ' O ' HD13 ' A' ' 81' ' ' LEU . 36.6 m-85 -56.39 114.22 1.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.393 -1.063 . . . . 0.0 109.766 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.33 2.14 3.37 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -163.47 139.22 6.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.972 -1.311 . . . . 0.0 109.597 179.676 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.3 t -136.57 116.77 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.087 -1.008 . . . . 0.0 109.532 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.1 mt -103.8 99.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.533 -0.729 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.475 ' O ' ' SD ' ' A' ' 85' ' ' MET . 15.2 p -110.25 156.74 20.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.56 162.96 14.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.468 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 42.0 t-105 -96.49 111.95 23.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 2.3 t-20 73.48 96.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.725 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.455 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.5 mtt 177.16 -50.63 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -66.27 -67.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 120.783 0.989 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.6 p30 -154.55 125.96 7.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 mtt 54.33 -86.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -149.0 144.0 26.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.06 1.78 4.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.266 . . . . 0.0 109.627 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.9 tt0 -46.31 -32.62 3.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -66.87 -52.06 48.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.916 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -58.58 -60.42 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' ALA . 10.5 tttt -42.82 -34.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 m -52.06 -44.45 64.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 108.692 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.69 -30.8 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -6.9 55.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -64.17 -51.38 64.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.835 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -46.9 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.27 -61.32 0.36 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.44 -8.15 59.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -1.151 . . . . 0.0 109.257 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.6 mtp -90.26 -7.1 54.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -74.98 65.79 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.58 -28.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 0.0 110.452 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 51' ' ' TYR . 30.0 mt -60.14 125.05 80.25 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 120.9 -1.125 . . . . 0.0 109.28 -179.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.9 150.79 75.82 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.231 1.287 . . . . 0.0 112.565 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.9 t -133.21 137.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 84' ' ' LEU . 34.2 tp -117.35 65.73 0.73 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.555 178.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' O ' ' A' ' 56' ' ' SER . 2.3 mmt -48.21 159.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.01 132.76 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 109.048 -179.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.1 t -150.12 166.47 29.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.49 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -87.35 -68.24 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.4 101.93 14.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -88.5 98.92 11.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.93 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -63.72 -151.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 108.977 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.6 pttt -118.42 -71.43 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 109.413 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -48.97 -9.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.364 -0.835 . . . . 0.0 110.056 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -89.53 -49.02 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.856 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 35.9 mt -61.58 -31.95 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.89 -63.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.087 -1.008 . . . . 0.0 109.651 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.88 19.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 108.834 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.97 -54.14 13.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.472 -0.768 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -53.04 -45.23 67.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.878 . . . . 0.0 110.1 -179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.72 -19.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 109.116 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -98.97 -113.54 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.611 -0.681 . . . . 0.0 109.59 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.35 -2.89 5.82 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.695 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -55.79 10.94 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 122.206 -0.585 . . . . 0.0 111.326 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 102' ' ' GLY . 14.0 m -29.45 -33.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.15 130.79 10.26 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.92 121.76 10.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 0.0 109.429 179.385 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.23 141.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 108' ' ' VAL . 8.5 p -92.13 100.68 11.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 108.907 179.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -62.53 159.87 38.77 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.921 -1.112 . . . . 0.0 109.345 -179.323 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.48 147.74 87.61 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 O-C-N 123.008 1.004 . . . . 0.0 109.835 -3.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 116' ' ' LEU . 6.4 p90 -126.36 159.03 34.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.143 0.973 . . . . 0.0 110.414 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -103.19 153.15 20.65 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -48.9 -12.92 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.691 -1.256 . . . . 0.0 109.487 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.67 -42.92 23.74 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -60.26 2.56 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 111' ' ' PHE . 4.1 tp -49.26 -37.91 25.14 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.094 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.477 ' OE1' HD11 ' A' ' 28' ' ' LEU . 41.8 tt0 -65.19 -48.83 72.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 109.866 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.35 -68.47 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 110.403 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.38 -47.49 9.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.83 . . . . 0.0 110.19 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.56 -44.56 96.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -34.84 79.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.247 -179.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -71.32 -34.57 70.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 109.8 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 mt -80.12 -41.31 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.74 -24.67 67.86 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.14 -29.84 65.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -29.4 29.65 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.4 tp -69.06 -22.11 64.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.89 5.38 57.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.373 -1.075 . . . . 0.0 109.372 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.696 ' HB2' ' SD ' ' A' ' 129' ' ' MET . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.449 0.643 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 63.01 131.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 109.369 -179.827 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -90.17 9.68 27.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.765 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -147.84 48.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.76 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 56.1 tp -76.35 115.86 16.48 Favored 'General case' 0 C--O 1.204 -1.302 0 O-C-N 120.612 -1.305 . . . . 0.0 107.827 178.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -57.43 120.19 7.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.851 -1.156 . . . . 0.0 111.694 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.2 m-85 -110.62 143.36 41.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.588 HD22 ' CD1' ' A' ' 46' ' ' LEU . 53.9 tp -116.94 113.03 21.84 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.99 98.14 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 36' ' ' ALA . 18.3 t -90.05 89.24 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.11 135.1 17.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.066 -1.021 . . . . 0.0 109.709 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.6 m-20 -87.41 1.48 53.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -66.17 140.23 58.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 19.8 5.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.8 -27.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.847 . . . . 0.0 109.499 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -63.85 -58.79 5.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.487 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.66 -36.12 6.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.396 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.5 -39.62 74.05 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.736 -178.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 21' ' ' VAL . 2.5 mt -60.13 -55.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.394 -0.816 . . . . 0.0 109.847 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.38 -34.0 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 110.638 -178.484 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -53.12 -53.28 52.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.936 -1.103 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -69.29 -56.12 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.12 -57.27 2.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.741 -179.467 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.1 -48.63 80.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.064 -1.023 . . . . 0.0 109.02 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -57.39 -28.99 63.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.55 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.17 -30.88 68.51 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.1 -1.0 . . . . 0.0 108.874 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.74 -66.73 0.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.187 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.55 29.58 0.02 OUTLIER Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -98.08 152.34 19.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 109.6 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -150.04 60.29 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.096 -1.003 . . . . 0.0 109.727 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.73 100.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.09 153.72 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.101 -0.999 . . . . 0.0 110.176 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.74 -167.46 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 108.987 179.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.92 145.67 26.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.053 -1.03 . . . . 0.0 110.042 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.48 -169.03 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.15 6.31 1.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.212 -0.93 . . . . 0.0 111.176 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB3' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER 177.58 -175.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.533 -1.354 . . . . 0.0 110.005 179.605 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.87 -41.12 73.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.01 -36.99 76.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -1.056 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.1 t0 -78.99 -45.47 20.19 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.87 98.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.989 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.76 -39.12 90.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.074 -1.016 . . . . 0.0 109.741 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -74.25 -23.96 59.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -0.961 . . . . 0.0 110.336 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -90.03 -28.92 18.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.04 . . . . 0.0 110.829 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.588 ' CD1' HD22 ' A' ' 9' ' ' LEU . 1.6 mp -60.46 -13.04 11.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.581 -1.325 . . . . 0.0 109.417 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.17 -6.84 48.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.161 -0.962 . . . . 0.0 108.613 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.81 -71.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.578 -0.701 . . . . 0.0 109.826 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.14 12.64 1.08 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.89 94.78 0.97 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.44 ' O ' HD22 ' A' ' 81' ' ' LEU . 17.2 m-85 -73.97 148.8 41.79 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.257 -1.143 . . . . 0.0 110.128 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' C ' HD13 ' A' ' 81' ' ' LEU . . . -105.82 -9.01 33.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.2 129.49 14.71 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.3 t -128.28 122.78 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.079 -1.013 . . . . 0.0 110.09 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -107.43 132.31 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -149.47 142.39 24.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -74.62 123.01 24.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.349 -0.845 . . . . 0.0 109.285 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 51.0 t-105 -61.61 98.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.871 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 63.13 122.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 109.826 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.496 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 169.99 -46.79 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 110.334 179.526 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.14 -55.37 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.719 0.946 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -172.51 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 179.892 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.27 -177.77 4.38 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -93.1 131.5 38.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.192 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.05 1.83 3.28 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 64' ' ' ASP . 58.6 tp -73.36 -68.73 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -1.227 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -43.99 -31.4 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.533 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -66.08 -56.34 12.02 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 102' ' ' GLY . 1.6 tt -63.42 -65.65 0.65 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.609 -0.682 . . . . 0.0 109.783 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' HH21 ' A' ' 73' ' ' ARG . 6.7 tttm -39.89 -32.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.835 -0.541 . . . . 0.0 109.879 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.7 m -71.29 -39.99 71.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.083 -1.011 . . . . 0.0 108.776 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 69' ' ' LEU . 96.4 mt -55.41 -42.05 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 HH21 ' NZ ' ' A' ' 70' ' ' LYS . 19.4 ptt85 -89.97 1.62 56.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.854 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.05 -28.25 48.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -36.21 53.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.73 -23.88 14.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.37 -52.41 65.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.16 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.9 mmt -90.04 16.58 8.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.1 p 46.55 -107.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.03 56.55 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 82' ' ' PRO . 1.2 pp -42.77 149.44 0.49 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.6 ' O ' HD12 ' A' ' 81' ' ' LEU . 4.2 Cg_exo -54.32 142.89 67.51 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 121.818 1.678 . . . . 0.0 113.505 -178.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 69' ' ' LEU . 2.3 t -134.55 128.77 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.514 HD21 HD11 ' A' ' 116' ' ' LEU . 48.0 tp -109.27 72.7 0.82 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.012 177.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt -53.06 169.46 0.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -141.16 129.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.449 -0.782 . . . . 0.0 109.664 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 88' ' ' ALA . 24.3 m -141.64 166.7 24.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 109.255 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 87' ' ' THR . . . -111.58 -27.86 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.65 -0.656 . . . . 0.0 109.269 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt-10 -99.91 -72.4 0.67 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -0.805 . . . . 0.0 109.684 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 62.14 118.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.24 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -122.16 -88.06 0.63 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.634 . . . . 0.0 109.67 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' ASN . 1.4 mtpp -152.98 -77.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -45.94 -16.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.744 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.551 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 12.4 t30 -89.99 -33.15 16.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.659 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.1 mt -90.04 -20.69 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 97' ' ' ALA . 60.9 mt -73.66 -72.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.29 -50.66 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -55.7 -51.96 65.52 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.561 -0.712 . . . . 0.0 109.54 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.72 -41.93 70.92 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.317 -0.864 . . . . 0.0 109.902 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.497 ' OE1' ' N ' ' A' ' 100' ' ' GLN . 2.9 mp0 -61.43 -11.85 12.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.859 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.36 -104.79 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 110.43 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.735 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -134.6 0.78 3.87 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.54 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.792 -0.828 . . . . 0.0 110.006 177.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 6.1 m -29.1 -32.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.59 126.28 7.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.0 112.01 5.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -1.217 . . . . 0.0 108.944 179.547 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.8 p -108.82 129.89 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.8 p -80.93 93.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 108.925 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 161.19 3.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.012 . . . . 0.0 109.314 -179.583 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.74 162.28 92.67 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 124.705 -0.956 . . . . 0.0 110.372 -2.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -143.64 155.04 44.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.166 0.984 . . . . 0.0 110.431 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.55 154.02 18.9 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.09 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.415 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -49.13 -12.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.684 -1.26 . . . . 0.0 109.499 -179.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.49 -40.17 23.66 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 108.44 178.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -59.2 2.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD11 HD21 ' A' ' 84' ' ' LEU . 4.7 tp -50.59 -38.31 44.74 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.289 -1.364 . . . . 0.0 108.614 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.25 -51.22 70.5 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.157 -0.964 . . . . 0.0 109.562 179.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -46.01 -59.94 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.65 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.115 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -45.71 -68.23 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.496 -0.752 . . . . 0.0 109.037 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.08 -22.4 39.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.464 ' O ' ' CG ' ' A' ' 125' ' ' GLU . 1.4 ttpt -81.14 -24.4 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 110.303 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mt -90.08 -38.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.0 110.779 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 120' ' ' LEU . 16.5 m-85 -67.79 -17.03 64.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.993 -1.067 . . . . 0.0 111.342 -177.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -62.03 -27.85 69.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.723 -1.236 . . . . 0.0 107.714 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -87.71 -27.72 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -26.04 64.22 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.65 68.3 1.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.696 ' SD ' ' HB2' ' A' ' 2' ' ' ALA . 2.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER 61.94 131.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -90.07 10.57 23.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -146.44 50.19 1.15 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 52' ' ' GLY . 22.4 tp -78.74 131.9 36.75 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.05 118.5 19.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 0.0 113.18 -175.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 45.3 m-85 -110.29 143.91 39.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.204 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 46' ' ' LEU . 41.3 tp -114.04 107.74 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.16 101.51 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.9 t -96.9 120.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.367 -0.833 . . . . 0.0 110.619 -178.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CE2' ' A' ' 14' ' ' PHE . 4.6 t0 -176.44 -178.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.467 -0.771 . . . . 0.0 109.389 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -114.94 9.96 16.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.064 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' ' CB ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -69.46 164.14 23.74 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.397 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.4 p -134.09 29.84 3.69 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -154.08 -60.62 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.481 -177.184 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CE2' ' A' ' 14' ' ' PHE . 4.7 ttt -45.69 -58.13 3.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HE ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -34.08 -33.99 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.469 0.652 . . . . 0.0 109.93 178.726 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -70.19 -46.54 64.38 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.621 -178.426 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.6 mp -54.46 -58.07 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.249 -0.907 . . . . 0.0 109.269 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -55.39 -43.25 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.504 -0.747 . . . . 0.0 110.157 -179.309 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' NH1' ' HE ' ' A' ' 18' ' ' ARG . 4.6 mtt85 -46.78 -53.36 12.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -64.69 -57.12 9.86 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.807 0.813 . . . . 0.0 109.192 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -38.43 -56.03 1.31 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.42 -52.18 65.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.01 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -52.53 -39.39 61.31 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.83 -31.22 26.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.95 -62.35 1.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.275 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 159.55 74.06 0.02 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 56.0 m-85 -150.1 155.12 39.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.215 . . . . 0.0 109.57 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.18 40.28 0.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.093 -1.004 . . . . 0.0 110.294 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -157.57 108.6 2.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.655 -1.278 . . . . 0.0 109.536 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -146.35 146.96 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.315 -0.865 . . . . 0.0 110.067 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.85 -172.55 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 74.5 mt-10 -149.95 154.11 37.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.01 -1.056 . . . . 0.0 110.38 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.15 -173.97 3.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.19 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.584 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 15.6 mm-40 -117.95 -2.13 11.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.487 -0.758 . . . . 0.0 110.443 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 165.01 166.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.31 -0.869 . . . . 0.0 109.041 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -42.74 -52.82 5.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 2.9 p -58.96 -42.27 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.881 -1.364 . . . . 0.0 109.176 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.584 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 8.7 t0 -58.83 -45.98 88.73 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.17 -40.99 91.86 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -49.65 -39.62 36.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.926 -1.109 . . . . 0.0 108.624 179.405 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -88.18 -33.01 18.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.232 -0.918 . . . . 0.0 110.35 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -89.9 -55.8 3.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.104 -0.998 . . . . 0.0 109.879 -179.603 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 9' ' ' LEU . 7.2 tt -45.68 -27.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.59 12.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 108.808 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -49.7 -55.47 13.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.52 -0.738 . . . . 0.0 109.652 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.65 33.78 0.07 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.89 124.52 2.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 53' ' ' PHE . 18.2 m-85 -113.64 107.18 15.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.76 -0.847 . . . . 0.0 110.193 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.89 0.46 1.7 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -168.39 144.32 3.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.257 . . . . 0.0 109.484 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.9 t -142.23 126.94 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.854 -1.154 . . . . 0.0 109.685 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.3 mt -110.51 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.7 p -91.04 141.62 28.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.88 -1.138 . . . . 0.0 109.461 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -106.61 24.71 12.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 110.521 -179.307 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.487 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 4.5 t-105 62.19 143.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.941 -1.099 . . . . 0.0 109.163 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -151.49 167.7 27.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 109.987 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.658 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -144.48 23.5 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 113.615 -179.932 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -59.33 -54.9 2.16 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 N-CA-C 108.598 -1.347 . . . . 0.0 108.598 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -155.31 -21.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.674 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 76.6 mtp -150.78 103.49 3.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.483 -0.76 . . . . 0.0 109.031 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -58.69 -175.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.081 -1.012 . . . . 0.0 110.183 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.02 -5.29 80.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.44 -50.53 67.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.795 -1.415 . . . . 0.0 107.832 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.45 -24.66 2.11 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' ILE . 3.8 tp -69.78 -57.43 5.11 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -50.08 -55.14 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.031 0.92 . . . . 0.0 109.052 178.988 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -59.79 -50.02 75.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.399 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.6 m -69.23 -14.86 63.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.847 HD13 HG21 ' A' ' 83' ' ' VAL . 1.1 mt -78.26 -29.72 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -77.24 -35.12 55.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.933 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -45.25 -27.98 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.168 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.54 78.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.942 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 43.69 -157.91 0.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.65 57.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.652 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.2 tpt -90.0 -8.81 50.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 108.907 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m 45.45 -119.19 0.79 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.548 -0.72 . . . . 0.0 109.938 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.03 60.58 0.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 47.65 -178.92 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.815 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.5 Cg_exo -62.83 142.93 90.64 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.533 2.156 . . . . 0.0 115.451 -174.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.847 HG21 HD13 ' A' ' 72' ' ' ILE . 15.2 t -137.01 104.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -91.48 104.78 17.24 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.722 178.388 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.0 ttm -77.44 119.4 20.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.704 -1.198 . . . . 0.0 108.726 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 107' ' ' VAL . 2.2 p -108.13 146.08 14.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.503 -0.748 . . . . 0.0 109.611 -178.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.444 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 3.0 t -150.12 -173.41 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.614 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . -129.8 -46.41 1.15 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.5 pt-20 -74.67 26.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.827 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.64 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.378 -0.826 . . . . 0.0 109.448 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ttmt -99.99 -69.12 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 109.481 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -169.94 -44.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -79.97 -24.57 40.85 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.281 -0.887 . . . . 0.0 109.796 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 4.6 t30 -87.95 -28.05 21.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.865 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.827 HD11 ' HB1' ' A' ' 90' ' ' ALA . 15.7 mt -72.67 -58.0 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 108.938 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.34 -29.39 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.362 -0.836 . . . . 0.0 109.162 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.77 -40.05 39.98 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.964 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -80.92 -62.11 1.77 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -53.39 -28.4 29.23 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.816 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.51 -35.39 68.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -76.9 -26.05 53.71 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 176.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.49 71.84 0.88 Allowed Glycine 0 N--CA 1.484 1.846 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.745 175.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.2 -111.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 117.495 -1.682 . . . . 0.0 109.391 177.629 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.58 -47.48 7.38 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.53 1.157 . . . . 0.0 108.833 177.224 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 166.7 -159.02 32.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -178.155 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -142.62 136.39 29.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.705 -0.879 . . . . 0.0 109.833 179.308 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.772 HG11 HD21 ' A' ' 116' ' ' LEU . 6.2 p -134.71 134.24 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -161.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.86 151.76 8.32 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 108.784 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.86 138.08 53.96 Favored 'Cis proline' 0 N--CA 1.486 1.035 0 C-N-CA 125.281 -0.716 . . . . 0.0 110.341 -2.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.822 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.3 p90 -97.89 160.21 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.78 146.95 23.25 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.01 -34.73 13.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 108.442 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.47 -35.38 80.75 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.8 m -70.44 -70.57 0.29 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -51.67 -28.34 14.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.429 -1.419 . . . . 0.0 109.841 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 10.2 tt0 -62.22 -62.66 1.61 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.463 -1.398 . . . . 0.0 108.997 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.32 -44.45 16.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -62.04 -31.43 71.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 tt -81.63 -53.5 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -33.96 74.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.701 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -70.78 -44.0 67.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.46 -36.65 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 109.264 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -73.79 -29.85 62.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -51.67 -29.88 19.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -86.37 -30.7 21.96 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 tp -79.91 -10.05 59.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 0.0 108.846 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.69 41.19 12.71 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.317 -1.108 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -45.75 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -69.03 26.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 109.942 -179.934 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 3' ' ' ASP . 30.6 mt-10 -134.62 35.71 3.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.85 136.16 34.23 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.2 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -83.94 129.91 34.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.91 -1.118 . . . . 0.0 111.237 -177.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.56 157.69 21.73 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.445 0.64 . . . . 0.0 109.767 179.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.043 HD23 HD12 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -132.64 108.35 9.0 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.461 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.554 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.5 m -92.63 110.12 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -177.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.5 t -90.03 92.68 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.071 -1.018 . . . . 0.0 109.506 179.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -144.99 151.69 38.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.15 -33.38 10.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.629 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.87 132.32 11.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 109.595 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -86.29 26.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -146.32 -23.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.27 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.4 ttt -65.67 -46.74 77.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -55.86 -30.97 62.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.645 ' NH2' HH12 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -70.02 -24.66 63.31 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.309 -177.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.15 -47.28 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 109.889 -179.639 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -34.43 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.22 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.645 HH12 ' NH2' ' A' ' 19' ' ' ARG . 8.6 mtp180 -47.43 -51.56 19.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.51 -58.53 3.86 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.677 0.751 . . . . 0.0 109.84 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -40.57 -46.41 2.51 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.474 -179.085 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -71.24 -41.91 69.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.124 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -61.91 -30.36 70.84 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.261 -0.9 . . . . 0.0 109.342 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.14 -23.27 62.02 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -90.78 -40.49 11.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 144.29 5.36 0.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.93 135.33 33.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.323 . . . . 0.0 109.794 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.53 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -145.76 64.24 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.102 -0.999 . . . . 0.0 109.894 -179.829 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.45 97.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 110.01 179.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.93 177.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -0.999 . . . . 0.0 110.228 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.677 ' HG3' HD13 ' A' ' 9' ' ' LEU . 13.5 pt-20 -134.91 -166.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 3.8 tt0 -147.39 155.03 41.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 110.905 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -148.37 -166.87 2.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -136.35 -7.94 1.99 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.387 -0.82 . . . . 0.0 110.211 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -178.12 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.052 . . . . 0.0 109.243 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 64' ' ' ASP . . . -64.12 -52.16 46.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -51.05 -35.28 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.916 -1.343 . . . . 0.0 107.812 179.198 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 20.8 t0 -68.23 -50.57 53.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.059 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.02 -18.95 65.68 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.279 -0.888 . . . . 0.0 108.708 179.44 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.652 ' CD2' HE22 ' A' ' 47' ' ' GLN . 0.7 OUTLIER -77.41 -27.59 52.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.149 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -90.64 -33.35 15.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.316 -179.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -58.7 2.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.009 -1.057 . . . . 0.0 110.076 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 HD23 ' A' ' 9' ' ' LEU . 2.1 tt -51.88 -22.41 3.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.652 HE22 ' CD2' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -51.84 -29.39 19.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 108.799 179.158 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.92 -59.31 2.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.42 112.18 3.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.39 -30.11 0.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.4 m-85 -64.21 85.29 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.296 -1.12 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.0 9.62 2.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -159.54 153.02 22.51 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.391 -1.064 . . . . 0.0 109.883 -179.355 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.3 t -146.07 142.93 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.918 -1.114 . . . . 0.0 109.687 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 55' ' ' ILE . 12.8 mt -126.4 104.14 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 p -114.7 150.54 35.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.383 -0.823 . . . . 0.0 110.272 -178.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.24 -85.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 109.236 179.522 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.627 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 59.6 t-105 -165.76 169.11 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.278 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.627 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -76.33 44.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.735 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtp -71.17 -46.74 14.27 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.401 -0.812 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.47 -50.6 1.81 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.12 1.213 . . . . 0.0 110.299 -179.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -164.03 154.21 14.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -46.09 125.17 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.827 . . . . 0.0 109.342 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER 177.01 -61.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.027 -1.045 . . . . 0.0 109.902 -179.952 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -38.26 -40.13 0.84 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -55.62 6.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.332 . . . . 0.0 109.003 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -10.01 15.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 108.76 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -73.95 -59.94 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.567 0.698 . . . . 0.0 109.126 179.621 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.837 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -76.68 -31.82 57.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.569 -0.707 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -67.35 -47.48 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.122 179.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.7 m -64.52 -41.45 96.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 108.973 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 46.4 mt -60.42 -26.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.845 . . . . 0.0 109.071 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -89.31 -25.49 21.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.749 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.27 69.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 109.362 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -78.36 93.03 4.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 109.477 179.98 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.13 -24.09 54.03 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.52 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -1.18 . . . . 0.0 109.59 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.3 mtt -149.14 21.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 75' ' ' ASP . 88.5 p -75.17 65.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.976 . . . . 0.0 109.397 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -149.98 -28.71 0.24 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -43.84 107.55 0.6 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 109.676 -179.362 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.6 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.469 1.446 . . . . 0.0 113.293 -178.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -110.72 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 176.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.89 105.11 17.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.279 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.67 118.48 22.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.084 -177.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -104.1 150.89 6.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.521 -0.737 . . . . 0.0 109.764 -178.532 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -150.01 165.99 31.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.98 -1.075 . . . . 0.0 110.046 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -90.55 -97.38 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 89' ' ' GLU . 9.2 mp0 -59.78 81.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.086 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -70.21 70.48 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.501 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.257 -0.902 . . . . 0.0 108.72 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER 179.53 -59.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.465 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' ' CG ' ' A' ' 92' ' ' LYS . 15.5 mt-10 -55.07 -34.78 63.9 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.27 -0.894 . . . . 0.0 109.655 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -79.11 -11.55 59.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.723 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 35.0 mm -85.1 -67.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.131 -0.98 . . . . 0.0 109.067 179.814 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.5 mp -48.09 -21.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' ILE . . . -57.37 -63.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.138 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -49.94 -58.81 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.567 179.166 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.44 -24.65 46.9 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.48 -178.939 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.9 tt0 -51.59 -31.79 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.65 -23.31 20.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.557 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.02 75.86 0.5 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.461 177.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.837 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.06 -112.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 117.009 -1.876 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -49.38 6.3 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 122.921 1.343 . . . . 0.0 108.042 175.554 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.94 -163.0 36.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.384 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.69 139.28 41.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.623 -0.927 . . . . 0.0 109.158 178.579 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.498 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.7 p -133.87 150.64 31.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.433 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 57.5 t -90.95 160.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.069 -1.02 . . . . 0.0 109.558 -179.528 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.463 ' N ' HG12 ' A' ' 108' ' ' VAL . 11.9 pttt -129.01 156.06 78.73 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.193 -0.942 . . . . 0.0 108.755 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.72 123.78 9.34 Favored 'Cis proline' 0 N--CA 1.486 1.084 0 O-C-N 122.618 0.799 . . . . 0.0 110.625 -2.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -89.9 165.84 13.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.031 . . . . 0.0 109.215 179.132 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -99.8 167.05 10.78 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.041 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.92 88.8 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.954 -179.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.57 66.29 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.45 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 112' ' ' THR . 5.4 m -78.41 -69.88 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.623 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.642 HD13 ' CE2' ' A' ' 111' ' ' PHE . 9.1 tp -46.61 -36.0 6.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.726 -1.234 . . . . 0.0 109.213 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -63.14 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.109 -0.994 . . . . 0.0 110.822 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -45.8 -29.85 1.47 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.158 -0.964 . . . . 0.0 110.153 -178.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -85.25 -32.88 22.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 0.0 108.891 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.81 -52.0 49.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.441 -0.787 . . . . 0.0 109.469 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.26 -61.09 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 109.707 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -52.77 -27.96 20.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 110.133 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 mt -76.92 -43.73 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 0.0 109.974 -179.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 128' ' ' GLY . 12.0 m-85 -66.77 -5.9 13.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.833 -179.269 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.42 -24.64 62.95 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.057 -1.027 . . . . 0.0 108.249 178.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.08 -24.72 16.75 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.153 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.76 -14.14 25.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.53 -0.732 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' PHE . . . 46.2 86.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.221 0.534 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -46.62 146.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.499 179.889 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -90.37 14.82 11.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 109.943 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.12 45.39 0.44 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.761 -1.212 . . . . 0.0 110.941 -178.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 46.5 tp -71.96 111.93 7.62 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.792 -1.193 . . . . 0.0 107.817 179.053 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' CG ' HD22 ' A' ' 32' ' ' ASN . 17.6 mttt -48.13 118.77 2.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.719 -177.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 38.2 m-85 -109.83 155.44 21.65 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.75 0.786 . . . . 0.0 110.487 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG12 ' A' ' 54' ' ' VAL . 7.6 tp -135.86 102.63 5.12 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.832 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 21' ' ' VAL . 16.7 m -89.99 103.84 14.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.5 t -97.96 110.35 25.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.424 -0.798 . . . . 0.0 109.354 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -169.72 159.08 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.85 -179.741 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 14' ' ' PHE . 13.1 t0 -97.45 -100.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.536 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 45.2 -163.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -0.859 . . . . 0.0 109.752 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.1 12.34 2.41 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.748 . . . . 0.0 109.238 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.1 ttt -67.43 -66.26 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.798 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.657 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.62 -35.67 4.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 109.84 -179.842 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -70.66 -41.2 72.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.52 -52.96 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -63.0 -45.34 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.091 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -46.27 -53.76 10.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.974 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.87 -57.23 8.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.857 0.836 . . . . 0.0 109.304 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -40.08 -59.77 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 -179.792 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.39 -48.05 68.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.784 . . . . 0.0 109.431 179.693 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.32 -42.91 78.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 -179.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.48 -29.95 59.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.273 -0.892 . . . . 0.0 109.239 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.72 -62.97 1.41 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.69 35.07 0.02 OUTLIER Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.535 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 47.3 m-85 -115.66 139.09 50.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.751 -0.852 . . . . 0.0 109.733 -179.589 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.3 63.88 1.54 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.469 -0.769 . . . . 0.0 109.69 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.472 HD22 ' CG ' ' A' ' 7' ' ' LYS . 2.4 t30 -176.8 95.57 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.967 -1.083 . . . . 0.0 108.551 179.796 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.11 147.09 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.693 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -118.83 -164.87 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.351 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -150.15 159.19 44.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.791 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.87 -170.87 3.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -121.73 -10.1 8.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 111.004 -178.985 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.51 171.81 2.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.565 -1.334 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.45 91.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.622 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 41' ' ' ASP . 9.4 p -57.32 -39.3 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.953 -1.322 . . . . 0.0 108.926 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.8 t70 -63.74 -51.11 66.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.253 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -51.89 -48.96 63.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.29 -44.48 16.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 109.706 179.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -79.64 -29.62 41.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.296 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -89.77 -10.33 45.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.085 -1.009 . . . . 0.0 110.371 -179.29 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.659 HD21 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.08 -6.37 38.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.058 . . . . 0.0 108.726 -179.992 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 47' ' ' GLN . 29.6 tp60 -95.14 -13.14 25.32 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.96 -66.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.472 -0.768 . . . . 0.0 109.459 179.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.97 7.14 1.87 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.96 84.33 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 82.1 m-85 -63.54 138.94 58.7 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -1.051 . . . . 0.0 110.4 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.45 -4.03 86.19 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 4.0 t80 -169.35 94.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.89 -1.359 . . . . 0.0 110.35 -178.618 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 HD21 ' A' ' 46' ' ' LEU . 30.2 m -94.86 141.9 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.129 -1.607 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.89 96.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.778 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -111.13 177.6 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.555 -0.716 . . . . 0.0 110.297 -179.476 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 11' ' ' VAL . 4.8 m-20 -89.8 -121.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.466 -0.771 . . . . 0.0 110.179 -179.2 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 61.3 t-105 -127.56 -173.64 2.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.52 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 1.2 p-10 -93.87 55.74 2.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 -179.762 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -75.87 -45.6 3.97 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.991 -1.068 . . . . 0.0 110.406 179.702 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -67.73 -44.77 3.89 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.208 1.272 . . . . 0.0 110.211 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.74 159.79 19.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 119.16 7.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -175.96 -63.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.978 179.901 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -34.22 -50.11 0.67 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.397 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.415 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -68.49 -60.55 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.768 -1.431 . . . . 0.0 108.81 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.75 -13.06 0.9 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 108.561 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -72.45 -55.08 7.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.375 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.862 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.96 -37.46 87.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -64.24 -55.03 24.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 108.851 179.44 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -54.18 -44.24 71.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.331 -0.856 . . . . 0.0 108.731 179.427 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.94 -19.19 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.309 -0.869 . . . . 0.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -36.33 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 109.227 179.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.88 72.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.774 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' SER . 15.4 t70 -47.68 145.43 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.42 -34.05 4.61 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.42 -27.0 45.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.71 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.7 mmt -137.18 -55.83 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 46.78 24.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.06 3.59 0.53 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.885 -179.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 51' ' ' TYR . 11.6 mt -54.52 115.26 8.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 108.292 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 2.7 Cg_endo -60.46 134.6 55.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 121.182 1.255 . . . . 0.0 113.715 -177.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -128.62 112.97 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.778 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.1 tp -97.85 96.52 8.26 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.447 179.245 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.3 144.14 54.44 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.713 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 107' ' ' VAL . 44.4 t -133.81 145.15 33.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.559 0.695 . . . . 0.0 110.707 -177.724 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -150.08 165.04 33.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.087 179.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.46 38.11 3.35 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.598 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' ALA . 1.7 mt-10 -165.75 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.407 -0.808 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 1.033 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 45.18 84.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.869 0.842 . . . . 0.0 108.754 -179.435 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -75.41 16.66 0.33 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.963 . . . . 0.0 109.805 -178.924 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.627 ' HA ' HD12 ' A' ' 95' ' ' ILE . 13.4 ttmt 75.44 -45.4 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.884 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.26 -45.16 49.55 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.454 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 2.9 m-80 -74.06 -4.76 37.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.0 109.337 179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.033 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.9 mt -80.26 -57.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 108.521 179.381 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 96' ' ' ILE . 79.5 mt -68.8 2.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.271 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -80.67 -47.52 13.92 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.508 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -70.68 -50.7 33.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.534 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.65 -25.79 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.289 -179.642 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -52.99 -33.04 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.593 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.862 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.53 -23.27 25.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.24 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 75.61 0.51 Allowed Glycine 0 N--CA 1.48 1.572 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.544 177.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -112.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.877 -1.929 . . . . 0.0 109.596 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 67.3 m -91.88 -49.02 6.46 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.7 1.238 . . . . 0.0 108.06 175.531 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 167.31 -159.68 33.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.525 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 137.61 26.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.568 -0.96 . . . . 0.0 109.055 178.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.478 HG12 HG22 ' A' ' 86' ' ' VAL . 12.4 p -131.76 134.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.2 p -89.14 96.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.585 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.419 ' CD ' ' C ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -61.04 155.7 53.2 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 0.0 108.557 179.812 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.38 154.44 99.65 Favored 'Cis proline' 0 N--CA 1.487 1.094 0 C-N-CA 125.335 -0.694 . . . . 0.0 111.313 -1.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -135.33 156.54 48.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.693 0.758 . . . . 0.0 108.998 178.422 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.29 150.0 21.5 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.95 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.82 -35.0 21.33 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.735 -1.228 . . . . 0.0 108.985 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.98 65.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 17.5 m -75.99 -65.23 0.94 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -49.73 -36.93 27.32 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.23 -1.388 . . . . 0.0 108.313 179.086 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 -53.21 39.16 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.002 -1.062 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -46.55 -25.02 0.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.516 -0.74 . . . . 0.0 109.05 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -88.51 -49.97 6.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 mt -48.49 -59.02 3.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.02 -61.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.34 -0.85 . . . . 0.0 110.237 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -45.4 -29.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 110.1 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 125' ' ' GLU . 4.6 mt -87.88 -44.01 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.217 -179.614 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -62.0 5.27 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.969 . . . . 0.0 110.579 -178.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.8 tt0 -77.91 -36.47 49.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -81.15 -35.56 31.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.33 -32.85 70.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.021 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.61 75.28 0.9 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.234 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.313 -1.11 . . . . 0.0 109.428 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -45.87 143.36 2.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 23.8 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.96 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.28 42.92 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 52' ' ' GLY . 51.3 tp -67.63 143.22 56.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.233 -0.917 . . . . 0.0 108.577 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -79.76 120.35 23.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.117 -0.989 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -109.05 152.79 24.55 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.672 -0.642 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.611 ' HB3' HG23 ' A' ' 54' ' ' VAL . 9.3 tp -130.43 110.76 11.72 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.342 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.12 104.38 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 36' ' ' ALA . 94.8 t -89.81 100.73 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 120.937 -1.102 . . . . 0.0 109.66 -179.723 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -163.58 1.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.775 . . . . 0.0 109.227 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.29 1.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.988 -179.886 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.63 153.3 28.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.051 -1.031 . . . . 0.0 109.376 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.1 p -93.63 41.11 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.712 -179.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -173.9 -21.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.8 ttt -62.41 -46.42 88.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -45.58 78.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -55.37 -34.24 64.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 110.701 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -63.86 -48.51 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.158 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.21 -36.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.993 . . . . 0.0 110.575 -178.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -50.7 -53.11 33.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.73 -56.65 10.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.672 0.749 . . . . 0.0 109.471 179.915 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.94 -57.67 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.954 -179.669 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.81 -51.87 65.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.213 179.382 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -53.82 -35.08 61.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -55.49 -28.92 57.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.228 -0.92 . . . . 0.0 109.552 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 mt -87.82 -62.56 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.71 65.5 0.03 OUTLIER Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -150.01 145.31 26.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.251 . . . . 0.0 109.574 -179.82 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -150.02 66.63 0.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -173.91 99.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.15 150.94 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.05 -167.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.233 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.14 152.55 34.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 110.536 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.959 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.41 168.12 20.87 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.069 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.08 9.26 9.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.56 -0.712 . . . . 0.0 109.911 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.6 p-10 178.05 -176.23 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.69 -39.24 49.11 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.7 -35.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.05 -1.265 . . . . 0.0 108.025 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.656 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.2 t0 -82.69 -47.49 11.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.59 -0.694 . . . . 0.0 109.316 179.503 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -55.05 30.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -59.09 6.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.08 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -53.02 -33.43 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.028 -179.465 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -88.76 -13.24 39.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -82.17 -29.57 31.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.716 -1.24 . . . . 0.0 109.178 -179.976 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -8.41 0.31 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.174 -0.954 . . . . 0.0 108.653 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.8 -69.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.602 -0.686 . . . . 0.0 109.795 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.98 15.26 0.51 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.352 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 93.6 0.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.866 ' O ' HD21 ' A' ' 81' ' ' LEU . 29.4 m-85 -72.11 104.91 3.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -1.083 . . . . 0.0 110.491 -178.899 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.23 -11.07 6.06 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.159 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.98 137.02 17.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.245 -1.15 . . . . 0.0 110.069 -178.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 83' ' ' VAL . 10.3 p -144.5 133.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.715 -1.241 . . . . 0.0 109.52 178.643 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 84' ' ' LEU . 8.8 mt -113.94 157.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.196 0.522 . . . . 0.0 109.775 -178.362 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.2 p -144.93 168.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 108.942 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -93.31 -21.63 19.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.923 . . . . 0.0 110.584 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.549 ' CH2' ' HB2' ' A' ' 98' ' ' ALA . 37.5 t-105 59.65 35.36 22.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.206 -0.933 . . . . 0.0 109.911 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -177.85 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.908 -1.12 . . . . 0.0 109.882 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 175.63 -50.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.148 -0.97 . . . . 0.0 110.732 179.573 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.8 Cg_endo -64.71 123.46 11.72 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 120.95 1.1 . . . . 0.0 110.455 -179.425 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 8.2 p30 41.82 -146.56 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.664 -0.647 . . . . 0.0 109.889 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 7.3 mtp -47.32 -65.2 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 108.811 179.753 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.47 -39.41 0.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 108.914 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.7 -3.57 2.34 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 69' ' ' LEU . 10.7 tp -71.64 -61.68 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.032 -1.275 . . . . 0.0 107.611 178.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LEU . 29.5 tt0 -47.17 -27.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.41 -36.5 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.0 109.246 179.818 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -90.03 -36.04 15.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.808 -178.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -59.32 -50.58 73.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.967 -1.083 . . . . 0.0 109.405 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -48.89 -44.91 40.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.262 -0.898 . . . . 0.0 109.407 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 69' ' ' LEU . 33.7 mt -57.51 -38.16 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.29 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -65.82 -53.98 32.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.57 -45.45 18.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.5 130.97 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.677 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.47 40.87 2.97 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.99 -15.75 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 0.0 109.335 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.8 31.64 2.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.086 179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 m -71.08 23.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -150.04 12.11 0.75 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.009 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' O ' ' A' ' 51' ' ' TYR . 8.2 tp -67.57 118.11 53.93 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 108.736 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.46 129.42 31.12 Favored 'Trans proline' 0 N--CA 1.479 0.648 0 C-N-CA 121.049 1.166 . . . . 0.0 112.366 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.643 HG22 HG13 ' A' ' 54' ' ' VAL . 3.0 t -118.52 114.97 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.4 tp -95.64 75.27 3.23 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.192 -1.403 . . . . 0.0 108.789 178.221 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.448 ' SD ' HG22 ' A' ' 87' ' ' THR . 9.6 tmm? -57.74 153.57 13.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.509 -0.744 . . . . 0.0 109.192 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.46 125.12 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 90' ' ' ALA . 4.9 t -150.22 125.81 10.28 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.477 -179.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -79.39 -27.52 41.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 0.0 109.015 179.344 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.75 39.86 1.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.434 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.791 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.44 106.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.438 ' CG ' ' H ' ' A' ' 92' ' ' LYS . 23.0 tptt -97.04 -144.73 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.572 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' ASN . 7.0 mtmp? -104.11 -80.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -45.18 -16.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.0 110.003 -179.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -82.0 -36.66 27.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.791 HD11 ' HB1' ' A' ' 90' ' ' ALA . 39.6 mt -89.97 -9.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.75 -179.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -89.76 -68.24 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.92 -1.113 . . . . 0.0 110.002 -179.645 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.33 -49.87 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.431 -179.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.52 -46.42 86.79 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.212 179.432 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.04 -50.43 27.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.085 -1.009 . . . . 0.0 109.941 -179.345 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -55.12 -24.42 25.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.592 -179.81 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.45 -104.91 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -141.58 7.59 2.51 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.488 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.22 11.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.014 -0.698 . . . . 0.0 110.6 178.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.672 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.27 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.799 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.03 125.72 8.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.98 110.7 5.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 179.817 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.2 p -107.68 134.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.072 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -89.6 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.049 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -53.84 160.92 1.9 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.108 -0.995 . . . . 0.0 109.775 -179.31 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.92 163.01 91.12 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.702 -2.491 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 12.1 p90 -146.02 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.088 0.947 . . . . 0.0 110.443 178.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.82 154.36 18.99 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.875 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.65 -11.98 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.629 -1.294 . . . . 0.0 109.361 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.33 -39.44 25.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.139 -0.975 . . . . 0.0 108.665 178.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -58.64 3.19 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 5.0 tp -50.56 -37.43 39.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 108.76 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.45 -52.84 62.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.101 -0.999 . . . . 0.0 109.654 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.29 -60.12 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 109.673 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.453 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 5.4 mptt -47.4 -41.36 19.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.84 -63.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -29.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.675 -179.727 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -34.26 67.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.493 HD11 ' CA ' ' A' ' 105' ' ' GLY . 41.4 mt -73.49 -40.65 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.589 -179.361 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -71.18 0.67 7.27 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.924 -1.11 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.7 -35.6 62.72 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -89.61 -22.03 22.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -84.25 -31.0 25.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.54 86.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.144 -1.21 . . . . 0.0 109.448 -179.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.451 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 40.8 m-20 -45.82 134.51 7.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -90.12 15.63 9.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.968 -1.083 . . . . 0.0 109.926 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.9 42.76 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 -179.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.01 147.32 30.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' TYR . 7.5 mtmm -94.5 134.52 36.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.515 -1.366 . . . . 0.0 110.656 -177.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -115.25 150.9 35.45 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.884 -0.51 . . . . 0.0 110.076 -179.678 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.676 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.1 tp -123.23 106.15 10.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.808 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -89.89 119.37 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.143 -178.664 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' A' ' 36' ' ' ALA . 21.7 t -124.27 57.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 O-C-N 121.698 -0.626 . . . . 0.0 109.571 -179.739 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -96.88 145.45 25.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 109.329 179.973 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 14' ' ' PHE . 7.9 p30 -71.93 -29.91 64.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.209 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.514 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -50.61 120.27 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.336 179.907 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.5 45.33 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.973 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -172.9 -27.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.9 ttt -60.06 -35.05 74.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -53.6 -34.37 58.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.51 -33.81 62.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.98 -51.12 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.498 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -33.52 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mtp85 -46.73 -53.94 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.3 t30 -64.53 -55.93 17.36 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.938 0.875 . . . . 0.0 109.089 179.745 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -38.37 -56.5 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.972 -179.737 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.94 -52.34 64.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.092 -1.005 . . . . 0.0 109.068 179.383 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -51.4 -36.58 44.13 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.132 179.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.16 -44.28 32.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.412 -0.805 . . . . 0.0 109.472 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -72.6 -62.32 1.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.45 54.46 0.01 OUTLIER Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 95.0 m-85 -129.11 149.91 50.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.608 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.2 OUTLIER -150.08 65.78 0.97 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.059 -1.026 . . . . 0.0 110.411 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -175.31 100.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.035 . . . . 0.0 109.31 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.25 151.38 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.976 -1.077 . . . . 0.0 110.591 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.19 -165.85 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.648 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -147.71 158.35 43.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.047 -1.033 . . . . 0.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.858 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.05 -168.85 3.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.45 5.79 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.108 -0.995 . . . . 0.0 110.778 -179.483 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 177.22 177.2 0.33 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.758 -1.214 . . . . 0.0 109.644 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.46 -27.72 73.57 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.27 -40.25 80.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -1.176 . . . . 0.0 108.754 179.314 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.47 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t70 -79.48 -37.91 35.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.411 -0.805 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.31 62.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.493 -0.754 . . . . 0.0 109.021 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.79 -43.18 72.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.179 -0.951 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -69.62 -27.44 65.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 47' ' ' GLN . 13.4 mttm -87.54 -39.14 15.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.368 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -45.87 -16.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 179.803 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' LYS . 33.5 mt-30 -91.81 22.4 4.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.312 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . -66.68 -65.23 0.71 Allowed 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.429 -0.794 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.6 23.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.4 179.76 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 83.96 1.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 7' ' ' LYS . 10.2 m-85 -63.98 -41.07 97.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.54 -0.977 . . . . 0.0 110.586 -178.347 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.5 -25.34 7.33 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 143.68 21.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.539 -0.977 . . . . 0.0 110.106 -179.745 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.746 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.2 t -140.03 124.98 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.093 -1.005 . . . . 0.0 109.806 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.67 105.91 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 15.3 p -126.31 144.75 50.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.056 -1.028 . . . . 0.0 110.708 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -64.94 -117.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' NE1' ' CG ' ' A' ' 94' ' ' ASN . 61.6 t-105 -173.81 134.73 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.728 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 62.39 129.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.5 mmm 177.8 -50.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 110.088 179.405 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.16 -69.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.758 0.972 . . . . 0.0 109.701 179.643 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.34 -34.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.09 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.6 mtt -102.03 -89.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.673 . . . . 0.0 109.398 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -172.31 175.55 3.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.44 179.95 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.71 26.21 1.13 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 84.0 mt -82.06 -56.65 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -1.202 . . . . 0.0 108.87 179.611 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.67 -19.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.017 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 ' HA2' ' A' ' 39' ' ' GLY . 3.2 mt -76.93 -70.65 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.875 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.045 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -45.91 -65.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.206 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -43.78 -47.77 8.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.626 -0.671 . . . . 0.0 109.827 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.1 m -67.74 -26.65 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 69' ' ' LEU . 44.3 mt -77.09 -14.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -84.43 -27.39 27.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.73 12.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.52 -179.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -50.64 116.73 2.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.994 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.64 -31.36 40.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.65 -63.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.99 -47.15 7.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 48.22 13.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -0.843 . . . . 0.0 109.349 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.64 18.82 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 0.0 109.626 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 tp -44.97 113.42 1.79 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.055 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 5.1 Cg_exo -59.01 133.49 53.76 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.124 1.216 . . . . 0.0 113.07 -178.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.746 HG22 ' HB ' ' A' ' 54' ' ' VAL . 14.7 t -132.48 108.93 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.076 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.88 100.86 13.59 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 117.064 -1.854 . . . . 0.0 107.538 178.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 6.7 tpp -68.69 128.53 36.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.597 0.713 . . . . 0.0 109.385 -178.305 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -99.16 140.28 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.634 -0.666 . . . . 0.0 109.366 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.04 129.2 12.75 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.046 -179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -66.05 96.77 0.33 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.388 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.819 ' H ' HG23 ' A' ' 108' ' ' VAL . 5.0 tt0 74.47 114.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.486 -0.758 . . . . 0.0 109.202 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 106' ' ' TYR . . . -45.09 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.354 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -69.78 11.78 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 109.425 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.8 mtpp 58.96 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.82 . . . . 0.0 109.8 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 66.9 mt-10 -45.34 -46.92 13.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.978 . . . . 0.0 110.164 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.447 ' CG ' ' NE1' ' A' ' 58' ' ' TRP . 21.1 m-20 -69.34 -73.04 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.464 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -44.49 -52.51 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 109.088 -179.47 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.634 HG22 ' OE1' ' A' ' 100' ' ' GLN . 92.3 mt -56.68 -32.0 36.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.652 -1.28 . . . . 0.0 109.464 -179.902 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -71.66 -45.61 61.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.044 -1.035 . . . . 0.0 108.959 179.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.19 72.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 109.008 179.182 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.51 -31.27 71.26 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.619 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.634 ' OE1' HG22 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -53.32 -33.38 53.21 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.363 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.744 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -85.26 -22.51 28.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.363 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.39 80.52 0.12 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.958 177.237 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.3 -112.44 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.243 -1.783 . . . . 0.0 109.825 179.225 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 43.6 m -92.04 -52.46 4.7 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 123.21 1.481 . . . . 0.0 108.178 175.407 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.18 -162.13 32.48 Favored Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.253 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.49 115.79 9.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.527 -0.984 . . . . 0.0 109.576 179.549 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -107.64 136.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.334 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.819 HG23 ' H ' ' A' ' 89' ' ' GLU . 1.8 p -83.41 145.59 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 108.929 179.808 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -115.14 154.25 47.27 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.17 132.48 27.63 Favored 'Cis proline' 0 N--CA 1.488 1.152 0 O-C-N 122.623 0.802 . . . . 0.0 110.68 -2.353 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.8 p90 -102.16 157.47 16.86 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 178.76 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.13 148.36 22.42 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 176.845 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.12 -25.32 1.41 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.728 -1.233 . . . . 0.0 109.701 -178.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.7 65.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -72.56 -62.48 1.43 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.977 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -52.11 -37.82 55.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.428 179.687 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -65.44 -51.71 58.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.988 -1.07 . . . . 0.0 109.624 -179.755 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 20.4 tp10 -48.04 -48.33 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.855 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.67 -42.0 98.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.1 -60.13 4.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.552 -0.717 . . . . 0.0 109.92 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -32.07 57.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.057 -1.027 . . . . 0.0 110.263 -179.457 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -78.97 -23.5 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.4 mt -89.97 -39.07 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 110.271 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 127' ' ' LEU . 20.5 m-85 -74.16 -39.42 63.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.095 -1.003 . . . . 0.0 109.835 -179.248 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -50.76 -19.89 1.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' PHE . 24.6 mmtt -95.83 -27.25 15.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 124' ' ' PHE . 17.6 tp -75.58 -21.3 57.97 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.21 71.62 1.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.6 t70 -47.89 125.09 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.033 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -71.94 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 109.663 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 3' ' ' ASP . 1.9 tp10 -159.54 32.69 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.122 -0.986 . . . . 0.0 109.955 -179.939 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.479 HD11 ' HA3' ' A' ' 52' ' ' GLY . 53.6 tp -69.85 135.27 49.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.018 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -81.43 128.1 33.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 -177.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 33' ' ' VAL . 24.1 m-85 -112.38 153.13 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 179.465 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -126.52 106.67 9.61 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.81 113.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.0 t -113.73 83.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 121.74 -0.6 . . . . 0.0 109.545 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.85 -154.18 0.55 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.345 0.593 . . . . 0.0 109.458 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -146.49 4.47 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.222 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 16' ' ' THR . 6.2 m-85 -95.26 122.74 38.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.78 33.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -151.74 -41.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.1 ttt -54.53 -43.35 71.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -40.17 68.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -68.59 -26.85 65.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 110.171 -178.507 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.97 -50.3 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.066 -1.021 . . . . 0.0 109.378 -179.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -39.39 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 -179.448 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -54.27 10.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.925 . . . . 0.0 109.591 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -56.78 12.78 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -54.44 1.96 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.353 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -59.63 -24.0 63.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.252 -0.905 . . . . 0.0 109.626 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -13.4 61.1 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.088 -1.007 . . . . 0.0 109.463 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mt -95.35 -38.71 10.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.764 -179.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.09 4.84 0.78 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 97.0 m-85 -89.89 148.79 22.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.803 -1.41 . . . . 0.0 109.489 -179.554 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -150.07 63.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 -179.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.33 96.02 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.118 -0.989 . . . . 0.0 109.237 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 8' ' ' PHE . 58.3 t -140.27 153.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.051 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.98 -172.37 2.52 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.1 154.04 37.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 111.164 -178.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.822 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.19 -173.57 3.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.789 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -120.83 -2.41 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.196 -0.94 . . . . 0.0 110.548 -179.481 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 172.0 179.48 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.968 -1.082 . . . . 0.0 109.923 179.643 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -42.08 96.19 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.359 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.3 p -59.46 -38.95 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.277 . . . . 0.0 109.23 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 46.0 t0 -71.21 -51.82 22.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.898 . . . . 0.0 108.941 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -50.05 -60.18 3.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.8 tp -45.23 -37.81 4.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.296 179.308 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 1.8 m-20 -70.77 -43.62 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 110.344 -179.578 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -90.11 -3.71 57.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.154 -0.966 . . . . 0.0 110.713 -179.194 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -73.93 -31.67 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 108.724 179.976 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -53.84 -20.41 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.108 179.859 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.9 -63.48 0.96 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.98 109.79 2.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . 147.41 -24.4 1.54 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 55.6 m-85 -64.81 78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.141 -1.211 . . . . 0.0 109.997 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.729 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -61.48 -3.31 3.97 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.493 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -148.03 130.41 15.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.569 -0.959 . . . . 0.0 108.777 -179.469 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 83' ' ' VAL . 75.4 t -127.06 126.91 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.738 -1.226 . . . . 0.0 109.057 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.16 125.06 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.726 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 57' ' ' ASP . 60.0 p -142.51 142.55 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.0 m-20 -61.65 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.0 109.669 -179.715 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -169.51 134.2 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.94 . . . . 0.0 108.887 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' H ' ' HA ' ' A' ' 64' ' ' ASP . 61.9 t30 52.92 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 108.864 -179.345 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 171.9 -46.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.65 -64.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.677 0.918 . . . . 0.0 110.098 -179.634 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' MET . 10.7 p30 -126.3 -39.47 2.05 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 25.6 ttt -172.62 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 59' ' ' ASN . 0.4 OUTLIER 171.63 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -49.79 -11.09 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.738 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' ASP . 5.7 mt -50.45 -35.06 27.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.641 -1.506 . . . . 0.0 107.719 179.197 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.23 -29.7 60.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.075 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 64.5 tp -74.1 -69.03 0.47 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.704 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -42.17 -67.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.364 0.602 . . . . 0.0 109.826 178.684 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -42.26 -51.76 4.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.585 -0.697 . . . . 0.0 110.262 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.4 m -49.3 -36.58 21.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.135 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.838 HG21 ' HB2' ' A' ' 80' ' ' ALA . 52.0 mt -64.22 -45.8 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.1 -1.0 . . . . 0.0 108.83 179.593 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -39.45 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.507 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.3 -28.57 59.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.5 111.28 2.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.07 -124.52 7.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.81 40.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -1.093 . . . . 0.0 109.617 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.15 -2.63 2.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.578 -0.701 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t 47.04 -134.94 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.672 179.827 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.838 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -126.38 40.29 3.76 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.717 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.729 HD12 ' HA2' ' A' ' 52' ' ' GLY . 3.0 mt 47.37 -163.58 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.492 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.564 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 6.2 Cg_exo -57.3 155.79 28.33 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 121.2 1.464 . . . . 0.0 114.876 -176.364 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.0 t -138.21 135.62 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.375 178.544 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 116' ' ' LEU . 53.7 tp -115.1 72.46 0.79 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.185 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -58.96 160.08 6.36 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.264 -179.346 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -127.89 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.789 -0.569 . . . . 0.0 110.227 -177.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -150.03 -176.35 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 109.79 -179.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.89 52.35 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.74 53.42 12.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -48.79 140.76 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -92.84 -87.65 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.046 179.508 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER 179.8 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.391 179.634 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.93 -6.89 0.26 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 92' ' ' LYS . 26.9 m-80 -90.06 -22.61 21.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.0 mm -89.99 -5.43 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.923 -179.582 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.76 -66.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.42 -41.11 13.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 109.031 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 103' ' ' ALA . . . -58.42 -56.72 18.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.732 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.77 -44.84 63.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.95 -26.51 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.756 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.52 -115.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.658 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.21 -11.71 4.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 179.099 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.02 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.887 -0.772 . . . . 0.0 110.626 178.718 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.6 m -29.75 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.914 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -101.42 125.91 8.72 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.295 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.41 124.14 16.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.057 . . . . 0.0 108.885 178.661 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.4 p -123.67 123.83 68.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.433 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 108' ' ' VAL . 13.6 p -76.43 102.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -64.42 161.22 44.44 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.273 -179.307 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -76.07 163.56 89.78 Favored 'Cis proline' 0 N--CA 1.485 0.985 0 O-C-N 122.879 0.937 . . . . 0.0 110.578 -2.327 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -143.28 161.0 39.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.902 178.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -101.85 152.22 21.16 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.234 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.02 -14.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.851 -1.156 . . . . 0.0 108.86 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.69 -41.17 38.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.663 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.5 -61.97 1.57 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.606 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 84' ' ' LEU . 3.1 tp -48.57 -37.83 18.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.029 178.741 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.66 -56.34 22.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.925 -1.11 . . . . 0.0 109.659 179.837 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -46.03 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.83 -26.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -67.91 -76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 108.925 179.68 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.08 -19.05 2.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.928 -1.107 . . . . 0.0 110.583 -179.722 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -23.36 35.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.0 109.892 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.1 mt -89.93 -40.93 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.032 -1.043 . . . . 0.0 110.018 -179.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 120' ' ' LEU . 23.8 m-85 -65.55 -5.57 8.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.992 -179.203 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.61 -26.53 66.3 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -90.82 -35.42 14.83 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -71.63 -24.42 61.86 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.95 89.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.444 179.718 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 43.8 t0 -45.04 141.28 2.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 109.311 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.17 13.61 14.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.944 -1.098 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -148.14 43.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.042 . . . . 0.0 110.332 -178.912 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.39 136.36 42.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.142 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.16 121.64 26.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.048 -1.032 . . . . 0.0 111.367 -177.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -106.71 157.59 17.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.702 -0.624 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 51' ' ' TYR . 21.5 tp -129.43 102.24 6.32 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.246 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -91.91 103.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.398 -179.082 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.938 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.6 t -96.12 113.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.276 -0.89 . . . . 0.0 109.25 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -171.7 163.92 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.504 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 2.9 m-20 -97.85 -58.36 2.01 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.968 -1.082 . . . . 0.0 108.781 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.6 ' CD2' ' N ' ' A' ' 15' ' ' SER . 22.2 p90 22.95 -145.77 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 CA-C-O 122.598 1.19 . . . . 0.0 112.831 177.398 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 179.47 -7.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.984 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' N ' ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -131.11 -34.15 1.47 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.967 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -37.34 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 111.117 -178.185 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' MET . 10.2 ptt180 -35.55 -31.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.805 -0.559 . . . . 0.0 110.473 -179.15 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.9 ttp180 -60.09 -49.66 76.77 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.877 -178.295 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -62.37 -54.51 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.716 -179.803 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.8 -18.52 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.341 -0.849 . . . . 0.0 110.84 -178.488 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -55.1 30.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.709 -1.245 . . . . 0.0 109.138 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -67.87 -53.39 27.06 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.673 0.749 . . . . 0.0 109.577 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -42.16 -56.23 2.96 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.544 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -58.95 -52.85 63.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 108.641 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -32.69 16.29 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.244 -0.91 . . . . 0.0 108.646 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -37.32 75.71 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.383 -0.823 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 117' ' ' GLU . 2.6 mp -75.63 -11.09 59.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.508 -0.745 . . . . 0.0 109.115 179.753 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.47 71.99 1.12 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 41.3 m-85 -150.0 146.19 26.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.325 . . . . 0.0 109.435 179.399 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.07 62.36 0.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.123 -0.985 . . . . 0.0 110.061 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.54 100.71 0.07 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.15 -0.968 . . . . 0.0 109.092 179.703 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.27 152.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.156 . . . . 0.0 110.179 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.48 -172.84 2.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.687 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -146.66 160.11 42.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.609 -179.276 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.938 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.08 -164.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -142.05 -5.08 1.01 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.11 -171.05 0.48 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.91 -1.118 . . . . 0.0 109.753 179.902 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.609 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -70.32 -45.01 57.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.86 -31.53 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.08 -1.247 . . . . 0.0 108.849 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.9 t0 -84.19 -51.84 6.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.448 179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.635 ' O ' HD23 ' A' ' 46' ' ' LEU . . . -54.54 -35.39 63.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.088 -1.008 . . . . 0.0 108.899 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -68.14 -56.96 6.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.3 -28.06 64.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.777 -179.743 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -90.06 -24.43 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 110.117 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -60.87 -20.05 61.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -87.23 -8.99 56.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 108.999 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.68 -72.23 0.06 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 109.757 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.67 10.1 1.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.01 87.48 0.77 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' HD22 ' A' ' 9' ' ' LEU . 54.6 m-85 -65.98 109.14 2.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.342 -1.093 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.62 -1.03 2.28 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' TYR . 6.5 t80 -165.57 148.02 7.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -1.1 . . . . 0.0 109.525 -178.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 9' ' ' LEU . 26.6 t -141.59 145.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.635 -1.291 . . . . 0.0 110.837 -178.769 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.24 122.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.032 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.7 p -144.72 141.45 29.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.006 -179.291 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.36 167.08 17.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.856 -1.152 . . . . 0.0 108.429 179.127 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.526 ' NE1' ' OD1' ' A' ' 64' ' ' ASP . 73.2 t-105 -69.99 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.042 -1.036 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.06 131.6 46.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.347 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.488 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -171.16 -54.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 110.583 179.825 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -62.72 -161.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 N-CA-C 109.911 -0.842 . . . . 0.0 109.911 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.745 HD22 ' H ' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -67.32 -10.32 49.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.06 179.532 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.4 mmt -140.88 -100.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -125.17 146.75 49.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 109.479 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.24 -6.42 0.26 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.558 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.39 -71.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.257 . . . . 0.0 109.641 -179.592 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -45.17 -44.36 10.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.14 -179.501 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -56.27 -33.49 65.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 -179.773 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.691 HD11 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -89.08 -36.76 15.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.862 . . . . 0.0 109.333 -179.904 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -61.48 -47.51 85.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.299 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -47.76 -39.22 17.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.55 -44.35 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 108.98 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -28.29 68.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 109.71 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.13 -29.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -168.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.41 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.49 -56.03 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.101 . . . . 0.0 109.519 180.0 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.98 16.46 12.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 p -77.6 50.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.596 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 15.76 0.84 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 51' ' ' TYR . 26.6 mt -65.16 127.74 93.13 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.102 -0.999 . . . . 0.0 108.658 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.37 141.19 95.07 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.888 1.059 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 54' ' ' VAL . 4.3 t -127.34 119.75 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.849 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.426 HD21 ' CD1' ' A' ' 116' ' ' LEU . 42.1 tp -101.82 72.2 1.34 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.917 178.707 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -47.41 165.69 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.75 122.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.726 -178.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -150.1 174.22 13.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 109.411 179.323 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.435 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -106.74 -37.99 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.556 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 14.9 tt0 -86.0 -72.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.684 -179.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 64.73 95.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 90' ' ' ALA . 13.9 mtpt -63.15 -128.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.148 -0.97 . . . . 0.0 109.327 179.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 93' ' ' GLU . 5.5 pttm -144.81 -48.75 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.361 179.751 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -75.06 -5.9 46.59 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.194 -0.941 . . . . 0.0 109.394 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -90.04 -28.06 19.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.666 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.9 -21.8 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.57 -65.94 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.29 -46.53 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.567 -0.708 . . . . 0.0 109.38 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.467 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -59.55 -53.23 60.48 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.738 . . . . 0.0 109.52 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.79 61.54 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.205 -0.934 . . . . 0.0 109.914 -179.312 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -22.35 33.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.79 -61.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.369 -0.832 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -175.58 -10.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.08 -179.731 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -55.84 11.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.49 -1.006 . . . . 0.0 110.848 179.255 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.37 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.449 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.45 128.52 9.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.142 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.547 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -148.19 109.9 4.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.273 . . . . 0.0 109.116 179.376 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 107' ' ' VAL . 12.6 p -105.98 135.51 43.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -85.65 95.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.358 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 pttt -56.37 155.12 14.1 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.789 -1.194 . . . . 0.0 109.283 -179.225 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.9 167.63 79.79 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 125.067 -0.806 . . . . 0.0 110.517 -2.086 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -146.73 163.55 35.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.102 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -102.36 146.83 27.49 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.721 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.19 -31.5 3.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.011 -1.056 . . . . 0.0 109.191 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.07 -37.34 78.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.585 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.4 m -68.78 -67.29 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.396 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -44.15 -39.73 4.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.259 178.753 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . 57.1 tt0 -62.47 -50.55 70.98 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.196 -0.94 . . . . 0.0 109.645 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -46.29 -58.62 3.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 109.55 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HZ1' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -49.15 -38.82 26.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.303 179.928 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -39.66 85.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.83 -33.14 70.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.59 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -71.46 -25.42 62.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.705 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.05 -34.72 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -82.86 8.93 11.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -178.581 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -75.66 -25.4 56.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.14 -27.97 13.94 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.226 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -83.17 -22.49 33.24 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.97 85.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.32 -1.106 . . . . 0.0 109.431 179.792 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -44.53 149.6 0.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 109.409 179.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -90.55 9.14 30.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.1 -1.0 . . . . 0.0 110.112 179.812 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.2 50.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.777 -1.202 . . . . 0.0 110.574 -178.545 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 53.8 tp -78.74 111.11 14.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -48.32 118.12 2.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.94 -1.1 . . . . 0.0 111.713 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 64.5 m-85 -112.66 151.31 30.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.573 -0.705 . . . . 0.0 109.562 178.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB3' HG13 ' A' ' 54' ' ' VAL . 62.1 tp -123.7 108.22 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.673 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.97 110.19 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.548 -179.328 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.3 t -114.73 118.0 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.67 41.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.47 -0.769 . . . . 0.0 109.279 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -106.44 6.52 30.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.674 -0.641 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -80.99 -21.57 40.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.864 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 p 75.17 -41.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 20' ' ' ILE . 5.2 t -98.13 1.24 47.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.7 ttt -80.05 -25.15 40.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -66.86 -45.75 77.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 109.668 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -22.29 56.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.283 -0.886 . . . . 0.0 109.777 -179.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -76.02 -55.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.4 -13.97 17.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.855 . . . . 0.0 110.271 -178.959 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -65.68 -53.43 41.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 108.911 179.423 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -66.58 -55.52 14.99 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.859 0.838 . . . . 0.0 109.066 179.593 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.3 tt -41.86 -49.28 4.48 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.496 -179.628 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.08 -41.51 86.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 108.56 179.058 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -56.53 -36.93 69.8 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.478 -0.764 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.95 -16.1 48.58 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -102.1 5.44 40.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.564 -0.71 . . . . 0.0 109.849 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 79.48 47.62 7.26 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.379 179.609 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 39.2 m-85 -126.93 122.19 33.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.57 -0.959 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.83 64.53 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.734 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -172.23 90.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.964 -1.085 . . . . 0.0 109.482 179.777 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.22 -179.86 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.805 -179.849 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' VAL . 9.1 mt-10 -137.52 -169.28 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -146.37 144.17 29.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.407 -179.065 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.26 -170.68 2.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.094 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 7.6 pt-20 -141.7 10.32 2.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 170.91 158.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.92 -1.113 . . . . 0.0 109.714 179.555 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.579 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -46.4 -44.29 15.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.46 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.24 -37.11 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.003 -1.292 . . . . 0.0 109.66 -179.555 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.2 t70 -71.58 -45.9 60.9 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.151 -0.968 . . . . 0.0 108.732 179.619 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.86 -62.49 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.7 -0.625 . . . . 0.0 109.541 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -44.47 -48.29 10.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -65.32 -37.93 88.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.15 -3.07 58.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.565 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -83.36 -30.85 27.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.874 -1.141 . . . . 0.0 109.017 -179.836 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -62.37 -0.33 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.48 -61.16 1.8 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.536 -0.728 . . . . 0.0 109.738 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.18 21.74 0.12 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.96 108.07 1.11 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -179.713 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.643 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.2 m-85 -92.66 101.98 14.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.327 -1.102 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.17 -10.41 5.21 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -156.97 141.21 16.47 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.074 -1.25 . . . . 0.0 111.079 -179.311 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.763 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.3 t -134.24 105.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.393 -0.817 . . . . 0.0 110.209 179.273 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.9 69.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.97 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -101.33 148.68 24.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.258 -0.901 . . . . 0.0 109.161 -179.271 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 3.5 p30 -113.0 170.78 7.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.554 0.692 . . . . 0.0 109.989 -179.411 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 57' ' ' ASP . 1.5 t-105 -46.46 172.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 109.406 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.02 124.42 13.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.578 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -77.9 -39.25 1.82 Allowed Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.446 -0.784 . . . . 0.0 111.845 -179.842 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.4 Cg_exo -64.68 125.05 14.15 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 120.985 1.123 . . . . 0.0 110.763 -178.86 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 63' ' ' MET . 9.7 p30 42.72 -155.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.362 0.601 . . . . 0.0 110.19 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.516 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.87 155.42 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.753 -179.724 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 10.9 p-10 -97.33 -164.04 1.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 0.0 109.657 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.66 2.53 53.67 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.474 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.25 -55.74 8.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.309 . . . . 0.0 109.087 179.93 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.32 -15.55 0.65 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.065 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.579 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -74.92 -62.77 1.43 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -43.92 -63.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.291 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -47.33 -43.54 22.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.7 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 m -70.86 -24.86 62.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 109.298 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.591 HD13 HG21 ' A' ' 83' ' ' VAL . 48.0 mt -80.15 -9.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 108.777 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -86.93 -41.56 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 109.581 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.9 49.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -179.806 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -47.76 109.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.23 31.48 4.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.793 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 46.55 58.63 4.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 mmt -90.14 -62.84 1.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.19 30.59 1.44 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 109.193 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.62 -28.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 110.066 -179.577 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.9 tp -48.27 112.1 2.11 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 108.535 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.22 107.76 0.44 Allowed 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 120.988 1.126 . . . . 0.0 112.962 -178.505 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.763 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.1 t -108.85 119.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.654 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.35 102.49 14.27 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.131 -1.427 . . . . 0.0 108.015 178.195 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 110.4 15.16 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.791 -179.154 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.37 140.58 20.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.299 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -150.13 133.86 16.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.593 -1.317 . . . . 0.0 110.242 179.598 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.43 -59.24 2.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 108.985 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.33 67.21 3.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.04 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -73.78 109.35 7.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.813 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -91.37 133.13 35.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 108.93 179.604 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.22 -23.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 109.694 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.96 -50.93 5.74 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -64.91 -33.33 75.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 110.328 -179.115 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.833 HD11 ' HB1' ' A' ' 90' ' ' ALA . 68.2 mt -56.67 -20.95 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.005 -1.059 . . . . 0.0 109.342 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.426 HD13 ' N ' ' A' ' 96' ' ' ILE . 4.9 mm -87.64 -16.09 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -67.4 -46.73 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.403 -179.945 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.6 -55.21 21.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.859 -1.151 . . . . 0.0 108.5 179.223 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.21 -30.87 70.69 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.272 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -53.99 -33.91 58.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.706 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -81.32 -25.25 36.58 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 176.747 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.63 74.02 0.65 Allowed Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.949 177.312 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.85 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.06 -111.95 0.08 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 117.184 -1.807 . . . . 0.0 109.36 178.592 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 51.7 m -91.79 -53.24 4.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 123.616 1.674 . . . . 0.0 107.483 175.344 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.6 37.99 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -177.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.92 153.46 51.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.509 -0.995 . . . . 0.0 110.353 179.865 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.636 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.2 p -145.46 150.19 15.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.325 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.54 -170.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.26 179.193 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.73 156.67 25.03 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.81 133.1 29.79 Favored 'Cis proline' 0 C--N 1.32 -0.972 0 C-N-CA 124.423 -1.074 . . . . 0.0 109.682 -2.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -89.92 162.8 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 -179.98 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.32 145.58 25.47 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 177.079 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.57 -22.58 0.78 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.765 -1.209 . . . . 0.0 109.227 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.33 53.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.9 m -70.9 -64.61 0.87 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -49.43 -36.17 21.52 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.21 -1.396 . . . . 0.0 108.921 179.575 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -57.18 -62.48 1.73 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.931 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 3.6 tm-20 -42.09 -42.6 2.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.794 -0.566 . . . . 0.0 109.877 -179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -74.1 -33.12 63.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.983 179.555 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -65.85 -65.52 0.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.803 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -45.5 -53.61 8.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 109.949 -179.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.95 -24.85 62.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 0.0 109.971 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 10.7 mt -84.32 -47.35 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.021 -1.049 . . . . 0.0 110.119 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.04 2.7 0.7 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.937 -1.102 . . . . 0.0 109.914 -179.202 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.2 tt0 -74.74 -34.89 62.61 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.136 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -82.72 -35.11 26.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.495 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.5 tt -65.25 -27.36 68.6 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.11 80.85 0.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.017 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.373 -1.075 . . . . 0.0 109.444 179.724 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 59.61 122.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.394 -0.816 . . . . 0.0 109.415 -179.722 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 8.1 mttt -89.85 12.49 17.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.892 -1.13 . . . . 0.0 109.679 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.48 45.29 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 -179.732 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 21.2 tp -80.13 124.83 29.12 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.448 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' NZ ' ' OD1' ' A' ' 32' ' ' ASN . 34.6 mttp -73.91 122.97 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.0 111.858 -177.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 49.2 m-85 -113.7 147.88 37.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.584 HD13 ' CE2' ' A' ' 51' ' ' TYR . 50.7 tp -114.89 126.41 54.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.543 177.951 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.65 102.78 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.622 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.947 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -97.18 24.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' OD2' ' OD1' ' A' ' 57' ' ' ASP . 2.1 m-20 -72.34 145.86 47.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.534 -179.995 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -103.97 9.96 36.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.56 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 109.577 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.87 4.06 9.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.679 -0.638 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -161.79 9.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpp -82.87 -43.44 16.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.31 -0.869 . . . . 0.0 109.267 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.54 -35.38 70.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.429 179.977 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -27.86 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.55 -46.41 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.521 -179.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -31.84 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.276 -179.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.445 HH21 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.55 -57.41 9.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.431 179.853 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -64.72 -54.88 24.56 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.034 0.921 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -42.02 -58.99 1.89 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.552 -179.835 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.34 -47.66 83.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.014 -1.053 . . . . 0.0 108.849 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -52.1 -34.18 42.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 50.9 tt0 -48.61 -39.86 25.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.94 -66.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.98 30.19 0.02 OUTLIER Glycine 0 N--CA 1.482 1.751 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.53 148.35 22.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.305 . . . . 0.0 109.977 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.17 62.02 1.24 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.148 -0.97 . . . . 0.0 109.79 -179.879 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -175.81 104.43 0.08 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.764 -1.21 . . . . 0.0 109.662 179.956 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HB ' HH21 ' A' ' 22' ' ' ARG . 93.9 t -144.47 149.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -0.884 . . . . 0.0 109.629 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 21.2 mp0 -124.85 -172.23 2.53 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.671 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -150.06 151.07 32.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.793 -1.192 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.947 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.54 -178.15 5.75 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.06 19.36 1.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.028 -1.045 . . . . 0.0 110.554 -179.62 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 176.5 154.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.827 -1.17 . . . . 0.0 108.788 179.66 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.4 -55.85 15.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.453 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.9 t -50.44 -24.62 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.1 t0 -85.18 -42.4 14.76 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.77 85.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.008 -1.058 . . . . 0.0 109.355 -179.856 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -65.53 -55.3 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.617 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -57.12 -33.59 67.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.993 -1.067 . . . . 0.0 110.237 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.79 -8.05 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.709 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -78.4 -37.26 44.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.593 -1.317 . . . . 0.0 109.25 -179.701 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -7.43 0.69 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 108.967 179.647 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.24 -67.45 0.28 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.422 -0.798 . . . . 0.0 109.801 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.24 -94.98 0.24 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.7 78.03 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.584 ' CE2' HD13 ' A' ' 9' ' ' LEU . 13.6 m-30 -59.62 86.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.329 -1.101 . . . . 0.0 109.915 179.663 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -62.18 -1.61 3.27 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.331 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -154.22 144.73 22.28 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.474 -1.016 . . . . 0.0 109.818 -178.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.0 t -142.51 119.99 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 0.0 110.389 -179.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.59 127.66 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' SD ' ' A' ' 85' ' ' MET . 13.3 p -149.22 146.59 27.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.998 -1.064 . . . . 0.0 109.873 -179.34 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' OD2' ' A' ' 12' ' ' ASP . 2.3 m-20 -71.59 163.36 27.89 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.242 -0.911 . . . . 0.0 108.81 179.406 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.82 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.519 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -172.75 171.85 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.016 -1.052 . . . . 0.0 110.027 -179.926 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.1 tpp 178.21 -46.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.495 179.014 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.2 Cg_endo -71.65 93.03 0.68 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.035 1.157 . . . . 0.0 109.524 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.497 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 41.91 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 0.0 109.845 179.999 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.2 tpp 47.6 -116.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.066 . . . . 0.0 109.062 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.76 -175.23 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 179.596 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.561 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 94.51 -72.08 1.11 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -47.52 63.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.998 -1.295 . . . . 0.0 107.854 178.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 15.7 mp0 -65.51 -22.63 66.74 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -64.65 -55.02 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.25 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 72' ' ' ILE . 2.0 mt -58.16 -67.09 0.38 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.21 0.528 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -37.55 -46.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.86 -0.525 . . . . 0.0 110.35 -179.56 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.2 m -57.64 -41.87 82.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.124 179.71 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -60.9 -30.07 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -76.98 -55.92 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.592 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.12 4.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 135.62 55.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . -87.3 161.19 32.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 76.35 -7.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.451 -1.029 . . . . 0.0 109.683 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.4 mmm -109.89 -19.13 13.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.6 m 51.83 -108.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.06 56.16 0.95 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 51' ' ' TYR . 73.6 mt -43.06 148.68 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.684 -0.635 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.42 143.31 94.46 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.475 1.45 . . . . 0.0 111.804 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -134.26 119.85 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.676 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.8 tp -103.8 75.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.55 178.309 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -48.89 169.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.894 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.12 122.57 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.494 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.5 t -140.54 -169.03 2.69 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.613 -179.549 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -140.99 16.43 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.925 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -138.59 -61.74 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.068 -179.688 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 1.049 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.48 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.48 31.85 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.966 -179.449 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ILE . 35.1 mtpt 54.49 -82.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 179.397 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.09 -25.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.337 -179.252 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 92' ' ' LYS . 22.0 t-20 -85.01 -31.49 23.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.0 109.857 -179.675 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.049 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.4 mt -67.19 -15.27 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 110.142 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.25 -64.51 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.86 -179.798 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.79 -31.34 2.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.913 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -69.31 -55.05 11.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.03 -42.66 60.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 -179.342 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -51.39 -26.8 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.97 -179.896 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.09 -113.43 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.423 179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.03 -1.17 6.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.414 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.583 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -56.32 11.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.154 -0.615 . . . . 0.0 110.831 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.48 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.275 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.43 130.62 10.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.391 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.85 115.16 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 108.866 179.112 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -114.26 121.89 67.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.617 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -76.51 96.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.835 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -59.44 160.87 11.86 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 0.0 109.141 -179.21 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.2 165.55 85.56 Favored 'Cis proline' 0 N--CA 1.485 0.988 0 O-C-N 122.86 0.926 . . . . 0.0 110.483 -2.257 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -146.03 159.36 43.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.121 -0.987 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.19 147.15 25.42 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.958 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.453 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -44.72 -28.26 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.625 -179.168 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.37 83.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.495 178.936 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -64.14 -64.6 0.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.962 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.6 tp -45.49 -43.51 11.71 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.058 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -61.98 -52.48 63.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.664 -1.272 . . . . 0.0 110.064 -179.882 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 117' ' ' GLU . 1.1 tp10 -43.59 -64.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.736 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -46.05 -46.41 16.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -45.56 -44.07 12.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -62.44 -42.91 99.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.375 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -58.86 -32.5 69.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.492 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.03 -34.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.248 -0.907 . . . . 0.0 109.907 -179.423 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -86.23 1.31 51.28 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 110.646 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -77.1 -28.47 54.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -94.81 -22.26 18.17 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -87.97 -29.05 21.07 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.22 86.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.475 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.296 -1.12 . . . . 0.0 109.53 -179.954 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.352 0.596 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 66.39 142.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.227 -0.921 . . . . 0.0 109.887 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 mmmm -90.3 19.57 5.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 0.0 109.413 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.53 49.45 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.952 -1.092 . . . . 0.0 109.635 -179.321 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 60.5 tp -60.24 111.0 1.37 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 0.0 108.934 179.885 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -43.91 105.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.894 -1.129 . . . . 0.0 111.144 -178.835 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 56.8 m-85 -102.33 154.77 18.74 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.793 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 tp -132.09 103.41 6.25 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.59 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -90.55 113.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.093 -178.983 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.5 t -103.04 69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.583 -0.698 . . . . 0.0 110.025 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -114.58 131.0 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -77.5 -5.63 50.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.664 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -80.83 143.76 32.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.944 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.08 12.36 24.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -31.25 1.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.437 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 8.1 ttt -55.81 -32.19 63.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.267 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.523 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -69.25 -43.51 73.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 -179.979 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -59.18 -25.25 63.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.16 -49.24 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.766 -179.67 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -30.74 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.589 -178.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -51.38 60.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.939 -1.101 . . . . 0.0 108.694 179.456 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.44 -60.51 2.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.842 0.83 . . . . 0.0 109.546 179.85 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 116' ' ' LEU . 1.7 tt -45.03 -35.99 3.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.715 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -74.22 -51.84 14.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 108.25 178.577 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -52.68 -33.82 49.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.45 -0.781 . . . . 0.0 108.968 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -49.24 -39.15 29.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.348 -0.845 . . . . 0.0 108.783 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 -64.98 0.98 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.422 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 160.06 41.43 0.02 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.765 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -113.8 134.6 54.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.61 -0.935 . . . . 0.0 109.184 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 65.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.946 -1.096 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -174.21 93.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.816 -1.178 . . . . 0.0 109.079 179.717 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.93 -179.73 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.036 -1.04 . . . . 0.0 110.653 -179.271 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.9 mt-10 -137.9 -171.39 3.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.516 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' CD ' HH11 ' A' ' 18' ' ' ARG . 58.3 mt-10 -140.13 154.2 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.038 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.962 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.03 -167.26 2.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -139.87 -10.68 1.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 0.0 111.004 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -174.57 -166.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.013 -1.054 . . . . 0.0 109.761 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.42 -42.81 32.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.1 t -55.46 -41.23 61.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.919 -1.342 . . . . 0.0 108.121 179.16 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.42 -54.48 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 109.291 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.42 -62.65 1.71 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.229 -0.92 . . . . 0.0 109.411 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.9 tp -41.73 -43.08 2.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.684 -0.635 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -74.36 -37.32 63.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -90.09 0.71 57.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -78.09 -40.56 37.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.051 -1.031 . . . . 0.0 109.029 179.955 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.98 -4.37 3.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -72.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.482 -0.761 . . . . 0.0 109.549 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.31 5.26 2.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.853 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.42 78.44 1.03 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.455 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.9 m-85 -57.51 114.75 2.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -1.034 . . . . 0.0 110.094 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.3 -7.61 2.04 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.437 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -160.75 137.23 8.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.732 -178.552 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.8 122.33 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.731 . . . . 0.0 109.847 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.44 151.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -167.64 162.58 14.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.007 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.38 -168.18 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 108.978 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 59' ' ' ASN . 13.7 t-105 -128.6 111.82 13.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.434 -0.791 . . . . 0.0 109.564 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER 52.76 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.751 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.473 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 177.38 -50.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 179.578 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.12 -54.93 0.54 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 120.832 1.021 . . . . 0.0 109.891 -179.873 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.97 -41.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.298 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -132.38 -179.83 5.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.43 151.66 32.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.606 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -79.3 -20.14 70.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -48.23 -29.04 3.4 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -1.196 . . . . 0.0 108.334 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 71' ' ' THR . 1.5 tp10 -83.15 -29.79 28.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 109.348 179.443 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -57.59 -35.02 69.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 108.707 179.719 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -86.74 -61.93 1.62 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 108.667 179.09 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -43.09 -26.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.914 -179.289 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 67' ' ' GLU . 5.2 p -72.82 -39.45 66.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.054 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . 81.2 mt -63.6 -45.27 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -61.07 -29.2 69.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 109.64 -179.85 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.91 -28.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.568 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.9 -153.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.07 -12.77 0.1 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.25 -27.97 19.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -1.183 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.1 mtm -92.56 -11.24 34.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t 52.32 -111.32 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.1 58.61 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 80' ' ' ALA . 10.5 mt -38.01 153.77 0.13 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 122.042 -0.412 . . . . 0.0 110.086 -179.303 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.26 140.36 94.04 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.566 1.51 . . . . 0.0 111.481 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 69' ' ' LEU . 2.9 t -133.32 130.44 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.56 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.43 HD21 HD21 ' A' ' 116' ' ' LEU . 55.1 tp -113.36 75.95 0.95 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.102 0.953 . . . . 0.0 108.543 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtt -51.24 172.24 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -145.75 125.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 109.273 -179.464 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 109' ' ' LYS . 15.2 t -150.06 178.11 9.26 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.026 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.61 -42.93 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.34 69.92 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.5 -0.75 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -65.37 107.83 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.927 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' CG ' ' N ' ' A' ' 92' ' ' LYS . 6.6 ttpt -73.52 -110.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 -179.778 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 31.5 ttpt -160.2 -75.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.351 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.5 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.758 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -89.32 -64.0 1.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 -179.766 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.6 mp -47.99 -39.32 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 97' ' ' ALA . 31.5 mt -68.57 -65.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.03 -53.0 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.434 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.97 -44.34 91.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.55 -0.718 . . . . 0.0 109.917 179.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.78 -47.51 51.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.707 -1.246 . . . . 0.0 109.333 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -58.97 -23.64 61.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.816 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.21 -103.66 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.718 -179.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -129.91 -6.88 3.9 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.609 ' H ' HD13 ' A' ' 69' ' ' LEU . . . -57.52 11.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.889 -0.771 . . . . 0.0 110.102 178.176 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.695 ' H ' ' C ' ' A' ' 102' ' ' GLY . 61.4 m -29.27 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.725 -176.339 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -115.94 129.9 8.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.97 110.18 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 108.39 179.385 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.9 p -110.68 123.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 109' ' ' LYS . 2.5 t -58.27 -178.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.9 pttt -155.61 157.95 31.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.32 -1.488 . . . . 0.0 109.194 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.85 164.51 87.3 Favored 'Cis proline' 0 N--CA 1.484 0.929 0 C-N-CA 124.706 -0.956 . . . . 0.0 110.298 -2.254 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.87 159.32 35.25 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.774 0.797 . . . . 0.0 109.938 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.21 145.45 24.49 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.149 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -47.08 -20.49 0.16 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.949 -1.095 . . . . 0.0 109.54 -178.746 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.57 -36.03 26.6 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.327 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.4 m -69.91 -59.86 2.66 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.792 HD12 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -49.09 -46.57 44.85 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.155 178.802 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -55.7 -50.78 69.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 110.308 -179.563 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 5.1 tt0 -51.41 -68.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -45.56 -35.27 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.091 -1.006 . . . . 0.0 110.208 -179.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.28 -65.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.041 . . . . 0.0 110.014 -179.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -45.43 -28.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.433 -179.356 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -69.16 -47.76 64.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.962 -1.086 . . . . 0.0 109.765 -179.549 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.53 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.6 mt -69.56 -38.19 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.958 -179.61 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -70.08 -4.77 22.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 110.723 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.04 -22.18 56.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.644 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -96.28 -24.37 16.24 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -86.08 -32.74 21.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.397 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 43.79 84.18 0.02 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.207 -1.172 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -45.88 135.36 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.522 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -90.54 16.17 9.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.668 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.28 47.27 2.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 108.785 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 22.3 tp -90.02 119.02 30.02 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.37 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -61.82 120.45 10.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.92 . . . . 0.0 110.986 -178.457 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 76.9 m-85 -110.81 152.03 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.889 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 tp -124.62 104.01 8.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' VAL . 27.9 m -93.57 107.68 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.973 -1.079 . . . . 0.0 110.013 -179.328 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 49.1 t -90.27 -96.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.915 -1.115 . . . . 0.0 109.564 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 52.91 -161.85 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.032 -1.042 . . . . 0.0 109.598 179.72 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.81 9.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -54.37 -21.07 8.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.651 -179.897 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER 72.26 -8.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.124 -179.743 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 14' ' ' PHE . 1.3 t -136.0 -10.33 2.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.629 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.412 ' C ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -69.58 -50.56 43.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 108.715 179.431 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -41.94 -41.54 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.338 0.59 . . . . 0.0 109.98 179.706 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -63.72 -45.11 91.43 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.049 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.95 -51.63 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.63 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -0.974 . . . . 0.0 110.53 -178.879 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -55.16 6.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t-20 -67.79 -58.26 4.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.1 -62.25 0.86 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.857 -179.698 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 15.1 mt -54.0 -42.16 68.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.228 -0.92 . . . . 0.0 109.519 179.543 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -62.16 -38.44 89.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -60.0 -33.74 72.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.634 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mt -76.12 -50.19 15.31 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 4' ' ' LYS . . . 148.38 54.2 0.02 OUTLIER Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.341 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -144.34 133.81 23.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.214 . . . . 0.0 110.04 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -145.37 55.47 1.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.354 179.947 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -162.18 98.02 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.03 152.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.112 -0.993 . . . . 0.0 110.428 -178.776 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.12 -170.87 1.76 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.754 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.91 151.01 32.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.991 -178.712 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.33 -171.39 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.185 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.93 10.9 1.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.133 -0.98 . . . . 0.0 110.032 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 169.03 163.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.804 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -55.27 -37.53 65.3 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.938 -179.38 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.516 HG23 ' OD2' ' A' ' 38' ' ' ASP . 61.2 t -54.83 -37.46 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.822 -1.399 . . . . 0.0 107.922 179.112 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.647 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 22.0 t0 -80.75 -55.45 4.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.598 -0.689 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.92 -54.1 33.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 109.281 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 43' ' ' LEU . 5.0 tt -52.68 -58.4 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -0.857 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -56.58 -34.63 67.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.934 -178.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -90.03 -17.58 27.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.891 -1.131 . . . . 0.0 110.815 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -59.93 -28.29 67.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 0.0 109.046 -179.779 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 7.4 tt0 -72.64 2.6 6.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.18 179.695 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.61 -75.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.421 -0.799 . . . . 0.0 109.634 -179.878 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.49 -35.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.47 67.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' PHE . 70.4 m-85 -49.54 100.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.35 -6.44 0.99 Allowed Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.5 t80 -161.03 144.82 13.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -1.073 . . . . 0.0 109.805 -178.414 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HB ' HG22 ' A' ' 83' ' ' VAL . 65.7 t -136.65 120.94 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.962 -1.086 . . . . 0.0 110.032 -179.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.32 97.67 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.568 -0.707 . . . . 0.0 109.107 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 p -99.4 -177.07 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 12.7 t70 -140.39 50.67 1.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 109.686 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 47.32 77.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.217 -179.935 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -48.35 141.23 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -100.64 -36.67 0.23 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 111.802 -179.972 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.45 122.73 10.49 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.849 1.033 . . . . 0.0 110.715 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 m-80 48.16 53.98 10.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.845 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mtp 53.48 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 54.34 178.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.5 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.11 -46.62 2.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.175 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.6 -69.28 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.288 . . . . 0.0 108.027 178.79 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.75 -22.11 13.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.23 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.11 -53.17 57.67 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.93 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 83' ' ' VAL . 43.9 mt -57.97 -65.72 0.59 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.077 0.942 . . . . 0.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -41.63 -36.5 0.96 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.78 -179.85 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -41.95 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 108.551 179.768 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.12 -39.75 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.063 -1.023 . . . . 0.0 108.254 178.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -23.8 67.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.294 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.36 51.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.626 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -45.74 -36.07 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 109.633 -179.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.04 32.91 85.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.1 -54.79 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.01 -67.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m 57.24 4.33 0.2 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.333 -0.854 . . . . 0.0 109.274 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -106.37 -12.24 15.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.635 -0.665 . . . . 0.0 109.651 -179.762 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.2 mt -45.18 107.78 0.69 Allowed Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.26 150.12 89.45 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.079 1.186 . . . . 0.0 112.899 -178.039 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 69' ' ' LEU . 2.5 t -136.39 126.87 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.044 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -113.83 72.95 0.8 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.512 179.059 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' LEU . 9.7 mtt -46.39 170.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.328 0.585 . . . . 0.0 109.504 -179.245 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.15 125.07 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.22 -179.312 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 148.82 29.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.645 -1.284 . . . . 0.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 -42.33 8.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -96.32 50.72 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 1.003 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -61.14 101.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 109.437 -179.973 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -68.33 -110.62 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 94' ' ' ASN . 3.1 ttmt -162.39 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -19.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 109.565 -179.95 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -90.06 -37.65 14.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.003 HD11 ' HB1' ' A' ' 90' ' ' ALA . 77.2 mt -63.54 -16.21 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.44 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.577 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.82 -38.81 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -54.54 -57.72 10.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.474 179.555 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.11 64.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -57.62 -17.39 14.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.69 -107.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.603 -0.685 . . . . 0.0 109.905 -179.664 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.62 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.86 -1.55 8.12 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.666 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.38 11.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.032 -0.687 . . . . 0.0 111.512 179.239 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.62 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.25 -31.44 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.119 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -116.84 135.08 11.71 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.661 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -151.23 114.15 4.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -1.152 . . . . 0.0 109.312 179.062 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.91 140.1 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.202 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.3 p -88.31 100.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.554 179.391 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.0 155.25 64.69 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.989 . . . . 0.0 109.531 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.58 167.75 79.39 Favored 'Cis proline' 0 N--CA 1.488 1.205 0 O-C-N 122.649 0.815 . . . . 0.0 111.068 -2.295 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.1 p90 -146.52 156.91 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.865 0.84 . . . . 0.0 109.829 178.73 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.09 146.17 23.85 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.053 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.5 -22.76 0.79 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.775 -1.203 . . . . 0.0 109.301 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.24 39.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.434 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 112' ' ' THR . 7.0 m -72.63 -61.72 1.7 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.779 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.67 -38.65 47.76 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.213 179.11 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.25 -48.16 76.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.61 -43.88 8.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.665 -179.577 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -66.57 -50.78 61.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -25.76 9.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.05 -22.96 36.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -80.61 -25.11 38.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 109.393 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.94 -34.81 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.667 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -80.2 -1.61 41.25 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 -178.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -76.94 -21.14 55.27 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.609 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.45 -26.88 14.31 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.474 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -79.83 -26.4 40.47 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.24 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.97 88.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.638 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.328 -1.101 . . . . 0.0 109.514 -179.783 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.4 0.619 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' ALA . 1.9 m-20 61.65 127.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.737 179.83 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -90.18 19.57 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 0.0 108.756 179.425 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -144.89 45.62 1.36 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.564 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 20.7 tp -78.49 117.77 20.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 108.442 -179.92 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -63.72 121.2 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 111.842 -177.737 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.636 ' HB2' HG22 ' A' ' 33' ' ' VAL . 96.0 m-85 -115.19 142.85 46.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 46' ' ' LEU . 43.5 tp -116.82 117.99 31.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.123 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 1.2 m -105.57 112.61 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 109.665 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.948 HG22 ' HB3' ' A' ' 36' ' ' ALA . 26.6 t -105.85 115.86 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.625 ' N ' ' NH2' ' A' ' 18' ' ' ARG . 13.4 t70 -149.89 -137.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.89 -20.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CD1' HG22 ' A' ' 16' ' ' THR . 0.1 OUTLIER -68.08 126.8 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.95 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.8 p -81.62 41.43 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.517 -179.933 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.449 HG22 ' CD1' ' A' ' 14' ' ' PHE . 7.4 t -166.05 -29.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.8 ttp -57.96 -47.79 81.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.625 ' NH2' ' N ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -46.58 -29.1 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.716 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -67.72 -34.9 77.78 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -61.25 -55.89 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -39.18 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 -179.079 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -46.89 -55.38 8.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -65.11 -56.12 14.77 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.859 0.838 . . . . 0.0 109.311 -179.968 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -38.84 -60.36 0.85 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.991 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.3 -46.5 86.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 109.114 179.428 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -32.7 65.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.326 -0.859 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.25 61.4 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.851 -1.156 . . . . 0.0 109.069 -179.53 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' CD1' ' OE1' ' A' ' 117' ' ' GLU . 3.3 tp -80.1 -66.56 0.86 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 109.188 179.533 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.73 0.02 OUTLIER Glycine 0 N--CA 1.482 1.719 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -101.85 153.14 20.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -1.18 . . . . 0.0 108.997 179.731 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.07 58.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.967 -1.083 . . . . 0.0 110.737 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.5 100.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.849 -1.157 . . . . 0.0 109.872 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 8' ' ' PHE . 93.2 t -139.42 150.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.34 -0.85 . . . . 0.0 109.919 -179.611 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -122.01 -173.25 2.62 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.687 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 18' ' ' ARG . 26.6 mt-10 -142.75 155.35 44.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.273 -0.892 . . . . 0.0 110.94 -178.345 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.948 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.6 -172.59 4.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' OE1' ' OD2' ' A' ' 41' ' ' ASP . 1.4 pm0 -143.46 2.57 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.103 -0.998 . . . . 0.0 110.652 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -168.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.781 -1.199 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -74.04 -47.05 19.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.203 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 4.1 p -52.22 -35.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.644 -1.504 . . . . 0.0 107.941 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t0 -80.32 -45.86 17.11 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.482 -0.762 . . . . 0.0 109.728 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -70.32 -57.66 4.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.899 -1.125 . . . . 0.0 108.872 179.649 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.712 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.9 tm? -44.78 -52.04 8.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 0.0 108.979 179.713 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 77.7 m-20 -65.07 -38.77 91.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.695 179.925 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -86.26 5.83 32.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 110.245 -179.436 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -90.15 -56.0 3.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 108.927 179.621 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.47 2.91 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 108.734 179.306 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.82 -65.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.817 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 4.84 2.64 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 79.34 1.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' O ' HD13 ' A' ' 81' ' ' LEU . 19.7 m-85 -66.59 108.72 2.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.5 -1.0 . . . . 0.0 109.954 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.86 -6.85 2.99 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.556 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' N ' ' C ' ' A' ' 51' ' ' TYR . 1.8 t80 -163.02 146.77 11.01 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.169 -1.195 . . . . 0.0 109.876 -178.601 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 46' ' ' LEU . 93.2 t -143.74 126.85 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.2 mt -110.01 134.98 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.348 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.9 p -146.94 137.41 23.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.642 -179.889 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.3 m-20 -71.83 -151.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 -179.979 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.595 ' CH2' HD23 ' A' ' 66' ' ' LEU . 52.9 t-105 -101.9 -177.98 3.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.546 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.07 90.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.874 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -95.98 -46.8 0.25 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.956 -179.895 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.5 -54.9 0.51 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.14 1.227 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' ASP . 5.7 p30 -173.03 -148.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.651 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -61.86 78.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 108.724 179.39 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ASN . 49.1 m-20 -154.82 -157.97 0.8 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.885 . . . . 0.0 109.441 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.725 ' H ' HD13 ' A' ' 68' ' ' LEU . . . 68.88 -72.78 0.38 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -66.42 -43.3 86.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.89 -1.359 . . . . 0.0 107.364 178.557 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.6 -27.58 67.82 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.406 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.725 HD13 ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -66.23 -60.69 2.55 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.618 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -55.97 -63.91 1.03 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.338 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' LEU . 13.7 ttmm -44.32 -39.43 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.523 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 m -68.82 -41.08 79.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.816 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 69' ' ' LEU . 61.1 mt -56.22 -23.83 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -27.47 19.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.479 -0.763 . . . . 0.0 109.183 179.803 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.22 -29.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.701 -179.825 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -172.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -58.77 -165.77 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.653 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.96 19.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . 3.9 tpt -89.94 -28.76 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.009 179.627 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 45.89 -125.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.538 -0.727 . . . . 0.0 109.172 179.937 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.495 ' C ' HD12 ' A' ' 81' ' ' LEU . . . -150.12 54.1 0.92 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER 44.0 -166.42 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.575 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.7 Cg_exo -61.63 151.21 81.74 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.966 1.381 . . . . 0.0 114.508 -176.336 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.58 138.42 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.769 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 55' ' ' ILE . 48.5 tp -117.1 78.46 1.22 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.403 ' N ' ' O ' ' A' ' 105' ' ' GLY . 18.0 ttp -61.9 159.54 13.83 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.337 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.547 HG23 HG13 ' A' ' 107' ' ' VAL . 7.5 p -150.19 142.33 17.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.806 -1.184 . . . . 0.0 109.953 -178.742 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 t -149.98 174.94 12.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.874 -179.973 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.7 -39.95 5.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.679 -0.638 . . . . 0.0 109.361 179.655 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.9 tt0 -81.77 -60.81 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.622 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 51.32 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 179.97 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.0 ttmt -94.44 125.42 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.985 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -45.53 -24.77 0.36 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.633 -179.574 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -85.31 -31.19 23.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.7 m-80 -89.95 -15.09 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.784 -179.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 95' ' ' ILE . 84.5 mt -75.84 -0.69 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.0 -58.24 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.762 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.04 -52.18 12.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -49.28 -54.06 18.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.722 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.59 -38.11 63.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.073 -1.017 . . . . 0.0 110.037 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -17.55 35.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.831 -179.688 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 -106.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.609 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.57 1.46 5.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -54.79 11.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.148 0.579 . . . . 0.0 111.385 179.001 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 102' ' ' GLY . 54.2 m -29.29 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.92 -0.487 . . . . 0.0 111.991 -176.55 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -114.86 123.68 6.08 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.237 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.456 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -138.29 114.6 10.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.363 -1.08 . . . . 0.0 109.883 179.441 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.7 p -114.89 138.65 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.351 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.454 ' H ' HG12 ' A' ' 108' ' ' VAL . 1.2 p -85.96 103.36 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.889 -1.132 . . . . 0.0 109.315 -179.582 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.5 pttt -63.28 159.16 51.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.943 -1.098 . . . . 0.0 109.199 -179.691 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.36 156.87 99.47 Favored 'Cis proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.693 -0.961 . . . . 0.0 110.103 -2.446 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.8 p90 -136.42 156.25 48.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.14 151.82 21.37 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.067 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.36 -18.15 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.691 -1.204 . . . . 0.0 108.909 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -72.42 -44.8 61.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.644 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -63.35 1.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.57 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 107' ' ' VAL . 2.7 tp -47.77 -35.68 10.37 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.29 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' CD1' ' A' ' 28' ' ' LEU . 23.0 tt0 -72.28 -60.12 2.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.642 -1.286 . . . . 0.0 110.725 -179.248 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -40.8 -35.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.67 -0.644 . . . . 0.0 110.774 -178.738 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -79.26 -54.28 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.996 -1.065 . . . . 0.0 109.982 -179.556 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -47.33 -44.33 23.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.824 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -53.67 -45.68 70.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.188 -179.427 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -62.51 -50.66 70.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.36 -34.74 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.815 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 -1.38 57.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.797 -179.051 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.26 -26.89 35.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.19 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -95.97 -21.28 18.12 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.4 OUTLIER -88.31 -34.97 17.48 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.429 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 42.63 77.89 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.469 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.118 -1.225 . . . . 0.0 109.492 -179.918 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.05 144.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.989 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -90.12 11.36 21.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.086 -1.009 . . . . 0.0 109.803 -179.815 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -146.25 48.12 1.21 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.532 -179.736 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.15 126.06 29.15 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.475 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.76 118.19 12.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.08 -1.013 . . . . 0.0 111.534 -177.367 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.81 149.96 26.01 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.687 ' HB3' HG22 ' A' ' 54' ' ' VAL . 18.4 tp -125.57 104.95 8.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.984 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.86 104.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.578 -179.096 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 36' ' ' ALA . 24.0 t -89.93 115.0 28.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 -179.929 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -174.35 -166.85 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.025 -1.047 . . . . 0.0 109.882 -179.206 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.7 9.68 0.47 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.337 -0.852 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -51.04 -35.66 35.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.732 -1.23 . . . . 0.0 108.536 179.781 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 72.5 31.67 1.71 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.871 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 t -177.23 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.47 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.43 ' CB ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -73.88 -35.71 64.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.493 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.72 -50.23 13.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.044 178.587 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -66.13 -26.84 67.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.353 -177.392 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -69.32 -54.31 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.019 179.649 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.0 -40.29 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 -179.414 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 18' ' ' ARG . 1.2 mtm180 -49.72 -52.18 33.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.441 179.347 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -59.05 -59.07 6.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.266 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 5.5 tt -42.71 -30.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.84 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.1 mt -84.6 -33.12 23.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.941 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' ASN . 5.8 tttp -69.94 -35.36 74.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.427 -0.796 . . . . 0.0 108.905 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.26 -35.63 60.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.273 -0.892 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.597 HD21 ' OE1' ' A' ' 117' ' ' GLU . 3.5 mp -80.44 -55.45 4.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.73 62.94 0.01 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.628 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 96.9 m-85 -150.12 141.84 23.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.909 -1.348 . . . . 0.0 109.757 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -150.15 66.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.042 -1.036 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.54 102.37 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.592 -1.317 . . . . 0.0 110.213 179.519 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.46 178.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 179.611 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.7 mt-10 -140.55 -167.11 2.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.367 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.52 149.52 32.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 111.1 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.57 -168.28 2.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.039 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.79 7.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.692 -179.449 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 15.7 t0 -176.46 151.4 0.96 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.052 -1.03 . . . . 0.0 109.674 179.881 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.578 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -52.54 -29.02 30.78 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.489 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.4 t -72.43 -38.61 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -1.183 . . . . 0.0 108.898 179.637 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -70.96 -43.82 67.31 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -65.52 -60.19 3.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.302 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.6 tp -45.38 -33.62 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.537 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.37 -38.98 23.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -86.26 -1.29 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.901 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -70.2 -10.74 59.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.235 -179.947 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -7.5 21.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.505 -0.747 . . . . 0.0 109.257 179.671 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.87 -55.01 7.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 109.573 -179.801 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.99 6.31 2.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 89.61 0.12 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.852 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.606 ' O ' HD11 ' A' ' 81' ' ' LEU . 44.0 m-85 -76.09 153.34 36.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.225 -1.162 . . . . 0.0 110.024 -179.606 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.98 5.94 39.9 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.301 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -165.7 141.64 5.15 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.627 -0.925 . . . . 0.0 108.89 -179.569 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 9' ' ' LEU . 46.0 t -137.93 109.43 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -0.837 . . . . 0.0 109.478 179.345 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.6 90.78 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 164.74 12.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.95 . . . . 0.0 109.142 -179.931 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.0 t0 -91.45 -95.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 110.189 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.555 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 55.7 t-105 -166.39 -123.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.975 . . . . 0.0 109.372 -179.266 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.433 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 21.2 t-20 -103.22 51.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.605 -0.684 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -92.74 -48.62 0.3 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 179.959 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.79 -71.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.006 1.138 . . . . 0.0 109.96 -179.581 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 63' ' ' MET . 4.2 p30 -153.71 -62.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.0 109.001 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.476 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 ttp -88.34 176.62 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.58 142.16 35.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 0.0 109.458 179.927 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.42 13.54 1.54 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -76.07 -58.15 3.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.038 -1.272 . . . . 0.0 108.264 179.25 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -13.16 26.25 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.772 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.578 HD13 ' CA ' ' A' ' 39' ' ' GLY . 56.7 tp -77.03 -43.62 33.88 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.834 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -81.32 -28.69 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.988 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -66.42 -41.05 89.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.332 -0.855 . . . . 0.0 108.9 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -71.34 -39.66 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.541 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.96 -30.3 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.12 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -90.15 -31.05 17.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.39 -0.819 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -29.89 3.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.16 151.04 38.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.22 16.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.98 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.64 -29.85 16.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -1.134 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 80' ' ' ALA . 15.8 mtt -89.97 6.23 43.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.371 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -73.77 34.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.804 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.61 21.73 3.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 109.27 -179.998 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -111.65 98.32 40.54 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.697 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.39 118.61 5.52 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.614 1.542 . . . . 0.0 114.03 -178.87 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -105.38 118.61 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 176.063 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.814 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -98.32 109.3 22.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.21 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.17 103.0 12.25 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.52 146.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.904 -1.122 . . . . 0.0 109.368 179.658 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.07 155.91 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.07 -50.29 6.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.141 179.579 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 91' ' ' LYS . 50.7 mt-10 -93.36 58.84 2.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 109.079 179.634 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -53.86 86.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.713 -179.724 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 89' ' ' GLU . 20.1 tttm -71.35 139.36 49.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.055 -1.028 . . . . 0.0 108.961 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 91' ' ' LYS . 1.4 tppp? -42.08 -28.2 0.17 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.99 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' LYS . 13.3 tp10 -88.32 -29.39 20.37 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.225 -0.922 . . . . 0.0 109.9 -179.937 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 2.6 t30 -68.86 -28.8 67.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.095 -1.003 . . . . 0.0 110.29 -179.423 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.813 HD11 ' HB1' ' A' ' 90' ' ' ALA . 2.2 mp -68.1 -58.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.728 -1.233 . . . . 0.0 108.711 179.503 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' GLN . 82.2 mt -63.63 -19.79 24.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.363 -0.836 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.14 -71.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.114 179.658 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.668 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -50.76 -44.75 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.968 -1.082 . . . . 0.0 108.169 179.059 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -66.22 -24.38 66.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.572 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 96' ' ' ILE . 6.8 tt0 -52.84 -30.99 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.879 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.41 -21.79 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.439 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 66.58 77.06 0.31 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.391 178.048 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.834 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -111.8 0.08 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 117.223 -1.791 . . . . 0.0 109.634 178.924 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.814 ' OG ' HD22 ' A' ' 84' ' ' LEU . 2.2 p -91.68 -50.3 5.83 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.997 1.379 . . . . 0.0 108.1 176.045 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.437 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 166.36 -163.6 37.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.373 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.506 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -143.52 124.7 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.547 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -72.57 115.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -87.64 161.42 45.03 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 108.665 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.68 131.03 21.98 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 124.798 -0.917 . . . . 0.0 110.432 -2.041 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.0 p90 -101.31 153.8 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.051 0.929 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.46 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -89.94 149.44 22.59 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.0 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.546 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.83 -24.25 1.37 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.834 -1.166 . . . . 0.0 109.513 -178.776 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.45 -34.48 60.95 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.561 178.962 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.91 -61.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.545 179.069 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.73 -36.9 38.68 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.178 -1.409 . . . . 0.0 108.295 179.127 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.597 ' OE1' HD21 ' A' ' 28' ' ' LEU . 7.2 tp10 -65.74 -56.95 9.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.025 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 117' ' ' GLU . 2.8 mt-10 -42.39 -34.37 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 109.997 -179.456 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -90.04 -25.86 20.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.284 179.833 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 117' ' ' GLU . 3.3 tp -66.74 -66.96 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.924 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -44.39 -50.44 9.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.56 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -61.14 -27.13 68.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 109.994 -179.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 120' ' ' LEU . 12.3 mt -81.39 -45.72 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.98 . . . . 0.0 109.926 -179.725 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.93 -6.34 8.18 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 -179.264 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.49 -29.31 68.71 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.227 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.52 -34.59 19.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.3 tt -72.2 -27.13 62.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.372 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.56 81.58 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.515 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.446 179.751 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -46.16 145.17 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.982 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 40.5 tttt -90.44 9.64 28.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.0 109.41 179.398 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.65 46.75 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.047 . . . . 0.0 110.356 -178.993 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.3 tp -78.29 112.34 15.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.528 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.01 123.34 17.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.927 -1.108 . . . . 0.0 111.98 -176.838 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 73.4 m-85 -109.45 152.04 25.9 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.942 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 54' ' ' VAL . 31.0 tp -121.89 106.14 10.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.283 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.82 105.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.423 -178.012 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.9 t -104.72 103.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.577 -0.702 . . . . 0.0 109.86 -179.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -149.06 148.64 29.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 9.1 t70 -85.08 -15.68 43.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -46.84 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.906 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.05 10.04 13.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 109.633 -179.71 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -155.52 -21.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.542 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' NZ ' ' A' ' 109' ' ' LYS . 13.8 tpt -48.89 -47.71 42.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.648 ' NH2' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.69 -37.14 17.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 -179.841 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -73.9 -30.72 62.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.784 -1.166 . . . . 0.0 109.769 -178.352 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.8 mt -67.62 -55.32 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.885 . . . . 0.0 109.338 -179.895 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.9 -32.34 47.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.86 -179.235 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.648 HH11 ' NH2' ' A' ' 18' ' ' ARG . 3.8 mtt180 -48.47 -52.31 22.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 108.949 179.475 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LYS . 1.4 t30 -66.15 -58.78 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.794 0.807 . . . . 0.0 109.28 179.901 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -42.18 -37.31 1.42 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.648 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.41 -42.94 58.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.75 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ASN . 23.1 tttm -61.12 -33.11 72.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.393 -0.817 . . . . 0.0 108.824 179.212 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.39 -50.34 65.32 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 179.654 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -49.69 59.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.98 74.66 0.04 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.551 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 56.4 m-85 -150.2 152.25 34.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.931 -1.335 . . . . 0.0 109.095 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.22 30.51 0.69 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 111.518 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.69 108.69 4.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.639 -1.288 . . . . 0.0 111.04 -179.255 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -150.06 179.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.04 . . . . 0.0 109.909 178.722 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.6 mt-10 -137.57 -168.02 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.87 150.38 31.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.984 -1.073 . . . . 0.0 111.167 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -136.82 -164.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.37 -6.63 5.3 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.67 . . . . 0.0 110.765 -179.528 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.96 179.8 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.728 -1.232 . . . . 0.0 109.948 179.873 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASN . . . -55.28 -57.56 17.91 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.7 p -51.99 -35.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.0 108.958 179.94 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.7 t0 -69.86 -41.89 74.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.73 -40.39 88.36 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.6 -35.46 77.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.911 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.84 -34.5 69.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -89.97 -26.49 20.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.434 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -54.72 -31.76 58.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.085 -1.009 . . . . 0.0 108.836 -179.776 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 1.6 mt-30 -52.88 -22.18 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.503 -0.748 . . . . 0.0 109.309 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -45.59 -59.43 2.74 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.829 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.7 52.8 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.307 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -148.62 -44.98 0.03 OUTLIER Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 53' ' ' PHE . 6.9 m-85 -49.7 92.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.367 -1.078 . . . . 0.0 110.636 -179.555 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -76.32 15.74 5.35 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 177.321 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -168.24 152.47 6.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.288 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.2 t -145.51 107.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.59 89.22 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.5 p -105.13 160.47 15.04 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -178.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.6 p-10 -73.13 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.221 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.3 t-105 -149.52 -6.46 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 108.79 179.035 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 4.7 m-80 43.4 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 110.959 178.468 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.48 20.87 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.884 178.76 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -59.09 -65.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 178.79 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.5 m-80 -151.94 -136.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.408 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.65 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.964 -1.085 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 9.4 m-20 -160.72 -167.77 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 -179.566 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.66 -79.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.32 -69.03 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -1.221 . . . . 0.0 109.327 -179.937 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.4 tt0 -61.32 -9.59 5.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.787 . . . . 0.0 109.744 -179.707 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tp -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 109.972 -179.491 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -79.16 -26.77 42.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.34 -179.687 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -59.93 -59.91 4.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.688 179.501 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -56.14 -31.44 63.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.151 -0.968 . . . . 0.0 109.877 -179.649 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -72.4 -21.74 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -31.49 17.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 75' ' ' ASP . . . -71.29 -60.43 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.208 179.812 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 79' ' ' SER . 6.1 p-10 39.94 -141.54 0.05 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.426 0.631 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.438 ' N ' ' OD2' ' A' ' 75' ' ' ASP . . . -159.84 -16.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.927 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.82 -7.26 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -1.107 . . . . 0.0 109.492 179.946 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -96.87 -72.43 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.579 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 11.2 t 44.72 45.26 8.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.579 -0.701 . . . . 0.0 109.831 179.824 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.09 -50.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.02 -1.05 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 80' ' ' ALA . 7.2 mt -27.41 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.455 -0.153 . . . . 0.0 111.112 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.477 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 6.3 Cg_exo -62.7 127.89 21.86 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.188 1.925 . . . . 0.0 114.02 -178.845 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -109.05 113.19 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 175.9 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.23 106.75 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.352 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.7 tpp -82.1 103.23 11.57 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.245 -178.004 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -98.85 148.31 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.854 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 160.06 43.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.37 129.0 35.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.864 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 49.56 74.76 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 179.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.27 120.19 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.278 179.684 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -68.89 -77.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.943 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -173.06 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.468 -179.763 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.1 mm-40 -69.5 -35.0 75.11 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -53.48 -35.11 60.23 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.12 -0.988 . . . . 0.0 109.69 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.802 HD11 ' HB1' ' A' ' 90' ' ' ALA . 63.9 mt -66.25 -55.15 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.994 -1.066 . . . . 0.0 108.591 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 100' ' ' GLN . 83.6 mt -69.28 -14.74 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.482 -0.761 . . . . 0.0 109.017 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' GLU . . . -67.72 -54.18 21.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 -179.997 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.579 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -68.61 -46.23 69.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.014 -1.054 . . . . 0.0 108.197 178.885 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -64.44 -27.34 68.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.726 -179.323 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HG2' HG22 ' A' ' 96' ' ' ILE . 2.7 mm-40 -52.08 -32.64 35.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.803 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.75 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.548 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 77.09 0.41 Allowed Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.627 177.874 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -88.79 -111.66 0.07 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 117.411 -1.716 . . . . 0.0 108.941 178.64 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 49.6 m -91.49 -49.75 6.15 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.905 1.336 . . . . 0.0 108.283 175.998 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.57 -162.89 33.74 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.071 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 150.07 42.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.127 -1.22 . . . . 0.0 109.75 179.461 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.69 126.06 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.274 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.92 113.25 10.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.138 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.589 ' NZ ' ' SD ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -87.35 162.53 42.6 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.579 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.4 123.36 8.49 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.836 -0.902 . . . . 0.0 110.478 -2.178 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -92.92 156.26 17.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.876 179.847 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.515 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.69 147.36 23.32 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.519 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.11 -25.5 0.88 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.053 . . . . 0.0 108.909 -179.414 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.92 78.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.728 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.87 -66.41 0.57 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.924 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tp -49.58 -36.08 22.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.506 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 4.5 tt0 -57.58 -62.41 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.031 -1.043 . . . . 0.0 110.227 -179.59 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' GLU . 34.9 mt-10 -46.09 -61.08 1.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 -179.51 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -50.97 -28.0 8.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.832 . . . . 0.0 109.691 179.832 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.489 HD13 ' CD1' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -65.85 -67.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.17 -0.956 . . . . 0.0 109.302 179.83 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.39 -28.46 66.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.003 -1.061 . . . . 0.0 110.506 -179.416 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -77.16 -23.79 51.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.966 -1.084 . . . . 0.0 109.84 -179.693 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.05 -42.38 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.506 -179.4 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 120' ' ' LEU . 11.8 m-85 -65.48 -14.89 61.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.087 -1.008 . . . . 0.0 110.104 -178.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -30.89 70.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.316 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -85.04 -26.49 27.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.541 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.5 -19.31 60.96 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.394 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.468 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 71.17 60.71 4.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.738 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.405 -179.705 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.26 150.45 0.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.997 -179.552 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.2 12.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.344 179.739 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -150.6 52.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.164 -179.665 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 50.5 tp -74.05 107.96 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.012 -1.055 . . . . 0.0 108.617 -179.879 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -49.73 106.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 111.458 -178.193 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 70.0 m-85 -99.53 153.84 18.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.268 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.585 ' HB3' HG13 ' A' ' 54' ' ' VAL . 30.9 tp -128.62 107.51 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.106 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.95 115.55 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 -179.813 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 36' ' ' ALA . 2.5 t -98.69 110.44 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 -179.144 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.455 ' CB ' ' HE ' ' A' ' 18' ' ' ARG . 37.7 t0 -166.28 168.47 15.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.028 -1.045 . . . . 0.0 109.758 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -103.06 -28.9 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.654 -0.654 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.3 138.5 55.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.974 . . . . 0.0 109.289 179.851 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.63 -33.48 11.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -75.94 -21.57 56.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.945 -179.634 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 ttm -73.72 -57.37 4.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.034 -1.041 . . . . 0.0 108.842 179.354 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.693 HH21 ' N ' ' A' ' 11' ' ' VAL . 19.2 mmt180 -58.67 -8.2 1.22 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.52 -178.708 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -76.73 -38.38 54.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 108.534 178.725 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -61.86 -55.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.76 -40.2 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.53 -179.185 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mtm180 -45.3 -53.45 8.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 -179.377 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -62.79 -56.77 14.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.328 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 tt -37.98 -58.16 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.94 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -53.52 -51.11 63.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.117 179.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.05 -40.11 73.03 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.135 -0.978 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.02 -41.33 62.15 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.272 -0.893 . . . . 0.0 109.217 -179.983 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 113' ' ' ALA . 15.3 mt -73.39 -61.76 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.511 -0.743 . . . . 0.0 109.073 179.77 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.22 68.66 0.01 OUTLIER Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.865 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.23 145.82 26.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.128 -1.219 . . . . 0.0 109.307 179.744 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -150.01 68.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -176.78 99.55 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 0.0 108.653 179.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.16 150.82 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 110.562 -178.988 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.31 -169.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.323 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -141.46 161.98 36.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.405 -0.809 . . . . 0.0 110.808 -178.771 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -144.4 -167.93 2.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.242 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.91 -2.24 4.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.465 -0.772 . . . . 0.0 110.666 -179.413 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.43 -171.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.204 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.625 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -69.24 -37.27 80.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.974 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 18.8 m -65.8 -42.3 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 0.0 109.16 179.952 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 40' ' ' VAL . 44.8 t0 -67.15 -50.53 60.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 108.464 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.89 -55.93 28.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.735 -0.603 . . . . 0.0 109.916 179.979 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.3 tm? -46.22 -53.82 9.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.94 . . . . 0.0 108.936 179.934 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 70.6 m-80 -61.27 -41.77 97.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.16 -12.25 59.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.106 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -66.71 -4.48 9.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 108.526 -179.908 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 27.3 tt0 -97.26 -4.56 38.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.768 . . . . 0.0 109.266 179.729 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.4 -72.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.524 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.12 9.5 1.3 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.962 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.0 87.27 1.08 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.7 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 53' ' ' PHE . 62.6 m-85 -66.8 109.62 2.96 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 -5.61 0.59 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.668 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.04 145.02 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 110.292 -178.842 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 83' ' ' VAL . 11.6 t -138.78 115.11 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.137 -0.977 . . . . 0.0 110.225 179.632 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.246 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 145.61 29.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -0.807 . . . . 0.0 109.638 -179.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.7 p30 -67.54 -112.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.589 -179.998 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 62.3 t-105 -169.9 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.779 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.462 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 15.5 m-80 -83.36 121.26 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.462 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.27 -50.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 110.129 179.617 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.58 -64.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 120.89 1.06 . . . . 0.0 109.888 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.94 -76.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.26 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -88.34 0.22 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.367 179.713 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 178.99 150.7 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.731 179.836 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.16 17.39 1.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 66' ' ' LEU . 4.4 tt -78.4 -56.6 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.847 -1.384 . . . . 0.0 108.203 179.287 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.51 -9.76 0.54 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.565 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD13 ' CA ' ' A' ' 39' ' ' GLY . 15.7 tp -81.91 -57.38 3.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -66.91 -34.91 78.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.603 -179.642 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -66.97 -59.07 3.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.146 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.9 m -54.84 -37.0 65.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.072 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt -57.44 -38.58 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.506 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -66.21 -7.55 18.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.909 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -71.81 -27.55 63.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.785 -179.907 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -51.36 -178.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 109.653 -179.746 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.09 -146.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.13 -12.49 60.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttp -90.04 -2.53 58.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ASP . 14.6 m 47.28 -120.03 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -0.894 . . . . 0.0 108.895 -179.741 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.08 56.9 0.96 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.251 178.955 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 80' ' ' ALA . 11.0 mt 57.53 155.39 0.08 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.648 -0.657 . . . . 0.0 110.035 178.112 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.47 140.39 54.15 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.314 2.009 . . . . 0.0 114.959 -177.166 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -129.32 116.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.134 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -103.06 108.51 19.72 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.523 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.62 138.52 57.51 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.671 -178.484 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 107' ' ' VAL . 2.0 t -116.35 139.92 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.675 -0.64 . . . . 0.0 110.168 -178.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -149.96 165.96 31.08 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.747 179.532 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . -100.19 128.63 46.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.667 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 91' ' ' LYS . 33.6 tt0 50.58 94.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.033 -179.598 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 95' ' ' ILE . . . -44.78 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.736 -179.683 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' CB ' HD21 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -76.57 16.81 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.474 -179.832 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 22.2 tttt 69.74 -70.28 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 94' ' ' ASN . 12.4 tm-20 -49.82 -49.32 49.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.179 -0.95 . . . . 0.0 110.176 -179.475 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.549 HD21 ' CB ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -65.14 -66.79 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.21 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.777 HD12 ' CE2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -45.54 -42.76 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.247 -0.908 . . . . 0.0 109.901 -179.16 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.19 -31.08 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.953 -1.092 . . . . 0.0 109.624 -179.782 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.41 85.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.655 -179.718 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.58 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -69.2 -53.69 18.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 108.366 179.39 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.61 -26.35 61.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.327 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -53.32 -32.44 48.97 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.45 -23.38 26.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.202 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.34 75.38 0.51 Allowed Glycine 0 N--CA 1.481 1.693 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.802 177.663 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.786 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -85.52 -111.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 117.107 -1.837 . . . . 0.0 108.911 178.541 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 34.9 m -91.49 -46.68 7.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.473 1.13 . . . . 0.0 107.995 175.697 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.426 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 171.3 -159.73 31.64 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.732 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.777 ' CE2' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.23 131.67 30.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.829 -0.806 . . . . 0.0 108.997 179.175 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.901 HG21 HD12 ' A' ' 116' ' ' LEU . 11.9 p -127.65 120.95 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.658 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 89' ' ' GLU . 2.0 p -70.32 157.92 6.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 108.964 -179.485 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -131.63 160.41 67.55 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.885 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.57 126.32 11.94 Favored 'Cis proline' 0 C--N 1.32 -0.93 0 C-N-CA 124.716 -0.951 . . . . 0.0 110.429 -2.06 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.701 ' CE1' HD22 ' A' ' 116' ' ' LEU . 4.9 p90 -91.4 159.91 15.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.828 179.932 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.38 149.86 20.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.991 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -49.96 -35.04 22.74 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.773 -1.204 . . . . 0.0 108.815 -179.53 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.93 -31.73 71.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.781 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.5 m -72.61 -68.13 0.5 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.729 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.901 HD12 HG21 ' A' ' 107' ' ' VAL . 3.6 tp -47.57 -36.72 11.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.62 -1.3 . . . . 0.0 109.253 178.861 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -62.31 -64.56 0.89 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.846 -1.159 . . . . 0.0 109.126 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -45.27 -51.0 11.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.629 -0.669 . . . . 0.0 109.738 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.739 ' NZ ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -55.5 -54.34 45.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.464 -179.836 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 120' ' ' LEU . 26.9 mt -55.97 -44.9 78.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.563 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -47.76 -69.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 109.977 -179.273 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -49.06 -27.44 3.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.317 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.34 -40.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.947 -1.096 . . . . 0.0 110.577 -179.208 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -74.28 -22.71 59.18 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.139 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -62.29 -20.43 64.29 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -97.51 -27.7 14.31 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.888 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.79 -13.07 49.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.264 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.21 71.94 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -159.72 147.32 16.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.1 8.48 32.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.989 -1.07 . . . . 0.0 109.972 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -155.62 52.74 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 0.0 109.844 -179.678 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 tp -77.21 131.04 38.03 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.881 -1.137 . . . . 0.0 107.943 179.471 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -67.48 110.7 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.107 . . . . 0.0 111.708 -177.388 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 81.7 m-85 -105.4 148.01 27.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.3 tp -124.72 105.08 9.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -91.4 111.24 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 109.998 -179.142 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.2 t -113.91 106.91 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 40.0 t0 -172.35 117.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.161 -0.962 . . . . 0.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.01 135.39 20.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.722 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -171.23 -153.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.478 -1.389 . . . . 0.0 112.121 -177.263 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.722 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -177.11 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.36 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.524 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -164.95 -59.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.516 0.674 . . . . 0.0 110.27 -177.868 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.4 ttt -35.62 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.034 -0.416 . . . . 0.0 111.296 179.596 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 34.5 mtm180 -46.2 -27.08 0.9 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.699 -1.251 . . . . 0.0 109.782 -178.615 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' THR . 4.0 ttp180 -78.54 -32.64 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.815 -1.178 . . . . 0.0 108.985 178.967 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 mt -66.94 -54.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 108.992 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.449 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -56.08 -40.37 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -180.0 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -43.58 -53.7 5.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.479 -0.763 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -63.0 -57.12 11.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.901 0.858 . . . . 0.0 108.783 179.168 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -37.76 -57.74 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.714 179.964 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.83 -52.43 65.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.076 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -48.39 -30.6 5.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.77 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -48.22 -41.36 27.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.233 -0.917 . . . . 0.0 108.9 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -75.03 -65.31 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.116 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.69 22.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 68.9 m-85 -89.99 145.72 24.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.75 -1.441 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -150.14 59.54 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.074 -1.016 . . . . 0.0 110.42 179.718 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -174.38 104.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.228 . . . . 0.0 110.295 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -146.47 179.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.149 -0.97 . . . . 0.0 109.762 179.423 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.5 mm-40 -139.21 -169.76 2.73 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.627 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.0 145.88 26.68 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.858 -179.068 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.873 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.98 -171.01 3.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.814 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 2.0 mp0 -132.38 -2.05 3.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.251 -0.905 . . . . 0.0 110.495 -179.197 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.82 -177.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.229 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -67.23 -36.29 89.59 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 41' ' ' ASP . 7.6 p -62.89 -45.68 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -1.202 . . . . 0.0 109.436 -179.935 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.0 t0 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.401 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -71.87 -22.93 61.44 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.414 179.956 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.659 -1.276 . . . . 0.0 108.294 179.205 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -72.92 -27.52 61.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.676 -0.64 . . . . 0.0 110.04 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.75 -37.87 14.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.959 . . . . 0.0 110.777 -178.868 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -49.96 -23.5 2.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.714 -1.241 . . . . 0.0 109.552 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 5.6 tp60 -96.89 -13.57 22.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -40.85 -62.08 0.86 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 -179.594 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.62 3.75 2.39 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.88 76.8 1.15 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.74 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.722 ' O ' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -57.68 131.49 50.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 110.131 -179.392 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.33 3.75 83.65 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.037 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -168.15 146.32 4.37 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.101 -1.235 . . . . 0.0 110.264 -179.149 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.7 t -143.93 121.38 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.067 -1.021 . . . . 0.0 109.895 179.389 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.477 ' CG2' HG21 ' A' ' 86' ' ' VAL . 44.5 mt -106.61 103.92 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.611 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.9 p -114.51 161.07 18.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.388 -0.82 . . . . 0.0 110.318 -178.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 17.1 p-10 -89.38 -110.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.541 -0.724 . . . . 0.0 109.2 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 77.3 t-105 -141.37 177.78 7.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 179.702 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.623 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -76.7 75.24 3.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.758 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtm -86.13 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.927 -1.108 . . . . 0.0 110.378 179.677 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.1 -55.2 0.41 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 C-N-CA 120.898 1.065 . . . . 0.0 109.747 179.932 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -172.49 -162.3 0.19 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.437 -0.789 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -47.55 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -164.91 137.08 4.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.565 -179.563 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 103.27 -50.53 0.89 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.699 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.613 ' H ' HD21 ' A' ' 59' ' ' ASN . 3.6 tp -85.78 -46.6 10.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.564 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.403 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.0 mm-40 -63.31 -20.03 65.13 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.581 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 65' ' ' GLY . 3.7 mt -68.52 -61.77 1.68 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.684 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.929 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -45.81 -64.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.984 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.91 -49.74 4.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.2 -179.438 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -64.19 -32.91 74.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.793 HD13 HG21 ' A' ' 83' ' ' VAL . 46.4 mt -74.82 -31.18 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.174 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -20.0 23.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.43 -30.07 4.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.357 -179.836 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.76 100.12 0.38 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.372 -0.83 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.74 46.41 2.32 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.791 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.32 -28.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -1.168 . . . . 0.0 109.292 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -96.98 -70.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.453 179.946 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 16.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.159 -179.799 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -104.89 -39.27 6.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.583 -0.698 . . . . 0.0 109.736 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.41 97.14 0.1 Allowed Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.629 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.88 102.49 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.652 0 C-N-CA 121.169 1.246 . . . . 0.0 112.064 -178.767 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 72' ' ' ILE . 2.5 t -107.67 116.24 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 177.364 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.42 106.66 17.24 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.58 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 98' ' ' ALA . 7.4 ttm -67.23 160.42 27.03 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.039 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 55' ' ' ILE . 18.6 t -137.49 144.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.29 -0.881 . . . . 0.0 110.183 -178.967 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -150.18 158.68 44.41 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.88 -82.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.115 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -77.51 68.88 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.933 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.759 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -42.83 123.67 2.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 110.646 -178.896 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.93 112.72 25.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.117 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -43.82 -25.97 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.468 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.87 -38.01 33.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.193 -0.942 . . . . 0.0 110.326 -179.447 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -90.06 -9.71 47.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.099 -1.001 . . . . 0.0 110.43 -179.299 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.3 mp -74.23 -27.05 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.972 -1.08 . . . . 0.0 108.55 -179.816 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 96' ' ' ILE . 13.0 mt -87.05 -8.59 11.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 108.909 179.591 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.37 -52.89 10.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.471 -0.768 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB2' ' SD ' ' A' ' 85' ' ' MET . . . -64.82 -48.59 73.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.905 -1.122 . . . . 0.0 108.026 178.867 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -63.71 -31.7 72.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.89 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -59.25 -32.6 70.14 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.932 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.929 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.2 -24.08 47.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 176.091 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.88 74.01 0.49 Allowed Glycine 0 N--CA 1.481 1.657 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.387 176.243 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.22 -112.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 116.984 -1.887 . . . . 0.0 109.606 177.818 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.4 m -91.96 -50.91 5.46 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 123.009 1.385 . . . . 0.0 107.645 174.983 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 169.04 -164.17 37.83 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.391 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -133.47 121.79 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.123 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -113.46 123.53 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.446 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.801 HG22 ' H ' ' A' ' 109' ' ' LYS . 12.5 p -64.44 -177.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.126 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.801 ' H ' HG22 ' A' ' 108' ' ' VAL . 1.2 pttt -154.62 158.76 32.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.595 -1.315 . . . . 0.0 108.602 179.848 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.41 136.81 45.98 Favored 'Cis proline' 0 C--N 1.317 -1.121 0 C-N-CA 124.54 -1.025 . . . . 0.0 110.446 -2.191 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.1 p90 -96.59 162.32 13.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.008 . . . . 0.0 109.179 178.997 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.79 144.94 24.8 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 177.132 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.1 -33.22 4.82 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.962 -1.086 . . . . 0.0 109.56 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -32.33 66.52 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.634 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' THR . 13.4 m -71.69 -64.42 0.93 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.966 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -48.96 -40.3 29.82 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.6 -1.313 . . . . 0.0 108.419 179.406 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.09 -57.67 11.81 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.858 -1.151 . . . . 0.0 109.833 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.7 tt0 -44.59 -28.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.391 -179.685 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.18 -37.52 14.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 108.742 179.214 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.06 -55.48 14.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.628 -0.67 . . . . 0.0 109.868 -179.467 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 122' ' ' LYS . 1.2 p30 -48.12 -54.23 13.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.166 -0.959 . . . . 0.0 109.96 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.557 ' H ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 mttt -53.38 -38.11 63.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.43 -0.794 . . . . 0.0 110.236 -179.517 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.76 -41.5 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.461 -179.138 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -72.97 -6.97 48.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.957 -1.089 . . . . 0.0 110.589 -178.908 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.01 -19.42 60.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.746 -1.221 . . . . 0.0 107.774 178.654 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -97.63 -27.45 14.37 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.935 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -25.96 24.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.9 84.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.797 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.2 m-20 49.36 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 108.533 -179.486 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.585 ' CB ' ' NZ ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -63.13 11.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 0.0 110.498 -178.871 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 3' ' ' ASP . 10.7 mm-40 -139.03 40.49 2.12 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.835 . . . . 0.0 109.339 -179.908 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.0 tp -75.23 129.51 37.58 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 120.603 -1.31 . . . . 0.0 108.178 179.782 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -80.24 124.62 28.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.153 -0.967 . . . . 0.0 111.991 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -113.55 143.52 44.41 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.36 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG13 ' A' ' 54' ' ' VAL . 17.7 tp -112.42 110.2 20.27 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.136 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -92.74 106.74 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.742 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 11' ' ' VAL . 15.2 t -89.92 16.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.535 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 13.7 p30 -51.0 162.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.984 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -144.9 33.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.195 179.952 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' ' CB ' ' A' ' 15' ' ' SER . 51.2 t80 -83.02 -75.97 0.29 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER 165.61 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.811 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.62 -5.7 1.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.511 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.9 ttm -56.02 -38.15 70.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.516 -0.74 . . . . 0.0 109.324 179.756 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.537 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -62.3 -56.35 19.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.887 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.14 -28.89 42.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -178.781 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.9 mt -67.81 -57.8 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.127 -0.983 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.97 -32.43 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.981 -179.25 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.658 ' CA ' ' HE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.11 -55.17 10.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.972 . . . . 0.0 109.449 179.703 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -63.33 -58.14 8.08 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.802 0.81 . . . . 0.0 109.223 179.896 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.4 tt -39.41 -55.95 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.003 -179.55 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.2 -42.21 94.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.069 -1.019 . . . . 0.0 108.926 179.263 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.581 ' NZ ' HD21 ' A' ' 31' ' ' ASN . 12.1 ttmm -58.79 -40.69 84.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.87 -46.6 67.98 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 -179.714 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 117' ' ' GLU . 10.6 mp -66.11 -56.37 11.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.334 -0.854 . . . . 0.0 109.093 179.811 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.04 69.35 0.01 OUTLIER Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.951 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -150.11 130.82 14.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.328 . . . . 0.0 109.184 179.822 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.581 HD21 ' NZ ' ' A' ' 26' ' ' LYS . 2.1 m120 -133.74 71.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.814 . . . . 0.0 109.971 -179.402 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.59 98.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 0.0 108.524 179.642 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.5 149.47 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.144 -0.973 . . . . 0.0 110.458 -178.544 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -121.75 -172.88 2.52 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.385 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CD ' HH11 ' A' ' 18' ' ' ARG . 39.8 mt-10 -141.71 155.44 45.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.919 0.866 . . . . 0.0 110.816 -178.608 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.05 -168.7 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.27 12.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 110.719 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD2' ' ND2' ' A' ' 62' ' ' ASN . 14.0 t0 -175.32 154.17 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.538 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.66 -28.63 60.23 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 179.033 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -75.02 -37.33 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.627 -0.925 . . . . 0.0 108.825 179.165 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.68 -39.77 80.4 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.055 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -69.38 -46.49 66.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.53 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.03 -37.37 61.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.965 -179.693 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -76.07 -34.76 59.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.107 -179.412 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -90.02 -13.31 36.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.173 -179.419 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -61.32 -14.69 28.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 -179.971 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -93.89 -4.17 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.12 -65.93 0.47 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.546 -0.721 . . . . 0.0 109.637 -179.929 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.45 -92.2 0.26 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.906 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -162.6 67.16 0.24 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.824 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' PHE . 56.4 m-85 -47.02 98.56 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.546 -0.973 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -65.53 1.56 4.07 Favored Glycine 0 C--N 1.297 -1.599 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.402 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.12 150.57 11.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.397 -1.06 . . . . 0.0 109.21 -179.548 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 83' ' ' VAL . 44.2 t -143.72 118.83 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.767 -1.208 . . . . 0.0 109.993 179.285 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' CG2' HG21 ' A' ' 86' ' ' VAL . 55.5 mt -99.46 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.477 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 36.0 p -102.39 148.72 25.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.406 -0.809 . . . . 0.0 109.818 -179.134 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.91 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 109.06 179.678 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.432 ' C ' ' SD ' ' A' ' 60' ' ' MET . 65.9 t-105 -172.09 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.981 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.445 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.0 t-20 -97.25 98.23 9.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 109.742 -179.731 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.05 162.3 54.68 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.708 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' O ' ' OD2' ' A' ' 38' ' ' ASP . 3.2 Cg_exo -56.3 148.93 58.33 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.373 1.382 . . . . 0.0 110.134 179.362 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 65.99 -159.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.184 -179.73 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.94 156.71 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.8 173.05 12.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.99 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.81 -3.02 2.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.835 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 64' ' ' ASP . 17.3 tp -58.92 -52.5 65.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.18 . . . . 0.0 108.807 179.921 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.81 -4.14 1.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 108.948 179.638 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' CA ' ' A' ' 39' ' ' GLY . 11.0 tp -85.59 -64.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -63.69 -32.34 73.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.865 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -67.35 -60.51 2.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.913 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.9 m -51.41 -40.29 58.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.408 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -60.68 -29.27 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 108.66 179.271 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.51 -22.9 32.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.441 -0.787 . . . . 0.0 109.426 179.787 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.53 -26.79 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.947 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -73.75 -53.12 11.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.346 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.09 -21.29 4.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.894 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.52 -86.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.596 -179.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.3 mpp? -96.53 -25.63 15.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.687 -179.691 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.8 m 53.46 -128.48 2.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -139.44 44.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.451 -0.781 . . . . 0.0 109.3 179.927 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.449 HD22 ' HA2' ' A' ' 52' ' ' GLY . 0.3 OUTLIER 50.87 177.04 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.914 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.23 135.96 46.06 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 N-CA-C 116.499 1.692 . . . . 0.0 116.499 -175.551 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -124.33 115.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.856 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -102.47 105.88 16.51 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 117.919 -1.512 . . . . 0.0 107.309 177.996 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.477 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 2.0 tpt -66.09 156.22 34.54 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.089 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.431 HG21 ' CG2' ' A' ' 55' ' ' ILE . 29.0 t -135.48 141.06 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -0.816 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -150.09 176.31 10.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -95.33 -130.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -52.71 88.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -48.7 118.35 2.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.58 -179.695 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 13.6 tttt -94.86 6.9 47.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 4.3 ttpp 75.06 -62.39 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.406 -179.891 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.15 -34.45 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.707 -179.8 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -84.4 -45.06 13.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.964 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 106' ' ' TYR . 29.4 mm -48.57 -42.23 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 108.935 179.545 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.7 mt -71.35 -26.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.307 -0.871 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.17 -51.77 67.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.212 -0.93 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -75.55 -51.69 12.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -58.3 -27.99 64.6 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.324 -0.95 . . . . 0.0 108.935 -179.254 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.0 tt0 -56.16 -33.22 65.02 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 178.151 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -82.7 -22.13 34.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.014 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 61.66 76.93 0.22 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.825 177.579 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.829 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.29 -112.08 0.05 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 116.75 -1.98 . . . . 0.0 109.104 178.661 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.0 m -91.86 -51.29 5.29 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 123.096 1.427 . . . . 0.0 107.913 175.058 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.413 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.65 -157.36 28.41 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -178.116 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.79 127.17 16.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.566 -0.961 . . . . 0.0 109.297 179.294 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.01 140.31 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.22 153.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.788 -179.926 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.21 153.38 80.42 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.785 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.64 132.23 26.1 Favored 'Cis proline' 0 N--CA 1.49 1.27 0 O-C-N 122.328 0.646 . . . . 0.0 111.259 -1.615 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.5 p90 -98.96 162.38 13.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.386 -0.821 . . . . 0.0 109.164 178.79 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -94.97 146.45 24.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.997 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.71 -31.21 4.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 109.127 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.29 -33.48 67.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.664 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.2 m -71.94 -65.61 0.75 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.446 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 111' ' ' PHE . 8.7 tp -47.13 -41.01 16.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 0.0 109.2 178.741 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HB2' HD21 ' A' ' 28' ' ' LEU . 40.2 tt0 -64.31 -58.09 7.51 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 -179.634 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -44.22 -48.55 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.646 -0.659 . . . . 0.0 109.682 -179.703 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -65.75 -47.22 75.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.5 -39.77 70.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 109.634 -179.984 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -46.24 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.93 -179.645 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -71.35 -19.58 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.638 -179.635 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.03 -40.44 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.902 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.0 m-85 -73.82 -33.81 64.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 -179.711 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -50.92 -27.89 8.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.05 -1.031 . . . . 0.0 108.413 179.543 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -90.64 -21.82 21.49 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.043 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 124' ' ' PHE . 13.1 tp -83.3 -20.71 33.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.371 -0.831 . . . . 0.0 108.866 179.431 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.25 76.14 0.14 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.623 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 62.76 134.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 108.962 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mtmm -90.04 17.44 6.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.982 -1.074 . . . . 0.0 109.78 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.63 42.88 0.49 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.938 -1.101 . . . . 0.0 110.593 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -66.41 141.91 57.77 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -78.13 131.36 37.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 0.0 111.104 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.646 ' HB2' HG22 ' A' ' 33' ' ' VAL . 83.2 m-85 -123.67 146.88 47.91 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.827 -0.545 . . . . 0.0 110.259 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.664 ' HB3' HG13 ' A' ' 54' ' ' VAL . 60.9 tp -121.78 116.18 24.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.688 -0.632 . . . . 0.0 109.368 177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.98 109.22 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -106.25 26.02 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.713 -0.617 . . . . 0.0 109.672 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.67 117.66 12.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.61 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.8 OUTLIER -64.83 -14.41 59.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.313 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.0 140.86 4.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.861 . . . . 0.0 109.533 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.474 ' C ' HG22 ' A' ' 16' ' ' THR . 53.5 p -97.96 47.77 1.01 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.446 -0.784 . . . . 0.0 109.512 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.474 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER 178.23 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.565 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 3.7 tpt -61.13 -46.68 89.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.614 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 ptt-85 -49.84 -31.69 12.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.912 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -74.01 -42.08 60.91 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.732 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.44 -52.73 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.755 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.85 -40.48 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 110.234 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.94 -53.11 13.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -68.64 -57.74 5.26 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.769 0.795 . . . . 0.0 109.686 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.67 HD22 HD12 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -39.64 -56.53 1.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.663 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -55.36 -51.17 67.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.095 -1.003 . . . . 0.0 108.757 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -47.76 -40.41 20.63 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.249 -0.907 . . . . 0.0 108.983 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -60.12 -34.37 73.41 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.416 -0.803 . . . . 0.0 109.308 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.48 HD11 ' HG3' ' A' ' 117' ' ' GLU . 1.6 mm? -81.09 4.32 20.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.55 62.53 1.78 Allowed Glycine 0 N--CA 1.482 1.748 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -143.58 126.85 16.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -1.184 . . . . 0.0 109.092 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -133.63 65.32 1.59 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.632 -0.668 . . . . 0.0 109.815 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -172.48 89.25 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -135.75 150.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 0.0 109.938 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -119.17 -177.12 3.27 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -150.09 155.22 39.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.863 -1.148 . . . . 0.0 110.81 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -146.6 -165.41 2.22 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 17.1 mt-10 -137.34 -5.15 1.83 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.463 -0.773 . . . . 0.0 110.359 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -177.23 -177.92 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.79 -1.193 . . . . 0.0 109.733 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.63 -52.24 47.57 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.9 p -51.55 -31.85 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.054 -1.263 . . . . 0.0 108.513 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.8 t0 -74.63 -47.64 30.94 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.422 -0.799 . . . . 0.0 109.122 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -59.08 -48.06 82.98 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.26 -0.9 . . . . 0.0 109.363 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -56.2 -40.09 73.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 109.954 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.47 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 5.9 m-20 -81.56 -25.67 35.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.058 -1.026 . . . . 0.0 110.544 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -90.25 -23.88 21.1 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.561 ' CD2' ' H ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -80.11 -17.27 53.03 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.53 -1.356 . . . . 0.0 110.21 -178.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -61.58 -5.94 2.15 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -52.77 -77.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.924 -0.485 . . . . 0.0 110.019 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.88 11.57 1.67 Allowed Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.473 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.44 86.21 0.26 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.826 ' O ' HD11 ' A' ' 81' ' ' LEU . 25.2 m-85 -58.92 157.58 9.63 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.406 -1.056 . . . . 0.0 110.43 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.73 -9.42 62.72 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.74 140.47 19.94 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.676 -0.896 . . . . 0.0 109.133 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 9' ' ' LEU . 20.6 t -135.17 120.43 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.0 110.164 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.8 mt -104.08 128.51 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -146.38 147.02 30.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.066 -1.021 . . . . 0.0 109.672 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 58' ' ' TRP . 16.6 t70 -63.84 -120.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.402 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.417 ' N ' ' OD2' ' A' ' 57' ' ' ASP . 61.9 t-105 -161.89 -28.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.782 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -166.64 34.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.633 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.2 -37.22 0.43 Allowed Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.194 -0.941 . . . . 0.0 111.204 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -68.83 -70.65 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 120.846 1.031 . . . . 0.0 110.152 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.71 HD22 ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -154.81 -81.07 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.71 ' H ' HD22 ' A' ' 62' ' ' ASN . 3.4 mpp? -76.0 -113.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.264 -0.898 . . . . 0.0 109.303 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -142.14 -178.42 5.71 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' N ' ' CG ' ' A' ' 64' ' ' ASP . . . -93.79 -17.97 39.43 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.662 -1.256 . . . . 0.0 111.396 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.572 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 1.4 mm? -46.79 -68.98 0.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.687 -1.478 . . . . 0.0 110.042 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -43.57 -41.79 4.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.96 -42.9 99.96 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.706 HD21 ' H ' ' A' ' 102' ' ' GLY . 5.4 tt -82.59 -64.21 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.877 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -33.75 -41.6 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.23 0.538 . . . . 0.0 110.144 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.465 HG21 HD21 ' A' ' 43' ' ' LEU . 19.6 m -58.96 -48.03 82.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 108.728 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 57.8 mt -50.76 -45.14 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.398 -0.814 . . . . 0.0 108.88 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -65.41 -39.29 91.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.384 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.34 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.392 -0.818 . . . . 0.0 109.574 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -67.35 -128.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -0.847 . . . . 0.0 109.361 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.621 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . 170.16 161.38 20.56 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 71.79 -14.14 0.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.296 -1.12 . . . . 0.0 109.413 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.469 ' H ' ' C ' ' A' ' 76' ' ' GLY . 2.3 mmt -146.82 17.43 1.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 m -68.78 7.23 0.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.351 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -93.92 2.7 56.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.366 -0.834 . . . . 0.0 109.645 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.826 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -43.86 107.59 0.61 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.543 -0.723 . . . . 0.0 109.397 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HD2' HD13 ' A' ' 81' ' ' LEU . 4.1 Cg_exo -62.58 136.5 58.92 Favored 'Trans proline' 0 C--N 1.326 -0.643 0 C-N-CA 120.76 0.973 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.2 t -130.27 129.27 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.617 ' CD2' HD21 ' A' ' 116' ' ' LEU . 38.4 tp -110.64 72.03 0.77 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.45 145.53 22.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 t -113.56 129.97 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -150.13 166.29 30.27 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.114 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -91.05 147.72 22.88 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 90' ' ' ALA . 6.4 mt-10 49.33 -152.0 0.15 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.909 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 176.76 115.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.803 -1.186 . . . . 0.0 110.43 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.63 121.02 40.93 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -43.88 -45.24 7.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.299 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -51.89 -32.81 34.08 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.198 -0.939 . . . . 0.0 110.376 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -87.58 -41.52 13.39 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 0.0 110.714 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.909 HD11 ' HB1' ' A' ' 90' ' ' ALA . 9.2 mt -67.54 -13.07 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.037 -1.04 . . . . 0.0 109.573 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.2 mt -80.56 -70.01 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.082 . . . . 0.0 109.885 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.11 -26.37 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.804 . . . . 0.0 109.0 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' A' ' 103' ' ' ALA . . . -70.35 -61.67 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.604 -0.685 . . . . 0.0 109.762 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.41 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -58.45 -34.63 71.05 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.222 -0.924 . . . . 0.0 109.699 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -50.91 -19.59 1.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.264 -0.897 . . . . 0.0 108.871 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -108.45 -115.03 0.29 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.83 -0.544 . . . . 0.0 109.603 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.731 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -120.67 -0.99 12.11 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' C ' ' A' ' 98' ' ' ALA . . . -59.18 11.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.665 -0.903 . . . . 0.0 109.23 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.731 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.2 m -29.2 -31.06 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.32 133.55 11.72 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.47 -1.348 . . . . 0.0 110.572 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.576 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.55 110.64 6.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.7 p -112.58 130.79 65.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.459 HG22 ' OH ' ' A' ' 106' ' ' TYR . 0.5 OUTLIER -64.86 -157.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -174.1 152.54 1.88 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.059 -1.026 . . . . 0.0 109.268 179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.3 146.4 86.14 Favored 'Cis proline' 0 N--CA 1.487 1.111 0 O-C-N 122.576 0.777 . . . . 0.0 110.512 -2.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -112.97 155.04 25.49 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.936 0.874 . . . . 0.0 109.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.17 146.88 23.46 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 177.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -46.03 -29.66 1.56 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.02 -1.05 . . . . 0.0 109.387 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.14 -35.1 59.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 112' ' ' THR . 16.2 m -69.07 -60.88 2.05 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.67 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -45.83 -50.71 13.92 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.677 -1.209 . . . . 0.0 108.17 178.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' HG3' HD11 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -51.06 -32.48 22.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.736 -179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 115' ' ' THR . 4.5 tp10 -67.76 -43.9 78.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.355 -0.84 . . . . 0.0 109.973 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -71.28 -51.33 25.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.139 -0.975 . . . . 0.0 109.922 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 tp -50.2 -59.59 3.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.127 -0.983 . . . . 0.0 109.856 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -52.74 -35.92 56.9 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.209 -0.932 . . . . 0.0 110.19 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 22.0 mmtt -66.48 -24.58 66.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.563 HD11 ' HA2' ' A' ' 105' ' ' GLY . 22.2 mt -88.83 -47.96 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.954 -1.091 . . . . 0.0 110.175 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -58.71 -12.4 4.2 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 110.339 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.09 -24.15 66.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.99 -29.09 16.8 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.35 -24.52 42.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.489 -0.757 . . . . 0.0 109.055 179.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.06 81.82 0.04 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.257 -1.143 . . . . 0.0 109.558 -179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.287 0.565 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.512 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.34 141.23 3.62 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.813 . . . . 0.0 109.451 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.2 mttp -90.59 10.17 26.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.283 -0.886 . . . . 0.0 109.952 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.96 51.42 1.61 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.143 -0.973 . . . . 0.0 109.431 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 46.9 tp -84.17 107.81 16.71 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -48.5 112.83 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.02 . . . . 0.0 111.705 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 63.0 m-85 -102.6 153.98 19.57 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD23 ' CD2' ' A' ' 46' ' ' LEU . 12.9 tp -131.17 105.61 7.79 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.344 -0.847 . . . . 0.0 108.884 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -93.71 108.7 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 110.073 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.914 HG22 ' HB3' ' A' ' 36' ' ' ALA . 62.4 t -96.0 40.49 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.824 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -70.6 144.58 51.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -97.53 0.51 47.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.616 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.69 143.49 27.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.557 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.8 p -85.35 34.27 0.57 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.56 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -165.33 -8.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -37.55 66.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.402 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 1.5 mpt_? -62.07 -16.08 49.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 108.967 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -75.07 -42.08 57.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.431 -0.793 . . . . 0.0 109.651 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.6 -53.44 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.871 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.57 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.954 . . . . 0.0 110.2 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.12 -54.71 8.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.09 -1.006 . . . . 0.0 109.761 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.71 -57.77 6.45 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.981 0.896 . . . . 0.0 109.315 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.27 -64.59 0.53 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.436 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.0 mt -50.1 -44.51 52.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.248 -0.907 . . . . 0.0 108.76 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -52.02 -48.01 64.72 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.356 -0.84 . . . . 0.0 109.205 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.09 -23.47 63.83 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.478 -0.764 . . . . 0.0 109.291 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' A' ' 117' ' ' GLU . 28.1 mt -89.51 3.58 51.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.436 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.1 59.41 2.43 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.512 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 52.8 m-85 -148.33 142.82 26.4 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.291 . . . . 0.0 109.329 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -150.1 27.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.046 . . . . 0.0 110.178 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -135.0 99.43 4.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.196 -179.477 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -146.3 179.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.149 -0.969 . . . . 0.0 109.599 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.1 mt-10 -138.7 -174.28 3.79 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -138.91 157.27 46.33 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.794 0.807 . . . . 0.0 110.826 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.914 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.97 -174.26 4.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.426 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.9 pt-20 -148.77 13.56 0.91 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.912 -1.118 . . . . 0.0 110.226 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 0.2 OUTLIER 178.16 -179.9 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.954 -1.091 . . . . 0.0 109.131 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -71.28 -39.55 61.96 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.1 -30.9 46.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.125 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.601 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 13.2 t0 -81.18 -46.09 15.38 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.507 -0.745 . . . . 0.0 109.674 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.43 -42.33 92.57 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.75 -58.04 7.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.061 -1.024 . . . . 0.0 110.301 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -54.75 -29.06 52.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 110.072 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.7 mmtm -90.13 -31.02 17.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.126 -0.984 . . . . 0.0 110.622 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -53.93 -41.01 67.25 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.037 -1.039 . . . . 0.0 109.712 -179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -67.7 -11.77 59.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.903 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.81 -65.21 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.775 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.4 7.65 1.81 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.43 87.04 0.24 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.693 ' O ' HD21 ' A' ' 81' ' ' LEU . 61.3 m-85 -67.81 110.45 3.81 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.327 -1.102 . . . . 0.0 110.076 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 81' ' ' LEU . . . -54.65 -10.1 2.02 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -149.75 126.78 11.22 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.195 -1.179 . . . . 0.0 110.289 -179.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' HB ' HG22 ' A' ' 83' ' ' VAL . 95.9 t -122.92 120.24 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.386 -0.821 . . . . 0.0 109.642 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 59.9 mt -103.61 123.89 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 53.6 p -139.27 168.38 19.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.737 . . . . 0.0 109.095 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 9.8 t70 -84.47 -97.01 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 59' ' ' ASN . 74.9 t-105 -172.4 -109.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.506 ' N ' ' CD1' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -91.48 126.79 36.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 109.528 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.47 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.2 mtp 176.62 -50.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.327 -0.858 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.0 Cg_exo -64.19 -168.87 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.808 0 C-N-CA 120.815 1.01 . . . . 0.0 110.113 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.579 HD22 ' H ' ' A' ' 63' ' ' MET . 0.1 OUTLIER -47.61 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 0.0 109.452 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.579 ' H ' HD22 ' A' ' 62' ' ' ASN . 21.6 mmt -69.76 -117.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.64 147.73 33.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 109.119 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -57.04 -8.6 3.27 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -74.71 -63.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.943 -1.328 . . . . 0.0 108.817 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.71 -25.78 12.05 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.714 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.3 tt -70.66 -33.64 71.17 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.785 HD21 ' H ' ' A' ' 103' ' ' ALA . 18.0 tp -86.55 -58.26 2.68 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -43.26 -47.2 6.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.852 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.0 m -51.41 -47.36 63.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 0.0 108.99 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.52 -38.47 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 108.924 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -83.94 -20.7 32.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.337 -0.852 . . . . 0.0 109.578 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.1 -28.96 43.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.214 -0.929 . . . . 0.0 109.692 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -52.27 -70.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.62 -63.39 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.8 -26.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -1.115 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 78' ' ' MET . 0.6 OUTLIER -90.11 -40.88 11.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 0.0 109.665 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' MET . 0.3 OUTLIER 75.78 -59.76 0.51 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -150.16 -54.34 0.16 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.653 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 51' ' ' TYR . 13.3 tp 59.3 120.3 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.85 131.76 43.83 Favored 'Trans proline' 0 C--N 1.325 -0.67 0 C-N-CA 120.606 0.87 . . . . 0.0 112.293 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -126.73 127.6 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.7 69.48 0.72 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.462 ' O ' ' CG ' ' A' ' 85' ' ' MET . 5.9 ptt? -61.33 123.62 18.29 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.83 127.13 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.068 -1.02 . . . . 0.0 109.511 -179.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.8 t -150.05 136.94 19.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.566 -1.334 . . . . 0.0 110.456 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.04 -14.34 34.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.288 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -102.94 34.52 2.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.464 -0.773 . . . . 0.0 109.669 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.603 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.58 114.19 3.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.143 -0.973 . . . . 0.0 109.513 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.65 -125.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -0.801 . . . . 0.0 109.536 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 94' ' ' ASN . 18.6 tttm -117.17 -89.46 0.58 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.659 -0.651 . . . . 0.0 109.816 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -18.74 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.307 -0.871 . . . . 0.0 110.054 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.477 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.4 OUTLIER -70.68 -35.31 72.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 -179.708 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.603 HD11 ' HB1' ' A' ' 90' ' ' ALA . 49.2 mt -85.25 -28.44 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -73.27 -60.75 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.019 -1.051 . . . . 0.0 109.676 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.61 -43.26 12.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.501 -0.749 . . . . 0.0 109.249 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -66.35 -47.54 73.13 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.34 50.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.94 -1.1 . . . . 0.0 109.721 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -56.76 -24.03 47.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.211 -0.93 . . . . 0.0 109.738 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.9 -103.9 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.717 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -135.89 -0.64 3.13 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.785 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -58.18 11.4 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.828 -0.807 . . . . 0.0 110.913 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.636 ' H ' ' C ' ' A' ' 102' ' ' GLY . 49.1 m -29.4 -31.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.65 132.72 11.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.458 ' OH ' ' CB ' ' A' ' 90' ' ' ALA . 0.5 OUTLIER -146.26 117.04 7.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -1.163 . . . . 0.0 109.446 179.213 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.7 p -117.57 139.05 46.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.4 103.26 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.76 -1.213 . . . . 0.0 108.337 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -71.72 155.33 92.43 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.873 -1.142 . . . . 0.0 109.38 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.33 168.64 75.49 Favored 'Cis proline' 0 N--CA 1.486 1.04 0 C-N-CA 124.811 -0.912 . . . . 0.0 110.234 -2.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -144.14 157.84 44.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.0 110.585 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -101.1 149.57 23.83 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.416 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -47.12 -32.15 4.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.965 -1.084 . . . . 0.0 109.254 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.62 82.01 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 5.7 m -69.23 -69.44 0.34 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.4 tp -43.9 -37.5 2.89 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.577 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' HB2' HD21 ' A' ' 28' ' ' LEU . 28.2 tt0 -59.07 -59.4 5.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 110.24 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.38 -40.11 7.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.626 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -59.94 -55.35 35.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.173 -0.955 . . . . 0.0 109.357 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 121' ' ' ASN . 10.6 mt -50.07 -72.66 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.098 -1.001 . . . . 0.0 109.553 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 120' ' ' LEU . 0.9 OUTLIER -38.96 -44.42 1.07 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.486 -0.759 . . . . 0.0 111.851 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp -66.5 -31.35 72.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.942 -1.099 . . . . 0.0 110.372 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.418 ' C ' ' H ' ' A' ' 125' ' ' GLU . 18.6 mt -89.97 -40.26 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.092 -1.005 . . . . 0.0 111.075 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -62.16 0.97 0.35 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.059 -1.026 . . . . 0.0 110.558 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.9 mt-10 -77.06 -25.39 52.38 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 11.5 mtpp -91.44 -29.52 17.0 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -73.07 -29.62 63.08 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.55 80.41 0.09 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.481 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.285 -1.127 . . . . 0.0 109.479 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 2' ' ' ALA . 34.6 t70 -43.68 146.44 0.54 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.461 -0.774 . . . . 0.0 109.776 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.03 14.05 13.29 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.071 -1.018 . . . . 0.0 108.674 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 29.1 mp0 -147.24 50.38 1.09 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 29.3 tp -78.72 118.44 20.8 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 120.615 -1.303 . . . . 0.0 108.858 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.56 118.79 4.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.141 -0.974 . . . . 0.0 111.418 -178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 60.5 m-85 -113.44 151.57 31.22 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG22 ' A' ' 54' ' ' VAL . 53.7 tp -129.82 102.94 6.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 21' ' ' VAL . 1.3 m -90.53 116.86 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.251 -0.905 . . . . 0.0 109.258 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.89 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.8 t -112.37 129.49 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.522 -0.737 . . . . 0.0 110.368 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.5 OUTLIER -165.42 -167.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 7.8 t70 -148.5 13.78 0.95 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 0.0 109.729 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.461 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -74.88 -18.7 60.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 109.783 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.07 2.9 4.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.321 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -150.69 -22.01 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.865 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -26.96 66.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.386 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -40.81 97.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.18 -0.95 . . . . 0.0 109.515 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -64.19 -23.93 67.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 0.0 110.041 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.55 -52.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.127 -0.983 . . . . 0.0 109.514 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -66.05 -35.27 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.255 -0.903 . . . . 0.0 109.955 -179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.03 -56.69 11.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.24 -56.61 19.49 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.953 0.882 . . . . 0.0 109.042 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.9 tt -37.73 -51.2 1.24 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.07 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 25' ' ' LEU . 28.9 mt -58.65 -52.27 66.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.968 -1.083 . . . . 0.0 108.593 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.4 mttt -52.6 -46.06 66.8 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.383 -0.823 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -53.22 -25.6 14.72 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.227 -0.921 . . . . 0.0 108.975 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.435 HD13 ' HE2' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -83.3 -64.57 1.14 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.557 -0.715 . . . . 0.0 109.134 179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.96 67.68 0.01 OUTLIER Glycine 0 N--CA 1.481 1.672 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' HE2' HD13 ' A' ' 28' ' ' LEU . 71.4 m-85 -149.96 155.38 39.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 109.98 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.09 61.05 0.98 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.206 -0.934 . . . . 0.0 109.918 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.89 99.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.191 -0.943 . . . . 0.0 108.545 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.17 149.46 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 110.701 -178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -122.02 -169.38 1.87 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -147.33 152.87 38.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.254 -0.904 . . . . 0.0 110.547 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.89 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.07 167.82 20.79 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 5.8 mt-10 -99.94 -2.48 34.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -0.902 . . . . 0.0 110.489 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER 169.12 -179.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.917 -1.114 . . . . 0.0 109.628 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.95 -49.25 76.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG23 ' OD2' ' A' ' 64' ' ' ASP . 58.3 t -54.19 -40.29 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.987 -1.302 . . . . 0.0 108.789 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 4.3 t70 -67.56 -42.13 83.11 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.59 -0.694 . . . . 0.0 109.199 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.36 -57.13 8.12 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.363 -0.835 . . . . 0.0 109.409 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 42' ' ' ALA . 53.5 tp -41.95 -43.03 2.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.624 -0.672 . . . . 0.0 110.02 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -71.34 -34.92 70.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.087 -1.008 . . . . 0.0 109.892 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -89.99 -14.04 34.83 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.173 -0.954 . . . . 0.0 110.625 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -64.55 -18.05 64.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.027 . . . . 0.0 108.569 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -85.89 -3.02 58.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.536 -0.727 . . . . 0.0 109.264 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.62 -73.56 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.407 -0.808 . . . . 0.0 109.468 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.5 8.46 1.38 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.0 71.77 1.25 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' HD21 ' A' ' 81' ' ' LEU . 34.0 m-85 -47.87 113.52 0.74 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -1.036 . . . . 0.0 110.14 -179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.3 -3.67 3.06 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.6 t80 -166.39 141.25 4.41 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.024 -1.28 . . . . 0.0 109.974 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG22 ' HB3' ' A' ' 9' ' ' LEU . 13.3 t -137.52 108.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.177 -0.952 . . . . 0.0 110.509 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 55' ' ' ILE . 51.9 mt -90.01 78.19 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.7 p -88.0 154.4 20.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.039 -1.038 . . . . 0.0 110.65 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.87 167.67 9.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -61.85 88.18 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.447 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -60.77 125.32 23.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.132 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.653 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 22.8 ttp -131.73 30.89 0.2 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.642 -0.661 . . . . 0.0 112.467 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -57.75 -59.06 0.62 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 N-CA-C 108.788 -1.274 . . . . 0.0 108.788 178.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -159.04 -28.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.458 ' O ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -175.52 108.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' OD2' HG23 ' A' ' 40' ' ' VAL . 0.7 OUTLIER -177.05 -172.83 0.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.954 -1.091 . . . . 0.0 110.077 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.63 -71.97 1.8 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.473 ' C ' ' N ' ' A' ' 68' ' ' LEU . 1.1 mm? -65.97 -65.06 0.72 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.007 -1.29 . . . . 0.0 108.57 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 73.7 tt0 -49.81 -19.91 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' N ' ' C ' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -72.33 -61.53 1.76 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 101' ' ' ALA . 2.0 tt -45.94 -63.18 1.04 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.518 -0.739 . . . . 0.0 109.067 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -42.72 -50.23 5.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.716 -0.615 . . . . 0.0 109.926 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.98 -32.81 74.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 69' ' ' LEU . 54.1 mt -73.59 -23.31 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.08 -29.55 20.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.611 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.76 -28.13 1.43 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.357 -0.839 . . . . 0.0 109.506 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -47.29 126.7 9.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.28 -34.25 5.93 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.49 -65.57 0.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -1.165 . . . . 0.0 109.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.481 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -89.97 -46.69 8.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.4 t 45.8 19.4 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.536 -0.727 . . . . 0.0 109.22 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -140.93 2.34 1.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.587 -0.695 . . . . 0.0 109.909 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 51' ' ' TYR . 2.5 tp -47.32 110.48 1.33 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.046 -1.034 . . . . 0.0 108.53 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -60.19 113.81 1.83 Allowed 'Trans proline' 0 C--N 1.327 -0.577 0 C-N-CA 121.196 1.264 . . . . 0.0 112.976 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.2 t -113.83 117.89 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.715 HD12 HG12 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -98.11 105.31 17.43 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 118.474 -1.291 . . . . 0.0 108.292 178.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.2 tpt -76.14 99.47 4.69 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 118.829 -1.148 . . . . 0.0 108.168 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 107' ' ' VAL . 0.6 OUTLIER -99.4 150.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.855 -1.153 . . . . 0.0 110.389 -178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 109' ' ' LYS . 3.3 t -150.25 -179.81 7.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 109.878 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.35 -73.28 0.68 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.41 54.66 1.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.138 -0.976 . . . . 0.0 109.147 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.428 ' HB1' ' CG1' ' A' ' 95' ' ' ILE . . . -50.34 107.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.774 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.98 177.78 8.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.241 -0.912 . . . . 0.0 108.9 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -75.07 -34.84 61.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -88.06 -34.41 17.97 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.214 -0.929 . . . . 0.0 110.224 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -69.86 -24.47 63.43 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.047 -1.033 . . . . 0.0 109.958 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.428 ' CG1' ' HB1' ' A' ' 90' ' ' ALA . 16.0 mt -72.6 -36.21 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.048 -1.033 . . . . 0.0 109.401 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 96' ' ' ILE . 21.9 mt -80.95 -14.55 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.268 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -63.43 -48.6 77.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.296 -0.878 . . . . 0.0 109.39 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.16 -58.98 6.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.127 -0.983 . . . . 0.0 108.849 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.7 -25.22 53.74 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.056 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -52.34 -32.26 37.28 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.07 -28.2 24.24 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 76.44 67.39 1.69 Allowed Glycine 0 N--CA 1.48 1.602 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.947 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.18 -111.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 117.103 -1.839 . . . . 0.0 110.368 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.575 ' HB2' HD22 ' A' ' 84' ' ' LEU . 50.0 m -91.46 -51.43 5.28 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 123.201 1.477 . . . . 0.0 107.554 176.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.77 -157.58 30.05 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.96 151.93 49.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -1.153 . . . . 0.0 109.244 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.715 HG12 HD12 ' A' ' 84' ' ' LEU . 8.5 p -147.15 124.74 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.189 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.9 p -61.88 162.3 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 108.828 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 87' ' ' THR . 3.9 pttt -135.65 159.5 71.2 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.329 -0.857 . . . . 0.0 108.747 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.34 132.88 29.01 Favored 'Cis proline' 0 C--N 1.32 -0.969 0 C-N-CA 124.622 -0.991 . . . . 0.0 110.44 -2.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.678 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.6 p90 -93.42 158.37 15.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.157 -0.965 . . . . 0.0 109.417 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -89.88 147.39 23.78 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.448 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.61 -36.97 11.63 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.96 -1.088 . . . . 0.0 109.064 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.52 -33.11 74.4 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.252 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.507 ' N ' ' O ' ' A' ' 112' ' ' THR . 10.8 m -71.74 -65.79 0.72 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.678 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.91 -38.74 23.63 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.343 -1.343 . . . . 0.0 108.637 179.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -62.44 -48.38 79.89 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 0.0 109.612 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -45.79 -43.17 12.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.474 -0.766 . . . . 0.0 109.594 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -78.62 -34.51 46.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 109.762 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.441 HD21 ' CE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -63.64 -35.61 81.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.208 -0.932 . . . . 0.0 109.824 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.94 -35.36 59.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -0.962 . . . . 0.0 109.944 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 -31.03 57.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 109.335 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.3 mt -77.7 -35.03 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.284 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -86.55 0.51 54.19 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 110.084 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -77.71 -26.72 50.33 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -96.43 -22.31 17.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.21 -24.97 22.0 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.42 85.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.215 -1.167 . . . . 0.0 109.501 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.84 128.54 11.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 108.742 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.71 30.95 0.87 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.999 -1.063 . . . . 0.0 109.459 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -148.39 38.14 0.86 Allowed 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -75.31 141.35 43.4 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.516 ' HZ3' ' CG ' ' A' ' 32' ' ' ASN . 11.0 mttm -81.6 131.63 35.28 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.105 -0.997 . . . . 0.0 110.971 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 38.4 m-85 -119.56 148.11 43.69 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.789 -0.57 . . . . 0.0 110.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.625 ' CD2' HD12 ' A' ' 46' ' ' LEU . 45.2 tp -121.71 112.42 18.39 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.97 98.87 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.55 -0.719 . . . . 0.0 110.022 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.613 HG13 ' HB3' ' A' ' 36' ' ' ALA . 3.8 t -95.16 116.95 37.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 0.4 OUTLIER 173.29 152.57 0.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.608 -1.308 . . . . 0.0 111.331 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 15' ' ' SER . 3.0 t0 -81.94 52.15 1.89 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -13.25 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 16' ' ' THR . 1.6 p 57.38 2.22 0.13 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 120.357 -1.465 . . . . 0.0 108.09 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.756 HG23 ' O ' ' A' ' 15' ' ' SER . 17.0 p 130.59 26.0 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 C-N-CA 124.594 1.157 . . . . 0.0 110.066 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' ARG . 30.1 tpp -92.19 -66.6 0.91 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.618 ' H ' ' HB2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -33.47 -31.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 120.989 0.423 . . . . 0.0 110.569 179.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -74.91 -39.05 61.65 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.123 -178.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.9 mt -66.37 -53.34 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.074 -1.016 . . . . 0.0 109.358 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -61.73 -30.44 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 0.0 110.232 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.2 -53.61 26.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.042 -1.036 . . . . 0.0 109.437 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.6 t30 -73.06 -57.04 4.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.731 0.777 . . . . 0.0 109.99 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 113' ' ' ALA . 1.2 tt -40.85 -49.18 3.18 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.933 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -63.54 -53.63 48.85 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.941 -1.099 . . . . 0.0 108.841 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -54.22 -28.89 44.08 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.205 -0.934 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -35.72 72.44 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.182 -0.949 . . . . 0.0 109.54 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.21 -57.78 2.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.35 -0.844 . . . . 0.0 109.639 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.51 74.4 0.02 OUTLIER Glycine 0 N--CA 1.48 1.604 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -150.12 139.17 21.09 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.434 . . . . 0.0 109.045 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -146.57 64.25 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.115 -0.99 . . . . 0.0 109.921 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.516 ' CG ' ' HZ3' ' A' ' 7' ' ' LYS . 10.8 t-20 -173.63 96.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 108.866 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.02 148.44 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.039 -1.038 . . . . 0.0 110.367 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 11.9 mt-10 -122.48 -166.66 1.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -150.2 158.65 44.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.04 -1.037 . . . . 0.0 110.529 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.613 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.13 -166.63 2.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.94 13.48 1.3 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 0.0 111.636 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 1.7 t0 -178.85 151.24 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.6 -1.313 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.41 -52.98 12.92 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 40' ' ' VAL . 4.8 t -55.52 -31.55 28.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.262 -1.14 . . . . 0.0 108.579 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 38' ' ' ASP . 6.0 t0 -71.89 -45.0 62.81 Favored 'General case' 0 C--N 1.308 -1.234 0 O-C-N 121.164 -0.96 . . . . 0.0 108.894 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -58.46 -58.12 9.95 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.396 -0.815 . . . . 0.0 109.39 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.498 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -46.37 -42.65 15.28 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 110.034 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -78.43 -32.23 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.012 -1.055 . . . . 0.0 110.485 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -90.08 -7.01 54.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.06 -1.025 . . . . 0.0 110.774 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.625 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -77.72 -16.06 58.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.569 -1.332 . . . . 0.0 108.892 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -78.55 -0.4 29.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.246 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.34 -61.09 1.81 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.45 -0.781 . . . . 0.0 109.609 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.72 15.75 0.46 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.82 102.81 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.565 ' O ' HD21 ' A' ' 81' ' ' LEU . 46.5 m-85 -85.81 142.68 28.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.225 -1.162 . . . . 0.0 110.235 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.17 -7.46 54.77 Favored Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -152.78 136.96 16.48 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.169 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.8 t -131.29 116.78 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.625 -1.297 . . . . 0.0 110.484 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mt -97.87 116.08 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.66 134.73 30.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 108.99 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.76 -177.62 1.31 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.161 -0.962 . . . . 0.0 109.479 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 33.4 t-105 -67.47 -143.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 109.002 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.552 ' ND2' ' N ' ' A' ' 60' ' ' MET . 3.0 t30 -91.82 165.03 13.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.996 -1.065 . . . . 0.0 109.612 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.552 ' N ' ' ND2' ' A' ' 59' ' ' ASN . 0.0 OUTLIER 179.03 -50.79 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.737 179.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.477 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -64.73 -77.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.323 -0.793 0 C-N-CA 120.779 0.986 . . . . 0.0 110.024 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.11 109.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 108.876 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 48.88 86.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.883 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.4 m-20 -163.71 -167.35 1.37 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.406 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.699 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 58.73 -76.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -59.03 -71.14 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.889 -1.359 . . . . 0.0 109.302 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -53.1 -38.77 62.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.955 -1.091 . . . . 0.0 108.853 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.699 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.1 tp -54.23 -47.18 72.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.857 HD21 ' H ' ' A' ' 103' ' ' ALA . 39.0 tp -65.7 -62.13 1.69 Allowed 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 69' ' ' LEU . 21.0 tttm -41.83 -45.97 3.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.675 -0.641 . . . . 0.0 109.994 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.41 -44.27 68.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.061 -1.024 . . . . 0.0 109.168 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.578 HD12 ' HA ' ' A' ' 69' ' ' LEU . 67.7 mt -57.35 -37.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.215 -0.928 . . . . 0.0 109.054 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -2.16 44.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.411 -0.806 . . . . 0.0 109.574 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.65 -28.54 16.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -63.57 1.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.581 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.44 -25.19 20.49 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.66 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -1.134 . . . . 0.0 109.351 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.494 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.3 ttm -90.11 -31.64 17.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.91 . . . . 0.0 109.218 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.03 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.839 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.95 9.27 0.67 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.21 -0.931 . . . . 0.0 109.946 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD21 ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -47.92 110.54 1.42 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.094 -1.004 . . . . 0.0 109.296 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HD2' HD23 ' A' ' 81' ' ' LEU . 6.3 Cg_exo -58.86 125.63 18.79 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 120.961 1.107 . . . . 0.0 112.394 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -112.5 124.44 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.678 HD21 HD21 ' A' ' 116' ' ' LEU . 50.7 tp -100.7 77.2 1.86 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.945 -1.102 . . . . 0.0 109.482 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 155.51 13.45 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.28 132.54 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.7 t -150.1 -176.9 5.63 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.761 -1.212 . . . . 0.0 109.975 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -114.7 -49.47 2.81 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.605 -0.684 . . . . 0.0 109.771 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -78.43 -69.75 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.972 . . . . 0.0 109.704 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 70.64 68.08 0.19 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.848 . . . . 0.0 109.251 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -61.68 -151.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.021 . . . . 0.0 109.899 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 13.3 mttt -97.39 -86.61 0.33 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.408 -0.807 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' OE2' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -47.65 -10.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.391 -0.818 . . . . 0.0 110.42 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.628 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -79.98 -33.4 39.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 0.0 109.512 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.604 HD11 ' HB1' ' A' ' 90' ' ' ALA . 61.0 mt -86.78 -9.9 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -87.45 -63.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.992 . . . . 0.0 109.859 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.31 -38.85 4.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.446 -0.784 . . . . 0.0 109.388 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.577 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -70.62 -49.09 51.25 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.468 -0.77 . . . . 0.0 109.822 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.31 -51.37 26.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.147 -0.971 . . . . 0.0 110.558 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.74 -10.57 48.39 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 0.0 110.768 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -95.58 -33.69 12.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.196 -0.94 . . . . 0.0 110.891 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.665 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.69 -15.01 0.71 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.857 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -56.89 11.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.981 -0.717 . . . . 0.0 110.816 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.665 ' H ' ' C ' ' A' ' 102' ' ' GLY . 71.6 m -29.38 -32.45 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 122.181 -0.324 . . . . 0.0 111.452 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.97 122.99 7.49 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -141.52 128.74 20.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.48 -1.012 . . . . 0.0 108.574 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -134.95 129.57 51.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -60.14 -165.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.89 150.91 5.62 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 120.452 -1.405 . . . . 0.0 109.779 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.62 155.36 99.79 Favored 'Cis proline' 0 N--CA 1.488 1.148 0 C-N-CA 125.275 -0.719 . . . . 0.0 110.621 -1.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.723 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -121.43 155.74 34.22 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.856 0.836 . . . . 0.0 109.803 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.418 ' H ' ' HB ' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.9 150.8 22.04 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -48.87 -38.43 22.49 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.762 -1.211 . . . . 0.0 109.445 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.24 -34.85 76.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 108.236 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.418 ' HB ' ' H ' ' A' ' 112' ' ' THR . 17.2 m -67.94 -65.26 0.71 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.723 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -48.03 -45.39 31.97 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 118.631 -1.228 . . . . 0.0 108.795 179.079 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.83 -56.09 16.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.965 -1.084 . . . . 0.0 109.809 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -46.41 -40.17 11.69 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.459 -0.776 . . . . 0.0 110.029 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -69.53 -60.52 2.27 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.147 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 tp -45.22 -58.99 2.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.45 -37.18 56.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.138 -0.977 . . . . 0.0 109.95 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.93 -30.1 68.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.168 -0.958 . . . . 0.0 109.741 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.463 HD11 ' HA2' ' A' ' 105' ' ' GLY . 64.1 mt -89.89 -53.24 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -57.46 -10.01 1.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.175 -0.953 . . . . 0.0 110.077 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -73.32 -31.16 63.85 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -91.64 -28.25 17.61 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.86 -28.3 44.22 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.26 86.38 0.01 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.285 -1.127 . . . . 0.0 109.359 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.27 146.05 1.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 109.335 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -89.97 22.15 3.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -155.26 42.59 0.45 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 109.213 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.531 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 29.6 tp -71.2 119.67 15.67 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 mttp -61.84 128.37 35.89 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.496 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.0 m-85 -115.47 156.18 26.13 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.578 0.704 . . . . 0.0 109.798 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.721 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.19 101.13 4.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 10' ' ' VAL . 5.0 m -92.17 116.65 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.394 -0.816 . . . . 0.0 109.867 -179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.572 HG13 ' HB3' ' A' ' 36' ' ' ALA . 5.5 t -95.49 93.78 3.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.354 -0.841 . . . . 0.0 109.414 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -130.58 121.7 26.15 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.739 . . . . 0.0 109.493 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.06 -23.46 67.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.078 -1.014 . . . . 0.0 109.548 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -57.28 145.68 31.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.562 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.2 t -94.81 21.54 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -154.2 -7.64 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.2 ttt -65.5 -35.25 80.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.178 -0.951 . . . . 0.0 109.228 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.645 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -48.74 -44.67 38.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.0 109.454 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -33.4 53.55 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.41 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.4 mm -61.18 -54.91 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.028 -1.045 . . . . 0.0 110.111 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -32.81 21.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.327 -0.858 . . . . 0.0 111.174 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.21 -55.04 27.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.869 -1.144 . . . . 0.0 109.174 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -64.33 -57.44 9.36 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.707 0.765 . . . . 0.0 109.329 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.0 OUTLIER -39.74 -58.6 1.31 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.775 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.8 mt -56.08 -50.53 70.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.311 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.23 -29.36 63.7 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.186 -0.946 . . . . 0.0 109.364 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.6 -36.93 72.39 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 mt -81.15 -59.79 2.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 159.4 58.24 0.01 OUTLIER Glycine 0 N--CA 1.481 1.685 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' HD2' ' H ' ' A' ' 6' ' ' LEU . 96.1 m-85 -138.13 149.55 46.01 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.273 -1.134 . . . . 0.0 109.181 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.574 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -149.91 69.17 1.01 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.003 -1.061 . . . . 0.0 110.293 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.4 96.25 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.204 -0.935 . . . . 0.0 108.677 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -150.12 149.73 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.96 -1.088 . . . . 0.0 110.565 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' OE2' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -121.36 -170.78 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.497 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 10.3 mp0 -143.67 153.63 42.68 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.269 -0.894 . . . . 0.0 110.495 -178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.572 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -137.8 -169.18 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 4.5 mt-10 -124.99 -2.18 7.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.501 -0.75 . . . . 0.0 110.742 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.73 -179.43 0.08 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.849 -1.157 . . . . 0.0 109.542 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.52 -38.0 95.65 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG22 ' SD ' ' A' ' 63' ' ' MET . 1.4 t -66.23 -42.92 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.145 . . . . 0.0 109.301 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 7.6 t70 -67.53 -42.96 81.89 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 108.705 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -61.97 -58.17 8.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 0.0 109.07 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tt -46.37 -33.38 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 109.332 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -85.16 -31.32 23.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -0.859 . . . . 0.0 109.694 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -89.95 -6.15 55.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.126 -0.984 . . . . 0.0 110.115 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD12 HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -88.32 -26.51 22.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.975 -1.078 . . . . 0.0 108.483 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -57.66 -10.38 1.56 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.268 -0.895 . . . . 0.0 108.644 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 46' ' ' LEU . . . -46.0 -68.75 0.17 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.547 -0.721 . . . . 0.0 109.222 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.53 -96.28 0.36 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.31 67.31 0.3 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.469 ' C ' ' N ' ' A' ' 53' ' ' PHE . 22.0 m-85 -44.49 96.16 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.69 -0.888 . . . . 0.0 109.867 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -50.61 -10.32 0.36 Allowed Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.515 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -157.57 141.11 15.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.191 -1.182 . . . . 0.0 110.467 -179.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' HG22 ' A' ' 83' ' ' VAL . 39.2 t -131.86 107.37 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG12 ' A' ' 10' ' ' VAL . 39.8 mt -89.88 80.67 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.99 165.66 16.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.335 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.1 m-20 -97.73 -137.94 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.609 -0.682 . . . . 0.0 109.41 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.711 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 49.7 t-105 -172.33 95.86 0.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.445 -0.785 . . . . 0.0 109.299 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -157.37 -157.66 0.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.001 . . . . 0.0 109.043 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.494 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.4 mmt -142.7 50.91 1.64 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.025 -1.047 . . . . 0.0 111.66 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.4 Cg_endo -59.96 -25.6 80.02 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.962 -1.592 . . . . 0.0 107.962 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -173.39 -28.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 40' ' ' VAL . 31.4 mtt -158.48 143.63 16.39 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -87.88 166.27 14.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.752 -1.218 . . . . 0.0 110.047 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.38 -5.48 77.54 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 68' ' ' LEU . 53.1 tp -57.82 -64.01 1.05 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.064 -1.256 . . . . 0.0 109.17 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -47.61 -15.77 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.315 -0.866 . . . . 0.0 109.096 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' A' ' 66' ' ' LEU . 6.1 tp -76.17 -57.18 4.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.812 . . . . 0.0 109.305 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.782 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.71 -33.1 68.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.203 -0.936 . . . . 0.0 109.329 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -62.83 -67.41 0.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.7 m -48.46 -30.04 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.6 HG23 ' HB3' ' A' ' 80' ' ' ALA . 11.7 mt -72.43 -40.28 63.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.489 -0.757 . . . . 0.0 109.266 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HE ' ' CA ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -84.21 -17.19 40.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.196 -0.94 . . . . 0.0 109.453 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.78 -28.55 9.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.38 -0.825 . . . . 0.0 109.372 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -63.94 -138.5 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.383 -0.823 . . . . 0.0 109.322 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -136.54 -123.63 2.28 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.77 22.51 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.255 -1.144 . . . . 0.0 109.57 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.51 ' H ' ' C ' ' A' ' 76' ' ' GLY . 37.0 mtt -150.15 57.7 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 108.717 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.505 ' O ' ' O ' ' A' ' 78' ' ' MET . 92.1 p -55.23 -113.13 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.6 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.35 58.42 0.95 Allowed 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.606 -1.309 . . . . 0.0 109.387 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' ALA . 12.3 mt 58.58 154.42 0.09 OUTLIER Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.831 -0.543 . . . . 0.0 109.967 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -49.29 144.56 17.17 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.565 2.176 . . . . 0.0 114.897 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -129.83 122.18 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.855 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -101.58 107.74 19.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.77 98.3 6.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.401 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.92 158.4 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.76 -1.212 . . . . 0.0 109.791 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.8 t -150.07 159.26 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.804 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -98.67 -4.48 33.67 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.415 -0.803 . . . . 0.0 109.647 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 91' ' ' LYS . 1.4 tt0 -145.75 54.47 1.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.588 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 1.002 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.46 91.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.188 -0.945 . . . . 0.0 108.733 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 89' ' ' GLU . 24.1 tttm -76.16 -72.24 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.659 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -177.64 -74.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.885 . . . . 0.0 109.336 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.38 -38.91 63.8 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 109.65 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.711 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 4.3 m-20 -69.04 -29.75 67.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.928 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.002 HD11 ' HB1' ' A' ' 90' ' ' ALA . 6.7 mt -67.89 -57.25 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 108.868 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -63.73 -18.94 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.394 -0.816 . . . . 0.0 109.205 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.38 -60.58 3.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.636 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -54.04 -54.23 42.15 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.001 -1.062 . . . . 0.0 108.65 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.11 -25.13 65.21 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.682 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.2 tp-100 -53.13 -31.15 40.72 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -89.26 -22.1 22.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 66.6 76.91 0.32 Allowed Glycine 0 N--CA 1.482 1.756 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.759 177.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.86 -111.89 0.08 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 117.088 -1.845 . . . . 0.0 109.795 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.855 ' OG ' HD22 ' A' ' 84' ' ' LEU . 10.1 p -91.59 -50.78 5.59 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 122.786 1.279 . . . . 0.0 108.536 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.422 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 165.83 -166.55 38.66 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.41 148.58 43.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.277 -1.131 . . . . 0.0 109.984 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.6 p -141.21 126.8 18.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.8 p -74.96 108.75 6.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.171 -0.955 . . . . 0.0 110.06 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.804 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.52 163.78 48.08 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.2 125.81 10.48 Favored 'Cis proline' 0 N--CA 1.485 0.999 0 C-N-CA 125.121 -0.783 . . . . 0.0 110.842 -1.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -96.44 154.85 17.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.525 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.6 OUTLIER -89.89 151.89 21.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 176.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.64 -31.51 4.67 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.938 -1.101 . . . . 0.0 109.432 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.54 -36.05 82.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.106 -0.996 . . . . 0.0 109.043 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.31 -66.67 0.57 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.995 -1.066 . . . . 0.0 108.336 179.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.84 -35.75 33.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.567 -1.333 . . . . 0.0 109.557 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -70.65 -67.92 0.47 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.827 -1.171 . . . . 0.0 109.768 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -42.84 -29.1 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.711 -0.618 . . . . 0.0 109.385 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -78.7 -43.69 25.33 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.482 -0.761 . . . . 0.0 109.02 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.515 HD11 ' CE2' ' A' ' 53' ' ' PHE . 2.6 tp -57.19 -66.05 0.52 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.515 -0.741 . . . . 0.0 109.947 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -40.2 -52.38 2.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.558 -0.714 . . . . 0.0 111.188 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -60.39 -28.6 68.36 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 110.557 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.98 -38.5 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.051 . . . . 0.0 110.402 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -76.53 -42.7 42.2 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.301 -0.874 . . . . 0.0 110.669 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -50.32 -23.09 2.1 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.899 -1.126 . . . . 0.0 108.207 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -92.77 -25.12 18.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 124' ' ' PHE . 2.1 tp -73.46 -26.14 60.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 144.01 -42.83 1.03 Allowed Glycine 0 N--CA 1.484 1.861 0 N-CA-C 109.716 -1.353 . . . . 0.0 109.716 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 129' ' ' MET . 1.0 OUTLIER . . . . . 0 C--N 1.304 -1.41 0 O-C-N 121.265 -1.138 . . . . 0.0 109.441 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.535 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER 63.88 130.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.058 -1.027 . . . . 0.0 108.9 -179.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -90.42 7.71 37.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.899 -1.126 . . . . 0.0 109.996 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.38 45.73 1.22 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.987 -1.07 . . . . 0.0 111.22 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.1 tp -78.31 138.5 38.61 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -79.38 122.87 26.92 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.956 -1.09 . . . . 0.0 111.972 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -112.71 149.32 33.09 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.16 107.13 10.45 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -90.36 131.53 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 109.961 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 36' ' ' ALA . 9.8 t -138.43 38.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.392 -0.817 . . . . 0.0 109.216 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.3 OUTLIER -76.35 22.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.14 -0.975 . . . . 0.0 109.36 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.5 OUTLIER 47.82 -124.3 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.132 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.401 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 46.52 -168.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.342 -0.849 . . . . 0.0 109.621 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.33 -9.41 1.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.531 -0.731 . . . . 0.0 109.052 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.66 -13.98 5.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.491 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 8.4 ttt -64.27 -49.48 71.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.346 -0.846 . . . . 0.0 109.483 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -45.48 16.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -52.23 -49.74 63.38 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.482 -0.761 . . . . 0.0 110.266 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -50.2 -55.56 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.952 . . . . 0.0 110.207 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.09 -38.15 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 110.892 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -47.34 -58.28 4.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 0.0 109.521 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -62.53 -55.46 27.16 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.804 0.811 . . . . 0.0 109.495 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.09 -48.47 2.48 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.6 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.2 mt -64.46 -49.37 71.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -48.87 -38.64 23.04 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.324 -0.86 . . . . 0.0 108.828 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -35.06 73.12 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.221 -0.924 . . . . 0.0 108.807 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.33 -3.47 33.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.472 -0.768 . . . . 0.0 109.053 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.65 33.25 16.65 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 26.2 m-85 -105.4 142.86 34.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.462 -1.022 . . . . 0.0 109.264 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -141.78 62.94 1.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -173.01 93.44 0.11 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.915 -1.116 . . . . 0.0 109.249 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.1 150.75 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.049 -1.032 . . . . 0.0 110.271 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.45 -170.5 2.19 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -147.32 157.84 43.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.049 -1.032 . . . . 0.0 110.918 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.57 -167.62 2.3 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.92 3.48 3.2 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.559 -0.713 . . . . 0.0 110.197 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 173.1 -179.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.036 -1.04 . . . . 0.0 109.63 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.681 ' HA2' HD22 ' A' ' 68' ' ' LEU . . . -63.75 -41.44 98.92 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 40' ' ' VAL . 0.9 OUTLIER -60.63 -39.79 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -1.085 . . . . 0.0 109.321 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.4 t70 -72.02 -46.67 56.23 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.344 -0.847 . . . . 0.0 109.065 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -59.04 -57.12 14.48 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.486 -0.758 . . . . 0.0 109.65 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 mt -46.46 -47.83 19.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.325 -0.859 . . . . 0.0 109.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -69.16 -37.02 77.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.954 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.87 9.73 26.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.252 -0.905 . . . . 0.0 110.161 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -85.25 -36.9 20.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 109.053 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -78.07 -1.28 31.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.23 -58.64 3.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 109.568 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.85 9.8 1.37 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.03 94.9 0.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.785 ' O ' HD21 ' A' ' 81' ' ' LEU . 31.6 m-85 -80.48 142.64 34.05 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.227 -1.161 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.54 6.22 65.19 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -164.07 142.71 7.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.616 -0.932 . . . . 0.0 108.618 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 83' ' ' VAL . 56.4 t -141.75 121.19 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.75 -1.219 . . . . 0.0 110.075 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 84' ' ' LEU . 10.1 mt -107.91 132.04 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 p -151.4 145.63 25.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.117 -0.989 . . . . 0.0 109.421 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.8 p-10 -47.79 -80.79 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.256 -0.903 . . . . 0.0 108.861 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.529 ' CH2' ' OD1' ' A' ' 94' ' ' ASN . 28.0 t-105 -177.34 -68.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 109.513 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.407 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 43.4 p-10 -170.54 53.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.948 -1.095 . . . . 0.0 109.742 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.524 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -60.65 -47.59 95.58 Favored Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.09 -1.006 . . . . 0.0 110.907 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -65.62 -73.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.9 0 C-N-CA 121.038 1.158 . . . . 0.0 110.246 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.635 HD22 ' N ' ' A' ' 63' ' ' MET . 0.2 OUTLIER 179.32 -106.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.331 -0.855 . . . . 0.0 109.039 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.635 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.1 mtp -70.99 73.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.956 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' CG ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -150.62 162.49 40.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.303 -0.873 . . . . 0.0 109.836 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.743 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 74.16 -66.93 1.83 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 69' ' ' LEU . 52.2 tp -68.68 -73.0 0.16 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.572 -1.546 . . . . 0.0 109.024 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 66' ' ' LEU . 1.3 tp10 -46.9 -32.9 4.11 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.743 HD23 ' HA2' ' A' ' 65' ' ' GLY . 1.7 tp -66.74 -41.13 88.36 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.822 HD21 ' H ' ' A' ' 103' ' ' ALA . 40.7 tp -76.66 -62.38 1.65 Allowed 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.497 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 69' ' ' LEU . 12.8 ttmt -42.96 -35.48 1.24 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.323 -0.861 . . . . 0.0 109.805 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.3 m -71.57 -34.94 70.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.224 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.3 mt -64.51 -26.15 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.326 -0.859 . . . . 0.0 109.214 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.06 -40.58 12.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.773 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.03 -28.57 1.21 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.916 . . . . 0.0 109.8 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.24 162.14 6.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 109.621 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -109.79 22.4 23.81 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.72 0.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -1.149 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.49 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -125.06 16.2 8.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.2 t -72.87 16.42 0.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.43 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -129.31 35.9 4.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.546 -0.721 . . . . 0.0 109.288 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.785 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -110.83 99.82 43.71 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.68 147.85 93.47 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.445 1.43 . . . . 0.0 112.624 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 69' ' ' LEU . 3.0 t -130.23 129.5 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 55' ' ' ILE . 24.6 tp -111.66 70.89 0.72 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.91 167.13 3.01 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.518 HG23 HG13 ' A' ' 107' ' ' VAL . 7.2 p -150.16 137.56 13.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.801 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.4 t -150.36 171.06 17.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.069 -1.02 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.02 131.0 48.72 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 50.83 75.31 0.19 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.007 -1.058 . . . . 0.0 108.581 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -44.04 138.08 3.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.757 . . . . 0.0 110.299 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 10.4 ttpt -71.67 -6.02 38.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 0.0 109.486 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 2.6 tttm 74.79 -73.28 0.1 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.81 . . . . 0.0 109.683 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -53.33 -11.53 0.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.041 -1.037 . . . . 0.0 109.838 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.529 ' OD1' ' CH2' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -89.87 -51.49 5.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.89 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mm -46.04 -46.77 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.324 -0.86 . . . . 0.0 109.982 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -58.77 -65.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.962 -1.086 . . . . 0.0 109.509 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.49 -60.08 2.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 108.743 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -44.6 -44.04 8.58 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.597 . . . . 0.0 109.82 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -60.81 -48.15 83.13 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.992 -1.067 . . . . 0.0 110.246 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -54.24 -11.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.152 -0.968 . . . . 0.0 109.437 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.04 -110.37 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.593 -0.692 . . . . 0.0 110.089 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -132.96 -2.16 3.89 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.822 ' H ' HD21 ' A' ' 69' ' ' LEU . . . -60.69 11.45 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 122.001 -0.705 . . . . 0.0 110.682 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -29.42 -30.56 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 -176.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 123' ' ' ILE . . . -107.24 128.23 9.14 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.124 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.64 117.82 7.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.267 -1.137 . . . . 0.0 109.563 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 116' ' ' LEU . 1.5 p -113.13 143.41 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -89.6 107.29 17.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.345 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 159.48 68.19 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.675 -1.265 . . . . 0.0 108.963 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.69 164.39 88.14 Favored 'Cis proline' 0 N--CA 1.487 1.139 0 C-N-CA 124.775 -0.927 . . . . 0.0 110.738 -1.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.494 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.6 p90 -144.57 152.99 41.34 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.097 0.951 . . . . 0.0 109.932 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.1 149.79 22.68 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 177.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.5 -37.95 12.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.982 -1.074 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.57 -33.52 75.85 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 112' ' ' THR . 88.9 m -72.57 -68.37 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.61 HD11 HG11 ' A' ' 107' ' ' VAL . 8.3 tp -43.87 -37.69 2.96 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.255 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.429 ' OE1' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp10 -56.33 -65.32 0.63 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.214 -0.929 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -42.27 -53.67 4.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.547 -0.721 . . . . 0.0 110.323 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm -57.2 -52.25 66.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.107 -0.996 . . . . 0.0 109.667 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.99 -61.27 2.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -49.52 -36.47 23.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.875 . . . . 0.0 109.799 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -28.88 70.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.607 HD11 ' HA2' ' A' ' 105' ' ' GLY . 13.0 mt -80.01 -48.67 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.239 -0.913 . . . . 0.0 110.019 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -55.17 -6.74 0.16 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.189 -0.944 . . . . 0.0 110.245 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 123' ' ' ILE . 1.5 mt-10 -70.31 -27.97 64.81 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.7 pttt -89.35 -26.06 21.28 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -79.25 -26.08 42.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.395 -0.816 . . . . 0.0 108.842 179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 53.9 81.7 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.247 -1.149 . . . . 0.0 109.491 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 5' ' ' GLU . 5.0 t70 51.58 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -71.98 34.39 0.06 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.576 -1.328 . . . . 0.0 110.04 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 3' ' ' ASP . 46.2 mt-10 -150.37 32.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.91 142.5 57.87 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.278 -0.889 . . . . 0.0 108.715 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -81.42 122.93 28.12 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.084 -1.01 . . . . 0.0 112.181 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -113.71 154.6 27.04 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.861 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB3' HG13 ' A' ' 54' ' ' VAL . 18.0 tp -130.43 99.84 5.15 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 10' ' ' VAL . 10.7 m -89.89 107.19 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.078 -1.014 . . . . 0.0 109.833 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.763 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.4 t -96.89 65.71 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 3.6 p30 -89.1 -139.59 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.325 -0.859 . . . . 0.0 108.927 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 31.3 t0 -172.13 -33.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.318 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.82 156.51 8.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -0.845 . . . . 0.0 109.746 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 26.2 t -91.02 39.38 0.99 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.71 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -175.17 3.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.215 -0.928 . . . . 0.0 109.485 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 12.3 ttm -84.01 -33.41 24.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.232 -0.917 . . . . 0.0 109.301 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.699 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.12 -48.62 70.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -55.88 -28.84 58.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.443 -0.786 . . . . 0.0 110.038 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -67.61 -55.3 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.16 -0.963 . . . . 0.0 109.693 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -34.88 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.502 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -55.13 18.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.857 -1.152 . . . . 0.0 109.395 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.6 t30 -58.09 -58.6 7.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.98 0.895 . . . . 0.0 108.73 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.2 tt -40.22 -62.55 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.907 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -52.85 -45.02 67.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.207 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -55.18 -43.13 74.07 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.148 -0.97 . . . . 0.0 109.393 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -19.34 21.16 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.278 -0.889 . . . . 0.0 109.789 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 117' ' ' GLU . 1.1 mt -99.88 -7.04 25.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.365 -0.835 . . . . 0.0 110.065 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.38 71.26 1.2 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -150.15 100.28 2.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.301 . . . . 0.0 108.819 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -108.41 67.51 0.67 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 110.084 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -173.08 93.43 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.084 -1.01 . . . . 0.0 109.082 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.3 p -150.16 147.79 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.96 -1.087 . . . . 0.0 110.398 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.12 -175.27 3.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -147.82 161.05 42.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.869 -1.145 . . . . 0.0 110.909 -179.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.763 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.34 -168.08 2.47 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -131.31 2.55 4.23 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.445 -0.785 . . . . 0.0 110.009 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.68 -176.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 0.0 108.819 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.734 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -72.83 -30.94 62.89 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.46 -36.28 76.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.123 -1.221 . . . . 0.0 108.33 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.623 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 6.7 t0 -75.51 -46.79 30.15 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.14 -54.94 39.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.268 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 ' O ' ' A' ' 43' ' ' LEU . 1.6 tt -48.08 -49.57 31.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.317 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -67.36 -34.39 77.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.037 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -90.02 -5.06 57.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.163 -0.961 . . . . 0.0 110.457 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -72.8 -27.76 62.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.072 -1.018 . . . . 0.0 108.938 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 20.3 tt0 -68.31 0.65 3.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.341 -0.849 . . . . 0.0 109.394 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.92 -77.71 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.37 -67.78 0.02 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -178.97 68.6 0.08 OUTLIER Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' PHE . 43.0 m-85 -47.12 101.99 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.487 -1.008 . . . . 0.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.53 8.96 2.74 Favored Glycine 0 N--CA 1.483 1.784 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.0 OUTLIER -169.52 146.55 3.4 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.162 -1.199 . . . . 0.0 109.588 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.0 t -145.31 120.44 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.744 -1.223 . . . . 0.0 110.404 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.622 HG23 HG21 ' A' ' 86' ' ' VAL . 9.4 mt -101.43 92.69 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 92.6 p -98.58 151.24 20.88 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.912 -1.117 . . . . 0.0 110.272 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 8.6 p-10 -86.19 -107.93 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.385 -0.822 . . . . 0.0 109.324 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.516 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 55.3 t-105 -146.3 176.6 9.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.091 -1.005 . . . . 0.0 109.529 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.489 ' OD1' ' CE2' ' A' ' 58' ' ' TRP . 0.6 OUTLIER -73.98 69.29 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.287 -0.883 . . . . 0.0 109.812 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -79.27 -47.55 1.58 Allowed Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.968 . . . . 0.0 110.336 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -67.17 -68.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.849 0 C-N-CA 121.082 1.188 . . . . 0.0 109.949 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -152.31 -126.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.399 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.475 ' N ' ' CG ' ' A' ' 62' ' ' ASN . 20.8 mtm -86.33 95.98 9.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 109.491 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 63' ' ' MET . 52.8 m-20 -160.98 171.73 18.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 74.43 -63.12 2.23 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.1 tp -74.04 -50.56 19.15 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.639 -1.507 . . . . 0.0 107.88 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -71.07 -14.73 62.41 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.734 HD11 ' HA2' ' A' ' 39' ' ' GLY . 9.8 mt -68.6 -58.17 4.66 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.891 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -61.37 -34.73 75.8 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -68.43 -37.91 80.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.9 m -68.53 -48.45 64.31 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -62.06 -25.91 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.433 -0.792 . . . . 0.0 109.027 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpp85 -90.05 -29.31 18.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.41 -0.806 . . . . 0.0 110.005 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.418 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -67.75 -38.2 83.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -53.16 -175.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.323 -0.861 . . . . 0.0 109.426 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.35 -79.28 1.44 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.87 54.94 2.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.303 -1.116 . . . . 0.0 109.827 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.7 mmt -137.37 1.95 2.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.456 -0.778 . . . . 0.0 109.296 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -94.06 59.99 2.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 0.0 109.432 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.04 -31.47 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.046 -1.034 . . . . 0.0 110.3 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 51' ' ' TYR . 10.1 mt -69.64 118.92 67.38 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 120.911 -1.118 . . . . 0.0 109.463 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.31 107.88 0.4 Allowed 'Trans proline' 0 N--CA 1.482 0.821 0 C-N-CA 121.474 1.449 . . . . 0.0 113.096 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.599 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.4 t -98.45 113.61 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -95.78 103.05 14.91 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.078 -1.449 . . . . 0.0 108.331 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 38.4 tpp -68.74 137.78 54.34 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.622 HG21 HG23 ' A' ' 55' ' ' ILE . 11.1 t -122.64 148.27 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.642 -0.661 . . . . 0.0 110.518 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.95 148.62 29.31 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.965 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.02 -45.92 8.44 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.213 -0.93 . . . . 0.0 108.789 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.8 mt-10 -93.66 43.75 1.12 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.417 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -43.91 94.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.488 -0.758 . . . . 0.0 110.086 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 89' ' ' GLU . 0.2 OUTLIER -95.47 143.57 26.7 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.444 -0.785 . . . . 0.0 108.94 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -47.56 -16.73 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.895 . . . . 0.0 109.332 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.3 mm-40 -90.09 -45.55 9.07 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.287 -0.883 . . . . 0.0 110.167 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' ND2' ' C ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.81 -13.77 55.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 0.0 110.065 -179.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.423 HG23 ' CD2' ' A' ' 106' ' ' TYR . 8.0 mt -73.64 -46.78 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.878 -1.139 . . . . 0.0 108.489 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 13.5 mt -74.74 -14.65 15.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.415 -0.803 . . . . 0.0 108.897 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.84 -43.75 95.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.36 -58.21 4.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.5 -25.96 60.6 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.775 -0.77 . . . . 0.0 109.228 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.54 -32.44 50.62 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.891 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -83.01 -29.61 28.78 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.05 70.01 1.32 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.453 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.775 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.02 -111.77 0.08 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 116.721 -1.991 . . . . 0.0 109.486 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.696 ' OG ' HD22 ' A' ' 84' ' ' LEU . 3.1 p -91.74 -49.72 6.12 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.844 1.306 . . . . 0.0 108.12 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.88 -168.62 39.78 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.697 -1.761 . . . . 0.0 108.697 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.19 151.19 51.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.505 -0.997 . . . . 0.0 109.961 179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.629 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 9.6 p -144.08 135.74 22.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 109' ' ' LYS . 11.8 p -80.47 157.19 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 118.629 -1.228 . . . . 0.0 108.014 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.512 ' HZ2' HG12 ' A' ' 86' ' ' VAL . 0.0 OUTLIER -130.69 160.19 67.5 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 108.901 -179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.49 129.94 19.69 Favored 'Cis proline' 0 N--CA 1.485 1.009 0 C-N-CA 124.754 -0.936 . . . . 0.0 110.683 -2.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.407 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -89.88 -179.18 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.153 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.492 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -110.64 145.08 38.54 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 176.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.516 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.77 -14.86 0.14 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.991 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -83.15 -36.72 24.52 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -71.7 -60.3 2.3 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' A' ' 116' ' ' LEU . 1.3 mt -50.03 -40.85 46.12 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.413 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' A' ' 28' ' ' LEU . 2.2 tm-20 -59.51 -54.69 43.62 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.514 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -47.5 -51.56 20.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.46 -0.775 . . . . 0.0 109.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -59.64 -39.8 85.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -54.03 -68.45 0.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.503 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -46.66 -48.15 20.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.168 -0.958 . . . . 0.0 109.477 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -47.25 -40.83 17.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.423 -0.798 . . . . 0.0 109.303 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 125' ' ' GLU . 69.5 mt -81.93 -59.42 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.0 109.19 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -58.2 0.5 0.07 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.852 -0.53 . . . . 0.0 110.382 -178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 123' ' ' ILE . 86.9 tt0 -73.78 -27.32 61.09 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.507 ' CD ' ' N ' ' A' ' 126' ' ' LYS . 4.5 mptt -92.78 -34.76 13.75 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.5 tp -72.33 -22.44 61.17 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.03 89.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 6.7 mmm . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.334 179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.6 m-20 -45.85 140.06 3.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.291 -0.881 . . . . 0.0 109.3 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -90.32 8.53 32.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 110.303 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -140.16 46.25 1.84 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.074 -1.016 . . . . 0.0 110.524 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.404 HD11 ' HA3' ' A' ' 52' ' ' GLY . 54.9 tp -80.6 131.45 35.51 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 127.63 33.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.905 -1.122 . . . . 0.0 111.621 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -114.61 153.72 29.65 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.656 ' HB3' HG13 ' A' ' 54' ' ' VAL . 35.9 tp -123.85 111.5 16.17 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.8 m -96.74 108.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.902 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.912 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.1 t -105.9 55.27 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.445 -0.784 . . . . 0.0 109.332 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -97.69 142.45 29.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.384 -0.823 . . . . 0.0 109.57 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -77.81 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.258 -0.902 . . . . 0.0 109.179 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 46.74 -160.07 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 0.0 109.362 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 t -139.45 13.38 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.397 -0.814 . . . . 0.0 109.057 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -164.55 -3.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.37 -0.831 . . . . 0.0 109.231 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.412 ' H ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -53.74 -45.31 70.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.845 . . . . 0.0 109.594 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -45.92 19.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.194 -0.941 . . . . 0.0 109.633 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -53.71 -53.03 57.89 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.394 -0.816 . . . . 0.0 109.895 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mp -47.34 -59.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.309 -0.87 . . . . 0.0 109.972 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.468 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -61.85 -40.68 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.729 -178.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.4 OUTLIER -49.61 -54.31 19.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.842 -1.161 . . . . 0.0 109.512 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -62.66 -57.77 9.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.048 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -40.04 -58.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.665 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.445 HD11 HD11 ' A' ' 55' ' ' ILE . 13.9 mt -57.42 -45.59 84.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.048 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -54.78 -40.9 69.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.6 -15.5 63.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.312 -0.867 . . . . 0.0 109.285 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.28 4.36 48.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.428 -0.795 . . . . 0.0 109.757 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.17 59.82 1.63 Allowed Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.804 -1.189 . . . . 0.0 110.138 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 51.2 m-85 -150.04 138.52 20.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.363 . . . . 0.0 109.549 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -146.37 64.8 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.197 -0.939 . . . . 0.0 109.908 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -173.85 96.62 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 108.799 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -150.17 153.86 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.899 -1.126 . . . . 0.0 110.379 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -118.13 -169.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -150.16 156.09 40.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.825 -1.172 . . . . 0.0 111.418 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.912 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.8 -164.4 1.91 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.483 ' N ' ' OD2' ' A' ' 41' ' ' ASP . 4.4 mt-10 -130.24 -14.37 3.83 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.542 -0.724 . . . . 0.0 110.547 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 1.2 p-10 -173.38 -178.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.005 -1.059 . . . . 0.0 109.886 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.553 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.42 -43.28 93.98 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG2' ' SD ' ' A' ' 63' ' ' MET . 91.0 t -63.92 -51.55 68.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.874 -1.368 . . . . 0.0 108.709 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 37' ' ' GLU . 45.6 t0 -51.31 -47.73 62.55 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -60.91 -48.83 80.03 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 42' ' ' ALA . 2.4 tp -40.61 -35.94 0.53 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 109.498 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -73.26 -39.76 65.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 108.931 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' GLN . 35.4 mmtt -79.91 -53.39 6.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.469 -0.769 . . . . 0.0 109.65 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.5 OUTLIER -42.49 -20.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.595 -0.69 . . . . 0.0 109.379 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 45' ' ' LYS . 8.9 tt0 -53.36 -44.75 68.81 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.87 -49.75 38.11 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.406 ' C ' ' N ' ' A' ' 51' ' ' TYR . . . 80.39 -20.51 5.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.14 -8.27 4.58 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.554 ' C ' ' H ' ' A' ' 53' ' ' PHE . 66.9 m-85 -71.33 89.85 0.92 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.277 -1.131 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -67.01 6.99 1.8 Allowed Glycine 0 C--O 1.205 -1.709 0 N-CA-C 107.731 -2.148 . . . . 0.0 107.731 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -165.86 141.08 4.83 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.463 -1.022 . . . . 0.0 109.241 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.701 ' HB ' HG22 ' A' ' 83' ' ' VAL . 10.0 t -131.56 117.51 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 120.675 -1.266 . . . . 0.0 109.724 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD11 HD11 ' A' ' 25' ' ' LEU . 59.0 mt -98.78 79.83 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 p -93.67 144.1 25.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.399 -0.813 . . . . 0.0 109.968 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -92.68 126.06 37.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.364 -0.835 . . . . 0.0 109.016 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.594 ' CH2' HD23 ' A' ' 66' ' ' LEU . 6.9 t90 -90.76 107.56 19.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.436 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.3 OUTLIER -161.69 -124.06 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.438 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 7.3 ttt -159.63 57.97 1.1 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 118.562 -1.255 . . . . 0.0 112.132 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.503 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.3 Cg_endo -64.3 -38.89 32.49 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 107.32 -1.838 . . . . 0.0 107.32 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 19.3 m-80 -161.5 -26.09 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.408 ' SD ' ' CG2' ' A' ' 40' ' ' VAL . 7.5 mtt -159.7 143.02 14.25 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.88 155.84 32.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.717 -1.24 . . . . 0.0 109.579 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -82.22 -7.84 87.2 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.368 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.594 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.2 OUTLIER -58.37 -49.3 77.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.419 -1.636 . . . . 0.0 107.716 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' O ' HG23 ' A' ' 71' ' ' THR . 78.9 tt0 -52.74 -15.8 0.82 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.553 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -79.34 -54.51 5.88 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -56.29 -60.51 3.41 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -44.93 -51.38 9.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.468 -0.77 . . . . 0.0 109.382 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 67' ' ' GLU . 10.9 p -61.69 -41.35 97.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.244 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.711 HD13 HG21 ' A' ' 83' ' ' VAL . 17.1 mt -59.33 -21.58 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.22 -0.925 . . . . 0.0 108.583 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -90.03 -23.3 21.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.883 . . . . 0.0 109.245 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.18 -29.39 1.55 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.28 -55.91 4.88 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 0.0 109.211 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.78 -58.38 3.85 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.16 -58.36 3.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 109.672 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 49.4 mtt -128.93 -9.73 4.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.0 109.416 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.8 p 46.21 -123.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.402 -0.811 . . . . 0.0 109.099 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.07 55.31 0.93 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 0.0 108.902 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 45.52 -177.73 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 O-C-N 121.664 -0.647 . . . . 0.0 109.602 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 5.3 Cg_exo -63.56 149.51 90.81 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.096 1.864 . . . . 0.0 115.005 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.711 HG21 HD13 ' A' ' 72' ' ' ILE . 32.3 t -138.53 110.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 2.7 tp -89.76 105.13 17.6 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.139 -1.825 . . . . 0.0 107.262 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 26.4 tpp -72.19 109.77 6.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.172 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.57 140.39 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.93 -1.106 . . . . 0.0 109.496 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.21 157.82 43.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.044 -1.035 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.43 -67.65 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.154 -0.966 . . . . 0.0 109.964 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 91' ' ' LYS . 2.9 mp0 -80.74 70.8 7.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.22 83.78 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 0.0 108.853 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 89' ' ' GLU . 13.7 tttp -44.69 -84.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.521 -0.737 . . . . 0.0 109.76 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.5 mttt 175.92 -77.46 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.201 -0.937 . . . . 0.0 108.857 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -52.7 -30.61 33.16 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.215 -0.928 . . . . 0.0 109.087 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.558 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 1.4 m-20 -61.5 -54.71 39.65 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.401 -0.812 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 mm -45.43 -53.83 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.481 -0.762 . . . . 0.0 109.61 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.535 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -57.19 -28.25 29.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.246 -0.909 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -64.13 -44.95 90.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.415 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -69.01 -53.99 17.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.058 . . . . 0.0 108.168 179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -56.78 -28.47 61.38 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -60.29 -34.0 73.15 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.45 -19.23 53.6 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 55.56 76.05 0.21 Allowed Glycine 0 N--CA 1.482 1.722 0 CA-C-N 113.946 -1.479 . . . . 0.0 112.857 176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.17 -112.04 0.08 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 116.763 -1.975 . . . . 0.0 110.51 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -50.28 5.83 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.732 1.253 . . . . 0.0 108.149 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.427 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 168.41 -155.31 25.86 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.56 122.82 12.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.547 -0.972 . . . . 0.0 108.782 178.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 107' ' ' VAL . 8.7 p -119.82 131.68 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.33 132.43 33.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.932 -1.105 . . . . 0.0 109.121 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.5 pttt -109.54 160.11 29.02 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.95 134.45 35.58 Favored 'Cis proline' 0 C--N 1.32 -0.924 0 C-N-CA 124.866 -0.889 . . . . 0.0 110.39 -1.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 2.1 p90 -100.69 160.39 14.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.971 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.88 149.76 21.51 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.03 -21.78 0.76 Allowed 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.174 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.07 -31.8 25.15 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.2 OUTLIER -76.78 -57.66 3.73 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -53.23 -40.72 64.75 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.106 -1.621 . . . . 0.0 107.842 178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -59.51 -52.3 66.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.939 -1.1 . . . . 0.0 109.74 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -45.54 -46.44 14.02 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.482 -0.761 . . . . 0.0 109.507 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.5 mmtm -70.31 -48.86 54.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 tp -47.08 -65.15 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.483 -0.761 . . . . 0.0 109.676 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 -45.13 45.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 0.0 109.907 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -68.66 -19.35 64.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.307 -0.871 . . . . 0.0 109.652 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.9 mt -90.08 -43.5 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 0.0 110.244 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -63.25 -16.47 60.33 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.083 -1.011 . . . . 0.0 109.964 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -70.84 -19.94 62.6 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -94.85 -34.18 12.55 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.4 -22.08 52.14 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.86 90.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.209 -1.171 . . . . 0.0 109.557 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -47.5 113.06 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 pttt -73.04 36.44 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.978 -1.076 . . . . 0.0 109.615 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 3' ' ' ASP . 23.9 tt0 -152.96 30.66 0.5 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.8 tp -72.83 138.8 46.58 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -81.29 127.36 32.64 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.969 -1.082 . . . . 0.0 111.697 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 40.7 m-85 -114.71 155.66 26.25 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.837 -0.539 . . . . 0.0 109.954 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.3 tp -127.61 109.34 11.6 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -97.3 107.62 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 110.355 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.767 HG22 ' HB3' ' A' ' 36' ' ' ALA . 37.8 t -98.5 99.55 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 O-C-N 121.4 -0.813 . . . . 0.0 109.372 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.54 170.13 18.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.061 -1.024 . . . . 0.0 109.734 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.25 26.04 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -70.76 -80.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 109.344 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 t 154.03 -20.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.14 -26.2 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.6 ttt -45.2 -63.4 0.94 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.724 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -48.58 -26.86 2.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -76.61 -31.68 57.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.624 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.85 -51.87 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.254 -0.904 . . . . 0.0 109.326 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -38.34 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.338 -0.851 . . . . 0.0 110.299 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.03 -52.72 23.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.946 -1.096 . . . . 0.0 109.23 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -58.29 4.13 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.992 0.901 . . . . 0.0 109.712 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.71 -41.18 3.06 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.836 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.77 -46.18 63.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.98 -1.075 . . . . 0.0 108.624 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -56.39 -38.17 71.13 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.341 -0.849 . . . . 0.0 109.148 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -53.93 -24.88 17.87 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.274 -0.891 . . . . 0.0 109.201 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.745 HD21 ' OE2' ' A' ' 117' ' ' GLU . 1.3 mt -86.28 -39.49 16.48 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -0.81 . . . . 0.0 109.675 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 137.54 6.9 1.51 Allowed Glycine 0 N--CA 1.484 1.843 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -89.6 141.4 28.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.852 -1.381 . . . . 0.0 109.389 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.536 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.3 OUTLIER -146.5 61.5 1.22 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.885 . . . . 0.0 109.682 -179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.89 97.58 0.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.307 -0.871 . . . . 0.0 108.847 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.03 152.79 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.044 -1.035 . . . . 0.0 109.83 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -120.52 -167.48 1.47 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' OE2' ' O ' ' A' ' 36' ' ' ALA . 1.1 tt0 -150.11 147.93 28.36 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.109 -0.994 . . . . 0.0 110.861 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -132.31 -167.72 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -140.12 -2.2 1.49 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.269 -0.894 . . . . 0.0 110.416 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 1.9 p-10 -176.4 -157.7 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 108.502 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.446 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -86.08 -43.12 6.42 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -51.46 -36.11 17.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.856 -1.379 . . . . 0.0 108.056 178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.607 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 15.1 t0 -77.69 -54.64 6.13 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.712 -0.618 . . . . 0.0 109.756 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -55.78 -53.48 56.21 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.087 -1.008 . . . . 0.0 110.018 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.77 -59.47 4.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.227 -0.921 . . . . 0.0 110.333 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -55.37 -33.67 63.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 110.528 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -90.03 -19.86 23.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.116 -0.99 . . . . 0.0 110.699 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -60.52 -22.13 63.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.841 -1.162 . . . . 0.0 109.287 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -90.69 -2.64 57.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.17 -0.956 . . . . 0.0 108.919 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.46 -71.9 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.57 -0.706 . . . . 0.0 109.848 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -132.36 -18.9 1.12 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.26 64.67 0.55 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.783 ' O ' HD11 ' A' ' 81' ' ' LEU . 84.7 m-85 -47.01 114.81 0.92 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.463 -1.022 . . . . 0.0 109.925 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.27 2.39 9.92 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -161.36 140.93 10.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.365 -1.08 . . . . 0.0 108.854 -179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.556 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.8 t -134.97 121.17 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.796 -1.19 . . . . 0.0 110.069 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 56' ' ' SER . 43.2 mt -110.43 139.14 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 36.7 m -165.98 157.5 13.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.098 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 6.5 m-20 -61.39 -131.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.211 -0.93 . . . . 0.0 110.085 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 35.6 t-105 -173.11 -2.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.072 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.682 HD22 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -143.25 -16.44 0.66 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' HD22 ' A' ' 59' ' ' ASN . 24.0 tpp -81.08 -33.01 0.67 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.134 -0.979 . . . . 0.0 111.857 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -66.98 -148.0 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.715 0.944 . . . . 0.0 109.871 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.479 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -57.44 -159.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.0 109.561 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.402 ' C ' ' O ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -44.67 -25.27 0.26 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.895 . . . . 0.0 109.582 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER 175.54 135.6 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.24 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.82 2.8 0.81 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 64' ' ' ASP . 12.3 tp -65.91 -60.13 3.16 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.809 -1.406 . . . . 0.0 108.068 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -49.34 -39.64 32.43 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 68' ' ' LEU . 4.6 tt -58.87 -35.5 73.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.524 HD13 ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -83.1 -63.66 1.32 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 69' ' ' LEU . 36.3 tttm -35.81 -49.95 0.63 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.083 0.468 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.4 m -49.2 -46.36 45.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 108.492 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 69' ' ' LEU . 55.3 mt -57.09 -33.18 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' CZ ' ' O ' ' A' ' 100' ' ' GLN . 9.8 ttt180 -67.58 -24.4 65.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 109.15 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.04 -28.54 1.73 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.238 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.54 82.16 8.02 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.32 -0.863 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.47 -34.1 89.05 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.35 -37.26 10.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.424 ' C ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -95.13 -71.79 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.872 . . . . 0.0 109.354 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.52 11.05 0.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.382 -0.824 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -107.28 -31.7 8.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.653 -0.654 . . . . 0.0 109.759 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.783 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.14 97.53 0.11 Allowed Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 122.288 -0.257 . . . . 0.0 110.418 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.58 139.09 52.08 Favored 'Trans proline' 0 C--N 1.326 -0.654 0 C-N-CA 121.055 1.17 . . . . 0.0 111.028 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.556 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.9 t -131.36 137.68 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 84' ' ' LEU . 39.7 tp -119.81 69.85 0.85 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -51.58 170.52 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.145 -1.022 . . . . 0.0 108.247 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.0 t -140.84 131.9 28.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.376 -0.828 . . . . 0.0 109.263 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.5 t -149.3 166.14 29.86 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.077 -1.014 . . . . 0.0 110.351 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -118.55 32.3 6.21 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.61 -0.681 . . . . 0.0 109.714 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' A' ' 91' ' ' LYS . 3.5 tt0 -153.84 -62.82 0.14 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.178 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . 57.16 83.57 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.664 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -68.8 8.93 0.44 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.174 -0.954 . . . . 0.0 109.443 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 90' ' ' ALA . 0.9 OUTLIER 73.18 -68.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.328 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -51.6 -43.45 62.52 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -18.64 65.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.4 mm -83.99 -13.97 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.21 -63.17 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 109.46 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.22 -46.27 17.52 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.531 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.64 -48.83 78.37 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.452 -0.78 . . . . 0.0 109.123 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.09 -46.76 61.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.252 -0.905 . . . . 0.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' CZ ' ' A' ' 73' ' ' ARG . 74.3 mt-30 -53.0 -23.77 8.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 109.379 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.77 -109.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.675 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.8 -1.85 4.93 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -56.43 11.06 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 122.086 -0.655 . . . . 0.0 110.87 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.675 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.4 m -29.46 -33.32 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.74 130.63 10.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.523 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.88 112.18 6.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -1.103 . . . . 0.0 108.626 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.823 HG21 ' CD2' ' A' ' 116' ' ' LEU . 13.6 p -115.48 133.25 62.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 106' ' ' TYR . 18.4 m -67.67 -167.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.54 151.46 17.03 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 120.706 -1.247 . . . . 0.0 108.991 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.83 165.68 83.17 Favored 'Cis proline' 0 N--CA 1.489 1.236 0 O-C-N 122.459 0.715 . . . . 0.0 111.217 -1.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.825 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.2 p90 -132.82 156.94 46.23 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.694 0.759 . . . . 0.0 109.6 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.536 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.07 143.93 26.78 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -42.97 -33.76 0.86 Allowed 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.253 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.04 95.97 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.0 m -65.2 -69.76 0.27 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.825 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -47.15 -31.69 3.72 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.972 -1.08 . . . . 0.0 109.986 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.745 ' OE2' HD21 ' A' ' 28' ' ' LEU . 6.1 tp10 -67.7 -62.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.647 -1.283 . . . . 0.0 109.637 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 5.9 tt0 -41.82 -59.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.747 -0.596 . . . . 0.0 110.137 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -50.06 -40.57 45.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 120' ' ' LEU . 0.4 OUTLIER -66.02 -50.61 63.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -0.907 . . . . 0.0 109.618 -179.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -18.4 62.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.099 -1.0 . . . . 0.0 109.811 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -81.91 -34.42 29.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.064 -1.022 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 19.7 mt -78.89 -37.32 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.102 -0.999 . . . . 0.0 109.453 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.472 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.6 m-85 -75.33 -30.22 60.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.427 -0.795 . . . . 0.0 110.131 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.23 -24.15 2.69 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 108.228 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -94.1 -23.26 18.04 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 124' ' ' PHE . 5.6 tp -83.3 -18.09 40.22 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 74.95 0.19 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.409 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -160.19 143.66 13.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.045 -1.035 . . . . 0.0 109.875 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -90.16 9.18 29.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.003 -1.061 . . . . 0.0 109.178 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -158.65 57.0 0.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 56.2 tp -84.87 120.57 26.61 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -57.29 112.12 1.29 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.988 -1.07 . . . . 0.0 111.764 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' A' ' 25' ' ' LEU . 67.1 m-85 -107.16 151.05 25.93 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -122.25 106.02 10.74 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -89.93 113.03 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.273 -178.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' A' ' 36' ' ' ALA . 31.2 t -119.23 106.78 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.591 -0.693 . . . . 0.0 109.331 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -155.49 126.83 7.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.396 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 12' ' ' ASP . 64.7 t0 -57.77 -107.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.919 . . . . 0.0 109.258 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.07 -156.67 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.282 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.434 ' C ' HG22 ' A' ' 16' ' ' THR . 38.1 t -150.35 24.98 0.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.115 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.434 HG22 ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -178.65 4.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.429 ' H ' ' H ' ' A' ' 16' ' ' THR . 1.8 tpp -68.84 -44.43 73.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.117 -0.989 . . . . 0.0 109.122 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -44.69 -47.03 10.61 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.527 -0.733 . . . . 0.0 109.85 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -56.38 -51.2 69.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.919 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -49.77 -58.51 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.196 -0.94 . . . . 0.0 110.004 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.427 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -62.49 -39.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.291 -0.881 . . . . 0.0 110.477 -178.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.44 -57.25 11.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 108.933 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.3 t-20 -57.63 -54.06 51.14 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -39.19 -55.08 1.72 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.814 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 8' ' ' PHE . 60.9 mt -61.82 -53.18 59.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 108.865 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 26' ' ' LYS . 8.1 mtpm? -52.55 -28.12 19.49 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.329 -0.857 . . . . 0.0 109.247 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.29 -32.66 62.59 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.086 -1.009 . . . . 0.0 108.838 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.91 -69.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.347 -0.845 . . . . 0.0 109.254 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 18.41 0.02 OUTLIER Glycine 0 N--CA 1.483 1.81 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.027 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.429 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 30.9 m-85 -96.07 153.99 17.49 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.904 -1.351 . . . . 0.0 109.06 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.456 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.4 OUTLIER -149.12 21.5 0.97 Allowed 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.87 -1.144 . . . . 0.0 110.894 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.855 ' H ' HD22 ' A' ' 32' ' ' ASN . 0.0 OUTLIER -138.29 107.65 6.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.917 -1.114 . . . . 0.0 111.106 -179.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -148.33 178.05 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.226 -0.921 . . . . 0.0 109.606 178.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.3 mm-40 -137.35 -166.69 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -150.1 154.68 38.51 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.935 -1.103 . . . . 0.0 110.824 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.846 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.87 -163.67 1.51 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.91 -4.15 2.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.0 110.484 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 2.8 p-10 179.7 -173.25 0.2 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.025 -1.047 . . . . 0.0 109.52 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.51 -27.71 67.05 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.7 t -71.93 -41.78 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.68 -1.482 . . . . 0.0 108.739 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 10.9 t70 -68.42 -44.45 74.99 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -68.73 -37.55 79.54 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -51.38 -57.8 7.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -66.43 -39.64 89.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.399 -0.813 . . . . 0.0 110.034 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -22.62 62.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.306 -0.871 . . . . 0.0 110.464 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -65.09 -4.8 5.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.831 -1.168 . . . . 0.0 109.325 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -106.05 -7.71 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.56 -0.712 . . . . 0.0 109.213 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.59 -65.87 0.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 109.614 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.61 5.34 2.04 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.72 76.93 1.1 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.816 ' O ' HD22 ' A' ' 81' ' ' LEU . 52.6 m-85 -54.07 113.62 1.3 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.502 -0.999 . . . . 0.0 110.214 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.52 -4.81 0.97 Allowed Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -165.48 141.35 5.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -1.14 . . . . 0.0 110.166 -179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 33.6 t -133.94 116.11 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.379 -0.826 . . . . 0.0 110.95 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 63.1 mt -98.34 85.16 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 87.8 p -92.64 172.07 8.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.082 -1.011 . . . . 0.0 110.457 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 1.5 p-10 -95.31 -109.58 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.531 -0.73 . . . . 0.0 109.855 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.642 ' CZ2' ' ND2' ' A' ' 94' ' ' ASN . 60.4 t-105 -159.82 -82.35 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.466 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.614 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 41.5 m-20 -139.16 8.57 2.48 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.181 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.484 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -53.45 -49.57 87.71 Favored Pre-proline 0 C--N 1.305 -1.357 0 O-C-N 120.956 -1.09 . . . . 0.0 109.72 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.2 -157.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.816 0 C-N-CA 120.98 1.12 . . . . 0.0 109.496 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.666 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -85.38 143.75 28.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.072 -1.017 . . . . 0.0 109.395 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.479 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 19.9 ttm 74.47 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -137.9 164.73 28.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.397 -0.814 . . . . 0.0 109.535 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 68' ' ' LEU . . . -91.49 -14.55 56.87 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -52.95 41.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.645 -1.503 . . . . 0.0 108.819 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.638 ' O ' HG23 ' A' ' 71' ' ' THR . 0.6 OUTLIER -53.18 -22.98 7.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.217 -0.927 . . . . 0.0 108.549 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' CB ' ' O ' ' A' ' 65' ' ' GLY . 10.2 tp -67.54 -55.16 14.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -57.69 -64.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.454 -0.779 . . . . 0.0 109.216 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -44.86 -46.2 10.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.394 -0.816 . . . . 0.0 109.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 67' ' ' GLU . 25.1 p -64.58 -43.77 92.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.006 -1.059 . . . . 0.0 109.163 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.973 HD13 HG21 ' A' ' 83' ' ' VAL . 25.4 mt -55.38 -27.25 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.344 -0.847 . . . . 0.0 108.735 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.01 -29.83 18.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.4 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.91 -29.92 9.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.27 -0.894 . . . . 0.0 109.355 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.19 113.33 19.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.37 -0.832 . . . . 0.0 109.384 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.67 -23.71 77.43 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.64 -46.35 77.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.178 . . . . 0.0 109.491 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.576 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.0 OUTLIER -100.34 -75.18 0.58 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 109.125 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 44.82 19.77 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.63 -0.669 . . . . 0.0 110.0 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.99 20.68 0.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.113 -0.992 . . . . 0.0 110.171 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 51' ' ' TYR . 10.5 mt -84.15 119.8 73.79 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.958 -1.089 . . . . 0.0 109.083 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.07 98.19 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 120.934 1.089 . . . . 0.0 112.13 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.973 HG21 HD13 ' A' ' 72' ' ' ILE . 2.4 t -99.17 121.26 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.684 HD12 HG12 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -99.95 107.13 19.02 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.51 110.52 18.74 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.061 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.436 HG12 ' CG1' ' A' ' 107' ' ' VAL . 0.7 OUTLIER -98.77 161.68 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.586 -1.321 . . . . 0.0 110.049 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.468 ' C ' ' NZ ' ' A' ' 109' ' ' LYS . 11.6 t -149.96 -155.59 0.64 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.497 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -151.42 32.57 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.536 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.99 -60.38 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.698 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.1 98.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 0.0 109.904 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 93' ' ' GLU . 32.0 tttp -112.59 54.62 0.71 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.1 mttt 54.12 -82.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.665 -0.647 . . . . 0.0 110.002 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 91' ' ' LYS . 1.9 mt-10 -43.76 -56.05 4.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.34 -0.85 . . . . 0.0 110.509 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.642 ' ND2' ' CZ2' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -55.32 -45.74 76.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.988 -1.07 . . . . 0.0 109.974 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.698 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.8 mt -48.86 -36.77 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 108.977 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 100' ' ' GLN . 15.2 mt -74.62 -25.62 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.279 -0.888 . . . . 0.0 109.037 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -56.18 -53.34 58.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.854 . . . . 0.0 109.53 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.42 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -58.32 -59.36 5.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.917 -1.115 . . . . 0.0 108.451 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.06 -21.84 34.61 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.44 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.7 tt0 -52.21 -32.27 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.66 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -90.07 -22.66 21.71 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.66 72.26 0.88 Allowed Glycine 0 N--CA 1.482 1.74 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.196 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.665 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.08 -112.32 0.08 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 116.55 -2.06 . . . . 0.0 110.192 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 20.5 m -91.93 -52.56 4.67 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.529 1.633 . . . . 0.0 107.58 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.48 -160.19 33.23 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.704 -2.158 . . . . 0.0 107.704 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.22 147.01 49.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -1.076 . . . . 0.0 109.849 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.824 HG21 HD12 ' A' ' 116' ' ' LEU . 7.5 p -136.99 128.74 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.38 149.96 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.887 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.468 ' NZ ' ' C ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -129.62 160.87 62.43 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.79 124.07 8.9 Favored 'Cis proline' 0 N--CA 1.485 1.028 0 C-N-CA 124.803 -0.915 . . . . 0.0 110.554 -1.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.66 ' CE1' HD22 ' A' ' 116' ' ' LEU . 5.0 p90 -93.4 156.43 16.78 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.309 -0.869 . . . . 0.0 109.967 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.527 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.28 150.06 22.09 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.19 -32.14 4.18 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.82 -35.46 80.74 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.112 -0.992 . . . . 0.0 109.095 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -71.38 -65.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.081 -1.012 . . . . 0.0 108.51 179.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.824 HD12 HG21 ' A' ' 107' ' ' VAL . 3.0 tp -52.34 -34.94 49.61 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.419 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 120' ' ' LEU . 4.3 tm-20 -69.12 -63.3 1.09 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.798 -1.189 . . . . 0.0 109.702 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.4 -41.84 9.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.632 -0.668 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HE3' HG23 ' A' ' 107' ' ' VAL . 2.6 mtmm -71.29 -27.78 63.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.221 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.1 tp -61.99 -62.1 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.36 -35.6 8.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.573 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -75.01 -29.89 60.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.166 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.6 mm -77.05 -40.0 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.382 -0.824 . . . . 0.0 109.44 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -76.86 -0.24 23.32 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -31.41 58.61 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -90.18 -25.53 20.6 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -77.93 -25.58 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 50.52 89.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.366 -1.079 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -46.28 132.36 10.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -90.46 18.63 5.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.043 -1.036 . . . . 0.0 109.646 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -129.32 42.6 3.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 108.669 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 6' ' ' LEU . 30.7 tp -90.14 130.22 36.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -76.93 124.79 28.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.186 -0.946 . . . . 0.0 111.422 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.495 ' HB2' HG22 ' A' ' 33' ' ' VAL . 62.4 m-85 -109.29 152.08 25.71 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.578 HD23 ' CD2' ' A' ' 46' ' ' LEU . 22.9 tp -131.15 105.59 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -92.51 104.62 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 110.085 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.7 t -94.45 88.15 2.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 O-C-N 121.414 -0.804 . . . . 0.0 109.436 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -149.33 157.15 43.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.262 -0.899 . . . . 0.0 109.476 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -108.56 -13.66 14.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.569 -0.707 . . . . 0.0 109.639 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' HB3' ' H ' ' A' ' 17' ' ' MET . 1.5 m-85 -47.4 136.06 10.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.536 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.4 t -86.14 30.44 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.35 -24.78 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.409 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 23.6 ttt -66.06 -61.17 2.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.266 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -47.82 -35.17 9.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.355 -0.841 . . . . 0.0 109.389 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -72.14 -39.86 68.47 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.164 -1.014 . . . . 0.0 109.963 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -62.6 -53.77 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.755 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -32.39 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.114 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.75 -55.26 20.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.749 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -69.86 -53.49 17.83 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.812 0.815 . . . . 0.0 109.543 -179.798 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.53 -52.37 2.83 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.508 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 HD21 ' CE2' ' A' ' 8' ' ' PHE . 5.2 mt -59.46 -55.16 38.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.393 -0.817 . . . . 0.0 108.999 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -52.1 -31.4 30.44 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.0 109.073 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -32.13 55.94 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.286 -0.884 . . . . 0.0 109.336 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -89.47 -61.14 1.76 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.339 -0.851 . . . . 0.0 109.693 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 162.16 73.34 0.02 OUTLIER Glycine 0 N--CA 1.482 1.707 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -150.15 134.52 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.79 -1.418 . . . . 0.0 109.839 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.97 26.16 3.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.507 -0.745 . . . . 0.0 110.449 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -137.82 93.71 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.031 -1.043 . . . . 0.0 109.393 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 8' ' ' PHE . 44.7 t -139.69 153.21 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.687 . . . . 0.0 110.336 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' CD ' ' OH ' ' A' ' 51' ' ' TYR . 12.4 mt-10 -127.63 -171.88 2.54 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -150.08 147.08 27.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.07 -1.019 . . . . 0.0 110.475 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.84 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.26 -165.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -137.11 0.77 2.39 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.365 -0.834 . . . . 0.0 110.76 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 3.8 t70 -176.43 164.77 2.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.766 -1.209 . . . . 0.0 109.849 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.632 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -56.67 -40.34 88.1 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.48 -40.38 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.119 -1.224 . . . . 0.0 108.336 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.569 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.3 t0 -66.88 -49.73 64.72 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.68 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.44 -56.98 13.2 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 42' ' ' ALA . 1.3 tp -41.1 -45.98 2.87 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.226 0.536 . . . . 0.0 109.735 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 -70.93 -37.36 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.85 . . . . 0.0 109.352 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' ALA . 31.2 mttt -90.09 4.4 50.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.345 -0.847 . . . . 0.0 110.045 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.578 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -90.08 -62.96 1.35 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.91 -1.119 . . . . 0.0 109.047 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -56.15 -8.51 0.49 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.135 -0.978 . . . . 0.0 108.861 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.33 -79.1 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.708 . . . . 0.0 109.742 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -121.75 1.4 11.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 77.55 0.94 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' O ' HD21 ' A' ' 81' ' ' LEU . 43.6 m-85 -64.71 109.54 2.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.389 -1.065 . . . . 0.0 109.772 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.97 -1.95 1.71 Allowed Glycine 0 N--CA 1.483 1.803 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.477 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -157.51 139.92 14.63 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.029 -1.277 . . . . 0.0 109.698 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.522 ' HB ' HG22 ' A' ' 83' ' ' VAL . 25.2 t -141.8 124.01 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.165 -0.96 . . . . 0.0 109.568 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 73.3 mt -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.1 p -132.52 168.95 17.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.445 -0.785 . . . . 0.0 109.389 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' CG ' ' N ' ' A' ' 58' ' ' TRP . 54.5 t0 -94.4 -109.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 110.158 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.638 ' HE1' ' ND2' ' A' ' 94' ' ' ASN . 46.8 t-105 -164.75 -55.52 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 109.229 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -84.51 71.41 10.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.086 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mmm -92.4 149.63 38.64 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.347 -0.845 . . . . 0.0 109.191 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.37 -179.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.324 -0.747 0 C-N-CA 120.941 1.094 . . . . 0.0 109.945 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 50.83 -104.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 31.7 mtp -106.62 161.54 14.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.565 -0.71 . . . . 0.0 109.447 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -73.4 179.28 4.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.488 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.429 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -82.6 6.78 67.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -75.08 -40.29 60.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.02 -1.282 . . . . 0.0 108.247 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 71' ' ' THR . 6.2 tp10 -71.36 -15.95 62.4 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.632 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.7 mt -74.01 -58.6 3.19 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.854 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.9 -38.43 91.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.209 -0.932 . . . . 0.0 109.34 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 74' ' ' ALA . 13.8 tptm -63.5 -51.18 66.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 108.892 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 67' ' ' GLU . 24.0 p -60.35 -45.59 92.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 109.341 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.9 mt -65.96 -34.63 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.252 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.15 -8.05 52.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.0 109.633 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -108.62 -16.91 14.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 109.733 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 74' ' ' ALA . 7.7 p30 -23.98 -95.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.234 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -169.09 -82.34 0.05 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.33 26.85 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.571 -0.958 . . . . 0.0 109.76 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 tpt -147.94 36.37 0.85 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.503 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.3 m -79.14 58.03 2.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.34 -18.74 0.44 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.84 . . . . 0.0 110.667 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -47.79 111.13 1.58 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.841 -1.162 . . . . 0.0 109.476 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.26 125.89 19.31 Favored 'Trans proline' 0 N--CA 1.482 0.833 0 C-N-CA 121.422 1.414 . . . . 0.0 113.442 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.522 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -121.26 116.93 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -97.53 107.42 19.92 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.708 -1.597 . . . . 0.0 106.926 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.475 ' C ' ' SD ' ' A' ' 85' ' ' MET . 5.0 ppp? -75.24 131.87 40.68 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 118.94 -1.104 . . . . 0.0 108.45 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.92 142.23 25.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 121.362 0.601 . . . . 0.0 110.834 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 109' ' ' LYS . 9.0 t -150.12 176.53 10.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.397 -0.814 . . . . 0.0 109.345 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -128.49 -5.92 5.28 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.558 -0.714 . . . . 0.0 109.232 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.8 pm0 -139.47 57.6 1.64 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.542 -0.724 . . . . 0.0 109.337 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -47.14 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.378 -0.826 . . . . 0.0 109.209 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 93' ' ' GLU . 12.1 tptt -77.93 48.15 0.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.871 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.6 mttp 52.44 -87.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.0 tt0 -45.11 -40.51 7.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.424 -0.797 . . . . 0.0 110.028 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.638 ' ND2' ' HE1' ' A' ' 58' ' ' TRP . 3.0 m-20 -57.44 -41.23 80.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.084 -1.01 . . . . 0.0 109.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.694 HD11 ' HB1' ' A' ' 90' ' ' ALA . 95.2 mt -59.78 -51.44 72.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.063 -1.023 . . . . 0.0 108.446 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 96' ' ' ILE . 3.4 mm -66.23 -26.36 37.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.523 -0.736 . . . . 0.0 109.313 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.71 39.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.089 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -79.42 -50.88 10.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.35 -0.843 . . . . 0.0 109.845 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.607 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -55.89 -30.08 61.01 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.088 -1.045 . . . . 0.0 108.998 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.452 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.6 tt0 -58.64 -34.16 70.89 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.854 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -77.88 -22.62 49.49 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 60.17 79.31 0.12 Allowed Glycine 0 N--CA 1.478 1.495 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.532 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.812 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.37 -111.95 0.06 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 116.932 -1.907 . . . . 0.0 109.288 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.8 t -91.94 -49.73 6.08 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.753 1.263 . . . . 0.0 108.278 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.47 -165.7 37.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.861 -1.695 . . . . 0.0 108.861 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.27 125.63 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.947 . . . . 0.0 109.484 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 107' ' ' VAL . 11.8 p -126.59 122.66 61.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -58.18 -167.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.8 pttm -164.71 155.25 12.68 Favored Pre-proline 0 C--N 1.297 -1.711 0 O-C-N 120.649 -1.282 . . . . 0.0 109.312 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.6 161.05 94.95 Favored 'Cis proline' 0 N--CA 1.485 0.991 0 C-N-CA 124.888 -0.88 . . . . 0.0 110.432 -2.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.6 p90 -127.92 166.23 18.7 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.704 0.764 . . . . 0.0 109.791 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -95.24 146.34 24.41 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.058 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.74 -25.39 0.73 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.998 -1.063 . . . . 0.0 109.596 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.92 -37.75 72.92 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.008 -1.057 . . . . 0.0 108.521 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.86 -64.67 0.82 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -49.67 -39.27 35.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.758 -1.214 . . . . 0.0 109.381 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 120' ' ' LEU . 30.4 tt0 -64.78 -64.47 0.86 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.063 -1.023 . . . . 0.0 109.749 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -44.97 -36.6 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.531 -0.731 . . . . 0.0 109.63 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -75.73 -29.53 58.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.195 -0.941 . . . . 0.0 109.155 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 117' ' ' GLU . 6.3 tp -66.61 -56.98 8.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.201 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -52.9 -41.66 64.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.262 -0.899 . . . . 0.0 110.265 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -67.9 -27.45 66.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 109.666 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.6 mt -83.32 -45.29 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.149 -0.969 . . . . 0.0 109.565 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 127' ' ' LEU . 13.7 m-85 -65.62 -27.64 68.54 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.376 -0.828 . . . . 0.0 110.179 -178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -51.35 -29.57 15.73 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.027 -1.046 . . . . 0.0 108.274 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -88.14 -21.11 24.81 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 124' ' ' PHE . 1.3 tt -80.2 -24.62 40.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.803 . . . . 0.0 108.861 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 143.34 -41.73 1.13 Allowed Glycine 0 N--CA 1.484 1.875 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.584 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.1 OUTLIER . . . . . 0 C--N 1.304 -1.397 0 O-C-N 121.271 -1.135 . . . . 0.0 109.521 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.35 0.595 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.495 ' O ' ' CE2' ' A' ' 30' ' ' PHE . 1.2 t0 -55.63 146.67 20.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -90.07 27.46 1.61 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.0 109.667 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -158.2 37.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.049 -1.032 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 6' ' ' LEU . 25.6 tp -72.45 137.7 46.6 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 2.3 mtmp? -76.89 136.62 38.85 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.039 -1.038 . . . . 0.0 111.531 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.8 m-85 -127.87 145.44 50.94 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.817 -0.552 . . . . 0.0 110.371 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.553 HD22 HD12 ' A' ' 46' ' ' LEU . 64.4 tp -118.4 118.35 31.54 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.31 104.49 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.997 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.2 t -98.79 116.57 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.501 -0.75 . . . . 0.0 109.383 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.77 178.42 8.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.172 -0.955 . . . . 0.0 109.723 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -118.99 13.63 13.07 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.98 -161.82 0.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.262 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -138.82 -0.7 1.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 109.101 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.65 3.12 0.84 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.411 -0.805 . . . . 0.0 109.199 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 1.6 ttt -74.72 -45.39 44.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.382 -0.824 . . . . 0.0 109.509 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.789 ' HE ' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -56.98 -27.11 61.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.618 ' N ' HH21 ' A' ' 18' ' ' ARG . 10.0 mmt180 -73.25 -31.23 63.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 mt -64.88 -54.16 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.315 -0.865 . . . . 0.0 109.6 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -35.68 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -0.955 . . . . 0.0 109.945 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' NH1' ' OE2' ' A' ' 35' ' ' GLU . 8.5 mtt85 -46.71 -54.98 8.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.193 -0.942 . . . . 0.0 109.701 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 24' ' ' LEU . 3.9 t30 -66.24 -58.47 5.3 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.438 -0.789 . . . . 0.0 109.432 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -37.26 -65.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.016 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -49.69 -45.92 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.163 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.03 -38.28 78.92 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.211 -0.93 . . . . 0.0 109.397 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -52.61 -41.72 63.95 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD11 ' CD ' ' A' ' 117' ' ' GLU . 2.1 mm? -70.94 -61.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.41 -0.806 . . . . 0.0 109.136 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.33 42.89 0.02 OUTLIER Glycine 0 N--CA 1.479 1.548 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 94.9 m-85 -126.1 150.45 48.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.448 -1.031 . . . . 0.0 109.052 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -149.99 67.41 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.884 -1.135 . . . . 0.0 110.4 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.68 97.82 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.029 . . . . 0.0 109.132 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.14 152.29 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.99 -1.069 . . . . 0.0 110.13 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -124.44 -167.3 1.63 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' OE2' ' NH1' ' A' ' 22' ' ' ARG . 17.9 mt-10 -147.62 146.49 29.37 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 110.153 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.997 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -133.11 -165.13 1.57 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -144.98 -0.74 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 0.0 110.909 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 39' ' ' GLY . 25.8 t0 -171.57 178.8 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.744 -1.222 . . . . 0.0 109.891 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' H ' ' CG ' ' A' ' 38' ' ' ASP . . . -67.22 -52.04 34.44 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -55.33 -27.66 20.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.335 -1.097 . . . . 0.0 108.615 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -79.86 -42.73 23.65 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.315 -0.866 . . . . 0.0 108.911 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -65.86 -36.26 82.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.338 -0.851 . . . . 0.0 109.644 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 tp -70.76 -37.42 73.39 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.545 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -82.95 -26.72 31.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 110.029 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 tptt -85.24 -14.36 46.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.903 . . . . 0.0 110.393 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.553 HD12 HD22 ' A' ' 9' ' ' LEU . 1.0 OUTLIER -76.88 -19.4 57.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.662 -1.274 . . . . 0.0 109.405 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -68.08 -5.68 18.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 108.879 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.51 -70.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.406 -0.809 . . . . 0.0 109.779 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.23 13.11 1.08 Allowed Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.01 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 87.53 91.41 1.02 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 9' ' ' LEU . 20.4 m-85 -70.82 140.71 51.27 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.377 -1.073 . . . . 0.0 110.09 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.84 -6.27 62.2 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.529 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.1 OUTLIER -156.54 142.95 18.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.762 -0.846 . . . . 0.0 108.756 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.1 t -132.93 118.32 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.671 -1.268 . . . . 0.0 110.006 179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.1 mt -100.89 153.52 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.9 p -170.86 166.0 7.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.105 -0.997 . . . . 0.0 109.266 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -91.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.032 -1.042 . . . . 0.0 109.189 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CD1' ' OD1' ' A' ' 59' ' ' ASN . 61.8 t-105 -167.12 -57.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.05 -1.031 . . . . 0.0 110.087 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.605 HD22 ' C ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER -172.54 72.0 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.71 -1.244 . . . . 0.0 110.434 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.52 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -91.49 -47.69 0.34 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.185 -0.947 . . . . 0.0 110.511 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.94 -160.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.321 -0.914 0 C-N-CA 121.129 1.219 . . . . 0.0 110.216 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.835 HD22 ' H ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -76.67 -40.6 48.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.388 -0.82 . . . . 0.0 109.658 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.8 mmm -79.95 143.98 33.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.33 146.16 27.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.264 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.603 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . -64.85 -15.35 60.0 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.5 OUTLIER -73.91 -72.74 0.25 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.163 -1.198 . . . . 0.0 109.951 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' LEU . 69.5 tt0 -45.86 -26.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -69.11 -46.89 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.643 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 7.8 tt -74.67 -62.65 1.46 Allowed 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.389 0.614 . . . . 0.0 109.397 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -43.39 -31.64 0.71 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -63.56 -41.84 98.39 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 69' ' ' LEU . 47.9 mt -57.91 -40.04 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -68.37 -3.16 10.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.26 69.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.245 -0.91 . . . . 0.0 109.4 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -73.14 139.92 46.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.317 -0.864 . . . . 0.0 109.505 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -94.31 80.34 0.95 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -170.9 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -1.182 . . . . 0.0 109.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.96 10.73 30.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.182 -0.949 . . . . 0.0 109.403 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.2 m 52.49 -117.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.12 -0.987 . . . . 0.0 109.18 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -125.91 0.92 7.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER 52.77 171.14 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.44 136.13 57.43 Favored 'Trans proline' 0 C--N 1.32 -0.94 0 C-N-CA 121.489 1.46 . . . . 0.0 112.874 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -129.94 139.85 50.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -117.82 68.28 0.76 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.486 ' O ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -61.57 131.57 50.51 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.45 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.89 135.74 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.192 -0.942 . . . . 0.0 110.813 -179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -150.07 156.11 41.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.255 -0.903 . . . . 0.0 109.567 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -85.53 156.8 20.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 6.3 tm-20 59.69 -75.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.57 -0.706 . . . . 0.0 110.225 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 79.4 97.2 0.06 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.482 -0.761 . . . . 0.0 109.205 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 90' ' ' ALA . 3.6 mmmt -58.33 -107.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.111 -0.993 . . . . 0.0 109.48 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -163.47 -69.16 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.247 -0.908 . . . . 0.0 109.34 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -52.56 -16.46 0.93 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.902 . . . . 0.0 109.372 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -78.64 -29.41 45.83 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.318 -0.864 . . . . 0.0 109.622 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.7 -15.7 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.664 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 97' ' ' ALA . 14.9 mt -82.22 -64.86 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.785 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.441 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -46.26 -47.85 18.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.394 -0.816 . . . . 0.0 109.376 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.654 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -58.2 -51.71 68.59 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.47 -0.769 . . . . 0.0 109.758 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.426 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -52.21 -48.65 64.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.144 -0.972 . . . . 0.0 109.844 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -47.99 -22.03 0.53 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.338 -0.851 . . . . 0.0 108.791 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -94.35 -116.11 0.1 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.659 -0.65 . . . . 0.0 109.531 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.707 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -127.58 -3.67 5.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -59.34 10.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.671 -0.899 . . . . 0.0 109.375 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.707 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.45 -33.96 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.26 130.98 10.41 Favored Glycine 0 N--CA 1.497 2.722 0 C-N-CA 119.492 -1.337 . . . . 0.0 109.899 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.525 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.89 109.24 5.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.409 -1.053 . . . . 0.0 109.351 179.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG1' HG12 ' A' ' 86' ' ' VAL . 7.3 p -107.54 139.82 28.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.503 HG22 ' OH ' ' A' ' 106' ' ' TYR . 1.2 t -81.82 119.18 30.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.34 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -88.4 151.62 48.72 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.892 -1.13 . . . . 0.0 109.624 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.82 162.24 92.57 Favored 'Cis proline' 0 N--CA 1.487 1.121 0 C-N-CA 125.226 -0.739 . . . . 0.0 110.512 -1.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -139.23 159.13 42.88 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.973 0.892 . . . . 0.0 109.993 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.59 151.5 21.53 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.45 -17.33 0.15 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 108.835 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.85 -43.6 58.15 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -67.25 -63.84 0.98 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.3 tp -46.88 -36.11 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.582 -1.247 . . . . 0.0 109.432 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.62 ' CD ' HD11 ' A' ' 28' ' ' LEU . 16.6 tt0 -63.62 -64.3 0.93 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 120.99 -1.069 . . . . 0.0 109.772 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.52 -52.99 7.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.734 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -46.53 -46.51 19.29 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.695 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.529 HD11 ' CE2' ' A' ' 53' ' ' PHE . 1.3 tp -57.92 -54.97 40.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 110.213 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -21.07 48.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 110.845 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -38.73 49.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.15 . . . . 0.0 109.624 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.8 mt -90.1 -36.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.353 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 127' ' ' LEU . 6.9 m-85 -73.29 -41.03 64.07 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -51.15 -18.83 0.96 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.843 -1.16 . . . . 0.0 108.046 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' N ' ' C ' ' A' ' 124' ' ' PHE . 0.6 OUTLIER -98.44 -23.72 15.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' PHE . 0.5 OUTLIER -82.33 -21.93 35.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 55.05 81.01 0.07 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 109.368 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.264 0.554 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER 62.2 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.362 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -90.05 19.2 5.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.95 -1.094 . . . . 0.0 109.335 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -137.42 41.21 2.41 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 18.4 tp -75.0 127.73 33.92 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.36 122.74 24.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 111.712 -177.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 44.6 m-85 -109.98 152.87 25.34 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.5 HD23 ' CD2' ' A' ' 46' ' ' LEU . 26.1 tp -117.36 109.45 16.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.64 121.05 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 0.0 109.86 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.953 HG22 ' HB3' ' A' ' 36' ' ' ALA . 46.1 t -123.45 27.08 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -51.73 173.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.915 . . . . 0.0 109.562 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -53.4 3.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.622 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -46.94 140.41 4.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.626 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 m -88.24 13.78 10.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 109.356 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.4 t -136.11 -18.56 1.55 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.563 -0.711 . . . . 0.0 109.299 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.417 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -68.97 -17.68 63.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -0.888 . . . . 0.0 109.244 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -34.91 78.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.306 -0.872 . . . . 0.0 109.36 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -24.39 62.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.246 -0.909 . . . . 0.0 108.914 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -69.91 -52.35 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.34 -30.7 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.747 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -49.2 -54.29 17.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.181 -0.95 . . . . 0.0 109.408 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.3 t-20 -67.41 -57.29 6.84 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.804 0.811 . . . . 0.0 109.278 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.21 -43.51 1.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.695 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 12.2 mt -70.07 -38.97 75.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.778 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -63.96 -38.26 90.42 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.29 -0.881 . . . . 0.0 109.157 179.532 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -51.0 -35.09 32.01 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.351 -0.843 . . . . 0.0 109.036 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 28' ' ' LEU . 11.0 mp -77.56 -50.9 11.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.336 -0.852 . . . . 0.0 109.133 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.83 35.71 0.06 OUTLIER Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -122.39 147.39 46.34 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.391 -1.064 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -150.17 57.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.05 -1.031 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.88 110.2 0.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.766 -1.209 . . . . 0.0 110.181 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 34' ' ' GLU . 1.3 m -148.2 -177.56 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.185 -0.947 . . . . 0.0 109.673 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 3.3 mm-40 -128.11 -171.89 2.56 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -145.77 145.77 30.95 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.125 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.953 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.09 -174.2 4.65 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.25 23.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.741 -1.224 . . . . 0.0 110.363 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER 179.53 147.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.865 -1.147 . . . . 0.0 109.336 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.59 -39.89 23.77 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 67.9 t -63.32 -32.05 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.383 -1.069 . . . . 0.0 108.793 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.546 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.2 t0 -76.98 -45.69 26.54 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -64.42 -32.55 74.21 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.555 -0.716 . . . . 0.0 109.394 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 43' ' ' LEU . 3.2 tt -68.22 -65.72 0.66 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 0.0 109.727 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -46.51 -27.36 1.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.856 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 3.9 mttm -90.0 -39.08 13.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.21 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.5 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -53.2 -37.6 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.035 -1.04 . . . . 0.0 108.885 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 48' ' ' ALA . 7.3 mt-30 -54.94 -24.36 23.42 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.433 -0.792 . . . . 0.0 109.49 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -44.23 -61.3 1.54 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.562 -0.711 . . . . 0.0 109.164 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.0 75.39 1.22 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -173.18 -31.62 0.03 OUTLIER Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.591 ' O ' HD21 ' A' ' 81' ' ' LEU . 15.2 m-85 -61.35 86.27 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.269 -1.136 . . . . 0.0 110.015 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -66.92 6.08 2.22 Favored Glycine 0 N--CA 1.481 1.647 0 N-CA-C 107.316 -2.314 . . . . 0.0 107.316 177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.6 t80 -158.08 146.2 18.69 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 121.565 -0.962 . . . . 0.0 109.099 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HB ' HG22 ' A' ' 83' ' ' VAL . 76.6 t -144.01 127.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.617 -1.302 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 53.2 mt -114.77 103.19 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.481 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 23.4 p -109.32 -178.91 3.69 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.384 -0.823 . . . . 0.0 110.46 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 85' ' ' MET . 32.3 t70 -89.44 -131.24 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.842 . . . . 0.0 110.292 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.452 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 46.7 t-105 -162.7 -55.0 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.165 -0.96 . . . . 0.0 110.092 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.531 ' O ' ' SD ' ' A' ' 60' ' ' MET . 24.0 t-20 -142.54 103.36 4.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.232 -0.917 . . . . 0.0 109.75 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.558 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.81 -46.22 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -69.36 -162.55 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.05 1.166 . . . . 0.0 109.979 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -54.07 130.38 37.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.271 -0.893 . . . . 0.0 109.106 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.425 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 36.7 mmm 51.17 -116.16 0.96 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.091 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -142.59 151.01 41.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 0.0 108.932 179.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.35 12.61 1.77 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 64' ' ' ASP . 1.2 tp -67.8 -57.2 6.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -1.185 . . . . 0.0 108.97 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -19.81 64.48 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.459 -0.776 . . . . 0.0 109.115 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.8 tp -65.76 -59.3 4.04 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.798 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.5 tt -70.95 -59.46 2.78 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.8 tttt -38.38 -37.71 0.31 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.3 m -63.3 -44.17 95.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 108.794 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 69' ' ' LEU . 56.0 mt -55.33 -38.0 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.97 -5.95 58.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.49 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -84.82 -26.74 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -0.885 . . . . 0.0 109.625 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.07 -15.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -0.779 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 67.31 -0.65 8.13 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.91 26.45 1.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -1.121 . . . . 0.0 109.413 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.7 mmt -139.79 20.61 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.459 -0.776 . . . . 0.0 109.339 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.2 p -85.61 49.23 1.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -145.52 6.02 1.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.309 -0.869 . . . . 0.0 109.843 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.591 HD21 ' O ' ' A' ' 51' ' ' TYR . 7.2 tp -92.98 119.59 67.64 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.122 -0.986 . . . . 0.0 108.636 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.91 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.328 -0.523 0 C-N-CA 120.774 0.982 . . . . 0.0 111.926 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.737 HG11 HD11 ' A' ' 69' ' ' LEU . 8.7 t -98.8 110.4 26.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.363 -0.836 . . . . 0.0 108.759 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -94.29 101.6 13.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 57' ' ' ASP . 1.1 tpt -75.5 152.14 37.88 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.72 147.3 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.632 -0.668 . . . . 0.0 110.151 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.55 HG22 ' N ' ' A' ' 88' ' ' ALA . 30.9 m -143.77 163.18 34.05 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.969 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.55 ' N ' HG22 ' A' ' 87' ' ' THR . . . -105.09 -62.43 1.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -96.57 87.19 4.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.094 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.48 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -81.79 161.09 23.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -0.89 . . . . 0.0 109.917 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.772 ' H ' HD22 ' A' ' 94' ' ' ASN . 14.4 tttt -147.39 154.23 40.61 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.467 -0.771 . . . . 0.0 109.169 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.19 -48.39 61.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -77.12 -52.81 8.65 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.131 -0.981 . . . . 0.0 110.632 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.772 HD22 ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -58.44 -10.21 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.113 -0.992 . . . . 0.0 110.561 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 9.9 mt -86.35 -7.29 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.827 -1.171 . . . . 0.0 109.586 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' C ' ' N ' ' A' ' 98' ' ' ALA . 1.5 mp -90.07 -46.59 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -46.01 -22.7 0.23 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -51.42 -52.57 45.02 Favored 'General case' 0 C--O 1.197 -1.685 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -49.22 -41.82 38.5 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 119.722 -1.861 . . . . 0.0 107.96 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -61.92 -31.27 71.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.798 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -134.82 -71.2 0.49 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.676 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -49.98 82.21 0.01 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 106.797 -2.521 . . . . 0.0 106.797 176.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.71 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -68.46 -110.13 0.0 OUTLIER 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 112.586 -1.807 . . . . 0.0 115.08 -174.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.576 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -37.44 -57.22 0.94 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.723 -176.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -155.67 171.16 33.65 Favored Glycine 0 N--CA 1.483 1.786 0 C-N-CA 119.222 -1.466 . . . . 0.0 109.852 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.559 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -135.46 113.48 11.2 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.618 HG13 ' O ' ' A' ' 107' ' ' VAL . 13.1 p -109.25 115.25 49.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG22 ' A' ' 108' ' ' VAL . 1.1 p -71.04 102.43 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.307 -0.871 . . . . 0.0 108.92 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.2 159.39 77.29 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.049 -1.032 . . . . 0.0 109.123 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.9 154.21 99.51 Favored 'Cis proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.711 -0.954 . . . . 0.0 110.357 -2.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -129.57 160.83 32.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.859 0.838 . . . . 0.0 110.138 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -97.97 148.49 23.42 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.13 -35.48 7.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 109.327 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.24 -35.38 80.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.0 m -70.43 -67.8 0.47 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 115' ' ' THR . 10.6 tp -47.28 -39.62 14.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.656 -1.278 . . . . 0.0 109.344 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.2 OUTLIER -62.7 -53.48 53.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.078 -1.014 . . . . 0.0 109.5 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.0 mm-40 -47.4 -28.32 2.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -0.812 . . . . 0.0 109.286 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -79.55 -49.83 11.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.445 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -48.26 73.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 109.307 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -60.13 -47.36 86.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -0.868 . . . . 0.0 109.956 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.99 69.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.8 mt -82.82 -35.86 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.888 . . . . 0.0 109.116 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -85.92 -2.15 57.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.46 -27.04 55.99 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -93.65 -31.09 14.61 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.59 -27.97 62.5 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.11 87.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.384 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -53.28 144.2 16.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.197 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 14.3 mttm -90.15 18.84 5.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.101 -0.999 . . . . 0.0 109.366 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' OE1' ' OD1' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -159.63 48.96 0.3 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 40.2 tp -77.51 113.02 14.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.999 -1.063 . . . . 0.0 108.433 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -53.78 106.54 0.19 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.938 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.594 ' HB2' HG22 ' A' ' 33' ' ' VAL . 69.0 m-85 -101.09 153.19 19.78 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.899 HD23 HD12 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -137.58 117.63 13.41 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.813 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.3 m -106.01 119.44 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.658 -0.651 . . . . 0.0 110.906 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.835 HG22 ' HB3' ' A' ' 36' ' ' ALA . 54.4 t -103.56 112.49 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 121.384 -0.823 . . . . 0.0 109.462 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.464 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -157.96 139.64 13.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.0 109.57 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -80.2 -12.17 59.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.918 . . . . 0.0 109.439 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.52 141.66 58.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.466 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 t -92.65 41.18 1.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -172.06 -40.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.545 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.464 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 14.1 ttm -46.94 -15.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.846 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 16' ' ' THR . 2.9 mtt180 -86.15 -44.34 12.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 109.684 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 ttp85 -65.64 -13.44 59.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.458 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.15 -49.48 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.41 -36.01 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' CZ ' ' OE2' ' A' ' 35' ' ' GLU . 8.0 mtt180 -50.81 -52.87 36.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.217 -0.927 . . . . 0.0 109.267 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.23 -57.06 7.4 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.977 0.894 . . . . 0.0 109.383 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.28 -48.88 3.67 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.836 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.8 mt -65.56 -51.05 62.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.835 -1.166 . . . . 0.0 108.518 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.28 -32.99 5.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.559 -0.713 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -48.59 -38.95 22.1 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.088 -1.008 . . . . 0.0 109.1 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' OE2' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -76.57 -68.61 0.58 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.353 -0.842 . . . . 0.0 109.384 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.09 20.95 0.02 OUTLIER Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.498 ' C ' HD22 ' A' ' 31' ' ' ASN . 29.1 m-85 -97.15 139.22 33.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.862 -1.375 . . . . 0.0 109.75 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.634 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -143.84 67.21 1.28 Allowed 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.124 -0.985 . . . . 0.0 110.198 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -174.82 91.56 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.199 -0.938 . . . . 0.0 108.82 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 8' ' ' PHE . 22.0 t -138.94 154.84 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.214 -0.929 . . . . 0.0 110.818 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.671 ' OE2' HD22 ' A' ' 9' ' ' LEU . 13.5 pt-20 -125.89 -171.02 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 13.3 mp0 -144.56 161.46 39.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.373 -0.83 . . . . 0.0 110.045 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.835 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.45 -170.45 3.0 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.535 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 68.1 mt-10 -134.32 0.71 3.11 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.376 -0.828 . . . . 0.0 110.532 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 0.2 OUTLIER 175.7 -175.22 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.785 -1.197 . . . . 0.0 109.314 -179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -63.97 -54.07 33.08 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 41' ' ' ASP . 29.6 m -57.3 -36.84 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.278 -1.131 . . . . 0.0 108.799 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 12.2 t0 -63.48 -45.09 92.35 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -55.73 -67.97 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.456 -0.778 . . . . 0.0 109.035 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -43.17 -28.52 0.3 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.38 -0.825 . . . . 0.0 110.305 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -79.42 -50.35 10.94 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.908 -1.12 . . . . 0.0 110.818 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' OE2' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -89.79 -3.79 57.97 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.086 -1.009 . . . . 0.0 110.605 -179.06 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.899 HD12 HD23 ' A' ' 9' ' ' LEU . 4.4 tt -90.11 -41.21 11.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.074 -1.016 . . . . 0.0 109.624 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.43 0.79 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 108.8 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -44.31 -60.57 1.86 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.572 -0.705 . . . . 0.0 109.843 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.35 11.1 1.0 Allowed Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.372 -1.394 . . . . 0.0 110.115 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.46 97.91 1.17 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.406 -1.877 . . . . 0.0 108.406 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' ' OE2' ' A' ' 34' ' ' GLU . 15.9 m-85 -79.22 124.23 28.16 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.204 -1.174 . . . . 0.0 110.405 -178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.83 -3.86 56.66 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -167.77 142.71 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.428 . . . . 0.0 109.369 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.5 t -134.78 158.27 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.065 -1.022 . . . . 0.0 111.278 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.797 HG23 ' O ' ' A' ' 84' ' ' LEU . 13.9 mt -143.31 127.59 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.414 ' H ' ' HA ' ' A' ' 85' ' ' MET . 15.7 p -147.61 157.45 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.892 -1.13 . . . . 0.0 110.175 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 8.8 t0 -65.78 -137.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.913 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.528 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 60.6 t-105 -173.37 111.13 0.19 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.355 -0.841 . . . . 0.0 109.468 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 66.97 27.43 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.602 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.1 tpt -101.8 -41.99 0.21 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 111.718 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.2 Cg_exo -65.57 -75.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 121.158 1.239 . . . . 0.0 110.518 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.89 -74.17 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.064 -1.023 . . . . 0.0 109.42 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.3 mtm -74.09 -88.64 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.224 -0.922 . . . . 0.0 109.139 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 65' ' ' GLY . 61.9 t0 -172.38 140.28 1.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.063 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -70.98 15.69 1.24 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 64' ' ' ASP . 13.7 tp -81.09 -56.76 3.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.08 -1.247 . . . . 0.0 107.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -60.28 -22.25 62.9 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD13 ' CA ' ' A' ' 39' ' ' GLY . 22.5 tp -64.32 -59.06 4.82 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -48.06 -63.18 1.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.752 0.787 . . . . 0.0 108.953 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.2 tttm -40.29 -44.08 1.84 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.142 0.496 . . . . 0.0 110.272 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -58.68 -39.13 79.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.915 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 69' ' ' LEU . 37.7 mt -58.98 -41.68 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.156 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -50.06 -30.07 10.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.339 -0.85 . . . . 0.0 109.559 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -45.98 -24.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.614 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' O ' ' A' ' 74' ' ' ALA . 12.2 t70 -44.1 -91.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 109.924 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -164.77 -142.88 3.54 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.25 -0.1 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -1.12 . . . . 0.0 109.686 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.93 7.38 37.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 47.29 -132.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.297 -0.877 . . . . 0.0 109.241 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.451 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -113.57 12.13 18.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.724 -0.61 . . . . 0.0 109.589 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER 52.5 173.85 0.03 OUTLIER Pre-proline 0 C--N 1.306 -1.322 0 O-C-N 121.224 -0.922 . . . . 0.0 108.722 178.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.33 144.02 99.54 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.326 1.351 . . . . 0.0 113.452 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -138.54 135.86 43.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.797 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.3 tp -114.76 69.86 0.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.414 ' HA ' ' H ' ' A' ' 56' ' ' SER . 5.1 ptm -56.66 156.07 6.8 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.205 -0.998 . . . . 0.0 108.557 -179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.0 t -120.08 138.1 51.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.852 -0.53 . . . . 0.0 109.588 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.2 t -146.63 179.88 7.25 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.466 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -130.69 -26.32 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.835 -0.54 . . . . 0.0 109.608 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -117.4 61.26 0.75 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.607 -0.683 . . . . 0.0 109.756 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.692 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -62.02 108.98 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.213 -0.929 . . . . 0.0 109.173 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -78.59 -79.65 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.794 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -174.48 -89.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.077 -1.014 . . . . 0.0 109.548 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -32.64 45.06 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.361 -0.837 . . . . 0.0 109.664 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -54.64 -26.15 31.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.332 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.692 HD11 ' HB1' ' A' ' 90' ' ' ALA . 36.4 mt -85.12 -17.47 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.406 -0.809 . . . . 0.0 109.264 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' ALA . 72.5 mt -82.94 -62.92 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.938 . . . . 0.0 109.708 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -45.82 -54.21 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.537 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.56 -52.38 17.84 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.42 -0.8 . . . . 0.0 109.418 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.11 -39.54 69.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 110.584 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -59.01 -17.18 22.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.044 -1.035 . . . . 0.0 109.968 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.85 -34.99 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.336 -0.852 . . . . 0.0 109.88 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.709 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 152.06 -13.07 0.73 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.607 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.5 10.92 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.769 -0.842 . . . . 0.0 109.885 178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.709 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.46 -35.21 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.113 -177.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.39 127.05 9.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.554 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -139.62 113.4 8.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.445 -1.032 . . . . 0.0 108.567 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.811 HG21 HD12 ' A' ' 116' ' ' LEU . 14.1 p -116.01 126.22 73.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.029 HG12 ' H ' ' A' ' 109' ' ' LYS . 33.1 t -61.27 -164.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 1.029 ' H ' HG12 ' A' ' 108' ' ' VAL . 9.9 pttm -164.88 156.09 13.03 Favored Pre-proline 0 C--N 1.294 -1.819 0 O-C-N 120.464 -1.398 . . . . 0.0 108.737 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.96 166.69 81.64 Favored 'Cis proline' 0 N--CA 1.486 1.034 0 C-N-CA 125.158 -0.768 . . . . 0.0 110.857 -1.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -144.03 161.98 37.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -102.28 171.28 7.57 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 176.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -61.41 -25.52 67.25 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.555 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.68 84.56 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.416 -0.802 . . . . 0.0 109.138 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -66.34 -64.55 0.83 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.811 HD12 HG21 ' A' ' 107' ' ' VAL . 4.1 tp -47.76 -36.44 11.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.811 -1.18 . . . . 0.0 109.779 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 2.9 mm-40 -59.2 -66.69 0.47 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.816 -1.178 . . . . 0.0 109.939 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -45.62 -25.71 0.5 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.637 -0.665 . . . . 0.0 110.532 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -86.34 -44.54 12.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 110.246 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -43.13 91.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.437 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -64.81 -40.83 95.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.286 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -56.57 -31.73 64.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.374 -0.829 . . . . 0.0 109.257 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.467 ' C ' ' H ' ' A' ' 125' ' ' GLU . 67.8 mt -85.69 -45.9 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 0.0 109.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -70.46 10.12 0.52 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.235 -0.915 . . . . 0.0 109.368 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.5 tt0 -83.29 -24.68 32.11 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 176.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -96.21 -30.85 13.25 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -72.3 -26.07 61.82 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.88 88.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.445 ' SD ' ' OXT' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.43 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER 52.88 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.206 -0.934 . . . . 0.0 109.395 -179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -73.15 32.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.176 -0.952 . . . . 0.0 109.137 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 3' ' ' ASP . 82.0 mt-10 -155.25 33.32 0.38 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.112 -0.993 . . . . 0.0 108.993 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 53' ' ' PHE . 39.2 tp -70.12 132.9 46.53 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -76.09 117.55 17.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 111.228 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -106.12 152.44 23.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.466 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.2 tp -126.78 111.06 13.78 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -97.77 116.27 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.463 -0.773 . . . . 0.0 109.782 -179.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' A' ' 36' ' ' ALA . 56.5 t -118.86 110.74 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.679 -0.638 . . . . 0.0 109.912 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -177.2 124.54 0.14 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.985 -1.072 . . . . 0.0 110.168 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.16 144.14 7.47 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.717 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -172.16 -154.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.439 -1.413 . . . . 0.0 112.258 -177.606 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.717 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.1 OUTLIER 177.91 16.43 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 178.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.491 HG22 ' C ' ' A' ' 15' ' ' SER . 0.2 OUTLIER -171.92 -48.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.927 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 22.0 ttt -38.85 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.665 -0.647 . . . . 0.0 110.853 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 51.1 mtm180 -43.37 -30.24 0.51 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.322 -0.861 . . . . 0.0 110.45 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.99 -30.27 39.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.642 -1.287 . . . . 0.0 109.445 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 3.8 mt -69.66 -49.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.93 -35.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mtm180 -46.95 -54.1 10.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 109.039 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t30 -61.23 -56.76 17.0 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.845 0.831 . . . . 0.0 108.787 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -36.89 -67.61 0.17 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.897 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.29 -42.79 74.08 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.925 -1.109 . . . . 0.0 108.997 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -59.16 -28.4 66.56 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.178 -0.951 . . . . 0.0 109.283 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 -46.61 68.92 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.138 -0.976 . . . . 0.0 109.213 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.0 -62.95 1.16 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.287 -0.883 . . . . 0.0 109.077 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.09 18.7 0.02 OUTLIER Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.826 -1.178 . . . . 0.0 111.198 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.97 123.72 34.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.488 -1.595 . . . . 0.0 109.156 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.18 69.27 1.28 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.73 96.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.95 -1.094 . . . . 0.0 109.223 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.8 p -150.07 149.79 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.004 -1.06 . . . . 0.0 109.916 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 3.6 mt-10 -118.95 -172.18 2.24 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.8 mp0 -147.11 165.69 29.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.08 -1.012 . . . . 0.0 110.396 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.902 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.98 -170.46 3.65 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -130.25 0.27 4.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.475 -0.766 . . . . 0.0 110.326 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.18 176.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.034 . . . . 0.0 109.601 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.433 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -60.32 -47.31 91.72 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.5 t -52.85 -35.07 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.088 -1.242 . . . . 0.0 108.42 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 34.9 t0 -74.06 -52.87 11.3 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.501 -0.749 . . . . 0.0 109.247 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.831 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -56.03 -57.44 12.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.34 -0.85 . . . . 0.0 109.304 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.857 HD11 HG21 ' A' ' 71' ' ' THR . 0.5 OUTLIER -46.28 -46.49 17.99 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.469 -0.769 . . . . 0.0 109.777 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -72.52 -31.6 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -0.967 . . . . 0.0 110.134 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -90.08 -7.06 54.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.973 . . . . 0.0 110.238 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -70.53 -6.44 36.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 0.0 108.77 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -91.51 -2.16 57.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.987 -1.07 . . . . 0.0 109.234 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.76 -67.82 0.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.384 -0.822 . . . . 0.0 109.456 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.48 -65.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.58 72.4 0.04 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.724 ' O ' HD21 ' A' ' 81' ' ' LEU . 76.7 m-85 -54.9 95.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.94 -6.13 1.68 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.495 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -153.42 139.24 18.03 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.49 -1.006 . . . . 0.0 109.587 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 9' ' ' LEU . 47.8 t -134.0 118.81 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.079 -1.013 . . . . 0.0 110.004 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 55' ' ' ILE . 34.8 mt -99.51 114.88 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.6 p -132.24 166.21 22.39 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.411 -0.806 . . . . 0.0 109.326 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 12.4 p-10 -90.01 -118.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.117 -0.99 . . . . 0.0 109.414 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.482 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 43.2 t-105 -162.36 -18.43 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -0.865 . . . . 0.0 109.331 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.38 96.21 5.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.312 0.577 . . . . 0.0 109.774 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 159.69 70.75 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.73 -41.82 73.65 Favored 'Trans proline' 0 C--N 1.317 -1.126 0 C-N-CA 121.144 1.23 . . . . 0.0 110.188 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.7 m120 -96.51 -107.74 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.839 . . . . 0.0 109.192 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 63' ' ' MET . 2.8 mpp? -69.56 -161.6 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.291 -0.881 . . . . 0.0 108.951 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -94.5 176.38 6.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.064 -1.022 . . . . 0.0 109.29 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.66 15.93 59.25 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.571 -1.3 . . . . 0.0 109.874 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.8 tp -86.24 -40.68 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.808 -1.407 . . . . 0.0 107.58 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -66.74 -18.03 65.17 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' CA ' ' A' ' 39' ' ' GLY . 25.6 tp -78.48 -66.48 0.85 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.67 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -56.73 -40.03 74.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -47.53 86.02 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.288 -0.882 . . . . 0.0 109.023 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.857 HG21 HD11 ' A' ' 43' ' ' LEU . 52.9 m -51.23 -47.38 62.38 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 109.001 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.4 mt -50.61 -46.09 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 108.795 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp180 -62.09 -29.0 70.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.257 -0.902 . . . . 0.0 109.6 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 71' ' ' THR . . . -45.27 -29.13 0.93 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.0 109.827 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.623 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 11.1 t70 -67.73 99.69 0.83 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.452 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.71 76.58 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -168.26 -60.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 0.0 109.405 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.1 mmt -92.91 -71.03 0.67 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.9 t 45.46 26.31 0.29 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.524 -0.735 . . . . 0.0 109.374 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.81 -12.59 4.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.654 -0.654 . . . . 0.0 109.487 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.724 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.2 tp -48.25 113.37 2.76 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.112 -0.993 . . . . 0.0 108.729 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.5 121.59 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 121.2 1.267 . . . . 0.0 112.751 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.3 t -108.52 115.52 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 85' ' ' MET . 5.5 tp -101.61 73.88 1.48 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.581 -1.248 . . . . 0.0 108.896 179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 84' ' ' LEU . 6.0 mtt -48.15 172.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.5 t -147.15 120.18 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.413 -0.805 . . . . 0.0 109.344 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.6 t -150.04 -178.47 6.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.743 -1.223 . . . . 0.0 110.042 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.31 -41.64 2.17 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -94.51 56.42 2.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.401 -0.812 . . . . 0.0 109.375 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -71.26 111.51 6.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.23 -0.919 . . . . 0.0 109.708 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -134.19 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.203 -0.936 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -136.36 -70.21 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -45.97 -16.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.406 -0.809 . . . . 0.0 109.553 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -90.13 -57.31 2.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.323 -0.86 . . . . 0.0 109.608 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.569 HD11 ' HB1' ' A' ' 90' ' ' ALA . 69.2 mt -47.44 -28.42 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.385 -0.822 . . . . 0.0 109.377 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.95 -60.04 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.313 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.69 -52.8 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.427 -0.795 . . . . 0.0 108.971 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.462 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -50.64 -48.45 58.21 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.495 -0.753 . . . . 0.0 108.992 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.75 -45.92 49.92 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.258 -0.901 . . . . 0.0 109.462 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.687 ' N ' HE21 ' A' ' 100' ' ' GLN . 0.0 OUTLIER -50.23 -29.18 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.215 -0.928 . . . . 0.0 108.864 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -112.4 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.47 -0.769 . . . . 0.0 109.191 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -131.64 0.14 4.98 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.67 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -56.6 11.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 122.143 -0.622 . . . . 0.0 110.621 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 21.8 m -29.44 -32.38 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 122.265 -0.272 . . . . 0.0 111.723 -177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.81 135.48 12.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -152.06 110.23 3.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 108.822 179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.5 p -104.44 139.75 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -88.07 105.19 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.531 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.21 160.12 83.47 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 120.903 -1.123 . . . . 0.0 109.059 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.08 166.33 83.54 Favored 'Cis proline' 0 N--CA 1.484 0.944 0 C-N-CA 124.747 -0.939 . . . . 0.0 110.577 -2.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.613 ' CE1' HD12 ' A' ' 116' ' ' LEU . 6.6 p90 -142.4 -170.98 3.3 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.978 0.894 . . . . 0.0 109.554 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.529 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -135.22 150.18 50.04 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.514 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -47.45 -33.65 6.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.887 -1.133 . . . . 0.0 109.418 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.83 -30.96 61.54 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -79.32 -61.3 2.05 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.613 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -49.99 -32.45 15.18 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.45 -1.406 . . . . 0.0 108.388 178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.19 -56.99 10.85 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.066 -1.021 . . . . 0.0 109.942 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -44.16 -36.41 2.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.668 -0.645 . . . . 0.0 109.459 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -43.52 81.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.293 -0.879 . . . . 0.0 109.342 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.56 -63.07 1.27 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.185 -0.947 . . . . 0.0 109.481 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -44.73 -49.48 10.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.339 -0.851 . . . . 0.0 110.598 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.13 -29.61 63.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.288 -0.883 . . . . 0.0 110.726 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.55 HD11 ' HA2' ' A' ' 105' ' ' GLY . 15.1 mt -89.98 -44.63 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.851 -1.156 . . . . 0.0 110.785 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -59.14 -9.95 2.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.014 -1.054 . . . . 0.0 110.571 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.38 -20.9 63.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -95.49 -31.88 13.14 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -22.37 43.52 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.87 88.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.562 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.256 -1.143 . . . . 0.0 109.459 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -46.27 109.86 0.22 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.945 . . . . 0.0 109.637 -179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 2.0 mmtp -56.36 7.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.157 -0.964 . . . . 0.0 110.635 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.606 ' H ' ' C ' ' A' ' 3' ' ' ASP . 73.3 mt-10 -141.92 45.34 1.68 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.058 -1.026 . . . . 0.0 108.738 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 45.0 tp -76.64 107.97 9.31 Favored 'General case' 0 C--O 1.203 -1.365 0 C-N-CA 118.215 -1.394 . . . . 0.0 108.715 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -48.95 113.83 0.87 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.0 111.437 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 68.8 m-85 -104.94 155.46 18.92 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.7 tp -130.97 103.4 6.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.96 107.78 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 0.0 109.802 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 36' ' ' ALA . 50.3 t -107.87 106.14 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 121.612 -0.68 . . . . 0.0 109.471 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.18 -163.51 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -0.82 . . . . 0.0 109.393 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.02 4.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.529 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.05 165.28 14.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 t -97.69 9.7 41.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.725 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -149.74 10.22 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.095 -1.003 . . . . 0.0 109.642 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 17.1 ttt -92.13 -47.14 7.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -28.81 69.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 0.0 109.291 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' CG ' HH21 ' A' ' 22' ' ' ARG . 31.6 ttp85 -68.49 -52.77 28.66 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.778 -178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.446 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.5 mt -46.24 -55.05 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.365 -0.835 . . . . 0.0 109.689 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.4 -43.27 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.616 -178.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.432 HH21 ' CG ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -46.88 -55.01 8.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.038 -1.039 . . . . 0.0 109.755 -179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.33 -55.13 19.97 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.111 0.958 . . . . 0.0 109.039 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -39.73 -55.25 1.96 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.893 -179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 25' ' ' LEU . 30.6 mt -59.94 -49.89 75.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.16 -0.962 . . . . 0.0 109.07 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.79 -34.11 38.37 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.909 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 2.8 tt0 -58.24 -30.17 66.31 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.285 -0.884 . . . . 0.0 109.52 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -87.08 -14.48 41.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.775 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.22 46.05 1.77 Allowed Glycine 0 N--CA 1.486 2.001 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.228 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -117.28 129.36 55.85 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.308 -1.113 . . . . 0.0 108.9 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 0.3 OUTLIER -128.68 67.99 1.39 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 109.536 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -174.95 94.91 0.08 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.169 -0.957 . . . . 0.0 108.861 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.05 149.19 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 110.843 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.78 -169.06 1.81 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -150.0 154.52 38.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.021 -1.05 . . . . 0.0 110.69 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.887 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.11 -172.4 3.48 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -139.09 15.47 2.63 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.169 -0.957 . . . . 0.0 110.619 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER 175.24 146.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.713 -1.242 . . . . 0.0 109.868 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -48.17 -32.98 10.05 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 12.7 t -69.04 -35.72 70.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.337 -1.096 . . . . 0.0 108.657 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 26.5 t0 -70.87 -44.94 65.34 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -63.25 -54.13 42.11 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -46.73 -43.15 17.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.836 . . . . 0.0 109.922 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -73.94 -33.27 63.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.15 -0.969 . . . . 0.0 110.053 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -90.02 -7.68 53.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.012 . . . . 0.0 110.006 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -68.07 -13.6 62.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 108.927 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -85.82 -2.83 58.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.45 -75.95 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.464 -0.772 . . . . 0.0 109.722 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.61 9.97 1.43 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.84 83.75 1.21 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.485 ' C ' ' N ' ' A' ' 53' ' ' PHE . 57.2 m-85 -62.69 99.89 0.17 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.29 -1.123 . . . . 0.0 109.693 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.96 -14.28 0.41 Allowed Glycine 0 N--CA 1.485 1.949 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -148.99 119.23 7.27 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.48 -1.012 . . . . 0.0 109.884 -179.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HB ' HG22 ' A' ' 83' ' ' VAL . 53.8 t -116.65 124.05 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.238 -0.913 . . . . 0.0 109.524 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 55' ' ' ILE . 1.1 mt -107.45 126.16 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 p -143.44 145.15 32.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.449 -0.782 . . . . 0.0 108.987 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -98.74 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.886 -1.134 . . . . 0.0 109.081 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 65.1 t-105 -172.57 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.145 -0.972 . . . . 0.0 109.726 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.684 HD22 ' N ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -134.84 -1.39 2.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.333 -0.854 . . . . 0.0 109.761 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.684 ' N ' HD22 ' A' ' 59' ' ' ASN . 2.2 mtp -60.16 -47.33 97.08 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.106 -0.996 . . . . 0.0 110.67 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.22 -66.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.842 0 C-N-CA 121.118 1.212 . . . . 0.0 110.598 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -130.22 -152.43 0.51 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.596 -0.69 . . . . 0.0 109.634 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.6 mtt -51.53 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 109.699 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 64' ' ' ASP . 2.3 p30 -142.68 138.45 30.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.404 -0.81 . . . . 0.0 109.373 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.29 -2.8 21.55 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.42 -45.83 62.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.829 -1.395 . . . . 0.0 108.163 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.42 -39.16 71.25 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.465 HD13 ' CA ' ' A' ' 39' ' ' GLY . 66.5 tp -53.78 -29.1 38.72 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -88.07 -64.37 1.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.6 -0.687 . . . . 0.0 109.333 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 69' ' ' LEU . 6.7 ttpp -34.88 -52.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.105 0.478 . . . . 0.0 110.381 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -45.53 41.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.204 -0.935 . . . . 0.0 108.766 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.58 HD12 ' HA ' ' A' ' 69' ' ' LEU . 53.4 mt -59.37 -30.43 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.42 -0.8 . . . . 0.0 108.846 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' LYS . 4.3 ttp85 -83.47 -23.01 32.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.49 -0.756 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -46.53 -28.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.563 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 18.0 t0 -61.37 -150.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.474 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . -161.54 33.92 0.37 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -163.06 6.68 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -1.195 . . . . 0.0 109.404 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.449 ' HB2' HD23 ' A' ' 81' ' ' LEU . 5.9 ptm -150.03 52.94 0.91 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.372 -0.83 . . . . 0.0 109.349 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.7 t -92.76 -5.58 50.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 109.647 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -95.91 2.92 53.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 78' ' ' MET . 0.7 OUTLIER -49.44 111.35 1.96 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 108.897 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -62.13 144.1 95.45 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 121.009 1.139 . . . . 0.0 112.584 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.4 t -140.26 137.88 37.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD21 HD11 ' A' ' 116' ' ' LEU . 55.5 tp -115.13 75.13 0.92 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 6.4 mtt -65.42 122.69 17.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.0 OUTLIER -109.19 140.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.891 . . . . 0.0 110.774 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 109' ' ' LYS . 2.4 t -150.09 161.11 43.0 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.36 25.36 10.77 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' O ' ' O ' ' A' ' 90' ' ' ALA . 48.8 tt0 -142.8 -64.85 0.4 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.306 -0.871 . . . . 0.0 109.725 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.475 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . 48.77 93.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 0.0 109.165 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 94' ' ' ASN . 22.0 mtmm -59.63 -102.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.208 -0.932 . . . . 0.0 109.811 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -145.25 -101.0 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.571 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -49.99 -27.28 5.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.022 -1.049 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -52.16 -27.12 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 0.0 109.613 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 89.6 mt -71.62 -27.83 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.201 -0.937 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.462 HG22 HE21 ' A' ' 100' ' ' GLN . 68.7 mt -74.29 -51.43 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.1 26.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.083 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.676 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -57.19 -52.88 63.52 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.496 -0.753 . . . . 0.0 109.552 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.63 -43.0 65.13 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -0.879 . . . . 0.0 110.228 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.462 HE21 HG22 ' A' ' 96' ' ' ILE . 79.7 mt-30 -48.67 -27.97 3.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.104 -0.997 . . . . 0.0 108.821 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.45 -114.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.608 -0.682 . . . . 0.0 109.444 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -123.82 -8.32 6.27 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.676 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.53 10.72 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 122.026 -0.691 . . . . 0.0 110.581 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 4.7 m -29.59 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -98.46 132.94 11.13 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.185 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.504 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 0.8 OUTLIER -145.33 129.03 17.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.335 -1.097 . . . . 0.0 109.222 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -134.77 124.99 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.434 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -71.16 103.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.038 -1.065 . . . . 0.0 108.733 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 87' ' ' THR . 2.9 pttp -71.47 157.84 89.14 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.222 -0.924 . . . . 0.0 109.115 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.34 166.97 81.26 Favored 'Cis proline' 0 N--CA 1.485 1.011 0 C-N-CA 125.01 -0.829 . . . . 0.0 110.683 -1.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.02 158.0 43.95 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.04 0.924 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.36 148.94 23.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 176.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -45.88 -23.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 109.377 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -70.23 -41.96 72.9 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.14 -65.28 0.7 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HG11 ' A' ' 107' ' ' VAL . 2.4 tp -47.59 -36.32 10.52 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.553 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -65.21 -66.13 0.58 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.975 -1.078 . . . . 0.0 109.733 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -45.21 -30.09 1.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.534 -0.729 . . . . 0.0 109.995 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 106' ' ' TYR . 11.0 mmmt -81.35 -50.28 9.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.032 -1.043 . . . . 0.0 110.01 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -31.06 70.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 0.0 109.725 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.23 -28.73 47.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -77.82 -22.91 49.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.2 mt -82.77 -43.54 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.185 -0.947 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.502 ' CD2' ' SD ' ' A' ' 129' ' ' MET . 17.8 m-30 -73.82 -0.62 16.43 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.912 -1.118 . . . . 0.0 109.45 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -69.34 -20.28 63.86 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -101.35 -29.11 12.23 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -80.71 -16.54 53.66 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.99 90.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 124' ' ' PHE . 4.4 mtt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.319 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.13 145.13 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.392 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.25 17.64 6.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.073 . . . . 0.0 109.312 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -152.05 44.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.168 -0.958 . . . . 0.0 109.742 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.7 tp -70.26 143.11 52.23 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -78.3 131.85 37.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.988 -1.07 . . . . 0.0 111.247 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 25' ' ' LEU . 76.6 m-85 -122.94 147.52 46.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.736 -0.603 . . . . 0.0 109.821 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.607 ' CD2' HD12 ' A' ' 46' ' ' LEU . 12.9 tp -126.97 110.72 13.29 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 177.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -95.76 105.25 16.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.0 t -98.62 95.67 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.413 -0.805 . . . . 0.0 109.86 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.2 t0 -142.1 -159.22 0.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.563 -0.711 . . . . 0.0 109.231 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.95 1.56 1.67 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.305 -0.872 . . . . 0.0 109.512 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' THR . 8.9 m-85 -91.21 98.06 11.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.419 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.51 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -93.25 -34.49 13.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 109.721 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.48 ' SD ' ' OD2' ' A' ' 12' ' ' ASP . 3.9 ttt -56.06 -56.63 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.11 -0.994 . . . . 0.0 109.77 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -35.28 5.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.318 -0.863 . . . . 0.0 109.669 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.8 ttm-85 -72.97 -35.66 66.95 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.065 -178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.2 mp -65.3 -54.0 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.933 . . . . 0.0 109.382 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -60.95 -32.85 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.104 -0.998 . . . . 0.0 109.767 -179.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -50.74 -53.62 30.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.88 -58.24 5.39 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.939 0.876 . . . . 0.0 109.282 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.05 -44.17 2.36 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.739 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -73.39 -41.89 62.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.87 -27.78 69.59 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' OE2' ' A' ' 27' ' ' GLU . 7.5 tp10 -59.85 -35.9 75.73 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.054 -1.029 . . . . 0.0 109.375 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -81.11 -59.55 2.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.16 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.62 73.91 0.02 OUTLIER Glycine 0 N--CA 1.481 1.656 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -149.97 144.54 25.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.24 . . . . 0.0 110.021 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.04 63.11 0.98 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -173.44 100.89 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.74 -1.225 . . . . 0.0 108.881 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.14 152.36 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.007 -1.058 . . . . 0.0 110.509 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -120.6 -173.35 2.56 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 13.5 mp0 -145.28 155.05 42.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.295 -0.878 . . . . 0.0 110.553 -179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.95 -172.75 4.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.01 8.65 1.25 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.045 . . . . 0.0 110.555 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.454 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 11.9 t70 -179.32 167.7 1.5 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.333 -0.855 . . . . 0.0 109.194 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.504 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -63.48 -25.59 68.81 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 t -72.46 -40.69 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -1.179 . . . . 0.0 108.52 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 12.3 t0 -69.7 -45.67 67.75 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -66.66 -39.21 88.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.2 tp -57.47 -37.34 72.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.351 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -86.92 -34.88 19.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 110.034 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -89.96 -53.98 4.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.113 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 HG21 ' A' ' 54' ' ' VAL . 4.9 tt -50.07 -27.35 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.43 ' O ' ' OE1' ' A' ' 47' ' ' GLN . 1.4 tm0? -69.63 8.21 0.71 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.201 -0.937 . . . . 0.0 108.959 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.66 -68.72 0.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.65 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.45 18.98 0.31 Allowed Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.126 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.62 99.16 1.79 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.84 ' O ' HD22 ' A' ' 81' ' ' LEU . 16.9 m-85 -79.53 110.39 14.8 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.373 -1.075 . . . . 0.0 110.437 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.76 -14.75 4.06 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.52 145.96 21.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -1.209 . . . . 0.0 110.179 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.779 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.5 t -141.93 120.36 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.088 -1.008 . . . . 0.0 110.138 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.491 ' CG2' HG21 ' A' ' 86' ' ' VAL . 53.6 mt -103.14 78.12 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -85.48 149.99 25.01 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.936 -1.102 . . . . 0.0 110.448 -177.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 27.7 t70 -94.64 178.21 5.67 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.567 -0.708 . . . . 0.0 109.291 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.539 ' NE1' ' OD1' ' A' ' 94' ' ' ASN . 53.5 t-105 -114.71 46.09 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.496 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -65.25 -154.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.473 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.511 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -162.81 60.05 0.95 Allowed Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 120.749 -1.219 . . . . 0.0 111.981 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -62.68 -39.53 42.82 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 N-CA-C 107.576 -1.74 . . . . 0.0 107.576 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.42 ' H ' ' H ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -147.46 -22.75 0.38 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.42 ' H ' ' H ' ' A' ' 62' ' ' ASN . 1.2 mtt -150.77 -83.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 65' ' ' GLY . 4.9 p-10 169.94 -107.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' H ' ' CG ' ' A' ' 64' ' ' ASP . . . -137.96 18.2 3.37 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' LEU . 25.3 tp -79.75 -54.17 6.11 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.083 -1.245 . . . . 0.0 108.152 179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -50.36 -21.89 1.61 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD11 ' HA2' ' A' ' 39' ' ' GLY . 1.9 mt -72.7 -59.67 2.6 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.962 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.95 -61.02 2.06 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 69' ' ' LEU . 18.7 tttm -40.84 -48.55 3.09 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.17 -48.59 80.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.911 HD13 HG21 ' A' ' 83' ' ' VAL . 6.6 mt -57.76 -24.0 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -89.68 -28.04 19.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.41 -0.806 . . . . 0.0 109.709 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.72 -33.32 55.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.193 -0.942 . . . . 0.0 109.525 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.1 102.31 0.8 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.213 -0.929 . . . . 0.0 109.206 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.9 50.12 2.95 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.07 -71.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -1.142 . . . . 0.0 109.555 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.36 25.57 6.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.836 . . . . 0.0 109.283 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER -65.93 6.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -95.22 20.99 8.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.932 . . . . 0.0 109.82 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 51' ' ' TYR . 9.9 mt -67.23 118.78 59.39 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.048 -1.032 . . . . 0.0 108.661 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -58.79 98.57 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 120.909 1.072 . . . . 0.0 112.592 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.911 HG21 HD13 ' A' ' 72' ' ' ILE . 8.9 t -106.1 106.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -90.12 107.27 19.03 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 117.133 -1.827 . . . . 0.0 107.407 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.427 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -63.88 150.52 44.71 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 118.902 -1.119 . . . . 0.0 108.05 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 55' ' ' ILE . 53.7 t -132.39 140.76 46.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.051 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.591 HG23 ' HB2' ' A' ' 90' ' ' ALA . 7.4 t -149.96 157.68 43.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.236 -0.915 . . . . 0.0 109.678 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.36 -44.33 7.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.842 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.8 -64.41 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 0.0 109.836 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.591 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 57.24 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -100.5 -88.61 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.504 -0.748 . . . . 0.0 109.14 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -156.81 -68.25 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.313 -0.867 . . . . 0.0 108.937 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -54.95 -32.56 61.48 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.193 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.539 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 2.4 t-20 -76.64 -47.45 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 66.5 mt -53.03 -45.27 52.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.026 -1.046 . . . . 0.0 108.892 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 100' ' ' GLN . 17.7 mt -66.25 -17.04 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.821 . . . . 0.0 109.218 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 94' ' ' ASN . . . -62.68 -69.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 109.326 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -47.43 -45.71 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 108.5 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -67.88 -27.35 66.59 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.326 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.499 ' N ' ' O ' ' A' ' 96' ' ' ILE . 5.5 tp-100 -55.79 -31.76 62.92 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.962 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -86.86 -20.17 27.87 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.44 76.11 0.3 Allowed Glycine 0 N--CA 1.482 1.742 0 CA-C-N 114.992 -1.004 . . . . 0.0 112.373 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.681 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.21 -112.09 0.08 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 116.844 -1.942 . . . . 0.0 110.454 178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.87 -50.69 5.59 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.832 1.301 . . . . 0.0 108.047 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.438 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 169.85 -155.66 25.78 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.66 127.49 18.23 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.46 -1.023 . . . . 0.0 109.586 179.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.458 ' CG1' HG22 ' A' ' 86' ' ' VAL . 13.6 p -117.96 134.87 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -88.94 121.85 39.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.15 -0.969 . . . . 0.0 109.567 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -94.18 162.06 27.62 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.253 -0.904 . . . . 0.0 108.611 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.6 128.32 15.98 Favored 'Cis proline' 0 N--CA 1.485 1.014 0 C-N-CA 124.755 -0.936 . . . . 0.0 110.427 -2.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.509 ' CE2' HD13 ' A' ' 116' ' ' LEU . 3.9 p90 -99.48 158.27 15.85 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.93 0.871 . . . . 0.0 110.084 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.25 146.79 23.44 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 117' ' ' GLU . . . -45.56 -23.85 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.973 -1.08 . . . . 0.0 109.829 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -73.47 -38.29 65.48 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.035 -1.041 . . . . 0.0 108.49 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -68.84 -62.46 1.37 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 111' ' ' PHE . 7.1 tp -47.67 -41.76 23.18 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.721 -1.191 . . . . 0.0 108.939 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 19.3 mt-10 -61.82 -52.26 64.9 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 121.053 -1.029 . . . . 0.0 109.499 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -46.4 -49.19 18.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.479 -0.763 . . . . 0.0 109.503 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -38.61 76.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.914 . . . . 0.0 109.517 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.87 -63.41 1.17 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 0.0 109.79 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -47.59 -53.06 15.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.103 -0.998 . . . . 0.0 109.874 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm -62.62 -18.21 61.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.11 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 8.8 mt -89.64 -45.66 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 0.0 109.987 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 127' ' ' LEU . 16.7 m-85 -66.63 -31.48 72.19 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.002 -1.061 . . . . 0.0 110.014 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -52.71 -26.63 14.54 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -87.35 -26.48 23.34 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 124' ' ' PHE . 44.0 tp -70.44 -24.01 62.82 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.19 23.41 19.83 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.7 mmt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.337 -1.096 . . . . 0.0 109.465 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.578 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -177.13 150.84 0.77 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.21 -0.931 . . . . 0.0 109.009 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -90.47 17.78 6.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.861 -1.149 . . . . 0.0 110.499 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -164.94 43.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.512 -1.368 . . . . 0.0 111.232 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.2 tp -67.02 110.98 3.6 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.86 -1.15 . . . . 0.0 108.424 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -45.59 111.29 0.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.828 -1.17 . . . . 0.0 111.611 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 62.2 m-85 -105.77 155.14 19.58 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.5 tp -132.65 104.06 6.45 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' H ' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -89.95 130.16 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.183 -0.948 . . . . 0.0 110.261 -179.156 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 36' ' ' ALA . 13.4 t -137.99 105.37 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.44 -0.788 . . . . 0.0 109.078 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -149.6 116.39 5.92 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.148 -0.97 . . . . 0.0 109.431 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.17 -16.85 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.225 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' N ' ' O ' ' A' ' 12' ' ' ASP . 1.5 m-85 -59.49 130.03 44.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.8 m -92.26 48.7 1.43 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.959 . . . . 0.0 109.513 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.3 t -175.72 -14.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.5 ttt -72.37 -35.56 68.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.628 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -63.05 -32.38 73.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.744 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -75.85 -20.16 58.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -75.33 -47.2 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.334 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -32.99 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.215 -179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.6 mtt-85 -46.03 -52.61 11.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.607 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -73.64 -59.58 2.65 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.601 0.715 . . . . 0.0 110.161 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.667 HD22 HD12 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -40.22 -55.41 2.16 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.916 -179.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -58.23 -50.45 73.52 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.065 -1.022 . . . . 0.0 108.926 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -54.0 -34.5 60.04 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -50.87 -38.53 49.93 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.391 -0.818 . . . . 0.0 109.38 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.5 -65.03 0.98 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.299 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.48 26.2 0.02 OUTLIER Glycine 0 N--CA 1.483 1.785 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.578 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 54.0 m-85 -100.52 141.47 33.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.251 -1.147 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -150.04 59.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 110.183 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -173.23 96.01 0.11 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.72 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.6 -178.26 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 109.895 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.495 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.8 mm-40 -139.55 -175.62 4.26 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 11.1 mp0 -144.35 150.21 37.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.276 -0.89 . . . . 0.0 110.87 -178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.642 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -141.65 176.29 9.02 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.67 3.56 14.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.267 -0.896 . . . . 0.0 110.477 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.29 -176.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.026 -1.046 . . . . 0.0 109.262 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.04 -26.42 73.9 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.76 -43.13 93.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.076 -1.249 . . . . 0.0 108.132 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.4 t70 -75.68 -40.85 55.22 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -62.2 -39.26 92.15 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.238 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.515 ' CD2' HG21 ' A' ' 71' ' ' THR . 3.5 mt -62.49 -49.3 75.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.294 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 10.2 m-80 -63.55 -29.13 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.865 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -24.16 21.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.622 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.2 -23.06 61.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 0.0 109.625 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.4 OUTLIER -76.72 -1.62 28.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.124 -0.985 . . . . 0.0 109.472 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.42 -78.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.424 -0.797 . . . . 0.0 109.604 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.85 12.18 0.97 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.79 88.21 1.37 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' PHE . 58.4 m-85 -69.23 103.95 2.07 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.297 -1.119 . . . . 0.0 109.588 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.69 -9.19 0.45 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.63 131.28 10.66 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.188 -1.183 . . . . 0.0 109.986 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HB ' HG22 ' A' ' 83' ' ' VAL . 94.5 t -125.18 114.61 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.418 -0.801 . . . . 0.0 109.551 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.46 77.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 p -100.33 128.74 46.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.473 -0.767 . . . . 0.0 110.541 -179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 59' ' ' ASN . 4.5 t70 -65.12 164.0 13.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.793 -1.192 . . . . 0.0 108.645 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.489 ' CH2' HD13 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -55.38 -2.2 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.057 -1.027 . . . . 0.0 108.877 179.375 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.546 ' H ' ' C ' ' A' ' 57' ' ' ASP . 32.1 m120 46.88 -153.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.647 -1.283 . . . . 0.0 110.302 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.515 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 171.25 -44.95 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.284 -0.885 . . . . 0.0 110.739 -179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.08 125.21 14.23 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.678 0.918 . . . . 0.0 110.259 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.11 -148.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.856 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.17 115.73 1.3 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -85.72 -162.32 0.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.381 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . -60.84 2.79 0.51 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.489 HD13 ' CH2' ' A' ' 58' ' ' TRP . 6.5 tp -82.26 -65.21 1.04 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.768 -1.431 . . . . 0.0 110.341 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -48.3 -19.96 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.472 ' N ' ' C ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -67.98 -62.23 1.5 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.75 HD21 HG11 ' A' ' 83' ' ' VAL . 83.2 mt -56.04 -67.66 0.27 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.562 0.696 . . . . 0.0 109.236 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 69' ' ' LEU . 25.2 tttp -30.46 -53.28 0.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.626 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.515 HG21 ' CD2' ' A' ' 43' ' ' LEU . 6.7 m -59.29 -47.94 83.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.997 -1.064 . . . . 0.0 108.755 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 69' ' ' LEU . 35.5 mt -58.48 -38.06 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.469 -0.77 . . . . 0.0 109.281 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -84.2 -8.11 59.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.356 -0.84 . . . . 0.0 109.604 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -75.77 -26.59 57.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.21 -0.931 . . . . 0.0 109.494 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.2 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.4 -0.813 . . . . 0.0 109.747 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 46.3 -143.35 4.56 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.02 76.85 4.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.309 -1.112 . . . . 0.0 109.363 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.493 ' C ' ' H ' ' A' ' 80' ' ' ALA . 1.3 ttt -132.02 43.71 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.604 -0.685 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.92 33.47 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.99 -47.41 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.228 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.462 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -32.8 97.85 0.12 Allowed Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HG3' HD12 ' A' ' 127' ' ' LEU . 4.2 Cg_exo -64.61 139.04 61.96 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.422 1.415 . . . . 0.0 112.326 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.75 HG11 HD21 ' A' ' 69' ' ' LEU . 6.1 t -130.93 125.5 58.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' CD2' HD21 ' A' ' 116' ' ' LEU . 42.3 tp -107.39 72.23 0.86 Allowed 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.199 -1.0 . . . . 0.0 108.425 177.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.476 ' SD ' HD11 ' A' ' 69' ' ' LEU . 5.7 mtp -51.63 151.71 3.13 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.5 t -126.51 128.55 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.635 0.731 . . . . 0.0 110.745 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 88' ' ' ALA . 0.6 OUTLIER -150.05 177.05 10.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 108' ' ' VAL . . . -89.39 -123.42 0.06 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.93 -1.106 . . . . 0.0 108.862 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -47.92 133.26 14.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 109.306 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -93.34 109.94 21.48 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.696 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -73.12 -171.06 0.84 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.197 -0.939 . . . . 0.0 108.872 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 45.3 mttp -94.32 -84.93 0.31 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.902 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HA ' HD12 ' A' ' 96' ' ' ILE . 0.8 OUTLIER -49.54 -8.0 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.317 -0.864 . . . . 0.0 110.382 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -76.84 -52.43 9.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 110.107 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.871 HD11 ' HB1' ' A' ' 90' ' ' ALA . 5.6 mt -68.77 -28.08 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.554 HD12 ' HA ' ' A' ' 93' ' ' GLU . 52.0 mt -64.75 -64.06 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 109.979 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.86 -57.16 3.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -60.08 -43.69 95.31 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.023 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.62 -44.33 73.05 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.63 -19.92 59.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 109.831 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.22 -103.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.279 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.629 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -133.22 0.7 4.4 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.99 11.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.179 -0.601 . . . . 0.0 111.198 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.629 ' H ' ' C ' ' A' ' 102' ' ' GLY . 22.0 m -29.24 -34.74 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.995 -0.441 . . . . 0.0 111.8 -176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.2 130.43 10.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.668 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 49.7 t80 -136.5 112.58 9.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.437 -1.037 . . . . 0.0 109.492 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.6 p -115.39 129.01 72.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 88' ' ' ALA . 2.6 p -91.37 103.07 14.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 154.89 89.71 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.035 -1.041 . . . . 0.0 109.165 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.26 158.84 98.46 Favored 'Cis proline' 0 N--CA 1.49 1.295 0 O-C-N 122.506 0.74 . . . . 0.0 111.368 -1.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -136.16 154.65 50.9 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.853 0.835 . . . . 0.0 109.204 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.5 146.29 23.79 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 178.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.69 -40.44 20.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.969 -1.082 . . . . 0.0 108.699 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.67 -34.07 76.19 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 112' ' ' THR . 25.4 m -68.38 -67.11 0.49 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -40.92 -46.94 2.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.584 178.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -57.32 -54.82 42.45 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 110.302 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.412 ' OE2' HG23 ' A' ' 115' ' ' THR . 1.6 pt-20 -47.84 -30.13 3.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.343 -0.848 . . . . 0.0 109.885 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -72.19 -49.32 36.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.389 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 123' ' ' ILE . 11.0 mt -48.45 -54.9 12.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.81 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.52 -25.15 1.02 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.676 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -86.85 -27.07 23.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.022 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 120' ' ' LEU . 37.7 mm -81.52 -34.35 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -86.5 -8.61 57.42 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.099 -1.001 . . . . 0.0 110.755 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.57 -17.5 60.03 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -101.31 -30.31 11.57 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -77.17 -29.96 54.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 66.04 74.49 0.51 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.271 -1.134 . . . . 0.0 109.438 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 1.1 t0 -44.78 151.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.274 -0.891 . . . . 0.0 110.116 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 29' ' ' GLY . 8.7 mttm -90.14 20.36 4.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.059 -1.026 . . . . 0.0 109.835 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -163.77 45.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.042 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 25.4 tp -71.82 121.09 18.36 Favored 'General case' 0 C--O 1.203 -1.344 0 O-C-N 121.025 -1.047 . . . . 0.0 108.231 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mttp -53.61 117.31 3.02 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.932 -1.105 . . . . 0.0 112.176 -177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 70.7 m-85 -112.4 147.77 35.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' CD2' HD12 ' A' ' 46' ' ' LEU . 62.4 tp -121.69 108.29 13.36 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.154 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -92.95 104.46 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.171 -0.956 . . . . 0.0 108.735 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.5 t -89.94 38.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.83 147.01 23.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.118 -0.989 . . . . 0.0 109.503 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -98.76 -13.94 19.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.511 -0.743 . . . . 0.0 109.541 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -61.08 137.65 58.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.5 t -88.08 17.4 5.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.233 -0.917 . . . . 0.0 109.316 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.44 -40.91 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.336 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.421 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 6.2 ttt -50.33 -35.0 25.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' CG ' ' N ' ' A' ' 19' ' ' ARG . 4.7 ptm85 -63.27 -47.91 80.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -0.915 . . . . 0.0 110.031 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' N ' ' CG ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -53.73 -32.54 52.46 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.129 -177.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -53.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -0.933 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -31.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.019 -1.051 . . . . 0.0 110.679 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.09 15.42 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.903 -1.123 . . . . 0.0 109.408 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -69.96 -59.44 2.92 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.757 0.789 . . . . 0.0 109.858 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.23 -52.7 2.61 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.046 -179.287 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.0 mt -62.59 -50.22 72.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.014 . . . . 0.0 108.988 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -55.52 -30.71 61.18 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -57.89 -27.86 63.68 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.7 mt -87.49 -37.57 16.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 139.28 7.69 1.07 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.9 m-85 -89.89 139.74 30.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.66 -1.494 . . . . 0.0 109.754 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 31' ' ' ASN . 1.1 p30 -148.16 62.89 1.11 Allowed 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.03 -1.044 . . . . 0.0 110.302 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.52 105.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.591 -1.318 . . . . 0.0 110.143 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.501 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.15 179.34 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.105 -0.997 . . . . 0.0 109.99 179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' N ' HG23 ' A' ' 33' ' ' VAL . 1.8 mm-40 -137.26 -170.37 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 18' ' ' ARG . 47.1 mt-10 -141.97 149.7 40.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.324 -0.86 . . . . 0.0 110.741 -178.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.02 -172.82 4.26 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -148.67 7.15 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.982 -1.074 . . . . 0.0 110.015 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.568 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER 175.73 177.86 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.695 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -69.39 -39.57 80.59 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 118.955 -1.593 . . . . 0.0 110.066 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.0 t -54.59 -40.79 51.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.406 -1.644 . . . . 0.0 107.654 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -81.01 -43.21 19.94 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.499 -0.751 . . . . 0.0 109.87 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -73.98 -58.22 3.44 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.391 -0.818 . . . . 0.0 109.504 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.668 ' C ' HD12 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -53.53 -37.87 63.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 109.946 -179.643 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -72.66 -42.91 63.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.371 -1.456 . . . . 0.0 109.216 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -77.35 -14.29 59.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.535 -0.728 . . . . 0.0 110.389 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.479 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -71.77 -25.05 61.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.701 -1.249 . . . . 0.0 108.711 -179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -66.11 -2.29 4.03 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.393 -0.817 . . . . 0.0 109.237 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.09 -66.49 0.39 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.471 -0.768 . . . . 0.0 109.482 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.19 13.42 0.54 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.505 -1.331 . . . . 0.0 109.937 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.67 88.17 1.28 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.605 ' O ' HD13 ' A' ' 81' ' ' LEU . 29.1 m-85 -64.3 122.45 16.69 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.398 -1.06 . . . . 0.0 110.516 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.21 -6.1 82.55 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -159.17 136.78 10.07 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.011 -1.288 . . . . 0.0 109.34 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.8 t -130.42 123.97 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.099 -1.001 . . . . 0.0 109.81 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mt -109.16 96.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.771 -0.581 . . . . 0.0 109.457 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.07 145.38 42.37 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.88 -162.58 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.971 -1.081 . . . . 0.0 109.178 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -103.76 -26.01 12.89 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.446 -0.784 . . . . 0.0 109.258 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.1 OUTLIER -96.79 135.33 38.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.538 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.487 ' SD ' ' O ' ' A' ' 59' ' ' ASN . 0.0 OUTLIER -133.95 159.29 72.96 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.96 -68.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.968 0 C-N-CA 121.368 1.378 . . . . 0.0 110.517 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 63' ' ' MET . 2.8 p30 -85.62 -102.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 109.67 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 1.6 mmt -63.3 -178.06 0.23 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.656 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.74 -179.53 5.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -86.41 -31.63 18.65 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 40.4 tp -47.57 -37.92 13.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -1.198 . . . . 0.0 108.984 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.21 -35.13 75.88 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 0.0 109.333 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.695 HD11 ' N ' ' A' ' 39' ' ' GLY . 4.8 mp -63.88 -27.19 68.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.338 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.815 HD21 ' N ' ' A' ' 103' ' ' ALA . 53.8 tp -77.76 -60.21 2.46 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 69' ' ' LEU . 1.4 tmtp? -43.7 -32.56 1.03 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -55.57 -52.99 61.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.865 . . . . 0.0 109.348 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.5 mp -57.95 -36.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 108.902 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -69.15 -27.97 66.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 109.557 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.56 -28.81 2.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -0.941 . . . . 0.0 109.262 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.6 -38.25 20.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . 59.8 46.14 94.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 167.3 -52.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.281 -1.129 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.445 ' C ' ' H ' ' A' ' 80' ' ' ALA . 12.8 mtt -94.46 21.47 7.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 109.438 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 77.2 p -74.7 37.57 0.11 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -97.5 -20.12 17.94 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.795 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 51' ' ' TYR . 15.0 mt -52.51 113.38 4.34 Favored Pre-proline 0 C--N 1.306 -1.318 0 O-C-N 121.011 -1.055 . . . . 0.0 109.174 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.16 145.99 90.25 Favored 'Trans proline' 0 N--CA 1.479 0.635 0 C-N-CA 121.164 1.243 . . . . 0.0 112.983 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 69' ' ' LEU . 2.4 t -126.08 132.17 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 116' ' ' LEU . 43.8 tp -113.48 70.79 0.73 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.662 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.432 ' SD ' ' N ' ' A' ' 86' ' ' VAL . 14.0 tmm? -49.48 159.81 0.31 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' N ' ' SD ' ' A' ' 85' ' ' MET . 39.5 t -137.94 121.26 20.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.488 -0.758 . . . . 0.0 110.16 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.8 t -150.13 178.88 8.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 0.0 110.02 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.94 -45.64 2.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.533 -0.73 . . . . 0.0 109.362 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 13.3 mt-10 -70.59 -77.05 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.558 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.63 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 63.27 117.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.52 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -131.8 148.67 52.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -42.5 -48.59 5.3 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.529 -0.732 . . . . 0.0 110.259 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -64.44 -29.72 70.76 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.283 -0.886 . . . . 0.0 110.665 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -89.99 -23.56 21.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.037 -1.039 . . . . 0.0 110.561 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.63 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.3 mt -89.95 -16.35 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.98 -1.075 . . . . 0.0 109.659 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 97' ' ' ALA . 19.1 mt -74.95 -68.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.18 -43.78 21.6 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -59.97 -51.19 70.74 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.42 -0.8 . . . . 0.0 109.223 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.84 -46.66 64.45 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.803 . . . . 0.0 110.593 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -77.19 6.26 6.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.06 -1.025 . . . . 0.0 110.4 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD23 ' A' ' 69' ' ' LEU . . . -110.53 -17.79 13.35 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 0.0 110.396 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' A' ' 104' ' ' SER . . . 136.36 -12.39 4.06 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.815 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -55.41 11.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.861 -0.788 . . . . 0.0 111.467 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.8 m -29.41 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.917 -0.489 . . . . 0.0 111.312 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -105.74 124.11 7.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.549 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -145.02 105.7 4.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.102 -1.234 . . . . 0.0 109.405 -179.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 107' ' ' VAL . 9.5 p -103.03 136.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.45 HG22 ' CZ ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -87.41 100.07 9.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.097 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 87' ' ' THR . 10.9 pttt -63.52 154.44 79.52 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 120.71 -1.244 . . . . 0.0 109.09 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.33 161.93 93.5 Favored 'Cis proline' 0 N--CA 1.491 1.36 0 O-C-N 122.479 0.726 . . . . 0.0 111.225 -1.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -142.9 162.75 34.64 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.009 0.909 . . . . 0.0 110.082 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.09 148.95 26.27 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.76 -19.9 0.25 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.982 -1.074 . . . . 0.0 109.249 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.44 -37.31 51.84 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.401 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.27 -61.39 1.84 Allowed 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD11 HD21 ' A' ' 84' ' ' LEU . 5.3 tp -47.92 -38.64 16.99 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.005 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.49 -44.82 77.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 15.4 tt0 -56.38 -26.69 53.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.333 -0.854 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -81.95 -58.83 2.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.261 -0.899 . . . . 0.0 109.982 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 tt -46.28 -48.72 18.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.865 . . . . 0.0 109.55 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -62.68 -33.49 75.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -67.83 -31.48 71.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.474 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.1 mt -88.72 -38.01 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.865 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -73.03 -3.69 27.73 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.149 -0.969 . . . . 0.0 109.736 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -74.03 -29.33 61.87 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -88.68 -30.62 19.0 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -74.39 -28.99 61.35 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.36 83.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmm . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.252 -1.146 . . . . 0.0 109.509 179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 60.56 129.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.38 -0.825 . . . . 0.0 109.151 -179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -90.06 24.04 2.61 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.889 -1.132 . . . . 0.0 110.058 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.22 40.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.789 -1.194 . . . . 0.0 110.773 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 HD11 ' HA3' ' A' ' 52' ' ' GLY . 58.5 tp -67.03 133.24 49.51 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -75.08 120.39 20.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.893 -1.13 . . . . 0.0 111.32 -177.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.628 ' HB2' HG22 ' A' ' 33' ' ' VAL . 74.1 m-85 -109.66 148.16 31.83 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' CD2' HD12 ' A' ' 46' ' ' LEU . 35.6 tp -122.29 118.97 29.79 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.92 103.96 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.577 -0.702 . . . . 0.0 109.77 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.896 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.5 t -93.41 31.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 121.201 -0.937 . . . . 0.0 109.487 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -63.27 157.46 22.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.745 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.85 -30.96 13.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.412 -0.805 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.35 150.36 49.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.457 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.45 -24.2 18.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 0.0 109.534 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -92.46 -20.58 20.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -52.25 49.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.439 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.51 HH11 ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -49.43 -32.13 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.29 179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' HA ' ' HE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -69.4 -40.71 77.17 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.113 -1.035 . . . . 0.0 109.802 -178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 21' ' ' VAL . 4.8 mt -57.86 -57.87 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.802 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.88 -38.16 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -178.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.618 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.29 -52.85 19.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.968 -1.082 . . . . 0.0 109.193 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.5 t30 -64.34 -56.9 11.27 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.775 0.798 . . . . 0.0 109.171 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.86 -52.39 2.38 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.744 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 24.4 mt -63.1 -46.26 88.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 0.0 108.811 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 ttmm -57.25 -32.58 66.71 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.342 -0.848 . . . . 0.0 109.419 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 4.7 tt0 -55.48 -41.96 73.71 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.284 -0.885 . . . . 0.0 109.382 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.503 HD21 ' CG ' ' A' ' 117' ' ' GLU . 6.2 mp -75.43 -55.39 5.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.792 . . . . 0.0 109.298 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.01 78.01 0.02 OUTLIER Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -150.01 147.46 27.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -1.151 . . . . 0.0 109.223 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -150.03 58.53 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.126 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -169.55 93.32 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.077 -1.014 . . . . 0.0 109.177 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 8' ' ' PHE . 73.4 t -138.5 151.28 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.373 -0.829 . . . . 0.0 110.036 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 6.7 mt-10 -125.77 -171.83 2.47 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -150.16 157.11 42.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.924 -1.11 . . . . 0.0 110.884 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.896 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.54 -168.97 2.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -138.81 0.32 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.375 -0.828 . . . . 0.0 110.478 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 9.7 t70 -174.21 174.9 2.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.007 -1.058 . . . . 0.0 109.412 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.52 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -59.57 -57.21 20.72 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.576 HG22 ' ND2' ' A' ' 44' ' ' ASN . 13.2 p -50.97 -28.24 6.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.359 -1.083 . . . . 0.0 108.535 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 31.4 t0 -76.27 -47.01 25.29 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.41 -0.806 . . . . 0.0 109.133 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.581 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -54.65 -66.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.346 -0.847 . . . . 0.0 109.786 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.6 mt -50.06 -45.21 52.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.446 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.576 ' ND2' HG22 ' A' ' 40' ' ' VAL . 72.4 m-20 -63.63 -39.25 93.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.0 -1.063 . . . . 0.0 110.554 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -90.1 -1.08 57.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.085 -1.009 . . . . 0.0 110.549 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -87.52 -30.87 20.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.836 -1.165 . . . . 0.0 108.882 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -54.81 -9.09 0.31 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.105 -0.997 . . . . 0.0 108.574 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.02 -67.01 0.32 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.512 -0.743 . . . . 0.0 109.757 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.63 -92.3 0.16 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -156.96 78.29 0.19 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' O ' HD21 ' A' ' 81' ' ' LEU . 41.9 m-85 -57.35 91.68 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.431 -1.04 . . . . 0.0 110.158 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.96 -9.31 5.38 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.5 137.64 20.57 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.246 -1.15 . . . . 0.0 110.057 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 83' ' ' VAL . 97.0 t -134.92 120.02 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.155 -0.966 . . . . 0.0 109.684 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 mt -106.53 131.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' ASP . 83.7 p -149.79 150.14 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.309 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 56' ' ' SER . 36.9 m-20 -60.67 -115.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.184 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -150.45 -42.52 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.603 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 59' ' ' ASN . 0.2 OUTLIER 178.15 114.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.929 -179.758 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.712 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.35 -54.72 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.761 -0.587 . . . . 0.0 110.283 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.712 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.13 -61.2 0.11 Allowed 'Trans proline' 0 C--O 1.217 -0.563 0 N-CA-C 108.846 -1.251 . . . . 0.0 108.846 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' OD1' ' A' ' 59' ' ' ASN . 2.8 m-80 -154.47 -148.96 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.6 mtt -48.16 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.101 -0.999 . . . . 0.0 108.423 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER 42.55 -156.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.518 -0.739 . . . . 0.0 110.785 178.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.667 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 48.17 -83.82 0.01 OUTLIER Glycine 0 N--CA 1.493 2.469 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -51.11 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.869 -1.371 . . . . 0.0 110.037 -178.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -48.98 -33.78 11.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.786 -1.196 . . . . 0.0 108.813 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -62.65 -35.67 80.35 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.729 ' CD2' ' H ' ' A' ' 102' ' ' GLY . 8.9 tt -90.05 -60.51 1.91 Allowed 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -36.06 -34.49 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.131 0.491 . . . . 0.0 110.012 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.5 m -59.14 -50.1 75.35 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 69' ' ' LEU . 2.0 mt -54.41 -37.86 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -70.36 -32.74 70.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.452 -0.78 . . . . 0.0 109.515 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.68 33.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.927 . . . . 0.0 109.582 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 77' ' ' ALA . 7.8 t0 -75.71 98.59 4.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.327 -0.858 . . . . 0.0 109.595 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -23.71 66.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' A' ' 75' ' ' ASP . . . -65.19 -38.47 90.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -1.186 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.4 mtm -136.39 45.88 2.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.525 -0.734 . . . . 0.0 109.189 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 79' ' ' SER . 9.3 t -77.95 45.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.358 -0.839 . . . . 0.0 109.509 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.03 10.22 0.69 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.0 -1.062 . . . . 0.0 110.063 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.822 HD21 ' O ' ' A' ' 51' ' ' TYR . 9.6 tp -55.36 120.74 32.97 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.054 -1.029 . . . . 0.0 108.382 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.25 131.36 38.38 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 120.962 1.108 . . . . 0.0 112.233 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.8 t -125.69 125.18 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.0 tp -107.05 70.12 0.78 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.086 -1.046 . . . . 0.0 108.571 177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 mtt -51.53 168.91 0.06 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -143.11 126.67 13.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.532 -0.73 . . . . 0.0 109.801 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.2 t -150.1 178.44 8.96 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.911 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.37 -24.43 3.94 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -99.72 50.78 0.92 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.44 -0.787 . . . . 0.0 109.521 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -75.5 101.92 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.192 -0.943 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.33 -82.62 0.21 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.154 -0.967 . . . . 0.0 109.332 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -173.01 -73.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.165 -0.959 . . . . 0.0 109.3 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.29 -33.6 29.45 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.151 -0.968 . . . . 0.0 109.663 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -71.5 -24.3 61.95 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.77 HD11 ' HB1' ' A' ' 90' ' ' ALA . 96.3 mt -83.16 -36.98 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 97' ' ' ALA . 1.4 mp -57.5 -57.51 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.237 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.423 ' N ' HG22 ' A' ' 96' ' ' ILE . . . -47.2 -37.77 10.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 0.0 109.229 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -64.65 -60.28 3.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.423 -0.798 . . . . 0.0 109.733 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.479 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -55.1 -40.19 70.18 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.221 -0.924 . . . . 0.0 109.837 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -48.23 -19.61 0.3 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.479 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -103.26 -123.96 0.2 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.729 ' H ' ' CD2' ' A' ' 69' ' ' LEU . . . -111.87 2.24 27.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.71 11.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.623 -0.928 . . . . 0.0 109.98 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 102' ' ' GLY . 1.4 m -29.54 -33.69 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -109.64 127.67 8.56 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.53 120.31 9.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.196 -1.179 . . . . 0.0 108.825 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 116' ' ' LEU . 7.5 p -119.59 130.17 74.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -83.01 105.04 12.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.154 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -66.79 161.08 64.46 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.02 -1.05 . . . . 0.0 109.257 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.46 166.35 83.34 Favored 'Cis proline' 0 N--CA 1.488 1.153 0 C-N-CA 124.832 -0.904 . . . . 0.0 110.801 -2.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.77 164.1 33.86 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 110.344 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -105.46 148.21 27.43 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.462 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -45.87 -36.66 5.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.048 . . . . 0.0 109.479 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.35 -37.4 87.39 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.9 m -69.85 -67.01 0.52 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.572 HD11 HG11 ' A' ' 107' ' ' VAL . 5.7 tp -45.62 -36.89 5.09 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.855 -1.138 . . . . 0.0 109.033 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 6.5 tm-20 -66.99 -46.85 73.31 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.209 -0.932 . . . . 0.0 109.643 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 26.9 tt0 -47.77 -60.01 2.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 0.0 109.495 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -34.89 64.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.474 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 tp -53.88 -72.18 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.902 . . . . 0.0 109.6 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -49.45 -17.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.926 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -75.47 -33.13 60.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.14 -0.975 . . . . 0.0 109.733 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.447 HD11 ' HA2' ' A' ' 105' ' ' GLY . 8.0 mt -89.97 -43.33 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 109.934 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -57.16 -21.13 30.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.634 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -57.36 -20.37 28.8 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.763 -1.211 . . . . 0.0 108.221 179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.5 tttm -96.82 -22.03 17.17 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.542 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -89.32 -18.98 25.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.68 79.07 0.06 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.95 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.541 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER -142.57 135.0 27.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.357 -0.839 . . . . 0.0 108.883 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -90.05 21.55 3.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.977 . . . . 0.0 109.572 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -160.13 44.0 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.068 -1.02 . . . . 0.0 109.956 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 6' ' ' LEU . 36.6 tp -84.46 125.7 32.6 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -74.67 123.28 24.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.169 -0.957 . . . . 0.0 112.155 -176.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 65.9 m-85 -114.88 140.89 48.6 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.8 tp -106.02 116.76 32.49 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.57 102.8 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' HB3' ' A' ' 36' ' ' ALA . 30.0 t -95.02 62.85 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.243 -0.91 . . . . 0.0 109.644 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -103.27 132.48 49.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.505 -0.747 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.12 -21.26 36.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.133 -0.979 . . . . 0.0 109.299 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -57.86 146.82 30.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.33 -0.856 . . . . 0.0 109.513 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 m -90.6 29.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.16 -38.22 0.08 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.429 ' SD ' ' OD2' ' A' ' 57' ' ' ASP . 27.5 ttt -48.41 -45.57 36.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -56.65 9.83 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -56.34 -41.59 76.34 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 110.133 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.9 mt -54.61 -53.78 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.748 -179.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -44.99 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 0.0 110.408 -178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -49.01 -52.83 22.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.872 -1.143 . . . . 0.0 109.034 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -62.02 -56.79 15.47 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.89 0.853 . . . . 0.0 109.049 179.568 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -39.32 -59.75 1.01 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.066 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.3 mt -59.44 -47.28 86.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.983 -1.073 . . . . 0.0 108.948 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -53.43 -33.35 53.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.358 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.19 -33.16 39.54 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.165 -0.96 . . . . 0.0 109.177 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 28' ' ' LEU . 9.9 mp -80.43 -67.62 0.75 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 172.08 17.54 0.02 OUTLIER Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.294 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 76.0 m-85 -90.66 129.46 36.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.749 -1.442 . . . . 0.0 109.197 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -129.86 68.95 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.502 -0.749 . . . . 0.0 109.93 -179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.5 103.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.082 -1.011 . . . . 0.0 108.569 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.9 t -149.98 148.24 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.518 -178.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.82 -171.4 2.18 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -149.86 150.31 31.75 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.94 -1.1 . . . . 0.0 110.832 -178.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.96 165.5 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 1.8 mp0 -135.96 32.69 2.93 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.125 -0.984 . . . . 0.0 110.729 -178.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 7.4 t0 175.04 145.53 0.07 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.277 -0.89 . . . . 0.0 108.832 179.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -50.6 -29.85 18.96 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.3 OUTLIER -73.79 -28.37 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.254 . . . . 0.0 108.534 179.171 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.1 t0 -81.4 -41.81 21.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.83 86.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.446 -0.784 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mt -70.73 -41.94 71.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 0.0 109.454 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -63.36 -27.04 69.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -53.45 4.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.671 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.406 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -56.63 -19.67 17.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 108.645 179.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -50.36 -28.05 7.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.0 -73.48 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.41 68.02 0.47 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 178.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -174.81 24.24 0.06 OUTLIER Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' O ' HD21 ' A' ' 81' ' ' LEU . 52.6 m-85 -94.74 83.06 3.98 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.28 -1.13 . . . . 0.0 109.904 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.51 0.48 2.07 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -162.95 152.82 15.79 Favored 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.1 -1.235 . . . . 0.0 109.805 -179.115 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG13 ' HB3' ' A' ' 9' ' ' LEU . 93.6 t -149.4 128.8 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.724 -1.235 . . . . 0.0 109.78 179.209 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.44 128.79 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.5 p -132.67 163.04 29.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.47 -0.769 . . . . 0.0 109.171 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 18.3 m-20 -91.33 -106.08 0.1 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.196 -0.94 . . . . 0.0 110.645 -178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.864 ' CZ2' HD21 ' A' ' 66' ' ' LEU . 36.5 t-105 -164.09 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -95.66 137.19 35.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.504 ' C ' ' H ' ' A' ' 62' ' ' ASN . 3.6 mmt -139.78 155.24 71.36 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.542 -0.724 . . . . 0.0 109.221 -179.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.14 -1.13 0.16 Allowed 'Trans proline' 0 C--N 1.322 -0.817 0 C-N-CA 121.431 1.421 . . . . 0.0 111.076 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -133.63 107.87 8.22 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.433 -0.792 . . . . 0.0 109.083 179.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.421 ' O ' ' OD2' ' A' ' 64' ' ' ASP . 42.1 mtm 53.67 -86.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.0 109.405 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 62' ' ' ASN . 1.2 m-20 -169.93 150.64 3.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 108.86 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.21 8.86 2.49 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.864 HD21 ' CZ2' ' A' ' 58' ' ' TRP . 9.2 mt -67.09 -52.85 36.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -1.107 . . . . 0.0 109.082 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -74.06 -14.13 60.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.416 -0.802 . . . . 0.0 109.563 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.516 HD13 ' HA2' ' A' ' 39' ' ' GLY . 7.7 tp -67.62 -57.35 6.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.346 -0.846 . . . . 0.0 108.836 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.896 ' O ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.24 -36.02 66.36 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 -179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 74' ' ' ALA . 16.8 tttt -47.03 -47.91 22.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.192 -0.943 . . . . 0.0 108.82 178.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 99.1 m -47.16 -59.24 3.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.477 -0.765 . . . . 0.0 109.638 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mt -49.82 -40.09 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.66 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.54 -10.68 55.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -92.43 -26.62 17.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.287 -0.883 . . . . 0.0 109.612 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -45.13 158.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 0.0 109.702 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -49.28 -52.85 21.85 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.06 109.44 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -1.155 . . . . 0.0 109.528 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.503 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -144.25 12.71 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.858 . . . . 0.0 109.281 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -65.31 4.84 0.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.175 179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -89.87 -15.49 32.08 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.498 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.1 tp -112.03 99.13 44.88 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.561 -0.712 . . . . 0.0 109.445 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.66 139.0 78.63 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.037 1.825 . . . . 0.0 113.695 -178.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 69' ' ' LEU . 2.5 t -124.75 119.55 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.527 ' HA ' ' HG ' ' A' ' 104' ' ' SER . 2.1 tp -99.0 109.78 22.49 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.458 ' CE ' HD23 ' A' ' 69' ' ' LEU . 6.8 ttm -86.2 146.85 26.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.9 144.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.8 t -150.09 173.92 13.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.943 -1.098 . . . . 0.0 110.74 -179.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' ' HE2' ' A' ' 109' ' ' LYS . . . -113.61 148.7 35.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 49.08 84.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.162 -0.961 . . . . 0.0 108.927 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.521 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -83.42 119.08 24.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.146 -0.971 . . . . 0.0 110.022 -179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.9 -169.28 0.56 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.326 -0.859 . . . . 0.0 109.051 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -99.6 -39.05 8.49 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.306 -0.871 . . . . 0.0 109.704 179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.89 -19.08 25.01 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.113 -0.992 . . . . 0.0 110.284 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.6 m-20 -80.23 -22.59 41.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 110.106 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.521 HD11 ' HB1' ' A' ' 90' ' ' ALA . 24.7 mt -69.16 -8.68 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.132 . . . . 0.0 109.932 -179.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' C ' ' N ' ' A' ' 98' ' ' ALA . 10.1 mt -90.17 -49.11 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.05 -24.63 0.16 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.718 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -50.28 -56.8 9.65 Favored 'General case' 0 C--O 1.193 -1.878 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 98' ' ' ALA . . . -45.58 -44.73 13.17 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 119.629 -1.919 . . . . 0.0 108.924 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -59.69 -36.8 77.21 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 177.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' ALA . . . -126.33 -72.51 0.65 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.718 ' N ' ' O ' ' A' ' 98' ' ' ALA . . . -48.8 82.17 0.01 OUTLIER Glycine 0 N--CA 1.496 2.643 0 N-CA-C 106.576 -2.609 . . . . 0.0 106.576 176.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -70.03 -109.81 0.0 OUTLIER 'General case' 0 C--N 1.248 -3.824 0 CA-C-N 111.508 -2.346 . . . . 0.0 114.994 -174.236 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.527 ' HG ' ' HA ' ' A' ' 84' ' ' LEU . 2.0 p -38.87 -54.18 1.65 Allowed 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.564 -176.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.402 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . -156.8 171.17 34.29 Favored Glycine 0 N--CA 1.486 1.986 0 C-N-CA 119.044 -1.55 . . . . 0.0 110.215 -179.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.12 116.2 15.15 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.407 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.1 p -115.59 126.34 73.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.5 p -78.67 108.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -68.54 157.38 88.33 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 120.991 -1.068 . . . . 0.0 109.583 -179.633 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -75.79 159.39 97.22 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 O-C-N 122.768 0.878 . . . . 0.0 110.626 -2.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.463 ' CE2' HD13 ' A' ' 116' ' ' LEU . 2.7 p90 -136.63 160.06 39.93 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.658 0.742 . . . . 0.0 109.783 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.47 148.81 22.42 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.518 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.0 -32.09 8.61 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.97 -1.082 . . . . 0.0 108.833 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.06 71.99 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 112' ' ' THR . 6.0 m -70.89 -66.94 0.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 111' ' ' PHE . 11.6 tp -45.58 -41.62 10.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.859 -1.151 . . . . 0.0 109.195 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.72 -50.06 70.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.301 -0.874 . . . . 0.0 109.804 -179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -46.22 -41.71 13.22 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 0.0 109.436 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -77.98 -43.69 28.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.306 -0.871 . . . . 0.0 109.124 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 tp -47.44 -47.48 26.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 108.957 179.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.481 ' N ' ' OD1' ' A' ' 121' ' ' ASN . 1.2 m-20 -49.9 -59.88 3.44 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.323 -0.861 . . . . 0.0 109.947 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -50.32 -35.46 27.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.351 -0.843 . . . . 0.0 110.016 -179.584 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 23.7 mt -73.15 -41.54 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.933 . . . . 0.0 110.005 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -77.92 0.85 22.58 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.095 -1.003 . . . . 0.0 110.215 -179.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -75.65 -32.66 60.28 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -88.71 -25.97 22.05 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -33.61 27.67 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.28 82.43 0.03 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.464 -179.975 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.553 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER 61.08 116.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.873 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -90.39 27.24 1.73 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.745 -1.222 . . . . 0.0 110.31 -179.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -145.82 36.83 1.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.174 -0.954 . . . . 0.0 109.886 -179.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.9 tp -80.38 141.09 35.7 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -80.02 129.87 34.82 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.915 -1.116 . . . . 0.0 111.349 -177.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.598 ' HB2' HG22 ' A' ' 33' ' ' VAL . 63.2 m-85 -118.79 151.56 37.82 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.781 -0.574 . . . . 0.0 109.655 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -127.04 109.88 12.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -98.77 114.45 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.843 . . . . 0.0 109.347 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.851 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.8 t -110.56 108.76 26.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 O-C-N 121.524 -0.735 . . . . 0.0 109.832 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 124.31 4.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.329 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -29.29 70.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.678 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -48.77 139.18 10.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.483 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.9 p -93.56 22.24 5.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.3 p -145.79 -15.87 0.47 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.6 ttt -70.95 -39.3 72.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.642 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -35.35 80.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ttp85 -68.93 -21.02 64.23 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.077 -178.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.1 -45.19 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.868 . . . . 0.0 109.744 -179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.76 -36.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.287 -0.883 . . . . 0.0 110.017 -179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.1 mtt-85 -47.42 -53.02 15.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.364 179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -66.31 -57.56 7.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.818 0.818 . . . . 0.0 109.371 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -40.18 -60.67 1.01 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.816 -179.578 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 8' ' ' PHE . 3.7 mt -56.45 -46.05 80.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.215 -0.928 . . . . 0.0 109.125 179.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.0 ttmt -55.45 -35.24 65.25 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.175 -0.953 . . . . 0.0 109.305 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -54.32 -28.14 40.44 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.406 -0.809 . . . . 0.0 109.783 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.09 -33.6 22.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.43 10.69 2.09 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.553 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 79.4 m-85 -89.69 141.2 28.83 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.743 -1.445 . . . . 0.0 109.418 -179.214 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -143.64 28.4 1.45 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.481 -0.762 . . . . 0.0 109.728 -179.774 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -131.61 88.23 2.55 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 8' ' ' PHE . 57.8 t -137.31 153.24 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.627 -0.671 . . . . 0.0 110.11 -178.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -125.57 -173.6 2.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.19 148.2 28.64 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 110.28 -179.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.851 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -128.05 166.7 17.9 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 12.5 mm-40 -94.53 -3.02 50.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.036 . . . . 0.0 110.867 -178.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 37' ' ' GLU . 0.3 OUTLIER 169.63 173.85 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.917 -1.114 . . . . 0.0 109.691 179.988 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.45 -48.42 54.87 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 t -53.96 -42.87 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.988 -1.301 . . . . 0.0 108.727 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.626 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 27.5 t0 -63.99 -50.44 68.52 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -53.36 -49.38 67.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.485 -0.759 . . . . 0.0 109.276 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.8 tp -53.22 -35.39 59.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.447 -0.783 . . . . 0.0 109.908 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -80.75 -33.44 35.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 110.371 -179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -90.07 -12.54 38.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.068 -1.02 . . . . 0.0 110.464 -179.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -63.42 -20.58 65.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.029 -1.044 . . . . 0.0 109.212 -179.751 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -78.93 1.21 24.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.138 179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.94 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.409 -0.807 . . . . 0.0 109.657 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.25 11.93 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.32 80.63 1.47 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.765 ' O ' HD21 ' A' ' 81' ' ' LEU . 38.3 m-85 -60.06 102.14 0.15 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.348 -1.089 . . . . 0.0 109.769 -179.723 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.47 -12.54 1.0 Allowed Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -153.24 134.59 14.25 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.378 -1.072 . . . . 0.0 109.499 -179.427 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.477 ' HB ' HG22 ' A' ' 83' ' ' VAL . 88.9 t -131.26 117.69 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 120.827 -1.171 . . . . 0.0 109.939 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.7 mt -102.94 119.6 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 11.8 p -141.47 144.1 34.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.406 -0.808 . . . . 0.0 109.248 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.7 p-10 -60.47 -112.45 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.979 -1.075 . . . . 0.0 109.229 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -173.87 -32.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 108.834 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -95.5 58.57 2.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 0.0 109.54 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.423 ' HG3' ' H ' ' A' ' 62' ' ' ASN . 2.1 ptm -47.88 159.24 0.48 Allowed Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -55.47 -48.47 20.33 Favored 'Trans proline' 0 C--N 1.318 -1.069 0 C-N-CA 121.248 1.299 . . . . 0.0 110.514 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.423 ' H ' ' HG3' ' A' ' 60' ' ' MET . 0.9 OUTLIER -79.09 -100.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.853 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.1 mmt -90.9 -110.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.938 . . . . 0.0 109.869 -179.565 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.3 -175.56 4.59 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.78 12.29 70.2 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.25 -62.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.8 -1.411 . . . . 0.0 108.569 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -48.8 -37.52 19.44 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.3 -42.67 82.22 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.695 ' HA ' HD12 ' A' ' 72' ' ' ILE . 1.2 mt -75.41 -63.5 1.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.524 0.678 . . . . 0.0 109.18 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 69' ' ' LEU . 39.9 tttp -40.29 -34.95 0.36 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.759 -0.588 . . . . 0.0 109.986 -179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.1 m -73.2 -37.19 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.036 -1.04 . . . . 0.0 108.664 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 69' ' ' LEU . 39.6 mt -61.08 -21.41 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -88.68 5.33 43.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.358 -0.839 . . . . 0.0 109.319 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -122.01 -20.88 6.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 74' ' ' ALA . 17.5 m-20 -59.67 -140.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.54 0.686 . . . . 0.0 110.214 -179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -55.37 -167.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.81 50.32 1.79 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.512 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.04 -70.19 0.68 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.8 t 44.29 17.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -145.87 -3.52 0.68 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.765 HD21 ' O ' ' A' ' 51' ' ' TYR . 5.4 tp -54.43 113.56 5.38 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 109.05 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.95 140.31 89.49 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.119 1.213 . . . . 0.0 112.351 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.477 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.8 t -129.83 127.88 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 116' ' ' LEU . 54.8 tp -108.42 78.42 1.16 Allowed 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 177.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.8 mtt -72.24 132.2 43.75 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.3 m -113.23 140.2 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.9 t -150.02 171.49 16.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.343 -0.848 . . . . 0.0 109.604 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.01 -87.15 0.24 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.817 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.557 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -46.95 -66.29 0.43 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.136 -0.978 . . . . 0.0 109.864 -179.659 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 67.72 99.87 0.05 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.142 -0.974 . . . . 0.0 109.174 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -95.59 119.62 34.42 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 0.0 109.207 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -43.51 -50.07 7.2 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.445 -0.785 . . . . 0.0 109.983 -179.504 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -47.23 -35.11 7.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.174 -0.954 . . . . 0.0 109.686 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 96' ' ' ILE . 2.3 t-20 -85.53 -39.04 17.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.191 -179.549 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 95' ' ' ILE . 35.1 mm -58.24 -0.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.092 -1.005 . . . . 0.0 109.666 -179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' A' ' 94' ' ' ASN . 71.9 mt -89.82 -65.97 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 109.54 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.33 -34.72 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.54 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.708 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -65.33 -53.95 36.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.329 -0.857 . . . . 0.0 109.876 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.74 -46.7 67.58 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.044 -1.035 . . . . 0.0 110.011 -179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.47 -19.51 1.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 109.135 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.18 -112.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 0.0 109.527 179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.81 -5.38 4.9 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.708 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -57.56 10.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.927 -0.749 . . . . 0.0 110.348 179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.686 ' H ' ' C ' ' A' ' 102' ' ' GLY . 2.3 m -29.75 -35.19 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.009 -178.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -100.05 125.68 8.66 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.49 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -142.38 109.38 5.51 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.286 -1.126 . . . . 0.0 109.697 179.189 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.681 HG11 ' CD1' ' A' ' 116' ' ' LEU . 2.7 p -110.53 150.45 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.48 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 39.9 t -90.52 111.72 23.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.729 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 152.44 78.07 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.786 -1.196 . . . . 0.0 109.514 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.85 165.6 84.49 Favored 'Cis proline' 0 N--CA 1.49 1.314 0 O-C-N 122.52 0.748 . . . . 0.0 110.909 -1.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -144.4 156.89 44.43 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.855 0.836 . . . . 0.0 110.106 179.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 114' ' ' ALA . 1.0 OUTLIER -95.67 150.79 19.98 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 176.755 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.37 -15.36 0.13 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.783 -1.198 . . . . 0.0 109.194 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.27 -38.34 35.68 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.33 -62.41 1.4 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.537 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.681 ' CD1' HG11 ' A' ' 107' ' ' VAL . 4.6 tp -48.6 -38.73 21.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.195 178.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.56 -56.81 11.6 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.021 -1.049 . . . . 0.0 110.068 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -45.18 -66.13 0.44 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.554 -0.716 . . . . 0.0 109.931 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -35.25 5.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 109.287 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.25 -68.54 0.24 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -49.03 -32.91 10.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -0.956 . . . . 0.0 109.709 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -59.78 -38.17 81.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 0.0 110.071 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.9 mt -89.07 -47.83 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.055 -1.028 . . . . 0.0 109.963 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.457 ' CE2' HD13 ' A' ' 127' ' ' LEU . 23.2 m-85 -53.19 -19.0 2.63 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.122 -0.986 . . . . 0.0 110.232 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -55.95 -35.43 66.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 107.949 178.72 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -79.6 -32.23 41.83 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 127' ' ' LEU . 7.6 tt -65.11 -23.58 67.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.76 61.34 1.29 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.418 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.44 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER 51.81 95.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.161 -0.962 . . . . 0.0 108.818 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 29' ' ' GLY . 1.2 ptmm? -76.83 47.24 0.5 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.006 -1.059 . . . . 0.0 109.544 -179.525 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' OE1' ' O ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -160.42 27.11 0.16 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.6 tp -69.65 143.21 53.27 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.421 ' NZ ' ' O ' ' A' ' 50' ' ' GLY . 1.9 mtmp? -82.35 127.76 33.56 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.125 -0.984 . . . . 0.0 111.508 -177.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.455 ' HB2' HG22 ' A' ' 33' ' ' VAL . 35.4 m-85 -116.32 150.7 37.24 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.865 -0.522 . . . . 0.0 109.974 179.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.8 tp -125.15 106.9 10.25 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.37 105.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.145 -0.972 . . . . 0.0 109.05 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 11' ' ' VAL . 25.3 t -89.99 24.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 O-C-N 121.155 -0.965 . . . . 0.0 109.455 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -56.64 126.58 27.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.854 . . . . 0.0 109.625 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -93.63 -2.59 53.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.319 -0.863 . . . . 0.0 109.34 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -58.81 -158.75 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.597 179.965 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.05 8.52 5.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.638 -0.664 . . . . 0.0 109.578 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -22.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.09 -1.006 . . . . 0.0 109.748 179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 20.3 tpp -47.71 -50.39 25.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -0.98 . . . . 0.0 109.243 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.45 ' NE ' ' OE1' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -45.38 -55.41 6.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 110.469 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -56.24 -37.39 69.67 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.577 -177.319 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.78 -49.02 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.119 -0.988 . . . . 0.0 110.046 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -33.25 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.995 -1.066 . . . . 0.0 110.515 -179.031 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.26 -53.51 21.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.989 -1.07 . . . . 0.0 109.525 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 26' ' ' LYS . 3.1 t30 -67.57 -58.15 5.2 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.881 0.848 . . . . 0.0 109.63 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.814 HD22 HD12 ' A' ' 116' ' ' LEU . 4.5 tt -40.09 -34.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.125 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.95 -42.08 27.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.905 -1.122 . . . . 0.0 108.233 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.626 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -58.88 -34.9 72.18 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.346 -0.846 . . . . 0.0 108.925 179.318 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -53.85 -29.14 39.88 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.347 -0.845 . . . . 0.0 109.236 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -88.27 -12.86 42.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 109.73 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 106.09 15.39 18.16 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -89.83 126.84 35.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.685 -1.479 . . . . 0.0 109.0 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -130.42 67.72 1.48 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.468 -0.77 . . . . 0.0 109.808 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.4 89.53 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 108.594 179.691 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.455 HG22 ' HB2' ' A' ' 8' ' ' PHE . 45.2 t -140.23 151.69 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.188 -0.945 . . . . 0.0 110.489 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CG ' ' OH ' ' A' ' 51' ' ' TYR . 5.2 mt-10 -126.18 -173.23 2.8 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 7.6 tt0 -149.13 159.48 44.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.769 -1.207 . . . . 0.0 111.157 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.674 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -149.99 -171.79 3.99 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' ASP . 3.6 pt-20 -139.41 8.57 2.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.805 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.16 -170.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.567 ' CA ' HD11 ' A' ' 68' ' ' LEU . . . -74.34 -38.96 44.5 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.98 -1.581 . . . . 0.0 109.293 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.438 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 62.9 t -52.52 -40.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.915 -1.344 . . . . 0.0 107.763 178.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.674 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 21.7 t0 -79.15 -50.6 10.74 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.677 -0.639 . . . . 0.0 109.847 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -62.56 -59.46 4.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.906 . . . . 0.0 109.086 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 71' ' ' THR . 49.9 tp -44.75 -50.75 9.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.555 -0.716 . . . . 0.0 109.313 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.438 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 60.6 m-20 -66.7 -36.28 82.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.082 -1.012 . . . . 0.0 109.577 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -90.13 8.0 35.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 110.33 -179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -87.98 -44.18 11.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.898 -1.126 . . . . 0.0 109.076 179.681 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -65.75 1.55 1.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.186 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.44 -69.5 0.13 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.391 -0.818 . . . . 0.0 109.859 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.34 9.35 1.26 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' O ' ' NZ ' ' A' ' 7' ' ' LYS . . . 85.27 88.11 0.92 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.906 ' O ' HD11 ' A' ' 81' ' ' LEU . 38.4 m-85 -71.1 136.66 48.33 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.304 -1.115 . . . . 0.0 109.66 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.49 -5.67 71.77 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 178.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.41 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -152.14 135.88 16.26 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.578 -0.954 . . . . 0.0 108.95 -179.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.05 116.98 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.817 -1.177 . . . . 0.0 109.781 179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -95.62 95.42 4.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 85.5 p -105.61 131.99 52.3 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.264 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 59' ' ' ASN . 37.7 p-10 -100.15 123.31 44.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.467 -179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.517 ' CH2' HD12 ' A' ' 66' ' ' LEU . 1.4 t-105 -45.76 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.244 -0.91 . . . . 0.0 108.679 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASP . 80.1 m-20 -92.57 -150.45 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.162 -0.961 . . . . 0.0 110.635 -178.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.719 ' H ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -124.65 -29.82 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.2 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -177.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.719 ' CD ' ' H ' ' A' ' 60' ' ' MET . 4.1 Cg_exo -62.01 164.48 16.7 Favored 'Trans proline' 0 C--N 1.323 -0.803 0 CA-C-N 119.812 0.968 . . . . 0.0 110.842 -177.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.629 ' N ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -41.73 -62.31 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.785 -0.572 . . . . 0.0 109.633 -179.712 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.511 ' H ' HD22 ' A' ' 62' ' ' ASN . 0.8 OUTLIER -79.24 56.08 1.99 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.275 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 63' ' ' MET . 0.2 OUTLIER -46.9 -94.41 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.38 -0.825 . . . . 0.0 109.618 -179.472 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.72 -24.29 0.07 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.517 HD12 ' CH2' ' A' ' 58' ' ' TRP . 1.0 OUTLIER -70.67 -58.06 4.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.876 -1.367 . . . . 0.0 108.612 179.616 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.41 -33.46 6.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.567 HD11 ' CA ' ' A' ' 39' ' ' GLY . 5.8 mp -66.59 -42.63 86.65 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.727 HD11 ' H ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -69.06 -45.05 71.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.529 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -58.66 -32.34 68.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.133 -0.98 . . . . 0.0 108.884 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.67 HG21 HD13 ' A' ' 43' ' ' LEU . 3.9 m -66.85 -42.98 84.79 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.282 -0.886 . . . . 0.0 108.999 179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.27 -31.6 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.373 -0.829 . . . . 0.0 108.953 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -30.57 71.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.073 179.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -59.0 -24.14 62.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.434 -0.791 . . . . 0.0 109.72 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 76' ' ' GLY . 6.3 t70 -42.85 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 110.041 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.525 ' N ' ' OD1' ' A' ' 75' ' ' ASP . . . 152.32 -96.78 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.05 -21.67 1.33 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.181 -1.187 . . . . 0.0 109.206 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.506 ' C ' ' H ' ' A' ' 80' ' ' ALA . 3.0 mtm -116.84 36.77 4.04 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -65.64 7.35 0.25 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.518 -0.739 . . . . 0.0 109.648 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.74 24.12 3.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 109.466 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 51' ' ' TYR . 4.7 tt -48.89 125.56 13.45 Favored Pre-proline 0 N--CA 1.49 1.573 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.688 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -56.68 114.85 2.1 Favored 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.667 0.912 . . . . 0.0 112.257 -178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.34 118.74 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 177.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.549 HD21 HD21 ' A' ' 116' ' ' LEU . 37.2 tp -97.49 79.1 2.72 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.512 -1.275 . . . . 0.0 109.229 178.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtp -64.75 108.85 1.85 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.378 -0.826 . . . . 0.0 108.782 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 ' CG1' ' A' ' 107' ' ' VAL . 1.8 m -96.42 134.57 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.632 -1.292 . . . . 0.0 109.362 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 109' ' ' LYS . 13.2 t -150.2 177.57 9.8 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.812 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -122.76 141.51 51.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.478 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.404 ' CB ' ' O ' ' A' ' 88' ' ' ALA . 5.8 tt0 67.99 35.59 3.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 0.0 109.148 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -45.52 127.33 7.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.397 -0.814 . . . . 0.0 109.914 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -83.31 -133.97 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.233 -0.917 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 -28.62 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 0.0 109.241 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.44 -29.69 21.24 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.215 -0.928 . . . . 0.0 109.882 -179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -79.33 -36.43 39.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 -179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.663 HD11 ' HB1' ' A' ' 90' ' ' ALA . 56.1 mt -64.68 -5.92 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.864 . . . . 0.0 108.966 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.611 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 16.6 mt -89.94 -58.44 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.301 -0.874 . . . . 0.0 109.354 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.92 -60.57 2.0 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.675 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -49.02 -41.46 34.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 108.755 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 96' ' ' ILE . . . -47.64 -48.91 28.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.982 -1.074 . . . . 0.0 109.419 -179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.28 -27.84 56.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.228 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.84 -106.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.224 -0.923 . . . . 0.0 109.558 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.727 ' H ' HD11 ' A' ' 69' ' ' LEU . . . -145.36 12.11 1.8 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.675 ' HB2' ' HB1' ' A' ' 98' ' ' ALA . . . -56.6 11.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 123.045 0.538 . . . . 0.0 110.775 179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.0 m -29.33 -30.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -177.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.99 126.96 8.02 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.08 111.11 6.32 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.535 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.634 ' CG1' HG12 ' A' ' 86' ' ' VAL . 8.7 p -117.95 121.9 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -53.3 172.03 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.179 179.37 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 87' ' ' THR . 15.4 pttt -147.4 156.96 45.85 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 120.579 -1.326 . . . . 0.0 108.911 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.98 167.89 77.35 Favored 'Cis proline' 0 N--CA 1.485 0.983 0 C-N-CA 124.862 -0.891 . . . . 0.0 110.348 -1.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -134.6 155.64 50.1 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.017 0.913 . . . . 0.0 110.473 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.3 OUTLIER -93.12 151.42 19.86 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 177.114 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -46.73 -38.39 9.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.918 -1.114 . . . . 0.0 109.733 -178.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.3 -38.02 84.32 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.453 ' O ' ' C ' ' A' ' 116' ' ' LEU . 19.0 m -66.31 -65.1 0.72 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.814 HD12 HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -42.68 -48.71 5.57 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.619 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.75 80.34 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.312 -0.868 . . . . 0.0 110.048 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 115' ' ' THR . 3.1 tp10 -57.63 -33.84 68.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 110.027 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.01 -36.71 14.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.068 -1.02 . . . . 0.0 110.042 -179.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -58.12 -67.42 0.35 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 110.236 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.1 -28.69 1.27 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.118 -179.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -71.76 -33.06 68.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.146 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 105' ' ' GLY . 21.0 mt -79.88 -42.28 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.078 -1.014 . . . . 0.0 110.075 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -62.63 4.99 0.13 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.267 -0.896 . . . . 0.0 110.577 -178.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 123' ' ' ILE . 6.1 mm-40 -81.91 -28.61 32.75 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -86.89 -34.86 19.27 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -63.75 -30.06 71.2 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.115 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.1 77.09 0.32 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.273 -1.133 . . . . 0.0 109.47 179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.54 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 3.0 m-20 -43.94 145.53 0.71 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.343 -0.848 . . . . 0.0 110.005 -179.564 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 29' ' ' GLY . 7.8 mtmm -90.5 7.48 38.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.221 -0.925 . . . . 0.0 110.302 179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 45.7 mp0 -144.46 50.88 1.28 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.813 -1.18 . . . . 0.0 109.952 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.4 tp -80.26 114.76 19.4 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 121.5 7.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.059 -1.025 . . . . 0.0 112.046 -177.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.3 m-85 -113.41 149.5 34.05 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.113 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' HB3' HG13 ' A' ' 54' ' ' VAL . 27.0 tp -121.55 109.45 14.82 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -93.61 99.77 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.367 -0.833 . . . . 0.0 110.122 -178.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.974 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.6 t -91.94 12.48 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.09 -1.006 . . . . 0.0 109.758 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 17' ' ' MET . 0.2 OUTLIER -62.18 156.32 22.14 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.172 -0.955 . . . . 0.0 109.393 179.907 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 14' ' ' PHE . 14.2 p-10 -94.86 -142.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.592 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.493 ' O ' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER 61.27 146.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.84 . . . . 0.0 109.619 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 t -92.46 17.0 10.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -0.926 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -143.49 -12.89 0.69 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 109.446 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 12' ' ' ASP . 5.8 ttm -71.51 -57.79 4.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.934 . . . . 0.0 109.617 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -47.22 -28.87 2.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -51.17 20.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.186 179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mt -47.93 -53.49 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.798 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -44.64 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.863 . . . . 0.0 110.333 -178.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -46.87 -55.43 8.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.0 109.562 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -59.69 -58.03 10.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.108 0.956 . . . . 0.0 108.518 179.428 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.7 tt -39.29 -42.76 1.06 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.641 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.8 mt -71.18 -41.96 69.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 108.899 179.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 23' ' ' ASN . 47.8 tttt -63.1 -30.71 71.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.287 -0.883 . . . . 0.0 109.22 179.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.57 -40.03 71.43 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 28' ' ' LEU . 1.3 tt -76.96 -58.6 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 109.659 -179.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 159.55 43.22 0.02 OUTLIER Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.54 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 48.5 m-85 -126.98 125.42 41.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.821 -0.811 . . . . 0.0 109.662 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -137.67 66.22 1.46 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.566 -0.708 . . . . 0.0 109.518 -179.705 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.64 93.37 0.12 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.923 -1.111 . . . . 0.0 109.76 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -145.54 179.29 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.059 -1.026 . . . . 0.0 109.856 -179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.4 mt-10 -138.73 -164.98 1.74 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -147.68 149.86 33.26 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.156 -1.018 . . . . 0.0 111.141 -178.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -142.3 -168.87 2.83 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -146.61 3.6 0.86 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 110.643 -179.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 p30 175.66 -172.82 0.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.123 -0.986 . . . . 0.0 109.185 179.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -69.88 -42.24 70.19 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -57.11 -34.02 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.099 -1.236 . . . . 0.0 109.049 179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.97 -57.16 3.31 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.413 -0.804 . . . . 0.0 109.251 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -46.96 -38.22 10.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tt -69.39 -58.92 3.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 0.0 109.561 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -58.16 -21.51 47.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.931 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -90.15 -43.09 10.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.211 -0.931 . . . . 0.0 110.587 -179.422 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -61.94 -18.44 60.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.669 -1.269 . . . . 0.0 109.291 -179.333 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -63.05 -4.54 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -53.95 -74.91 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.564 -0.71 . . . . 0.0 109.855 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.16 10.8 1.18 Allowed Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.545 -179.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.5 81.64 1.27 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.761 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.8 m-85 -54.94 144.74 22.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.548 -0.972 . . . . 0.0 110.297 -179.226 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.56 -4.64 73.03 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -161.93 145.56 12.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.418 -1.048 . . . . 0.0 110.004 -179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.702 ' HB ' HG22 ' A' ' 83' ' ' VAL . 24.2 t -139.92 125.93 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.353 -0.842 . . . . 0.0 109.877 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.51 104.27 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.499 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 90.2 p -104.94 178.27 4.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.349 -0.844 . . . . 0.0 109.964 -179.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 29.2 p-10 -99.98 -115.08 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.498 -0.751 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.444 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 61.4 t-105 -140.12 -81.14 0.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.365 -0.834 . . . . 0.0 110.135 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.406 HD21 ' HA ' ' A' ' 63' ' ' MET . 29.1 t-20 -170.43 68.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.964 -1.085 . . . . 0.0 109.93 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.508 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -89.08 -48.33 0.41 Allowed Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 179.523 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.05 -160.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.887 0 C-N-CA 121.012 1.141 . . . . 0.0 109.822 179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.691 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -84.75 107.48 16.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 0.0 109.094 179.653 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 62' ' ' ASN . 2.4 mmm 50.31 93.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.107 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 66' ' ' LEU . 10.9 t70 -152.24 -177.43 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 110.132 -179.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.648 ' HA2' HD23 ' A' ' 68' ' ' LEU . . . 54.47 -80.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 64' ' ' ASP . 95.7 mt -44.84 -68.65 0.18 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 109.66 -179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -60.17 -35.69 75.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.846 -1.159 . . . . 0.0 109.375 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.919 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -57.23 -33.93 68.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.506 -0.746 . . . . 0.0 109.007 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 101' ' ' ALA . 1.6 tt -87.08 -59.99 2.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.912 . . . . 0.0 109.173 179.61 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 69' ' ' LEU . 15.0 ttpt -40.31 -32.81 0.2 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 m -66.2 -44.18 84.65 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 69' ' ' LEU . 55.6 mt -54.65 -36.23 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 108.769 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.9 mtp-105 -75.59 -16.23 60.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.417 -0.802 . . . . 0.0 109.408 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -54.42 -28.61 45.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.858 . . . . 0.0 109.845 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 76' ' ' GLY . 38.0 t70 -61.55 -121.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 0.0 109.606 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.484 ' H ' ' CG ' ' A' ' 75' ' ' ASP . . . 154.0 -32.65 0.73 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.09 -12.41 57.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -1.159 . . . . 0.0 109.413 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.48 42.44 2.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.604 -0.685 . . . . 0.0 109.381 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.8 p -77.89 51.55 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.249 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -130.71 -26.14 2.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.644 -0.66 . . . . 0.0 109.715 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.761 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -38.65 103.18 0.27 Allowed Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.896 -0.503 . . . . 0.0 109.78 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -64.2 108.87 1.04 Allowed 'Trans proline' 0 C--O 1.217 -0.552 0 C-N-CA 120.93 1.087 . . . . 0.0 111.574 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.702 HG22 ' HB ' ' A' ' 54' ' ' VAL . 25.5 t -108.81 111.51 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.411 -0.806 . . . . 0.0 109.463 178.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -89.99 110.75 21.71 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.8 ' SD ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -91.51 116.28 28.73 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.34 -176.859 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -102.23 150.43 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.887 -1.133 . . . . 0.0 110.867 -178.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 88' ' ' ALA . 9.3 t -150.09 -143.49 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' N ' HG23 ' A' ' 87' ' ' THR . . . -161.38 -17.67 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.672 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' CA ' ' OE1' ' A' ' 89' ' ' GLU . 0.1 OUTLIER -79.85 -75.45 0.25 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.168 -0.957 . . . . 0.0 109.506 -179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.458 ' HB2' ' CE1' ' A' ' 106' ' ' TYR . . . 58.83 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.629 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 6.8 tptp -148.58 59.33 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 0.0 109.266 179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 94' ' ' ASN . 74.1 tttt 53.12 -88.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 3.9 pt-20 -47.17 -19.0 0.11 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.189 -0.945 . . . . 0.0 109.789 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' HB2' ' H ' ' A' ' 91' ' ' LYS . 3.0 m-20 -89.78 -35.78 15.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.132 -0.98 . . . . 0.0 109.82 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.87 -18.27 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.091 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.7 mp -83.54 -43.39 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.751 -1.218 . . . . 0.0 107.93 178.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -48.45 -24.82 1.39 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.825 ' HB1' ' O ' ' A' ' 102' ' ' GLY . . . -51.1 -54.34 25.95 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.695 -0.802 . . . . 0.0 109.583 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.83 -41.72 64.49 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.069 -1.644 . . . . 0.0 107.963 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -27.73 68.51 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.236 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.879 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -146.46 -68.18 0.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.526 -0.734 . . . . 0.0 109.347 179.274 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.825 ' O ' ' HB1' ' A' ' 98' ' ' ALA . . . -58.61 79.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 107.4 -2.28 . . . . 0.0 107.4 178.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.647 ' N ' ' O ' ' A' ' 101' ' ' ALA . . . -61.82 -108.76 0.0 OUTLIER 'General case' 0 C--N 1.26 -3.302 0 CA-C-N 111.549 -2.325 . . . . 0.0 115.676 -175.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -29.83 -58.0 0.17 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.164 -175.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.31 176.26 37.0 Favored Glycine 0 N--CA 1.485 1.943 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.95 -179.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -130.65 115.0 16.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.87 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.3 p -122.6 123.01 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 107' ' ' VAL . 28.0 m -54.18 -169.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.15 153.19 11.77 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 120.504 -1.372 . . . . 0.0 109.469 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.11 154.06 99.45 Favored 'Cis proline' 0 N--CA 1.487 1.101 0 C-N-CA 125.187 -0.755 . . . . 0.0 110.636 -1.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.646 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.9 p90 -118.32 155.25 30.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.84 0.829 . . . . 0.0 109.661 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.483 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.4 OUTLIER -90.07 150.49 22.05 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -50.61 -15.55 0.28 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 120.684 -1.26 . . . . 0.0 109.327 -178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -81.69 -34.44 30.66 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.483 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -74.13 -61.21 1.93 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.646 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.6 OUTLIER -51.1 -36.16 38.98 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 117.992 -1.483 . . . . 0.0 108.58 179.662 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 113' ' ' ALA . 15.9 mt-10 -54.66 -66.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.009 -1.057 . . . . 0.0 109.521 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -44.25 -26.93 0.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.768 -0.583 . . . . 0.0 109.781 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -83.53 -44.03 15.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.159 -0.963 . . . . 0.0 110.325 -179.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 120' ' ' LEU . 18.6 mt -67.57 -57.23 6.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.805 -1.184 . . . . 0.0 109.64 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.53 -27.02 5.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.986 -1.072 . . . . 0.0 109.82 -179.405 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -84.4 -22.71 30.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.181 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 10.6 mt -88.36 -39.0 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.645 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -65.76 -5.68 9.46 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.188 -0.945 . . . . 0.0 109.998 -179.199 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -72.02 -26.17 62.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -90.38 -34.46 15.66 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.26 -15.52 59.42 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 58.41 85.76 0.03 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.492 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.228 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.539 ' O ' ' CD1' ' A' ' 30' ' ' PHE . 0.4 OUTLIER 173.52 134.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.397 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 28.69 1.34 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -171.68 41.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.01 -1.056 . . . . 0.0 110.579 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 60.2 tp -80.41 112.95 18.23 Favored 'General case' 0 C--O 1.205 -1.249 0 O-C-N 120.576 -1.328 . . . . 0.0 107.921 179.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -54.54 114.36 1.64 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.187 -0.946 . . . . 0.0 112.481 -177.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 82.8 m-85 -109.2 151.12 26.91 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 54' ' ' VAL . 20.5 tp -119.15 108.62 14.91 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.02 122.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.265 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 33.3 t -126.9 105.92 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.491 -0.756 . . . . 0.0 109.574 179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.5 133.47 19.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.346 -0.846 . . . . 0.0 109.425 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.55 53.52 1.32 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 109.596 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.64 135.53 22.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.397 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.4 t -85.12 15.99 3.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.02 -1.64 1.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.469 -0.769 . . . . 0.0 109.558 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 13.0 ttt -89.96 -21.71 22.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.123 -0.986 . . . . 0.0 109.074 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' NH2' ' O ' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -76.08 -45.39 34.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.835 . . . . 0.0 109.419 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -58.63 -20.87 51.35 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.878 . . . . 0.0 109.575 -179.34 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.5 mt -73.81 -55.56 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.849 -179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.16 -23.14 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 110.263 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.536 ' NH1' HG22 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -59.81 -53.05 62.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.937 -1.102 . . . . 0.0 109.122 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -66.05 -56.08 13.37 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.014 0.911 . . . . 0.0 108.991 179.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.3 tt -40.6 -46.43 2.54 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.92 -179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -70.32 -45.0 67.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.974 -1.079 . . . . 0.0 108.541 179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -57.28 -30.4 64.67 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.478 -0.763 . . . . 0.0 109.147 179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.95 -41.54 74.83 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.177 -0.952 . . . . 0.0 109.354 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.688 HD22 ' OE2' ' A' ' 117' ' ' GLU . 14.9 tp -76.86 -57.01 4.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.35 -0.844 . . . . 0.0 109.283 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . 152.3 77.37 0.02 OUTLIER Glycine 0 N--CA 1.478 1.483 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -150.22 147.99 28.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -1.073 . . . . 0.0 109.29 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.15 55.88 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.946 -1.096 . . . . 0.0 110.634 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -173.74 105.25 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.703 -1.248 . . . . 0.0 110.514 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.536 HG22 ' NH1' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -146.76 -179.9 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.147 -0.971 . . . . 0.0 109.384 179.21 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.1 mm-40 -134.71 -167.52 1.99 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -149.97 150.69 32.2 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.074 -1.051 . . . . 0.0 111.342 -178.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.39 -169.22 2.82 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 5.5 mt-10 -139.73 9.31 2.4 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.257 -0.902 . . . . 0.0 110.222 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 37' ' ' GLU . 1.2 m-20 170.85 173.32 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.056 -1.027 . . . . 0.0 108.896 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.688 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.1 -25.5 73.39 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -37.09 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.937 -1.331 . . . . 0.0 108.243 178.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 5.9 t0 -74.66 -39.96 61.72 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -75.32 -35.5 61.21 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.56 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.57 -52.72 64.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.151 -0.968 . . . . 0.0 109.183 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -62.08 -30.93 71.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 0.0 109.839 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -90.0 -18.83 25.28 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.308 -0.87 . . . . 0.0 110.323 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -61.02 -32.96 72.55 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.569 179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -84.06 -0.15 50.65 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.38 -72.78 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.659 -0.651 . . . . 0.0 109.553 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.03 -86.78 0.3 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -165.17 72.79 0.18 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 53' ' ' PHE . 34.6 m-85 -54.27 98.5 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.312 -1.111 . . . . 0.0 109.041 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.29 1.19 0.44 Allowed Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.731 -1.748 . . . . 0.0 108.731 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -169.2 142.82 2.83 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.187 -1.184 . . . . 0.0 109.919 -179.652 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 83' ' ' VAL . 12.8 t -133.59 145.43 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.088 -1.008 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.5 mt -132.19 85.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.436 ' OG ' ' CE ' ' A' ' 85' ' ' MET . 3.6 p -103.98 143.54 32.74 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.696 -178.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.3 p30 -60.37 -122.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.578 -0.701 . . . . 0.0 110.395 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.532 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 75.2 t-105 -158.25 -77.11 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.02 122.88 32.8 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.342 -0.849 . . . . 0.0 109.089 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.495 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 179.25 -50.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 110.44 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.09 -173.67 0.22 Allowed 'Trans proline' 0 C--N 1.324 -0.712 0 C-N-CA 120.747 0.965 . . . . 0.0 110.055 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.7 ' N ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -52.68 -13.67 0.43 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.168 -0.958 . . . . 0.0 109.546 -179.853 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.44 ' N ' HD22 ' A' ' 62' ' ' ASN . 3.7 mmt -147.23 -86.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.42 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -152.94 177.85 10.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.204 179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.9 -9.52 77.43 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 97' ' ' ALA . 46.7 tp -50.81 -25.65 4.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.679 -1.483 . . . . 0.0 108.239 179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 64' ' ' ASP . 7.6 pt-20 -72.59 -34.48 67.46 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.688 HD11 ' HA2' ' A' ' 39' ' ' GLY . 25.7 mt -63.18 -56.13 19.28 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.893 HD21 ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt -57.11 -58.73 6.92 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.606 0.717 . . . . 0.0 109.193 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -53.86 -38.02 64.26 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.316 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 70.4 m -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.938 . . . . 0.0 109.097 179.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.934 HD13 HG21 ' A' ' 83' ' ' VAL . 4.2 mt -67.09 -24.79 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.54 -18.68 37.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.401 -0.812 . . . . 0.0 108.918 179.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.4 -52.22 22.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.0 109.176 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 79' ' ' SER . 4.1 t70 -66.71 83.85 0.11 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.036 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.85 -29.94 43.44 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -46.76 -89.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -1.195 . . . . 0.0 109.564 -179.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 7.0 mtt -118.16 20.98 13.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.0 109.25 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.522 ' N ' ' OD2' ' A' ' 75' ' ' ASP . 17.5 t 46.93 -118.31 0.86 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.629 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.09 52.71 0.91 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER 46.07 -175.03 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.116 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.6 Cg_exo -63.03 144.79 93.53 Favored 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 121.68 1.586 . . . . 0.0 114.522 -176.071 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.934 HG21 HD13 ' A' ' 72' ' ' ILE . 5.4 t -139.5 111.38 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 177.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -95.13 106.07 18.05 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 117.551 -1.659 . . . . 0.0 106.964 177.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.436 ' CE ' ' OG ' ' A' ' 56' ' ' SER . 1.1 ttm -74.56 107.68 6.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.539 -0.865 . . . . 0.0 109.392 -178.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -92.17 144.83 8.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.407 ' CG2' ' HB2' ' A' ' 90' ' ' ALA . 5.8 t -146.24 170.2 17.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.015 -1.053 . . . . 0.0 110.426 -178.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.528 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -109.86 -57.29 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.709 -0.619 . . . . 0.0 109.551 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -70.74 29.2 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -0.942 . . . . 0.0 109.692 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -46.45 110.9 0.32 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.29 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 94' ' ' ASN . 3.8 ttpp -148.47 94.89 2.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.743 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 mttt 44.61 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.85 . . . . 0.0 110.156 179.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -45.93 -73.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.333 -0.855 . . . . 0.0 110.419 -179.183 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -41.19 -34.43 0.47 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.477 -0.764 . . . . 0.0 110.764 -178.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.607 HG23 ' CD2' ' A' ' 106' ' ' TYR . 24.6 mt -75.58 -66.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.969 -1.082 . . . . 0.0 109.304 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 96' ' ' ILE . 69.2 mt -62.16 -0.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.023 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -76.02 -37.85 57.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.401 -0.812 . . . . 0.0 109.119 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.611 ' O ' HD13 ' A' ' 69' ' ' LEU . . . -71.98 -59.87 2.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.09 -1.006 . . . . 0.0 108.306 178.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -59.55 -22.37 61.6 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.514 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' ALA . 0.3 OUTLIER -49.32 -33.38 13.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 178.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 69' ' ' LEU . . . -85.54 -36.82 20.23 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 176.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 90.29 64.94 1.22 Allowed Glycine 0 N--CA 1.482 1.71 0 C-N-CA 120.965 -0.636 . . . . 0.0 114.001 175.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.893 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.12 -111.16 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 119.935 1.867 . . . . 0.0 108.678 177.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.62 -46.05 8.15 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 122.423 1.106 . . . . 0.0 108.611 177.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 163.23 -157.87 30.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -178.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.607 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -137.77 146.48 43.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.679 -0.895 . . . . 0.0 109.248 178.95 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.4 p -140.61 136.1 35.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 109' ' ' LYS . 3.0 p -80.08 159.71 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.034 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.528 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.27 154.79 80.65 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.403 -0.811 . . . . 0.0 109.523 -179.301 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.26 126.85 13.46 Favored 'Cis proline' 0 N--CA 1.488 1.194 0 O-C-N 122.564 0.771 . . . . 0.0 110.14 -2.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.93 156.6 18.33 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.376 179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -92.99 148.44 22.0 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 176.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.496 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -49.28 -12.44 0.05 Allowed 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.706 -1.246 . . . . 0.0 109.343 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -83.07 -37.74 23.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.475 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -70.72 -59.69 2.67 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.144 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -50.62 -40.71 53.71 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 117.923 -1.511 . . . . 0.0 107.983 179.46 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.688 ' OE2' HD22 ' A' ' 28' ' ' LEU . 24.0 mm-40 -61.09 -55.12 36.31 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.185 -0.947 . . . . 0.0 110.394 179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -41.62 -38.27 1.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.42 0.628 . . . . 0.0 109.752 -179.33 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -88.19 -29.63 20.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.214 179.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.4 tp -65.53 -65.71 0.64 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.613 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -47.81 -36.36 11.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.478 ' HB3' ' HZ3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -73.73 -25.53 60.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.589 -179.847 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.44 -41.38 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.922 . . . . 0.0 109.849 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -70.83 -19.83 62.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.119 -0.988 . . . . 0.0 110.252 -179.142 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' CA ' ' OE1' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -61.27 -20.88 63.37 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.758 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -94.51 -31.76 13.79 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 127' ' ' LEU . 2.7 tt -72.82 -26.05 61.35 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.246 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.62 77.73 0.14 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.478 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.266 -1.138 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -46.71 136.61 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -90.04 48.48 1.58 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.121 -0.987 . . . . 0.0 109.432 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -178.55 33.66 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.675 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 50.5 tp -71.12 111.12 6.23 Favored 'General case' 0 C--O 1.206 -1.212 0 O-C-N 120.599 -1.313 . . . . 0.0 108.147 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.513 ' CG ' HD22 ' A' ' 32' ' ' ASN . 13.6 mtpt -58.04 119.8 7.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.984 -1.072 . . . . 0.0 111.409 -177.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 80.9 m-85 -110.79 148.76 31.68 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB3' HG13 ' A' ' 54' ' ' VAL . 66.6 tp -119.34 110.88 17.48 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.52 106.11 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.286 179.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 36' ' ' ALA . 27.4 t -96.96 92.03 2.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.504 -0.748 . . . . 0.0 109.59 -179.634 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.412 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -147.42 132.47 18.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.533 -179.988 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.8 -24.68 66.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.64 130.82 48.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.268 -0.895 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.6 p -82.83 -20.08 36.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -33.3 13.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.499 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 25.6 ttt -57.6 -30.51 65.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 -179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -71.71 -34.75 69.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.923 -1.11 . . . . 0.0 108.679 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -75.87 -16.13 60.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.519 -0.738 . . . . 0.0 109.068 179.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 mm -75.78 -50.83 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 109.486 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.48 -32.23 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.37 -0.831 . . . . 0.0 110.26 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -47.76 -53.35 15.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.173 -0.955 . . . . 0.0 109.391 179.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -70.02 -57.4 5.04 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.514 -0.742 . . . . 0.0 109.771 -179.576 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -40.42 -61.02 0.98 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.423 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 25' ' ' LEU . 23.7 mt -51.46 -50.78 59.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 108.72 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -49.07 -33.18 10.98 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.241 -0.912 . . . . 0.0 108.918 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -49.43 -51.07 37.94 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.404 -0.81 . . . . 0.0 109.531 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.519 HD23 ' CE2' ' A' ' 30' ' ' PHE . 35.9 tp -70.56 -48.1 57.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.274 -0.891 . . . . 0.0 109.005 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.45 81.59 0.06 OUTLIER Glycine 0 C--O 1.208 -1.477 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.519 ' CE2' HD23 ' A' ' 28' ' ' LEU . 67.2 m-85 -150.08 149.26 30.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.34 -1.094 . . . . 0.0 108.896 179.177 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -150.1 64.06 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.916 -1.115 . . . . 0.0 110.224 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.513 HD22 ' CG ' ' A' ' 7' ' ' LYS . 2.2 t30 -176.7 103.93 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.864 -1.147 . . . . 0.0 109.258 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -150.15 151.83 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.966 -1.084 . . . . 0.0 110.288 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -120.55 -170.45 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 8.8 mp0 -146.63 155.99 42.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.258 -0.901 . . . . 0.0 110.721 -179.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.16 -163.02 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -137.47 -7.89 1.71 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 0.0 110.783 -179.252 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 62' ' ' ASN . 6.8 t0 -177.42 -165.57 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.99 -1.069 . . . . 0.0 109.975 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -79.24 -26.59 57.28 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 6.3 p -75.64 -42.08 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.025 -1.28 . . . . 0.0 107.847 178.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 12.4 t0 -68.98 -43.73 74.34 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 45' ' ' LYS . . . -64.75 -52.79 55.12 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' ALA . 3.4 tt -43.34 -36.71 1.98 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.419 -0.801 . . . . 0.0 109.242 179.578 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -71.62 -34.62 69.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.268 -0.895 . . . . 0.0 109.08 179.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 47' ' ' GLN . 11.7 mmmt -86.38 -53.59 4.92 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.877 . . . . 0.0 109.332 179.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -41.13 -22.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.666 -0.646 . . . . 0.0 109.371 179.682 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.535 ' N ' ' O ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -52.35 -43.63 64.74 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.986 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.36 -56.95 5.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 51' ' ' TYR . . . 88.35 -19.26 36.7 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -59.75 -5.37 3.92 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.773 ' O ' HD22 ' A' ' 81' ' ' LEU . 61.6 m-85 -75.43 83.88 2.52 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.469 -1.019 . . . . 0.0 110.212 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.02 -3.93 1.46 Allowed Glycine 0 N--CA 1.482 1.751 0 N-CA-C 107.919 -2.073 . . . . 0.0 107.919 177.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.556 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -155.87 144.57 20.33 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.53 -0.982 . . . . 0.0 110.221 -179.473 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 9' ' ' LEU . 98.8 t -141.09 116.77 6.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 108.76 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.18 117.59 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.315 -0.866 . . . . 0.0 108.861 -179.67 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.1 p -120.05 166.95 12.7 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.629 -0.669 . . . . 0.0 109.681 -179.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD2' ' OD1' ' A' ' 12' ' ' ASP . 61.6 m-20 -95.58 -106.39 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.533 -0.73 . . . . 0.0 109.458 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.445 ' CD1' ' OD2' ' A' ' 64' ' ' ASP . 56.6 t-105 -168.95 -78.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.721 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.5 104.99 5.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.059 -1.026 . . . . 0.0 109.114 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.411 ' CE ' ' CA ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -130.9 174.09 5.1 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.339 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.42 -1.93 1.66 Allowed 'Trans proline' 0 N--CA 1.48 0.712 0 C-N-CA 121.462 1.441 . . . . 0.0 112.345 -178.396 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 8.5 m120 -127.05 83.67 2.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.283 -0.886 . . . . 0.0 109.488 179.539 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.9 mmt 48.46 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 0.0 109.599 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -165.04 179.09 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.961 -1.087 . . . . 0.0 109.405 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 60' ' ' MET . . . -70.96 14.66 1.46 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.626 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -68.3 -51.93 39.35 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -1.178 . . . . 0.0 108.854 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' O ' HG23 ' A' ' 71' ' ' THR . 1.8 mt-10 -63.53 -15.66 58.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.418 -0.801 . . . . 0.0 109.198 179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.58 HD11 ' HA2' ' A' ' 39' ' ' GLY . 6.2 mt -79.98 -67.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.98 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -46.91 -62.17 1.53 Allowed 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.682 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.63 -58.23 3.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.597 -0.689 . . . . 0.0 109.865 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.552 HG23 ' O ' ' A' ' 67' ' ' GLU . 16.6 p -52.91 -41.15 64.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.897 -1.127 . . . . 0.0 109.476 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 69' ' ' LEU . 43.9 mt -64.22 -42.37 95.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.399 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -84.75 -4.86 59.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 109.698 -179.691 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.78 -29.12 22.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.105 -0.997 . . . . 0.0 109.528 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -51.5 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 162.92 -90.35 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.78 -32.39 70.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.224 -1.162 . . . . 0.0 109.158 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.9 mtm -92.45 10.22 31.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.304 -0.872 . . . . 0.0 109.238 179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 92.4 p -76.49 44.61 0.36 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.585 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 8.57 0.65 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.141 -0.974 . . . . 0.0 110.38 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.773 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.6 mt -72.19 121.14 83.9 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.525 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.07 113.82 1.9 Allowed 'Trans proline' 0 N--CA 1.481 0.76 0 C-N-CA 121.415 1.41 . . . . 0.0 113.433 -178.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.649 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -103.25 105.65 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 175.224 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 tp -90.42 105.92 18.14 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 116.749 -1.98 . . . . 0.0 106.55 178.587 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.521 ' O ' ' SD ' ' A' ' 85' ' ' MET . 2.7 ppp? -79.88 124.02 28.28 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.926 -177.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.19 140.78 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 O-C-N 121.209 -0.932 . . . . 0.0 109.103 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 t -150.07 174.98 12.14 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.03 -1.044 . . . . 0.0 110.948 -178.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB2' ' HE3' ' A' ' 109' ' ' LYS . . . -106.88 -64.68 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.459 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -75.82 63.96 1.73 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.391 -0.818 . . . . 0.0 108.873 179.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.671 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -67.34 91.99 0.27 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.909 -179.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 144.12 25.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.43 -24.03 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -78.2 -54.18 6.52 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 -179.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' ALA . 1.2 t30 -68.74 -45.27 71.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.119 -0.988 . . . . 0.0 109.917 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.671 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.2 mt -48.65 -30.48 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 109.073 179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 53.8 mt -89.86 -20.42 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.358 -0.839 . . . . 0.0 109.075 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.92 -45.75 92.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.409 -0.807 . . . . 0.0 109.625 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.434 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -73.88 -54.34 8.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.993 -1.067 . . . . 0.0 108.199 179.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -55.86 -27.24 50.75 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.307 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -53.78 -34.03 57.79 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 178.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.98 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -83.04 -25.09 32.46 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 176.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.24 75.87 0.43 Allowed Glycine 0 N--CA 1.481 1.64 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.04 177.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.696 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.26 -112.11 0.08 Allowed 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 116.824 -1.95 . . . . 0.0 111.158 179.174 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 0.8 OUTLIER -91.67 -53.77 4.16 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.801 1.286 . . . . 0.0 109.019 176.633 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 173.41 -161.0 31.66 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -177.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.73 136.55 34.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 0.0 109.962 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.3 p -136.1 122.05 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.98 176.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.792 -1.193 . . . . 0.0 108.223 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -151.3 149.41 24.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.772 -1.205 . . . . 0.0 109.065 179.636 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -72.93 139.87 63.75 Favored 'Cis proline' 0 N--CA 1.484 0.923 0 C-N-CA 125.302 -0.707 . . . . 0.0 110.399 -1.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.426 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.8 p90 -99.04 163.79 12.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 179.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.77 146.05 23.94 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 177.63 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.35 -34.45 6.94 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.984 -1.073 . . . . 0.0 109.106 -179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -34.26 76.11 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.2 m -70.54 -66.97 0.53 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.509 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 111' ' ' PHE . 6.8 tp -48.33 -40.12 24.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.593 -1.317 . . . . 0.0 109.497 178.701 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 119' ' ' LYS . 3.4 tm-20 -68.04 -68.45 0.39 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.056 -1.027 . . . . 0.0 109.782 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 117' ' ' GLU . 86.0 tt0 -42.25 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.362 0.601 . . . . 0.0 109.67 -179.82 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' GLU . 5.5 mmmt -90.01 -47.57 7.76 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.306 -0.871 . . . . 0.0 109.071 179.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 120' ' ' LEU . 17.5 mt -56.07 -54.76 41.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.223 -0.923 . . . . 0.0 109.106 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -46.34 -49.93 17.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 109.788 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -57.15 -28.37 62.68 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.423 179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mt -86.13 -40.95 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -0.858 . . . . 0.0 110.47 -179.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -68.65 -6.61 26.93 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.974 -1.079 . . . . 0.0 110.427 -178.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -71.84 -19.88 61.91 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.57 -29.53 13.02 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.16 -21.54 29.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.475 -0.766 . . . . 0.0 108.94 179.361 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.87 75.18 0.17 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.266 -1.138 . . . . 0.0 109.404 179.979 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.545 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 2.0 t0 76.85 131.33 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.466 -0.771 . . . . 0.0 109.289 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.526 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 0.0 OUTLIER -90.41 18.44 6.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 110.172 -179.876 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 2.1 tm-20 -152.78 41.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.688 -1.257 . . . . 0.0 111.072 -178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 31.4 tp -81.87 118.67 23.1 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 120.497 -1.377 . . . . 0.0 107.912 178.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -63.87 123.28 18.54 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.19 -0.944 . . . . 0.0 111.754 -177.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 91.8 m-85 -115.56 144.51 43.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.62 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.0 tp -119.13 111.56 18.41 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -95.4 100.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.206 -0.934 . . . . 0.0 108.609 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.007 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -94.95 98.96 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 121.388 -0.82 . . . . 0.0 109.633 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD2' ' SD ' ' A' ' 17' ' ' MET . 2.1 t0 -156.86 142.88 17.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.0 109.389 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -94.23 93.71 7.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.6 OUTLIER -162.21 149.56 13.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.4 179.926 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.11 16.95 13.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.603 -179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -145.19 -22.11 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.469 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.438 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 2.2 ttt -60.8 -65.8 0.63 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.486 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.65 -33.66 7.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -38.63 67.77 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.0 -177.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mt -64.51 -56.05 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.674 -179.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -31.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 0.0 110.011 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -51.79 -54.29 30.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.118 -0.989 . . . . 0.0 109.319 179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -65.77 -57.23 8.49 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.52 -0.737 . . . . 0.0 109.215 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.7 -59.48 0.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.977 -179.507 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -54.02 -50.19 67.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.015 179.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -56.07 -39.11 71.57 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.323 -0.861 . . . . 0.0 109.505 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -54.77 -44.47 73.69 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.287 -0.883 . . . . 0.0 109.184 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.581 HD21 ' OE2' ' A' ' 117' ' ' GLU . 4.5 mt -69.5 -58.49 3.91 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.94 74.8 0.01 OUTLIER Glycine 0 N--CA 1.48 1.571 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 46.0 m-85 -150.21 152.38 34.53 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -1.174 . . . . 0.0 108.976 179.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.74 62.33 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.93 -1.106 . . . . 0.0 110.065 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -176.42 97.93 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.825 -1.172 . . . . 0.0 109.667 179.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.0 p -150.2 149.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.91 -1.119 . . . . 0.0 110.161 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -126.4 -166.31 1.56 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -148.59 149.28 31.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.997 . . . . 0.0 110.655 -179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.007 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -141.32 -169.32 2.83 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -143.98 3.54 1.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 111.237 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -176.72 157.84 1.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.519 -1.363 . . . . 0.0 109.765 179.893 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.551 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -49.1 -52.83 21.14 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.789 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -50.78 -31.06 9.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 120.895 -1.356 . . . . 0.0 108.139 179.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 17.5 t0 -79.24 -46.13 18.44 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.616 -0.678 . . . . 0.0 109.465 179.603 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -64.54 -56.62 12.83 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.2 -0.937 . . . . 0.0 109.222 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 mt -48.65 -52.95 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.862 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -69.19 -33.55 73.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 -10.71 58.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.242 -179.257 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.601 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.8 OUTLIER -81.55 -22.65 37.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.148 179.93 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -63.65 -6.67 5.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.29 -0.881 . . . . 0.0 108.639 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.11 -69.3 0.14 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.584 -0.698 . . . . 0.0 109.843 -179.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.06 10.2 1.0 Allowed Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.085 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.05 85.53 1.27 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 -179.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' O ' HD11 ' A' ' 81' ' ' LEU . 22.4 m-85 -64.71 139.23 58.74 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.435 -1.038 . . . . 0.0 110.494 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.01 3.1 62.02 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 178.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -165.89 146.86 6.81 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.532 -0.981 . . . . 0.0 109.196 -179.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 9' ' ' LEU . 89.7 t -148.63 123.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.786 -1.196 . . . . 0.0 109.759 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.98 93.52 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.7 p -96.36 158.1 15.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.322 -0.861 . . . . 0.0 108.999 -179.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 59' ' ' ASN . 4.4 p-10 -119.57 161.81 20.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.765 -0.584 . . . . 0.0 109.815 -179.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 93.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 108.795 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -108.76 121.54 45.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.443 -0.786 . . . . 0.0 109.721 -179.297 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.627 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.6 ppp? -137.99 38.19 0.34 Allowed Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.599 -0.688 . . . . 0.0 111.78 179.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -55.89 -24.97 50.35 Favored 'Trans proline' 0 C--N 1.322 -0.842 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 178.034 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 63' ' ' MET . 7.8 p30 179.63 58.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 62' ' ' ASN . 2.2 ttm 77.99 99.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.629 -0.67 . . . . 0.0 109.209 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -168.25 -172.53 1.76 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 109.528 -179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.689 ' H ' HD12 ' A' ' 68' ' ' LEU . . . 71.12 -69.68 0.82 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD11 ' O ' ' A' ' 97' ' ' ALA . 1.7 mm? -67.75 -61.62 1.79 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.109 -1.23 . . . . 0.0 108.992 179.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.61 -12.12 9.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.144 -0.973 . . . . 0.0 108.653 179.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.689 HD12 ' H ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -73.02 -46.44 52.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.87 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.88 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -84.2 -30.57 25.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.242 179.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.5 tttt -61.68 -40.43 94.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.384 -0.822 . . . . 0.0 109.114 179.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.5 m -68.66 -41.49 79.25 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.018 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.4 mt -66.64 -29.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.389 -0.82 . . . . 0.0 108.795 179.506 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -90.03 -24.13 21.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.686 179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.18 -28.94 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 78' ' ' MET . 0.3 OUTLIER -87.69 131.79 34.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.351 -179.961 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.05 -23.72 77.82 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.23 -28.56 17.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.172 -1.193 . . . . 0.0 109.543 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.484 ' C ' ' H ' ' A' ' 80' ' ' ALA . 23.1 tpp -91.97 5.49 49.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.522 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.3 t -71.7 13.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.259 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -99.97 -37.24 9.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.708 . . . . 0.0 109.639 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -38.55 102.67 0.25 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.766 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 96.25 0.23 Allowed 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.164 1.243 . . . . 0.0 111.528 -178.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' HG12 ' A' ' 83' ' ' VAL . 2.1 t -98.84 105.79 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 1.3 tp -96.02 103.72 15.62 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.827 -1.549 . . . . 0.0 106.86 178.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 ttm -62.56 161.67 11.67 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.731 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -135.73 137.72 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.7 t -150.04 156.24 41.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.74 -1.225 . . . . 0.0 110.059 179.658 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.31 -31.14 10.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.559 -0.713 . . . . 0.0 109.45 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -80.14 -61.2 2.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.576 -179.862 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 47.15 33.36 2.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.16 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -44.84 -67.27 0.3 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.399 -0.813 . . . . 0.0 109.795 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -167.35 -80.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.452 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -13.32 1.96 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.237 -0.915 . . . . 0.0 109.741 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -83.12 -21.88 33.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.637 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.56 HG23 ' CD2' ' A' ' 106' ' ' TYR . 66.1 mt -78.89 -49.58 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.945 -1.097 . . . . 0.0 108.657 179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.8 mp -63.49 -19.5 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.336 -0.852 . . . . 0.0 108.949 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.512 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -60.36 -59.56 5.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.476 -179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.83 -53.42 48.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 108.57 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -66.79 -19.87 65.83 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.993 -178.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -50.61 -30.79 14.2 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.04 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.706 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -92.54 -26.62 17.84 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 177.329 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 75.46 72.54 1.05 Allowed Glycine 0 N--CA 1.481 1.644 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.815 177.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.88 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.24 -112.04 0.07 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 116.619 -2.032 . . . . 0.0 109.05 178.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.91 -49.41 6.25 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 122.754 1.264 . . . . 0.0 108.102 175.396 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.42 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.58 -160.0 32.48 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.56 ' CD2' HG23 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.57 124.38 19.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.757 -0.849 . . . . 0.0 109.289 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.5 p -113.39 130.55 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.175 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.459 ' H ' HG12 ' A' ' 108' ' ' VAL . 0.6 OUTLIER -84.23 124.18 39.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.059 -1.026 . . . . 0.0 108.972 -179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 161.55 25.63 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.159 -0.963 . . . . 0.0 108.94 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.48 129.04 17.35 Favored 'Cis proline' 0 N--CA 1.484 0.933 0 O-C-N 122.842 0.917 . . . . 0.0 110.747 -2.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.7 p90 -96.93 163.76 12.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.203 -0.935 . . . . 0.0 109.632 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.56 147.18 25.6 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 176.862 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.436 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.66 -20.76 0.49 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.808 -1.182 . . . . 0.0 109.047 -179.071 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -82.51 -33.73 28.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.1 OUTLIER -75.74 -58.4 3.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.538 178.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.639 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -52.41 -38.81 59.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.207 -1.558 . . . . 0.0 107.972 178.612 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.581 ' OE2' HD21 ' A' ' 28' ' ' LEU . 11.3 tt0 -57.14 -57.3 13.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.046 -1.034 . . . . 0.0 109.895 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.56 -39.19 7.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.439 -0.788 . . . . 0.0 109.532 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.43 -29.22 63.51 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -73.46 -45.37 54.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.521 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' O ' ' N ' ' A' ' 125' ' ' GLU . 2.6 m120 -57.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.0 109.914 -179.584 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -61.04 -46.31 91.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 109.729 -179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.26 -34.34 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.371 -0.83 . . . . 0.0 109.459 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -88.27 -7.18 57.17 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.919 -178.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 121' ' ' ASN . 5.9 mt-10 -71.44 -28.55 64.05 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.342 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -94.14 -25.11 17.27 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 127' ' ' LEU . 0.9 OUTLIER -84.54 -22.4 30.13 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.487 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.41 79.62 0.06 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.741 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.285 -1.126 . . . . 0.0 109.465 179.925 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 7.4 m-20 -45.37 146.7 0.92 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.313 179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 5.6 tttp -90.25 13.13 16.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.876 -1.14 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -152.46 45.59 0.72 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.708 -1.245 . . . . 0.0 110.415 -179.316 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 tp -73.56 136.56 44.03 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.0 mtpp -73.98 115.9 13.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.958 -1.088 . . . . 0.0 111.978 -176.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 80.3 m-85 -106.4 153.24 22.53 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.063 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.784 ' C ' HD12 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -136.72 104.53 5.55 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 178.411 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.515 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -91.67 122.92 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.969 -178.986 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.2 t -111.97 93.33 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.32 -0.863 . . . . 0.0 109.069 178.745 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' OD1' ' NE ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -127.34 -178.03 4.3 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.596 -0.69 . . . . 0.0 109.597 -179.788 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -147.02 28.06 1.03 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.532 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.476 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.3 OUTLIER -90.9 -7.85 51.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.427 -179.967 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER 73.51 -10.09 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.387 -0.821 . . . . 0.0 109.747 179.745 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.42 -8.88 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 109.718 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.9 ttt -64.9 -22.53 67.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.128 -0.982 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -72.05 -63.64 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -46.75 -14.08 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.174 -178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' ARG . 4.2 mt -81.83 -50.13 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.014 -1.053 . . . . 0.0 109.628 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.06 -27.72 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 0.0 109.786 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -55.71 -53.08 61.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 108.89 179.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -62.67 -59.22 5.22 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.525 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -40.61 -56.81 2.02 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.773 -179.985 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 mt -55.84 -39.82 71.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.198 -0.939 . . . . 0.0 108.846 179.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -62.36 -50.71 70.5 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.282 -0.886 . . . . 0.0 109.207 179.642 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -50.04 -36.93 30.89 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 109.102 179.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.477 HD11 ' OE1' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -71.55 -61.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.563 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 153.19 65.12 0.01 OUTLIER Glycine 0 C--N 1.3 -1.465 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 44.2 m-85 -150.14 148.53 29.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.01 -1.288 . . . . 0.0 109.129 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.4 OUTLIER -150.15 59.28 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.806 -1.183 . . . . 0.0 111.159 179.908 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.21 98.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.703 -1.248 . . . . 0.0 110.684 179.511 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.71 178.71 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.035 -1.04 . . . . 0.0 110.352 179.058 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -142.31 -177.34 5.21 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 178.456 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 34' ' ' GLU . 13.5 mt-10 -140.85 156.23 46.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.052 -1.03 . . . . 0.0 111.483 -178.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.796 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.99 -173.0 4.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.03 19.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.689 -1.257 . . . . 0.0 110.87 -179.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.488 ' OD1' ' ND2' ' A' ' 62' ' ' ASN . 42.0 t0 -174.48 145.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -0.992 . . . . 0.0 109.342 179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -47.19 -42.37 17.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 t -63.01 -33.37 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.245 -1.15 . . . . 0.0 108.492 179.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 18.8 t0 -73.29 -47.55 41.93 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.397 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -58.12 -48.2 80.93 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.42 -0.8 . . . . 0.0 108.845 179.318 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.721 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.5 tm? -49.91 -50.43 46.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.474 -0.766 . . . . 0.0 109.708 -179.588 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -55.44 -40.17 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.267 -0.895 . . . . 0.0 111.05 -178.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -26.31 20.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.015 -1.053 . . . . 0.0 111.06 -178.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.688 HD22 HD23 ' A' ' 9' ' ' LEU . 0.4 OUTLIER -58.59 -19.51 39.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.818 -1.176 . . . . 0.0 109.256 -179.209 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -95.89 -5.9 40.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.362 -0.836 . . . . 0.0 110.125 -179.442 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.29 -62.81 1.19 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.965 . . . . 0.0 109.317 -179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.55 8.77 1.38 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.753 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.45 77.14 1.16 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -179.544 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.478 ' O ' HD13 ' A' ' 81' ' ' LEU . 36.6 m-85 -56.39 114.22 1.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.393 -1.063 . . . . 0.0 109.766 -179.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.33 2.14 3.37 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -163.47 139.22 6.65 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.972 -1.311 . . . . 0.0 109.597 179.676 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.547 ' HB ' HG22 ' A' ' 83' ' ' VAL . 45.3 t -136.57 116.77 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.087 -1.008 . . . . 0.0 109.532 179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' HB ' HG12 ' A' ' 10' ' ' VAL . 8.1 mt -103.8 99.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.533 -0.729 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.475 ' O ' ' SD ' ' A' ' 85' ' ' MET . 15.2 p -110.25 156.74 20.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -91.56 162.96 14.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.468 ' O ' ' CB ' ' A' ' 59' ' ' ASN . 42.0 t-105 -96.49 111.95 23.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 58' ' ' TRP . 2.3 t-20 73.48 96.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.278 -0.889 . . . . 0.0 109.725 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.455 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 2.5 mtt 177.16 -50.63 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.455 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -66.27 -67.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.323 -0.778 0 C-N-CA 120.783 0.989 . . . . 0.0 109.543 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 64' ' ' ASP . 7.6 p30 -154.55 125.96 7.41 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.7 mtt 54.33 -86.08 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.242 -0.911 . . . . 0.0 109.352 -179.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -149.0 144.0 26.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 109.097 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -66.06 1.78 4.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.28 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.266 . . . . 0.0 109.627 -179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' O ' ' OG1' ' A' ' 71' ' ' THR . 2.9 tt0 -46.31 -32.62 3.24 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -66.87 -52.06 48.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.916 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -58.58 -60.42 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' ALA . 10.5 tttt -42.82 -34.73 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 5.2 m -52.06 -44.45 64.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 108.692 179.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.69 -30.8 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -6.9 55.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.829 . . . . 0.0 109.943 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -64.17 -51.38 64.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.912 -1.117 . . . . 0.0 109.835 -179.585 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -46.9 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.339 -0.851 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.27 -61.32 0.36 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.44 -8.15 59.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -1.151 . . . . 0.0 109.257 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 18.6 mtp -90.26 -7.1 54.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -74.98 65.79 1.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 109.294 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -149.58 -28.38 0.26 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 0.0 110.452 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 51' ' ' TYR . 30.0 mt -60.14 125.05 80.25 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 120.9 -1.125 . . . . 0.0 109.28 -179.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.9 150.79 75.82 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 121.231 1.287 . . . . 0.0 112.565 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.547 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.9 t -133.21 137.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 84' ' ' LEU . 34.2 tp -117.35 65.73 0.73 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.555 178.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.475 ' SD ' ' O ' ' A' ' 56' ' ' SER . 2.3 mmt -48.21 159.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.01 132.76 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.33 -0.856 . . . . 0.0 109.048 -179.166 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.1 t -150.12 166.47 29.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.49 179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 109' ' ' LYS . . . -87.35 -68.24 0.77 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.23 -0.919 . . . . 0.0 109.301 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -88.4 101.93 14.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.546 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -88.5 98.92 11.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.213 -0.93 . . . . 0.0 109.874 -179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 18.8 tptt -63.72 -151.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 108.977 179.686 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.6 pttt -118.42 -71.43 0.74 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.565 -0.709 . . . . 0.0 109.413 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -48.97 -9.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.364 -0.835 . . . . 0.0 110.056 -179.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -89.53 -49.02 6.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.812 -179.856 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.546 HD11 ' HB1' ' A' ' 90' ' ' ALA . 35.9 mt -61.58 -31.95 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.779 -179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.0 mt -68.89 -63.58 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.087 -1.008 . . . . 0.0 109.651 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.45 -47.88 19.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 108.834 179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -47.97 -54.14 13.8 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.472 -0.768 . . . . 0.0 109.279 179.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' A' ' 101' ' ' ALA . . . -53.04 -45.23 67.94 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.296 -0.878 . . . . 0.0 110.1 -179.379 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.72 -19.43 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 109.116 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.419 ' N ' ' C ' ' A' ' 99' ' ' ALA . . . -98.97 -113.54 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.611 -0.681 . . . . 0.0 109.59 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.35 -2.89 5.82 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.695 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -55.79 10.94 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 122.206 -0.585 . . . . 0.0 111.326 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.668 ' H ' ' C ' ' A' ' 102' ' ' GLY . 14.0 m -29.45 -33.2 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.15 130.79 10.26 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.429 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -145.92 121.76 10.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.165 -1.197 . . . . 0.0 109.429 179.385 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.23 141.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 108' ' ' VAL . 8.5 p -92.13 100.68 11.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.108 -0.995 . . . . 0.0 108.907 179.739 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -62.53 159.87 38.77 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 120.921 -1.112 . . . . 0.0 109.345 -179.323 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.48 147.74 87.61 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 O-C-N 123.008 1.004 . . . . 0.0 109.835 -3.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.497 ' CE2' HD13 ' A' ' 116' ' ' LEU . 6.4 p90 -126.36 159.03 34.33 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.143 0.973 . . . . 0.0 110.414 179.154 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.522 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -103.19 153.15 20.65 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.933 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.469 ' HB1' HD23 ' A' ' 28' ' ' LEU . . . -48.9 -12.92 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.691 -1.256 . . . . 0.0 109.487 -179.158 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -79.67 -42.92 23.74 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.48 -60.26 2.56 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.497 HD13 ' CE2' ' A' ' 111' ' ' PHE . 4.1 tp -49.26 -37.91 25.14 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.094 179.04 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.477 ' OE1' HD11 ' A' ' 28' ' ' LEU . 41.8 tt0 -65.19 -48.83 72.04 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.076 -1.015 . . . . 0.0 109.866 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -53.35 -68.47 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 110.403 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.38 -47.49 9.72 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.371 -0.83 . . . . 0.0 110.19 -179.242 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.56 -44.56 96.04 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 -179.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -34.84 79.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.363 -0.835 . . . . 0.0 110.247 -179.425 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -71.32 -34.57 70.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.143 -0.973 . . . . 0.0 109.8 -179.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.7 mt -80.12 -41.31 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.705 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -63.74 -24.67 67.86 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.84 -178.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -58.14 -29.84 65.88 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -29.4 29.65 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.4 tp -69.06 -22.11 64.04 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.505 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 97.89 5.38 57.5 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.373 -1.075 . . . . 0.0 109.372 179.979 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.696 ' HB2' ' SD ' ' A' ' 129' ' ' MET . . . . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.449 0.643 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER 63.01 131.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.089 -1.007 . . . . 0.0 109.369 -179.827 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -90.17 9.68 27.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.985 . . . . 0.0 109.765 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -147.84 48.07 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.76 -179.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 56.1 tp -76.35 115.86 16.48 Favored 'General case' 0 C--O 1.204 -1.302 0 O-C-N 120.612 -1.305 . . . . 0.0 107.827 178.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -57.43 120.19 7.79 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.851 -1.156 . . . . 0.0 111.694 -177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 75.2 m-85 -110.62 143.36 41.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.123 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.588 HD22 ' CD1' ' A' ' 46' ' ' LEU . 53.9 tp -116.94 113.03 21.84 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.99 98.14 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.452 -0.78 . . . . 0.0 109.169 179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 36' ' ' ALA . 18.3 t -90.05 89.24 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 O-C-N 121.236 -0.915 . . . . 0.0 109.269 -179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -150.11 135.1 17.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.066 -1.021 . . . . 0.0 109.709 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 1.6 m-20 -87.41 1.48 53.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.289 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -66.17 140.23 58.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 19.8 5.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.8 -27.05 0.6 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.344 -0.847 . . . . 0.0 109.499 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.451 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -63.85 -58.79 5.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.487 -179.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -46.66 -36.12 6.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.396 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.5 -39.62 74.05 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.927 -1.109 . . . . 0.0 109.736 -178.294 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 21' ' ' VAL . 2.5 mt -60.13 -55.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.394 -0.816 . . . . 0.0 109.847 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.414 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -66.38 -34.0 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 110.638 -178.484 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -53.12 -53.28 52.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.936 -1.103 . . . . 0.0 109.404 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.4 t30 -69.29 -56.12 8.47 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -41.12 -57.27 2.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.741 -179.467 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.1 -48.63 80.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.064 -1.023 . . . . 0.0 109.02 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -57.39 -28.99 63.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.28 -0.888 . . . . 0.0 109.55 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.17 -30.88 68.51 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.1 -1.0 . . . . 0.0 108.874 179.67 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -79.74 -66.73 0.84 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.187 179.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.55 29.58 0.02 OUTLIER Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -98.08 152.34 19.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -1.178 . . . . 0.0 109.6 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -150.04 60.29 0.98 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.096 -1.003 . . . . 0.0 109.727 -179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -174.73 100.96 0.09 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.09 153.72 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.101 -0.999 . . . . 0.0 110.176 -179.265 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -126.74 -167.46 1.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.41 -0.806 . . . . 0.0 108.987 179.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -149.92 145.67 26.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.053 -1.03 . . . . 0.0 110.042 -179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.48 -169.03 2.59 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.15 6.31 1.94 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.212 -0.93 . . . . 0.0 111.176 -179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB3' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER 177.58 -175.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.533 -1.354 . . . . 0.0 110.005 179.605 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.87 -41.12 73.87 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.01 -36.99 76.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.405 -1.056 . . . . 0.0 109.241 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.1 t0 -78.99 -45.47 20.19 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.87 98.16 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.517 -0.739 . . . . 0.0 109.989 -179.579 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -65.76 -39.12 90.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.074 -1.016 . . . . 0.0 109.741 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -74.25 -23.96 59.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.162 -0.961 . . . . 0.0 110.336 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -90.03 -28.92 18.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.037 -1.04 . . . . 0.0 110.829 -179.055 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.588 ' CD1' HD22 ' A' ' 9' ' ' LEU . 1.6 mp -60.46 -13.04 11.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.581 -1.325 . . . . 0.0 109.417 -179.281 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -73.17 -6.84 48.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.161 -0.962 . . . . 0.0 108.613 179.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.81 -71.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.578 -0.701 . . . . 0.0 109.826 -179.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.14 12.64 1.08 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.89 94.78 0.97 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.44 ' O ' HD22 ' A' ' 81' ' ' LEU . 17.2 m-85 -73.97 148.8 41.79 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.257 -1.143 . . . . 0.0 110.128 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' C ' HD13 ' A' ' 81' ' ' LEU . . . -105.82 -9.01 33.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 178.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.2 129.49 14.71 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.667 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.3 t -128.28 122.78 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.079 -1.013 . . . . 0.0 110.09 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.4 mt -107.43 132.31 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 p -149.47 142.39 24.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.058 -1.026 . . . . 0.0 109.806 -179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -74.62 123.01 24.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.349 -0.845 . . . . 0.0 109.285 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 51.0 t-105 -61.61 98.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.871 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 60' ' ' MET . 0.2 OUTLIER 63.13 122.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -0.918 . . . . 0.0 109.826 179.769 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.496 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 169.99 -46.79 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.354 -0.841 . . . . 0.0 110.334 179.526 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -66.14 -55.37 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.719 0.946 . . . . 0.0 109.799 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.404 HD21 ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -172.51 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.387 179.892 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.27 -177.77 4.38 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER -93.1 131.5 38.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.192 179.887 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.05 1.83 3.28 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' H ' ' C ' ' A' ' 64' ' ' ASP . 58.6 tp -73.36 -68.73 0.47 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.114 -1.227 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 66' ' ' LEU . 0.5 OUTLIER -43.99 -31.4 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.533 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.5 tp -66.08 -56.34 12.02 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.562 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 102' ' ' GLY . 1.6 tt -63.42 -65.65 0.65 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.609 -0.682 . . . . 0.0 109.783 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' HH21 ' A' ' 73' ' ' ARG . 6.7 tttm -39.89 -32.84 0.17 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.835 -0.541 . . . . 0.0 109.879 -179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.7 m -71.29 -39.99 71.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.083 -1.011 . . . . 0.0 108.776 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 69' ' ' LEU . 96.4 mt -55.41 -42.05 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.646 179.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 HH21 ' NZ ' ' A' ' 70' ' ' LYS . 19.4 ptt85 -89.97 1.62 56.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.125 -0.984 . . . . 0.0 109.854 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.05 -28.25 48.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -36.21 53.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.73 -23.88 14.88 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.37 -52.41 65.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -1.16 . . . . 0.0 109.477 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.9 mmt -90.04 16.58 8.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.1 p 46.55 -107.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.819 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.03 56.55 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD12 ' O ' ' A' ' 82' ' ' PRO . 1.2 pp -42.77 149.44 0.49 Allowed Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.6 ' O ' HD12 ' A' ' 81' ' ' LEU . 4.2 Cg_exo -54.32 142.89 67.51 Favored 'Trans proline' 0 N--CA 1.482 0.84 0 C-N-CA 121.818 1.678 . . . . 0.0 113.505 -178.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 69' ' ' LEU . 2.3 t -134.55 128.77 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.514 HD21 HD11 ' A' ' 116' ' ' LEU . 48.0 tp -109.27 72.7 0.82 Allowed 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.012 177.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 mtt -53.06 169.46 0.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.8 t -141.16 129.14 22.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.449 -0.782 . . . . 0.0 109.664 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 88' ' ' ALA . 24.3 m -141.64 166.7 24.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 109.255 -179.442 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.596 ' N ' HG22 ' A' ' 87' ' ' THR . . . -111.58 -27.86 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.65 -0.656 . . . . 0.0 109.269 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 1.3 mt-10 -99.91 -72.4 0.67 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -0.805 . . . . 0.0 109.684 179.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 62.14 118.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 109.24 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -122.16 -88.06 0.63 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.685 -0.634 . . . . 0.0 109.67 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' ASN . 1.4 mtpp -152.98 -77.29 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 109.617 -179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -45.94 -16.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.893 . . . . 0.0 109.744 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.551 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 12.4 t30 -89.99 -33.15 16.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.932 . . . . 0.0 109.542 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.659 HD11 ' HB1' ' A' ' 90' ' ' ALA . 54.1 mt -90.04 -20.69 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.65 -179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.416 ' O ' ' C ' ' A' ' 97' ' ' ALA . 60.9 mt -73.66 -72.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.29 -50.66 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 58' ' ' TRP . . . -55.7 -51.96 65.52 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.561 -0.712 . . . . 0.0 109.54 179.266 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -54.72 -41.93 70.92 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.317 -0.864 . . . . 0.0 109.902 -179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.497 ' OE1' ' N ' ' A' ' 100' ' ' GLN . 2.9 mp0 -61.43 -11.85 12.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.859 -179.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -97.36 -104.79 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 110.43 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.735 ' N ' HD21 ' A' ' 69' ' ' LEU . . . -134.6 0.78 3.87 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -57.54 11.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.792 -0.828 . . . . 0.0 110.006 177.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 6.1 m -29.1 -32.56 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -175.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -110.59 126.28 7.79 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 178.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -147.0 112.01 5.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -1.217 . . . . 0.0 108.944 179.547 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.8 p -108.82 129.89 62.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.724 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.8 p -80.93 93.85 2.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 108.925 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 161.19 3.39 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.012 . . . . 0.0 109.314 -179.583 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.74 162.28 92.67 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 124.705 -0.956 . . . . 0.0 110.372 -2.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -143.64 155.04 44.13 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.166 0.984 . . . . 0.0 110.431 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -100.55 154.02 18.9 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 177.09 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.415 ' N ' HD11 ' A' ' 24' ' ' LEU . . . -49.13 -12.3 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.684 -1.26 . . . . 0.0 109.499 -179.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.49 -40.17 23.66 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 108.44 178.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.42 -59.2 2.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD11 HD21 ' A' ' 84' ' ' LEU . 4.7 tp -50.59 -38.31 44.74 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.289 -1.364 . . . . 0.0 108.614 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.25 -51.22 70.5 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.157 -0.964 . . . . 0.0 109.562 179.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -46.01 -59.94 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.504 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -55.65 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.115 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -45.71 -68.23 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.496 -0.752 . . . . 0.0 109.037 179.687 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.08 -22.4 39.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.975 -1.078 . . . . 0.0 110.508 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.464 ' O ' ' CG ' ' A' ' 125' ' ' GLU . 1.4 ttpt -81.14 -24.4 37.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.947 -1.096 . . . . 0.0 110.303 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 25.7 mt -90.08 -38.43 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.928 -1.108 . . . . 0.0 110.779 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' CD1' HD13 ' A' ' 120' ' ' LEU . 16.5 m-85 -67.79 -17.03 64.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.993 -1.067 . . . . 0.0 111.342 -177.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 122' ' ' LYS . 0.6 OUTLIER -62.03 -27.85 69.17 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.723 -1.236 . . . . 0.0 107.714 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.7 tttt -87.71 -27.72 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.64 -26.04 64.22 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.65 68.3 1.72 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.696 ' SD ' ' HB2' ' A' ' 2' ' ' ALA . 2.0 ptt? . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.43 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER 61.94 131.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.345 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt -90.07 10.57 23.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.141 -0.974 . . . . 0.0 109.667 -179.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -146.44 50.19 1.15 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.284 -0.885 . . . . 0.0 109.505 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.441 HD11 ' HA3' ' A' ' 52' ' ' GLY . 22.4 tp -78.74 131.9 36.75 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -77.05 118.5 19.67 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.213 -0.929 . . . . 0.0 113.18 -175.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 45.3 m-85 -110.29 143.91 39.79 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 177.204 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.627 HD23 HD12 ' A' ' 46' ' ' LEU . 41.3 tp -114.04 107.74 16.06 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.16 101.51 12.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.9 t -96.9 120.08 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.367 -0.833 . . . . 0.0 110.619 -178.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CE2' ' A' ' 14' ' ' PHE . 4.6 t0 -176.44 -178.81 0.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.467 -0.771 . . . . 0.0 109.389 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -114.94 9.96 16.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.064 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' ' CB ' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -69.46 164.14 23.74 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.397 -179.813 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 89.4 p -134.09 29.84 3.69 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 178.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 17' ' ' MET . 0.5 OUTLIER -154.08 -60.62 0.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.481 -177.184 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.524 ' SD ' ' CE2' ' A' ' 14' ' ' PHE . 4.7 ttt -45.69 -58.13 3.69 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.609 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.593 ' HE ' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -34.08 -33.99 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.469 0.652 . . . . 0.0 109.93 178.726 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 17' ' ' MET . 0.8 OUTLIER -70.19 -46.54 64.38 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.621 -178.426 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.6 mp -54.46 -58.07 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.249 -0.907 . . . . 0.0 109.269 179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -55.39 -43.25 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.504 -0.747 . . . . 0.0 110.157 -179.309 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' NH1' ' HE ' ' A' ' 18' ' ' ARG . 4.6 mtt85 -46.78 -53.36 12.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -64.69 -57.12 9.86 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.807 0.813 . . . . 0.0 109.192 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.2 tt -38.43 -56.03 1.31 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.961 -179.632 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.42 -52.18 65.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.197 -0.939 . . . . 0.0 109.01 179.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -52.53 -39.39 61.31 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.251 -0.906 . . . . 0.0 109.229 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -51.83 -31.22 26.68 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.399 -0.813 . . . . 0.0 109.163 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.95 -62.35 1.54 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 109.275 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.513 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 159.55 74.06 0.02 OUTLIER Glycine 0 N--CA 1.479 1.519 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.513 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 56.0 m-85 -150.1 155.12 39.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -1.215 . . . . 0.0 109.57 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.18 40.28 0.78 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.093 -1.004 . . . . 0.0 110.294 -179.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -157.57 108.6 2.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.655 -1.278 . . . . 0.0 109.536 179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -146.35 146.96 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.315 -0.865 . . . . 0.0 110.067 -179.329 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -121.85 -172.55 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.549 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 74.5 mt-10 -149.95 154.11 37.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.01 -1.056 . . . . 0.0 110.38 -178.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.628 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.15 -173.97 3.73 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.19 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.584 ' H ' ' CB ' ' A' ' 41' ' ' ASP . 15.6 mm-40 -117.95 -2.13 11.35 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.487 -0.758 . . . . 0.0 110.443 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 165.01 166.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.31 -0.869 . . . . 0.0 109.041 179.968 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' N ' ' CG ' ' A' ' 38' ' ' ASP . . . -42.74 -52.82 5.43 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 2.9 p -58.96 -42.27 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.881 -1.364 . . . . 0.0 109.176 -179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.584 ' CB ' ' H ' ' A' ' 37' ' ' GLU . 8.7 t0 -58.83 -45.98 88.73 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.17 -40.99 91.86 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -49.65 -39.62 36.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.926 -1.109 . . . . 0.0 108.624 179.405 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -88.18 -33.01 18.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.232 -0.918 . . . . 0.0 110.35 -179.667 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -89.9 -55.8 3.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.104 -0.998 . . . . 0.0 109.879 -179.603 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.627 HD12 HD23 ' A' ' 9' ' ' LEU . 7.2 tt -45.68 -27.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.386 -0.821 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -72.59 12.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.936 . . . . 0.0 108.808 179.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -49.7 -55.47 13.74 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.52 -0.738 . . . . 0.0 109.652 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.65 33.78 0.07 OUTLIER Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.254 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 90.89 124.52 2.99 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.481 ' C ' ' H ' ' A' ' 53' ' ' PHE . 18.2 m-85 -113.64 107.18 15.43 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.76 -0.847 . . . . 0.0 110.193 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.441 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -61.89 0.46 1.7 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CD2' ' CE2' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -168.39 144.32 3.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.257 . . . . 0.0 109.484 179.953 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.76 ' HB ' HG22 ' A' ' 83' ' ' VAL . 92.9 t -142.23 126.94 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.854 -1.154 . . . . 0.0 109.685 179.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.3 mt -110.51 93.63 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.7 p -91.04 141.62 28.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.88 -1.138 . . . . 0.0 109.461 -179.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -106.61 24.71 12.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 110.521 -179.307 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.487 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 4.5 t-105 62.19 143.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.941 -1.099 . . . . 0.0 109.163 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -151.49 167.7 27.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 109.987 -179.834 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.658 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -144.48 23.5 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.139 -0.975 . . . . 0.0 113.615 -179.932 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.3 Cg_endo -59.33 -54.9 2.16 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 N-CA-C 108.598 -1.347 . . . . 0.0 108.598 177.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -155.31 -21.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.674 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 38' ' ' ASP . 76.6 mtp -150.78 103.49 3.09 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.483 -0.76 . . . . 0.0 109.031 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -58.69 -175.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.081 -1.012 . . . . 0.0 110.183 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.02 -5.29 80.88 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.44 -50.53 67.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.795 -1.415 . . . . 0.0 107.832 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -49.45 -24.66 2.11 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' ILE . 3.8 tp -69.78 -57.43 5.11 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -50.08 -55.14 16.07 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.031 0.92 . . . . 0.0 109.052 178.988 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -59.79 -50.02 75.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.399 179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.6 m -69.23 -14.86 63.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.492 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.847 HD13 HG21 ' A' ' 83' ' ' VAL . 1.1 mt -78.26 -29.72 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -77.24 -35.12 55.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.547 -0.721 . . . . 0.0 109.933 -179.751 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 76' ' ' GLY . . . -45.25 -27.98 0.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.313 -0.867 . . . . 0.0 110.168 -179.54 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.54 78.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 109.942 -179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 74' ' ' ALA . . . 43.69 -157.91 0.13 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.418 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.9 -3.65 57.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.396 -1.061 . . . . 0.0 109.652 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 4.2 tpt -90.0 -8.81 50.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 108.907 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m 45.45 -119.19 0.79 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.548 -0.72 . . . . 0.0 109.938 179.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.03 60.58 0.98 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER 47.65 -178.92 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 178.815 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.5 Cg_exo -62.83 142.93 90.64 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.533 2.156 . . . . 0.0 115.451 -174.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.847 HG21 HD13 ' A' ' 72' ' ' ILE . 15.2 t -137.01 104.27 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.31 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -91.48 104.78 17.24 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 117.116 -1.834 . . . . 0.0 106.722 178.388 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 27.0 ttm -77.44 119.4 20.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.704 -1.198 . . . . 0.0 108.726 -178.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 107' ' ' VAL . 2.2 p -108.13 146.08 14.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 121.503 -0.748 . . . . 0.0 109.611 -178.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.444 ' OG1' ' N ' ' A' ' 88' ' ' ALA . 3.0 t -150.12 -173.41 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -0.83 . . . . 0.0 109.614 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 90' ' ' ALA . . . -129.8 -46.41 1.15 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 91' ' ' LYS . 5.5 pt-20 -74.67 26.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.353 -0.842 . . . . 0.0 109.156 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.827 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -52.64 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.378 -0.826 . . . . 0.0 109.448 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 89' ' ' GLU . 7.3 ttmt -99.99 -69.12 0.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.445 -0.784 . . . . 0.0 109.481 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -169.94 -44.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.111 -0.993 . . . . 0.0 109.39 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 2.8 pt-20 -79.97 -24.57 40.85 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.281 -0.887 . . . . 0.0 109.796 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.413 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 4.6 t30 -87.95 -28.05 21.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.865 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.827 HD11 ' HB1' ' A' ' 90' ' ' ALA . 15.7 mt -72.67 -58.0 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 108.938 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 35.7 mt -60.34 -29.39 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.362 -0.836 . . . . 0.0 109.162 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.77 -40.05 39.98 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.088 -1.008 . . . . 0.0 109.964 -179.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 101' ' ' ALA . . . -80.92 -62.11 1.77 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -53.39 -28.4 29.23 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.816 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.51 -35.39 68.0 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.494 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -76.9 -26.05 53.71 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 176.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 67.49 71.84 0.88 Allowed Glycine 0 N--CA 1.484 1.846 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.745 175.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.906 ' HB2' HD21 ' A' ' 69' ' ' LEU . . . -90.2 -111.4 0.08 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 117.495 -1.682 . . . . 0.0 109.391 177.629 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.58 -47.48 7.38 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 122.53 1.157 . . . . 0.0 108.833 177.224 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 166.7 -159.02 32.25 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -178.155 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -142.62 136.39 29.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.705 -0.879 . . . . 0.0 109.833 179.308 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.772 HG11 HD21 ' A' ' 116' ' ' LEU . 6.2 p -134.71 134.24 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -161.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.86 151.76 8.32 Favored Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.319 -0.863 . . . . 0.0 108.784 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.86 138.08 53.96 Favored 'Cis proline' 0 N--CA 1.486 1.035 0 C-N-CA 125.281 -0.716 . . . . 0.0 110.341 -2.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.822 ' CG ' HD23 ' A' ' 116' ' ' LEU . 3.3 p90 -97.89 160.21 14.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.78 146.95 23.25 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.831 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.01 -34.73 13.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 108.442 -179.588 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.47 -35.38 80.75 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.8 m -70.44 -70.57 0.29 Allowed 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.822 HD23 ' CG ' ' A' ' 111' ' ' PHE . 0.4 OUTLIER -51.67 -28.34 14.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.429 -1.419 . . . . 0.0 109.841 179.51 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 10.2 tt0 -62.22 -62.66 1.61 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.463 -1.398 . . . . 0.0 108.997 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -46.32 -44.45 16.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.759 . . . . 0.0 109.527 -179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -62.04 -31.43 71.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 tt -81.63 -53.5 6.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.542 -179.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.58 -33.96 74.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.701 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -70.78 -44.0 67.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.46 -36.65 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.264 -0.898 . . . . 0.0 109.264 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -73.79 -29.85 62.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.431 -0.793 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -51.67 -29.88 19.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -86.37 -30.7 21.96 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.7 tp -79.91 -10.05 59.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.37 -0.831 . . . . 0.0 108.846 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 46.69 41.19 12.71 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.317 -1.108 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.577 ' C ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -45.75 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 179.776 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -69.03 26.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.981 -1.074 . . . . 0.0 109.942 -179.934 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 3' ' ' ASP . 30.6 mt-10 -134.62 35.71 3.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp -83.85 136.16 34.23 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.2 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.3 mtmt -83.94 129.91 34.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.91 -1.118 . . . . 0.0 111.237 -177.382 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -113.56 157.69 21.73 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 121.445 0.64 . . . . 0.0 109.767 179.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.043 HD23 HD12 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -132.64 108.35 9.0 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.461 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.554 ' N ' HD12 ' A' ' 9' ' ' LEU . 1.5 m -92.63 110.12 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.633 -177.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 36' ' ' ALA . 57.5 t -90.03 92.68 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.071 -1.018 . . . . 0.0 109.506 179.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -144.99 151.69 38.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.15 -33.38 10.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.571 -0.706 . . . . 0.0 109.629 -179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.87 132.32 11.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 109.595 -179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -86.29 26.28 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.435 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.4 t -146.32 -23.83 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.856 . . . . 0.0 109.27 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.4 ttt -65.67 -46.74 77.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -55.86 -30.97 62.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 109.439 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.645 ' NH2' HH12 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -70.02 -24.66 63.31 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.309 -177.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.0 mt -73.15 -47.28 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 109.889 -179.639 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.44 -34.43 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.182 -179.22 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.645 HH12 ' NH2' ' A' ' 19' ' ' ARG . 8.6 mtp180 -47.43 -51.56 19.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.131 -0.981 . . . . 0.0 109.234 179.764 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.51 -58.53 3.86 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.677 0.751 . . . . 0.0 109.84 -179.806 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tt -40.57 -46.41 2.51 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.474 -179.085 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.1 mt -71.24 -41.91 69.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.004 -1.06 . . . . 0.0 109.124 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -61.91 -30.36 70.84 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.261 -0.9 . . . . 0.0 109.342 179.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.14 -23.27 62.02 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.224 -0.922 . . . . 0.0 109.464 -179.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -90.78 -40.49 11.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.232 -0.918 . . . . 0.0 110.155 -179.626 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 144.29 5.36 0.61 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.86 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.93 135.33 33.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.951 -1.323 . . . . 0.0 109.794 -179.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.53 ' ND2' ' N ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -145.76 64.24 1.24 Allowed 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.102 -0.999 . . . . 0.0 109.894 -179.829 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -172.45 97.68 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.839 -1.163 . . . . 0.0 110.01 179.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -147.93 177.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.102 -0.999 . . . . 0.0 110.228 179.895 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.677 ' HG3' HD13 ' A' ' 9' ' ' LEU . 13.5 pt-20 -134.91 -166.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.937 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 3.8 tt0 -147.39 155.03 41.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 110.905 -179.259 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB1' ' HB3' ' A' ' 41' ' ' ASP . . . -148.37 -166.87 2.66 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.618 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -136.35 -7.94 1.99 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.387 -0.82 . . . . 0.0 110.211 -179.565 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -174.46 -178.12 1.33 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.018 -1.052 . . . . 0.0 109.243 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 64' ' ' ASP . . . -64.12 -52.16 46.87 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 40' ' ' VAL . 0.3 OUTLIER -51.05 -35.28 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.916 -1.343 . . . . 0.0 107.812 179.198 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 20.8 t0 -68.23 -50.57 53.13 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.059 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.02 -18.95 65.68 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.279 -0.888 . . . . 0.0 108.708 179.44 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.652 ' CD2' HE22 ' A' ' 47' ' ' GLN . 0.7 OUTLIER -77.41 -27.59 52.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.149 179.777 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -90.64 -33.35 15.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 0.0 110.316 -179.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.0 -58.7 2.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.009 -1.057 . . . . 0.0 110.076 -179.544 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.043 HD12 HD23 ' A' ' 9' ' ' LEU . 2.1 tt -51.88 -22.41 3.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.652 HE22 ' CD2' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -51.84 -29.39 19.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.037 . . . . 0.0 108.799 179.158 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.92 -59.31 2.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.648 -0.657 . . . . 0.0 109.463 179.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.42 112.18 3.55 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.701 -1.359 . . . . 0.0 109.701 179.553 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.39 -30.11 0.78 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.837 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 84.4 m-85 -64.21 85.29 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.296 -1.12 . . . . 0.0 109.875 -179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.0 9.62 2.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.126 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -159.54 153.02 22.51 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.391 -1.064 . . . . 0.0 109.883 -179.355 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.66 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.3 t -146.07 142.93 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.918 -1.114 . . . . 0.0 109.687 -179.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.435 ' O ' HG22 ' A' ' 55' ' ' ILE . 12.8 mt -126.4 104.14 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.9 p -114.7 150.54 35.08 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.383 -0.823 . . . . 0.0 110.272 -178.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 86' ' ' VAL . 0.0 OUTLIER -78.24 -85.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.474 -0.766 . . . . 0.0 109.236 179.522 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.627 ' CD1' ' ND2' ' A' ' 59' ' ' ASN . 59.6 t-105 -165.76 169.11 15.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.932 . . . . 0.0 109.278 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.627 ' ND2' ' CD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -76.33 44.34 0.34 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.735 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.531 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtp -71.17 -46.74 14.27 Favored Pre-proline 0 C--N 1.303 -1.416 0 O-C-N 121.401 -0.812 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.1 Cg_exo -65.47 -50.6 1.81 Allowed 'Trans proline' 0 C--N 1.321 -0.879 0 C-N-CA 121.12 1.213 . . . . 0.0 110.299 -179.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -164.03 154.21 14.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.493 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.2 mtt -46.09 125.17 6.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.378 -0.827 . . . . 0.0 109.342 -179.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER 177.01 -61.06 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.027 -1.045 . . . . 0.0 109.902 -179.952 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -38.26 -40.13 0.84 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -179.463 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.59 -55.62 6.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.936 -1.332 . . . . 0.0 109.003 179.318 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -10.01 15.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.154 -0.966 . . . . 0.0 108.76 179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.4 OUTLIER -73.95 -59.94 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.567 0.698 . . . . 0.0 109.126 179.621 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.837 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -76.68 -31.82 57.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.569 -0.707 . . . . 0.0 109.742 -179.421 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -67.35 -47.48 70.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.122 179.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.7 m -64.52 -41.45 96.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.208 -0.932 . . . . 0.0 108.973 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' ' OD1' ' A' ' 75' ' ' ASP . 46.4 mt -60.42 -26.86 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.349 -0.845 . . . . 0.0 109.071 179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.5 ttp85 -89.31 -25.49 21.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.351 -0.843 . . . . 0.0 109.749 180.0 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.27 69.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 109.362 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 79' ' ' SER . 0.5 OUTLIER -78.36 93.03 4.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.364 -0.835 . . . . 0.0 109.477 179.98 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.13 -24.09 54.03 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.36 -10.52 59.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -1.18 . . . . 0.0 109.59 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 58.3 mtt -149.14 21.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 75' ' ' ASP . 88.5 p -75.17 65.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.139 -0.976 . . . . 0.0 109.397 179.812 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -149.98 -28.71 0.24 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 0.0 110.524 -179.732 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.501 HD21 ' O ' ' A' ' 51' ' ' TYR . 1.5 tp -43.84 107.55 0.6 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 109.676 -179.362 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.6 117.61 4.4 Favored 'Trans proline' 0 N--CA 1.481 0.785 0 C-N-CA 121.469 1.446 . . . . 0.0 113.293 -178.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.6 t -110.72 105.79 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 176.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.89 105.11 17.58 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 117.229 -1.788 . . . . 0.0 106.279 178.739 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -80.67 118.48 22.27 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.084 -177.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.6 OUTLIER -104.1 150.89 6.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 121.521 -0.737 . . . . 0.0 109.764 -178.532 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -150.01 165.99 31.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.98 -1.075 . . . . 0.0 110.046 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -90.55 -97.38 0.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' CD ' ' N ' ' A' ' 89' ' ' GLU . 9.2 mp0 -59.78 81.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.086 179.872 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -70.21 70.48 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.501 -179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -85.47 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.257 -0.902 . . . . 0.0 108.72 179.683 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER 179.53 -59.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.465 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' H ' ' CG ' ' A' ' 92' ' ' LYS . 15.5 mt-10 -55.07 -34.78 63.9 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.27 -0.894 . . . . 0.0 109.655 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.528 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -79.11 -11.55 59.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.723 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' ALA . 35.0 mm -85.1 -67.11 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.131 -0.98 . . . . 0.0 109.067 179.814 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 100' ' ' GLN . 2.5 mp -48.09 -21.53 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.24 -0.912 . . . . 0.0 108.634 179.503 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 95' ' ' ILE . . . -57.37 -63.54 1.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.138 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -49.94 -58.81 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 108.567 179.166 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -56.44 -24.65 46.9 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.824 -0.751 . . . . 0.0 109.48 -178.939 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 96' ' ' ILE . 11.9 tt0 -51.59 -31.79 26.17 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.75 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.65 -23.31 20.81 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.557 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 69.02 75.86 0.5 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.461 177.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.837 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -90.06 -112.13 0.08 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 117.009 -1.876 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.74 -49.38 6.3 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 122.921 1.343 . . . . 0.0 108.042 175.554 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 164.94 -163.0 36.13 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -178.384 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -136.69 139.28 41.85 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.623 -0.927 . . . . 0.0 109.158 178.579 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.498 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 14.7 p -133.87 150.64 31.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.433 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' CG2' ' OH ' ' A' ' 106' ' ' TYR . 57.5 t -90.95 160.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.069 -1.02 . . . . 0.0 109.558 -179.528 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.463 ' N ' HG12 ' A' ' 108' ' ' VAL . 11.9 pttt -129.01 156.06 78.73 Favored Pre-proline 0 N--CA 1.505 2.313 0 O-C-N 121.193 -0.942 . . . . 0.0 108.755 178.471 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.72 123.78 9.34 Favored 'Cis proline' 0 N--CA 1.486 1.084 0 O-C-N 122.618 0.799 . . . . 0.0 110.625 -2.515 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.642 ' CE2' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -89.9 165.84 13.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.051 -1.031 . . . . 0.0 109.215 179.132 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -99.8 167.05 10.78 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.041 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.88 -37.92 88.8 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.871 -1.132 . . . . 0.0 108.954 -179.47 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.67 -24.57 66.29 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.45 179.056 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 112' ' ' THR . 5.4 m -78.41 -69.88 0.53 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.623 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.642 HD13 ' CE2' ' A' ' 111' ' ' PHE . 9.1 tp -46.61 -36.0 6.49 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.726 -1.234 . . . . 0.0 109.213 178.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.02 -63.14 1.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.109 -0.994 . . . . 0.0 110.822 -179.28 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -45.8 -29.85 1.47 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.158 -0.964 . . . . 0.0 110.153 -178.89 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -85.25 -32.88 22.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.025 -1.047 . . . . 0.0 108.891 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 tp -66.81 -52.0 49.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.441 -0.787 . . . . 0.0 109.469 179.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -53.26 -61.09 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.293 -0.879 . . . . 0.0 109.707 -179.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -52.77 -27.96 20.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.437 -0.79 . . . . 0.0 110.133 -179.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 mt -76.92 -43.73 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 0.0 109.974 -179.55 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 128' ' ' GLY . 12.0 m-85 -66.77 -5.9 13.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.024 -1.048 . . . . 0.0 109.833 -179.269 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -70.42 -24.64 62.95 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.057 -1.027 . . . . 0.0 108.249 178.924 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -95.08 -24.72 16.75 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.153 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.76 -14.14 25.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.53 -0.732 . . . . 0.0 109.147 179.825 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 124' ' ' PHE . . . 46.2 86.7 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.863 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.224 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.221 0.534 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -46.62 146.37 1.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.353 -0.842 . . . . 0.0 109.499 179.889 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.4 mmtp -90.37 14.82 11.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.004 -1.06 . . . . 0.0 109.943 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -156.12 45.39 0.44 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.761 -1.212 . . . . 0.0 110.941 -178.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 46.5 tp -71.96 111.93 7.62 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.792 -1.193 . . . . 0.0 107.817 179.053 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' CG ' HD22 ' A' ' 32' ' ' ASN . 17.6 mttt -48.13 118.77 2.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.043 -1.036 . . . . 0.0 110.719 -177.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.519 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 38.2 m-85 -109.83 155.44 21.65 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.75 0.786 . . . . 0.0 110.487 179.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG12 ' A' ' 54' ' ' VAL . 7.6 tp -135.86 102.63 5.12 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.832 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.504 HG11 ' HB ' ' A' ' 21' ' ' VAL . 16.7 m -89.99 103.84 14.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.98 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.791 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.5 t -97.96 110.35 25.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 O-C-N 121.424 -0.798 . . . . 0.0 109.354 -179.377 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -169.72 159.08 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.99 -1.069 . . . . 0.0 109.85 -179.741 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' CG ' ' N ' ' A' ' 14' ' ' PHE . 13.1 t0 -97.45 -100.11 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.536 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.453 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 45.2 -163.76 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.325 -0.859 . . . . 0.0 109.752 179.61 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.1 12.34 2.41 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.53 -6.11 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.504 -0.748 . . . . 0.0 109.238 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 27.1 ttt -67.43 -66.26 0.58 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.798 -179.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.657 ' H ' ' CD ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -45.62 -35.67 4.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.33 -0.856 . . . . 0.0 109.84 -179.842 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -70.66 -41.2 72.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.52 -52.96 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' HB ' HG11 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -63.0 -45.34 99.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.281 -0.887 . . . . 0.0 110.27 -179.091 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -46.27 -53.76 10.12 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.974 . . . . 0.0 109.508 -179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -65.87 -57.23 8.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.857 0.836 . . . . 0.0 109.304 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -40.08 -59.77 1.17 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.728 -179.792 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -53.39 -48.05 68.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.784 . . . . 0.0 109.431 179.693 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -56.32 -42.91 78.4 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 -179.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -55.48 -29.95 59.7 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.273 -0.892 . . . . 0.0 109.239 179.949 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mp -75.72 -62.97 1.41 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.542 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 155.69 35.07 0.02 OUTLIER Glycine 0 N--CA 1.482 1.701 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.535 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 47.3 m-85 -115.66 139.09 50.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.751 -0.852 . . . . 0.0 109.733 -179.589 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.3 63.88 1.54 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.469 -0.769 . . . . 0.0 109.69 -179.609 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.472 HD22 ' CG ' ' A' ' 7' ' ' LYS . 2.4 t30 -176.8 95.57 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.967 -1.083 . . . . 0.0 108.551 179.796 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.11 147.09 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.906 -1.121 . . . . 0.0 110.693 -178.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -118.83 -164.87 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.351 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -150.15 159.19 44.61 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.117 -0.989 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.791 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.87 -170.87 3.42 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -121.73 -10.1 8.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 111.004 -178.985 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -176.51 171.81 2.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.565 -1.334 . . . . 0.0 110.027 179.685 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.76 -45.45 91.02 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.622 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 41' ' ' ASP . 9.4 p -57.32 -39.3 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.953 -1.322 . . . . 0.0 108.926 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.8 t70 -63.74 -51.11 66.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.253 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.559 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -51.89 -48.96 63.87 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.155 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.29 -44.48 16.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.942 . . . . 0.0 109.706 179.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -79.64 -29.62 41.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.296 -179.334 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -89.77 -10.33 45.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.085 -1.009 . . . . 0.0 110.371 -179.29 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.659 HD21 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -71.08 -6.37 38.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.058 . . . . 0.0 108.726 -179.992 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' NE2' ' O ' ' A' ' 47' ' ' GLN . 29.6 tp60 -95.14 -13.14 25.32 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.96 -66.72 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.472 -0.768 . . . . 0.0 109.459 179.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -143.97 7.14 1.87 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.96 84.33 0.35 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CZ ' HD13 ' A' ' 9' ' ' LEU . 82.1 m-85 -63.54 138.94 58.7 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.413 -1.051 . . . . 0.0 110.4 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -85.45 -4.03 86.19 Favored Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.543 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 4.0 t80 -169.35 94.39 0.29 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.89 -1.359 . . . . 0.0 110.35 -178.618 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.659 HG11 HD21 ' A' ' 46' ' ' LEU . 30.2 m -94.86 141.9 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.129 -1.607 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.89 96.27 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.778 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -111.13 177.6 4.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.555 -0.716 . . . . 0.0 110.297 -179.476 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 11' ' ' VAL . 4.8 m-20 -89.8 -121.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.466 -0.771 . . . . 0.0 110.179 -179.2 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.52 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 61.3 t-105 -127.56 -173.64 2.97 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.52 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 1.2 p-10 -93.87 55.74 2.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.327 -0.858 . . . . 0.0 109.73 -179.762 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.57 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -75.87 -45.6 3.97 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.991 -1.068 . . . . 0.0 110.406 179.702 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -67.73 -44.77 3.89 Favored 'Trans proline' 0 C--N 1.321 -0.88 0 C-N-CA 121.208 1.272 . . . . 0.0 110.211 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.74 159.79 19.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.19 -0.944 . . . . 0.0 109.714 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 119.16 7.07 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.557 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -175.96 -63.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 109.978 179.901 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 64' ' ' ASP . . . -34.22 -50.11 0.67 Allowed Glycine 0 N--CA 1.502 3.057 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.397 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.415 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -68.49 -60.55 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.768 -1.431 . . . . 0.0 108.81 179.835 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -54.75 -13.06 0.9 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.191 -0.943 . . . . 0.0 108.561 179.404 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 42' ' ' ALA . 0.8 OUTLIER -72.45 -55.08 7.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.375 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.862 HD21 ' HB3' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -63.96 -37.46 87.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 108.94 179.628 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -64.24 -55.03 24.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -0.822 . . . . 0.0 108.851 179.44 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.8 p -54.18 -44.24 71.37 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.331 -0.856 . . . . 0.0 108.731 179.427 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.9 mt -63.94 -19.19 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.309 -0.869 . . . . 0.0 108.798 179.454 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 -36.33 15.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 109.227 179.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.17 -33.88 72.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.774 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 79' ' ' SER . 15.4 t70 -47.68 145.43 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -101.42 -34.05 4.61 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.42 -27.0 45.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -1.105 . . . . 0.0 109.71 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.7 mmt -137.18 -55.83 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.55 -0.719 . . . . 0.0 109.411 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 46.78 24.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.06 3.59 0.53 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.049 . . . . 0.0 110.885 -179.514 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 51' ' ' TYR . 11.6 mt -54.52 115.26 8.23 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 108.292 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' CB ' ' OG ' ' A' ' 104' ' ' SER . 2.7 Cg_endo -60.46 134.6 55.93 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 121.182 1.255 . . . . 0.0 113.715 -177.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -128.62 112.97 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.778 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.1 tp -97.85 96.52 8.26 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.447 179.245 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.3 144.14 54.44 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.713 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 107' ' ' VAL . 44.4 t -133.81 145.15 33.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.559 0.695 . . . . 0.0 110.707 -177.724 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.6 t -150.08 165.04 33.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.308 -0.87 . . . . 0.0 109.087 179.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.46 38.11 3.35 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.598 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' ALA . 1.7 mt-10 -165.75 -44.35 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.407 -0.808 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 1.033 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 45.18 84.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.869 0.842 . . . . 0.0 108.754 -179.435 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -75.41 16.66 0.33 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.963 . . . . 0.0 109.805 -178.924 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.627 ' HA ' HD12 ' A' ' 95' ' ' ILE . 13.4 ttmt 75.44 -45.4 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.884 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.26 -45.16 49.55 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.454 ' OD1' ' CZ2' ' A' ' 58' ' ' TRP . 2.9 m-80 -74.06 -4.76 37.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.158 -0.964 . . . . 0.0 109.337 179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.033 HD11 ' HB1' ' A' ' 90' ' ' ALA . 8.9 mt -80.26 -57.53 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.166 -0.959 . . . . 0.0 108.521 179.381 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 96' ' ' ILE . 79.5 mt -68.8 2.43 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.271 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 95' ' ' ILE . . . -80.67 -47.52 13.92 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.508 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.519 ' HB2' ' HZ3' ' A' ' 58' ' ' TRP . . . -70.68 -50.7 33.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.534 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -60.65 -25.79 66.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.289 -179.642 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -52.99 -33.04 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.593 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.862 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.53 -23.27 25.94 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.24 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 75.61 0.51 Allowed Glycine 0 N--CA 1.48 1.572 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.544 177.771 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -112.11 0.08 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.877 -1.929 . . . . 0.0 109.596 179.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 67.3 m -91.88 -49.02 6.46 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 122.7 1.238 . . . . 0.0 108.06 175.531 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.411 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 167.31 -159.68 33.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -178.525 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.08 137.61 26.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.568 -0.96 . . . . 0.0 109.055 178.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.478 HG12 HG22 ' A' ' 86' ' ' VAL . 12.4 p -131.76 134.89 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.2 p -89.14 96.46 6.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.066 -1.054 . . . . 0.0 109.585 -179.369 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.419 ' CD ' ' C ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -61.04 155.7 53.2 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.971 -1.081 . . . . 0.0 108.557 179.812 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.38 154.44 99.65 Favored 'Cis proline' 0 N--CA 1.487 1.094 0 C-N-CA 125.335 -0.694 . . . . 0.0 111.313 -1.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.667 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.1 p90 -135.33 156.54 48.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.693 0.758 . . . . 0.0 108.998 178.422 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.29 150.0 21.5 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.95 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.82 -35.0 21.33 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.735 -1.228 . . . . 0.0 108.985 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.6 -28.98 65.27 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 17.5 m -75.99 -65.23 0.94 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.667 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -49.73 -36.93 27.32 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.23 -1.388 . . . . 0.0 108.313 179.086 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.31 -53.21 39.16 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.002 -1.062 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -46.55 -25.02 0.61 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.516 -0.74 . . . . 0.0 109.05 179.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -88.51 -49.97 6.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.294 -0.879 . . . . 0.0 109.122 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.7 mt -48.49 -59.02 3.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -44.02 -61.43 1.46 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.34 -0.85 . . . . 0.0 110.237 -179.368 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -45.4 -29.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 0.0 110.1 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 125' ' ' GLU . 4.6 mt -87.88 -44.01 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.012 -1.055 . . . . 0.0 110.217 -179.614 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -62.0 5.27 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.15 -0.969 . . . . 0.0 110.579 -178.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.8 tt0 -77.91 -36.47 49.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.3 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -81.15 -35.56 31.33 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -59.33 -32.85 70.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.021 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.61 75.28 0.9 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.234 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.313 -1.11 . . . . 0.0 109.428 179.938 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -45.87 143.36 2.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 -179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -90.02 23.8 2.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.96 . . . . 0.0 109.121 179.604 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -158.28 42.92 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.0 109.259 -179.742 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 52' ' ' GLY . 51.3 tp -67.63 143.22 56.13 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.233 -0.917 . . . . 0.0 108.577 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -79.76 120.35 23.91 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.117 -0.989 . . . . 0.0 110.831 -178.166 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -109.05 152.79 24.55 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.672 -0.642 . . . . 0.0 109.676 179.272 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' HB3' HG23 ' A' ' 54' ' ' VAL . 9.3 tp -130.43 110.76 11.72 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.342 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 m -99.12 104.38 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -0.966 . . . . 0.0 109.705 -179.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.959 HG22 ' HB3' ' A' ' 36' ' ' ALA . 94.8 t -89.81 100.73 11.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 120.937 -1.102 . . . . 0.0 109.66 -179.723 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.42 -163.58 1.64 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.775 . . . . 0.0 109.227 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.29 1.54 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.031 -1.043 . . . . 0.0 109.988 -179.886 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.63 153.3 28.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.051 -1.031 . . . . 0.0 109.376 179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 84.1 p -93.63 41.11 1.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.712 -179.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -173.9 -21.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.8 ttt -62.41 -46.42 88.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.599 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -45.58 78.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.965 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -55.37 -34.24 64.14 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 110.701 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.7 mt -63.86 -48.51 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.158 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.21 -36.9 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.993 . . . . 0.0 110.575 -178.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtp85 -50.7 -53.11 33.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 0.0 109.469 -179.96 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -65.73 -56.65 10.9 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.672 0.749 . . . . 0.0 109.471 179.915 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 0.5 OUTLIER -37.94 -57.67 1.01 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.954 -179.669 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.81 -51.87 65.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.161 -0.962 . . . . 0.0 109.213 179.382 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -53.82 -35.08 61.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -55.49 -28.92 57.49 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.228 -0.92 . . . . 0.0 109.552 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 mt -87.82 -62.56 1.47 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.601 -179.848 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.71 65.5 0.03 OUTLIER Glycine 0 N--CA 1.481 1.687 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.822 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -150.01 145.31 26.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.251 . . . . 0.0 109.574 -179.82 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -150.02 66.63 0.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 109.752 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -173.91 99.37 0.11 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.15 150.94 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.493 -179.06 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -122.05 -167.38 1.53 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.233 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.14 152.55 34.88 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.12 -0.987 . . . . 0.0 110.536 -179.11 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.959 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -144.41 168.12 20.87 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.069 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -122.08 9.26 9.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.56 -0.712 . . . . 0.0 109.911 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 3.6 p-10 178.05 -176.23 0.19 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.69 -39.24 49.11 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.646 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 t -54.7 -35.21 32.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.05 -1.265 . . . . 0.0 108.025 178.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.656 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 8.2 t0 -82.69 -47.49 11.96 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.59 -0.694 . . . . 0.0 109.316 179.503 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -55.05 30.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -59.09 6.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 110.08 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -53.02 -33.43 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.192 -0.942 . . . . 0.0 110.028 -179.465 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -88.76 -13.24 39.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 110.632 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -82.17 -29.57 31.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.716 -1.24 . . . . 0.0 109.178 -179.976 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.26 -8.41 0.31 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.174 -0.954 . . . . 0.0 108.653 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.8 -69.36 0.14 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.602 -0.686 . . . . 0.0 109.795 -179.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.98 15.26 0.51 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.342 -1.408 . . . . 0.0 110.352 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 86.97 93.6 0.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.866 ' O ' HD21 ' A' ' 81' ' ' LEU . 29.4 m-85 -72.11 104.91 3.76 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -1.083 . . . . 0.0 110.491 -178.899 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 6' ' ' LEU . . . -57.23 -11.07 6.06 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.159 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.98 137.02 17.31 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.245 -1.15 . . . . 0.0 110.069 -178.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.643 HG13 HG22 ' A' ' 83' ' ' VAL . 10.3 p -144.5 133.15 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.715 -1.241 . . . . 0.0 109.52 178.643 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.795 HG23 ' O ' ' A' ' 84' ' ' LEU . 8.8 mt -113.94 157.26 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.196 0.522 . . . . 0.0 109.775 -178.362 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.2 p -144.93 168.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 108.942 179.017 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -93.31 -21.63 19.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.224 -0.923 . . . . 0.0 110.584 -179.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.549 ' CH2' ' HB2' ' A' ' 98' ' ' ALA . 37.5 t-105 59.65 35.36 22.39 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.206 -0.933 . . . . 0.0 109.911 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -177.85 48.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.908 -1.12 . . . . 0.0 109.882 179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.469 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 175.63 -50.31 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.148 -0.97 . . . . 0.0 110.732 179.573 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 2.8 Cg_endo -64.71 123.46 11.72 Favored 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 120.95 1.1 . . . . 0.0 110.455 -179.425 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 61' ' ' PRO . 8.2 p30 41.82 -146.56 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.664 -0.647 . . . . 0.0 109.889 179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.506 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 7.3 mtp -47.32 -65.2 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.361 -0.837 . . . . 0.0 108.811 179.753 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.47 -39.41 0.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.352 -0.843 . . . . 0.0 108.914 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.7 -3.57 2.34 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 69' ' ' LEU . 10.7 tp -71.64 -61.68 1.69 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.032 -1.275 . . . . 0.0 107.611 178.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 66' ' ' LEU . 29.5 tt0 -47.17 -27.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.726 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.2 tt -72.41 -36.5 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.51 0.671 . . . . 0.0 109.246 179.818 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.654 ' CD2' ' HB2' ' A' ' 103' ' ' ALA . 1.4 tp -90.03 -36.04 15.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.539 -0.726 . . . . 0.0 109.808 -178.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -59.32 -50.58 73.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.967 -1.083 . . . . 0.0 109.405 179.719 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m -48.89 -44.91 40.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.262 -0.898 . . . . 0.0 109.407 179.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 69' ' ' LEU . 33.7 mt -57.51 -38.16 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.29 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -65.82 -53.98 32.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.346 -0.846 . . . . 0.0 109.814 -179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.57 -45.45 18.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.246 -0.909 . . . . 0.0 110.141 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -46.5 130.97 11.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -0.91 . . . . 0.0 109.663 -179.677 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -90.47 40.87 2.97 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.99 -15.75 0.46 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -1.115 . . . . 0.0 109.335 179.888 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.512 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -137.8 31.64 2.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.712 . . . . 0.0 109.086 179.986 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 m -71.08 23.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.161 -0.962 . . . . 0.0 109.878 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -150.04 12.11 0.75 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.009 . . . . 0.0 109.528 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.866 HD21 ' O ' ' A' ' 51' ' ' TYR . 8.2 tp -67.57 118.11 53.93 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.174 -0.954 . . . . 0.0 108.736 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.46 129.42 31.12 Favored 'Trans proline' 0 N--CA 1.479 0.648 0 C-N-CA 121.049 1.166 . . . . 0.0 112.366 -179.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.643 HG22 HG13 ' A' ' 54' ' ' VAL . 3.0 t -118.52 114.97 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 55' ' ' ILE . 53.4 tp -95.64 75.27 3.23 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.192 -1.403 . . . . 0.0 108.789 178.221 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.448 ' SD ' HG22 ' A' ' 87' ' ' THR . 9.6 tmm? -57.74 153.57 13.36 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.509 -0.744 . . . . 0.0 109.192 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.46 125.12 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 90' ' ' ALA . 4.9 t -150.22 125.81 10.28 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.477 -179.751 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 109' ' ' LYS . . . -79.39 -27.52 41.86 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.198 -0.939 . . . . 0.0 109.015 179.344 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.75 39.86 1.47 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.585 -0.697 . . . . 0.0 109.434 179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.791 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.44 106.94 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.303 -0.873 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.438 ' CG ' ' H ' ' A' ' 92' ' ' LYS . 23.0 tptt -97.04 -144.73 0.29 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.359 -0.838 . . . . 0.0 109.572 179.939 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 94' ' ' ASN . 7.0 mtmp? -104.11 -80.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.507 -0.746 . . . . 0.0 109.733 -179.734 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -45.18 -16.5 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.344 -0.847 . . . . 0.0 110.003 -179.546 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.7 OUTLIER -82.0 -36.66 27.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.759 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.791 HD11 ' HB1' ' A' ' 90' ' ' ALA . 39.6 mt -89.97 -9.72 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 109.75 -179.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.1 mt -89.76 -68.24 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.92 -1.113 . . . . 0.0 110.002 -179.645 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -44.33 -49.87 9.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.541 -0.724 . . . . 0.0 109.431 -179.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.645 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.52 -46.42 86.79 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.415 -0.803 . . . . 0.0 109.212 179.432 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -48.04 -50.43 27.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.085 -1.009 . . . . 0.0 109.941 -179.345 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -55.12 -24.42 25.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.592 -179.81 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.45 -104.91 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.261 -0.9 . . . . 0.0 110.382 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -141.58 7.59 2.51 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.488 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.654 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -57.22 11.07 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.014 -0.698 . . . . 0.0 110.6 178.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.672 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.27 -34.1 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -176.799 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -104.03 125.72 8.51 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.279 -1.529 . . . . 0.0 109.279 179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.524 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.98 110.7 5.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.385 -1.068 . . . . 0.0 109.468 179.817 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.2 p -107.68 134.73 48.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.072 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.724 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -89.6 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.049 179.807 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -53.84 160.92 1.9 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.108 -0.995 . . . . 0.0 109.775 -179.31 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.92 163.01 91.12 Favored 'Cis proline' 0 N--CA 1.488 1.149 0 C-N-CA 124.727 -0.947 . . . . 0.0 110.702 -2.491 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.491 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 12.1 p90 -146.02 158.29 43.87 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.088 0.947 . . . . 0.0 110.443 178.679 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.82 154.36 18.99 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.875 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.426 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -49.65 -11.98 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.629 -1.294 . . . . 0.0 109.361 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -81.33 -39.44 25.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.139 -0.975 . . . . 0.0 108.665 178.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.75 -58.64 3.19 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 5.0 tp -50.56 -37.43 39.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.647 -1.283 . . . . 0.0 108.76 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.45 -52.84 62.88 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.101 -0.999 . . . . 0.0 109.654 -179.943 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -55.29 -60.12 3.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.435 -0.791 . . . . 0.0 109.673 -179.751 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.453 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 5.4 mptt -47.4 -41.36 19.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.541 -179.814 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 123' ' ' ILE . 0.7 OUTLIER -65.84 -63.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 109.826 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.55 -29.08 1.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.675 -179.727 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 -34.26 67.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.297 -0.877 . . . . 0.0 109.338 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.493 HD11 ' CA ' ' A' ' 105' ' ' GLY . 41.4 mt -73.49 -40.65 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.589 -179.361 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -71.18 0.67 7.27 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.924 -1.11 . . . . 0.0 110.67 -178.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -74.7 -35.6 62.72 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.705 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -89.61 -22.03 22.53 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.616 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -84.25 -31.0 25.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.54 86.37 0.01 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.144 -1.21 . . . . 0.0 109.448 -179.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.451 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 40.8 m-20 -45.82 134.51 7.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.374 -0.829 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -90.12 15.63 9.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.968 -1.083 . . . . 0.0 109.926 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -143.9 42.76 1.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 110.296 -179.142 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.0 tp -81.01 147.32 30.24 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.001 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' O ' ' A' ' 51' ' ' TYR . 7.5 mtmm -94.5 134.52 36.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.515 -1.366 . . . . 0.0 110.656 -177.811 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -115.25 150.9 35.45 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.884 -0.51 . . . . 0.0 110.076 -179.678 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.676 ' HB3' HG13 ' A' ' 54' ' ' VAL . 36.1 tp -123.23 106.15 10.49 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.808 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.432 HG12 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -89.89 119.37 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.143 -178.664 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' A' ' 36' ' ' ALA . 21.7 t -124.27 57.68 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 O-C-N 121.698 -0.626 . . . . 0.0 109.571 -179.739 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' OD1' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -96.88 145.45 25.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.42 -0.8 . . . . 0.0 109.329 179.973 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 14' ' ' PHE . 7.9 p30 -71.93 -29.91 64.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.209 179.82 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.514 ' N ' ' OD1' ' A' ' 13' ' ' ASP . 0.7 OUTLIER -50.61 120.27 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.915 . . . . 0.0 109.336 179.907 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.5 45.33 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.572 -179.973 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -172.9 -27.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.607 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 4.9 ttt -60.06 -35.05 74.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.517 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.8 mtt85 -53.6 -34.37 58.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.89 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.51 -33.81 62.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mt -63.98 -51.12 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.498 -179.858 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -64.99 -33.52 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.109 -179.238 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 mtp85 -46.73 -53.94 10.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.956 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.3 t30 -64.53 -55.93 17.36 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.938 0.875 . . . . 0.0 109.089 179.745 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -38.37 -56.5 1.24 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.972 -179.737 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.94 -52.34 64.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.092 -1.005 . . . . 0.0 109.068 179.383 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -51.4 -36.58 44.13 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.236 -0.915 . . . . 0.0 109.132 179.79 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -48.16 -44.28 32.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.412 -0.805 . . . . 0.0 109.472 -179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 28' ' ' LEU . 10.9 mp -72.6 -62.32 1.49 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.341 -0.849 . . . . 0.0 109.161 179.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.45 54.46 0.01 OUTLIER Glycine 0 N--CA 1.481 1.663 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 95.0 m-85 -129.11 149.91 50.72 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.608 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' C ' HD22 ' A' ' 31' ' ' ASN . 0.2 OUTLIER -150.08 65.78 0.97 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.059 -1.026 . . . . 0.0 110.411 -179.961 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -175.31 100.29 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.045 -1.035 . . . . 0.0 109.31 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 p -150.25 151.38 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.976 -1.077 . . . . 0.0 110.591 -179.158 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.19 -165.85 1.33 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.648 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -147.71 158.35 43.97 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.047 -1.033 . . . . 0.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.858 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.05 -168.85 3.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.304 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.45 5.79 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.108 -0.995 . . . . 0.0 110.778 -179.483 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 177.22 177.2 0.33 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.758 -1.214 . . . . 0.0 109.644 179.809 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HD11 ' A' ' 68' ' ' LEU . . . -67.46 -27.72 73.57 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.785 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.27 -40.25 80.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -1.176 . . . . 0.0 108.754 179.314 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.47 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t70 -79.48 -37.91 35.7 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.411 -0.805 . . . . 0.0 109.099 179.727 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.88 -30.31 62.55 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.493 -0.754 . . . . 0.0 109.021 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.3 tp -69.79 -43.18 72.64 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.179 -0.951 . . . . 0.0 108.478 179.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -69.62 -27.44 65.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 109.784 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 47' ' ' GLN . 13.4 mttm -87.54 -39.14 15.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.368 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -45.87 -16.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.18 -0.95 . . . . 0.0 109.126 179.803 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' LYS . 33.5 mt-30 -91.81 22.4 4.22 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.312 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 45' ' ' LYS . . . -66.68 -65.23 0.71 Allowed 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.429 -0.794 . . . . 0.0 109.169 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.6 23.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.27 -1.443 . . . . 0.0 110.4 179.76 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.68 83.96 1.62 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 7' ' ' LYS . 10.2 m-85 -63.98 -41.07 97.64 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.54 -0.977 . . . . 0.0 110.586 -178.347 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.5 -25.34 7.33 Favored Glycine 0 C--N 1.285 -2.254 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 -179.242 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -154.17 143.68 21.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.539 -0.977 . . . . 0.0 110.106 -179.745 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.746 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.2 t -140.03 124.98 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.093 -1.005 . . . . 0.0 109.806 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 61.6 mt -109.67 105.91 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 15.3 p -126.31 144.75 50.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.056 -1.028 . . . . 0.0 110.708 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -64.94 -117.97 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.347 -0.846 . . . . 0.0 109.032 179.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' NE1' ' CG ' ' A' ' 94' ' ' ASN . 61.6 t-105 -173.81 134.73 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.915 . . . . 0.0 109.728 -179.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 62.39 129.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.957 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.459 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 1.5 mmm 177.8 -50.74 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 110.088 179.405 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -66.16 -69.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 120.758 0.972 . . . . 0.0 109.701 179.643 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -169.34 -34.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.09 179.777 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.6 mtt -102.03 -89.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.624 -0.673 . . . . 0.0 109.398 179.81 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -172.31 175.55 3.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 109.44 179.95 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.71 26.21 1.13 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.935 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 84.0 mt -82.06 -56.65 3.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -1.202 . . . . 0.0 108.87 179.611 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -48.67 -19.48 0.36 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.017 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.615 HD11 ' HA2' ' A' ' 39' ' ' GLY . 3.2 mt -76.93 -70.65 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.875 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.045 HD11 ' HB2' ' A' ' 103' ' ' ALA . 0.4 OUTLIER -45.91 -65.36 0.56 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.206 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -43.78 -47.77 8.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.626 -0.671 . . . . 0.0 109.827 -179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.1 m -67.74 -26.65 66.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.106 -0.996 . . . . 0.0 109.534 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 69' ' ' LEU . 44.3 mt -77.09 -14.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 109.352 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -84.43 -27.39 27.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -50.84 -29.73 12.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.52 -179.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' HB3' ' H ' ' A' ' 79' ' ' SER . 0.2 OUTLIER -50.64 116.73 2.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 109.415 179.994 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.64 -31.36 40.89 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.65 -63.56 1.14 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.223 -1.163 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.516 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.99 -47.15 7.44 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.901 . . . . 0.0 109.512 179.971 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 75' ' ' ASP . 0.1 OUTLIER 48.22 13.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.352 -0.843 . . . . 0.0 109.349 -179.887 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -149.64 18.82 0.92 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 0.0 109.626 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 tp -44.97 113.42 1.79 Allowed Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.371 -0.831 . . . . 0.0 109.055 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 5.1 Cg_exo -59.01 133.49 53.76 Favored 'Trans proline' 0 N--CA 1.48 0.697 0 C-N-CA 121.124 1.216 . . . . 0.0 113.07 -178.918 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.746 HG22 ' HB ' ' A' ' 54' ' ' VAL . 14.7 t -132.48 108.93 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.076 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.88 100.86 13.59 Favored 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 117.064 -1.854 . . . . 0.0 107.538 178.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 6.7 tpp -68.69 128.53 36.96 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.597 0.713 . . . . 0.0 109.385 -178.305 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 t -99.16 140.28 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 121.634 -0.666 . . . . 0.0 109.366 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.04 129.2 12.75 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.046 -179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 89' ' ' GLU . . . -66.05 96.77 0.33 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.146 -0.971 . . . . 0.0 109.125 179.388 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.819 ' H ' HG23 ' A' ' 108' ' ' VAL . 5.0 tt0 74.47 114.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.486 -0.758 . . . . 0.0 109.202 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.636 ' HB2' ' OH ' ' A' ' 106' ' ' TYR . . . -45.09 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.457 -0.777 . . . . 0.0 109.354 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -69.78 11.78 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 109.425 -179.807 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.5 ' H ' ' C ' ' A' ' 90' ' ' ALA . 3.8 mtpp 58.96 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.82 . . . . 0.0 109.8 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' LYS . 66.9 mt-10 -45.34 -46.92 13.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.136 -0.978 . . . . 0.0 110.164 -179.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.447 ' CG ' ' NE1' ' A' ' 58' ' ' TRP . 21.1 m-20 -69.34 -73.04 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.464 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.416 ' C ' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -44.49 -52.51 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.27 -0.894 . . . . 0.0 109.088 -179.47 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.634 HG22 ' OE1' ' A' ' 100' ' ' GLN . 92.3 mt -56.68 -32.0 36.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.652 -1.28 . . . . 0.0 109.464 -179.902 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -71.66 -45.61 61.46 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.044 -1.035 . . . . 0.0 108.959 179.626 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.19 72.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 109.008 179.182 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.51 -31.27 71.26 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.619 -179.415 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.634 ' OE1' HG22 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -53.32 -33.38 53.21 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.363 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.744 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -85.26 -22.51 28.59 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.363 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 63.39 80.52 0.12 Allowed Glycine 0 N--CA 1.482 1.748 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.958 177.237 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.045 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.3 -112.44 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 117.243 -1.783 . . . . 0.0 109.825 179.225 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 43.6 m -92.04 -52.46 4.7 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 123.21 1.481 . . . . 0.0 108.178 175.407 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 174.18 -162.13 32.48 Favored Glycine 0 N--CA 1.488 2.134 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.253 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -140.49 115.79 9.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.527 -0.984 . . . . 0.0 109.576 179.549 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.5 p -107.64 136.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.334 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.819 HG23 ' H ' ' A' ' 89' ' ' GLU . 1.8 p -83.41 145.59 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 108.929 179.808 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -115.14 154.25 47.27 Favored Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 -179.602 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.17 132.48 27.63 Favored 'Cis proline' 0 N--CA 1.488 1.152 0 O-C-N 122.623 0.802 . . . . 0.0 110.68 -2.353 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 116' ' ' LEU . 3.8 p90 -102.16 157.47 16.86 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.845 0.831 . . . . 0.0 109.402 178.76 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -91.13 148.36 22.42 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 176.845 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.12 -25.32 1.41 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.728 -1.233 . . . . 0.0 109.701 -178.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.46 -33.7 65.01 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -72.56 -62.48 1.43 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.977 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -52.11 -37.82 55.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 118.089 -1.444 . . . . 0.0 108.428 179.687 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -65.44 -51.71 58.28 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.988 -1.07 . . . . 0.0 109.624 -179.755 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 20.4 tp10 -48.04 -48.33 33.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.855 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.67 -42.0 98.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.361 -0.837 . . . . 0.0 108.804 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.1 -60.13 4.35 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.552 -0.717 . . . . 0.0 109.92 -179.591 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -54.57 -32.07 57.85 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.057 -1.027 . . . . 0.0 110.263 -179.457 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -78.97 -23.5 44.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.67 -179.836 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.4 mt -89.97 -39.07 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.945 . . . . 0.0 110.271 -179.574 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 127' ' ' LEU . 20.5 m-85 -74.16 -39.42 63.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.095 -1.003 . . . . 0.0 109.835 -179.248 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -50.76 -19.89 1.1 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.44 ' N ' ' C ' ' A' ' 124' ' ' PHE . 24.6 mmtt -95.83 -27.25 15.3 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.508 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.492 ' N ' ' O ' ' A' ' 124' ' ' PHE . 17.6 tp -75.58 -21.3 57.97 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.19 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.21 71.62 1.31 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.357 179.636 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.6 t70 -47.89 125.09 8.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.033 179.719 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -71.94 29.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.955 -1.091 . . . . 0.0 109.663 -179.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 3' ' ' ASP . 1.9 tp10 -159.54 32.69 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.122 -0.986 . . . . 0.0 109.955 -179.939 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.479 HD11 ' HA3' ' A' ' 52' ' ' GLY . 53.6 tp -69.85 135.27 49.4 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.018 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 mtmm -81.43 128.1 33.5 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.876 -1.14 . . . . 0.0 111.258 -177.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 33' ' ' VAL . 24.1 m-85 -112.38 153.13 27.76 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 179.465 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -126.52 106.67 9.61 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.81 113.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.669 -179.648 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 36' ' ' ALA . 61.0 t -113.73 83.7 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 121.74 -0.6 . . . . 0.0 109.545 -179.941 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -117.85 -154.18 0.55 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.345 0.593 . . . . 0.0 109.458 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -146.49 4.47 0.9 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.355 -0.84 . . . . 0.0 109.222 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.485 ' C ' ' H ' ' A' ' 16' ' ' THR . 6.2 m-85 -95.26 122.74 38.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -73.78 33.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.316 -0.865 . . . . 0.0 109.483 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.485 ' H ' ' C ' ' A' ' 14' ' ' PHE . 0.5 OUTLIER -151.74 -41.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.1 ttt -54.53 -43.35 71.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.48 -40.17 68.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.293 -0.879 . . . . 0.0 110.368 -179.595 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 mtt-85 -68.59 -26.85 65.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.13 -0.981 . . . . 0.0 110.171 -178.507 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.97 -50.3 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.066 -1.021 . . . . 0.0 109.378 -179.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.93 -39.39 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.942 -179.448 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -46.72 -54.27 10.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.219 -0.925 . . . . 0.0 109.591 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -56.78 12.78 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.969 0.89 . . . . 0.0 109.201 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -54.44 1.96 Allowed 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.353 -179.633 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt -65.53 -47.57 75.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.927 -1.108 . . . . 0.0 109.267 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -59.63 -24.0 63.48 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.252 -0.905 . . . . 0.0 109.626 -179.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.33 -13.4 61.1 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.088 -1.007 . . . . 0.0 109.463 179.962 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mt -95.35 -38.71 10.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 0.0 109.764 -179.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.09 4.84 0.78 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 -179.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE2' ' O ' ' A' ' 3' ' ' ASP . 97.0 m-85 -89.89 148.79 22.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.803 -1.41 . . . . 0.0 109.489 -179.554 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -150.07 63.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -0.945 . . . . 0.0 110.292 -179.678 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.33 96.02 0.09 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.118 -0.989 . . . . 0.0 109.237 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.553 HG22 ' HB2' ' A' ' 8' ' ' PHE . 58.3 t -140.27 153.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.051 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -123.98 -172.37 2.52 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.1 154.04 37.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 111.164 -178.752 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.822 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -140.19 -173.57 3.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.789 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -120.83 -2.41 9.81 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.196 -0.94 . . . . 0.0 110.548 -179.481 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 172.0 179.48 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.968 -1.082 . . . . 0.0 109.923 179.643 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.484 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -42.08 96.19 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -179.359 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 40' ' ' VAL . 1.3 p -59.46 -38.95 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.029 -1.277 . . . . 0.0 109.23 -179.777 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.58 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 46.0 t0 -71.21 -51.82 22.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.898 . . . . 0.0 108.941 179.391 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -50.05 -60.18 3.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.491 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.8 tp -45.23 -37.81 4.92 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.511 -0.743 . . . . 0.0 109.296 179.308 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 1.8 m-20 -70.77 -43.62 68.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.358 -0.839 . . . . 0.0 110.344 -179.578 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -90.11 -3.71 57.75 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.154 -0.966 . . . . 0.0 110.713 -179.194 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -73.93 -31.67 63.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.857 -1.152 . . . . 0.0 108.724 179.976 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' CG ' ' O ' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -53.84 -20.41 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.34 -0.85 . . . . 0.0 109.108 179.859 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.9 -63.48 0.96 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.98 109.79 2.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.235 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . 147.41 -24.4 1.54 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' PHE . 55.6 m-85 -64.81 78.57 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.141 -1.211 . . . . 0.0 109.997 -179.67 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.729 ' HA2' HD12 ' A' ' 81' ' ' LEU . . . -61.48 -3.31 3.97 Favored Glycine 0 N--CA 1.48 1.612 0 N-CA-C 107.748 -2.141 . . . . 0.0 107.748 178.493 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -148.03 130.41 15.7 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.569 -0.959 . . . . 0.0 108.777 -179.469 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 83' ' ' VAL . 75.4 t -127.06 126.91 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.738 -1.226 . . . . 0.0 109.057 179.425 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.1 mt -105.16 125.06 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -179.726 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 57' ' ' ASP . 60.0 p -142.51 142.55 32.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.289 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 56' ' ' SER . 2.0 m-20 -61.65 -139.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.0 109.669 -179.715 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 21.9 t-105 -169.51 134.2 1.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.94 . . . . 0.0 108.887 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' H ' ' HA ' ' A' ' 64' ' ' ASP . 61.9 t30 52.92 91.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.357 -0.84 . . . . 0.0 108.864 -179.345 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' A' ' 60' ' ' MET . 0.0 OUTLIER 171.9 -46.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -179.799 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.9 Cg_endo -64.65 -64.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 120.677 0.918 . . . . 0.0 110.098 -179.634 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 63' ' ' MET . 10.7 p30 -126.3 -39.47 2.05 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.853 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.523 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 25.6 ttt -172.62 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.83 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' HA ' ' H ' ' A' ' 59' ' ' ASN . 0.4 OUTLIER 171.63 128.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -49.79 -11.09 0.3 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.738 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 64' ' ' ASP . 5.7 mt -50.45 -35.06 27.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.641 -1.506 . . . . 0.0 107.719 179.197 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.23 -29.7 60.34 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.075 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 65' ' ' GLY . 64.5 tp -74.1 -69.03 0.47 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.704 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.612 ' CD1' ' HB2' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -42.17 -67.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.364 0.602 . . . . 0.0 109.826 178.684 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.3 ttpt -42.26 -51.76 4.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.585 -0.697 . . . . 0.0 110.262 -179.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 77.4 m -49.3 -36.58 21.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.909 -1.119 . . . . 0.0 109.135 -179.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.838 HG21 ' HB2' ' A' ' 80' ' ' ALA . 52.0 mt -64.22 -45.8 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.1 -1.0 . . . . 0.0 108.83 179.593 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.01 -39.45 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 0.0 109.507 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.3 -28.57 59.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.51 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.5 111.28 2.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.07 -124.52 7.47 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.81 40.19 1.07 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -1.093 . . . . 0.0 109.617 -179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.15 -2.63 2.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.578 -0.701 . . . . 0.0 109.485 179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t 47.04 -134.94 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.672 179.827 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.838 ' HB2' HG21 ' A' ' 72' ' ' ILE . . . -126.38 40.29 3.76 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.717 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.729 HD12 ' HA2' ' A' ' 52' ' ' GLY . 3.0 mt 47.37 -163.58 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.492 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.564 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 6.2 Cg_exo -57.3 155.79 28.33 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 CA-C-N 121.2 1.464 . . . . 0.0 114.876 -176.364 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 54' ' ' VAL . 3.0 t -138.21 135.62 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.375 178.544 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.436 HD21 HD11 ' A' ' 116' ' ' LEU . 53.7 tp -115.1 72.46 0.79 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.185 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' A' ' 85' ' ' MET . 0.0 OUTLIER -58.96 160.08 6.36 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 118.823 -1.151 . . . . 0.0 108.264 -179.346 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -127.89 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.789 -0.569 . . . . 0.0 110.227 -177.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.8 t -150.03 -176.35 5.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.087 -1.008 . . . . 0.0 109.79 -179.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.89 52.35 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 49.74 53.42 12.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.238 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -48.79 140.76 8.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 0.0 109.756 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -92.84 -87.65 0.23 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.046 179.508 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER 179.8 -74.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.391 179.634 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.93 -6.89 0.26 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.176 -0.952 . . . . 0.0 109.631 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 92' ' ' LYS . 26.9 m-80 -90.06 -22.61 21.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.173 -0.954 . . . . 0.0 109.831 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 95' ' ' ILE . 4.0 mm -89.99 -5.43 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.923 -179.582 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.4 mt -89.76 -66.93 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.072 -1.017 . . . . 0.0 109.861 -179.766 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.42 -41.11 13.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 0.0 109.031 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 103' ' ' ALA . . . -58.42 -56.72 18.51 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.527 -0.733 . . . . 0.0 109.732 179.643 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.77 -44.84 63.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.95 -26.51 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 108.756 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.52 -115.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.658 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.21 -11.71 4.6 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 179.099 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' CD1' ' A' ' 69' ' ' LEU . . . -58.02 10.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.887 -0.772 . . . . 0.0 110.626 178.718 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 102' ' ' GLY . 3.6 m -29.75 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -177.914 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -101.42 125.91 8.72 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.295 -179.63 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.502 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.41 124.14 16.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.057 . . . . 0.0 108.885 178.661 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.4 p -123.67 123.83 68.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.433 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 108' ' ' VAL . 13.6 p -76.43 102.2 3.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.582 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -64.42 161.22 44.44 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.273 -179.307 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -76.07 163.56 89.78 Favored 'Cis proline' 0 N--CA 1.485 0.985 0 O-C-N 122.879 0.937 . . . . 0.0 110.578 -2.327 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -143.28 161.0 39.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.879 . . . . 0.0 109.902 178.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -101.85 152.22 21.16 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 177.234 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.02 -14.09 0.13 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.851 -1.156 . . . . 0.0 108.86 -179.546 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -77.69 -41.17 38.93 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.663 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -69.5 -61.97 1.57 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.606 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 84' ' ' LEU . 3.1 tp -48.57 -37.83 18.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.029 178.741 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -60.66 -56.34 22.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.925 -1.11 . . . . 0.0 109.659 179.837 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -46.03 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.484 -0.76 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.83 -26.13 0.9 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.361 -0.837 . . . . 0.0 109.448 179.811 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 120' ' ' LEU . 0.2 OUTLIER -67.91 -76.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.181 -0.949 . . . . 0.0 108.925 179.68 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.08 -19.05 2.48 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.928 -1.107 . . . . 0.0 110.583 -179.722 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -23.36 35.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.933 -1.104 . . . . 0.0 109.892 -179.444 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.1 mt -89.93 -40.93 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.032 -1.043 . . . . 0.0 110.018 -179.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.461 ' CE1' HD13 ' A' ' 120' ' ' LEU . 23.8 m-85 -65.55 -5.57 8.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.992 -179.203 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.61 -26.53 66.3 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.181 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -90.82 -35.42 14.83 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -71.63 -24.42 61.86 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.97 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 58.95 89.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.444 179.718 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 43.8 t0 -45.04 141.28 2.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -0.819 . . . . 0.0 109.311 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -90.17 13.61 14.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.944 -1.098 . . . . 0.0 109.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -148.14 43.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.033 -1.042 . . . . 0.0 110.332 -178.912 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.2 tp -74.39 136.36 42.42 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.142 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.16 121.64 26.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.048 -1.032 . . . . 0.0 111.367 -177.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -106.71 157.59 17.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.702 -0.624 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 51' ' ' TYR . 21.5 tp -129.43 102.24 6.32 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.246 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -91.91 103.83 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.188 -0.945 . . . . 0.0 110.398 -179.082 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.938 HG22 ' HB3' ' A' ' 36' ' ' ALA . 48.6 t -96.12 113.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.276 -0.89 . . . . 0.0 109.25 179.528 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -171.7 163.92 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.445 -179.504 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' C ' ' CD1' ' A' ' 14' ' ' PHE . 2.9 m-20 -97.85 -58.36 2.01 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.968 -1.082 . . . . 0.0 108.781 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.6 ' CD2' ' N ' ' A' ' 15' ' ' SER . 22.2 p90 22.95 -145.77 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 CA-C-O 122.598 1.19 . . . . 0.0 112.831 177.398 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.6 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.0 OUTLIER 179.47 -7.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 179.984 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' N ' ' HD2' ' A' ' 14' ' ' PHE . 0.2 OUTLIER -131.11 -34.15 1.47 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.967 179.862 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -37.34 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.644 -0.66 . . . . 0.0 111.117 -178.185 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' C ' ' O ' ' A' ' 17' ' ' MET . 10.2 ptt180 -35.55 -31.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.805 -0.559 . . . . 0.0 110.473 -179.15 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' MET . 8.9 ttp180 -60.09 -49.66 76.77 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.804 -1.158 . . . . 0.0 109.877 -178.295 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -62.37 -54.51 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.716 -179.803 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -67.8 -18.52 23.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.341 -0.849 . . . . 0.0 110.84 -178.488 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -55.1 30.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.709 -1.245 . . . . 0.0 109.138 179.542 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.2 t30 -67.87 -53.39 27.06 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.673 0.749 . . . . 0.0 109.577 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -42.16 -56.23 2.96 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.544 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.8 mt -58.95 -52.85 63.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 108.641 179.275 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.08 -32.69 16.29 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.244 -0.91 . . . . 0.0 108.646 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.98 -37.32 75.71 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.383 -0.823 . . . . 0.0 108.901 179.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 117' ' ' GLU . 2.6 mp -75.63 -11.09 59.94 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.508 -0.745 . . . . 0.0 109.115 179.753 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.47 71.99 1.12 Allowed Glycine 0 N--CA 1.48 1.581 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.523 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 41.3 m-85 -150.0 146.19 26.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.948 -1.325 . . . . 0.0 109.435 179.399 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -150.07 62.36 0.98 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.123 -0.985 . . . . 0.0 110.061 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -175.54 100.71 0.07 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.15 -0.968 . . . . 0.0 109.092 179.703 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.27 152.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.851 -1.156 . . . . 0.0 110.179 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -120.48 -172.84 2.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.687 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -146.66 160.11 42.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 0.0 110.609 -179.276 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.938 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.08 -164.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -142.05 -5.08 1.01 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.11 -171.05 0.48 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.91 -1.118 . . . . 0.0 109.753 179.902 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.609 ' HA2' HD13 ' A' ' 68' ' ' LEU . . . -70.32 -45.01 57.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.86 -31.53 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.08 -1.247 . . . . 0.0 108.849 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 17.9 t0 -84.19 -51.84 6.72 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.484 -0.76 . . . . 0.0 109.448 179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.635 ' O ' HD23 ' A' ' 46' ' ' LEU . . . -54.54 -35.39 63.17 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.088 -1.008 . . . . 0.0 108.899 179.821 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -68.14 -56.96 6.91 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.398 -0.814 . . . . 0.0 109.297 179.854 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.3 -28.06 64.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.308 -0.87 . . . . 0.0 109.777 -179.743 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -90.06 -24.43 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.121 -0.987 . . . . 0.0 110.117 -179.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 42' ' ' ALA . 0.6 OUTLIER -60.87 -20.05 61.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -87.23 -8.99 56.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 108.999 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.68 -72.23 0.06 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 109.757 -179.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.67 10.1 1.65 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.01 87.48 0.77 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.685 ' CE2' HD22 ' A' ' 9' ' ' LEU . 54.6 m-85 -65.98 109.14 2.43 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.342 -1.093 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.62 -1.03 2.28 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.479 ' H ' ' C ' ' A' ' 51' ' ' TYR . 6.5 t80 -165.57 148.02 7.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.33 -1.1 . . . . 0.0 109.525 -178.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 9' ' ' LEU . 26.6 t -141.59 145.1 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.635 -1.291 . . . . 0.0 110.837 -178.769 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.24 122.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.032 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.7 p -144.72 141.45 29.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.006 -179.291 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.36 167.08 17.26 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.856 -1.152 . . . . 0.0 108.429 179.127 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.526 ' NE1' ' OD1' ' A' ' 64' ' ' ASP . 73.2 t-105 -69.99 -86.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.042 -1.036 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -67.06 131.6 46.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.004 . . . . 0.0 109.347 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.488 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER -171.16 -54.73 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 0.0 110.583 179.825 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -62.72 -161.82 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.625 0 N-CA-C 109.911 -0.842 . . . . 0.0 109.911 -179.945 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.745 HD22 ' H ' ' A' ' 62' ' ' ASN . 0.3 OUTLIER -67.32 -10.32 49.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.342 -0.849 . . . . 0.0 109.06 179.532 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.4 mmt -140.88 -100.82 0.15 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' OD1' ' NE1' ' A' ' 58' ' ' TRP . 0.5 OUTLIER -125.17 146.75 49.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.663 -0.648 . . . . 0.0 109.479 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -52.24 -6.42 0.26 Allowed Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.558 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.39 -71.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.257 . . . . 0.0 109.641 -179.592 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -45.17 -44.36 10.72 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.197 -0.939 . . . . 0.0 110.14 -179.501 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.904 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -56.27 -33.49 65.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 0.0 109.208 -179.773 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.691 HD11 ' N ' ' A' ' 102' ' ' GLY . 0.5 OUTLIER -89.08 -36.76 15.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -0.862 . . . . 0.0 109.333 -179.904 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -61.48 -47.51 85.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.299 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -47.76 -39.22 17.31 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.304 -0.872 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.4 mt -64.55 -44.35 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.395 -0.816 . . . . 0.0 108.98 179.5 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -28.29 68.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.381 -0.824 . . . . 0.0 109.71 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.13 -29.44 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.336 -0.853 . . . . 0.0 109.721 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -168.27 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -143.41 -31.98 0.1 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 179.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.49 -56.03 3.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -1.101 . . . . 0.0 109.519 180.0 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.98 16.46 12.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.663 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 p -77.6 50.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 109.596 179.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -150.01 15.76 0.84 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.651 -179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 51' ' ' TYR . 26.6 mt -65.16 127.74 93.13 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 121.102 -0.999 . . . . 0.0 108.658 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.37 141.19 95.07 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 120.888 1.059 . . . . 0.0 111.351 -179.63 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.404 HG22 ' HB ' ' A' ' 54' ' ' VAL . 4.3 t -127.34 119.75 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.849 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.426 HD21 ' CD1' ' A' ' 116' ' ' LEU . 42.1 tp -101.82 72.2 1.34 Allowed 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.917 178.707 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 mtt -47.41 165.69 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 54.7 t -145.75 122.07 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.726 -178.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -150.1 174.22 13.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 109.411 179.323 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -106.74 -37.99 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.624 -0.672 . . . . 0.0 109.556 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 14.9 tt0 -86.0 -72.06 0.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.903 . . . . 0.0 109.684 -179.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 89' ' ' GLU . . . 64.73 95.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 179.875 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 90' ' ' ALA . 13.9 mtpt -63.15 -128.32 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.148 -0.97 . . . . 0.0 109.327 179.797 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 93' ' ' GLU . 5.5 pttm -144.81 -48.75 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.361 179.751 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.478 ' N ' ' CG ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -75.06 -5.9 46.59 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.194 -0.941 . . . . 0.0 109.394 179.978 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -90.04 -28.06 19.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.666 -179.803 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.0 mm -72.9 -21.8 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.605 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 92.5 mt -75.57 -65.94 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.132 -0.98 . . . . 0.0 109.644 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.29 -46.53 12.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.567 -0.708 . . . . 0.0 109.38 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.467 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -59.55 -53.23 60.48 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.738 . . . . 0.0 109.52 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -52.01 -40.79 61.54 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.205 -0.934 . . . . 0.0 109.914 -179.312 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.6 -22.35 33.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.678 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -93.79 -61.1 1.61 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.369 -0.832 . . . . 0.0 110.229 -179.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.691 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -175.58 -10.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.08 -179.731 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.623 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . . . -55.84 11.14 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.49 -1.006 . . . . 0.0 110.848 179.255 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.691 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.37 -32.06 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -177.449 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -107.45 128.52 9.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.142 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.547 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -148.19 109.9 4.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.036 -1.273 . . . . 0.0 109.116 179.376 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 107' ' ' VAL . 12.6 p -105.98 135.51 43.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -85.65 95.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.358 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.9 pttt -56.37 155.12 14.1 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.789 -1.194 . . . . 0.0 109.283 -179.225 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.9 167.63 79.79 Favored 'Cis proline' 0 N--CA 1.487 1.097 0 C-N-CA 125.067 -0.806 . . . . 0.0 110.517 -2.086 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -146.73 163.55 35.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.176 -0.953 . . . . 0.0 110.409 179.102 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -102.36 146.83 27.49 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.721 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.19 -31.5 3.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.011 -1.056 . . . . 0.0 109.191 -179.339 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.07 -37.34 78.45 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.585 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.4 m -68.78 -67.29 0.48 Allowed 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.396 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' C ' ' O ' ' A' ' 115' ' ' THR . 5.7 tp -44.15 -39.73 4.52 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.259 178.753 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' HB2' HD21 ' A' ' 28' ' ' LEU . 57.1 tt0 -62.47 -50.55 70.98 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.196 -0.94 . . . . 0.0 109.645 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -46.29 -58.62 3.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 109.55 -179.904 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HZ1' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -49.15 -38.82 26.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.303 179.928 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -39.66 85.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 109.82 -179.723 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -70.83 -33.14 70.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.931 . . . . 0.0 109.893 -179.59 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -71.46 -25.42 62.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.177 -0.952 . . . . 0.0 109.705 -179.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 95.0 mt -90.05 -34.72 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 0.0 109.472 -179.816 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -82.86 8.93 11.05 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 110.292 -178.581 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -75.66 -25.4 56.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.14 -27.97 13.94 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.226 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.4 tp -83.17 -22.49 33.24 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.97 85.25 0.01 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.416 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.32 -1.106 . . . . 0.0 109.431 179.792 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.3 OUTLIER -44.53 149.6 0.39 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.0 109.409 179.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -90.55 9.14 30.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.1 -1.0 . . . . 0.0 110.112 179.812 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.2 50.76 1.02 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.777 -1.202 . . . . 0.0 110.574 -178.545 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 53.8 tp -78.74 111.11 14.53 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -48.32 118.12 2.29 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.94 -1.1 . . . . 0.0 111.713 -178.326 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 64.5 m-85 -112.66 151.31 30.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.573 -0.705 . . . . 0.0 109.562 178.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB3' HG13 ' A' ' 54' ' ' VAL . 62.1 tp -123.7 108.22 12.31 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.673 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.2 OUTLIER -90.97 110.19 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.338 -0.851 . . . . 0.0 109.548 -179.328 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 36' ' ' ALA . 44.3 t -114.73 118.0 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.35 -0.844 . . . . 0.0 109.944 -179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.54 158.67 41.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.47 -0.769 . . . . 0.0 109.279 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -106.44 6.52 30.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.674 -0.641 . . . . 0.0 109.516 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.5 OUTLIER -80.99 -21.57 40.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.864 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 1.4 p 75.17 -41.49 0.46 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.0 109.62 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.406 ' O ' HD13 ' A' ' 20' ' ' ILE . 5.2 t -98.13 1.24 47.31 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.433 -0.792 . . . . 0.0 109.453 179.93 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 9.7 ttt -80.05 -25.15 40.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.18 -0.95 . . . . 0.0 109.313 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -66.86 -45.75 77.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.867 . . . . 0.0 109.668 179.919 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -22.29 56.11 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.283 -0.886 . . . . 0.0 109.777 -179.404 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.4 mp -76.02 -55.53 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.4 -13.97 17.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.331 -0.855 . . . . 0.0 110.271 -178.959 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -65.68 -53.43 41.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 108.911 179.423 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -66.58 -55.52 14.99 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.859 0.838 . . . . 0.0 109.066 179.593 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 1.3 tt -41.86 -49.28 4.48 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.496 -179.628 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.08 -41.51 86.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 108.56 179.058 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -56.53 -36.93 69.8 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.478 -0.764 . . . . 0.0 109.316 179.683 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -61.95 -16.1 48.58 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 mt -102.1 5.44 40.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.564 -0.71 . . . . 0.0 109.849 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 79.48 47.62 7.26 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.379 179.609 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.547 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 39.2 m-85 -126.93 122.19 33.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.57 -0.959 . . . . 0.0 109.154 179.349 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.83 64.53 1.6 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.423 -0.798 . . . . 0.0 109.734 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -172.23 90.26 0.11 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.964 -1.085 . . . . 0.0 109.482 179.777 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.22 -179.86 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.158 -0.964 . . . . 0.0 109.805 -179.849 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' N ' HG23 ' A' ' 33' ' ' VAL . 9.1 mt-10 -137.52 -169.28 2.49 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -146.37 144.17 29.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.407 -179.065 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.874 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.26 -170.68 2.78 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.094 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.44 ' O ' ' CB ' ' A' ' 38' ' ' ASP . 7.6 pt-20 -141.7 10.32 2.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 110.605 -179.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER 170.91 158.72 0.08 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.92 -1.113 . . . . 0.0 109.714 179.555 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.579 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -46.4 -44.29 15.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.46 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 t -63.24 -37.11 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.003 -1.292 . . . . 0.0 109.66 -179.555 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.2 t70 -71.58 -45.9 60.9 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.151 -0.968 . . . . 0.0 108.732 179.619 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.86 -62.49 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.7 -0.625 . . . . 0.0 109.541 179.727 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 tt -44.47 -48.29 10.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.551 -0.718 . . . . 0.0 109.875 -179.836 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -65.32 -37.93 88.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.758 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -90.15 -3.07 58.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.238 -0.914 . . . . 0.0 110.4 -179.393 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.565 HD12 ' CD2' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -83.36 -30.85 27.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.874 -1.141 . . . . 0.0 109.017 -179.836 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -62.37 -0.33 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -45.48 -61.16 1.8 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.536 -0.728 . . . . 0.0 109.738 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -166.18 21.74 0.12 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.96 108.07 1.11 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -179.713 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.643 ' O ' HD21 ' A' ' 81' ' ' LEU . 24.2 m-85 -92.66 101.98 14.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.327 -1.102 . . . . 0.0 110.701 -178.818 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.17 -10.41 5.21 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 179.088 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -156.97 141.21 16.47 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.074 -1.25 . . . . 0.0 111.079 -179.311 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.763 ' HB ' HG22 ' A' ' 83' ' ' VAL . 17.3 t -134.24 105.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.393 -0.817 . . . . 0.0 110.209 179.273 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.9 69.04 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.97 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.9 t -101.33 148.68 24.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.258 -0.901 . . . . 0.0 109.161 -179.271 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 3.5 p30 -113.0 170.78 7.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.554 0.692 . . . . 0.0 109.989 -179.411 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 57' ' ' ASP . 1.5 t-105 -46.46 172.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 109.406 179.542 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.02 124.42 13.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.365 -0.834 . . . . 0.0 109.578 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.609 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -77.9 -39.25 1.82 Allowed Pre-proline 0 N--CA 1.487 1.4 0 O-C-N 121.446 -0.784 . . . . 0.0 111.845 -179.842 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.4 Cg_exo -64.68 125.05 14.15 Favored 'Trans proline' 0 C--N 1.323 -0.787 0 C-N-CA 120.985 1.123 . . . . 0.0 110.763 -178.86 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 63' ' ' MET . 9.7 p30 42.72 -155.12 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.362 0.601 . . . . 0.0 110.19 179.734 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.516 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -46.87 155.42 0.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.397 -0.814 . . . . 0.0 109.753 -179.724 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 10.9 p-10 -97.33 -164.04 1.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 0.0 109.657 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.66 2.53 53.67 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' C ' ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.25 -55.74 8.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.975 -1.309 . . . . 0.0 109.087 179.93 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -52.32 -15.55 0.65 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.065 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.579 HD13 ' CA ' ' A' ' 39' ' ' GLY . 7.1 tp -74.92 -62.77 1.43 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.184 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.966 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -43.92 -63.52 0.84 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.291 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -47.33 -43.54 22.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.579 -0.7 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.2 m -70.86 -24.86 62.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.151 -0.968 . . . . 0.0 109.298 179.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.591 HD13 HG21 ' A' ' 83' ' ' VAL . 48.0 mt -80.15 -9.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 108.777 179.611 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -86.93 -41.56 13.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 109.581 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.68 -25.9 49.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.642 -179.806 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -47.76 109.35 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.658 -179.767 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 46.23 31.48 4.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.793 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 46.55 58.63 4.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -1.176 . . . . 0.0 109.478 -179.988 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 mmt -90.14 -62.84 1.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.268 -0.895 . . . . 0.0 109.509 -179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 47.19 30.59 1.44 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 109.193 -179.817 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -142.62 -28.91 0.58 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 110.066 -179.577 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 51' ' ' TYR . 4.9 tp -48.27 112.1 2.11 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.015 -1.053 . . . . 0.0 108.535 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -60.22 107.76 0.44 Allowed 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 120.988 1.126 . . . . 0.0 112.962 -178.505 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.763 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.1 t -108.85 119.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.654 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -97.35 102.49 14.27 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.131 -1.427 . . . . 0.0 108.015 178.195 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 110.4 15.16 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.256 -0.978 . . . . 0.0 108.791 -179.154 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.37 140.58 20.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.363 -0.836 . . . . 0.0 110.299 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 7.0 t -150.13 133.86 16.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.593 -1.317 . . . . 0.0 110.242 179.598 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.43 -59.24 2.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.341 -0.849 . . . . 0.0 108.985 179.296 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -77.33 67.21 3.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.04 179.54 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.833 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -73.78 109.35 7.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.813 -179.56 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -91.37 133.13 35.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 108.93 179.604 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.22 -23.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.932 . . . . 0.0 109.694 -179.664 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -89.96 -50.93 5.74 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -64.91 -33.33 75.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.096 -1.003 . . . . 0.0 110.328 -179.115 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.833 HD11 ' HB1' ' A' ' 90' ' ' ALA . 68.2 mt -56.67 -20.95 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.005 -1.059 . . . . 0.0 109.342 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.426 HD13 ' N ' ' A' ' 96' ' ' ILE . 4.9 mm -87.64 -16.09 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.435 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -67.4 -46.73 72.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.403 -179.945 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.6 -55.21 21.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.859 -1.151 . . . . 0.0 108.5 179.223 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -61.21 -30.87 70.69 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.272 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -53.99 -33.91 58.4 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 178.706 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.966 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -81.32 -25.25 36.58 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 176.747 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.63 74.02 0.65 Allowed Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.949 177.312 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.85 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.06 -111.95 0.08 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 117.184 -1.807 . . . . 0.0 109.36 178.592 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 51.7 m -91.79 -53.24 4.37 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 123.616 1.674 . . . . 0.0 107.483 175.344 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 165.55 -165.6 37.99 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -177.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -132.92 153.46 51.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.509 -0.995 . . . . 0.0 110.353 179.865 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.636 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 13.2 p -145.46 150.19 15.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.325 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -80.54 -170.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.664 -1.214 . . . . 0.0 108.26 179.193 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.73 156.67 25.03 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 109.114 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.81 133.1 29.79 Favored 'Cis proline' 0 C--N 1.32 -0.972 0 C-N-CA 124.423 -1.074 . . . . 0.0 109.682 -2.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.552 ' CE1' HD12 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -89.92 162.8 15.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.82 -1.175 . . . . 0.0 109.619 -179.98 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -96.32 145.58 25.47 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 177.079 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.57 -22.58 0.78 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.765 -1.209 . . . . 0.0 109.227 -178.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.5 -35.33 53.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 2.9 m -70.9 -64.61 0.87 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.552 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.5 OUTLIER -49.43 -36.17 21.52 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.21 -1.396 . . . . 0.0 108.921 179.575 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 120' ' ' LEU . 2.4 mm-40 -57.18 -62.48 1.73 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.931 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 117' ' ' GLU . 3.6 tm-20 -42.09 -42.6 2.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.794 -0.566 . . . . 0.0 109.877 -179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 7.1 mmmt -74.1 -33.12 63.5 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.983 179.555 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' GLU . 2.6 tp -65.85 -65.52 0.67 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.353 -0.842 . . . . 0.0 109.803 -179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -45.5 -53.61 8.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.22 -0.925 . . . . 0.0 109.949 -179.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -58.95 -24.85 62.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 0.0 109.971 -179.603 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 125' ' ' GLU . 10.7 mt -84.32 -47.35 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.021 -1.049 . . . . 0.0 110.119 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -65.04 2.7 0.7 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.937 -1.102 . . . . 0.0 109.914 -179.202 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 123' ' ' ILE . 3.2 tt0 -74.74 -34.89 62.61 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.136 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -82.72 -35.11 26.98 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.495 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.5 tt -65.25 -27.36 68.6 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.931 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.11 80.85 0.41 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.017 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.373 -1.075 . . . . 0.0 109.444 179.724 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER 59.61 122.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.394 -0.816 . . . . 0.0 109.415 -179.722 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 8.1 mttt -89.85 12.49 17.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.892 -1.13 . . . . 0.0 109.679 -179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -145.48 45.29 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.041 -179.732 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 21.2 tp -80.13 124.83 29.12 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.448 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' NZ ' ' OD1' ' A' ' 32' ' ' ASN . 34.6 mttp -73.91 122.97 23.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.0 111.858 -177.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 49.2 m-85 -113.7 147.88 37.4 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.434 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.584 HD13 ' CE2' ' A' ' 51' ' ' TYR . 50.7 tp -114.89 126.41 54.77 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.543 177.951 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.65 102.78 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.622 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.947 HG22 ' HB3' ' A' ' 36' ' ' ALA . 58.2 t -97.18 24.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.319 -0.863 . . . . 0.0 109.684 -179.244 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' OD2' ' OD1' ' A' ' 57' ' ' ASP . 2.1 m-20 -72.34 145.86 47.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.534 -179.995 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -103.97 9.96 36.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -59.56 -171.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.0 109.577 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.87 4.06 9.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.679 -0.638 . . . . 0.0 109.527 -179.735 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -161.79 9.25 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 tpp -82.87 -43.44 16.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.31 -0.869 . . . . 0.0 109.267 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.455 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -57.54 -35.38 70.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.93 . . . . 0.0 109.429 179.977 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -27.86 61.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 -179.919 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.2 mt -68.55 -46.41 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.521 -179.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.34 -31.84 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 110.276 -179.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.445 HH21 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -51.55 -57.41 9.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.066 . . . . 0.0 109.431 179.853 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 1.5 t30 -64.72 -54.88 24.56 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.034 0.921 . . . . 0.0 109.395 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -42.02 -58.99 1.89 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.552 -179.835 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.5 mt -58.34 -47.66 83.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.014 -1.053 . . . . 0.0 108.849 179.265 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -52.1 -34.18 42.88 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.311 -0.868 . . . . 0.0 109.352 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' A' ' 113' ' ' ALA . 50.9 tt0 -48.61 -39.86 25.47 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.149 -0.969 . . . . 0.0 109.069 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -73.94 -66.08 0.76 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.076 179.626 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.98 30.19 0.02 OUTLIER Glycine 0 N--CA 1.482 1.751 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -94.53 148.35 22.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.982 -1.305 . . . . 0.0 109.977 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -146.17 62.02 1.24 Allowed 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.148 -0.97 . . . . 0.0 109.79 -179.879 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.469 ' OD1' ' NZ ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER -175.81 104.43 0.08 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.764 -1.21 . . . . 0.0 109.662 179.956 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' HB ' HH21 ' A' ' 22' ' ' ARG . 93.9 t -144.47 149.53 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -0.884 . . . . 0.0 109.629 -179.794 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 21.2 mp0 -124.85 -172.23 2.53 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.671 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -150.06 151.07 32.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.793 -1.192 . . . . 0.0 110.853 -178.406 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.947 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -143.54 -178.15 5.75 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.06 19.36 1.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.028 -1.045 . . . . 0.0 110.554 -179.62 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER 176.5 154.67 0.22 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.827 -1.17 . . . . 0.0 108.788 179.66 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.4 -55.85 15.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.453 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 1.9 t -50.44 -24.62 2.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.197 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.1 t0 -85.18 -42.4 14.76 Favored 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.532 -0.73 . . . . 0.0 109.684 179.657 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.77 85.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.008 -1.058 . . . . 0.0 109.355 -179.856 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -65.53 -55.3 18.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.934 . . . . 0.0 110.167 -179.617 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -57.12 -33.59 67.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.993 -1.067 . . . . 0.0 110.237 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -87.79 -8.05 56.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.709 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -78.4 -37.26 44.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.593 -1.317 . . . . 0.0 109.25 -179.701 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.71 -7.43 0.69 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 108.967 179.647 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 46' ' ' LEU . . . -46.24 -67.45 0.28 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.422 -0.798 . . . . 0.0 109.801 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.24 -94.98 0.24 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.696 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -155.7 78.03 0.2 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.809 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.584 ' CE2' HD13 ' A' ' 9' ' ' LEU . 13.6 m-30 -59.62 86.45 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.329 -1.101 . . . . 0.0 109.915 179.663 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -62.18 -1.61 3.27 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 178.331 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -154.22 144.73 22.28 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.474 -1.016 . . . . 0.0 109.818 -178.692 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 83' ' ' VAL . 49.0 t -142.51 119.99 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.695 -1.253 . . . . 0.0 110.389 -179.914 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.59 127.66 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.256 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.496 ' O ' ' SD ' ' A' ' 85' ' ' MET . 13.3 p -149.22 146.59 27.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.998 -1.064 . . . . 0.0 109.873 -179.34 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' OD2' ' A' ' 12' ' ' ASP . 2.3 m-20 -71.59 163.36 27.89 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.242 -0.911 . . . . 0.0 108.81 179.406 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.9 t-105 -47.82 -65.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.519 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.521 ' O ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -172.75 171.85 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.016 -1.052 . . . . 0.0 110.027 -179.926 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.544 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 3.1 tpp 178.21 -46.48 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.495 179.014 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.2 Cg_endo -71.65 93.03 0.68 Allowed 'Trans proline' 0 C--N 1.325 -0.701 0 C-N-CA 121.035 1.157 . . . . 0.0 109.524 -179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' ND2' ' C ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 41.91 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.27 -0.894 . . . . 0.0 109.845 179.999 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.2 tpp 47.6 -116.39 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.066 . . . . 0.0 109.062 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 56.76 -175.23 0.06 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.151 -0.968 . . . . 0.0 110.038 179.596 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.561 ' H ' ' CD1' ' A' ' 68' ' ' LEU . . . 94.51 -72.08 1.11 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.48 -47.52 63.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.998 -1.295 . . . . 0.0 107.854 178.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 15.7 mp0 -65.51 -22.63 66.74 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' CD1' ' H ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -64.65 -55.02 22.83 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.25 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 72' ' ' ILE . 2.0 mt -58.16 -67.09 0.38 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.21 0.528 . . . . 0.0 109.723 179.687 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -37.55 -46.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.86 -0.525 . . . . 0.0 110.35 -179.56 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.2 m -57.64 -41.87 82.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.057 -1.027 . . . . 0.0 109.124 179.71 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 69' ' ' LEU . 60.3 mt -60.9 -30.07 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.329 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -76.98 -55.92 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.592 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.12 4.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 109.363 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.45 135.62 55.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 77' ' ' ALA . . . -87.3 161.19 32.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 76' ' ' GLY . . . 76.35 -7.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.451 -1.029 . . . . 0.0 109.683 179.909 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.4 mmm -109.89 -19.13 13.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.6 m 51.83 -108.83 0.41 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.06 56.16 0.95 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 51' ' ' TYR . 73.6 mt -43.06 148.68 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.684 -0.635 . . . . 0.0 109.344 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.42 143.31 94.46 Favored 'Trans proline' 0 C--N 1.324 -0.734 0 C-N-CA 121.475 1.45 . . . . 0.0 111.804 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.433 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.7 t -134.26 119.85 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.676 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.8 tp -103.8 75.43 1.3 Allowed 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 118.925 -1.11 . . . . 0.0 108.55 178.309 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.496 ' SD ' ' O ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -48.89 169.36 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.894 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 t -144.12 122.57 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.446 -0.784 . . . . 0.0 109.494 -178.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 109' ' ' LYS . 5.5 t -140.54 -169.03 2.69 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.731 -0.787 . . . . 0.0 109.613 -179.549 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.41 ' N ' ' OG1' ' A' ' 87' ' ' THR . . . -140.99 16.43 2.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.565 -0.709 . . . . 0.0 109.287 -179.925 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 90' ' ' ALA . 0.3 OUTLIER -138.59 -61.74 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.417 -0.802 . . . . 0.0 110.068 -179.688 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 1.049 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . 54.48 98.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.057 -1.027 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.48 31.85 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.91 . . . . 0.0 109.966 -179.449 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ILE . 35.1 mtpt 54.49 -82.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.297 -0.877 . . . . 0.0 110.295 179.397 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -43.09 -25.47 0.11 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.372 -0.83 . . . . 0.0 110.337 -179.252 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 92' ' ' LYS . 22.0 t-20 -85.01 -31.49 23.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.035 -1.041 . . . . 0.0 109.857 -179.675 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.049 HD11 ' HB1' ' A' ' 90' ' ' ALA . 72.4 mt -67.19 -15.27 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 110.142 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.25 -64.51 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.033 -1.042 . . . . 0.0 109.86 -179.798 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -45.79 -31.34 2.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 109.913 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.583 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -69.31 -55.05 11.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.75 -179.81 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -51.03 -42.66 60.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.218 -0.926 . . . . 0.0 110.161 -179.342 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -51.39 -26.8 8.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 0.0 108.97 -179.896 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.09 -113.43 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.473 -0.767 . . . . 0.0 109.423 179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.681 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -128.03 -1.17 6.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.414 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.583 ' CB ' ' HB1' ' A' ' 98' ' ' ALA . . . -56.32 11.22 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 122.154 -0.615 . . . . 0.0 110.831 178.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.6 OUTLIER -29.48 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -177.275 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -108.43 130.62 10.16 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.391 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.85 115.16 7.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.259 -1.142 . . . . 0.0 108.866 179.112 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 107' ' ' VAL . 14.0 p -114.26 121.89 67.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.617 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.496 ' O ' HG22 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -76.51 96.61 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.835 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -59.44 160.87 11.86 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.132 -0.98 . . . . 0.0 109.141 -179.21 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.2 165.55 85.56 Favored 'Cis proline' 0 N--CA 1.485 0.988 0 O-C-N 122.86 0.926 . . . . 0.0 110.483 -2.257 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -146.03 159.36 43.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.121 -0.987 . . . . 0.0 110.504 179.019 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -99.19 147.15 25.42 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.958 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.453 ' CB ' ' OE1' ' A' ' 27' ' ' GLU . . . -44.72 -28.26 0.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.063 -1.023 . . . . 0.0 109.625 -179.168 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.37 83.66 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.495 178.936 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -64.14 -64.6 0.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.962 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.6 tp -45.49 -43.51 11.71 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.058 179.28 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' A' ' 113' ' ' ALA . 0.4 OUTLIER -61.98 -52.48 63.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.664 -1.272 . . . . 0.0 110.064 -179.882 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 117' ' ' GLU . 1.1 tp10 -43.59 -64.55 0.63 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.625 -0.672 . . . . 0.0 109.736 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -46.05 -46.41 16.7 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 109.348 179.853 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 tp -45.56 -44.07 12.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.49 -0.756 . . . . 0.0 109.995 -179.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -62.44 -42.91 99.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.375 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -58.86 -32.5 69.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.492 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.03 -34.35 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.248 -0.907 . . . . 0.0 109.907 -179.423 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -86.23 1.31 51.28 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.059 -1.026 . . . . 0.0 110.646 -178.438 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -77.1 -28.47 54.5 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -94.81 -22.26 18.17 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -87.97 -29.05 21.07 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.22 86.48 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.475 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mmt . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.296 -1.12 . . . . 0.0 109.53 -179.954 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.352 0.596 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 t0 66.39 142.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.227 -0.921 . . . . 0.0 109.887 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLY . 2.1 mmmm -90.3 19.57 5.04 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.082 -1.011 . . . . 0.0 109.413 179.782 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.53 49.45 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.952 -1.092 . . . . 0.0 109.635 -179.321 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 60.5 tp -60.24 111.0 1.37 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.26 -0.9 . . . . 0.0 108.934 179.885 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -43.91 105.47 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.894 -1.129 . . . . 0.0 111.144 -178.835 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 56.8 m-85 -102.33 154.77 18.74 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.793 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.9 tp -132.09 103.41 6.25 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.59 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -90.55 113.0 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.136 -0.977 . . . . 0.0 110.093 -178.983 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.962 HG22 ' HB3' ' A' ' 36' ' ' ALA . 42.5 t -103.04 69.14 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 O-C-N 121.583 -0.698 . . . . 0.0 110.025 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -114.58 131.0 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -77.5 -5.63 50.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.664 -179.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' HB3' ' H ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -80.83 143.76 32.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.483 -179.944 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.08 12.36 24.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.02 -31.25 1.5 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.437 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 8.1 ttt -55.81 -32.19 63.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.267 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.523 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -69.25 -43.51 73.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.423 -179.979 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -59.18 -25.25 63.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.841 -179.48 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -72.16 -49.24 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.766 -179.67 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -30.74 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.589 -178.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 -51.38 60.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.939 -1.101 . . . . 0.0 108.694 179.456 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -68.44 -60.51 2.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.842 0.83 . . . . 0.0 109.546 179.85 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.792 HD22 HD12 ' A' ' 116' ' ' LEU . 1.7 tt -45.03 -35.99 3.26 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.715 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.8 mt -74.22 -51.84 14.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 108.25 178.577 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -52.68 -33.82 49.15 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.45 -0.781 . . . . 0.0 108.968 179.399 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -49.24 -39.15 29.14 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.348 -0.845 . . . . 0.0 108.783 179.732 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.34 -64.98 0.98 Allowed 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.422 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' LYS . . . 160.06 41.43 0.02 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.765 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -113.8 134.6 54.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.61 -0.935 . . . . 0.0 109.184 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.03 65.62 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.946 -1.096 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -174.21 93.35 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.816 -1.178 . . . . 0.0 109.079 179.717 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -144.93 -179.73 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.036 -1.04 . . . . 0.0 110.653 -179.271 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' N ' HG23 ' A' ' 33' ' ' VAL . 2.9 mt-10 -137.9 -171.39 3.0 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.516 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' CD ' HH11 ' A' ' 18' ' ' ARG . 58.3 mt-10 -140.13 154.2 46.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.448 -0.782 . . . . 0.0 110.794 -179.038 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.962 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -150.03 -167.26 2.77 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.148 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -139.87 -10.68 1.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 0.0 111.004 -179.455 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -174.57 -166.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.013 -1.054 . . . . 0.0 109.761 -179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 43' ' ' LEU . . . -74.42 -42.81 32.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.1 t -55.46 -41.23 61.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.919 -1.342 . . . . 0.0 108.121 179.16 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -73.42 -54.48 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.59 -0.694 . . . . 0.0 109.291 179.406 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -60.42 -62.65 1.71 Allowed 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.229 -0.92 . . . . 0.0 109.411 179.9 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 39' ' ' GLY . 38.9 tp -41.73 -43.08 2.77 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.684 -0.635 . . . . 0.0 109.952 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -74.36 -37.32 63.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -90.09 0.71 57.0 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.241 -0.912 . . . . 0.0 110.132 -179.659 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -78.09 -40.56 37.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.051 -1.031 . . . . 0.0 109.029 179.955 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -63.98 -4.37 3.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -72.27 0.06 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.482 -0.761 . . . . 0.0 109.549 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -141.31 5.26 2.38 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.853 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.42 78.44 1.03 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.455 ' C ' ' H ' ' A' ' 53' ' ' PHE . 54.9 m-85 -57.51 114.75 2.37 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -1.034 . . . . 0.0 110.094 -179.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.3 -7.61 2.04 Favored Glycine 0 N--CA 1.48 1.595 0 N-CA-C 108.717 -1.753 . . . . 0.0 108.717 179.437 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.455 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -160.75 137.23 8.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -1.156 . . . . 0.0 110.732 -178.552 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -129.8 122.33 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.731 . . . . 0.0 109.847 179.179 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 60.9 mt -105.44 151.56 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.613 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 p -167.64 162.58 14.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.088 -1.007 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.38 -168.18 1.86 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.248 -0.908 . . . . 0.0 108.978 179.708 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.423 ' O ' ' O ' ' A' ' 59' ' ' ASN . 13.7 t-105 -128.6 111.82 13.63 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.434 -0.791 . . . . 0.0 109.564 179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 58' ' ' TRP . 0.3 OUTLIER 52.76 100.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.72 179.751 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.473 ' H ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 177.38 -50.37 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.863 . . . . 0.0 110.386 179.578 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.12 -54.93 0.54 Allowed 'Trans proline' 0 C--N 1.323 -0.81 0 C-N-CA 120.832 1.021 . . . . 0.0 109.891 -179.873 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.97 -41.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -0.891 . . . . 0.0 109.298 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.1 mtm -132.38 -179.83 5.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 109.206 -179.976 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.43 151.66 32.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.606 -179.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 68' ' ' LEU . . . -79.3 -20.14 70.23 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 61.4 tp -48.23 -29.04 3.4 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.167 -1.196 . . . . 0.0 108.334 179.42 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 71' ' ' THR . 1.5 tp10 -83.15 -29.79 28.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.707 . . . . 0.0 109.348 179.443 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -57.59 -35.02 69.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 108.707 179.719 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.609 HD13 ' H ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -86.74 -61.93 1.62 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.033 -1.042 . . . . 0.0 108.667 179.09 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mmtp -43.09 -26.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.914 -179.289 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 67' ' ' GLU . 5.2 p -72.82 -39.45 66.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.169 -0.957 . . . . 0.0 109.054 179.594 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 69' ' ' LEU . 81.2 mt -63.6 -45.27 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -61.07 -29.2 69.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.36 -0.837 . . . . 0.0 109.64 -179.85 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.91 -28.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 109.568 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.9 -153.34 0.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.521 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -150.07 -12.77 0.1 OUTLIER Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 -179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.25 -27.97 19.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -1.183 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 13.1 mtm -92.56 -11.24 34.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.284 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 46.3 t 52.32 -111.32 0.57 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 110.0 179.653 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.1 58.61 0.97 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' A' ' 80' ' ' ALA . 10.5 mt -38.01 153.77 0.13 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 122.042 -0.412 . . . . 0.0 110.086 -179.303 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.26 140.36 94.04 Favored 'Trans proline' 0 C--N 1.324 -0.741 0 C-N-CA 121.566 1.51 . . . . 0.0 111.481 179.893 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 69' ' ' LEU . 2.9 t -133.32 130.44 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.56 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.43 HD21 HD21 ' A' ' 116' ' ' LEU . 55.1 tp -113.36 75.95 0.95 Allowed 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 122.102 0.953 . . . . 0.0 108.543 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.6 mtt -51.24 172.24 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.65 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -145.75 125.8 6.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.418 -0.801 . . . . 0.0 109.273 -179.464 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 109' ' ' LYS . 15.2 t -150.06 178.11 9.26 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.026 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.61 -42.93 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.847 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -100.34 69.92 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.5 -0.75 . . . . 0.0 109.643 -179.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' CB ' ' OH ' ' A' ' 106' ' ' TYR . . . -65.37 107.83 1.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.927 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' CG ' ' N ' ' A' ' 92' ' ' LYS . 6.6 ttpt -73.52 -110.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 109.672 -179.778 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 94' ' ' ASN . 31.5 ttpt -160.2 -75.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.351 -179.894 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.5 -15.01 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.758 -179.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -89.32 -64.0 1.21 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.889 . . . . 0.0 109.673 -179.766 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 95' ' ' ILE . 1.6 mp -47.99 -39.32 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 0.0 109.65 -179.82 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 97' ' ' ALA . 31.5 mt -68.57 -65.98 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 -179.79 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 96' ' ' ILE . . . -44.03 -53.0 6.67 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.577 -0.702 . . . . 0.0 109.434 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 103' ' ' ALA . . . -58.97 -44.34 91.52 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.55 -0.718 . . . . 0.0 109.917 179.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -49.78 -47.51 51.05 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.707 -1.246 . . . . 0.0 109.333 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -58.97 -23.64 61.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.816 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.21 -103.66 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.009 -1.057 . . . . 0.0 109.718 -179.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.695 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -129.91 -6.88 3.9 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.609 ' H ' HD13 ' A' ' 69' ' ' LEU . . . -57.52 11.38 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.889 -0.771 . . . . 0.0 110.102 178.176 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.695 ' H ' ' C ' ' A' ' 102' ' ' GLY . 61.4 m -29.27 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.725 -176.339 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -115.94 129.9 8.76 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.226 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.97 110.18 5.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.34 -1.094 . . . . 0.0 108.39 179.385 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.9 p -110.68 123.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.818 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 109' ' ' LYS . 2.5 t -58.27 -178.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 178.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.56 ' N ' ' O ' ' A' ' 87' ' ' THR . 7.9 pttt -155.61 157.95 31.69 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 120.32 -1.488 . . . . 0.0 109.194 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.85 164.51 87.3 Favored 'Cis proline' 0 N--CA 1.484 0.929 0 C-N-CA 124.706 -0.956 . . . . 0.0 110.298 -2.254 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -127.87 159.32 35.25 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.774 0.797 . . . . 0.0 109.938 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.21 145.45 24.49 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.149 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.433 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -47.08 -20.49 0.16 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.949 -1.095 . . . . 0.0 109.54 -178.746 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' A' ' 112' ' ' THR . . . -82.57 -36.03 26.6 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.327 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 112' ' ' THR . 3.4 m -69.91 -59.86 2.66 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.506 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.792 HD12 HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -49.09 -46.57 44.85 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 118.463 -1.295 . . . . 0.0 108.155 178.802 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 118' ' ' GLU . 0.5 OUTLIER -55.7 -50.78 69.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.16 -0.962 . . . . 0.0 110.308 -179.563 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 5.1 tt0 -51.41 -68.51 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.27 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -45.56 -35.27 3.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.091 -1.006 . . . . 0.0 110.208 -179.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 tp -63.28 -65.83 0.63 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.041 . . . . 0.0 110.014 -179.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -45.43 -28.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.878 . . . . 0.0 110.433 -179.356 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -69.16 -47.76 64.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.962 -1.086 . . . . 0.0 109.765 -179.549 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.53 HD11 ' HA2' ' A' ' 105' ' ' GLY . 32.6 mt -69.56 -38.19 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.958 -179.61 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -70.08 -4.77 22.7 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 110.723 -178.751 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.04 -22.18 56.0 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.644 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.8 tttm -96.28 -24.37 16.24 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.847 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.1 OUTLIER -86.08 -32.74 21.22 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.397 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 43.79 84.18 0.02 OUTLIER Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.559 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.207 -1.172 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -45.88 135.36 7.2 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.522 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -90.54 16.17 9.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.242 -0.911 . . . . 0.0 109.831 179.668 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -133.28 47.27 2.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.144 -0.972 . . . . 0.0 108.785 -179.369 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 22.3 tp -90.02 119.02 30.02 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.37 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -61.82 120.45 10.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.227 -0.92 . . . . 0.0 110.986 -178.457 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 76.9 m-85 -110.81 152.03 27.13 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.889 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 tp -124.62 104.01 8.45 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 10' ' ' VAL . 27.9 m -93.57 107.68 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.973 -1.079 . . . . 0.0 110.013 -179.328 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.779 HG22 ' HB3' ' A' ' 36' ' ' ALA . 49.1 t -90.27 -96.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.915 -1.115 . . . . 0.0 109.564 -179.766 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 t0 52.91 -161.85 0.1 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.032 -1.042 . . . . 0.0 109.598 179.72 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.81 9.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 0.0 109.24 179.972 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -54.37 -21.07 8.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 0.0 109.651 -179.897 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.7 OUTLIER 72.26 -8.87 1.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.923 . . . . 0.0 109.124 -179.743 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 14' ' ' PHE . 1.3 t -136.0 -10.33 2.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.629 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.412 ' C ' ' SD ' ' A' ' 17' ' ' MET . 0.7 OUTLIER -69.58 -50.56 43.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.153 -0.967 . . . . 0.0 108.715 179.431 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -41.94 -41.54 2.5 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.338 0.59 . . . . 0.0 109.98 179.706 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -63.72 -45.11 91.43 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.278 -0.889 . . . . 0.0 110.049 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.95 -51.63 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.341 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -35.63 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -0.974 . . . . 0.0 110.53 -178.879 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.73 -55.16 6.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.733 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 24' ' ' LEU . 2.6 t-20 -67.79 -58.26 4.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.921 0.867 . . . . 0.0 109.641 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.4 OUTLIER -41.1 -62.25 0.86 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.857 -179.698 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 15.1 mt -54.0 -42.16 68.76 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.228 -0.92 . . . . 0.0 109.519 179.543 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -62.16 -38.44 89.02 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -60.0 -33.74 72.39 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.186 -0.946 . . . . 0.0 109.792 -179.634 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.8 mt -76.12 -50.19 15.31 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.256 -0.902 . . . . 0.0 109.743 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 4' ' ' LYS . . . 148.38 54.2 0.02 OUTLIER Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.341 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 60.7 m-85 -144.34 133.81 23.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.137 -1.214 . . . . 0.0 110.04 -179.817 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -145.37 55.47 1.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.476 -0.765 . . . . 0.0 109.354 179.947 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -162.18 98.02 1.03 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.03 152.03 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.112 -0.993 . . . . 0.0 110.428 -178.776 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.12 -170.87 1.76 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.754 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.91 151.01 32.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.991 -178.712 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -137.33 -171.39 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.185 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -143.93 10.9 1.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.133 -0.98 . . . . 0.0 110.032 -179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER 169.03 163.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.804 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 38' ' ' ASP . . . -55.27 -37.53 65.3 Favored Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.356 -1.402 . . . . 0.0 109.938 -179.38 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.516 HG23 ' OD2' ' A' ' 38' ' ' ASP . 61.2 t -54.83 -37.46 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.822 -1.399 . . . . 0.0 107.922 179.112 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.647 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 22.0 t0 -80.75 -55.45 4.82 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.598 -0.689 . . . . 0.0 109.616 179.761 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -51.92 -54.1 33.36 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.198 -0.939 . . . . 0.0 109.281 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 43' ' ' LEU . 5.0 tt -52.68 -58.4 6.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.329 -0.857 . . . . 0.0 109.801 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -56.58 -34.63 67.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.911 . . . . 0.0 110.934 -178.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -90.03 -17.58 27.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.891 -1.131 . . . . 0.0 110.815 -179.074 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -59.93 -28.29 67.49 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 0.0 109.046 -179.779 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 7.4 tt0 -72.64 2.6 6.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.18 179.695 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.61 -75.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.421 -0.799 . . . . 0.0 109.634 -179.878 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.49 -35.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.986 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.47 67.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 53' ' ' PHE . 70.4 m-85 -49.54 100.74 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.636 -179.838 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.35 -6.44 0.99 Allowed Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' TYR . 2.5 t80 -161.03 144.82 13.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -1.073 . . . . 0.0 109.805 -178.414 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HB ' HG22 ' A' ' 83' ' ' VAL . 65.7 t -136.65 120.94 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.962 -1.086 . . . . 0.0 110.032 -179.782 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 85.5 mt -104.32 97.67 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.568 -0.707 . . . . 0.0 109.107 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.3 p -99.4 -177.07 3.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 12.7 t70 -140.39 50.67 1.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.357 -0.84 . . . . 0.0 109.686 -179.655 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 16.3 t-105 47.32 77.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.217 -179.935 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -48.35 141.23 6.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.845 -179.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.631 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -100.64 -36.67 0.23 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.597 -0.689 . . . . 0.0 111.802 -179.972 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.45 122.73 10.49 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.849 1.033 . . . . 0.0 110.715 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.554 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.7 m-80 48.16 53.98 10.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.48 -0.763 . . . . 0.0 109.611 179.845 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mtp 53.48 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 109.487 -179.909 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 54.34 178.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.5 179.86 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.11 -46.62 2.16 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.175 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.6 -69.28 0.44 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.01 -1.288 . . . . 0.0 108.027 178.79 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -54.75 -22.11 13.08 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.23 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tt -63.11 -53.17 57.67 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.93 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 83' ' ' VAL . 43.9 mt -57.97 -65.72 0.59 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.077 0.942 . . . . 0.0 109.131 179.352 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -41.63 -36.5 0.96 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.78 -179.85 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.38 -41.95 63.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.078 -1.014 . . . . 0.0 108.551 179.768 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.12 -39.75 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.063 -1.023 . . . . 0.0 108.254 178.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.58 -23.8 67.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.476 -0.765 . . . . 0.0 109.294 179.73 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.36 51.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.626 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -45.74 -36.07 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.385 -0.822 . . . . 0.0 109.633 -179.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 64.04 32.91 85.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -147.1 -54.79 0.23 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -1.148 . . . . 0.0 109.324 179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.496 ' C ' ' H ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -90.01 -67.53 0.84 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 109.372 179.952 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 m 57.24 4.33 0.2 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.333 -0.854 . . . . 0.0 109.274 -179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -106.37 -12.24 15.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.635 -0.665 . . . . 0.0 109.651 -179.762 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 51' ' ' TYR . 13.2 mt -45.18 107.78 0.69 Allowed Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.26 150.12 89.45 Favored 'Trans proline' 0 C--O 1.217 -0.569 0 C-N-CA 121.079 1.186 . . . . 0.0 112.899 -178.039 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 69' ' ' LEU . 2.5 t -136.39 126.87 41.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.044 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' A' ' 85' ' ' MET . 0.9 OUTLIER -113.83 72.95 0.8 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 118.969 -1.092 . . . . 0.0 108.512 179.059 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' LEU . 9.7 mtt -46.39 170.93 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.328 0.585 . . . . 0.0 109.504 -179.245 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.15 125.07 6.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.22 -179.312 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 148.82 29.46 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.645 -1.284 . . . . 0.0 110.334 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.13 -42.33 8.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.134 -0.979 . . . . 0.0 109.2 179.596 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -96.32 50.72 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 1.003 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -61.14 101.56 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 0.0 109.437 -179.973 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -68.33 -110.62 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.183 -0.948 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 94' ' ' ASN . 3.1 ttmt -162.39 -73.66 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.2 -19.62 0.08 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.346 -0.846 . . . . 0.0 109.565 -179.95 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -90.06 -37.65 14.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -0.869 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.003 HD11 ' HB1' ' A' ' 90' ' ' ALA . 77.2 mt -63.54 -16.21 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.531 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.0 mt -78.44 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.577 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.82 -38.81 10.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.465 -0.772 . . . . 0.0 109.115 179.903 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.666 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -54.54 -57.72 10.28 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.454 -0.779 . . . . 0.0 109.474 179.555 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.07 -35.11 64.21 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.272 -0.893 . . . . 0.0 109.898 -179.579 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -57.62 -17.39 14.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -104.69 -107.54 0.29 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.603 -0.685 . . . . 0.0 109.905 -179.664 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.62 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -124.86 -1.55 8.12 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.666 ' N ' HD13 ' A' ' 69' ' ' LEU . . . -55.38 11.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.032 -0.687 . . . . 0.0 111.512 179.239 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.62 ' H ' ' C ' ' A' ' 102' ' ' GLY . 0.4 OUTLIER -29.25 -31.44 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.119 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -116.84 135.08 11.71 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.661 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -151.23 114.15 4.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.242 -1.152 . . . . 0.0 109.312 179.062 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.8 p -107.91 140.1 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.202 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 108' ' ' VAL . 9.3 p -88.31 100.6 10.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.554 179.391 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.0 155.25 64.69 Favored Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.989 . . . . 0.0 109.531 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.58 167.75 79.39 Favored 'Cis proline' 0 N--CA 1.488 1.205 0 O-C-N 122.649 0.815 . . . . 0.0 111.068 -2.295 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.684 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.1 p90 -146.52 156.91 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.865 0.84 . . . . 0.0 109.829 178.73 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.09 146.17 23.85 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.053 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.5 -22.76 0.79 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.775 -1.203 . . . . 0.0 109.301 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.24 39.43 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.434 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 112' ' ' THR . 7.0 m -72.63 -61.72 1.7 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.779 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.684 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.67 -38.65 47.76 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.213 179.11 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -64.25 -48.16 76.81 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.61 -43.88 8.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.665 -179.577 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -66.57 -50.78 61.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.87 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.99 -25.76 9.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.295 -0.878 . . . . 0.0 109.801 -179.692 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.05 -22.96 36.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 109.679 -179.818 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -80.61 -25.11 38.63 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.197 -0.939 . . . . 0.0 109.393 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 91.7 mt -89.94 -34.81 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.667 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -80.2 -1.61 41.25 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.604 -178.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -76.94 -21.14 55.27 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.609 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.45 -26.88 14.31 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.474 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 127' ' ' LEU . 0.2 OUTLIER -79.83 -26.4 40.47 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.24 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.97 88.67 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.638 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.543 ' N ' ' SD ' ' A' ' 129' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.328 -1.101 . . . . 0.0 109.514 -179.783 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.4 0.619 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 2' ' ' ALA . 1.9 m-20 61.65 127.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.333 -0.854 . . . . 0.0 109.737 179.83 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 mtpt -90.18 19.57 4.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 0.0 108.756 179.425 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 5' ' ' GLU . 1.3 tt0 -144.89 45.62 1.36 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.564 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 20.7 tp -78.49 117.77 20.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 108.442 -179.92 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -63.72 121.2 13.39 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.387 -0.821 . . . . 0.0 111.842 -177.737 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.636 ' HB2' HG22 ' A' ' 33' ' ' VAL . 96.0 m-85 -115.19 142.85 46.1 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.356 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.484 HD23 ' CD2' ' A' ' 46' ' ' LEU . 43.5 tp -116.82 117.99 31.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.123 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 18' ' ' ARG . 1.2 m -105.57 112.61 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 0.0 109.665 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.948 HG22 ' HB3' ' A' ' 36' ' ' ALA . 26.6 t -105.85 115.86 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.464 -0.772 . . . . 0.0 109.506 -179.797 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.625 ' N ' ' NH2' ' A' ' 18' ' ' ARG . 13.4 t70 -149.89 -137.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -0.934 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.89 -20.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.492 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.449 ' CD1' HG22 ' A' ' 16' ' ' THR . 0.1 OUTLIER -68.08 126.8 30.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.232 -0.918 . . . . 0.0 109.504 -179.95 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 60.8 p -81.62 41.43 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.292 -0.88 . . . . 0.0 109.517 -179.933 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.449 HG22 ' CD1' ' A' ' 14' ' ' PHE . 7.4 t -166.05 -29.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.8 ttp -57.96 -47.79 81.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.419 179.933 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.625 ' NH2' ' N ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -46.58 -29.1 1.66 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.897 . . . . 0.0 109.545 -179.716 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.4 mmt-85 -67.72 -34.9 77.78 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.178 -0.951 . . . . 0.0 109.977 -178.946 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -61.25 -55.89 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.854 -179.789 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -39.18 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 110.289 -179.079 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -46.89 -55.38 8.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.071 -1.018 . . . . 0.0 109.876 -179.85 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -65.11 -56.12 14.77 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.859 0.838 . . . . 0.0 109.311 -179.968 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.5 OUTLIER -38.84 -60.36 0.85 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.991 -179.722 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.3 -46.5 86.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.138 -0.976 . . . . 0.0 109.114 179.428 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.69 -32.7 65.71 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.326 -0.859 . . . . 0.0 109.977 -179.709 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.94 -30.25 61.4 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 120.851 -1.156 . . . . 0.0 109.069 -179.53 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' CD1' ' OE1' ' A' ' 117' ' ' GLU . 3.3 tp -80.1 -66.56 0.86 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 109.188 179.533 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.95 28.73 0.02 OUTLIER Glycine 0 N--CA 1.482 1.719 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.919 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -101.85 153.14 20.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.194 -1.18 . . . . 0.0 108.997 179.731 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.07 58.05 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.967 -1.083 . . . . 0.0 110.737 -179.622 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -174.5 100.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.849 -1.157 . . . . 0.0 109.872 179.705 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.636 HG22 ' HB2' ' A' ' 8' ' ' PHE . 93.2 t -139.42 150.28 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.34 -0.85 . . . . 0.0 109.919 -179.611 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -122.01 -173.25 2.62 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.687 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' HG2' ' HE ' ' A' ' 18' ' ' ARG . 26.6 mt-10 -142.75 155.35 44.84 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.273 -0.892 . . . . 0.0 110.94 -178.345 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.948 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -149.6 -172.59 4.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' OE1' ' OD2' ' A' ' 41' ' ' ASP . 1.4 pm0 -143.46 2.57 1.27 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.103 -0.998 . . . . 0.0 110.652 -179.74 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -168.92 0.16 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.781 -1.199 . . . . 0.0 109.226 179.952 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 68' ' ' LEU . . . -74.04 -47.05 19.94 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.203 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 4.1 p -52.22 -35.23 19.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.644 -1.504 . . . . 0.0 107.941 179.475 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.636 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.5 t0 -80.32 -45.86 17.11 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.482 -0.762 . . . . 0.0 109.728 179.579 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -70.32 -57.66 4.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.899 -1.125 . . . . 0.0 108.872 179.649 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.712 ' C ' HD13 ' A' ' 43' ' ' LEU . 2.9 tm? -44.78 -52.04 8.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 0.0 108.979 179.713 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 77.7 m-20 -65.07 -38.77 91.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.695 179.925 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -86.26 5.83 32.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 110.245 -179.436 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -90.15 -56.0 3.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.822 -1.174 . . . . 0.0 108.927 179.621 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.47 2.91 4.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -0.96 . . . . 0.0 108.734 179.306 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.82 -65.97 0.46 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.574 -0.704 . . . . 0.0 109.817 -179.815 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.21 4.84 2.64 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.18 79.34 1.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' O ' HD13 ' A' ' 81' ' ' LEU . 19.7 m-85 -66.59 108.72 2.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.5 -1.0 . . . . 0.0 109.954 -179.525 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.86 -6.85 2.99 Favored Glycine 0 N--CA 1.481 1.659 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 179.556 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' N ' ' C ' ' A' ' 51' ' ' TYR . 1.8 t80 -163.02 146.77 11.01 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.169 -1.195 . . . . 0.0 109.876 -178.601 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 46' ' ' LEU . 93.2 t -143.74 126.85 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.913 -1.117 . . . . 0.0 110.273 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.2 mt -110.01 134.98 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.348 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.9 p -146.94 137.41 23.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.642 -179.889 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.3 m-20 -71.83 -151.43 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.249 -0.907 . . . . 0.0 109.191 -179.979 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.595 ' CH2' HD23 ' A' ' 66' ' ' LEU . 52.9 t-105 -101.9 -177.98 3.58 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.546 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 59' ' ' ASN . 0.5 OUTLIER -61.07 90.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 109.459 179.874 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.529 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -95.98 -46.8 0.25 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 110.956 -179.895 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 60' ' ' MET . 3.3 Cg_exo -65.5 -54.9 0.51 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 121.14 1.227 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 64' ' ' ASP . 5.7 p30 -173.03 -148.83 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.651 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 63' ' ' MET . 0.8 OUTLIER -61.86 78.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.141 -0.975 . . . . 0.0 108.724 179.39 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ASN . 49.1 m-20 -154.82 -157.97 0.8 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.283 -0.885 . . . . 0.0 109.441 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.725 ' H ' HD13 ' A' ' 68' ' ' LEU . . . 68.88 -72.78 0.38 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.632 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD23 ' CH2' ' A' ' 58' ' ' TRP . 0.3 OUTLIER -66.42 -43.3 86.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.89 -1.359 . . . . 0.0 107.364 178.557 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -66.6 -27.58 67.82 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.406 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.725 HD13 ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -66.23 -60.69 2.55 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.618 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.659 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -55.97 -63.91 1.03 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.338 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' LEU . 13.7 ttmm -44.32 -39.43 4.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 179.523 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 m -68.82 -41.08 79.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.977 . . . . 0.0 108.816 179.289 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.659 HD12 ' HA ' ' A' ' 69' ' ' LEU . 61.1 mt -56.22 -23.83 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -27.47 19.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.479 -0.763 . . . . 0.0 109.183 179.803 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.22 -29.01 1.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.837 . . . . 0.0 109.701 -179.825 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -172.55 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 179.967 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 78' ' ' MET . . . -58.77 -165.77 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.653 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.96 19.22 0.23 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.426 -179.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 76' ' ' GLY . 3.9 tpt -89.94 -28.76 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.009 179.627 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 t 45.89 -125.43 1.3 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.538 -0.727 . . . . 0.0 109.172 179.937 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' C ' HD12 ' A' ' 81' ' ' LEU . . . -150.12 54.1 0.92 Allowed 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.303 -0.873 . . . . 0.0 109.676 179.585 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER 44.0 -166.42 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.575 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 81' ' ' LEU . 4.7 Cg_exo -61.63 151.21 81.74 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 CA-C-N 120.966 1.381 . . . . 0.0 114.508 -176.336 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.58 138.42 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.769 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 55' ' ' ILE . 48.5 tp -117.1 78.46 1.22 Allowed 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.403 ' N ' ' O ' ' A' ' 105' ' ' GLY . 18.0 ttp -61.9 159.54 13.83 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 179.337 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.547 HG23 HG13 ' A' ' 107' ' ' VAL . 7.5 p -150.19 142.33 17.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.806 -1.184 . . . . 0.0 109.953 -178.742 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 90' ' ' ALA . 3.1 t -149.98 174.94 12.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.874 -179.973 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -105.7 -39.95 5.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.679 -0.638 . . . . 0.0 109.361 179.655 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ALA . 1.9 tt0 -81.77 -60.81 2.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.443 179.942 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.622 ' HB2' HG23 ' A' ' 87' ' ' THR . . . 51.32 97.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 179.97 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 94' ' ' ASN . 4.0 ttmt -94.44 125.42 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.985 179.576 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -45.53 -24.77 0.36 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.633 -179.574 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -85.31 -31.19 23.17 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.949 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 91' ' ' LYS . 2.7 m-80 -89.95 -15.09 32.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 0.0 109.784 -179.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 95' ' ' ILE . 84.5 mt -75.84 -0.69 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.0 -58.24 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.762 -179.855 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -46.04 -52.18 12.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 109.416 179.993 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 103' ' ' ALA . . . -49.28 -54.06 18.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.722 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -53.59 -38.11 63.64 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.073 -1.017 . . . . 0.0 110.037 -179.389 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -17.55 35.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 0.0 109.831 -179.688 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.3 -106.26 0.16 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.609 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' A' ' 104' ' ' SER . . . -130.57 1.46 5.62 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 105' ' ' GLY . . . -54.79 11.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.148 0.579 . . . . 0.0 111.385 179.001 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 102' ' ' GLY . 54.2 m -29.29 -32.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.92 -0.487 . . . . 0.0 111.991 -176.55 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -114.86 123.68 6.08 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.237 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.456 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -138.29 114.6 10.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.363 -1.08 . . . . 0.0 109.883 179.441 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 116' ' ' LEU . 1.7 p -114.89 138.65 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.351 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' H ' HG12 ' A' ' 108' ' ' VAL . 1.2 p -85.96 103.36 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.889 -1.132 . . . . 0.0 109.315 -179.582 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' THR . 4.5 pttt -63.28 159.16 51.45 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.943 -1.098 . . . . 0.0 109.199 -179.691 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.36 156.87 99.47 Favored 'Cis proline' 0 N--CA 1.484 0.921 0 C-N-CA 124.693 -0.961 . . . . 0.0 110.103 -2.446 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.462 ' HE2' HG21 ' A' ' 86' ' ' VAL . 17.8 p90 -136.42 156.25 48.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 110.166 179.455 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.466 ' C ' ' N ' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -101.14 151.82 21.37 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 177.067 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -48.36 -18.15 0.2 Allowed 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 118.691 -1.204 . . . . 0.0 108.909 -179.301 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' N ' ' C ' ' A' ' 112' ' ' THR . . . -72.42 -44.8 61.93 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.644 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -63.35 1.08 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.57 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 107' ' ' VAL . 2.7 tp -47.77 -35.68 10.37 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.29 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' OE1' ' CD1' ' A' ' 28' ' ' LEU . 23.0 tt0 -72.28 -60.12 2.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.642 -1.286 . . . . 0.0 110.725 -179.248 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -40.8 -35.48 0.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.67 -0.644 . . . . 0.0 110.774 -178.738 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -79.26 -54.28 6.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.996 -1.065 . . . . 0.0 109.982 -179.556 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.6 tp -47.33 -44.33 23.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.935 . . . . 0.0 109.824 -179.604 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -53.67 -45.68 70.38 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.253 -0.904 . . . . 0.0 110.188 -179.427 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.3 tptp -62.51 -50.66 70.51 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 0.0 109.69 -179.68 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.36 -34.74 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.397 -0.815 . . . . 0.0 109.588 -179.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.08 -1.38 57.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.363 -0.836 . . . . 0.0 110.797 -179.051 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -81.26 -26.89 35.44 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.19 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -95.97 -21.28 18.12 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.418 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 128' ' ' GLY . 0.4 OUTLIER -88.31 -34.97 17.48 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 108.914 179.429 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 127' ' ' LEU . . . 42.63 77.89 0.08 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.469 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtp . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.118 -1.225 . . . . 0.0 109.492 -179.918 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.5 OUTLIER -46.05 144.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.117 -0.989 . . . . 0.0 109.366 179.983 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -90.12 11.36 21.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.086 -1.009 . . . . 0.0 109.803 -179.815 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -146.25 48.12 1.21 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.532 -179.736 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.5 tp -73.15 126.06 29.15 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.475 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.76 118.19 12.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.08 -1.013 . . . . 0.0 111.534 -177.367 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -105.81 149.96 26.01 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.681 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.687 ' HB3' HG22 ' A' ' 54' ' ' VAL . 18.4 tp -125.57 104.95 8.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.984 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.86 104.22 14.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.578 -179.096 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 36' ' ' ALA . 24.0 t -89.93 115.0 28.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 -179.929 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 0.8 OUTLIER -174.35 -166.85 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.025 -1.047 . . . . 0.0 109.882 -179.206 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.7 9.68 0.47 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.337 -0.852 . . . . 0.0 109.883 179.794 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CZ ' ' CB ' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -51.04 -35.66 35.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.732 -1.23 . . . . 0.0 108.536 179.781 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.4 OUTLIER 72.5 31.67 1.71 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.871 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 t -177.23 -30.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.47 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.43 ' CB ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -73.88 -35.71 64.75 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.493 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.72 -50.23 13.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.044 178.587 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -66.13 -26.84 67.64 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.596 -1.242 . . . . 0.0 110.353 -177.392 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' VAL . 0.9 OUTLIER -69.32 -54.31 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.019 179.649 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -59.0 -40.29 80.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 -179.414 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.52 HH22 HH22 ' A' ' 18' ' ' ARG . 1.2 mtm180 -49.72 -52.18 33.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.095 -1.003 . . . . 0.0 108.441 179.347 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -59.05 -59.07 6.06 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.266 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 5.5 tt -42.71 -30.0 0.34 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.84 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.1 mt -84.6 -33.12 23.42 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.941 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.544 ' N ' ' O ' ' A' ' 23' ' ' ASN . 5.8 tttp -69.94 -35.36 74.46 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.427 -0.796 . . . . 0.0 108.905 178.949 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -53.26 -35.63 60.25 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.273 -0.892 . . . . 0.0 109.167 179.766 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.597 HD21 ' OE1' ' A' ' 117' ' ' GLU . 3.5 mp -80.44 -55.45 4.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.38 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.73 62.94 0.01 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.628 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 96.9 m-85 -150.12 141.84 23.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.909 -1.348 . . . . 0.0 109.757 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -150.15 66.88 0.97 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.042 -1.036 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.54 102.37 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.592 -1.317 . . . . 0.0 110.213 179.519 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -147.46 178.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.042 -1.036 . . . . 0.0 110.104 179.611 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.7 mt-10 -140.55 -167.11 2.27 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.367 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.52 149.52 32.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 111.1 -179.108 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.524 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -138.57 -168.28 2.36 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.039 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -144.79 7.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.692 -179.449 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 15.7 t0 -176.46 151.4 0.96 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.052 -1.03 . . . . 0.0 109.674 179.881 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.578 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -52.54 -29.02 30.78 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.489 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.4 t -72.43 -38.61 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.188 -1.183 . . . . 0.0 108.898 179.637 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -70.96 -43.82 67.31 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.182 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -65.52 -60.19 3.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.302 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.6 tp -45.38 -33.62 2.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.474 -0.766 . . . . 0.0 109.537 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -82.37 -38.98 23.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 109.557 -179.928 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -86.26 -1.29 57.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.279 179.901 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -70.2 -10.74 59.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.439 -0.788 . . . . 0.0 109.235 -179.947 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -7.5 21.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.505 -0.747 . . . . 0.0 109.257 179.671 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.87 -55.01 7.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.436 -0.79 . . . . 0.0 109.573 -179.801 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -142.99 6.31 2.03 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.07 89.61 0.12 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 -179.852 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.606 ' O ' HD11 ' A' ' 81' ' ' LEU . 44.0 m-85 -76.09 153.34 36.41 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.225 -1.162 . . . . 0.0 110.024 -179.606 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.98 5.94 39.9 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 107.429 -2.268 . . . . 0.0 107.429 178.301 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -165.7 141.64 5.15 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.627 -0.925 . . . . 0.0 108.89 -179.569 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 9' ' ' LEU . 46.0 t -137.93 109.43 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.361 -0.837 . . . . 0.0 109.478 179.345 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.9 mt -91.6 90.78 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.69 164.74 12.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.179 -0.95 . . . . 0.0 109.142 -179.931 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 58' ' ' TRP . 7.0 t0 -91.45 -95.88 0.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 110.189 -179.274 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.555 ' CE2' ' ND2' ' A' ' 94' ' ' ASN . 55.7 t-105 -166.39 -123.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.975 . . . . 0.0 109.372 -179.266 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.433 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 21.2 t-20 -103.22 51.73 0.79 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.605 -0.684 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.502 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -92.74 -48.62 0.3 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.223 -0.923 . . . . 0.0 110.723 179.959 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.7 Cg_endo -65.79 -71.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 C-N-CA 121.006 1.138 . . . . 0.0 109.96 -179.581 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' CG ' ' H ' ' A' ' 63' ' ' MET . 4.2 p30 -153.71 -62.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.873 . . . . 0.0 109.001 179.803 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.476 ' H ' ' CG ' ' A' ' 62' ' ' ASN . 4.6 ttp -88.34 176.62 7.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.362 -0.836 . . . . 0.0 108.93 179.453 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.58 142.16 35.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.586 -0.696 . . . . 0.0 109.458 179.927 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.42 13.54 1.54 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' A' ' 64' ' ' ASP . 0.6 OUTLIER -76.07 -58.15 3.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.038 -1.272 . . . . 0.0 108.264 179.25 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.37 -13.16 26.25 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.772 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.578 HD13 ' CA ' ' A' ' 39' ' ' GLY . 56.7 tp -77.03 -43.62 33.88 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.834 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -81.32 -28.69 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.988 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -66.42 -41.05 89.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.332 -0.855 . . . . 0.0 108.9 179.431 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 m -71.34 -39.66 71.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.541 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.96 -30.3 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.12 179.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -90.15 -31.05 17.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.39 -0.819 . . . . 0.0 109.53 -179.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.5 -29.89 3.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.566 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.16 151.04 38.56 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -0.87 . . . . 0.0 109.485 -179.884 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -93.35 -26.22 16.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.98 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.64 -29.85 16.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -1.134 . . . . 0.0 109.38 179.949 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.502 ' C ' ' H ' ' A' ' 80' ' ' ALA . 15.8 mtt -89.97 6.23 43.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.21 -0.931 . . . . 0.0 109.371 179.878 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 p -73.77 34.94 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.134 179.804 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 78' ' ' MET . . . -135.61 21.73 3.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.604 -0.685 . . . . 0.0 109.27 -179.998 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -111.65 98.32 40.54 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.697 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.39 118.61 5.52 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.614 1.542 . . . . 0.0 114.03 -178.87 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 83' ' ' VAL . 0.9 OUTLIER -105.38 118.61 53.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 176.063 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.814 HD22 ' OG ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -98.32 109.3 22.08 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 178.21 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.17 103.0 12.25 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.52 146.62 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.904 -1.122 . . . . 0.0 109.368 179.658 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.07 155.91 40.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.118 -0.989 . . . . 0.0 110.014 -179.82 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.07 -50.29 6.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.141 179.579 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.521 ' O ' ' N ' ' A' ' 91' ' ' LYS . 50.7 mt-10 -93.36 58.84 2.89 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 109.079 179.634 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.813 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -53.86 86.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.713 -179.724 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 89' ' ' GLU . 20.1 tttm -71.35 139.36 49.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.055 -1.028 . . . . 0.0 108.961 179.707 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 91' ' ' LYS . 1.4 tppp? -42.08 -28.2 0.17 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.99 -179.608 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' LYS . 13.3 tp10 -88.32 -29.39 20.37 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.225 -0.922 . . . . 0.0 109.9 -179.937 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.555 ' ND2' ' CE2' ' A' ' 58' ' ' TRP . 2.6 t30 -68.86 -28.8 67.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.095 -1.003 . . . . 0.0 110.29 -179.423 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.813 HD11 ' HB1' ' A' ' 90' ' ' ALA . 2.2 mp -68.1 -58.84 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.728 -1.233 . . . . 0.0 108.711 179.503 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 100' ' ' GLN . 82.2 mt -63.63 -19.79 24.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.363 -0.836 . . . . 0.0 109.379 179.826 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -62.14 -71.08 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.114 179.658 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.668 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -50.76 -44.75 58.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.968 -1.082 . . . . 0.0 108.169 179.059 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -66.22 -24.38 66.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.629 -0.828 . . . . 0.0 109.572 -179.255 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 96' ' ' ILE . 6.8 tt0 -52.84 -30.99 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.879 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.515 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -90.41 -21.79 21.76 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 177.439 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 66.58 77.06 0.31 Allowed Glycine 0 N--CA 1.481 1.664 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.391 178.048 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.834 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -89.99 -111.8 0.08 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 117.223 -1.791 . . . . 0.0 109.634 178.924 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.814 ' OG ' HD22 ' A' ' 84' ' ' LEU . 2.2 p -91.68 -50.3 5.83 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 122.997 1.379 . . . . 0.0 108.1 176.045 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.437 ' N ' ' OG ' ' A' ' 104' ' ' SER . . . 166.36 -163.6 37.01 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.373 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 107' ' ' VAL . 0.0 OUTLIER -139.55 149.46 43.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.22 -1.165 . . . . 0.0 109.497 179.506 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' A' ' 106' ' ' TYR . 7.1 p -143.52 124.7 10.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.547 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 108' ' ' VAL . 7.7 p -72.57 115.05 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.203 -0.936 . . . . 0.0 109.699 -179.542 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -87.64 161.42 45.03 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 108.665 179.717 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.68 131.03 21.98 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 124.798 -0.917 . . . . 0.0 110.432 -2.041 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.695 ' CE1' HD12 ' A' ' 116' ' ' LEU . 5.0 p90 -101.31 153.8 19.33 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 122.051 0.929 . . . . 0.0 110.091 179.899 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.46 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.3 OUTLIER -89.94 149.44 22.59 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 177.0 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.546 ' HB2' ' HG ' ' A' ' 24' ' ' LEU . . . -48.83 -24.25 1.37 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.834 -1.166 . . . . 0.0 109.513 -178.776 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.45 -34.48 60.95 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.561 178.962 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.46 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -73.91 -61.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.545 179.069 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.695 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -50.73 -36.9 38.68 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 118.178 -1.409 . . . . 0.0 108.295 179.127 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.597 ' OE1' HD21 ' A' ' 28' ' ' LEU . 7.2 tp10 -65.74 -56.95 9.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.025 -179.76 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 117' ' ' GLU . 2.8 mt-10 -42.39 -34.37 0.8 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.684 -0.635 . . . . 0.0 109.997 -179.456 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -90.04 -25.86 20.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.284 179.833 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 117' ' ' GLU . 3.3 tp -66.74 -66.96 0.49 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 109.924 -179.803 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -44.39 -50.44 9.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.212 -0.93 . . . . 0.0 110.079 -179.56 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -61.14 -27.13 68.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 109.994 -179.627 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 120' ' ' LEU . 12.3 mt -81.39 -45.72 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.133 -0.98 . . . . 0.0 109.926 -179.725 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.93 -6.34 8.18 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.021 -1.049 . . . . 0.0 109.92 -179.264 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -67.49 -29.31 68.71 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.227 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.52 -34.59 19.94 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.682 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 127' ' ' LEU . 1.3 tt -72.2 -27.13 62.36 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.372 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 48.56 81.58 0.04 OUTLIER Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.515 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.446 179.751 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.2 OUTLIER -46.16 145.17 1.69 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.255 -0.903 . . . . 0.0 109.663 -179.982 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' LYS . 40.5 tttt -90.44 9.64 28.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.038 . . . . 0.0 109.41 179.398 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -143.65 46.75 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.024 -1.047 . . . . 0.0 110.356 -178.993 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 61.3 tp -78.29 112.34 15.18 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 178.528 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.01 123.34 17.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.927 -1.108 . . . . 0.0 111.98 -176.838 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 73.4 m-85 -109.45 152.04 25.9 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.942 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' HB3' HG13 ' A' ' 54' ' ' VAL . 31.0 tp -121.89 106.14 10.98 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.283 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.82 105.29 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.313 -0.867 . . . . 0.0 110.423 -178.012 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 36' ' ' ALA . 63.9 t -104.72 103.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 121.577 -0.702 . . . . 0.0 109.86 -179.936 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -149.06 148.64 29.94 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 9.1 t70 -85.08 -15.68 43.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -46.84 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.539 -179.906 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.05 10.04 13.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.668 -0.645 . . . . 0.0 109.633 -179.71 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 t -155.52 -21.18 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.126 -0.984 . . . . 0.0 109.542 -179.977 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.589 ' SD ' ' NZ ' ' A' ' 109' ' ' LYS . 13.8 tpt -48.89 -47.71 42.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.933 . . . . 0.0 109.469 -179.971 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.648 ' NH2' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.69 -37.14 17.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.267 -179.841 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -73.9 -30.72 62.76 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 118.784 -1.166 . . . . 0.0 109.769 -178.352 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.8 mt -67.62 -55.32 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.285 -0.885 . . . . 0.0 109.338 -179.895 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -58.9 -32.34 47.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.86 -179.235 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.648 HH11 ' NH2' ' A' ' 18' ' ' ARG . 3.8 mtt180 -48.47 -52.31 22.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 108.949 179.475 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' LYS . 1.4 t30 -66.15 -58.78 4.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.794 0.807 . . . . 0.0 109.28 179.901 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.7 OUTLIER -42.18 -37.31 1.42 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.648 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -74.41 -42.94 58.37 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.75 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 23' ' ' ASN . 23.1 tttm -61.12 -33.11 72.85 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.393 -0.817 . . . . 0.0 108.824 179.212 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.39 -50.34 65.32 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.329 -0.857 . . . . 0.0 108.843 179.654 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -49.69 59.91 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.105 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 140.98 74.66 0.04 OUTLIER Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.551 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.492 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 56.4 m-85 -150.2 152.25 34.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.931 -1.335 . . . . 0.0 109.095 179.26 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -150.22 30.51 0.69 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.737 -1.227 . . . . 0.0 111.518 179.743 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -145.69 108.69 4.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.639 -1.288 . . . . 0.0 111.04 -179.255 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -150.06 179.35 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.04 . . . . 0.0 109.909 178.722 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' N ' HG23 ' A' ' 33' ' ' VAL . 11.6 mt-10 -137.57 -168.02 2.24 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.427 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.87 150.38 31.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.984 -1.073 . . . . 0.0 111.167 -179.251 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -136.82 -164.59 1.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.248 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.37 -6.63 5.3 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.627 -0.67 . . . . 0.0 110.765 -179.528 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 173.96 179.8 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.728 -1.232 . . . . 0.0 109.948 179.873 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' A' ' 59' ' ' ASN . . . -55.28 -57.56 17.91 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.7 p -51.99 -35.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.127 -1.219 . . . . 0.0 108.958 179.94 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 7.7 t0 -69.86 -41.89 74.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.533 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.755 ' HB2' HG21 ' A' ' 11' ' ' VAL . . . -66.73 -40.39 88.36 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.44 179.993 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.6 -35.46 77.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.166 -0.959 . . . . 0.0 109.911 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -71.84 -34.5 69.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 110.047 -179.397 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -89.97 -26.49 20.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.165 -0.959 . . . . 0.0 110.446 -179.395 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.434 ' CD2' HD23 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -54.72 -31.76 58.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.085 -1.009 . . . . 0.0 108.836 -179.776 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 1.6 mt-30 -52.88 -22.18 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.503 -0.748 . . . . 0.0 109.309 -179.717 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -45.59 -59.43 2.74 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.829 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.7 52.8 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.307 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -148.62 -44.98 0.03 OUTLIER Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 53' ' ' PHE . 6.9 m-85 -49.7 92.31 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.367 -1.078 . . . . 0.0 110.636 -179.555 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 50' ' ' GLY . . . -76.32 15.74 5.35 Favored Glycine 0 N--CA 1.48 1.598 0 N-CA-C 106.976 -2.45 . . . . 0.0 106.976 177.321 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.563 ' H ' ' C ' ' A' ' 51' ' ' TYR . 1.1 t80 -168.24 152.47 6.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -179.288 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.2 t -145.51 107.89 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 110.742 -179.649 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.59 89.22 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.445 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.5 p -105.13 160.47 15.04 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.169 -0.957 . . . . 0.0 110.453 -178.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 1.6 p-10 -73.13 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.221 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CZ3' ' HB2' ' A' ' 98' ' ' ALA . 5.3 t-105 -149.52 -6.46 0.35 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 108.79 179.035 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 4.7 m-80 43.4 101.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.215 0.531 . . . . 0.0 110.959 178.468 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.682 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -127.48 20.87 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.884 178.76 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.682 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.5 Cg_endo -59.09 -65.46 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 N-CA-C 109.011 -1.188 . . . . 0.0 109.011 178.79 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 64' ' ' ASP . 1.5 m-80 -151.94 -136.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.408 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.65 88.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.964 -1.085 . . . . 0.0 108.651 179.261 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 66' ' ' LEU . 9.4 m-20 -160.72 -167.77 1.94 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 -179.566 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.66 -79.29 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.929 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -50.32 -69.03 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.125 -1.221 . . . . 0.0 109.327 -179.937 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' OG1' ' A' ' 71' ' ' THR . 1.4 tt0 -61.32 -9.59 5.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.442 -0.787 . . . . 0.0 109.744 -179.707 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tp -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 109.972 -179.491 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.827 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -79.16 -26.77 42.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.206 -0.934 . . . . 0.0 109.34 -179.687 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -59.93 -59.91 4.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.353 -0.842 . . . . 0.0 109.688 179.501 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -56.14 -31.44 63.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.151 -0.968 . . . . 0.0 109.877 -179.649 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.7 mt -72.4 -21.74 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.595 -179.921 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -31.49 17.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 179.925 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' A' ' 75' ' ' ASP . . . -71.29 -60.43 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.208 179.812 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.579 ' CG ' ' H ' ' A' ' 79' ' ' SER . 6.1 p-10 39.94 -141.54 0.05 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.426 0.631 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' N ' ' OD2' ' A' ' 75' ' ' ASP . . . -159.84 -16.53 0.03 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.927 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -151.82 -7.26 0.23 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.319 -1.107 . . . . 0.0 109.492 179.946 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -96.87 -72.43 0.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.0 109.273 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.579 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 11.2 t 44.72 45.26 8.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.579 -0.701 . . . . 0.0 109.831 179.824 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 81' ' ' LEU . . . -150.09 -50.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.02 -1.05 . . . . 0.0 110.447 -179.746 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 80' ' ' ALA . 7.2 mt -27.41 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 122.455 -0.153 . . . . 0.0 111.112 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.477 ' CA ' ' OG ' ' A' ' 104' ' ' SER . 6.3 Cg_exo -62.7 127.89 21.86 Favored 'Trans proline' 0 N--CA 1.48 0.728 0 C-N-CA 122.188 1.925 . . . . 0.0 114.02 -178.845 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 54' ' ' VAL . 1.5 t -109.05 113.19 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 175.9 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.23 106.75 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.352 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 56.7 tpp -82.1 103.23 11.57 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.245 -178.004 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.8 OUTLIER -98.85 148.31 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.084 -1.01 . . . . 0.0 109.605 179.854 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 t -150.09 160.06 43.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.145 -179.992 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.37 129.0 35.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.542 179.864 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 49.56 74.76 0.18 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.294 -0.879 . . . . 0.0 109.629 179.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.802 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -46.27 120.19 2.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.278 179.684 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -68.89 -77.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.088 -1.007 . . . . 0.0 109.943 -179.434 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 tttp -173.06 -70.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.468 -179.763 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 2.1 mm-40 -69.5 -35.0 75.11 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.243 -0.911 . . . . 0.0 109.906 -179.669 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -53.48 -35.11 60.23 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.12 -0.988 . . . . 0.0 109.69 -179.614 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.802 HD11 ' HB1' ' A' ' 90' ' ' ALA . 63.9 mt -66.25 -55.15 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 120.994 -1.066 . . . . 0.0 108.591 179.351 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 100' ' ' GLN . 83.6 mt -69.28 -14.74 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.482 -0.761 . . . . 0.0 109.017 179.652 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' GLU . . . -67.72 -54.18 21.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.381 -0.824 . . . . 0.0 109.336 -179.997 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.579 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -68.61 -46.23 69.85 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.014 -1.054 . . . . 0.0 108.197 178.885 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -64.44 -27.34 68.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.726 -179.323 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HG2' HG22 ' A' ' 96' ' ' ILE . 2.7 mm-40 -52.08 -32.64 35.7 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.803 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.75 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -87.87 -23.33 24.0 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.548 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.83 77.09 0.41 Allowed Glycine 0 N--CA 1.479 1.543 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.627 177.874 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -88.79 -111.66 0.07 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 117.411 -1.716 . . . . 0.0 108.941 178.64 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 49.6 m -91.49 -49.75 6.15 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.905 1.336 . . . . 0.0 108.283 175.998 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 160.57 -162.89 33.74 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.071 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.11 150.07 42.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.127 -1.22 . . . . 0.0 109.75 179.461 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.69 126.06 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.274 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.92 113.25 10.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.19 -0.944 . . . . 0.0 110.147 -179.138 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.589 ' NZ ' ' SD ' ' A' ' 17' ' ' MET . 0.1 OUTLIER -87.35 162.53 42.6 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.579 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.4 123.36 8.49 Favored 'Cis proline' 0 N--CA 1.483 0.9 0 C-N-CA 124.836 -0.902 . . . . 0.0 110.478 -2.178 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -92.92 156.26 17.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.142 -0.974 . . . . 0.0 109.876 179.847 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.515 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.2 OUTLIER -90.69 147.36 23.32 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.519 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' O ' ' CB ' ' A' ' 117' ' ' GLU . . . -47.11 -25.5 0.88 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.053 . . . . 0.0 108.909 -179.414 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.28 -39.92 78.08 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.728 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 112' ' ' THR . 0.0 OUTLIER -67.87 -66.41 0.57 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.924 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tp -49.58 -36.08 22.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 118.585 -1.246 . . . . 0.0 109.506 179.197 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 113' ' ' ALA . 4.5 tt0 -57.58 -62.41 1.81 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.031 -1.043 . . . . 0.0 110.227 -179.59 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 117' ' ' GLU . 34.9 mt-10 -46.09 -61.08 1.91 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.372 -0.83 . . . . 0.0 109.252 -179.51 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -50.97 -28.0 8.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.37 -0.832 . . . . 0.0 109.691 179.832 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.489 HD13 ' CD1' ' A' ' 124' ' ' PHE . 0.2 OUTLIER -65.85 -67.43 0.44 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.17 -0.956 . . . . 0.0 109.302 179.83 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -59.39 -28.46 66.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.003 -1.061 . . . . 0.0 110.506 -179.416 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -77.16 -23.79 51.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.966 -1.084 . . . . 0.0 109.84 -179.693 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 14.8 mt -90.05 -42.38 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 0.0 110.506 -179.4 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.489 ' CD1' HD13 ' A' ' 120' ' ' LEU . 11.8 m-85 -65.48 -14.89 61.98 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.087 -1.008 . . . . 0.0 110.104 -178.508 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.54 -30.89 70.93 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.316 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -85.04 -26.49 27.0 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.541 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.5 -19.31 60.96 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.394 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.468 ' O ' ' SD ' ' A' ' 129' ' ' MET . . . 71.17 60.71 4.31 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.738 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.468 ' SD ' ' O ' ' A' ' 128' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.405 -179.705 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.26 150.45 0.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.997 -179.552 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.2 12.01 19.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.344 179.739 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -150.6 52.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.311 -0.868 . . . . 0.0 109.164 -179.665 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.53 ' O ' ' CD2' ' A' ' 8' ' ' PHE . 50.5 tp -74.05 107.96 6.57 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.012 -1.055 . . . . 0.0 108.617 -179.879 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -49.73 106.04 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 111.458 -178.193 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 6' ' ' LEU . 70.0 m-85 -99.53 153.84 18.72 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.268 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.585 ' HB3' HG13 ' A' ' 54' ' ' VAL . 30.9 tp -128.62 107.51 9.76 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.106 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.95 115.55 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.359 -0.838 . . . . 0.0 109.089 -179.813 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 36' ' ' ALA . 2.5 t -98.69 110.44 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.595 -0.691 . . . . 0.0 110.118 -179.144 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.455 ' CB ' ' HE ' ' A' ' 18' ' ' ARG . 37.7 t0 -166.28 168.47 15.1 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.028 -1.045 . . . . 0.0 109.758 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -103.06 -28.9 11.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.654 -0.654 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.3 138.5 55.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.141 -0.974 . . . . 0.0 109.289 179.851 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.63 -33.48 11.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.799 . . . . 0.0 109.47 -179.923 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -75.94 -21.57 56.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.233 -0.917 . . . . 0.0 109.945 -179.634 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.7 ttm -73.72 -57.37 4.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.034 -1.041 . . . . 0.0 108.842 179.354 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.693 HH21 ' N ' ' A' ' 11' ' ' VAL . 19.2 mmt180 -58.67 -8.2 1.22 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.52 -178.708 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.4 tpt85 -76.73 -38.38 54.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 108.534 178.725 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.6 mt -61.86 -55.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.606 179.955 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -57.76 -40.2 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.0 110.53 -179.185 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' VAL . 1.3 mtm180 -45.3 -53.45 8.42 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.145 -0.972 . . . . 0.0 109.351 -179.377 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -62.79 -56.77 14.52 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.328 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 113' ' ' ALA . 2.6 tt -37.98 -58.16 0.97 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.94 179.887 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.3 mt -53.52 -51.11 63.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.117 179.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -56.05 -40.11 73.03 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.135 -0.978 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.02 -41.33 62.15 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.272 -0.893 . . . . 0.0 109.217 -179.983 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HB1' ' A' ' 113' ' ' ALA . 15.3 mt -73.39 -61.76 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.511 -0.743 . . . . 0.0 109.073 179.77 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.22 68.66 0.01 OUTLIER Glycine 0 N--CA 1.479 1.549 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.865 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -150.23 145.82 26.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.128 -1.219 . . . . 0.0 109.307 179.744 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -150.01 68.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.043 -1.036 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -176.78 99.55 0.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 0.0 108.653 179.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.16 150.82 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.989 -1.069 . . . . 0.0 110.562 -178.988 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -123.31 -169.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.323 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -141.46 161.98 36.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.405 -0.809 . . . . 0.0 110.808 -178.771 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -144.4 -167.93 2.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.242 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.91 -2.24 4.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.465 -0.772 . . . . 0.0 110.666 -179.413 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 170.43 -171.49 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.204 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.625 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -69.24 -37.27 80.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.974 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' O ' ' ND2' ' A' ' 44' ' ' ASN . 18.8 m -65.8 -42.3 92.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.245 . . . . 0.0 109.16 179.952 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 40' ' ' VAL . 44.8 t0 -67.15 -50.53 60.88 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 108.464 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -56.89 -55.93 28.14 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.735 -0.603 . . . . 0.0 109.916 179.979 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 43' ' ' LEU . 1.3 tm? -46.22 -53.82 9.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.94 . . . . 0.0 108.936 179.934 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 40' ' ' VAL . 70.6 m-80 -61.27 -41.77 97.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.16 -12.25 59.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.197 -0.939 . . . . 0.0 110.411 -179.106 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.521 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -66.71 -4.48 9.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.965 -1.084 . . . . 0.0 108.526 -179.908 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 47' ' ' GLN . 27.3 tt0 -97.26 -4.56 38.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.768 . . . . 0.0 109.266 179.729 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.4 -72.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.412 -0.805 . . . . 0.0 109.524 -179.777 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -147.12 9.5 1.3 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.962 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.0 87.27 1.08 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.7 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.535 ' C ' ' H ' ' A' ' 53' ' ' PHE . 62.6 m-85 -66.8 109.62 2.96 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 -179.895 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.76 -5.61 0.59 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.668 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.04 145.02 8.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -1.119 . . . . 0.0 110.292 -178.842 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.661 ' HB ' HG22 ' A' ' 83' ' ' VAL . 11.6 t -138.78 115.11 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.137 -0.977 . . . . 0.0 110.225 179.632 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.83 101.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.246 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 145.61 29.91 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -0.807 . . . . 0.0 109.638 -179.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 26.7 p30 -67.54 -112.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.589 -179.998 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.462 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 62.3 t-105 -169.9 -121.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.361 -179.779 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.462 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 15.5 m-80 -83.36 121.26 26.91 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.996 -1.065 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.462 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 176.27 -50.42 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.387 -0.821 . . . . 0.0 110.129 179.617 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.8 Cg_endo -65.58 -64.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.325 -0.707 0 C-N-CA 120.89 1.06 . . . . 0.0 109.888 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -150.94 -76.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.26 179.978 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -92.98 -88.34 0.22 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 109.367 179.713 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 178.99 150.7 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.983 -1.073 . . . . 0.0 109.731 179.836 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -72.16 17.39 1.39 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 66' ' ' LEU . 4.4 tt -78.4 -56.6 4.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.847 -1.384 . . . . 0.0 108.203 179.287 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.51 -9.76 0.54 Allowed 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.565 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD13 ' CA ' ' A' ' 39' ' ' GLY . 15.7 tp -81.91 -57.38 3.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.8 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -66.91 -34.91 78.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.347 -0.846 . . . . 0.0 109.603 -179.642 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 ttmt -66.97 -59.07 3.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.146 179.333 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.9 m -54.84 -37.0 65.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.072 179.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 80' ' ' ALA . 1.3 mt -57.44 -38.58 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.506 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -66.21 -7.55 18.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 -179.909 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' ASP . . . -71.81 -27.55 63.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -0.946 . . . . 0.0 109.785 -179.907 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -51.36 -178.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.273 -0.892 . . . . 0.0 109.653 -179.746 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.09 -146.02 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.801 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.13 -12.49 60.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 0.0 109.573 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 1.1 ttp -90.04 -2.53 58.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 -179.985 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 75' ' ' ASP . 14.6 m 47.28 -120.03 1.08 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.269 -0.894 . . . . 0.0 108.895 -179.741 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB3' HG23 ' A' ' 72' ' ' ILE . . . -150.08 56.9 0.96 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.251 178.955 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' O ' ' O ' ' A' ' 80' ' ' ALA . 11.0 mt 57.53 155.39 0.08 OUTLIER Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 121.648 -0.657 . . . . 0.0 110.035 178.112 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -52.47 140.39 54.15 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.314 2.009 . . . . 0.0 114.959 -177.166 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.661 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -129.32 116.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.134 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -103.06 108.51 19.72 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.523 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -66.62 138.52 57.51 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.671 -178.484 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 HG13 HG13 ' A' ' 107' ' ' VAL . 2.0 t -116.35 139.92 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.675 -0.64 . . . . 0.0 110.168 -178.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 109' ' ' LYS . 0.0 OUTLIER -149.96 165.96 31.08 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.171 -1.011 . . . . 0.0 109.747 179.532 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 89' ' ' GLU . . . -100.19 128.63 46.23 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.667 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' N ' ' A' ' 91' ' ' LYS . 33.6 tt0 50.58 94.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.311 -0.868 . . . . 0.0 109.033 -179.598 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.744 ' HB1' HG21 ' A' ' 95' ' ' ILE . . . -44.78 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 0.0 109.736 -179.683 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' CB ' HD21 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -76.57 16.81 0.45 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.339 -0.851 . . . . 0.0 109.474 -179.832 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 22.2 tttt 69.74 -70.28 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.578 -0.701 . . . . 0.0 109.896 179.768 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 94' ' ' ASN . 12.4 tm-20 -49.82 -49.32 49.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.179 -0.95 . . . . 0.0 110.176 -179.475 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.549 HD21 ' CB ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -65.14 -66.79 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 0.0 110.496 -179.21 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.777 HD12 ' CE2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -45.54 -42.76 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.247 -0.908 . . . . 0.0 109.901 -179.16 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.19 -31.08 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.953 -1.092 . . . . 0.0 109.624 -179.782 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.04 -47.41 85.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.153 -0.967 . . . . 0.0 109.655 -179.718 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.58 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -69.2 -53.69 18.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.013 -1.054 . . . . 0.0 108.366 179.39 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 102' ' ' GLY . . . -57.61 -26.35 61.42 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.327 -179.416 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -53.32 -32.44 48.97 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 178.633 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -86.45 -23.38 26.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 177.202 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 99' ' ' ALA . . . 68.34 75.38 0.51 Allowed Glycine 0 N--CA 1.481 1.693 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.802 177.663 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.786 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -85.52 -111.69 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 117.107 -1.837 . . . . 0.0 108.911 178.541 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 34.9 m -91.49 -46.68 7.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.473 1.13 . . . . 0.0 107.995 175.697 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.426 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 171.3 -159.73 31.64 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -178.732 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.777 ' CE2' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -138.23 131.67 30.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.829 -0.806 . . . . 0.0 108.997 179.175 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.901 HG21 HD12 ' A' ' 116' ' ' LEU . 11.9 p -127.65 120.95 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.658 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 89' ' ' GLU . 2.0 p -70.32 157.92 6.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.079 -1.013 . . . . 0.0 108.964 -179.485 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' N ' HG22 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -131.63 160.41 67.55 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.885 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.57 126.32 11.94 Favored 'Cis proline' 0 C--N 1.32 -0.93 0 C-N-CA 124.716 -0.951 . . . . 0.0 110.429 -2.06 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.701 ' CE1' HD22 ' A' ' 116' ' ' LEU . 4.9 p90 -91.4 159.91 15.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.828 179.932 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -93.38 149.86 20.91 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.991 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.643 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -49.96 -35.04 22.74 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.773 -1.204 . . . . 0.0 108.815 -179.53 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.93 -31.73 71.69 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.781 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.5 m -72.61 -68.13 0.5 Allowed 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.729 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.901 HD12 HG21 ' A' ' 107' ' ' VAL . 3.6 tp -47.57 -36.72 11.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.62 -1.3 . . . . 0.0 109.253 178.861 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -62.31 -64.56 0.89 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.846 -1.159 . . . . 0.0 109.126 179.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -45.27 -51.0 11.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.629 -0.669 . . . . 0.0 109.738 -179.821 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.739 ' NZ ' HG23 ' A' ' 107' ' ' VAL . 0.0 OUTLIER -55.5 -54.34 45.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.887 . . . . 0.0 109.464 -179.836 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 120' ' ' LEU . 26.9 mt -55.97 -44.9 78.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.613 -179.563 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -47.76 -69.79 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 109.977 -179.273 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -49.06 -27.44 3.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.32 -0.863 . . . . 0.0 110.354 -179.317 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.34 -40.87 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.947 -1.096 . . . . 0.0 110.577 -179.208 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -74.28 -22.71 59.18 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.139 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -62.29 -20.43 64.29 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.4 mmtt -97.51 -27.7 14.31 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.888 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -85.79 -13.07 49.3 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -0.814 . . . . 0.0 108.882 179.264 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 47.21 71.94 0.48 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.897 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.21 -1.171 . . . . 0.0 109.549 -179.996 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' O ' ' CE1' ' A' ' 30' ' ' PHE . 0.1 OUTLIER -159.72 147.32 16.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 109.12 179.814 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.1 8.48 32.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.989 -1.07 . . . . 0.0 109.972 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -155.62 52.74 0.59 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.044 -1.035 . . . . 0.0 109.844 -179.678 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 32.5 tp -77.21 131.04 38.03 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.881 -1.137 . . . . 0.0 107.943 179.471 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -67.48 110.7 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.107 . . . . 0.0 111.708 -177.388 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 53' ' ' PHE . 81.7 m-85 -105.4 148.01 27.59 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.53 ' HB3' HG13 ' A' ' 54' ' ' VAL . 61.3 tp -124.72 105.08 9.03 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.185 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -91.4 111.24 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.187 -0.945 . . . . 0.0 109.998 -179.142 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' A' ' 36' ' ' ALA . 45.2 t -113.91 106.91 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.467 -0.771 . . . . 0.0 109.846 -179.764 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' OD1' ' OD2' ' A' ' 57' ' ' ASP . 40.0 t0 -172.35 117.21 0.35 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.161 -0.962 . . . . 0.0 110.214 -179.808 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.01 135.39 20.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.236 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.722 ' CG ' ' N ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -171.23 -153.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.478 -1.389 . . . . 0.0 112.121 -177.263 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.722 ' N ' ' CG ' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -177.11 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.36 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.524 ' N ' ' CD2' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -164.95 -59.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.516 0.674 . . . . 0.0 110.27 -177.868 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 20' ' ' ILE . 3.4 ttt -35.62 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 122.034 -0.416 . . . . 0.0 111.296 179.596 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.634 ' NE ' ' CE1' ' A' ' 14' ' ' PHE . 34.5 mtm180 -46.2 -27.08 0.9 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.699 -1.251 . . . . 0.0 109.782 -178.615 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 16' ' ' THR . 4.0 ttp180 -78.54 -32.64 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.815 -1.178 . . . . 0.0 108.985 178.967 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.449 ' N ' ' O ' ' A' ' 17' ' ' MET . 1.3 mt -66.94 -54.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 108.992 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.449 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -56.08 -40.37 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.563 -180.0 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -43.58 -53.7 5.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.479 -0.763 . . . . 0.0 109.549 -179.86 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER -63.0 -57.12 11.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.901 0.858 . . . . 0.0 108.783 179.168 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 23' ' ' ASN . 0.8 OUTLIER -37.76 -57.74 0.97 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.714 179.964 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -57.83 -52.43 65.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.076 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -48.39 -30.6 5.16 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.77 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -48.22 -41.36 27.14 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.233 -0.917 . . . . 0.0 108.9 179.652 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.9 tt -75.03 -65.31 0.89 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.116 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.69 22.08 0.02 OUTLIER Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.773 179.678 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' CE1' ' O ' ' A' ' 3' ' ' ASP . 68.9 m-85 -89.99 145.72 24.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.75 -1.441 . . . . 0.0 109.429 -179.993 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -150.14 59.54 0.97 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.074 -1.016 . . . . 0.0 110.42 179.718 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -174.38 104.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.228 . . . . 0.0 110.295 179.722 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -146.47 179.54 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.149 -0.97 . . . . 0.0 109.762 179.423 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 33' ' ' VAL . 5.5 mm-40 -139.21 -169.76 2.73 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.627 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -150.0 145.88 26.68 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.061 -1.056 . . . . 0.0 110.858 -179.068 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.873 ' HB3' HG22 ' A' ' 11' ' ' VAL . . . -139.98 -171.01 3.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.814 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' CD ' ' A' ' 37' ' ' GLU . 2.0 mp0 -132.38 -2.05 3.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.251 -0.905 . . . . 0.0 110.495 -179.197 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -175.82 -177.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.229 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' N ' ' OD1' ' A' ' 64' ' ' ASP . . . -67.23 -36.29 89.59 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 -179.79 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.582 HG13 ' N ' ' A' ' 41' ' ' ASP . 7.6 p -62.89 -45.68 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.157 -1.202 . . . . 0.0 109.436 -179.935 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' VAL . 8.0 t0 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.401 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 68' ' ' LEU . . . -71.87 -22.93 61.44 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.414 179.956 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.659 -1.276 . . . . 0.0 108.294 179.205 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -72.92 -27.52 61.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.676 -0.64 . . . . 0.0 110.04 -179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -89.75 -37.87 14.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.165 -0.959 . . . . 0.0 110.777 -178.868 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -49.96 -23.5 2.03 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.714 -1.241 . . . . 0.0 109.552 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 48' ' ' ALA . 5.6 tp60 -96.89 -13.57 22.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 -179.572 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 47' ' ' GLN . . . -40.85 -62.08 0.86 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.575 -0.703 . . . . 0.0 110.219 -179.594 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -140.62 3.75 2.39 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.88 76.8 1.15 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 -179.74 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.722 ' O ' HD11 ' A' ' 81' ' ' LEU . 46.2 m-85 -57.68 131.49 50.42 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.447 -1.031 . . . . 0.0 110.131 -179.392 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.33 3.75 83.65 Favored Glycine 0 N--CA 1.48 1.585 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.037 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -168.15 146.32 4.37 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.101 -1.235 . . . . 0.0 110.264 -179.149 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 83' ' ' VAL . 21.7 t -143.93 121.38 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.067 -1.021 . . . . 0.0 109.895 179.389 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.477 ' CG2' HG21 ' A' ' 86' ' ' VAL . 44.5 mt -106.61 103.92 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 178.611 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.9 p -114.51 161.07 18.5 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.388 -0.82 . . . . 0.0 110.318 -178.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 58' ' ' TRP . 17.1 p-10 -89.38 -110.85 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.541 -0.724 . . . . 0.0 109.2 179.787 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.623 ' CG ' ' N ' ' A' ' 59' ' ' ASN . 77.3 t-105 -141.37 177.78 7.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.235 -0.916 . . . . 0.0 109.814 179.702 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.623 ' N ' ' CG ' ' A' ' 58' ' ' TRP . 0.7 OUTLIER -76.7 75.24 3.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.697 -179.758 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.48 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 2.4 mtm -86.13 -49.85 0.51 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 120.927 -1.108 . . . . 0.0 110.378 179.677 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 60' ' ' MET . 2.6 Cg_endo -66.1 -55.2 0.41 Allowed 'Trans proline' 0 C--N 1.322 -0.833 0 C-N-CA 120.898 1.065 . . . . 0.0 109.747 179.932 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -172.49 -162.3 0.19 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.437 -0.789 . . . . 0.0 108.979 -179.923 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -47.55 96.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -164.91 137.08 4.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.182 -0.949 . . . . 0.0 109.565 -179.563 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.467 ' HA2' HD12 ' A' ' 68' ' ' LEU . . . 103.27 -50.53 0.89 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.699 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.613 ' H ' HD21 ' A' ' 59' ' ' ASN . 3.6 tp -85.78 -46.6 10.51 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.564 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.403 ' O ' ' OG1' ' A' ' 71' ' ' THR . 3.0 mm-40 -63.31 -20.03 65.13 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.581 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.467 HD12 ' HA2' ' A' ' 65' ' ' GLY . 3.7 mt -68.52 -61.77 1.68 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.684 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.929 HD13 ' HB3' ' A' ' 101' ' ' ALA . 0.5 OUTLIER -45.81 -64.65 0.69 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.984 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -41.91 -49.74 4.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.2 -179.438 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -64.19 -32.91 74.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.028 -1.045 . . . . 0.0 109.242 179.991 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.793 HD13 HG21 ' A' ' 83' ' ' VAL . 46.4 mt -74.82 -31.18 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.386 -0.821 . . . . 0.0 109.174 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -20.0 23.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.439 -0.788 . . . . 0.0 109.365 179.899 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.43 -30.07 4.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.357 -179.836 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -64.76 100.12 0.38 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.372 -0.83 . . . . 0.0 109.283 179.868 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.74 46.41 2.32 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.791 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -154.32 -28.23 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -1.168 . . . . 0.0 109.292 179.926 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.486 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -96.98 -70.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.474 -0.766 . . . . 0.0 109.453 179.946 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 47.71 16.15 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.159 -179.799 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 78' ' ' MET . . . -104.89 -39.27 6.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.583 -0.698 . . . . 0.0 109.736 -179.711 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD11 ' O ' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -32.41 97.14 0.1 Allowed Pre-proline 0 N--CA 1.502 2.149 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -179.629 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -65.88 102.49 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.652 0 C-N-CA 121.169 1.246 . . . . 0.0 112.064 -178.767 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.793 HG21 HD13 ' A' ' 72' ' ' ILE . 2.5 t -107.67 116.24 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 177.364 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.42 106.66 17.24 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.58 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 98' ' ' ALA . 7.4 ttm -67.23 160.42 27.03 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -179.039 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.477 HG21 ' CG2' ' A' ' 55' ' ' ILE . 18.6 t -137.49 144.28 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.29 -0.881 . . . . 0.0 110.183 -178.967 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.1 t -150.18 158.68 44.41 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.566 179.87 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.88 -82.5 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.115 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -77.51 68.88 3.69 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.933 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.759 ' HB1' HD11 ' A' ' 95' ' ' ILE . . . -42.83 123.67 2.8 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.59 0.709 . . . . 0.0 110.646 -178.896 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.93 112.72 25.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.117 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -43.82 -25.97 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 0.0 110.224 -179.468 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.87 -38.01 33.61 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.193 -0.942 . . . . 0.0 110.326 -179.447 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -90.06 -9.71 47.51 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.099 -1.001 . . . . 0.0 110.43 -179.299 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 ' HB1' ' A' ' 90' ' ' ALA . 1.3 mp -74.23 -27.05 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.972 -1.08 . . . . 0.0 108.55 -179.816 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 96' ' ' ILE . 13.0 mt -87.05 -8.59 11.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.453 -0.779 . . . . 0.0 108.909 179.591 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.37 -52.89 10.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.471 -0.768 . . . . 0.0 109.306 179.89 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.473 ' HB2' ' SD ' ' A' ' 85' ' ' MET . . . -64.82 -48.59 73.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.905 -1.122 . . . . 0.0 108.026 178.867 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -63.71 -31.7 72.96 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.89 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.441 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 0.8 OUTLIER -59.25 -32.6 70.14 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 177.932 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.929 ' HB3' HD13 ' A' ' 69' ' ' LEU . . . -78.2 -24.08 47.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 176.091 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 63.88 74.01 0.49 Allowed Glycine 0 N--CA 1.481 1.657 0 CA-C-N 114.248 -1.342 . . . . 0.0 113.387 176.243 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . . . -90.22 -112.18 0.08 Allowed 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 116.984 -1.887 . . . . 0.0 109.606 177.818 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.557 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.4 m -91.96 -50.91 5.46 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-O 123.009 1.385 . . . . 0.0 107.645 174.983 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 169.04 -164.17 37.83 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.391 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.529 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -133.47 121.79 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.123 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 107' ' ' VAL . 8.3 p -113.46 123.53 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.446 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.801 HG22 ' H ' ' A' ' 109' ' ' LYS . 12.5 p -64.44 -177.09 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.126 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.801 ' H ' HG22 ' A' ' 108' ' ' VAL . 1.2 pttt -154.62 158.76 32.29 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.595 -1.315 . . . . 0.0 108.602 179.848 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -76.41 136.81 45.98 Favored 'Cis proline' 0 C--N 1.317 -1.121 0 C-N-CA 124.54 -1.025 . . . . 0.0 110.446 -2.191 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.634 ' CE1' HD12 ' A' ' 116' ' ' LEU . 1.1 p90 -96.59 162.32 13.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.008 . . . . 0.0 109.179 178.997 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -92.79 144.94 24.8 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 177.132 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' THR . . . -47.1 -33.22 4.82 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.962 -1.086 . . . . 0.0 109.56 -178.966 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -32.33 66.52 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.634 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 112' ' ' THR . 13.4 m -71.69 -64.42 0.93 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.966 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 111' ' ' PHE . 0.2 OUTLIER -48.96 -40.3 29.82 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.6 -1.313 . . . . 0.0 108.419 179.406 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -60.09 -57.67 11.81 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.858 -1.151 . . . . 0.0 109.833 179.816 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.551 ' O ' ' ND2' ' A' ' 121' ' ' ASN . 1.7 tt0 -44.59 -28.4 0.59 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 109.391 -179.685 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.18 -37.52 14.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 108.742 179.214 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tp -67.06 -55.48 14.15 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.628 -0.67 . . . . 0.0 109.868 -179.467 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.557 ' ND2' ' H ' ' A' ' 122' ' ' LYS . 1.2 p30 -48.12 -54.23 13.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.166 -0.959 . . . . 0.0 109.96 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.557 ' H ' ' ND2' ' A' ' 121' ' ' ASN . 22.5 mttt -53.38 -38.11 63.05 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.43 -0.794 . . . . 0.0 110.236 -179.517 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.76 -41.5 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.157 -0.964 . . . . 0.0 110.461 -179.138 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -72.97 -6.97 48.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.957 -1.089 . . . . 0.0 110.589 -178.908 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -74.01 -19.42 60.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.746 -1.221 . . . . 0.0 107.774 178.654 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -97.63 -27.45 14.37 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.935 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 -25.96 24.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.497 -0.752 . . . . 0.0 109.012 179.533 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 44.9 84.81 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.797 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 5' ' ' GLU . 2.2 m-20 49.36 92.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 108.533 -179.486 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.585 ' CB ' ' NZ ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -63.13 11.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.133 -0.979 . . . . 0.0 110.498 -178.871 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.548 ' H ' ' C ' ' A' ' 3' ' ' ASP . 10.7 mm-40 -139.03 40.49 2.12 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.363 -0.835 . . . . 0.0 109.339 -179.908 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 37.0 tp -75.23 129.51 37.58 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 120.603 -1.31 . . . . 0.0 108.178 179.782 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -80.24 124.62 28.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.153 -0.967 . . . . 0.0 111.991 -176.99 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -113.55 143.52 44.41 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.36 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.61 ' HB3' HG13 ' A' ' 54' ' ' VAL . 17.7 tp -112.42 110.2 20.27 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 178.136 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -92.74 106.74 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -0.917 . . . . 0.0 109.412 -179.742 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 11' ' ' VAL . 15.2 t -89.92 16.14 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.535 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 13.7 p30 -51.0 162.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.984 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -144.9 33.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 109.195 179.952 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.459 ' O ' ' CB ' ' A' ' 15' ' ' SER . 51.2 t80 -83.02 -75.97 0.29 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 14' ' ' PHE . 0.6 OUTLIER 165.61 -27.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.811 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.62 -5.7 1.18 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.511 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.9 ttm -56.02 -38.15 70.14 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.516 -0.74 . . . . 0.0 109.324 179.756 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.537 HH11 ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -62.3 -56.35 19.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.887 179.961 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.14 -28.89 42.89 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.437 -0.789 . . . . 0.0 110.075 -178.781 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 21' ' ' VAL . 1.9 mt -67.81 -57.8 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.127 -0.983 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -61.97 -32.43 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.981 -179.25 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.658 ' CA ' ' HE ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -48.11 -55.17 10.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.146 -0.972 . . . . 0.0 109.449 179.703 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.401 ' O ' ' C ' ' A' ' 24' ' ' LEU . 0.8 OUTLIER -63.33 -58.14 8.08 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.802 0.81 . . . . 0.0 109.223 179.896 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 23' ' ' ASN . 1.4 tt -39.41 -55.95 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.003 -179.55 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.3 mt -60.2 -42.21 94.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.069 -1.019 . . . . 0.0 108.926 179.263 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.581 ' NZ ' HD21 ' A' ' 31' ' ' ASN . 12.1 ttmm -58.79 -40.69 84.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.818 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.87 -46.6 67.98 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 -179.714 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD21 ' HB2' ' A' ' 117' ' ' GLU . 10.6 mp -66.11 -56.37 11.79 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.334 -0.854 . . . . 0.0 109.093 179.811 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.04 69.35 0.01 OUTLIER Glycine 0 N--CA 1.48 1.584 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.951 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -150.11 130.82 14.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.328 . . . . 0.0 109.184 179.822 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.581 HD21 ' NZ ' ' A' ' 26' ' ' LYS . 2.1 m120 -133.74 71.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.397 -0.814 . . . . 0.0 109.971 -179.402 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -177.59 98.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.027 -1.046 . . . . 0.0 108.524 179.642 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.1 t -147.5 149.47 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.144 -0.973 . . . . 0.0 110.458 -178.544 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -121.75 -172.88 2.52 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.385 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.537 ' CD ' HH11 ' A' ' 18' ' ' ARG . 39.8 mt-10 -141.71 155.44 45.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.919 0.866 . . . . 0.0 110.816 -178.608 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB3' HG13 ' A' ' 11' ' ' VAL . . . -150.05 -168.7 3.18 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.676 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.27 12.71 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.878 -1.139 . . . . 0.0 110.719 -179.713 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.52 ' OD2' ' ND2' ' A' ' 62' ' ' ASN . 14.0 t0 -175.32 154.17 1.66 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.036 -1.04 . . . . 0.0 109.501 179.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' CA ' HD13 ' A' ' 68' ' ' LEU . . . -57.66 -28.63 60.23 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.214 -1.955 . . . . 0.0 108.214 179.033 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -75.02 -37.33 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.627 -0.925 . . . . 0.0 108.825 179.165 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.68 -39.77 80.4 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.055 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' LEU . . . -69.38 -46.49 66.78 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.53 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -53.03 -37.37 61.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 109.965 -179.693 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -76.07 -34.76 59.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.066 -1.021 . . . . 0.0 110.107 -179.412 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -90.02 -13.31 36.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.082 -1.011 . . . . 0.0 110.173 -179.419 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 42' ' ' ALA . 0.3 OUTLIER -61.32 -14.69 28.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.15 -0.969 . . . . 0.0 109.014 -179.971 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -93.89 -4.17 50.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -0.889 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.12 -65.93 0.47 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.546 -0.721 . . . . 0.0 109.637 -179.929 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -138.45 -92.2 0.26 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.906 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 52' ' ' GLY . . . -162.6 67.16 0.24 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.824 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' PHE . 56.4 m-85 -47.02 98.56 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.546 -0.973 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' HD22 ' A' ' 81' ' ' LEU . . . -65.53 1.56 4.07 Favored Glycine 0 C--N 1.297 -1.599 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 179.402 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -164.12 150.57 11.32 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.397 -1.06 . . . . 0.0 109.21 -179.548 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.68 ' HB ' HG22 ' A' ' 83' ' ' VAL . 44.2 t -143.72 118.83 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.767 -1.208 . . . . 0.0 109.993 179.285 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' CG2' HG21 ' A' ' 86' ' ' VAL . 55.5 mt -99.46 98.27 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.477 ' OG ' ' SD ' ' A' ' 85' ' ' MET . 36.0 p -102.39 148.72 25.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.406 -0.809 . . . . 0.0 109.818 -179.134 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.91 -109.58 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.295 -0.878 . . . . 0.0 109.06 179.678 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.432 ' C ' ' SD ' ' A' ' 60' ' ' MET . 65.9 t-105 -172.09 -42.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.981 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.445 ' C ' ' SD ' ' A' ' 60' ' ' MET . 2.0 t-20 -97.25 98.23 9.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 109.742 -179.731 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 60' ' ' MET . 0.0 OUTLIER -130.05 162.3 54.68 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.708 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' O ' ' OD2' ' A' ' 38' ' ' ASP . 3.2 Cg_exo -56.3 148.93 58.33 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.373 1.382 . . . . 0.0 110.134 179.362 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 38' ' ' ASP . 0.4 OUTLIER 65.99 -159.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.184 -179.73 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -47.94 156.71 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.186 -0.946 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER -78.8 173.05 12.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -0.927 . . . . 0.0 109.295 -179.99 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.81 -3.02 2.91 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 179.835 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' A' ' 64' ' ' ASP . 17.3 tp -58.92 -52.5 65.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.195 -1.18 . . . . 0.0 108.807 179.921 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -61.81 -4.14 1.4 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 108.948 179.638 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' CA ' ' A' ' 39' ' ' GLY . 11.0 tp -85.59 -64.56 1.13 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.246 179.992 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -63.69 -32.34 73.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.865 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -67.35 -60.51 2.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.913 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 89.9 m -51.41 -40.29 58.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.408 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 mt -60.68 -29.27 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.285 -0.884 . . . . 0.0 108.66 179.271 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -83.51 -22.9 32.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.441 -0.787 . . . . 0.0 109.426 179.787 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -45.53 -26.79 0.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.186 -0.947 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -73.75 -53.12 11.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 109.346 179.945 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.09 -21.29 4.18 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.894 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.52 -86.94 0.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -1.165 . . . . 0.0 109.596 -179.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 78' ' ' MET . 1.3 mpp? -96.53 -25.63 15.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.401 -0.812 . . . . 0.0 109.687 -179.691 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.8 m 53.46 -128.48 2.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.232 -0.918 . . . . 0.0 109.533 179.939 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' LEU . . . -139.44 44.01 1.99 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.451 -0.781 . . . . 0.0 109.3 179.927 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD22 ' HA2' ' A' ' 52' ' ' GLY . 0.3 OUTLIER 50.87 177.04 0.02 OUTLIER Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.914 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.23 135.96 46.06 Favored 'Trans proline' 0 N--CA 1.487 1.094 0 N-CA-C 116.499 1.692 . . . . 0.0 116.499 -175.551 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.68 HG22 ' HB ' ' A' ' 54' ' ' VAL . 2.3 t -124.33 115.7 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 175.856 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' CD1' ' C ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -102.47 105.88 16.51 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 117.919 -1.512 . . . . 0.0 107.309 177.996 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.477 ' SD ' ' OG ' ' A' ' 56' ' ' SER . 2.0 tpt -66.09 156.22 34.54 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -179.089 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.431 HG21 ' CG2' ' A' ' 55' ' ' ILE . 29.0 t -135.48 141.06 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.395 -0.816 . . . . 0.0 110.104 -178.529 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 t -150.09 176.31 10.93 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 90' ' ' ALA . . . -95.33 -130.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.471 -0.768 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 89' ' ' GLU . 0.5 OUTLIER -52.71 88.83 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.294 -0.879 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -48.7 118.35 2.5 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.439 -0.788 . . . . 0.0 109.58 -179.695 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 92' ' ' LYS . 13.6 tttt -94.86 6.9 47.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.3 -0.875 . . . . 0.0 109.488 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 91' ' ' LYS . 4.3 ttpp 75.06 -62.39 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.0 109.406 -179.891 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.15 -34.45 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.314 -0.866 . . . . 0.0 109.707 -179.8 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.461 ' ND2' ' C ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -84.4 -45.06 13.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.964 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 106' ' ' TYR . 29.4 mm -48.57 -42.23 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.029 -1.045 . . . . 0.0 108.935 179.545 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 100' ' ' GLN . 13.7 mt -71.35 -26.62 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.307 -0.871 . . . . 0.0 109.012 179.705 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 94' ' ' ASN . . . -61.17 -51.77 67.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.212 -0.93 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.492 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -75.55 -51.69 12.33 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.436 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.592 ' C ' ' H ' ' A' ' 102' ' ' GLY . . . -58.3 -27.99 64.6 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.324 -0.95 . . . . 0.0 108.935 -179.254 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' A' ' 96' ' ' ILE . 2.0 tt0 -56.16 -33.22 65.02 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 178.151 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.499 ' HB3' HD21 ' A' ' 69' ' ' LEU . . . -82.7 -22.13 34.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.014 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 99' ' ' ALA . . . 61.66 76.93 0.22 Allowed Glycine 0 N--CA 1.481 1.654 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.825 177.579 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.829 ' HB2' HD22 ' A' ' 69' ' ' LEU . . . -87.29 -112.08 0.05 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 116.75 -1.98 . . . . 0.0 109.104 178.661 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.585 ' OG ' ' N ' ' A' ' 83' ' ' VAL . 2.0 m -91.86 -51.29 5.29 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 123.096 1.427 . . . . 0.0 107.913 175.058 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.413 ' C ' ' CD1' ' A' ' 84' ' ' LEU . . . 170.65 -157.36 28.41 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -178.116 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.527 ' O ' ' CG ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -143.79 127.17 16.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.566 -0.961 . . . . 0.0 109.297 179.294 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.01 140.31 36.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.838 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.22 153.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 C-N-CA 119.034 -1.067 . . . . 0.0 108.788 -179.926 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.496 ' NZ ' ' HB2' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -129.21 153.38 80.42 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.785 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -73.64 132.23 26.1 Favored 'Cis proline' 0 N--CA 1.49 1.27 0 O-C-N 122.328 0.646 . . . . 0.0 111.259 -1.615 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.582 ' CE2' HD13 ' A' ' 116' ' ' LEU . 1.5 p90 -98.96 162.38 13.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.386 -0.821 . . . . 0.0 109.164 178.79 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -94.97 146.45 24.24 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 177.997 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.71 -31.21 4.49 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.036 -1.04 . . . . 0.0 109.127 -179.351 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.29 -33.48 67.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.664 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 112' ' ' THR . 4.2 m -71.94 -65.61 0.75 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.446 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 111' ' ' PHE . 8.7 tp -47.13 -41.01 16.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.787 -1.196 . . . . 0.0 109.2 178.741 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.447 ' HB2' HD21 ' A' ' 28' ' ' LEU . 40.2 tt0 -64.31 -58.09 7.51 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.286 -0.884 . . . . 0.0 109.812 -179.634 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -44.22 -48.55 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.646 -0.659 . . . . 0.0 109.682 -179.703 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -65.75 -47.22 75.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.264 -0.897 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 tp -55.5 -39.77 70.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.905 . . . . 0.0 109.634 -179.984 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -46.24 71.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.93 -179.645 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -71.35 -19.58 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.638 -179.635 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.6 mt -89.03 -40.44 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.258 -0.902 . . . . 0.0 109.414 179.973 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' O ' ' N ' ' A' ' 127' ' ' LEU . 7.0 m-85 -73.82 -33.81 64.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 -179.711 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -50.92 -27.89 8.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.05 -1.031 . . . . 0.0 108.413 179.543 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt -90.64 -21.82 21.49 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.043 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' A' ' 124' ' ' PHE . 13.1 tp -83.3 -20.71 33.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.371 -0.831 . . . . 0.0 108.866 179.431 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.25 76.14 0.14 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 179.623 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.246 -1.15 . . . . 0.0 109.418 179.825 . . . . . . . . 1 1 . 1 stop_ save_